PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ganesh, VK; Barbu, EM; Deivanayagam, CCS; Le, B; Anderson, AS; Matsuka, YV; Lin, SL; Foster, TJ; Narayana, SVL; Hook, M				Ganesh, Vannakambadi K.; Barbu, E. Magda; Deivanayagam, Champion C. S.; Binh Le; Anderson, Analiesa S.; Matsuka, Yury V.; Lin, Shuo L.; Foster, Timothy J.; Narayana, Sthanam V. L.; Hoeoek, Magnus			Structural and Biochemical Characterization of Staphylococcus aureus Clumping Factor B/Ligand Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-B CLFB; FIBRONECTIN-BINDING-PROTEINS; NASAL CARRIAGE; MOLECULAR CHARACTERIZATION; SURFACE-PROTEINS; MSCRAMM; ADHESIN; ADHERENCE; PROMOTE; MODEL	Clumping factor B (ClfB) from Staphylococcus aureus is a bifunctional protein that binds to human cytokeratin 10 (K10) and fibrinogen (Fg). ClfB has been implicated in S. aureus colonization of nasal epithelium and is therefore a key virulence factor. People colonized with S. aureus are at an increased risk for invasive staphylococcal disease. In this study, we have determined the crystal structures of the ligand-binding region of ClfB in an apo-form and in complex with human K10 and Fg alpha-chain-derived peptides, respectively. We have determined the structures of MSCRAMM binding to two ligands with different sequences in the same site showing the versatile nature of the ligand recognition mode of microbial surface components recognizing adhesive matrix molecules. Both ligands bind ClfB by parallel beta-sheet complementation as observed for the clumping factor A.gamma-chain peptide complex. The beta-sheet complementation is shorter in the ClfB.Fg alpha-chain peptide complex. The structures show that several residues in ClfB are important for binding to both ligands, whereas others only make contact with one of the ligands. A common motif GSSGXG found in both ligands is part of the ClfB-binding site. This motif is found in many human proteins thus raising the possibility that ClfB recognizes additional ligands.	[Ganesh, Vannakambadi K.; Barbu, E. Magda; Binh Le; Hoeoek, Magnus] Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX 77030 USA; [Deivanayagam, Champion C. S.; Narayana, Sthanam V. L.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35205 USA; [Anderson, Analiesa S.; Matsuka, Yury V.; Lin, Shuo L.] Pfizer Vaccine Res, Pearl River, NY 10965 USA; [Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Dept Microbiol, Dublin 2, Ireland	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Alabama System; University of Alabama Birmingham; Pfizer; Trinity College Dublin	Ganesh, VK (corresponding author), Texas A&M Univ Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	vganesh@ibt.tamhsc.edu		Deivanayagam, Champion/0000-0003-2972-1824	Pfizer Vaccine Research; Science Foundation of Ireland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073521] Funding Source: NIH RePORTER	Pfizer Vaccine Research; Science Foundation of Ireland(Science Foundation Ireland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from Pfizer Vaccine Research (to V. K. G. and M. H.) and by Science Foundation of Ireland (to T. J. F.). A. S. A., Y. V. M., and S. L. L. are employees of Pfizer. M. H. and T. J. F. are inventors on a United States patent claiming the use of ClfB as an S. aureus vaccine component and licensed to Pfizer through Inhibitex Inc.	Barbu EM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000726; Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chambers HF, 2009, J INFECT DIS, V199, P291, DOI 10.1086/595983; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murphy E, 2011, HUM VACCINES, V7, P51, DOI 10.4161/hv.7.0.14562; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; TALON D, 1995, J HOSP INFECT, V30, P39, DOI 10.1016/0195-6701(95)90247-3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Walsh EJ, 2008, MICROBIOL-SGM, V154, P550, DOI 10.1099/mic.0.2007/010868-0; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	42	57	60	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25963	25972		10.1074/jbc.M110.217414	http://dx.doi.org/10.1074/jbc.M110.217414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21543319	hybrid, Green Published			2022-12-25	WOS:000293073000055
J	Nowak, AJ; Alfieri, C; Stirnimann, CU; Rybin, V; Baudin, F; Ly-Hartig, N; Lindner, D; Muller, CW				Nowak, Agnieszka J.; Alfieri, Claudio; Stirnimann, Christian U.; Rybin, Vladimir; Baudin, Florence; Ly-Hartig, Nga; Lindner, Doris; Mueller, Christoph W.			Chromatin-modifying Complex Component Nurf55/p55 Associates with Histones H3 and H4 and Polycomb Repressive Complex 2 Subunit Su(z) 12 through Partially Overlapping Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTRANSFERASE ACTIVITY; STRUCTURAL BASIS; RECOGNITION; PROTEIN; MECHANISMS; ENHANCER; ESC	Drosophila Nurf55 is a component of different chromatin-modifying complexes, including the PRC2(Polycomb repressive complex 2). Based on the 1.75-angstrom crystal structure of Nurf55 bound to histone H4 helix 1, we analyzed interactions of Nurf55 (Nurf55 or p55 in fly and RbAp48/46 in human) with the N-terminal tail of histone H3, the first helix of histone H4, and an N-terminal fragment of the PRC2 subunit Su(z) 12 using isothermal calorimetry and pulldown experiments. Site-directed mutagenesis identified the binding site of histone H3 at the top of the Nurf55 WD40 propeller. Unmodified or K9me3- or K27me3-containing H3 peptides were bound with similar affinities, whereas the affinity for K4me3-containing H3 peptides was reduced. Helix 1 of histone H4 and Su(z) 12 bound to the edge of the beta-propeller using overlapping binding sites. Our results show similarities in the recognition of histone H4 and Su(z) 12 and identify Nurf55 as a versatile interactor that simultaneously contacts multiple partners.	[Nowak, Agnieszka J.; Alfieri, Claudio; Stirnimann, Christian U.; Rybin, Vladimir; Baudin, Florence; Ly-Hartig, Nga; Lindner, Doris; Mueller, Christoph W.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Baudin, Florence] UJF EMBL CNRS UMI 3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Muller, CW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cmueller@embl.de	Müller, Christian/AAB-4783-2022; Müller, Christoph W/I-7420-2012	Müller, Christian/0000-0002-1120-6405; Müller, Christoph W/0000-0003-2176-8337; Stirnimann, Christian/0000-0002-1030-8864; Baudin, Florence/0000-0003-0816-0861; Alfieri, Claudio/0000-0003-3215-1607	Marie Curie Framework Program; European Molecular Biology Organization; European Molecular Biology Laboratory/European Synchrotron Radiation Facility Joint Structural Biology Group	Marie Curie Framework Program; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Molecular Biology Laboratory/European Synchrotron Radiation Facility Joint Structural Biology Group	Supported by Marie Curie Framework Program 7 and the European Molecular Biology Organization Long-Term Fellowship Program.; We thank J. Muller for expression constructs and advice, M. Agez for recombinant histone H3/H4 heterodimers, the Proteomics and the Protein Expression and Purification Core Facilities at EMBL Heidelberg for support, and the European Molecular Biology Laboratory/European Synchrotron Radiation Facility Joint Structural Biology Group for access and support at the European Synchrotron Radiation Facility beamlines.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Song JJ, 2008, GENE DEV, V22, P1313, DOI 10.1101/gad.1653308; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suganuma T, 2008, GENE DEV, V22, P1265, DOI 10.1101/gad.1676208; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tie F, 2001, DEVELOPMENT, V128, P275; Tie F, 2007, MOL CELL BIOL, V27, P2014, DOI 10.1128/MCB.01822-06; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5	27	52	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23388	23396		10.1074/jbc.M110.207407	http://dx.doi.org/10.1074/jbc.M110.207407			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550984	Green Published, hybrid			2022-12-25	WOS:000292025000070
J	Serebryakova, MV; Demina, IA; Galyamina, MA; Kondratov, IG; Ladygina, VG; Govorun, VM				Serebryakova, Marina V.; Demina, Irina A.; Galyamina, Maria A.; Kondratov, Ilya G.; Ladygina, Valentina G.; Govorun, Vadim M.			The Acylation State of Surface Lipoproteins of Mollicute Acholeplasma laidlawii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PROTEINS; SELECTIVE ACYLATION; ESCHERICHIA-COLI; CHEMICAL-ANALYSIS; LIPID-COMPOSITION; CHAINS; AGENT; ACID	Acylation of the N-terminal Cys residue is an essential, ubiquitous, and uniquely bacterial posttranslational modification that allows anchoring of proteins to the lipid membrane. In Gram-negative bacteria, acylation proceeds through three sequential steps requiring lipoprotein diacylglyceryltransferase, lipoprotein signal peptidase, and finally lipoprotein N-acyltransferase. The apparent lack of genes coding for recognizable homologs of lipoproteinN-acyltransferase in Gram-positive bacteria and Mollicutes suggests that the final step of the protein acylation process may be absent in these organisms. In this work, we monitored the acylation state of eight major lipoproteins of the mollicute Acholeplasma laidlawii using a combination of standard two-dimensional gel electrophoresis protein separation, blotting to nitrocellulose membranes, and MALDI-MS identification of modified N-terminal tryptic peptides. We show that for each A. laidlawii lipoprotein studied a third fatty acid in an amide linkage on the N-terminal Cys residue is present, whereas diacylated species were not detected. The result thus proves that A. laidlawii encodes a lipoprotein N-acyltransferase activity. We hypothesize that N-acyltransferases encoded by genes non-homologous to N-acyltransferases of Gram-negative bacteria are also present in other mollicutes and Gram-positive bacteria.	[Serebryakova, Marina V.; Demina, Irina A.; Galyamina, Maria A.; Kondratov, Ilya G.; Ladygina, Valentina G.; Govorun, Vadim M.] Fed Medicobiol Agcy, Inst Physicochem Med, Moscow 119992, Russia; [Serebryakova, Marina V.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Serebryakova, MV (corresponding author), Fed Medicobiol Agcy, Inst Physicochem Med, Malaya Pirogovskaya 1A, Moscow 119992, Russia.	mserebr@mail.ru	Kondratov, Ilya/I-5859-2016; Irina, Demina/A-7876-2014; Serebryakova, Marina/E-2986-2012; Govorun, Vadim M/A-9043-2018	Irina, Demina/0000-0002-4317-2094; Serebryakova, Marina/0000-0002-5402-8215; 	Ministry of Education and Science of the Russian Federation [14.740.11.0763, 16.740.11.0371]; Russian Academy of Sciences	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by Ministry of Education and Science of the Russian Federation State Contracts 14.740.11.0763 and 16.740.11.0371 (to V. M. G.) and Molecular and Cellular Biology program grant from the Russian Academy of Sciences (to Konstantin Severinov).	Andersson AS, 1998, BIOPHYS J, V75, P2877, DOI 10.1016/S0006-3495(98)77730-6; Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; Golovina AY, 2009, RNA, V15, P1134, DOI 10.1261/rna.1494409; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Jan G, 1996, CURR MICROBIOL, V32, P38, DOI 10.1007/s002849900007; Jan G, 1995, RES MICROBIOL, V146, P739, DOI 10.1016/0923-2508(96)81070-9; Jan G, 2001, ARCH MICROBIOL, V177, P81, DOI 10.1007/s00203-001-0364-4; Le Henaff M, 2000, CURR MICROBIOL, V40, P23, DOI 10.1007/s002849910005; Le Henaff M, 2000, ARCH MICROBIOL, V173, P339, DOI 10.1007/s002030000145; Le Henaff M, 2001, CURR MICROBIOL, V43, P424, DOI 10.1007/s002840010332; Lindblom G, 2002, BIOCHEMISTRY-US, V41, P11512, DOI 10.1021/bi0263098; LISKA B, 1974, FOLIA MICROBIOL, V19, P107, DOI 10.1007/BF02872843; Muhlradt PF, 1998, INFECT IMMUN, V66, P4804; NIEMI AR, 1995, BBA-BIOMEMBRANES, V1239, P186, DOI 10.1016/0005-2736(95)00132-M; NYSTROM S, 1992, EUR J BIOCHEM, V204, P231, DOI 10.1111/j.1432-1033.1992.tb16629.x; NYSTROM S, 1986, EUR J BIOCHEM, V156, P85, DOI 10.1111/j.1432-1033.1986.tb09552.x; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; SAITO Y, 1978, J BACTERIOL, V133, P66, DOI 10.1128/JB.133.1.66-74.1978; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; Serebryakova MV, 2006, EUR J MASS SPECTROM, V12, P51, DOI 10.1255/ejms.792; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; WIESLANDER A, 1982, REV INFECT DIS, V4, pS43	27	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22769	22776		10.1074/jbc.M111.231316	http://dx.doi.org/10.1074/jbc.M111.231316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540185	Green Published, hybrid			2022-12-25	WOS:000292025000011
J	Nissim, I; Horyn, O; Nissim, I; Daikhin, Y; Caldovic, L; Barcelona, B; Cervera, J; Tuchman, M; Yudkoff, M				Nissim, Itzhak; Horyn, Oksana; Nissim, Ilana; Daikhin, Yevgeny; Caldovic, Ljubica; Barcelona, Belen; Cervera, Javier; Tuchman, Mendel; Yudkoff, Marc			Down-regulation of Hepatic Urea Synthesis by Oxypurines XANTHINE AND URIC ACID INHIBIT N-ACETYLGLUTAMATE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; RAT-LIVER MITOCHONDRIA; ACETYL-L-GLUTAMATE; CITRULLINE SYNTHESIS; AMMONIA; UREAGENESIS; MECHANISM; ARGININE; BINDING; CARBAMYLGLUTAMATE	We previously reported that isobutylmethylxanthine (IBMX), a derivative of oxypurine, inhibits citrulline synthesis by an as yet unknown mechanism. Here, we demonstrate that IBMX and other oxypurines containing a 2,6-dione group interfere with the binding of glutamate to the active site of N-acetylglutamate synthetase (NAGS), thereby decreasing synthesis of N-acetylglutamate, the obligatory activator of carbamoyl phosphate synthase-1 (CPS1). The result is reduction of citrulline and urea synthesis. Experiments were performed with N-15-labeled substrates, purified hepatic CPS1, and recombinant mouse NAGS as well as isolated mitochondria. We also used isolated hepatocytes to examine the action of various oxypurines on ureagenesis and to assess the ameliorating affect of N-carbamylglutamate and/or L-arginine on NAGS inhibition. Among various oxypurines tested, only IBMX, xanthine, or uric acid significantly increased the apparent K-m for glutamate and decreased velocity of NAGS, with little effect on CPS1. The inhibition of NAGS is time-and dose-dependent and leads to decreased formation of the CPS1-N-acetylglutamate complex and consequent inhibition of citrulline and urea synthesis. However, such inhibition was reversed by supplementation with N-carbamylglutamate. The data demonstrate that xanthine and uric acid, both physiologically occurring oxypurines, inhibit the hepatic synthesis of N-acetylglutamate. An important and novel concept emerging from this study is that xanthine and/or uric acid may have a role in the regulation of ureagenesis and, thus, nitrogen homeostasis in normal and disease states.	[Nissim, Itzhak; Horyn, Oksana; Nissim, Ilana; Daikhin, Yevgeny; Yudkoff, Marc] Childrens Hosp Philadelphia, Div Child Dev Rehabil Med & Metab Dis, Philadelphia, PA 19104 USA; [Caldovic, Ljubica; Tuchman, Mendel] George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Barcelona, Belen; Cervera, Javier] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Nissim, Itzhak; Yudkoff, Marc] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's National Health System; George Washington University; Prince Felipe Research Center; University of Pennsylvania; University of Pennsylvania	Nissim, I (corresponding author), Abramson Pediat Res Ctr, Rm 510D,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	nissim@email.chop.edu	Barcelona, Belén/K-6409-2014	Barcelona, Belén/0000-0002-9818-2329; Caldovic, Ljubica/0000-0002-9140-5585	National Institutes of Health [DK-053761, DK-R56-053761, R01DK064913, R01DK047870, PO1HD26979, U54RR019453, HD058567]; Spanish Ministry for Science [SAF2010-17993]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979, R01HD058567] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053761, R56DK053761, R01DK047870, R01DK064913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry for Science(Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-053761 and DK-R56-053761 (to Itzhak Nissim) and Grants R01DK064913, R01DK047870, PO1HD26979, U54RR019453, and HD058567. This work was also supported in part by Spanish Ministry for Science Grant SAF2010-17993.	Ahuja V, 2008, J INHERIT METAB DIS, V31, P481, DOI 10.1007/s10545-008-0913-y; ALONSO E, 1992, J BIOL CHEM, V267, P4524; ALONSO E, 1983, EUR J BIOCHEM, V135, P331, DOI 10.1111/j.1432-1033.1983.tb07658.x; AOYAGI K, 1979, BIOCHIM BIOPHYS ACTA, V587, P515; BRITTON HG, 1988, EUR J BIOCHEM, V171, P615, DOI 10.1111/j.1432-1033.1988.tb13832.x; Caldovic L, 2006, MOL GENET METAB, V87, P226, DOI 10.1016/j.ymgme.2005.10.003; Caldovic L, 2003, BIOCHEM J, V372, P279, DOI 10.1042/BJ20030002; Caldovic L, 2010, MOL GENET METAB, V100, pS13, DOI 10.1016/j.ymgme.2010.02.018; CLARKE S, 1976, J BIOL CHEM, V251, P950; COHEN NS, 1984, ARCH BIOCHEM BIOPHYS, V234, P31, DOI 10.1016/0003-9861(84)90321-7; COHEN NS, 1992, BIOCHEM J, V282, P173, DOI 10.1042/bj2820173; COHEN NS, 1982, J BIOL CHEM, V257, P6898; Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007; COUDE FX, 1979, J CLIN INVEST, V64, P1544, DOI 10.1172/JCI109614; COUDE FX, 1983, BIOCHEM J, V216, P233, DOI 10.1042/bj2160233; Gropman AL, 2007, J INHERIT METAB DIS, V30, P865, DOI 10.1007/s10545-007-0709-5; GUTHOHRL.G, 1968, EUR J BIOCHEM, V7, P119, DOI 10.1111/j.1432-1033.1968.tb19582.x; Holden HM, 1999, CELL MOL LIFE SCI, V56, P507, DOI 10.1007/s000180050448; Jaing TH, 2009, J PEDIAT HEMATOL ONC, V31, P955, DOI 10.1097/MPH.0b013e3181b8beb1; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; KAWAMOTO S, 1985, BIOCHEM J, V232, P329, DOI 10.1042/bj2320329; KIM S, 1972, P NATL ACAD SCI USA, V69, P3530, DOI 10.1073/pnas.69.12.3530; LUND P, 1987, BIOCHEM J, V243, P273, DOI 10.1042/bj2430273; LUSTY CJ, 1978, EUR J BIOCHEM, V85, P373, DOI 10.1111/j.1432-1033.1978.tb12249.x; McCudden CR, 1996, J BIOL CHEM, V271, P18285, DOI 10.1074/jbc.271.30.18285; MCGIVAN JD, 1976, BIOCHEM J, V154, P415, DOI 10.1042/bj1540415; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; Mew NA, 2009, MOL GENET METAB, V98, P325, DOI 10.1016/j.ymgme.2009.07.010; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; MORIMOTO BH, 1990, BIOCHEM J, V272, P671, DOI 10.1042/bj2720671; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Nissim I, 2006, J BIOL CHEM, V281, P8486, DOI 10.1074/jbc.M506984200; Nissim I, 2005, J BIOL CHEM, V280, P17715, DOI 10.1074/jbc.M500607200; Nissim I, 1996, J BIOL CHEM, V271, P31234, DOI 10.1074/jbc.271.49.31234; Nissim I, 2008, J BIOL CHEM, V283, P15063, DOI 10.1074/jbc.M800163200; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; RAIJMAN L, 1976, ARCH BIOCHEM BIOPHYS, V175, P270, DOI 10.1016/0003-9861(76)90508-7; RUBIO V, 1983, EUR J BIOCHEM, V134, P337, DOI 10.1111/j.1432-1033.1983.tb07572.x; Rus DA, 2007, FRONT BIOSCI, V12, P1184, DOI 10.2741/2136; Sancho-Vaello E, 2009, FEBS LETT, V583, P202, DOI 10.1016/j.febslet.2008.12.001; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Treberg JR, 2010, ADV ENZYME REGUL, V50, P34, DOI 10.1016/j.advenzreg.2009.10.029; Tsouli SG, 2006, METABOLISM, V55, P1293, DOI 10.1016/j.metabol.2006.05.013; Tuchman M, 2008, PEDIATR RES, V64, P213, DOI 10.1203/PDR.0b013e318179454b	46	15	16	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22055	22068		10.1074/jbc.M110.209023	http://dx.doi.org/10.1074/jbc.M110.209023			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540182	hybrid, Green Published			2022-12-25	WOS:000291719900012
J	Whicher, JR; Florova, G; Sydor, PK; Singh, R; Alhamadsheh, M; Challis, GL; Reynolds, KA; Smith, JL				Whicher, Jonathan R.; Florova, Galina; Sydor, Paulina K.; Singh, Renu; Alhamadsheh, Mamoun; Challis, Gregory L.; Reynolds, Kevin A.; Smith, Janet L.			Structure and Function of the RedJ Protein, a Thioesterase from the Prodiginine Biosynthetic Pathway in Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; COMBINATORIAL MUTAGENESIS; II THIOESTERASE; SYNTHASE; ENZYME; DOMAIN; UNDECYLPRODIGIOSIN; IDENTIFICATION; INTERMEDIATE; PRODIGIOSIN	Prodiginines are a class of red-pigmented natural products with immunosuppressant, anticancer, and antimalarial activities. Recent studies on prodiginine biosynthesis in Streptomyces coelicolor have elucidated the function of many enzymes within the pathway. However, the function of RedJ, which was predicted to be an editing thioesterase based on sequence similarity, is unknown. We report here the genetic, biochemical, and structural characterization of the redJ gene product. Deletion of redJ in S. coelicolor leads to a 75% decrease in prodiginine production, demonstrating its importance for prodiginine biosynthesis. RedJ exhibits thioesterase activity with selectivity for substrates having long acyl chains and lacking a beta-carboxyl substituent. The thioesterase has 1000-fold greater catalytic efficiency with substrates linked to an acyl carrier protein (ACP) than with the corresponding CoA thioester substrates. Also, RedJ strongly discriminates against the streptomycete ACP of fatty acid biosynthesis in preference to RedQ, an ACP of the prodiginine pathway. The 2.12 angstrom resolution crystal structure of RedJ provides insights into the molecular basis for the observed substrate selectivity. A hydrophobic pocket in the active site chamber is positioned to bind long acyl chains, as suggested by a long-chain ligand from the crystallization solution bound in this pocket. The accessibility of the active site is controlled by the position of a highly flexible entrance flap. These data combined with previous studies of prodiginine biosynthesis in S. coelicolor support a novel role for RedJ in facilitating transfer of a dodecanoyl chain from one acyl carrier protein to another en route to the key biosynthetic intermediate 2-undecylpyrrole.	[Whicher, Jonathan R.; Smith, Janet L.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Whicher, Jonathan R.] Univ Michigan, Chem Biol Grad Program, Ann Arbor, MI 48109 USA; [Smith, Janet L.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Florova, Galina; Singh, Renu; Alhamadsheh, Mamoun; Reynolds, Kevin A.] Portland State Univ, Dept Chem, Portland, OR 97201 USA; [Sydor, Paulina K.; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Portland State University; University of Warwick	Smith, JL (corresponding author), Univ Michigan, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	JanetSmith@umich.edu	Singh, Renu/AAD-5532-2020	Challis, Gregory/0000-0001-5976-3545; Reynolds, Kevin/0000-0003-0270-9809	National Institutes of Health [GM77147]; Warwick Postgraduate Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303, R37DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Warwick Postgraduate Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM77147 (to K. A. R. and G. L. C.) and DK42303 (to J. L. S.).; Recipient of the Warwick Postgraduate Research Fellowship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Cerdeno AM, 2001, CHEM BIOL, V8, P817, DOI 10.1016/S1074-5521(01)00054-0; Claxton HB, 2009, J BIOL CHEM, V284, P5021, DOI 10.1074/jbc.M808604200; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Gust B., 2002, REDIRECT TECHNOLOGY; Haynes SW, 2008, CHEM COMMUN, P1865, DOI 10.1039/b801677a; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Kieser T., 2000, PRACTICAL STREPTOMYC, P43; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Lai JR, 2006, P NATL ACAD SCI USA, V103, P5314, DOI 10.1073/pnas.0601038103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mo S, 2005, CHEM BIOL, V12, P191, DOI 10.1016/j.chembiol.2004.11.006; Mo S, 2008, CHEM BIOL, V15, P137, DOI 10.1016/j.chembiol.2007.11.015; Mortellaro A, 1999, J IMMUNOL, V162, P7102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Qiu XY, 2004, ACTA CRYSTALLOGR D, V60, P1545, DOI 10.1107/S0907444904015422; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Russell D.W, 2001, MOL CLONING; Samel SA, 2006, J MOL BIOL, V359, P876, DOI 10.1016/j.jmb.2006.03.062; Scaglione JB, 2010, ANGEW CHEM INT EDIT, V49, P5726, DOI 10.1002/anie.201000032; Schwarzer D, 2002, P NATL ACAD SCI USA, V99, P14083, DOI 10.1073/pnas.212382199; Smirnova N, 2001, J BACTERIOL, V183, P2335, DOI 10.1128/JB.183.7.2335-2342.2001; Stanley AE, 2006, CHEM COMMUN, P3981, DOI 10.1039/b609556a; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Thomas MG, 2002, CHEM BIOL, V9, P171, DOI 10.1016/S1074-5521(02)00100-X; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Trudel S, 2007, BLOOD, V109, P5430, DOI 10.1182/blood-2006-10-047951; Tsai SC, 2001, P NATL ACAD SCI USA, V98, P14808, DOI 10.1073/pnas.011399198; Tsai SC, 2002, BIOCHEMISTRY-US, V41, P12598, DOI 10.1021/bi0260177; TSAO SW, 1985, J ANTIBIOT, V38, P128, DOI 10.7164/antibiotics.38.128; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Williamson NR, 2005, MOL MICROBIOL, V56, P971, DOI 10.1111/j.1365-2958.2005.04602.x; Yeh E, 2004, CHEMBIOCHEM, V5, P1290, DOI 10.1002/cbic.200400077; Zelyas N, 2009, GENE, V443, P48, DOI 10.1016/j.gene.2009.03.022; Zhou Z, 2006, CHEM BIOL, V13, P869, DOI 10.1016/j.chembiol.2006.06.011	45	35	38	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22558	22569		10.1074/jbc.M110.213512	http://dx.doi.org/10.1074/jbc.M110.213512			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543318	hybrid, Green Published			2022-12-25	WOS:000291719900063
J	Park, M; Youn, B; Zheng, XL; Wu, DH; Xu, AM; Sweeney, G				Park, Min; Youn, ByungSoo; Zheng, Xi-long; Wu, Donghai; Xu, Aimin; Sweeney, Gary			Globular Adiponectin, Acting via AdipoR1/APPL1, Protects H9c2 Cells from Hypoxia/Reoxygenation-Induced Apoptosis	PLOS ONE			English	Article							COMPLEMENT-RELATED PROTEIN; HEART-FAILURE; MYOCARDIAL-INFARCTION; REPERFUSION INJURY; MUSCLE-CELLS; ACTIVATION; CARDIOPROTECTION; CARDIOMYOCYTES; RECEPTORS; OBESITY	Cardiomyocyte apoptosis is an important remodeling event contributing to heart failure and adiponectin may mediate cardioprotective effects at least in part via attenuating apoptosis. Here we used hypoxia-reoxygenation (H/R) induced apoptosis in H9c2 cells to examine the effect of adiponectin and cellular mechanisms of action. We first used TUNEL labeling in combination with laser scanning cytometry to demonstrate that adiponectin prevented H/R-induced DNA fragmentation. The anti-apoptotic effect of adiponectin was also verified via attenuation of H/R-induced phosphatidylserine exposure using annexin V binding. H/R-induced apoptosis via the mitochondrial-mediated intrinsic pathway of apoptosis as assessed by cytochrome c release into cytosol and caspase-3 activation, both of which were attenuated by adiponectin. Mechanistically, we demonstrated that adiponectin enhanced anti-oxidative potential in these cells which led to attenuation of the increase in intracellular reactive oxygen species (ROS) caused by H/R. To further address the mechanism of adiponctins antiapoptotic effects we used siRNA to efficiently knockdown adiponectin receptor (AdipoR1) expression and found that this attenuated the protective effects of adiponectin on ROS production and caspase 3 activity. Knockdown of APPL1, an important intracellular binding partner for AdipoR, also significantly reduced the ability of adiponectin to prevent H/R-induced ROS generation and caspase 3 activity. In summary, H/R-induced ROS generation and activation of the intrinsic apoptotic pathway was prevented by adiponectin via AdipoR1/APPL1 signaling and increased anti-oxidant potential.	[Park, Min; Sweeney, Gary] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Park, Min; Sweeney, Gary] Inst Pasteur Korea, Seoul, South Korea; [Youn, ByungSoo] AdipoGen Inc, Inchon, South Korea; [Zheng, Xi-long] Univ Calgary, Dept Biochem & Mol Biol, Smooth Muscle Res Grp, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Wu, Donghai] Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Fac Med, Dept Pharmacol, Hong Kong, Hong Kong, Peoples R China	York University - Canada; Institut Pasteur Korea; Libin Cardiovascular Institute Of Alberta; University of Calgary; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Hong Kong	Park, M (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	gsweeney@yorku.ca	Xu, Aimin/D-3291-2013	Xu, Aimin/0000-0002-0668-033X; Zheng, Xi-Long/0000-0002-0889-1827	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research (CIHR) [RT734076]; Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Heritage Foundation for Medical Research	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported by Heart and Stroke Foundation of Canada via a Grant-in-Aid to GS. GS and DW also acknowledge support from The Canadian Institutes of Health Research (CIHR) China Collaborative grant, MP holds a Natural Sciences and Engineering Research Council of Canada (NSERC) postgraduate studentship award. Work by XLZ was partially supported by Canadian Institutes of Health Research (RT734076) and XLZ is the recipient of Senior Scholar Award of Alberta Heritage Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; BOLLI R, 1989, CIRC RES, V65, P607, DOI 10.1161/01.RES.65.3.607; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Clerk A, 2003, PHARMACOL THERAPEUT, V97, P223, DOI 10.1016/S0163-7258(02)00339-X; Fang X, 2006, BIOCHEM SOC T, V34, P798, DOI 10.1042/BST0340798; Fang XP, 2010, AM J PHYSIOL-ENDOC M, V299, pE721, DOI 10.1152/ajpendo.00086.2010; Fiorillo C, 2006, CELL MOL LIFE SCI, V63, P3061, DOI 10.1007/s00018-006-6345-7; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Habbu A, 2006, AM J CARDIOL, V98, P944, DOI 10.1016/j.amjcard.2006.04.039; Jung TW, 2006, BIOCHEM PHARMACOL, V72, P616, DOI 10.1016/j.bcp.2006.05.013; Kadowaki T, 2008, FEBS LETT, V582, P74, DOI 10.1016/j.febslet.2007.11.070; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kitsis RN, 2008, HEART FAIL REV, V13, P107, DOI 10.1007/s10741-008-9080-3; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Rakatzi I, 2004, DIABETOLOGIA, V47, P249, DOI 10.1007/s00125-003-1293-3; SAITO S, 2007, ATHEROSCLEROSIS; Sharma AK, 2007, AM J PHYSIOL-HEART C, V293, pH1384, DOI 10.1152/ajpheart.00553.2007; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, FUTUR CARDIOL, V3, P647, DOI 10.2217/14796678.3.6.647; Shin E, 2009, J CELL PHYSIOL, V221, P490, DOI 10.1002/jcp.21883; Skurk C, 2008, EUR HEART J, V29, P1168, DOI 10.1093/eurheartj/ehn136; Takahashi T, 2005, J INT MED RES, V33, P207, DOI 10.1177/147323000503300208; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Tao L, 2010, CIRC RES, V106, P409, DOI 10.1161/CIRCRESAHA.109.211797; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Vanden Hoek TL, 2000, CIRC RES, V86, P541, DOI 10.1161/01.RES.86.5.541; Wang CH, 2009, J BIOL CHEM, V284, P31608, DOI 10.1074/jbc.M109.010355; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	44	65	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19143	10.1371/journal.pone.0019143	http://dx.doi.org/10.1371/journal.pone.0019143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552570	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700032
J	Ansong, D; Asante, KP; Vekemans, J; Owusu, SK; Owusu, R; Brobby, NAW; Dosoo, D; Osei-Akoto, A; Osei-Kwakye, K; Asafo-Adjei, E; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Apanga, S; Kayan, K; Janssens, MH; Lievens, MJJ; Olivier, AC; Jongert, E; Dubois, P; Savarese, BM; Cohen, J; Antwi, S; Greenwood, BM; Evans, JA; Agbenyega, T; Moris, PJ; Owusu-Agyei, S				Ansong, Daniel; Asante, Kwaku P.; Vekemans, Johan; Owusu, Sandra K.; Owusu, Ruth; Brobby, Naana A. W.; Dosoo, David; Osei-Akoto, Alex; Osei-Kwakye, Kingsley; Asafo-Adjei, Emmanuel; Boahen, Kwadwo O.; Sylverken, Justice; Adjei, George; Sambian, David; Apanga, Stephen; Kayan, Kingsley; Janssens, Michel H.; Lievens, Marc J. J.; Olivier, Aurelie C.; Jongert, Erik; Dubois, Patrice; Savarese, Barbara M.; Cohen, Joe; Antwi, Sampson; Greenwood, Brian M.; Evans, Jennifer A.; Agbenyega, Tsiri; Moris, Philippe J.; Owusu-Agyei, Seth			T Cell Responses to the RTS,S/AS01(E) and RTS,S/AS02(D) Malaria Candidate Vaccines Administered According to Different Schedules to Ghanaian Children	PLOS ONE			English	Article							FALCIPARUM CIRCUMSPOROZOITE-PROTEIN; IMMUNE ADULT MEN; DOUBLE-BLIND; B-CELL; SAFETY; IMMUNOGENICITY; EFFICACY; ANTIBODIES; ANTIGEN; CD4(+)	Background: The Plasmodium falciparum pre-erythrocytic stage candidate vaccine RTS, S is being developed for protection of young children against malaria in sub-Saharan Africa. RTS, S formulated with the liposome based adjuvant AS01(E) or the oil-in-water based adjuvant AS02(D) induces P. falciparum circumsporozoite (CSP) antigen-specific antibody and T cell responses which have been associated with protection in the experimental malaria challenge model in adults. Methods: This study was designed to evaluate the safety and immunogenicity induced over a 19 month period by three vaccination schedules (0,1-, 0,1,2-and 0,1,7-month) of RTS, S/AS01(E) and RTS, S/AS02(D) in children aged 5-17 months in two research centers in Ghana. Control Rabies vaccine using the 0,1,2-month schedule was used in one of two study sites. Results: Whole blood antigen stimulation followed by intra-cellular cytokine staining showed RTS, S/AS01(E) induced CSP specific CD4 T cells producing IL-2, TNF-alpha, and IFN-gamma. Higher T cell responses were induced by a 0,1,7-month immunization schedule as compared with a 0,1-or 0,1,2-month schedule. RTS, S/AS01(E) induced higher CD4 T cell responses as compared to RTS, S/AS02(D) when given on a 0,1,7-month schedule. Conclusions: These findings support further Phase III evaluation of RTS, S/AS01(E). The role of immune effectors and immunization schedules on vaccine protection are currently under evaluation.	[Ansong, Daniel; Owusu, Sandra K.; Osei-Akoto, Alex; Sylverken, Justice; Antwi, Sampson; Agbenyega, Tsiri] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Asante, Kwaku P.; Owusu, Ruth; Dosoo, David; Osei-Kwakye, Kingsley; Boahen, Kwadwo O.; Adjei, George; Apanga, Stephen; Kayan, Kingsley; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Hlth Res Unit, Kintampo, Ghana; [Asante, Kwaku P.; Greenwood, Brian M.; Owusu-Agyei, Seth] London Sch Hyg & Trop Med, London WC1, England; [Vekemans, Johan; Janssens, Michel H.; Lievens, Marc J. J.; Olivier, Aurelie C.; Jongert, Erik; Cohen, Joe; Moris, Philippe J.] GlaxoSmithKline Biol, Rixensart, Belgium; [Brobby, Naana A. W.; Asafo-Adjei, Emmanuel; Sambian, David] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Dubois, Patrice] ImmunoVacc Consulting, Brussels, Belgium; [Dubois, Patrice] PATH Malaria Vaccine Initiat, Bethesda, MD USA; [Evans, Jennifer A.] Kumasi Ctr Collaborat Res, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; Kwame Nkrumah University Science & Technology; Kumasi Center for Collaborative Research	Ansong, D (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana.	ansongd@yahoo.com	Owusu, Sandra Kwarteng/ACO-7623-2022	ANSONG, Daniel/0000-0003-1328-9117; Owusu-Agyei, Seth/0000-0002-0807-1781	Path MVI	Path MVI	This trial was supported by a grant from Path MVI. Path MVI played no deciding role in study design or data collection and analysis, nor were they involved in the decision to publish.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang K, 2009, HUM VACCINES, V5, P242, DOI 10.4161/hv.5.4.7050; Frevert U, 2008, CELL MICROBIOL, V10, P1956, DOI 10.1111/j.1462-5822.2008.01211.x; Garcon Nathalie, 2003, Expert Rev Vaccines, V2, P231, DOI 10.1586/14760584.2.2.231; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; HOLLINGDALE MR, 1982, J IMMUNOL, V128, P1929; Horowitz A, 2010, J IMMUNOL, V184, P6043, DOI 10.4049/jimmunol.1000106; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Litjens NHR, 2008, J IMMUNOL, V181, P3665, DOI 10.4049/jimmunol.181.5.3665; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Maecker HT, 2000, J CLIN IMMUNOL, V20, P391, DOI 10.1023/A:1026403724413; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; NUSSLER A, 1991, INT IMMUNOL, V3, P317, DOI 10.1093/intimm/3.4.317; Owusu-Agyei S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007302; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; RENIA L, 1993, J IMMUNOL, V150, P1471; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; WEISS WR, 1993, J IMMUNOL, V151, P2690	34	46	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18891	10.1371/journal.pone.0018891	http://dx.doi.org/10.1371/journal.pone.0018891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556142	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000290019400012
J	Pomeroy, J; Brage, S; Curtis, JM; Swan, PD; Knowler, WC; Franks, PW				Pomeroy, Jeremy; Brage, Soren; Curtis, Jeffrey M.; Swan, Pamela D.; Knowler, William C.; Franks, Paul W.			Between-Monitor Differences in Step Counts Are Related to Body Size: Implications for Objective Physical Activity Measurement	PLOS ONE			English	Article							AMBULATORY ACTIVITY; PEDOMETER ACCURACY; BLOOD-PRESSURE; LIFE-STYLE; WALKING; PREVENTION; OVERWEIGHT; SEDENTARY; FITNESS; ADULTS	Background: The quantification of the relationships between walking and health requires that walking is measured accurately. We correlated different measures of step accumulation to body size, overall physical activity level, and glucose regulation. Methods: Participants were 25 men and 25 women American Indians without diabetes (Age: 20-34 years) in Phoenix, Arizona, USA. We assessed steps/day during 7 days of free living, simultaneously with three different monitors (Accusplit-AX120, MTI-ActiGraph, and Dynastream-AMP). We assessed total physical activity during free-living with doubly labeled water combined with resting metabolic rate measured by expired gas indirect calorimetry. Glucose tolerance was determined during an oral glucose tolerance test. Findings: Based on observed counts in the laboratory, the AMP was the most accurate device, followed by the MTI and the AX120, respectively. The estimated energy cost of 1000 steps per day was lower in the AX120 than the MTI or AMP. The correlation between AX120-assessed steps/day and waist circumference was significantly higher than the correlation between AMP steps and waist circumference. The difference in steps per day between the AX120 and both the AMP and the MTI were significantly related to waist circumference. Interpretation: Between-monitor differences in step counts influence the observed relationship between walking and obesity-related traits.	[Pomeroy, Jeremy; Brage, Soren; Curtis, Jeffrey M.; Knowler, William C.; Franks, Paul W.] NIDDK, Diabet Epidemiol & Clin Res Sect, Phoenix, AZ USA; [Pomeroy, Jeremy; Swan, Pamela D.] Arizona State Univ, Coll Nursing & Hlth Innovat, Hlth Lifestyle Res Ctr, Phoenix, AZ USA; [Franks, Paul W.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Brage, Soren] MRC Epidemiol Unit, Cambridge, England	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Arizona State University; Arizona State University-Downtown Phoenix; Lund University	Pomeroy, J (corresponding author), NIDDK, Diabet Epidemiol & Clin Res Sect, Phoenix, AZ USA.	jeremy.pomeroy@nih.gov	Franks, Paul/AAA-3300-2020; Brage, Soren/C-6415-2013	Brage, Soren/0000-0002-1265-7355; Franks, Paul/0000-0002-0520-7604	NIDDK; National Cancer Institute; Visare Norr Foundation; Medical Research Council [MC_U106179473] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069085] Funding Source: NIH RePORTER; MRC [MC_U106179473] Funding Source: UKRI	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Visare Norr Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the NIDDK intramural research program and the National Cancer Institute. PWF was also supported in part by a grant from the Visare Norr Foundation. Dynastream Inc, Cochrane, Alberta, Canada loaned the AMP-331 activity monitors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALLISON DB, 1995, INT J OBESITY, V19, P644; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Chan CB, 2003, OBES RES, V11, P1563, DOI 10.1038/oby.2003.208; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Crouter SE, 2005, MED SCI SPORT EXER, V37, P1673, DOI 10.1249/01.mss.0000181677.36658.a8; Darter Benjamin J, 2006, J Phys Act Health, V3, P277, DOI 10.1123/jpah.3.3.277; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Foster RC, 2005, PREV MED, V41, P778, DOI 10.1016/j.ypmed.2005.07.006; Frisard MI, 2007, J GERONTOL A-BIOL, V62, P783, DOI 10.1093/gerona/62.7.783; Karabulut M, 2005, EUR J APPL PHYSIOL, V95, P335, DOI 10.1007/s00421-005-0018-3; Kleinbaum DG, 1988, APPL REGRESSION ANAL, P99; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Le Masurier GC, 2004, MED SCI SPORT EXER, V36, P905, DOI 10.1249/01.MSS.0000126777.50188.73; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Melanson EL, 2004, PREV MED, V39, P361, DOI 10.1016/j.ypmed.2004.01.032; Mitre N, 2009, PEDIATRICS, V123, pE127, DOI 10.1542/peds.2008-1908; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; RAVUSSIN E, 1991, AM J PHYSIOL, V261, pE402, DOI 10.1152/ajpendo.1991.261.3.E402; Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Simpson ME, 2003, AM J PREV MED, V25, P95, DOI 10.1016/S0749-3797(03)00112-0; Sirard JR, 2000, MED SCI SPORT EXER, V32, P695, DOI 10.1097/00005768-200003000-00022; Sisson SB, 2010, AM J PREV MED, V38, P575, DOI 10.1016/j.amepre.2010.02.015; Storti KL, 2009, AM J PREV MED, V37, P481, DOI 10.1016/j.amepre.2009.07.019; Tudor-Locke C, 2004, SPORTS MED, V34, P281, DOI 10.2165/00007256-200434050-00001; Tudor-Locke C, 2001, INT J OBESITY, V25, P1571, DOI 10.1038/sj.ijo.0801783; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Tyo BM, 2011, MED SCI SPORT EXER, V43, P350, DOI 10.1249/MSS.0b013e3181e9b133; World Health Organization, 1999, DEF DIAGN CLASS DI 1; Wyatt HR, 2005, MED SCI SPORT EXER, V37, P724, DOI 10.1249/01.MSS.0000161750.84096.D4; Yates T, 2009, DIABETES CARE	31	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18942	10.1371/journal.pone.0018942	http://dx.doi.org/10.1371/journal.pone.0018942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556140	gold, Green Submitted, Green Published			2022-12-25	WOS:000290019400020
J	Twery, EN; Raper, JA				Twery, E. Naomi; Raper, Jonathan A.			SDF1-Induced Antagonism of Axonal Repulsion Requires Multiple G-Protein Coupled Signaling Components That Work in Parallel	PLOS ONE			English	Article							ALPHA-SUBUNIT; CALCIUM MOBILIZATION; PHOSPHOLIPASE-C; IN-VIVO; CELLS; RECEPTORS; CHEMOKINE; REPELLENTS; ACTIVATION; EXPRESSION	SDF1 reduces the responsiveness of axonal growth cones to repellent guidance cues in a pertussis-toxin-sensitive, cAMP-dependent manner. Here, we show that SDF1's antirepellent effect can be blocked in embryonic chick dorsal root ganglia (DRGs) by expression of peptides or proteins inhibiting either G alpha(i), G alpha(q), or G beta gamma. SDF1 antirepellent activity is also blocked by pharmacological inhibition of PLC, a common effector protein for G alpha(q). We also show that SDF1 antirepellent activity can be mimicked by overexpression of constitutively active G alpha(i), G alpha(q), or G alpha(s). These results suggest a model in which multiple G protein components cooperate to produce the cAMP levels required for SDF1 antirepellent activity.	[Twery, E. Naomi] Univ Penn, Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Raper, Jonathan A.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Twery, EN (corresponding author), Univ Penn, Sch Med, Neurosci Grad Grp, Philadelphia, PA 19104 USA.	raperj@mail.med.upenn.edu			National Institutes of Health, NIDA [RO1-DA025407];  [T32HD007516];  [GM-7229-36]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025407] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institutes of Health, http://www.nih.gov/, via RO1-DA025407 from NIDA to JAR. Additional support for ENT came from training grants T32HD007516 and GM-7229-36 to the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalasani SH, 2003, J NEUROSCI, V23, P1360, DOI 10.1523/JNEUROSCI.23-04-01360.2003; Chalasani SH, 2003, J NEUROSCI, V23, P4601; Chalasani SH, 2007, J NEUROSCI, V27, P973, DOI 10.1523/JNEUROSCI.4132-06.2007; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Erskine L, 2000, J NEUROSCI, V20, P4975; Ghahremani MH, 1999, J BIOL CHEM, V274, P9238, DOI 10.1074/jbc.274.14.9238; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; GUTTRIDGE KL, 1995, P NATL ACAD SCI USA, V92, P1297, DOI 10.1073/pnas.92.5.1297; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; Heximer SP, 2004, METHOD ENZYMOL, V390, P65; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kapfhammer JP, 2007, NAT PROTOC, V2, P2005, DOI 10.1038/nprot.2007.295; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; KROLL SD, 1992, J BIOL CHEM, V267, P23183; Li Q, 2005, J NEUROSCI, V25, P1711, DOI 10.1523/JNEUROSCI.4393-04.2005; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; Niclou SP, 2000, J NEUROSCI, V20, P4962; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Rubin JB, 2009, SEMIN CANCER BIOL, V19, P116, DOI 10.1016/j.semcancer.2008.10.001; Selkirk JV, 2001, NEUROPHARMACOLOGY, V40, P645, DOI 10.1016/S0028-3908(00)00208-2; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Soede RDM, 2000, BLOOD, V96, P691; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Vanhauwe JF, 2002, J BIOL CHEM, V277, P34143, DOI 10.1074/jbc.M204477200; Vlahakis SR, 2002, J IMMUNOL, V169, P5546, DOI 10.4049/jimmunol.169.10.5546; WANG J, 2010, CELL SIGNAL; WINITZ S, 1994, J BIOL CHEM, V269, P1889; Xu H, 2010, J NEUROSCI, V30, P7423, DOI 10.1523/JNEUROSCI.0699-10.2010; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18896	10.1371/journal.pone.0018896	http://dx.doi.org/10.1371/journal.pone.0018896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556147	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400015
J	Shenoy, RT; Thangamani, S; Velazquez-Campoy, A; Ho, B; Ding, JL; Sivaraman, J				Shenoy, Rajesh T.; Thangamani, Saravanan; Velazquez-Campoy, Adrian; Ho, Bow; Ding, Jeak Ling; Sivaraman, J.			Structural Basis for Dual-Inhibition Mechanism of a Non-Classical Kazal-Type Serine Protease Inhibitor from Horseshoe Crab in Complex with Subtilisin	PLOS ONE			English	Article							LEECH HIRUDO-MEDICINALIS; PROTEINASE-INHIBITOR; ELASTASE INHIBITOR; CARCINOSCORPIUS-ROTUNDICAUDA; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; COAGULATION; PURIFICATION; ARTHROPODS; CARLSBERG	Serine proteases play a crucial role in host-pathogen interactions. In the innate immune system of invertebrates, multidomain protease inhibitors are important for the regulation of host-pathogen interactions and antimicrobial activities. Serine protease inhibitors, 9.3-kDa CrSPI isoforms 1 and 2, have been identified from the hepatopancreas of the horseshoe crab, Carcinoscorpius rotundicauda. The CrSPIs were biochemically active, especially CrSPI-1, which potently inhibited subtilisin (Ki = 1.43 nM). CrSPI has been grouped with the non-classical Kazal-type inhibitors due to its unusual cysteine distribution. Here we report the crystal structure of CrSPI-1 in complex with subtilisin at 2.6 angstrom resolution and the results of biophysical interaction studies. The CrSPI-1 molecule has two domains arranged in an extended conformation. These two domains act as heads that independently interact with two separate subtilisin molecules, resulting in the inhibition of subtilisin activity at a ratio of 1: 2 (inhibitor to protease). Each subtilisin molecule interacts with the reactive site loop from each domain of CrSPI-1 through a standard canonical binding mode and forms a single ternary complex. In addition, we propose the substrate preferences of each domain of CrSPI-1. Domain 2 is specific towards the bacterial protease subtilisin, while domain 1 is likely to interact with the host protease, Furin. Elucidation of the structure of the CrSPI-1: subtilisin (1: 2) ternary complex increases our understanding of host-pathogen interactions in the innate immune system at the molecular level and provides new strategies for immunomodulation.	[Shenoy, Rajesh T.; Thangamani, Saravanan; Ding, Jeak Ling; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Ho, Bow] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Fdn ARAID, Zaragoza, Spain; [Thangamani, Saravanan] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA	National University of Singapore; National University of Singapore; University of Zaragoza; University of Texas System; University of Texas Medical Branch Galveston	Shenoy, RT (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsdjl@nus.edu.sg; dbsjayar@nus.edu.sg	Thangamani, Saravanan/E-7371-2010; Sivaraman, J/H-8028-2012; Velazquez-Campoy, Adrian/E-7946-2012; Shenoy, Rajesh/ABD-3976-2020; Ding, Jeak/H-8057-2012	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Shenoy, Rajesh/0000-0002-5035-8321; J, Sivaraman/0000-0001-9781-5326; Thangamani, Saravanan/0000-0002-4269-5993	National University of Singapore (NUS) [R154000438112]; Spanish Ministry of Science and Innovation [BFU2010-19451]; Diputacion General de Aragon [PI044/09]; Fundacion ARAID, Diputacion General de Aragon; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National University of Singapore (NUS)(National University of Singapore); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Diputacion General de Aragon(Gobierno de Aragon); Fundacion ARAID, Diputacion General de Aragon(Gobierno de Aragon); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Academic Research Fund (ARF), National University of Singapore (NUS), grant no. R154000438112. A.V.-C was supported by the Spanish Ministry of Science and Innovation [grant number BFU2010-19451]; the Diputacion General de Aragon [grant number PI044/09]; and the Fundacion ARAID, Diputacion General de Aragon (to A. V.-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rajesh T. Shenoy is a graduate scholar in receipt of a research scholarship from the NUS.	Armstrong PB, 2001, TRENDS IMMUNOL, V22, P47, DOI 10.1016/S1471-4906(00)01803-2; Bao R, 2009, J BIOL CHEM, V284, P26676, DOI 10.1074/jbc.M109.022095; Barrette-Ng IH, 2003, J BIOL CHEM, V278, P24062, DOI 10.1074/jbc.M302020200; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding Jeak L., 2004, Current Genomics, V5, P147, DOI 10.2174/1389202043489944; Ding JL, 2001, TRENDS BIOTECHNOL, V19, P277, DOI 10.1016/S0167-7799(01)01694-8; DING JL, 1993, BIOCHIM BIOPHYS ACTA, V1202, P149, DOI 10.1016/0167-4838(93)90076-4; Donpudsa S, 2009, DEV COMP IMMUNOL, V33, P481, DOI 10.1016/j.dci.2008.09.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINK E, 1986, BIOL CHEM H-S, V367, P1235, DOI 10.1515/bchm3.1986.367.2.1235; Freire E, 2009, METHOD ENZYMOL, V455, P127, DOI 10.1016/S0076-6879(08)04205-5; FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216; Giri PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015258; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hemmi H, 2005, BIOCHEMISTRY-US, V44, P9626, DOI 10.1021/bi0472806; Hemmi H, 2002, BIOCHEMISTRY-US, V41, P10657, DOI 10.1021/bi026035o; Hiemstra PS, 2002, BIOCHEM SOC T, V30, P116, DOI 10.1042/BST0300116; Iwanaga S., 1998, FRONT BIOSCI-LANDMRK, V3, P973; Jiang N, 2009, J INNATE IMMUN, V1, P465, DOI 10.1159/000209224; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Jobichen C, 2009, BIOCHEM J, V420, P191, DOI 10.1042/BJ20081588; JOHANSSON MW, 1994, EUR J BIOCHEM, V223, P389, DOI 10.1111/j.1432-1033.1994.tb19005.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Kawabata S, 1996, FEBS LETT, V386, P201, DOI 10.1016/0014-5793(96)00440-1; Kleanthous C, 2000, PROTEIN PROTEIN RECO; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LU WY, 1993, J BIOL CHEM, V268, P14583; Maynes JT, 2005, ACTA CRYSTALLOGR D, V61, P580, DOI 10.1107/S0907444905004889; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muta T, 1996, CURR OPIN IMMUNOL, V8, P41, DOI 10.1016/S0952-7915(96)80103-8; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Odum L, 1999, EUR J BIOCHEM, V259, P872, DOI 10.1046/j.1432-1327.1999.00113.x; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schmitke JL, 1998, J MOL BIOL, V218, P183; SOMMERHOFF CP, 1994, BIOL CHEM H-S, V375, P685, DOI 10.1515/bchm3.1994.375.10.685; Somprasong N, 2006, DEV COMP IMMUNOL, V30, P998, DOI 10.1016/j.dci.2006.01.004; Stoll VS, 1998, BIOCHEMISTRY-US, V37, P451, DOI 10.1021/bi971166o; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tian Miaoying, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-15; TSCHESCHE H, 1987, BIOL CHEM H-S, V368, P1297, DOI 10.1515/bchm3.1987.368.2.1297; Tulsidas SR, 2009, ACTA CRYSTALLOGR F, V65, P533, DOI 10.1107/S1744309109014420; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x	56	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18838	10.1371/journal.pone.0018838	http://dx.doi.org/10.1371/journal.pone.0018838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541315	gold, Green Published, Green Submitted			2022-12-25	WOS:000290018400012
J	de Wit, NJW; Boekschoten, MV; Bachmair, EM; Hooiveld, GJEJ; de Groot, PJ; Rubio-Aliaga, I; Daniel, H; Muller, M				de Wit, Nicole J. W.; Boekschoten, Mark V.; Bachmair, Eva-Maria; Hooiveld, Guido J. E. J.; de Groot, Philip J.; Rubio-Aliaga, Isabel; Daniel, Hannelore; Muller, Michael			Dose-Dependent Effects of Dietary Fat on Development of Obesity in Relation to Intestinal Differential Gene Expression in C57BL/6J Mice	PLOS ONE			English	Article							METABOLIC SYNDROME; MODEL	Excessive intake of dietary fat is known to be a contributing factor in the development of obesity. In this study, we determined the dose-dependent effects of dietary fat on the development of this metabolic condition with a focus on changes in gene expression in the small intestine. C57BL/6J mice were fed diets with either 10, 20, 30 or 45 energy% (E%) derived from fat for four weeks (n = 10 mice/diet). We found a significant higher weight gain in mice fed the 30E% and 45E% fat diet compared to mice on the control diet. These data indicate that the main shift towards an obese phenotype lies between a 20E% and 30E% dietary fat intake. Analysis of differential gene expression in the small intestine showed a fat-dose dependent gradient in differentially expressed genes, with the highest numbers in mice fed the 45E% fat diet. The main shift in fat-induced differential gene expression was found between the 30E% and 45E% fat diet. Furthermore, approximately 70% of the differentially expressed genes were changed in a fat-dose dependent manner. Many of these genes were involved in lipid metabolism-related processes and were already differentially expressed on a 30E% fat diet. Taken together, we conclude that up to 20E% of dietary fat, the small intestine has an effective 'buffer capacity' for fat handling. From 30E% of dietary fat, a switch towards an obese phenotype is triggered. We further speculate that especially fat-dose dependently changed lipid metabolism-related genes are involved in development of obesity.	[de Wit, Nicole J. W.; Boekschoten, Mark V.; Hooiveld, Guido J. E. J.; de Groot, Philip J.; Muller, Michael] Top Inst Food & Nutr, Netherlands Nutrigen Ctr, Wageningen, Netherlands; [de Wit, Nicole J. W.; Boekschoten, Mark V.; Hooiveld, Guido J. E. J.; de Groot, Philip J.; Muller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Bachmair, Eva-Maria] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Rubio-Aliaga, Isabel; Daniel, Hannelore] Tech Univ Munich, Res Ctr Nutr & Food Sci, Mol Nutr Unit, D-8050 Freising Weihenstephan, Germany	Top Institute Food & Nutrition; Wageningen University & Research; University of Aberdeen; Technical University of Munich	de Wit, NJW (corresponding author), Top Inst Food & Nutr, Netherlands Nutrigen Ctr, Wageningen, Netherlands.	Mark.Boekschoten@wur.nl	Hooiveld, Guido JEJ/F-4912-2010; Boekschoten, Mark/AAS-4597-2021; Muller, Michael/B-5795-2008; Boekschoten, Mark V/A-2458-2011; Daniel, Hannelore/B-8982-2009; Muller, Michael/M-5724-2019	Hooiveld, Guido JEJ/0000-0003-1954-3542; Boekschoten, Mark/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark V/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Rubio-Aliaga, Isabel/0000-0003-1051-9511	NuGO; European Nutrigenomics Organization	NuGO; European Nutrigenomics Organization(European Commission)	The study was funded by NuGO, the European Nutrigenomics Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; DEMEIJER VE, METABOLISM IN PRESS; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Kondo H, 2006, AM J PHYSIOL-ENDOC M, V291, pE1092, DOI 10.1152/ajpendo.00583.2005; Mauer J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000938; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Roche HM, 2005, P NUTR SOC, V64, P371, DOI 10.1079/PNS2005445; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; Simonen P, 2000, AM J CLIN NUTR, V72, P82; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	17	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19145	10.1371/journal.pone.0019145	http://dx.doi.org/10.1371/journal.pone.0019145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547079	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800034
J	McGowan, CC; Weinstein, DD; Samenow, CP; Stinnette, SE; Barkanic, G; Rebeiro, PF; Sterling, TR; Moore, RD; Hulgan, T				McGowan, Catherine C.; Weinstein, David D.; Samenow, Charles P.; Stinnette, Samuel E.; Barkanic, Gema; Rebeiro, Peter F.; Sterling, Timothy R.; Moore, Richard D.; Hulgan, Todd			Drug Use and Receipt of Highly Active Antiretroviral Therapy among HIV-Infected Persons in Two US Clinic Cohorts	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; DISEASE PROGRESSION; TREATMENT INTERRUPTIONS; VIROLOGICAL RESPONSE; PROTEASE INHIBITORS; GENDER-DIFFERENCES; CRACK-COCAINE; INJECTION; ADHERENCE; MORTALITY	Objective: Drug use and receipt of highly active antiretroviral therapy (HAART) were assessed in HIV-infected persons from the Comprehensive Care Center (CCC; Nashville, TN) and Johns Hopkins University HIV Clinic (JHU; Baltimore, MD) between 1999 and 2005. Methods: Participants with and without injection drug use (IDU) history in the CCC and JHU cohorts were evaluated. Additional analysis of persons with history of IDU, non-injection drug use (NIDU), and no drug use from CCC were performed. Activity of IDU and NIDU also was assessed for the CCC cohort. HAART use and time on HAART were analyzed according to drug use category and site of care. Results: 1745 persons were included from CCC: 268 (15%) with IDU history and 796 (46%) with NIDU history. 1977 persons were included from JHU: 731 (35%) with IDU history. Overall, the cohorts differed in IDU risk factor rates, age, race, sex, and time in follow-up. In multivariate analyses, IDU was associated with decreased HAART receipt overall (OR = 0.61, 95% CI: [0.45-0.84] and OR = 0.58, 95% CI: [0.46-0.73], respectively for CCC and JHU) and less time on HAART at JHU (0.70, [0.55-0.88]), but not statistically associated with time on HAART at CCC (0.78, [0.56-1.09]). NIDU was independently associated with decreased HAART receipt (0.62, [0.47-0.81]) and less time on HAART (0.66, [0.52-0.85]) at CCC. These associations were not altered significantly whether patients at CCC were categorized according to historical drug use or drug use during the study period. Conclusions: Persons with IDU history from both clinic populations were less likely to receive HAART and tended to have less cumulative time on HAART. Effects of NIDU were similar to IDU at CCC. NIDU without IDU is an important contributor to HAART utilization.	[McGowan, Catherine C.; Stinnette, Samuel E.; Barkanic, Gema; Rebeiro, Peter F.; Sterling, Timothy R.; Hulgan, Todd] Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, Nashville, TN 37212 USA; [Weinstein, David D.; Samenow, Charles P.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Sterling, Timothy R.; Hulgan, Todd] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA; [Moore, Richard D.] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Johns Hopkins University	McGowan, CC (corresponding author), Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, Nashville, TN 37212 USA.	c.mcgowan@Vanderbilt.Edu	Hulgan, Todd/B-3947-2014; Hulgan, Todd/AAG-7491-2019	Hulgan, Todd/0000-0002-3339-067X; Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health: the Vanderbilt-Meharry Center for AIDS Research [P30 AI54999, K24 A1065298, R01 DA11602, R01 AA16893, K24 DA00432]; Tennessee Valley VA Clinical Research Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999, K24AI065298, U01AI069918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011602, K24DA000432] Funding Source: NIH RePORTER	National Institutes of Health: the Vanderbilt-Meharry Center for AIDS Research; Tennessee Valley VA Clinical Research Center of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this work was provided by the National Institutes of Health: the Vanderbilt-Meharry Center for AIDS Research (P30 AI54999 [SES, GB, PFR, CCM, TRS]); K24 A1065298 (TRS, GB, SES, RA, KX, DC); R01 DA11602, R01 AA16893, K24 DA00432 (RDM), and by the Tennessee Valley VA Clinical Research Center of Excellence (TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bae JW, 2011, AIDS, V25, P279, DOI 10.1097/QAD.0b013e328340feb0; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baldwin GC, 1998, J NEUROIMMUNOL, V83, P133, DOI 10.1016/S0165-5728(97)00229-4; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; BOOTH RE, 1993, AM J PUBLIC HEALTH, V83, P1144, DOI 10.2105/AJPH.83.8.1144; Braitstein P, 2006, AIDS, V20, P323, DOI 10.1097/01.aids.0000198091.70325.f4; BRYANT HU, 1988, J PHARMACOL EXP THER, V245, P913; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; CARR DJJ, 1993, J PHARMACOL EXP THER, V264, P1179; Cavazos-Rehg PA, 2009, AIDS PATIENT CARE ST, V23, P727, DOI 10.1089/apc.2008.0272; *CDCP, 2007, HIV AIDS SURV REP, V19; *CDCP, 2008, HIV AIDS SURV S REP; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; CHAISSON RE, 1995, NEW ENGL J MED, V333, P751, DOI 10.1056/NEJM199509213331202; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Cofrancesco J, 2008, AIDS, V22, P357, DOI 10.1097/QAD.0b013e3282f3cc21; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; Ding L, 2005, ARCH INTERN MED, V165, P618, DOI 10.1001/archinte.165.6.618; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galai N, 2003, AM J EPIDEMIOL, V158, P695, DOI 10.1093/aje/kwg209; Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; Grigoryan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004445; Hinkin CH, 2007, AIDS BEHAV, V11, P185, DOI 10.1007/s10461-006-9152-0; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Junghans C, 1999, AIDS, V13, P2547, DOI 10.1097/00002030-199912240-00008; Kavasery R, 2009, JAIDS-J ACQ IMM DEF, V50, P360, DOI 10.1097/QAI.0b013e318198a800; Kempf MC, 2009, JAIDS-J ACQ IMM DEF, V52, P336, DOI 10.1097/QAI.0b013e3181b628be; Knowlton AR, 2010, AIDS PATIENT CARE ST, V24, P421, DOI 10.1089/apc.2009.0240; Lopez E, 2007, AM J INFECT DIS, V3, P240, DOI 10.3844/ajidsp.2007.240.247; Lori F, 2001, JAMA-J AM MED ASSOC, V286, P2981, DOI 10.1001/jama.286.23.2981; Lucas GM, 2006, AM J EPIDEMIOL, V163, P412, DOI 10.1093/aje/kwj059; Lucas GM, 2003, JAIDS-J ACQ IMM DEF, V33, P321, DOI 10.1097/00126334-200307010-00005; Lucas GM, 2001, J ACQ IMMUN DEF SYND, V27, P251, DOI 10.1097/00126334-200107010-00006; Mitty JA, 2005, JAIDS-J ACQ IMM DEF, V39, P545; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V22, P369; Mocroft A, 2000, J ACQ IMMUN DEF SYND, V24, P475, DOI 10.1097/00126334-200008150-00013; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Moore RD, 1998, J ACQ IMMUN DEF SYND, V17, pS38, DOI 10.1097/00042560-199801001-00011; Moore RD, 2004, JAIDS-J ACQ IMM DEF, V35, P46, DOI 10.1097/00126334-200401010-00006; Murri R, 1999, J ACQ IMMUN DEF SYND, V22, P461; *NAT I DRUG AB COM, 2006, EP TRENDS DRUG AB; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palepu A, 2003, JAIDS-J ACQ IMM DEF, V32, P522, DOI 10.1097/00126334-200304150-00009; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Poundstone KE, 2001, AIDS, V15, P1115, DOI 10.1097/00002030-200106150-00006; Rodriguez-Arenas MA, 2006, AIDS RES HUM RETROV, V22, P715, DOI 10.1089/aid.2006.22.715; Roth MD, 2002, J INFECT DIS, V185, P701, DOI 10.1086/339012; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Shepherd BE, 2009, J CLIN EPIDEMIOL, V62, P729, DOI 10.1016/j.jclinepi.2008.09.002; Silverberg MJ, 2009, J PAIN SYMPTOM MANAG, V38, P197, DOI 10.1016/j.jpainsymman.2008.08.007; Strathdee SA, 2003, J URBAN HEALTH, V80, P7; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Tucker JS, 2003, AM J MED, V114, P573, DOI 10.1016/S0002-9343(03)00093-7; UNAIDS, 2008, REP GLOB AIDS EP; Xu W, 1999, INT J IMMUNOPHARMACO, V21, P463, DOI 10.1016/S0192-0561(99)00023-5	57	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18462	10.1371/journal.pone.0018462	http://dx.doi.org/10.1371/journal.pone.0018462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756MU	21541016	gold, Green Published			2022-12-25	WOS:000290016800010
J	Findeisen, HM; Pearson, KJ; Gizard, F; Zhao, Y; Qing, H; Jones, KL; Cohn, D; Heywood, EB; de Cabo, R; Bruemmer, D				Findeisen, Hannes M.; Pearson, Kevin J.; Gizard, Florence; Zhao, Yue; Qing, Hua; Jones, Karrie L.; Cohn, Dianne; Heywood, Elizabeth B.; de Cabo, Rafael; Bruemmer, Dennis			Oxidative Stress Accumulates in Adipose Tissue during Aging and Inhibits Adipogenesis	PLOS ONE			English	Article							INSULIN SENSITIVITY; ADIPOCYTE PRECURSORS; BODY-COMPOSITION; ANATOMIC SITE; RISK-FACTORS; PPAR-GAMMA; AGE; GLUTATHIONE; OBESITY; DIFFERENTIATION	Aging constitutes a major independent risk factor for the development of type 2 diabetes and is accompanied by insulin resistance and adipose tissue dysfunction. One of the most important factors implicitly linked to aging and age-related chronic diseases is the accumulation of oxidative stress. However, the effect of increased oxidative stress on adipose tissue biology remains elusive. In this study, we demonstrate that aging in mice results in a loss of fat mass and the accumulation of oxidative stress in adipose tissue. In vitro, increased oxidative stress through glutathione depletion inhibits preadipocyte differentiation. This inhibition of adipogenesis is at least in part the result of reduced cell proliferation and an inhibition of G(1)-> S-phase transition during the initial mitotic clonal expansion of the adipocyte differentiation process. While phosphorylation of the retinoblastoma protein (Rb) by cyclin/cdk complexes remains unaffected, oxidative stress decreases the expression of S-phase genes downstream of Rb. This silencing of S phase gene expression by increased oxidative stress is mediated through a transcriptional mechanism involving the inhibition of E2F recruitment and transactivation of its target promoters. Collectively, these data demonstrate a previously unrecognized role of oxidative stress in the regulation of adipogenesis which may contribute to age-associated adipose tissue dysfunction.	[Findeisen, Hannes M.; Gizard, Florence; Zhao, Yue; Qing, Hua; Jones, Karrie L.; Cohn, Dianne; Heywood, Elizabeth B.; Bruemmer, Dennis] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Pearson, Kevin J.; Zhao, Yue; Bruemmer, Dennis] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA	University of Kentucky; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Findeisen, HM (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA.	Dennis.Bruemmer@uky.edu	de Cabo, Rafael/E-7996-2010; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442	American Diabetes Association (ADA) [1-09-CD-02]; National Institutes of Health COBRE on Obesity and Cardiovascular Diseases [P20 RR021954]; NIA, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER	American Diabetes Association (ADA)(American Diabetes Association); National Institutes of Health COBRE on Obesity and Cardiovascular Diseases; NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	These studies were supported by the American Diabetes Association (ADA Award No.: 1-09-CD-02), the National Institutes of Health COBRE on Obesity and Cardiovascular Diseases (P20 RR021954) and in part by the Intramural Research Program of the NIA, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Araki K, 2008, ONCOGENE, V27, P5696, DOI 10.1038/onc.2008.184; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Bruemmer D, 2003, MOL ENDOCRINOL, V17, P1005, DOI 10.1210/me.2002-0410; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Cattan V, 2008, FREE RADICAL BIO MED, V44, P1592, DOI 10.1016/j.freeradbiomed.2008.01.007; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; De Mattia G, 1998, METABOLISM, V47, P993, DOI 10.1016/S0026-0495(98)90357-2; DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; DJIAN P, 1983, J CLIN INVEST, V72, P1200, DOI 10.1172/JCI111075; Droge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gambert S.R., 2006, DIABETES SPECTRUM, V19, P221, DOI [10.2337/diaspect.19.4.221, DOI 10.2337/DIASPECT.19.4.221]; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; HARMAN D, 1957, J GERONTOL, V12, P257, DOI 10.1093/geronj/12.3.257; Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475; Karagiannides I, 2001, AM J PHYSIOL-REG I, V280, pR1772, DOI 10.1152/ajpregu.2001.280.6.R1772; KIRKLAND JL, 1990, AM J PHYSIOL, V258, pC206, DOI 10.1152/ajpcell.1990.258.2.C206; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; Miard S, 2009, AGING CELL, V8, P449, DOI 10.1111/j.1474-9726.2009.00490.x; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056; O'Connor DJ, 2000, ONCOGENE, V19, P2369, DOI 10.1038/sj.onc.1203540; Ogihara T, 2004, DIABETOLOGIA, V47, P794, DOI 10.1007/s00125-004-1391-x; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Selvin E, 2006, DIABETES CARE, V29, P2415, DOI 10.2337/dc06-1058; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SILVERSTONE FA, 1957, J CLIN INVEST, V36, P504, DOI 10.1172/JCI103448; Sinclair DA, 2009, AGEING RES REV, V8, P189, DOI 10.1016/j.arr.2009.04.004; SPENCE JC, 1921, Q J MED, V14; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wojtanik KM, 2009, J LIPID RES, V50, P1068, DOI 10.1194/jlr.M800491-JLR200; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111	48	64	65	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18532	10.1371/journal.pone.0018532	http://dx.doi.org/10.1371/journal.pone.0018532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533223	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600008
J	Shi, F; Yap, PT; Wu, GR; Jia, HJ; Gilmore, JH; Lin, WL; Shen, DG				Shi, Feng; Yap, Pew-Thian; Wu, Guorong; Jia, Hongjun; Gilmore, John H.; Lin, Weili; Shen, Dinggang			Infant Brain Atlases from Neonates to 1-and 2-Year-Olds	PLOS ONE			English	Article							MAGNETIC-RESONANCE IMAGES; AUTOMATIC SEGMENTATION; SPATIAL NORMALIZATION; PROBABILISTIC ATLAS; MR-IMAGES; REGISTRATION	Studies for infants are usually hindered by the insufficient image contrast, especially for neonates. Prior knowledge, in the form of atlas, can provide additional guidance for the data processing such as spatial normalization, label propagation, and tissue segmentation. Although it is highly desired, there is currently no such infant atlas which caters for all these applications. The reason may be largely due to the dramatic early brain development, image processing difficulties, and the need of a large sample size. Methodology: To this end, after several years of subject recruitment and data acquisition, we have collected a unique longitudinal dataset, involving 95 normal infants (56 males and 39 females) with MRI scanned at 3 ages, i.e., neonate, 1-year-old, and 2-year-old. State-of-the-art MR image segmentation and registration techniques were employed, to construct which include the templates (grayscale average images), tissue probability maps (TPMs), and brain parcellation maps (i.e., meaningful anatomical regions of interest) for each age group. In addition, the longitudinal correspondences between age-specific atlases were also obtained. Experiments of typical infant applications validated that the proposed atlas outperformed other atlases and is hence very useful for infant- related studies. Conclusions: We expect that the proposed infant 0-1-2 brain atlases would be significantly conducive to structural and functional studies of the infant brains. These atlases are publicly available in our website, http://bric.unc.edu/ideagroup/free-softwares/.	[Shi, Feng; Yap, Pew-Thian; Wu, Guorong; Jia, Hongjun; Shen, Dinggang] Univ N Carolina, IDEA Lab, Chapel Hill, NC 27515 USA; [Gilmore, John H.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Lin, Weili] Univ N Carolina, Dept Radiol, MRI Lab, Chapel Hill, NC USA; [Lin, Weili] Univ N Carolina, BRIC, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Shi, F (corresponding author), Univ N Carolina, IDEA Lab, Chapel Hill, NC 27515 USA.	dgshen@med.unc.edu	Shen, Dinggang/ABF-6812-2020; Gilmore, John H./AAE-1398-2019; Shi, Feng/G-3247-2012; Wu, Guorong/G-3744-2014; Wang, Li/O-1425-2015; Yap, Pew-Thian/G-3292-2012	Shen, Dinggang/0000-0002-7934-5698; Gilmore, John H./0000-0002-0939-6764; Shi, Feng/0000-0003-1522-9943; Wang, Li/0000-0001-8927-6772; 	NIH [EB006733, EB008760, EB008374, EB009634, MH088520, MH070890, MH064065, NS055754, HD053000]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008374, R01EB009634, R01EB006733, R03EB008760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088520, P50MH064065, U01MH070890, R01MH070890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055754] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIH grants EB006733, EB008760, EB008374, EB009634, MH088520, MH070890, MH064065, NS055754, and HD053000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baloch S, 2009, NEUROIMAGE, V45, pS73, DOI 10.1016/j.neuroimage.2008.10.048; Brodmann K., 1909, VERGLEICHENDE LOKALI; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Habas PA, 2009, LECT NOTES COMPUT SC, V5761, P289, DOI 10.1007/978-3-642-04268-3_36; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jia HJ, 2010, NEUROIMAGE, V51, P1057, DOI 10.1016/j.neuroimage.2010.03.010; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kazemi K, 2007, NEUROIMAGE, V37, P463, DOI 10.1016/j.neuroimage.2007.05.004; Kikinis R, 1996, IEEE T VIS COMPUT GR, V2, P232, DOI 10.1109/2945.537306; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Pham DL, 1999, PATTERN RECOGN LETT, V20, P57, DOI 10.1016/S0167-8655(98)00121-4; Prastawa M, 2005, MED IMAGE ANAL, V9, P457, DOI 10.1016/j.media.2005.05.007; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shi F, 2010, NEUROIMAGE, V51, P684, DOI 10.1016/j.neuroimage.2010.02.025; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Song Z, 2007, LECT NOTES COMPUT SC, V4791, P883; Spitzer V, 1996, J AM MED INFORM ASSN, V3, P118, DOI 10.1136/jamia.1996.96236280; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang SY, 2009, NEUROIMAGE, V47, P1277, DOI 10.1016/j.neuroimage.2009.02.043; Thompson P. M., 2002, Computing and Visualization in Science, V5, P13, DOI 10.1007/s00791-002-0084-6; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; Toga A.W., 2002, BRAIN MAPPING METHOD; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VANHORN JD, 2009, BRAIN ATLASES THEIR, P263; Weisenfeld NI, 2006, I S BIOMED IMAGING, P766; Weisenfeld NI, 2006, LECT NOTES COMPUT SC, V4190, P199; Weisenfeld NI, 2009, NEUROIMAGE, V47, P564, DOI 10.1016/j.neuroimage.2009.04.068; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; WU G, 2011, HUMAN BRAIN IN PRESS; Wu GR, 2010, NEUROIMAGE, V49, P2225, DOI 10.1016/j.neuroimage.2009.10.065; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	47	309	313	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18746	10.1371/journal.pone.0018746	http://dx.doi.org/10.1371/journal.pone.0018746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533194	Green Published, Green Submitted, gold			2022-12-25	WOS:000289505600028
J	Arnold, W; Ruf, T; Frey-Roos, F; Bruns, U				Arnold, Walter; Ruf, Thomas; Frey-Roos, Fredy; Bruns, Ute			Diet-Independent Remodeling of Cellular Membranes Precedes Seasonally Changing Body Temperature in a Hibernator	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SQUIRREL CITELLUS-CITELLUS; MARMOTS MARMOTA-MARMOTA; BROWN ADIPOSE-TISSUE; PROTEIN FUNCTION; GROUND-SQUIRREL; MAMMALIAN HIBERNATION; ANTIOXIDANT DEFENSES; LIPID-COMPOSITION; ELDERLY-PEOPLE	Polyunsaturated fatty acids (PUFA) have a multitude of health effects. Their incorporation into membrane phospholipids (PL) is generally believed to depend directly on dietary influx. PL influence transmembrane protein activity and thus can compensate temperature effects; e.g. PL n-6 PUFA are thought to stabilize heart function at low body temperature (T(b)), whereas long chain (>C18) n-3 PUFA may boost oxidative capacity. We found substantial remodeling of membranes in free-living alpine marmots which was largely independent of direct dietary supply. Organ PL n-6 PUFA and n-6 to n-3 ratios were highest at onset and end of hibernation after rapid increases during a brief transitional period prior to hibernation. In contrast, longer chain PL n-3 PUFA content was low at end of summer but maximal at end of hibernation. After termination of hibernation in spring, these changes in PL composition were rapidly reversed. Our results demonstrate selective trafficking of PUFA within the body, probably governed by a circannual endogenous rhythm, as hibernating marmots were in winter burrows isolated for seven months from food and external cues signaling the approaching spring. High concentrations of PL n-6 PUFA throughout hibernation are in line with their hypothesized function of boosting SERCA 2a activity at low T(b). Furthermore, we found increasing rate of rewarming from torpor during winter indicating increasing oxidative capacity that could be explained by the accumulation of long-chain PL n-3 PUFA. It may serve to minimize the time necessary for rewarming despite the increasing temperature range to be covered, because rewarming is a period of highest metabolic rate and hence production of reactive oxygen species. Considering the importance of PUFA for health our results may have important biomedical implications, as seasonal changes of T(b) and associated remodeling of membranes are not restricted to hibernators but presumably common among endothermic organisms.	[Arnold, Walter; Ruf, Thomas; Frey-Roos, Fredy; Bruns, Ute] Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria	University of Veterinary Medicine Vienna	Arnold, W (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Vienna, Austria.	walter.arnold@fiwi.at	Arnold, Walter/C-3394-2013	Arnold, Walter/0000-0001-6785-5685; Ruf, Thomas/0000-0002-9235-7079	Austrian Science Fund (FWF) [P12430-BIO]; Swiss Bank UBS	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss Bank UBS	Supported by Austrian Science Fund (FWF project P12430-BIO), and the Swiss Bank UBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA RC, 1989, BIOCHIM BIOPHYS ACTA, V988, P123, DOI 10.1016/0304-4157(89)90007-5; Armstrong VT, 2003, ARCH BIOCHEM BIOPHYS, V414, P74, DOI 10.1016/S0003-9861(03)00159-0; ARNOLD W, 1991, J THERM BIOL, V16, P223, DOI 10.1016/0306-4565(91)90029-2; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; ARNOLD W, 1990, BEHAV ECOL SOCIOBIOL, V27, P239; Arnold W, 2006, J EXP BIOL, V209, P4566, DOI 10.1242/jeb.02536; Arnold Walter, 1993, P65; Arnold Walter, 1993, Verhandlungen der Deutschen Zoologischen Gesellschaft, V86, P79; Arntz HR, 2000, EUR HEART J, V21, P315, DOI 10.1053/euhj.1999.1739; BEZARD J, 1994, REPROD NUTR DEV, V34, P539, DOI 10.1051/rnd:19940603; BUZADZIC B, 1990, FREE RADICAL BIO MED, V9, P401, DOI 10.1016/0891-5849(90)90016-C; BUZADZIC B, 1990, FREE RADICAL BIO MED, V9, P407, DOI 10.1016/0891-5849(90)90017-D; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; CARLIER H, 1991, REPROD NUTR DEV, V31, P475, DOI 10.1051/rnd:19910501; Carrillo-Tripp M, 2005, BIOCHEMISTRY-US, V44, P10164, DOI 10.1021/bi050822e; CHRISTIE WW, 1996, LIPID ANAL; Connor WE, 1996, J LIPID RES, V37, P290; Corcoran MP, 2007, AM J CLIN NUTR, V85, P662; Crawford VLS, 2003, AGE AGEING, V32, P661, DOI 10.1093/ageing/afg113; Crawford VLS, 2003, QJM-INT J MED, V96, P45, DOI 10.1093/qjmed/hcg005; Crockett EL, 2008, J COMP PHYSIOL B, V178, P795, DOI 10.1007/s00360-008-0275-7; Cuculescu M, 1999, P NATL ACAD SCI USA, V96, P6501, DOI 10.1073/pnas.96.11.6501; De Vriese SR, 2004, PROSTAG LEUKOTR ESS, V71, P13, DOI 10.1016/j.plefa.2003.12.002; EDER K, 1995, J CHROMATOGR B, V671, P113, DOI 10.1016/0378-4347(95)00142-6; Falkenstein F, 2001, J COMP PHYSIOL B, V171, P189, DOI 10.1007/s003600000157; Florant GL, 1998, AM ZOOL, V38, P331; FLORANT GL, 1990, AM J PHYSIOL, V258, pR1123, DOI 10.1152/ajpregu.1990.258.5.R1123; FLORANT GL, 1991, DIET OBESITY, P45; Geiser F, 2007, NATURWISSENSCHAFTEN, V94, P319, DOI 10.1007/s00114-006-0193-z; Gerson AR, 2008, J EXP BIOL, V211, P2689, DOI 10.1242/jeb.013714; Goodwin J, 2001, AGE AGEING, V30, P311, DOI 10.1093/ageing/30.4.311; Guderley H, 2008, J COMP PHYSIOL B, V178, P385, DOI 10.1007/s00360-007-0231-y; HALBERG F, 1983, International Journal of Chronobiology, V8, P225; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; Hill VL, 1999, CAN J ZOOL, V77, P1494, DOI 10.1139/cjz-77-9-1494; Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399; INGEMANNHANSEN T, 1982, EUR J APPL PHYSIOL O, V49, P151, DOI 10.1007/BF02334063; Kakela R, 2008, AM J PHYSIOL-REG I, V294, pR1716, DOI 10.1152/ajpregu.00883.2007; Lakatta Edward G, 2002, Mol Interv, V2, P431, DOI 10.1124/mi.2.7.431; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; Leaf A, 2005, J MEMBRANE BIOL, V206, P129, DOI 10.1007/s00232-005-0789-9; LEPAGE G, 1986, J LIPID RES, V27, P114; Lundbaek JA, 2006, J PHYS-CONDENS MAT, V18, pS1305, DOI 10.1088/0953-8984/18/28/S13; Nagahuedi S, 2009, J EXP BIOL, V212, P1106, DOI 10.1242/jeb.027888; Ocloo A, 2007, AM J PHYSIOL-REG I, V293, pR1086, DOI 10.1152/ajpregu.00128.2007; Orr AL, 2009, COMP BIOCHEM PHYS A, V153, P213, DOI 10.1016/j.cbpa.2009.02.016; Ortmann S, 2000, AM J PHYSIOL-REG I, V278, pR698, DOI 10.1152/ajpregu.2000.278.3.R698; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2009, R FDN STAT COMP; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; ROTERMUND AJ, 1981, COMP BIOCHEM PHYS B, V69, P523, DOI 10.1016/0305-0491(81)90345-X; Ruf T, 2000, LIFE IN THE COLD, P81; Ruf T, 2008, AM J PHYSIOL-REG I, V294, pR1044, DOI 10.1152/ajpregu.00688.2007; SIGNER C, 2010, FUNCT ECOL, DOI DOI 10.1111/J.1365-2435.2010.01806.X; Soriguer FJ, 2000, EUR J EPIDEMIOL, V16, P585, DOI 10.1023/A:1007684808188; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; TIAN X, 1993, AM J PHYSIOL, V265, pR414; Tull SP, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000177; Urbankova E, 2003, J BIOL CHEM, V278, P32497, DOI 10.1074/jbc.M303721200; Valencak TG, 2007, AGING CELL, V6, P15, DOI 10.1111/j.1474-9726.2006.00257.x; Valencak TG, 2003, J COMP PHYSIOL B, V173, P695, DOI 10.1007/s00360-003-0382-4; Yan J, 2006, PHYSIOL GENOMICS, V25, P346, DOI 10.1152/physiolgenomics.00260.2005	63	61	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18641	10.1371/journal.pone.0018641	http://dx.doi.org/10.1371/journal.pone.0018641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533242	gold, Green Submitted, Green Published			2022-12-25	WOS:000289458800024
J	Karinen, S; Heikkinen, T; Nevanlinna, H; Hautaniemi, S				Karinen, Sirkku; Heikkinen, Tuomas; Nevanlinna, Heli; Hautaniemi, Sampsa			Data Integration Workflow for Search of Disease Driving Genes and Genetic Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BREAST-CANCER; POLYMORPHIC VARIANTS; SUSCEPTIBILITY LOCI; HUMAN SNPS; P53; ANNOTATION; PATHWAYS; EXPRESSION; SELECTION	Comprehensive characterization of a gene's impact on phenotypes requires knowledge of the context of the gene. To address this issue we introduce a systematic data integration method Candidate Genes and SNPs (CANGES) that links SNP and linkage disequilibrium data to pathway-and protein-protein interaction information. It can be used as a knowledge discovery tool for the search of disease associated causative variants from genome-wide studies as well as to generate new hypotheses on synergistically functioning genes. We demonstrate the utility of CANGES by integrating pathway and protein-protein interaction data to identify putative functional variants for (i) the p53 gene and (ii) three glioblastoma multiforme (GBM) associated risk genes. For the GBM case, we further integrate the CANGES results with clinical and genome-wide data for 209 GBM patients and identify genes having effects on GBM patient survival. Our results show that selecting a focused set of genes can result in information beyond the traditional genome-wide association approaches. Taken together, holistic approach to identify possible interacting genes and SNPs with CANGES provides a means to rapidly identify networks for any set of genes and generate novel hypotheses. CANGES is available in http://csbi.ltdk.helsinki.fi/CANGES/	[Karinen, Sirkku] Univ Helsinki, Sirkku Karinen Inst Biomed, Helsinki, Finland; [Karinen, Sirkku; Hautaniemi, Sampsa] Univ Helsinki, Genome Scale Biol Res Program, Helsinki, Finland; [Heikkinen, Tuomas] Univ Helsinki, Cent Hosp, Tuomas Heikkinen Dept Obstet & Gynecol, Helsinki, Finland; [Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Heli Nevanlinna Dept Obstet & Gynecol, Helsinki, Finland; [Hautaniemi, Sampsa] Univ Helsinki, Sampsa Hautaniemi Inst Biomed, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Karinen, S (corresponding author), Univ Helsinki, Sirkku Karinen Inst Biomed, Helsinki, Finland.	sampsa.hautaniemi@helsinki.fi	Hautaniemi, Sampsa/CAG-0362-2022; Hautaniemi, Sampsa/A-3122-2009	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Nevanlinna, Heli/0000-0002-0916-2976; Heikkinen, Tuomas/0000-0003-1154-6204	Academy of Finland [125826, 110663]; University of Helsinki; Biocentrum Helsinki and Finnish Graduate School in Computational Sciences; Finnish Cancer Society; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); University of Helsinki; Biocentrum Helsinki and Finnish Graduate School in Computational Sciences; Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work has been supported by the Academy of Finland (projects 125826, 110663), University of Helsinki Funds, Biocentrum Helsinki and Finnish Graduate School in Computational Sciences (SK), Helsinki University Central Hospital Research Fund, the Finnish Cancer Society, and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen K, 2009, BRIT J CANCER, V100, P1055, DOI 10.1038/sj.bjc.6604874; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Calabria A, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-138; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Haider S., 2009, NUCL ACIDS RES; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karchin R, 2009, BRIEF BIOINFORM, V10, P35, DOI 10.1093/bib/bbn047; Lee PH, 2008, NUCLEIC ACIDS RES, V36, pD820, DOI 10.1093/nar/gkm904; Li ST, 2007, NUCLEIC ACIDS RES, V35, pD707, DOI 10.1093/nar/gkl969; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Pico AR, 2009, NUCLEIC ACIDS RES, V37, pD803, DOI 10.1093/nar/gkn756; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Savas S, 2009, INT J CANCER, V125, P1257, DOI 10.1002/ijc.24535; Schmidt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2460; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Siddique MM, 2005, CANCER EPIDEM BIOMAR, V14, P2245, DOI 10.1158/1055-9965.EPI-05-0153; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thomas DC, 2005, CANCER EPIDEM BIOMAR, V14, P557, DOI 10.1158/1055-9965.EPI-14-3-EDB; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; Weber RG, 2001, INT J CANCER, V91, P213, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1036>3.3.CO;2-D; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; YU K, 2009, EUR J HUM GENET; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18636	10.1371/journal.pone.0018636	http://dx.doi.org/10.1371/journal.pone.0018636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533266	Green Submitted, Green Published, gold			2022-12-25	WOS:000289404700024
J	Nakatsuji, T; Tang, DCC; Zhang, LF; Gallo, RL; Huang, CM				Nakatsuji, Teruaki; Tang, De-chu C.; Zhang, Liangfang; Gallo, Richard L.; Huang, Chun-Ming			Propionibacterium acnes CAMP Factor and Host Acid Sphingomyelinase Contribute to Bacterial Virulence: Potential Targets for Inflammatory Acne Treatment	PLOS ONE			English	Article							GROUP-B STREPTOCOCCI; NEUTRAL SPHINGOMYELINASES; LISTERIA-MONOCYTOGENES; CYTOKINE RESPONSES; ANCHORED PROTEINS; HUMAN SEBOCYTES; COMPLETE GENOME; IN-VIVO; AGALACTIAE; EXPRESSION	Background: In the progression of acne vulgaris, the disruption of follicular epithelia by an over-growth of Propionibacterium acnes (P. acnes) permits the bacteria to spread and become in contact with various skin and immune cells. Methodology/Principal Findings: We have demonstrated in the present study that the Christie, Atkins, Munch-Peterson (CAMP) factor of P. acnes is a secretory protein with co-hemolytic activity with sphingomyelinase that can confer cytotoxicity to HaCaT keratinocytes and RAW264.7 macrophages. The CAMP factor from bacteria and acid sphingomyelinase (ASMase) from the host cells were simultaneously present in the culture supernatant only when the cells were co-cultured with P. acnes. Either anti-CAMP factor serum or desipramine, a selective ASMase inhibitor, significantly abrogated the P. acnes-induced cell death of HaCaT and RAW264.7 cells. Intradermal injection of ICR mouse ears with live P. acnes induced considerable ear inflammation, macrophage infiltration, and an increase in cellular soluble ASMase. Suppression of ASMase by systemic treatment with desipramine significantly reduced inflammatory reaction induced by intradermal injection with P. acnes, suggesting the contribution of host ASMase in P. acnes-induced inflammatory reaction in vivo. Vaccination of mice with CAMP factor elicited a protective immunity against P. acnes-induced ear inflammation, indicating the involvement of CAMP factor in P. acnes-induced inflammation. Most notably, suppression of both bacterial CAMP factor and host ASMase using vaccination and specific antibody injection, respectively, cooperatively alleviated P. acnes-induced inflammation. Conclusions/Significance: These findings envision a novel infectious mechanism by which P. acnes CAMP factor may hijack host ASMase to amplify bacterial virulence to degrade and invade host cells. This work has identified both CAMP factor and ASMase as potential molecular targets for the development of drugs and vaccines against acne vulgaris.	[Nakatsuji, Teruaki; Gallo, Richard L.; Huang, Chun-Ming] Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA; [Nakatsuji, Teruaki; Gallo, Richard L.; Huang, Chun-Ming] VA San Diego Healthcare Ctr, San Diego, CA USA; [Zhang, Liangfang] Univ Calif San Diego, Dept Nanoengn, San Diego, CA 92103 USA; [Tang, De-chu C.] Vaxin Inc, Birmingham, AL USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Nakatsuji, T (corresponding author), Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA.	chunming@ucsd.edu	Gallo, Richard L/A-8931-2009; Nakatsuji, Teruaki/O-6794-2014; , Chun-Ming/AAM-1856-2020	Gallo, Richard L/0000-0002-1401-7861; Nakatsuji, Teruaki/0000-0002-6187-2991; , Chun-Ming/0000-0002-3352-5394	National Institutes of Health [R01-AI067395-01, R21-R022754-01, R21-I58002-01, 1R41-AR056169-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083358, R01AI067395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R41AR056169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants (R01-AI067395-01, R21-R022754-01, R21-I58002-01 and 1R41-AR056169-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBOUZ S, 1986, LIFE SCI, V38, P357, DOI 10.1016/0024-3205(86)90083-4; ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Bernard P, 2008, CURR OPIN INFECT DIS, V21, P122, DOI 10.1097/QCO.0b013e3282f44c63; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROWN J, 1974, INFECT IMMUN, V9, P377, DOI 10.1128/IAI.9.2.377-383.1974; Bruggemann H, 2005, SEMIN CUTAN MED SURG, V24, P67, DOI 10.1016/j.sder.2005.03.001; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Chavant P, 2004, FEMS MICROBIOL LETT, V236, P241, DOI 10.1111/j.1574-6968.2004.tb09653.x; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; CUNLIFFE WJ, 2001, ACNE, P29; Degitz Klaus, 2007, J Dtsch Dermatol Ges, V5, P316, DOI 10.1111/j.1610-0387.2007.06274.x; DEYOUNG LM, 1985, J INVEST DERMATOL, V85, P255, DOI 10.1111/1523-1747.ep12276732; DEYOUNG LM, 1984, J INVEST DERMATOL, V83, P394, DOI 10.1111/1523-1747.ep12264715; El-Huneidi W, 2007, MED MICROBIOL IMMUN, V196, P73, DOI 10.1007/s00430-006-0028-8; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Haider A, 2004, JAMA-J AM MED ASSOC, V292, P726, DOI 10.1001/jama.292.6.726; Hensler ME, 2008, MICROB PATHOGENESIS, V44, P84, DOI 10.1016/j.micpath.2007.08.005; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P374, DOI 10.1016/S0968-0004(98)01289-4; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Jiang M, 1996, MICROB PATHOGENESIS, V20, P297, DOI 10.1006/mpat.1996.0028; JURGENS D, 1987, J EXP MED, V165, P720, DOI 10.1084/jem.165.3.720; KARCHOUDHURY TK, 1978, J CLIN MICROBIOL, V8, P238; Kim J, 2005, DERMATOLOGY, V211, P193, DOI 10.1159/000087011; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; KLIGMAN AM, 1974, J INVEST DERMATOL, V62, P268, DOI 10.1111/1523-1747.ep12676801; KOBAYASHI F, 1980, INFECT IMMUN, V27, P391, DOI 10.1128/IAI.27.2.391-396.1980; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; LEEMING JP, 1988, BRIT J DERMATOL, V118, P203, DOI 10.1111/j.1365-2133.1988.tb01775.x; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Leyden JJ, 1998, DERMATOLOGY, V196, P55, DOI 10.1159/000017868; Litwin CM, 2005, INFECT IMMUN, V73, P4205, DOI 10.1128/IAI.73.7.4205-4213.2005; Liu GY, 2004, P NATL ACAD SCI USA, V101, P14491, DOI 10.1073/pnas.0406143101; Liu YT, 2008, PROTEIN EXPRES PURIF, V57, P72, DOI 10.1016/j.pep.2007.08.016; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; MARTIN A, 1993, CYTOTECHNOLOGY, V11, P49, DOI 10.1007/BF00749057; MARTIN A, 1991, IN VITRO CELL DEV B, V27, P183; McCollister BD, 2007, INFECT IMMUN, V75, P5346, DOI 10.1128/IAI.00689-07; Nagafuku M, 2003, J BIOL CHEM, V278, P51920, DOI 10.1074/jbc.M307674200; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2009, J INVEST DERMATOL; Nakatsuji T, 2008, J INVEST DERMATOL, V128, P2451, DOI 10.1038/jid.2008.117; Nakatsuji T, 2008, PROTEOMICS, V8, P3406, DOI 10.1002/pmic.200800044; Nakatsuji T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001551; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Perry AL, 2006, LETT APPL MICROBIOL, V42, P185, DOI 10.1111/j.1472-765X.2006.01866.x; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Rosen Ted, 2007, J Drugs Dermatol, V6, P582; ROWE GE, 1994, METHOD ENZYMOL, V235, P657; Schnupf P, 2007, MICROBES INFECT, V9, P1176, DOI 10.1016/j.micinf.2007.05.005; SCHRAMM M, 2008, CELL MICROBIOL; SKALKA B, 1981, ZBL BAKT-INT J MED M, V249, P190; SMITH JP, 1979, AM J MED TECHNOL, V45, P199; Stoffel W, 1999, CHEM PHYS LIPIDS, V102, P107, DOI 10.1016/S0009-3084(99)00079-1; Till AE, 2000, BRIT J DERMATOL, V142, P885, DOI 10.1046/j.1365-2133.2000.03467.x; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Toyoda Masahiko, 2001, Medical Electron Microscopy, V34, P29, DOI 10.1007/s007950100002; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Utermohlen O, 2003, J IMMUNOL, V170, P2621, DOI 10.4049/jimmunol.170.5.2621; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; WEBSTER GF, 1985, INFECT IMMUN, V49, P116, DOI 10.1128/IAI.49.1.116-121.1985; Wu XM, 2008, CARBOHYD RES, V343, P1718, DOI 10.1016/j.carres.2008.03.033; Yang J, 2004, CELL BIOCHEM BIOPHYS, V40, P323, DOI 10.1385/CBB:40:3:323	66	76	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e14797	10.1371/journal.pone.0014797	http://dx.doi.org/10.1371/journal.pone.0014797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533261	Green Published, Green Submitted, gold			2022-12-25	WOS:000289404700002
J	Whitney, JB; Asmal, M; Geiben-Lynn, R				Whitney, James B.; Asmal, Mohammed; Geiben-Lynn, Ralf			Serpin Induced Antiviral Activity of Prostaglandin Synthetase-2 against HIV-1 Replication	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LEUKOCYTE PROTEASE INHIBITOR; ANTITHROMBIN-III; ALPHA-1-ANTITRYPSIN DEFICIENCY; ISCHEMIA-REPERFUSION; IN-VITRO; STRAIN; COAGULATION; RECRUITMENT; INFECTION	The serine protease inhibitors (serpins) are anti-inflammatory proteins that have various functions. By screening a diverse panel of viruses, we demonstrate that the serpin antithrombin III (ATIII) has a broad-spectrum anti-viral activity for HIV-1, HCV and HSV. To investigate the mechanism of action in more detail we investigated the HIV-1 inhibition. Using gene-expression arrays we found that multiple host cell signal transduction pathways were activated by ATIII in HIV-1 infected cells but not in uninfected controls. Moreover, the signal pathways initiated by ATIII treatment, were more than 200-fold increased by the use of heparin-activated ATIII. The most up-regulated transcript in HIV-1 infected cells was prostaglandin synthetase-2 (PTGS2). Furthermore, we found that over-expression of PTGS2 reduced levels of HIV-1 replication in human PBMC. These findings suggest a central role for serpins in the host innate anti-viral response. Host factors such as PTGS2 elicited by ATIII treatment could be exploited in the development of novel anti-viral interventions.	[Whitney, James B.; Asmal, Mohammed; Geiben-Lynn, Ralf] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Whitney, James B.; Asmal, Mohammed; Geiben-Lynn, Ralf] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Whitney, JB (corresponding author), Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	acceleration@rcn.com			NIH [N01 AI30048, N01 AI30049];  [AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, R01AI030048, R37AI030048, U19AI067854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the NIH biodefense program (N01 AI30048, N01 AI30049) and AI067854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aytekin FO, 2005, AM J SURG, V189, P161, DOI 10.1016/j.amjsurg.2004.11.003; Barnard DL, 2001, ANTIVIR CHEM CHEMOTH, V12, P241, DOI 10.1177/095632020101200405; BARNARD DL, 1993, CHEMOTHERAPY, V39, P212, DOI 10.1159/000239128; Burgener A, 2008, J PROTEOME RES, V7, P4446, DOI 10.1021/pr800406r; Chan ED, 2007, SCAND J INFECT DIS, V39, P690, DOI 10.1080/00365540701225744; Cheung KJ, 2009, J VIRAL HEPATITIS, V16, P418, DOI 10.1111/j.1365-2893.2009.01083.x; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Drusano GL, 1996, ANTIMICROB AGENTS CH, V40, P1143, DOI 10.1128/AAC.40.5.1143; Duru S, 2005, ACTA ANAESTH SCAND, V49, P1142, DOI 10.1111/j.1399-6576.2005.00764.x; Elmaleh DR, 2005, INT J MOL MED, V16, P191; Feistritzer C, 2007, EXPERT OPIN BIOL TH, V7, P855, DOI 10.1517/14712598.7.6.855; Geiben-Lynn R, 2002, J BIOL CHEM, V277, P42352, DOI 10.1074/jbc.M207079200; Geiben-Lynn R, 2001, J VIROL, V75, P8306, DOI 10.1128/JVI.75.17.8306-8316.2001; Hashemi M, 2007, DIABETES RES CLIN PR, V75, P246, DOI 10.1016/j.diabres.2006.06.020; Hoffmann JN, 2000, AM J PHYSIOL-CELL PH, V279, pC98, DOI 10.1152/ajpcell.2000.279.1.C98; HUGHESFULFORD M, 1992, ANTIMICROB AGENTS CH, V36, P2253, DOI 10.1128/AAC.36.10.2253; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; KRAMER HB, PLOS PATHOG, V6; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; ORiordan K, 1997, TRANSPLANTATION, V63, P480, DOI 10.1097/00007890-199702150-00028; Ostrovsky L, 1997, CIRCULATION, V96, P2302; Potthoff AV, 2007, AIDS, V21, P2115, DOI 10.1097/QAD.0b013e3282f08b97; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; Sauri H, 1996, J LEUKOCYTE BIOL, V59, P925, DOI 10.1002/jlb.59.6.925; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; SIDWELL RW, 1971, APPL MICROBIOL, V22, P797, DOI 10.1128/AEM.22.5.797-801.1971; Steenbakkers PJM, 2008, MYCOL RES, V112, P999, DOI 10.1016/j.mycres.2008.01.021; Tsuboi H, 2007, AM J PHYSIOL-GASTR L, V292, pG678, DOI 10.1152/ajpgi.00361.2006	34	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18589	10.1371/journal.pone.0018589	http://dx.doi.org/10.1371/journal.pone.0018589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533265	Green Published, Green Submitted, gold			2022-12-25	WOS:000289404700022
J	Jha, S; Patil, SM; Gibson, J; Nelson, CE; Alder, NN; Alexandrescu, AT				Jha, Suman; Patil, Sharadrao M.; Gibson, Jason; Nelson, Craig E.; Alder, Nathan N.; Alexandrescu, Andrei T.			Mechanism of Amylin Fibrillization Enhancement by Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET-AMYLOID-POLYPEPTIDE; FIBRIL FORMATION; IN-VITRO; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; BETA-CELLS; AGGREGATION; PEPTIDE; BINDING; CYTOTOXICITY	We characterized the interaction of amylin with heparin fragments of defined length, which model the glycosaminoglycan chains associated with amyloid deposits found in type 2 diabetes. Binding of heparin fragments to the positively charged N-terminal half of monomeric amylin depends on the concentration of negatively charged saccharides but is independent of oligosaccharide length. By contrast, amylin fibrillogenesis has a sigmoidal dependence on heparin fragment length, with an enhancement observed for oligosaccharides longer than four monomers and a leveling off of effects beyond 12 monomers. The length dependence suggests that the negatively charged helical structure of heparin electrostatically complements the positively charged surface of the fibrillar amylin cross-beta structure. Fluorescence resonance energy transfer and total internal reflection fluorescence microscopy experiments indicate that heparin associates with amylin fibrils, rather than enhancing fibrillogenesis catalytically. Short heparin fragments containing two-or eight-saccharide monomers protect against amylin cytotoxicity toward a MIN6 mouse cell model of pancreatic beta-cells.	[Jha, Suman; Patil, Sharadrao M.; Gibson, Jason; Nelson, Craig E.; Alder, Nathan N.; Alexandrescu, Andrei T.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Alexandrescu, AT (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT 06269 USA.	andrei@uconn.edu	Jha, Suman/AAD-5041-2019	Jha, Suman/0000-0003-3139-7621; Alder, Nathan/0000-0003-4474-7803	American Diabetes Association [1-10-BS-04]; National Institutes of Health National Center for Research Resources [1S10RR016760]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016760] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Basic Science Award 1-10-BS-04 from the American Diabetes Association.; NMR instrumentation was funded in part by Grant 1S10RR016760 from the National Institutes of Health National Center for Research Resources. We thank Dr. Anil Rustgi (University of Pennsylvania) for the MIN6 cell line.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Abedini A, 2006, BIOCHEMISTRY-US, V45, P9228, DOI 10.1021/bi0510936; Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Ban T, 2006, METHOD ENZYMOL, V413, P91, DOI 10.1016/S0076-6879(06)13005-0; Bergamaschini L, 2002, NEUROBIOL AGING, V23, P531, DOI 10.1016/S0197-4580(02)00003-9; Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Brender JR, 2010, J AM CHEM SOC, V132, P8973, DOI 10.1021/ja1007867; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; Garrett R. H., 1999, BIOCHEMISTRY-US, P234; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Green A, 2003, DIABETES-METAB RES, V19, P3, DOI 10.1002/dmrr.340; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222; Knight JD, 2008, PROTEIN SCI, V17, P1850, DOI 10.1110/ps.036350.108; Konarkowska B, 2006, FEBS J, V273, P3614, DOI 10.1111/j.1742-4658.2006.05367.x; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Ma Z, 2001, AMYLOID, V8, P242, DOI 10.3109/13506120108993820; Madine J, 2010, EUR BIOPHYS J BIOPHY, V39, P1281, DOI 10.1007/s00249-010-0581-3; Matveyenko AV, 2006, ILAR J, V47, P225, DOI 10.1093/ilar.47.3.225; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Newgard CB, 2010, NAT MED, V16, P388, DOI 10.1038/nm0410-388; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Patil SM, 2011, BIOCHEMISTRY-US, V50, P2808, DOI 10.1021/bi101908m; Potter K., 2007, CLIN INVEST MED, V30, pS92; Potter-Perigo S, 2003, ARCH BIOCHEM BIOPHYS, V413, P182, DOI 10.1016/S0003-9861(03)00116-4; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Sheftic SR, 2009, METHOD ENZYMOL, V466, P233, DOI 10.1016/S0076-6879(09)66010-9; UCHIYAMA H, 1981, J BIOCHEM-TOKYO, V89, P185, DOI 10.1093/oxfordjournals.jbchem.a133180; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; Zdrojewicz Z., 2006, DIABETOLOGIA DOOESWI, V6, P169; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345	60	57	57	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22894	22904		10.1074/jbc.M110.215814	http://dx.doi.org/10.1074/jbc.M110.215814			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555785	Green Published, hybrid			2022-12-25	WOS:000292025000024
J	Khan, SZ; Mitra, D				Khan, Sohrab Zafar; Mitra, Debashis			Cyclin K Inhibits HIV-1 Gene Expression and Replication by Interfering with Cyclin-dependent Kinase 9 (CDK9)-Cyclin T1 Interaction in Nef-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; CELL-ACTIVATION; IN-VITRO; LENTIVIRAL REPLICATION; VIRAL REPLICATION; BINDING DOMAIN; 7SK SNRNA; TAT; PROTEIN	Human immunodeficiency virus-1 (HIV-1) exploits a number of host cellular factors for successful survival and propagation. The viral protein Nef plays an important role in HIV-1 pathogenesis by interacting with various cellular proteins. In the present work, we identified Cyclin K (CycK) as a novel Nef-interacting protein, and for the first time, we showed that CycK inhibits HIV-1 gene expression and replication in a Nef-dependent manner. The positive elongation factor b complex comprising cyclin-dependent kinase 9 (CDK9) and Cyclin T1 is a critical cellular complex required for viral gene expression and replication. Enhanced expression of CycK in the presence of Nef induced CycK-CDK9 binding, which prevented CDK9-Cyclin T1 complex formation and nuclear translocation of CDK9, resulting in inhibition of HIV-1 long terminal repeat-driven gene expression. Furthermore, this effect of CycK was not observed with Nef-deleted virus, indicating the importance of Nef in this phenomenon. Finally, silencing of CycK in HIV-1-infected cells resulted in increased translocation of CDK9 into the nucleus, leading to increased viral gene expression and replication. These data also suggest that endogenous CycK might act as an inhibitory factor for HIV-1 gene expression and replication in T-cells. Thus, our results clearly demonstrate that CycK utilizes HIV-1 Nef protein to displace CycT1 from the positive elongation factor b complex, resulting in inhibition of HIV-1 gene expression and replication.	[Khan, Sohrab Zafar; Mitra, Debashis] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Mitra, D (corresponding author), Natl Ctr Cell Sci, Pune Univ Campus, Pune 411007, Maharashtra, India.	dmitra@nccs.res.in	Khan, Sohrab/H-4074-2019	Khan, Sohrab/0000-0002-9564-5092	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; AHMAD N, 1988, SCIENCE, V241, P1481, DOI 10.1126/science.3262235; Arora VK, 2002, MICROBES INFECT, V4, P189, DOI 10.1016/S1286-4579(01)01527-1; Baek K, 2007, J MOL BIOL, V366, P563, DOI 10.1016/j.jmb.2006.11.057; Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Boutwell CL, 2010, J INFECT DIS, V202, pS309, DOI 10.1086/655653; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Collette Y, 1999, VIROLOGY, V265, P173, DOI 10.1006/viro.1999.0053; Dandekar DH, 2005, ANAL BIOCHEM, V342, P341, DOI 10.1016/j.ab.2005.02.006; Das SR, 2005, INDIAN J MED RES, V121, P315; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Fackler OT, 2001, J VIROL, V75, P6601, DOI 10.1128/JVI.75.14.6601-6608.2001; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Glushakova S, 1999, J VIROL, V73, P3968, DOI 10.1128/JVI.73.5.3968-3974.1999; Iordanskiy S, 2004, BLOOD, V104, P1867, DOI 10.1182/blood-2004-01-0081; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Joseph AM, 2005, CURR HIV RES, V3, P87, DOI 10.2174/1570162052773013; Joseph AM, 2003, FEBS LETT, V548, P37, DOI 10.1016/S0014-5793(03)00725-7; Jubier-Maurin V, 1999, AIDS RES HUM RETROV, V15, P23, DOI 10.1089/088922299311673; Kamp W, 2000, EUR J CLIN INVEST, V30, P740; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lundquist CA, 2004, J VIROL, V78, P6287, DOI 10.1128/JVI.78.12.6287-6296.2004; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Napolitano G, 2002, J CELL PHYSIOL, V192, P209, DOI 10.1002/jcp.10130; NIEDERMAN TMJ, 1989, P NATL ACAD SCI USA, V86, P1128, DOI 10.1073/pnas.86.4.1128; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Saksela Kalle, 1997, Frontiers in Bioscience, V2, pD606; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Shimizu S, 2007, AIDS, V21, P575, DOI 10.1097/QAD.0b013e32801424a5; Simmons A, 2001, IMMUNITY, V14, P763, DOI 10.1016/S1074-7613(01)00158-3; Stoddart CA, 2003, J VIROL, V77, P2124, DOI 10.1128/JVI.77.3.2124-2133.2003; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Urano E, 2008, AIDS, V22, P1081, DOI 10.1097/QAD.0b013e3282fc7319; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	51	10	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22943	22954		10.1074/jbc.M110.201194	http://dx.doi.org/10.1074/jbc.M110.201194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555514	Green Published, hybrid			2022-12-25	WOS:000292025000029
J	Kim, KB; Yi, JS; Nguyen, N; Lee, JH; Kwon, YC; Ahn, BY; Cho, H; Kim, YK; Yoo, HJ; Lee, JS; Ko, YG				Kim, Ki-Bum; Yi, Jae-Sung; Nga Nguyen; Lee, Joo-Hyung; Kwon, Young-Chan; Ahn, Byung-Yoon; Cho, Hana; Kim, Yoon Ki; Yoo, Hee-Jung; Lee, Jae-Seon; Ko, Young-Gyu			Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAFT PROTEOME REVEALS; ACID BINDING-PROTEIN; ATP SYNTHASE COMPLEX; LIPID RAFTS; GLOBULAR HEADS; CUTTING EDGE; ADHESION; TARGET; CD44; LOCALIZATION	We previously demonstrated that the receptor for the complement component C1q (gC1qR) is a lipid raft protein that is indispensable for adipogenesis and insulin signaling. Here, we provide the first report that gC1qR is an essential component of lamellipodia in human lung carcinoma A549 cells. Cell-surface gC1qR was concentrated in the lamellipodia along with CD44, monosialoganglioside, actin, and phosphorylated focal adhesion kinase in cells stimulated with insulin, IGF-1, EGF, or serum. The growth factor-induced lamellipodia formation and cell migration were significantly decreased in gC1qR-depleted cells, with a concomitant blunt activation of the focal adhesion kinase and the respective receptor tyrosine kinases. Moreover, the gC1qR-depleted cells exhibited a reduced proliferation rate in culture as well as diminished tumorigenic and metastatic activities in grafted mice. We therefore conclude that cell-surface gC1qR regulates lamellipodia formation and metastasis via receptor tyrosine kinase activation.	[Kim, Ki-Bum; Yi, Jae-Sung; Nga Nguyen; Lee, Joo-Hyung; Kwon, Young-Chan; Ahn, Byung-Yoon; Cho, Hana; Kim, Yoon Ki; Ko, Young-Gyu] Korea Univ, Coll Life Sci & Biotechnol, Seoul 136701, South Korea; [Yoo, Hee-Jung; Lee, Jae-Seon] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea	Korea University; Korea Institute of Radiological & Medical Sciences	Ko, YG (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, 1,5 Ka, Seoul 136701, South Korea.	ygko@korea.ac.kr	Lee, Joo-Hyung/ABB-7759-2021	Lee, Joo-Hyung/0000-0001-5345-1102; Kim, Yoon Ki/0000-0003-1303-072X; Cho, Hana/0000-0002-7520-7108	Korea Research Foundation [0001197, 20100025943]; Ministry of Health, Welfare and Family Affairs [09201800]	Korea Research Foundation(National Research Foundation of Korea); Ministry of Health, Welfare and Family Affairs(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Basic Research Laboratory Program of the Korea Research Foundation Grant 0001197 (to Y.-G. K.), National R&D Program for Cancer Control, Ministry of Health, Welfare and Family Affairs Grant 09201800, and Nuclear Research and Development Program of Korea Research Foundation Grant 20100025943 (to J.-S. L.).	Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Baillat G, 2008, BBA-MOL CELL RES, V1783, P2323, DOI 10.1016/j.bbamcr.2008.08.008; Baumgartner M, 2006, P NATL ACAD SCI USA, V103, P13391, DOI 10.1073/pnas.0605950103; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Chen YB, 2009, J SURG ONCOL, V100, P382, DOI 10.1002/jso.21329; Choi Y, 2008, VIROLOGY, V381, P178, DOI 10.1016/j.virol.2008.08.035; Chowdhury A. R., 2009, HYALURONAN BINDING P, P51; Fausther-Bovendo H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000975; Feng XD, 2002, J IMMUNOL, V168, P2441, DOI 10.4049/jimmunol.168.5.2441; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Giepmans BNG, 2009, BBA-BIOMEMBRANES, V1788, P820, DOI 10.1016/j.bbamem.2008.07.015; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; GUPTA S, 1991, EUR J CELL BIOL, V56, P58; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; Kim BW, 2010, EXPERT REV PROTEOMIC, V7, P849, DOI 10.1586/EPR.10.87; Kim KB, 2006, PROTEOMICS, V6, P2444, DOI 10.1002/pmic.200500574; Kim KB, 2009, PROTEOMICS, V9, P2373, DOI 10.1002/pmic.200800811; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kindzelskii AL, 2004, J IMMUNOL, V172, P4681, DOI 10.4049/jimmunol.172.8.4681; Lim BL, 1996, J BIOL CHEM, V271, P26739, DOI 10.1074/jbc.271.43.26739; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Menzies CA, 2008, FASEB J, V22; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Oliferenko S, 2000, J CELL BIOL, V148, P1159, DOI 10.1083/jcb.148.6.1159; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Park JH, 2010, P NATL ACAD SCI USA, V107, P981, DOI 10.1073/pnas.0909565107; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Sanchez-Martin D, 2011, J BIOL CHEM, V286, P5197, DOI 10.1074/jbc.M110.161927; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435	39	56	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23093	23101		10.1074/jbc.M111.233304	http://dx.doi.org/10.1074/jbc.M111.233304			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536672	hybrid, Green Published			2022-12-25	WOS:000292025000043
J	Matsuda, M; Takeshita, K; Kurokawa, T; Sakata, S; Suzuki, M; Yamashita, E; Okamura, Y; Nakagawa, A				Matsuda, Makoto; Takeshita, Kohei; Kurokawa, Tatsuki; Sakata, Souhei; Suzuki, Mamoru; Yamashita, Eiki; Okamura, Yasushi; Nakagawa, Atsushi			Crystal Structure of the Cytoplasmic Phosphatase and Tensin Homolog (PTEN)-like Region of Ciona intestinalis Voltage-sensing Phosphatase Provides Insight into Substrate Specificity and Redox Regulation of the Phosphoinositide Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR; CI-VSP; MEMBRANE-BINDING; PTEN; DOMAIN; SENSOR; DEPHOSPHORYLATES; MECHANISM; GENE	Ciona intestinalis voltage-sensing phosphatase (Ci-VSP) has a transmembrane voltage sensor domain and a cytoplasmic region sharing similarity to the phosphatase and tensin homolog (PTEN). It dephosphorylates phosphatidylinositol 4,5-bis-phosphate and phosphatidylinositol 3,4,5-trisphosphate upon membrane depolarization. The cytoplasmic region is composed of a phosphatase domain and a putative membrane interaction domain, C2. Here we determined the crystal structures of the Ci-VSP cytoplasmic region in three distinct constructs, wildtype (248-576), wild-type (236-576), and G365A mutant (248-576). The crystal structure of WT-236 and G365A-248 had the disulfide bond between the catalytic residue Cys-363 and the adjacent residue Cys-310. On the other hand, the disulfide bond was not present in the crystal structure of WT-248. These suggest the possibility that Ci-VSP is regulated by reactive oxygen species as found in PTEN. These structures also revealed that the conformation of the TI loop in the active site of the Ci-VSP cytoplasmic region was distinct from the corresponding region of PTEN; Ci-VSP has glutamic acid (Glu-411) in the TI loop, orienting toward the center of active site pocket. Mutation of Glu-411 led to acquirement of increased activity toward phosphatidylinositol 3,5-bisphosphate, suggesting that this site is required for determining substrate specificity. Our results provide the basic information of the enzymatic mechanism of Ci-VSP.	[Kurokawa, Tatsuki; Sakata, Souhei; Okamura, Yasushi] Osaka Univ, Grad Sch Med, Lab Integrat Physiol, Dept Physiol, Suita, Osaka 5650871, Japan; [Matsuda, Makoto; Takeshita, Kohei; Suzuki, Mamoru; Yamashita, Eiki; Nakagawa, Atsushi] Osaka Univ, Grad Sch Med, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Okamura, Y (corresponding author), Osaka Univ, Grad Sch Med, Lab Integrat Physiol, Dept Physiol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yokamura@phys2.med.osaka-u.ac.jp; atsushi@protein.osaka-u.ac.jp	Yamashita, Eiki/V-6758-2019; Nakagawa, Atsushi/M-5731-2019; Suzuki, Mamoru/G-6576-2016; Nakagawa, Atsushi/D-4329-2009	Yamashita, Eiki/0000-0002-4278-0039; Nakagawa, Atsushi/0000-0002-1700-7861; Suzuki, Mamoru/0000-0001-7071-5093; Nakagawa, Atsushi/0000-0002-1700-7861	Ministry of Education, Culture, Sports, Science, and Technology; Human Frontier Science Program; Japan Aerospace Exploration Agency; Grants-in-Aid for Scientific Research [21229003] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Japan Aerospace Exploration Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology (to Y. O. and A. N.), a research grant from the Human Frontier Science Program (to Y. O.), and the Japan Aerospace Exploration Agency-Granada Crystallization Facility High Quality Protein Crystallization Project on the Protein Structure and Function Analysis for Application (to A. N.).	Afonine PV, 2005, CCP4 NEWSL, V42; Agarwal R, 2008, J BIOL CHEM, V283, P8946, DOI 10.1074/jbc.M708945200; AITKEN RJ, 1995, J CELL SCI, V108, P2017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Buhrman G, 2005, BIOCHEMISTRY-US, V44, P5307, DOI 10.1021/bi047449f; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Cho SH, 2004, FEBS LETT, V560, P7, DOI 10.1016/S0014-5793(04)00112-7; Chu HM, 2007, PROTEINS, V66, P996, DOI 10.1002/prot.21262; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kishore AI, 2003, BIOPHYS J, V85, P3848, DOI 10.1016/S0006-3495(03)74799-7; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Kohout SC, 2010, NAT CHEM BIOL, V6, P369, DOI 10.1038/nchembio.349; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogasawara M, 2011, GENE EXPR PATTERNS, V11, P233, DOI 10.1016/j.gep.2010.12.004; Okamura Y, 2007, PFLUG ARCH EUR J PHY, V454, P361, DOI 10.1007/s00424-007-0222-6; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; Okamura Y, 2009, J PHYSIOL-LONDON, V587, P513, DOI 10.1113/jphysiol.2008.163097; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsai SJ, 2009, BIOCHEMISTRY-US, V48, P4838, DOI 10.1021/bi900166y; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215	42	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23368	23377		10.1074/jbc.M110.214361	http://dx.doi.org/10.1074/jbc.M110.214361			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543329	hybrid, Green Published			2022-12-25	WOS:000292025000068
J	Farris, SD; Hu, JH; Krishnan, R; Emery, I; Chu, T; Du, L; Kremen, M; Dichek, HL; Gold, E; Ramsey, SA; Dichek, DA				Farris, Stephen D.; Hu, Jie Hong; Krishnan, Ranjini; Emery, Isaac; Chu, Talyn; Du, Liang; Kremen, Michal; Dichek, Helen L.; Gold, Elizabeth; Ramsey, Stephen A.; Dichek, David A.			Mechanisms of Urokinase Plasminogen Activator (uPA)-mediated Atherosclerosis ROLE OF THE uPA RECEPTOR AND S100A8/A9 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEIN; E-DEFICIENT MICE; IN-VIVO; MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; KNOCKOUT MICE; VESSEL WALL; RECEPTOR; MACROPHAGES	Data from clinical studies, cell culture, and animal models implicate the urokinase plasminogen activator (uPA)/uPA receptor (uPAR)/plasminogen system in the development of atherosclerosis and aneurysms. However, the mechanisms through which uPA/uPAR/plasminogen stimulate these diseases are not yet defined. We used genetically modified, atherosclerosis-prone mice, including mice with macrophage-specific uPA overexpression and mice genetically deficient in uPAR to elucidate mechanisms of uPA/uPAR/plasminogen-accelerated atherosclerosis and aneurysm formation. We found that macrophage-specific uPA overexpression accelerates atherosclerosis and causes aortic root dilation in fat-fed Ldlr(-/-) mice (as we previously reported in Apoe(-/-) mice). Macrophage-expressed uPA accelerates atherosclerosis by stimulation of lesion progression rather than initiation and causes disproportionate lipid accumulation in early lesions. uPA-accelerated atherosclerosis and aortic dilation are largely, if not completely, independent of uPAR. In the absence of uPA overexpression, however, uPAR contributes modestly to both atherosclerosis and aortic dilation. Microarray studies identified S100A8 and S100A9 mRNA as the most highly up-regulated transcripts in uPA-overexpressing macrophages; up-regulation of S100A9 protein in uPA-overexpressing macrophages was confirmed by Western blotting. S100A8/A9, which are atherogenic in mice and are expressed in human atherosclerotic plaques, are also up-regulated in the aortae of mice with uPA-overexpressing macrophages, and macrophage S100A9 mRNA is up-regulated by exposure of wild-type macrophages to medium from uPA-overexpressing macrophages. Macrophage microarray data suggest significant effects of uPA overexpression on cell migration and cell-matrix interactions. Our results confirm in a second animal model that macrophage-expressed uPA stimulates atherosclerosis and aortic dilation. They also reveal uPAR independence of these actions and implicate specific pathways in uPA/Plg-accelerated atherosclerosis and aneurysmal disease.	[Dichek, David A.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Dichek, Helen L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Gold, Elizabeth; Ramsey, Stephen A.] Inst Syst Biol, Seattle, WA 98103 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Dichek, DA (corresponding author), 1959 NE Pacific St,Box 357710, Seattle, WA 98195 USA.	ddichek@uw.edu	Emery, Isaac/G-6601-2011	Emery, Isaac/0000-0002-8757-2698; Dichek, David/0000-0002-5224-2736	National Institutes of Health [R01HL080597]; John L. Locke, Jr. Charitable Trust; Howard Hughes Medical Institute; NHLBI, National Institutes of Health [T32HL07828, K25HL098807]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828, K25HL098807, R01HL080597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John L. Locke, Jr. Charitable Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL080597. This work was also supported by the John L. Locke, Jr. Charitable Trust.; Supported by a Howard Hughes Medical Institute Medical Student Fellowship.; Supported by NHLBI, National Institutes of Health Grant T32HL07828.; Supported by NHLBI, National Institutes of Health Grant K25HL098807.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Cozen AE, 2004, CIRCULATION, V109, P2129, DOI 10.1161/01.CIR.0000127369.24127.03; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dichek HL, 2004, J LIPID RES, V45, P551, DOI 10.1194/jlr.M300459-JLR200; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; ELLIS V, 1991, J BIOL CHEM, V266, P12752; Falkenberg M, 1998, CARDIOVASC PATHOL, V7, P223, DOI 10.1016/S1054-8807(97)00114-2; Folsom AR, 2001, ARTERIOSCL THROM VAS, V21, P611, DOI 10.1161/01.ATV.21.4.611; Fuhrman B, 2007, ATHEROSCLEROSIS, V195, pE108, DOI 10.1016/j.atherosclerosis.2007.06.025; Fuhrman B, 2008, ARTERIOSCL THROM VAS, V28, P1361, DOI 10.1161/ATVBAHA.108.166041; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Gu JM, 2005, J CELL PHYSIOL, V204, P73, DOI 10.1002/jcp.20262; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Higashimori M, 2011, ARTERIOSCL THROM VAS, V31, P50, DOI 10.1161/ATVBAHA.110.210971; Hu JH, 2010, CIRCULATION, V121, P1637, DOI 10.1161/CIRCULATIONAHA.109.914945; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ionita MG, 2009, ARTERIOSCL THROM VAS, V29, P1220, DOI 10.1161/ATVBAHA.109.190314; Irizarry R. A., 2003, ANAL GENE EXPRESSION, P102; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Johansson F, 2008, P NATL ACAD SCI USA, V105, P2082, DOI 10.1073/pnas.0709958105; Kienast J, 1998, THROMB HAEMOSTASIS, V79, P579; Kremen M, 2008, P NATL ACAD SCI USA, V105, P17109, DOI 10.1073/pnas.0808650105; Krishnan R, 2009, ARTERIOSCL THROM VAS, V29, P1737, DOI 10.1161/ATVBAHA.109.195529; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; Larson MG, 2008, CIRCULATION, V117, P115, DOI 10.1161/CIRCULATIONAHA.107.654335; LAU W, 1995, J CLIN INVEST, V95, P1957, DOI 10.1172/JCI117879; Li XH, 2010, ARTERIOSCL THROM VAS, V30, P582, DOI 10.1161/ATVBAHA.109.202044; LIJNEN HR, 1981, THROMB RES, V24, P151, DOI 10.1016/0049-3848(81)90040-2; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Lijnen HR, 2002, BIOCHEM SOC T, V30, P163, DOI 10.1042/bst0300163; Ludwig A, 2007, THROMB HAEMOSTASIS, V97, P694; May AE, 2002, BLOOD, V100, P3611, DOI 10.1182/blood-2002-03-0778; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Newton RA, 1998, J IMMUNOL, V160, P1427; Ohwaki K, 2007, ARTERIOSCL THROM VAS, V27, P1050, DOI 10.1161/ATVBAHA.106.137091; PADRO T, 1995, ARTERIOSCL THROM VAS, V15, P893, DOI 10.1161/01.ATV.15.7.893; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Piguet PF, 1999, CIRCULATION, V99, P3315, DOI 10.1161/01.CIR.99.25.3315; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Sakkinen PA, 1999, ARTERIOSCL THROM VAS, V19, P499, DOI 10.1161/01.ATV.19.3.499; SCHNEIDERMAN J, 1995, J CLIN INVEST, V96, P639, DOI 10.1172/JCI118079; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; SHI GY, 1992, J BIOL CHEM, V267, P19363; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Steins MB, 2004, BLOOD COAGUL FIBRIN, V15, P383, DOI 10.1097/01.mbc.0000114441.59147.56; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Veniant MM, 2001, ARTERIOSCL THROM VAS, V21, P1567, DOI 10.1161/hq1001.097780; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Virmani R, 2002, PROG CARDIOVASC DIS, V44, P349, DOI 10.1053/pcad.2002.122475; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821	65	41	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22665	22677		10.1074/jbc.M110.202135	http://dx.doi.org/10.1074/jbc.M110.202135			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536666	Green Published, hybrid			2022-12-25	WOS:000291719900073
J	Clarke, CJ; Mediwala, K; Jenkins, RW; Sutton, CA; Tholanikunnel, BG; Hannun, YA				Clarke, Christopher J.; Mediwala, Krutika; Jenkins, Russell W.; Sutton, Che A.; Tholanikunnel, Baby G.; Hannun, Yusuf A.			Neutral Sphingomyelinase-2 Mediates Growth Arrest by Retinoic Acid through Modulation of Ribosomal S6 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BREAST-CANCER CELLS; MAMMALIAN TARGET; UP-REGULATION; CERAMIDE; ACTIVATION; PROTEIN; DIFFERENTIATION; INHIBITION; SMPD3	All-trans-retinoic acid (ATRA) induces growth arrest of many cell types. Previous studies have reported that ATRA can modulate cellular sphingolipids, but the role of sphingolipids in the ATRA response is not clear. Using MCF-7 cells as a model system, we show that ATRA stimulates an increase in ceramide levels followed by G(0)/G(1) growth arrest. Notably, induction of nSMase2 was the primary effect of ATRA on the sphingolipid network and was both time-and dose-dependent. Importantly, pretreatment with nSMase2 siRNA significantly inhibited ATRA effects on ceramide levels and growth arrest. In contrast, nSMase2 overexpression was sufficient to increase ceramide levels and induce G(0)/G(1) growth arrest of asynchronous MCF-7 cells. Surprisingly, neither ATRA stimulation nor nSMase2 overexpression had significant effects on classical cell cycle regulators such as p21/WAF1 or retinoblastoma. In contrast, ATRA suppressed phosphorylation of ribosomal S6 kinase (S6K) and its downstream targets S6 and eIF4B. Importantly, these effects were significantly inhibited by nSMase2 siRNA. Reciprocally, nSMase2 overexpression was sufficient to suppress S6K phosphorylation and signaling. Notably, neither ATRA effects nor nSMase2 effects on S6K phosphorylation required the ceramide-activated protein phosphatase PP2A, previously identified as important for S6K regulation. Finally, nSMase2 overexpression was sufficient to decrease translation as measured by methionine incorporation and analysis of polyribosome profiles. Taken together, these results implicate nSMase2 as a major component of ATRA-induced growth arrest of MCF-7 cells and identify S6K as a novel downstream target of nSMase2.	[Clarke, Christopher J.; Mediwala, Krutika; Jenkins, Russell W.; Sutton, Che A.; Tholanikunnel, Baby G.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [GM 43825]; American Heart Association; National Center for Research Resources [C06 RR01882]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 43825 (to Y. A. H.). This work was also supported by an American Heart Association predoctoral fellowship (to R. W. J.). Work conducted in the Lipidomics Core was supported by NIH grant C06 RR01882 from the extramural research program of the National Center for Research Resources.	Adams SL, 2007, J CELL PHYSIOL, V213, P635, DOI 10.1002/jcp.21262; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Chae YM, 2009, BMB REP, V42, P86, DOI 10.5483/BMBRep.2009.42.2.086; Cho JY, 2006, GENE, V372, P71, DOI 10.1016/j.gene.2005.12.010; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Corlazzoli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004305; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DELEENHEER AP, 1982, J LIPID RES, V23, P1362; Demircan B, 2009, GENE CHROMOSOME CANC, V48, P83, DOI 10.1002/gcc.20620; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ito H, 2009, BBA-GENE REGUL MECH, V1789, P681, DOI 10.1016/j.bbagrm.2009.08.006; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Lal L, 2005, BLOOD, V105, P1669, DOI 10.1182/blood-2004-06-2078; Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; MAZARS P, 1995, FEBS LETT, V362, P295, DOI 10.1016/0014-5793(95)00247-7; Murakami M, 2010, J NEUROCHEM, V112, P511, DOI 10.1111/j.1471-4159.2009.06486.x; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074/jbc.M111594200; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Somenzi G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000836; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Sun W, 2009, FASEB J, V23, P656, DOI 10.1096/fj.08-115634; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Wang Q, 2001, BREAST CANCER RES TR, V67, P157, DOI 10.1023/A:1010643323268; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012	43	21	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21565	21576		10.1074/jbc.M110.193375	http://dx.doi.org/10.1074/jbc.M110.193375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21536668	Green Published, hybrid			2022-12-25	WOS:000291464700054
J	Guo, BH; Lin, JZ; Ye, KQ				Guo, Bihong; Lin, Jinzhong; Ye, Keqiong			Structure of the Autocatalytic Cysteine Protease Domain of Potyvirus Helper-component Proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO-ETCH-POTYVIRUS; LONG-DISTANCE MOVEMENT; HYPOVIRULENCE-ASSOCIATED VIRUS; CHESTNUT BLIGHT FUNGUS; SMALL RNA-BINDING; HC-PRO; MULTIFUNCTIONAL PROTEIN; SILENCING SUPPRESSION; GENOME AMPLIFICATION; APHID TRANSMISSION	The helper-component proteinase (HC-Pro) of potyvirus is involved in polyprotein processing, aphid transmission, and suppression of antiviral RNA silencing. There is no high resolution structure reported for any part of HC-Pro, hindering mechanistic understanding of its multiple functions. We have determined the crystal structure of the cysteine protease domain of HC-Pro from turnip mosaic virus at 2.0 angstrom resolution. As a protease, HC-Pro only cleaves a Gly-Gly dipeptide at its own C terminus. The structure represents a postcleavage state in which the cleaved C terminus remains tightly bound at the active site cleft to prevent trans activity. The structure adopts a compact alpha/beta-fold, which differs from papain-like cysteine proteases and shows weak similarity to nsP2 protease from Venezuelan equine encephalitis alphavirus. Nevertheless, the catalytic cysteine and histidine residues constitute an active site that is highly similar to these in papain-like and nsP2 proteases. HC-Pro recognizes a consensus sequence YXVGG around the cleavage site between the two glycine residues. The structure delineates the sequence specificity at sites P1-P4. Structural modeling and covariation analysis across the Potyviridae family suggest a tryptophan residue accounting for the glycine specificity at site P1'. Moreover, a surface of the protease domain is conserved in potyvirus but not in other genera of the Potyviridae family, likely due to extra functional constrain. The structure provides insight into the catalysis mechanism, cis-acting mode, cleavage site specificity, and other functions of the HC-Pro protease domain.	[Guo, Bihong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Guo, Bihong; Lin, Jinzhong; Ye, Keqiong] Natl Inst Biol Sci, Beijing 102206, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing	Ye, KQ (corresponding author), 7 Sci Pk Rd, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526	Chinese Ministry of Science and Technology [2010CB835402, 2008AA022310]; Beijing Municipal Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government	This work was supported by the Chinese Ministry of Science and Technology through projects 973 (2010CB835402) and 863 (2008AA022310) and the Beijing Municipal Government.	Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Blanc S, 1998, J GEN VIROL, V79, P3119, DOI 10.1099/0022-1317-79-12-3119; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; CARRINGTON JC, 1992, VIROLOGY, V187, P308, DOI 10.1016/0042-6822(92)90319-K; CARRINGTON JC, 1989, J VIROL, V63, P4459, DOI 10.1128/JVI.63.10.4459-4463.1989; CARRINGTON JC, 1987, J VIROL, V61, P2540, DOI 10.1128/JVI.61.8.2540-2548.1987; CARRINGTON JC, 1989, EMBO J, V8, P365, DOI 10.1002/j.1460-2075.1989.tb03386.x; Carstens EB, 2010, ARCH VIROL, V155, P133, DOI 10.1007/s00705-009-0547-x; CHOI GH, 1991, VIROLOGY, V183, P747, DOI 10.1016/0042-6822(91)91004-Z; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; CRONIN S, 1995, PLANT CELL, V7, P549, DOI 10.1105/tpc.7.5.549; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; DOLJA VV, 1993, J VIROL, V67, P5968, DOI 10.1128/JVI.67.10.5968-5975.1993; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAUQUET CM, 2005, VIRUS TAXONOMY 8 REP, P819; GOVIER DA, 1974, VIROLOGY, V61, P420, DOI 10.1016/0042-6822(74)90278-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KASSCHAU KD, 1995, VIROLOGY, V209, P268, DOI 10.1006/viro.1995.1254; Kasschau KD, 1997, VIROLOGY, V228, P251, DOI 10.1006/viro.1996.8368; Kasschau KD, 2001, VIROLOGY, V285, P71, DOI 10.1006/viro.2001.0901; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Li WM, 2008, VIRUS RES, V135, P213, DOI 10.1016/j.virusres.2008.03.015; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maia IG, 1996, J GEN VIROL, V77, P1335, DOI 10.1099/0022-1317-77-7-1335; MAVANKAL G, 1991, VIROLOGY, V185, P721, DOI 10.1016/0042-6822(91)90543-K; Mbanzibwa DR, 2009, J VIROL, V83, P6934, DOI 10.1128/JVI.00537-09; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; OH CS, 1989, VIROLOGY, V173, P692, DOI 10.1016/0042-6822(89)90582-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng YH, 1998, J GEN VIROL, V79, P897, DOI 10.1099/0022-1317-79-4-897; Plisson C, 2003, J BIOL CHEM, V278, P23753, DOI 10.1074/jbc.M302512200; POLGAR L, 2004, HDB PROTEOLYTIC ENZY, P1072; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Ruiz-Ferrer V, 2005, J VIROL, V79, P3758, DOI 10.1128/JVI.79.6.3758-3765.2005; Russo AT, 2006, STRUCTURE, V14, P1449, DOI 10.1016/j.str.2006.07.010; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SHAPIRA R, 1991, J BIOL CHEM, V266, P19419; Shi XM, 1997, VIROLOGY, V231, P35, DOI 10.1006/viro.1997.8488; Shiboleth YM, 2007, J VIROL, V81, P13135, DOI 10.1128/JVI.01031-07; Stenger DC, 2005, J VIROL, V79, P12077, DOI 10.1128/JVI.79.18.12077-12080.2005; Torres-Barcelo C, 2008, GENETICS, V180, P1039, DOI 10.1534/genetics.108.091363; Urcuqui-Inchima S, 2001, VIRUS RES, V74, P157, DOI 10.1016/S0168-1702(01)00220-9; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Varrelmann M, 2007, J GEN VIROL, V88, P1005, DOI 10.1099/vir.0.82200-0; VERCHOT J, 1991, VIROLOGY, V185, P527, DOI 10.1016/0042-6822(91)90522-D; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	56	29	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21937	21943		10.1074/jbc.M111.230706	http://dx.doi.org/10.1074/jbc.M111.230706			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21543324	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000291464700088
J	Chen, J; Sprouffske, K; Huang, QH; Maley, CC				Chen, Jun; Sprouffske, Kathleen; Huang, Qihong; Maley, Carlo C.			Solving the Puzzle of Metastasis: The Evolution of Cell Migration in Neoplasms	PLOS ONE			English	Article							BREAST-CANCER; TUMOR OXYGENATION; MALIGNANT PROGRESSION; DISTANT METASTASIS; RADIATION-THERAPY; VASCULAR COLLAPSE; SOLID TUMORS; HYPOXIA; INVASION; GROWTH	Background: Metastasis represents one of the most clinically important transitions in neoplastic progression. The evolution of metastasis is a puzzle because a metastatic clone is at a disadvantage in competition for space and resources with non-metastatic clones in the primary tumor. Metastatic clones waste some of their reproductive potential on emigrating cells with little chance of establishing metastases. We suggest that resource heterogeneity within primary tumors selects for cell migration, and that cell emigration is a by-product of that selection. Methods and Findings: We developed an agent-based model to simulate the evolution of neoplastic cell migration. We simulated the essential dynamics of neoangiogenesis and blood vessel occlusion that lead to resource heterogeneity in neoplasms. We observed the probability and speed of cell migration that evolves with changes in parameters that control the degree of spatial and temporal resource heterogeneity. Across a broad range of realistic parameter values, increasing degrees of spatial and temporal heterogeneity select for the evolution of increased cell migration and emigration. Conclusions: We showed that variability in resources within a neoplasm (e. g. oxygen and nutrients provided by angiogenesis) is sufficient to select for cells with high motility. These cells are also more likely to emigrate from the tumor, which is the first step in metastasis and the key to the puzzle of metastasis. Thus, we have identified a novel potential solution to the puzzle of metastasis.	[Chen, Jun; Sprouffske, Kathleen; Huang, Qihong] Univ Penn, Sch Med, Genom & Computat Biol Program, Philadelphia, PA 19104 USA; [Sprouffske, Kathleen; Huang, Qihong] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Huang, Qihong] Univ Penn, Sch Med, Cell & Mol Biol Program, Philadelphia, PA 19104 USA; [Maley, Carlo C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Maley, Carlo C.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Chen, J (corresponding author), Univ Penn, Sch Med, Genom & Computat Biol Program, Philadelphia, PA 19104 USA.	cmaley@alum.mit.edu			National Institutes of Health [R01 CA119224, R03 CA137811, P01 CA91955, R01 CA140657, R21 NS059478, P30 CA010815, T32 HG000046, R01CA148759]; Landon AACR Innovator Award for Cancer Prevention; American Cancer Society [117209-RSG-09-163-01-CNE]; PhRMA Foundation; Breast Cancer Alliance; Edward Mallinckrodt Jr. Foundation; W.W. Smith; NATIONAL CANCER INSTITUTE [R03CA137811, R01CA119224, P30CA010815, R01CA140657, R01CA148759, P01CA091955] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Landon AACR Innovator Award for Cancer Prevention; American Cancer Society(American Cancer Society); PhRMA Foundation; Breast Cancer Alliance; Edward Mallinckrodt Jr. Foundation; W.W. Smith; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health (http://nih.gov/) (R01 CA119224, R03 CA137811, P01 CA91955, R01 CA140657 to CCM, R21 NS059478 to QH, P30 CA010815 to CCM and QH, and T32 HG000046 for KS); Landon AACR Innovator Award for Cancer Prevention (http://www.aacr.org/home/scientists/research-funding-fellowships/landon-aacr-innovator-award-for-cancer-prevention-research.aspx), Research Scholar Grant # 117209-RSG-09-163-01-CNE from the American Cancer Society (http://www.cancer.org/), the PhRMA Foundation (http://www.phrmafoundation.org/) and a Mclean contributionship (http://foundationcenter.org/grantmaker/mclean/) for CCM; National Institutes of Health (http://nih.gov/) (R01CA148759), the Breast Cancer Alliance (http://www.breastcanceralliance.org/), Edward Mallinckrodt Jr. Foundation (http://fundingopps.cos.com/cgi-bin/getRec?id=3691) and W.W. Smith (http://www.wwsmithcharitabletrust.org/) for QH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2009, J MATH BIOL, V58, P579, DOI 10.1007/s00285-008-0210-2; Araujo RP, 2004, J THEOR BIOL, V228, P335, DOI 10.1016/j.jtbi.2004.01.009; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bearer EL, 2009, CANCER RES, V69, P4493, DOI 10.1158/0008-5472.CAN-08-3834; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; BOUCHER Y, 1992, CANCER RES, V52, P5110; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brizel DM, 1996, CANCER RES, V56, P941; Brurberg KG, 2003, BRIT J CANCER, V89, P350, DOI 10.1038/sj.bjc.6601047; Brurberg KG, 2005, RADIOTHER ONCOL, V77, P220, DOI 10.1016/j.radonc.2005.09.009; Butler LM, 2000, CANCER RES, V60, P5165; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Cairns RA, 2001, CANCER RES, V61, P8903; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Dingli D, 2007, CANCER BIOL THER, V6, P383, DOI 10.4161/cbt.6.3.3720; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Etzioni R., 2003, NATURE REV CANC, V3, P1, DOI DOI 10.1038/NRC1041; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Gatenby RA, 2002, NATURE, V420, P462, DOI 10.1038/420462b; Gerlee P, 2009, J THEOR BIOL, V259, P67, DOI 10.1016/j.jtbi.2009.03.005; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hockel M, 1996, CANCER RES, V56, P4509; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; KENDAL WS, 1992, MATH BIOSCI, V108, P81, DOI 10.1016/0025-5564(92)90005-H; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michor F, 2006, J THEOR BIOL, V240, P521, DOI 10.1016/j.jtbi.2005.10.021; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Rofstad EK, 2007, CLIN CANCER RES, V13, P1971, DOI 10.1158/1078-0432.CCR-06-1967; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Soon LL, 2007, IUBMB LIFE, V59, P60, DOI 10.1080/15216540701201033; Tsai AG, 1998, P NATL ACAD SCI USA, V95, P6590, DOI 10.1073/pnas.95.12.6590; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; WILENSKY U, 1999, NETLOGO 4 0; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Zhang XY, 2005, P NATL ACAD SCI USA, V102, P13968, DOI 10.1073/pnas.0502330102	49	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e17933	10.1371/journal.pone.0017933	http://dx.doi.org/10.1371/journal.pone.0017933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556134	Green Submitted, gold, Green Published			2022-12-25	WOS:000290019400004
J	Goldstein, JD; Balderas, RS; Marodon, G				Goldstein, Jeremie D.; Balderas, Robert S.; Marodon, Gilles			Continuous Activation of the CD122/STAT-5 Signaling Pathway during Selection of Antigen-Specific Regulatory T Cells in the Murine Thymus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; MAMMARY-TUMOR VIRUS; STAT5 ACTIVATION; TARGET GENES; EXPRESSION; INTERLEUKIN-2; GENERATION; ONTOGENY; DELETION; RECEPTOR	Signaling events affecting thymic selection of un-manipulated polyclonal natural CD25(+) foxp3(+) regulatory T cells (nTreg) have not been established ex vivo. Here, we report a higher frequency of phosphorylated STAT-5 (pSTAT-5) in nTreg cells in the adult murine thymus and to a lesser extent in the periphery, compared to other CD4(+)CD8(-) subsets. In the neonatal thymus, the numbers of pSTAT-5(+) cells in CD25(+)foxp3(-) and nTreg cells increased in parallel, suggesting that pSTAT-5(+) CD25(+) foxp3(-) cells might represent the precursors of foxp3(+) regulatory T cells. This "specific'' pSTAT-5 expression detected in nTreg cells ex vivo was likely due to a very recent signal given by IL-2/IL-15 cytokines in vivo since (i) it disappeared rapidly if cells were left unstimulated in vitro and (ii) was also observed if total thymocytes were stimulated in vitro with saturating amounts of IL-2 and/or IL-15 but not IL-7. Interestingly, STAT-5 activation upon IL-2 stimulation correlated better with foxp3 and CD122 than with CD25 expression. Finally, we show that expression of an endogenous superantigen strongly affected the early Treg cell repertoire but not the proportion of pSTAT-5(+) cells within this repertoire. Our results reveal that continuous activation of the CD122/STAT-5 signaling pathway characterize regulatory lineage differentiation in the murine thymus.	[Goldstein, Jeremie D.; Marodon, Gilles] Univ Paris 06, UPMC, UMR 7211, Paris, France; [Goldstein, Jeremie D.; Marodon, Gilles] CNRS, UMR 7211, Paris, France; [Goldstein, Jeremie D.; Marodon, Gilles] INSERM, U959, Paris, France; [Balderas, Robert S.] Becton Dickinson, San Diego, CA USA	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Becton Dickinson	Goldstein, JD (corresponding author), Univ Paris 06, UPMC, UMR 7211, Paris, France.	gilles.marodon@upmc.fr	marodon, gilles/E-7202-2017	marodon, gilles/0000-0003-4889-6785	Agence Nationale de la Recherche (ANR); Agence Nationale de la Recherche contre le SIDA (ANRS); Association Francaise contre les Myopathies (AFM); French Ministere de l'Enseignement Superieur et de la Recherche	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Agence Nationale de la Recherche contre le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); French Ministere de l'Enseignement Superieur et de la Recherche	This work was funded by the Agence Nationale de la Recherche (ANR), Agence Nationale de la Recherche contre le SIDA (ANRS), and the Association Francaise contre les Myopathies (AFM). J.D. Goldstein is a recipient of a Ph.D fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bensinger SJ, 2004, J IMMUNOL, V172, P5287, DOI 10.4049/jimmunol.172.9.5287; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Czarneski J, 2003, IMMUNOL RES, V27, P469, DOI 10.1385/IR:27:2-3:469; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Darrasse-Jeze G, 2005, BLOOD, V105, P4715, DOI 10.1182/blood-2004-10-4051; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Imamichi H, 2008, EUR J IMMUNOL, V38, P1621, DOI 10.1002/eji.200737607; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; Kawahata K, 2002, J IMMUNOL, V168, P4399, DOI 10.4049/jimmunol.168.9.4399; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; MARODON G, 1994, INT IMMUNOL, V6, P1899, DOI 10.1093/intimm/6.12.1899; MARODON G, 1994, EUR J IMMUNOL, V24, P196, DOI 10.1002/eji.1830240131; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Papiernik M, 1997, J IMMUNOL, V158, P4642; Pillemer BBL, 2007, EUR J IMMUNOL, V37, P2082, DOI 10.1002/eji.200737193; Ribot J, 2006, J IMMUNOL, V177, P1101, DOI 10.4049/jimmunol.177.2.1101; Schallenberg S, 2010, J EXP MED, V207, P1393, DOI 10.1084/jem.20100045; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19038	10.1371/journal.pone.0019038	http://dx.doi.org/10.1371/journal.pone.0019038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541329	Green Published, gold			2022-12-25	WOS:000290018400022
J	Zhang, ZY; Slobodianski, A; Ito, WD; Arnold, A; Nehlsen, J; Weng, SX; Lund, N; Liu, JH; Egana, JT; Lohmeyer, JA; Muller, DF; Machens, HG				Zhang, Ziyang; Slobodianski, Alex; Ito, Wulf D.; Arnold, Astrid; Nehlsen, Jessica; Weng, Shaoxiang; Lund, Natalie; Liu, Jihong; Egana, Jose-Tomas; Lohmeyer, Joern A.; Mueller, Daniel F.; Machens, Hans-Guenther			Enhanced Collateral Growth by Double Transplantation of Gene-Nucleofected Fibroblasts in Ischemic Hindlimb of Rats	PLOS ONE			English	Article							LOWER-LIMB ISCHEMIA; IN-VIVO; THERAPEUTIC ANGIOGENESIS; INTERMITTENT CLAUDICATION; RABBIT MODEL; STEM-CELLS; TISSUE; VEGF(165); DELIVERY; DISEASE	Background: Induction of neovascularization by releasing therapeutic growth factors is a promising application of cell-based gene therapy to treat ischemia-related problems. In the present study, we have developed a new strategy based on nucleofection with alternative solution and cuvette to promote collateral growth and re-establishment of circulation in ischemic limbs using double transplantation of gene nucleofected primary cultures of fibroblasts, which were isolated from rat receiving such therapy. Methods and Results: Rat dermal fibroblasts were nucleofected ex vivo to release bFGF or VEGF165 in a hindlimb ischemia model in vivo. After femoral artery ligation, gene-modified cells were injected intramuscularly. One week post injection, local confined plasmid expression and transient distributions of the plasmids in other organs were detected by quantitative PCR. Quantitative micro-CT analyses showed improvements of vascularization in the ischemic zone (No. of collateral vessels via micro CT: 6.8 +/- 2.3 vs. 10.1 +/- 2.6; p<0.05). Moreover, improved collateral proliferation (BrdU incorporation: 0.48 +/- 0.05 vs. 0.57 +/- 0.05; p<0.05) and increase in blood perfusion (microspheres ratio: gastrocnemius: 0.41 +/- 0.10 vs. 0.50 +/- 0.11; p<0.05; soleus ratio: soleus: 0.42 +/- 0.08 vs. 0.60 +/- 0.08; p<0.01) in the lower hindlimb were also observed. Conclusions: These results demonstrate the feasibility and effectiveness of double transplantation of gene nucleofected primary fibroblasts in producing growth factors and promoting the formation of collateral circulation in ischemic hindlimb, suggesting that isolation and preparation of gene nucleofected cells from individual accepting gene therapy may be an alternative strategy for treating limb ischemia related diseases.	[Zhang, Ziyang; Egana, Jose-Tomas; Lohmeyer, Joern A.; Mueller, Daniel F.; Machens, Hans-Guenther] Tech Univ Munich, Univ Hosp Rechts Isar, Fac Med, Dept Plast Surg & Hand Surg, Munich, Germany; [Zhang, Ziyang; Slobodianski, Alex; Arnold, Astrid; Nehlsen, Jessica] Univ Lubeck, Dept Plast Surg & Hand Surg, Lubeck, Germany; [Ito, Wulf D.] Univ Ulm, Acad Teaching Hosp, Cardiovasc Ctr Oberallgaeu, Immenstadt, Germany; [Weng, Shaoxiang] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Cardiovasc Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Weng, Shaoxiang; Lund, Natalie] Univ Hosp Lubeck, Dept Med 2, Lubeck, Germany; [Liu, Jihong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urol, Wuhan 430074, Peoples R China; [Egana, Jose-Tomas] Univ Chile, Fac Ciencias, Ctr Genome Regulat, Santiago, Chile	Technical University of Munich; University of Lubeck; Ulm University; Zhejiang University; University of Lubeck; Huazhong University of Science & Technology; Universidad de Chile	Zhang, ZY (corresponding author), Tech Univ Munich, Univ Hosp Rechts Isar, Fac Med, Dept Plast Surg & Hand Surg, Munich, Germany.	zhangziyang776@googlemail.com	Lohmeyer, Jörn/H-9592-2019; Zhang, Ziyang/A-1823-2012; Liu, Jihong/Q-1364-2015	Liu, Jihong/0000-0001-8685-3036; Lohmeyer, Jorn/0000-0003-1721-9706; Egana, Jose Tomas/0000-0003-2624-6992	Innovations fund Schleswig-Holstein; University Hospital rechts der Isar, Technische Universitat Munchen; Technische Universitat Munchen [8744556]; German Research Council (DFG) [IT-13/1, IT-13/2, IT-13/3]; FONDAP [15090007]; China Scholarship Council	Innovations fund Schleswig-Holstein; University Hospital rechts der Isar, Technische Universitat Munchen; Technische Universitat Munchen; German Research Council (DFG)(German Research Foundation (DFG)); FONDAP; China Scholarship Council(China Scholarship Council)	This work was supported by grants from Innovations fund Schleswig-Holstein and University Hospital rechts der Isar, Technische Universitat Munchen to HGM; a clinic research grant from Technische Universitat Munchen to ZZ (KKF. No. 8744556); German Research Council (DFG) IT-13/1, IT-13/2, IT-13/3 to WDI and FONDAP (Nr. 15090007) to JTE. ZZ was supported by a scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluigi M, 2006, STEM CELLS, V24, P454, DOI 10.1634/stemcells.2005-0198; ASAHARA T, 1995, CIRCULATION, V92, P365, DOI 10.1161/01.CIR.92.9.365; BAFFOUR R, 1992, J VASC SURG, V16, P181, DOI 10.1016/0741-5214(92)90106-I; Beard JD, 2000, WESTERN J MED, V173, P60, DOI 10.1136/ewjm.173.1.60; Bembenek A, 1998, SURGERY, V123, P712, DOI 10.1016/S0039-6060(98)70214-4; Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473; Cesnulevicius K, 2006, STEM CELLS, V24, P2776, DOI 10.1634/stemcells.2006-0176; Choo PW, 2000, PHARMACOEPIDEM DR S, V9, P557, DOI 10.1002/pds.539; CUEVAS P, 1991, SCIENCE, V254, P1208, DOI 10.1126/science.1957172; Doi K, 2007, HEART VESSELS, V22, P104, DOI 10.1007/s00380-006-0934-0; Ferraro B, 2009, MOL THER, V17, P651, DOI 10.1038/mt.2009.12; Fujita M, 2007, WOUND REPAIR REGEN, V15, P58, DOI 10.1111/j.1524-475X.2006.00185.x; George ML, 2000, CLIN CANCER RES, V6, P3147; Gravier R, 2007, VACCINE, V25, P6930, DOI 10.1016/j.vaccine.2007.07.001; Harder Y, 2008, J PLAST RECONSTR AES, V61, P503, DOI 10.1016/j.bjps.2007.11.032; Herzog S, 2002, AM J PHYSIOL-HEART C, V283, pH2012, DOI 10.1152/ajpheart.00257.2002; Holzbach T, 2010, J CELL MOL MED, V14, P587, DOI 10.1111/j.1582-4934.2008.00592.x; Ito WD, 1997, AM J PHYSIOL-HEART C, V273, pH1255, DOI 10.1152/ajpheart.1997.273.3.H1255; Jacobsen F, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26060; Kang J, 2009, ANAL BIOCHEM, V386, P251, DOI 10.1016/j.ab.2008.12.021; Khmelewski E, 2004, CIRC RES, V95, pE56, DOI 10.1161/01.RES.0000143013.04985.E7; Kondoh K, 2004, CARDIOVASC RES, V61, P132, DOI 10.1016/j.cardiores.2003.10.003; Lazarous DF, 1997, CARDIOVASC RES, V36, P78, DOI 10.1016/S0008-6363(97)00142-9; Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7; Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181; Mueller CK, 2010, J SURG RES, V160, P340, DOI 10.1016/j.jss.2008.12.007; Mullane EM, 2008, J DENT RES, V87, P1144, DOI 10.1177/154405910808701204; Nikol S, 2008, CURR OPIN MOL THER, V10, P479; Nikol S, 2007, CARDIOVASC RES, V73, P443, DOI 10.1016/j.cardiores.2006.12.005; Olea FD, 2009, GENE THER, V16, P716, DOI 10.1038/gt.2009.30; Parker SE, 2001, GENE THER, V8, P1011, DOI 10.1038/sj.gt.3301491; Rajagopalan S, 2003, CIRCULATION, V108, P1933, DOI 10.1161/01.CIR.0000093398.16124.29; SPANHOLTZ TA, 2010, J SURG RES; Spanholtz T, 2009, J SURG RES, V151, P153, DOI 10.1016/j.jss.2008.01.038; Takeshita S, 1998, CIRCULATION, V98, P1261, DOI 10.1161/01.CIR.98.13.1261; Yasuhara T, 2005, BRAIN RES, V1038, P1, DOI 10.1016/j.brainres.2004.12.055; ZEITELHOFER M, 2009, CURR PROTOC NEUROSCI, pCH4	37	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19192	10.1371/journal.pone.0019192	http://dx.doi.org/10.1371/journal.pone.0019192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547081	gold, Green Submitted, Green Published			2022-12-25	WOS:000290016800036
J	Handstad, T; Rye, MB; Drablos, F; Saetrom, P				Handstad, Tony; Rye, Morten Beck; Drablos, Finn; Saetrom, Pal			A ChIP-Seq Benchmark Shows That Sequence Conservation Mainly Improves Detection of Strong Transcription Factor Binding Sites	PLOS ONE			English	Article							HUMAN GENOME; REGULATORY ELEMENTS; IDENTIFICATION; PREDICTION; MODELS	Background: Transcription factors are important controllers of gene expression and mapping transcription factor binding sites (TFBS) is key to inferring transcription factor regulatory networks. Several methods for predicting TFBS exist, but there are no standard genome-wide datasets on which to assess the performance of these prediction methods. Also, it is believed that information about sequence conservation across different genomes can generally improve accuracy of motif-based predictors, but it is not clear under what circumstances use of conservation is most beneficial. Results: Here we use published ChIP-seq data and an improved peak detection method to create comprehensive benchmark datasets for prediction methods which use known descriptors or binding motifs to detect TFBS in genomic sequences. We use this benchmark to assess the performance of five different prediction methods and find that the methods that use information about sequence conservation generally perform better than simpler motif-scanning methods. The difference is greater on high-affinity peaks and when using short and information-poor motifs. However, if the motifs are specific and information-rich, we find that simple motif-scanning methods can perform better than conservation-based methods. Conclusions: Our benchmark provides a comprehensive test that can be used to rank the relative performance of transcription factor binding site prediction methods. Moreover, our results show that, contrary to previous reports, sequence conservation is better suited for predicting strong than weak transcription factor binding sites.	[Handstad, Tony; Rye, Morten Beck; Drablos, Finn; Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol, Dept Comp & Informat Sci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Handstad, T (corresponding author), Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	pal.satrom@ntnu.no	Sætrom, Pål/AAH-1216-2019; Drablos, Finn/L-4970-2019	Sætrom, Pål/0000-0001-8142-7441; Drablos, Finn/0000-0001-5794-828X	Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Functional Genomics Program (FUGE) of the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; BRYNE JC, 2007, NUCL ACIDS RES; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Ernst J, 2010, GENOME RES, V20, P526, DOI 10.1101/gr.096305.109; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hawkins J, 2009, BIOINFORMATICS, V25, pI339, DOI 10.1093/bioinformatics/btp201; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Klepper K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-123; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Moses AM, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-19; Naughton BT, 2006, NUCLEIC ACIDS RES, V34, P5730, DOI 10.1093/nar/gkl585; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; RYE M, 2010, NUCL ACIDS RES; Sandve GK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-193; Siepel A, 2006, LECT NOTES COMPUT SC, V3909, P190; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Vavouri T, 2005, CURR OPIN GENET DEV, V15, P395, DOI 10.1016/j.gde.2005.05.002; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	26	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18430	10.1371/journal.pone.0018430	http://dx.doi.org/10.1371/journal.pone.0018430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533218	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600005
J	Chang, KA; Kim, JW; Kim, JA; Lee, S; Kim, S; Suh, WH; Kim, HS; Kwon, S; Kim, SJ; Suh, YH				Chang, Keun-A; Kim, Jin Won; Kim, Jeong A.; Lee, Sungeun; Kim, Saeromi; Suh, Won Hyuk; Kim, Hye-Sun; Kwon, Sunghoon; Kim, Sung June; Suh, Yoo-Hun			Biphasic Electrical Currents Stimulation Promotes both Proliferation and Differentiation of Fetal Neural Stem Cells	PLOS ONE			English	Article							NEURONAL PRECURSORS; MAGNETIC-FIELDS; EXPRESSION; NEUROTROPHINS; INDUCE	The use of non-chemical methods to differentiate stem cells has attracted researchers from multiple disciplines, including the engineering and the biomedical fields. No doubt, growth factor based methods are still the most dominant of achieving some level of proliferation and differentiation control - however, chemical based methods are still limited by the quality, source, and amount of the utilized reagents. Well-defined non-chemical methods to differentiate stem cells allow stem cell scientists to control stem cell biology by precisely administering the pre-defined parameters, whether they are structural cues, substrate stiffness, or in the form of current flow. We have developed a culture system that allows normal stem cell growth and the option of applying continuous and defined levels of electric current to alter the cell biology of growing cells. This biphasic current stimulator chip employing ITO electrodes generates both positive and negative currents in the same culture chamber without affecting surface chemistry. We found that biphasic electrical currents (BECs) significantly increased the proliferation of fetal neural stem cells (NSCs). Furthermore, BECs also promoted the differentiation of fetal NSCs into neuronal cells, as assessed using immunocytochemistry. Our results clearly show that BECs promote both the proliferation and neuronal differentiation of fetal NSCs. It may apply to the development of strategies that employ NSCs in the treatment of various neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.	[Chang, Keun-A; Kim, Jeong A.; Kim, Saeromi; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Dept Pharmacol,MRC, Seoul, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Pharmacol, Songnam, Kyungki, South Korea; [Kim, Jin Won; Lee, Sungeun; Kwon, Sunghoon; Kim, Sung June] Seoul Natl Univ, Sch Elect Engn & Comp Sci, Seoul, South Korea; [Suh, Won Hyuk] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of California System; University of California Berkeley	Chang, KA (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Dept Pharmacol,MRC, Seoul, South Korea.	kimsj@snu.ac; yhsuh@snu.ac.kr	Suh, Won Hyuk/A-1242-2011; Kim, Hye Sun/J-2752-2012; Suh, Yoo-Hun/J-2761-2012	Suh, Won Hyuk/0000-0002-4036-8307; 	Ministry of Education [03 - 2007 - 008, R33-10167]; Ministry of Education, Science and Technology, the Republic of Korea [2009-0082268]; Ministry of Knowledge Economy (MKE) of Korea [10033657]; College of Engineering (or College of Natural Sciences) and College of Medicine, Seoul National University	Ministry of Education; Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Knowledge Economy (MKE) of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); College of Engineering (or College of Natural Sciences) and College of Medicine, Seoul National University	This work was financially supported by Bundang Hospital Research fund (03 - 2007 - 008), in part by WCU program (R33-10167) of the Ministry of Education, and in part by the Conversing Research Center Program (2009-0082268) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, the Republic of Korea. Also, this work was supported by the Technology Innovation Program (10033657) funded by the Ministry of Knowledge Economy (MKE) of Korea and the Interdisciplinary Research Initiatives Program by College of Engineering (or College of Natural Sciences) and College of Medicine, Seoul National University (2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1998, TRENDS CARDIOVAS MED, V8, P59, DOI 10.1016/S1050-1738(97)00133-3; Ahuja YR, 2005, ELECTROMAGN BIOL MED, V24, P121, DOI 10.1080/15368370500205480; Arsenijevic Y, 1998, J NEUROSCI, V18, P2118; Blank M, 2004, J CELL PHYSIOL, V199, P359, DOI 10.1002/jcp.20004; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Felaco M, 1999, MOL CELL BIOCHEM, V201, P49, DOI 10.1023/A:1007004316433; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gritti A, 1996, J NEUROSCI, V16, P1091; Heng BC, 2004, CELL TISSUE RES, V315, P291, DOI 10.1007/s00441-003-0847-5; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Kim IS, 2006, BBA-MOL CELL RES, V1763, P907, DOI 10.1016/j.bbamcr.2006.06.007; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; LUSKIN MB, 1994, FASEB J, V8, P722, DOI 10.1096/fasebj.8.10.8050671; Markwardt S, 2008, J PHYSIOL-LONDON, V586, P3745, DOI 10.1113/jphysiol.2008.155713; Markwardt SJ, 2009, J NEUROSCI, V29, P15063, DOI 10.1523/JNEUROSCI.2727-09.2009; Marmur R, 1998, J NEUROSCI, V18, P9800; Matzke MA, 1996, BIOESSAYS, V18, P849, DOI 10.1002/bies.950181013; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Mie M, 2003, J BIOTECHNOL, V100, P231, DOI 10.1016/S0168-1656(02)00284-5; Pappas IS, 1997, EXP NEUROL, V144, P302, DOI 10.1006/exnr.1997.6411; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Rollwitz J, 2004, BBA-GEN SUBJECTS, V1674, P231, DOI 10.1016/j.bbagen.2004.06.024; Song JK, 2009, BIOELECTROMAGNETICS, V30, P374, DOI 10.1002/bem.20482; Storch Alexander, 2002, Curr Opin Investig Drugs, V3, P774; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Svendsen CN, 1999, TRENDS NEUROSCI, V22, P357, DOI 10.1016/S0166-2236(99)01428-9; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Ventura C, 2004, FASEB J, V18, P155, DOI 10.1096/fj.04-2695fje; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; Yamada T, 2000, IN VITRO CELL DEV-AN, V36, P139	34	108	110	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18738	10.1371/journal.pone.0018738	http://dx.doi.org/10.1371/journal.pone.0018738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533199	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800034
J	Fort, AG; Murray, JW; Dandachi, N; Davidson, MW; Dermietzel, R; Wolkoff, AW; Spray, DC				Fort, Alfredo G.; Murray, John W.; Dandachi, Nadine; Davidson, Michael W.; Dermietzel, Rolf; Wolkoff, Allan W.; Spray, David C.			In Vitro Motility of Liver Connexin Vesicles along Microtubules Utilizes Kinesin Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION FORMATION; ENDOCYTIC VESICLES; DEPENDENT MOVEMENT; EPITHELIAL-CELLS; PLASMA-MEMBRANE; TRAFFICKING; TRANSPORT; PATHWAYS; PROTEINS; CHANNELS	Trafficking of the proteins that form gap junctions (connexins) from the site of synthesis to the junctional domain appears to require cytoskeletal delivery mechanisms. Although many cell types exhibit specific delivery of connexins to polarized cell sites, such as connexin32 (Cx32) gap junctions specifically localized to basolateral membrane domains of hepatocytes, the precise roles of actin-and tubulin-based systems remain unclear. We have observed fluorescently tagged Cx32 trafficking linearly at speeds averaging 0.25 mu m/s in a polarized hepatocyte cell line (WIF-B9), which is abolished by 50 mu M of the microtubule-disrupting agent nocodazole. To explore the involvement of cytoskeletal components in the delivery of connexins, we have used a preparation of isolated Cx32-containing vesicles from rat hepatocytes and assayed their ATP-driven motility along stabilized rhodamine-labeled microtubules in vitro. These assays revealed the presence of Cx32 and kinesin motor proteins in the same vesicles. The addition of 50 mu M ATP stimulated vesicle motility along linear microtubule tracks with velocities of 0.4-0.5 mu m/s, which was inhibited with 1 mM of the kinesin inhibitor AMP-PNP (adenylyl-imidodiphosphate) and by anti-kinesin antibody but only minimally affected by 5 mu M vanadate, a dynein inhibitor, or by anti-dynein antibody. These studies provide evidence that Cx32 can be transported intracellularly along microtubules and presumably to junctional domains in cells and highlight an important role of kinesin motor proteins in microtubule-dependent motility of Cx32.	[Fort, Alfredo G.; Dandachi, Nadine; Spray, David C.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Murray, John W.; Wolkoff, Allan W.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA; [Dermietzel, Rolf] Ruhr Univ Bochum, D-44801 Bochum, Germany	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Ruhr University Bochum	Spray, DC (corresponding author), 1300 Morris Pk Ave,Kennedy 830, Bronx, NY 10461 USA.	david.spray@einstein.yu.edu		Spray, David/0000-0001-8368-5073	National Institutes of Health [DK41918]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK41918 (to D. C. S. and A. W. W.).	Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; BRADY ST, 1991, NEURON, V7, P521, DOI 10.1016/0896-6273(91)90365-7; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; FALK MM, 1994, J CELL BIOL, V127, P343, DOI 10.1083/jcb.127.2.343; George CH, 1999, J BIOL CHEM, V274, P8678, DOI 10.1074/jbc.274.13.8678; Giessmann D, 2005, ANAT EMBRYOL, V209, P391, DOI 10.1007/s00429-005-0456-z; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Guo YH, 2004, CHEST, V125, p110S, DOI 10.1378/chest.125.5_suppl.110S-a; Harrison RE, 1997, CELL MOTIL CYTOSKEL, V36, P355, DOI 10.1002/(SICI)1097-0169(1997)36:4<355::AID-CM5>3.0.CO;2-4; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; Jordan K, 2001, J CELL SCI, V114, P763; KOBAYASHI T, 1978, BIOCHEM BIOPH RES CO, V81, P1313, DOI 10.1016/0006-291X(78)91279-2; Kojima T, 2009, HISTOL HISTOPATHOL, V24, P1463, DOI 10.14670/HH-24.1463; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASEK RJ, 1985, NATURE, V316, P645, DOI 10.1038/316645a0; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Leithe E, 2006, BIOCHEM J, V393, P59, DOI 10.1042/BJ20050674; LEOPOLD PL, 1992, CELL MOTIL CYTOSKEL, V23, P19, DOI 10.1002/cm.970230104; Manders M. M., 1993, J MICROSC-OXFORD, V169, P375; Martin PEM, 2001, J CELL SCI, V114, P3845; Maza J, 2005, J BIOL CHEM, V280, P21115, DOI 10.1074/jbc.M412612200; MELLER K, 1981, ANAT EMBRYOL, V163, P321, DOI 10.1007/BF00315708; Murray JW, 2000, MOL BIOL CELL, V11, P419, DOI 10.1091/mbc.11.2.419; Murray JW, 2002, ANAL BIOCHEM, V305, P55, DOI 10.1006/abio.2002.5655; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Olk S, 2009, CELL MOTIL CYTOSKEL, V66, P1000, DOI 10.1002/cm.20404; Paulson AF, 2000, J CELL SCI, V113, P3037; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; WANG YJ, 1995, J CELL SCI, V108, P3501; YOUSON JH, 1983, ANAT EMBRYOL, V167, P379, DOI 10.1007/BF00315676	36	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22875	22885		10.1074/jbc.M111.219709	http://dx.doi.org/10.1074/jbc.M111.219709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536677	hybrid, Green Published			2022-12-25	WOS:000292025000022
J	Shi, XL; Lepere, C; Scanlan, DJ; Vaulot, D				Shi, Xiao Li; Lepere, Cecile; Scanlan, David J.; Vaulot, Daniel			Plastid 16S rRNA Gene Diversity among Eukaryotic Picophytoplankton Sorted by Flow Cytometry from the South Pacific Ocean	PLOS ONE			English	Article							18S RDNA SEQUENCES; EAST PACIFIC; IN-SITU; PHYLOGENETIC ANALYSIS; MARINE ECOSYSTEMS; ENGLISH-CHANNEL; ATLANTIC-OCEAN; PCR; PHYTOPLANKTON; PICOPLANKTON	The genetic diversity of photosynthetic picoeukaryotes was investigated in the South East Pacific Ocean. Genetic libraries of the plastid 16S rRNA gene were constructed on picoeukaryote populations sorted by flow cytometry, using two different primer sets, OXY107F/OXY1313R commonly used to amplify oxygenic organisms, and PLA491F/OXY1313R, biased towards plastids of marine algae. Surprisingly, the two sets revealed quite different photosynthetic picoeukaryote diversity patterns, which were moreover different from what we previously reported using the 18S rRNA nuclear gene as a marker. The first 16S primer set revealed many sequences related to Pelagophyceae and Dictyochophyceae, the second 16S primer set was heavily biased toward Prymnesiophyceae, while 18S sequences were dominated by Prasinophyceae, Chrysophyceae and Haptophyta. Primer mismatches with major algal lineages is probably one reason behind this discrepancy. However, other reasons, such as DNA accessibility or gene copy numbers, may be also critical. Based on plastid 16S rRNA gene sequences, the structure of photosynthetic picoeukaryotes varied along the BIOSOPE transect vertically and horizontally. In oligotrophic regions, Pelagophyceae, Chrysophyceae, and Prymnesiophyceae dominated. Pelagophyceae were prevalent at the DCM depth and Chrysophyceae at the surface. In mesotrophic regions Pelagophyceae were still important but Chlorophyta contribution increased. Phylogenetic analysis revealed a new clade of Prasinophyceae (clade 16S-IX), which seems to be restricted to hyper-oligotrophic stations. Our data suggest that a single gene marker, even as widely used as 18S rRNA, provides a biased view of eukaryotic communities and that the use of several markers is necessary to obtain a complete image.	[Shi, Xiao Li; Lepere, Cecile; Vaulot, Daniel] UPMC Paris 06, Roscoff, France; [Shi, Xiao Li; Lepere, Cecile; Vaulot, Daniel] CNRS, Stn Biol Roscoff, UMR 7144, Roscoff, France; [Lepere, Cecile; Scanlan, David J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Shi, Xiao Li] Chinese Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing, Peoples R China	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; University of Warwick; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS	Shi, XL (corresponding author), UPMC Paris 06, Roscoff, France.	vaulot@sb-roscoff.fr	Vaulot, Daniel/T-6649-2019; Scanlan, David J/G-4080-2016	Vaulot, Daniel/0000-0002-0717-5685; Scanlan, David J/0000-0003-3093-4245	Centre National de la Recherche Scientifique-Institut National des Science de l'Univers; Agence Nationale de la Recherche [06-BDIV-013]; National Environment Reseach Council [NE/C003160/1]; China Scholarship Council (CSC); Universite Pierre et Marie Curie (UPMC); Fondation Franco-Chinoise pour la Science et ses Applications (FFCSA); NERC [NE/G005125/1] Funding Source: UKRI; Natural Environment Research Council [NE/C003160/1, NE/G005125/1] Funding Source: researchfish	Centre National de la Recherche Scientifique-Institut National des Science de l'Univers(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Environment Reseach Council; China Scholarship Council (CSC)(China Scholarship Council); Universite Pierre et Marie Curie (UPMC); Fondation Franco-Chinoise pour la Science et ses Applications (FFCSA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by the following programs: BIOSOPE cruise (funded by Centre National de la Recherche Scientifique-Institut National des Science de l'Univers), PICOFUNPAC (funded by Agence Nationale de la Recherche, Biodiversite grant 06-BDIV-013) and National Environment Reseach Council grant NE/C003160/1. X. L. S. was supported by postdoctoral fellowships from the China Scholarship Council (CSC), the Universite Pierre et Marie Curie (UPMC), and the Fondation Franco-Chinoise pour la Science et ses Applications (FFCSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN RA, 1993, J PHYCOL, V29, P701, DOI 10.1111/j.0022-3646.1993.00701.x; Andersen RA, 1999, PROTIST, V150, P71, DOI 10.1016/S1434-4610(99)70010-6; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Claustre H, 2008, BIOGEOSCIENCES, V5, P679, DOI 10.5194/bg-5-679-2008; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; Fuller NJ, 2006, AQUAT MICROB ECOL, V43, P79, DOI 10.3354/ame043079; Gomez F, 2007, BIOGEOSCIENCES, V4, P1101, DOI 10.5194/bg-4-1101-2007; Grob C, 2007, BIOGEOSCIENCES, V4, P837, DOI 10.5194/bg-4-837-2007; Jardillier L, 2010, ISME J, V4, P1180, DOI 10.1038/ismej.2010.36; Junier P, 2008, APPL ENVIRON MICROB, V74, P5231, DOI 10.1128/AEM.00288-08; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; LANE DJ, 1991, 16S 23S RRNA SEQUENC, P115; Le Gall F, 2008, BIOGEOSCIENCES, V5, P203, DOI 10.5194/bg-5-203-2008; Lepere C, 2009, ENVIRON MICROBIOL, V11, P3105, DOI 10.1111/j.1462-2920.2009.02015.x; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Maguire MJ, 1995, AM J BOT, V82, P1496, DOI 10.2307/2446177; Man-Aharonovich D, 2010, ISME J, V4, P1044, DOI 10.1038/ismej.2010.25; Marie D, 2010, FEMS MICROBIOL ECOL, V72, P165, DOI 10.1111/j.1574-6941.2010.00842.x; Marin B, 2010, PROTIST, V161, P304, DOI 10.1016/j.protis.2009.10.002; McDonald SM, 2007, AQUAT MICROB ECOL, V50, P75, DOI 10.3354/ame01148; Moon-van der Staay SY, 2000, LIMNOL OCEANOGR, V45, P98, DOI 10.4319/lo.2000.45.1.0098; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ras J, 2008, BIOGEOSCIENCES, V5, P353, DOI 10.5194/bg-5-353-2008; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Shi XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007657; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Takano Y, 2006, MAR MICROPALEONTOL, V60, P145, DOI 10.1016/j.marmicro.2006.04.002; URBACH E, 1992, NATURE, V355, P267, DOI 10.1038/355267a0; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Viprey M, 2008, ENVIRON MICROBIOL, V10, P1804, DOI 10.1111/j.1462-2920.2008.01602.x; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	37	62	65	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18979	10.1371/journal.pone.0018979	http://dx.doi.org/10.1371/journal.pone.0018979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552558	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700010
J	Tang, ZY; Fang, JY; Sun, JY; Gaston, KJ				Tang, Zhiyao; Fang, Jingyun; Sun, Jinyu; Gaston, Kevin J.			Effectiveness of Protected Areas in Maintaining Plant Production	PLOS ONE			English	Article							NORTH-AMERICAN GRASSLANDS; TROPICAL FORESTS; GLOBAL CONSERVATION; SHRUB ENCROACHMENT; AMAZON BASIN; ECOSYSTEM; SATELLITE; VEGETATION; BIODIVERSITY; NETWORKS	Given the central importance of protected area systems in local, regional and global conservation strategies, it is vital that there is a good understanding of their effectiveness in maintaining ecological functioning. Here, we provide, to our knowledge, the first such global analysis, focusing on plant production, a "supporting'' ecosystem function necessary for multiple other ecosystem services. We use data on the normalized difference vegetation index (NDVI) as a measure of variation in plant production in the core, boundary and surroundings of more than 1000 large protected areas over a 25 year period. Forested protected areas were higher (or similar), and those non-forested were lower (or similar), in NDVI than their surrounding areas, and these differences have been sustained. The differences from surrounding areas have increased for evergreen broadleaf forests and barren grounds, decreased for grasslands, and remained similar for deciduous forests, woodlands, and shrublands, reflecting different pressures on those surroundings. These results are consistent with protected areas being effective both in the representation and maintenance of plant production. However, widespread overall increases in NDVI during the study period suggest that plant production within the core of non-forested protected areas has become higher than it was in the surroundings of those areas in 1982, highlighting that whilst the distinctiveness of protected areas from their surroundings has persisted the nature of that difference has changed.	[Tang, Zhiyao; Fang, Jingyun; Sun, Jinyu] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Tang, Zhiyao; Fang, Jingyun; Sun, Jinyu] Peking Univ, MOE Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Gaston, Kevin J.] Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	Peking University; Peking University; University of Sheffield	Tang, ZY (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	zytang@urban.pku.edu.cn	Tang, Zhiyao/B-8795-2008; Wrbka, Thomas/A-5699-2010	Wrbka, Thomas/0000-0002-1451-9108; Gaston, Kevin J./0000-0002-7235-7928; Tang, Zhiyao/0000-0003-0154-6403	NSFC [40871030, 40638039, 40701065, 90211016]; National Basic Research Program of China [2010CB950600]; Leverhulme Trust; China Scholar Council; Royal Society	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Leverhulme Trust(Leverhulme Trust); China Scholar Council; Royal Society(Royal Society of London)	This work was supported by NSFC (#40871030, 40638039, 40701065, & 90211016), National Basic Research Program of China (#2010CB950600) (Z.Y.T. and J.Y.F.) and the Leverhulme Trust (K.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was largely completed when Z.Y.T. worked as a visiting researcher in K.J.G.'s laboratory. Z.Y.T. holds a China Scholar Council fellowship and K.J.G. holds a Royal Society-Wolfson Research Merit Award. We are grateful to C.A. Bell, F. Eigenbrod, J.R. Leake and Z.H. Wang for comments and discussion. We thank the UNEP-WCMC for kindly providing the spatial database on global protected areas (UNEP-WCMC bears no responsibility for the integrity or accuracy of the data contained herein), Global Land Cover Facility (GLCF) for the NDVI and land-cover data, and Center for International Earth Science Information Network (CIESIN), Columbia University and Centro Internacional de Agricultura Tropical (CIAT) for the population data.	Alcaraz-Segura D, 2009, ENVIRON MANAGE, V43, P38, DOI 10.1007/s00267-008-9154-y; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; [Anonymous], 2005, EC HUM WELL BEING SY; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Banda T, 2006, FOREST ECOL MANAG, V230, P179, DOI 10.1016/j.foreco.2006.04.032; Berry SL, 2002, GLOBAL ECOL BIOGEOGR, V11, P23, DOI 10.1046/j.1466-822X.2002.00183.x; Blaum N, 2007, ACTA OECOL, V31, P86, DOI 10.1016/j.actao.2006.10.004; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Bradford JB, 2005, ECOLOGY, V86, P1863, DOI 10.1890/04-0493; Brown KA, 2009, ENVIRON MANAGE, V44, P136, DOI 10.1007/s00267-008-9257-5; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; [Center for International Earth Science Information Network (CIESIN) Columbia University Centro Internacional de Agricultura Tropical (CIAT)], 2005, GRIDD POP WORLD VERS; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Ewers RM, 2008, TRENDS ECOL EVOL, V23, P113, DOI 10.1016/j.tree.2007.11.008; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Foster DR, 1999, ECOL APPL, V9, P555, DOI 10.1890/1051-0761(1999)009[0555:HONDLS]2.0.CO;2; Garbulsky MF, 2004, J VEG SCI, V15, P711, DOI 10.1111/j.1654-1103.2004.tb02313.x; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Hansen M, 1998, UMD GLOBAL LAND COVE; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hashimoto H, 2010, GLOBAL CHANGE BIOL, V16, P255, DOI 10.1111/j.1365-2486.2009.01921.x; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Jackson SF, 2008, GLOBAL CHANGE BIOL, V14, P2132, DOI 10.1111/j.1365-2486.2008.01628.x; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Lepers E, 2005, BIOSCIENCE, V55, P115, DOI 10.1641/0006-3568(2005)055[0115:ASOIOR]2.0.CO;2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDonald RI, 2011, BIOL CONSERV, V144, P383, DOI 10.1016/j.biocon.2010.09.016; Mooney H, 2009, CURR OPIN ENV SUST, V1, P46, DOI 10.1016/j.cosust.2009.07.006; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; O'Neill DW, 2009, ECOL ECON, V69, P319, DOI 10.1016/j.ecolecon.2009.08.028; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Paruelo JM, 2001, GLOBAL CHANGE BIOL, V7, P631, DOI 10.1046/j.1365-2486.2001.00387.x; Pelkey NW, 2000, BIOL CONSERV, V94, P297, DOI 10.1016/S0006-3207(99)00195-0; Peres CA, 2006, TRENDS ECOL EVOL, V21, P227, DOI 10.1016/j.tree.2006.03.007; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002634; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; Rodrigues ASL, 2001, ECOL LETT, V4, P602, DOI 10.1046/j.1461-0248.2001.00275.x; Rodrigues ASL, 1999, P ROY SOC B-BIOL SCI, V266, P1453, DOI 10.1098/rspb.1999.0800; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Roman-Cuesta RM, 2006, CONSERV BIOL, V20, P1074, DOI 10.1111/j.1523-1739.2006.00478.x; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schmitt CB, 2009, BIOL CONSERV, V142, P2122, DOI 10.1016/j.biocon.2009.04.012; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Songer M, 2009, BIODIVERS CONSERV, V18, P1001, DOI 10.1007/s10531-008-9490-5; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Turner WR, 2007, BIOSCIENCE, V57, P868, DOI 10.1641/B571009; [UNEP-WCMC IUCN-WCPA], 2007, WORLD DAT PROT AR WD; UNEP-WCMC, 2008, STAT WORLDS PROT AR; United Nations, 2009, WORLD POP PROSP 2008; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	67	37	45	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19116	10.1371/journal.pone.0019116	http://dx.doi.org/10.1371/journal.pone.0019116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552560	Green Submitted, gold, Green Published			2022-12-25	WOS:000290020700028
J	Zhang, YZ; Wang, D; Chen, ML; Yang, B; Zhang, FX; Cao, KJ				Zhang, Yuzhen; Wang, Dan; Chen, Minglong; Yang, Bing; Zhang, Fengxiang; Cao, Kejiang			Intramyocardial Transplantation of Undifferentiated Rat Induced Pluripotent Stem Cells Causes Tumorigenesis in the Heart	PLOS ONE			English	Article							TERATOMA FORMATION; COPY NUMBER; DIFFERENTIATION; GENERATION; GENES	Background: Induced pluripotent stem cells (iPSCs) are a novel candidate for use in cardiac stem cell therapy. However, their intrinsic tumorigenicity requires further investigation prior to use in a clinical setting. In this study we investigated whether undifferentiated iPSCs are tumorigenic after intramyocardial transplantation into immunocompetent allogeneic recipients. Methodology/Principal Findings: We transplanted 2 x 10(4), 2 x 10(5), or 2 x 10(6) cells from the established rat iPSC line M13 intramyocardially into intact or infarcted hearts of immunocompetent allogeneic rats. Transplant duration was 2, 4, or 6 weeks. Histological examination with hematoxylin-eosin staining confirmed that undifferentiated rat iPSCs could generate heterogeneous tumors in both intracardiac and extracardiac sites. Furthermore, tumor incidence was independent of cell dose, transplant duration, and the presence or absence of myocardial infarction. Conclusions/Significance: Our study demonstrates that allogeneic iPSC transplantation in the heart will likely result in in situ tumorigenesis, and that cells leaked from the beating heart are a potential source of tumor spread, underscoring the importance of evaluating the safety of future iPSC therapy for cardiac disease.	[Zhang, Yuzhen; Wang, Dan; Chen, Minglong; Yang, Bing; Zhang, Fengxiang; Cao, Kejiang] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Peoples R China	Nanjing Medical University	Zhang, YZ (corresponding author), Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Peoples R China.	kjcao@njmu.edu.cn	Zhang, Fengxiang/Z-2807-2019		National Natural Science Foundation of China [30871077, 30800464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (30871077, 30800464; http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hu Q, 2010, STEM CELLS; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koch CA, 2006, J IMMUNOL, V177, P4803, DOI 10.4049/jimmunol.177.7.4803; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; NELSON TJ, 2009, REPAIR ACUTE MYOCARD; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Singla DK, 2006, J MOL CELL CARDIOL, V40, P195, DOI 10.1016/j.yjmcc.2005.09.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teng CJ, 2006, J THORAC CARDIOV SUR, V132, P628, DOI 10.1016/j.jtcvs.2006.05.034; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Yamashita T., 2010, CELL TRANSPLANT; Ye J, 1997, MOL CELL BIOCHEM, V176, P227, DOI 10.1023/A:1006853112920	30	48	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19012	10.1371/journal.pone.0019012	http://dx.doi.org/10.1371/journal.pone.0019012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552563	gold, Green Published, Green Submitted			2022-12-25	WOS:000290020700015
J	Breton, S; Ghiselli, F; Passamonti, M; Milani, L; Stewart, DT; Hoeh, WR				Breton, Sophie; Ghiselli, Fabrizio; Passamonti, Marco; Milani, Liliana; Stewart, Donald T.; Hoeh, Walter R.			Evidence for a Fourteenth mtDNA-Encoded Protein in the Female-Transmitted mtDNA of Marine Mussels (Bivalvia: Mytilidae)	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; MITOCHONDRIAL-DNA TRANSMISSION; REGULATORY REGION RNAS; OXIDASE-II GENE; BLUE MUSSEL; COMPLETE SEQUENCES; AMINO-ACID; MYTILUS-GALLOPROVINCIALIS; SPERM MITOCHONDRIA; C-TERMINUS	Background: A novel feature for animal mitochondrial genomes has been recently established: i.e., the presence of additional, lineage-specific, mtDNA-encoded proteins with functional significance. This feature has been observed in freshwater mussels with doubly uniparental inheritance of mtDNA (DUI). The latter unique system of mtDNA transmission, which also exists in some marine mussels and marine clams, is characterized by one mt genome inherited from the female parent (F mtDNA) and one mt genome inherited from the male parent (M mtDNA). In freshwater mussels, the novel mtDNA-encoded proteins have been shown to be mt genome-specific (i.e., one novel protein for F genomes and one novel protein for M genomes). It has been hypothesized that these novel, F-and M-specific, mtDNA-encoded proteins (and/or other F-and/or M-specific mtDNA sequences) could be responsible for the different modes of mtDNA transmission in bivalves but this remains to be demonstrated. Methodology/Principal Findings: We investigated all complete (or nearly complete) female-and male-transmitted marine mussel mtDNAs previously sequenced for the presence of ORFs that could have functional importance in these bivalves. Our results confirm the presence of a novel F genome-specific mt ORF, of significant length (>100aa) and located in the control region, that most likely has functional significance in marine mussels. The identification of this ORF in five Mytilus species suggests that it has been maintained in the mytilid lineage (subfamily Mytilinae) for similar to 13 million years. Furthermore, this ORF likely has a homologue in the F mt genome of Musculista senhousia, a DUI-containing mytilid species in the subfamily Crenellinae. We present evidence supporting the functionality of this F-specific ORF at the transcriptional, amino acid and nucleotide levels. Conclusions/Significance: Our results offer support for the hypothesis that "novel F genome-specific mitochondrial genes" are involved in key biological functions in bivalve species with DUI.	[Breton, Sophie; Hoeh, Walter R.] Kent State Univ, Kent, OH 44242 USA; [Ghiselli, Fabrizio; Passamonti, Marco; Milani, Liliana] Univ Bologna, Dept Biol Evoluzionist Sperimentale, Bologna, Italy; [Stewart, Donald T.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Bologna; Acadia University	Breton, S (corresponding author), Kent State Univ, Kent, OH 44242 USA.	breton.sophie@gmail.com	Ghiselli, Fabrizio/D-2260-2010; Passamonti, Marco/J-7502-2012; Breton, Sophie/U-9335-2019; Milani, Liliana/B-7063-2015	Ghiselli, Fabrizio/0000-0002-1680-8616; Breton, Sophie/0000-0002-8286-486X; Milani, Liliana/0000-0001-5052-2075; Stewart, Donald/0000-0002-4402-1757; Passamonti, Marco/0000-0002-6222-8225	National Science Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a National Science Foundation grant to WRH and by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to DTS. SB was financially supported by an NSERC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beagley CT, 1999, GENETICS, V152, P641; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2004, MOL BIOL EVOL, V21, P1492, DOI 10.1093/molbev/msh090; Breton S, 2006, GENETICS, V172, P1107, DOI 10.1534/genetics.105.047159; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Breton S, 2010, MAR GENOM, V3, P11, DOI 10.1016/j.margen.2010.01.001; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Burger G, 2003, NUCLEIC ACIDS RES, V31, P2353, DOI 10.1093/nar/gkg326; Burzynski A, 2003, MOL BIOL EVOL, V20, P388, DOI 10.1093/molbev/msg058; Burzynski A, 2006, GENETICS, V174, P1081, DOI 10.1534/genetics.106.063180; Burzynski A, 2009, MOL BIOL EVOL, V26, P1441, DOI 10.1093/molbev/msp085; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cao LQ, 2009, GENETICS, V181, P1045, DOI 10.1534/genetics.108.093229; Cao LQ, 2004, GENETICS, V166, P883, DOI 10.1534/genetics.166.2.883; Cao LQ, 2004, GENETICS, V167, P835, DOI 10.1534/genetics.103.026187; Chakrabarti R, 2007, FEBS LETT, V581, P5213, DOI 10.1016/j.febslet.2007.10.006; Chakrabarti R, 2006, FEBS LETT, V580, P862, DOI 10.1016/j.febslet.2005.12.104; Chapman EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-165; Chase CD, 2007, TRENDS GENET, V23, P81, DOI 10.1016/j.tig.2006.12.004; Chichvarkhin A. Yu., 2000, Genetika, V36, P1206; Cogswell AT, 2006, GENOME, V49, P799, DOI 10.1139/G06-036; Curole JP, 2010, BIOL BULL-US, V218, P122, DOI 10.1086/BBLv218n2p122; Curole JP, 2002, MOL BIOL EVOL, V19, P1323, DOI 10.1093/oxfordjournals.molbev.a004193; Curole JP, 2005, J MOL EVOL, V61, P381, DOI 10.1007/s00239-004-0192-7; Dalziel AC, 2002, GENOME, V45, P348, DOI 10.1139/G01-159; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Echols N, 2002, NUCLEIC ACIDS RES, V30, P2515, DOI 10.1093/nar/30.11.2515; Elson JL, 2006, TRENDS GENET, V22, P603, DOI 10.1016/j.tig.2006.09.004; Endo K, 2005, J MOL EVOL, V61, P36, DOI 10.1007/s00239-004-0214-5; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Filipowicz M, 2008, J MOL EVOL, V67, P377, DOI 10.1007/s00239-008-9157-6; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Ghiselli F, 2011, MOL BIOL EVOL, V28, P949, DOI 10.1093/molbev/msq271; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Hasegawa M, 1998, MOL BIOL EVOL, V15, P1499, DOI 10.1093/oxfordjournals.molbev.a025877; Hoeh WR, 2002, EVOLUTION, V56, P2252; Hoeh WR, 1997, MOL BIOL EVOL, V14, P959, DOI 10.1093/oxfordjournals.molbev.a025839; HOFFMANN RJ, 1992, GENETICS, V131, P397; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Khalturin K, 2008, PLOS BIOL, V6, P2436, DOI 10.1371/journal.pbio.0060278; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P2541, DOI 10.1093/nar/21.11.2541; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lane N, 2009, NATURE, V462, P272, DOI 10.1038/462272a; LONGO FJ, 1967, J ULTRA MOL STRUCT R, V20, P462, DOI 10.1016/S0022-5320(67)80113-8; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mizi A, 2005, MOL BIOL EVOL, V22, P952, DOI 10.1093/molbev/msi079; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Nakamichi N, 2000, CYTOTECHNOLOGY, V33, P175, DOI 10.1023/A:1008154027997; Nakamichi N, 1998, J BIOCHEM, V123, P392; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Obata M, 2006, DEV GROWTH DIFFER, V48, P253, DOI [10.1111/j.1440-169x.2006.00863.x, 10.1111/j.1440-169X.2006.00863.x]; Obata M, 2007, DEV GROWTH DIFFER, V49, P335, DOI [10.1111/j.1440-169X.2007.00930.x, 10.1111/j.1440-169x.2007.00930.x]; OJALA D, 1981, J MOL BIOL, V150, P303, DOI 10.1016/0022-2836(81)90454-X; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Ort BS, 2007, GENETICS, V177, P1087, DOI 10.1534/genetics.107.072934; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Passamonti M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S7; Plazzi F, 2010, MOL PHYLOGENET EVOL, V57, P641, DOI 10.1016/j.ympev.2010.08.032; Pont-Kingdon G, 1998, J MOL EVOL, V46, P419, DOI 10.1007/PL00006321; PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0; PRITCHARD AE, 1986, GENE, V44, P243, DOI 10.1016/0378-1119(86)90188-5; Rand DM, 1998, GENETICA, V102-3, P393, DOI 10.1023/A:1017006118852; Rawson PD, 2005, J MOL EVOL, V61, P717, DOI 10.1007/s00239-004-0035-6; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SACCONE C, 1987, J MOL EVOL, V26, P205, DOI 10.1007/BF02099853; SBISA E, 1992, FEBS LETT, V296, P311, DOI 10.1016/0014-5793(92)80311-4; SBISA E, 1990, CURR GENET, V17, P247, DOI 10.1007/BF00312616; Schmitz J, 2002, MOL BIOL EVOL, V19, P544, DOI 10.1093/oxfordjournals.molbev.a004110; Shao ZY, 2006, GENE, V381, P92, DOI 10.1016/j.gene.2006.06.021; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; SKIBINSKI DOF, 1994, GENETICS, V138, P801; SKIBINSKI DOF, 1987, P WORLD S SELECTION, V1, P209; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Smietanka B, 2010, J MOL EVOL, V71, P385, DOI 10.1007/s00239-010-9393-4; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Stewart DT, 2009, EVOLUTIONARY BIOLOGY: CONCEPT, MODELING, AND APPLICATION, P163, DOI 10.1007/978-3-642-00952-5_9; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; Theologidis L, 2007, GENETICS, V176, P1367, DOI 10.1534/genetics.106.069930; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Venetis C, 2007, GENE, V406, P79, DOI 10.1016/j.gene.2007.06.001; Venetis C, 2006, P R SOC B, V273, P2483, DOI 10.1098/rspb.2006.3607; Venier P, 2003, GENE, V314, P29, DOI 10.1016/S0378-1119(03)00708-X; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Zbawicka M, 2007, GENE, V406, P191, DOI 10.1016/j.gene.2007.10.003; Zbawicka M, 2010, GENE, V456, P45, DOI 10.1016/j.gene.2010.02.009; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0; Zouros E, 2000, GENES GENET SYST, V75, P313, DOI 10.1266/ggs.75.313	111	44	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19365	10.1371/journal.pone.0019365	http://dx.doi.org/10.1371/journal.pone.0019365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556327	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400053
J	Yi, SY; Nonaka, D; Nomoto, M; Kobayashi, J; Mizoue, T				Yi, Siyan; Nonaka, Daisuke; Nomoto, Marino; Kobayashi, Jun; Mizoue, Tetsuya			Predictors of the Uptake of A (H1N1) Influenza Vaccine: Findings from a Population-Based Longitudinal Study in Tokyo	PLOS ONE			English	Article							ATTITUDES; WORKERS	Background: Overall pandemic A (H1N1) influenza vaccination rates remain low across all nations, including Japan. To increase the rates, it is important to understand the motives and barriers for the acceptance of the vaccine. We conducted this study to determine potential predictors of the uptake of A (H1N1) influenza vaccine in a cohort of Japanese general population. Methodology/Principal Findings: By using self-administered questionnaires, this population-based longitudinal study was conducted from October 2009 to April 2010 among 428 adults aged 18-65 years randomly selected from each household residing in four wards and one city in Tokyo. Multiple logistic regression analyses were performed. Of total, 38.1% of participants received seasonal influenza vaccine during the preceding season, 57.0% had willingness to accept A (H1N1) influenza vaccine at baseline, and 12.1% had received A (H1N1) influenza vaccine by the time of follow-up. After adjustment for potential confounding variables, people who had been vaccinated were significantly more likely to be living with an underlying disease (p = 0.001), to perceive high susceptibility to influenza (p = 0.03), to have willingness to pay even if the vaccine costs >= US$44 (p = 0.04), to have received seasonal influenza vaccine during the preceding season (p < 0.001), and to have willingness to accept A (H1N1) influenza vaccine at baseline (p < 0.001) compared to those who had not been vaccinated. Conclusions/Significance: While studies have reported high rates of willingness to receive A (H1N1) influenza vaccine, these rates may not transpire in the actual practices. The uptake of the vaccine may be determined by several potential factors such as perceived susceptibility to influenza and sensitivity to vaccination cost in general population.	[Yi, Siyan; Nonaka, Daisuke; Nomoto, Marino; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Epidemiol & Int Hlth, Tokyo, Japan; [Yi, Siyan; Nonaka, Daisuke; Nomoto, Marino] Univ Tokyo, Grad Sch Med, Sch Int Hlth, Dept Community & Global Hlth, Tokyo, Japan; [Kobayashi, Jun] Natl Ctr Global Hlth & Med, Bur Int Cooperat, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; National Center for Global Health & Medicine - Japan	Yi, SY (corresponding author), Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Epidemiol & Int Hlth, Tokyo, Japan.	siyan@doctor.com	Daisuke, Nonaka/AAB-8509-2020; Nonaka, Daisuke/AAP-7918-2021	Daisuke, Nonaka/0000-0001-6793-2062; 	National Center for Global Health and Medicine, Tokyo, Japan [22-7]	National Center for Global Health and Medicine, Tokyo, Japan	This study was financially supported by a research grant (22-7) from the National Center for Global Health and Medicine, Tokyo, Japan (http://www.ncgm.go.jp/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkuwari MG, 2011, VACCINE IN PRESS; Barriere J, 2010, VACCINE, V28, P7030, DOI 10.1016/j.vaccine.2010.08.021; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Gargano LM, 2011, HUM VACCINES, V7, P89, DOI 10.4161/hv.7.1.13460; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Goldstein AO, 2004, INFECT CONT HOSP EP, V25, P908, DOI 10.1086/502318; Harris KM, 2010, NEW ENGL J MED, V363, P2183, DOI 10.1056/NEJMp1012333; Infectious Disease Surveillance Center, 2010, PAND INFL A H1N1 SIT; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Kwon Y, 2010, VACCINE, V29, P161, DOI 10.1016/j.vaccine.2010.10.063; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Matsumoto C, 2010, EMERG INFECT DIS, V16, P722, DOI 10.3201/eid1604.091795; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Maurer J, 2009, VACCINE, V27, P5732, DOI 10.1016/j.vaccine.2009.07.080; Ministry of Health Labor and Welfare Tokyo Japan, 2009, SUPPL INFL VACC; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Rachiotis G, 2010, EURO SURVEILL, V15; RAUDE J, 2009, PLOS CURR, V2; Schwartz KL, 2006, J GEN INTERN MED, V21, P346, DOI 10.1111/j.1525-1497.2006.00401.x; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Shimada T, 2009, EUROSURVEILLANCE, V14; SteelFisher GK, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1005102; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; White SW, 2010, MED J AUSTRALIA, V193, P405, DOI 10.5694/j.1326-5377.2010.tb03970.x; Wong LP, 2010, VACCINE, V28, P4499, DOI 10.1016/j.vaccine.2010.04.043; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 2009, WORLD NOW START 2009; Zijtregtop EAM, 2009, VACCINE, V28, P207, DOI 10.1016/j.vaccine.2009.09.099	30	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18893	10.1371/journal.pone.0018893	http://dx.doi.org/10.1371/journal.pone.0018893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556152	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400014
J	Dortay, H; Akula, UM; Westphal, C; Sittig, M; Mueller-Roeber, B				Dortay, Hakan; Akula, Usha Madhuri; Westphal, Christin; Sittig, Marie; Mueller-Roeber, Bernd			High-Throughput Protein Expression Using a Combination of Ligation-Independent Cloning (LIC) and Infrared Fluorescent Protein (IFP) Detection	PLOS ONE			English	Article							SIGNALING PATHWAY; DNA; SPECIFICITY; SYSTEM	Protein expression in heterologous hosts for functional studies is a cumbersome effort. Here, we report a superior platform for parallel protein expression in vivo and in vitro. The platform combines highly efficient ligation-independent cloning (LIC) with instantaneous detection of expressed proteins through N- or C-terminal fusions to infrared fluorescent protein (IFP). For each open reading frame, only two PCR fragments are generated (with three PCR primers) and inserted by LIC into ten expression vectors suitable for protein expression in microbial hosts, including Escherichia coli, Kluyveromyces lactis, Pichia pastoris, the protozoon Leishmania tarentolae, and an in vitro transcription/translation system. Accumulation of IFP-fusion proteins is detected by infrared imaging of living cells or crude protein extracts directly after SDS-PAGE without additional processing. We successfully employed the LIC-IFP platform for in vivo and in vitro expression of ten plant and fungal proteins, including transcription factors and enzymes. Using the IFP reporter, we additionally established facile methods for the visualisation of protein-protein interactions and the detection of DNA-transcription factor interactions in microtiter and gel-free format. We conclude that IFP represents an excellent reporter for high-throughput protein expression and analysis, which can be easily extended to numerous other expression hosts using the setup reported here.	[Dortay, Hakan; Akula, Usha Madhuri; Westphal, Christin; Sittig, Marie; Mueller-Roeber, Bernd] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Mueller-Roeber, Bernd] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	University of Potsdam; Max Planck Society	Dortay, H (corresponding author), Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany.	bmr@uni-potsdam.de	Mueller-Roeber, Bernd/Z-4052-2019		German Ministry of Education and Research (BMBF) [FKZ 03IP515]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry of Education and Research (BMBF) within the InnoProfile initiative, project "Integrated Protein Chips for the Point-of-Care Diagnostics - iPOC" (FKZ 03IP515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah James M., 2009, V498, P117, DOI 10.1007/978-1-59745-196-3_8; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Balhana R, 2010, J MICROBIOL METH, V83, P34, DOI 10.1016/j.mimet.2010.07.014; Battle T, 2006, COMB CHEM HIGH T SCR, V9, P639, DOI 10.2174/138620706778700143; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; Benita Y, 2006, MOL CELL PROTEOMICS, V5, P1567, DOI 10.1074/mcp.M600140-MCP200; Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Breitling R, 2002, PROTEIN EXPRES PURIF, V25, P209, DOI 10.1016/S1046-5928(02)00001-3; Buchs Mirjam, 2009, V498, P199, DOI 10.1007/978-1-59745-196-3_14; Chapple SDJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-49; Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5; Dortay H, 2010, MICROB CELL FACT, V10, P9; Dortay H, 2008, J PROTEOME RES, V7, P3649, DOI 10.1021/pr0703831; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Esposito Dominic, 2009, V498, P31, DOI 10.1007/978-1-59745-196-3_3; Francis Dana M, 2010, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0524s61; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Khnouf R, 2010, ANAL CHEM, V82, P7021, DOI 10.1021/ac1015479; Latz A, 2007, PLANT J, V52, P449, DOI 10.1111/j.1365-313X.2007.03255.x; Lesley SA, 2009, METHOD ENZYMOL, V463, P767, DOI 10.1016/S0076-6879(09)63041-X; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Sorensen HP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-27; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; van Ooyen AJJ, 2006, FEMS YEAST RES, V6, P381, DOI 10.1111/j.1567-1364.2006.00049.x; Voelker C, 2010, PLANT BIOLOGY, V12, P56, DOI 10.1111/j.1438-8677.2010.00353.x; Xu GY, 2010, NEW PHYTOL, V187, P240, DOI 10.1111/j.1469-8137.2010.03253.x; Xue GP, 2005, PLANT J, V41, P638, DOI 10.1111/j.1365-313X.2004.02323.x; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	34	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18900	10.1371/journal.pone.0018900	http://dx.doi.org/10.1371/journal.pone.0018900			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541323	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400015
J	Hartigan, A; Fiala, I; Dykova, I; Jirku, M; Okimoto, B; Rose, K; Phalen, DN; Slapeta, J				Hartigan, Ashlie; Fiala, Ivan; Dykova, Iva; Jirku, Miloslav; Okimoto, Ben; Rose, Karrie; Phalen, David N.; Slapeta, Jan			A Suspected Parasite Spill-Back of Two Novel Myxidium spp. (Myxosporea) Causing Disease in Australian Endemic Frogs Found in the Invasive Cane Toad	PLOS ONE			English	Article							BUFO-MARINUS; TREE FROG; MYXOZOA; INFECTION; PHYLOGENY; GREEN; PHYLOGEOGRAPHY; BIODIVERSITY; POPULATION; SEQUENCES	Infectious diseases are contributing to the decline of endangered amphibians. We identified myxosporean parasites, Myxidium spp. (Myxosporea: Myxozoa), in the brain and liver of declining native frogs, the Green and Golden Bell frog (Litoria aurea) and the Southern Bell frog (Litoria raniformis). We unequivocally identified two Myxidium spp. (both generalist) affecting Australian native frogs and the invasive Cane toad (Bufo marinus, syn. Rhinella marina) and demonstrated their association with disease. Our study tested the identity of Myxidium spp. within native frogs and the invasive Cane toad (brought to Australia in 1935, via Hawaii) to resolve the question whether the Cane toad introduced them to Australia. We showed that the Australian brain and liver Myxidium spp. differed 9%, 7%, 34% and 37% at the small subunit rDNA, large subunit rDNA, internal transcribed spacers 1 and 2, but were distinct from Myxidium cf. immersum from Cane toads in Brazil. Plotting minimum within-group distance against maximum intra-group distance confirmed their independent evolutionary trajectory. Transmission electron microscopy revealed that the brain stages localize inside axons. Myxospores were morphologically indistinguishable, therefore genetic characterisation was necessary to recognise these cryptic species. It is unlikely that the Cane toad brought the myxosporean parasites to Australia, because the parasites were not found in 261 Hawaiian Cane toads. Instead, these data support the enemy-release hypothesis predicting that not all parasites are translocated with their hosts and suggest that the Cane toad may have played an important spill-back role in their emergence and facilitated their dissemination. This work emphasizes the importance of accurate species identification of pathogens relevant to wildlife management and disease control. In our case it is paving the road for the spill-back role of the Cane toad and the parasite emergence.	[Hartigan, Ashlie; Phalen, David N.; Slapeta, Jan] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Fiala, Ivan; Dykova, Iva; Jirku, Miloslav] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Okimoto, Ben] Honolulu Zoo, Oahu, HI USA; [Rose, Karrie] Taronga Conservat Soc Australia, Australian Registry Wildlife Hlth, Mosman, NSW, Australia	University of Sydney; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Hartigan, A (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	jan.slapeta@sydney.edu.au	Dykova, Iva/B-9699-2013; Hartigan, Ashlie/G-7310-2014; Jirku, Miloslav/G-7823-2014; Fiala, Ivan/G-7962-2014	Jirku, Miloslav/0000-0002-4258-6543; Fiala, Ivan/0000-0003-1536-9778; Slapeta, Jan/0000-0003-1459-9117; Dykova, Iva/0000-0001-9254-5582	Australian Academy of Science; Dr William Richards Award in Veterinary Pathology; ARC/NH&MRC Network for Parasitology; Grant Agency of the Academy of Sciences of the Czech Republic [KJB600960701]; Grant Agency of the Czech Republic [204/09/P519]	Australian Academy of Science; Dr William Richards Award in Veterinary Pathology; ARC/NH&MRC Network for Parasitology(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This study was financially supported by the Australian Academy of Science, Dr William Richards Award in Veterinary Pathology, ARC/NH&MRC Network for Parasitology, and in part by the Grant Agency of the Academy of Sciences of the Czech Republic (KJB600960701) and the Grant Agency of the Czech Republic (204/09/P519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar AA, 1957, J BRAS NEFROL, V9, P137; Bartosova P, 2009, MOL PHYLOGENET EVOL, V53, P81, DOI 10.1016/j.ympev.2009.05.018; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blackburn DC, 2010, AFR J HERPETOL, V59, P111, DOI 10.1080/04416651.2010.495674; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Canning EU, 2002, J EUKARYOT MICROBIOL, V49, P280, DOI 10.1111/j.1550-7408.2002.tb00371.x; Carlton JT, 1996, ECOLOGY, V77, P1653, DOI 10.2307/2265767; Coleman AW, 2002, J MOL EVOL, V54, P246, DOI 10.1007/s00239-001-0006-0; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DELVINQUIER BLJ, 1986, AUST J ZOOL, V34, P843, DOI 10.1071/ZO9860843; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; Duncan AE, 2004, J ZOO WILDLIFE MED, V35, P381, DOI 10.1638/03-048; Dunn AM, 2009, ADV PARASIT, V68, P161, DOI 10.1016/S0065-308X(08)00607-6; Dykova I., 2007, HISTOPATHOLOGY PROTI; EASTEAL S, 1981, BIOL J LINN SOC, V16, P93, DOI 10.1111/j.1095-8312.1981.tb01645.x; Fiala I, 2006, INT J PARASITOL, V36, P1521, DOI 10.1016/j.ijpara.2006.06.016; Green DE, 2009, AMPHIBIAN ECOLOGY CO, P481; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunter NL, 2009, INT J PARASITOL, V39, P1395, DOI 10.1016/j.ijpara.2009.04.008; Hartigan A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-50; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hedrick RP, 1998, IMMUNOL REV, V166, P365, DOI 10.1111/j.1600-065X.1998.tb01276.x; Hemmerter S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-100; Henderson M, 2004, P ROY SOC B-BIOL SCI, V271, P1729, DOI 10.1098/rspb.2004.2677; Hershberger PK, 2010, BIOL INVASIONS, V12, P3665, DOI 10.1007/s10530-010-9760-5; Hill BD, 1997, AUST VET J, V75, P910, DOI 10.1111/j.1751-0813.1997.tb11266.x; Holzer AS, 2004, INT J PARASITOL, V34, P1099, DOI 10.1016/j.ijpara.2004.06.002; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufbauer Ruth A., 2007, V193, P79; Jirku M, 2006, J PARASITOL, V92, P611, DOI 10.1645/GE-728R.1; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Kent ML, 2001, J EUKARYOT MICROBIOL, V48, P395, DOI 10.1111/j.1550-7408.2001.tb00173.x; KUDO R. R., 1940, REV MED TROP Y PARASITOL BAD CLIN Y LAB [HAVANA], V6, P65; LOM J, 1989, J FISH DIS, V12, P15, DOI 10.1111/j.1365-2761.1989.tb01235.x; Lom J, 1997, DIS AQUAT ORGAN, V30, P1, DOI 10.3354/dao030001; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Mahony M, 1999, DECLINES DISAPPEARAN, P81; Mahony Michael, 1996, Australian Zoologist, V30, P237; Marr SR, 2008, BIOL INVASIONS, V10, P1289, DOI 10.1007/s10530-007-9203-0; McFadden Michael, 2008, Australian Zoologist, V34, P291; Mutschmann F, 2004, DIS AQUAT ORGAN, V60, P215, DOI 10.3354/dao060215; O'Donoghue Peter J., 2000, Memoirs of the Queensland Museum, V45, P1; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Rose K, 2005, WILDLIFE HLTH INVEST; Sitja-Bobadilla A, 2009, P R SOC B, V276, P2861, DOI 10.1098/rspb.2009.0368; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Steinbach-Elwell LC, 2009, WHIRLING DIS US SUMM; STENSAAS LJ, 1967, J PROTOZOOL, V14, P585, DOI 10.1111/j.1550-7408.1967.tb02045.x; Sutherst RW, 1996, CONSERV BIOL, V10, P294, DOI 10.1046/j.1523-1739.1996.10010294.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teacher AGF, 2010, ANIM CONSERV, V13, P514, DOI 10.1111/j.1469-1795.2010.00373.x; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tompkins DM, 2006, BIOL INVASIONS NZ, P67; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Wassens Skye, 2008, Australian Zoologist, V34, P446; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Whipps CM, 2006, J EUKARYOT MICROBIOL, V53, P364, DOI 10.1111/j.1550-7408.2006.00114.x; Whipps CM, 2004, DIS AQUAT ORGAN, V60, P105, DOI 10.3354/dao060105; White Arthur W., 2008, Australian Zoologist, V34, P319	69	42	44	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18871	10.1371/journal.pone.0018871	http://dx.doi.org/10.1371/journal.pone.0018871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541340	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800023
J	Watanabe, M; Ishimaru, N; Ashrin, MN; Arakaki, R; Yamada, A; Ichikawa, T; Hayashi, Y				Watanabe, Megumi; Ishimaru, Naozumi; Ashrin, Meinar Nur; Arakaki, Rieko; Yamada, Akiko; Ichikawa, Tetsuo; Hayashi, Yoshio			A Novel DC Therapy with Manipulation of MKK6 Gene on Nickel Allergy in Mice	PLOS ONE			English	Article							DENDRITIC CELL MATURATION; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; CONTACT-DERMATITIS; IMMUNE-RESPONSES; COSTIMULATORY MOLECULES; LANGERHANS CELLS; METAL-IONS; TNF-ALPHA; IN-VITRO	Background: Although the activation of dermal dendritic cells (DCs) or Langerhans cells (LCs) via p38 mitogen-activated protein kinase (MAPK) plays a crucial role in the pathogenesis of metal allergy, the in vivo molecular mechanisms have not been identified and a possible therapeutic strategy using the control of dermal DCs or LCs has not been established. In this study, we focused on dermal DCs to define the in vivo mechanisms of metal allergy pathogenesis in a mouse nickel (Ni) allergy model. The effects of DC therapy on Ni allergic responses were also investigated. Methods and Finding: The activation of dermal DCs via p38 MAPK triggered a T cell-mediated allergic immune response in this model. In the MAPK signaling cascade in DCs, Ni potently phosphorylated MAP kinase kinase 6 (MKK6) following increased DC activation. Ni-stimulated DCs could prime T cell activation to induce Ni allergy. Interestingly, when MKK6 gene-transfected DCs were transferred into the model mice, a more pronounced allergic reaction was observed. In addition, injection of short interfering (si) RNA targeting the MKK6 gene protected against a hypersensitivity reaction after Ni immunization. The cooperative action between T cell activation and MKK6-mediated DC activation by Ni played an important role in the development of Ni allergy. Conclusions: DC activation by Ni played an important role in the development of Ni allergy. Manipulating the MKK6 gene in DCs may be a good therapeutic strategy for dermal Ni allergy.	[Watanabe, Megumi; Ishimaru, Naozumi; Ashrin, Meinar Nur; Arakaki, Rieko; Yamada, Akiko; Hayashi, Yoshio] Univ Tokushima, Dept Oral Mol Pathol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan; [Watanabe, Megumi; Ashrin, Meinar Nur; Ichikawa, Tetsuo] Univ Tokushima, Dept Oral Maxillofacial Prosthodont, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan	Tokushima University; Tokushima University	Watanabe, M (corresponding author), Univ Tokushima, Dept Oral Mol Pathol, Inst Hlth Biosci, Grad Sch, Tokushima 770, Japan.	ishimaru@dent.tokushima-u.ac.jp		Ashrin, Meinar Nur/0000-0002-9214-7733	Ministry of Education, Culture, Sports, Science and Technology of Japan [17109016, 21390518, 21791901]; Japan Chemical Industry Association [LRi 2005CS02]; Grants-in-Aid for Scientific Research [21390518, 23390429] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Chemical Industry Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research (Nos. 17109016, 21390518, and 21791901) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and research grants from Japan Chemical Industry Association (No. LRi 2005CS02). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERER W, 1993, CONTACT DERMATITIS, V28, P163, DOI 10.1111/j.1600-0536.1993.tb03379.x; Ade N, 2007, TOXICOL SCI, V99, P488, DOI 10.1093/toxsci/kfm178; Aiba S, 1997, EUR J IMMUNOL, V27, P3031, DOI 10.1002/eji.1830271141; Antonios D, 2009, TOXICOL IN VITRO, V23, P227, DOI 10.1016/j.tiv.2008.11.009; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Artik S, 1999, J IMMUNOL, V163, P1143; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x; Bennett CL, 2007, J IMMUNOL, V179, P6830, DOI 10.4049/jimmunol.179.10.6830; Black JT, 1999, J MANUF SYST, pU1; Boisleve F, 2005, TOXICOLOGY, V206, P233, DOI 10.1016/j.tox.2004.08.015; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Budinger L, 2000, ALLERGY, V55, P108, DOI 10.1034/j.1398-9995.2000.00107.x; Cavani A, 2000, J INVEST DERMATOL, V114, P295, DOI 10.1046/j.1523-1747.2000.00881.x; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; Forte Giovanni, 2008, Inflammation & Allergy Drug Targets, V7, P145, DOI 10.2174/187152808785748146; Geissmann F, 2002, J EXP MED, V196, P417, DOI 10.1084/jem.20020018; Jorgl A, 2007, BLOOD, V109, P185, DOI 10.1182/blood-2006-05-022954; Kaisho T, 2008, TRENDS IMMUNOL, V29, P329, DOI 10.1016/j.it.2008.03.005; KAPSENBERG ML, 1992, J INVEST DERMATOL, V98, P59, DOI 10.1111/1523-1747.ep12494841; Kinouchi N, 2008, GENE THER, V15, P1126, DOI 10.1038/gt.2008.24; Koski GK, 2008, IMMUNOL REV, V222, P256, DOI 10.1111/j.1600-065X.2008.00617.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lore K, 1998, J IMMUNOL METHODS, V218, P173; Martin SF, 2008, CURR OPIN ALLERGY CL, V8, P289, DOI 10.1097/ACI.0b013e3283088cf9; Miyazawa M, 2008, J TOXICOL SCI, V33, P51, DOI 10.2131/jts.33.51; Moed H, 2004, BRIT J DERMATOL, V151, P32, DOI 10.1111/j.1365-2133.2004.05975.x; Mortz CG, 2001, BRIT J DERMATOL, V144, P523, DOI 10.1046/j.1365-2133.2001.04078.x; Nakae S, 2001, INT IMMUNOL, V13, P1471, DOI 10.1093/intimm/13.12.1471; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nosbaum A, 2009, EUR J DERMATOL, V19, P325, DOI 10.1684/ejd.2009.0686; O'Neill D, 2005, METH MOLEC MED, V109, P1; Riedl E, 2000, BLOOD, V96, P4276; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Rustemeyer T, 2004, CLIN EXP ALLERGY, V34, P1458, DOI 10.1111/j.1365-2222.2004.02045.x; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; SINIGAGLIA F, 1985, J IMMUNOL, V135, P3929; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Thierse HJ, 2005, TOXICOLOGY, V209, P101, DOI 10.1016/j.tox.2004.12.015; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Toebak MJ, 2009, CONTACT DERMATITIS, V60, P2, DOI 10.1111/j.1600-0536.2008.01443.x; Trompezinski S, 2008, TOXICOL APPL PHARM, V230, P397, DOI 10.1016/j.taap.2008.03.012; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0	47	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19017	10.1371/journal.pone.0019017	http://dx.doi.org/10.1371/journal.pone.0019017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544193	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800031
J	Xu, BS; Chen, SJ; Luo, Y; Chen, Z; Liu, L; Zhou, HY; Chen, WX; Shen, T; Han, XZ; Chen, L; Huang, S				Xu, Baoshan; Chen, Sujuan; Luo, Yan; Chen, Zi; Liu, Lei; Zhou, Hongyu; Chen, Wenxing; Shen, Tao; Han, Xiuzhen; Chen, Long; Huang, Shile			Calcium Signaling Is Involved in Cadmium-Induced Neuronal Apoptosis via Induction of Reactive Oxygen Species and Activation of MAPK/mTOR Network	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; C-JUN; MESANGIAL CELLS; TUBULAR CELLS; PROTEIN; KINASE; MTOR; HOMEOSTASIS; NEURODEGENERATION	Cadmium (Cd), a toxic environmental contaminant, induces oxidative stress, leading to neurodegenerative disorders. Recently we have demonstrated that Cd induces neuronal apoptosis in part by activation of the mitogen-activated protein kineses (MAPK) and mammalian target of rapamycin (mTOR) pathways. However, the underlying mechanism remains elusive. Here we show that Cd elevated intracellular calcium ion ([Ca2+](i)) level in PC12, SH-SY5Y cells and primary murine neurons. BAPTA/AM, an intracellular Ca2+ chelator, abolished Cd-induced [Ca2+](i) elevation, and blocked Cd activation of MAKPs including extracellular signal-regulated kinase 1/2 (Erk1/2), c-Jun N-terminal kinase (JNK) and p38, and mTOR-mediated signaling pathways, as well as cell death. Pretreatment with the extracellular Ca2+ chelator EGTA also prevented Cd-induced [Ca2+](i) elevation, MAPK/mTOR activation, as well as cell death, suggesting that Cd-induced extracellular Ca2+ influx plays a critical role in contributing to neuronal apoptosis. In addition, calmodulin (CaM) antagonist trifluoperazine (TFP) or silencing CaM attenuated the effects of Cd on MAPK/mTOR activation and cell death. Furthermore, Cd-induced [Ca2+](i) elevation or CaM activation resulted in induction of reactive oxygen species (ROS). Pretreatment with BAPTA/AM, EGTA or TFP attenuated Cd-induced ROS and cleavage of caspase-3 in the neuronal cells. Our findings indicate that Cd elevates [Ca2+](i), which induces ROS and activates MAPK and mTOR pathways, leading to neuronal apoptosis. The results suggest that regulation of Cd-disrupted [Ca2+](i) homeostasis may be a new strategy for prevention of Cd-induced neurodegenerative diseases.	[Xu, Baoshan; Chen, Sujuan; Luo, Yan; Liu, Lei; Zhou, Hongyu; Chen, Wenxing; Shen, Tao; Han, Xiuzhen; Huang, Shile] Louisiana State Univ, Dept Biochem & Mol Biol, Feist Weiller Canc Ctr, Hlth Sci Ctr, Shreveport, LA 71105 USA; [Chen, Zi; Chen, Long] Nanjing Normal Univ, Jiangsu Prov Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Nanjing Normal University	Xu, BS (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Feist Weiller Canc Ctr, Hlth Sci Ctr, Shreveport, LA 71105 USA.	lchen@njnu.edu.cn; shuan1@lsuhsc.edu	Chen, Wenxing/GSI-9910-2022; Xu, Baoshan/H-6435-2011; luo, yan/I-5305-2015; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072; Chen, Wenxing/0000-0003-4571-7622; Xu, Baoshan/0000-0001-8902-1243	NIH [CA115414]; American Cancer Society [RSG-08-135-01-CNE]; Louisiana Board of Regents [NSF-2009-PFUND-144]; National Natural Science Fundation of China [30971486]; Scientific Research Foundation of the State Education Ministry of China [SEMR20091341]; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Louisiana Board of Regents; National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of the State Education Ministry of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the grants from NIH (CA115414; S.H.), American Cancer Society (RSG-08-135-01-CNE; S.H.), Louisiana Board of Regents (NSF-2009-PFUND-144; S.H.), the National Natural Science Fundation of China (No. 30971486; L.C.), and the Scientific Research Foundation of the State Education Ministry of China (SEMR20091341, L.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Sela S, 2001, Int J Occup Environ Health, V7, P109; Baxter LC, 2006, J ALZHEIMERS DIS, V9, P253; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; Chen L, 2008, FREE RADICAL BIO MED, V45, P1035, DOI 10.1016/j.freeradbiomed.2008.07.011; Chen L, 2008, J NEUROCHEM, V105, P251, DOI 10.1111/j.1471-4159.2007.05133.x; Chen L, 2011, FREE RADICAL BIO MED, V50, P624, DOI 10.1016/j.freeradbiomed.2010.12.032; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen-Deutsch XW, 2009, LEUKEMIA RES, V33, P1372, DOI 10.1016/j.leukres.2009.03.003; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Figueiredo-Pereira ME, 1998, J BIOL CHEM, V273, P12703, DOI 10.1074/jbc.273.21.12703; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; GOERING PL, 1993, TOXICOL APPL PHARM, V122, P139, DOI 10.1006/taap.1993.1181; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Jiang LF, 2007, BBA-PROTEINS PROTEOM, V1774, P1414, DOI 10.1016/j.bbapap.2007.08.014; Karassek S, 2010, J BIOL CHEM, V285, P33979, DOI 10.1074/jbc.M109.095968; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; LEE TP, 1987, J IMMUNOL, V139, P42; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Li ZM, 2004, J NEUROCHEM, V90, P19, DOI 10.1111/j.1471-4159.2004.02456.x; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010578; Liu Y, 2008, J CELL PHYSIOL, V217, P307, DOI 10.1002/jcp.21499; Liu ZM, 2007, CELL MOL LIFE SCI, V64, P1428, DOI 10.1007/s00018-007-7107-x; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; MANCA D, 1994, ARCH TOXICOL, V68, P364, DOI 10.1007/s002040050083; Marambaud P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-20; MARLOWE M, 1985, J ABNORM CHILD PSYCH, V13, P185, DOI 10.1007/BF00910641; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Okuda B, 1997, CLIN NEUROL NEUROSUR, V99, P263, DOI 10.1016/S0303-8467(97)00090-5; Pan G, 1998, IMMUNOPHARMACOLOGY, V40, P91, DOI 10.1016/S0162-3109(98)00018-6; PIHL RO, 1977, SCIENCE, V198, P204, DOI 10.1126/science.905825; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Ruiz A, 2009, CELL CALCIUM, V46, P273, DOI 10.1016/j.ceca.2009.08.005; Sarkar S, 1997, J TRACE ELEM MED BIO, V11, P8, DOI 10.1016/S0946-672X(97)80002-8; Shaikh ZA, 1999, TOXICOL APPL PHARM, V154, P256, DOI 10.1006/taap.1998.8586; Shen HM, 2001, TOXICOL APPL PHARM, V171, P12, DOI 10.1006/taap.2000.9092; Shukla GS, 2000, TOXICOLOGY, V151, P45, DOI 10.1016/S0300-483X(00)00263-8; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Szuster-Ciesielska A, 2000, TOXICOLOGY, V145, P159, DOI 10.1016/S0300-483X(00)00144-X; Thevenod F, 2009, TOXICOL APPL PHARM, V238, P221, DOI 10.1016/j.taap.2009.01.013; TORRA M, 1995, SCI TOTAL ENVIRON, V170, P53, DOI 10.1016/0048-9697(95)04534-8; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wang L, 2009, BIOL TRACE ELEM RES, V127, P53, DOI 10.1007/s12011-008-8223-7; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Xie ZY, 2010, TOXICOL LETT, V192, P115, DOI 10.1016/j.toxlet.2009.10.011; Yang CS, 2008, J CELL BIOCHEM, V103, P825, DOI 10.1002/jcb.21452; Yang LY, 2009, AUTOPHAGY, V5, P571, DOI 10.4161/auto.5.4.8311; Yeh JH, 2009, BASIC CLIN PHARMACOL, V104, P345, DOI 10.1111/j.1742-7843.2009.00391.x; Zhang J, 2011, EXP CELL RES, V317, P117, DOI 10.1016/j.yexcr.2010.08.010; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	60	155	167	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19052	10.1371/journal.pone.0019052	http://dx.doi.org/10.1371/journal.pone.0019052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544200	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800037
J	Blech, I; Katzenellenbogen, M; Katzenellenbogen, A; Wainstein, J; Rubinstein, A; Harman-Boehm, I; Cohen, J; Pollin, TI; Glaser, B				Blech, Ilana; Katzenellenbogen, Mark; Katzenellenbogen, Alexandra; Wainstein, Julio; Rubinstein, Ardon; Harman-Boehm, Ilana; Cohen, Joseph; Pollin, Toni I.; Glaser, Benjamin			Predicting Diabetic Nephropathy Using a Multifactorial Genetic Model	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITION; URINARY ALBUMIN EXCRETION; WIDE LINKAGE SCAN; RENAL-FUNCTION; RISK-FACTORS; FAMILIES; HERITABILITY; SUSCEPTIBILITY; MACROPHAGES; VARIANTS	Aims: The tendency to develop diabetic nephropathy is, in part, genetically determined, however this genetic risk is largely undefined. In this proof-of-concept study, we tested the hypothesis that combined analysis of multiple genetic variants can improve prediction. Methods: Based on previous reports, we selected 27 SNPs in 15 genes from metabolic pathways involved in the pathogenesis of diabetic nephropathy and genotyped them in 1274 Ashkenazi or Sephardic Jewish patients with Type 1 or Type 2 diabetes of > 10 years duration. A logistic regression model was built using a backward selection algorithm and SNPs nominally associated with nephropathy in our population. The model was validated by using random "training" (75%) and "test" (25%) subgroups of the original population and by applying the model to an independent dataset of 848 Ashkenazi patients. Results: The logistic model based on 5 SNPs in 5 genes (HSPG2, NOS3, ADIPOR2, AGER, and CCL5) and 5 conventional variables (age, sex, ethnicity, diabetes type and duration), and allowing for all possible two-way interactions, predicted nephropathy in our initial population (C-statistic = 0.672) better than a model based on conventional variables only (C = 0.569). In the independent replication dataset, although the C-statistic of the genetic model decreased (0.576), it remained highly associated with diabetic nephropathy (chi(2) = 17.79, p < 0.0001). In the replication dataset, the model based on conventional variables only was not associated with nephropathy (chi(2) = 3.2673, p = 0.07). Conclusion: In this proof-of-concept study, we developed and validated a genetic model in the Ashkenazi/Sephardic population predicting nephropathy more effectively than a similarly constructed non-genetic model. Further testing is required to determine if this modeling approach, using an optimally selected panel of genetic markers, can provide clinically useful prediction and if generic models can be developed for use across multiple ethnic groups or if population-specific models are required.	[Blech, Ilana; Glaser, Benjamin] Hadassah Hebrew Univ Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel; [Katzenellenbogen, Mark] Bar Ilan Univ, Bioinformat & Microarray Unit, Mina & Everard Goodman Fac Life Sci, Tel Aviv, Israel; [Katzenellenbogen, Alexandra] Cent Bur Stat, Jerusalem, Israel; [Wainstein, Julio] E Wolfson Med Ctr, Diabet Unit, Holon, Israel; [Rubinstein, Ardon] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Metab Unit, IL-69978 Tel Aviv, Israel; [Harman-Boehm, Ilana] Ben Gurion Univ Negev, Soroka Hosp, IL-84105 Beer Sheva, Israel; [Cohen, Joseph] Macabbi Hlth Serv, Endocrine Clin, Tel Aviv, Israel; [Pollin, Toni I.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA	Hebrew University of Jerusalem; Bar Ilan University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Soroka Medical Center; University System of Maryland; University of Maryland Baltimore	Blech, I (corresponding author), Hadassah Hebrew Univ Med Ctr, Endocrinol & Metab Serv, Jerusalem, Israel.	beng@cc.huji.ac.il	Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000	Israel Ministry of Health; Russell Berrie Foundation; D-Cure; Diabetes Care in Israel; Novo-Nordisk	Israel Ministry of Health; Russell Berrie Foundation; D-Cure; Diabetes Care in Israel; Novo-Nordisk(Novo Nordisk)	The study was supported by grants from the Israel Ministry of Health, The Russell Berrie Foundation, D-Cure, Diabetes Care in Israel and an unrestricted research grant from Novo-Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; BARNETT AH, 1986, CLIN ENDOCRINOL META, V15, P715, DOI 10.1016/S0300-595X(86)80070-6; BEHAR DM, 2010, NATURE, P1; Bochud M, 2005, KIDNEY INT, V67, P61, DOI 10.1111/j.1523-1755.2005.00055.x; BORCHJOHNSEN K, 1992, KIDNEY INT, V41, P719, DOI 10.1038/ki.1992.112; Chanock S, 2002, TRENDS MOL MED, V8, P266, DOI 10.1016/S1471-4914(02)02356-0; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Conway BR, 2009, NEPHRON CLIN PRACT, V112, pC213, DOI 10.1159/000224787; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; *FED ID, 2009, IDF DIAB ATL; Fogarty DG, 2000, KIDNEY INT, V57, P250, DOI 10.1046/j.1523-1755.2000.00833.x; Forsblom CM, 1999, DIABETOLOGIA, V42, P1359, DOI 10.1007/s001250051450; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Harjutsalo V, 2004, DIABETES, V53, P2449, DOI 10.2337/diabetes.53.9.2449; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Krolewski AS, 2006, KIDNEY INT, V69, P129, DOI 10.1038/sj.ki.5000023; Langefeld CD, 2004, AM J KIDNEY DIS, V43, P796, DOI 10.1053/j.ajkd.2003.12.043; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lu Qing, 2009, BMC Proc, V3 Suppl 7, pS49; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Maeda S, 2007, KIDNEY INT, V72, pS43, DOI 10.1038/sj.ki.5002385; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Parving HH, 1996, J AM SOC NEPHROL, V7, P2509; PARVING HH, 1995, AM J KIDNEY DIS, V26, P99, DOI 10.1016/0272-6386(95)90162-0; Perry DJ, 1999, BEST PRACT RES CL HA, V12, P451, DOI 10.1053/beha.1999.0036; Pezzolesi MG, 2009, DIABETES, V58, P1403, DOI 10.2337/db08-1514; Placha G, 2006, DIABETES, V55, P3358, DOI 10.2337/db06-0781; Quinn M, 1996, DIABETOLOGIA, V39, P940; Rich SS, 2006, J AM SOC NEPHROL, V17, P353, DOI 10.1681/ASN.2005070770; Rich SS, 2009, HORM RES, V71, P17, DOI 10.1159/000178031; Rincon-Choles Hernan, 2005, Am J Ther, V12, P555, DOI 10.1097/01.mjt.0000178770.52610.bf; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Sealey JE, 1990, HYPERTENSION PATHOPH, P1287; SEAQUIST ER, 1989, NEW ENGL J MED, V320, P1161, DOI 10.1056/NEJM198905043201801; Shen YY, 2008, NEPHROLOGY, V13, P528, DOI 10.1111/j.1440-1797.2008.01018.x; 't Hart LM, 2010, DIABETES, V59, P287, DOI 10.2337/db09-0736; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Wald A, 1943, T AM MATH SOC, V54, P426, DOI 10.2307/1990256; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	42	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18743	10.1371/journal.pone.0018743	http://dx.doi.org/10.1371/journal.pone.0018743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533139	Green Submitted, Green Published, gold			2022-12-25	WOS:000289505600027
J	Winter, N; Nimzyk, R; Bosche, C; Meyer, A; Bullerdiek, J				Winter, Nina; Nimzyk, Rolf; Boesche, Carolin; Meyer, Anke; Bullerdiek, Joern			Chromatin Immunoprecipitation to Analyze DNA Binding Sites of HMGA2	PLOS ONE			English	Article							GROUP CHROMOSOMAL-PROTEINS; EMBRYONIC STEM-CELLS; ARCHITECTURAL FACTOR; BREAST-CANCER; EXPRESSION; CARCINOMA; TRANSCRIPTION; MARKER; GENES; LINES	Background: HMGA2 is an architectonic transcription factor abundantly expressed during embryonic and fetal development and it is associated with the progression of malignant tumors. The protein harbours three basically charged DNA binding domains and an acidic protein binding C-terminal domain. DNA binding induces changes of DNA conformation and hence results in global overall change of gene expression patterns. Recently, using a PCR-based SELEX (Systematic Evolution of Ligands by Exponential Enrichment) procedure two consensus sequences for HMGA2 binding have been identified. Methodology/Principal Findings: In this investigation chromatin immunoprecipitation (ChIP) experiments and bioinformatic methods were used to analyze if these binding sequences can be verified on chromatin of living cells as well. Conclusion: After quantification of HMGA2 protein in different cell lines the colon cancer derived cell line HCT116 was chosen for further ChIP experiments because of its 3.4-fold higher HMGA2 protein level. 49 DNA fragments were obtained by ChIP. These fragments containing HMGA2 binding sites have been analyzed for their AT-content, location in the human genome and similarities to sequences generated by a SELEX study. The sequences show a significantly higher AT-content than the average of the human genome. The artificially generated SELEX sequences and short BLAST alignments (11 and 12 bp) of the ChIP fragments from living cells show similarities in their organization. The flanking regions are AT-rich, whereas a lower conservation is present in the center of the sequences.	[Winter, Nina; Nimzyk, Rolf; Boesche, Carolin; Meyer, Anke; Bullerdiek, Joern] Univ Bremen, Ctr Human Genet, Bremen, Germany; [Bullerdiek, Joern] Univ Vet Med, Clin Small Anim & Res Cluster REBIRTH, Hannover, Germany	University of Bremen; University of Veterinary Medicine Hannover, Foundation	Winter, N (corresponding author), Univ Bremen, Ctr Human Genet, Bremen, Germany.	bullerd@uni-bremen.de						Antonov J, 2005, LAB INVEST, V85, P1040, DOI 10.1038/labinvest.3700303; BELGE G, 1992, CELL BIOL INT REP, V16, P339, DOI 10.1016/S0309-1651(06)80139-6; BRATTAIN MG, 1982, J NATL CANCER I, V69, P767; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cleynen I, 2008, INT J ONCOL, V32, P289; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Cui TJ, 2007, BIOCHEMISTRY-US, V46, P13059, DOI 10.1021/bi701269s; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Dassoulas K, 2010, J CANCER RES CLIN, V136, P703, DOI 10.1007/s00432-009-0709-y; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Goretzki P E, 1990, Recent Results Cancer Res, V118, P48; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JESSUP JM, 1995, DIS COLON RECTUM, V38, P1257, DOI 10.1007/BF02049149; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANOTTE M, 1991, BLOOD, V77, P1080; Li O, 2007, FEBS LETT, V581, P3533, DOI 10.1016/j.febslet.2007.06.072; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; NAMBA H, 1995, CANCER RES, V55, P2075; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; PFANNKUCHE K, 2009, STEM CELL REV REP; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; REEVES R, 1990, J BIOL CHEM, V265, P8573; ROGALLA P, 1994, CANCER GENET CYTOGEN, V77, P19, DOI 10.1016/0165-4608(94)90143-0; Rohozinski J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005064; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; Sgarra R, 2005, PROTEOMICS, V5, P1494, DOI 10.1002/pmic.200401028; SGARRA R, 2009, BIOCH BIOPHYS ACTA; SMITH SD, 1984, CANCER RES, V44, P5657; SOLOMON MJ, 1986, P NATL ACAD SCI USA, V83, P1276, DOI 10.1073/pnas.83.5.1276; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Summer H, 2009, NUCLEIC ACIDS RES, V37, P4371, DOI 10.1093/nar/gkp375; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; TANAKA J, 1987, VIROLOGY, V161, P62, DOI 10.1016/0042-6822(87)90171-1; Urruticoechea A, 2008, BREAST CANCER RES TR, V109, P463, DOI 10.1007/s10549-007-9676-7; Yasui Yumiko, 2009, J Carcinog, V8, P10, DOI 10.4103/1477-3163.51851; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	44	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18837	10.1371/journal.pone.0018837	http://dx.doi.org/10.1371/journal.pone.0018837			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533145	gold, Green Submitted, Green Published			2022-12-25	WOS:000289505600035
J	Lechner, W; Heiss, E; Schwaha, T; Glosmann, M; Ladich, F				Lechner, Walter; Heiss, Egon; Schwaha, Thomas; Gloesmann, Martin; Ladich, Friedrich			Ontogenetic Development of Weberian Ossicles and Hearing Abilities in the African Bullhead Catfish	PLOS ONE			English	Article							DANIO-RERIO OSTARIOPHYSI; AUDITORY-SENSITIVITY; ACOUSTIC COMMUNICATION; ZEBRAFISH; APPARATUS; SILURIFORMES; VOCALIZATION; HOMOLOGY; PISCES; FISHES	Background: The Weberian apparatus of otophysine fishes facilitates sound transmission from the swimbladder to the inner ear to increase hearing sensitivity. It has been of great interest to biologists since the 19(th) century. No studies, however, are available on the development of the Weberian ossicles and its effect on the development of hearing in catfishes. Methodology/Principal Findings: We investigated the development of the Weberian apparatus and auditory sensitivity in the catfish Lophiobagrus cyclurus. Specimens from 11.3 mm to 85.5 mm in standard length were studied. Morphology was assessed using sectioning, histology, and X-ray computed tomography, along with 3D reconstruction. Hearing thresholds were measured utilizing the auditory evoked potentials recording technique. Weberian ossicles and interossicular ligaments were fully developed in all stages investigated except in the smallest size group. In the smallest catfish, the intercalarium and the interossicular ligaments were still missing and the tripus was not yet fully developed. Smallest juveniles revealed lowest auditory sensitivity and were unable to detect frequencies higher than 2 or 3 kHz; sensitivity increased in larger specimens by up to 40 dB, and frequency detection up to 6 kHz. In the size groups capable of perceiving frequencies up to 6 kHz, larger individuals had better hearing abilities at low frequencies (0.05-2 kHz), whereas smaller individuals showed better hearing at the highest frequencies (4-6 kHz). Conclusions/Significance: Our data indicate that the ability of otophysine fish to detect sounds at low levels and high frequencies largely depends on the development of the Weberian apparatus. A significant increase in auditory sensitivity was observed as soon as all Weberian ossicles and interossicular ligaments are present and the chain for transmitting sounds from the swimbladder to the inner ear is complete. This contrasts with findings in another otophysine, the zebrafish, where no threshold changes have been observed.	[Lechner, Walter; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Heiss, Egon; Schwaha, Thomas] Univ Vienna, Dept Morphol, Vienna, Austria; [Gloesmann, Martin] Univ Vet Med Vienna, VetCore Core Facil Res, VetImaging Unit, Vienna, Austria	University of Vienna; University of Vienna; University of Veterinary Medicine Vienna	Lechner, W (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	walter.lechner@univie.ac.at	Glösmann, Martin/F-9349-2019	Glösmann, Martin/0000-0002-2094-3247; Heiss, Egon/0000-0002-5257-8889; Schwaha, Thomas/0000-0003-0526-6791	Austrian Science Fund [P22319-B17, P20094-B17, P22696-B17]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Walter Lechner, Egon Heiss and Thomas Schwaha were supported by the Austrian Science Fund (http://www.fwf.ac.at/) (grants P22319-B17 to Friedrich Ladich, P20094-B17 to Josef Weisgram and P22696-B17 to Andrey N. Ostrovsky). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 2003, CATFISHES, VOLS 1-2, P639; BAMFORD TW, 1948, P ZOOL SOC LOND, V118, P364; Belanger AJ, 2010, J FISH BIOL, V77, P1488, DOI 10.1111/j.1095-8649.2010.02773.x; Bird NC, 2009, ZOOLOGY, V112, P97, DOI 10.1016/j.zool.2008.05.003; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; BORNBUSCH AH, 1995, ZOOL J LINN SOC-LOND, V115, P1; Chardon M, 2003, CATFISHES, VOLS 1-2, P71; Coburn MM, 1998, COPEIA, P301, DOI 10.2307/1447426; Coburn MT, 1996, ZOOL J LINN SOC-LOND, V116, P333; Dahdul WM, 2010, SYST BIOL, V59, P369, DOI 10.1093/sysbio/syq013; Egner SA, 2005, MAR ECOL PROG SER, V285, P213, DOI 10.3354/meps285213; Ferraris Carl J. Jr., 2007, Zootaxa, V1418, P1; Fuiman LA, 1998, COPEIA, P602, DOI 10.2307/1447790; Grande T, 2004, ZOOL J LINN SOC-LOND, V140, P241, DOI 10.1111/j.1096-3642.2003.00097.x; Grande Terry, 2002, Fieldiana Zoology, V99, P1; Higgs D. M., 2001, JARO-J ASSOC RES OTO, V3, P174, DOI [10.1007/s101620020035, DOI 10.1007/S101620020035]; Higgs DM, 2004, J EXP BIOL, V207, P155, DOI 10.1242/jeb.00735; Higgs DM, 2003, J ACOUST SOC AM, V113, P1145, DOI 10.1121/1.1536185; Hoffmann M, 2006, ZOOL J LINN SOC-LOND, V147, P301, DOI 10.1111/j.1096-3642.2006.00220.x; Holcik J., 1989, FRESHWATER FISHES 2, P18; Ichiyanagi Tetsuya, 1993, Journal of the Tokyo University of Fisheries, V80, P205; Ichiyanagi Tetsuya, 1997, Journal of the Tokyo University of Fisheries, V84, P93; Iwashita A, 1999, NIPPON SUISAN GAKK, V65, P833; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Kenyon TN, 1996, J COMP PHYSIOL A, V179, P553; Kiernan JA., 2003, HISTOLOGICAL HISTOCH; KULSHRESTHA SK, 1977, ANAT ANZEIGER, V141, P433; Ladich F, 2003, HEARING RES, V182, P119, DOI 10.1016/S0378-5955(03)00188-6; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Lechner W, 2008, J EXP BIOL, V211, P1681, DOI 10.1242/jeb.016436; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; MATVEIEV B., 1929, ZOOL JAHRB ABT ANAT U ONT TIERE, V51, P463; Nelson JS, 1984, FISHES WORLD; POGGENDORF D, 1952, Z VERGL PHYSIOL, V34, P222, DOI 10.1007/BF00298202; POPPER AN, 1971, J AUD RES, V11, P239; RADERMAKER F, 1989, CAN J ZOOL, V67, P2090, DOI 10.1139/z89-298; Romeis B., 1989, MIKROSKOPISCHE TECHN; Rosen D. E, 1970, Am. Mus. Novit., VNo. 2428, P1; Ruthensteiner B, 2008, ZOOSYMPOSIA, V1, P63, DOI 10.11646/zoosymposia.1.1.8; Sisneros JA, 2005, J EXP BIOL, V208, P3121, DOI 10.1242/jeb.01742; STETTER H., 1929, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V9, P339, DOI 10.1007/BF00340160; Vasconcelos RO, 2008, J EXP BIOL, V211, P502, DOI 10.1242/jeb.008474; von Frisch K., 1932, Z FURVERGLEICHENDE P, V17, P686; VONFRISCH K, 1923, BIOL ZENTRBLATT, P439; Watson JM, 1939, PROC R SOC SER B-BIO, V127, P452, DOI 10.1098/rspb.1939.0034; WEBER EH, 1820, AURE AUDIU HOMINIS A; WRIGHT RR, 1884, P CAN I N S, V2, P418; Wysocki LE, 2005, JARO-J ASSOC RES OTO, V6, P28, DOI 10.1007/s10162-004-4043-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2001, J COMP PHYSIOL A, V187, P177, DOI 10.1007/s003590100186; Zeddies DG, 2005, J EXP BIOL, V208, P1363, DOI 10.1242/jeb.01534	51	15	15	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18511	10.1371/journal.pone.0018511	http://dx.doi.org/10.1371/journal.pone.0018511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533262	gold, Green Published			2022-12-25	WOS:000289404700017
J	Meiringer, CTA; Rethmeier, R; Auffarth, K; Wilson, J; Perz, A; Barlowe, C; Schmitt, HD; Ungermann, C				Meiringer, Christoph T. A.; Rethmeier, Ralf; Auffarth, Kathrin; Wilson, Joshua; Perz, Angela; Barlowe, Charles; Schmitt, Hans Dieter; Ungermann, Christian			The Dsl1 Protein Tethering Complex Is a Resident Endoplasmic Reticulum Complex, Which Interacts with Five Soluble NSF (N-Ethylmaleimide-sensitive Factor) Attachment Protein Receptors (SNAREs) IMPLICATIONS FOR FUSION AND FUSION REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MEMBRANE-FUSION; RETRIEVAL-SYSTEM; GOLGI-COMPLEX; YEAST; VESICLE; TRANSPORT; ER; REQUIRES; SEC22P; ZW10	Retrograde vesicular transport from the Golgi to the ER requires the Dsl1 tethering complex, which consists of the three subunits Dsl1, Dsl3, and Tip20. It forms a stable complex with the SNAREs Ufe1, Use1, and Sec20 to mediate fusion of COPI vesicles with the endoplasmic reticulum. Here, we analyze molecular interactions between five SNAREs of the ER (Ufe1, Use1, Sec20, Sec22, and Ykt6) and the Dsl1 complex in vitro and in vivo. Of the two R-SNAREs, Sec22 is preferred over Ykt6 in the Dsl-SNARE complex. The NSF homolog Sec18 can displace Ykt6 but not Sec22, suggesting a regulatory function for Ykt6. In addition, our data also reveal that subunits of the Dsl1 complex (Dsl1, Dsl3, and Tip20), as well as the SNAREs Ufe1 and Sec20, are ER-resident proteins that do not seem to move into COPII vesicles. Our data support a model, in which a tethering complex is stabilized at the organelle membrane by binding to SNAREs, recognizes the incoming vesicle via its coat and then promotes its SNARE-mediated fusion.	[Meiringer, Christoph T. A.; Rethmeier, Ralf; Auffarth, Kathrin; Perz, Angela; Ungermann, Christian] Univ Osnabruck, Dept Biol & Chem, Biochem Sect, D-49076 Osnabruck, Germany; [Wilson, Joshua; Barlowe, Charles] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Schmitt, Hans Dieter] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37070 Gottingen, Germany	University Osnabruck; Dartmouth College; Max Planck Society	Ungermann, C (corresponding author), Univ Osnabruck, Dept Biol & Chem, Biochem Sect, Barbarastr 13, D-49076 Osnabruck, Germany.	cu@uos.de			Deutsche Forschungsgemeinschaft [SFB 431, 944, UN111/4-2]; Hans-Muhlenhoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052549] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans-Muhlenhoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 431, 944, and UN111/4-2) and the Hans-Muhlenhoff Foundation (to C. U.).	Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Angers CG, 2011, SEMIN CELL DEV BIOL, V22, P18, DOI 10.1016/j.semcdb.2010.07.003; Angers CG, 2009, MOL BIOL CELL, V20, P4563, DOI 10.1091/mbc.E09-04-0272; Arasaki K, 2007, BIOCHEM BIOPH RES CO, V359, P811, DOI 10.1016/j.bbrc.2007.05.188; Ballensiefen W, 1998, J CELL SCI, V111, P1507; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Diefenbacher M, 2011, J BIOL CHEM, V286, P25027, DOI 10.1074/jbc.M110.215657; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Frigerio G, 1998, YEAST, V14, P633, DOI 10.1002/(SICI)1097-0061(199805)14:7<633::AID-YEA267>3.0.CO;2-3; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Meiringer CTA, 2008, TRAFFIC, V9, P1510, DOI 10.1111/j.1600-0854.2008.00778.x; Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schmitt HD, 2010, TRENDS CELL BIOL, V20, P257, DOI 10.1016/j.tcb.2010.02.001; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; SWEET DJ, 1992, EMBO J, V11, P423, DOI 10.1002/j.1460-2075.1992.tb05071.x; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x; Varma D, 2006, J CELL BIOL, V172, P655, DOI 10.1083/jcb.200510120; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	37	35	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					25039	25046		10.1074/jbc.M110.215327	http://dx.doi.org/10.1074/jbc.M110.215327			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21550981	Green Published, hybrid			2022-12-25	WOS:000292547900052
J	Noble, E; Mathews, DH; Chen, JL; Turner, DH; Takimoto, T; Kim, B				Noble, Erin; Mathews, David H.; Chen, Jonathan L.; Turner, Douglas H.; Takimoto, Toru; Kim, Baek			Biophysical Analysis of Influenza A Virus RNA Promoter at Physiological Temperatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-RNA; ENDONUCLEASE ACTIVITY; SECONDARY STRUCTURE; INFECTED-CELLS; POLYMERASE; TRANSCRIPTION; PANHANDLE; BINDING; VRNA; NUCLEOPROTEIN	Each segment of the influenza A virus (IAV) genome contains conserved sequences at the 5'- and 3'-terminal ends, which form the promoter region necessary for polymerase binding and initiation of RNA synthesis. Although several models of interaction have been proposed it remains unclear if these two short, partially complementary, and highly conserved sequences can form a stable RNA duplex at physiological temperatures. First, our time-resolved FRET analysis revealed that a 14-mer 3'-RNA and a 15-mer 5'-RNA associate in solution, even at 42 degrees C. We also found that a nonfunctional RNA promoter containing the 3'-G3U mutation, as well as a promoter containing the compensatory 3'-G3U/C8A mutations, was able to form a duplex as efficiently as wild type. Second, UV melting analysis demonstrated that the wild-type and mutant RNA duplexes have similar stabilities in solution. We also observed an increase in thermostability for a looped promoter structure. The absence of differences in the stability and binding kinetics between wild type and a nonfunctional sequence suggests that the IAV promoter can be functionally inactivated without losing the capability to form a stable RNA duplex. Finally, using uridine specific chemical probing combined with mass spectrometry, we confirmed that the 5' and 3' sequences form a duplex which protects both RNAs from chemical modification, consistent with the previously published panhandle structure. These data support that these short, conserved promoter sequences form a stable complex at physiological temperatures, and this complex likely is important for polymerase recognition and viral replication.	[Noble, Erin; Takimoto, Toru; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Mathews, David H.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Chen, Jonathan L.; Turner, Douglas H.] Univ Rochester, Dept Chem, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu			National Institutes of Health (NIH) [HHSN266200700008C]; Oral Cellular and Molecular Biology Training Grant [T32 DE007202];  [GM22939];  [R01HG004002]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022939] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral Cellular and Molecular Biology Training Grant; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health (NIH) contract granted to the New York Influenza Center of Excellence (NIH/NIAID HHSN266200700008C), the Oral Cellular and Molecular Biology Training Grant (T32 DE007202), GM22939 (to D. H. T.), and R01HG004002 (to D. H. M.).	Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798; BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; CIANCI C, 1995, J VIROL, V69, P3995, DOI 10.1128/JVI.69.7.3995-3999.1995; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; Flick R, 1996, RNA, V2, P1046; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Gonzalez S, 1999, J VIROL, V73, P631; HERZ C, 1981, CELL, V26, P391, DOI 10.1016/0092-8674(81)90208-7; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Ishihama A, 1996, BIOCHIMIE, V78, P1097, DOI 10.1016/S0300-9084(97)86735-1; Kim HJ, 1997, J GEN VIROL, V78, P353, DOI 10.1099/0022-1317-78-2-353; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kobasa D, 2005, CURR MOL MED, V5, P791, DOI 10.2174/156652405774962281; Leahy MB, 2001, J VIROL, V75, P134, DOI 10.1128/JVI.75.1.134-142.2001; Leahy MB, 2001, J VIROL, V75, P7042, DOI 10.1128/JVI.75.15.7042-7049.2001; Lee KH, 1998, J GEN VIROL, V79, P1923, DOI 10.1099/0022-1317-79-8-1923; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schroeder SJ, 2009, METHOD ENZYMOL, V468, P371, DOI 10.1016/S0076-6879(09)68017-4; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Turner KB, 2009, RNA, V15, P1605, DOI 10.1261/rna.1615409	23	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22965	22970		10.1074/jbc.M111.239509	http://dx.doi.org/10.1074/jbc.M111.239509			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555520	Green Published, hybrid			2022-12-25	WOS:000292025000031
J	Vidal-Dupiol, J; Ladriere, O; Destoumieux-Garzon, D; Sautiere, PE; Meistertzheim, AL; Tambutte, E; Tambutte, S; Duval, D; Foure, L; Adjeroud, M; Mitta, G				Vidal-Dupiol, Jeremie; Ladriere, Ophelie; Destoumieux-Garzon, Delphine; Sautiere, Pierre-Eric; Meistertzheim, Anne-Leila; Tambutte, Eric; Tambutte, Sylvie; Duval, David; Foure, Laurent; Adjeroud, Mehdi; Mitta, Guillaume			Innate Immune Responses of a Scleractinian Coral to Vibriosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER ACANTHOSCURRIA-GOMESIANA; CHANNEL-BLOCKING TOXINS; ANTIMICROBIAL PEPTIDE; CLIMATE-CHANGE; POCILLOPORA-DAMICORNIS; ANTIBACTERIAL PEPTIDE; CRASSOSTREA-GIGAS; INSECT IMMUNITY; SCORPION TOXINS; PCR DATA	Scleractinian corals are the most basal eumetazoan taxon and provide the biological and physical framework for coral reefs, which are among the most diverse of all ecosystems. Over the past three decades and coincident with climate change, these phototrophic symbiotic organisms have been subject to increasingly frequent and severe diseases, which are now geographically widespread and a major threat to these ecosystems. Although coral immunity has been the subject of increasing study, the available information remains fragmentary, especially with respect to coral antimicrobial responses. In this study, we characterized damicornin from Pocillopora damicornis, the first scleractinian antimicrobial peptide (AMP) to be reported. We found that its precursor has a segmented organization comprising a signal peptide, an acidic proregion, and the C-terminal AMP. The 40-residue AMP is cationic, C-terminally amidated, and characterized by the presence of six cysteine molecules joined by three intramolecular disulfide bridges. Its cysteine array is common to another AMP and toxins from cnidarians; this suggests a common ancestor, as has been proposed for AMPs and toxins from arthropods. Damicornin was active in vitro against Gram-positive bacteria and the fungus Fusarium oxysporum. Damicornin expression was studied using a combination of immunohistochemistry, reverse phase HPLC, and quantitative RT-PCR. Our data show that damicornin is constitutively transcribed in ectodermal granular cells, where it is stored, and further released in response to nonpathogenic immune challenge. Damicornin gene expression was repressed by the coral pathogen Vibrio coralliilyticus. This is the first evidence of AMP gene repression in a host-Vibrio interaction.	[Vidal-Dupiol, Jeremie; Meistertzheim, Anne-Leila; Duval, David; Adjeroud, Mehdi; Mitta, Guillaume] Univ Perpignan Via Domitia, CNRS UPVD EPHE, UMR 5244, F-66000 Perpignan, France; [Ladriere, Ophelie] Univ Liege, Unite Ecol Marine, Lab Ecol Anim & Ecotoxicol, B-4000 Liege, Belgium; [Destoumieux-Garzon, Delphine] Univ Montpellier 2, CNRS, IFREMER, UMR 5119, F-34095 Montpellier, France; [Sautiere, Pierre-Eric] Univ Lille 1, CNRS FRE 3249, IFR 147, Univ Lille Nord France, F-59655 Villeneuve Dascq, France; [Tambutte, Eric; Tambutte, Sylvie] Ctr Sci Monaco, MC-98000 Monaco, Monaco; [Foure, Laurent] Aquarium Cap dAgde, F-34300 Cap Dagde, France; [Adjeroud, Mehdi] Inst Rech Dev, Unite 227 CoReUs2, Noumea 98848, New Caledonia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; University of Liege; Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille; Institut de Recherche pour le Developpement (IRD)	Mitta, G (corresponding author), Univ Perpignan Via Domitia, UMR CNRS UPVD EPHE 5244, 52 Ave Paul Alduy, F-66860 Perpignan, France.	mitta@univ-perp.fr	MITTA, Guillaume/A-6489-2010; Vidal-Dupiol, Jeremie/ABG-8874-2020; DUVAL, David/B-8586-2011; Vidal-Dupiol, Jérémie/B-3165-2010; Meistertzheim, Anne-Leïla AL/C-7365-2009; Destoumieux-Garzón, Delphine/O-3328-2014; Adjeroud, Mehdi/J-6411-2016	Vidal-Dupiol, Jeremie/0000-0002-0577-2953; Meistertzheim, Anne-Leïla AL/0000-0002-5005-9794; Destoumieux-Garzón, Delphine/0000-0002-8793-9138; Adjeroud, Mehdi/0000-0002-6825-8759; SAUTIERE, Pierre-Eric/0000-0003-4974-7116; Duval, David/0000-0001-6933-3354; mitta, guillaume/0000-0003-1188-1467	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the CNRS.	Alessandri-Haber N, 1999, J BIOL CHEM, V274, P35653, DOI 10.1074/jbc.274.50.35653; Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Baumann T, 2010, CELL MOL LIFE SCI, V67, P2787, DOI 10.1007/s00018-010-0364-0; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; BONTEMS F, 1991, EUR J BIOCHEM, V196, P19, DOI 10.1111/j.1432-1033.1991.tb15780.x; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bosch TCG, 2009, DEV COMP IMMUNOL, V33, P559, DOI 10.1016/j.dci.2008.10.004; Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; BULET P, 1991, J BIOL CHEM, V266, P24520; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Choquet G, 2003, DIS AQUAT ORGAN, V57, P109, DOI 10.3354/dao057109; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Cotton J, 1997, EUR J BIOCHEM, V244, P192, DOI 10.1111/j.1432-1033.1997.00192.x; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; De Zoysa M, 2010, FISH SHELLFISH IMMUN, V28, P261, DOI 10.1016/j.fsi.2009.11.005; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Destoumieux-Garzon D, 2003, MOL MICROBIOL, V49, P1031, DOI 10.1046/j.1365-2958.2003.03610.x; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; FEHLBAUM P, 1994, J BIOL CHEM, V269, P33159; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Geffen Y, 2009, FEMS MICROBIOL LETT, V295, P103, DOI 10.1111/j.1574-6968.2009.01590.x; Gendeh GS, 1997, BIOCHEMISTRY-US, V36, P11461, DOI 10.1021/bi970253d; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; HANCOCK CD, 1992, METHODS MOL BIOL IMM, P33; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herbiniere J, 2005, DEV COMP IMMUNOL, V29, P489, DOI 10.1016/j.dci.2004.11.001; HETRU C, 1997, ANTIBACTERIAL PEPTID, P35; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Karlsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-37; Kelman D, 2006, MAR BIOL, V149, P357, DOI 10.1007/s00227-005-0218-8; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Kushmaro A, 1998, MAR ECOL PROG SER, V171, P131, DOI 10.3354/meps171131; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Labreuche Y, 2006, DEV COMP IMMUNOL, V30, P367, DOI 10.1016/j.dci.2005.05.003; Labreuche Y, 2006, MICROBES INFECT, V8, P2715, DOI 10.1016/j.micinf.2006.07.020; Lesser MP, 2007, P NATL ACAD SCI USA, V104, P5259, DOI 10.1073/pnas.0700910104; Li C, 2008, DEV COMP IMMUNOL, V32, P1430, DOI 10.1016/j.dci.2008.06.013; Lorenzini DM, 2003, DEV COMP IMMUNOL, V27, P781, DOI 10.1016/S0145-305X(03)00058-2; Mateo DR, 2009, J INVERTEBR PATHOL, V102, P50, DOI 10.1016/j.jip.2009.06.008; Mitta G, 1999, J CELL SCI, V112, P4233; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; Mullen KM, 2004, CORAL HEALTH AND DISEASE, P377; MURTHY ASN, 1986, J BIOL CHEM, V261, P1815; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; Ovchinnikova TV, 2006, BIOCHEM BIOPH RES CO, V348, P514, DOI 10.1016/j.bbrc.2006.07.078; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2010, FASEB J, V24, P1935, DOI 10.1096/fj.09-152447; Palmer CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007298; Pohl Jan, 1995, Letters in Peptide Science, V1, P291, DOI 10.1007/BF00119770; PORATH J, 1983, BIOCHEMISTRY-US, V22, P1621, DOI 10.1021/bi00276a015; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Rees JA, 1997, INSECT BIOCHEM MOLEC, V27, P413, DOI 10.1016/S0965-1748(97)00013-1; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Rosenberg E, 2004, CORAL HEALTH AND DISEASE, P445; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Rozenblat YBH, 2004, CORAL HEALTH AND DISEASE, P301; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; STEFANSKY W, 1972, TECHNOMETRICS, V14, P469, DOI 10.2307/1267436; VAITUKAITIS J, 1971, J CLIN ENDOCR METAB, V33, P988, DOI 10.1210/jcem-33-6-988; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zoccola D, 2004, BBA-BIOMEMBRANES, V1663, P117, DOI 10.1016/j.bbamem.2004.02.010	79	79	80	1	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22688	22698		10.1074/jbc.M110.216358	http://dx.doi.org/10.1074/jbc.M110.216358			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536670	Green Published, hybrid			2022-12-25	WOS:000291719900075
J	Colonques, J; Ceron, J; Reichert, H; Tejedor, FJ				Colonques, Jordi; Ceron, Julian; Reichert, Heinrich; Tejedor, Francisco J.			A Transient Expression of Prospero Promotes Cell Cycle Exit of Drosophila Postembryonic Neurons through the Regulation of Dacapo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DEPENDENT KINASE INHIBITOR; NEUROBLAST LINEAGES; SELF-RENEWAL; ASYMMETRIC LOCALIZATION; PROLIFERATION PATTERN; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MOSAIC ANALYSIS	Cell proliferation, specification and terminal differentiation must be precisely coordinated during brain development to ensure the correct production of different neuronal populations. Most Drosophila neuroblasts (NBs) divide asymmetrically to generate a new NB and an intermediate progenitor called ganglion mother cell (GMC) which divides only once to generate two postmitotic cells called ganglion cells (GCs) that subsequently differentiate into neurons. During the asymmetric division of NBs, the homeodomain transcription factor PROSPERO is segregated into the GMC where it plays a key role as cell fate determinant. Previous work on embryonic neurogenesis has shown that PROSPERO is not expressed in postmitotic neuronal progeny. Thus, PROSPERO is thought to function in the GMC by repressing genes required for cell-cycle progression and activating genes involved in terminal differentiation. Here we focus on postembryonic neurogenesis and show that the expression of PROSPERO is transiently upregulated in the newly born neuronal progeny generated by most of the larval NBs of the OL and CB. Moreover, we provide evidence that this expression of PROSPERO in GCs inhibits their cell cycle progression by activating the expression of the cyclin-dependent kinase inhibitor (CKI) DACAPO. These findings imply that PROSPERO, in addition to its known role as cell fate determinant in GMCs, provides a transient signal to ensure a precise timing for cell cycle exit of prospective neurons, and hence may link the mechanisms that regulate neurogenesis and those that control cell cycle progression in postembryonic brain development.	[Colonques, Jordi; Ceron, Julian; Tejedor, Francisco J.] CSIC UMH, Inst Neurosci, Alicante, Spain; [Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; University of Basel	Colonques, J (corresponding author), CSIC UMH, Inst Neurosci, Alicante, Spain.	f.tejedor@umh.es	ceron, julian/AAA-8008-2019	Ceron, Julian/0000-0003-4739-2243; Tejedor, Francisco J/0000-0003-1942-2580	Ministry of Science and Innovation; Generalitat Valenciana; Fundacioen Inocente Inocente; Ministry of Education and Science	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacioen Inocente Inocente; Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Science and Innovation, the Generalitat Valenciana, and the Fundacioen Inocente Inocente to FJT. J. Ceron and J. Colonques were recipients of PhD fellowships from the Ministry of Education and Science. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Bayraktar OA, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-26; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Colonques J, 2007, MECH DEVELOP, V124, P327, DOI 10.1016/j.mod.2007.01.004; DATTA S, 1995, DEVELOPMENT, V121, P1173; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Grosjean Y, 2003, J NEUROBIOL, V55, P1, DOI 10.1002/neu.10208; Hassan B, 1997, P NATL ACAD SCI USA, V94, P10991, DOI 10.1073/pnas.94.20.10991; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Kurusu M, 2009, DEV BIOL, V326, P224, DOI 10.1016/j.ydbio.2008.11.013; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Li L, 2000, GENE DEV, V14, P147; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Liu TH, 2002, MECH DEVELOP, V112, P25, DOI 10.1016/S0925-4773(01)00626-8; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Meinertzhagen Ian A., 1993, P1363; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Reddy GV, 1999, DEVELOPMENT, V126, P2083; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Torii MA, 1999, DEVELOPMENT, V126, P443; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wallace K, 2000, GENESIS, V26, P77, DOI 10.1002/(SICI)1526-968X(200001)26:1<77::AID-GENE10>3.3.CO;2-I; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844	53	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19342	10.1371/journal.pone.0019342	http://dx.doi.org/10.1371/journal.pone.0019342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552484	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700049
J	Kiya, T; Kubo, T				Kiya, Taketoshi; Kubo, Takeo			Dance Type and Flight Parameters Are Associated with Different Mushroom Body Neural Activities in Worker Honeybee Brains	PLOS ONE			English	Article							APIS-MELLIFERA; NAVIGATION; ORGANIZATION; ODOMETER; BODIES	Background: Honeybee foragers can transmit the information concerning the location of food sources to their nestmates using dance communication. We previously used a novel immediate early gene, termed kakusei, to demonstrate that the neural activity of a specific mushroom body (MB) neuron subtype is preferentially enhanced in the forager brain. The sensory information related to this MB neuron activity, however, remained unclear. Methodology/Principal Findings: Here, we used kakusei to analyze the relationship between MB neuron activity and types of foraging behavior. The number of kakusei-positive MB neurons was higher in the round dancers that had flown a short distance than in the waggle dancers that had flown a long distance. Furthermore, the amount of kakusei transcript in the MBs inversely related to the waggle-phase duration of the waggle dance, which correlates with the flight distance. Using a narrow tunnel whose inside was vertically or axially lined, we manipulated the pattern of visual input, which is received by the foragers during flight, and analysed kakusei expression. The amount of kakusei transcript in the MBs was related to the foraging frequency but not to the tunnel pattern. In contrast, the number of kakusei-positive MB neurons was affected by the tunnel patterns, but not related to foraging frequency. Conclusions/Significance: These results suggest that the MB neuron activity depends on the foraging frequency, whereas the number of active MB neurons is related to the pattern of visual input received during foraging flight. Our results suggest that the foraging frequency and visual experience during foraging are associated with different MB neural activities.	[Kiya, Taketoshi; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	University of Tokyo	Kiya, T (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Life Sci, Kanazawa, Ishikawa 9201192, Japan.	kiya@staff.kanazawa-u.ac.jp	KUBO, TAKEO/G-4951-2014; Kiya, Taketoshi/J-9032-2015; Kiya, Taketoshi/ABE-6519-2020	Kiya, Taketoshi/0000-0002-5709-8016; Kubo, Takeo/0000-0002-5914-5269	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) and the Grant-in-Aid for Scientific Research on Innovative Areas "Systems Molecular Ethology'' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron A, 2006, J EXP BIOL, V209, P978, DOI 10.1242/jeb.02085; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Ehmer B, 2002, J COMP NEUROL, V451, P362, DOI 10.1002/cne.10355; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kiya T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008833; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Seeley T., 1995, WISDOM HIVE SOCIAL P; Si A, 2003, J EXP BIOL, V206, P1265, DOI 10.1242/jeb.00236; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Tautz J, 2004, PLOS BIOL, V2, P915, DOI 10.1371/journal.pbio.0020211; von Frisch K, 1969, DANCE LANGUAGE ORIEN; Winston M.L., 1991, BIOL HONEY BEE	19	15	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19301	10.1371/journal.pone.0019301	http://dx.doi.org/10.1371/journal.pone.0019301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541290	Green Published, gold			2022-12-25	WOS:000290018400046
J	Martina, BEE; van den Doel, P; Koraka, P; van Amerongen, G; Spohn, G; Haagmans, BL; Provacia, LBV; Osterhaus, ADME; Rimmelzwaan, GF				Martina, Byron E. E.; van den Doel, Petra; Koraka, Penelope; van Amerongen, Geert; Spohn, Gunther; Haagmans, Bart L.; Provacia, Lisette B. V.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.			A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus	PLOS ONE			English	Article							CD8(+) T-CELLS; NEUTRALIZING ANTIBODIES; ENVELOPE PROTEIN; VACCINE CANDIDATE; IMMUNIZATION; ENCEPHALITIS; INFECTION; MICE; IMMUNOGENICITY; EPITOPES	West Nile virus (WNV) continues to circulate in the USA and forms a threat to the rest of the Western hemisphere. Since methods for the treatment of WNV infections are not available, there is a need for the development of safe and effective vaccines. Here, we describe the construction of a recombinant influenza virus expressing domain III of the WNV glycoprotein E (Flu-NA-DIII) and its evaluation as a WNV vaccine candidate in a mouse model. FLU-NA-DIII-vaccinated mice were protected from severe body weight loss and mortality caused by WNV infection, whereas control mice succumbed to the infection. In addition, it was shown that one subcutaneous immunization with 10(5) TCID50 Flu-NA-DIII provided 100% protection against challenge. Adoptive transfer experiments demonstrated that protection was mediated by antibodies and CD4+T cells. Furthermore, mice vaccinated with FLU-NA-DIII developed protective influenza virus-specific antibody titers. It was concluded that this vector system might be an attractive platform for the development of bivalent WNV-influenza vaccines.	[Martina, Byron E. E.; van den Doel, Petra; Koraka, Penelope; Haagmans, Bart L.; Provacia, Lisette B. V.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [van Amerongen, Geert] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Spohn, Gunther] Cytos Biotechnol AG, Zurich, Switzerland	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment	Martina, BEE (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	b.martina@erasmusmc.nl	Haagmans, Bart/E-9791-2015	Haagmans, Bart/0000-0001-6221-2015; Martina, Byron/0000-0003-4980-4619; Osterhaus, Albert/0000-0002-6074-1172	European Union [LSH-2003-1.2.4-5]; Viroclinics B.V.; Cytos Biotechnology	European Union(European Commission); Viroclinics B.V.; Cytos Biotechnology	The project was partly funded by the European Union grant LSH-2003-1.2.4-5 (COMPUVAC), Viroclinics B.V., and Cytos Biotechnology. The funders played a role in study design and decision to publish, but had no role in data collection and analysis, or preparation of the manuscript.	Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Bonafe N, 2009, VACCINE, V27, P213, DOI 10.1016/j.vaccine.2008.10.046; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; CASTRUCCI MR, 1994, J VIROL, V68, P3486, DOI 10.1128/JVI.68.6.3486-3490.1994; Chang YS, MED J AUST, V192, P90; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699; Couissinier-Paris P, 2006, Bull Soc Pathol Exot, V99, P348; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; de Jong J C, 2003, Dev Biol (Basel), V115, P63; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; de Wit E, 2007, J GEN VIROL, V88, P1281, DOI 10.1099/vir.0.82452-0; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; Ferko B, 1998, J INFECT DIS, V178, P1359, DOI 10.1086/314445; Figuerola J, 2007, EMERG INFECT DIS, V13, P1915, DOI 10.3201/eid1312.070343; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Giri PK, 2005, FEMS IMMUNOL MED MIC, V45, P87, DOI 10.1016/j.femsim.2005.02.009; Grazzini G, 2008, BLOOD TRANSFUS-ITALY, V6, P235, DOI 10.2450/2008.0065-08; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Iyer AV, 2009, VACCINE, V27, P893, DOI 10.1016/j.vaccine.2008.11.087; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Li L, 2005, VIROLOGY, V335, P99, DOI 10.1016/j.virol.2005.02.011; LI SQ, 1993, J VIROL, V67, P6659, DOI 10.1128/JVI.67.11.6659-6666.1993; Li ZN, 2005, J VIROL, V79, P10003, DOI 10.1128/JVI.79.15.10003-10012.2005; LIGTHART GJ, 1984, MECH AGEING DEV, V28, P47, DOI 10.1016/0047-6374(84)90152-0; Lim CK, 2008, VIROLOGY, V374, P60, DOI 10.1016/j.virol.2007.12.021; Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055; MASUREL N, 1981, J HYG-CAMBRIDGE, V87, P201, DOI 10.1017/S0022172400069412; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Mishin VR, 2005, VACCINE, V23, P2922, DOI 10.1016/j.vaccine.2004.11.058; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pawelec G, 1997, IMMUNOL REV, V160, P31, DOI 10.1111/j.1600-065X.1997.tb01025.x; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Pletnev AG, 2002, P NATL ACAD SCI USA, V99, P3036, DOI 10.1073/pnas.022652799; Rimmelzwaan GF, 2007, VIRUS RES, V129, P175, DOI 10.1016/j.virusres.2007.07.007; Rossini G, 2008, EURO SURVEILL, V13; Sanchez MD, 2005, VIROLOGY, V336, P70, DOI 10.1016/j.virol.2005.02.020; Seregin A, 2006, VIROLOGY, V356, P115, DOI 10.1016/j.virol.2006.07.038; Shinya K, 2004, J VIROL, V78, P3083, DOI 10.1128/JVI.78.6.3083-3088.2004; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shrestha B, 2008, VACCINE, V26, P2020, DOI 10.1016/j.vaccine.2008.02.009; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wang Y, 2006, J GEN VIROL, V87, P3599, DOI 10.1099/vir.0.81306-0; Watts DM, 2007, VACCINE, V25, P2913, DOI 10.1016/j.vaccine.2006.08.008; Widman DG, 2009, VACCINE, V27, P5550, DOI 10.1016/j.vaccine.2009.07.016; Yamshchikov G, 2004, VIROLOGY, V330, P304, DOI 10.1016/j.virol.2004.09.014	58	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18995	10.1371/journal.pone.0018995	http://dx.doi.org/10.1371/journal.pone.0018995			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541326	gold, Green Published, Green Submitted			2022-12-25	WOS:000290018400021
J	Robinson, JO; Lamoth, F; Bally, F; Knaup, M; Calandra, T; Marchetti, O				Robinson, James Owen; Lamoth, Frederic; Bally, Frank; Knaup, Marlies; Calandra, Thierry; Marchetti, Oscar			Monitoring Procalcitonin in Febrile Neutropenia: What Is Its Utility for Initial Diagnosis of Infection and Reassessment in Persistent Fever?	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM PROCALCITONIN; MARROW-TRANSPLANTATION; FUNGAL-INFECTIONS; MARKERS; CHILDREN; ADULTS; SPECIFICITY; SENSITIVITY; BACTEREMIA	Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinical documentation of infection. We aimed at evaluating the utility of monitoring blood procalcitonin (PCT) in FE for initial diagnosis of infection and reassessment in persistent fever. Methods: PCT kinetics was prospectively monitored in 194 consecutive FE (1771 blood samples): 65 microbiologically documented infections (MDI, 33.5%; 49 due to non-coagulase-negative staphylococci, non-CNS), 68 clinically documented infections (CDI, 35%; 39 deep-seated), and 61 fever of unexplained origin (FUO, 31.5%). Results: At fever onset median PCT was 190 pg/mL (range 30-26'800), without significant difference among MDI, CDI and FUO. PCT peak occurred on day 2 after onset of fever: non-CNS-MDI/deep-seated-CDI (656, 80-86350) vs. FUO (205, 33-771; p<0.001). PCT >500 pg/mL distinguished non-CNS-MDI/deep-seated-CDI from FUO with 56% sensitivity and 90% specificity. PCT was >500 pg/ml in only 10% of FUO (688, 570-771). A PCT peak >500 pg/mL (1196, 524-11950) occurred beyond 3 days of persistent fever in 17/21 (81%) invasive fungal diseases (IFD). This late PCT peak identified IFD with 81% sensitivity and 57% specificity and preceded diagnosis according to EORTC-MSG criteria in 41% of cases. In IFD responding to therapy, median days to PCT <500 pg/mL and defervescence were 5 (1-23) vs. 10 (3-22; p = 0.026), respectively. Conclusion: While procalcitonin is not useful for diagnosis of infection at onset of neutropenic fever, it may help to distinguish a minority of potentially severe infections among FUOs on day 2 after onset of fever. In persistent fever monitoring procalcitonin contributes to early diagnosis and follow-up of invasive mycoses.	[Robinson, James Owen; Lamoth, Frederic; Bally, Frank; Knaup, Marlies; Calandra, Thierry; Marchetti, Oscar] CHU Vaudois, Infect Dis Serv, Dept Med, Lausanne, Switzerland; [Robinson, James Owen; Lamoth, Frederic; Bally, Frank; Knaup, Marlies; Calandra, Thierry; Marchetti, Oscar] Univ Lausanne UNIL, Lausanne, Switzerland; [Robinson, James Owen] Royal Perth Hosp, Dept Microbiol & Infect Dis, Perth, WA, Australia	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Royal Perth Hospital; University of Western Australia	Robinson, JO (corresponding author), CHU Vaudois, Infect Dis Serv, Dept Med, Lausanne, Switzerland.	owen.robinson@health.wa.gov.au; Oscar.Marchetti@chuv.ch	Calandra, Thierry/D-9017-2015; Lamoth, Frederic/H-5790-2019; Lamoth, Frederic/K-6454-2017; Robinson, Owen/GNP-1638-2022	Calandra, Thierry/0000-0003-3051-1285; Lamoth, Frederic/0000-0002-1023-5597; Lamoth, Frederic/0000-0002-1023-5597; 	Foundation for the Advancement in Medical Microbiology and Infectious Diseases (FAMMID), Lausanne, Switzerland	Foundation for the Advancement in Medical Microbiology and Infectious Diseases (FAMMID), Lausanne, Switzerland	This research was possible thanks to the Foundation for the Advancement in Medical Microbiology and Infectious Diseases (FAMMID), Lausanne, Switzerland, thanks to an unrestricted grant support. Procalcitonin measurements were done free of charge by BRAHMS Diagnostica, Hennigsdorf bei Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Beaune G, 1998, INFECTION, V26, P168, DOI 10.1007/BF02771844; Blijlevens N, 2008, J CLIN ONCOL, V26, P1519, DOI 10.1200/JCO.2007.13.6028; Brunkhorst FM, 2000, INTENS CARE MED, V26, pS148, DOI 10.1007/BF02900728; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Christofilopoulou Sofia, 2002, Eur J Intern Med, V13, P493, DOI 10.1016/S0953-6205(02)00160-7; Cometta A, 2003, CLIN INFECT DIS, V37, P382, DOI 10.1086/376637; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Engel A, 1999, SCAND J INFECT DIS, V31, P185, DOI 10.1080/003655499750006254; Fleischhack G, 2000, BRIT J HAEMATOL, V111, P1093, DOI 10.1046/j.1365-2141.2000.02458.x; Giamarellos-Bourboulis EJ, 2001, CLIN INFECT DIS, V32, P1718, DOI 10.1086/320744; Giamarellou H, 2004, CLIN MICROBIOL INFEC, V10, P628, DOI 10.1111/j.1469-0691.2004.00883.x; Gilbert DN, 2010, J CLIN MICROBIOL, V48, P2325, DOI 10.1128/JCM.00655-10; Huber W, 1997, INFECTION, V25, P377, DOI 10.1007/BF01740823; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; *I CALS, 2006, M7A7 I CALS; Jimeno A, 2004, CANCER-AM CANCER SOC, V100, P2462, DOI 10.1002/cncr.20275; JS G, 1996, CDC DEFINITIONS NONS, pA1; Kern WV, 1999, NEW ENGL J MED, V341, P312, DOI 10.1056/NEJM199907293410502; Kuse ER, 2000, CRIT CARE MED, V28, P555, DOI 10.1097/00003246-200002000-00044; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-00011; Ortega M, 2006, BONE MARROW TRANSPL, V37, P499, DOI 10.1038/sj.bmt.1705262; Ortega M, 2004, BRIT J HAEMATOL, V126, P372, DOI 10.1111/j.1365-2141.2004.05053.x; Persson L, 2004, SCAND J INFECT DIS, V36, P365, DOI 10.1080/00365540410020217; Petrikkos GL, 2005, EUR J CLIN MICROBIOL, V24, P272, DOI 10.1007/s10096-005-1312-z; PIZZO PA, 1990, J INFECT DIS, V161, P397, DOI 10.1093/infdis/161.3.397; Pulliam PN, 2001, PEDIATRICS, V108, P1275, DOI 10.1542/peds.108.6.1275; Ruokonen E, 1999, EUR J CLIN MICROBIOL, V18, P283, DOI 10.1007/s100960050277; Sakr Y, 2008, INFECTION, V36, P396, DOI 10.1007/s15010-008-7374-Y; Sauer M, 2003, BONE MARROW TRANSPL, V31, P1137, DOI 10.1038/sj.bmt.1704045; Schuttrumpf S, 2006, CLIN INFECT DIS, V43, P468, DOI 10.1086/505394; Scire CA, 2006, CLIN EXP RHEUMATOL, V24, P123; Senn L, 2008, CLIN INFECT DIS, V46, P878, DOI 10.1086/527382; Steinbach G, 2004, CLIN CHEM LAB MED, V42, P440, DOI 10.1515/CCLM.2004.077; Stryjewski Glenn R, 2005, Pediatr Crit Care Med, V6, P129, DOI 10.1097/01.PCC.0000149317.15274.48; Svaldi M, 2001, BRIT J HAEMATOL, V115, P53, DOI 10.1046/j.1365-2141.2001.03083.x; Viallon A, 1999, CLIN INFECT DIS, V28, P1313, DOI 10.1086/514793; von Lilienfeld-Toal M, 2004, EUR J CLIN MICROBIOL, V23, P539, DOI 10.1007/s10096-004-1156-y	39	43	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18886	10.1371/journal.pone.0018886	http://dx.doi.org/10.1371/journal.pone.0018886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541027	Green Published, gold			2022-12-25	WOS:000290016800024
J	Mezzanotte, L; Que, I; Kaijzel, E; Branchini, B; Roda, A; Lowik, C				Mezzanotte, Laura; Que, Ivo; Kaijzel, Eric; Branchini, Bruce; Roda, Aldo; Lowik, Clemens			Sensitive Dual Color In Vivo Bioluminescence Imaging Using a New Red Codon Optimized Firefly Luciferase and a Green Click Beetle Luciferase	PLOS ONE			English	Article							GENE-EXPRESSION; REPORTER	Background: Despite a plethora of bioluminescent reporter genes being cloned and used for cell assays and molecular imaging purposes, the simultaneous monitoring of multiple events in small animals is still challenging. This is partly attributable to the lack of optimization of cell reporter gene expression as well as too much spectral overlap of the color-coupled reporter genes. A new red emitting codon-optimized luciferase reporter gene mutant of Photinus pyralis, Ppy RE8, has been developed and used in combination with the green click beetle luciferase, CBG99. Principal Findings: Human embryonic kidney cells (HEK293) were transfected with vectors that expressed red Ppy RE8 and green CBG99 luciferases. Populations of red and green emitting cells were mixed in different ratios. After addition of the shared single substrate, D-luciferin, bioluminescent (BL) signals were imaged with an ultrasensitive cooled CCD camera using a series of band pass filters (20 nm). Spectral unmixing algorithms were applied to the images where good separation of signals was observed. Furthermore, HEK293 cells that expressed the two luciferases were injected at different depth in the animals. Spectrally-separate images and quantification of the dual BL signals in a mixed population of cells was achieved when cells were either injected subcutaneously or directly into the prostate. Significance: We report here the re-engineering of different luciferase genes for in vitro and in vivo dual color imaging applications to address the technical issues of using dual luciferases for imaging. In respect to previously used dual assays, our study demonstrated enhanced sensitivity combined with spatially separate BL spectral emissions using a suitable spectral unmixing algorithm. This new D-luciferin-dependent reporter gene couplet opens up the possibility in the future for more accurate quantitative gene expression studies in vivo by simultaneously monitoring two events in real time.	[Mezzanotte, Laura; Roda, Aldo] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Que, Ivo; Kaijzel, Eric; Lowik, Clemens] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Branchini, Bruce] Connecticut Coll, Dept Chem, New London, CT 06320 USA	University of Bologna; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Connecticut College	Mezzanotte, L (corresponding author), Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy.	aldo.roda@unibo.it; c.w.g.m.lowik@lumc.nl	Kaijzel, Eric/GZN-2333-2022	Kaijzel, Eric/0000-0003-3118-9910; Mezzanotte, Laura/0000-0001-5592-8904; Roda, Aldo/0000-0001-7649-4797	Air Force Office of Scientific Research [FA9550-07-1-0043, FA9550-10-1-0174]; National Science Foundation [MCB0842831]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF))	The authors gratefully acknowledge the financial support provided by the Air Force Office of Scientific Research (FA9550-07-1-0043 and FA9550-10-1-0174) and the National Science Foundation (MCB0842831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND B, 2003, 85 PROM, P85; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Branchini BR, 2010, ANAL BIOCHEM, V396, P290, DOI 10.1016/j.ab.2009.09.009; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Caysa H, 2009, PHOTOCH PHOTOBIO SCI, V8, P52, DOI 10.1039/b814566k; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; HINDA N, 2009, PLOS ONE, V4, pE5868; Kaijzel EL, 2007, CLIN CANCER RES, V13, P3490, DOI 10.1158/1078-0432.CCR-07-0402; Kwon H, 2010, BIOTECHNIQUES, V48, P460, DOI 10.2144/000113419; Li XY, 2010, PROTEIN SCI, V19, P26, DOI 10.1002/pro.279; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Maguire CA, 2009, ANAL CHEM, V81, P7102, DOI 10.1021/ac901234r; Mezzanotte L, 2010, MOL IMAGING BIOL, V12, P406, DOI 10.1007/s11307-009-0291-3; Michelini E, 2008, ANAL CHEM, V80, P260, DOI 10.1021/ac7016579; Miloud T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2800386; Miyawaki A, 2007, NAT METHODS, V4, P616, DOI 10.1038/nmeth0807-616; Noguchi T, 2010, BIOCHEMISTRY-US, V49, P8053, DOI 10.1021/bi100545h; Roda A, 2004, TRENDS BIOTECHNOL, V22, P295; Roda A, 2009, TRAC-TREND ANAL CHEM, V28, P307, DOI 10.1016/j.trac.2008.11.015; SUMIDA M, 2007, NATURE, V449, P521; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Welsh JP, 2009, BIOCHEM BIOPH RES CO, V389, P563, DOI 10.1016/j.bbrc.2009.09.006; Wenner M, 2009, NAT MED, V15, P1106, DOI 10.1038/nm1009-1106; Xu H, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3258838; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	29	73	78	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19277	10.1371/journal.pone.0019277	http://dx.doi.org/10.1371/journal.pone.0019277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544210	gold, Green Published, Green Submitted			2022-12-25	WOS:000290015800055
J	Ruiz, JC; D'Afonseca, V; Silva, A; Ali, A; Pinto, AC; Santos, AR; Rocha, AAMC; Lopes, DO; Dorella, FA; Pacheco, LGC; Costa, MP; Turk, MZ; Seyffert, N; Moraes, PMRO; Soares, SC; Almeida, SS; Castro, TLP; Abreu, VAC; Trost, E; Baumbach, J; Tauch, A; Schneider, MPC; McCulloch, J; Cerdeira, LT; Ramos, RTJ; Zerlotini, A; Dominitini, A; Resende, DM; Coser, EM; Oliveira, LM; Pedrosa, AL; Vieira, CU; Guimaraes, CT; Bartholomeu, DC; Oliveira, DM; Santos, FR; Rabelo, EM; Lobo, FP; Franco, GR; Costa, AF; Castro, IM; Dias, SRC; Ferro, JA; Ortega, JM; Paiva, LV; Goulart, LR; Almeida, JF; Ferro, MIT; Carneiro, NP; Falcao, PRK; Grynberg, P; Teixeira, SMR; Brommonschenkel, S; Oliveira, SC; Meyer, R; Moore, RJ; Miyoshi, A; Oliveira, GC; Azevedo, V				Ruiz, Jeronimo C.; D'Afonseca, Vivian; Silva, Artur; Ali, Amjad; Pinto, Anne C.; Santos, Anderson R.; Rocha, Aryanne A. M. C.; Lopes, Debora O.; Dorella, Fernanda A.; Pacheco, Luis G. C.; Costa, Marcilia P.; Turk, Meritxell Z.; Seyffert, Nubia; Moraes, Pablo M. R. O.; Soares, Siomar C.; Almeida, Sintia S.; Castro, Thiago L. P.; Abreu, Vinicius A. C.; Trost, Eva; Baumbach, Jan; Tauch, Andreas; Schneider, Maria Paula C.; McCulloch, John; Cerdeira, Louise T.; Ramos, Rommel T. J.; Zerlotini, Adhemar; Dominitini, Anderson; Resende, Daniela M.; Coser, Elisangela M.; Oliveira, Luciana M.; Pedrosa, Andre L.; Vieira, Carlos U.; Guimaraes, Claudia T.; Bartholomeu, Daniela C.; Oliveira, Diana M.; Santos, Fabricio R.; Rabelo, Elida Mara; Lobo, Francisco P.; Franco, Gloria R.; Costa, Ana Flavia; Castro, Ieso M.; Costa Dias, Silvia Regina; Ferro, Jesus A.; Ortega, Jose Miguel; Paiva, Luciano V.; Goulart, Luiz R.; Almeida, Juliana Franco; Ferro, Maria Ines T.; Carneiro, Newton P.; Falcao, Paula R. K.; Grynberg, Priscila; Teixeira, Santuza M. R.; Brommonschenkel, Sergio; Oliveira, Sergio C.; Meyer, Roberto; Moore, Robert J.; Miyoshi, Anderson; Oliveira, Guilherme C.; Azevedo, Vasco			Evidence for Reductive Genome Evolution and Lateral Acquisition of Virulence Functions in Two Corynebacterium pseudotuberculosis Strains	PLOS ONE			English	Article							OVINE CASEOUS-LYMPHADENITIS; METABOLIC FLUX ANALYSIS; ESCHERICHIA-COLI; NECROTIZING LYMPHADENITIS; PROLINE IMINOPEPTIDASE; UNITED-KINGDOM; CULLED SHEEP; GENE; SEQUENCE; EXPRESSION	Background: Corynebacterium pseudotuberculosis, a Gram-positive, facultative intracellular pathogen, is the etiologic agent of the disease known as caseous lymphadenitis (CL). CL mainly affects small ruminants, such as goats and sheep; it also causes infections in humans, though rarely. This species is distributed worldwide, but it has the most serious economic impact in Oceania, Africa and South America. Although C. pseudotuberculosis causes major health and productivity problems for livestock, little is known about the molecular basis of its pathogenicity. Methodology and Findings: We characterized two C. pseudotuberculosis genomes (Cp1002, isolated from goats; and CpC231, isolated from sheep). Analysis of the predicted genomes showed high similarity in genomic architecture, gene content and genetic order. When C. pseudotuberculosis was compared with other Corynebacterium species, it became evident that this pathogenic species has lost numerous genes, resulting in one of the smallest genomes in the genus. Other differences that could be part of the adaptation to pathogenicity include a lower GC content, of about 52%, and a reduced gene repertoire. The C. pseudotuberculosis genome also includes seven putative pathogenicity islands, which contain several classical virulence factors, including genes for fimbrial subunits, adhesion factors, iron uptake and secreted toxins. Additionally, all of the virulence factors in the islands have characteristics that indicate horizontal transfer. Conclusions: These particular genome characteristics of C. pseudotuberculosis, as well as its acquired virulence factors in pathogenicity islands, provide evidence of its lifestyle and of the pathogenicity pathways used by this pathogen in the infection process. All genomes cited in this study are available in the NCBI Genbank database (http://www.ncbi.nlm.nih.gov/genbank/) under accession numbers CP001809 and CP001829.	[Ruiz, Jeronimo C.; Oliveira, Guilherme C.] Fundacao Oswaldo Cruz, Res Ctr Rene Rachou, Ctr Excellence Bioinformat, Natl Inst Sci & Technol, Belo Horizonte, MG, Brazil; [D'Afonseca, Vivian; Ali, Amjad; Pinto, Anne C.; Santos, Anderson R.; Rocha, Aryanne A. M. C.; Dorella, Fernanda A.; Pacheco, Luis G. C.; Turk, Meritxell Z.; Seyffert, Nubia; Moraes, Pablo M. R. O.; Soares, Siomar C.; Almeida, Sintia S.; Castro, Thiago L. P.; Abreu, Vinicius A. C.; Santos, Fabricio R.; Costa, Ana Flavia; Miyoshi, Anderson; Azevedo, Vasco] Univ Fed Minas Gerais, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Silva, Artur; Schneider, Maria Paula C.; McCulloch, John; Cerdeira, Louise T.; Ramos, Rommel T. J.] Fed Univ Para, Dept Genet, BR-66059 Belem, Para, Brazil; [Lopes, Debora O.] Univ Fed Sao Joao del Rei, Hlth Sci Ctr, Divinopilis, MG, Brazil; [Costa, Marcilia P.; Oliveira, Diana M.] Univ Estadual Ceara, Dept Vet Med, Fortaleza, Ceara, Brazil; [Trost, Eva; Tauch, Andreas] Univ Bielefeld, Dept Genet, CeBiTech, Bielefeld, Nordrhein Westf, Germany; [Baumbach, Jan] Max Planck Inst Informat, Dept Comp Sci, Saarbrucken, Saarlan, Germany; [Resende, Daniela M.; Pedrosa, Andre L.] Univ Fed Ouro Preto, Dept Pharmaceut Sci, Ouro Preto, MG, Brazil; [Oliveira, Luciana M.] Univ Fed Ouro Preto, Dept Phis, Ouro Preto, MG, Brazil; [Pedrosa, Andre L.] Univ Fed Triangulo Mineiro, Dept Biol Sci, Uberaba, MG, Brazil; [Vieira, Carlos U.; Goulart, Luiz R.; Almeida, Juliana Franco] Univ Fed Uberlandia, Dept Biochem & Genet, BR-38400 Uberlandia, MG, Brazil; [Guimaraes, Claudia T.; Carneiro, Newton P.] Brazilian Agr Res Corp EMBRAPA, Sete Lagoas, MG, Brazil; [Bartholomeu, Daniela C.; Lobo, Francisco P.; Franco, Gloria R.; Ortega, Jose Miguel; Grynberg, Priscila; Teixeira, Santuza M. R.; Oliveira, Sergio C.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Rabelo, Elida Mara; Costa Dias, Silvia Regina] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Castro, Ieso M.] Univ Fed Ouro Preto, Dept Pharm, Ouro Preto, MG, Brazil; [Ferro, Jesus A.; Ferro, Maria Ines T.] State Univ Sao Paulo, Dept Technol, Jaboticabal, SP, Brazil; [Paiva, Luciano V.] Univ Fed Lavras, Dept Chem, Lavras, MG, Brazil; [Falcao, Paula R. K.] Brazilian Agr Res Corp EMBRAPA, Campinas, SP, Brazil; [Brommonschenkel, Sergio] Univ Fed Vicosa, Dept Plant Pathol, Vicosa, MG, Brazil; [Pacheco, Luis G. C.; Meyer, Roberto] Univ Fed Bahia, Dept Biointeract Sci, Salvador, BA, Brazil; [Moore, Robert J.] CSIRO Livestock Ind, Clayton, Vic, Australia	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal do Para; Universidade Federal de Sao Joao del-Rei; Universidade Estadual do Ceara; University of Bielefeld; Max Planck Society; Universidade Federal de Ouro Preto; Universidade Federal de Ouro Preto; Universidade Federal do Triangulo Mineiro; Universidade Federal de Uberlandia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Estadual Paulista; Universidade Federal de Lavras; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa; Universidade Federal da Bahia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ruiz, JC (corresponding author), Fundacao Oswaldo Cruz, Res Ctr Rene Rachou, Ctr Excellence Bioinformat, Natl Inst Sci & Technol, Belo Horizonte, MG, Brazil.	vasco@icb.ufmg.br	Rabelo, Elida ML/C-2401-2015; Costa, Marcilia Pinheiro/AAF-1546-2021; Luiz Silva, Artur da Costa da/AAI-3516-2021; Lobo, Francisco Pereira/AAG-3118-2021; Kuser-Falcão, Paula R/A-5799-2010; Pacheco, Luis/AAW-2341-2020; Ortega, J Miguel/E-8272-2011; Resende, Daniela M/E-7476-2011; Oliveira, Luciana/AAJ-6178-2020; Silva, Artur/E-1474-2014; Brommonschenkel, Sergio/C-5748-2013; D'Afonseca, Vívian/J-7548-2018; Seyffert, Nubia/N-6410-2014; Ferro, Jesus Aparecido A/C-8251-2013; Ali, Amjad/AAG-4441-2021; Moore, Robert J/D-8352-2011; Oliveira, Sergio Costa/AAG-5408-2021; Zerlotini, Adhemar/E-6533-2012; McCulloch, John A/D-3120-2014; Abreu, Vinicius AC/G-3694-2014; Santos, Fabrício Rodrigues/H-2370-2011; Azevedo, Vasco/B-1556-2019; Pedrosa, Andre/C-1559-2014; Cerdeira, Louise/C-3749-2013; Ueira-Vieira, Carlos/J-8998-2014; Zurita Turk, Meritxell/C-6994-2018; de Paula Castro, Thiago Luiz/H-5135-2019; Azevedo, Vasco A.C/F-4315-2011; Castro, Ieso Miranda/G-7281-2012; Pacheco, Luis G C/K-3092-2012; Goulart, Luiz R/G-7357-2012; DoenÃas Tropicais, Inct/K-2308-2013; Grynberg, Priscila/AAX-3019-2020; Paiva, Luciano/AAU-3333-2020; Bartholomeu, Daniella C./J-4714-2015; Almeida, Sintia/K-1217-2012; Franco, Glória/I-3654-2013; Castro, Thiago/F-9314-2012; lopes, debora O/L-3601-2016; FERRO, MARIA INÊS TIRABOSCHI/D-3634-2012; dos Santos, Anderson Rodrigues/G-3020-2011; Ramos, Rommel Thiago Juca/L-9329-2013; de Castro Soares, Siomar/I-2705-2012; Cerdeira, Louise Teixeira/AAR-4668-2020; Oliveira, Guilherme/E-2624-2014	Rabelo, Elida ML/0000-0002-2566-5012; Costa, Marcilia Pinheiro/0000-0001-6093-6781; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Lobo, Francisco Pereira/0000-0002-9671-9313; Kuser-Falcão, Paula R/0000-0002-0034-0932; Pacheco, Luis/0000-0003-2500-0800; Ortega, J Miguel/0000-0002-8047-9191; Resende, Daniela M/0000-0002-5139-3022; Silva, Artur/0000-0002-4082-1132; Seyffert, Nubia/0000-0002-2193-6508; Ferro, Jesus Aparecido A/0000-0002-3966-1303; Ali, Amjad/0000-0002-0486-4661; Moore, Robert J/0000-0002-0776-5861; Oliveira, Sergio Costa/0000-0003-4062-5577; Zerlotini, Adhemar/0000-0002-7739-0284; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Azevedo, Vasco/0000-0002-4775-2280; Pedrosa, Andre/0000-0001-8682-813X; Cerdeira, Louise/0000-0002-4495-2615; Ueira-Vieira, Carlos/0000-0002-8369-9069; Zurita Turk, Meritxell/0000-0001-8656-4664; de Paula Castro, Thiago Luiz/0000-0002-2869-5065; Azevedo, Vasco A.C/0000-0002-4775-2280; Castro, Ieso Miranda/0000-0002-1319-1251; Goulart, Luiz R/0000-0002-1803-4861; Grynberg, Priscila/0000-0003-4009-9538; Bartholomeu, Daniella C./0000-0003-0974-7357; Almeida, Sintia/0000-0003-0270-9059; Franco, Glória/0000-0001-5245-2365; Castro, Thiago/0000-0002-2869-5065; lopes, debora O/0000-0002-8559-8552; FERRO, MARIA INÊS TIRABOSCHI/0000-0003-3389-9131; dos Santos, Anderson Rodrigues/0000-0003-3418-0823; Ramos, Rommel Thiago Juca/0000-0002-8032-1474; de Castro Soares, Siomar/0000-0001-7299-3724; Oliveira, Guilherme/0000-0003-0054-3438; Marcia de Oliveira, Luciana/0000-0002-0300-5232; Trost, Eva/0000-0002-1924-1416; /0000-0002-1361-9721; Baumbach, Jan/0000-0002-0282-0462	FAPEMIG (Fundacao de Amparo a pesquisa do Estado de Minas Gerais) [CBB-1181/0, REDE-186/08]; NIH (National Institutes of Health) - Fogarty [TW007012]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); FOGARTY INTERNATIONAL CENTER [D43TW007012] Funding Source: NIH RePORTER	FAPEMIG (Fundacao de Amparo a pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NIH (National Institutes of Health) - Fogarty(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project received financial support from the following grants: FAPEMIG (Fundacao de Amparo a pesquisa do Estado de Minas Gerais) (CBB-1181/0 and REDE-186/08 to Guilherme Oliveira), NIH (National Institutes of Health) - Fogarty (TW007012 to Guilherme Oliveira). Guilherme Oliveira and Vasco Azevedo are CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) fellows. The work also received support from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arsenault J, 2003, PREV VET MED, V59, P67, DOI 10.1016/S0167-5877(03)00060-6; AYERS JL, 1977, J AM VET MED ASSOC, V171, P1251; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Ben Said M S, 2002, Arch Inst Pasteur Tunis, V79, P51; Binns SH, 2002, VET REC, V150, P263, DOI 10.1136/vr.150.9.263; Blombach B, 2009, APPL ENVIRON MICROB, V75, P1197, DOI 10.1128/AEM.02351-08; Boltner D, 2002, J BACTERIOL, V184, P5158, DOI 10.1128/JB.184.18.5158-5169.2002; BROWN CC, 1987, CAN J VET RES, V51, P46; Burne RA, 2000, MICROBES INFECT, V2, P533, DOI 10.1016/S1286-4579(00)00312-9; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; Carson SDB, 1999, J BACTERIOL, V181, P2895, DOI 10.1128/JB.181.9.2895-2901.1999; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casalino M, 2010, INT J MED MICROBIOL, V300, P289, DOI 10.1016/j.ijmm.2009.10.008; CASPI R, 2007, CURR PROTOC BIOINFOR, pCH17; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Connor KM, 2000, J CLIN MICROBIOL, V38, P2633, DOI 10.1128/JCM.38.7.2633-2637.2000; D'Afonseca V, 2008, GENET MOL RES, V7, P252, DOI 10.4238/vol7-1gmr438; Dobrindt U, 2002, CURR TOP MICROBIOL, V264, P157; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dorella FA, 2006, VET RES, V37, P201, DOI 10.1051/vetres:2005056; Dorella FA, 2006, APPL ENVIRON MICROB, V72, P7368, DOI 10.1128/AEM.00294-06; EGGLETON DG, 1991, AUST VET J, V68, P317, DOI 10.1111/j.1751-0813.1991.tb03085.x; Enkavi G, 2010, BIOCHEMISTRY-US, V49, P1105, DOI 10.1021/bi901412a; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Guimaraes AS, 2009, SMALL RUMINANT RES, V87, P86, DOI 10.1016/j.smallrumres.2009.09.027; Hall BG, 2010, MICROBIOL-SGM, V156, P1060, DOI 10.1099/mic.0.035188-0; Hentschel U, 2001, MICROBES INFECT, V3, P545, DOI 10.1016/S1286-4579(01)01410-1; Hodgson ALM, 1999, VACCINE, V17, P802, DOI 10.1016/S0264-410X(98)00264-3; HUNTLEY RP, 2009, DATABASE, V10, P1; Join-Lambert OF, 2006, PEDIATR INFECT DIS J, V25, P848, DOI 10.1097/01.inf.0000234071.93044.77; Kabus A, 2007, APPL MICROBIOL BIOT, V75, P47, DOI 10.1007/s00253-006-0804-9; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Khamis A, 2005, J CLIN MICROBIOL, V43, P1934, DOI 10.1128/JCM.43.4.1934-1936.2005; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Kiefer P, 2004, APPL ENVIRON MICROB, V70, P229, DOI 10.1128/AEM.70.1.229-239.2004; Klaffl S, 2010, J BACTERIOL, V192, P2604, DOI 10.1128/JB.01678-09; Krauthammer M, 2000, GENE, V259, P245, DOI 10.1016/S0378-1119(00)00431-5; Kunkle CA, 2005, J BACTERIOL, V187, P422, DOI 10.1128/JB.187.2.422-433.2005; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; May T, 2009, ANTIMICROB AGENTS CH, V53, P4628, DOI 10.1128/AAC.00454-09; MCNAMARA PJ, 1995, GENE, V156, P113, DOI 10.1016/0378-1119(95)00002-N; MERCHANT IA, 1967, VET BACTERIOLOGY VIR, P425; Merhej V, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-13; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; Nakamura Y, 2003, GENE, V317, P149, DOI 10.1016/S0378-1119(03)00653-X; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Parche S, 2001, J MOL MICROB BIOTECH, V3, P415; Paton MW, 2003, AUST VET J, V81, P91, DOI 10.1111/j.1751-0813.2003.tb11443.x; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Pinheiro RR, 2000, ARQ BRAS MED VET ZOO, V52, P534, DOI 10.1590/S0102-09352000000500021; Piontkowski MD, 1998, J AM VET MED ASSOC, V212, P1765; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ribeiro M. G., 2001, Arquivos do Instituto Biologico (Sao Paulo), V68, P23; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rittmann D, 2003, ARCH MICROBIOL, V180, P285, DOI 10.1007/s00203-003-0588-6; Rubenhagen R, 2000, J BIOL CHEM, V275, P735, DOI 10.1074/jbc.275.2.735; Rumbold K, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-64; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Schonert S, 1998, J BACTERIOL, V180, P2574; Schumann W, 2007, J BIOSCIENCES, V32, P549, DOI 10.1007/s12038-007-0054-8; Selby T, 2003, ORAL MICROBIOL IMMUN, V18, P256, DOI 10.1034/j.1399-302X.2003.00066.x; Seyffert N, 2010, RES VET SCI, V88, P50, DOI 10.1016/j.rvsc.2009.07.002; SHIMIZU T, 1991, INFECT IMMUN, V59, P137, DOI 10.1128/IAI.59.1.137-142.1991; Shiotani H, 2008, J GEN PLANT PATHOL, V74, P133, DOI 10.1007/s10327-008-0074-8; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Song Catharine, 2009, Genomics Proteomics & Bioinformatics, V7, P37, DOI 10.1016/S1672-0229(08)60031-5; Soto CY, 2004, J CLIN MICROBIOL, V42, P212, DOI 10.1128/JCM.42.1.212-219.2004; STOOPS SG, 1984, AM J VET RES, V45, P557; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Trost E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-728; Urbina P, 2009, CHEM PHYS LIPIDS, V159, P51, DOI 10.1016/j.chemphyslip.2009.02.007; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; Veyrier F, 2008, J BACTERIOL, V190, P1891, DOI 10.1128/JB.01452-07; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Webb SAR, 2008, CRIT CARE, V12, DOI 10.1186/cc7091; Wittmann C, 2004, APPL ENVIRON MICROB, V70, P7277, DOI 10.1128/AEM.70.12.7277-7287.2004; Wittmann C, 2001, METAB ENG, V3, P173, DOI 10.1006/mben.2000.0178; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Yamamoto H, 2001, J BACTERIOL, V183, P5110, DOI 10.1128/JB.183.17.5110-5121.2001; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang LL, 2007, MOL MICROBIOL, V65, P121, DOI 10.1111/j.1365-2958.2007.05775.x; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791	90	69	74	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18551	10.1371/journal.pone.0018551	http://dx.doi.org/10.1371/journal.pone.0018551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533164	Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100009
J	Kagawa, H; Shino, Y; Kobayashi, D; Demizu, S; Shimada, M; Ariga, H; Kawahara, H				Kagawa, Hiroki; Shino, Yuka; Kobayashi, Daigo; Demizu, Syunsuke; Shimada, Masumi; Ariga, Hiroyoshi; Kawahara, Hiroyuki			A Novel Signaling Pathway Mediated by the Nuclear Targeting of C-Terminal Fragments of Mammalian Patched 1	PLOS ONE			English	Article							SEX-DETERMINING GENE; SONIC HEDGEHOG; HUMAN HOMOLOG; MESENCHYMAL DYSPLASIA; MOLECULAR ANALYSIS; MUTATIONS; RECEPTOR; PROTEIN; MICE; DIFFERENTIATION	Background: Patched 1 (Ptc1) is a polytopic receptor protein that is essential for growth and differentiation. Its extracellular domains accept its ligand, Sonic Hedgehog, while the function of its C-terminal intracellular domain is largely obscure. Principal Findings: In this study, we stably expressed human Ptc1 protein in HeLa cells and found that it is subjected to proteolytic cleavage at the C-terminus, resulting in the generation of soluble C-terminal fragments. These fragments accumulated in the nucleus, while the N-terminal region of Ptc1 remained in the cytoplasmic membrane fractions. Using an anti-Ptc1 C-terminal domain antibody, we provide conclusive evidence that C-terminal fragments of endogenous Ptc1 accumulate in the nucleus of C3H10T1/2 cells. Similar nuclear accumulation of endogenous C-terminal fragments was observed not only in C3H10T1/2 cells but also in mouse embryonic primary cells. Importantly, the C-terminal fragments of Ptc1 modulate transcriptional activity of Gli1. Conclusions: Although Ptc1 protein was originally thought to be restricted to cell membrane fractions, our findings suggest that its C-terminal fragments can function as an alternative signal transducer that is directly transported to the cell nucleus.	[Kagawa, Hiroki; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Kagawa, Hiroki; Shino, Yuka; Kobayashi, Daigo; Demizu, Syunsuke; Shimada, Masumi; Kawahara, Hiroyuki] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan	Hokkaido University; Tokyo Metropolitan University	Kagawa, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Sapporo, Hokkaido, Japan.	hkawa@tmu.ac.jp	Ariga, Hiroyoshi/B-5895-2013	Ariga, Hiroyoshi/0000-0001-7384-2143	Ministry of Education, Culture, Science and Technology of Japan [20058001, 18076004]; Japan Society for the Promotion of Science for Young Scientists [211398]	Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Ministry of Education, Culture, Science and Technology of Japan to HK (20058001, 18076004). HK is supported by the Research Fellowship of Japan Society for the Promotion of Science for Young Scientists (211398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Boutet N, 2003, J INVEST DERMATOL, V121, P478, DOI 10.1046/j.1523-1747.2003.12423.x; Briscoe J, 2005, DEV CELL, V8, P143, DOI 10.1016/j.devcel.2005.01.008; Burglin TR, 2006, WORMBOOK, V28, P1; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jenkins D, 2009, CELL SIGNAL, V21, P1023, DOI 10.1016/j.cellsig.2009.01.033; Johnson RL, 2000, MOL CELL, V6, P467, DOI 10.1016/S1097-2765(00)00045-9; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kinto N, 1997, FEBS LETT, V404, P319, DOI 10.1016/S0014-5793(97)00014-8; Lench NJ, 1997, HUM GENET, V100, P497, DOI 10.1007/s004390050541; Li Z, 2008, INT J BIOL SCI, V4, P29; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Lum DH, 2000, GENE DEV, V14, P3153; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Moraes RC, 2009, DEVELOPMENT, V136, P1423, DOI 10.1242/dev.023994; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; OKKEMA PG, 1991, EMBO J, V10, P171, DOI 10.1002/j.1460-2075.1991.tb07933.x; Rahnama F, 2006, BIOCHEM J, V394, P19, DOI 10.1042/BJ20050941; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Savino Maria, 2004, Hum Mutat, V24, P441, DOI 10.1002/humu.9289; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shimada M, 2006, MOL BIOL CELL, V17, P5356, DOI 10.1091/mbc.E06-05-0437; Sokol SB, 2000, GENE DEV, V14, P901; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Sweet HO, 1996, J HERED, V87, P87, DOI 10.1093/oxfordjournals.jhered.a022981; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Varjosalo M, 2007, J CELL SCI, V120, P3, DOI 10.1242/jcs.03309; Vorechovsky I, 1997, ONCOGENE, V15, P361, DOI 10.1038/sj.onc.1201340; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; Wetmore C, 2000, CANCER RES, V60, P2239; Wolter M, 1997, CANCER RES, V57, P2581; Xie JW, 1997, CANCER RES, V57, P2369; ZARKOWER D, 1992, CELL, V70, P237, DOI 10.1016/0092-8674(92)90099-X; Zarkower D, 2006, WORMBOOK, V1, P1, DOI DOI 10.1895/WORMBOOK.1.84.1; Zehentner BK, 2000, DNA CELL BIOL, V19, P275, DOI 10.1089/10445490050021186; Zurawel RH, 2000, GENE CHROMOSOME CANC, V28, P77, DOI 10.1002/(SICI)1098-2264(200005)28:1<77::AID-GCC9>3.0.CO;2-Y	60	14	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18638	10.1371/journal.pone.0018638	http://dx.doi.org/10.1371/journal.pone.0018638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533246	Green Submitted, Green Published, gold			2022-12-25	WOS:000289458800023
J	Natalello, A; Frana, AM; Relini, A; Apicella, A; Invernizzi, G; Casari, C; Gliozzi, A; Doglia, SM; Tortora, P; Regonesi, ME				Natalello, Antonino; Frana, Anna Maria; Relini, Annalisa; Apicella, Alessandra; Invernizzi, Gaetano; Casari, Carlo; Gliozzi, Alessandra; Doglia, Silvia Maria; Tortora, Paolo; Regonesi, Maria Elena			A Major Role for Side-Chain Polyglutamine Hydrogen Bonding in Irreversible Ataxin-3 Aggregation	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; JOSEPHIN DOMAIN; AMYLOID FIBRILS; PROTEIN ATAXIN-3; DISEASE; OLIGOMERS; PEPTIDE; PATHWAY; MODEL; MICROSPECTROSCOPY	The protein ataxin-3 consists of an N-terminal globular Josephin domain (JD) and an unstructured C-terminal region containing a stretch of consecutive glutamines that triggers the neurodegenerative disorder spinocerebellar ataxia type 3, when it is expanded beyond a critical threshold. The disease results from misfolding and aggregation, although the pathway and structure of the aggregation intermediates are not fully understood. In order to provide insight into the mechanism of the process, we monitored the aggregation of a normal (AT3Q24) ataxin-3, an expanded (AT3Q55) ataxin-3, and the JD in isolation. We observed that all of them aggregated, although the latter did so at a much slower rate. Furthermore, the expanded AT3Q55 displayed a substantially different behavior with respect to the two other variants in that at the latest stages of the process it was the only one that did the following: i) lost its reactivity towards an antioligomer antibody, ii) generated SDS-insoluble aggregates, iii) gave rise to bundles of elongated fibrils, and iv) displayed two additional bands at 1604 and 1656 cm(-1) in FTIR spectroscopy. Although these were previously observed in other aggregated polyglutamine proteins, no one has assigned them unambiguously, yet. By H/D exchange experiments we show for the first time that they can be ascribed to glutamine side-chain hydrogen bonding, which is therefore the hallmark of irreversibly SDS-insoluble aggregated protein. FTIR spectra also showed that main-chain intermolecular hydrogen bonding preceded that of glutamine side-chains, which suggests that the former favors the latter by reorganizing backbone geometry.	[Natalello, Antonino; Frana, Anna Maria; Invernizzi, Gaetano; Doglia, Silvia Maria; Tortora, Paolo; Regonesi, Maria Elena] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy; [Relini, Annalisa; Gliozzi, Alessandra] Univ Genoa, Dept Phys, Genoa, Italy; [Apicella, Alessandra; Casari, Carlo] Polythechn Milan, Dept Energy, Milan, Italy	University of Milano-Bicocca; University of Genoa	Natalello, A (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy.	silviamaria.doglia@unimib.it; paolo.tortora@unimib.it	invernizzi, gaetano/K-4375-2014; Casari, Carlo S./C-6189-2008; Relini, Annalisa/AHC-3105-2022; Natalello, Antonino/B-9659-2012	Casari, Carlo S./0000-0001-9144-6822; Natalello, Antonino/0000-0002-1489-272X; RELINI, ANNALISA/0000-0002-4040-9279; Tortora, Paolo/0000-0001-5234-601X	Fondazione Cariplo (N.O.B.E.L. project); Italian Ministry for Instruction, University and Research [2007XY59ZJ_004]; Regione Lombardia; Fondo Ateneo per la Ricerca of the University of Milano-Bicocca; University of Genova (Progetti di Ateneo); University of Milano-Bicocca	Fondazione Cariplo (N.O.B.E.L. project)(Fondazione Cariplo); Italian Ministry for Instruction, University and Research; Regione Lombardia(Regione Lombardia); Fondo Ateneo per la Ricerca of the University of Milano-Bicocca; University of Genova (Progetti di Ateneo); University of Milano-Bicocca	The work was funded by the following: Fondazione Cariplo (N.O.B.E.L. project) (www.fondazionecariplo.it); Italian Ministry for Instruction, University and Research (PRIN 2007: "A multidisciplinary approach to the study of in vivo and vitro aggregation of polyglutamine-containing proteins. Role of molecular and environmental factors" and project n. 2007XY59ZJ_004) (http://www.istruzione.it/web/universita/Finanziamenti); Regione Lombardia ("Network Tecnologico integrato per lo studio proteomico e trascrittomico di malattie neurodegenerative correlate a deposizioni di amiloidi") (www.regione.lombardia.it); Fondo Ateneo per la Ricerca of the University of Milano-Bicocca (www.unimib.it); University of Genova (Progetti di Ateneo) (www.unige.it). A.N. and G.I. acknowledge postdoctoral fellowships of the University of Milano-Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2004, FEBS LETT, V576, P297, DOI 10.1016/j.febslet.2004.09.022; Ami D, 2006, BBA-PROTEINS PROTEOM, V1764, P793, DOI 10.1016/j.bbapap.2005.12.005; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Bader R, 2006, J BIOL CHEM, V281, P18816, DOI 10.1074/jbc.M603628200; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chow MKM, 2006, METHOD ENZYMOL, V413, P1, DOI 10.1016/S0076-6879(06)13001-3; Chow MKM, 2004, J MOL BIOL, V335, P333, DOI 10.1016/j.jmb.2003.08.064; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Natalello A, 2005, BIOCHEM J, V385, P511, DOI 10.1042/BJ20041296; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nozaki K, 2001, NEUROREPORT, V12, P3357, DOI 10.1097/00001756-200110290-00042; Orsini F, 2000, J MICROBIOL METH, V42, P17, DOI 10.1016/S0167-7012(00)00168-8; Padiath QS, 2005, AM J MED GENET B, V133B, P124, DOI 10.1002/ajmg.b.30088; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Peralvarez-Marin A, 2008, J MOL BIOL, V379, P589, DOI 10.1016/j.jmb.2008.04.014; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; Sharma D, 1999, FEBS LETT, V456, P181, DOI 10.1016/S0014-5793(99)00933-3; Shehi E, 2003, BIOCHEMISTRY-US, V42, P14626, DOI 10.1021/bi0352825; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Smith MH, 2010, PROTEINS, V78, P1971, DOI 10.1002/prot.22713; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	43	53	53	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18789	10.1371/journal.pone.0018789	http://dx.doi.org/10.1371/journal.pone.0018789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533208	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800042
J	Nam, SY; Sabapathy, K				Nam, S. Y.; Sabapathy, K.			p53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1	ONCOGENE			English	Article						haeme-oxygenease-1; hydrogen peroxide; p53; survival	MALIGNANT GLIOMA-CELLS; HEME OXYGENASE-1 INDUCTION; NITRIC-OXIDE; ANTICANCER TREATMENT; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; SENSITIVITY; PROTEIN; MICE; O-6-METHYLGUANINE	A variety of cellular insults activate the tumour suppressor p53, leading generally to cell-cycle arrest or apoptosis. However, it is not inconceivable that cellular protective mechanisms may be required to keep cells alive while cell-fate decisions are made. In this respect, p53 has been suggested to perform functions that allow cells to survive, by halting of the cell-cycle, and thus preventing immediate cell death. Nonetheless, the existence of direct prosurvival p53 target genes regulating cellular survival is lacking. We show here evidence for p53-dependent cellular survival in a context-dependent manner. Both mouse and human cells lacking p53 are hypersensitive to hydrogen peroxide (H2O2)-induced cell death compared with their isogenic wild-type counterparts. By contrast, p53(-/-) cells are expectedly resistant to cell death upon exposure to DNA-damaging agents such as cisplatin (CDDP) and etoposide. Although p53 and its classical targets such as p21 and Mdm2 are activated by both H2O2 and CDDP, we found that the expression of haeme-oxygenase-1 (HO-1)-an antioxidant and antiapoptotic protein-was directly induced only upon H2O2 treatment in a p53-dependent manner. Consistently, p53, but not its homologue p73, activated HO-1 expression and was bound to the HO-1 promoter specifically only upon H2O2 treatment. Moreover, silencing HO-1 expression enhanced cell death upon H2O2 treatment only in p53-proficient cells. Finally, H2O2-mediated cell death was rescued significantly in p53-deficient cells by antioxidant treatment, as well as by bilirubin, a by-product of HO-1 metabolism. Taken together, these data demonstrate a direct role for p53 in promoting cellular survival in a context-specific manner through the activation of a direct transcriptional target, HO-1. Oncogene (2011) 30, 4476-4486; doi: 10.1038/onc.2011.150; published online 9 May 2011	[Nam, S. Y.; Sabapathy, K.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Sabapathy, K.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Sabapathy, K.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; National University of Singapore	Sabapathy, K (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, 11 Hosp Dr, Singapore 169610, Singapore.	cmrksb@nccs.com.sg			National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	We thank Dr Vogelstein for the gift of the RKO cells; Ms Amy Chua HW for technical assistance during the revision phase; Dr Lee MK for critical reading of the paper and the National Medical Research Council of Singapore for the funding to KS.	Batista LFZ, 2007, CANCER RES, V67, P11886, DOI 10.1158/0008-5472.CAN-07-2964; Brooks CL, 2010, CELL RES, V20, P614, DOI 10.1038/cr.2010.53; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Burdelya LG, 2006, CANCER RES, V66, P9356, DOI 10.1158/0008-5472.CAN-06-1223; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Jing CR, 2005, J NEUROSCI RES, V82, P802, DOI 10.1002/jnr.20681; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Lackinger D, 2000, MUTAT RES-FUND MOL M, V457, P113, DOI 10.1016/S0027-5107(00)00133-0; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lassus P, 1996, EMBO J, V15, P4566, DOI 10.1002/j.1460-2075.1996.tb00834.x; Lee MK, 2005, J CELL SCI, V118, P819, DOI 10.1242/jcs.01673; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Meiller A, 2007, NUCLEIC ACIDS RES, V35, P6924, DOI 10.1093/nar/gkm824; Motterlini R, 2002, ANTIOXID REDOX SIGN, V4, P615, DOI 10.1089/15230860260220111; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Roepke M, 2007, CANCER BIOL THER, V6, P160, DOI 10.4161/cbt.6.2.3575; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Vikhanskaya F, 1998, EXP CELL RES, V241, P96, DOI 10.1006/excr.1998.4018; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhang Y, 2009, INT J BIOCHEM CELL B, V41, P907, DOI 10.1016/j.biocel.2008.08.040; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	37	25	25	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2011	30	44					4476	4486		10.1038/onc.2011.150	http://dx.doi.org/10.1038/onc.2011.150			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	844FN	21552291				2022-12-25	WOS:000296733200003
J	Ilatovskaya, DV; Pavlov, TS; Levchenko, V; Negulyaev, YA; Staruschenko, A				Ilatovskaya, Daria V.; Pavlov, Tengis S.; Levchenko, Vladislav; Negulyaev, Yuri A.; Staruschenko, Alexander			Cortical actin binding protein cortactin mediates ENaC activity via Arp2/3 complex	FASEB JOURNAL			English	Article						aldosterone; epithelial transport; endocytosis	EPITHELIAL NA+ CHANNEL; SODIUM-CHANNEL; TYROSINE PHOSPHORYLATION; MEMBRANE DYNAMICS; N-WASP; LOCALIZATION; CYTOSKELETON; ASSOCIATION; ACTIVATION; EXPRESSION	Epithelial Na+ channel (ENaC) activity is regulated, in part, by the cortical cytoskeleton. Here we demonstrate that cortactin is highly expressed in the kidney cortex and polarized epithelial cells, and is localized to the cortical collecting duct. Coexpression of cortactin with ENaC decreases ENaC activity, as measured in patch-clamp experiments. Biotinylation experiments and single-channel analysis reveal that cortactin decreases ENaC activity via affecting channel open probability (P-o). Knockdown of cortactin in mpkCCD(c14) principal cells results in an increase in ENaC activity and sodium reabsorption. Coimmuno-precipitation analysis shows direct interactions between cortactin and all three ENaC subunits in cultured and native cells. To address the question of what mechanism underlies the action of cortactin on ENaC activity, we assayed the effects of various mutants of cortactin. The data show that only a cortactin mutant unable to bind Arp2/3 complex does not influence ENaC activity. Furthermore, inhibitor of the Arp2/3 complex CK-0944666 precludes the effect of cortactin. Depolymerization of the actin microfilaments and inhibition of the Arp2/3 complex does not result in the loss of association between ENaC and cortactin. Thus, these results indicate that cortactin is functionally important for ENaC activity and that Arp2/3 complex is involved in this mechanism.-Ilatovskaya, D. V., Pavlov, T. S., Levchenko, V., Negulyaev, Y. A., Staruschenko, A. Cortical actin binding protein cortactin mediates ENaC activity via Arp2/3 complex. FASEB J. 25, 2688-2699 (2011). www.fasebj.org	[Ilatovskaya, Daria V.; Pavlov, Tengis S.; Levchenko, Vladislav; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA; [Negulyaev, Yuri A.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Medical College of Wisconsin; Medical College of Wisconsin; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Staruschenko, A (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	staruschenko@mcw.edu	Negulyaev, Yuri/N-6531-2015	Negulyaev, Yuri/0000-0002-1773-9798; Ilatovskaya, Daria/0000-0003-4832-4170; Staruschenko, Alexander/0000-0002-5190-8356	American Heart Association [0730111N]; American Society of Nephrology; SR Foundation; Russian Foundation for Basic Research [RFBR-10-04-00995]; Russian Academy of Sciences	American Heart Association(American Heart Association); American Society of Nephrology; SR Foundation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences)	The authors thank Drs. A. Sorokin and M. Hodges (Medical College of Wisconsin, Milwaukeee, WI, USA) for helpful discussions and critical reading of the manuscript. The authors are grateful to Dr. J. T. Parsons (University of Virginia, Charlottesville, VA, USA) and Dr. A. D. Morielli (University of Vermont, Burlington, VT, USA) for providing cortactin constructs used in this study and Dr. L. G. Palmer (Weill Medical College of Cornell University, New York, NY, USA) for ENaC antibodies. This research was supported by American Heart Association grant 0730111N, an American Society of Nephrology Carl W. Gottschalk Research Scholar grant, and an S&R Foundation Ryuji Ueno award (to A.S.); Russian Foundation for Basic Research grant RFBR-10-04-00995 and the Molecular and Cell Biology Program of the Russian Academy of Sciences (to Y.A.N. and D.V.I.). Glen Slocum and Christine Duris are recognized for excellent technical assistance with immunohistochemistry experiments. Dr. A. Karpushev is recognized for initial help with biochemistry experiments.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berdiev BK, 1996, J BIOL CHEM, V271, P17704, DOI 10.1074/jbc.271.30.17704; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Blanchoin L, 2009, CHEM BIOL, V16, P1125, DOI 10.1016/j.chembiol.2009.11.001; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; CANTIELLO HF, 1995, KIDNEY INT, V48, P970, DOI 10.1038/ki.1995.379; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Connors EC, 2008, J BIOL CHEM, V283, P3445, DOI 10.1074/jbc.M708875200; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gumz ML, 2010, BBA-GENE REGUL MECH, V1799, P622, DOI 10.1016/j.bbagrm.2010.09.003; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; Karpushev AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008827; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; MCDONALD FJ, 1995, BIOCHEM J, V312, P491, DOI 10.1042/bj3120491; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pavlov TS, 2010, J AM SOC NEPHROL, V21, P833, DOI 10.1681/ASN.2009080885; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; ROTIN D, 1994, EMBO J, V13, P4440, DOI 10.1002/j.1460-2075.1994.tb06766.x; Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Soderling SH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.255pe5; Staruschenko A, 2005, J BIOL CHEM, V280, P39161, DOI 10.1074/jbc.M509608200; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Staruschenko Alexander, 2006, V337, P3; Tian L, 2008, J BIOL CHEM, V283, P3067, DOI 10.1074/jbc.M706826200; Tian LJ, 2006, FASEB J, V20, P2588, DOI 10.1096/fj.06-6152fje; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	60	34	36	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2688	2699		10.1096/fj.10-167262	http://dx.doi.org/10.1096/fj.10-167262			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21536685				2022-12-25	WOS:000293337800018
J	Lu, BGC; Sofian, T; Law, RHP; Coughlin, PB; Horvath, AJ				Lu, Bernadine G. C.; Sofian, Trifina; Law, Ruby H. P.; Coughlin, Paul B.; Horvath, Anita J.			Contribution of Conserved Lysine Residues in the alpha(2)-Antiplasmin C Terminus to Plasmin Binding and Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERPIN; SITE; ALPHA-2-ANTIPLASMIN; ANTIPLASMIN; KINETICS	alpha(2)-Antiplasmin is the physiological inhibitor of plasmin and is unique in the serpin family due to N- and C-terminal extensions beyond its core domain. The C-terminal extension comprises 55 amino acids from Asn-410 to Lys-464, and the lysine residues (Lys-418, Lys-427, Lys-434, Lys-441, Lys-448, and Lys-464) within this region are important in mediating the initial interaction with kringle domains of plasmin. To understand the role of lysine residues within the C terminus of alpha(2)-antiplasmin, we systematically and sequentially mutated the C-terminal lysines, studied the effects on the rate of plasmin inhibition, and measured the binding affinity for plasmin via surface plasmon resonance. We determined that the C-terminal lysine (Lys-464) is individually most important in initiating binding to plasmin. Using two independent methods, we also showed that the conserved internal lysine residues play a major role mediating binding of the C terminus of alpha(2)-antiplasmin to kringle domains of plasmin and in accelerating the rate of interaction between alpha(2)-antiplasmin and plasmin. When the C terminus of alpha(2)-antiplasmin was removed, the binding affinity for active site-blocked plasmin remained high, suggesting additional exosite interactions between the serpin core and plasmin.	[Lu, Bernadine G. C.; Sofian, Trifina; Coughlin, Paul B.; Horvath, Anita J.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Law, Ruby H. P.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Coughlin, Paul B.] Monash Univ, Box Hill Hosp, Dept Med & Haematol, Box Hill, Vic 3128, Australia	Monash University; Monash University; Box Hill Hospital; Monash University	Horvath, AJ (corresponding author), Monash Univ, Australian Ctr Blood Dis, Level 6 Burnet Bldg,89 Commercial Rd, Melbourne, Vic 3004, Australia.	anita.horvath@monash.edu		law, ruby/0000-0001-5432-5781	National Health and Medical Research Council (NHMRC) of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia.	Christensen U, 1996, FEBS LETT, V387, P58, DOI 10.1016/0014-5793(96)00429-2; CLEMMENSEN I, 1981, EUR J BIOCHEM, V120, P105, DOI 10.1111/j.1432-1033.1981.tb05675.x; Coughlin PB, 2005, FEBS J, V272, P4852, DOI 10.1111/j.1742-4658.2005.04881.x; Frank PS, 2003, BIOCHEMISTRY-US, V42, P1078, DOI 10.1021/bi026917n; Gerber SS, 2010, CELL MOL LIFE SCI, V67, P1505, DOI 10.1007/s00018-010-0264-3; Gross PL, 2009, CLIN PHARMACOL THER, V86, P139, DOI 10.1038/clpt.2009.98; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; Law RHP, 2008, BLOOD, V111, P2049, DOI 10.1182/blood-2007-09-114215; Lee KN, 2000, J BIOL CHEM, V275, P37382, DOI 10.1074/jbc.M003375200; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; Matsuno H, 2006, CURR PHARM DESIGN, V12, P841, DOI 10.2174/138161206776056038; Morris EC, 2003, BIOCHEM J, V371, P165, DOI 10.1042/BJ20021567; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Schechter NM, 2004, METHODS, V32, P159, DOI 10.1016/S1046-2023(03)00207-X; SHIEH BH, 1987, J BIOL CHEM, V262, P6055; Wang HY, 2003, EUR J BIOCHEM, V270, P2023, DOI 10.1046/j.1432-1033.2003.03578.x; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408	19	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24544	24552		10.1074/jbc.M111.229013	http://dx.doi.org/10.1074/jbc.M111.229013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21543325	hybrid, Green Published			2022-12-25	WOS:000292547900004
J	Yang, D; He, QY; Kim, H; Ma, WB; Zhou, SY				Yang, Dong; He, Quanyuan; Kim, Hyeung; Ma, Wenbin; Zhou Songyang			TIN2 Protein Dyskeratosis Congenita Missense Mutants Are Defective in Association with Telomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW FAILURE; REVERSE-TRANSCRIPTASE; LENGTH REGULATOR; APLASTIC-ANEMIA; STEM-CELLS; COMPLEX; MUTATIONS; TRF2; MAINTENANCE; COMPONENT	Dyskeratosis congenita (DC) is a progressive and heterogeneous congenital disorder that affects multiple systems and is characterized by bone marrow failure and a triad of abnormal skin pigmentation, nail dystrophy, and oral leukoplakia. One common feature for all DC patients is abnormally short telomeres and defects in telomere biology. Most of the known DC mutations have been found to affect core components of the telomerase holoenzyme. Recently, multiple mutations in the gene encoding the telomeric protein TIN2 have been identified in DC patients with intact telomerase genes, but the molecular mechanisms underlying TIN2 mutation-mediated DC remain unknown. Here, we demonstrate that ectopic expression of TIN2 with DC missense mutations in human cells led to accelerated telomere shortening, similar to the telomere phenotypes found in DC patients. However, this telomere shortening was not accompanied by changes in total telomerase activity, localization of TIN2, or telomere end protection status. Interestingly, we found TIN2 to participate in the TPP1-dependent recruitment of telomerase activity. Furthermore, DC mutations in TIN2 led to its decreased ability to associate with TERC and telomerase activity. Taken together, our data suggest that TIN2 mutations in DC may compromise the telomere recruitment of telomerase, leading to telomere shortening and the associated pathogenesis.	[Yang, Dong; He, Quanyuan; Kim, Hyeung; Ma, Wenbin; Zhou Songyang] Baylor Coll Med, Verna & Mars McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ma, Wenbin; Zhou Songyang] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Baylor College of Medicine; Sun Yat Sen University	Ma, WB (corresponding author), Baylor Coll Med, Verna & Mars McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	wma@bcm.edu; songyang@bcm.edu		Ma, Wenbin/0000-0001-8774-7593	NCI [CA133249]; NIGMS [GM081627]; Welch Foundation [Q-1673]; National Basic Research Program [2010CB945400]; NATIONAL CANCER INSTITUTE [R01CA133249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); National Basic Research Program(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA133249 from NCI and Grant GM081627 from NIGMS. This work was also supported by Welch Foundation Grant Q-1673 and National Basic Research Program Grant 2010CB945400.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Cerone MA, 2005, CELL CYCLE, V4, P585; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; Du HY, 2009, PEDIATR BLOOD CANCER, V52, P687, DOI 10.1002/pbc.21903; HarleBachor C, 1996, P NATL ACAD SCI USA, V93, P6476, DOI 10.1073/pnas.93.13.6476; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Kaminker P, 2005, J CELL SCI, V118, P1321, DOI 10.1242/jcs.01709; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sasa G., 2011, CLIN GENET IN PRESS; Savage SA, 2008, MECH AGEING DEV, V129, P35, DOI 10.1016/j.mad.2007.11.002; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Tsangaris E, 2008, HUM GENET, V124, P507, DOI 10.1007/s00439-008-0576-7; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wong JMY, 2004, HUM GENET, V115, P448, DOI 10.1007/s00439-004-1178-7; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	57	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23022	23030		10.1074/jbc.M111.225870	http://dx.doi.org/10.1074/jbc.M111.225870			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536674	hybrid, Green Published			2022-12-25	WOS:000292025000037
J	Bhattacharya, S; Qian, J; Tzimas, C; Baker, DP; Koumenis, C; Diehl, JA; Fuchs, SY				Bhattacharya, Sabyasachi; Qian, Juan; Tzimas, Christos; Baker, Darren P.; Koumenis, Constantinos; Diehl, J. Alan; Fuchs, Serge Y.			Role of p38 Protein Kinase in the Ligand-independent Ubiquitination and Down-regulation of the IFNAR1 Chain of Type I Interferon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCEPHALITIS-VIRUS INFECTION; ABL-EXPRESSING CELLS; ALPHA RECEPTOR; TRANSCRIPTIONAL ACTIVATION; SERINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MAP KINASE; PATHWAY; STRESS; REPLICATION	Phosphorylation-dependent ubiquitination and degradation of the IFNAR1 chain of type I interferon (IFN) receptor is a robust and specific mechanism that limits the magnitude and duration of IFN alpha/beta signaling. Besides the ligand-inducible IFNAR1 degradation, the existence of an "inside-out" signaling that accelerates IFNAR1 turnover in the cells undergoing the endoplasmic reticulum (ER) stress and activated unfolded protein responses has been recently described. The latter pathway does not require either presence of ligands (IFN alpha/beta) or catalytic activity of Janus kinases (JAK). Instead, this pathway relies on activation of the PKR-like ER kinase (PERK) and ensuing specific priming phosphorylation of IFNAR1. Here, we describe studies that identify the stress activated p38 protein kinase as an important regulator of IFNAR1 that acts downstream of PERK. Results of the experiments using pharmacologic p38 kinase inhibitors, RNA interference approach, and cells from p38 alpha knock-out mice suggest that p38 kinase activity is required for priming phosphorylation of IFNAR1 in cells undergoing unfolded protein response. We further demonstrate an important role of p38 kinase in the ligand-independent stimulation of IFNAR1 ubiquitination and degradation and ensuing attenuation of IFN alpha/beta signaling and anti-viral defenses. We discuss the distinct importance of p38 kinase in regulating the overall responses to type I IFN in cells that have been already exposed to IFN alpha/beta versus those cells that are yet to encounter these cytokines.	[Bhattacharya, Sabyasachi; Qian, Juan; Tzimas, Christos; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bhattacharya, Sabyasachi; Qian, Juan; Tzimas, Christos; Fuchs, Serge Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA 02142 USA; [Koumenis, Constantinos] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Diehl, J. Alan] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Biogen; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Fuchs, SY (corresponding author), 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Koumenis, Constantinos/B-2002-2008	Koumenis, Costas/0000-0001-5945-4726	National Institutes of Health [CA92900, CA142425, CA94214, CA104838]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [P01CA104838, R01CA092900, R01CA094214, R01CA142425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92900 and CA142425 ( to S. Y. F.), CA94214 ( to C. K.), and CA104838 ( to J. A. D.). This work was also supported by a grant with the Pennsylvania Department of Health ( to J. A. D., C. K., and S. Y. F.).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Chang WW, 2008, J VIRAL HEPATITIS, V15, P490, DOI [10.1111/j.1365-2893.2008.00968.x, 10.1111/j.1365-2893.2007.00968.x]; Chen CJ, 2002, J GEN VIROL, V83, P1897, DOI 10.1099/0022-1317-83-8-1897; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Gauzzi MC, 1997, P NATL ACAD SCI USA, V94, P11839, DOI 10.1073/pnas.94.22.11839; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Hale KK, 1999, J IMMUNOL, V162, P4246; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Huangfu Wei-Chun, 2010, Genes Cancer, V1, P725, DOI 10.1177/1947601910382901; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Johnson RA, 1999, ANTIVIR RES, V41, P101, DOI 10.1016/S0166-3542(99)00002-9; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Karaca G, 2004, VIROLOGY, V329, P142, DOI 10.1016/j.virol.2004.08.020; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kono M, 2008, ANTIVIR RES, V77, P150, DOI 10.1016/j.antiviral.2007.10.011; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Kumar KGS, 2008, J BIOL CHEM, V283, P18566, DOI 10.1074/jbc.M800991200; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; KYRIAKIS JM, 2000, SCI STKE, pPE1; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; PFEFFER LM, 1991, PHARMACOL THERAPEUT, V52, P149, DOI 10.1016/0163-7258(91)90005-7; Pfeffer LM, 1998, CANCER RES, V58, P2489; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Rani MRS, 1999, J BIOL CHEM, V274, P32507, DOI 10.1074/jbc.274.45.32507; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Si XN, 2005, J VIROL, V79, P13875, DOI 10.1128/JVI.79.22.13875-13881.2005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	52	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22069	22076		10.1074/jbc.M111.238766	http://dx.doi.org/10.1074/jbc.M111.238766			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540188	Green Published, hybrid			2022-12-25	WOS:000291719900013
J	Zuo, XF; Fogelgren, B; Lipschutz, JH				Zuo, Xiaofeng; Fogelgren, Ben; Lipschutz, Joshua H.			The Small GTPase Cdc42 Is Necessary for Primary Ciliogenesis in Renal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; SPINDLE ORIENTATION; AUTOSOMAL-DOMINANT; PRIMARY CILIUM; EXOCYST; POLARITY; CYSTOGENESIS; MEMBRANE; COMPLEX; RAC1	Primary cilia are found on many epithelial cell types, including renal tubular epithelial cells, where they participate in flow sensing. Disruption of cilia function has been linked to the pathogenesis of polycystic kidney disease. We demonstrated previously that the exocyst, a highly conserved eight-protein membrane trafficking complex, localizes to primary cilia of renal tubular epithelial cells, is required for ciliogenesis, biochemically and genetically interacts with polycystin-2 (the protein product of the polycystic kidney disease 2 gene), and, when disrupted, results in MAPK pathway activation both in vitro and in vivo. The small GTPase Cdc42 is a candidate for regulation of the exocyst at the primary cilium. Here, we demonstrate that Cdc42 biochemically interacts with Sec10, a crucial component of the exocyst complex, and that Cdc42 colocalizes with Sec10 at the primary cilium. Expression of dominant negative Cdc42 and shRNA-mediated knockdown of both Cdc42 and Tuba, a Cdc42 guanine nucleotide exchange factor, inhibit ciliogenesis in Madin-Darby canine kidney cells. Furthermore, exocyst Sec8 and polycystin-2 no longer localize to primary cilia or the ciliary region following Cdc42 and Tuba knockdown. We also show that Sec10 directly interacts with Par6, a member of the Par complex that itself directly interacts with Cdc42. Finally, we show that Cdc42 knockdown results in activation of the MAPK pathway, something observed in cells with dysfunctional primary cilia. These data support a model in which Cdc42 localizes the exocyst to the primary cilium, whereupon the exocyst then targets and docks vesicles carrying proteins necessary for ciliogenesis.	[Zuo, Xiaofeng; Fogelgren, Ben; Lipschutz, Joshua H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Lipschutz, Joshua H.] Philadelphia Vet Affairs Med Ctr, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Lipschutz, JH (corresponding author), 413 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	jhlipsch@mail.med.upenn.edu			National Institutes of Health [DK069909, K01DK087852]; Veterans Affairs; Satellite Healthcare; University of Pennsylvania Translational Medicine Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868, R01DK069909, K01DK087852] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Satellite Healthcare; University of Pennsylvania Translational Medicine Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK069909 (to J. H. L.) and K01DK087852 (to B. F.). This work was also supported by a Veterans Affairs Merit Award (to J. H. L.), a Satellite Healthcare Norman S. Coplon extramural research grant (to J. H. L.), and a University of Pennsylvania Translational Medicine Institute pilot grant (to J. H. L).	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; FAWCETT DW, 1954, J MORPHOL, V94, P221, DOI 10.1002/jmor.1050940202; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Park KM, 2010, AM J PHYSIOL-RENAL, V298, pF818, DOI 10.1152/ajprenal.00596.2009; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Rogers KK, 2003, KIDNEY INT, V63, P1632, DOI 10.1046/j.1523-1755.2003.00902.x; Schwartz MA, 1998, ONCOGENE, V17, P625, DOI 10.1038/sj.onc.1201977; Sfakianos J, 2007, J CELL BIOL, V179, P1133, DOI 10.1083/jcb.200709111; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Smyth BJ, 2003, INT REV CYTOL, V231, P51, DOI 10.1016/S0074-7696(03)31002-2; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; WEBBER WA, 1975, ANAT RECORD, V182, P339, DOI 10.1002/ar.1091820307; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	41	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22469	22477		10.1074/jbc.M111.238469	http://dx.doi.org/10.1074/jbc.M111.238469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543338	Green Published, hybrid			2022-12-25	WOS:000291719900055
J	Cashman, SM; Ramo, K; Kumar-Singh, R				Cashman, Siobhan M.; Ramo, Kasmir; Kumar-Singh, Rajendra			A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration	PLOS ONE			English	Article							ADENOVIRUS-MEDIATED DELIVERY; COMPLEMENT-SYSTEM; POTENTIAL THERAPY; ATTACK COMPLEX; IN-VIVO; 2 PARTS; RECOMBINANT; VECTORS; DEFICIENCY; DISEASE	Age related macular degeneration (AMD) is the most common cause of blindness amongst the elderly. Approximately 10% of AMD patients suffer from an advanced form of AMD characterized by choroidal neovascularization (CNV). Recent evidence implicates a significant role for complement in the pathogenesis of AMD. Activation of complement terminates in the incorporation of the membrane attack complex (MAC) in biological membranes and subsequent cell lysis. Elevated levels of MAC have been documented on choroidal blood vessels and retinal pigment epithelium (RPE) of AMD patients. CD59 is a naturally occurring membrane bound inhibitor of MAC formation. Previously we have shown that membrane bound human CD59 delivered to the RPE cells of mice via an adenovirus vector can protect those cells from human complement mediated lysis ex vivo. However, application of those observations to choroidal blood vessels are limited because protection from MAC-mediated lysis was restricted only to the cells originally transduced by the vector. Here we demonstrate that subretinal delivery of an adenovirus vector expressing a transgene for a soluble non-membrane binding form of human CD59 can attenuate the formation of laser-induced choroidal neovascularization and murine MAC formation in mice even when the region of vector delivery is distal to the site of laser induced CNV. Furthermore, this same recombinant transgene delivered to the intravitreal space of mice by an adeno-associated virus vector (AAV) can also attenuate laser-induced CNV. To our knowledge, this is the first demonstration of a non-membrane targeting CD59 having biological potency in any animal model of disease in vivo. We propose that the above approaches warrant further exploration as potential approaches for alleviating complement mediated damage to ocular tissues in AMD.	[Cashman, Siobhan M.; Ramo, Kasmir; Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University	Cashman, SM (corresponding author), Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA.	rajendra.kumar-singh@tufts.edu		Kumar-Singh, Rajendra/0000-0002-7754-0713	Ellison Foundation; Virginia B. Smith Trust; NIH/NEI [EY014991, EY013887]; Lions Eye Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY014991] Funding Source: NIH RePORTER	Ellison Foundation(Lawrence Ellison Foundation); Virginia B. Smith Trust; NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lions Eye Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by grants to R.K.-S. from The Ellison Foundation, The Virginia B. Smith Trust, NIH/NEI (EY014991 and EY013887) and grants to the Department of Ophthalmology at Tufts University from the Lions Eye Foundation and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Bora NS, 2010, J BIOL CHEM, V285, P33826, DOI 10.1074/jbc.M110.153130; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Cashman SM, 2007, MOL THER, V15, P1640, DOI 10.1038/sj.mt.6300203; Cashman SM, 2006, INVEST OPHTH VIS SCI, V47, P3496, DOI 10.1167/iovs.05-1610; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Colella P, 2009, TRENDS MOL MED, V15, P23, DOI 10.1016/j.molmed.2008.11.003; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fijen CAP, 1999, CLIN INFECT DIS, V28, P98, DOI 10.1086/515075; Fijen CAP, 1998, J CLIN MICROBIOL, V36, P2342, DOI 10.1128/JCM.36.8.2342-2345.1998; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Homann C, 1997, GUT, V40, P544, DOI 10.1136/gut.40.4.544; ILDEFONSO CJ, MOL THER, V18, P1885; Jiang H, 2004, MOL THER, V10, P1140, DOI 10.1016/j.ymthe.2004.08.015; Jiang HY, 2006, MOL THER, V14, P452, DOI 10.1016/j.ymthe.2006.05.004; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; LEHTO T, 1993, J IMMUNOL, V151, P4941; Lukason M, 2011, MOL THER, V19, P260, DOI 10.1038/mt.2010.230; MacLachlan TK, 2011, MOL THER, V19, P326, DOI 10.1038/mt.2010.258; MERI S, 1990, IMMUNOLOGY, V71, P1; Michels Stephan, 2006, Expert Opin Investig Drugs, V15, P779, DOI 10.1517/13543784.15.7.779; Mizuno M, 2001, ARTHRITIS RHEUM-US, V44, P2425, DOI 10.1002/1529-0131(200110)44:10<2425::AID-ART407>3.0.CO;2-4; Ramo K, 2008, INVEST OPHTH VIS SCI, V49, P4126, DOI 10.1167/iovs.08-2025; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Rosen AM, 2010, ADV EXP MED BIOL, V703, P75, DOI 10.1007/978-1-4419-5635-4_6; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, pS674; SUGITA Y, 1994, IMMUNOLOGY, V82, P34; VAKEVA A, 1994, IMMUNOLOGY, V82, P28; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	41	80	86	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19078	10.1371/journal.pone.0019078	http://dx.doi.org/10.1371/journal.pone.0019078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552568	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700022
J	Hu, HY; Armstrong, PCJ; Khalil, E; Chen, YC; Straub, A; Li, M; Soosairajah, J; Hagemeyer, CE; Bassler, N; Huang, DX; Ahrens, I; Krippner, G; Gardiner, E; Peter, K				Hu, Houyuan; Armstrong, Paul C. J.; Khalil, Elie; Chen, Yung-Chih; Straub, Andreas; Li, Min; Soosairajah, Juliana; Hagemeyer, Christoph E.; Bassler, Nicole; Huang, Dexing; Ahrens, Ingo; Krippner, Guy; Gardiner, Elizabeth; Peter, Karlheinz			GPVI and GPIb alpha Mediate Staphylococcal Superantigen-Like Protein 5 (SSL5) Induced Platelet Activation and Direct toward Glycans as Potential Inhibitors	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; GLYCOPROTEIN-IB-ALPHA; E-SELECTIN; IX-V; ADHESION; COMPLEX; BINDING; GENOME; AUREUS; POLYMORPHISM	Background: Staphylococcus aureus (S. aureus) is a common pathogen capable of causing life-threatening infections. Staphylococcal superantigen-like protein 5 (SSL5) has recently been shown to bind to platelet glycoproteins and induce platelet activation. This study investigates further the interaction between SSL5 and platelet glycoproteins. Moreover, using a glycan discovery approach, we aim to identify potential glycans to therapeutically target this interaction and prevent SSL5-induced effects. Methodology/Principal Findings: In addition to platelet activation experiments, flow cytometry, immunoprecipitation, surface plasmon resonance and a glycan binding array, were used to identify specific SSL5 binding regions and mediators. We independently confirm SSL5 to interact with platelets via GPIb alpha and identify the sulphated-tyrosine residues as an important region for SSL5 binding. We also identify the novel direct interaction between SSL5 and the platelet collagen receptor GPVI. Together, these receptors offer one mechanistic explanation for the unique functional influences SSL5 exerts on platelets. A role for specific families of platelet glycans in mediating SSL5-platelet interactions was also discovered and used to identify and demonstrate effectiveness of potential glycan based inhibitors in vitro. Conclusions/Significance: These findings further elucidate the functional interactions between SSL5 and platelets, including the novel finding of a role for the GPVI receptor. We demonstrate efficacy of possible glycan-based approaches to inhibit the SSL5-induced platelet activation. Our data warrant further work to prove SSL5-platelet effects in vivo.	[Hu, Houyuan; Armstrong, Paul C. J.; Khalil, Elie; Chen, Yung-Chih; Straub, Andreas; Li, Min; Soosairajah, Juliana; Hagemeyer, Christoph E.; Bassler, Nicole; Huang, Dexing; Ahrens, Ingo; Krippner, Guy; Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Hu, Houyuan; Li, Min] Third Mil Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China; [Chen, Yung-Chih; Peter, Karlheinz] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Gardiner, Elizabeth] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Baker Heart and Diabetes Institute; Army Medical University; Monash University; Monash University	Hu, HY (corresponding author), Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia.	karlheinz.peter@bakeridi.edu.au	Hagemeyer, Christoph/E-8958-2011; Armstrong, Paul/Z-1408-2019; /S-2765-2019; Peter, Karlheinz/E-8772-2010; Gardiner, Elizabeth/P-8716-2019; Chen, Yung-Chih/I-6959-2019	Hagemeyer, Christoph/0000-0002-7114-4023; /0000-0002-8040-2258; Peter, Karlheinz/0000-0002-8040-2258; Gardiner, Elizabeth/0000-0001-9453-9688; Chen, Yung Chih/0000-0002-5387-5818; Armstrong, Paul/0000-0003-0904-677X	National Health & Medical Research Council (NHMRC) of Australia	National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health & Medical Research Council (NHMRC) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar-Kharghan V, 2001, BLOOD, V97, P3306, DOI 10.1182/blood.V97.10.3306; Al-Shangiti AM, 2004, INFECT IMMUN, V72, P4261, DOI 10.1128/IAI.72.7.4261-4270.2004; Ali M, 2004, FASEB J, V18, P152, DOI 10.1096/fj.03-0346fje; Andrews RK, 2003, INT J BIOCHEM CELL B, V35, P1170, DOI 10.1016/S1357-2725(02)00280-7; Arthur JF, 2005, THROMB HAEMOSTASIS, V93, P716, DOI 10.1160/TH04-09-0584; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baker HM, 2007, J MOL BIOL, V374, P1298, DOI 10.1016/j.jmb.2007.09.091; Beeh KM, 2006, PULM PHARMACOL THER, V19, P233, DOI 10.1016/j.pupt.2005.07.004; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Bestebroer J, 2009, BLOOD, V113, P328, DOI 10.1182/blood-2008-04-153882; Cheng XH, 2000, J ORG CHEM, V65, P2544, DOI 10.1021/jo991898h; Chung MC, 2007, MOL MICROBIOL, V66, P1342, DOI 10.1111/j.1365-2958.2007.05989.x; De Haas CJC, 2009, J THROMB HAEMOST, V7, P1867, DOI 10.1111/j.1538-7836.2009.03564.x; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fitzgerald JR, 2003, INFECT IMMUN, V71, P2827, DOI 10.1128/IAI.71.5.2827-2838.2003; Hallahan DE, 1997, RADIAT RES, V147, P41, DOI 10.2307/3579441; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hicks AER, 2005, J LEUKOCYTE BIOL, V77, P59, DOI 10.1189/jlb.1103573; Kaila N, 2002, MED RES REV, V22, P566, DOI 10.1002/med.10018; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Kessler CM, 1997, BLOOD, V89, P4393, DOI 10.1182/blood.V89.12.4393; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li S, 2009, P NATL ACAD SCI USA, V106, P4349, DOI 10.1073/pnas.0810844106; LOPEZ JA, 1992, J BIOL CHEM, V267, P10055; Meyer M, 2007, BRIT J CLIN PHARMACO, V63, P451, DOI 10.1111/j.1365-2125.2006.02775.x; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Petti CA, 2003, CARDIOL CLIN, V21, pvii; Petti Cathy A., 2003, Cardiology Clinics, V21, P219, DOI 10.1016/S0733-8651(03)00030-4; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Takamatsu D, 2005, MOL MICROBIOL, V58, P380, DOI 10.1111/j.1365-2958.2005.04830.x; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Zhanel GG, 2008, ANTIMICROB AGENTS CH, V52, P1430, DOI 10.1128/AAC.01538-07	38	31	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19190	10.1371/journal.pone.0019190	http://dx.doi.org/10.1371/journal.pone.0019190			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552524	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000290020700037
J	Koepfli, C; Schoepflin, S; Bretscher, M; Lin, E; Kiniboro, B; Zimmerman, PA; Siba, P; Smith, TA; Mueller, I; Felger, I				Koepfli, Cristian; Schoepflin, Sonja; Bretscher, Michael; Lin, Enmoore; Kiniboro, Benson; Zimmerman, Peter A.; Siba, Peter; Smith, Thomas A.; Mueller, Ivo; Felger, Ingrid			How Much Remains Undetected? Probability of Molecular Detection of Human Plasmodia in the Field	PLOS ONE			English	Article							ASYMPTOMATIC MALARIA INFECTIONS; FALCIPARUM; DETECTABILITY; RATES; DYNAMICS; CHILDREN; TRANSMISSION; POPULATIONS; DURATION; PARASITE	Background: In malaria endemic areas, most people are simultaneously infected with different parasite clones. Detection of individual clones is hampered when their densities fluctuate around the detection limit and, in case of P. falciparum, by sequestration during part of their life cycle. This has important implications for measures of levels of infection or for the outcome of clinical trials. This study aimed at measuring the detectability of individual P. falciparum and P. vivax parasite clones in consecutive samples of the same patient and at investigating the impact of sampling strategies on basic epidemiological measures such as multiplicity of infection (MOI). Methods: Samples were obtained in a repeated cross-sectional field survey in 1 to 4.5 years old children from Papua New Guinea, who were followed up in 2-monthly intervals over 16 months. At each follow-up visit, two consecutive blood samples were collected from each child at intervals of 24 hours. Samples were genotyped for the polymorphic markers msp2 for P. falciparum and msp1F3 and MS16 for P. vivax. Observed prevalence and mean MOI estimated from single samples per host were compared to combined data from sampling twice within 24 h. Findings and Conclusion: Estimated detectability was high in our data set (0.79 [95% CI 0.76-0.82] for P. falciparum and, depending on the marker, 0.61 [0.58-0.63] or 0.73 [0.71-0.75] for P. vivax). When genotyping data from sequential samples, collected 24 hours apart, were combined, the increase in measured prevalence was moderate, 6 to 9% of all infections were missed on a single day. The effect on observed MOI was more pronounced, 18 to 31% of all individual clones were not detected in a single bleed. Repeated sampling revealed little difference between detectability of P. falciparum and P. vivax.	[Koepfli, Cristian; Schoepflin, Sonja; Bretscher, Michael; Smith, Thomas A.; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Koepfli, Cristian; Schoepflin, Sonja; Bretscher, Michael; Smith, Thomas A.; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Lin, Enmoore; Kiniboro, Benson; Siba, Peter; Mueller, Ivo] Papua New Guinea Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Zimmerman, Peter A.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; PNG Institute Of Medical Research; Case Western Reserve University	Koepfli, C (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	ingrid.felger@unibas.ch	Mueller, Ivo/C-7251-2013; Smith, Thomas/B-5569-2015; Koepfli, Cristian/H-8772-2019	Mueller, Ivo/0000-0001-6554-6889; Smith, Thomas/0000-0002-3650-9381; Koepfli, Cristian/0000-0002-9354-0414; Felger, Ingrid/0000-0003-1255-2606; Zimmerman, Peter/0000-0002-5349-4513; Lin, Enmoore/0000-0002-8584-7627	Swiss National Science Foundation [31003A-112196, 320030_125316/1]; National Institute of Health [AI063135, TW007872]; Forlen Foundation; FOGARTY INTERNATIONAL CENTER [R01TW007872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089686, R03AI063135] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Forlen Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the Swiss National Science Foundation (www.snf.ch, grants no: 31003A-112196, 320030_125316/1) and the National Institute of Health (www.nih.gov, grants no: AI063135, TW007872). SS was supported by the Forlen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, MALARIA PARASITE BIO; Bignami A., 1890, RIFORMA MED, V232, P1334; Bretscher MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-234; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; CARVALHO BO, 2010, J INFECT DIS; Daubersies P, 1996, AM J TROP MED HYG, V54, P18, DOI 10.4269/ajtmh.1996.54.18; Falk N, 2006, AM J TROP MED HYG, V74, P944, DOI 10.4269/ajtmh.2006.74.944; Farnert A, 1997, AM J TROP MED HYG, V56, P538, DOI 10.4269/ajtmh.1997.56.538; Garnham PCC, 1966, MALARIA PARASITES OT; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Havryliuk T, 2008, EXP PARASITOL, V120, P330, DOI 10.1016/j.exppara.2008.08.012; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hill WG, 1995, P ROY SOC B-BIOL SCI, V262, P249, DOI 10.1098/rspb.1995.0203; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Juliano JJ, 2010, TRENDS PARASITOL, V26, P119, DOI 10.1016/j.pt.2009.12.007; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Liu SF, 2008, AM J TROP MED HYG, V79, P178, DOI 10.4269/ajtmh.2008.79.178; Martensson A, 2007, J INFECT DIS, V195, P597, DOI 10.1086/510910; McNamara DT, 2006, AM J TROP MED HYG, V74, P413, DOI 10.4269/ajtmh.2006.74.413; MILLER LH, 1969, AM J TROP MED HYG, V18, P860, DOI 10.4269/ajtmh.1969.18.860; Nsanzabana C, 2010, J INFECT DIS, V201, P435, DOI 10.1086/649784; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; Sama W, 2006, PARASITOLOGY, V132, P13, DOI 10.1017/S0031182005008607; Sama W, 2005, STAT MED, V24, P3269, DOI 10.1002/sim.2189; Schoepflin S, 2010, AM J TROP MED HYG, V82, P529, DOI 10.4269/ajtmh.2010.09-0334; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Smith T, 2003, STAT MED, V22, P1709, DOI 10.1002/sim.1274; Thuilliez J, 2010, SOC SCI MED, V71, P314, DOI 10.1016/j.socscimed.2010.03.034	34	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19010	10.1371/journal.pone.0019010	http://dx.doi.org/10.1371/journal.pone.0019010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552561	Green Published, gold, Green Accepted			2022-12-25	WOS:000290020700014
J	Berger, DS; Moyer, M; Kliment, GM; van Lunteren, E; Ladd, AN				Berger, Dara S.; Moyer, Michelle; Kliment, Gregory M.; van Lunteren, Erik; Ladd, Andrea N.			Expression of a Dominant Negative CELF Protein In Vivo Leads to Altered Muscle Organization, Fiber Size, and Subtype	PLOS ONE			English	Article							EXPANDED CTG REPEATS; RNA-BINDING PROTEIN; MYOTONIC-DYSTROPHY; TRIPLET REPEAT; SKELETAL-MUSCLE; MOLECULAR-BASIS; MOUSE MODEL; EDEN-BP; MICE; CUGBP1	Background: CUG-BP and ETR-3-like factor (CELF) proteins regulate tissue-and developmental stage-specific alternative splicing in striated muscle. We previously demonstrated that heart muscle-specific expression of a nuclear dominant negative CELF protein in transgenic mice (MHC-CELFD) effectively disrupts endogenous CELF activity in the heart in vivo, resulting in impaired cardiac function. In this study, transgenic mice that express the dominant negative protein under a skeletal muscle-specific promoter (Myo-CELFD) were generated to investigate the role of CELF-mediated alternative splicing programs in normal skeletal muscle. Methodology/Principal Findings: Myo-CELFD mice exhibit modest changes in CELF-mediated alternative splicing in skeletal muscle, accompanied by a reduction of endomysial and perimysial spaces, an increase in fiber size variability, and an increase in slow twitch muscle fibers. Weight gain and mean body weight, total number of muscle fibers, and overall muscle strength were not affected. Conclusions/Significance: Although these findings demonstrate that CELF activity contributes to the normal alternative splicing of a subset of muscle transcripts in vivo, the mildness of the effects in Myo-CELFD muscles compared to those in MHC-CELFD hearts suggests CELF activity may be less determinative for alternative splicing in skeletal muscle than in heart muscle. Nonetheless, even these small changes in CELF-mediated splicing regulation were sufficient to alter muscle organization and muscle fiber properties affected in myotonic dystrophy. This lends further evidence to the hypothesis that dysregulation of CELF-mediated alternative splicing programs may be responsible for the disruption of these properties during muscle pathogenesis.	[Berger, Dara S.; Kliment, Gregory M.; Ladd, Andrea N.] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Moyer, Michelle; van Lunteren, Erik] Cleveland Vet Affairs Med Ctr, Cleveland, OH USA; [van Lunteren, Erik] Case Western Reserve Univ, Dept Med, Div Pulm & Crit Care, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Berger, DS (corresponding author), Montefiore Med Ctr, Inst Reprod Med & Hlth, Hartsdale, NY USA.	ladda@ccf.org		Ladd, Andrea/0000-0003-4725-5644	Muscular Dystrophy Association [MDA3812, MDA87845]; Department of Veterans Affairs Medical Research Service; National Institutes of Health [T32HL007914]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007914] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); Department of Veterans Affairs Medical Research Service(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to A.N.L. from the Muscular Dystrophy Association (Development Grant MDA3812 and Research Grant MDA87845) and to E. v. L. from the Department of Veterans Affairs Medical Research Service. D. S. B. was supported by a National Institutes of Health training grant (T32HL007914). The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Brimacombe KR, 2007, DEV DYNAM, V236, P2216, DOI 10.1002/dvdy.21209; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; CHENG TC, 1992, J CELL BIOL, V119, P1649, DOI 10.1083/jcb.119.6.1649; CHENG TC, 1995, P NATL ACAD SCI USA, V92, P561, DOI 10.1073/pnas.92.2.561; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Gautier-Courteille C, 2004, DEVELOPMENT, V131, P6107, DOI 10.1242/dev.01528; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Kalsotra A, 2010, GENES DEV; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Koshelev M, 2010, HUM MOL GENET, V19, P1066, DOI 10.1093/hmg/ddp570; Kress C, 2007, MOL CELL BIOL, V27, P1146, DOI 10.1128/MCB.01009-06; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Kuyumcu-Martinez NM, 2006, PROG MOLEC, V44, P133; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Ladd AN, 2005, MOL CELL BIOL, V25, P6267, DOI 10.1128/MCB.25.14.6267-6278.2005; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Milne CA, 1999, CURR BIOL, V9, P1243, DOI 10.1016/S0960-9822(99)80504-1; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Paillard L, 2003, BIOL CELL, V95, P107, DOI 10.1016/S0248-4900(03)00010-8; Paillard L, 1998, EMBO J, V17, P278, DOI 10.1093/emboj/17.1.278; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Passerieux E, 2007, J STRUCT BIOL, V159, P19, DOI 10.1016/j.jsb.2007.01.022; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Terenzi F, 2009, J MOL CELL CARDIOL, V46, P395, DOI 10.1016/j.yjmcc.2008.10.030; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; TOHGI H, 1994, MUSCLE NERVE, V17, P1037, DOI 10.1002/mus.880170911; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, J CLIN INVEST, V117, P2802, DOI 10.1172/JCI32308	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19274	10.1371/journal.pone.0019274	http://dx.doi.org/10.1371/journal.pone.0019274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541285	gold, Green Published			2022-12-25	WOS:000290018400038
J	Hamame, CM; Cosmelli, D; Henriquez, R; Aboitiz, F				Hamame, Carlos M.; Cosmelli, Diego; Henriquez, Rodrigo; Aboitiz, Francisco			Neural Mechanisms of Human Perceptual Learning: Electrophysiological Evidence for a Two-Stage Process	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; VISUAL-SEARCH; FOCUSED ATTENTION; GAMMA ACTIVITY; EEG; OSCILLATIONS; TASK; SYNCHRONIZATION; SPECIFICITY; COMPONENT	Background: Humans and other animals change the way they perceive the world due to experience. This process has been labeled as perceptual learning, and implies that adult nervous systems can adaptively modify the way in which they process sensory stimulation. However, the mechanisms by which the brain modifies this capacity have not been sufficiently analyzed. Methodology/Principal Findings: We studied the neural mechanisms of human perceptual learning by combining electroencephalographic (EEG) recordings of brain activity and the assessment of psychophysical performance during training in a visual search task. All participants improved their perceptual performance as reflected by an increase in sensitivity (d') and a decrease in reaction time. The EEG signal was acquired throughout the entire experiment revealing amplitude increments, specific and unspecific to the trained stimulus, in event-related potential (ERP) components N2pc and P3 respectively. P3 unspecific modification can be related to context or task-based learning, while N2pc may be reflecting a more specific attentional-related boosting of target detection. Moreover, bell and U-shaped profiles of oscillatory brain activity in gamma (30-60 Hz) and alpha (8-14 Hz) frequency bands may suggest the existence of two phases for learning acquisition, which can be understood as distinctive optimization mechanisms in stimulus processing. Conclusions/Significance: We conclude that there are reorganizations in several neural processes that contribute differently to perceptual learning in a visual search task. We propose an integrative model of neural activity reorganization, whereby perceptual learning takes place as a two-stage phenomenon including perceptual, attentional and contextual processes.	[Hamame, Carlos M.; Cosmelli, Diego; Henriquez, Rodrigo; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Lab Neurociencia Cognitiva, Dept Psiquiatria, Escuela Med, Santiago, Chile; [Cosmelli, Diego] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile; [Hamame, Carlos M.; Cosmelli, Diego; Henriquez, Rodrigo; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Santiago, Chile; [Hamame, Carlos M.] Univ Chile, Inst Ciencias Biomed, Santiago, Chile; [Hamame, Carlos M.] Claude Bernard UL1, Lyon Neurosci Ctr, INSERM U1028, CNRS UMR5292, Lyon, France	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Hamame, CM (corresponding author), Pontificia Univ Catolica Chile, Lab Neurociencia Cognitiva, Dept Psiquiatria, Escuela Med, Alameda 340, Santiago, Chile.	carlos.hamame@inserm.fr	Henríquez, Rodrigo A./AAM-9515-2021	Henríquez, Rodrigo A./0000-0002-4970-8013	CONICYT; ECOS-Sud/CONICYT [C08S02]; FONDECYT [1090612]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); ECOS-Sud/CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was supported by CONICYT doctoral grant to C. M. H. and by an ECOS-Sud/CONICYT grant C08S02 and FONDECYT 1090612 grant to D. C. and F. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Baeck A, 2010, J VISION, V10, DOI 10.1167/10.2.17; Campana G, 2003, PERCEPT PSYCHOPHYS, V65, P1197, DOI 10.3758/BF03194845; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cosmelli D, 2011, PSYCHOPHYSIOLOGY, V48, P312, DOI 10.1111/j.1469-8986.2010.01066.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Ellison A, 1998, VISION RES, V38, P333, DOI 10.1016/S0042-6989(97)00195-8; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Freeman WJ, 1975, MASS ACTION NERVOUS; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Golcu D, 2009, J NEUROSCI, V29, P13621, DOI 10.1523/JNEUROSCI.2612-09.2009; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gruber T, 2002, J COGNITIVE NEUROSCI, V14, P732, DOI 10.1162/08989290260138636; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Koch SP, 2009, J NEUROSCI, V29, P13962, DOI 10.1523/JNEUROSCI.1402-09.2009; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Leonards U, 2002, VISION RES, V42, P2193, DOI 10.1016/S0042-6989(02)00134-7; Lobley K, 1998, PERCEPTION, V27, P1245, DOI 10.1068/p271245; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Poirier CC, 2006, NEUROBIOL LEARN MEM, V85, P36, DOI 10.1016/j.nlm.2005.08.006; Pourtois G, 2008, VISION RES, V48, P55, DOI 10.1016/j.visres.2007.10.027; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; SIRETEANU R, 1995, VISION RES, V35, P2037, DOI 10.1016/0042-6989(94)00295-W; Sireteanu R, 2000, VISION RES, V40, P2902; Skrandies W, 2001, INT J PSYCHOPHYSIOL, V41, P119, DOI 10.1016/S0167-8760(00)00177-X; Song Y, 2005, CLIN NEUROPHYSIOL, V116, P632, DOI 10.1016/j.clinph.2004.09.019; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidal JR, 2006, J COGNITIVE NEUROSCI, V18, P1850, DOI 10.1162/jocn.2006.18.11.1850; Walsh V, 1998, NEUROPSYCHOLOGIA, V36, P363, DOI 10.1016/S0028-3932(97)00113-9; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001; Worden MS, 2000, J NEUROSCI, V20; Yotsumoto Y, 2008, NEURON, V57, P827, DOI 10.1016/j.neuron.2008.02.034; Yotsumoto Y, 2008, PLOS BIOL, V6, P1623, DOI 10.1371/journal.pbio.0060221; Yund EW, 1996, BRAIN COGNITION, V31, P369, DOI 10.1006/brcg.1996.0051; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	61	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19221	10.1371/journal.pone.0019221	http://dx.doi.org/10.1371/journal.pone.0019221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541280	Green Published, gold, Green Submitted			2022-12-25	WOS:000290018400035
J	Kim, S; Goel, S; Alexander, CM				Kim, Soyoung; Goel, Shruti; Alexander, Caroline M.			Differentiation Generates Paracrine Cell Pairs That Maintain Basaloid Mouse Mammary Tumors: Proof of Concept	PLOS ONE			English	Article							CANCER STEM-CELLS; BREAST-CANCER; TRANSGENIC MICE; SELF-RENEWAL; TUMORIGENESIS; SUBTYPES; GLAND; PROGENITORS; EXPRESSION; EXPANSION	There is a paradox offered up by the cancer stem cell hypothesis. How are the mixed populations that are characteristic of heterogeneous solid tumors maintained at constant proportion, given their high, and different, mitotic indices? In this study, we evaluate a well-characterized mouse model of human basaloid tumors (induced by the oncogene Wnt1), which comprise mixed populations of mammary epithelial cells resembling their normal basal and luminal counterparts. We show that these cell types are substantially inter-dependent, since the MMTV LTR drives expression of Wnt1 ligand in luminal cells, whereas the functional Wnt1-responsive receptor (Lrp5) is expressed by basal cells, and both molecules are necessary for tumor growth. There is a robust tumor initiating activity (tumor stem cell) in the basal cell population, which is associated with the ability to differentiate into luminal and basal cells, to regenerate the oncogenic paracrine signaling cell pair. However, we found an additional tumor stem cell activity in the luminal cell population. Knowing that tumors depend upon Wnt1-Lrp5, we hypothesized that this stem cell must express Lrp5, and found that indeed, all the stem cell activity could be retrieved from the Lrp5-positive cell population. Interestingly, this reflects post-transcriptional acquisition of Lrp5 protein expression in luminal cells. Furthermore, this plasticity of molecular expression is reflected in plasticity of cell fate determination. Thus, in vitro, Wnt1-expressing luminal cells retro-differentiate to basal cell types, and in vivo, tumors initiated with pure luminal cells reconstitute a robust basal cell subpopulation that is indistinguishable from the populations initiated by pure basal cells. We propose this is an important proof of concept, demonstrating that bipotential tumor stem cells are essential in tumors where oncogenic ligand-receptor pairs are separated into different cell types, and suggesting that Wnt-induced molecular and fate plasticity can close paracrine loops that are usually separated into distinct cell types.	[Kim, Soyoung; Goel, Shruti; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kim, S (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu			Department of Defense [W81XWH-06-1-0491]	Department of Defense(United States Department of Defense)	This work was supported by the Department of Defense Breast Cancer Research Program, Era of Hope Scholars Award to CMA (W81XWH-06-1-0491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2008, SEMIN REPROD MED, V26, P522, DOI 10.1055/s-0028-1096132; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Badve S, 2010, MOD PATHOL; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Fillmore CM, 2010, P NATL ACAD SCI US; GEYER FC, 2011, MOD PATHOL; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	40	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19310	10.1371/journal.pone.0019310	http://dx.doi.org/10.1371/journal.pone.0019310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541292	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400048
J	Marques, FZ; Campain, AE; Davern, PJ; Yang, YHJ; Head, GA; Morris, BJ				Marques, Francine Z.; Campain, Anna E.; Davern, Pamela J.; Yang, Yee Hwa J.; Head, Geoffrey A.; Morris, Brian J.			Genes Influencing Circadian Differences in Blood Pressure in Hypertensive Mice	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; PARAVENTRICULAR NUCLEUS; RECEPTOR; EXPRESSION; OXYTOCIN; OLIGONUCLEOTIDE; VASOPRESSIN; MODULATION; NEURONS; OREXINS	Essential hypertension is a common multifactorial heritable condition in which increased sympathetic outflow from the central nervous system is involved in the elevation in blood pressure (BP), as well as the exaggerated morning surge in BP that is a risk factor for myocardial infarction and stroke in hypertensive patients. The Schlager BPH/2J mouse is a genetic model of hypertension in which increased sympathetic outflow from the hypothalamus has an important etiological role in the elevation of BP. Schlager hypertensive mice exhibit a large variation in BP between the active and inactive periods of the day, and also show a morning surge in BP. To investigate the genes responsible for the circadian variation in BP in hypertension, hypothalamic tissue was collected from BPH/2J and normotensive BPN/3J mice at the 'peak' (n = 12) and 'trough' (n = 6) of diurnal BP. Using Affymetrix GeneChip (R) Mouse Gene 1.0 ST Arrays, validation by quantitative real-time PCR and a statistical method that adjusted for clock genes, we identified 212 hypothalamic genes whose expression differed between 'peak' and 'trough' BP in the hypertensive strain. These included genes with known roles in BP regulation, such as vasopressin, oxytocin and thyrotropin releasing hormone, as well as genes not recognized previously as regulators of BP, including chemokine (C-C motif) ligand 19, hypocretin and zinc finger and BTB domain containing 16. Gene ontology analysis showed an enrichment of terms for inflammatory response, mitochondrial proton-transporting ATP synthase complex, structural constituent of ribosome, amongst others. In conclusion, we have identified genes whose expression differs between the peak and trough of 24-hour circadian BP in BPH/2J mice, pointing to mechanisms responsible for diurnal variation in BP. The findings may assist in the elucidation of the mechanism for the morning surge in BP in essential hypertension.	[Marques, Francine Z.; Morris, Brian J.] Univ Sydney, Basic & Clin Genom Lab, Sch Med Sci, Sydney, NSW 2006, Australia; [Marques, Francine Z.; Morris, Brian J.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Campain, Anna E.; Yang, Yee Hwa J.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Davern, Pamela J.; Head, Geoffrey A.] Baker IDI Heart Res Inst, Neuropharmacol Lab, Melbourne, Australia	University of Sydney; University of Sydney; University of Sydney; Baker Heart and Diabetes Institute	Marques, FZ (corresponding author), Univ Sydney, Basic & Clin Genom Lab, Sch Med Sci, Sydney, NSW 2006, Australia.	brian.morris@sydney.edu.au	Campain, Anna/E-2217-2014; Head, Geoffrey A./B-2177-2010; Yang, Jean YH/D-2920-2015; Marques, Francine/AAA-5767-2020; Marques, Francine/AAH-1562-2021	Head, Geoffrey A./0000-0002-7623-137X; Yang, Jean YH/0000-0002-5271-2603; Marques, Francine/0000-0003-4920-9991; Campain, Anna/0000-0003-1057-0085	National Health and Medical Research Council of Australia [526662]; Australian Research Council [DP0770395]; Endeavour International Postgraduate Research Scholarship; Australian Postgraduate Award; Clive and Vera Ramaciotti Foundation; Prostate Cancer Foundation of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Endeavour International Postgraduate Research Scholarship(Australian Government); Australian Postgraduate Award(Australian Government); Clive and Vera Ramaciotti Foundation; Prostate Cancer Foundation of Australia	This work was supported by National Health and Medical Research Council of Australia grant 526662 (to GAH, PJD, BJM), in part by Australian Research Council grant DP0770395 (to YHJY), an Endeavour International Postgraduate Research Scholarship (to FZM) and an Australian Postgraduate Award (to AEC). The Clive and Vera Ramaciotti Foundation and Prostate Cancer Foundation of Australia co-funded the LightCycler480 qPCR machine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; BANSINATH M, 1987, PEPTIDES, V8, P227, DOI 10.1016/0196-9781(87)90094-5; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Cuadra AE, 2010, PHARMACOL THERAPEUT, V125, P27, DOI 10.1016/j.pharmthera.2009.07.007; Davern PJ, 2010, NEUROSCIENCE, V170, P551, DOI 10.1016/j.neuroscience.2010.07.040; Davern PJ, 2010, AM J HYPERTENS, V23, P838, DOI 10.1038/ajh.2010.69; Davern PJ, 2009, HYPERTENSION, V54, P852, DOI 10.1161/HYPERTENSIONAHA.109.136069; Delles C, 2010, BBA-MOL BASIS DIS, V1802, P1299, DOI 10.1016/j.bbadis.2009.12.006; Garcia SI, 2005, REGUL PEPTIDES, V128, P239, DOI 10.1016/j.regpep.2005.01.002; Grassi G, 2010, HYPERTENS RES, V33, P381, DOI 10.1038/hr.2010.26; Grassi G, 2010, EXP PHYSIOL, V95, P581, DOI 10.1113/expphysiol.2009.047381; Hashimoto J, 2003, J HYPERTENS, V21, P805, DOI 10.1097/00004872-200304000-00025; Head GA, 2004, J HYPERTENS, V22, P2075, DOI 10.1097/00004872-200411000-00008; Head GA, 2006, AM J HYPERTENS, V19, P1010, DOI 10.1016/j.amjhyper.2006.03.014; Horiuchi J, 2004, AM J PHYSIOL-REG I, V287, pR824, DOI 10.1152/ajpregu.00221.2004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; Kayaba Y, 2003, AM J PHYSIOL-REG I, V285, pR581, DOI 10.1152/ajpregu.00671.2002; Kc P, 2010, RESP PHYSIOL NEUROBI, V174, P55, DOI 10.1016/j.resp.2010.08.001; Lalor SJ, 2010, J NEUROIMMUNOL, V224, P56, DOI 10.1016/j.jneuroim.2010.05.017; Landa MS, 2007, AM J PHYSIOL-ENDOC M, V292, pE1388, DOI 10.1152/ajpendo.00234.2006; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Mack SO, 2002, J APPL PHYSIOL, V92, P826, DOI 10.1152/japplphysiol.00839.2001; Marfella R, 2005, AM J HYPERTENS, V18, P308, DOI 10.1016/j.amjhyper.2004.09.013; Marques F, 2011, HYPERTENSION UNPUB, V112, P57; Marques FZ, 2010, HYPERTENSION, V56, P319, DOI 10.1161/HYPERTENSIONAHA.110.155366; Michelini LC, 2003, AM J PHYSIOL-HEART C, V284, pH2269, DOI 10.1152/ajpheart.00774.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schefe JH, 2008, J HYPERTENS, V26, P1787, DOI 10.1097/HJH.0b013e3283060f2e; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; Schlager G, 1997, LAB ANIM SCI, V47, P288; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Shirasaka T, 2002, REGUL PEPTIDES, V104, P91, DOI 10.1016/S0167-0115(01)00352-4; Silverthorn DU, 2009, HUMAN PHYSL INTEGRAT, V5th; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sober S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006034; Takahashi K, 2010, J NEUROENDOCRINOL, V22, P453, DOI 10.1111/j.1365-2826.2010.01980.x; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zhang K, 1997, AM J PHYSIOL-REG I, V273, pR864, DOI 10.1152/ajpregu.1997.273.3.R864; ZINGG HH, 1986, J BIOL CHEM, V261, P2956	45	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19203	10.1371/journal.pone.0019203	http://dx.doi.org/10.1371/journal.pone.0019203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541337	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400032
J	Randazzo, J; Zhang, P; Makita, J; Blessing, K; Kador, PF				Randazzo, James; Zhang, Peng; Makita, Jun; Blessing, Karen; Kador, Peter F.			Orally Active Multi-Functional Antioxidants Delay Cataract Formation in Streptozotocin (Type 1) Diabetic and Gamma-Irradiated Rats	PLOS ONE			English	Article							CHAIN-BREAKING ANTIOXIDANTS; ALDOSE REDUCTASE INHIBITOR; AGE-RELATED CATARACT; OXIDATIVE STRESS; LIPID-PEROXIDATION; VITAMIN-E; BUTYLATED HYDROXYTOLUENE; RADIATION CATARACTS; OSMOTIC CHANGES; LENS	Background: Age-related cataract is a worldwide health care problem whose progression has been linked to oxidative stress and the accumulation of redox-active metals. Since there is no specific animal model for human age-related cataract, multiple animal models must be used to evaluate potential therapies that may delay and/or prevent cataract formation. Methods/Principal Findings: Proof of concept studies were conducted to evaluate 4-(5-hydroxypyrimidin-2-yl)-N, N-dimethyl- 3,5-dioxopiperazine-1-sulfonamide (compound 4) and 4-(5-hydroxy-4,6-dimethoxypyrimidin-2-yl)-N, N-dimethyl-3,5- dioxopiperazine-1-sulfonamide (compound 8), multi-functional antioxidants that can independently chelate redox metals and quench free radicals, on their ability to delay the progression of diabetic "sugar'' cataracts and gamma radiation-induced cataracts. Prior to 15 Gy of whole head irradiation, select groups of Long Evans rats received either diet containing compound 4 or 8, or a single i.p. injection of panthethine, a radioprotective agent. Compared to untreated, irradiated rats, treatment with pantethine, 4 and 8 delayed initial lens changes by 4, 47, and 38 days, respectively, and the average formation of posterior subcapsular opacities by 23, 53 and 58 days, respectively. In the second study, select groups of diabetic Sprague Dawley rats were administered chow containing compounds 4, 8 or the aldose reductase inhibitor AL1576. As anticipated, treatment with AL1576 prevented cataract by inhibiting sorbitol formation in the lens. However, compared to untreated rats, compounds 4 and 8 delayed vacuole formation by 20 days and 12 days, respectively, and cortical cataract formation by 8 and 3 days, respectively, without reducing lenticular sorbitol. Using in vitro lens culture in 30 mM xylose to model diabetic "sugar'' cataract formation, western blots confirmed that multi-functional antioxidants reduced endoplasmic reticulum stress. Conclusions/Significance: Multi-functional antioxidants delayed cataract formation in two diverse rat models. These studies provide a proof of concept that a general cataract treatment focused on reducing oxidative stress instead of a specific mechanism of cataractogenesis can be developed.	[Randazzo, James; Zhang, Peng; Makita, Jun; Blessing, Karen; Kador, Peter F.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE USA; [Kador, Peter F.] Univ Nebraska Med Ctr, Dept Ophthalmol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Randazzo, J (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE USA.	pkador@unmc.edu			National Institutes of Health [EY016730]; NATIONAL EYE INSTITUTE [R01EY016730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY016730. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI NH, 1994, RES COMMUN CHEM PATH, V84, P93; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer GJ, 2007, EXP BIOL MED, V232, P323; Brian G, 2001, B WORLD HEALTH ORGAN, V79, P249; BUCHER JR, 1983, BIOCHEM BIOPH RES CO, V111, P777, DOI 10.1016/0006-291X(83)91366-9; Chan AWH, 2008, EXP EYE RES, V87, P454, DOI 10.1016/j.exer.2008.08.001; Chiu CJ, 2007, EXP EYE RES, V84, P229, DOI 10.1016/j.exer.2006.05.015; CHYLACK LT, 1984, OPHTHALMOLOGY, V91, P596; Clark JI, 1996, EXP EYE RES, V62, P75, DOI 10.1006/exer.1996.0009; Congdon NG, 2001, BRIT J OPHTHALMOL, V85, P516, DOI 10.1136/bjo.85.5.516; CREIGHTON MO, 1979, EXP EYE RES, V29, P689, DOI 10.1016/0014-4835(79)90025-3; FRANCOIS J, 1955, Bull Soc Belge Ophtalmol, V110, P150; HANNA C, 1963, ARCH INT PHARMACOD T, V142, P198; Hegde KR, 2005, FREE RADICAL RES, V39, P513, DOI 10.1080/10715760400013755; Jin HX, 2010, J MED CHEM, V53, P1117, DOI 10.1021/jm901381j; Kador PF, 2007, J OCUL PHARMACOL TH, V23, P116, DOI 10.1089/jop.2006.0112; Kador PF, 2010, POSTGRAD MED, V122, P138, DOI 10.3810/pgm.2010.05.2151; Kador PF, 2004, J OCUL PHARMACOL TH, V20, P333, DOI 10.1089/1080768041725281; Kador PF, 2000, J OCUL PHARMACOL TH, V16, P149, DOI 10.1089/jop.2000.16.149; Kador PF, 1998, EXP EYE RES, V67, P203, DOI 10.1006/exer.1998.0502; Kador PF, 1994, BIOCH LENS INTERMEDI, P146; Kador PF, 2007, OCULAR PATHOLOGY DIA, P1; Kakehi T, 2008, SEMIN IMMUNOPATHOL, V30, P301, DOI 10.1007/s00281-008-0122-7; Karslioglu I, 2004, EUR J OPHTHALMOL, V14, P478, DOI 10.1177/112067210401400606; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; KINOSHITA JH, 1962, NATURE, V194, P1085, DOI 10.1038/1941085a0; KINOSHITA JH, 1962, EXP EYE RES, V1, P405, DOI 10.1016/S0014-4835(62)80030-X; KINOSHITA JH, 1981, JAMA-J AM MED ASSOC, V246, P257, DOI 10.1001/jama.246.3.257; KOBAYASHI S, 1992, CURR EYE RES, V11, P1099, DOI 10.3109/02713689209015081; KORBASHI P, 1986, J BIOL CHEM, V261, P2472; Kubo E, 1999, EXP EYE RES, V68, P457, DOI 10.1006/exer.1998.0624; LINKLATER HA, 1986, EXP EYE RES, V43, P305, DOI 10.1016/S0014-4835(86)80068-9; LIVESEY JC, 1995, RADIAT RES, V141, P99, DOI 10.2307/3579097; Lofgren S, 2010, ACTA OPHTHALMOL; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Marsili S, 2004, EXP EYE RES, V79, P595, DOI 10.1016/j.exer.2004.06.008; MEDVEDOVSKY C, 1991, RADIAT RES, V128, pS103, DOI 10.2307/3578010; MENARD TW, 1986, INT J RADIAT ONCOL, V12, P1483, DOI 10.1016/0360-3016(86)90199-9; MERRIAM GR, 1957, AMER J ROENTGENOL RA, V77, P759; Mulhern ML, 2006, INVEST OPHTH VIS SCI, V47, P3951, DOI 10.1167/iovs.06-0193; Nam TG, 2009, ORG BIOMOL CHEM, V7, P5103, DOI 10.1039/b912528k; Obara Yoshitaka, 1995, Nippon Ganka Gakkai Zasshi, V99, P1303; Pratt DA, 2001, J AM CHEM SOC, V123, P4625, DOI 10.1021/ja005679l; REIF DW, 1988, ARCH BIOCHEM BIOPHYS, V264, P238, DOI 10.1016/0003-9861(88)90590-5; Richards R D, 1966, Trans Am Ophthalmol Soc, V64, P700; ROSS WM, 1983, EXP EYE RES, V36, P645, DOI 10.1016/0014-4835(83)90102-1; Rowe S, 2004, JAMA-J AM MED ASSOC, V291, P1487, DOI 10.1001/jama.291.12.1487; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; SHIONO T, 1985, EXP EYE RES, V40, P421, DOI 10.1016/0014-4835(85)90154-X; Shrank W, 2005, ARCH OPHTHALMOL-CHIC, V123, P1733, DOI 10.1001/archopht.123.12.1733; SOMOGYI M, 1945, J BIOL CHEM, V160, P69; SRIVASTAVA SK, 1988, DIABETES, V37, P1505, DOI 10.2337/diabetes.37.11.1505; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Valgimigli L, 2003, CHEM-EUR J, V9, P4997, DOI 10.1002/chem.200304960; VONSALLMANN L, 1951, AMA ARCH OPHTHALMOL, V45, P149, DOI 10.1001/archopht.1951.01700010154003; Watkins Rodney, 2002, Clin Exp Optom, V85, P59; Wijtmans M, 2003, ANGEW CHEM INT EDIT, V42, P4370, DOI 10.1002/anie.200351881; Worgul B V, 1989, Lens Eye Toxic Res, V6, P559; ZAIDI SAA, 1993, SYN REACT INORG MET, V23, P1571, DOI 10.1080/15533179308016707	60	29	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18980	10.1371/journal.pone.0018980	http://dx.doi.org/10.1371/journal.pone.0018980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541328	Green Published, gold			2022-12-25	WOS:000290018400020
J	Uchtenhagen, H; Friemann, R; Raszewski, G; Spetz, AL; Nilsson, L; Achour, A				Uchtenhagen, Hannes; Friemann, Rosmarie; Raszewski, Grzegorz; Spetz, Anna-Lena; Nilsson, Lennart; Achour, Adnane			Crystal Structure of the HIV-2 Neutralizing Fab Fragment 7C8 with High Specificity to the V3 Region of gp125	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; ENVELOPE GLYCOPROTEIN; CANONICAL STRUCTURES; GENETIC-VARIABILITY; MONOCLONAL-ANTIBODY; BINDING MODE; PROTEIN; ANTIGEN; LOOP; CONFORMATIONS	7C8 is a mouse monoclonal antibody specific for the third hypervariable region (V3) of the human immunodeficiency virus type 2 (HIV-2)-associated protein gp125. The three-dimensional crystal structure of the Fab fragment of 7C8, determined to 2.7 angstrom resolution, reveals a deep and narrow antigen-binding cleft with architecture appropriate for an elongated epitope. The highly hydrophobic cleft is bordered on one side by the negatively charged second complementarity determining region (CDR2) and the unusually long positively charged CDR3 of the heavy chain and, on the other side, by the CDR1 of the light chain. Analysis of 7C8 in complex with molecular models of monomeric and trimeric gp125 highlights the importance of a conserved stretch of residues FHSQ that is localized centrally on the V3 region of gp125. Furthermore, modeling also indicates that the Fab fragment neutralizes the virus by sterically impairing subsequent engagement of the gp125 trimer with the co-receptor on the target cell.	[Uchtenhagen, Hannes; Spetz, Anna-Lena; Achour, Adnane] Karolinska Univ, Huddinge Hosp, Huddinge Karolinska Inst, CIM,Dept Med F59, Stockholm, Sweden; [Friemann, Rosmarie] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden; [Raszewski, Grzegorz; Nilsson, Lennart] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet	Uchtenhagen, H (corresponding author), Karolinska Univ, Huddinge Hosp, Huddinge Karolinska Inst, CIM,Dept Med F59, Stockholm, Sweden.	adnane.achour@ki.se	Raszewski, Grzegorz/AAF-3418-2019; Spetz, Anna-Lena/C-3543-2016; Nilsson, Lennart/B-7208-2009; Friemann, Rosmarie/C-1018-2008	Spetz, Anna-Lena/0000-0003-3964-9512; Nilsson, Lennart/0000-0002-5067-6397; Friemann, Rosmarie/0000-0002-5633-2894; Achour, Adnane/0000-0003-0432-710X	European Vaccines and Microbicides Enterprise [EC-FP6 037611]; Swedish Research Council; Swedish National Board of Health and Welfare	European Vaccines and Microbicides Enterprise; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Board of Health and Welfare	This study was financially supported by grants from the European Vaccines and Microbicides Enterprise EC-FP6 037611 (EUROPRISE), the Swedish Research Council and the Swedish National Board of Health and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; AREVALO JH, 1993, J MOL BIOL, V231, P103, DOI 10.1006/jmbi.1993.1260; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BJORLING E, 1994, J IMMUNOL, V152, P1952; BOERI E, 1992, J VIROL, V66, P4546, DOI 10.1128/JVI.66.7.4546-4550.1992; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Damond F, 2001, VIROLOGY, V280, P19, DOI 10.1006/viro.2000.0685; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GHIARA JB, 1994, SCIENCE, V264, P82, DOI 10.1126/science.7511253; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Johnson G, 1998, INT IMMUNOL, V10, P1801, DOI 10.1093/intimm/10.12.1801; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JNT CCP4 ESF EACBM N, V26; LEVITT M, 1983, J MOL BIOL, V168, P621, DOI 10.1016/S0022-2836(83)80306-4; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; MATSUSHITA S, 1995, J VIROL, V69, P3333, DOI 10.1128/JVI.69.6.3333-3340.1995; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKnight A, 1996, J VIROL, V70, P4598, DOI 10.1128/JVI.70.7.4598-4606.1996; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Morner A, 1999, VIRUS RES, V59, P49, DOI 10.1016/S0168-1702(98)00133-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parreira R, 2000, AIDS RES HUM RETROV, V16, P1307, DOI 10.1089/08892220050117069; Piscitelli CL, 2006, J BIOL CHEM, V281, P6813, DOI 10.1074/jbc.M510175200; Pons C, 2010, PROTEINS, V78, P95, DOI 10.1002/prot.22564; PUTNEY SD, 1986, SCIENCE, V234, P1392, DOI 10.1126/science.2431482; Reeves JD, 2002, J GEN VIROL, V83, P1253, DOI 10.1099/0022-1317-83-6-1253; RINI JM, 1993, P NATL ACAD SCI USA, V90, P6325, DOI 10.1073/pnas.90.13.6325; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Rosen O, 2005, BIOCHEMISTRY-US, V44, P7250, DOI 10.1021/bi047387t; Sheriff S, 1996, J MOL BIOL, V263, P385, DOI 10.1006/jmbi.1996.0582; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Sourial S, 2006, CURR HIV RES, V4, P229, DOI 10.2174/157016206776055066; Sourial S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-96; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stanfield RL, 2003, VIROLOGY, V315, P159, DOI 10.1016/S0042-6822(03)00525-7; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; Stanfield RL, 1999, STRUCTURE, V7, P131, DOI 10.1016/S0969-2126(99)80020-3; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Uchtenhagen H, 2009, ACTA CRYSTALLOGR F, V65, P705, DOI 10.1107/S1744309109020685; Valjakka J, 2002, J BIOL CHEM, V277, P4183, DOI 10.1074/jbc.M105579200; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; VARGASMADRAZO E, 1995, J MOL BIOL, V254, P497, DOI 10.1006/jmbi.1995.0633; WEBSTER DM, 1994, CURR OPIN STRUC BIOL, V4, P123, DOI 10.1016/S0959-440X(94)90070-1; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zemla A, 2005, NUCLEIC ACIDS RES, V33, pW111, DOI 10.1093/nar/gki457; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	76	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18767	10.1371/journal.pone.0018767	http://dx.doi.org/10.1371/journal.pone.0018767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541316	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400009
J	Zulato, E; Favaretto, F; Veronese, C; Campanaro, S; Marshall, JD; Romano, S; Cabrelle, A; Collin, GB; Zavan, B; Belloni, AS; Rampazzo, E; Naggert, JK; Abatangelo, G; Sicolo, N; Maffei, P; Milan, G; Vettor, R				Zulato, Elisabetta; Favaretto, Francesca; Veronese, Caterina; Campanaro, Stefano; Marshall, Jan D.; Romano, Sara; Cabrelle, Anna; Collin, Gayle B.; Zavan, Barbara; Belloni, Anna S.; Rampazzo, Enrica; Naggert, Juergen K.; Abatangelo, Giovanni; Sicolo, Nicola; Maffei, Pietro; Milan, Gabriella; Vettor, Roberto			ALMS1-Deficient Fibroblasts Over-Express Extra-Cellular Matrix Components, Display Cell Cycle Delay and Are Resistant to Apoptosis	PLOS ONE			English	Article							ALSTROM-SYNDROME; PULMONARY-FIBROSIS; ALMS1; DIFFERENTIATION; PATHOGENESIS; CENTROSOME; DISORDERS; DISEASES; OBESITY; GENE	Alstrom Syndrome (ALMS) is a rare genetic disorder (483 living cases), characterized by many clinical manifestations, including blindness, obesity, type 2 diabetes and cardiomyopathy. ALMS is caused by mutations in the ALMS1 gene, encoding for a large protein with implicated roles in ciliary function, cellular quiescence and intracellular transport. Patients with ALMS have extensive fibrosis in nearly all tissues resulting in a progressive organ failure which is often the ultimate cause of death. To focus on the role of ALMS1 mutations in the generation and maintenance of this pathological fibrosis, we performed gene expression analysis, ultrastructural characterization and functional assays in 4 dermal fibroblast cultures from ALMS patients. Using a genome-wide gene expression analysis we found alterations in genes belonging to specific categories (cell cycle, extracellular matrix (ECM) and fibrosis, cellular architecture/motility and apoptosis). ALMS fibroblasts display cytoskeleton abnormalities and migration impairment, up-regulate the expression and production of collagens and despite the increase in the cell cycle length are more resistant to apoptosis. Therefore ALMS1-deficient fibroblasts showed a constitutively activated myofibroblast phenotype even if they do not derive from a fibrotic lesion. Our results support a genetic basis for the fibrosis observed in ALMS and show that both an excessive ECM production and a failure to eliminate myofibroblasts are key mechanisms. Furthermore, our findings suggest new roles for ALMS1 in both intra-and extra-cellular events which are essential not only for the normal cellular function but also for cell-cell and ECM-cell interactions.	[Zulato, Elisabetta; Favaretto, Francesca; Veronese, Caterina; Romano, Sara; Sicolo, Nicola; Maffei, Pietro; Milan, Gabriella; Vettor, Roberto] Univ Padua, Dept Med & Surg Sci, Padua, Italy; [Campanaro, Stefano] Univ Padua, Dept Biol, CRIBI, Padua, Italy; [Marshall, Jan D.; Collin, Gayle B.; Naggert, Juergen K.] Jackson Lab, Bar Harbor, ME 04609 USA; [Cabrelle, Anna] Univ Padua, Dept Clin & Expt Med, Padua, Italy; [Zavan, Barbara; Abatangelo, Giovanni] Univ Padua, Dept Histol Microbiol & Biomed Technol, Padua, Italy; [Belloni, Anna S.] Univ Padua, Dept Human Anat & Physiol, Padua, Italy; [Rampazzo, Enrica] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy	University of Padua; University of Padua; Jackson Laboratory; University of Padua; University of Padua; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua	Zulato, E (corresponding author), Univ Padua, Dept Med & Surg Sci, Padua, Italy.	gabriella.milan@unipd.it	VETTOR, ROBERTO/K-7121-2016; Campanaro, Stefano/I-5657-2019; Maffei, Pietro/O-1878-2013; Zulato, Elisabetta/J-6527-2018; Milan, Gabriella/AAB-6234-2022	Zulato, Elisabetta/0000-0002-2624-5060; Milan, Gabriella/0000-0001-8987-5310; Vettor, Roberto/0000-0003-0625-6667; CAMPANARO, STEFANO/0000-0002-9431-1648; Maffei, Pietro/0000-0002-1717-263X	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN 2005060925_002]; U.S. National Institute of Health [NIH-HD036878]; Executive Agency for Health and Consumer [2010 12 05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036878] Funding Source: NIH RePORTER	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Executive Agency for Health and Consumer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN 2005060925_002 to R. V.] and the U.S. National Institute of Health [NIH-HD036878 to J.K.N.]. This work was also supported by the Executive Agency for Health and Consumer [an EU rare diseases registry for Wolfram syndrome, Alstrom syndrome and Bardet Bield syndrome (EURO-Rare diabetes); agreement number 2010 12 05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Campanaro S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-383; Collin GB, 2005, HUM MOL GENET, V14, P2323, DOI 10.1093/hmg/ddi235; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Desmouliere A, 1997, INT J BIOCHEM CELL B, V29, P19, DOI 10.1016/S1357-2725(96)00117-3; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Jelaska A, 2000, ARTHRITIS RHEUM-US, V43, P2230, DOI 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Laurent GJ, 2007, BIOCHEM SOC T, V35, P647, DOI 10.1042/BST0350647; Li GC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030008; Lu F, 2007, PLAST RECONSTR SURG, V119, P1714, DOI 10.1097/01.prs.0000258851.47193.06; Marshall JD, 2007, EUR J HUM GENET, V15, P1193, DOI 10.1038/sj.ejhg.5201933; Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Loo B, 1998, EXP CELL RES, V241, P309, DOI 10.1006/excr.1998.4035; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	29	51	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19081	10.1371/journal.pone.0019081	http://dx.doi.org/10.1371/journal.pone.0019081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541333	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400023
J	Takahashi, KH; Daborn, PJ; Hoffmann, AA; Takano-Shimizu, T				Takahashi, Kazuo H.; Daborn, Phillip J.; Hoffmann, Ary A.; Takano-Shimizu, Toshiyuki			Environmental Stress-Dependent Effects of Deletions Encompassing Hsp70Ba on Canalization and Quantitative Trait Asymmetry in Drosophila melanogaster	PLOS ONE			English	Article							SHOCK-PROTEIN HSP70; HEAT-SHOCK; DEVELOPMENTAL STABILITY; FLUCTUATING ASYMMETRY; GEOMETRIC MORPHOMETRICS; GENETIC CANALIZATION; MORPHOLOGICAL TRAITS; TRANSCRIPTION FACTOR; WING SHAPE; HSP90	Hsp70 genes may influence the expression of wing abnormalities in Drosophila melanogaster but their effects on variability in quantitative characters and developmental instability are unclear. In this study, we focused on one of the six Hsp70 genes, Hsp70Ba, and investigated its effects on within-and among-individual variability in orbital bristle number, sternopleural bristle number, wing size and wing shape under different environmental conditions. To do this, we studied a newly constructed deletion, Df(3R)ED5579, which encompasses Hsp70Ba and nine non-Hsp genes, in the heterozygous condition and another, Hsp70Ba(304), which deletes only Hsp70Ba, in the homozygous condition. We found no significant effect of both deletions on within-individual variation quantified by fluctuating asymmetry (FA) of morphological traits. On the other hand, the Hsp70Ba(304)/Hsp70Ba(304) genotype significantly increased among-individual variation quantified by coefficient of variation (CV) of bristle number and wing size in female, while the Df(3R)ED5579 heterozygote showed no significant effect. The expression level of Hsp70Ba in the deletion heterozygote was 6 to 20 times higher than in control homozygotes, suggesting that the overexpression of Hsp70Ba did not influence developmental stability or canalization significantly. These findings suggest that the absence of expression of Hsp70Ba increases CV of some morphological traits and that HSP70Ba may buffer against environmental perturbations on some quantitative traits.	[Takahashi, Kazuo H.; Takano-Shimizu, Toshiyuki] Natl Inst Genet, Dept Populat Genet, Mishima, Shizuoka 411, Japan; [Takahashi, Kazuo H.; Daborn, Phillip J.; Hoffmann, Ary A.] Univ Melbourne, Ctr Environm Stress & Adaptat Res, Melbourne, Vic, Australia; [Takahashi, Kazuo H.; Daborn, Phillip J.; Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Takano-Shimizu, Toshiyuki] Grad Univ Adv Studies SOKENDAI, Dept Genet, Shizuoka, Japan; [Takano-Shimizu, Toshiyuki] Grad Univ Adv Studies SOKENDAI, Dept Biosyst Sci, Kanagawa, Japan; [Takano-Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Melbourne; University of Melbourne; Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; University of Tokyo	Takahashi, KH (corresponding author), Natl Inst Genet, Dept Populat Genet, Mishima, Shizuoka 411, Japan.	kaz_tak@cc.okayama-u.ac.jp	Takahashi, Kazuo H/B-2425-2011; Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019	Hoffmann, Ary/0000-0001-9497-7645; Takahashi, Kazuo/0000-0002-1353-4971	Japan Society for the Promotion of Science for Young ScientistS; MEXT (The Ministry of Education, Sport, Culture, Science and Technology) of Japan; Australian Research Council	Japan Society for the Promotion of Science for Young ScientistS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT (The Ministry of Education, Sport, Culture, Science and Technology) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Australian Research Council(Australian Research Council)	This work was financially supported by Research Fellowships of the Japan Society for the Promotion of Science for Young ScientistS, by Special Coordination Funds for Promoting Sciences and Technology of MEXT (The Ministry of Education, Sport, Culture, Science and Technology) of Japan to KT, and by Grants-in-Aid for Scientific Research (C) from MEXT of Japan to TT-S. It was also supported by a Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bettencourt BR, 2002, EVOLUTION, V56, P1796, DOI 10.1111/j.0014-3820.2002.tb00193.x; Bogwitz MR, 2005, P NATL ACAD SCI USA, V102, P12807, DOI 10.1073/pnas.0503709102; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bubliy OA, 2001, HEREDITY, V86, P363, DOI 10.1046/j.1365-2540.2001.00837.x; Bubliy OA, 2000, HEREDITAS, V133, P59, DOI 10.1111/j.1601-5223.2000.00059.x; Bubliy OA, 2000, EVOLUTION, V54, P1444, DOI 10.1554/0014-3820(2000)054[1444:EOSANG]2.0.CO;2; Connolly MH, 2008, INT J DEV BIOL, V52, P71, DOI 10.1387/ijdb.062241mc; Dahlgaard J, 1998, FUNCT ECOL, V12, P786, DOI 10.1046/j.1365-2435.1998.00246.x; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Debat V, 2000, P ROY SOC B-BIOL SCI, V267, P423, DOI 10.1098/rspb.2000.1017; Debat V, 2003, EVOLUTION, V57, P2773, DOI 10.1111/j.0014-3820.2003.tb01519.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Debat V, 2006, EVOLUTION, V60, P2529, DOI 10.1554/06-045.1; DeMoed GH, 1997, GENET RES, V70, P35, DOI 10.1017/S0016672397002930; Dworkin I, 2005, EVOLUTION, V59, P1500; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Flury B, 1997, 1 COURSE MULTIVARIAT; FLURY BK, 1986, AM STAT, V40, P249, DOI 10.2307/2684560; FOWLER K, 1994, HEREDITY, V73, P373, DOI 10.1038/hdy.1994.184; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; Golic KG, 1996, GENETICS, V144, P1693; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Kawecki TJ, 2000, EVOLUTION, V54, P1, DOI 10.1111/j.0014-3820.2000.tb00001.x; Kellermann VM, 2007, BIOL J LINN SOC, V92, P457, DOI 10.1111/j.1095-8312.2007.00875.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Marchler G, 2001, EMBO J, V20, P499, DOI 10.1093/emboj/20.3.499; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Michalak P, 2001, P NATL ACAD SCI USA, V98, P13195, DOI 10.1073/pnas.231478298; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Milton CC, 2005, GENETICS, V171, P119, DOI 10.1534/genetics.104.038463; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pedersen KS, 2005, J EVOLUTION BIOL, V18, P756, DOI 10.1111/j.1420-9101.2005.00884.x; Pelabon C, 2004, J EVOLUTION BIOL, V17, P19, DOI 10.1046/j.1420-9101.2003.00663.x; Pelabon C, 2010, EVOLUTION, V64, P1912, DOI 10.1111/j.1558-5646.2010.00979.x; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rego C, 2006, EVOLUTION, V60, P746, DOI 10.1111/j.0014-3820.2006.tb01153.x; RICHTSMEIER JT, 1992, ANNU REV ANTHROPOL, V21, P283; Roberts SP, 1999, OECOLOGIA, V121, P323, DOI 10.1007/s004420050935; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1993, TRENDS ECOL EVOL, V8; Ruden DM, 2003, SEMIN CELL DEV BIOL, V14, P301, DOI 10.1016/j.semcdb.2003.09.024; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Samakovli D, 2007, J EXP BOT, V58, P3513, DOI 10.1093/jxb/erm191; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Smith DR, 1997, J EVOLUTION BIOL, V10, P551; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Sorensen JG, 1999, HEREDITAS, V131, P155, DOI 10.1111/j.1601-5223.1999.00155.x; Sorensen JG, 2001, J INSECT PHYSIOL, V47, P1301, DOI 10.1016/S0022-1910(01)00119-6; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; Takahashi KH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-284; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; Wicker-Thomas C, 1997, INSECT BIOCHEM MOLEC, V27, P963, DOI 10.1016/S0965-1748(97)00077-5; Williams KD, 2003, MOL ECOL, V12, P1165, DOI 10.1046/j.1365-294X.2003.01771.x; Woods RE, 1999, EVOLUTION, V53, P493, DOI [10.2307/2640785, 10.1111/j.1558-5646.1999.tb03784.x]; Yahara I, 1999, GENES CELLS, V4, P375, DOI 10.1046/j.1365-2443.1999.00271.x; Zhong M, 1998, MOL CELL, V2, P101, DOI 10.1016/S1097-2765(00)80118-5; Zhong M, 1996, METHOD ENZYMOL, V274, P113	69	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e17295	10.1371/journal.pone.0017295	http://dx.doi.org/10.1371/journal.pone.0017295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541022	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800004
J	Pillot, B; Duraffourd, C; Begeot, M; Joly, A; Luquet, S; Houberdon, I; Naville, D; Vigier, M; Gautier-Stein, A; Magnan, C; Mithieux, G				Pillot, Bruno; Duraffourd, Celine; Begeot, Martine; Joly, Aurelie; Luquet, Serge; Houberdon, Isabelle; Naville, Danielle; Vigier, Michele; Gautier-Stein, Amandine; Magnan, Christophe; Mithieux, Gilles			Role of Hypothalamic Melanocortin System in Adaptation of Food Intake to Food Protein Increase in Mice	PLOS ONE			English	Article							NPY/AGRP NEURONS; OBESITY; RECEPTOR; SATIETY; GLUCOSE; LEPTIN; BRAIN; CHOLECYSTOKININ; MECHANISMS; EXPRESSION	The hypothalamic melanocortin system-the melanocortin receptor of type 4 (MC4R) and its ligands: alpha-melanin-stimulating hormone (alpha-MSH, agonist, inducing hypophagia), and agouti-related protein (AgRP, antagonist, inducing hyperphagia)-is considered to play a central role in the control of food intake. We tested its implication in the mediation of the hunger-curbing effects of protein-enriched diets (PED) in mice. Whereas there was a 20% decrease in food intake in mice fed on the PED, compared to mice fed on an isocaloric starch-enriched diet, there was a paradoxical decrease in expression of the hypothalamic proopiomelanocortin gene, precursor of alpha-MSH, and increase in expression of the gene encoding AgRP. The hypophagia effect of PED took place in mice with invalidation of either MC4R or POMC, and was even strengthened in mice with ablation of the AgRP-expressing neurons. These data strongly suggest that the hypothalamic melanocortin system does not mediate the hunger-curbing effects induced by changes in the macronutrient composition of food. Rather, the role of this system might be to defend the body against the variations in food intake generated by the nutritional environment.	[Pillot, Bruno; Duraffourd, Celine; Begeot, Martine; Houberdon, Isabelle; Naville, Danielle; Vigier, Michele; Gautier-Stein, Amandine; Mithieux, Gilles] INSERM, U855, Lyon, France; [Pillot, Bruno; Duraffourd, Celine; Begeot, Martine; Houberdon, Isabelle; Naville, Danielle; Vigier, Michele; Gautier-Stein, Amandine; Mithieux, Gilles] Univ Lyon, Lyon, France; [Pillot, Bruno; Duraffourd, Celine; Begeot, Martine; Houberdon, Isabelle; Naville, Danielle; Vigier, Michele; Gautier-Stein, Amandine; Mithieux, Gilles] Univ Lyon 1, F-69622 Villeurbanne, France; [Joly, Aurelie; Luquet, Serge; Magnan, Christophe] Univ Paris Diderot, Unit Funct & Adapt Biol EAC4413, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Paris Cite	Pillot, B (corresponding author), INSERM, U855, Lyon, France.	gilles.mithieux@inserm.fr	Pillot, Bruno/D-5448-2015; Naville, Danielle/N-1200-2017; Luquet, serge/AAT-1809-2021; magnan, christophe/AAJ-7622-2021	Pillot, Bruno/0000-0002-1499-3299; Naville, Danielle/0000-0003-2615-6161; Luquet, serge/0000-0001-8668-6645; magnan, christophe/0000-0002-7044-2571; Gilles, Mithieux/0000-0003-3579-8529; Gautier-Stein, Amandine/0000-0002-6003-1891	CNRS; INSERM; Societe Francaise de Nutrition	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Societe Francaise de Nutrition	Work was supported by funding from CNRS and INSERM. Bruno Pillot has been supported by a grant from the "Societe Francaise de Nutrition". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Archer ZA, 2007, J NUTR, V137, P1483, DOI 10.1093/jn/137.6.1483; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; BARKELING B, 1990, INT J OBESITY, V14, P743; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Benoit SC, 2002, J NEUROSCI, V22, P9048; BOOTH DA, 1970, PHYSIOL BEHAV, V5, P1201, DOI 10.1016/0031-9384(70)90216-7; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Delaere F, 2010, DIABETES METAB, V36, pA9, DOI 10.1016/S1262-3636(10)70037-9; Elmquist J, 2006, AM J PSYCHIAT, V163, P1137, DOI 10.1176/appi.ajp.163.7.1137; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gannon MC, 2004, DIABETES, V53, P2375, DOI 10.2337/diabetes.53.9.2375; GANTZ I, 1993, J BIOL CHEM, V268, P15174; Gout J, 2008, OBESITY, V16, P1763, DOI 10.1038/oby.2008.303; Gout J, 2010, MOL CELL ENDOCRINOL, V319, P99, DOI 10.1016/j.mce.2010.01.021; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; IRANI BG, 2011, EUR J PHARM IN PRESS; Koda S, 2005, ENDOCRINOLOGY, V146, P2369, DOI 10.1210/en.2004-1266; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Mithieux G, 2005, CURR OPIN CLIN NUTR, V8, P445, DOI 10.1097/01.mco.0000172587.17385.aa; Mithieux G, 2002, DIABETES, V51, P139, DOI 10.2337/diabetes.51.1.139; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; Pillot B, 2009, ENDOCRINOLOGY, V150, P616, DOI 10.1210/en.2008-0601; ROLLS BJ, 1988, PHYSIOL BEHAV, V43, P145, DOI 10.1016/0031-9384(88)90230-2; Schwartz MW, 2002, NATURE, V418, P595, DOI 10.1038/418595a; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Wang HQ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1352, DOI 10.1152/ajpendo.00230.2001; Yang YS, 1997, FASEB J, V11, pA1136	37	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19107	10.1371/journal.pone.0019107	http://dx.doi.org/10.1371/journal.pone.0019107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544212	Green Published, gold			2022-12-25	WOS:000290015800044
J	Winheim, S; Hieb, AR; Silbermann, M; Surmann, EM; Wedig, T; Herrmann, H; Langowski, J; Mucke, N				Winheim, Stefan; Hieb, Aaron R.; Silbermann, Marleen; Surmann, Eva-Maria; Wedig, Tatjana; Herrmann, Harald; Langowski, Joerg; Muecke, Norbert			Deconstructing the Late Phase of Vimentin Assembly by Total Internal Reflection Fluorescence Microscopy (TIRFM)	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; IN-VITRO; INTERMEDIATE-FILAMENTS; TEMPERATURE; KINETICS; KERATIN; DESMIN; MODEL; UNITS; HEAD	Quantitative imaging of intermediate filaments (IF) during the advanced phase of the assembly process is technically difficult, since the structures are several mm long and therefore they exceed the field of view of many electron (EM) or atomic force microscopy (AFM) techniques. Thereby quantitative studies become extremely laborious and time-consuming. To overcome these difficulties, we prepared fluorescently labeled vimentin for visualization by total internal reflection fluorescence microscopy (TIRFM). In order to investigate if the labeling influences the assembly properties of the protein, we first determined the association state of unlabeled vimentin mixed with increasing amounts of labeled vimentin under low ionic conditions by analytical ultracentrifugation. We found that bona fide tetrameric complexes were formed even when half of the vimentin was labeled. Moreover, we demonstrate by quantitative atomic force microscopy and electron microscopy that the morphology and the assembly properties of filaments were not affected when the fraction of labeled vimentin was below 10%. Using fast frame rates we observed the rapid deposition of fluorescently labeled IFs on glass supports by TIRFM in real time. By tracing their contours, we have calculated the persistence length of long immobilized vimentin IFs to 1 mu m, a value that is identical to those determined for shorter unlabeled vimentin. These results indicate that the structural properties of the filaments were not affected significantly by the dye. Furthermore, in order to analyze the late elongation phase, we mixed long filaments containing either Alexa 488- or Alexa 647-labeled vimentin. The 'patchy' structure of the filaments obtained unambiguously showed the elongation of long IFs through direct end-to-end annealing of individual filaments.	[Winheim, Stefan; Hieb, Aaron R.; Silbermann, Marleen; Surmann, Eva-Maria; Langowski, Joerg; Muecke, Norbert] German Canc Res Ctr, Div Biophys Macromol, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Winheim, S (corresponding author), German Canc Res Ctr, Div Biophys Macromol, D-6900 Heidelberg, Germany.	norbert.muecke@dkfz-heidelberg.de	Langowski, Jörg/A-1843-2011	Langowski, Jörg/0000-0001-8600-0666; Mucke, Norbert/0000-0002-0683-4386	German research Foundation (DFG) [HE 1853/9-1, LA 500/17-1]	German research Foundation (DFG)(German Research Foundation (DFG))	German research Foundation (DFG) HE 1853/9-1 and LA 500/17-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bausch AR, 2006, NAT PHYS, V2, P231, DOI 10.1038/nphys260; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Georgakopoulou S, 2009, J MOL BIOL, V386, P544, DOI 10.1016/j.jmb.2008.12.053; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1996, J CELL SCI, V109, P569; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2004, METHOD CELL BIOL, V78, P3; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200; Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101; Koester Sarah, 2007, Biophysical Reviews and Letters, V2, P155, DOI 10.1142/S1793048007000374; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Mucke N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007756; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; PARRY DAD, 1995, PROTEINS, V22, P267, DOI 10.1002/prot.340220307; Portet S, 2009, LANGMUIR, V25, P8817, DOI 10.1021/la900509r; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069; Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206; Schmidt M, 1995, EUR J CELL BIOL, V68, P345; STROMER MH, 1987, BIOCHEM J, V246, P75, DOI 10.1042/bj2460075; Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004	32	55	55	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19202	10.1371/journal.pone.0019202	http://dx.doi.org/10.1371/journal.pone.0019202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544245	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800051
J	Belaunzaran, OM; Cordero, MI; Setola, V; Bianchi, S; Galli, C; Bouche, N; Mlynarik, V; Gruetter, R; Sandi, C; Bensadoun, JC; Molinari, M; Aebischer, P				Belaunzaran, Osiris Marroquin; Cordero, Maria Isabel; Setola, Veronica; Bianchi, Siro; Galli, Carmela; Bouche, Nicolas; Mlynarik, Vladimir; Gruetter, Rolf; Sandi, Carmen; Bensadoun, Jean-Charles; Molinari, Maurizio; Aebischer, Patrick			Chronic Delivery of Antibody Fragments Using Immunoisolated Cell Implants as a Passive Vaccination Tool	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; ADENOASSOCIATED VIRUS; BETA IMMUNOTHERAPY; TRANSGENIC MOUSE; MICE; DEPOSITION; MODEL; ANGIOPATHY; IMPAIRMENT	Background: Monoclonal antibodies and antibody fragments are powerful biotherapeutics for various debilitating diseases. However, high production costs, functional limitations such as inadequate pharmacokinetics and tissue accessibility are the current principal disadvantages for broadening their use in clinic. Methodology and Principal Findings: We report a novel method for the long-term delivery of antibody fragments. We designed an allogenous immunoisolated implant consisting of polymer encapsulated myoblasts engineered to chronically release scFv antibodies targeted against the N-terminus of the Ab peptide. Following a 6-month intracerebral therapy we observed a significant reduction of the production and aggregation of the Ab peptide in the APP23 transgenic mouse model of Alzheimer's disease. In addition, functional assessment showed prevention of behavioral deficits related to anxiety and memory traits. Conclusions and Significance: The chronic local release of antibodies using immunoisolated polymer cell implants represents an alternative passive vaccination strategy in Alzheimer's disease. This novel technique could potentially benefit other diseases presently treated by local and systemic antibody administration.	[Belaunzaran, Osiris Marroquin; Setola, Veronica; Bouche, Nicolas; Bensadoun, Jean-Charles; Aebischer, Patrick] Ecole Polytech Fed Lausanne, Brain Mind Inst, Neurodegenerat Studies Lab, Lausanne, Switzerland; [Cordero, Maria Isabel; Sandi, Carmen] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Behav Genet, Lausanne, Switzerland; [Bianchi, Siro; Galli, Carmela; Molinari, Maurizio] Inst Biomed Res, Bellinzona, Switzerland; [Mlynarik, Vladimir; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Belaunzaran, OM (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Neurodegenerat Studies Lab, Lausanne, Switzerland.	patrick.aebischer@epfl.ch	Molinari, Maurizio/N-2587-2019; Cordero, Maria Isabel/A-2532-2013; Cordero, Maria Isabel/AAF-2935-2019; Aebischer, Patrick/E-1387-2013; Mlynarik, Vladimir/D-8884-2011; Dunnett, Stephen B/A-5869-2010; Gruetter, Rolf/H-6260-2011	Molinari, Maurizio/0000-0002-7636-5829; Cordero, Maria Isabel/0000-0003-0692-8064; Cordero, Maria Isabel/0000-0003-0692-8064; Mlynarik, Vladimir/0000-0002-5789-8179; Dunnett, Stephen B/0000-0003-1826-1578; Gruetter, Rolf/0000-0003-1870-4025; Sandi, Carmen/0000-0001-7713-8321; Bianchi, Siro/0000-0002-5100-8905	Swiss National Science Foundation; Consejo Nacional de Ciencia y Tecnologia of Mexico; Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair; ONELIFE Advisors SA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Foundation for Research on Neurodegenerative Diseases; Fondazione San Salvatore; Swiss National Center of Competence in Research on Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); ONELIFE Advisors SA	This work was supported by the Swiss National Science Foundation, Consejo Nacional de Ciencia y Tecnologia of Mexico, the Foundation for Research on Neurodegenerative Diseases, the Fondazione San Salvatore, the Swiss National Center of Competence in Research on Neural Plasticity and Repair, the Swiss National Science Foundation, and ONELIFE Advisors SA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968; Calhoun ME, 1999, P NATL ACAD SCI USA, V96, P14088, DOI 10.1073/pnas.96.24.14088; Carty NC, 2008, MOL THER, V16, P1580, DOI 10.1038/mt.2008.148; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Deyev SM, 2008, BIOESSAYS, V30, P904, DOI 10.1002/bies.20805; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Foster JK, 2009, MOL PSYCHIATR, V14, P239, DOI 10.1038/mp.2008.115; Fukuchi K, 2006, NEUROBIOL DIS, V23, P502, DOI 10.1016/j.nbd.2006.04.012; Furrer E, 2009, J NEUROIMMUNOL, V215, P65, DOI 10.1016/j.jneuroim.2009.08.005; Geylis V, 2006, AUTOIMMUN REV, V5, P33, DOI 10.1016/j.autrev.2005.06.007; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Kishima H, 2004, NEUROBIOL DIS, V16, P428, DOI 10.1016/j.nbd.2004.03.012; Kubetzko S, 2006, J BIOL CHEM, V281, P35186, DOI 10.1074/jbc.M604127200; Le Cudennec C, 2008, GENES BRAIN BEHAV, V7, P83, DOI 10.1111/j.1601-183X.2007.00374.x; Lee KW, 2004, J NEUROSCI RES, V76, P572, DOI 10.1002/jnr.20127; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Lichtlen P, 2008, J NEUROCHEM, V104, P859, DOI 10.1111/j.1471-4159.2007.05064.x; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nieri P, 2009, CURR MED CHEM, V16, P753, DOI 10.2174/092986709787458380; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Paxinos G, 2001, MOUSE BRAIN STEREOTA, pxxv; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Relkin NR, 2008, NEUROBIOL AGING; Sajadi A, 2006, NEUROBIOL DIS, V22, P119, DOI 10.1016/j.nbd.2005.10.006; Schneider BL, 2003, MOL THER, V7, P506, DOI 10.1016/S1525-0016(03)00055-8; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; Wang YJ, 2009, NEUROBIOL AGING, V30, P364, DOI 10.1016/j.neurobiolaging.2007.06.013; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Wilcock DM, 2008, J ALZHEIMERS DIS, V15, P555; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001	37	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18268	10.1371/journal.pone.0018268	http://dx.doi.org/10.1371/journal.pone.0018268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533130	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400007
J	Li, YJ; Minear, MA; Rimmler, J; Zhao, B; Balajonda, E; Hauser, MA; Allingham, RR; Eghrari, AO; Riazuddin, SA; Katsanis, N; Gottsch, JD; Gregory, SG; Klintworth, GK; Afshari, NA				Li, Yi-Ju; Minear, Mollie A.; Rimmler, Jacqueline; Zhao, Bei; Balajonda, Elmer; Hauser, Michael A.; Allingham, R. Rand; Eghrari, Allen O.; Riazuddin, S. Amer; Katsanis, Nicholas; Gottsch, John D.; Gregory, Simon G.; Klintworth, Gordon K.; Afshari, Natalie A.			Replication of TCF4 through Association and Linkage Studies in Late-Onset Fuchs Endothelial Corneal Dystrophy	PLOS ONE			English	Article							MISSENSE MUTATIONS; COL8A2; GENE; INHERITANCE; LOCUS; EXPRESSION; CHROMATIN; TESTS; MAPS	Fuchs endothelial corneal dystrophy (FECD) is a common, late-onset disorder of the corneal endothelium. Although progress has been made in understanding the genetic basis of FECD by studying large families in which the phenotype is transmitted in an autosomal dominant fashion, a recently reported genome-wide association study identified common alleles at a locus on chromosome 18 near TCF4 which confer susceptibility to FECD. Here, we report the findings of our independent validation study for TCF4 using the largest FECD dataset to date (450 FECD cases and 340 normal controls). Logistic regression with sex as a covariate was performed for three genetic models: dominant (DOM), additive (ADD), and recessive (REC). We found significant association with rs613872, the target marker reported by Baratz et al.(2010), for all three genetic models (DOM: P = 9.33 x 10(-35); ADD: P = 7.48 x 10(-30); REC: P = 5.27 x 10(-6)). To strengthen the association study, we also conducted a genome-wide linkage scan on 64 multiplex families, composed primarily of affected sibling pairs (ASPs), using both parametric and non-parametric two-point and multipoint analyses. The most significant linkage region localizes to chromosome 18 from 69.94cM to 85.29cM, with a peak multipoint HLOD = 2.5 at rs1145315 (75.58cM) under the DOM model, mapping 1.5 Mb proximal to rs613872. In summary, our study presents evidence to support the role of the intronic TCF4 single nucleotide polymorphism rs613872 in late-onset FECD through both association and linkage studies.	[Li, Yi-Ju] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Li, Yi-Ju; Minear, Mollie A.; Rimmler, Jacqueline; Zhao, Bei; Hauser, Michael A.; Gregory, Simon G.] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Balajonda, Elmer; Allingham, R. Rand; Klintworth, Gordon K.; Afshari, Natalie A.] Duke Univ, Med Ctr, Ctr Eye, Durham, NC 27710 USA; [Eghrari, Allen O.; Riazuddin, S. Amer; Gottsch, John D.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Klintworth, Gordon K.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Duke University	Li, YJ (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA.	yiju.li@duke.edu	Eghrari, Allen/ABH-4964-2020; Eghrari, Allen/AAI-9282-2021; Katsanis, Nicholas/E-1837-2012	Eghrari, Allen/0000-0003-2798-038X; Gregory, Simon/0000-0002-7805-1743; Li, Yi-Ju/0000-0001-6996-4834; Katsanis, Nicholas/0000-0002-2480-0171	NEI R01 [EY016514, EY016835, EY015543, EY019126, EY013315]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY019126, R01EY015543, R01EY016514, R01EY013315, R01EY016835] Funding Source: NIH RePORTER	NEI R01; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this work was provided by NEI R01 grants EY016514 (GKK), EY016835 (JDG and NK), EY015543 (RRA), EY019126 (MAH) and EY013315 (MAH); and Research to Prevent Blindness (NAA; http://www.rpbusa.org/rpb/). NK is a Distinguished Brumley Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Afshari NA, 2006, ARCH OPHTHALMOL-CHIC, V124, P777, DOI 10.1001/archopht.124.6.777; Afshari NA, 2009, INVEST OPHTH VIS SCI, V50, P1093, DOI 10.1167/iovs.08-1839; Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P3787, DOI 10.1167/iovs.05-1635; [Anonymous], MOUS GEN DAT MGD MOU; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Borboli Sheila, 2002, Ophthalmol Clin North Am, V15, P17, DOI 10.1016/S0896-1549(01)00016-5; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CHANG S, 1998, GENETIC DIS EYE TXB; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CROSS HE, 1971, ARCH OPHTHALMOL-CHIC, V85, P268; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46; Hemadevi B, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-3; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Kobayashi A, 2004, JPN J OPHTHALMOL, V48, P195, DOI 10.1007/s10384-003-0063-6; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Liskova P, 2007, BRIT J OPHTHALMOL, V91, P1717, DOI 10.1136/bjo.2007.115154; Liu YT, 2010, AM J HUM GENET, V86, P498, DOI 10.1016/j.ajhg.2009.11.018; MAGOVERN M, 1979, OPHTHALMOLOGY, V86, P1897; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1986, GENET EPIDEMIOL, P251; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; RIAZUDDIN SA, 2011, INVEST OPHTHALMOL VI; RIAZUDDIN SA, 2010, HUM MUTAT; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; ROSENBLUM P, 1980, AM J OPHTHALMOL, V90, P455, DOI 10.1016/S0002-9394(14)75011-1; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162	47	55	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18044	10.1371/journal.pone.0018044	http://dx.doi.org/10.1371/journal.pone.0018044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533127	gold, Green Submitted, Green Published			2022-12-25	WOS:000289719400005
J	van Loosdregt, J; Brunen, D; Fleskens, V; Pals, CEGM; Lam, EWF; Coffer, PJ				van Loosdregt, Jorg; Brunen, Diede; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Lam, Eric W. F.; Coffer, Paul J.			Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1	PLOS ONE			English	Article							REGULATORY T-CELLS; ACETYLATION; DEACETYLASE; EXPRESSION; GENERATION; STABILITY; P53; INHIBITION; OCCUPANCY; ARTHRITIS	Maintenance of Foxp3 protein expression in regulatory T cells (Treg) is crucial for a balanced immune response. We have previously demonstrated that Foxp3 protein stability can be regulated through acetylation, however the specific mechanisms underlying this observation remain unclear. Here we demonstrate that SIRT1 a member of the lysine deacetylase Sirtuin (SIRT) family, but not the related SIRTs 2-7, co-localize with Foxp3 in the nucleus. Ectopic expression of SIRT1, but not SIRTs 2-7 results in decreased Foxp3 acetylation, while conversely inhibition of endogenous SIRT activity increased Foxp3 acetylation. We show that SIRT1 inhibition decreases Foxp3 poly-ubiquitination, thereby increasing Foxp3 protein levels. Co-transfection of SIRT1 with Foxp3 results in increased Foxp3 proteasomal degradation, while SIRT inhibition increases FOXP3 transcriptional activity in human Treg. Taken together, these data support a central role for SIRT1 in the regulation of Foxp3 protein levels and thereby in regulation of Treg suppressive capacity. Pharmacological modulation of SIRT1 activity in Treg may therefore provide a novel therapeutic strategy for controlling immune responses.	[van Loosdregt, Jorg; Brunen, Diede; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands; [van Loosdregt, Jorg; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [Brunen, Diede; Fleskens, Veerle; Pals, Cornelieke E. G. M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Lam, Eric W. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, CR UK Labs, London, England; [Lam, Eric W. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Imperial College London; Imperial College London	van Loosdregt, J (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Lam, Eric W-F/AAW-8566-2020; Coffer, Paul/AAF-7970-2020	Lam, Eric W-F/0000-0003-1274-3576; van Loosdregt, Jorg/0000-0003-1411-3754	Dutch Rheumatology Foundation; Cancer Research UK [12011] Funding Source: researchfish	Dutch Rheumatology Foundation; Cancer Research UK(Cancer Research UK)	V. F. was supported by a grant from the Dutch Rheumatology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; BEIER UH, 2011, MOL CELL BIOL; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Greenbaum CJ, 1996, DIABETES, V45, P1631, DOI 10.2337/diabetes.45.11.1631; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; HOFFER A, 1959, Can Med Assoc J, V80, P736; Jonas WB, 1996, INFLAMM RES, V45, P330, DOI 10.1007/BF02252945; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Lampeter EF, 1998, DIABETES, V47, P980, DOI 10.2337/diabetes.47.6.980; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Saouaf SJ, 2009, EXP MOL PATHOL, V87, P99, DOI 10.1016/j.yexmp.2009.06.003; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; van Loosdregt J, 2006, CIRCULATION, V114, P1599, DOI 10.1161/CIRCULATIONAHA.105.597526; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Xiao Y, 2010, CURR OPIN IMMUNOL, V22, P583, DOI 10.1016/j.coi.2010.08.013; Zhang HS, 2010, J CELL BIOCHEM, V110, P1464, DOI 10.1002/jcb.22704; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	39	90	90	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19047	10.1371/journal.pone.0019047	http://dx.doi.org/10.1371/journal.pone.0019047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533107	Green Submitted, Green Published, gold			2022-12-25	WOS:000289719400055
J	Catellani, S; Pierri, I; Gobbi, M; Poggi, A; Zocchi, MR				Catellani, Silvia; Pierri, Ivana; Gobbi, Marco; Poggi, Alessandro; Zocchi, Maria Raffaella			Imatinib Treatment Induces CD5+B Lymphocytes and IgM Natural Antibodies with Anti-Leukemic Reactivity in Patients with Chronic Myelogenous Leukemia	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MEMORY B-CELLS; TYROSINE KINASE; STROMAL CELLS; TERMINAL DIFFERENTIATION; PLASMA-CELLS; MECHANISMS; EXPRESSION; RESISTANCE; INHIBITOR	Imatinib mesylate is a first line treatment of Chronic Myelogenous Leukemia and of a rare form of gastrointestinal stromal cancer, where the response to the drug is also linked to the immune system activation with production of antineoplastic cytokines. In this study, forty patients in the chronic phase of disease, treated with imatinib mesylate, were analyzed. Bone marrow aspirates were drawn at diagnosis, after 3, 6, 12, 18 months for haematological, cytofluorimetric, cytogenetic, biomolecular evaluation and cytokine measurement. Responder and non responder patients were defined according to the European LeukemiaNet recommendations. In responder patients (n = 32), the percentage of bone marrow CD20(+) CD5(+) sIgM(+) lymphocytes, and the plasma levels of IgM, were significantly higher, at 3 months and up to 9 months, than in non responders. These IgM reacted with O-linked sugars expressed by leukemic cells and could induce tumor cell apoptosis. In responeider patients the stromal-derived factor-1 and the B-lymphocyte-activating factor of the tumor necrosis factor family significantly raised in the bone marrow after imatinib administration, together with the bone morphogenetic proteins-2 and -7. All patients with high number of CD20(+) CD5(+) sIgM(+) cells and high stromal-derived factor-1 and B lymphocyte activating factor levels, underwent complete cytogenetic and/or molecular remission by 12 months. We propose that CD20(+) CD5(+) sIgM(+) lymphocytes producing anti-carbohydrate antibodies with anti-tumor activity, might contribute to the response to imatinib treatment. As in multivariate analysis bone marrow CD20(+) CD5(+) sIgM(+) cells and stromal-derived factor-1 and B-lymphocyte-activating factor levels were significantly related to cytogenetical and molecular changes, they might contribute to the definition of the pharmacological response.	[Catellani, Silvia; Pierri, Ivana; Gobbi, Marco] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Poggi, Alessandro] Natl Inst Canc Res, Unit Mol Oncol & Angiogenesis, Genoa, Italy; [Zocchi, Maria Raffaella] Ist Sci San Raffaele, Div Immunol Transplants & Infect Dis, I-20132 Milan, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Catellani, S (corresponding author), Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy.	alessandro.poggi@istge.it; zocchi.maria@hsr.it	Poggi, Alessandro/K-6664-2016	Poggi, Alessandro/0000-0002-1860-430X; Zocchi, Maria Raffaella/0000-0002-0022-8385	Italian Ministero della Salute; Novartis Pharma S.p.A.	Italian Ministero della Salute(Ministry of Health, Italy); Novartis Pharma S.p.A.	This work was partially supported by the Italian Ministero della Salute Coordinated Grant Special Project 2008 (Innovative therapeutic models for the treatment of haematological malignancies) (to A. P. and M.R.Z.), and by Novartis Pharma S.p.A. We also thank Novartis Pharma AG (Basel, Switzerland) for providing the purified imatinib for in vitro experiments (MTA31812). EUDRACT 2007-005102-42; EUDRACT 2008-004384-19. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Brandlein S, 2003, CANCER RES, V63, P7995; Brandlein Stephanie, 2002, Hum Antibodies, V11, P107; Carulli G, 2010, LEUKEMIA RES, V34, P1336, DOI 10.1016/j.leukres.2010.01.012; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Dono M, 2007, EUR J IMMUNOL, V37, P2138, DOI 10.1002/eji.200636887; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Durig J, 2000, LEUKEMIA, V14, P1652, DOI 10.1038/sj.leu.2401875; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Hochhaus A, 2004, LEUKEMIA, V18, P1321, DOI 10.1038/sj.leu.2403426; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Jabbour E, 2010, LEUKEMIA, V24, P6, DOI 10.1038/leu.2009.193; Kantarjian HM, 2009, CANCER-AM CANCER SOC, V115, P551, DOI 10.1002/cncr.24066; Kindler V, 1997, J IMMUNOL, V159, P2085; Larkin JMG, 2006, MELANOMA RES, V16, P157, DOI 10.1097/01.cmr.0000200490.62723.b0; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; MERVILLE P, 1995, INT IMMUNOL, V7, P635, DOI 10.1093/intimm/7.4.635; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Mueller L, 2007, CANCER LETT, V250, P329, DOI 10.1016/j.canlet.2006.10.024; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; O'Brien S, 2009, J NATL COMPR CANC NE, V7, P984, DOI 10.6004/jnccn.2009.0065; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pellegrino A, 2005, BRIT J HAEMATOL, V129, P248, DOI 10.1111/j.1365-2141.2005.05443.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; Rohon P, 2010, EUR J HAEMATOL, V85, P387, DOI 10.1111/j.1600-0609.2010.01501.x; ROLDAN E, 1991, EUR J IMMUNOL, V21, P2671, DOI 10.1002/eji.1830211105; Sato N, 2003, HEMATOL ONCOL, V21, P67, DOI 10.1002/hon.705; Schaumann DHS, 2007, MOL IMMUNOL, V44, P1606, DOI 10.1016/j.molimm.2006.08.021; Schwartz-Albiez R, 2008, AUTOIMMUN REV, V7, P491, DOI 10.1016/j.autrev.2008.03.012; Smyth MJ, 2006, NEW ENGL J MED, V354, P2282, DOI 10.1056/NEJMcibr061878; Tibullo D, 2009, EXP HEMATOL, V37, P461, DOI 10.1016/j.exphem.2008.12.008; Vianello F, 2010, HAEMATOL-HEMATOL J, V95, P1081, DOI 10.3324/haematol.2009.017178; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074	40	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18925	10.1371/journal.pone.0018925	http://dx.doi.org/10.1371/journal.pone.0018925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533122	Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100030
J	Ceballos, S; Kiorboe, T				Ceballos, Sara; Kiorboe, Thomas			Senescence and Sexual Selection in a Pelagic Copepod	PLOS ONE			English	Article							FIELD CRICKETS ORTHOPTERA; MATING SUCCESS; MALE AGE; OITHONA-DAVISAE; FEMALE CHOICE; BODY-SIZE; MATE CHOICE; POPULATION; EVOLUTION; MORTALITY	The ecology of senescence in marine zooplankton is not well known. Here we demonstrate senescence effects in the marine copepod Oithona davisae and show how sex and sexual selection accelerate the rate of ageing in the males. We show that adult mortality increases and male mating capacity and female fertility decrease with age and that the deterioration in reproductive performance is faster for males. Males have a limited mating capacity because they can fertilize, 2 females day(-1) and their reproductive life span is 10 days on average. High female encounter rates in nature (. 10 day 21), a rapid age-dependent decline in female fertility, and a high mortality cost of mating in males are conducive to the development of male choosiness. In our experiments males in fact show a preference for mating with young females that are 3 times more fertile than 30-day old females. We argue that this may lead to severe male-male competition for young virgin females and a trade-off that favours investment in mate finding over maintenance. In nature, mate finding leads to a further elevated mortality of males, because these swim rapidly in their search for attractive partners, further relaxing fitness benefits of maintenance investments. We show that females have a short reproductive period compared to their average longevity but virgin females stay fertile for most of their life. We interpret this as an adaptation to a shortage of males, because a long life increases the chance of fertilization and/or of finding a high quality partner. The very long post reproductive life that many females experience is thus a secondary effect of such an adaptation.	[Ceballos, Sara; Kiorboe, Thomas] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark	Technical University of Denmark	Ceballos, S (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	sca@aqua.dtu.dk; tk@aqua.dtu.dk	Ceballos, Sara/K-2469-2014; Kiørboe, Thomas/G-3190-2011; Kiørboe, Thomas/ABI-4733-2020	Ceballos, Sara/0000-0002-7274-5082; Kiørboe, Thomas/0000-0002-3265-336X; Kiørboe, Thomas/0000-0002-3265-336X	European Community [219552]	European Community(European Commission)	This research was supported by a Marie Curie Intra European Fellowship within the seventh European Community Framework Programme (contract n. 219552) to SC and a grant from the Danish Council for Independent Research to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Andersson Malte, 1994; Avery DE, 2008, LIMNOL OCEANOGR, V53, P2627, DOI 10.4319/lo.2008.53.6.2627; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bonduriansky R, 2005, J EVOLUTION BIOL, V18, P1332, DOI 10.1111/j.1420-9101.2005.00957.x; Bonduriansky R, 2002, NATURE, V420, P377, DOI 10.1038/420377a; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; Carlotti F, 1997, J PLANKTON RES, V19, P1143, DOI 10.1093/plankt/19.8.1143; Catry P, 2006, P ROY SOC B-BIOL SCI, V273, P1625, DOI 10.1098/rspb.2006.3482; Ceballos S, 2010, OECOLOGIA, V164, P627, DOI 10.1007/s00442-010-1755-5; Choi KH, 2008, LIMNOL OCEANOGR, V53, P1656, DOI 10.4319/lo.2008.53.4.1656; Choi KH, 2009, MAR ECOL PROG SER, V377, P183, DOI 10.3354/meps07819; Eiane K, 2004, MAR ECOL PROG SER, V268, P183, DOI 10.3354/meps268183; Elandt-Johnson R C, 1980, SURVIVAL MODELS DATA; Fischer K, 2008, P ROY SOC B-BIOL SCI, V275, P1517, DOI 10.1098/rspb.2007.1455; GILBERT JJ, 1983, ANNU REV ECOL SYST, V14, P1, DOI 10.1146/annurev.es.14.110183.000245; GRAHN M, 1994, P ROY SOC B-BIOL SCI, V255, P237, DOI 10.1098/rspb.1994.0034; Gray DA, 1999, J INSECT BEHAV, V12, P691, DOI 10.1023/A:1020983821436; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; HIROTA R, 1990, MAR BIOL, V105, P307, DOI 10.1007/BF01344300; Hirst AG, 2010, LIMNOL OCEANOGR, V55, P2193, DOI 10.4319/lo.2010.55.5.2193; Hu HH, 2004, BEHAV ECOL, V15, P883, DOI 10.1093/beheco/arh114; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Jones TM, 2000, P ROY SOC B-BIOL SCI, V267, P681, DOI 10.1098/rspb.2000.1056; Kelly LS, 1998, PHILOS T R SOC B, V353, P737, DOI 10.1098/rstb.1998.0239; Kiorboe T, 2006, OECOLOGIA, V148, P40, DOI 10.1007/s00442-005-0346-3; Kiorboe T, 2005, LIMNOL OCEANOGR, V50, P1999, DOI 10.4319/lo.2005.50.6.1999; Kiorboe T, 2008, OECOLOGIA, V155, P179, DOI 10.1007/s00442-007-0893-x; Kiorboe T, 2007, LIMNOL OCEANOGR, V52, P1511, DOI 10.4319/lo.2007.52.4.1511; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Kokko H, 1996, P ROY SOC B-BIOL SCI, V263, P1533, DOI 10.1098/rspb.1996.0224; LANDENPERA M, 2004, NATURE, V428, P128; Legendre L, 2002, MAR ECOL PROG SER, V242, P95, DOI 10.3354/meps242095; LONG CE, 1980, BEHAV GENET, V10, P163, DOI 10.1007/BF01066266; Mauchline J, 1998, BIOL CALANOID COPEPO; McElligott AG, 2000, BEHAV ECOL SOCIOBIOL, V48, P203, DOI 10.1007/s002650000234; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; Moore PJ, 2001, P NATL ACAD SCI USA, V98, P9171, DOI 10.1073/pnas.161154598; PARRISH KK, 1978, MAR BIOL, V46, P65, DOI 10.1007/BF00393822; Price DK, 1998, BEHAV GENET, V28, P395, DOI 10.1023/A:1021677804038; Prokop ZM, 2007, BEHAV ECOL, V18, P597, DOI 10.1093/beheco/arm012; Radwan J, 2003, ECOL LETT, V6, P581, DOI 10.1046/j.1461-0248.2003.00484.x; Radwan J, 2005, ANIM BEHAV, V69, P1101, DOI 10.1016/j.anbehav.2004.09.006; Ricklefs RE, 2008, FUNCT ECOL, V22, P379, DOI 10.1111/j.1365-2435.2008.01420.x; Rodriguez-Grana L, 2010, MAR ECOL PROG SER, V401, P1, DOI 10.3354/meps08459; Serre V, 1998, FERTIL STERIL, V70, P625, DOI 10.1016/S0015-0282(98)00259-3; Sibly RM, 1997, J ZOOL, V243, P1, DOI 10.1111/j.1469-7998.1997.tb05751.x; Simmons LW, 1995, BEHAV ECOL, V6, P376, DOI 10.1093/beheco/6.4.376; SIMMONS LW, 1994, ANIM BEHAV, V47, P117, DOI 10.1006/anbe.1994.1013; Titelman J, 2007, J PLANKTON RES, V29, P1023, DOI 10.1093/plankt/fbm076; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tufvesson M, 1999, J ANIM BREED GENET, V116, P127, DOI 10.1046/j.1439-0388.1999.00179.x; UCHIMA M, 1988, MAR BIOL, V99, P39, DOI 10.1007/BF00644975; UYE S, 1995, MAR ECOL PROG SER, V118, P121, DOI 10.3354/meps118121; Wedekind C, 1998, OIKOS, V81, P458, DOI 10.2307/3546767; ZUK M, 1987, ANIM BEHAV, V35, P1240, DOI 10.1016/S0003-3472(87)80182-3; ZUK M, 1988, EVOLUTION, V42, P969, DOI 10.1111/j.1558-5646.1988.tb02515.x	61	41	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18870	10.1371/journal.pone.0018870	http://dx.doi.org/10.1371/journal.pone.0018870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533149	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600042
J	Korfali, N; Srsen, V; Waterfall, M; Batrakou, DG; Pekovic, V; Hutchison, CJ; Schirmer, EC				Korfali, Nadia; Srsen, Vlastimil; Waterfall, Martin; Batrakou, Dzmitry G.; Pekovic, Vanja; Hutchison, Christopher J.; Schirmer, Eric C.			A Flow Cytometry-Based Screen of Nuclear Envelope Transmembrane Proteins Identifies NET4/Tmem53 as Involved in Stress-Dependent Cell Cycle Withdrawal	PLOS ONE			English	Article							RETINOBLASTOMA GENE-PRODUCT; MEMBRANE-PROTEIN; LAMIN-A/C; MYOD PATHWAYS; EMERIN; PHOSPHORYLATION; LAP2-ALPHA; MUTATION; ASSOCIATION; CENTROSOME	Disruption of cell cycle regulation is one mechanism proposed for how nuclear envelope protein mutation can cause disease. Thus far only a few nuclear envelope proteins have been tested/found to affect cell cycle progression: to identify others, 39 novel nuclear envelope transmembrane proteins were screened for their ability to alter flow cytometry cell cycle/DNA content profiles when exogenously expressed. Eight had notable effects with seven increasing and one decreasing the 4N:2N ratio. We subsequently focused on NET4/Tmem53 that lost its effects in p53(-/-) cells and retinoblastoma protein-deficient cells. NET4/TMEM53 knockdown by siRNA altered flow cytometry cell cycle/DNA content profiles in a similar way as overexpression. NET4/TMEM53 knockdown did not affect total retinoblastoma protein levels, unlike nuclear envelope-associated proteins Lamin A and LAP2 alpha. However, a decrease in phosphorylated retinoblastoma protein was observed along with a doubling of p53 levels and a 7-fold increase in p21. Consequently cells withdrew from the cell cycle, which was confirmed in MRC5 cells by a drop in the percentage of cells expressing Ki-67 antigen and an increase in the number of cells stained for beta-galactosidase. The beta-galactosidase upregulation suggests that cells become prematurely senescent. Finally, the changes in retinoblastoma protein, p53, and p21 resulting from loss of NET4/Tmem53 were dependent upon active p38 MAP kinase. The finding that roughly a fifth of nuclear envelope transmembrane proteins screened yielded alterations in flow cytometry cell cycle/DNA content profiles suggests a much greater influence of the nuclear envelope on the cell cycle than is widely held.	[Korfali, Nadia; Srsen, Vlastimil; Batrakou, Dzmitry G.; Schirmer, Eric C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Korfali, Nadia; Srsen, Vlastimil; Batrakou, Dzmitry G.; Schirmer, Eric C.] Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Waterfall, Martin] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Pekovic, Vanja; Hutchison, Christopher J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of Edinburgh; University of Edinburgh; University of Edinburgh; Durham University	Korfali, N (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	e.schirmer@ed.ac.uk		Pekovic-Vaughan, Vanja/0000-0002-7876-652X; Schirmer, Eric/0000-0003-2635-1338	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust Senior Research Fellowship to ECS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Buch C, 2009, J CELL SCI, V122, P2100, DOI 10.1242/jcs.047373; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; DECAPRIO JA, 1992, P NATL ACAD SCI USA, V89, P1795, DOI 10.1073/pnas.89.5.1795; Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fairley EAL, 2002, J CELL SCI, V115, P341; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; GERDES J, 1984, J IMMUNOL, V133, P1710; Grossel MJ, 1999, J BIOL CHEM, V274, P29960, DOI 10.1074/jbc.274.42.29960; Haffner C, 2007, J BIOL CHEM, V282, P10632, DOI 10.1074/jbc.M611033200; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Korfali N, 2010, MOL CELL PROTEOMICS, V9, P2571, DOI 10.1074/mcp.M110.002915; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; Mounkes L, 2004, CURR TOP DEV BIOL, V61, P191, DOI 10.1016/S0070-2153(04)61008-8; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; OZAKI T, 1994, ONCOGENE, V9, P2649; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; PONTEN J, 1967, INT J CANCER, V2, P434, DOI 10.1002/ijc.2910020505; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Wilkie GS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003129; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu WL, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh010; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	49	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18762	10.1371/journal.pone.0018762	http://dx.doi.org/10.1371/journal.pone.0018762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533191	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600029
J	Singh, PP; LeMaire, C; Tan, JC; Zeng, EL; Schorey, JS				Singh, Prachi P.; LeMaire, Christopher; Tan, John C.; Zeng, Erliang; Schorey, Jeffery S.			Exosomes Released from M.tuberculosis Infected Cells Can Suppress IFN-gamma Mediated Activation of Naive Macrophages	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CLASS-II; TRANSCRIPTIONAL RESPONSES; PROINFLAMMATORY RESPONSE; 19-KDA LIPOPROTEIN; INTERFERON-GAMMA; IN-VITRO; T-CELLS; INHIBITION; VESICLES	Background: Macrophages infected with Mycobacterium tuberculosis (M.tb) are known to be refractory to IFN-gamma stimulation. Previous studies have shown that M.tb express components such as the 19-kDa lipoprotein and peptidoglycan that can bind to macrophage receptors including the Toll-like receptor 2 resulting in the loss in IFN-gamma responsiveness. However, it is unclear whether this effect is limited to infected macrophages. We have previously shown that M.tb-infected macrophages release exosomes which are 30-100 nm membrane bound vesicles of endosomal origin that function in intercellular communication. These exosomes contain mycobacterial components including the 19-kDa lipoprotein and therefore we hypothesized that macrophages exposed to exosomes may show limited response to IFN-gamma stimulation. Methodology/Principal Findings: Exosomes were isolated from resting as well as M.tb-infected RAW264.7 macrophages. Mouse bone marrow-derived macrophages (BMM circle divide) were treated with exosomes +/- IFN-gamma. Cells were harvested and analyzed for suppression of IFN-gamma responsive genes by flow cytometry and real time PCR. We found that exosomes derived from M.tb H37Rv-infected but not from uninfected macrophages inhibited IFN-gamma induced MHC class II and CD64 expression on BMM circle divide. This inhibition was only partially dependent on the presence of lipoproteins but completely dependent on TLR2 and MyD88. The exosomes isolated from infected cells did not inhibit STAT1 Tyrosine phosphorylation but down-regulated IFN-gamma induced expression of the class II major histocompatibity complex transactivator; a key regulator of class II MHC expression. Microarray studies showed that subsets of genes induced by IFN-gamma were inhibited by exosomes from H37Rv-infeced cells including genes involved in antigen presentation. Moreover, this set of genes partially overlapped with the IFN-gamma induced genes inhibited by H37Rv infection. Conclusions: Our study suggests that exosomes, as carriers of M.tb pathogen associated molecular patterns (PAMPs), may provide a mechanism by which M.tb may exert its suppression of a host immune response beyond the infected cell.	[Singh, Prachi P.; LeMaire, Christopher; Tan, John C.; Schorey, Jeffery S.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Singh, Prachi P.; LeMaire, Christopher; Tan, John C.; Zeng, Erliang; Schorey, Jeffery S.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Zeng, Erliang] Univ Notre Dame, Dept Comp Sci & Engn, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Singh, PP (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	schorey.1@nd.edu	Zeng, Erliang/AAH-2289-2019; Zeng, Erliang/B-4933-2011	Zeng, Erliang/0000-0003-3354-6416; Zeng, Erliang/0000-0002-2891-6497	National Institute of Allergy and Infectious Diseases [AI056979, AI052439]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056979, R01AI052439] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through grants AI056979 and AI052439 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beatty WL, 2001, EUR J CELL BIOL, V80, P31, DOI 10.1078/0171-9335-00131; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; DOUVAS GS, 1985, INFECT IMMUN, V50, P1; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Feng CG, 2009, AUTOPHAGY, V5, P232, DOI 10.4161/auto.5.2.7445; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Giri PK, 2010, PROTEOMICS, V10, P3190, DOI 10.1002/pmic.200900840; Giri PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002461; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; Kincaid EZ, 2003, J IMMUNOL, V171, P2042, DOI 10.4049/jimmunol.171.4.2042; LANDMANN SL, 2004, NAT IMMUNOL, V5, P899; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Peche H, 2003, TRANSPLANTATION, V76, P1503, DOI 10.1097/01.TP.0000092494.75313.38; Pennini ME, 2007, J IMMUNOL, V179, P6910, DOI 10.4049/jimmunol.179.10.6910; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; SICHER SC, 1995, J IMMUNOL, V155, P5826; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Ting LM, 1999, J IMMUNOL, V163, P3898; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Ulrichs T, 2005, J PATHOL, V205, P633, DOI 10.1002/path.1728; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	42	79	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18564	10.1371/journal.pone.0018564	http://dx.doi.org/10.1371/journal.pone.0018564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533172	Green Published, Green Submitted, gold			2022-12-25	WOS:000289505600010
J	Boisson-Dupuis, S; El Baghdadi, J; Parvaneh, N; Bousfiha, A; Bustamante, J; Feinberg, J; Samarina, A; Grant, AV; Janniere, L; El Hafidi, N; Hassani, A; Nolan, D; Najib, J; Camcioglu, Y; Hatipoglu, N; Aydogmus, C; Tanir, G; Aytekin, C; Keser, M; Somer, A; Aksu, G; Kutukculer, N; Mansouri, D; Mahdaviani, A; Mamishi, S; Alcais, A; Abel, L; Casanova, JL				Boisson-Dupuis, Stephanie; El Baghdadi, Jamila; Parvaneh, Nima; Bousfiha, Aziz; Bustamante, Jacinta; Feinberg, Jacqueline; Samarina, Arina; Grant, Audrey V.; Janniere, Lucile; El Hafidi, Naima; Hassani, Amal; Nolan, Daniel; Najib, Jilali; Camcioglu, Yildiz; Hatipoglu, Nevin; Aydogmus, Cigdem; Tanir, Gonul; Aytekin, Caner; Keser, Melike; Somer, Ayper; Aksu, Guside; Kutukculer, Necil; Mansouri, Davood; Mahdaviani, Alireza; Mamishi, Setareh; Alcais, Alexandre; Abel, Laurent; Casanova, Jean-Laurent			IL-12R beta 1 Deficiency in Two of Fifty Children with Severe Tuberculosis from Iran, Morocco, and Turkey	PLOS ONE			English	Article							RECEPTOR BETA-1 DEFICIENCY; SEQUENCING-BASED DISCOVERY; MYCOBACTERIAL INFECTION; CONSANGUINEOUS MARRIAGE; TUBERCLE-BACILLI; SUSCEPTIBILITY; IMMUNITY; MUTATION; PREDISPOSITION; IMPAIRMENT	Background and Objectives: In the last decade, autosomal recessive IL-12R beta 11 deficiency has been diagnosed in four children with severe tuberculosis from three unrelated families from Morocco, Spain, and Turkey, providing proof-of-principle that tuberculosis in otherwise healthy children may result from single-gene inborn errors of immunity. We aimed to estimate the fraction of children developing severe tuberculosis due to IL-12R beta 1 deficiency in areas endemic for tuberculosis and where parental consanguinity is common. Methods and Principal Findings: We searched for IL12RB1 mutations in a series of 50 children from Iran, Morocco, and Turkey. All children had established severe pulmonary and/or disseminated tuberculosis requiring hospitalization and were otherwise normally resistant to weakly virulent BCG vaccines and environmental mycobacteria. In one child from Iran and another from Morocco, homozygosity for loss-of-function IL12RB1 alleles was documented, resulting in complete IL-12R beta 1 deficiency. Despite the small sample studied, our findings suggest that IL-12R beta 1 deficiency is not a very rare cause of pediatric tuberculosis in these countries, where it should be considered in selected children with severe disease. Significance: This finding may have important medical implications, as recombinant IFN-gamma is an effective treatment for mycobacterial infections in IL-12R beta 1-deficient patients. It also provides additional support for the view that severe tuberculosis in childhood may result from a collection of single-gene inborn errors of immunity.	[Boisson-Dupuis, Stephanie; Bustamante, Jacinta; Feinberg, Jacqueline; Samarina, Arina; Grant, Audrey V.; Janniere, Lucile; Nolan, Daniel; Alcais, Alexandre; Abel, Laurent; Casanova, Jean-Laurent] INSERM, Lab Human Genet Infect Dis, U980, Paris, France; [Boisson-Dupuis, Stephanie; Bustamante, Jacinta; Feinberg, Jacqueline; Samarina, Arina; Grant, Audrey V.; Janniere, Lucile; Nolan, Daniel; Alcais, Alexandre; Abel, Laurent; Casanova, Jean-Laurent] Univ Paris 05, Necker Med Sch, Paris, France; [El Baghdadi, Jamila] Mil Hosp Mohamed V, Genet Unit, Hay Riad Rabat, Morocco; [Parvaneh, Nima; Mamishi, Setareh] Univ Tehran Med Sci, Dept Pediat, Infect Dis Res Ctr, Tehran, Iran; [Boisson-Dupuis, Stephanie; Alcais, Alexandre; Abel, Laurent; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA; [Bousfiha, Aziz; Najib, Jilali] King Hassan II Univ, Ibn Rochd Hosp, Clin Immunol Unit, Casablanca, Morocco; [El Hafidi, Naima] Rabat Children Hosp, Dept Pediat, Rabat, Morocco; [Hassani, Amal] Mil Hosp Mohamed V, Dept Pediat, Hay Riad Rabat, Morocco; [Camcioglu, Yildiz] Istanbul Univ, Cerrahpasa Med Sch, Dept Pediat, Infect Dis Clin Immunol & Allergy Div, Istanbul, Turkey; [Hatipoglu, Nevin; Aydogmus, Cigdem] Bakirkoy Matern & Childrens State Hosp, Dept Pediat Infect Dis & Immunol, Istanbul, Turkey; [Tanir, Gonul; Aytekin, Caner] Dr Sami Ulus Childrens Hlth & Dis Training & Res, Ankara, Turkey; [Keser, Melike; Somer, Ayper] Istanbul Univ, Fac Med, Dept Pediat Infect Dis & Clin Immunol, Istanbul, Turkey; [Aksu, Guside; Kutukculer, Necil; Mansouri, Davood] Ege Univ, Sch Med, Dept Pediat, Izmir, Turkey; [Mansouri, Davood] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Div Infect Dis & Clin Immunol, Tehran, Iran; [Mahdaviani, Alireza] Shahid Beheshti Univ Med Sci, NRITLD, Pediat Resp Dis Res Ctr, Tehran, Iran; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Pediat Immunol Hematol Unit, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Tehran University of Medical Sciences; Rockefeller University; Hassan II University of Casablanca; Ibn Rochd University Hospital Center of Casablanca; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Istanbul University; Istanbul University - Cerrahpasa; Bakirkoy Children's & Maternity Hospital; Dr. Sami Ulus Education & Research Hospital; Istanbul University; Ege University; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Boisson-Dupuis, S (corresponding author), Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, 1230 York Ave, New York, NY 10021 USA.	jean-laurent.casanova@rockefeller.edu	Parvaneh, Nima/A-2523-2010; Bustamante, Jacinta/H-7877-2017; Somer, Ayper/AAE-5459-2020; Casanova, Jean-Laurent/I-3418-2017; Emiroğlu, Melike/AAH-3566-2019; mahdaviani, alireza/G-3256-2017; mansouri, davood/G-6471-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Alcais, Alexandre/J-5882-2017; Boisson-Dupuis, Stéphanie/I-2040-2017; Abel, Laurent/H-8888-2017	Parvaneh, Nima/0000-0002-3397-9716; Bustamante, Jacinta/0000-0002-3439-2482; mahdaviani, alireza/0000-0001-6224-4797; mansouri, davood/0000-0002-0564-8282; Alcais, Alexandre/0000-0002-1012-2226; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Casanova, Jean-Laurent/0000-0002-7782-4169; Emiroglu, Melike/0000-0003-1307-0246; Abel, Laurent/0000-0001-7016-6493; Aksu, Guzide/0000-0003-2714-0903; Nolan, Daniel/0000-0003-3584-6148	Schlumberger Foundation; BNP-Paribas Foundation; Foundation for Medical Research (FRM); Institut Universitaire de France; French National Agency for Research (ANR); EU [HEALTH-F3-2008-200732]; Bill and Melinda Gates Foundation; St. Giles Foundation; Jeffrey Modell Foundation; Talecris Biotherapeutics; Rockefeller University Center for Clinical and Translational Science [5UL1RR024143]; Rockefeller University; National Institute of Allergy and Infectious Diseases [1U01AI088685]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI088685] Funding Source: NIH RePORTER	Schlumberger Foundation(Schlumberger); BNP-Paribas Foundation; Foundation for Medical Research (FRM)(Fondation pour la Recherche Medicale); Institut Universitaire de France; French National Agency for Research (ANR)(French National Research Agency (ANR)); EU(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); St. Giles Foundation; Jeffrey Modell Foundation; Talecris Biotherapeutics; Rockefeller University Center for Clinical and Translational Science; Rockefeller University; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Laboratory of Human Genetics of Infectious Diseases is supported in part by grants from the Schlumberger Foundation, the BNP-Paribas Foundation, The Foundation for Medical Research (FRM), the "Institut Universitaire de France," the French National Agency for Research (ANR), the EU-grant HOMITB (HEALTH-F3-2008-200732), the Bill and Melinda Gates Foundation, the St. Giles Foundation, the Jeffrey Modell Foundation and Talecris Biotherapeutics, the Rockefeller University Center for Clinical and Translational Science grant number 5UL1RR024143, the Rockefeller University, and the National Institute of Allergy and Infectious Diseases grant number 1U01AI088685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alangari AA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/691956; Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; Alcais A, 2010, ANN NY ACAD SCI, V1214, P18, DOI 10.1111/j.1749-6632.2010.05834.x; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; Altare F, 2001, J INFECT DIS, V184, P231, DOI 10.1086/321999; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; Caragol I, 2003, CLIN INFECT DIS, V37, P302, DOI 10.1086/375587; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; de Beaucoudrey L, 2010, MEDICINE, V89, P381, DOI 10.1097/MD.0b013e3181fdd832; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Duval CW, 1909, J EXP MED, V11, P403, DOI 10.1084/jem.11.3.403; El Baghdadi J, 2006, J EXP MED, V203, P1679, DOI 10.1084/jem.20060269; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; HAMBLETON S, N ENGL J ME IN PRESS; Holland SM, 2000, MICROBES INFECT, V2, P1579, DOI 10.1016/S1286-4579(00)01314-9; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Opie EL, 1927, ARCH PATHOL LAB MED, V4, P1; Ozbek N, 2005, CLIN INFECT DIS, V40, pE55, DOI 10.1086/427879; PEARSON K, 1912, EUGENICS LAB LECT SE, V8, P694; PFUFFER R, 1944, FAMILIAL SUSCEPTIBIL, V5; Ranke K, 1910, ARCH KINDERHEILKD, V54, P279; Rosenzweig SD, 2004, J IMMUNOL, V173, P4000, DOI 10.4049/jimmunol.173.6.4000; Saadat M, 2004, ANN HUM BIOL, V31, P263, DOI 10.1080/03014460310001652211; Sanal O, 2007, PEDIATR INFECT DIS J, V26, P366, DOI 10.1097/01.inf.0000258696.64507.0f; Schurr E, 2007, J INTERN MED, V261, P106, DOI 10.1111/j.1365-2796.2006.01741.x; Smith T., 1934, Princeton; TABARSI P, J CLIN IMMU IN PRESS; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; TUNCBILEK E, 1994, ANN HUM GENET, V58, P321, DOI 10.1111/j.1469-1809.1994.tb00729.x; Vogt G, 2008, J EXP MED, V205, P1729, DOI 10.1084/jem.20071987; Von Pirquet C., 1909, J AMER MED ASSOC, V52, P675; VONVERSCHUER OF, 1955, DEUT MED WOCHENSCHR, V80, P1635, DOI 10.1055/s-0028-1116258; White WC, 1909, J MED RES, V20, P347; World Health Organization, 2006, WHOHTMTB2006362	44	92	93	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18524	10.1371/journal.pone.0018524	http://dx.doi.org/10.1371/journal.pone.0018524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533230	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800016
J	Gomez, MD; Urbez, C; Perez-Amador, MA; Carbonell, J				Dolores Gomez, Maria; Urbez, Cristina; Perez-Amador, Miguel A.; Carbonell, Juan			Characterization of constricted fruit (ctf) Mutant Uncovers a Role for AtMYB117/LOF1 in Ovule and Fruit Development in Arabidopsis thaliana	PLOS ONE			English	Article							MADS-BOX GENES; CARPEL; PROTEIN; TRANSFORMATION; TRANSCRIPTION; EXPRESSION; BOUNDARIES; GYNOECIUM; SPATULA; GROWTH	Pistil and fruit morphogenesis is the result of a complex gene network that is not yet fully understood. A search for novel genes is needed to make a more comprehensive model of pistil and fruit development. Screening for mutants with alterations in fruit morphology generated by an activation tagging strategy resulted in the isolation of the ctf (constricted fruit) mutant. It is characterized by a) small and wrinkled fruits, with an enlarged replum, an amorphous structure of the septum and an irregular distribution of ovules and seeds; b) ectopic carpelloid structures in sepals bearing ovule-like structures and c) dwarf plants with curled rosette leaves. The overexpressed gene in ctf was AtMYB117, also named LOF1 (LATERAL ORGAN FUSION1). AtMYB117/LOF1 transcripts were localized in boundary regions of the vegetative shoot apical meristem and leaf primordia and in a group of cells in the adaxial base of petioles and bracts. Transcripts were also detected in the boundaries between each of the four floral whorls and during pistil development in the inner of the medial ridges, the placenta, the base of the ovule primordia, the epidermis of the developing septum and the outer cell layers of the ovule funiculi. Analysis of changes of expression of pistil-related genes in the ctf mutant showed an enhancement of SHATTERPROOF1 (SHP1) and SHP2 expression. All these results suggest that AtMYB117/LOF1 is recruited by a variety of developmental programs for the establishment of boundary regions, including the development of floral organs and the initiation of ovule outgrowth.	[Dolores Gomez, Maria; Urbez, Cristina; Perez-Amador, Miguel A.; Carbonell, Juan] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Gomez, MD (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain.	jcarbon@ibmcp.upv.es	Gomez/K-8775-2014; Urbez, Cristina/L-1012-2014; Perez-Amador, Miguel A./J-7123-2012; Carbonell, Juan/F-6406-2011	Gomez/0000-0001-9445-2056; Urbez, Cristina/0000-0001-9345-7322; Perez-Amador, Miguel A./0000-0003-4518-3544; Carbonell, Juan/0000-0002-6936-6540	Spanish Ministry of Science and Innovation [BIO2005-07156-C02-01, BIO2008-01039]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the Spanish Ministry of Science and Innovation (grants BIO2005-07156-C02-01 and BIO2008-01039). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2006, PLANT MOL BIOL, V60, P915, DOI 10.1007/s11103-005-2760-7; Alonso-Cantabrana H, 2007, DEVELOPMENT, V134, P2663, DOI 10.1242/DEV.02864; Balanza V, 2006, J EXP BOT, V57, P3457, DOI 10.1093/jxb/erl188; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Borghi L, 2007, PLANT CELL, V19, P1795, DOI 10.1105/tpc.106.047159; CHRISTENSEN S, 2002, ARABIDOPSIS LAB MANU, P104; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colombo M, 2010, DEV BIOL, V337, P294, DOI 10.1016/j.ydbio.2009.10.043; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dorcey E, 2009, PLANT J, V58, P318, DOI 10.1111/j.1365-313X.2008.03781.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; FERRANDIZ C, 2002, ARABIDOPSIS LAB MANU, P195; Girin T, 2009, J EXP BOT, V60, P1493, DOI 10.1093/jxb/erp031; Gomez M, 2004, PLANTA, V219, P967, DOI 10.1007/s00425-004-1300-z; Groszmann M, 2010, J EXP BOT, V61, P1495, DOI 10.1093/jxb/erq015; Gu Q, 1998, DEVELOPMENT, V125, P1509; Heisler MGB, 2001, DEVELOPMENT, V128, P1089; Ishida T, 2000, PLANT CELL PHYSIOL, V41, P60, DOI 10.1093/pcp/41.1.60; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kelley DR, 2009, SEX PLANT REPROD, V22, P229, DOI 10.1007/s00497-009-0107-2; Kuromori T, 2009, PLANT CELL PHYSIOL, V50, P1215, DOI 10.1093/pcp/pcp078; Lee DK, 2009, DEVELOPMENT, V136, P2423, DOI 10.1242/dev.031971; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Roeder A.H., 2006, ARABIDOPSIS BOOK; Roeder AHK, 2003, CURR BIOL, V13, P1630, DOI 10.1016/j.cub.2003.08.027; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003	33	30	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18760	10.1371/journal.pone.0018760	http://dx.doi.org/10.1371/journal.pone.0018760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533201	Green Published, gold			2022-12-25	WOS:000289458800037
J	Pine, SO; Kublin, JG; Hammer, SM; Borgerding, J; Huang, YD; Casimiro, DR; McElrath, MJ				Pine, Samuel O.; Kublin, James G.; Hammer, Scott M.; Borgerding, Joleen; Huang, Yunda; Casimiro, Danilo R.; McElrath, M. Juliana			Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans	PLOS ONE			English	Article							REPLICATION-DEFECTIVE ADENOVIRUS; COLONY-STIMULATING FACTOR; IL-1 RECEPTOR ANTAGONIST; T-CELL RESPONSES; HIV-1 VACCINE; GM-CSF; VIRUS; INFECTION; IMMUNOGENICITY; INTERLEUKIN-10	The results of the recent Step Study highlight a need to clarify the effects of pre-existing natural immunity to a vaccine vector on vaccine-induced T-cell responses. To investigate this interaction, we examined the relationship between preexisting Ad5 immunity and T-cell cytokine response profiles in healthy, HIV-uninfected recipients of MRKAd5 HIV-1 gag vaccine (HVTN 050, ClinicalTrials.gov #NCT00849732). Participants were grouped by baseline Ad5 neutralizing antibody titer as either Ad5-seronegative (titer <= 18; n = 36) or Ad5-seropositive (titer >200; n = 34). Samples from vaccine recipients were analyzed for immune responses to either HIV-1 Gag peptide pools or Ad5 empty vector using an ex vivo assay that measures thirty cytokines in the absence of long-term culture. The overall profiles of cytokine responses to Gag and Ad5 had similar combinations of induced Th1- and Th2-type cytokines, including IFN-gamma, IL-2, TNF-alpha, IP-10, IL-13, and IL-10, although the Ad5-specific responses were uniformly higher than the Gag-specific responses (p<0.0001 for 9 out of 11 significantly expressed analytes). At the peak response time point, PBMC from Ad5-seronegative vaccinees secreted significantly more IP-10 in response to Gag (p = 0.008), and significantly more IP-10 (p = 0.0009), IL-2 (p = 0.006) and IL-10 (p = 0.05) in response to Ad5 empty vector than PBMC from Ad5-seropositive vaccinees. Additionally, similar responses to the Ad5 vector prior to vaccination were observed in almost all subjects, regardless of Ad5 neutralizing antibody status, and the levels of secreted IFN-gamma, IL-10, IL-1Ra and GM-CSF were blunted following vaccination. The cytokine response profile of Gag-specific T cells mirrored the Ad5-specific response present in all subjects before vaccination, and included a number of Th1- and Th2-associated cytokines not routinely assessed in current vaccine trials, such as IP-10, IL-10, IL-13, and GM-CSF. Together, these results suggest that vector-specific humoral responses may reduce vaccine-induced T-cell responses by previously undetected mechanisms.	[Pine, Samuel O.; McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Program Pathobiol, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Pine, Samuel O.; Kublin, James G.; Borgerding, Joleen; Huang, Yunda; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Hammer, Scott M.] Columbia Univ Coll Phys & Surg, Div Infect Dis, New York, NY 10032 USA; [Casimiro, Danilo R.] Merck Res Labs, Vaccine Basic Res, West Point, PA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Columbia University; Merck & Company	Pine, SO (corresponding author), Infect Dis Res Inst, Seattle, WA 98104 USA.	jmcelrat@fhcrc.org		Huang, Yunda/0000-0003-1546-6172	Public Health Service [U01 AI068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068618] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by Public Health Service grant U01 AI068618. Merck Research Laboratories provided the vaccine product used in the HVTN 050 clinical trial. Merck and the HIV Vaccine Trials Network (HVTN) contributed to the preparation of this manuscript and decision to publish. HVTN contributed to the study design. Data analysis was conducted by HVTN and the Statistical Center for HIV/AIDS Research and Prevention (SCHARP).	AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Alter G, 2010, J CLIN INVEST, V120, P1905, DOI 10.1172/JCI40913; Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Armstrong WS, 2001, CLIN INFECT DIS, V32, P766, DOI 10.1086/319227; Aste-Amezaga M, 2004, HUM GENE THER, V15, P293, DOI 10.1089/104303404322886147; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Calcedo R, 2009, J VIROL, V83, P2623, DOI 10.1128/JVI.02160-08; Casimiro DR, 2004, J VIROL, V78, P11434, DOI 10.1128/JVI.78.20.11434-11438.2004; CHAPMAN BS, 1991, NUCLEIC ACIDS RES, V19, P3979, DOI 10.1093/nar/19.14.3979; CHATTERJEE A, 2008, J CLIN IMMUNOL, V29, P71; CHROBOCZEK J, 1992, VIROLOGY, V186, P280, DOI 10.1016/0042-6822(92)90082-Z; Crowe SM, 1997, J LEUKOCYTE BIOL, V62, P41, DOI 10.1002/jlb.62.1.41; DAFTARIAN MP, 1995, CLIN DIAGN LAB IMMUN, V2, P712, DOI 10.1128/CDLI.2.6.712-718.1995; DUBEY DP, 1994, J EXP MED, V179, P1193, DOI 10.1084/jem.179.4.1193; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Faul EJ, 2008, VIROLOGY, V382, P226, DOI 10.1016/j.virol.2008.09.019; HAMMER SM, 1990, BLOOD, V75, P1215; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Huang XL, 2008, J LEUKOCYTE BIOL, V83, P1530, DOI 10.1189/jlb.1107795; Hutnick NA, 2010, VACCINE, V28, P1932, DOI 10.1016/j.vaccine.2009.10.091; Hutnick NA, 2009, NAT MED, V15, P876, DOI 10.1038/nm.1989; Kedzierska K, 2000, AIDS, V14, P1739, DOI 10.1097/00002030-200008180-00008; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; Koup RA, 2009, J VIROL, V83, P6318, DOI 10.1128/JVI.00384-09; Kreuzer KA, 1997, CLIN EXP IMMUNOL, V109, P54, DOI 10.1046/j.1365-2249.1997.4181315.x; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Lin FC, 2009, J VIROL, V83, P1216, DOI 10.1128/JVI.01870-08; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Liu J, 2008, VACCINE, V26, P4062, DOI 10.1016/j.vaccine.2008.05.018; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; NICHOLSON O, 2010, AIDS RES HU IN PRESS; O'Brien KL, 2009, NAT MED, V15, P873, DOI 10.1038/nm.1991; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Promadej-Lanier N, 2008, VIROLOGY, V375, P492, DOI 10.1016/j.virol.2008.01.040; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Santra S, 2009, VACCINE, V27, P5837, DOI 10.1016/j.vaccine.2009.07.050; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; Yang CF, 2003, AIDS RES HUM RETROV, V19, P661, DOI 10.1089/088922203322280883; Youil R, 2003, HUM GENE THER, V14, P1017, DOI 10.1089/104303403766682278; Yu SQ, 2008, VACCINE, V26, P6124, DOI 10.1016/j.vaccine.2008.09.017; ZAVALA F, 1995, J IMMUNOL, V155, P2784; Zhang XG, 2007, J VIROL, V81, P7022, DOI 10.1128/JVI.02654-06; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	58	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18526	10.1371/journal.pone.0018526	http://dx.doi.org/10.1371/journal.pone.0018526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533229	gold, Green Submitted, Green Published			2022-12-25	WOS:000289458800017
J	Przybycien-Szymanska, MM; Mott, NN; Paul, CR; Gillespie, RA; Pak, TR				Przybycien-Szymanska, Magdalena M.; Mott, Natasha N.; Paul, Caitlin R.; Gillespie, Roberta A.; Pak, Toni R.			Binge-Pattern Alcohol Exposure during Puberty Induces Long-Term Changes in HPA Axis Reactivity	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL RESPONSE; SUBSTANCE USE DISORDERS; PARAVENTRICULAR NUCLEUS; MALE RATS; ADOLESCENT BRAIN; INTAKE LEADS; ADULT-RAT; STRESS; VASOPRESSIN	Adolescence is a dynamic and important period of brain development however, little is known about the long-term neurobiological consequences of alcohol consumption during puberty. Our previous studies showed that binge-pattern ethanol (EtOH) treatment during pubertal development negatively dysregulated the responsiveness of the hypothalamopituitary-adrenal (HPA) axis, as manifested by alterations in corticotrophin-releasing hormone (CRH), arginine vasopressin (AVP), and corticosterone (CORT) during this time period. Thus, the primary goal of this study was to determine whether these observed changes in important central regulators of the stress response were permanent or transient. In this study, juvenile male Wistar rats were treated with a binge-pattern EtOH treatment paradigm or saline alone for 8 days. The animals were left undisturbed until adulthood when they received a second round of treatments consisting of saline alone, a single dose of EtOH, or a second binge-pattern treatment paradigm. The results showed that pubertal binge-pattern EtOH exposure induced striking long-lasting alterations of many HPA axis parameters. Overall, our data provide strong evidence that binge-pattern EtOH exposure during pubertal maturation has long-term detrimental effects for the healthy development of the HPA axis.	[Przybycien-Szymanska, Magdalena M.; Mott, Natasha N.; Paul, Caitlin R.; Gillespie, Roberta A.; Pak, Toni R.] Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Chicago, IL 60611 USA	Loyola University Chicago	Przybycien-Szymanska, MM (corresponding author), Loyola Univ, Stritch Sch Med, Dept Cell & Mol Physiol, Chicago, IL 60611 USA.	tpak@lumc.edu			NIH [R01AG033605, R21AA018398, T32AA013527]; NATIONAL INSTITUTE ON AGING [R01AG033605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018398, T32AA013527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding sources include: NIH R01AG033605 (TRP), NIH R21AA018398 (TRP), and NIH T32AA013527 (MMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Evuarherhe O, 2009, J PHYSIOL-LONDON, V587, P2977, DOI 10.1113/jphysiol.2008.168393; Evuarherhe O, 2009, J ENDOCRINOL, V202, P279, DOI 10.1677/JOE-09-0175; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Isgor C, 2003, NEUROSCIENCE, V121, P837, DOI 10.1016/S0306-4522(03)00561-X; JANKORD R, ENDOCRINOLOGY, V152, P629; KETELSLEGERS JM, 1978, ENDOCRINOLOGY, V103, P212, DOI 10.1210/endo-103-1-212; Lauing K, 2008, ALCOHOL, V42, P649, DOI 10.1016/j.alcohol.2008.08.005; Li ZQ, 2005, MOL CELL NEUROSCI, V29, P345, DOI 10.1016/j.mcn.2005.04.002; MALDONADODEVINC.AM, ALCOHOL, V44, P57; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; McEvoy PM, 2008, J ANXIETY DISORD, V22, P1087, DOI 10.1016/j.janxdis.2007.11.007; Ogilvie K, 1997, ALCOHOL CLIN EXP RES, V21, P467, DOI 10.1111/j.1530-0277.1997.tb03792.x; Ogilvie KM, 1997, BRAIN RES, V744, P83, DOI 10.1016/S0006-8993(96)01082-7; Ogilvie KM, 1998, J NEUROSCI, V18, P4344; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Przybycien-Szymanska MM, 2009, AM J PHYSL ENDOCRINO; Rivier C, 1996, BRAIN RES, V726, P1, DOI 10.1016/0006-8993(96)00301-0; Romeo RD, 2006, ENDOCRINOLOGY, V147, P1664, DOI 10.1210/en.2005-1432; Romeo RD, 2004, NEUROENDOCRINOLOGY, V79, P125, DOI 10.1159/000077270; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; Roy A, 2002, J PHARMACOL EXP THER, V301, P774, DOI 10.1124/jpet.301.2.774; Silva SM, 2002, BRAIN RES, V954, P82, DOI 10.1016/S0006-8993(02)03346-2; Silva SM, 2002, BRAIN RES, V925, P76, DOI 10.1016/S0006-8993(01)03261-9; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Smith KL, 2008, OBESITY, V16, P2239, DOI 10.1038/oby.2008.366; SODERSTEN P, 1975, HORM BEHAV, V6, P307, DOI 10.1016/0018-506X(75)90001-X; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; VAZQUEZ DM, 1993, PEDIATR RES, V34, P646, DOI 10.1203/00006450-199311000-00017; Walker BM, 2009, PHARMACOL BIOCHEM BE, V91, P560, DOI 10.1016/j.pbb.2008.09.017; Zilberman ML, 2003, CAN J PSYCHIAT, V48, P5, DOI 10.1177/070674370304800103	34	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18350	10.1371/journal.pone.0018350	http://dx.doi.org/10.1371/journal.pone.0018350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533237	Green Published, gold, Green Submitted			2022-12-25	WOS:000289458800009
J	Salichos, L; Rokas, A				Salichos, Leonidas; Rokas, Antonis			Evaluating Ortholog Prediction Algorithms in a Yeast Model Clade	PLOS ONE			English	Article							GENOME; GENE; DATABASE; SACCHAROMYCES; EVOLUTION; IDENTIFICATION; DUPLICATION; RECONSTRUCTION; INFERENCE; HOMOLOGY	Background: Accurate identification of orthologs is crucial for evolutionary studies and for functional annotation. Several algorithms have been developed for ortholog delineation, but so far, manually curated genome-scale biological databases of orthologous genes for algorithm evaluation have been lacking. We evaluated four popular ortholog prediction algorithms (MULTIPARANOID; and ORTHOMCL; RBH: Reciprocal Best Hit; RSD: Reciprocal Smallest Distance; the last two extended into clustering algorithms CRBH and CRSD, respectively, so that they can predict orthologs across multiple taxa) against a set of 2,723 groups of high-quality curated orthologs from 6 Saccharomycete yeasts in the Yeast Gene Order Browser. Results: Examination of SENSITIVITY [TP/(TP+ FN)], SPECIFICITY [TN/(TN+FP)], and ACCURACY [(TP+TN)/(TP+TN+FP+FN)] across a broad parameter range showed that CRBH was the most accurate and specific algorithm, whereas ORTHOMCL was the most sensitive. Evaluation of the algorithms across a varying number of species showed that CRBH had the highest ACCURACY and lowest FALSE DISCOVERY RATE [FP/(FP+TP)], followed by CRSD. Of the six species in our set, three descended from an ancestor that underwent whole genome duplication. Subsequent differential duplicate loss events in the three descendants resulted in distinct classes of gene loss patterns, including cases where the genes retained in the three descendants are paralogs, constituting 'traps' for ortholog prediction algorithms. We found that the FALSE DISCOVERY RATE of all algorithms dramatically increased in these traps. Conclusions: These results suggest that simple algorithms, like CRBH, may be better ortholog predictors than more complex ones (e.g., ORTHOMCL and MULTIPARANOID) for evolutionary and functional genomics studies where the objective is the accurate inference of single-copy orthologs (e.g., molecular phylogenetics), but that all algorithms fail to accurately predict orthologs when paralogy is rampant.	[Salichos, Leonidas; Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37240 USA	Vanderbilt University	Salichos, L (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37240 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551	National Science Foundation [DEB-0844968]; Vanderbilt University	National Science Foundation(National Science Foundation (NSF)); Vanderbilt University	LS is funded by the Graduate Program in Biological Sciences at Vanderbilt University. Research in AR's laboratory is supported by the Searle Scholars Program and the National Science Foundation (DEB-0844968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; BORK P, 1995, MOL MICROBIOL, V16, P955, DOI 10.1111/j.1365-2958.1995.tb02321.x; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chiu JC, 2006, BIOINFORMATICS, V22, P699, DOI 10.1093/bioinformatics/btk040; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Dessimoz C, 2006, NUCLEIC ACIDS RES, V34, P3309, DOI 10.1093/nar/gkl433; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Ehrlich J, 1997, GENETICS, V147, P289; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Grossetete S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-81; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kent BN, 2011, GENOME BIOL EVOL, V3, P209, DOI 10.1093/gbe/evr007; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koonin EV, 2001, CURR BIOL, V11, pR155, DOI 10.1016/S0960-9822(01)00081-1; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Lemoine F, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-237; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Mindell DP, 2001, TRENDS ECOL EVOL, V16, P434, DOI 10.1016/S0169-5347(01)02206-6; Mirny LA, 2002, GENOME BIOL, V3; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Salichos L, 2010, MYCOLOGIA, V102, P269, DOI 10.3852/09-073; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Sokal R. R., 2012, BIOMETRY; Storm CEV, 2003, GENOME RES, V13, P2353, DOI 10.1101/gr1305203; Storm CEV, 2002, BIOINFORMATICS, V18, P92, DOI 10.1093/bioinformatics/18.1.92; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 1996, CURR BIOL, V6, P279, DOI 10.1016/S0960-9822(02)00478-5; van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zmasek CM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-14	56	63	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18755	10.1371/journal.pone.0018755	http://dx.doi.org/10.1371/journal.pone.0018755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533202	gold, Green Submitted, Green Published			2022-12-25	WOS:000289458800035
J	Meng, XB; Ezzati, P; Wilkins, JA				Meng, Xiaobo; Ezzati, Peyman; Wilkins, John A.			Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CANCER CELLS; E-CADHERIN; TRANSCRIPTIONAL REPRESSOR; BREAST-CANCER; BHLH FACTORS; EXPRESSION; PLASTICITY; EMT; FIBROBLASTS	Epithelial mesenchymal transition (EMT) is characterized by the development of mesenchymal properties such as a fibroblast-like morphology with altered cytoskeletal organization and enhanced migratory potential. We report that the expression of podocalyxin (PODXL), a member of the CD34 family, is markedly increased during TGF-beta induced EMT. PODXL is enriched on the leading edges of migrating A549 cells. Silencing of podocalyxin expression reduced cell ruffle formation, spreading, migration and affected the expression patterns of several proteins that normally change during EMT (e. g., vimentin, E-cadherin). Cytoskeletion assembly in EMT was also found to be dependent on the production of podocalyin. Compositional analysis of podocalyxin containing immunoprecipitates revealed that collagen type 1 was consistently associated with these isolates. Collagen type 1 was also found to co-localize with podocalyxin on the leading edges of migrating cells. The interactions with collagen may be a critical aspect of podocalyxin function. Podocalyxin is an important regulator of the EMT like process as it regulates the loss of epithelial features and the acquisition of a motile phenotype.	[Meng, Xiaobo; Ezzati, Peyman; Wilkins, John A.] Univ Manitoba, Dept Internal Med, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada	University of Manitoba	Meng, XB (corresponding author), Univ Manitoba, Dept Internal Med, Manitoba Ctr Prote & Syst Biol, Winnipeg, MB, Canada.	mengx@cc.umanitoba.ca			Province of Manitoba, Department of Science, Technology, Energy and Mines	Province of Manitoba, Department of Science, Technology, Energy and Mines	The authors acknowledge the support of this research through an operating grant to JAW from the Province of Manitoba, Department of Science, Technology, Energy and Mines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YX, 2010, AM J NEPHROL, V31, P24, DOI 10.1159/000253865; CORNAIRE E, NEPHROL THER; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Fera E, 2004, J BIOL CHEM, V279, P35573, DOI 10.1074/jbc.M400711200; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hajra KM, 2002, CANCER RES, V62, P1613; HSU YH, 2010, PODOCALYXIN EDP50 EZ; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kobayashi T, 2009, NEPHRON EXP NEPHROL, V113, pE89, DOI 10.1159/000235245; Larrucea S, 2007, CELL MOL LIFE SCI, V64, P2965, DOI 10.1007/s00018-007-7374-6; Larrucea S, 2008, EXP CELL RES, V314, P2004, DOI 10.1016/j.yexcr.2008.03.009; Lenferink AEG, 2010, ONCOGENE, V29, P831, DOI 10.1038/onc.2009.399; Li SH, 2000, J BIOL CHEM, V275, P35384, DOI 10.1074/jbc.M005139200; Li Y, 2002, AM J PHYSIOL-RENAL, V282, pF1129, DOI 10.1152/ajprenal.00131.2001; Mathias RA, 2009, BBA-PROTEINS PROTEOM, V1794, P1325, DOI 10.1016/j.bbapap.2009.05.001; Mathias RA, 2009, J PROTEOME RES, V8, P2827, DOI 10.1021/pr8010974; Milosevic J, 2009, PROTEOMICS, V9, P1230, DOI 10.1002/pmic.200700604; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; SAWADA H, 1986, AM J PATHOL, V125, P309; Schopperle WM, 2010, BIOCHEM BIOPH RES CO, V398, P372, DOI 10.1016/j.bbrc.2010.06.074; Sizemore S, 2007, CANCER RES, V67, P6183, DOI 10.1158/0008-5472.CAN-06-3575; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; STOKER M, 1985, J CELL SCI, V77, P209; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zvaifler NJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1963	48	41	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18715	10.1371/journal.pone.0018715	http://dx.doi.org/10.1371/journal.pone.0018715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533279	Green Published, gold, Green Submitted			2022-12-25	WOS:000289404700030
J	Ueda, K; Saichi, N; Takami, S; Kang, D; Toyama, A; Daigo, Y; Ishikawa, N; Kohno, N; Tamura, K; Shuin, T; Nakayama, M; Sato, TA; Nakamura, Y; Nakagawa, H				Ueda, Koji; Saichi, Naomi; Takami, Sachiko; Kang, Daechun; Toyama, Atsuhiko; Daigo, Yataro; Ishikawa, Nobuhisa; Kohno, Nobuoki; Tamura, Kenji; Shuin, Taro; Nakayama, Masato; Sato, Taka-Aki; Nakamura, Yusuke; Nakagawa, Hidewaki			A Comprehensive Peptidome Profiling Technology for the Identification of Early Detection Biomarkers for Lung Adenocarcinoma	PLOS ONE			English	Article							TOF MASS-SPECTROMETRY; APOLIPOPROTEIN-A-IV; CANCER DIAGNOSIS; SERUM; PROTEASES; MARKERS; QUANTIFICATION; FIBRINOPEPTIDE; PROJECT; TUMORS	The mass spectrometry-based peptidomics approaches have proven its usefulness in several areas such as the discovery of physiologically active peptides or biomarker candidates derived from various biological fluids including blood and cerebrospinal fluid. However, to identify biomarkers that are reproducible and clinically applicable, development of a novel technology, which enables rapid, sensitive, and quantitative analysis using hundreds of clinical specimens, has been eagerly awaited. Here we report an integrative peptidomic approach for identification of lung cancer-specific serum peptide biomarkers. It is based on the one-step effective enrichment of peptidome fractions (molecular weight of 1,000-5,000) with size exclusion chromatography in combination with the precise label-free quantification analysis of nano-LC/MS/MS data set using Expressionist proteome server platform. We applied this method to 92 serum samples well-managed with our SOP (standard operating procedure) (30 healthy controls and 62 lung adenocarcinoma patients), and quantitatively assessed the detected 3,537 peptide signals. Among them, 118 peptides showed significantly altered serum levels between the control and lung cancer groups (p < 0.01 and fold change > 5.0). Subsequently we identified peptide sequences by MS/MS analysis and further assessed the reproducibility of Expressionist-based quantification results and their diagnostic powers by MRM-based relative-quantification analysis for 96 independently prepared serum samples and found that APOA4 273-283, FIBA 5-16, and LBN 306-313 should be clinically useful biomarkers for both early detection and tumor staging of lung cancer. Our peptidome profiling technology can provide simple, high-throughput, and reliable quantification of a large number of clinical samples, which is applicable for diverse peptidome-targeting biomarker discoveries using any types of biological specimens.	[Ueda, Koji; Saichi, Naomi; Kang, Daechun; Toyama, Atsuhiko; Nakagawa, Hidewaki] RIKEN, Ctr Genom Med, Lab Biomarker Dev, Yokohama, Kanagawa, Japan; [Takami, Sachiko] CSK Inst Sustainabil Ltd, Tokyo, Japan; [Kang, Daechun; Toyama, Atsuhiko; Daigo, Yataro; Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Toyama, Atsuhiko; Sato, Taka-Aki] Shimadzu Co Ltd, Kyoto, Japan; [Ishikawa, Nobuhisa; Kohno, Nobuoki] Hiroshima Univ, Dept Mol & Internal Med, Hiroshima, Japan; [Tamura, Kenji; Shuin, Taro] Kochi Univ, Sch Med, Dept Urol, Nankoku, Kochi, Japan; [Nakayama, Masato] Toppan Printing Co Ltd, Tokyo, Japan	RIKEN; University of Tokyo; Shimadzu Corporation; Hiroshima University; Kochi University; Toppan Printing Co Ltd	Ueda, K (corresponding author), RIKEN, Ctr Genom Med, Lab Biomarker Dev, Yokohama, Kanagawa, Japan.	k-ueda@riken.jp; hidewaki@ims.u-tokyo.ac.jp	Hiyama, Eiso/A-2013-2019	Hiyama, Eiso/0000-0001-9179-5037; Daigo, Yataro/0000-0002-0915-3025	Japanese Ministry of Education, Culture, Sports, Science and Technology [22680064]; Shimadzu Corporation; CSK Institute for Sustainability, Ltd.; Toppan Printing Co., Ltd.; Grants-in-Aid for Scientific Research [221S0001, 22680064] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shimadzu Corporation; CSK Institute for Sustainability, Ltd.; Toppan Printing Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japanese Ministry of Education, Culture, Sports, Science and Technology (Wakate-A, 22680064, http://kaken.nii.ac.jp/ja/p/22680064). This study was also funded by Shimadzu Corporation, CSK Institute for Sustainability, Ltd., Toppan Printing Co., Ltd. As employers of ST, AT, TS, or MN in this study, these funders did play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrethsen J, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-8; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Ebert MPA, 2006, J PROTEOME RES, V5, P2152, DOI 10.1021/pr060011c; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; GAIL MH, 1988, J NATL CANCER I, V80, P97, DOI 10.1093/jnci/80.2.97; Galdzicka M, 2002, MOL GENET METAB, V77, P291, DOI 10.1016/S1096-7192(02)00178-6; Gamez-Pozo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007731; Gianazza E, 2010, J PROTEOMICS, V73, P593, DOI 10.1016/j.jprot.2009.07.006; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Grunder S, 2000, NEUROREPORT, V11, P1607; Hanniman EA, 2006, J LIPID RES, V47, P2503, DOI 10.1194/jlr.M600303-JLR200; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Huang ZC, 2009, RHEUMATOLOGY, V48, P626, DOI 10.1093/rheumatology/kep058; Liu M, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-16; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Maurya P, 2007, ANTICANCER RES, V27, P1247; McCarthy NJ, 2001, CANCER J, V7, P175; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Qiu FM, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-126; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Sasaki K, 2010, J PROTEOME RES, V9, P5047, DOI 10.1021/pr1003455; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Shen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013133; Sung HJ, 2008, BMB REP, V41, P615, DOI 10.5483/BMBRep.2008.41.9.615; Ueda K, 2010, MOL CELL PROTEOMICS, V9, P1819, DOI 10.1074/mcp.2010/000893; Villanueva J, 2009, NAT PROTOC, V4, P1167, DOI 10.1038/nprot.2009.88; Wang Q, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-287; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wong MYM, 2010, ELECTROPHORESIS, V31, P1721, DOI 10.1002/elps.200900571; Zito F, 2000, CIRCULATION, V102, P2058, DOI 10.1161/01.CIR.102.17.2058	36	24	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18567	10.1371/journal.pone.0018567	http://dx.doi.org/10.1371/journal.pone.0018567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533267	gold, Green Submitted, Green Published			2022-12-25	WOS:000289404700020
J	Basco, D; Nicchia, GP; D'Alessandro, A; Zolla, L; Svelto, M; Frigeri, A				Basco, Davide; Nicchia, Grazia Paola; D'Alessandro, Angelo; Zolla, Lello; Svelto, Maria; Frigeri, Antonio			Absence of Aquaporin-4 in Skeletal Muscle Alters Proteins Involved in Bioenergetic Pathways and Calcium Handling	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; WATER CHANNEL; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; KNOCKOUT MICE; MDX-MICE; EXPRESSION; LOCALIZATION; EXERCISE; CELLS	Aquaporin-4 (AQP4) is a water channel expressed at the sarcolemma of fast-twitch skeletal muscle fibers, whose expression is altered in several forms of muscular dystrophies. However, little is known concerning the physiological role of AQP4 in skeletal muscle and its functional and structural interaction with skeletal muscle proteome. Using AQP4-null mice, we analyzed the effect of the absence of AQP4 on the morphology and protein composition of sarcolemma as well as on the whole skeletal muscle proteome. Immunofluorescence analysis showed that the absence of AQP4 did not perturb the expression and cellular localization of the dystrophin-glycoprotein complex proteins, aside from those belonging to the extracellular matrix, and no alteration was found in sarcolemma integrity by dye extravasation assay. With the use of a 2DE-approach (BN/SDS-PAGE), protein maps revealed that in quadriceps, out of 300 Coomassie-blue detected and matched spots, 19 proteins exhibited changed expression in AQP4(-/-) compared to WT mice. In particular, comparison of the protein profiles revealed 12 up-and 7 down-regulated protein spots in AQP4(-/-) muscle. Protein identification by MS revealed that the perturbed expression pattern belongs to proteins involved in energy metabolism (i.e. GAPDH, creatine kinase), as well as in Ca2+ handling (i.e. parvalbumin, SERCA1). Western blot analysis, performed on some significantly changed proteins, validated the 2D results. Together these findings suggest AQP4 as a novel determinant in the regulation of skeletal muscle metabolism and better define the role of this water channel in skeletal muscle physiology.	[Basco, Davide; Nicchia, Grazia Paola; Svelto, Maria; Frigeri, Antonio] Univ Bari Aldo Moro, Dept Gen & Environm Physiol, Bari, Italy; [Basco, Davide; Nicchia, Grazia Paola; Svelto, Maria; Frigeri, Antonio] Univ Bari Aldo Moro, Ctr Excellence Comparat Gen CEGBA, Bari, Italy; [D'Alessandro, Angelo; Zolla, Lello] Largo Univ Snc, Univ Tuscia, Dept Environm Sci, Viterbo, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Tuscia University	Basco, D (corresponding author), Univ Bari Aldo Moro, Dept Gen & Environm Physiol, Bari, Italy.	a.frigeri@biologia.uniba.it	frigeri, Antonio/AAC-6336-2022; D'Alessandro, Angelo/AAA-4695-2019; Svelto, Maria/P-6186-2014	D'Alessandro, Angelo/0000-0002-2258-6490; Frigeri, Antonio/0000-0002-5284-2934; Svelto, Maria/0000-0002-5584-9541; Basco, Davide/0000-0002-7984-5676	Association Francaise Contre les Myopathies [14336]; FIRB - Rete Nazionale di Proteomica [RBRN07BMCT_009]	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); FIRB - Rete Nazionale di Proteomica	Funding was provided by the Association Francaise Contre les Myopathies (www.afm-telethon.fr; project no. 14336 to AF) and FIRB - Rete Nazionale di Proteomica (www.prin.miur.it; RBRN07BMCT_009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Assereto S, 2008, CELL CYCLE, V7, P2199, DOI 10.4161/cc.7.14.6272; Basco D, 2010, NEUROMUSCULAR DISORD, V20, P680, DOI 10.1016/j.nmd.2010.07.267; Basco D, 2010, EUR J APPL PHYSIOL, V110, P1215, DOI 10.1007/s00421-010-1592-6; Blake DJ, 1996, BRAIN PATHOL, V6, P37, DOI 10.1111/j.1750-3639.1996.tb00781.x; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; CRENSHAW AG, 1994, ACTA PHYSIOL SCAND, V152, P265, DOI 10.1111/j.1748-1716.1994.tb09806.x; Cros N, 1999, AM J PHYSIOL-REG I, V276, pR308, DOI 10.1152/ajpregu.1999.276.2.R308; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; DIAZMUNOZ M, 1990, J BIOL CHEM, V265, P15894; Fan Y, 2005, J NEUROSCI RES, V82, P458, DOI 10.1002/jnr.20664; Fan Y, 2008, NEUROBIOL AGING, V29, P1226, DOI 10.1016/j.neurobiolaging.2007.02.015; Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545; Frigeri A, 2002, FASEB J, V16, P1120, DOI 10.1096/fj.01-0797fje; FRIGERI A, 1995, J CELL SCI, V108, P2993; Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com; Frigeri A, 2001, FASEB J, V15, P1282, DOI 10.1096/fj.00-0525fje; GREENLEAF JE, 1979, AM J PHYSIOL, V236, pR206, DOI 10.1152/ajpregu.1979.236.3.R206; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kell R, 1999, J APPL PHYSIOL, V86, P236, DOI 10.1152/jappl.1999.86.1.236; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; LEWIS SF, 1989, EXERCISE SPORT SCI R, V17, P67; LINDINGER MI, 1994, AM J PHYSIOL, V266, pR1896, DOI 10.1152/ajpregu.1994.266.6.R1896; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; Miura P, 2010, HUM MOL GENET, V19, P1211, DOI 10.1093/hmg/ddp591; Murgiano L, 2010, J PROTEOME RES, V9, P6450, DOI 10.1021/pr100693h; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHOTLAND DL, 1981, ACTA NEUROPATHOL, V54, P189, DOI 10.1007/BF00687741; Shaw CE, 2010, NEURON, V68, P812, DOI 10.1016/j.neuron.2010.11.040; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Vajda Z, 2004, NEUROSCIENCE, V129, P993, DOI 10.1016/j.neuroscience.2004.08.055; van Gestel RA, 2010, J PROTEOMICS, V73, P456, DOI 10.1016/j.jprot.2009.08.010; Wakayama Y, 2002, ARCH NEUROL-CHICAGO, V59, P431, DOI 10.1001/archneur.59.3.431; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; WELLER B, 1990, J NEUROL SCI, V100, P9, DOI 10.1016/0022-510X(90)90005-8; Zeng XN, 2007, MOL CELL NEUROSCI, V34, P34, DOI 10.1016/j.mcn.2006.09.008; Zhou JP, 2008, NEUROREPORT, V19, P1, DOI 10.1097/WNR.0b013e3282f2b4eb	47	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19225	10.1371/journal.pone.0019225	http://dx.doi.org/10.1371/journal.pone.0019225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552523	Green Submitted, gold, Green Published			2022-12-25	WOS:000290020700041
J	Tu, YK; Smith, GD; Gilthorpe, MS				Tu, Yu-Kang; Smith, George Davey; Gilthorpe, Mark S.			A New Approach to Age-Period-Cohort Analysis Using Partial Least Squares Regression: The Trend in Blood Pressure in the Glasgow Alumni Cohort	PLOS ONE			English	Article							INTRINSIC ESTIMATOR; DISEASE; MODELS; RESTRICTION; DEHYDRATION; UNIVERSITY; INFANCY; HEALTH; RATES	Due to a problem of identification, how to estimate the distinct effects of age, time period and cohort has been a controversial issue in the analysis of trends in health outcomes in epidemiology. In this study, we propose a novel approach, partial least squares (PLS) analysis, to separate the effects of age, period, and cohort. Our example for illustration is taken from the Glasgow Alumni cohort. A total of 15,322 students (11,755 men and 3,567 women) received medical screening at the Glasgow University between 1948 and 1968. The aim is to investigate the secular trends in blood pressure over 1925 and 1950 while taking into account the year of examination and age at examination. We excluded students born before 1925 or aged over 25 years at examination and those with missing values in confounders from the analyses, resulting in 12,546 and 12,516 students for analysis of systolic and diastolic blood pressure, respectively. PLS analysis shows that both systolic and diastolic blood pressure increased with students' age, and students born later had on average lower blood pressure (SBP: -0.17 mmHg/per year [95% confidence intervals: -0.19 to -0.15] for men and -0.25 [-0.28 to -0.22] for women; DBP: -0.14 [-0.15 to -0.13] for men; -0.09 [-0.11 to -0.07] for women). PLS also shows a decreasing trend in blood pressure over the examination period. As identification is not a problem for PLS, it provides a flexible modelling strategy for age-period-cohort analysis. More emphasis is then required to clarify the substantive and conceptual issues surrounding the definitions and interpretations of age, period and cohort effects.	[Tu, Yu-Kang; Gilthorpe, Mark S.] Univ Leeds, Div Biostat, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [Tu, Yu-Kang] Univ Leeds, Leeds Dent Inst, Leeds, W Yorkshire, England; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England	University of Leeds; University of Leeds; University of Bristol	Tu, YK (corresponding author), Univ Leeds, Div Biostat, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England.	y.k.tu@leeds.ac.uk	Davey Smith, George/A-7407-2013; Gilthorpe, Mark S/C-1240-2008	Davey Smith, George/0000-0002-1407-8314; Gilthorpe, Mark S/0000-0001-8783-7695; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tu, Yu-Kang/0000-0002-2461-474X; s, hema/0000-0002-3440-9475	Higher Education Funding Council in England (HEFCE); UK research council; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	Higher Education Funding Council in England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); UK research council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors were funded by the Higher Education Funding Council in England (HEFCE). YKT currently holds a UK research council fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Basilevsky A., 2005, APPL MATRIX ALGEBRA; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Carroll J.D., 1997, MATH TOOLS APPL MULT, DOI [10.1016/B978-012160954-2/50007-X, DOI 10.1016/B978-012160954-2/50007-X]; Chevallier S, 2006, J CHEMOMETR, V20, P221, DOI 10.1002/cem.994; DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X; Ebrahim S, 1998, J PUBLIC HEALTH MED, V20, P441, DOI 10.1093/oxfordjournals.pubmed.a024800; Eriksson L., 2003, HDB CHEMOINFORMATICS, V1134-1166; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Fox J, 2008, APPL REGRESSION ANAL, P307; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; GLENN ND, 1976, AM SOCIOL REV, V41, P900, DOI 10.2307/2094738; GLENN ND, 2003, HDB LIFE COUSE; Glenn Norval D., 2005, COHORT ANAL; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2009, LANCET, V373, P1654, DOI 10.1016/S0140-6736(09)60234-8; GOLDSTEIN H, 1979, J APPL STAT, V6, P19; Hadi AS, 1998, AM STAT, V52, P15, DOI 10.2307/2685559; HARRELL FE, 2001, REGRESSION MODELING, P20; Harville D.A., 2008, MATRIX ALGEBRA STAT; Hastie T., 2009, UNSUPERVISED LEARNIN; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; KASPAR MH, 1993, COMPUT CHEM ENG, V17, P985, DOI 10.1016/0098-1354(93)80079-3; Keyes KM, 2010, SOC SCI MED, V70, P1100, DOI 10.1016/j.socscimed.2009.12.018; Khuri AI, 2010, LINEAR MODEL METHODO, P179; Lawlor DA, 2006, AM J EPIDEMIOL, V163, P608, DOI 10.1093/aje/kwj085; Lee WC, 1996, STAT MED, V15, P273, DOI 10.1002/(SICI)1097-0258(19960215)15:3<273::AID-SIM172>3.0.CO;2-R; Lee WC, 1996, BIOMETRICAL J, V38, P97, DOI 10.1002/bimj.4710380109; MAZUMDAR S, 1980, AM STAT, V34, P103, DOI 10.2307/2684114; McCarron P, 1999, PUBLIC HEALTH, V113, P265, DOI 10.1016/S0033-3506(99)00178-X; McCarron P, 2001, BMJ-BRIT MED J, V322, P885, DOI 10.1136/bmj.322.7291.885; O'Brien RM, 2011, QUAL QUANT, V45, P1429, DOI 10.1007/s11135-010-9397-6; Osmond C, 1982, Stat Med, V1, P245, DOI 10.1002/sim.4780010306; Phatak A, 1997, J CHEMOMETR, V11, P311, DOI 10.1002/(SICI)1099-128X(199707)11:4<311::AID-CEM478>3.0.CO;2-4; Pringle RM, 1971, GEN INVERSE MATRICES, P80; Rencher AC, 2008, LINEAR MODELS IN STATISTICS, 2ND EDITION, P295; Robertson C, 1998, STAT MED, V17, P1305, DOI 10.1002/(SICI)1097-0258(19980630)17:12<1305::AID-SIM853>3.0.CO;2-W; Robertson C, 1999, J CLIN EPIDEMIOL, V52, P569, DOI 10.1016/S0895-4356(99)00033-5; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; SEARLE SR, AM STAT, V38, P53; Smith GD, 2006, J EPIDEMIOL COMMUN H, V60, P142, DOI 10.1136/jech.2005.040006; Sundberg R., 2006, ENCY STAT SCI, V2nd, P1342; Tu YK, 2004, EUR J ORAL SCI, V112, P389, DOI 10.1111/j.1600-0722.2004.00160.x; Tu YK, 2010, EPIDEMIOLOGY, V21, P440, DOI 10.1097/EDE.0b013e3181d62123; WAKELING IN, 1993, J CHEMOMETR, V7, P291, DOI 10.1002/cem.1180070407; Wold S., 2001, CHEMOMETR INTELL LAB, V58; Yang Y, 2004, SOCIOL METHODOL, V34, P75, DOI 10.1111/j.0081-1750.2004.00148.x; Yang Y, 2008, AM J SOCIOL, V113, P1697, DOI 10.1086/587154	49	31	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19401	10.1371/journal.pone.0019401	http://dx.doi.org/10.1371/journal.pone.0019401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756NO	21556329	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400055
J	Gabrielsen, TM; Minge, MA; Espelund, M; Tooming-Klunderud, A; Patil, V; Nederbragt, AJ; Otis, C; Turmel, M; Shalchian-Tabrizi, K; Lemieux, C; Jakobsen, KS				Gabrielsen, Tove M.; Minge, Marianne A.; Espelund, Mari; Tooming-Klunderud, Ave; Patil, Vishwanath; Nederbragt, Alexander J.; Otis, Christian; Turmel, Monique; Shalchian-Tabrizi, Kamran; Lemieux, Claude; Jakobsen, Kjetill S.			Genome Evolution of a Tertiary Dinoflagellate Plastid	PLOS ONE			English	Article							TRANSFER-RNA GENES; CHLOROPLAST GENOME; SEQUENCE; ORIGIN; PHYLOGENY; PERIDININ; TRANSCRIPTS	The dinoflagellates have repeatedly replaced their ancestral peridinin-plastid by plastids derived from a variety of algal lineages ranging from green algae to diatoms. Here, we have characterized the genome of a dinoflagellate plastid of tertiary origin in order to understand the evolutionary processes that have shaped the organelle since it was acquired as a symbiont cell. To address this, the genome of the haptophyte-derived plastid in Karlodinium veneficum was analyzed by Sanger sequencing of library clones and 454 pyrosequencing of plastid enriched DNA fractions. The sequences were assembled into a single contig of 143 kb, encoding 70 proteins, 3 rRNAs and a nearly full set of tRNAs. Comparative genomics revealed massive rearrangements and gene losses compared to the haptophyte plastid; only a small fraction of the gene clusters usually found in haptophytes as well as other types of plastids are present in K. veneficum. Despite the reduced number of genes, the K. veneficum plastid genome has retained a large size due to expanded intergenic regions. Some of the plastid genes are highly diverged and may be pseudogenes or subject to RNA editing. Gene losses and rearrangements are also features of the genomes of the peridinin-containing plastids, apicomplexa and Chromera, suggesting that the evolutionary processes that once shaped these plastids have occurred at multiple independent occasions over the history of the Alveolata.	[Gabrielsen, Tove M.; Minge, Marianne A.; Espelund, Mari; Tooming-Klunderud, Ave; Patil, Vishwanath; Nederbragt, Alexander J.; Jakobsen, Kjetill S.] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Shalchian-Tabrizi, Kamran] Univ Oslo, Dept Biol, Microbial Evolut Res Grp, Oslo, Norway; [Otis, Christian; Turmel, Monique; Lemieux, Claude] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	University of Oslo; University of Oslo; Laval University	Gabrielsen, TM (corresponding author), Univ Ctr Svalbard, Dept Arctic Biol, Longyearbyen, Norway.	k.s.jakobsen@bio.uio.no	Lemieux, Claude/L-8831-2015; Turmel, Monique/AAC-9752-2020	Lemieux, Claude/0000-0001-9580-8042; Turmel, Monique/0000-0001-7060-035X; Nederbragt, Lex/0000-0001-5539-0999	Research Council of Norway; Natural Sciences and Engineering Research Council of Canada; UiO	Research Council of Norway(Research Council of Norway); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UiO	The project was funded by the Research Council of Norway and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KST thanks the UiO for starting grants and RCN for travelling grants. We thank the Bioportal (www.bioportal.uio.no) for computing resources, the Norwegian Sequencing Centre (NSC) for performing the 454 sequencing, professor Dag Klaveness for help with culturing, and Marcel J.W. Veldhuis for testing for bacteria in our cultures using flow-cytometry.	Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Barbrook AC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-297; BJORNLAND T, 1979, J PHYCOL, V15, P457; Chesnick JM, 1996, J PHYCOL, V32, P850, DOI 10.1111/j.0022-3646.1996.00850.x; Dang Y, 2009, GENE, V442, P73, DOI 10.1016/j.gene.2009.04.006; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Eppley RW, 1967, J EXP MAR BIOL ECOL, V1, P191, DOI [10.1016/0022-0981(67)90014-7, DOI 10.1016/0022-0981(67)90014-7]; GRAY MW, 1996, EVOLUTION MICROBIAL, P00109; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; Ishida K, 2002, P NATL ACAD SCI USA, V99, P9294, DOI 10.1073/pnas.142091799; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Lin S, 2002, J MOL BIOL, V320; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; McFadden GI, 1999, J EUKARYOT MICROBIOL, V46, P339, DOI 10.1111/j.1550-7408.1999.tb04613.x; Minge MA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-191; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nederbragt AJ, 2010, SEQUENCING; Nelson MJ, 2007, GENE, V392, P291, DOI 10.1016/j.gene.2007.01.018; Nosenko T, 2006, MOL BIOL EVOL, V23, P2026, DOI 10.1093/molbev/msl074; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Patron NJ, 2006, J MOL BIOL, V357, P1373, DOI 10.1016/j.jmb.2006.01.084; Puerta MVS, 2005, DNA RES, V12, P151, DOI 10.1093/dnares/12.2.151; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; SCHNEPF E, 1988, BOT ACTA, V101, P196, DOI 10.1111/j.1438-8677.1988.tb00033.x; Shalchian-Tabrizi K, 2006, J EUKARYOT MICROBIOL, V53, P217, DOI 10.1111/j.1550-7408.2006.00098.x; Shalchian-Tabrizi K, 2006, MOL BIOL EVOL, V23, P1504, DOI 10.1093/molbev/msl011; Stoebe B, 1999, TRENDS GENET, V15, P344, DOI 10.1016/S0168-9525(99)01815-6; Takishita K, 2004, PROTIST, V155, P447, DOI 10.1078/1434461042650325; Tengs T, 2000, MOL BIOL EVOL, V17, P718, DOI 10.1093/oxfordjournals.molbev.a026350; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Turmel M, 2006, MOL BIOL EVOL, V23, P1324, DOI 10.1093/molbev/msk018; Wang Y, 2006, NUCLEIC ACIDS RES, V34, P659; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799; Zauner S, 2004, FEBS LETT, V577, P535, DOI 10.1016/j.febslet.2004.10.060; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099	41	48	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19132	10.1371/journal.pone.0019132	http://dx.doi.org/10.1371/journal.pone.0019132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541332	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400025
J	Gruszczynska-Biegala, J; Pomorski, P; Wisniewska, MB; Kuznicki, J				Gruszczynska-Biegala, Joanna; Pomorski, Pawel; Wisniewska, Marta B.; Kuznicki, Jacek			Differential Roles for STIM1 and STIM2 in Store-Operated Calcium Entry in Rat Neurons	PLOS ONE			English	Article							CA2+ ENTRY; CHANNEL FUNCTION; ACTIVATION; ORAI1; OLIGOMERIZATION; TRANSDUCTION; EXPRESSION; KINETICS; INFLUX; GENES	The interaction between Ca2+ sensors STIM1 and STIM2 and Ca2+ channel-forming protein ORAI1 is a crucial element of store-operated calcium entry (SOCE) in non-excitable cells. However, the molecular mechanism of SOCE in neurons remains unclear. We addressed this issue by establishing the presence and function of STIM proteins. Real-time polymerase chain reaction from cortical neurons showed that these cells contain significant amounts of Stim1 and Stim2 mRNA. Thapsigargin (TG) treatment increased the amount of both endogenous STIM proteins in neuronal membrane fractions. The number of YFP-STIM1/ORAI1 and YFP-STIM2/ORAI1 complexes was also enhanced by such treatment. The differences observed in the number of STIM1 and STIM2 complexes under SOCE conditions and the differential sensitivity to SOCE inhibitors suggest their distinct roles. Endoplasmic reticulum (ER) store depletion by TG enhanced intracellular Ca2+ levels in loaded with Fura-2 neurons transfected with YFP-STIM1 and ORAI1, but not with YFP-STIM2 and ORAI1, which correlated well with the number of complexes formed. Moreover, the SOCE inhibitors ML-9 and 2-APB reduced Ca2+ influx in neurons expressing YFP-STIM1/ORAI1 but produced no effect in cells transfected with YFP-STIM2/ORAI1. Moreover, in neurons transfected with YFP-STIM2/ORAI1, the increase in constitutive calcium entry was greater than with YFP-STIM1/ORAI1. Our data indicate that both STIM proteins are involved in calcium homeostasis in neurons. STIM1 mainly activates SOCE, whereas STIM2 regulates resting Ca2+ levels in the ER and Ca2+ leakage with the additional involvement of STIM1.	[Gruszczynska-Biegala, Joanna; Wisniewska, Marta B.; Kuznicki, Jacek] Int Inst Mol & Cell Biol, Lab Neurodegenerat, Warsaw, Poland; [Pomorski, Pawel; Kuznicki, Jacek] Nencki Inst Expt Biol, Dept Biochem, Warsaw, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Gruszczynska-Biegala, J (corresponding author), Int Inst Mol & Cell Biol, Lab Neurodegenerat, Warsaw, Poland.	jkuznicki@iimcb.gov.pl	Wisniewska, Marta B./A-6691-2009; Gruszczynska-Biegala, Joanna/U-4945-2019; Kuznicki, Jacek/AAW-9239-2020; Pomorski, Pawel/AAC-3993-2020; Pomorski, Paweł/R-4170-2016	Wisniewska, Marta B./0000-0002-1593-0361; Gruszczynska-Biegala, Joanna/0000-0003-3541-2550; Kuznicki, Jacek/0000-0001-6486-0657; Pomorski, Pawel/0000-0002-1658-7649; Pomorski, Paweł/0000-0002-1658-7649	Polish-German grant [S001/P-N/2007/01, 01GZ0713]; European Union [REG-POT229676]; Polish Ministerial grant [1900/B/P01/2010/39]	Polish-German grant; European Union(European Commission); Polish Ministerial grant	This work was supported by funds from a Polish-German grant (S001/P-N/2007/01, 01GZ0713, JK), from the European Union's Seventh Framework Programme HEALTH-PROT (REG-POT229676, JK), and from a Polish Ministerial grant (1900/B/P01/2010/39, JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bojarski L, 2009, BBA-MOL CELL RES, V1793, P1050, DOI 10.1016/j.bbamcr.2008.11.008; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Keil JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013465; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Martin ACL, 2009, MOL PHARMACOL, V75, P830, DOI 10.1124/mol.108.051748; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 2003, CELL CALCIUM, V34, P339, DOI 10.1016/S0143-4160(03)00143-X; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Siow NL, 2010, MOL PHARMACOL, V78, P1059, DOI 10.1124/mol.110.066506; Skibinska-Kijek A, 2009, ACTA NEUROBIOL EXP, V69, P413; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Tung EKK, 2004, MOL PHARMACOL, V66, P794, DOI 10.1124/mol.104.003269; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Venkiteswaran G, 2009, P NATL ACAD SCI USA, V106, P10326, DOI 10.1073/pnas.0902982106; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wojda U, 2008, IUBMB LIFE, V60, P575, DOI 10.1002/iub.91; Zawadzka M, 2003, MOL CELL NEUROSCI, V22, P202, DOI 10.1016/S1044-7431(03)00036-8; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	41	103	106	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19285	10.1371/journal.pone.0019285	http://dx.doi.org/10.1371/journal.pone.0019285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541286	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400041
J	Heinonen, KM; Vanegas, JR; Lew, D; Krosl, J; Perreault, C				Heinonen, Krista M.; Vanegas, Juan Ruiz; Lew, Deborah; Krosl, Jana; Perreault, Claude			Wnt4 Enhances Murine Hematopoietic Progenitor Cell Expansion Through a Planar Cell Polarity-Like Pathway	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; SELF-RENEWAL; IDENTIFICATION; RECEPTOR; EVENTS; NICHE; COLLABORATION; ACTIVATION; EXPRESSION	Background: While the role of canonical (beta-catenin-mediated) Wnt signaling in hematolymphopoiesis has been studied extensively, little is known of the potential importance of non-canonical Wnt signals in hematopoietic cells. Wnt4 is one of the Wnt proteins that can elicit non-canonical pathways. We have previously shown that retroviral overexpression of Wnt4 by hematopoietic cells increased thymic cellularity as well as the frequency of early thymic progenitors and bone marrow hematopoietic progenitor cells (HPCs). However, the molecular pathways responsible for its effect in HPCs are not known. Methodology/Principal Findings: Here we report that Wnt4 stimulation resulted in the activation of the small GTPase Rac1 as well as Jnk kinases in an HPC cell line. Jnk activity was necessary, while beta-catenin was dispensable, for the Wnt4-mediated expansion of primary fetal liver HPCs in culture. Furthermore, Jnk2-deficient and Wnt4 hemizygous mice presented lower numbers of HPCs in their bone marrow, and Jnk2-deficient HPCs showed increased rates of apoptosis. Wnt4 also improved HPC activity in a competitive reconstitution model in a cell-autonomous, Jnk2-dependent manner. Lastly, we identified Fz6 as a receptor for Wnt4 in immature HPCs and showed that the absence of Wnt4 led to a decreased expression of four polarity complex genes. Conclusions/Significance: Our results establish a functional role for non-canonical Wnt signaling in hematopoiesis through a pathway involving Wnt4, Fz6, Rac1 and Jnk kinases.	[Heinonen, Krista M.; Vanegas, Juan Ruiz; Lew, Deborah; Krosl, Jana; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Heinonen, Krista M.; Vanegas, Juan Ruiz; Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Perreault, Claude] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Heinonen, KM (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	c.perreault@videotron.ca	Heinonen, Krista M/G-9769-2016; Perreault, Claude/A-7220-2008	Heinonen, Krista M/0000-0002-2410-4432; Perreault, Claude/0000-0001-9453-7383	Canadian Institutes of Health Research (CIHR) [MOP42384]; Terry Fox Foundation; Canadian Center of Excellence in Commercialization and Research; Canada Foundation for Innovation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation; Canadian Center of Excellence in Commercialization and Research; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	Grant #MOP42384 from the Canadian Institutes of Health Research (CIHR) supported this work. KMH was supported by a training grant from the Terry Fox Foundation. CP holds a Canada Research Chair in Immunobiology. The Institute for Research in Immunology and Cancer (IRIC) is supported in part by the Canadian Center of Excellence in Commercialization and Research, the Canada Foundation for Innovation, and the Fonds de la Recherche en Sante du Quebec. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Aguado R, 2010, BLOOD, V116, P1705, DOI 10.1182/blood-2009-10-246777; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Buckley S M, 2010, EXP HEMATOL; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Jiang Y, 2009, BLOOD, V114, P3773, DOI 10.1182/blood-2009-05-219840; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kokolus K, 2010, IMMUNOL RES, V46, P155, DOI 10.1007/s12026-009-8116-7; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Louis I, 2008, IMMUNITY, V29, P57, DOI 10.1016/j.immuni.2008.04.023; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nemeth MJ, 2009, STEM CELLS, V27, P1109, DOI 10.1002/stem.32; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Ranheim EA, 2005, BLOOD, V105, P2487, DOI 10.1182/blood-2004-06-2334; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; TSAI S, 1994, GENE DEV, V8, P2831, DOI 10.1101/gad.8.23.2831; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vijayaragavan K, 2009, CELL STEM CELL, V4, P248, DOI 10.1016/j.stem.2008.12.011; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	54	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19279	10.1371/journal.pone.0019279	http://dx.doi.org/10.1371/journal.pone.0019279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541287	gold, Green Published, Green Submitted			2022-12-25	WOS:000290018400039
J	Negovetich, NJ; Feeroz, MM; Jones-Engel, L; Walker, D; Alam, SMR; Hasan, K; Seiler, P; Ferguson, A; Friedman, K; Barman, S; Franks, J; Turner, J; Krauss, S; Webby, RJ; Webster, RG				Negovetich, Nicholas J.; Feeroz, Mohammed M.; Jones-Engel, Lisa; Walker, David; Alam, S. M. Rabiul; Hasan, Kamrul; Seiler, Patrick; Ferguson, Angie; Friedman, Kim; Barman, Subrata; Franks, John; Turner, Jasmine; Krauss, Scott; Webby, Richard J.; Webster, Robert G.			Live Bird Markets of Bangladesh: H9N2 Viruses and the Near Absence of Highly Pathogenic H5N1 Influenza	PLOS ONE			English	Article							A VIRUSES; HONG-KONG; GENETIC-CHARACTERIZATION; POULTRY MARKETS; SOUTHERN CHINA; WILD BIRDS; CHICKENS; TRANSMISSION; REPLICATION; EVOLUTION	Avian influenza surveillance in Bangladesh has been passive, relying on poultry farmers to report suspected outbreaks of highly pathogenic H5N1 influenza. Here, the results of an active surveillance effort focusing on the live-bird markets are presented. Prevalence of influenza infection in the birds of the live bird markets is 23.0%, which is similar to that in poultry markets in other countries. Nearly all of the isolates (94%) were of the non-pathogenic H9N2 subtype, but viruses of the H1N2, H1N3, H3N6, H4N2, H5N1, and H10N7 subtypes were also observed. The highly pathogenic H5N1-subtype virus was observed at extremely low prevalence in the surveillance samples (0.08%), and we suggest that the current risk of infection for humans in the retail poultry markets in Bangladesh is negligible. However, the high prevalence of the H9 subtype and its potential for interaction with the highly pathogenic H5N1-subtype, i.e., reassortment and attenuation of host morbidity, highlight the importance of active surveillance of the poultry markets.	[Negovetich, Nicholas J.; Walker, David; Seiler, Patrick; Ferguson, Angie; Friedman, Kim; Barman, Subrata; Franks, John; Turner, Jasmine; Krauss, Scott; Webby, Richard J.; Webster, Robert G.] St Jude Childrens Hosp, Memphis, TN 38105 USA; [Feeroz, Mohammed M.; Alam, S. M. Rabiul; Hasan, Kamrul] Jahangirnagar Univ, Dhaka, Bangladesh; [Jones-Engel, Lisa] Univ Washington, Seattle, WA 98195 USA	St Jude Children's Research Hospital; Jahangirnagar University; University of Washington; University of Washington Seattle	Negovetich, NJ (corresponding author), St Jude Childrens Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	robert.webster@stjude.org	Webby, Richard J/N-5657-2018; Alam, S M Rabiul/Z-2031-2019; hasan, kamrul/HGV-0910-2022	Alam, S M Rabiul/0000-0002-3419-4769; Jones-Engel, Lisa/0000-0001-6912-494X; Negovetich, Nicholas/0000-0003-1207-2012; Edwards, Kimberly Marie/0000-0003-0944-3118	National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; American Lebanese Syrian Associated Charities (ALSAC)	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the National Institute of Allergy and Infectious Diseases (contract number HHSN266200700005C) and by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Banet-Noach C, 2007, AVIAN DIS, V51, P290, DOI 10.1637/7590-040206R1.1; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Khalenkov A, 2009, VIROLOGY, V383, P32, DOI 10.1016/j.virol.2008.09.026; Lee HJ, 2010, AVIAN DIS, V54, P738, DOI 10.1637/8785-040109-ResNote.1; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Moon HJ, 2010, ARCH VIROL, V155, P229, DOI 10.1007/s00705-009-0577-4; Moosakhani F, 2010, AVIAN DIS, V54, P870, DOI 10.1637/9103-101309-Reg.1; *OIE, 2011, 29 OIE; Palmer DF, 1975, IMMUNOLOGY SERIES, V6; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Shi HY, 2010, AVIAN DIS, V54, P22, DOI 10.1637/8937-052809-Reg.1; Shortridge K F, 1992, Semin Respir Infect, V7, P11; SHORTRIDGE KF, 1977, B WORLD HEALTH ORGAN, V55, P15; Shortridge KF, 1999, VACCINE, V17, pS26, DOI 10.1016/S0264-410X(99)00102-4; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2009, CDC PROT REALT RTPGR; World Health Organization, 2002, WHO MAN AN INFL DIAG; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Yu H, 2008, VET MICROBIOL, V131, P82, DOI 10.1016/j.vetmic.2008.02.024	40	72	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19311	10.1371/journal.pone.0019311	http://dx.doi.org/10.1371/journal.pone.0019311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541296	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400049
J	Shi, YY; Huang, ZY; Zeng, ZJ; Wang, ZL; Wu, XB; Yan, WY				Shi, Yuan Yuan; Huang, Zachary Y.; Zeng, Zhi Jiang; Wang, Zi Long; Wu, Xiao Bo; Yan, Wei Yu			Diet and Cell Size Both Affect Queen-Worker Differentiation through DNA Methylation in Honey Bees (Apis mellifera, Apidae)	PLOS ONE			English	Article								Background: Young larvae of the honey bee (Apis mellifera) are totipotent; they can become either queens (reproductives) or workers (largely sterile helpers). DNA methylation has been shown to play an important role in this differentiation. In this study, we examine the contributions of diet and cell size to caste differentiation. Methodology/Principal Findings: We measured the activity and gene expression of one key enzyme involved in methylation, Dnmt3; the rates of methylation in the gene dynactin p62; as well as morphological characteristics of adult bees developed either from larvae fed with worker jelly or royal jelly; and larvae raised in either queen or worker cells. We show that both diet type and cell size contributed to the queen-worker differentiation, and that the two factors affected different methylation sites inside the same gene dynactin p62. Conclusions/Significance: We confirm previous findings that Dnmt3 plays a critical role in honey bee caste differentiation. Further, we show for the first time that cell size also plays a role in influencing larval development when diet is kept the same.	[Shi, Yuan Yuan; Zeng, Zhi Jiang; Wang, Zi Long; Wu, Xiao Bo; Yan, Wei Yu] Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Huang, Zachary Y.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Jiangxi Agricultural University; Michigan State University; Michigan State University	Shi, YY (corresponding author), Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Jiangxi, Peoples R China.	bees@msu.edu; bees1965@sina.com	Wang, Zhiquan/HHS-6768-2022; Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	China Agriculture Research System [CARS-45]; National Natural Science Foundation of China [31060327]; Ministry of Education of China [20103603110003]; Michigan Agricultural Experiment Station at Michigan State University	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Michigan Agricultural Experiment Station at Michigan State University	This work was supported by China Agriculture Research System (No. CARS-45), the National Natural Science Foundation of China (No. 31060327), Doctoral Fund of Ministry of Education of China (NO. 20103603110003) and Michigan Agricultural Experiment Station at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASENCOT M, 1985, COMP BIOCHEM PHYS A, V81, P203, DOI 10.1016/0300-9629(85)90289-0; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Evans JD, 2001, GENOME BIOL, V2; Foret S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-472; HARTFELDER K, 1993, ROUX ARCH DEV BIOL, V202, P176, DOI 10.1007/BF00365308; Jiang JH, 1999, EXPT REARING HONEYBE; Jung-Hoffmann I., 1966, BIENENFORSCH, V8, P296; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Maleszka R, 2008, EPIGENETICS-US, V3, P188, DOI 10.4161/epi.3.4.6697; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; SEELEY TD, 1989, AM SCI, V77, P546; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; WEAVER N, 1966, ANNU REV ENTOMOL, V11, P79, DOI 10.1146/annurev.en.11.010166.000455; Winston M.L., 1991, BIOL HONEY BEE; Wu Jing, 2010, Scientia Agricultura Sinica, V43, P176; Xu SY, 1984, APICULTURE CHINA, V4, P18; Zeng ZJ, 2008, Applied Patents, China, Patent No. [ZL 200720008203.0, 2007200082030]; Zeng ZJ, 2009, APICULTURE	21	63	78	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18808	10.1371/journal.pone.0018808	http://dx.doi.org/10.1371/journal.pone.0018808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541319	Green Published, gold, Green Submitted			2022-12-25	WOS:000290018400011
J	Kalua, K; Lindfield, R; Mtupanyama, M; Mtumodzi, D; Msiska, V				Kalua, Khumbo; Lindfield, Robert; Mtupanyama, Maxwell; Mtumodzi, Davie; Msiska, Vincent			Findings from a Rapid Assessment of Avoidable Blindness (RAAB) in Southern Malawi	PLOS ONE			English	Article							CATARACT SURGICAL SERVICES; VISUAL IMPAIRMENT; KILIMANJARO REGION; VISION 2020; TANZANIA; DISTRICT; PREVALENCE; COVERAGE; SURGERY	Background: Data on prevalence and causes of avoidable blindness in Malawi are not readily available. The purpose of this study was to determine the prevalence and causes of blindness in persons aged 50 and above in southern Malawi to plan eye care services for the community. Methodology: A population-based survey was conducted in 7 districts in southern Malawi. Villages were selected by probability proportionate to size within each district. Clusters were further subdivided into segments. A predetermined number of segments were selected randomly in each cluster. The survey team moved from house to house in each segment until they had examined 50 people over the age of 50. Examination consisted of visual acuity measurement with tumbling "E" chart and ocular examination by an ophthalmologist. Participants were categorized by visual acuity. Those who were visually impaired (VA<6/18 in the better eye with available correction) were assigned a main cause of visual loss. Further information was sought from anyone who had received cataract surgery. Results: A total number of 3,583 persons aged 50 and above were sampled; among these 3,430 (95.7%) were examined. The prevalence of blindness (presenting visual acuity <3/60 in the better eye) among persons aged 50 and above was 3.3% (95% CI 2.5-4.1). Cataract was the most common cause of blindness contributing to 48.2% of all cases, followed by glaucoma (15.8%) and cornea scarring (12.3%). The cataract surgical coverage in blind persons was 44.6%. Conclusion: The prevalence of blindness and visual impairment in persons aged 50 and above was lower than the WHO estimate for Malawi. The majority of the causes were avoidable, with cataract accounting for approximately half of all cases of blindness. The data suggests that expansion of eye care programs to address avoidable causes of blindness is necessary in this area of southern Malawi.	[Kalua, Khumbo] Univ Malawi, Coll Med, Dept Ophthalmol, Blantyre, Malawi; [Kalua, Khumbo; Lindfield, Robert] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, London WC1, England; [Mtupanyama, Maxwell] Chiradzulu Dist Hosp, Minist Hlth, Chiradzulu, Malawi; [Mtumodzi, Davie] Thyolo Dist Hosp, Minist Hlth, Thyolo, Malawi; [Msiska, Vincent] Mzuzu Cent Hosp, Minist Hlth, Mzuzu, Malawi	University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Kalua, K (corresponding author), Univ Malawi, Coll Med, Dept Ophthalmol, Blantyre, Malawi.	khumbokalua@yahoo.com	Kalua, Khumbo k/D-8449-2019	Kalua, Khumbo k/0000-0001-9284-9009	Sight Savers	Sight Savers	Sight Savers funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; [Anonymous], 2008, MAL HOUS POP 2008 CE; Courtright P, 2008, BRIT J OPHTHALMOL, V92, P1031, DOI 10.1136/bjo.2007.136168; Courtright P, 2004, CAN J OPHTHALMOL, V39, P25, DOI 10.1016/S0008-4182(04)80049-8; Courtright P, 2003, BRIT J OPHTHALMOL, V87, P1079, DOI 10.1136/bjo.87.9.1079; Courtright Paul, 2007, Community Eye Health, V20, P68; Courtright Paul, 2009, Community Eye Health, V22, P17; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Foster A, 2003, EPIDEMIOLOGY EYE DIS, P373; Geneau R, 2005, BRIT J OPHTHALMOL, V89, P1399, DOI 10.1136/bjo.2005.075572; Habiyakire C, 2010, OPHTHAL EPIDEMIOL, V17, P90, DOI 10.3109/09286580903453514; Lewallen S, 2002, B WORLD HEALTH ORGAN, V80, P300; Lewallen S, 2009, BRIT J OPHTHALMOL, V93, P295, DOI 10.1136/bjo.2008.140301; Lewallen Susan, 2006, Community Eye Health, V19, P59; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Oie M, 1999, AM J PSYCHIAT, V156, P1216; Oye JE, 2006, BRIT J OPHTHALMOL, V90, P538, DOI 10.1136/bjo.2005.082271; Resnikoff S, 2008, ANN TROP MED PARASIT, V102, P3, DOI 10.1179/136485908X337409; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210	21	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19226	10.1371/journal.pone.0019226	http://dx.doi.org/10.1371/journal.pone.0019226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547074	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800037
J	Richardson, TO; Christensen, K; Franks, NR; Jensen, HJ; Sendova-Franks, AB				Richardson, Thomas Owen; Christensen, Kim; Franks, Nigel Rigby; Jensen, Henrik Jeldtoft; Sendova-Franks, Ana Blagovestova			Ants in a Labyrinth: A Statistical Mechanics Approach to the Division of Labour	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; WORKER BUMBLE-BEES; NEST THERMOREGULATION; TERMITE ARCHITECTURE; PHEIDOLE-PALLIDULA; SPATIAL-PATTERNS; AGE POLYETHISM; SIZE; AGGREGATION; HYMENOPTERA	Division of labour (DoL) is a fundamental organisational principle in human societies, within virtual and robotic swarms and at all levels of biological organisation. DoL reaches a pinnacle in the insect societies where the most widely used model is based on variation in response thresholds among individuals, and the assumption that individuals and stimuli are well-mixed. Here, we present a spatially explicit model of DoL. Our model is inspired by Pierre de Gennes' 'Ant in a Labyrinth' which laid the foundations of an entire new field in statistical mechanics. We demonstrate the emergence, even in a simplified one-dimensional model, of a spatial patterning of individuals and a right-skewed activity distribution, both of which are characteristics of division of labour in animal societies. We then show using a two-dimensional model that the work done by an individual within an activity bout is a sigmoidal function of its response threshold. Furthermore, there is an inverse relationship between the overall stimulus level and the skewness of the activity distribution. Therefore, the difference in the amount of work done by two individuals with different thresholds increases as the overall stimulus level decreases. Indeed, spatial fluctuations of task stimuli are minimised at these low stimulus levels. Hence, the more unequally labour is divided amongst individuals, the greater the ability of the colony to maintain homeostasis. Finally, we show that the non-random spatial distribution of individuals within biological and social systems could be caused by indirect (stigmergic) interactions, rather than direct agent-to-agent interactions. Our model links the principle of DoL with principles in the statistical mechanics and provides testable hypotheses for future experiments.	[Richardson, Thomas Owen; Sendova-Franks, Ana Blagovestova] Univ W England, Dept Engn Design & Math, Bristol BS16 1QY, Avon, England; [Richardson, Thomas Owen; Franks, Nigel Rigby] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Christensen, Kim; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England; [Christensen, Kim] Univ London Imperial Coll Sci Technol & Med, Dept Phys, London, England; [Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England	University of West England; University of Bristol; Imperial College London; Imperial College London; Imperial College London	Richardson, TO (corresponding author), Univ W England, Dept Engn Design & Math, Bristol BS16 1QY, Avon, England.	tom.richardson@bristol.ac.uk	Franks, Nigel/AAG-8207-2019; Richardson, Thomas/H-9898-2019	Franks, Nigel/0000-0001-8139-9604; Richardson, Thomas/0000-0002-0220-4897; Christensen, Kim/0000-0002-7648-7332	EPSRC [EP/E061796/1, EP/E061761/1]; Engineering and Physical Sciences Research Council [EP/E061761/1, EP/E061796/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TOR and ABS-F acknowledge EPSRC grant EP/E061796/1. KC acknowledges EPSRC grant EP/E061761/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NOTICES AM MATH SOC; Backen SJ, 2000, BEHAV ECOL SOCIOBIOL, V48, P125, DOI 10.1007/s002650000219; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Bak P., 1997, NATURE WORKS SCI SEL; Baracchi D, 2010, ETHOLOGY, V116, P579, DOI 10.1111/j.1439-0310.2010.01770.x; Beshers SN, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P115; Bird R, 1999, EVOL ANTHROPOL, V8, P65, DOI 10.1002/(SICI)1520-6505(1999)8:2<65::AID-EVAN5>3.3.CO;2-V; Bonabeau E, 1998, PHILOS T R SOC B, V353, P1561, DOI 10.1098/rstb.1998.0310; Bonabeau E, 1996, P ROY SOC B-BIOL SCI, V263, P1565, DOI 10.1098/rspb.1996.0229; Bonabeau E, 1998, B MATH BIOL, V60, P753, DOI 10.1006/bulm.1998.0041; Bonabeau E, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P141; BREED MD, 1990, BEHAV ECOL SOCIOBIOL, V27, P395, DOI 10.1007/BF00164065; CAMAZINE S, 2001, SELF ORG BIOL SYSTEM, P217; Carreras BA, 1999, PHYS REV E, V60, P4770, DOI 10.1103/PhysRevE.60.4770; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; Couvillon MJ, 2009, P ROY SOC B-BIOL SCI, V276, P2411, DOI 10.1098/rspb.2009.0172; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; CUSHMAN JH, 1988, OECOLOGIA, V77, P522, DOI 10.1007/BF00377268; DEGENNES PG, 1976, LA RECHERCHE, V7; DENEUBOURG JL, 1995, J INSECT BEHAV, V8, P417, DOI 10.1007/BF01995316; DENEUBOURG JL, 1991, FROM ANIMALS TO ANIMATS, P356; Depickere S, 2004, J INSECT BEHAV, V17, P81, DOI 10.1023/B:JOIR.0000025134.06111.be; Depickere S, 2004, INSECT SOC, V51, P81, DOI 10.1007/s00040-003-0719-8; Depickere S, 2008, ECOL ENTOMOL, V33, P225, DOI 10.1111/j.1365-2311.2007.00955.x; DETRAIN C, 1991, J INSECT BEHAV, V4, P157, DOI 10.1007/BF01054609; DETRAIN C, 1992, BEHAV ECOL SOCIOBIOL, V29, P405, DOI 10.1007/BF00170170; DORIGO M, 2000, ANT ALGORITHMS STIGM, P851; Dornhaus A, 2008, PLOS BIOL, V6, P2368, DOI 10.1371/journal.pbio.0060285; Dornhaus A, 2008, BEHAV ECOL SOCIOBIOL, V63, P43, DOI 10.1007/s00265-008-0634-0; Dornhaus A, 2009, BEHAV ECOL, V20, P922, DOI 10.1093/beheco/arp070; FRANKS ABS, 1995, ANIM BEHAV, V50, P121; Franks NR, 1997, ANIM BEHAV, V54, P779, DOI 10.1006/anbe.1996.0496; FRANKS NR, 1992, BEHAV ECOLOGY SOCIOB, V30; Gove R, 2009, INSECT SOC, V56, P319, DOI 10.1007/s00040-009-0028-y; Graham S, 2006, INSECT SOC, V53, P226, DOI 10.1007/s00040-005-0862-5; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; GRASSE PP, 1952, B INS SOC, V1, P32; Halley JD, 2004, INSECT SOC, V51, P226, DOI 10.1007/s00040-003-0725-x; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Havlin S, 2002, ADV PHYS, V51, P187, DOI 10.1080/00018730110116353; Hurd CR, 2003, BEHAVIOUR, V140, P827, DOI 10.1163/156853903770238337; Jandt JM, 2009, ANIM BEHAV, V77, P641, DOI 10.1016/j.anbehav.2008.11.019; Jeanson R, 2007, AM NAT, V170, P47, DOI 10.1086/518570; Jensen H.J., 1998, SELF ORG CRITICALITY; Johnson BR, 2008, NATURWISSENSCHAFTEN, V95, P523, DOI 10.1007/s00114-008-0354-3; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; LEVINGS SC, 1982, ECOLOGY, V63, P338, DOI 10.2307/1938951; LU ET, 1991, ASTROPHYS J, V380, pL89, DOI 10.1086/186180; MAJID I, 1984, PHYS REV B, V30, P1626, DOI 10.1103/PhysRevB.30.1626; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Moglich M., 1974, Psyche Camb, V81, P219, DOI 10.1155/1974/25763; Myerscough MR, 2004, INSECT SOC, V51, P146, DOI 10.1007/s00040-003-0713-1; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Donnell S, 1998, ANIM BEHAV, V55, P417, DOI 10.1006/anbe.1997.0627; O'Donnell S, 2001, ETHOLOGY, V107, P387, DOI 10.1046/j.1439-0310.2001.00668.x; O'Toole DV, 2003, J THEOR BIOL, V221, P15, DOI 10.1006/jtbi.2003.3047; O'Toole DV, 2003, J THEOR BIOL, V221, P1, DOI 10.1006/jtbi.2003.3046; O'Toole DV, 1999, J THEOR BIOL, V198, P305, DOI 10.1006/jtbi.1999.0917; Oster G.F., 1978, Monographs in Population Biology, pi; Ravary F, 2007, CURR BIOL, V17, P1308, DOI 10.1016/j.cub.2007.06.047; Robinson EJH, 2009, INSECT SOC, V56, P1, DOI 10.1007/s00040-008-1035-0; Robinson EJH, 2009, BEHAV ECOL SOCIOBIOL, V63, P627, DOI 10.1007/s00265-008-0696-z; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Robinson GE, 2002, AM NAT, V160, pS160, DOI 10.1086/342901; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; ROISIN Y, 1990, J CHEM ECOL, V16, P2865, DOI 10.1007/BF00979479; RYTI RT, 1986, OECOLOGIA, V69, P446, DOI 10.1007/BF00377067; Sanchez R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.068302; SEELEY TD, 1989, BEHAV ECOL SOCIOBIOL, V24, P181, DOI 10.1007/BF00292101; Sempo G, 2006, INSECT SOC, V53, P241, DOI 10.1007/s00040-006-0864-y; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sinha-Ray P, 2000, PHYS REV E, V62, P3215, DOI 10.1103/PhysRevE.62.3215; Smith Adam, 1776, INQUIRY NATURE CAUSE; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Stauffer D., 1992, INTRO PERCOLATION TH; Tautz J, 1997, J COMP PHYSIOL A, V180, P537, DOI 10.1007/s003590050070; Theraulaz G, 1998, P ROY SOC B-BIOL SCI, V265, P327, DOI 10.1098/rspb.1998.0299; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; Tripet F, 2004, ETHOLOGY, V110, P863, DOI 10.1111/j.1439-0310.2004.01023.x; Trumbo ST, 1997, ETHOLOGY, V103, P966; Weidenmuller A, 2009, CURR BIOL, V19, P1897, DOI 10.1016/j.cub.2009.08.059; Weidenmuller A, 2004, BEHAV ECOL, V15, P120, DOI 10.1093/beheco/arg101; Wilson E.O., 1971, INSECT SOC; WILSON EO, 1985, BEHAV ECOL SOCIOBIOL, V17, P35, DOI 10.1007/BF00299425	87	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18416	10.1371/journal.pone.0018416	http://dx.doi.org/10.1371/journal.pone.0018416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756MU	21541019	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800008
J	Cambui, CA; Svennerstam, H; Gruffman, L; Nordin, A; Ganeteg, U; Nasholm, T				Cambui, Camila Aguetoni; Svennerstam, Henrik; Gruffman, Linda; Nordin, Annika; Ganeteg, Ulrika; Nasholm, Torgny			Patterns of Plant Biomass Partitioning Depend on Nitrogen Source	PLOS ONE			English	Article							AMINO-ACID-UPTAKE; ROOT-GROWTH; LATERAL ROOT; SHOOT; NITRATE; METABOLISM; NUTRITION; PRODUCTIVITY; ALLOCATION; RESPONSES	Nitrogen (N) availability is a strong determinant of plant biomass partitioning, but the role of different N sources in this process is unknown. Plants inhabiting low productivity ecosystems typically partition a large share of total biomass to belowground structures. In these systems, organic N may often dominate plant available N. With increasing productivity, plant biomass partitioning shifts to aboveground structures, along with a shift in available N to inorganic forms of N. We tested the hypothesis that the form of N taken up by plants is an important determinant of plant biomass partitioning by cultivating Arabidopsis thaliana on different N source mixtures. Plants grown on different N mixtures were similar in size, but those supplied with organic N displayed a significantly greater root fraction. N-15 labelling suggested that, in this case, a larger share of absorbed organic N was retained in roots and split-root experiments suggested this may depend on a direct incorporation of absorbed amino acid N into roots. These results suggest the form of N acquired affects plant biomass partitioning and adds new information on the interaction between N and biomass partitioning in plants.	[Cambui, Camila Aguetoni; Svennerstam, Henrik; Nordin, Annika; Ganeteg, Ulrika] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Gruffman, Linda; Nasholm, Torgny] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Cambui, CA (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden.	torgny.nasholm@slu.se		Nasholm, Torgny/0000-0002-2275-2030	Swedish Research Council Formas; Swedish University of Agricultural Sciences; research programme Trees and Crops for the Future; Foundation for Strategic Environmental Research	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish University of Agricultural Sciences; research programme Trees and Crops for the Future; Foundation for Strategic Environmental Research	Financial support from the Swedish Research Council Formas, the Swedish University of Agricultural Sciences, the research programme Trees and Crops for the Future (to TN) and from the Foundation for Strategic Environmental Research (to AN and TN) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN GI, 1987, PLANT CELL ENVIRON, V10, P579, DOI 10.1111/j.1365-3040.1987.tb01838.x; Andrews M, 2006, ANN BOT-LONDON, V97, P3, DOI 10.1093/aob/mcj009; ANDREWS M, 1986, PLANT CELL ENVIRON, V9, P511, DOI 10.1111/j.1365-3040.1986.tb01582.x; Berthrong ST, 2006, SOIL BIOL BIOCHEM, V38, P861, DOI 10.1016/j.soilbio.2005.08.002; Bloom AJ, 2002, J PLANT GROWTH REGUL, V21, P416, DOI 10.1007/s00344-003-0009-8; Britto DT, 2005, PLANT CELL ENVIRON, V28, P1396, DOI 10.1111/j.1365-3040.2005.01372.x; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P399; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; COOPER HD, 1989, J EXP BOT, V40, P753, DOI 10.1093/jxb/40.7.753; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; DREW MC, 1975, J EXP BOT, V26, P79, DOI 10.1093/jxb/26.1.79; Forsum O, 2008, NEW PHYTOL, V179, P1058, DOI 10.1111/j.1469-8137.2008.02546.x; Freixes S, 2002, PLANT CELL ENVIRON, V25, P1357, DOI 10.1046/j.1365-3040.2002.00912.x; Gorska A, 2008, PLANT PHYSIOL, V148, P1159, DOI 10.1104/pp.108.122499; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hodge A, 2009, PLANT CELL ENVIRON, V32, P628, DOI 10.1111/j.1365-3040.2008.01891.x; INGESTAD T, 1991, ECOL APPL, V1, P168, DOI 10.2307/1941809; Jamtgard S, 2008, PLANT SOIL, V302, P221, DOI 10.1007/s11104-007-9473-4; Kielland K, 1995, BIOGEOCHEMISTRY, V31, P85, DOI 10.1007/BF00000940; KIELLAND K, 1994, ECOLOGY, V75, P2373, DOI 10.2307/1940891; Kielland K, 2006, PLANT SOIL, V288, P297, DOI 10.1007/s11104-006-9117-0; LARSSON CM, 1991, PHYSIOL PLANTARUM, V82, P345, DOI 10.1111/j.1399-3054.1991.tb02916.x; LEVIN SA, 1989, ANN BOT-LONDON, V64, P71, DOI 10.1093/oxfordjournals.aob.a087810; Lipson DA, 1999, ECOLOGY, V80, P1623; Majerowicz N, 2002, ENVIRON EXP BOT, V47, P249, DOI 10.1016/S0098-8472(01)00131-9; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Nordin A, 2004, ECOLOGY, V85, P955, DOI 10.1890/03-0084; Nordin A, 2001, OECOLOGIA, V129, P125, DOI 10.1007/s004420100698; Owen AG, 2001, SOIL BIOL BIOCHEM, V33, P651, DOI 10.1016/S0038-0717(00)00209-1; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Persson J, 2006, J EXP BOT, V57, P2651, DOI 10.1093/jxb/erl028; Raab TK, 1996, OECOLOGIA, V108, P488, DOI 10.1007/BF00333725; RAVEN JA, 1992, NEW PHYTOL, V121, P19, DOI 10.1111/j.1469-8137.1992.tb01088.x; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; SATTELMACHER B, 1993, ENVIRON EXP BOT, V33, P63, DOI 10.1016/0098-8472(93)90056-L; Scheible WR, 1997, PLANT J, V11, P671, DOI 10.1046/j.1365-313X.1997.11040671.x; Schmidt S, 1999, AUST J PLANT PHYSIOL, V26, P253, DOI 10.1071/PP98116; Stitt M, 1999, PLANT SOIL, V215, P143, DOI 10.1023/A:1004676605336; Tan WX, 1998, ANN BOT-LONDON, V81, P195, DOI 10.1006/anbo.1997.0539; Tinker P.B., 2000, SOLUTE MOVEMENT RHIZ, V2nd, DOI [10.1093/oso/9780195124927.001.0001, DOI 10.1093/OSO/9780195124927.001.0001]; Walch-Liu P, 2005, PHOTOSYNTH RES, V83, P239, DOI 10.1007/s11120-004-2080-9; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Warren CR, 2006, FUNCT PLANT BIOL, V33, P653, DOI 10.1071/FP06045; YANAI RD, 1994, SOIL SCI SOC AM J, V58, P1562, DOI 10.2136/sssaj1994.03615995005800050041x; Zerihun A, 1998, NEW PHYTOL, V138, P1, DOI 10.1046/j.1469-8137.1998.00893.x; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	49	75	79	6	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19211	10.1371/journal.pone.0019211	http://dx.doi.org/10.1371/journal.pone.0019211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544211	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800053
J	Lee, CH; Gouaux, E				Lee, Chia-Hsueh; Gouaux, Eric			Amino Terminal Domains of the NMDA Receptor Are Organized as Local Heterodimers	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; ENDOPLASMIC-RETICULUM RETENTION; GLUTAMATE-RECEPTOR; ION CHANNELS; CRYSTAL-STRUCTURE; CELL-SURFACE; NR1 SUBUNIT; EXPRESSION; MECHANISM; DYNAMICS	The N-methyl-D-aspartate (NMDA) receptor, an obligate heterotetrameric assembly organized as a dimer of dimers, is typically composed of two glycine-binding GluN1 subunits and two glutamate-binding GluN2 subunits. Despite the crucial role that the NMDA receptor plays in the nervous system, the specific arrangement of subunits within the dimer-of-dimer assemblage is not conclusively known. Here we studied the organization of the amino terminal domain (ATD) of the rat GluN1/GluN2A and GluN1/GluN2B NMDA receptors by cysteine-directed, disulfide bond-mediated cross-linking. We found that GluN1 ATDs and GluN2 ATDs spontaneously formed disulfide bond-mediated dimers after introducing cysteines into the L1 interface of GluN2A or GluN2B ATD. The formation of dimer could be prevented by knocking out endogenous cysteines located near the L1 interface of GluN1. These results indicate that GluN1 and GluN2 ATDs form local heterodimers through the interactions in the L1-L1 interface and further demonstrate a dimer-of-heterodimer arrangement in GluN1/GluN2A and GluN1/GluN2B NMDA receptors.	[Lee, Chia-Hsueh; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Lee, CH (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360	National Institutes of Health; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This study was supported by National Institutes of Health and Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; Choi YB, 2001, J NEUROSCI, V21, P392, DOI 10.1523/JNEUROSCI.21-02-00392.2001; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Das U, 2010, P NATL ACAD SCI USA, V107, P8463, DOI 10.1073/pnas.1000838107; Dingledine R, 1999, PHARMACOL REV, V51, P7; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Han X, 2008, J NEUROCHEM, V107, P1566, DOI 10.1111/j.1471-4159.2008.05729.x; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Ivanovic A, 1998, J BIOL CHEM, V273, P19933, DOI 10.1074/jbc.273.32.19933; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Puddifoot CA, 2009, BRIT J PHARMACOL, V156, P509, DOI 10.1111/j.1476-5381.2008.00040.x; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stroebel D, 2011, NEUROPHARMACOLOGY, V60, P151, DOI 10.1016/j.neuropharm.2010.07.003; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009	38	28	30	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19180	10.1371/journal.pone.0019180	http://dx.doi.org/10.1371/journal.pone.0019180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544205	gold, Green Published, Green Submitted			2022-12-25	WOS:000290015800050
J	Jaeger, JJ; Soe, AN; Chavasseau, O; Coster, P; Emonet, EG; Guy, F; Lebrun, R; Maung, A; Khyaw, AA; Shwe, H; Tun, ST; Oo, KL; Rugbumrung, M; Bocherens, H; Benammi, M; Chaivanich, K; Tafforeau, P; Chaimanee, Y				Jaeger, Jean-Jacques; Soe, Aung Naing; Chavasseau, Olivier; Coster, Pauline; Emonet, Edouard-Georges; Guy, Franck; Lebrun, Renaud; Maung, Aye; Khyaw, Aung Aung; Shwe, Hla; Tun, Soe Thura; Oo, Kyaw Linn; Rugbumrung, Mana; Bocherens, Herve; Benammi, Mouloud; Chaivanich, Kamol; Tafforeau, Paul; Chaimanee, Yaowalak			First Hominoid from the Late Miocene of the Irrawaddy Formation (Myanmar)	PLOS ONE			English	Article							MAGNETIC-POLARITY STRATIGRAPHY; MIDDLE MIOCENE; NORTHERN THAILAND; POTWAR PLATEAU; SIWALIK GROUP; TOOTH ENAMEL; DIAGENESIS; ANTHRACOTHERIIDAE; CARBONATE; PASALAR	For over a century, a Neogene fossil mammal fauna has been known in the Irrawaddy Formation in central Myanmar. Unfortunately, the lack of accurately located fossiliferous sites and the absence of hominoid fossils have impeded paleontological studies. Here we describe the first hominoid found in Myanmar together with a Hipparion (s.l.) associated mammal fauna from Irrawaddy Formation deposits dated between 10.4 and 8.8 Ma by biochronology and magnetostratigraphy. This hominoid documents a new species of Khoratpithecus, increasing thereby the Miocene diversity of southern Asian hominoids. The composition of the associated fauna as well as stable isotope data on Hipparion (s.l.) indicate that it inhabited an evergreen forest in a C3-plant environment. Our results enlighten that late Miocene hominoids were more regionally diversified than other large mammals, pointing towards regionally-bounded evolution of the representatives of this group in Southeast Asia. The Irrawaddy Formation, with its extensive outcrops and long temporal range, has a great potential for improving our knowledge of hominoid evolution in Asia.	[Jaeger, Jean-Jacques; Chavasseau, Olivier; Coster, Pauline; Emonet, Edouard-Georges; Guy, Franck; Benammi, Mouloud; Chaimanee, Yaowalak] Univ Poitiers, CNRS, Inst Int Paleoprimatol & Paleontol Humaine, UMR 6046, Poitiers, France; [Soe, Aung Naing] Dagon Univ, Dept Geol, Yangon, Myanmar; [Lebrun, Renaud] Univ Montpellier 2, Inst Sci Evolut Montpellier, Montpellier, France; [Maung, Aye; Khyaw, Aung Aung; Shwe, Hla] Natl Museum & Lib, Dept Archaeol, Mandalay, Myanmar; [Tun, Soe Thura] Myanmar Geosci Soc, Yangon, France; [Oo, Kyaw Linn] Univ Yangon, Dept Geol, Yangon, Myanmar; [Rugbumrung, Mana; Chaimanee, Yaowalak] Dept Mineral Resources, Paleontol Sect, Bangkok, Thailand; [Bocherens, Herve] Univ Tubingen, Inst Geowissensch, Tubingen, Germany; [Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Yangon; Department of Mineral Resources - Thailand; Eberhard Karls University of Tubingen; European Synchrotron Radiation Facility (ESRF)	Jaeger, JJ (corresponding author), Univ Poitiers, CNRS, Inst Int Paleoprimatol & Paleontol Humaine, UMR 6046, Poitiers, France.	olivier.chavasseau@univ-poitiers.fr	Oo, Kyaw Linn/V-9084-2019; BOCHERENS, Hervé/F-3580-2011	BOCHERENS, Hervé/0000-0002-0494-0126; GUY, Franck/0000-0001-7032-7963; Benammi, Mouloud/0000-0003-4707-7518; chaimanee, yaowalak/0000-0002-8432-3880; Lebrun, Renaud/0000-0002-5819-2653; Chavasseau, Olivier/0000-0001-8638-4583; Tafforeau, Paul/0000-0002-5962-1683; Coster, Pauline/0000-0003-4015-252X	CNRS; Agence Nationale de la Recherche [05-BLAN-235]; Fyssen foundation; Ministry of Culture of the Union of Myanmar	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fyssen foundation; Ministry of Culture of the Union of Myanmar	This work was supported by a CNRS Eclipse II program grant (http://www.cnrs.fr/), an Agence Nationale de la Recherche 05-BLAN-235 grant (http://www.agence-nationale-recherche.fr/), and a Fyssen foundation grant (http://www.fondation-fyssen.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ministry of Culture of the Union of Myanmar for supporting the project and the organization of the fieldwork campaigns, MM. Stephane Dovert, Fabrice Etienne and Emmanuel Mouriez, Mrs Wah Wah Tin and Shwe Zin Nyunt from the French Embassy in Yangon for their help to our project, Jay Kelley (Arizona State University) for fruitful discussions and comments, J. Baruchel and the ID 17 and 19 beamline staff of the ESRF (Grenoble) for their assistance in X-ray imaging, J. Barry (Harvard University) for discussion and providing comparative material, X. Valentin (iPIIEP, Univ. Poitiers) for material preparation, C. Fontaine and A. Decarreau (HydrASA, Univ. Poitiers) for providing X-Ray diffraction data, B. Steinhilber (Univ. Tubingen) for technical assistance in stable isotope analysis of Hipparion material, H. Cappetta (Univ. Montpellier II) for identification of the shark teeth, L. de Bonis (iPHEP, Univ. Poitiers) for giving us access to the Ouranopithecus material, Yves Gallet and Maxime Legoff (IPGP, Paris) for access to paleomagnetism equipment and technical help.	ALPAGUT B, 1990, J HUM EVOL, V19, P397, DOI 10.1016/0047-2484(90)90052-D; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P339; Benammi M, 2004, INT GEOL REV, V46, P646, DOI 10.2747/0020-6814.46.7.646; Bender F., 1983, GEOLOGY BURMA; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; BROWN B, 1989, MANDIBLES SIVAPITHEC; Brown Barbara, 1997, P153; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chaimanee Y, 2004, NATURE, V427, P439, DOI 10.1038/nature02245; Chaimanee Y, 2003, NATURE, V422, P61, DOI 10.1038/nature01449; Chaimanee Y, 2006, AM J PHYS ANTHROPOL, V131, P311, DOI 10.1002/ajpa.20437; Chavasseau O, 2006, J ASIAN EARTH SCI, V28, P354, DOI 10.1016/j.jseaes.2005.10.012; Chhibber H.L., 1934, GEOLOGY BURMA; Coster P, 2010, GEOL SOC AM BULL, V122, P1180, DOI 10.1130/B26568.1; COTTER GD, 1938, MEMOIRS GEOLOGICAL S, V72, P1; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; FORTELIUS M, GEOLOGY PALEONTOLOGY; Fricke HC, 1999, EARTH PLANET SC LETT, V170, P181, DOI 10.1016/S0012-821X(99)00105-3; Gradstein F.M., 2004, A; Gulec E, 2003, COUR FOR SEKENBG, V240, P89; Guy F, 2008, J HUM EVOL, V55, P37, DOI 10.1016/j.jhevol.2007.12.003; Jacques L, 2008, PALAEOGEOGR PALAEOCL, V266, P200, DOI 10.1016/j.palaeo.2008.03.040; JOHNSON NM, 1982, PALAEOGEOGR PALAEOCL, V37, P17, DOI 10.1016/0031-0182(82)90056-6; KELLEY J, 2002, PRIMATE FOSSIL RECOR, P385; Kelley J, 2008, J HUM EVOL, V54, P455, DOI 10.1016/j.jhevol.2007.08.007; KHIN A, 1969, UNION BURMA J SCI TE, V2, P53; KIRSCHVINK JL, 1980, GEOPHYS J ROY ASTR S, V62, P699, DOI 10.1111/j.1365-246X.1980.tb02601.x; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Koufs GD, 2006, GEOBIOS-LYON, V39, P223, DOI 10.1016/j.geobios.2004.11.009; Lee-Thorp J, 2003, J ANTHROPOL ARCHAEOL, V22, P208, DOI 10.1016/S0278-4165(03)00035-7; LEETHORP JA, 1991, J ARCHAEOL SCI, V18, P343, DOI 10.1016/0305-4403(91)90070-6; Lihoreau F, 2007, PALAEONTOLOGY, V50, P503, DOI 10.1111/j.1475-4983.2006.00643.x; Lihoreau F, 2004, CR PALEVOL, V3, P653, DOI 10.1016/j.crpv.2004.07.001; MCCROSSIN ML, 1993, P NATL ACAD SCI USA, V90, P1962, DOI 10.1073/pnas.90.5.1962; Nelson SV, 2007, PALAEOGEOGR PALAEOCL, V243, P204, DOI 10.1016/j.palaeo.2006.07.017; Nelson SV, 2005, PALAEOGEOGR PALAEOCL, V222, P122, DOI 10.1016/j.palaeo.2005.03.012; NOETLING F., 1901, MEMOIRS GEOLOGICAL S, V1, P1; Noetling F., 1895, RECORDS GEOLOGICAL S, V28, P59; Pascoe E. H, 1964, MANUAL GEOLOGY INDIA, V1; PILGRIM GE, 1904, RECORDS GEOLOGICAL S, V31, P103; PILGRIM GUY E., 1927, REC GEOL SURV INDIA, V60, P160; QI GQ, 2005, LUFENGPITHECUS HUDIE; Qi Guoqin, 2006, Chinese Science Bulletin, V51, P704, DOI 10.1007/s11434-006-0704-5; QUADE J, 1992, CHEM GEOL, V94, P183, DOI 10.1016/0168-9622(92)90011-X; RINK WJ, 1995, J ARCHAEOL SCI, V22, P251, DOI 10.1006/jasc.1995.0026; SCHUMACHER GH, 1983, ANATOMIE BIOCH ZAHNE; SEN S, 1988, B SOC GEOL FR, V4, P161; Sepulchre P, 2010, CLIM PAST, V6, P461, DOI 10.5194/cp-6-461-2010; Stamp L.D., 1922, GEOL MAG, V59, P481, DOI DOI 10.1017/S001675680010915X; Suganuma Y, 2006, PALAEOGEOGR PALAEOCL, V239, P75, DOI 10.1016/j.palaeo.2006.01.010; Takai M., 2006, ASIAN PALEOPRIMATOLO, V4, P143; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; Ward S, 1999, SCIENCE, V285, P1382, DOI 10.1126/science.285.5432.1382; Woo J. K., 1957, Vertebrata Palasiatica, V1, P25; WOO JU-KANG, 1958, VERTEBR PALASIATI [CHINA], V2, P38; XU Q, 2008, LUFENG HOMINOID FAUN	59	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e17065	10.1371/journal.pone.0017065	http://dx.doi.org/10.1371/journal.pone.0017065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752UE	21533131	gold, Green Published			2022-12-25	WOS:000289719400001
J	Sandler, VM; Lailler, N; Bouhassira, EE				Sandler, Vladislav M.; Lailler, Nathalie; Bouhassira, Eric E.			Reprogramming of Embryonic Human Fibroblasts into Fetal Hematopoietic Progenitors by Fusion with Human Fetal Liver CD34(+) Cells	PLOS ONE			English	Article							STEM-CELLS; SOMATIC-CELLS; SINGLE-CELL; NEURONS; TRANSPLANTATION; PLURIPOTENCY; EXPRESSION; PATHWAY; HYBRIDS	Experiments with somatic cell nuclear transfer, inter-cellular hybrid formation_ENREF_3, and ectopic expression of transcription factors have clearly demonstrated that cell fate can be dramatically altered by changing the epigenetic state of cell nuclei. Here we demonstrate, using chemical fusion, direct reprogramming of the genome of human embryonic fibroblasts (HEF) into the state of human fetal liver hFL CD34+ (hFL) hematopoietic progenitors capable of proliferating and differentiating into multiple hematopoietic lineages. We show that hybrid cells retain their ploidy and can differentiate into several hematopoietic lineages. Hybrid cells follow transcription program of differentiating hFL cells as shown by genome-wide transcription profiling. Using whole-genome single nucleotide polymorphism (SNP) profiling of both donor genomes we demonstrate reprogramming of HEF genome into the state of hFL hematopoietic progenitors. Our results prove that it is possible to convert the fetal somatic cell genome into the state of fetal hematopoietic progenitors by fusion. This suggests a possibility of direct reprogramming of human somatic cells into tissue specific progenitors/stem cells without going all the way back to the embryonic state. Direct reprogramming of terminally differentiated cells into the tissue specific progenitors will likely prove useful for the development of novel cell therapies.	[Sandler, Vladislav M.; Lailler, Nathalie; Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Bouhassira, EE (corresponding author), Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10467 USA.	vladislav.sandler@einstein.yu.edu; eric.bouhassira@einstein.yu.edu	Bouhassira, Eric/AAZ-4184-2021		NYSTEM [C0244172, C024405]; NIH [R-01 5RO1 HL088467]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088467] Funding Source: NIH RePORTER	NYSTEM; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	VS and NL were funded in part through NYSTEM grant C0244172; EEB is funded in part though NYSTEM grants C0244172 and C024405 and NIH R-01 5RO1 HL088467. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blau HM, 1999, SEMIN CELL DEV BIOL, V10, P267, DOI 10.1006/scdb.1999.0311; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Egli D, 2009, CURR BIOL, V19, P1403, DOI 10.1016/j.cub.2009.06.065; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Szabo E, 2010, NATURE; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	31	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18265	10.1371/journal.pone.0018265	http://dx.doi.org/10.1371/journal.pone.0018265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533226	Green Submitted, Green Published, gold			2022-12-25	WOS:000289505600003
J	Willis, BS; Niswender, CM; Su, T; Amieux, PS; McKnight, GS				Willis, Brandon S.; Niswender, Colleen M.; Su, Thomas; Amieux, Paul S.; McKnight, G. Stanley			Cell-Type Specific Expression of a Dominant Negative PKA Mutation in Mice	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; A MUTANT MICE; CYCLIC-AMP; REGULATORY SUBUNIT; HEPATIC GLUCONEOGENESIS; CARNEY COMPLEX; PHOSPHOENOLPYRUVATE CARBOXYKINASE; TRANSCRIPTIONAL COACTIVATOR; GENE-TRANSCRIPTION; CATALYTIC SUBUNIT	We employed the Cre recombinase/loxP system to create a mouse line in which PKA activity can be inhibited in any cell-type that expresses Cre recombinase. The mouse line carries a mutant Prkar1a allele encoding a glycine to aspartate substitution at position 324 in the carboxy-terminal cAMP-binding domain (site B). This mutation produces a dominant negative RI alpha regulatory subunit (RI alpha B) and leads to inhibition of PKA activity. Insertion of a loxP-flanked neomycin cassette in the intron preceding the site B mutation prevents expression of the mutant RIaB allele until Cre-mediated excision of the cassette occurs. Embryonic stem cells expressing RIaB demonstrated a reduction in PKA activity and inhibition of cAMP-responsive gene expression. Mice expressing RIaB in hepatocytes exhibited reduced PKA activity, normal fasting induced gene expression, and enhanced glucose disposal. Activation of the RIaB allele in vivo provides a novel system for the analysis of PKA function in physiology.	[Willis, Brandon S.; Niswender, Colleen M.; Su, Thomas; Amieux, Paul S.; McKnight, G. Stanley] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Willis, BS (corresponding author), Array BioPharma, Boulder, CO 80301 USA.	mcknight@u.washington.edu	Amieux, Paul/AAG-4102-2021		National Institutes of Health [GM 032875, F32 DK10005-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK010005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM 032875 (G. S. M.) and National Institutes of Health Grant F32 DK10005-03 to C.M.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Brandon EP, 1998, J NEUROSCI, V18, P3639; BRANDON EP, 1995, RECENT PROG HORM RES, V50, P403; Burton KA, 1997, P NATL ACAD SCI USA, V94, P11067, DOI 10.1073/pnas.94.20.11067; Burton KA, 2006, MOL ENDOCRINOL, V20, P2504, DOI 10.1210/me.2006-0060; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; CLEGG CH, 1992, BIOCHEMISTRY-US, V31, P3720, DOI 10.1021/bi00129a023; Coffino P, 1976, Recent Prog Horm Res, V32, P669; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; CORRELL LA, 1989, J BIOL CHEM, V264, P16672; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Desseyn JL, 2000, P NATL ACAD SCI USA, V97, P6433, DOI 10.1073/pnas.97.12.6433; EKANGER R, 1989, J BIOL CHEM, V264, P4374; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOFMANN F, 1975, J BIOL CHEM, V250, P7795; Howe DG, 2006, J NEUROBIOL, V66, P256, DOI 10.1002/neu.20217; Howe DG, 2002, MOL CELL NEUROSCI, V20, P515, DOI 10.1006/mcne.2002.1119; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; LIU JS, 1991, J BIOL CHEM, V266, P19095; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; MEINKOTH JL, 1990, P NATL ACAD SCI USA, V87, P9595, DOI 10.1073/pnas.87.24.9595; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; Mitchell C, 2002, AM J PATHOL, V160, P31, DOI 10.1016/S0002-9440(10)64345-3; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MURPHY CS, 1985, SOMAT CELL MOLEC GEN, V11, P605, DOI 10.1007/BF01534725; NAKAGAWA J, 1988, J BIOL CHEM, V263, P2460; Niswender CM, 2005, GENESIS, V43, P109, DOI 10.1002/gene.20159; Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Veugelers M, 2004, P NATL ACAD SCI USA, V101, P14222, DOI 10.1073/pnas.0405535101; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; WOODFORD TA, 1989, J BIOL CHEM, V264, P13321; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	51	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18772	10.1371/journal.pone.0018772	http://dx.doi.org/10.1371/journal.pone.0018772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533282	Green Submitted, Green Published, gold			2022-12-25	WOS:000289404700034
J	Decarreau, JA; James, NG; Chrin, LR; Berger, CL				Decarreau, Justin A.; James, Nicholas G.; Chrin, Lynn R.; Berger, Christopher L.			Switch I Closure Simultaneously Promotes Strong Binding to Actin and ADP in Smooth Muscle Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL LIGHT-CHAIN; KINETIC MECHANISM; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; MOTOR DOMAIN; LEVER ARM; SUBFRAGMENT-1; NUCLEOTIDE; MOVEMENT; COMPLEX	The motor protein myosin uses energy derived from ATP hydrolysis to produce force and motion. Important conserved components (P-loop, switch I, and switch II) help propagate small conformational changes at the active site into large scale conformational changes in distal regions of the protein. Structural and biochemical studies have indicated that switch I may be directly responsible for the reciprocal opening and closing of the actin and nucleotide-binding pockets during the ATPase cycle, thereby aiding in the coordination of these important substrate-binding sites. Smooth muscle myosin has displayed the ability to simultaneously bind tightly to both actin and ADP, although it is unclear how both substrate-binding clefts could be closed if they are rigidly coupled to switch I. Here we use single tryptophan mutants of smooth muscle myosin to determine how conformational changes in switch I are correlated with structural changes in the nucleotide and actin-binding clefts in the presence of actin and ADP. Our results suggest that a closed switch I conformation in the strongly bound actomyosin-ADP complex is responsible for maintaining tight nucleotide binding despite an open nucleotide-binding pocket. This unique state is likely to be crucial for prolonged tension maintenance in smooth muscle.	[Chrin, Lynn R.; Berger, Christopher L.] Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Decarreau, Justin A.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [James, Nicholas G.] John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA	University of Vermont; University of Vermont	Berger, CL (corresponding author), Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	cberger@uvm.edu	James, Nicholas/G-3666-2011	, Nicholas/0000-0003-1539-2759	National Institutes of Health [R01-HL63798]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL63798 (to C. L. B.).	Ajtai K, 1999, BIOCHEMISTRY-US, V38, P6428, DOI 10.1021/bi990149r; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; Coluccio LR, 1999, J BIOL CHEM, V274, P21575, DOI 10.1074/jbc.274.31.21575; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Corrie JET, 1999, NATURE, V400, P425, DOI 10.1038/22704; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; CREMO CR, 1990, BIOCHEMISTRY-US, V29, P3309, DOI 10.1021/bi00465a023; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; DILLON PF, 1981, SCIENCE, V211, P495, DOI 10.1126/science.6893872; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Geeves MA, 2000, J BIOL CHEM, V275, P21624, DOI 10.1074/jbc.M000342200; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Hannemann DE, 2005, BIOCHEMISTRY-US, V44, P8826, DOI 10.1021/bi0473509; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kintses B, 2007, EMBO J, V26, P265, DOI 10.1038/sj.emboj.7601482; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021; Naber N, 2007, BIOPHYS J, V92, P172, DOI 10.1529/biophysj.106.090035; Naber N, 2010, J MOL BIOL, V396, P937, DOI 10.1016/j.jmb.2009.12.035; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Nyitrai M, 2004, PHILOS T R SOC B, V359, P1867, DOI 10.1098/rstb.2004.1560; Palm T, 1999, BIOCHEMISTRY-US, V38, P13026, DOI 10.1021/bi991164z; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Risal D, 2004, P NATL ACAD SCI USA, V101, P8930, DOI 10.1073/pnas.0403002101; Robertson CI, 2005, BIOPHYS J, V89, P1882, DOI 10.1529/biophysj.105.059840; Rosenfeld SS, 2005, J BIOL CHEM, V280, P6072, DOI 10.1074/jbc.M412717200; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Rosenfeld SS, 2000, J BIOL CHEM, V275, P25418, DOI 10.1074/jbc.M002685200; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SOBIESZEK A, 1977, EUR J BIOCHEM, V73, P477, DOI 10.1111/j.1432-1033.1977.tb11340.x; SPENCER RD, 1970, J CHEM PHYS, V52, P1654, DOI 10.1063/1.1673201; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sun MX, 2006, J BIOL CHEM, V281, P5711, DOI 10.1074/jbc.M508103200; Suzuki Y, 1998, NATURE, V396, P380, DOI 10.1038/24640; TRYBUS KM, 1994, J BIOL CHEM, V269, P20819; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WHITE HD, 1982, METHOD ENZYMOL, V85, P698; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0; Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200; Yengo CM, 2002, J BIOL CHEM, V277, P24114, DOI 10.1074/jbc.M111253200; Yengo CM, 1998, P NATL ACAD SCI USA, V95, P12944, DOI 10.1073/pnas.95.22.12944	50	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22300	22307		10.1074/jbc.M111.219014	http://dx.doi.org/10.1074/jbc.M111.219014			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536675	Green Published, hybrid			2022-12-25	WOS:000291719900038
J	Shapovalov, Y; Hoffman, D; Zuch, D; Bentley, KLD; Elisee, RA				Shapovalov, Yuriy; Hoffman, David; Zuch, Daniel; Bentley, Karen L. de Mesy; Elisee, Roman A.			Mitochondrial Dysfunction in Cancer Cells Due to Aberrant Mitochondrial Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING-PROTEIN; HUMAN PERIPHERAL LYMPHOCYTES; OXIDATIVE-PHOSPHORYLATION; CARBOHYDRATE-METABOLISM; FREE NUCLEAR; OSTEOSARCOMA; GLYCOLYSIS; EXPRESSION; STIMULATION; MAINTENANCE	Warburg effect is a hallmark of cancer manifested by continuous prevalence of glycolysis and dysregulation of oxidative metabolism. Glycolysis provides survival advantage to cancer cells. To investigate molecular mechanisms underlying the Warburg effect, we first compared oxygen consumption among hFOB osteoblasts, benign osteosarcoma cells, Saos2, and aggressive osteosarcoma cells, 143B. We demonstrate that, as both proliferation and invasiveness increase in osteosarcoma, cells utilize significantly less oxygen. We proceeded to evaluate mitochondrial morphology and function. Electron microscopy showed that in 143B cells, mitochondria are enlarged and increase in number. Quantitative PCR revealed an increase in mtDNA in 143B cells when compared with hFOB and Saos2 cells. Gene expression studies showed that mitochondrial single-strand DNA-binding protein (mtSSB), a key catalyst of mitochondrial replication, was significantly up-regulated in 143B cells. In addition, increased levels of the mitochondrial respiratory complexes were accompanied by significant reduction of their activities. These changes indicate hyperactive mitochondrial replication in 143B cells. Forced overexpression of mtSSB in Saos2 cells caused an increase in mtDNA and a decrease in oxygen consumption. In contrast, knockdown of mtSSB in 143B cells was accompanied by a decrease in mtDNA, increase in oxygen consumption, and retardation of cell growth in vitro and in vivo. In summary, we have found that mitochondrial dysfunction in cancer cells correlates with abnormally increased mitochondrial replication, which according to our gain- and loss-of-function experiments, may be due to overexpression of mtSSB. Our study provides insight into mechanisms of mitochondrial dysfunction in cancer and may offer potential therapeutic targets.	[Shapovalov, Yuriy; Zuch, Daniel; Elisee, Roman A.] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Hoffman, David] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Bentley, Karen L. de Mesy] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Elisee, RA (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, 575 Elmwood Ave, Rochester, NY 14642 USA.	Roman_Eliseev@urmc.rochester.edu		Hoffman, David/0000-0002-8661-3291; Zuch, Daniel/0000-0001-8245-4492	National Institutes of Health [KL2 RR 024136]; James P. Wilmot Foundation; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James P. Wilmot Foundation; Karen D'Amico Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health KL2 RR 024136 (Center for Research Resources; to R. A. E.). This work was also supported by the James P. Wilmot Foundation and the Karen D'Amico Foundation.	Arakaki N, 2006, BBA-GEN SUBJECTS, V1760, P1364, DOI 10.1016/j.bbagen.2006.05.012; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Butler LM, 2000, CANCER RES, V60, P5165; Czarnecka AM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-31; Eliseev RA, 2005, J CELL BIOCHEM, V96, P1262, DOI 10.1002/jcb.20607; Eliseev RA, 2002, MITOCHONDRION, V1, P361, DOI 10.1016/S1567-7249(01)00039-3; Ellinger J, 2009, BJU INT, V104, P48, DOI 10.1111/j.1464-410X.2008.08289.x; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Longley MJ, 2009, METHODS MOL BIOL, V554, P73, DOI 10.1007/978-1-59745-521-3_5; LOOS JA, 1973, EXP CELL RES, V79, P136, DOI 10.1016/0014-4827(73)90498-9; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Muller-Hocker J, 2001, APPL IMMUNOHISTO M M, V9, P276, DOI 10.1097/00022744-200109000-00013; Nathan SS, 2009, MOL BIOL REP, V36, P153, DOI 10.1007/s11033-008-9378-1; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; TIRANTI V, 1993, GENE, V126, P219, DOI 10.1016/0378-1119(93)90370-I; Tomaska L, 2001, BIOL CHEM, V382, P179, DOI 10.1515/BC.2001.025; Verma M, 2003, NAT REV CANCER, V3, P789, DOI 10.1038/nrc1192; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O. H., 1930, METABOLISM TUMOURS I; Zachariah RR, 2008, OBSTET GYNECOL, V112, P843, DOI 10.1097/AOG.0b013e3181867bc0; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131; Zhang PY, 2008, CLIN CANCER RES, V14, P2962, DOI 10.1158/1078-0432.CCR-07-1992	35	42	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22331	22338		10.1074/jbc.M111.250092	http://dx.doi.org/10.1074/jbc.M111.250092			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536680	Green Published, hybrid			2022-12-25	WOS:000291719900042
J	Singh, NK; Wang, D; Kundumani-Sridharan, V; Quyen, DV; Niu, JX; Rao, GN				Singh, Nikhlesh K.; Wang, Dong; Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Niu, Jixiao; Rao, Gadiparthi N.			15-Lipoxygenase-1-enhanced Src-Janus Kinase 2-Signal Transducer and Activator of Transcription 3 Stimulation and Monocyte Chemoattractant Protein-1 Expression Require Redox-sensitive Activation of Epidermal Growth Factor Receptor in Vascular Wall Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RAT CAROTID-ARTERY; LOW-DENSITY-LIPOPROTEIN; NEOINTIMA FORMATION; INTIMAL HYPERPLASIA; ARACHIDONIC-ACID; JAK/STAT PATHWAY; DEFICIENT MICE; EGF RECEPTOR; INJURY	To understand the mechanisms by which 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE) activates signal transducer and activator of transcription 3 (STAT3), we studied the role of epidermal growth factor receptor (EGFR). 15(S)-HETE stimulated tyrosine phosphorylation of EGFR in a time-dependent manner in vascular smooth muscle cells (VSMCs). Interference with EGFR activation blocked 15(S)-HETE-induced Src and STAT3 tyrosine phosphorylation, monocyte chemoattractant protein-1 (MCP-1) expression and VSMC migration. 15(S)-HETE also induced tyrosine phosphorylation of Janus kinase 2 (Jak2) in VSMCs, and its inhibition substantially reduced STAT3 phosphorylation, MCP-1 expression, and VSMC migration. In addition, Src formed a complex with EGFR and Jak2, and its inhibition completely blocked Jak2 and STAT3 phosphorylation, MCP-1 expression, and VSMC migration. 15(S)-HETE induced the production of H2O2 via an NADPH oxidase-dependent manner and its scavengers, N-acetyl cysteine (NAC) and catalase suppressed 15(S)-HETE-stimulated EGFR, Src, Jak2, and STAT3 phosphorylation and MCP-1 expression. Balloon injury (BI) induced EGFR, Src, Jak2, and STAT3 phosphorylation, and inhibition of these signaling molecules attenuated BI-induced MCP-1 expression and smooth muscle cell migration from the medial to the luminal surface resulting in reduced neointima formation. In addition, inhibition of EGFR blocked BI-induced Src, Jak2, and STAT3 phosphorylation. Similarly, interference with Src activation suppressed BI-induced Jak2 and STAT3 phosphorylation. Furthermore, adenovirus-mediated expression of dnJak2 also blocked BI-induced STAT3 phosphorylation. Consistent with the effects of 15(S)-HETE on the activation of EGFR-Src-Jak2-STAT3 signaling in VSMCs in vitro, adenovirus-mediated expression of 15-lipoxygenase 1 (15-Lox1) enhanced BI-induced EGFR, Src, Jak2, and STAT3 phosphorylation leading to enhanced MCP-1 expression in vivo. Blockade of Src or Jak2 suppressed BI-induced 15-Lox1-enhanced STAT3 phosphorylation, MCP-1 expression, and neointima formation. In addition, whereas dominant negative Src blocked BI-induced 15-Lox1-enhanced Jak2 phosphorylation, dnJak2 had no effect on Src phosphorylation. Together, these observations demonstrate for the first time that the 15-Lox1-15(S)-HETE axis activates EGFR via redox-sensitive manner, which in turn mediates Src-Jak2-STAT3-dependent MCP-1 expression leading to vascular wall remodeling.	[Singh, Nikhlesh K.; Wang, Dong; Kundumani-Sridharan, Venkatesh; Dong Van Quyen; Niu, Jixiao; Rao, Gadiparthi N.] Univ Tennessee Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/AAB-4535-2020	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health [HL064165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL064165 (NHLBI; to G. N. R.).	BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Chan AK, 2003, J VASC SURG, V37, P644, DOI 10.1067/mva.2003.92; Chaturvedi P, 1998, ONCOGENE, V16, P1749, DOI 10.1038/sj.onc.1201972; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Fujiyama S, 2001, CIRC RES, V88, P22, DOI 10.1161/01.RES.88.1.22; Gschwind A, 2002, CANCER RES, V62, P6329; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; HUGOU I, 1995, ATHEROSCLEROSIS, V113, P189, DOI 10.1016/0021-9150(94)05446-P; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Lim YB, 2008, J BIOL CHEM, V283, P33110, DOI 10.1074/jbc.M804255200; LIN L, 1994, CIRC RES, V74, P197, DOI 10.1161/01.RES.74.2.197; Liu YP, 2003, CIRC RES, V93, P573, DOI 10.1161/01.RES.0000091261.19387.AE; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Oeckler RA, 2003, CIRC RES, V92, P23, DOI 10.1161/01.RES.0000051860.84509.CE; Palomeque J, 2009, CIRC RES, V105, P1204, DOI 10.1161/CIRCRESAHA.109.204172; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; RAO GN, 1994, J BIOL CHEM, V269, P32586; Rao GN, 1996, ONCOGENE, V13, P713; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schwaiberger AV, 2010, ARTERIOSCL THROM VAS, V30, P2475, DOI 10.1161/ATVBAHA.110.212654; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Seki Y, 2000, CIRC RES, V87, P12, DOI 10.1161/01.RES.87.1.12; Shibata R, 2003, HUM GENE THER, V14, P601, DOI 10.1089/104303403321618128; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Tang X, 2006, ARTERIOSCL THROM VAS, V26, P78, DOI 10.1161/01.ATV.0000191640.73313.ad; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhu DL, 2003, CIRC RES, V92, P992, DOI 10.1161/01.RES.0000070881.65194.8F; Zhu H, 2003, J BIOL CHEM, V278, P13350, DOI 10.1074/jbc.M212104200	50	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22478	22488		10.1074/jbc.M111.225060	http://dx.doi.org/10.1074/jbc.M111.225060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536676	Green Published, hybrid			2022-12-25	WOS:000291719900056
J	Bengtsson, F; Ekerot, CF; Jorntell, H				Bengtsson, Fredrik; Ekerot, Carl-Fredrik; Jorntell, Henrik			In Vivo Analysis of Inhibitory Synaptic Inputs and Rebounds in Deep Cerebellar Nuclear Neurons	PLOS ONE			English	Article							FIBER RECEPTIVE-FIELDS; COMPLEX SPIKE SYNCHRONY; INTERPOSITUS ANTERIOR; CLIMBING FIBERS; PURKINJE-CELLS; OLIVOCEREBELLAR SYSTEM; TOPOGRAPHICAL ORGANIZATION; BIDIRECTIONAL PLASTICITY; PARAVERMAL CEREBELLUM; CAT	Neuronal function depends on the properties of the synaptic inputs the neuron receive and on its intrinsic responsive properties. However, the conditions for synaptic integration and activation of intrinsic responses may to a large extent depend on the level of background synaptic input. In this respect, the deep cerebellar nuclear (DCN) neurons are of particular interest: they feature a massive background synaptic input and an intrinsic, postinhibitory rebound depolarization with profound effects on the synaptic integration. Using in vivo whole cell patch clamp recordings from DCN cells in the cat, we find that the background of Purkinje cell input provides a tonic inhibitory synaptic noise in the DCN cell. Under these conditions, individual Purkinje cells appear to have a near negligible influence on the DCN cell and clear-cut rebounds are difficult to induce. Peripheral input that drives the simple spike output of the afferent PCs to the DCN cell generates a relatively strong DCN cell inhibition, but do not induce rebounds. In contrast, synchronized climbing fiber activation, which leads to a synchronized input from a large number of Purkinje cells, can induce profound rebound responses. In light of what is known about climbing fiber activation under behaviour, the present findings suggest that DCN cell rebound responses may be an unusual event. Our results also suggest that cortical modulation of DCN cell output require a substantial co-modulation of a large proportion of the PCs that innervate the cell, which is a possible rationale for the existence of the cerebellar microcomplex.	[Bengtsson, Fredrik; Ekerot, Carl-Fredrik; Jorntell, Henrik] Lund Univ, Dept Expt Med Sci, Sect Neurophysiol, Lund, Sweden; [Jorntell, Henrik] Lund Univ, Dept Expt Med Sci, NeuroNano Res Ctr, Lund, Sweden	Lund University; Lund University	Bengtsson, F (corresponding author), Lund Univ, Dept Expt Med Sci, Sect Neurophysiol, Lund, Sweden.	henrik.jorntell@med.lu.se			EU [IST-028056-SENSOPAC]; National Institute of Neurological Disorders and Stroke [R01 NS-040863]; Swedish Research Council [K2005-04X-14780-03A, K2006-04X-08291-19-3, 60012701]; Segerfalk Foundation; Swedish Medical Society; Knut and Alice Wallenberg Foundation [KAW 2004.0119]; Medical Faculty at Lund University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040863] Funding Source: NIH RePORTER	EU(European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Segerfalk Foundation; Swedish Medical Society; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Medical Faculty at Lund University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by SENSOPAC (an Integrated Project funded by the EU under FP6, IST-028056-SENSOPAC), by the National Institute of Neurological Disorders and Stroke Grant (R01 NS-040863), the Swedish Research Council (project no. K2005-04X-14780-03A and K2006-04X-08291-19-3), the Segerfalk Foundation, the Swedish Medical Society, a Linne grant (project number 60012701) from the Swedish Research Council, the Knut and Alice Wallenberg Foundation (project number: KAW 2004.0119) and the Medical Faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Alvina K, 2009, NEUROSCIENCE, V158, P635, DOI 10.1016/j.neuroscience.2008.09.052; Alvina K, 2008, NAT NEUROSCI, V11, P1256, DOI 10.1038/nn.2195; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; ANDERSSON G, 1978, EXP BRAIN RES, V32, P565; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; Apps R, 2000, EUR J NEUROSCI, V12, P205, DOI 10.1046/j.1460-9568.2000.00897.x; Apps R, 1997, J PHYSIOL-LONDON, V502, P203, DOI 10.1111/j.1469-7793.1997.203bl.x; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Bengtsson F, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.007.2009; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Cerminara NL, 2009, J PHYSIOL-LONDON, V587, P429, DOI 10.1113/jphysiol.2008.163337; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chorev E, 2007, J NEUROSCI, V27, P5043, DOI 10.1523/JNEUROSCI.5187-06.2007; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 2006, SCIENCE, V314, P85, DOI 10.1126/science.1127241; DeZeeuw CI, 1997, J NEUROPHYSIOL, V77, P1747, DOI 10.1152/jn.1997.77.4.1747; DeZeeuw CI, 1996, ANN NY ACAD SCI, V781, P607; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; EKEROT CF, 1991, J PHYSIOL-LONDON, V441, P257, DOI 10.1113/jphysiol.1991.sp018750; EKEROT CF, 1979, EXP BRAIN RES, V36, P219, DOI 10.1007/BF00238906; EKEROT CF, 1995, EXP BRAIN RES, V106, P365; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; GARWICZ M, 1994, J PHYSIOL-LONDON, V474, P245, DOI 10.1113/jphysiol.1994.sp020017; Garwicz M, 1996, EUR J NEUROSCI, V8, P2726, DOI 10.1111/j.1460-9568.1996.tb01567.x; Gauck V, 2000, J NEUROSCI, V20, P3006; Gauck V, 2003, J NEUROSCI, V23, P8109; Gauck V, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-15-j0004.2001; Gibson AR, 2004, CEREBELLUM, V3, P212, DOI 10.1080/14734220410018995; HESSLOW G, 1994, J PHYSIOL-LONDON, V476, P245, DOI 10.1113/jphysiol.1994.sp020127; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Horn KM, 2004, BRAIN RES, V996, P148, DOI 10.1016/j.brainres.2003.10.021; Horn KM, 1996, J NEUROPHYSIOL, V76, P4140, DOI 10.1152/jn.1996.76.6.4140; Ito M, 1984, CEREBELLUM NEURAL CO; Jacobson GA, 2008, TRENDS NEUROSCI, V31, P617, DOI 10.1016/j.tins.2008.09.005; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; Jorntell H, 1999, J PHYSIOL-LONDON, V514, P551, DOI 10.1111/j.1469-7793.1999.551ae.x; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Kistler WM, 2003, CEREBELLUM, V2, P44, DOI 10.1080/14734220309426; KITAI ST, 1977, BRAIN RES, V122, P197, DOI 10.1016/0006-8993(77)90289-X; Lang EJ, 1999, J NEUROSCI, V19, P2728; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Mason CR, 1998, J NEUROPHYSIOL, V79, P537, DOI 10.1152/jn.1998.79.2.537; MATSUSHI.M, 1971, BRAIN RES, V35, P17, DOI 10.1016/0006-8993(71)90592-0; Medina JF, 2007, J NEUROSCI, V27, P6832, DOI 10.1523/JNEUROSCI.1323-07.2007; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; OSCARSSON O, 1979, TRENDS NEUROSCI, V2, P144; PALKOVITS M, 1977, EXP BRAIN RES, V28, P189; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Pedroarena CM, 2003, J NEUROPHYSIOL, V89, P704, DOI 10.1152/jn.00558.2002; Raman IM, 2000, J NEUROSCI, V20, P9004; Sangrey T, 2010, EUR J NEUROSCI, V32, P1646, DOI 10.1111/j.1460-9568.2010.07408.x; Sugihara I, 2001, J NEUROSCI, V21, P7715, DOI 10.1523/JNEUROSCI.21-19-07715.2001; SUGIHARA I, 2010, COMPARTMENTALIZATION; Sugihara I, 2007, J COMP NEUROL, V501, P13, DOI 10.1002/cne.21223; Sultan F, 2002, J COMP NEUROL, V452, P311, DOI 10.1002/cne.10365; Uusisaari M, 2007, J NEUROPHYSIOL, V97, P901, DOI 10.1152/jn.00974.2006; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P57, DOI 10.1152/jn.1993.69.1.57; Wetmore DZ, 2008, J NEUROPHYSIOL, V100, P2328, DOI 10.1152/jn.00344.2007; Wise AK, 2010, J PHYSIOL-LONDON, V588, P2373, DOI 10.1113/jphysiol.2010.189704; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591; Zheng N, 2009, J NEUROSCI, V29, P9826, DOI 10.1523/JNEUROSCI.2069-09.2009	69	84	85	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18822	10.1371/journal.pone.0018822	http://dx.doi.org/10.1371/journal.pone.0018822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552556	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700004
J	Diribarne, M; Mata, X; Chantry-Darmon, C; Vaiman, A; Auvinet, G; Bouet, S; Deretz, S; Cribiu, EP; de Rochambeau, H; Allain, D; Guerin, G				Diribarne, Mathieu; Mata, Xavier; Chantry-Darmon, Celine; Vaiman, Anne; Auvinet, Gerard; Bouet, Stephan; Deretz, Severine; Cribiu, Edmond-Paul; de Rochambeau, Hubert; Allain, Daniel; Guerin, Gerard			A Deletion in Exon 9 of the LIPH Gene Is Responsible for the Rex Hair Coat Phenotype in Rabbits (Oryctolagus cuniculus)	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE HYPOTRICHOSIS; LIPASE-H GENE; WOOLLY HAIR/HYPOTRICHOSIS; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE A(1); FOUNDER MUTATIONS; FAMILY; GROWTH; LAH2; DNA	The fur of common rabbits is constituted of 3 types of hair differing in length and diameter while that of rex animals is essentially made up of amazingly soft down-hair. Rex short hair coat phenotypes in rabbits were shown to be controlled by three distinct loci. We focused on the "r1'' mutation which segregates at a simple autosomal-recessive locus in our rabbit strains. A positional candidate gene approach was used to identify the rex gene and the corresponding mutation. The gene was primo-localized within a 40 cM region on rabbit chromosome 14 by genome scanning families of 187 rabbits in an experimental mating scheme. Then, fine mapping refined the region to 0.5 cM (Z = 78) by genotyping an additional 359 offspring for 94 microsatellites present or newly generated within the first defined interval. Comparative mapping pointed out a candidate gene in this 700 kb region, namely LIPH (Lipase Member H). In humans, several mutations in this major gene cause alopecia, hair loss phenotypes. The rabbit gene structure was established and a deletion of a single nucleotide was found in LIPH exon 9 of rex rabbits (1362delA). This mutation results in a frameshift and introduces a premature stop codon potentially shortening the protein by 19 amino acids. The association between this deletion and the rex phenotype was complete, as determined by its presence in our rabbit families and among a panel of 60 rex and its absence in all 60 non-rex rabbits. This strongly suggests that this deletion, in a homozygous state, is responsible for the rex phenotype in rabbits.	[Diribarne, Mathieu; Mata, Xavier; Chantry-Darmon, Celine; Vaiman, Anne; Bouet, Stephan; Cribiu, Edmond-Paul; Guerin, Gerard] INRA, UMR1313, Unite Genet Anim & Biol Integrat, Jouy En Josas, France; [Auvinet, Gerard; Deretz, Severine] INRA, UR967, Surgeres, France; [de Rochambeau, Hubert; Allain, Daniel] INRA, Stn Ameliorat Genet Animaux, UR631, F-31326 Castanet Tolosan, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Diribarne, M (corresponding author), INRA, UMR1313, Unite Genet Anim & Biol Integrat, Jouy En Josas, France.	gerard.guerin@jouy.inra.fr	Allain, Daniel/AAT-6658-2020	CHANTRY DARMON, Celine/0000-0002-1313-7650	Poitou-Charentes region; Animal Genetics Department; Animal Genetics and Integrative Biology unit of INRA	Poitou-Charentes region(Region Nouvelle-Aquitaine); Animal Genetics Department; Animal Genetics and Integrative Biology unit of INRA	This work was supported by a grant from the Poitou-Charentes region, the Animal Genetics Department and by the Animal Genetics and Integrative Biology unit of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali G, 2007, HUM GENET, V121, P319, DOI 10.1007/s00439-007-0344-0; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Carriere F, 1998, BBA-REV BIOMEMBRANES, V1376, P417, DOI 10.1016/S0304-4157(98)00016-1; Castle WE, 1929, J HERED, V20, P193, DOI 10.1093/oxfordjournals.jhered.a103177; Castle WE, 1933, P NATL ACAD SCI USA, V19, P1006, DOI 10.1073/pnas.19.12.1006; Chantry-Darmon C, 2006, ANIM GENET, V37, P335, DOI 10.1111/j.1365-2052.2006.01462.x; Chantry-Darmon C, 2005, CYTOGENET GENOME RES, V111, P134, DOI 10.1159/000086382; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crew FAE, 1939, J GENET, V38, P341, DOI 10.1007/BF02982178; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; Green P, 1988, RAPID CONSTRUCTION M; Hiramatsu T, 2003, J BIOL CHEM, V278, P49438, DOI 10.1074/jbc.M213018200; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Jelani M, 2008, CLIN GENET, V74, P184, DOI 10.1111/j.1399-0004.2008.01011.x; Jin WJ, 2002, GENOMICS, V80, P268, DOI 10.1006/geno.2002.6837; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kubiak RJ, 2001, BIOCHEMISTRY-US, V40, P5422, DOI 10.1021/bi002371y; Kuramoto T, 2010, J VET MED SCI, V72, P909, DOI 10.1292/jvms.09-0554; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Nahum S, 2009, ARCH DERMATOL RES, V301, P391, DOI 10.1007/s00403-008-0903-9; Naqvi SKUH, 2009, BRIT J DERMATOL, V160, P194, DOI 10.1111/j.1365-2133.2008.08822.x; Naz G, 2009, J DERMATOL SCI, V54, P12, DOI 10.1016/j.jdermsci.2008.12.001; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pasternack SM, 2009, J INVEST DERMATOL, V129, P2772, DOI 10.1038/jid.2009.154; Petukhova L, 2009, HUM HERED, V68, P117, DOI 10.1159/000212504; Rafat SA, 2007, J ANIM SCI, V85, P3116, DOI 10.2527/jas.2007-0109; Remington SG, 2002, INVEST OPHTH VIS SCI, V43, P3617; ROBINSON R, 1981, J HERED, V72, P131, DOI 10.1093/oxfordjournals.jhered.a109445; ROBINSON R, 1968, GENETICA, V39, P351, DOI 10.1007/BF02324474; Rogel-Gaillard C, 2001, MAMM GENOME, V12, P253, DOI 10.1007/s003350010260; Rougeot J, 1989, LAPIN ANGORA; Rozen S, 2000, Methods Mol Biol, V132, P365; Shimomura Y, 2009, J DERMATOL SCI, V56, P205, DOI 10.1016/j.jdermsci.2009.08.005; Shimomura Y, 2009, J INVEST DERMATOL, V129, P1927, DOI 10.1038/jid.2009.19; Shimomura Y, 2009, J INVEST DERMATOL, V129, P622, DOI 10.1038/jid.2008.290; Shinkuma S, 2010, HUM MUTAT, V31, P602, DOI 10.1002/humu.21235; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Vrillon J. L., 1988, 4 C WORLD RABB SCI A, V2, P244; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Wen XY, 1998, HUM MOL GENET, V7, P743, DOI 10.1093/hmg/7.4.743	46	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19281	10.1371/journal.pone.0019281	http://dx.doi.org/10.1371/journal.pone.0019281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552526	Green Published, gold			2022-12-25	WOS:000290020700046
J	Levinton, J; Doall, M; Ralston, D; Starke, A; Allam, B				Levinton, Jeffrey; Doall, Michael; Ralston, David; Starke, Adam; Allam, Bassem			Climate Change, Precipitation and Impacts on an Estuarine Refuge from Disease	PLOS ONE			English	Article							OYSTERS CRASSOSTREA-VIRGINICA; HAPLOSPORIDIUM-NELSONI MSX; CHESAPEAKE BAY; PERKINSUS-MARINUS; DELAWARE BAY; SALINITY; RESTORATION; EUTROPHICATION; TEMPERATURE; INFECTION	Background: Oysters play important roles in estuarine ecosystems but have suffered recently due to overfishing, pollution, and habitat loss. A tradeoff between growth rate and disease prevalence as a function of salinity makes the estuarine salinity transition of special concern for oyster survival and restoration. Estuarine salinity varies with discharge, so increases or decreases in precipitation with climate change may shift regions of low salinity and disease refuge away from optimal oyster bottom habitat, negatively impacting reproduction and survival. Temperature is an additional factor for oyster survival, and recent temperature increases have increased vulnerability to disease in higher salinity regions. Methodology/Principal Findings: We examined growth, reproduction, and survival of oysters in the New York Harbor-Hudson River region, focusing on a low-salinity refuge in the estuary. Observations were during two years when rainfall was above average and comparable to projected future increases in precipitation in the region and a past period of about 15 years with high precipitation. We found a clear tradeoff between oyster growth and vulnerability to disease. Oysters survived well when exposed to intermediate salinities during two summers (2008, 2010) with moderate discharge conditions. However, increased precipitation and discharge in 2009 reduced salinities in the region with suitable benthic habitat, greatly increasing oyster mortality. To evaluate the estuarine conditions over longer periods, we applied a numerical model of the Hudson to simulate salinities over the past century. Model results suggest that much of the region with suitable benthic habitat that historically had been a low salinity refuge region may be vulnerable to higher mortality under projected increases in precipitation and discharge. Conclusions/Significance: Predicted increases in precipitation in the northeastern United States due to climate change may lower salinities past important thresholds for oyster survival in estuarine regions with appropriate substrate, potentially disrupting metapopulation dynamics and impeding oyster restoration efforts, especially in the Hudson estuary where a large basin constitutes an excellent refuge from disease.	[Levinton, Jeffrey; Doall, Michael] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Ralston, David] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Starke, Adam; Allam, Bassem] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Woods Hole Oceanographic Institution; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Levinton, J (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	Levinton@life.bio.sunysb.edu		Allam, Bassem/0000-0003-1278-7915	Hudson River Foundation [00607A]; New York State Department of Environmental Conservation	Hudson River Foundation; New York State Department of Environmental Conservation	Funding was provided by the Hudson River Foundation, grant number 00607A, and the New York State Department of Environmental Conservation (MOU 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright BW, 2007, J SHELLFISH RES, V26, P451, DOI 10.2983/0730-8000(2007)26[451:GAMODJ]2.0.CO;2; Bain J., 2007, TARGET ECOSYSTEM CHA; Black FR, 1981, JAMAICA BAY HIST, P1; Bromley A, 1953, OYSTER BROTHERS FLOW, P4; Burreson EM, 2000, J AQUAT ANIM HEALTH, V12, P1, DOI [10.1577/1548-8667(2000)012<0001:IVIAIP>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0001:IVIAIP&gt;2.0.CO;2]; Burreson EM, 2004, AQUAT LIVING RESOUR, V17, P499, DOI 10.1051/alr:2004056; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Coleman FC, 2002, TRENDS ECOL EVOL, V17, P40, DOI 10.1016/S0169-5347(01)02330-8; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; CRAIG A, 1989, ESTUARIES, V12, P82, DOI 10.2307/1351499; DUNGAN CF, 1995, J EUKARYOT MICROBIOL, V42, P379, DOI 10.1111/j.1550-7408.1995.tb01598.x; FISHER WS, 1986, BIOL BULL-US, V170, P122, DOI 10.2307/1541385; FORD SE, 1988, DIS AQUAT ORGAN, V4, P121, DOI 10.3354/dao004121; Ford SE, 2007, MAR BIOL, V151, P119, DOI 10.1007/s00227-006-0454-6; Franz D.R., 1982, P181; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HASKIN HH, 1982, J INVERTEBR PATHOL, V40, P388, DOI 10.1016/0022-2011(82)90178-1; HASKIN HH, 1979, US NMFS MAR FISH REV, V41, P54; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Hofmann E, 2001, HYDROBIOLOGIA, V460, P195, DOI 10.1023/A:1013159329598; Hofmann E, 2009, OCEANOGRAPHY, V22, P212, DOI 10.5670/oceanog.2009.110; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kraeuter JN, 2003, J SHELLFISH RES, V22, P39; La Peyre MK, 2009, ESTUAR COAST, V32, P522, DOI 10.1007/s12237-009-9149-9; La Peyre MK, 2003, MAR ECOL PROG SER, V248, P165, DOI 10.3354/meps248165; Lipcius RN, 2008, REV FISH SCI, V16, P101, DOI 10.1080/10641260701812574; MACKIN JG, 1950, SCIENCE, V111, P328, DOI 10.1126/science.111.2883.328; MACKIN JOHN G., 1961, PUBL INST MAR SCI [PORT ARANSAS TEXAS], V7, P132; Mann R, 2004, J SHELLFISH RES, V23, P41; Mann R, 2007, J SHELLFISH RES, V26, P905, DOI 10.2983/0730-8000(2007)26[905:WORGIT]2.0.CO;2; McCollough CB, 2007, J SHELLFISH RES, V26, P465, DOI 10.2983/0730-8000(2007)26[465:AAPOPM]2.0.CO;2; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Najjar RG, 2000, CLIMATE RES, V14, P219, DOI 10.3354/cr014219; Newell R.I.E., 2005, COMP ROLES SUSPENSIO; Newell RIE, 1988, UNDERSTANDING ESTUAR, P536; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; North EW, 2008, MARINE ECOLOGY PROGR, V359, P90; OFFICER CB, 1982, MAR ECOL PROG SER, V9, P203, DOI 10.3354/meps009203; Ralston DK, 2008, J PHYS OCEANOGR, V38, P753, DOI 10.1175/2007JPO3808.1; Ralston DK, 2009, ESTUAR COAST, V32, P1130, DOI 10.1007/s12237-009-9206-4; RAY SAMMY, 1953, BULL MARINE SCI GULF AND CARIBBEAN, V3, P6; RAY SM, 1952, SCIENCE, V116, P360, DOI 10.1126/science.116.3014.360; RISTICH SS, 1977, ESTUAR COAST MAR SCI, V5, P255, DOI 10.1016/0302-3524(77)90021-4; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; Shumway Sandra E., 1996, P467; Starke AF, 2010, RESTORATION HUDSON R; USEPA, 1998, COND MID ATL EST	48	46	49	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18849	10.1371/journal.pone.0018849	http://dx.doi.org/10.1371/journal.pone.0018849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552552	Green Published, gold			2022-12-25	WOS:000290020700005
J	Mocholi, E; Ballester-Lurbe, B; Arque, G; Poch, E; Peris, B; Guerri, C; Dierssen, M; Guasch, RM; Terrado, J; Perez-Roger, I				Mocholi, Enric; Ballester-Lurbe, Begona; Arque, Gloria; Poch, Enric; Peris, Blanca; Guerri, Consuelo; Dierssen, Mara; Guasch, Rosa M.; Terrado, Jose; Perez-Roger, Ignacio			RhoE Deficiency Produces Postnatal Lethality, Profound Motor Deficits and Neurodevelopmental Delay in Mice	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; GTP-BINDING PROTEINS; GTPASES; FAMILY; GENE; ALPHA-2-CHIMAERIN; PHOSPHORYLATION; IDENTIFICATION; CYTOSKELETON; ENDOCYTOSIS	Rnd proteins are a subfamily of Rho GTPases involved in the control of actin cytoskeleton dynamics and other cell functions such as motility, proliferation and survival. Unlike other members of the Rho family, Rnd proteins lack GTPase activity and therefore remain constitutively active. We have recently described that RhoE/Rnd3 is expressed in the Central Nervous System and that it has a role in promoting neurite formation. Despite their possible relevance during development, the role of Rnd proteins in vivo is not known. To get insight into the in vivo function of RhoE we have generated mice lacking RhoE expression by an exon trapping cassette. RhoE null mice (RhoE gt/gt) are smaller at birth, display growth retardation and early postnatal death since only half of RhoE gt/gt mice survive beyond postnatal day (PD) 15 and 100% are dead by PD 29. RhoE gt/gt mice show an abnormal body position with profound motor impairment and impaired performance in most neurobehavioral tests. Null mutant mice are hypoactive, show an immature locomotor pattern and display a significant delay in the appearance of the hindlimb mature responses. Moreover, they perform worse than the control littermates in the wire suspension, vertical climbing and clinging, righting reflex and negative geotaxis tests. Also, RhoE ablation results in a delay of neuromuscular maturation and in a reduction in the number of spinal motor neurons. Finally, RhoE gt/gt mice lack the common peroneal nerve and, consequently, show a complete atrophy of the target muscles. This is the first model to study the in vivo functions of a member of the Rnd subfamily of proteins, revealing the important role of Rnd3/RhoE in the normal development and suggesting the possible involvement of this protein in neurological disorders.	[Mocholi, Enric; Poch, Enric; Perez-Roger, Ignacio] Univ CEU Cardenal Herrera, Sch Hlth Sci, Dept Chem Biochem & Mol Biol, Valencia, Spain; [Ballester-Lurbe, Begona; Terrado, Jose] Univ CEU Cardenal Herrera, Dept Anim Med & Surg, Sch Vet Sci, Valencia, Spain; [Arque, Gloria; Dierssen, Mara] PRBB, CRG, Genes & Dis Program, Barcelona, Spain; [Arque, Gloria; Dierssen, Mara] CIBERER, Barcelona, Spain; [Peris, Blanca; Guerri, Consuelo; Guasch, Rosa M.] Ctr Invest Principe Felipe, Lab Cellular Pathol, Valencia, Spain	Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center	Mocholi, E (corresponding author), Univ CEU Cardenal Herrera, Sch Hlth Sci, Dept Chem Biochem & Mol Biol, Valencia, Spain.	jterrado@uch.ceu.es; iperez@uch.ceu.es	Guerri, Consuelo/B-5181-2014; Guerri, Consuelo/R-1171-2019; Mocholi, Enric/ABH-5275-2020; Lurbe, Begoña Ballester/D-6949-2017; GUASCH, ROSA MARIA/ABG-9879-2020; Pérez Roger, Ignacio/K-1346-2014; Poch, Enric/C-5258-2013; Arque, Gloria/AHD-3561-2022; Arque, Gloria/AAT-7266-2020; Guasch, Rosa/B-7520-2014; Dierssen, Mara/G-3552-2015	Guerri, Consuelo/0000-0001-9485-6202; Lurbe, Begoña Ballester/0000-0002-7413-9334; GUASCH, ROSA MARIA/0000-0001-8284-786X; Pérez Roger, Ignacio/0000-0002-5564-6912; Arque, Gloria/0000-0002-8039-3726; Dierssen, Mara/0000-0003-0853-6865; Mocholi Gimeno, Enric/0000-0002-6614-3173; Terrado, Jose/0000-0002-7356-2341	Univ. CEU-Cardenal Herrera; Instituto de Salud Carlos III; Generalitat Valenciana	Univ. CEU-Cardenal Herrera; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Univ. CEU-Cardenal Herrera (PRUCH and Santander-Copernicus to IPR and JT) the Instituto de Salud Carlos III (to IPR and RMG) and the Generalitat Valenciana (to EP). The work was also supported by fellowships from the Univ. Cardenal Herrera-CEU to EM and from the Generalitat Valenciana to BBL and BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ballester-Lurbe B, 2009, NEUROSCIENCE, V163, P586, DOI 10.1016/j.neuroscience.2009.06.062; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Bernstein BW, 2010, CURR BIOL, V20, pR360, DOI 10.1016/j.cub.2010.03.008; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Foster R, 1996, MOL CELL BIOL, V16, P2689; FOX M. W., 1965, ANIM BEHAV, V13, P234; Goda T, 2009, DEV DYNAM, V238, P2867, DOI 10.1002/dvdy.22099; Goh LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012409; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jurney WM, 2002, J NEUROSCI, V22, P6019; Lalonde R, 2011, BRAIN RES REV, V67, P252, DOI 10.1016/j.brainresrev.2011.02.005; LALONDE R, 1987, EXP BRAIN RES, V68, P417; Lanuza MA, 2002, J NEUROSCI RES, V67, P607, DOI 10.1002/jnr.10122; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Maystadt I, 2007, AM J HUM GENET, V81, P67, DOI 10.1086/518900; Mei H, 2011, CELL SIGNAL, V23, P389, DOI 10.1016/j.cellsig.2010.10.009; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pereira JA, 2009, J CELL BIOL, V185, P147, DOI 10.1083/jcb.200809008; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Samuel F, 2010, MOL NEUROBIOL, V42, P133, DOI 10.1007/s12035-010-8144-2; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Talens-Visconti R, 2010, J NEUROCHEM, V112, P1074, DOI 10.1111/j.1471-4159.2009.06526.x; Tarchini B, 2005, GENE DEV, V19, P2862, DOI 10.1101/gad.351105; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	49	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19236	10.1371/journal.pone.0019236	http://dx.doi.org/10.1371/journal.pone.0019236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552537	gold, Green Submitted, Green Published			2022-12-25	WOS:000290020700042
J	Dzeja, PP; Chung, S; Faustino, RS; Behfar, A; Terzic, A				Dzeja, Petras P.; Chung, Susan; Faustino, Randolph S.; Behfar, Atta; Terzic, Andre			Developmental Enhancement of Adenylate Kinase-AMPK Metabolic Signaling Axis Supports Stem Cell Cardiac Differentiation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTHELIAL PROGENITOR CELLS; GENE-EXPRESSION; CATALYZED PHOSPHOTRANSFER; AK1 GENE; HEART; LKB1; PHOSPHORYLATION; NETWORKS; PATHWAY	Background: Energetic and metabolic circuits that orchestrate cell differentiation are largely unknown. Adenylate kinase (AK) and associated AMP-activated protein kinase (AMPK) constitute a major metabolic signaling axis, yet the role of this system in guiding differentiation and lineage specification remains undefined. Methods and Results: Cardiac stem cell differentiation is the earliest event in organogenesis, and a suitable model of developmental bioenergetics. Molecular profiling of embryonic stem cells during cardiogenesis revealed here a distinct expression pattern of adenylate kinase and AMPK genes that encode the AK-AMP-AMPK metabolic surveillance axis. Cardiac differentiation upregulated cytosolic AK1 isoform, doubled AMP-generating adenylate kinase activity, and increased AMP/ATP ratio. At cell cycle initiation, AK1 translocated into the nucleus and associated with centromeres during energy-consuming metaphase. Concomitantly, the cardiac AMP-signal receptor AMPK alpha 2 was upregulated and redistributed to the nuclear compartment as signaling-competent phosphorylated p-AMPK alpha(Thr172). The cardiogenic growth factor TGF-beta promoted AK1 expression, while knockdown of AK1, AK2 and AK5 activities with siRNA or suppression by hyperglycemia disrupted cardiogenesis compromising mitochondrial and myofibrillar network formation and contractile performance. Induction of creatine kinase, the alternate phosphotransfer pathway, compensated for adenylate kinase-dependent energetic deficits. Conclusions: Developmental deployment and upregulation of the adenylate kinase/AMPK tandem provides a nucleocytosolic energetic and metabolic signaling vector integral to execution of stem cell cardiac differentiation. Targeted redistribution of the adenylate kinase-AMPK circuit associated with cell cycle and asymmetric cell division uncovers a regulator for cardiogenesis and heart tissue regeneration.	[Dzeja, Petras P.; Chung, Susan; Faustino, Randolph S.; Behfar, Atta; Terzic, Andre] Mayo Clin, Dept Med Mol Pharmacol & Expt Therapeut & Med Gen, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Rochester, MN 55905 USA	Mayo Clinic	Dzeja, PP (corresponding author), Mayo Clin, Dept Med Mol Pharmacol & Expt Therapeut & Med Gen, Div Cardiovasc Dis, Marriott Heart Dis Res Program, Rochester, MN 55905 USA.	dzeja.petras@mayo.edu; terzic.andre@mayo.edu		Behfar, Atta/0000-0003-3775-5784	National Institutes of Health; Marriott Heart Disease Research Program; Marriott Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marriott Heart Disease Research Program; Marriott Foundation; Mayo Clinic; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the National Institutes of Health, Marriott Heart Disease Research Program, Marriott Foundation and Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrell DK, 2008, STEM CELLS, V26, P387, DOI 10.1634/stemcells.2007-0599; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Behfar A, 2008, J MOL CELL CARDIOL, V45, P523, DOI 10.1016/j.yjmcc.2008.09.122; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Boyer P.D, 1973, ENZYMES, P279; Burkart A, 2011, J BIOL CHEM, V286, P4081, DOI 10.1074/jbc.M110.134106; Cabarcas SM, 2010, CURR MOL MED, V10, P741; Cai F, 2007, J ENDOCRINOL, V192, P605, DOI 10.1677/JOE-06-0080; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; Chiriac A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009943; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Chung S, 2008, ANN NY ACAD SCI, V1147, P254, DOI 10.1196/annals.1427.004; Collavin L, 1999, ONCOGENE, V18, P5879, DOI 10.1038/sj.onc.1202970; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Dzeja PP, 2007, J BIOL CHEM, V282, P31366, DOI 10.1074/jbc.M705268200; Dzeja PP, 1999, CIRC RES, V84, P1137, DOI 10.1161/01.RES.84.10.1137; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; Dzeja PP, 2002, P NATL ACAD SCI USA, V99, P10156, DOI 10.1073/pnas.152259999; Dzeja PP, 2007, MOL SYSTEM BIOENERGE, P265; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Faustino RS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r6; Faustino RS, 2008, CTS-CLIN TRANSL SCI, V1, P174, DOI 10.1111/j.1752-8062.2008.00038.x; Fujisawa K, 2009, COMP BIOCHEM PHYS B, V153, P29, DOI 10.1016/j.cbpb.2009.01.006; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Grey C, 2005, HUM MOL GENET, V14, P1367, DOI 10.1093/hmg/ddi146; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hancock CR, 2006, J APPL PHYSIOL, V100, P406, DOI 10.1152/japplphysiol.00885.2005; Hand NJ, 2009, GASTROENTEROLOGY, V136, P1081, DOI 10.1053/j.gastro.2008.12.006; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; He TR, 2004, ARTERIOSCL THROM VAS, V24, P2021, DOI 10.1161/01.ATV.0000142810.27849.8f; Hosoda T, 2010, CIRC J, V74, P13, DOI 10.1253/circj.CJ-09-0665; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Ingwall JS, 2010, EUR J HEART FAIL, V12, P1268, DOI 10.1093/eurjhf/hfq193; Inouye S, 1998, J NEUROCHEM, V71, P125; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Janssen E, 2004, MOL CELL BIOCHEM, V256, P59, DOI 10.1023/B:MCBI.0000009859.15267.db; Ju JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE347, DOI 10.1152/ajpendo.00238.2004; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Lagresle-Peyrou C, 2009, NAT GENET, V41, P106, DOI 10.1038/ng.278; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Leff T, 2003, BIOCHEM SOC T, V31, P224; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; McGee SL, 2010, CLIN EXP PHARMACOL P, V37, P392, DOI 10.1111/j.1440-1681.2009.05311.x; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Noma T, 2005, J MED INVESTIG, V52, P127, DOI 10.2152/jmi.52.127; Nury D, 2009, J CELL PHYSIOL, V218, P455, DOI 10.1002/jcp.21631; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; Panayiotou C, 2011, BIOCHEM J, V433, P527, DOI 10.1042/BJ20101443; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Perez-Terzic C, 2003, CIRC RES, V92, P444, DOI 10.1161/01.RES.0000059415.25070.54; Perez-Terzic Carmen, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS68, DOI 10.1038/ncpcardio0763; Pucar D, 2002, AM J PHYSIOL-HEART C, V283, pH776, DOI 10.1152/ajpheart.00116.2002; Rafalski VA, 2011, PROG NEUROBIOL, V93, P182, DOI 10.1016/j.pneurobio.2010.10.007; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Smoak IW, 2004, DEV DYNAM, V231, P179, DOI 10.1002/dvdy.20123; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Urbanek K, 2010, CIRC RES, V107, P429, DOI 10.1161/CIRCRESAHA.110.218487; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Van Rompay AR, 2000, PHARMACOL THERAPEUT, V87, P189, DOI 10.1016/S0163-7258(00)00048-6; Vazquez-Martin A, 2009, CELL CYCLE, V8, P2385, DOI 10.4161/cc.8.15.9082; Vissing K, 2008, AM J PHYSIOL-ENDOC M, V294, pE408, DOI 10.1152/ajpendo.00403.2007; WANG TC, 1987, LIFE SCI, V40, P239, DOI 10.1016/0024-3205(87)90338-9; Wirschell M, 2004, MOL BIOL CELL, V15, P2729, DOI 10.1091/mbc.E03-11-0820; Young LH, 2005, TRENDS CARDIOVAS MED, V15, P110, DOI 10.1016/j.tcm.2005.04.005; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; ZHANG S, 2010, CIRCULATION, V122; Zungu M, 2011, AM J PATHOL, V178, P4, DOI 10.1016/j.ajpath.2010.11.030	86	53	54	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19300	10.1371/journal.pone.0019300	http://dx.doi.org/10.1371/journal.pone.0019300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556322	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400047
J	Bob, P; Jasova, D; Bizik, G; Raboch, J				Bob, Petr; Jasova, Denisa; Bizik, Gustav; Raboch, Jiri			Epileptiform Activity in Alcohol Dependent Patients and Possibilities of Its Indirect Measurement	PLOS ONE			English	Article							TEMPORAL-LOBE; NEUROBIOLOGICAL CONSEQUENCES; CHILDHOOD MALTREATMENT; EARLY STRESS; WITHDRAWAL; SYMPTOMS; EPILEPSY; SEIZURES; BRAIN; ANTICONVULSANTS	Background: Alcohol dependence during withdrawal and also in abstinent period in many cases is related to reduced inhibitory functions and kindling that may appear in the form of psychosensory symptoms similar to temporal lobe epilepsy frequently in conditions of normal EEG and without seizures. Because temporal lobe epileptic activity tend to spread between hemispheres, it is possible to suppose that measures reflecting interhemispheric information transfer such as electrodermal activity (EDA) might be related to the psychosensory symptoms. Methods and Findings: We have performed measurement of bilateral EDA, psychosensory symptoms (LSCL-33) and alcohol craving (ACQ) in 34 alcohol dependent patients and 32 healthy controls. The results in alcohol dependent patients show that during rest conditions the psychosensory symptoms (LSCL-33) are related to EDA transinformation (PTI) between left and right EDA records (Spearman r = 0.44, p<0.01). Conclusions: The result may present potentially useful clinical finding suggesting a possibility to indirectly assess epileptiform changes in alcohol dependent patients.	[Bob, Petr; Jasova, Denisa; Bizik, Gustav; Raboch, Jiri] Charles Univ Prague, Ctr Neuropsychiat Res Traumat Stress, Dept Psychiat, Fac Med 1, Prague, Czech Republic	Charles University Prague; General University Hospital Prague	Bob, P (corresponding author), Charles Univ Prague, Ctr Neuropsychiat Res Traumat Stress, Dept Psychiat, Fac Med 1, Prague, Czech Republic.	petrbob@netscape.net	Bob, Petr/E-3414-2012; raboch, jiri/N-7445-2017	raboch, jiri/0000-0001-6667-1497	Center for Neuropsychiatric Research of Traumatic Stress, Czech Ministry of Education [1M06039];  [MSM0021620849];  [MSM0021622404]	Center for Neuropsychiatric Research of Traumatic Stress, Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); ; 	This work was supported by research grants MSM0021620849 and MSM0021622404 and support of the research project of the Center for Neuropsychiatric Research of Traumatic Stress 1M06039 by the Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1994, AM PSYCH ASS DSM 4 D; Baumgartner C, 2001, EPILEPTIC DISORD, V3, P103; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Bob P, 2010, PROG NEURO-PSYCHOPH, V34, P143, DOI 10.1016/j.pnpbp.2009.10.015; Book SW, 2005, EXPERT OPIN INV DRUG, V14, P371, DOI 10.1517/13543784.14.4.371; Brailowsky S, 1999, ARCH MED RES, V30, P3, DOI 10.1016/S0188-0128(98)00013-X; Breese GR, 2005, PSYCHOPHARMACOLOGY, V178, P367, DOI 10.1007/s00213-004-2016-2; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; De Witte P, 2003, NEUROSCI BIOBEHAV R, V27, P189, DOI 10.1016/S0149-7634(03)00030-7; Devinsky Orrin, 2004, Epilepsy Curr, V4, P43, DOI 10.1111/j.1535-7597.2004.42001.x; Duka T, 2002, ALCOHOL CLIN EXP RES, V26, P785, DOI 10.1097/00000374-200206000-00007; GLUE P, 1990, BRIT J PSYCHIAT, V157, P491, DOI 10.1192/bjp.157.4.491; Kantz H., 1997, NONLINEAR TIME SERIE; Krystal JH, 2006, ARCH GEN PSYCHIAT, V63, P957, DOI 10.1001/archpsyc.63.9.957; Lambertz M, 2000, J AUTONOM NERV SYST, V78, P141, DOI 10.1016/S0165-1838(99)00072-7; Malcolm R, 2001, AM J ADDICTION, V10, P16, DOI 10.1080/10550490190942489; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; McIntyre DC, 2008, EPILEPSIA, V49, P23, DOI 10.1111/j.1528-1167.2008.01507.x; McIntyre DC, 2002, EPILEPSY RES, V50, P79, DOI 10.1016/S0920-1211(02)00071-2; Poprawski TJ, 2007, CLIN EEG NEUROSCI, V38, P175, DOI 10.1177/155005940703800316; Post RM, 2004, EPILEPSIA, V45, P5, DOI 10.1111/j.0013-9580.2004.452001.x; Raabe A, 2005, ADDICTION, V100, P227, DOI 10.1111/j.1360-0443.2005.00960.x; ROBERTS RJ, 1992, EPILEPSY RES, V13, P167, DOI 10.1016/0920-1211(92)90073-3; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Teicher MH, 2006, ANN NY ACAD SCI, V1071, P313, DOI 10.1196/annals.1364.024; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; TEICHER MH, 1993, J NEUROPSYCH CLIN N, V5, P301; Weinand Martin E, 2006, Pathophysiology, V13, P233, DOI 10.1016/j.pathophys.2006.08.002; Weinand ME, 2001, EPILEPSY RES, V44, P33, DOI 10.1016/S0920-1211(00)00205-9; WISE RA, 1988, J ABNORM PSYCHOL, V97, P118, DOI 10.1037/0021-843X.97.2.118	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18678	10.1371/journal.pone.0018678	http://dx.doi.org/10.1371/journal.pone.0018678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541318	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400008
J	Strathdee, SA; Lozada, R; Martinez, G; Vera, A; Rusch, M; Nguyen, L; Pollini, RA; Uribe-Salas, F; Beletsky, L; Patterson, TL				Strathdee, Steffanie A.; Lozada, Remedios; Martinez, Gustavo; Vera, Alicia; Rusch, Melanie; Lucie Nguyen; Pollini, Robin A.; Uribe-Salas, Felipe; Beletsky, Leo; Patterson, Thomas L.			Social and Structural Factors Associated with HIV Infection among Female Sex Workers Who Inject Drugs in the Mexico-US Border Region	PLOS ONE			English	Article							LAW-ENFORCEMENT; CIUDAD-JUAREZ; SUBSTANCE USE; RISK; BEHAVIORS; TIJUANA; CITIES; USERS; INTERVENTION; VIOLENCE	Background: FSWs who inject drugs (FSW-IDUs) can acquire HIV through high risk sexual and injection behaviors. We studied correlates of HIV infection among FSW-IDUs in northern Mexico, where sex work is quasi-legal and syringes can be legally obtained without a prescription. Methods: FSW-IDUs>18 years old who reported injecting drugs and recent unprotected sex with clients in Tijuana and Ciudad Juarez underwent surveys and HIV/STI testing. Logistic regression identified correlates of HIV infection. Results: Of 620 FSW-IDUs, prevalence of HIV, gonorrhea, Chlamydia, trichomonas, syphilis titers >= 1:8, or any of these infections was 5.3%, 4%, 13%, 35%, 10% and 72%, respectively. Compared to other FSW-IDUs, HIV-positive women were more likely to: have syphilis titers >= 1:8 (36% vs. 9%, p<0.001), often/always inject drugs with clients (55% vs. 32%, p = 0.01), and experience confiscation of syringes by police (49% vs. 28%, p = 0.02). Factors independently associated with HIV infection were syphilis titers >= 1:8, often/always injecting with clients and police confiscation of syringes. Women who obtained syringes from NEPs (needle exchange programs) within the last month had lower odds of HIV infection associated with active syphilis, but among non-NEP attenders, the odds of HIV infection associated with active syphilis was significantly elevated. Conclusions: Factors operating in both the micro-social environment (i.e., injecting drugs with clients) and policy environment (i.e., having syringes confiscated by police, attending NEPs) predominated as factors associated with risk of HIV infection, rather than individual-level risk behaviors. Interventions should target unjustified policing practices, clients' risk behaviors and HIV/STI prevention through NEPs.	[Strathdee, Steffanie A.; Vera, Alicia; Rusch, Melanie; Lucie Nguyen; Pollini, Robin A.; Beletsky, Leo; Patterson, Thomas L.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Strathdee, Steffanie A.; Vera, Alicia; Rusch, Melanie; Lucie Nguyen; Pollini, Robin A.; Beletsky, Leo; Patterson, Thomas L.] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Lozada, Remedios] Prevencasa AC, Tijuana, Baja California, Mexico; [Martinez, Gustavo] Salud & Desarollo Comunitario Ciudad Juarez AC SA, Ciudad Juarez, Mexico; [Martinez, Gustavo] Federac Mexicana Asociac Privadas FEMAP, Ciudad Juarez, Mexico; [Uribe-Salas, Felipe] Colegio Frontera No, Tijuana, Mexico	University of California System; University of California San Diego; University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	HARVEY-VERA, ALICIA/0000-0002-8708-8169; Strathdee, Steffanie/0000-0002-7724-691X	National Institute on Drug Abuse (NIDA) [R01 DA023877];  [K01DA022923];  [R00DA024135-03];  [R25DA025771]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024135, K01DA022923, R01DA023877] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the National Institute on Drug Abuse (NIDA; R01 DA023877). Dr. Pollini is supported by K01DA022923, Dr. Rusch by R00DA024135-03 and Dr. Beletsky by R25DA025771. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandea CI, 2009, J CLIN MICROBIOL, V47, P215, DOI 10.1128/JCM.01338-08; Beletsky L, 2011, AM J PUBLIC IN PRESS; Beletsky L, 2011, ADDICTION, V106, P357, DOI 10.1111/j.1360-0443.2010.03149.x; Moreno JGB, 2010, LANCET, V376, P493, DOI 10.1016/S0140-6736(10)60883-5; Centers for Disease Control (CDC), 1987, MMWR Morb Mortal Wkly Rep, V36, P157; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; Davis CS, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-16; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; El-Bassel N, 2001, AIDS PATIENT CARE ST, V15, P41, DOI 10.1089/108729101460092; El-Bassel N, 2010, AIDS BEHAV, V14, P1045, DOI 10.1007/s10461-010-9695-y; El-Bassel N, 2010, LANCET, V376, P312, DOI 10.1016/S0140-6736(10)61026-4; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; Garfein RS, 2007, AIDS, V21, P1923, DOI 10.1097/QAD.0b013e32823f9066; Hammett TM, 2005, INT J DRUG POLICY, V16, P235, DOI 10.1016/j.drugpo.2005.05.009; Lau JTF, 2008, DRUG ALCOHOL DEPEN, V97, P54, DOI 10.1016/j.drugalcdep.2008.03.024; Loza O, 2010, ADDICTION, V105, P1448, DOI 10.1111/j.1360-0443.2010.02985.x; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; MCKEGANEY N, 1992, BMJ-BRIT MED J, V305, P801, DOI 10.1136/bmj.305.6857.801; Meyer Maureen, 2010, ABUSED AFRAID CIUDAD; Patterson TL, 2008, AM J PUBLIC HEALTH, V98, P2051, DOI 10.2105/AJPH.2007.130096; Patterson TL, 2009, AIDS, V23, P1763, DOI 10.1097/QAD.0b013e32832f08a1; Philbin M, 2008, AIDS BEHAV, V12, P552, DOI 10.1007/s10461-008-9372-6; Pollini RA, 2008, ADDICTION, V103, P101, DOI 10.1111/j.1360-0443.2007.02051.x; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Ramos R, 2009, HEALTH PLACE, V15, P999, DOI 10.1016/j.healthplace.2009.04.004; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Semple SJ, 2004, DRUG ALCOHOL DEPEN, V76, P203, DOI 10.1016/j.drugalcdep.2004.05.003; Shannon K, 2008, AIDS CARE, V20, P235, DOI 10.1080/09540120701561270; Shannon K, 2010, JAMA-J AM MED ASSOC, V304, P573, DOI 10.1001/jama.2010.1090; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Stockman JK, 2010, JAIDS-J ACQ IMM DEF, V55, pS17, DOI 10.1097/QAI.0b013e3181f9c04c; Strathdee SA, 2005, J URBAN HEALTH, V82, pIV58, DOI 10.1093/jurban/jti108; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690; Tran TN, 2005, JAIDS-J ACQ IMM DEF, V39, P581; Ulibarri MD, 2010, CURR OPIN PSYCHIATR, V23, P215, DOI 10.1097/YCO.0b013e32833864d5; VANDENHOEK JAR, 1989, GENITOURIN MED, V65, P146; Weber AE, 2002, J URBAN HEALTH, V79, P525, DOI 10.1093/jurban/79.4.525; Wood E, 2004, CAN MED ASSOC J, V170, P1551, DOI 10.1503/cmaj.1031928	43	139	139	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19048	10.1371/journal.pone.0019048	http://dx.doi.org/10.1371/journal.pone.0019048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756MU	21541349	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800033
J	Paino, A; Tuominen, H; Jaaskelainen, M; Alanko, J; Nuutila, J; Asikainen, SE; Pelliniemi, LJ; Pollanen, MT; Chen, C; Ihalin, R				Paino, Annamari; Tuominen, Heidi; Jaaskelainen, Mari; Alanko, Jonna; Nuutila, Jari; Asikainen, Sirkka E.; Pelliniemi, Lauri J.; Pollanen, Marja T.; Chen, Casey; Ihalin, Riikka			Trimeric Form of Intracellular ATP Synthase Subunit beta of Aggregatibacter actinomycetemcomitans Binds Human Interleukin-1 beta	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; CORONARY-HEART-DISEASE; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; ESCHERICHIA-COLI; YERSINIA-PESTIS; GROWTH; CELLS; MODEL	Bacterial biofilms resist host defenses and antibiotics partly because of their decreased metabolism. Some bacteria use proinflammatory cytokines, such as interleukin (IL)-1 beta, as cues to promote biofilm formation and to alter virulence. Although one potential bacterial IL-1 beta receptor has been identified, current knowledge of the bacterial IL-1 beta sensing mechanism is limited. In chronic biofilm infection, periodontitis, Aggregatibacter actinomycetemcomitans requires tight adherence (tad)locus to form biofilms, and tissue destroying active lesions contain more IL-1 beta than inactive ones. The effect of IL-1 beta on the metabolic activity of A. actinomycetemcomitans biofilm was tested using alamarBlue (TM). The binding of IL-1 beta to A. actinomycetemcomitans cells was investigated using transmission electron microscopy and flow cytometry. To identify the proteins which interacted with IL-1 beta, different protein fractions from A. actinomycetemcomitans were run in native-PAGE and blotted using biotinylated IL-1 beta and avidin-HRP, and identified using mass spectroscopy. We show that although IL-1 beta slightly increases the biofilm formation of A. actinomycetemcomitans, it reduces the metabolic activity of the biofilm. A similar reduction was observed with all tad-locus mutants except the secretin mutant, although all tested mutant strains as well as wild type strains bound IL-1 beta. Our results suggest that IL-1 beta might be transported into the A. actinomycetemcomitans cells, and the trimeric form of intracellular ATP synthase subunit beta interacted with IL-1 beta, possibly explaining the decreased metabolic activity. Because ATP synthase is highly conserved, it might universally enhance biofilm resistance to host defense by binding IL-1 beta during inflammation.	[Paino, Annamari; Tuominen, Heidi; Jaaskelainen, Mari; Alanko, Jonna; Nuutila, Jari; Ihalin, Riikka] Univ Turku, Dept Biochem & Food Chem, Turku, Finland; [Alanko, Jonna; Asikainen, Sirkka E.] Umea Univ, Dept Odontol, Umea, Sweden; [Pelliniemi, Lauri J.] Univ Turku, Lab Electron Microscopy, Turku, Finland; [Pollanen, Marja T.] Univ Turku, Inst Dent, Dept Periodontol, Turku, Finland; [Chen, Casey] Univ So Calif, Div Periodontol Diagnost Sci & Dent Hyg, USC Sch Dent, Los Angeles, CA USA	University of Turku; Umea University; University of Turku; University of Turku; University of Southern California	Paino, A (corresponding author), Univ Turku, Dept Biochem & Food Chem, Turku, Finland.	riikka.ihalin@utu.fi	Ihalin, Riikka/I-4411-2019; Tuominen, Heidi/A-7075-2010	Ihalin, Riikka/0000-0003-4118-0370; Tuominen, Heidi/0000-0003-2412-7658; Nuutila, Jari/0000-0002-9077-0273; Alanko, Jonna/0000-0002-7698-3061	Academy of Finland [126557]; Turku University Foundation; Ella & Georg Ehrnrooth Foundation; Finnish Cultural Foundation; Paulo Foundation; Emil and Blida Maunula Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012212] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Turku University Foundation; Ella & Georg Ehrnrooth Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Paulo Foundation; Emil and Blida Maunula Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the grants from the Academy of Finland (126557) (http://www.aka.fi/en-gb/A/), Turku University Foundation, (http://www.turunyliopistosaatio.fi/engframes.htm), Ella & Georg Ehrnrooth Foundation (http://www.ellageorg.fi/en/about), The Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId=12256), Paulo Foundation (http://www.paulo.fi/foundation.html) and Emil and Blida Maunula Fund to RI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; ASSELINEAU D, 1984, BRIT J DERMATOL, V111, P219, DOI 10.1111/j.1365-2133.1984.tb15608.x; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Buhlin K, 2009, ATHEROSCLEROSIS, V206, P518, DOI 10.1016/j.atherosclerosis.2009.03.035; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Clock SA, 2008, J BACTERIOL, V190, P980, DOI 10.1128/JB.01347-07; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; FROJDMAN K, 1992, DIFFERENTIATION, V50, P113, DOI 10.1111/j.1432-0436.1992.tb00492.x; Gursoy UK, 2010, J PERIODONTOL, V81, P1084, DOI 10.1902/jop.2010.090664; Haase EM, 1999, INFECT IMMUN, V67, P2901, DOI 10.1128/IAI.67.6.2901-2908.1999; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Ihalin R, 2006, J MICROBIOL METH, V65, P417, DOI 10.1016/j.mimet.2005.08.016; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Kanangat S, 2001, J INFECT DIS, V183, P65, DOI 10.1086/317645; Kanangat S, 2007, MICROBES INFECT, V9, P408, DOI 10.1016/j.micinf.2006.12.018; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; Karched M, 2007, J MICROBIOL METH, V68, P46, DOI 10.1016/j.mimet.2006.06.004; Laughlin TF, 2010, INT J BIOL MACROMOL, V46, P367, DOI 10.1016/j.ijbiomac.2010.01.015; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Makela M, 1998, BIOCHEM BIOPH RES CO, V253, P325, DOI 10.1006/bbrc.1998.9641; McLaughlin RA, 2006, MICROB PATHOGENESIS, V41, P67, DOI 10.1016/j.micpath.2006.04.005; Montebugnoli L, 2005, J CLIN PERIODONTOL, V32, P188, DOI 10.1111/j.1600-051X.2005.00641.x; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; OConnell KL, 1997, ELECTROPHORESIS, V18, P349, DOI 10.1002/elps.1150180309; Oksanen J, 2002, J PERIODONTOL, V73, P86, DOI 10.1902/jop.2002.73.1.86; Paul-Satyaseela M, 2006, J MED MICROBIOL, V55, P931, DOI 10.1099/jmm.0.46470-0; Perez BA, 2006, J BACTERIOL, V188, P6361, DOI 10.1128/JB.00496-06; PORAT R, 1991, SCIENCE, V254, P430, DOI 10.1126/science.1833820; Pussinen PJ, 2007, ARTERIOSCL THROM VAS, V27, P1433, DOI 10.1161/ATVBAHA.106.138743; Pussinen PJ, 2004, J LIPID RES, V45, P139, DOI 10.1194/jlr.M300250-JLR200; Runco LM, 2008, J BACTERIOL, V190, P3381, DOI 10.1128/JB.01840-07; Schreiner HC, 2003, P NATL ACAD SCI USA, V100, P7295, DOI 10.1073/pnas.1237223100; STASHENKO P, 1991, J CLIN PERIODONTOL, V18, P548, DOI 10.1111/j.1600-051X.1991.tb00088.x; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Venketaraman V, 2008, MICROB PATHOGENESIS, V45, P173, DOI 10.1016/j.micpath.2008.05.007; Wang Y, 2005, GENE, V351, P61, DOI 10.1016/j.gene.2005.02.010; Wang Y, 2005, INFECT IMMUN, V73, P3749, DOI 10.1128/IAI.73.6.3749-3753.2005; Wang Y, 2003, GENE, V312, P249, DOI 10.1016/S0378-1119(03)00620-6; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; ZAVYALOV VP, 1995, FEBS LETT, V371, P65, DOI 10.1016/0014-5793(95)00878-D	43	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18929	10.1371/journal.pone.0018929	http://dx.doi.org/10.1371/journal.pone.0018929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533109	gold, Green Published, Green Submitted			2022-12-25	WOS:000289620100032
J	Ogawa, Y; Koike, N; Kurosawa, G; Soga, T; Tomita, M; Tei, H				Ogawa, Yukino; Koike, Nobuya; Kurosawa, Gen; Soga, Tomoyoshi; Tomita, Masaru; Tei, Hajime			Positive Autoregulation Delays the Expression Phase of Mammalian Clock Gene Per2	PLOS ONE			English	Article							CIRCADIAN CLOCK; PERIOD HOMOLOGS; MOUSE; MPER1; TRANSCRIPTION; MODEL; IDENTIFICATION; COMPONENTS; PROTEINS; RHYTHMS	In mammals, cellular circadian rhythms are generated by a transcriptional-translational autoregulatory network that consists of clock genes that encode transcriptional regulators. Of these clock genes, Period1 (Per1) and Period2 (Per2) are essential for sustainable circadian rhythmicity and photic entrainment. Intriguingly, Per1 and Per2 mRNAs exhibit circadian oscillations with a 4-hour phase difference, but they are similarly transactivated by CLOCK-BMAL1. In this study, we investigated the mechanism underlying the phase difference between Per1 and Per2 through a combination of mathematical simulations and molecular experiments. Mathematical analyses of a model for the mammalian circadian oscillator demonstrated that the slow synthesis and fast degradation of mRNA tend to advance the oscillation phase of mRNA expression. However, the phase difference between Per1 and Per2 was not reproduced by the model, which implemented a 1.1-fold difference in degradation rates and a 3-fold difference in CLOCK-BMAL1 mediated inductions of Per1 and Per2 as estimated in cultured mammalian cells. Thus, we hypothesized the existence of a novel transcriptional activation of Per2 by PER1/2 such that the Per2 oscillation phase was delayed. Indeed, only the Per2 promoter, but not Per1, was strongly induced by both PER1 and PER2 in the presence of CLOCK-BMAL1 in a luciferase reporter assay. Moreover, a 3-hour advance was observed in the transcriptional oscillation of the delta-Per2 reporter gene lacking cis-elements required for the induction by PER1/2. These results indicate that the Per2 positive feedback regulation is a significant factor responsible for generating the phase difference between Per1 and Per2 gene expression.	[Ogawa, Yukino; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Yamagata, Japan; [Ogawa, Yukino] Keio Univ, Grad Sch Media & Governance, Syst Biol Program, Kanagawa, Japan; [Ogawa, Yukino; Koike, Nobuya] Mitsubishikagaku Inst Life Sci, Tokyo, Japan; [Koike, Nobuya] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX USA; [Kurosawa, Gen] RIKEN Adv Sci Inst, Theoret Biol Lab, Wako, Saitama, Japan; [Tei, Hajime] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan	Keio University; Keio University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Texas System; University of Texas Southwestern Medical Center Dallas; RIKEN; Kanazawa University	Ogawa, Y (corresponding author), Keio Univ, Inst Adv Biosci, Yamagata, Japan.	tei@staff.kanazawa-u.ac.jp	Kurosawa, Gen/AAC-9390-2022; Koike, Nobuya/G-1116-2016; Soga, Tomoyoshi/B-8105-2014	Soga, Tomoyoshi/0000-0001-9502-2509; Kurosawa, Gen/0000-0002-2151-783X	Japan Society for the Promotion of Science (JSPS); Yamagata prefecture; Mitsubishikagaku Institute of Life Sciences,; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Tsuruoka city	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamagata prefecture; Mitsubishikagaku Institute of Life Sciences,; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tsuruoka city(Tsuruoka City Government)	This work was supported by a Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science (JSPS), a research fund provided by Yamagata prefecture and Tsuruoka city, Mitsubishikagaku Institute of Life Sciences, and a research grant from the Japanese Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Jacobshagen S, 2008, J BIOL RHYTHM, V23, P511, DOI 10.1177/0748730408325753; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kawaguchi S, 2007, BIOCHEM BIOPH RES CO, V355, P555, DOI 10.1016/j.bbrc.2007.02.009; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Roenneberg T, 2008, CURR BIOL, V18, pR826, DOI 10.1016/j.cub.2008.07.017; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi K, 2004, BIOINFORMATICS, V20, P538, DOI 10.1093/bioinformatics/btg442; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Yamajuku D, 2010, NUCLEIC ACIDS RES, V38, P7964, DOI 10.1093/nar/gkq678; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18663	10.1371/journal.pone.0018663	http://dx.doi.org/10.1371/journal.pone.0018663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533189	Green Submitted, Green Published, gold			2022-12-25	WOS:000289505600021
J	Ohba, K; Sasaki, S; Matsushita, A; Iwaki, H; Matsunaga, H; Suzuki, S; Ishizuka, K; Misawa, H; Oki, Y; Nakamura, H				Ohba, Kenji; Sasaki, Shigekazu; Matsushita, Akio; Iwaki, Hiroyuki; Matsunaga, Hideyuki; Suzuki, Shingo; Ishizuka, Keiko; Misawa, Hiroko; Oki, Yutaka; Nakamura, Hirotoshi			GATA2 Mediates Thyrotropin-Releasing Hormone-Induced Transcriptional Activation of the Thyrotropin beta Gene	PLOS ONE			English	Article							PROTEIN-KINASE-C; PITUITARY-THYROID AXIS; ALPHA-SUBUNIT GENE; GATA2-DEPENDENT TRANSACTIVATION; FUNCTIONAL-PROPERTIES; NEGATIVE REGULATION; ENDOTHELIAL-CELLS; SENSITIVE REGIONS; PROMOTER ACTIVITY; BINDING PROTEINS	Thyrotropin-releasing hormone (TRH) activates not only the secretion of thyrotropin (TSH) but also the transcription of TSH beta and alpha-glycoprotein (alpha GSU) subunit genes. TSH beta expression is maintained by two transcription factors, Pit1 and GATA2, and is negatively regulated by thyroid hormone (T3). Our prior studies suggest that the main activator of the TSH beta gene is GATA2, not Pit1 or unliganded T3 receptor (TR). In previous studies on the mechanism of TRH-induced activation of the TSH beta gene, the involvements of Pit1 and TR have been investigated, but the role of GATA2 has not been clarified. Using kidney-derived CV1 cells and pituitary-derived GH3 and T alpha T1 cells, we demonstrate here that TRH signaling enhances GATA2-dependent activation of the TSH beta promoter and that TRH-induced activity is abolished by amino acid substitution in the GATA2-Zn finger domain or mutation of GATA-responsive element in the TSH beta gene. In CV1 cells transfected with TRH receptor expression plasmid, GATA2-dependent transactivation of alpha GSU and endothelin-1 promoters was enhanced by TRH. In the gel shift assay, TRH signal potentiated the DNA-binding capacity of GATA2. While inhibition by T3 is dominant over TRH-induced activation, unliganded TR or the putative negative T3-responsive element are not required for TRH-induced stimulation. Studies using GH3 cells showed that TRH-induced activity of the TSH beta promoter depends on protein kinase C but not the mitogen-activated protein kinase, suggesting that the signaling pathway is different from that in the prolactin gene. These results indicate that GATA2 is the principal mediator of the TRH signaling pathway in TSH beta expression.	[Ohba, Kenji; Sasaki, Shigekazu; Matsushita, Akio; Iwaki, Hiroyuki; Matsunaga, Hideyuki; Suzuki, Shingo; Ishizuka, Keiko; Misawa, Hiroko; Oki, Yutaka; Nakamura, Hirotoshi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Shizuoka, Japan	Hamamatsu University School of Medicine	Ohba, K (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Shizuoka, Japan.	sasakis@hama-med.ac.jp	Ohba, Kenji/AAU-5180-2021	Ohba, Kenji/0000-0001-8538-8742	Health Sciences Research; Ministry of Education, Culture, Sports, Science and Technology in Japan [20591092]; Yamaguchi Endocrine Research Association	Health Sciences Research; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamaguchi Endocrine Research Association	This work was supported in part by a Health Sciences Research Grant to H.N., a Grant-in Aid for Scientific Research to S.S. and H.N. from the Ministry of Education, Culture, Sports, Science and Technology in Japan (grant number 20591092) and a Yamaguchi Endocrine Research Association grant to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, J CLIN INVEST, V107, P1017, DOI 10.1172/JCI10858; ABRAHAMSON MJ, 1987, J CLIN ENDOCR METAB, V65, P1159, DOI 10.1210/jcem-65-6-1159; AKERBLOM IE, 1990, MOL ENDOCRINOL, V4, P589, DOI 10.1210/mend-4-4-589; CARR FE, 1992, J BIOL CHEM, V267, P18689; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; CHAN V, 1979, J CLIN ENDOCR METAB, V49, P127, DOI 10.1210/jcem-49-1-127; Charles MA, 2006, MOL ENDOCRINOL, V20, P1366, DOI 10.1210/me.2005-0378; Cohen LE, 2002, ENDOCR REV, V23, P431, DOI 10.1210/er.2001-0030; COHEN RN, 2005, WERNER INGBARS THYRO, P159; DELAPENA P, 1992, J BIOL CHEM, V267, P25703; Duval DL, 2007, MOL ENDOCRINOL, V21, P172, DOI 10.1210/me.2006-0245; Fowkes RC, 2002, BIOL REPROD, V67, P725, DOI 10.1095/biolreprod67.3.725; FRANKLYN JA, 1986, J ENDOCRINOL, V111, pR1, DOI 10.1677/joe.0.111R001; Gershengorn MC, 1996, PHYSIOL REV, V76, P175, DOI 10.1152/physrev.1996.76.1.175; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; GORDON DF, 1993, MOL CELL ENDOCRINOL, V96, P75, DOI 10.1016/0303-7207(93)90097-4; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Gutierrez-Hartmann A, 2007, TRENDS ENDOCRIN MET, V18, P150, DOI 10.1016/j.tem.2007.03.002; Hashimoto K, 2000, J BIOL CHEM, V275, P33365, DOI 10.1074/jbc.M006819200; Haugen BR, 1996, J BIOL CHEM, V271, P385, DOI 10.1074/jbc.271.1.385; HOWARD PW, 1994, J BIOL CHEM, V269, P28662; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; JinsiParimoo A, 1997, ENDOCRINOLOGY, V138, P1471, DOI 10.1210/en.138.4.1471; Kadri Z, 2005, MOL CELL BIOL, V25, P7412, DOI 10.1128/MCB.25.17.7412-7422.2005; KAPILOFF MS, 1991, SCIENCE, V253, P786, DOI 10.1126/science.1652153; Kashiwabara Y, 2009, J MOL ENDOCRINOL, V42, P225, DOI 10.1677/JME-08-0099; KILEY SC, 1991, J BIOL CHEM, V266, P23761; KIM GD, 1994, J BIOL CHEM, V269, P19933; Kim KK, 2007, ENDOCRINOLOGY, V148, P3468, DOI 10.1210/en.2006-1088; KIM MK, 1993, J BIOL CHEM, V268, P23366; LEE ME, 1991, J BIOL CHEM, V266, P16188; MASON ME, 1993, BIOCHEMISTRY-US, V32, P8932, DOI 10.1021/bi00085a026; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Mittag J, 2009, ENDOCRINOLOGY, V150, P4443, DOI 10.1210/en.2009-0327; Nagayama K, 2008, J ENDOCRINOL, V199, P113, DOI 10.1677/JOE-08-0128; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Nikrodhanond AA, 2006, J BIOL CHEM, V281, P5000, DOI 10.1074/jbc.M511530200; OKIMURA Y, 1994, MOL ENDOCRINOL, V8, P1559, DOI 10.1210/me.8.11.1559; Ooi GT, 2004, MOL CELL ENDOCRINOL, V228, P1, DOI 10.1016/j.mce.2004.07.018; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Rabeler R, 2004, MOL ENDOCRINOL, V18, P1450, DOI 10.1210/me.2004-0017; Sarapura VD, 2002, PITUITARY, SECOND EDITION, P172; SASAKI S, 1995, MOL CELL ENDOCRINOL, V113, P109, DOI 10.1016/0303-7207(95)03621-D; Shibusawa N, 2000, MOL ENDOCRINOL, V14, P137, DOI 10.1210/me.14.1.137; Shupnik M A, 2000, Rev Endocr Metab Disord, V1, P35, DOI 10.1023/A:1010008318961; Shupnik MA, 1996, MOL ENDOCRINOL, V10, P90, DOI 10.1210/me.10.1.90; SHUPNIK MA, 1986, J BIOL CHEM, V261, P2675; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P829, DOI 10.1210/mend-4-6-829; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; STEINFELDER HJ, 1992, J CLIN INVEST, V89, P409, DOI 10.1172/JCI115600; STEINFELDER HJ, 1992, P NATL ACAD SCI USA, V89, P5942, DOI 10.1073/pnas.89.13.5942; Sun Y, 2003, J MOL ENDOCRINOL, V30, P87, DOI 10.1677/jme.0.0300087; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; TOWATARI M, 1995, J BIOL CHEM, V270, P4101, DOI 10.1074/jbc.270.8.4101; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WONDISFORD FE, 1993, J BIOL CHEM, V268, P2749; WOOD WM, 1990, MOL ENDOCRINOL, V4, P1897, DOI 10.1210/mend-4-12-1897; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	65	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18667	10.1371/journal.pone.0018667	http://dx.doi.org/10.1371/journal.pone.0018667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533184	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600022
J	Grindberg, RV; Ishoey, T; Brinza, D; Esquenazi, E; Coates, RC; Liu, WT; Gerwick, L; Dorrestein, PC; Pevzner, P; Lasken, R; Gerwick, WH				Grindberg, Rashel V.; Ishoey, Thomas; Brinza, Dumitru; Esquenazi, Eduardo; Coates, R. Cameron; Liu, Wei-ting; Gerwick, Lena; Dorrestein, Pieter C.; Pevzner, Pavel; Lasken, Roger; Gerwick, William H.			Single Cell Genome Amplification Accelerates Identification of the Apratoxin Biosynthetic Pathway from a Complex Microbial Assemblage	PLOS ONE			English	Article							GENE-CLUSTER; POLYKETIDE SYNTHASE; PEPTIDE SYNTHETASE; NATURAL-PRODUCT; SECONDARY METABOLITES; MARINE CYANOBACTERIA; CARRIER PROTEINS; CURACIN-A; ORIGIN; DIVERSITY	Filamentous marine cyanobacteria are extraordinarily rich sources of structurally novel, biomedically relevant natural products. To understand their biosynthetic origins as well as produce increased supplies and analog molecules, access to the clustered biosynthetic genes that encode for the assembly enzymes is necessary. Complicating these efforts is the universal presence of heterotrophic bacteria in the cell wall and sheath material of cyanobacteria obtained from the environment and those grown in uni-cyanobacterial culture. Moreover, the high similarity in genetic elements across disparate secondary metabolite biosynthetic pathways renders imprecise current gene cluster targeting strategies and contributes sequence complexity resulting in partial genome coverage. Thus, it was necessary to use a dual-method approach of single-cell genomic sequencing based on multiple displacement amplification (MDA) and metagenomic library screening. Here, we report the identification of the putative apratoxin. A biosynthetic gene cluster, a potent cancer cell cytotoxin with promise for medicinal applications. The roughly 58 kb biosynthetic gene cluster is composed of 12 open reading frames and has a type I modular mixed polyketide synthase/nonribosomal peptide synthetase (PKS/NRPS) organization and features loading and off-loading domain architecture never previously described. Moreover, this work represents the first successful isolation of a complete biosynthetic gene cluster from Lyngbya bouillonii, a tropical marine cyanobacterium renowned for its production of diverse bioactive secondary metabolites.	[Grindberg, Rashel V.; Esquenazi, Eduardo; Coates, R. Cameron; Gerwick, Lena; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Ishoey, Thomas; Lasken, Roger] J Craig Venter Inst, San Diego, CA USA; [Brinza, Dumitru; Pevzner, Pavel] Univ Calif San Diego, Dept Comp Sci & Engn, Ctr Algorithm & Syst Biol, La Jolla, CA 92093 USA; [Esquenazi, Eduardo; Dorrestein, Pieter C.; Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Liu, Wei-ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem, La Jolla, CA USA; [Liu, Wei-ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; J. Craig Venter Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Grindberg, RV (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	wgerwick@ucsd.edu	Dorrestein, Pieter/D-5012-2012; t, lf/AAJ-4924-2020; Dorrestein, Pieter/ABF-2930-2020		National Institutes of Health [CA108874]; University of California San Diego; V-Foundation; Hearst Foundation;  [NIHGM086283]; NATIONAL CANCER INSTITUTE [R01CA108874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego(University of California System); V-Foundation; Hearst Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding is gratefully acknowledged from National Institutes of Health CA108874 (http://www.nih.gov/) and the University of California San Diego (http://www.ucsd.edu/)(WHG), NIHGM086283 (http://www.nih.gov/), V-Foundation (http://www.jimmyv.org/), and the Hearst Foundation (http://www.hearstfdn.org/)(PCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; CAFFREY P, 1992, FEBS LETT, V304, P225, DOI 10.1016/0014-5793(92)80624-P; Calderone CT, 2007, CHEM BIOL, V14, P835, DOI 10.1016/j.chembiol.2007.06.008; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Cheng YQ, 2007, APPL ENVIRON MICROB, V73, P3460, DOI 10.1128/AEM.01751-06; Cox R, 2009, NAT PROD REP, V26, P1361, DOI 10.1039/b918715b; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Ehrenreich IM, 2005, APPL ENVIRON MICROB, V71, P7401, DOI 10.1128/AEM.71.11.7401-7413.2005; El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7; ENGENE N, J PHYCOLOGY, V46, P591; Erhard M, 1997, NAT BIOTECHNOL, V15, P906, DOI 10.1038/nbt0997-906; Esquenazi E, 2008, MOL BIOSYST, V4, P562, DOI 10.1039/b720018h; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gatto GJ, 2005, BIOCHEMISTRY-US, V44, P5993, DOI 10.1021/bi050230w; Gerwick WH, 2008, MICROBE, V3, P8; GRINDBERG RV, 2007, ERNESTO FATTORUSSO P, P139; GU L, 2011, ANGEW CHEM IN PRESS, V50; Gu LC, 2007, SCIENCE, V318, P970, DOI 10.1126/science.1148790; Gu LC, 2006, J AM CHEM SOC, V128, P9014, DOI 10.1021/ja0626382; Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Gutierrez M, 2008, J NAT PROD, V71, P1099, DOI 10.1021/np800121a; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hrvatin S, 2007, J MICROBIOL METH, V68, P434, DOI 10.1016/j.mimet.2006.09.009; Hube AE, 2009, SYST APPL MICROBIOL, V32, P256, DOI 10.1016/j.syapm.2009.03.001; Ishida K, 2007, CHEM BIOL, V14, P565, DOI 10.1016/j.chembiol.2007.04.006; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jensen ON, 1999, METH MOL B, V112, P571; Jones AC, 2009, CURR OPIN CHEM BIOL, V13, P216, DOI 10.1016/j.cbpa.2009.02.019; Kvist T, 2007, APPL MICROBIOL BIOT, V74, P926, DOI 10.1007/s00253-006-0725-7; Lasken RS, 2007, CURR OPIN MICROBIOL, V10, P510, DOI 10.1016/j.mib.2007.08.005; Liu WT, 2009, ANAL CHEM, V81, P4200, DOI 10.1021/ac900114t; Liu XY, 2009, BIOCHEMISTRY-US, V48, P8746, DOI 10.1021/bi901123r; Liu YX, 2009, MOL PHARMACOL, V76, P91, DOI 10.1124/mol.109.056085; Luesch H, 2002, BIOORGAN MED CHEM, V10, P1973, DOI 10.1016/S0968-0896(02)00014-7; Luesch H, 2001, J AM CHEM SOC, V123, P5418, DOI 10.1021/ja010453j; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Ngoka LCM, 1999, J AM SOC MASS SPECTR, V10, P360, DOI 10.1016/S1044-0305(99)00006-9; Piel J, 2004, CHEMBIOCHEM, V5, P93, DOI 10.1002/cbic.200300782; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rahman AS, 2005, J BIOL CHEM, V280, P6399, DOI 10.1074/jbc.M409814200; Ramaswamy AV, 2007, J NAT PROD, V70, P1977, DOI 10.1021/np0704250; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rounge TB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-396; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Sitachitta N, 2000, TETRAHEDRON, V56, P9103, DOI 10.1016/S0040-4020(00)00763-8; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tidgewell K, 2010, NATURAL PRODUCTS CHE; Tidgewell K, 2010, CHEMBIOCHEM, V11, P1458, DOI 10.1002/cbic.201000070; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051	70	102	104	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18565	10.1371/journal.pone.0018565	http://dx.doi.org/10.1371/journal.pone.0018565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533272	gold, Green Published, Green Submitted			2022-12-25	WOS:000289404700019
J	Makarova, AM; Lebedeva, TV; Nassar, T; Higazi, AA; Xue, J; Carinato, ME; Bdeir, K; Cines, DB; Stepanova, V				Makarova, Anastasia M.; Lebedeva, Tatiana V.; Nassar, Taher; Higazi, Abd Al-Roof; Xue, Jing; Carinato, Maria E.; Bdeir, Khalil; Cines, Douglas B.; Stepanova, Victoria			Urokinase-type Plasminogen Activator (uPA) Induces Pulmonary Microvascular Endothelial Permeability through Low Density Lipoprotein Receptor-related Protein (LRP)-dependent Activation of Endothelial Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; KINASE-A PHOSPHORYLATION; BLOOD-BRAIN-BARRIER; ACUTE LUNG INJURY; FIBRIN DEPOSITION; ADENYLYL-CYCLASE; CELL BARRIER; VASCULAR-PERMEABILITY; MEDIATED ENDOCYTOSIS; ISCHEMIA-REPERFUSION	Urokinase plasminogen activator (uPA) and PA inhibitor type 1 (PAI-1) are elevated in acute lung injury, which is characterized by a loss of endothelial barrier function and the development of pulmonary edema. Two-chain uPA and uPA-PAI-1 complexes (1-20 nM) increased the permeability of monolayers of human pulmonary microvascular endothelial cells (PMVECs) in vitro and lung permeability in vivo. The effects of uPA-PAI-1 were abrogated by the nitric-oxide synthase (NOS) inhibitor L-NAME (N-D-nitro-L-arginine methyl ester). Two-chain uPA (1-20 nM) and uPA-PAI-1 induced phosphorylation of endothelial NOS-Ser(1177) in PMVECs, which was followed by generation of NO and the nitrosylation and dissociation of beta-catenin from VE-cadherin. uPA-induced phosphorylation of eNOS was decreased by anti-low density lipoprotein receptor-related protein-1 (LRP) antibody and an LRP antagonist, receptor-associated protein (RAP), and when binding to the uPA receptor was blocked by the isolated growth factor-like domain of uPA. uPA-induced phosphorylation of eNOS was also inhibited by the protein kinase A (PKA) inhibitor, myristoylated PKI, but was not dependent on PI3K-Akt signaling. LRP blockade and inhibition of PKA prevented uPA- and uPA-PAI-1-induced permeability of PMVEC monolayers in vitro and uPA-induced lung permeability in vivo. These studies identify a novel pathway involved in regulating PMVEC permeability and suggest the utility of uPA-based approaches that attenuate untoward permeability following acute lung injury while preserving its salutary effects on fibrinolysis and airway remodeling.	[Makarova, Anastasia M.; Lebedeva, Tatiana V.; Higazi, Abd Al-Roof; Xue, Jing; Carinato, Maria E.; Bdeir, Khalil; Cines, Douglas B.; Stepanova, Victoria] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Nassar, Taher; Higazi, Abd Al-Roof] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Clin Biochem, IL-91120 Jerusalem, Israel; [Xue, Jing] Tianjin Huanhu Hosp, Dept Lab Med, Tianjin 300060, Peoples R China	University of Pennsylvania; Hebrew University of Jerusalem; Hadassah University Medical Center	Stepanova, V (corresponding author), 512 Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	vstepano@mail.med.upenn.edu			National Institutes of Health [HL-077760, 5T32 HL07971-07, NS053410-04S1, HD057355, HL076406, CA141228]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA141228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007971, R01HL077760, P01HL076406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-077760 (to A. A. H.), 5T32 HL07971-07, NS053410-04S1, HD057355, and HL076406 (to D. B. C.), and CA141228 (to V. S.).	Abraham E, 2003, J IMMUNOL, V170, P5644, DOI 10.4049/jimmunol.170.11.5644; ANDREASEN PA, 1986, J BIOL CHEM, V261, P7644; Armstead WM, 2008, J NEUROTRAUM, V25, P1375, DOI 10.1089/neu.2008.0666; Armstead WM, 2005, STROKE, V36, P2265, DOI 10.1161/01.STR.0000181078.74698.b0; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; BACHOFEN M, 1982, CLIN CHEST MED, V3, P35; Barazzone C, 1996, J CLIN INVEST, V98, P2666, DOI 10.1172/JCI119089; BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bdeir K, 2003, BLOOD, V102, P3600, DOI 10.1182/blood-2003-03-0949; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Bindewald K, 2004, AM J PHYSIOL-CELL PH, V287, pC1246, DOI 10.1152/ajpcell.00132.2004; Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bogatcheva NV, 2009, J CELL PHYSIOL, V221, P750, DOI 10.1002/jcp.21913; BONE RC, 1976, AM J MED, V61, P585, DOI 10.1016/0002-9343(76)90135-2; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Bucci M, 2005, P NATL ACAD SCI USA, V102, P904, DOI 10.1073/pnas.0408906102; Cate JM, 2007, CURR DRUG TARGETS, V8, P971, DOI 10.2174/138945007781662337; Chen HI, 2003, J BIOMED SCI, V10, P588, DOI 10.1159/000073523; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; CONESE M, 1995, J CELL BIOL, V131, P1609, DOI 10.1083/jcb.131.6.1609; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Dear AE, 1998, EUR J BIOCHEM, V252, P185, DOI 10.1046/j.1432-1327.1998.2520185.x; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Goretzki L, 1998, BIOCHEM J, V336, P381, DOI 10.1042/bj3360381; Goretzki L, 1997, J CELL SCI, V110, P1395; Hardaway RM, 2001, AM SURGEON, V67, P377; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Hiroi YK, 2008, FASEB J, V22, P1450, DOI 10.1096/fj.07-9309com; Idell S, 2003, CRIT CARE MED, V31, pS213, DOI 10.1097/01.CCM.0000057846.21303.AB; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; Idell S, 1994, New Horiz, V2, P566; IDELL S, 1991, AM REV RESPIR DIS, V144, P187, DOI 10.1164/ajrccm/144.1.187; ISCHIROPOULOS H, 1994, AM J RESP CRIT CARE, V150, P337, DOI 10.1164/ajrccm.150.2.8049812; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; Kao SJ, 2003, J BIOMED SCI, V10, P58, DOI 10.1159/000068090; KASAI S, 1985, J BIOL CHEM, V260, P2377; Klein RC, 1999, NEUROSCI LETT, V273, P171, DOI 10.1016/S0304-3940(99)00649-7; Kondrikov D, 2006, AM J PHYSIOL-LUNG C, V290, pL41, DOI 10.1152/ajplung.00444.2004; KUBES P, 1992, AM J PHYSIOL, V262, pH611, DOI 10.1152/ajpheart.1992.262.2.H611; Kuramoto E, 2009, AM J PHYSIOL-LUNG C, V296, pL337, DOI 10.1152/ajplung.90434.2008; Lardot CG, 1998, AM J RESP CRIT CARE, V157, P617, DOI 10.1164/ajrccm.157.2.9707052; LASZLO F, 1995, EUR J PHARMACOL, V283, P47, DOI 10.1016/0014-2999(95)00281-O; Lee NPY, 2003, ENDOCRINOLOGY, V144, P3114, DOI 10.1210/en.2002-0167; LI H, 1994, J BIOL CHEM, V269, P8153; Li YH, 2001, MOL CELL BIOL, V21, P1185, DOI 10.1128/MCB.21.4.1185-1195.2001; Loskutoff DJ, 2000, J CLIN INVEST, V106, P1441, DOI 10.1172/JCI11765; MAJNO G, 1969, J CELL BIOL, V42, P647, DOI 10.1083/jcb.42.3.647; Martins-Green M, 2008, METHOD ENZYMOL, V443, P137, DOI 10.1016/S0076-6879(08)02008-9; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Mundy AL, 2000, BRIT J ANAESTH, V85, P570, DOI 10.1093/bja/85.4.570; Nagata K, 2003, CHEST, V124, P2293, DOI 10.1378/chest.124.6.2293; Namiki A, 1992, JPN J PHARM S2, V58, p326P; Nassar T, 2002, J BIOL CHEM, V277, P40499, DOI 10.1074/jbc.M207172200; Nassar T, 2010, AM J RESP CELL MOL, V43, P703, DOI 10.1165/rcmb.2009-0257OC; NEUHOF H, 1986, RESUSCITATION, V14, P23, DOI 10.1016/0300-9572(86)90004-3; NYKJAER A, 1994, J BIOL CHEM, V269, P25668; NYKJAER A, 1992, J BIOL CHEM, V267, P14543; Pinsky DJ, 1998, J CLIN INVEST, V102, P919, DOI 10.1172/JCI307; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; Polavarapu R, 2007, BLOOD, V109, P3270, DOI 10.1182/blood-2006-08-043125; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Rampersad SN, 2010, J BIOL CHEM, V285, P33614, DOI 10.1074/jbc.M110.140004; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; SEEKAMP A, 1993, AM J PATHOL, V142, P1217; Shetty S, 2008, AM J PHYSIOL-LUNG C, V295, pL967, DOI 10.1152/ajplung.90349.2008; STEFFENS GJ, 1982, H-S Z PHYSIOL CHEM, V363, P1043, DOI 10.1515/bchm2.1982.363.2.1043; Stepanova V, 2008, BLOOD, V112, P100, DOI 10.1182/blood-2007-07-104455; Sugiura H, 1999, AM J RESP CRIT CARE, V160, P663, DOI 10.1164/ajrccm.160.2.9807160; Symons JD, 2009, CIRC RES, V104, P1085, DOI 10.1161/CIRCRESAHA.108.189316; Tarui T, 2006, THROMB HAEMOSTASIS, V95, P524, DOI 10.1160/TH05-06-0457; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Umapathy NS, 2010, J CELL PHYSIOL, V223, P215, DOI 10.1002/jcp.22029; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Zhu B, 2010, AM J PHYSIOL-LUNG C, V299, pL493, DOI 10.1152/ajplung.00431.2009	92	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23044	23053		10.1074/jbc.M110.210195	http://dx.doi.org/10.1074/jbc.M110.210195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540184	Green Published, hybrid			2022-12-25	WOS:000292025000039
J	Fernandez-Alvarez, A; Alvarez, MS; Gonzalez, R; Cucarella, C; Muntane, J; Casado, M				Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Gonzalez, Raul; Cucarella, Carme; Muntane, Jordi; Casado, Marta			Human SREBP1c Expression in Liver Is Directly Regulated by Peroxisome Proliferator-activated Receptor alpha (PPAR alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1C; FATTY-ACID SYNTHESIS; X-RECEPTOR; CHOLESTEROL HOMEOSTASIS; GENE-EXPRESSION; RAT HEPATOCYTES; HEPATOMA-CELLS; CROSS-TALK; PROMOTER; INSULIN	Sterol regulatory element binding proteins (SREBPs) regulate the expression of a number of enzymes, which catalyze the synthesis of fatty acids, cholesterol, triglycerides, and phospholipids. SREBP1c is the most relevant isoform in the adult liver, and its expression is controlled by the nutritional state. Transcriptional regulation studies into the SREBP1c gene, performed in the last few years, have improved our knowledge of the variability of signals that converge on its promoter region. Insulin, cholesterol derivatives, T3 and other endogenous molecules have been demonstrated to regulate the SREBP1c expression, particularly in rodents. The present study aimed to perform a detailed analysis of the human SREBP1c gene promoter structure in liver cells by focusing on responses to diverse metabolic signals. Serial deletion and mutation assays reveal that both SREBP (SRE) and LXR (LXRE) response elements are involved in SREBP1c transcription regulation mediated by insulin and cholesterol derivatives. We discovered that peroxisome proliferation-activated receptor alpha (PPAR alpha) agonists enhance the activity of the SREBP1c promoter; a DR1 element, at -453 in the human promoter was involved in this activation. Moreover, PPAR alpha agonists act in cooperation with LXR or insulin to induce lipogenesis. Collectively, our results identify PPAR alpha as a novel regulatory factor in SREBP1c regulation which plays a relevant role in the interplay between lipids and insulin metabolic regulation.	[Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Cucarella, Carme; Casado, Marta] CSIC, IBV, Valencia 46010, Spain; [Gonzalez, Raul; Muntane, Jordi] Reina Sofia Univ Hosp, Liver Res Unit, Cordoba 14004, Spain; [Gonzalez, Raul; Muntane, Jordi; Casado, Marta] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); Hospital Universitario Reina Sofia - Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Casado, M (corresponding author), CSIC, IBV, Jaime Roig 11, Valencia 46010, Spain.	mcasado@ibv.csic.es	Casado, Marta/L-2078-2014	Casado, Marta/0000-0001-6457-4650; Fernandez-Alvarez, Ana/0000-0002-5296-5678	Spanish Ministry of Science and Innovation [SAF2006-06760, SAF2009-12602]; Carlos III Health Institute [FIS-RECAVA RD06/0014/0025]; Consejo Superior de Investigaciones Cientificas (Spanish National Research Council)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute(Instituto de Salud Carlos III); Consejo Superior de Investigaciones Cientificas (Spanish National Research Council)	This work was supported by the Spanish Ministry of Science and Innovation (SAF2006-06760; SAF2009-12602) and the Carlos III Health Institute (Red de Centros FIS-RECAVA RD06/0014/0025).; Supported by a fellowship from Consejo Superior de Investigaciones Cientificas (Spanish National Research Council) (JAE-predoctoral).	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; CASTELEIN H, 1994, J BIOL CHEM, V269, P26754; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Fernandez-Alvarez A, 2008, FEBS LETT, V582, P177, DOI 10.1016/j.febslet.2007.11.083; Fernandez-Alvarez A, 2010, J BIOL CHEM, V285, P11765, DOI 10.1074/jbc.M109.067447; Fernandez-Miranda C, 2008, DIGEST LIVER DIS, V40, P200, DOI 10.1016/j.dld.2007.10.002; Ferrini J B, 1998, Methods Mol Biol, V107, P341; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hebbachi AM, 2008, J BIOL CHEM, V283, P4866, DOI 10.1074/jbc.M709471200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Konig B, 2009, EUR J PHARMACOL, V605, P23, DOI 10.1016/j.ejphar.2009.01.009; Le Jossic-Corcos C, 2004, BBA-MOL CELL BIOL L, V1683, P49, DOI 10.1016/j.bbalip.2004.04.004; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McMillian MK, 2001, IN VITRO MOL TOXICOL, V14, P177, DOI 10.1089/109793301753407948; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Patel DD, 2001, J LIPID RES, V42, P328; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Tarling E, 2004, BIOCHEM SOC T, V32, P107, DOI 10.1042/BST0320107; Tobin KAR, 2000, MOL ENDOCRINOL, V14, P741, DOI 10.1210/me.14.5.741; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	36	91	94	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21466	21477		10.1074/jbc.M110.209973	http://dx.doi.org/10.1074/jbc.M110.209973			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21540177	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000291464700045
J	Hornberg, E; Ylitalo, EB; Crnalic, S; Antti, H; Stattin, P; Widmark, A; Bergh, A; Wikstrom, P				Hornberg, Emma; Ylitalo, Erik Bovinder; Crnalic, Sead; Antti, Henrik; Stattin, Par; Widmark, Anders; Bergh, Anders; Wikstrom, Pernilla			Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival	PLOS ONE			English	Article							INHIBITOR ABIRATERONE ACETATE; APOPTOTIC CELL-DEATH; THERAPY RESISTANCE; ANTITUMOR-ACTIVITY; GROWTH; MUTATION; ANTIANDROGEN; PROGRESSION; ACTIVATION; MECHANISM	Background: Constitutively active androgen receptor variants (AR-V) lacking the ligand binding domain (LBD) may promote the development of castration-resistant prostate cancer (CRPC). The expression of AR-Vs in the clinically most important metastatic site, the bone, has, however, not been well documented. Our aim was therefore to compare levels of AR-Vs in hormone-naive (HN) and CRPC bone metastases in comparison to primary PC and non-malignant prostate tissue, as well as in relation to AR protein expression, whole-genome transcription profiles and patient survival. Methodology/Principal Findings: Hormone-naive (n = 10) and CRPC bone metastases samples (n = 30) were obtained from 40 patients at metastasis surgery. Non-malignant and malignant prostate samples were acquired from 13 prostatectomized men. Levels of full length AR (ARfl) and AR-Vs termed AR-V1, AR-V7, and AR-V567es mRNA were measured with RT-PCR and whole-genome transcription profiles with an Illumina Beadchip array. Protein levels were examined by Western blotting and immunohistochemistry. Transcripts for ARfl, AR-V1, and AR-V7 were detected in most primary tumors and metastases, and levels were significantly increased in CRPC bone metastases. The AR-V567es transcript was detected in 23% of the CRPC bone metastases only. A sub-group of CRPC bone metastases expressed LBD-truncated AR proteins at levels comparable to the ARfl. Detectable AR-V567es and/or AR-V7 mRNA in the upper quartile, seen in 1/3 of all CRPC bone metastases, was associated with a high nuclear AR immunostaining score, disturbed cell cycle regulation and short survival. Conclusions/Significance: Expression of AR-Vs is increased in CRPC compared to HN bone metastases and associated with a particularly poor prognosis. Further studies are needed to test if patients expressing such AR-Vs in their bone metastases benefit more from drugs acting on or down-stream of these AR-Vs than from therapies inhibiting androgen synthesis.	[Hornberg, Emma; Ylitalo, Erik Bovinder; Bergh, Anders; Wikstrom, Pernilla] Umea Univ, Dept Med Biosci, Umea, Sweden; [Crnalic, Sead; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci Orthoped & Urol & Andr, Umea, Sweden; [Antti, Henrik] Umea Univ, Dept Chem, Umea, Sweden; [Widmark, Anders] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Hornberg, E (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	pernilla.wikstrom@medbio.umu.se	Crnalic, Sead/AAF-3475-2021		Swedish Cancer Society; Swedish Research Council; Lions Cancer Research Foundation; Northern Sweden Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Research Foundation; Northern Sweden Cancer Foundation	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Lions Cancer Research Foundation, and the Northern Sweden Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Crnalic S, 2010, ENDOCR-RELAT CANCER, V17, P885, DOI 10.1677/ERC-10-0059; D'Antonio JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011475; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Denmeade SR, 1996, PROSTATE, V28, P251; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Halin S, 2004, CANCER RES, V64, P5664, DOI 10.1158/0008-5472.CAN-04-0835; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Koh C, 2010, MYC PROSTATE CANC GE, P617; LANDSTROM M, 1994, CANCER RES, V54, P4281; Lapouge G, 2007, INT J CANCER, V121, P1238, DOI 10.1002/ijc.22830; Marcias G, 2010, HUM MUTAT, V31, P74, DOI 10.1002/humu.21138; Mashima T, 2010, MOL PHARMACOL, V78, P846, DOI 10.1124/mol.110.064790; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tepper CG, 2002, CANCER RES, V62, P6606; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107	28	363	382	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19059	10.1371/journal.pone.0019059	http://dx.doi.org/10.1371/journal.pone.0019059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552559	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700019
J	Huang, QY; Liu, ZZ; Liao, YQ; Chen, XY; Zhang, Y; Li, QG				Huang, Qiuying; Liu, Zanzan; Liao, Yiqun; Chen, Xiaoyun; Zhang, Yi; Li, Qingge			Multiplex Fluorescence Melting Curve Analysis for Mutation Detection with Dual-Labeled, Self-Quenched Probes	PLOS ONE			English	Article							REAL-TIME PCR; FACTOR-V-LEIDEN; HYBRIDIZATION PROBES; MOLECULAR BEACONS; IDENTIFICATION; SYSTEM; OLIGONUCLEOTIDES; DIAGNOSIS	Probe-based fluorescence melting curve analysis (FMCA) is a powerful tool for mutation detection based on melting temperature generated by thermal denaturation of the probe-target hybrid. Nevertheless, the color multiplexing, probe design, and cross-platform compatibility remain to be limited by using existing probe chemistries. We hereby explored two dual-labeled, self-quenched probes, TaqMan and shared-stem molecular beacons, in their ability to conduct FMCA. Both probes could be directly used for FMCA and readily integrated with closed-tube amplicon hybridization under asymmetric PCR conditions. Improved flexibility of FMCA by using these probes was illustrated in three representative applications of FMCA: mutation scanning, mutation identification and mutation genotyping, all of which achieved improved color-multiplexing with easy probe design and versatile probe combination and all were validated with a large number of real clinical samples. The universal cross-platform compatibility of these probes-based FMCA was also demonstrated by a 4-color mutation genotyping assay performed on five different real-time PCR instruments. The dual-labeled, self-quenched probes offered unprecedented combined advantage of enhanced multiplexing, improved flexibility in probe design, and expanded cross-platform compatibility, which would substantially improve FMCA in mutation detection of various applications.	[Huang, Qiuying; Liu, Zanzan; Chen, Xiaoyun; Li, Qingge] Xiamen Univ, Engn Res Ctr Mol Diagnost, Minist Educ, Dept Biomed Sci,Sch Life Sci, Xiamen, Fujian, Peoples R China; [Huang, Qiuying; Liu, Zanzan; Chen, Xiaoyun; Li, Qingge] Xiamen Univ, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen, Fujian, Peoples R China; [Liao, Yiqun; Zhang, Yi] Xiamen Univ, Inst Biomed Res, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Huang, QY (corresponding author), Xiamen Univ, Engn Res Ctr Mol Diagnost, Minist Educ, Dept Biomed Sci,Sch Life Sci, Xiamen, Fujian, Peoples R China.	qgli@xmu.edu.cn	Chen, Xiaoyun/K-4786-2019		Important National Science & Technology Specific Project [2008ZX10003-004]; National High Technology Research and Development Program ("863'' Program) of China [2009AA02Z114]; Science Research Foundation of Ministry of Health & United Fujian Provincial Health and Education Project for Tackling the Key Research [WKJ2005-2-002, WKJ2008-2-39]; Important Disease Research Project of Xiamen [3502Z20074004/XMWZK06-01]	Important National Science & Technology Specific Project; National High Technology Research and Development Program ("863'' Program) of China(National High Technology Research and Development Program of China); Science Research Foundation of Ministry of Health & United Fujian Provincial Health and Education Project for Tackling the Key Research; Important Disease Research Project of Xiamen	This work was supported by the Important National Science & Technology Specific Project (2008ZX10003-004), the National High Technology Research and Development Program ("863'' Program) of China (2009AA02Z114), Science Research Foundation of Ministry of Health & United Fujian Provincial Health and Education Project for Tackling the Key Research (WKJ2005-2-002 and WKJ2008-2-39) and Important Disease Research Project of Xiamen (3502Z20074004/XMWZK06-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IA, 2002, BIOTECHNIQUES, V32, P940, DOI 10.2144/02324pf01; Bernard PS, 1999, ANAL BIOCHEM, V273, P221, DOI 10.1006/abio.1999.4217; Bernard PS, 1998, AM J PATHOL, V153, P1055, DOI 10.1016/S0002-9440(10)65650-7; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Crockett AO, 2001, ANAL BIOCHEM, V290, P89, DOI 10.1006/abio.2000.4957; Dorak M.T., 2007, REAL TIME PCR, P1, DOI [10.4324/9780203967317, DOI 10.4324/9780203967317]; El Housni H, 2003, CLIN CHEM, V49, P1669, DOI 10.1373/49.10.1669; El-Hajj HH, 2009, J CLIN MICROBIOL, V47, P1190, DOI 10.1128/JCM.02043-08; Elenitoba-Johnson KSJ, 2001, NAT MED, V7, P249, DOI 10.1038/84708; French DJ, 2001, MOL CELL PROBE, V15, P363, DOI 10.1006/mcpr.2001.0384; Gibson NJ, 2006, CLIN CHIM ACTA, V363, P32, DOI 10.1016/j.cccn.2005.06.022; Gupta AP, 2007, US Patent Appl., Patent No. [2007/0020664 A1, 20070020664]; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Howell WM, 2002, GENOME RES, V12, P1401, DOI 10.1101/gr.297202; Kostrikis LG, 1998, SCIENCE, V279, P1228, DOI 10.1126/science.279.5354.1228; Lay MJ, 1997, CLIN CHEM, V43, P2262; Li QG, 2000, ANAL SCI, V16, P245, DOI 10.2116/analsci.16.245; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; Livak K.J., 1998, US Patent, Patent No. 5723591; Livak Kenneth J, 2003, Methods Mol Biol, V212, P129; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Logan JMJ, 2001, J CLIN MICROBIOL, V39, P2227, DOI 10.1128/JCM.39.6.2227-2232.2001; Lukhtanov EA, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1136; Lyon E, 2009, J MOL DIAGN, V11, P93, DOI 10.2353/jmoldx.2009.080094; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Millward H, 2002, CLIN CHEM, V48, P1321; Niesters HG, ANTIMICROB AGENTS CH, V54, P1283; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Pont-Kingdon G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni090; Ragoussis J, 2009, ANNU REV GENOM HUM G, V10, P117, DOI 10.1146/annurev-genom-082908-150116; Ruiz M, 2004, J CLIN MICROBIOL, V42, P1585, DOI 10.1128/JCM.42.4.1585-1589.2004; Tsourkas A, 2002, NUCLEIC ACIDS RES, V30, P4208, DOI 10.1093/nar/gkf536; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Vrettou C, 2003, CLIN CHEM, V49, P769, DOI 10.1373/49.5.769; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322	36	70	91	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19206	10.1371/journal.pone.0019206	http://dx.doi.org/10.1371/journal.pone.0019206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552536	Green Submitted, Green Published, gold			2022-12-25	WOS:000290020700038
J	Kornhuber, J; Erhard, G; Lenz, B; Kraus, T; Sperling, W; Bayerlein, K; Biermann, T; Stoessel, C				Kornhuber, Johannes; Erhard, Gabriele; Lenz, Bernd; Kraus, Thomas; Sperling, Wolfgang; Bayerlein, Kristina; Biermann, Teresa; Stoessel, Christina			Low Digit Ratio 2D:4D in Alcohol Dependent Patients	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER ADHD; FINGER LENGTH; RECEPTOR GENE; 2ND; PERSONALITY; HAND; TESTOSTERONE; PREDICTION; HANDEDNESS; ESTROGEN	The ratio of the lengths of the second and fourth finger (2D:4D) has been described as reflecting the degree of prenatal androgen exposure in humans. 2D:4D is smaller for males than females and is associated with traits such as left-handedness, physical aggression, attention-deficit-hyperactivity disorder and a genetic polymorphism of the androgen receptor. All of these traits are known to be correlated to the vulnerability for alcohol dependency. We therefore hypothesized low 2D:4D in patients with alcohol dependency. In the present study on 131 patients suffering from alcohol dependency and 185 healthy volunteers, we found that alcohol dependent patients had smaller 2D:4D ratios compared to controls with preserved sexual dimorphism but with reduced right-left differences. The detection of alcohol dependency based on 2D:4D ratios was most accurate using the right hand of males (ROC-analysis: AUC 0.725, sensitivity 0.667, specificity 0.723). These findings provide novel insights into the role of prenatal androgen exposure in the development of alcohol dependency and for the use of 2D:4D as a possible trait marker in identifying patients with alcohol dependency.	[Kornhuber, Johannes; Erhard, Gabriele; Lenz, Bernd; Kraus, Thomas; Sperling, Wolfgang; Bayerlein, Kristina; Biermann, Teresa; Stoessel, Christina] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany; [Kraus, Thomas] Frankenalbklin Engelthal, Dept Psychiat & Psychotherapy, Engelthal, Germany	University of Erlangen Nuremberg	Kornhuber, J (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany.	Johannes.kornhuber@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Biermann, Teresa/0000-0003-4876-3915; Lenz, Bernd/0000-0001-6086-0924	University Hospital of the Friedrich-Alexander University Erlangen-Nuremberg	University Hospital of the Friedrich-Alexander University Erlangen-Nuremberg	Funding for this study was provided by intramural grants of the University Hospital of the Friedrich-Alexander University Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin EJ, 2002, PERS INDIV DIFFER, V33, P1115, DOI 10.1016/S0191-8869(02)00002-8; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Beaton AA, 2011, LATERALITY, V16, P136, DOI 10.1080/13576500903410369; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bourne VJ, 2009, PSYCHONEUROENDOCRINO, V34, P1214, DOI 10.1016/j.psyneuen.2009.03.010; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; BRENNAN AF, 1986, INT J ADDICT, V21, P449, DOI 10.3109/10826088609083536; Brosnan MJ, 2006, BRIT J PSYCHOL, V97, P455, DOI 10.1348/000712605X85808; Conigrave KM, 2003, ADDICTION, V98, P31, DOI 10.1046/j.1359-6357.2003.00581.x; Fink B, 2004, BIOL PSYCHOL, V67, P375, DOI 10.1016/j.biopsycho.2004.03.012; Forstmeier W, 2010, P ROY SOC B-BIOL SCI, V277, P3353, DOI 10.1098/rspb.2010.1007; Honekopp J, 2010, AM J HUM BIOL, V22, P619, DOI 10.1002/ajhb.21054; Hurd PL, 2011, BEHAV GENET, V41, P543, DOI 10.1007/s10519-010-9404-7; Jackson C, 2008, LATERALITY, V13, P34, DOI 10.1080/13576500701692507; JACKSON CP, 1988, ALCOHOL ALCOHOLISM, V23, P305; Lenz B, 2009, PSYCHONEUROENDOCRINO, V34, P968, DOI 10.1016/j.psyneuen.2009.01.009; LEX BW, 1991, HEALTH PSYCHOL, V10, P121, DOI 10.1037/0278-6133.10.2.121; LONDON WP, 1985, J NERV MENT DIS, V173, P570, DOI 10.1097/00005053-198509000-00009; Malas MA, 2006, EARLY HUM DEV, V82, P469, DOI 10.1016/j.earlhumdev.2005.12.002; Manning JT, 2009, LATERALITY, V14, P528, DOI 10.1080/13576500802637872; Manning JT, 2011, PERS INDIV DIFFER, V50, P344, DOI 10.1016/j.paid.2010.10.016; Manning JT, 2010, AM J HUM BIOL, V22, P604, DOI 10.1002/ajhb.21051; Manning JT, 2003, EVOL HUM BEHAV, V24, P399, DOI 10.1016/S1090-5138(03)00052-7; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT., 2002, DIGIT RATIO POINTER; McFadden D, 2002, HORM BEHAV, V42, P492, DOI 10.1006/hbeh.2002.1833; McMechan AP, 2004, DEV PSYCHOBIOL, V45, P251, DOI 10.1002/dev.20035; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Ohlmeier MD, 2008, ALCOHOL ALCOHOLISM, V43, P300, DOI 10.1093/alcalc/agn014; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Poikolainen K, 2000, ALCOHOL ALCOHOLISM, V35, P190, DOI 10.1093/alcalc/35.2.190; Romano M, 2006, BIOL PSYCHOL, V71, P175, DOI 10.1016/j.biopsycho.2005.03.006; Stevenson JC, 2007, AM J HUM BIOL, V19, P41, DOI 10.1002/ajhb.20571; Williams JHG, 2003, EARLY HUM DEV, V72, P57, DOI 10.1016/S0378-3782(03)00012-4; Wills T A, 1994, J Subst Abuse, V6, P1, DOI 10.1016/S0899-3289(94)90039-6	35	51	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19332	10.1371/journal.pone.0019332	http://dx.doi.org/10.1371/journal.pone.0019332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756MU	21547078	Green Submitted, gold, Green Published			2022-12-25	WOS:000290016800042
J	Malcom, JW				Malcom, Jacob W.			Evolution of Competitive Ability: An Adaptation Speed vs. Accuracy Tradeoff Rooted in Gene Network Size	PLOS ONE			English	Article							COMMUNITY; TRAITS; POPULATION; PLEIOTROPY; EPISTASIS; SELECTION; ECOLOGY; PREY	Ecologists have increasingly come to understand that evolutionary change on short time-scales can alter ecological dynamics (and vice-versa), and this idea is being incorporated into community ecology research programs. Previous research has suggested that the size and topology of the gene network underlying a quantitative trait should constrain or facilitate adaptation and thereby alter population dynamics. Here, I consider a scenario in which two species with different genetic architectures compete and evolve in fluctuating environments. An important trade-off emerges between adaptive accuracy and adaptive speed, driven by the size of the gene network underlying the ecologically-critical trait and the rate of environmental change. Smaller, scale-free networks confer a competitive advantage in rapidly-changing environments, but larger networks permit increased adaptive accuracy when environmental change is sufficiently slow to allow a species time to adapt. As the differences in network characteristics increase, the time-to-resolution of competition decreases. These results augment and refine previous conclusions about the ecological implications of the genetic architecture of quantitative traits, emphasizing a role of adaptive accuracy. Along with previous work, in particular that considering the role of gene network connectivity, these results provide a set of expectations for what we may observe as the field of ecological genomics develops.	Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Malcom, JW (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	jmalcom@mail.utexas.edu		Malcom, Jacob/0000-0002-4904-8369	University of Texas at Austin	University of Texas at Austin	This work was supported in part by a start-up grant from the University of Texas at Austin; remaining costs were borne by the author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; ABRAMS PA, 1994, EVOL ECOL, V8, P667, DOI 10.1007/BF01237849; Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Akima H, 2009, PACKAGE AKIMA INTERP; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Antonovics J., 1976, Systematic Botany, V1, P233, DOI 10.2307/2418718; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barreiro A, 2007, ACTA OECOL, V32, P279, DOI 10.1016/j.actao.2007.05.009; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHEVERUD JM, 1995, GENETICS, V139, P1455; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Dybzinski R, 2009, PRINCETON GUIDE ECOL, P186; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1958, GENETICAL THEORY NAT; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Hansen TF, 2006, AM NAT, V168, P168, DOI 10.1086/505768; Hermisson J, 2003, AM NAT, V161, P708, DOI 10.1086/374204; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lynch M, 2000, GENETICS, V154, P459; MacArthur R.H., 1972, pvii; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malcom J, PLOS ONE IN PRESS; Malcom JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014645; McCullagh P., 1999, GEN LINEAR MODELS; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Nuismer SL, 2004, EVOLUTION, V58, P1165, DOI 10.1111/j.0014-3820.2004.tb01697.x; R Development Core Team, 2009, R FDN STAT COMP; Repsilber D, 2009, EURASIP J BIOINFO SY, V2009; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Smetacek V, 2001, NATURE, V411, P745, DOI 10.1038/35081210; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Tilman D., 1982, Monographs in Population Biology, pi; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Urban MC, 2009, P ROY SOC B; Wang Z, 2010, P NATL ACAD SCI USA, V107, P18034, DOI 10.1073/pnas.1004666107; Wilenski U., 1999, NETLOGO; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235; Young S, 1997, J PLANKTON RES, V19, P391, DOI 10.1093/plankt/19.3.391	54	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e14799	10.1371/journal.pone.0014799	http://dx.doi.org/10.1371/journal.pone.0014799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541014	Green Submitted, Green Published, gold			2022-12-25	WOS:000290016800002
J	Liu, LZ; Li, CY; Chen, Q; Jing, Y; Carpenter, R; Jiang, Y; Kung, HF; Lai, LH; Jiang, BH				Liu, Ling-Zhi; Li, Chongyong; Chen, Qi; Jing, Yi; Carpenter, Richard; Jiang, Yue; Kung, Hsiang-Fu; Lai, Lihui; Jiang, Bing-Hua			MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1 alpha Expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR; TUMOR-SUPPRESSOR GENE; MICRORNA EXPRESSION; BREAST-CANCER; CELLS; TRANSCRIPTION; INVOLVEMENT; INVASION; TARGETS	MicroRNAs (miRNAs) are endogenous, small noncoding RNAs that play important roles in various cellular functions and tumor development. Recent studies have indicated that miR-21 is one of the important miRNAs associated with tumor growth and metastasis, but the role and molecular mechanism of miR-21 in regulating tumor angiogenesis remain to be elucidated. In this study, miR-21 was overexpressed by transfecting pre-miR-21 into human prostate cancer cells and tumor angiogenesis was assayed using chicken chorioallantoic membrane (CAM). We found that overexpression of miR-21 in DU145 cells increased the expression of HIF-1 alpha and VEGF, and induced tumor angiogenesis. AKT and extracellular regulated kinases (ERK) 1/2 are activated by miR-21. Inhibition of miR-21 by the antigomir blocked this process. Overexpression of the miR-21 target, PTEN, also inhibited tumor angiogenesis by partially inactivating AKT and ERK and decreasing the expression of HIF-1 and VEGF. The AKT and ERK inhibitors, LY294002 and U0126, suppressed HIF-1 alpha and VEGF expression and angiogenesis. Moreover, inhibition of HIF-1 alpha expression alone abolished miR-21-inducing tumor angiogenesis, indicating that HIF-1 alpha is required for miR-21-upregulated angiogenesis. Therefore, we demonstrate that miR-21 induces tumor angiogenesis through targeting PTEN, leading to activate AKT and ERK1/2 signaling pathways, and thereby enhancing HIF-1 alpha and VEGF expression; HIF-1 alpha is a key downstream target of miR-21 in regulating tumor angiogenesis.	[Liu, Ling-Zhi; Li, Chongyong; Chen, Qi; Jiang, Bing-Hua] Nanjing Med Univ, Lab Reprod Med, Dept Pathol, Ctr Canc, Nanjing, Peoples R China; [Liu, Ling-Zhi; Jing, Yi; Carpenter, Richard; Jiang, Yue; Jiang, Bing-Hua] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Liu, Ling-Zhi; Jing, Yi; Carpenter, Richard; Jiang, Yue; Jiang, Bing-Hua] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Kung, Hsiang-Fu] Chinese Univ Hong Kong, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lai, Lihui] E China Normal Univ, Inst Mol & Chem Biol, Shanghai 200062, Peoples R China	Nanjing Medical University; Jefferson University; Jefferson University; Chinese University of Hong Kong; East China Normal University	Liu, LZ (corresponding author), Nanjing Med Univ, Lab Reprod Med, Dept Pathol, Ctr Canc, Nanjing, Peoples R China.	binghjiang@yahoo.com		Jiang, Bing-Hua/0000-0003-4526-2031; Hartl, Carla/0000-0001-9769-7462; Liu, Ling-Zhi/0000-0001-9234-457X	National Basic Research Program of China [2007CB947002, 2007CB947001]; National Natural Science Foundation of China [30470361, 30570962]; State High Technology Developing Project [2008AA02Z115]; National Cancer Institute, National Institutes of Health (NIH) [CA109460]; NATIONAL CANCER INSTITUTE [R01CA109460] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State High Technology Developing Project(National High Technology Research and Development Program of China); National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge financial support from the National Basic Research Program of China grants 2007CB947002 and 2007CB947001; the National Natural Science Foundation of China 30470361 and 30570962 grants; State High Technology Developing Project (2008AA02Z115), and the National Cancer Institute, National Institutes of Health (NIH) CA109460 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; BREIER G, 1992, DEVELOPMENT, V114, P521; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jiang BH, 1997, CANCER RES, V57, P5328; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Jiang BH, 2008, BBA-PROTEINS PROTEOM, V1784, P150, DOI 10.1016/j.bbapap.2007.09.008; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Liu LZ, 2005, MOL PHARMACOL, V68, P635, DOI 10.1124/mol.105.011254; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng F, 2006, GASTROENTEROLOGY, V130, pA429; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang FS, 2004, J BIOL CHEM, V279, P10331, DOI 10.1074/jbc.M308013200; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Xia C, 2006, J CELL PHYSIOL, V209, P56, DOI 10.1002/jcp.20707; Zhong H, 2000, CANCER RES, V60, P1541; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	51	289	311	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19139	10.1371/journal.pone.0019139	http://dx.doi.org/10.1371/journal.pone.0019139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544242	Green Submitted, Green Published, gold			2022-12-25	WOS:000290015800046
J	Shen, OX; Wu, W; Du, GZ; Liu, RP; Yu, LG; Sun, H; Han, XM; Jiang, Y; Shi, W; Hu, W; Song, L; Xia, YK; Wang, SL; Wang, XR				Shen, Ouxi; Wu, Wei; Du, Guizhen; Liu, Renping; Yu, Lugang; Sun, Hong; Han, Xiumei; Jiang, Yi; Shi, Wei; Hu, Wei; Song, Ling; Xia, Yankai; Wang, Shoulin; Wang, Xinru			Thyroid Disruption by Di-n-Butyl Phthalate (DBP) and Mono-n-Butyl Phthalate (MBP) in Xenopus laevis	PLOS ONE			English	Article							RETINOIC ACID RECEPTORS; BISPHENOL-A; IN-VIVO; ENDOCRINE DISRUPTORS; HORMONE RECEPTORS; SYSTEM DISRUPTION; X-RECEPTOR; BETA GENE; METAMORPHOSIS; EXPRESSION	laevis Background: Di-n-butyl phthalate (DBP), a chemical widely used in many consumer products, is estrogenic and capable of producing seriously reproductive and developmental effects in laboratory animals. However, recent in vitro studies have shown that DBP and mono-n-butyl phthalate (MBP), the major metabolite of DBP, possessed thyroid hormone receptor (TR) antagonist activity. It is therefore important to consider DBP and MBP that may interfere with thyroid hormone system. Methodology/Principal Findings: Nieuwkoop and Faber stage 51 Xenopus laevis were exposed to DBP and MBP (2, 10 or 15 mg/L) separately for 21 days. The two test chemicals decelerated spontaneous metamorphosis in X. laevis at concentrations of 10 and 15 mg/L. Moreover, MBP seemed to possess stronger activity. The effects of DBP and MBP on inducing changes of expression of selected thyroid hormone response genes: thyroid hormone receptor-beta (TR beta), retinoid X receptor gamma (RXR gamma), alpha and beta subunits of thyroid-stimulating hormone (TSH alpha and TSH beta) were detected by qPCR at all concentrations of the compounds. Using mammalian two-hybrid assay in vitro, we found that DBP and MBP enhanced the interactions between co-repressor SMRT (silencing mediator for retinoid and thyroid hormone receptors) and TR in a dose-dependent manner, and MBP displayed more markedly. In addition, MBP at low concentrations (2 and 10 mg/L) caused aberrant methylation of TR beta in head tissue. Conclusions: The current findings highlight potential disruption of thyroid signalling by DBP and MBP and provide data for human risk assessment.	[Shen, Ouxi; Liu, Renping; Yu, Lugang] Ctr Dis Control & Prevent, Suzhou, Peoples R China; [Shen, Ouxi; Wu, Wei; Du, Guizhen; Han, Xiumei; Song, Ling; Xia, Yankai; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Key Lab Reprod Med, Inst Toxicol, Sch Publ Hlth, Nanjing, Peoples R China; [Shen, Ouxi; Wu, Wei; Du, Guizhen; Han, Xiumei; Song, Ling; Xia, Yankai; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Key Lab Modern Toxicol, Minist Educ, Nanjing, Peoples R China; [Sun, Hong] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Jiang, Yi] Nanjing Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Nanjing, Peoples R China; [Shi, Wei; Hu, Wei] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Peoples R China	Chinese Center for Disease Control & Prevention; Nanjing Medical University; Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention; Nanjing Medical University; Nanjing University	Wang, XR (corresponding author), Nanjing Med Univ, Key Lab Reprod Med, Inst Toxicol, Sch Publ Hlth, Nanjing, Peoples R China.	xrwang@njmu.edu.cn	Wang, Xin/AAN-8435-2021; Wu, Wei/C-4409-2012	Wang, Xin/0000-0002-4457-7376; Wu, Wei/0000-0002-0267-1284; Shi, Wei/0000-0002-6263-5664	National Basic Research Program of China [2009CB941703]; National Natural Science Foundation of China [30930079, 30771830, 30901222]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (No. 2009CB941703); The Key Project of National Natural Science Foundation of China (No. 30930079) and National Natural Science Foundation of China (No. 30771830; No. 30901222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSSON S, 1992, DEV GROWTH DIFFER, V34, P181; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Chen JD, 1996, P NATL ACAD SCI USA, V93, P7567, DOI 10.1073/pnas.93.15.7567; Colborn T, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110s3363; Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999; Crump D, 2002, ENVIRON HEALTH PERSP, V110, P1199, DOI 10.1289/ehp.021101199; Degitz SJ, 2005, TOXICOL SCI, V87, P353, DOI 10.1093/toxsci/kfi246; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fini JB, 2007, ENVIRON SCI TECHNOL, V41, P5908, DOI 10.1021/es0704129; Furlow JD, 2006, TRENDS ENDOCRIN MET, V17, P38, DOI 10.1016/j.tem.2006.01.007; Heimeier RA, 2009, ENDOCRINOLOGY, V150, P2964, DOI 10.1210/en.2008-1503; Hermelink B, 2010, GEN COMP ENDOCR, V168, P245, DOI 10.1016/j.ygcen.2010.03.005; Hubinger JC, 2006, J COSMET SCI, V57, P127; Iwamuro S, 2003, GEN COMP ENDOCR, V133, P189, DOI 10.1016/S0016-6480(03)00188-6; Iwamuro S, 2006, LIFE SCI, V79, P2165, DOI 10.1016/j.lfs.2006.07.013; Jiang JT, 2007, TOXICOLOGY, V232, P286, DOI 10.1016/j.tox.2007.01.018; KANAMORI A, 1992, J BIOL CHEM, V267, P739; KAWAHARA A, 1991, DEVELOPMENT, V112, P933; Kinyamu HK, 2000, J BIOL CHEM, V275, P20061, DOI 10.1074/jbc.M001142200; Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5; Krain LP, 2004, J ENDOCRINOL, V181, P91, DOI 10.1677/joe.0.1810091; Lague E, 2008, ENDOCRINOLOGY, V149, P4688, DOI 10.1210/en.2008-0310; Lee SK, 2005, J TOXICOL ENV HEAL A, V68, P763, DOI 10.1080/15287390590930243; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; MACHUCA I, 1995, MOL ENDOCRINOL, V9, P96, DOI 10.1210/me.9.1.96; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Oofusa K, 2001, MOL CELL ENDOCRINOL, V181, P97, DOI 10.1016/S0303-7207(01)00529-9; Opitz R, 2006, TOXICOL SCI, V90, P337, DOI 10.1093/toxsci/kfj083; Opitz R, 2005, ENVIRON TOXICOL CHEM, V24, P653, DOI 10.1897/04-214R.1; PAGE BD, 1992, FOOD ADDIT CONTAM, V9, P197, DOI 10.1080/02652039209374064; Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Sripriya S, 2006, MOL VIS, V12, P816; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; Wong JM, 1998, J BIOL CHEM, V273, P14186, DOI 10.1074/jbc.273.23.14186; Xing MZ, 2007, ENDOCRINOLOGY, V148, P948, DOI 10.1210/en.2006-0927; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w; Zoeller RT, 2003, RISK ANAL, V23, P143, DOI 10.1111/1539-6924.00296	46	31	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19159	10.1371/journal.pone.0019159	http://dx.doi.org/10.1371/journal.pone.0019159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544203	Green Submitted, gold, Green Published			2022-12-25	WOS:000290015800048
J	Forschler, MI; Bairlein, F				Foerschler, Marc I.; Bairlein, Franz			Morphological Shifts of the External Flight Apparatus across the Range of a Passerine (Northern Wheatear) with Diverging Migratory Behaviour	PLOS ONE			English	Article							BLACKCAPS SYLVIA-ATRICAPILLA; WING SHAPE; INTRASPECIFIC VARIATION; POINTED WINGS; ECOMORPHOLOGY; SEDENTARY; FINCHES; BIRDS	We studied morphological differentiation in the flight apparatus of the four currently recognised sub-species of Northern Wheatears, Oenanthe oenanthe. Considering all measured birds without assigning them a priori to any sub-species we found a clinal morphological shift. Relative wing length, wing pointedness, and the degree of tail forking were positively correlated with migratory distance, whereas tail length (relative to wing length) was negatively correlated. The large-sized, long-distance migrant "Greenland'' Wheatear, O. o. leucorhoa, is characterized by relatively longer, broader and more pointed wings and more forked tails, similar to the smaller-sized nominate Northern Wheatear, O. o. oenanthe, from North Europe, Siberia and Russia. In contrast, the short distance migrant "Seebohm's'' Wheatear, O. o. seebohmi, from northwest Africa, possesses much rounder wings, and the tail is relatively longer and less forked. Sub-species with intermediate migratory habits (different populations of nominate Northern Wheatear, O. o. oenanthe, and "Mediterranean'' Northern Wheatear, O. o. libanotica) show, as expected, intermediate features according to their intermediate migratory behaviour. Our results are congruent with other inter-and intraspecific studies finding similar adaptations for energy-effective flight in relation to migration distance (morphological migratory syndrome).	[Foerschler, Marc I.; Bairlein, Franz] Vogelwarte Helgoland, Inst Avian Res, Wilhelmshaven, Germany		Forschler, MI (corresponding author), Vogelwarte Helgoland, Inst Avian Res, Wilhelmshaven, Germany.	marc.foerschler@ifv-vogelwarte.de						Aliabadian M, 2007, MOL PHYLOGENET EVOL, V42, P665, DOI 10.1016/j.ympev.2006.08.018; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Calmaestra RG, 2001, ARDEA, V89, P407; Copete JL, 1999, BIRD STUDY, V46, P100, DOI 10.1080/00063659909461119; Del Hoyo J, 2005, HDB BIRDS WORLD, V10; Delingat J, 2011, J ORNITHOL, V152, P383, DOI 10.1007/s10336-010-0599-4; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; Egbert JR, 2003, CONDOR, V105, P825, DOI 10.1650/7275; Fiedler W, 2005, ANN NY ACAD SCI, V1046, P253, DOI 10.1196/annals.1343.022; Fitzpatrick S, 1998, J AVIAN BIOL, V29, P248, DOI 10.2307/3677107; Forschler MI, 2008, VIE MILIEU, V58, P277; Foerschler Marc I., 2008, Bulletin of the African Bird Club, V15, P242; Imboden C., 1972, Vogelwarte, V26, P336; Kralj J, 2010, ACTA ORNITHOL, V45, P51, DOI 10.3161/000164510X516083; LEISLER B, 1991, J ORNITHOL, V132, P373, DOI 10.1007/BF01640381; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; MONKKONEN M, 1995, EVOL ECOL, V9, P520, DOI 10.1007/BF01237833; MULVIHILL RS, 1990, AUK, V107, P490; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Niethammer G., 1937, Archiv fuer Naturgeschichte Leipzig, V6, P519; Norberg U., 1990, VERTEBRATE FLIGHT ME; Outlaw RK, 2010, MOL PHYLOGENET EVOL, V55, P284, DOI 10.1016/j.ympev.2009.09.023; Perez-Tris J, 1999, BIRD STUDY, V46, P299, DOI 10.1080/00063659909461142; Perez-Tris J, 2001, J AVIAN BIOL, V32, P207, DOI 10.1111/j.0908-8857.2001.320301.x; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Seebohm H., 1901, BIRDS SIBERIA; Seki SI, 2007, MOL ECOL, V16, P101, DOI 10.1111/j.1365-294X.2006.03117.x; Swaddle JP, 2003, IBIS, V145, P457, DOI 10.1046/j.1474-919X.2003.00189.x; Thomas ALR, 1996, J THEOR BIOL, V183, P237, DOI 10.1006/jtbi.1996.0217; Videler J.J., 2006, AVIAN FLIGHT; WALTHER BA, 2011, P 12 PAN OR IN PRESS; WIEDENFELD DA, 1991, CONDOR, V93, P712, DOI 10.2307/1368203; WINKLER H, 1992, IBIS, V134, P21	34	54	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18732	10.1371/journal.pone.0018732	http://dx.doi.org/10.1371/journal.pone.0018732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533160	gold, Green Published, Green Submitted			2022-12-25	WOS:000289620100013
J	Schaer, C; Hiltbrunner, S; Ernst, B; Mueller, C; Kurrer, M; Kopf, M; Harris, NL				Schaer, Corinne; Hiltbrunner, Stefanie; Ernst, Bettina; Mueller, Christoph; Kurrer, Michael; Kopf, Manfred; Harris, Nicola L.			HVEM Signalling Promotes Colitis	PLOS ONE			English	Article							HERPESVIRUS ENTRY MEDIATOR; T-LYMPHOCYTE ATTENUATOR; B-LYMPHOCYTE; NK-CELL; IMMUNODEFICIENT MICE; LYMPHOTOXIN-BETA; SCID MICE; LIGHT; RECEPTOR; ACTIVATION	Background: Tumor necrosis factor super family (TNFSF) members regulate important processes involved in cell proliferation, survival and differentiation and are therefore crucial for the balance between homeostasis and inflammatory responses. Several members of the TNFSF are closely associated with inflammatory bowel disease (IBD). Thus, they represent interesting new targets for therapeutic treatment of IBD. Methodology/Principal Findings: We have used mice deficient in TNFSF member HVEM in experimental models of IBD to investigate its role in the disease process. Two models of IBD were employed: i) chemical-induced colitis primarily mediated by innate immune cells; and ii) colitis initiated by CD4(+)CD45RB(high) T cells following their transfer into immuno-deficient RAG1(-/-) hosts. In both models of disease the absence of HVEM resulted in a significant reduction in colitis and inflammatory cytokine production. Conclusions: These data show that HVEM stimulatory signals promote experimental colitis driven by innate or adaptive immune cells.	[Schaer, Corinne; Hiltbrunner, Stefanie; Ernst, Bettina; Kopf, Manfred] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Mueller, Christoph] Univ Bern, Inst Pathol, Bern, Switzerland; [Kurrer, Michael] Cantonal Hosp Aarau, Inst Pathol, Aarau, Switzerland; [Harris, Nicola L.] Ecole Polytech Fed Lausanne, Swiss Vaccine Res Inst, Lausanne, Switzerland; [Harris, Nicola L.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Kantonsspital Aarau AG (KSA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Schaer, C (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland.	nicola.harris@epfl.ch	Kopf, Manfred/B-6907-2009; harris, nicola/E-5342-2019; Mueller, Christoph/F-2233-2014	Kopf, Manfred/0000-0002-0628-7140; harris, nicola/0000-0003-2922-0210; Mueller, Christoph/0000-0002-3921-8678; Hiltbrunner, Stefanie/0000-0002-3415-7992	Swiss Vaccine Research Institute; Swiss Federal Institute of Technology [TH-1407-3]	Swiss Vaccine Research Institute; Swiss Federal Institute of Technology	N. Harris is supported by the Swiss Vaccine Research Institute (http://www.swissvaccineresearchinstitute.ch/). The project was funded by a research grant (no. TH-1407-3) from the Swiss Federal Institute of Technology (http://www.ethz.ch/index_EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cohavy O, 2005, J IMMUNOL, V174, P646, DOI 10.4049/jimmunol.174.2.646; Cohavy O, 2004, J IMMUNOL, V173, P251, DOI 10.4049/jimmunol.173.1.251; COOPER HS, 1993, LAB INVEST, V69, P238; Deppong C, 2006, J IMMUNOL, V176, P3909, DOI 10.4049/jimmunol.176.7.3909; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Fan ZS, 2006, BLOOD, V107, P1342, DOI 10.1182/blood-2005-08-3485; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Granger SW, 2001, J IMMUNOL, V167, P5122, DOI 10.4049/jimmunol.167.9.5122; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; Hurchla MA, 2005, J IMMUNOL, V174, P3377, DOI 10.4049/jimmunol.174.6.3377; Jiang HQ, 2002, GASTROENTEROLOGY, V122, P1346, DOI 10.1053/gast.2002.32959; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Morel Y, 2000, J IMMUNOL, V165, P4397, DOI 10.4049/jimmunol.165.8.4397; Morel Y, 2001, J IMMUNOL, V167, P2479, DOI 10.4049/jimmunol.167.5.2479; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pakala R, 2001, J CARDIOVASC PHARM, V37, P619, DOI 10.1097/00005344-200105000-00013; Prestwood TR, 2008, J VIROL, V82, P8411, DOI 10.1128/JVI.00611-08; Sarrias MR, 2000, MOL IMMUNOL, V37, P665, DOI 10.1016/S0161-5890(00)00089-4; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Sedgmen BJ, 2006, INT IMMUNOL, V18, P797, DOI 10.1093/intimm/dxl016; Spahn TW, 2002, AM J PATHOL, V161, P2273, DOI 10.1016/S0002-9440(10)64503-8; Steinberg MW, 2008, J EXP MED, V205, P1463, DOI 10.1084/jem.20071160; Tamada K, 2000, J IMMUNOL, V164, P4105, DOI 10.4049/jimmunol.164.8.4105; Tao R, 2008, J IMMUNOL, V180, P6649, DOI 10.4049/jimmunol.180.10.6649; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x	32	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18495	10.1371/journal.pone.0018495	http://dx.doi.org/10.1371/journal.pone.0018495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533159	gold, Green Published, Green Submitted			2022-12-25	WOS:000289620100007
J	Kalen, M; Heikura, T; Karvinen, H; Nitzsche, A; Weber, H; Esser, N; Yla-Herttuala, S; Hellstrom, M				Kalen, Mattias; Heikura, Tommi; Karvinen, Henna; Nitzsche, Anja; Weber, Holger; Esser, Norbert; Yla-Herttuala, Seppo; Hellstrom, Mats			Gamma-Secretase Inhibitor Treatment Promotes VEGF-A-Driven Blood Vessel Growth and Vascular Leakage but Disrupts Neovascular Perfusion	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-GROWTH; GENE-THERAPY; ANGIOGENESIS; BLOCKADE; PATHWAY; CANCER; NOTCH1; NEOPLASMS; FUTURE	The Notch signaling pathway is essential for normal development due to its role in control of cell differentiation, proliferation and survival. It is also critically involved in tumorigenesis and cancer progression. A key enzyme in the activation of Notch signaling is the gamma-secretase protein complex and therefore, gamma-secretase inhibitors (GSIs)originally developed for Alzheimer's disease-are now being evaluated in clinical trials for human malignancies. It is also clear that Notch plays an important role in angiogenesis driven by Vascular Endothelial Growth Factor A (VEGF-A)-a process instrumental for tumor growth and metastasis. The effect of GSIs on tumor vasculature has not been conclusively determined. Here we report that Compound X (CX), a GSI previously reported to potently inhibit Notch signaling in vitro and in vivo, promotes angiogenic sprouting in vitro and during developmental angiogenesis in mice. Furthermore, CX treatment suppresses tumor growth in a mouse model of renal carcinoma, leads to the formation of abnormal vessels and an increased tumor vascular density. Using a rabbit model of VEGF-A-driven angiogenesis in skeletal muscle, we demonstrate that CX treatment promotes abnormal blood vessel growth characterized by vessel occlusion, disrupted blood flow, and increased vascular leakage. Based on these findings, we propose a model for how GSIs and other Notch inhibitors disrupt tumor blood vessel perfusion, which might be useful for understanding this new class of anti-cancer agents.	[Kalen, Mattias; Nitzsche, Anja; Hellstrom, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Heikura, Tommi; Karvinen, Henna; Yla-Herttuala, Seppo] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Kuopio, Finland; [Weber, Holger; Esser, Norbert] ProQinase GmbH, Freiburg, Germany	Uppsala University; University of Eastern Finland; ProQinase	Kalen, M (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	mats.hellstrom@igp.uu.se		Hellstrom, Mats/0000-0002-7088-9533; Yla-Herttuala, Seppo/0000-0001-7593-2708; Heikura, Tommi/0000-0001-6884-1402; Nitzsche, Anja/0000-0003-0567-6790	Family Janne Elgqvist Foundation; Finnish Academy of Sciences; Swedish Cancer Foundation; Uppsala University; Beijer Foundation; Angstromke Wiberg's Foundation	Family Janne Elgqvist Foundation; Finnish Academy of Sciences(Academy of Finland); Swedish Cancer Foundation; Uppsala University; Beijer Foundation; Angstromke Wiberg's Foundation	MK is supported by the Family Janne Elgqvist Foundation. SY-H receives funding from the Finnish Academy of Sciences. MH receives funding from Swedish Cancer Foundation, Uppsala University, The Beijer Foundation, and angstrom ke Wiberg's Foundation. HW and NE are employed by ProQinase GmbH, and performed the mouse tumor study as fee-for-service contract research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; HEWITT CD, 1989, CLIN CHEM, V35, P1777; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Korff T, 1999, J CELL SCI, V112, P3249; Korpisalo P, 2008, CIRC RES, V103, P1092, DOI 10.1161/CIRCRESAHA.108.182287; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Luistro L, 2009, CANCER RES, V69, P7672, DOI 10.1158/0008-5472.CAN-09-1843; Malyukova A, 2007, CANCER RES, V67, P5611, DOI 10.1158/0008-5472.CAN-06-4381; Masuda S, 2009, CANCER SCI, V100, P2444, DOI 10.1111/j.1349-7006.2009.01328.x; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nakajima M, 2003, MECH DEVELOP, V120, P657, DOI 10.1016/S0925-4773(03)00064-9; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Paris D, 2005, EUR J PHARMACOL, V514, P1, DOI 10.1016/j.ejphar.2005.02.050; Petit A, 2003, J NEUROSCI RES, V74, P370, DOI 10.1002/jnr.10747; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rissanen TT, 2005, CIRCULATION, V112, P3937, DOI 10.1161/CIRCULATIONAHA.105.543124; Rissanen TT, 2002, FASEB J, V16, P100, DOI 10.1096/fj.02-0377fje; Rissanen TT, 2008, JACC-CARDIOVASC IMAG, V1, P83, DOI 10.1016/j.jcmg.2007.10.009; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Schilsky RL, 2010, NAT REV DRUG DISCOV, V9, P363, DOI 10.1038/nrd3181; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wei P, 2010, MOL CANCER THER, V9, P1618, DOI 10.1158/1535-7163.MCT-10-0034; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751	48	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18709	10.1371/journal.pone.0018709	http://dx.doi.org/10.1371/journal.pone.0018709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533193	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600024
J	Dammann, P; Sumbera, R; Massmann, C; Scherag, A; Burda, H				Dammann, Philip; Sumbera, Radim; Massmann, Christina; Scherag, Andre; Burda, Hynek			Extended Longevity of Reproductives Appears to be Common in Fukomys Mole-Rats (Rodentia, Bathyergidae)	PLOS ONE			English	Article							CRYPTOMYS-MECHOWI RODENTIA; LONGEST-LIVING RODENT; LIFE-SPAN; SEXUAL-ACTIVITY; EUSOCIALITY; RESISTANCE; EVOLUTION; COLONIES; GROWTH	African mole-rats (Bathyergidae, Rodentia) contain several social, cooperatively breeding species with low extrinsic mortality and unusually high longevity. All social bathyergids live in multigenerational families where reproduction is skewed towards a few breeding individuals. Most of their offspring remain as reproductively inactive "helpers'' in their natal families, often for several years. This "reproductive subdivision'' of mole-rat societies might be of interest for ageing research, as in at least one social bathyergid (Ansell's mole-rats Fukomys anselli), breeders have been shown to age significantly slower than non-breeders. These animals thus provide excellent conditions for studying the epigenetics of senescence by comparing divergent longevities within the same genotypes without the inescapable short-comings of inter-species comparisons. It has been claimed that many if not all social mole-rat species may have evolved similar ageing patterns, too. However, this remains unclear on account of the scarcity of reliable datasets on the subject. We therefore analyzed a 20-year breeding record of Giant mole-rats Fukomys mechowii, another social bathyergid species. We found that breeders indeed lived significantly longer than helpers (ca. 1.5-2.2fold depending on the sex), irrespective of social rank or other potentially confounding factors. Considering the phylogenetic positions of F. mechowii and F. anselli and unpublished data on a third Fukomys-species (F. damarensis) showing essentially the same pattern, it seems probable that the reversal of the classic trade-off between somatic maintenance and sexual reproduction is characteristic of the whole genus and hence of the vast majority of social mole-rats.	[Dammann, Philip; Massmann, Christina; Burda, Hynek] Univ Duisburg Essen, Inst Biol, Dept Gen Zool, Essen, Germany; [Sumbera, Radim] Univ S Bohemia, Fac Sci, Dept Zool, Ceske Budejovice, Czech Republic; [Dammann, Philip] Univ Duisburg Essen, Sch Med, Cent Anim Lab, Essen, Germany; [Scherag, Andre] Univ Duisburg Essen, Sch Med, Inst Med Informat Biometry & Epidemol, Essen, Germany	University of Duisburg Essen; University of South Bohemia Ceske Budejovice; University of Duisburg Essen; University of Duisburg Essen	Dammann, P (corresponding author), Univ Duisburg Essen, Inst Biol, Dept Gen Zool, Essen, Germany.	philip.dammann@uk-essen.de	Scherag, Andre/B-3805-2014; Šumbera, Radim/D-9072-2016	Šumbera, Radim/0000-0001-8658-9378; Scherag, Andre/0000-0002-9406-4704	Ministry of Education of the Czech Republic [MSMT 6007665801]; Grant Agency of AV CR [IAA601410802]; University of Duisburg-Essen [t60140-19102009]	Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of AV CR; University of Duisburg-Essen	This work was supported by the Ministry of Education of the Czech Republic (MSMT 6007665801 to RS; www.msmt.cz), the Grant Agency of AV CR (IAA601410802 to RS; www.gaav.cz), and the Science Support Centre at the University of Duisburg-Essen (t60140-19102009 to PD; www.uni-due.de/ssc/index.php). Additionally, travel grants were approved to PD, HB and RS by the DAAD (http://www.daad.de/de/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begall S, 1998, Z SAUGETIERKD, V63, P297; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; BURDA H, 1995, EXPERIENTIA, V51, P411, DOI 10.1007/BF01928906; BURDA H, 1993, NATURWISSENSCHAFTEN, V80, P235, DOI 10.1007/BF01175742; Chapuisat M, 2002, P ROY SOC B-BIOL SCI, V269, P909, DOI 10.1098/rspb.2002.1962; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Holldobler B., 1990, pi; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; JARVIS JUM, 1993, BEHAV ECOL SOCIOBIOL, V33, P253, DOI 10.1007/BF02027122; Kawalika M, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P205, DOI 10.1007/978-3-540-69276-8_15; Keller L, 1998, INSECT SOC, V45, P235, DOI 10.1007/s000400050084; Kock D, 2006, ZOOTAXA, P51, DOI 10.11646/zootaxa.1142.1.4; Koenig W.D., 2004, ECOLOGY EVOLUTION CO; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; Mele J, 2010, RUSS J GEN CHEM+, V80, P1455, DOI 10.1134/S1070363210070418; PARTRIDGE L, 1981, NATURE, V294, P580, DOI 10.1038/294580a0; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Ricklefs RE, 2007, ECOL LETT, V10, P867, DOI 10.1111/j.1461-0248.2007.01085.x; Scharff A, 1999, MAMMALIA, V63, P217, DOI 10.1515/mamm.1999.63.2.217; Scharff A, 2001, J MAMMAL, V82, P1003, DOI 10.1644/1545-1542(2001)082<1003:NHOTGM>2.0.CO;2; Sharp SP, 2010, J ANIM ECOL, V79, P176, DOI 10.1111/j.1365-2656.2009.01616.x; Sherman PW, 2002, J ZOOL, V258, P307, DOI 10.1017/S0952836902001437; Sichilima AM, 2008, J ZOOL, V275, P276, DOI 10.1111/j.1469-7998.2008.00439.x; Smith GD, 1997, BMJ-BRIT MED J, V315, P1641, DOI 10.1136/bmj.315.7123.1641; Solomon N. G., 1997, COOPERATIVE BREEDING; Stearns S.C., 1992, pi; Thorne BL, 2002, J ANIM ECOL, V71, P1030, DOI 10.1046/j.1365-2656.2002.00666.x; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Van Daele PAAG, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P357; Wallace ED, 1998, J ZOOL, V244, P51, DOI 10.1111/j.1469-7998.1998.tb00006.x; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	39	47	50	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18757	10.1371/journal.pone.0018757	http://dx.doi.org/10.1371/journal.pone.0018757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533255	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800036
J	Helland, A; Anglesio, MS; George, J; Cowin, PA; Johnstone, CN; House, CM; Sheppard, KE; Etemadmoghadam, D; Melnyk, N; Rustgi, AK; Phillips, WA; Johnsen, H; Holm, R; Kristensen, GB; Birrer, MJ; Pearson, RB; Borresen-Dale, AL; Huntsman, DG; deFazio, A; Creighton, CJ; Smyth, GK; Bowtell, DDL				Helland, Aslaug; Anglesio, Michael S.; George, Joshy; Cowin, Prue A.; Johnstone, Cameron N.; House, Colin M.; Sheppard, Karen E.; Etemadmoghadam, Dariush; Melnyk, Nataliya; Rustgi, Anil K.; Phillips, Wayne A.; Johnsen, Hilde; Holm, Ruth; Kristensen, Gunnar B.; Birrer, Michael J.; Pearson, Richard B.; Borresen-Dale, Anne-Lise; Huntsman, David G.; deFazio, Anna; Creighton, Chad J.; Smyth, Gordon K.; Bowtell, David D. L.		Australian Ovarian Canc Study Grp	Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers	PLOS ONE			English	Article							B-CELL LYMPHOMA; SELF-RENEWAL; COPY NUMBER; EXPRESSION; GENE; MICRORNAS; HMGA2; IMPACT; TUMORS; PLURIPOTENCY	Molecular subtypes of serous ovarian cancer have been recently described. Using data from independent datasets including over 900 primary tumour samples, we show that deregulation of the Let-7 pathway is specifically associated with the C5 molecular subtype of serous ovarian cancer. DNA copy number and gene expression of HMGA2, alleles of Let-7, LIN28, LIN28B, MYC, MYCN, DICER1, and RNASEN were measured using microarray and quantitative reverse transcriptase PCR. Immunohistochemistry was performed on 127 samples using tissue microarrays and anti-HMGA2 antibodies. Fluorescence in situ hybridisation of bacterial artificial chromosomes hybridized to 239 ovarian tumours was used to measure translocation at the LIN28B locus. Short interfering RNA knockdown in ovarian cell lines was used to test the functionality of associations observed. Four molecular subtypes (C1, C2, C4, C5) of high-grade serous ovarian cancers were robustly represented in each dataset and showed similar pattern of patient survival. We found highly specific activation of a pathway involving MYCN, LIN28B, Let-7 and HMGA2 in the C5 molecular subtype defined by MYCN amplification and over-expression, over-expression of MYCN targets including the Let-7 repressor LIN28B, loss of Let-7 expression and HMGA2 amplification and over-expression. DICER1, a known Let-7 target, and RNASEN were over-expressed in C5 tumours. We saw no evidence of translocation at the LIN28B locus in C5 tumours. The reported interaction between LIN28B and Let-7 was recapitulated by siRNA knockdown in ovarian cancer cell lines. Our results associate deregulation of MYCN and downstream targets, including Let-7 and oncofetal genes, with serous ovarian cancer. We define for the first time how elements of an oncogenic pathway, involving multiple genes that contribute to stem cell renewal, is specifically altered in a molecular subtype of serous ovarian cancer. By defining the drivers of a molecular subtype of serous ovarian cancers we provide a novel strategy for targeted therapeutic intervention.	[Helland, Aslaug; Anglesio, Michael S.; George, Joshy; Cowin, Prue A.; Johnstone, Cameron N.; House, Colin M.; Sheppard, Karen E.; Etemadmoghadam, Dariush; Phillips, Wayne A.; Pearson, Richard B.; Bowtell, David D. L.; Australian Ovarian Canc Study Grp] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Helland, Aslaug; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [George, Joshy; Huntsman, David G.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [George, Joshy; Pearson, Richard B.; Bowtell, David D. L.] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Melnyk, Nataliya; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Gen, Vancouver, BC V5Z 4E6, Canada; [Helland, Aslaug; Johnsen, Hilde; Holm, Ruth; Kristensen, Gunnar B.; Borresen-Dale, Anne-Lise] Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Div Surg & Canc,Dept Genet, Oslo, Norway; [Rustgi, Anil K.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [deFazio, Anna] Westmead Hosp, Dept Gynaecol Oncol, Sydney, NSW, Australia; [deFazio, Anna] Univ Sydney, Westmead Inst Canc Res, Westmead Hosp, Westmead Millennium Inst, Sydney, NSW, Australia; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Smyth, Gordon K.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Birrer, Michael J.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Peter Maccallum Cancer Center; University of Oslo; University of British Columbia; University of Melbourne; British Columbia Cancer Agency; University of Oslo; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Sydney; University of Sydney; Westmead Institute for Medical Research; Baylor College of Medicine; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Harvard University; Harvard Medical School	Bowtell, DDL (corresponding author), Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Div Surg & Canc,Dept Genet, Oslo, Norway.	d.bowtell@petermac.org	friedlander, michael l/G-3490-2013; DeFazio, Anna/O-2385-2019; Smyth, Gordon/B-5276-2008; George, Joshy/K-4841-2019; Huntsman, David/ABE-6082-2020; Zeps, Nikolajs/C-4180-2013; deFazio, Anna/D-3939-2013; Haviv, Izhak/E-3782-2015; Sheppard, Karen E/U-5360-2017; Pearson, Richard Bruce/I-1451-2013; Phillips, Wayne A/H-8070-2013; Sheppard, Karen/P-5947-2019; Bowtell, David/H-1007-2016; Helland, Åslaug/H-3910-2015; Wyld, David/B-8893-2015	friedlander, michael l/0000-0002-6488-0604; DeFazio, Anna/0000-0003-0057-4744; Smyth, Gordon/0000-0001-9221-2892; Zeps, Nikolajs/0000-0002-6404-6839; deFazio, Anna/0000-0003-0057-4744; Haviv, Izhak/0000-0002-0837-5005; Sheppard, Karen E/0000-0002-2798-4703; Pearson, Richard Bruce/0000-0001-5919-5090; Phillips, Wayne A/0000-0002-7961-638X; Sheppard, Karen/0000-0002-2798-4703; Bowtell, David/0000-0001-9089-7525; Helland, Åslaug/0000-0002-5520-0275; Alsop, Kathryn/0000-0002-4107-3041; Anglesio, Michael/0000-0003-1639-5003; Wyld, David/0000-0001-9523-4333; Chenevix-Trench, Georgia/0000-0002-1878-2587	United States Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Tasmania; Cancer Foundation of Western Australia; National Health and Medical Research Council of Australia; Victorian Life Sciences Computation Initiative (VLSCI); Radium Hospital Foundation; Fredriksen Foundation for Ovarian Cancer Research	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative (VLSCI); Radium Hospital Foundation; Fredriksen Foundation for Ovarian Cancer Research	AOCS was supported by the United States Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Tasmania, The Cancer Foundation of Western Australia and the National Health and Medical Research Council of Australia. This research was supported by a Victorian Life Sciences Computation Initiative (VLSCI) grant on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government, and also by grants from the Radium Hospital Foundation and the Fredriksen Foundation for Ovarian Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bookman MA, 2009, INT J GYNECOL CANCER, V19, pS55, DOI 10.1111/IGC.0b013e3181c36ea0; BOYERINAS B, 2009, ENDOCR RELAT CANC; CHANG TC, 2009, P NATL ACAD SCI US; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cleynen I, 2008, INT J ONCOL, V32, P289; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Malek A, 2008, INT J CANCER, V123, P348, DOI 10.1002/ijc.23491; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murph MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005583; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schwab M, 2004, CANCER LETT, V204, P179, DOI 10.1016/S0304-3835(03)00454-3; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zitterbart K, 2011, J NEURO-ONCOL, V102, P25, DOI 10.1007/s11060-010-0289-3	43	139	144	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18064	10.1371/journal.pone.0018064	http://dx.doi.org/10.1371/journal.pone.0018064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533284	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800007
J	Latronico, N; Manenti, O; Baini, L; Rasulo, FA				Latronico, Nicola; Manenti, Ottavia; Baini, Luca; Rasulo, Frank A.			Quality of Reporting on the Vegetative State in Italian Newspapers. The Case of Eluana Englaro	PLOS ONE			English	Article							MINIMALLY CONSCIOUS STATE; NEWS MEDIA; BRAIN; DISORDERS; DIAGNOSIS; COVERAGE; LEGAL; CARE	Background: Media coverage of the vegetative state (VS) includes refutations of the VS diagnosis and describes behaviors inconsistent with VS. We used a quality score to assess the reporting in articles describing the medical characteristics of VS in Italian newspapers. Methodology/Principal Findings: Our search covered a 7-month period from July 1, 2008, to February 28, 2009, using the online searchable databases of four major Italian newspapers: Corriere della Sera, La Repubblica, La Stampa, and Avvenire. Medical reporting was judged as complete if three core VS characteristics were described: patient unawareness of self and the environment, preserved wakefulness (eyes open), and spontaneous respiration (artificial ventilator not needed). We retrieved 2,099 articles, and 967 were dedicated to VS. Of these, 853 (88.2%) were non-medical and mainly focused on describing the political, legal, and ethical aspects of VS. Of the 114 (11.8%) medical articles, 53 (5.5%) discussed other medical problems such as death by dehydration, artificial nutrition, neuroimaging, brain death, or uterine hemorrhage, and 61 (6.3%) described VS. Of these 61, only 18 (1.9%) reported all three CORE characteristics and were judged complete. We found no differences among the four investigated newspapers (Fisher's exact = 0.798), and incomplete articles were equally distributed between journalistic pieces and expert opinions (chi(2) = 1.8854, P = 0.170). Incorrect descriptions of VS were significantly more common among incomplete articles (13 of 43 vs. 1 of 18; Fisher's exact P = 0.047). Conclusions/Significance: Core VS characteristics are rarely reported in Italian newspaper articles, which can alter adequate comprehension of new developments and (mis) inform political, legal, and ethical decisions.	[Latronico, Nicola; Manenti, Ottavia; Baini, Luca; Rasulo, Frank A.] Univ Brescia, Spedali Civili, Dept Neuroanesthesia & Neurointens Care, Brescia, Italy	Hospital Spedali Civili Brescia; University of Brescia	Latronico, N (corresponding author), Univ Brescia, Spedali Civili, Dept Neuroanesthesia & Neurointens Care, Brescia, Italy.	nicola.latronico@med.unibs.it	LATRONICO, Nicola/F-1557-2010	LATRONICO, Nicola/0000-0002-2521-5871; RASULO, Francesco Antonio/0000-0002-7187-5168	University of Brescia	University of Brescia	The study was funded with internal funds of the University of Brescia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annas George J, 1996, Duquesne Law Rev, V34, P875; Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; ANNAS GJ, 1990, NEW ENGL J MED, V323, P670, DOI 10.1056/NEJM199009063231010; [Anonymous], 1989, NEUROLOGY, V39, P125; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Bernat JL, 2008, NEUROLOGY, V71, P964, DOI 10.1212/01.wnl.0000324281.33381.15; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Biondi S, 2009, MED LAW REV, V17, P447, DOI 10.1093/medlaw/fwp020; BROOKS D, 2005, NY TIMES         MAR, V26, pA13; Cantor NL, 2001, J LAW MED ETHICS, V29, P182; DEMERTZI A, 2009, PROGR BRAIN RES; Dentzer S, 2009, NEW ENGL J MED, V360, P1, DOI 10.1056/NEJMp0805753; ENTWISTLE V, 1995, BRIT MED J, V310, P920, DOI 10.1136/bmj.310.6984.920; Fins JJ, 2004, ARCH NEUROL-CHICAGO, V61, P1354, DOI 10.1001/archneur.61.9.1354; Fins JJ, 2000, NEUROL RES, V22, P273; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2002, J NEUROL NEUROSUR PS, V73, P355, DOI 10.1136/jnnp.73.4.355; JOHNP II, 2004, ISSUES LAW MED, V20, P167; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Kuriya B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002828; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006856; Lai WYY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006103; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Luchetti M, 2010, J MED ETHICS, V36, P333, DOI 10.1136/jme.2009.034835; MacKenzie R, 2007, MED J AUSTRALIA, V187, P507, DOI 10.5694/j.1326-5377.2007.tb01391.x; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moratti S, 2010, CAMB Q HEALTHC ETHIC, V19, P372, DOI 10.1017/S0963180110000150; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; *OBS, 2009, FATH PLEA LET MY DAU; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; OXMAN AD, 1993, J CLIN EPIDEMIOL, V46, P987, DOI 10.1016/0895-4356(93)90166-X; Perry JE, 2005, ANN INTERN MED, V143, P744, DOI 10.7326/0003-4819-143-10-200511150-00012; *PRES CONS MIN, 2005, COM NAZ BIOET DIC; Racine E, 2008, NEUROLOGY, V71, P1027, DOI 10.1212/01.wnl.0000320507.64683.ee; Racine E, 2010, CAN J NEUROL SCI, V37, P758, DOI 10.1017/S0317167100051416; Rubulotta F, 2010, MINERVA ANESTESIOL, V76, P203; Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Shewmon DA, 2004, NEUROREHABILITATION, V19, P343; *SINPE SOC IT NUTR, 2007, PREC MER IMPL BIOET; Striano P, 2009, INTENS CARE MED, V35, P1129, DOI 10.1007/s00134-009-1484-6; Timmer Antje, 2003, BMC Med Res Methodol, V3, P2, DOI 10.1186/1471-2288-3-2; TRESCH DD, 1991, J AM GERIATR SOC, V39, P17, DOI 10.1111/j.1532-5415.1991.tb05900.x; *UUAR UN DEGL AT D, 2011, ARCH ACC OM CONTR BE; VERONESI U, 2000, GRUPPO LAVORO NUTR I; Wade DT, 2001, BMJ-BRIT MED J, V322, P352, DOI 10.1136/bmj.322.7282.352; Wells J, 2001, ANN INTERN MED, V135, P1029, DOI 10.7326/0003-4819-135-12-200112180-00006; Wijdicks EFM, 2006, MAYO CLIN PROC, V81, P1155, DOI 10.4065/81.9.1155; Wilson A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004831	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18706	10.1371/journal.pone.0018706	http://dx.doi.org/10.1371/journal.pone.0018706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	748QE	21533275	Green Submitted, gold, Green Published			2022-12-25	WOS:000289404700028
J	Perez-Tilve, D; Heppner, K; Kirchner, H; Lockie, SH; Woods, SC; Smiley, DL; Tschop, M; Pfluger, P				Perez-Tilve, Diego; Heppner, Kristy; Kirchner, Henriette; Lockie, Sarah H.; Woods, Stephen C.; Smiley, David L.; Tschoep, Matthias; Pfluger, Paul			Ghrelin-induced adiposity is independent of orexigenic effects	FASEB JOURNAL			English	Article						brain; metabolism; melanocortin	LIPID-METABOLISM; SKELETAL-MUSCLE; INDUCED OBESITY; NEUROPEPTIDE-Y; ENERGY-BALANCE; OLDER-ADULTS; RATS; NEURONS; BRAIN; SECRETAGOGUE	Ghrelin is a hormone produced predominantly by the stomach that targets a number of specific areas in the central nervous system to promote a positive energy balance by increasing food intake and energy storage. In that respect, similarities exist with the effects of consuming a high-fat diet (HFD), which also increases caloric intake and the amount of stored calories. We determined whether the effects of ghrelin on feeding and adiposity are influenced by the exposure to an HFD. Chronic intracerebroventricular ghrelin (2.5 nmol/d) increased feeding in lean rats fed a low-fat control diet (CD) [192 +/- 5 g (ghrelin + CD) vs. 152 +/- 5 g (control i.c.v. saline + CD), P < 0.001], but the combination of ghrelin plus HFD did not result in significantly greater hyperphagia [150 +/- 7 g (ghrelin + HFD) vs. 136 +/- 4 g (saline + HFD)]. Despite failing to increase food intake in rats fed the HFD, ghrelin nonetheless increased adiposity [fat mass increase of 14 +/- 2 g (ghrelin + HFD) vs. 1 +/- 1 g (saline + HFD), P < 0.001] up-regulating the gene expression of lipogenic enzymes in white adipose tissue. Our findings demonstrate that factors associated with high-fat feeding functionally interact with pathways regulating the effect of ghrelin on food intake. We conclude that ghrelin's central effects on nutrient intake and nutrient partitioning can be separated and suggest an opportunity to identify respective independent neuronal pathways.-Perez-Tilve, D., Heppner, K., Kirchner, H., Lockie, S. H., Woods, S. C., Smiley, D. L., Tschop, M., and Pfluger, P. Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J. 25, 2814-2822 (2011). www.fasebj.org	[Perez-Tilve, Diego; Heppner, Kristy; Kirchner, Henriette; Tschoep, Matthias; Pfluger, Paul] Univ Cincinnati, Dept Internal Med, Metab Dis Inst, Cincinnati, OH 45237 USA; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat, Metab Dis Inst, Cincinnati, OH 45237 USA; [Lockie, Sarah H.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Smiley, David L.] Indiana Univ, Dept Chem, Bloomington, IN USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Monash University; Indiana University System; Indiana University Bloomington	Perez-Tilve, D (corresponding author), Univ Cincinnati, Dept Internal Med, Metab Dis Inst, 2180 E Galbraith Rd, Cincinnati, OH 45237 USA.	pereztdo@ucmail.uc.edu	Lockie, Sarah/M-1415-2019; Pfluger, Paul T/A-3770-2019; Tschoep, Matthias H/I-5443-2014	Pfluger, Paul T/0000-0002-8118-7588; Perez-Tilve, Diego/0000-0002-0351-4133; Tschoep, Matthias/0000-0002-4744-371X; Lockie, Sarah/0000-0002-3833-4714	U.S. National Institutes of Health [DK077975]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK017844, R01DK077975] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the U.S. National Institutes of Health (DK077975).	Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Clegg DJ, 2003, DIABETES, V52, P682, DOI 10.2337/diabetes.52.3.682; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Davies JS, 2009, MOL ENDOCRINOL, V23, P914, DOI 10.1210/me.2008-0432; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Faulconbridge LF, 2005, DIABETES, V54, P1985, DOI 10.2337/diabetes.54.7.1985; Gardiner JV, 2010, GASTROENTEROLOGY, V138, P2468, DOI 10.1053/j.gastro.2010.02.012; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Iwakura H, 2007, AM J PHYSIOL-ENDOC M, V293, pE819, DOI 10.1152/ajpendo.00681.2006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lall S, 2001, BIOCHEM BIOPH RES CO, V280, P132, DOI 10.1006/bbrc.2000.4065; Nass R, 2008, ANN INTERN MED, V149, P601, DOI 10.7326/0003-4819-149-9-200811040-00003; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Perreault M, 2004, INT J OBESITY, V28, P879, DOI 10.1038/sj.ijo.0802640; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Sangiao-Alvarellos S, 2009, ENDOCRINOLOGY, V150, P4562, DOI 10.1210/en.2009-0482; Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060; Strassburg S, 2008, AM J PHYSIOL-ENDOC M, V295, pE78, DOI 10.1152/ajpendo.00040.2008; Svensson J, 1998, J CLIN ENDOCR METAB, V83, P362, DOI 10.1210/jc.83.2.362; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; White HK, 2009, J CLIN ENDOCR METAB, V94, P1198, DOI 10.1210/jc.2008-0632; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	33	83	84	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2814	2822		10.1096/fj.11-183632	http://dx.doi.org/10.1096/fj.11-183632			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21543764	Green Published			2022-12-25	WOS:000293337800029
J	Ryu, JM; Han, HJ				Ryu, Jung Min; Han, Ho Jae			L-Threonine Regulates G(1)/S Phase Transition of Mouse Embryonic Stem Cells via PI3K/Akt, MAPKs, and mTORC Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; SIGNALING PATHWAYS; RAFT MICRODOMAINS; MAMMALIAN TARGET; HEPATOMA-CELLS; RAPAMYCIN; EXPRESSION; MEMBRANE; GROWTH; DIFFERENTIATION	Although amino acids can function as signaling molecules in the regulation of many cellular processes, mechanisms surrounding L-threonine involvement in embryonic stem cell (ESC) functions have not been explored. Thus, we investigated the effect of L-threonine on regulation of mouse (m) ESC self-renewal and related signaling pathways. In L-threonine-depleted mESC culture media mRNA of self-renewal marker genes, [H-3] thymidine incorporation, expression of c-Myc, Oct4, and cyclins protein was attenuated. In addition, resupplying L-threonine (500 mu M) after depletion restores/maintains the mESC proliferation. Disruption of the lipid raft/caveolae microdomain through treatment with methyl-beta-cyclodextrin or transfection with caveolin-1 specific small interfering RNA blocked L-threonine-induced proliferation of mESCs. Addition of L-threonine induced phosphorylation of Akt, ERK, p38, JNK/SAPK, and mTOR in a time-dependent manner. This activity was blocked by LY 294002 (PI3K inhibitor), wortmannin (PI3K inhibitor), or an Akt inhibitor. L-threonine-induced activation of mTOR, p70S6K, and 4E-BP1 as well as cyclins and Oct4 were blocked by PD 98059 (ERK inhibitor), SB 203580 (p38 inhibitor) or SP 600125 (JNK inhibitor). Furthermore, L-threonine induced phosphorylation of raptor and rictor binding to mTOR was completely inhibited by 24 h treatment with rapamycin (mTOR inhibitor); however, a 10 min treatment with rapamycin only partially inhibited rictor phosphorylation. L-Threonine induced translocation of rictor from the membrane to the cytosol/nuclear, which blocked by pretreatment with rapamycin. In addition, rapamycin blocked L-threonine-induced increases in mRNA expressions of trophoectoderm and mesoderm marker genes and mESC proliferation. In conclusion, L-threonine stimulated ESC G(1)/S transition through lipid raft/caveolae-dependent PI3K/Akt, MAPKs, mTOR, p70S6K, and 4E-BP1 signaling pathways.	[Ryu, Jung Min; Han, Ho Jae] Chonnam Natl Univ, Dept Vet Physiol, Coll Vet Med, Biotherapy Human Resources Ctr BK21, Kwangju 500757, South Korea	Chonnam National University	Han, HJ (corresponding author), Chonnam Natl Univ, Dept Vet Physiol, Coll Vet Med, Biotherapy Human Resources Ctr BK21, Kwangju 500757, South Korea.	hjhan@chonnam.ac.kr	Ryu, Jung Min/G-5233-2011; Han, Ho Jae/M-1476-2016	Han, Ho Jae/0000-0002-0657-1766; Ryu, Jung Min/0000-0002-2519-090X	Korean government (MEST) [2009-0081395, 2010-0020265]; Ministry of Education, Science and Technology, Republic of Korea	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by National Research Foundation Grant funded by the Korean government (MEST No. 2009-0081395 and No. 2010-0020265), and graduate fellowship of the Brain Korea 21 project provided by the Ministry of Education, Science and Technology, Republic of Korea.	Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETT CM, 1993, PHARM RES-DORDR, V10, P423, DOI 10.1023/A:1018948608211; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Conigrave AD, 2007, BIOCHEM SOC T, V35, P1195, DOI 10.1042/BST0351195; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gardner DK, 1998, THERIOGENOLOGY, V49, P83, DOI 10.1016/S0093-691X(97)00404-4; He Y, 2007, DEV DYNAM, V236, P1865, DOI 10.1002/dvdy.21185; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kwak JO, 2005, J NEPHROL, V18, P681; Liu X, 2009, BIOCHEM BIOPH RES CO, V384, P530, DOI 10.1016/j.bbrc.2009.05.014; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; O'Kane RL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1167, DOI 10.1152/ajpendo.00193.2003; Pantaleon M, 2008, BIOL REPROD, V78, P595, DOI 10.1095/biolreprod.107.062877; Que Jianwen, 2007, J Mol Signal, V2, P9, DOI 10.1186/1750-2187-2-9; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shan JX, 2010, PHYSIOL GENOMICS, V41, P315, DOI 10.1152/physiolgenomics.00217.2009; Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058; van Sluijters DA, 2000, BIOCHEM J, V351, P545, DOI 10.1042/0264-6021:3510545; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; Washington JM, 2010, AM J PHYSIOL-CELL PH, V298, pC982, DOI 10.1152/ajpcell.00498.2009; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106	37	51	54	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23667	23678		10.1074/jbc.M110.216283	http://dx.doi.org/10.1074/jbc.M110.216283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21550972	Green Published, hybrid			2022-12-25	WOS:000292294900008
J	Allen, MJ; Gemel, J; Beyer, EC; Lal, R				Allen, Michael J.; Gemel, Joanna; Beyer, Eric C.; Lal, Ratnesh			Atomic Force Microscopy of Connexin40 Gap Junction Hemichannels Reveals Calcium-dependent Three-dimensional Molecular Topography and Open-Closed Conformations of Both the Extracellular and Cytoplasmic Faces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNELS; SURFACE; CX43	Atomic force microscopy was used to study the three-dimensional molecular topography and calcium-sensitive conformational changes of Connexin40 hemichannels (connexons) reconstituted in 1,2-dioeloyl-sn-glycero-3-phosphatidylcholine lipid bilayers. Two classes of objects were observed that differed in their protrusion heights above the bilayer (2.6 versus 4.2 nm). Comparison to reconstituted connexons containing Connexin40 truncated to eliminate most of its C-terminal cytoplasmic domain showed that the two height classes corresponded to the shorter extracellular and taller cytoplasmic aspects of the hemichannels and that the C-terminal tail of Connexin40 contributes similar to 1.6nm in thickness. Hemichannels imaged in solutions containing < 10 mu M Ca2+ showed 3.1-3.2 nm depressions (openings) in 30% of the cytoplasmic faces and 65% of the extracellular faces, and high-resolution three-dimensional topography of extracellular or cytoplasmic aspects of some connexons was observed. After addition of 3.6 mM Ca2+, > 75% of the connexons in either orientation adopted closed conformations. In contrast, hemichannels imaged in the presence of 0.1mM EDTA showed large (5.6- to 5.8-nm diameter) openings in nearly all hemichannels regardless of orientation, and detailed topography was visible in many connexons. Real-time imaging following the addition of 3.6 mM Ca2+ showed transitions of both extracellular and cytoplasmic orientations from "open" into "closed" conformations within several minutes. These studies provide the first high-resolution topographic information regarding a connexin with a large cytoplasmic domain and suggest that the extramembranous portions of Connexin40 contribute to a channel entrance that is relaxed by chelation of residual divalent cations.	[Gemel, Joanna; Beyer, Eric C.] Univ Chicago, Dept Pediat, Hematol Oncol Sect, Chicago, IL 60637 USA; [Allen, Michael J.] Univ Chicago, Dept Med, Ctr Nanomed, Sect Pulm Crit Care, Chicago, IL 60637 USA; [Lal, Ratnesh] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Lal, Ratnesh] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of Chicago; University of Chicago; University of California System; University of California San Diego; University of California System; University of California San Diego	Beyer, EC (corresponding author), Univ Chicago, Dept Pediat, Hematol Oncol Sect, KCBD 5152,900 E 57th St, Chicago, IL 60637 USA.	ecbeyer@uchicago.edu	Beyer, Eric/V-1317-2019; Lal, Ratnesh/AAG-5424-2019	Beyer, Eric/0000-0001-8044-1356; 	National Institutes of Health [HL59199, NS067247, DA024871, DA025296]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024871, R01DA025296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL59199 (to E. C. B.), NS067247 (to M. J. A.), and DA024871 and DA025296 (to R. L.).	Anumonwo JMB, 2001, CIRC RES, V88, P666, DOI 10.1161/hh0701.088833; Bao XY, 2005, J BIOL CHEM, V280, P8647, DOI 10.1074/jbc.M413536200; Berthoud VM, 2001, EUR J CELL BIOL, V80, P11, DOI 10.1078/0171-9335-00132; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Dobrowolski R, 2007, J MEMBRANE BIOL, V219, P9, DOI 10.1007/s00232-007-9055-7; Gemel J, 2004, J CELL SCI, V117, P2469, DOI 10.1242/jcs.01084; Gemel J, 2008, BIOCHEM BIOPH RES CO, V369, P388, DOI 10.1016/j.bbrc.2008.02.040; Gemel J, 2006, J CELL SCI, V119, P2258, DOI 10.1242/jcs.02953; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; LAL R, 1995, AM J PHYSIOL-CELL PH, V268, pC968, DOI 10.1152/ajpcell.1995.268.4.C968; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Liu F, 2006, J BIOL CHEM, V281, P23207, DOI 10.1074/jbc.M605048200; LOEWENST.WR, 1966, ANN NY ACAD SCI, V137, P441, DOI 10.1111/j.1749-6632.1966.tb50175.x; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MANJUNATH CK, 1985, AM J PHYSIOL, V248, pH783, DOI 10.1152/ajpheart.1985.248.6.H783; MANJUNATH CK, 1984, AM J PHYSIOL, V246, pH865, DOI 10.1152/ajpheart.1984.246.6.H865; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Pfahnl A, 1999, PFLUG ARCH EUR J PHY, V437, P345, DOI 10.1007/s004240050788; Puljung MC, 2004, J GEN PHYSIOL, V124, P587, DOI 10.1085/jgp.200409023; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Unger VM, 1999, J STRUCT BIOL, V128, P98, DOI 10.1006/jsbi.1999.4184; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; Wang M, 2007, J CELL SCI, V120, P320, DOI 10.1242/jcs.03343	31	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22139	22146		10.1074/jbc.M111.240002	http://dx.doi.org/10.1074/jbc.M111.240002			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543330	Green Published, hybrid			2022-12-25	WOS:000291719900020
J	Beuster, G; Zarse, K; Kaleta, C; Thierbach, R; Kiehntopf, M; Steinberg, P; Schuster, S; Ristow, M				Beuster, Gregor; Zarse, Kim; Kaleta, Christoph; Thierbach, Rene; Kiehntopf, Michael; Steinberg, Pablo; Schuster, Stefan; Ristow, Michael			Inhibition of Alanine Aminotransferase in Silico and in Vivo Promotes Mitochondrial Metabolism to Impair Malignant Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; GLUTAMINE-METABOLISM; OXIDATIVE-METABOLISM; GLUCOSE-METABOLISM; TUMOR-CELLS; SWEET TOOTH; DICHLOROACETATE; VITRO; 2-DEOXY-D-GLUCOSE; NEUROBLASTOMA	Cancer cells commonly exhibit increased nonoxidative D-glucose metabolism whereas induction of mitochondrial metabolism may impair malignant growth. We have first used an in silico method called elementary mode analysis to identify inhibition of ALAT (L-alanine aminotransferase) as a putative target to promote mitochondrial metabolism. We then experimentally show that two competitive inhibitors of ALAT, L-cycloserine and beta-chloro-L-alanine, inhibit L-alanine production and impair D-glucose uptake of LLC1 Lewis lung carcinoma cells. The latter inhibition is linked to an initial energy deficit, as quantified by decreased ATP content, which is then followed by an activation of AMP-activated protein kinase and subsequently increased respiration rates and mitochondrial production of reactive oxygen species, culminating in ATP replenishment in ALAT-inhibited LLC1 cells. Moreover, we observe altered phosphorylation of p38 MAPK (mitogen-activated protein kinase 14), ERK (extracellular signal-regulated kinase 1/2), and Rb1 (retinoblastoma 1) proteins, as well as decreased expression of Cdc25a (cell decision cycle 25 homolog A) and Cdk4 (cyclin-dependent kinase 4). Importantly, these sequelae of ALAT inhibition culminate in similarly reduced anchorage-dependent and anchorage-independent growth rates of LLC1 cells, together suggesting that inhibition of ALAT efficiently impairs cancer growth by counteracting the Warburg effect due to compensatory activation of mitochondrial metabolism.	[Beuster, Gregor; Zarse, Kim; Ristow, Michael] Univ Jena, Inst Nutr, Dept Human Nutr, D-07743 Jena, Germany; [Ristow, Michael] German Inst Human Nutr Potsdam Rehbrucke, Dept Clin Nutr, D-14558 Nuthetal, Germany; [Kaleta, Christoph; Schuster, Stefan] Univ Jena, Sch Biol & Pharmaceut, Dept Bioinformat, D-07743 Jena, Germany; [Thierbach, Rene; Steinberg, Pablo] Univ Vet Med Hannover, Dept Food Toxicol & Complementary Methods Anim Te, D-30173 Hannover, Germany; [Kiehntopf, Michael] Univ Jena, Inst Clin Chem & Lab Med, D-07743 Jena, Germany	Friedrich Schiller University of Jena; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Friedrich Schiller University of Jena; University of Veterinary Medicine Hannover, Foundation; Friedrich Schiller University of Jena	Ristow, M (corresponding author), Univ Jena, Inst Nutr, Dept Human Nutr, D-07743 Jena, Germany.	mristow@mristow.org	Ristow, Michael/O-9858-2014; Zarse, Kim/D-2133-2016	Ristow, Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123; Kaleta, Christoph/0000-0001-8004-9514	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) [0315581]	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This work is part of the research program of the Jena Centre for Systems Biology of Ageing, JenAge, funded by the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) Grant 0315581.	Ashrafian H, 2006, LANCET, V367, P618, DOI 10.1016/S0140-6736(06)68228-7; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; CAY O, 1992, CANCER RES, V52, P5794; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Cinatl J, 1999, ANTICANCER RES, V19, P5349; CORNEL EB, 1993, J UROLOGY, V150, P2019, DOI 10.1016/S0022-5347(17)35957-8; CORNELL NW, 1984, BIOCHEM J, V220, P707, DOI 10.1042/bj2200707; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DROGE W, 1986, J IMMUNOL, V137, P1383; Fruman David A, 2008, Biochem J, V412, pe3, DOI 10.1042/BJ20080823; GOLICHOWSKI A, 1978, ARCH BIOCHEM BIOPHYS, V189, P109, DOI 10.1016/0003-9861(78)90122-4; GOODGAME JT, 1978, CANCER, V42, P800, DOI 10.1002/1097-0142(197808)42:2<800::AID-CNCR2820420253>3.0.CO;2-O; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLM E, 1995, CANCER RES, V55, P1373; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; LASKE R, 1989, ARCH PHARM, V322, P857, DOI 10.1002/ardp.19893221205; MANNING JM, 1974, P NATL ACAD SCI USA, V71, P417, DOI 10.1073/pnas.71.2.417; MARQUEZ J, 1989, ARCH BIOCHEM BIOPHYS, V268, P667, DOI 10.1016/0003-9861(89)90335-4; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Neermann J, 1996, J CELL PHYSIOL, V166, P152; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; RIBONI L, 1995, J BIOL CHEM, V270, P26868, DOI 10.1074/jbc.270.45.26868; Ristow M, 2006, CURR OPIN CLIN NUTR, V9, P339, DOI 10.1097/01.mco.0000232892.43921.98; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schwarz R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-135; Semenza G L, 2001, Novartis Found Symp, V240, P251; STACPOOLE PW, 1992, DIABETES CARE, V15, P785, DOI 10.2337/diacare.15.6.785; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sweetman L, 1991, TECHNIQUES DIAGNOSTI, P143; Thierbach R, 2009, ANAL BIOCHEM, V387, P318, DOI 10.1016/j.ab.2009.01.029; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Zhu ZJ, 2005, CANCER RES, V65, P7023, DOI 10.1158/0008-5472.CAN-05-0453; Ziegler A, 2001, CANCER RES, V61, P5595; Zimmermann S, 2008, HORM METAB RES, V40, P29, DOI 10.1055/s-2007-1004542	45	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22323	22330		10.1074/jbc.M110.205229	http://dx.doi.org/10.1074/jbc.M110.205229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540181	hybrid, Green Published			2022-12-25	WOS:000291719900041
J	Stepanek, O; Kalina, T; Draber, P; Skopcova, T; Svojgr, K; Angelisova, P; Horejsi, V; Weiss, A; Brdicka, T				Stepanek, Ondrej; Kalina, Tomas; Draber, Peter; Skopcova, Tereza; Svojgr, Karel; Angelisova, Pavla; Horejsi, Vaclav; Weiss, Arthur; Brdicka, Tomas			Regulation of Src Family Kinases Involved in T Cell Receptor Signaling by Protein-tyrosine Phosphatase CD148	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; ANTIGEN RECEPTOR; MOLECULAR-CLONING; IMMUNE CELLS; IN-VITRO; CD45; ACTIVATION; EXPRESSION; DEP-1; PHOSPHORYLATION	CD148 is a receptor-like protein-tyrosine phosphatase known to inhibit transduction of mitogenic signals in non-hematopoietic cells. Similarly, in the hematopoietic lineage, CD148 inhibited signal transduction downstream of T cell receptor. However, it also augmented immunoreceptor signaling in B cells and macrophages via dephosphorylating C-terminal tyrosine of Src family kinases (SFK). Accordingly, endogenous CD148 compensated for the loss of the main SFK activator CD45 in murine B cells and macrophages but not in T cells. Hypothetical explanations for the difference between T cells and other leukocyte lineages include the inability of CD148 to dephosphorylate a specific set of SFKs involved in T cell activation or the lack of CD148 expression during critical stages of T cell development. Here we describe striking differences in CD148 expression between human and murine thymocyte subsets, the only unifying feature being the absence of CD148 during the positive selection when the major developmental block occurs under CD45 deficiency. Moreover, we demonstrate that similar to CD45, CD148 has both activating and inhibitory effects on the SFKs involved in TCR signaling. However, in the absence of CD45, activating effects prevail, resulting in functional complementation of CD45 deficiency in human T cell lines. Importantly, this is independent of the tyrosines in the CD148 C-terminal tail, contradicting the recently proposed phosphotyrosine displacement model as a mechanism of SFK activation by CD148. Collectively, our data suggest that differential effects of CD148 in T cells and other leukocyte subsets cannot be explained by the CD148 inability to activate T cell SFKs but rather by its dual inhibitory/activatory function and specific expression pattern.	[Stepanek, Ondrej; Draber, Peter; Skopcova, Tereza; Angelisova, Pavla; Horejsi, Vaclav; Brdicka, Tomas] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic; [Kalina, Tomas; Svojgr, Karel] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague 15006, Czech Republic; [Kalina, Tomas; Svojgr, Karel] Charles Univ Prague, Fac Med 2, Childhood Leukemia Invest Prague, Prague 15006, Czech Republic; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Weiss, Arthur] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brdicka, T (corresponding author), Inst Mol Genet ASCR, Videnska 1083, Prague 14220, Czech Republic.	tomas.brdicka@img.cas.cz	Brdicka, Tomas/G-6205-2014; Horejsi, Vaclav/G-3113-2014; Stepanek, Ondrej/F-8882-2013; Stepanek, Ondrej/AAG-3180-2020; Angelisova, Pavla/G-3131-2014; Kalina, Tomas/AAE-5036-2019; Draber, Peter/G-3141-2014; Kalina, Tomas/AAC-6655-2019; Kalina, Tomas/C-1078-2009	Brdicka, Tomas/0000-0002-1560-4398; Horejsi, Vaclav/0000-0003-4925-0142; Stepanek, Ondrej/0000-0002-2735-3311; Stepanek, Ondrej/0000-0002-2735-3311; Kalina, Tomas/0000-0003-4475-2872; Draber, Peter/0000-0001-8658-4614; Kalina, Tomas/0000-0003-4475-2872	National Institutes of Health [AI066120]; National Program of Research II Project [2B06064]; Ministry of Education, Youth, and Sports of the Czech Republic [1M0506]; Faculty of Science, Charles University, Prague; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Program of Research II Project; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Science, Charles University, Prague; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI066120. This work was also supported by National Program of Research II Project 2B06064 and Center of Molecular and Cellular Immunology Project 1M0506 from Ministry of Education, Youth, and Sports of the Czech Republic.; Ph.D. students supported in part by the Faculty of Science, Charles University, Prague.	Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Cale CM, 1997, ARCH DIS CHILD, V76, P163, DOI 10.1136/adc.76.2.163; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chu DH, 1996, EMBO J, V15, P6251, DOI 10.1002/j.1460-2075.1996.tb01015.x; de la Fuente-Garcia MA, 1998, BLOOD, V91, P2800, DOI 10.1182/blood.V91.8.2800.2800_2800_2809; Ellison S, 2010, J THROMB HAEMOST, V8, P1575, DOI 10.1111/j.1538-7836.2010.03865.x; Gaya A, 1999, LEUKEMIA LYMPHOMA, V35, P237, DOI 10.3109/10428199909145726; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; HONDA H, 1994, BLOOD, V84, P4186, DOI 10.1182/blood.V84.12.4186.bloodjournal84124186; Keane MM, 1996, CANCER RES, V56, P4236; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Kung C, 2000, NAT MED, V6, P343; Kuramochi S, 1996, FEBS LETT, V378, P7, DOI 10.1016/0014-5793(95)01415-2; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Lin J, 2003, J CELL BIOL, V162, P673, DOI 10.1083/jcb.200303040; Marks DI, 2009, BLOOD, V114, P5136, DOI 10.1182/blood-2009-08-231217; Massa A, 2004, J BIOL CHEM, V279, P29004, DOI 10.1074/jbc.M403573200; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Palou E, 1997, IMMUNOL LETT, V57, P101, DOI 10.1016/S0165-2478(97)00069-2; PATEL DD, 1995, LEUKOCYTE TYPING, V5, P1725; PEYRON JF, 1991, INT IMMUNOL, V3, P1357, DOI 10.1093/intimm/3.12.1357; Res P, 1997, J EXP MED, V185, P141, DOI 10.1084/jem.185.1.141; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Schabath R, 2003, BEST PRACT RES CL HA, V16, P613, DOI 10.1016/S1521-6926(03)00087-2; SCHRAVEN B, 1997, LEUCOCYTE TYPING, V6, P576; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; SHIROO M, 1992, EMBO J, V11, P4887, DOI 10.1002/j.1460-2075.1992.tb05595.x; STAUDER R, 1995, LEUKOCYTE TYPING, V5, P1719; Tangye SG, 1998, J IMMUNOL, V161, P3249; Tangye SG, 1998, J IMMUNOL, V161, P3803; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Wuchter C, 2002, BLOOD, V99, P4109, DOI 10.1182/blood.V99.11.4109; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zikherman J, 2010, IMMUNITY, V32, P342, DOI 10.1016/j.immuni.2010.03.006	51	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22101	22112		10.1074/jbc.M110.196733	http://dx.doi.org/10.1074/jbc.M110.196733			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543337	Green Published, hybrid			2022-12-25	WOS:000291719900016
J	Cristino, AS; Tanaka, ED; Rubio, M; Piulachs, MD; Belles, X				Cristino, Alexandre S.; Tanaka, Erica D.; Rubio, Mercedes; Piulachs, Maria-Dolors; Belles, Xavier			Deep Sequencing of Organ- and Stage-Specific microRNAs in the Evolutionarily Basal Insect Blattella germanica (L.) (Dictyoptera, Blattellidae)	PLOS ONE			English	Article							TRIBOLIUM-CASTANEUM; REGULATORY RNA; DROSOPHILA; METAMORPHOSIS; EXPRESSION; LET-7; DIFFERENTIATION; TRANSCRIPTS; PREDICTION; NETWORKS	Background: microRNAs (miRNAs) have been reported as key regulators at post-transcriptional level in eukaryotic cells. In insects, most of the studies have focused in holometabolans while only recently two hemimetabolans (Locusta migratoria and Acyrthosiphon pisum) have had their miRNAs identified. Therefore, the study of the miRNAs of the evolutionarily basal hemimetabolan Blattella germanica may provide valuable insights on the structural and functional evolution of miRNAs. Methodology/Principal Findings: Small RNA libraries of the cockroach B. germanica were built from the whole body of the last instar nymph, and the adult ovaries. The high throughput Solexa sequencing resulted in approximately 11 and 8 million reads for the whole-body and ovaries, respectively. Bioinformatic analyses identified 38 known miRNAs as well as 11 known miRNA*s. We also found 70 miRNA candidates conserved in other insects and 170 candidates specific to B. germanica. The positive correlation between Solexa data and real-time quantitative PCR showed that number of reads can be used as a quantitative approach. Five novel miRNA precursors were identified and validated by PCR and sequencing. Known miRNAs and novel candidates were also validated by decreasing levels of their expression in dicer-1 RNAi knockdown individuals. The comparison of the two libraries indicates that whole-body nymph contain more known miRNAs than ovaries, whereas the adult ovaries are enriched with novel miRNA candidates. Conclusions/Significance: Our study has identified many known miRNAs and novel miRNA candidates in the basal hemimetabolan insect B. germanica, and most of the specific sequences were found in ovaries. Deep sequencing data reflect miRNA abundance and dicer-1 RNAi assay is shown to be a reliable method for validation of novel miRNAs.	[Cristino, Alexandre S.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Tanaka, Erica D.; Rubio, Mercedes; Piulachs, Maria-Dolors; Belles, Xavier] Inst Evolutionary Biol CSIC UPF, Barcelona, Spain	University of Queensland; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE)	Cristino, AS (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	mdolors.piulachs@ibe.upf-csic.es; xavier.belles@ibe.upf-csic.es	Cristino, Alexandre S/A-5834-2012; Piulachs, Maria-Dolors/C-3992-2011; Martinez, Mercedes Rubio/N-3636-2014; Rubio, Mercedes/K-9249-2015; Belles, Xavier/G-2354-2015	Cristino, Alexandre S/0000-0002-3468-0919; Piulachs, Maria-Dolors/0000-0002-4500-2718; Martinez, Mercedes Rubio/0000-0002-4331-3280; Belles, Xavier/0000-0002-1566-303X	Ministry of Science and Innovation, Spain [CGL2008-03517/BOS, BFU2008-00484]; Generalitat de Catalunya [2005 SGR 00053]; CSIC; Institute of Evolutionary Biology in Barcelona	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CSIC; Institute of Evolutionary Biology in Barcelona	Financial support from the Ministry of Science and Innovation, Spain (projects CGL2008-03517/BOS, granted to XB, and BFU2008-00484 granted to MDP) and the Generalitat de Catalunya (2005 SGR 00053) is gratefully acknowledged. EDT is a recipient of a postdoctoral CSIC contract (JAE program). MR is recipient of a predoctoral CSIC grant (JAE program). The 1-month stage of ASC in the Institute of Evolutionary Biology in Barcelona was granted with MDP and XB projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bashirullah A, 2003, DEV BIOL, V259, P1, DOI 10.1016/S0012-1606(03)00063-0; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Cai YM, 2010, FUNCT INTEGR GENOMIC, V10, P405, DOI 10.1007/s10142-010-0162-7; Caygill EE, 2008, CURR BIOL, V18, P943, DOI 10.1016/j.cub.2008.06.020; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen HM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp225; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Gomez-Orte E, 2009, P NATL ACAD SCI USA, V106, P21678, DOI 10.1073/pnas.0907391106; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hartig JV, 2007, GENE DEV, V21, P1707, DOI 10.1101/gad.1567007; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jung CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-77; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Legeai F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-281; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu SP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-88; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Luo QB, 2008, J GENET GENOMICS, V35, P349, DOI 10.1016/S1673-8527(08)60051-X; Mane-Padros D, 2008, DEV BIOL, V315, P147, DOI 10.1016/j.ydbio.2007.12.015; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nguyen HT, 2006, CURR OPIN GENET DEV, V16, P533, DOI 10.1016/j.gde.2006.08.010; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; PASCUAL N, 1992, J INSECT PHYSIOL, V38, P339, DOI 10.1016/0022-1910(92)90058-L; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Singh J, 2008, INSECT MOL BIOL, V17, P427, DOI 10.1111/j.1365-2583.2008.00816.x; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tennessen JM, 2008, CURR BIOL, V18, pR707, DOI 10.1016/j.cub.2008.07.013; Treiblmayr K, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.4301; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Wittkop T, 2010, NAT METHODS, V7, P419, DOI 10.1038/nmeth0610-419; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	79	84	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19350	10.1371/journal.pone.0019350	http://dx.doi.org/10.1371/journal.pone.0019350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552535	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700051
J	Luo, SX; Li, YQ; Chen, S; Zhang, DX; Renner, SS				Luo, Shixiao; Li, Yongquan; Chen, Shi; Zhang, Dianxiang; Renner, Susanne S.			Gelechiidae Moths Are Capable of Chemically Dissolving the Pollen of Their Host Plants: First Documented Sporopollenin Breakdown by an Animal	PLOS ONE			English	Article							OBLIGATE POLLINATION MUTUALISMS; DNA-SEQUENCE DATA; PLASTID MATK; MOLECULAR PHYLOGENETICS; EPICEPHALA ASSOCIATION; HELICONIUS BUTTERFLIES; NUCLEAR PHYC; PHYLLANTHACEAE; LEPIDOPTERA; EUPHORBIACEAE	Background: Many insects feed on pollen surface lipids and contents accessible through the germination pores. Pollen walls, however, are not broken down because they consist of sporopollenin and are highly resistant to physical and enzymatic damage. Here we report that certain Microlepidoptera chemically dissolve pollen grains with exudates from their mouthparts. Methodology/Principal Findings: Field observations and experiments in tropical China revealed that two species of Deltophora (Gelechioidea) are the exclusive pollinators of two species of Phyllanthus (Phyllanthaceae) on which their larvae develop and from which the adults take pollen and nectar. DNA sequences placed the moths and plants phylogenetically and confirmed that larvae were those of the pollinating moths; molecular clock dating suggests that the moth clade is younger than the plant clade. Captive moths with pollen on their mouthparts after 2-3 days of starvation no longer carried intact grains, and SEM photographs showed exine fragments on their proboscises. GC-MS revealed cis-beta-ocimene as the dominant volatile in leaves and flowers, but GC-MS analyses of proboscis extracts failed to reveal an obvious sporopollenin-dissolving compound. A candidate is ethanolamine, which occurs in insect hemolymphs and is used to dissolve sporopollenin by palynologists. Conclusions/Significance: This is the first report of any insect and indeed any animal chemically dissolving pollen.	[Luo, Shixiao; Li, Yongquan; Chen, Shi; Zhang, Dianxiang] Chinese Acad Sci, Key Lab Plant Resource Conservat & Sustainable Ut, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Renner, Susanne S.] Univ Munich LMU, Dept Biol, Munich, Germany	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Munich	Luo, SX (corresponding author), Chinese Acad Sci, Key Lab Plant Resource Conservat & Sustainable Ut, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	dx-zhang@scbg.ac.cn; renner@lrz.uni-muenchen.de		Zhang, Dianxiang/0000-0001-6549-8872	Chinese Academy of Sciences [SCBG-200734]; National Science Foundation of China [30700044, 30870367]; Natural Science Foundation of Guangdong Province [7301182]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by the Chinese Academy of Sciences (Grant SCBG-200734), the National Science Foundation of China (Grant 30700044, 30870367), and the Natural Science Foundation of Guangdong Province (Grant 7301182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTYGALLE AB, 1994, P NATL ACAD SCI USA, V91, P12790, DOI 10.1073/pnas.91.26.12790; Bailey I. W., 1960, Journal of the Arnold Arboretum, V41, P141; Bucheli SR, 2005, MOL PHYLOGENET EVOL, V35, P380, DOI 10.1016/j.ympev.2005.02.003; Dobritsa AA, 2009, PLANT PHYSIOL, V151, P574, DOI 10.1104/pp.109.144469; Doyle J.A., 1976, ORIGIN EARLY EVOLUTI, P139; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eberhard SH, 2007, J INSECT PHYSIOL, V53, P126, DOI 10.1016/j.jinsphys.2006.11.001; Eberhard SH, 2009, ANN ENTOMOL SOC AM, V102, P1105, DOI 10.1603/008.102.0619; Fleming TH, 1998, OECOLOGIA, V114, P368, DOI 10.1007/s004420050459; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; GILBERT LE, 1972, P NATL ACAD SCI USA, V69, P1403, DOI 10.1073/pnas.69.6.1403; GRUASCAVAGNETTO C, 1992, GRANA, V31, P291, DOI 10.1080/00173139209429452; Kaila L, 2004, CLADISTICS, V20, P303, DOI 10.1111/j.1096-0031.2004.00027.x; Kathriarachchi H, 2006, AM J BOT, V93, P637, DOI 10.3732/ajb.93.4.637; Kathriarachchi H, 2005, MOL PHYLOGENET EVOL, V36, P112, DOI 10.1016/j.ympev.2004.12.002; Kato M, 2003, P NATL ACAD SCI USA, V100, P5264, DOI 10.1073/pnas.0837153100; Kawakita A, 2009, P R SOC B, V276, P417, DOI 10.1098/rspb.2008.1226; Kawakita A, 2006, MOL ECOL, V15, P3567, DOI 10.1111/j.1365-294X.2006.03037.x; Krassillov VA, 2007, AFR INVERTEBR, V48, P3; Krenn HW, 2010, ANNU REV ENTOMOL, V55, P307, DOI 10.1146/annurev-ento-112408-085338; Krenn HW, 2009, ARTHROPOD-PLANT INTE, V3, P203, DOI 10.1007/s11829-009-9074-7; Li P-T, 2009, FLORA CHINA, V11, P180; Li YQ, 2009, SYST BOT, V34, P521, DOI 10.1600/036364409789271263; Luo SX, 2007, AM J BOT, V94, P260, DOI 10.3732/ajb.94.2.260; NAMBUDIRI EMV, 1989, REV PALAEOBOT PALYNO, V59, P57, DOI 10.1016/0034-6667(89)90006-7; O'Brien DM, 2003, P ROY SOC B-BIOL SCI, V270, P2631, DOI 10.1098/rspb.2003.2552; PELLMYR O, 1990, PLANT SYST EVOL, V173, P143, DOI 10.1007/BF00940859; PELLMYR O, 1992, P NATL ACAD SCI USA, V89, P2927, DOI 10.1073/pnas.89.7.2927; Pruesapan K, 2008, ANN BOT-LONDON, V102, P1007, DOI 10.1093/aob/mcn193; Rambaut A., 2003, TRACER MCMC TRACE AN; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Samuel R, 2005, AM J BOT, V92, P132, DOI 10.3732/ajb.92.1.132; Sattler K., 1979, Bulletin of the British Museum (Natural History) Entomology, V38, P263; Schmitz P, 2007, MOL PHYLOGENET EVOL, V45, P180, DOI 10.1016/j.ympev.2007.05.010; SOUTHWORTH D, 1974, AM J BOT, V61, P36, DOI 10.2307/2441242; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Svensson GP, 2010, NEW PHYTOL, V186, P995, DOI 10.1111/j.1469-8137.2010.03227.x; TIMMERMANS M, 1992, BIOCHEM SYST ECOL, V20, P343, DOI 10.1016/0305-1978(92)90047-H; Zeller-Lukashort H. Christof, 2007, Nota Lepidopterologica, V30, P235	39	19	21	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19219	10.1371/journal.pone.0019219	http://dx.doi.org/10.1371/journal.pone.0019219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552530	gold, Green Submitted, Green Published			2022-12-25	WOS:000290020700040
J	Alonso-Alvarez, C; Galvan, I				Alonso-Alvarez, Carlos; Galvan, Ismael			Free Radical Exposure Creates Paler Carotenoid-Based Ornaments: A Possible Interaction in the Expression of Black and Red Traits	PLOS ONE			English	Article							OXIDATIVE STRESS; PLUMAGE COLORATION; PARUS-MAJOR; TRADE-OFFS; TESTOSTERONE; COMPLEXITY; SIGNALS; ANTIOXIDANTS; HYPOTHESIS; EVOLUTION	Oxidative stress could be a key selective force shaping the expression of colored traits produced by the primary animal pigments in integuments: carotenoids and melanins. However, the impact of oxidative stress on melanic ornaments has only recently been explored, whereas its role in the expression of carotenoid-based traits is not fully understood. An interesting study case is that of those animal species simultaneously expressing both kinds of ornaments, such as the red-legged partridge (Alectoris rufa). In this bird, individuals exposed to an exogenous source of free radicals (diquat) during their development produced larger eumelanin-based (black) plumage traits than controls. Here, we show that the same red-legged partridges exposed to diquat simultaneously developed paler carotenoid-based ornaments (red beak and eye rings), and carried lower circulating carotenoid levels as well as lower levels of some lipids involved in carotenoid transport in the bloodstream (i.e., cholesterol). Moreover, partridges treated with a hormone that stimulates eumelanin production (i.e., alpha-melanocyte-stimulating hormone) also increased blood carotenoid levels, but this effect was not mirrored in the expression of carotenoid-based traits. The redness of carotenoid-based ornaments and the size of a conspicuous eumelanic trait (the black bib) were negatively correlated in control birds, suggesting a physiological trade-off during development. These findings contradict recent studies questioning the sensitivity of carotenoids to oxidative stress. Nonetheless, the impact of free radicals on plasma carotenoids seems to be partially mediated by changes in cholesterol metabolism, and not by direct carotenoid destruction/consumption. The results highlight the capacity of oxidative stress to create multiple phenotypes during development through differential effects on carotenoids and melanins, raising questions about evolutionary constraints involved in the production of multiple ornaments by the same organism.	[Alonso-Alvarez, Carlos] UCLM, Ecol Unit, Inst Invest Recursos Cineget, IREC,CSIC,JCCM, Ciudad Real, Spain; [Galvan, Ismael] Museo Nacl Ciencias Nat CSIC, Dept Evolutionary Ecol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Alonso-Alvarez, C (corresponding author), UCLM, Ecol Unit, Inst Invest Recursos Cineget, IREC,CSIC,JCCM, Ciudad Real, Spain.	carlos.alonso@uclm.es	Alonso-Alvarez, Carlos/M-6804-2014; Galvan, Ismael/H-8602-2015	Alonso-Alvarez, Carlos/0000-0002-4765-551X; Galvan, Ismael/0000-0002-6523-8592	Spanish Ministry of Science and Innovation [CGL2009-10883-C02-02]; Junta de Castilla-La Mancha [PII1I09-0271-5037]; CSIC JAE	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla-La Mancha; CSIC JAE	Financial support was obtained from the Spanish Ministry of Science and Innovation (project reference: CGL2009-10883-C02-02), and from the Junta de Castilla-La Mancha (project reference: PII1I09-0271-5037). I. G. benefited from a postdoctoral contract of the CSIC JAE-Doc program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2003, ARCH TOXICOL, V77, P353, DOI 10.1007/s00204-003-0449-8; Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; Alonso-Alvarez C, 2009, P ROY SOC B-BIOL SCI, V276, P2093, DOI 10.1098/rspb.2008.1891; Andersson S, 2002, AM NAT, V160, P683, DOI 10.1086/342817; Badyaev AV, 2004, J EVOLUTION BIOL, V17, P1317, DOI 10.1111/j.1420-9101.2004.00781.x; Badyaev AV, 2002, EVOLUTION, V56, P412; Bortolotti GR, 2006, ANIM BEHAV, V72, P423, DOI 10.1016/j.anbehav.2006.01.016; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Cohen AA, 2009, FUNCT ECOL, V23, P310, DOI 10.1111/j.1365-2435.2009.01540.x; Costantini D, 2008, FUNCT ECOL, V22, P367, DOI 10.1111/j.1365-2435.2007.01366.x; Dauwe T, 2008, NATURWISSENSCHAFTEN, V95, P969, DOI 10.1007/s00114-008-0400-1; De Block M, 2008, P ROY SOC B-BIOL SCI, V275, P781, DOI 10.1098/rspb.2007.1515; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foley J.D., 1984, FUNDAMENTALS INTERAC; Galvan I, 2009, PIGM CELL MELANOMA R, V22, P339, DOI 10.1111/j.1755-148X.2009.00559.x; Galvan I, 2009, P ROY SOC B-BIOL SCI, V276, P3089, DOI 10.1098/rspb.2009.0774; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Galvan I, 2008, BEHAV ECOL SOCIOBIOL, V63, P303, DOI 10.1007/s00265-008-0662-9; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hartley RC, 2004, TRENDS ECOL EVOL, V19, P353, DOI 10.1016/j.tree.2004.04.002; Hasson O, 1997, J THEOR BIOL, V185, P139, DOI 10.1006/jtbi.1996.0258; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hill GE, 2009, J EXP BIOL, V212, P1225, DOI 10.1242/jeb.026963; HOHN EO, 1980, AUK, V97, P601; Horak P, 2010, J EXP BIOL, V213, P2225, DOI 10.1242/jeb.042085; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; Isaksson C, 2008, P ROY SOC B-BIOL SCI, V275, P309, DOI 10.1098/rspb.2007.1474; Ishii K, 2002, FREE RADICAL RES, V36, P163, DOI 10.1080/10715760290006493; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; McGraw Kevin J., 2006, P243; McGraw Kevin J., 2006, P177; McGraw KJ, 2006, BEHAV ECOL SOCIOBIOL, V60, P117, DOI 10.1007/s00265-005-0135-3; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Mundy Nicholas I., 2006, P469; Perez-Rodriguez L, 2008, NATURWISSENSCHAFTEN, V95, P821, DOI 10.1007/s00114-008-0389-5; Perez-Rodriguez L, 2008, J EXP BIOL, V211, P2155, DOI 10.1242/jeb.017178; Perez-Rodriguez L, 2008, BEHAV ECOL SOCIOBIOL, V62, P995, DOI 10.1007/s00265-007-0527-7; Perez-Rodriguez L, 2010, J EXP BIOL, V213, P1685, DOI 10.1242/jeb.039982; Perez-Rodriguez L, 2009, BIOESSAYS, V31, P1116, DOI 10.1002/bies.200900070; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; SASInstitute, 2001, SAS STAT SOFTW CHANG, P2001; Senar JC, 2003, NATURWISSENSCHAFTEN, V90, P234, DOI 10.1007/s00114-003-0414-7; Sewalk CJ, 2000, J TOXICOL ENV HEAL A, V62, P33, DOI 10.1080/00984100050201659; Stevens L., 1996, AVIAN BIOCH MOL BIOL; Tobler M, 2009, J EXP BIOL, V212, P89, DOI 10.1242/jeb.020826; Torres R, 2003, BEHAV ECOL SOCIOBIOL, V55, P65, DOI 10.1007/s00265-003-0669-1; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; West-Eberhard Mary Jane, 2003, pi; Xu JM, 2007, J PINEAL RES, V42, P166, DOI 10.1111/j.1600-079X.2006.00401.x; Yeum KJ, 2002, ANNU REV NUTR, V22, P483, DOI 10.1146/annurev.nutr.22.010402.102834; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	60	54	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19403	10.1371/journal.pone.0019403	http://dx.doi.org/10.1371/journal.pone.0019403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556328	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400056
J	Osterberg, N; Wiehle, M; Oehlke, O; Heidrich, S; Xu, C; Fan, CM; Krieglstein, K; Roussa, E				Osterberg, Nadja; Wiehle, Michael; Oehlke, Oliver; Heidrich, Stefanie; Xu, Cheng; Fan, Chen-Ming; Krieglstein, Kerstin; Roussa, Eleni			Sim1 Is a Novel Regulator in the Differentiation of Mouse Dorsal Raphe Serotonergic Neurons	PLOS ONE			English	Article							SINGLE-MINDED GENE; GROWTH-FACTOR-BETA; DOPAMINERGIC-NEURONS; EXPRESSION PATTERNS; MOLECULAR-GENETICS; CELL FATE; IN-VITRO; DROSOPHILA; PROTEIN; MIDLINE	Background: Mesencephalic dopaminergic neurons (mDA) and serotonergic (5-HT) neurons are clinically important ventral neuronal populations. Degeneration of mDA is associated with Parkinson's disease; defects in the serotonergic system are related to depression, obsessive-compulsive disorder, and schizophrenia. Although these neuronal subpopulations reveal positional and developmental relationships, the developmental cascades that govern specification and differentiation of mDA or 5-HT neurons reveal missing determinants and are not yet understood. Methodology: We investigated the impact of the transcription factor Sim1 in the differentiation of mDA and rostral 5-HT neurons in vivo using Sim1(-/-) mouse embryos and newborn pups, and in vitro by gain- and loss-of-function approaches. Principal Findings: We show a selective significant reduction in the number of dorsal raphe nucleus (DRN) 5-HT neurons in Sim1(-/-) newborn mice. In contrast, 5-HT neurons of other raphe nuclei as well as dopaminergic neurons were not affected. Analysis of the underlying molecular mechanism revealed that tryptophan hydroxylase 2 (Tph2) and the transcription factor Pet1 are regulated by Sim1. Moreover, the transcription factor Lhx8 and the modulator of 5-HT1A-mediated neurotransmitter release, Rgs4, exhibit significant higher expression in ventral hindbrain, compared to midbrain and are target genes of Sim1. Conclusions: The results demonstrate for the first time a selective transcription factor dependence of the 5-HT cell groups, and introduce Sim1 as a regulator of DRN specification acting upstream of Pet1 and Tph2. Moreover, Sim1 may act to modulate serotonin release via regulating RGS4. Our study underscores that subpopulations of a common neurotransmitter phenotype use distinct combinations of transcription factors to control the expression of shared properties.	[Osterberg, Nadja; Wiehle, Michael; Heidrich, Stefanie; Roussa, Eleni] Univ Gottingen, Dept Neuroanat, Gottingen, Germany; [Osterberg, Nadja; Krieglstein, Kerstin; Roussa, Eleni] DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany; [Oehlke, Oliver; Krieglstein, Kerstin; Roussa, Eleni] Univ Freiburg, Dept Mol Embryol, Freiburg, Germany; [Xu, Cheng; Fan, Chen-Ming] Carnegie Inst, Dept Embryol, Baltimore, MD USA	University of Gottingen; German Research Foundation (DFG); University of Freiburg; Carnegie Institution for Science	Osterberg, N (corresponding author), Univ Gottingen, Dept Neuroanat, Gottingen, Germany.	eleni.roussa@anat.uni-freiburg.de			Deutsche Forschungsgemeinschaft [Kr1477/10-1, 10-2]; DFG-Research Center for Molecular Physiology of the Brain (CMPB); NIH [RO1 HD35596]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035596] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-Research Center for Molecular Physiology of the Brain (CMPB)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was funded by Deutsche Forschungsgemeinschaft (Kr1477/10-1, +10-2 to K. K.), and through the DFG-Research Center for Molecular Physiology of the Brain (CMPB, to E. R.). C.-M. Fan and C. Xu are supported by an NIH grant RO1 HD35596. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer CE, 2004, BRAIN RES, V1022, P214, DOI 10.1016/j.brainres.2004.06.073; BOSSING T, 1994, DEVELOPMENT, V120, P1895; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caqueret A, 2006, DEV BIOL, V298, P95, DOI 10.1016/j.ydbio.2006.06.019; Cheng LP, 2003, J NEUROSCI, V23, P9961; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Craven SE, 2004, DEVELOPMENT, V131, P1165, DOI 10.1242/dev.01024; CREWS S, 1992, J EXP ZOOL, V261, P234, DOI 10.1002/jez.1402610303; DeCarvalho AC, 2004, DEV DYNAM, V229, P869, DOI 10.1002/dvdy.10475; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Ema M, 1996, MOL CELL BIOL, V16, P5865; ERNSBERGER U, 1995, MECH DEVELOP, V52, P125, DOI 10.1016/0925-4773(95)00396-I; Fan CM, 1996, MOL CELL NEUROSCI, V7, P1, DOI 10.1006/mcne.1996.0001; Galter D, 1999, J NEUROSCI RES, V56, P531, DOI 10.1002/(SICI)1097-4547(19990601)56:5<531::AID-JNR8>3.0.CO;2-O; Ghavami A, 2004, CELL SIGNAL, V16, P711, DOI 10.1016/j.cellsig.2003.11.006; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Goshu E, 2002, MOL CELL BIOL, V22, P4147, DOI 10.1128/MCB.22.12.4147-4157.2002; Heller A, 1996, BRAIN RES, V725, P132, DOI 10.1016/S0006-8993(96)00345-9; Hendricks T, 1999, J NEUROSCI, V19, P10348; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; Liu CQ, 2003, J BIOL CHEM, V278, P44857, DOI 10.1074/jbc.M304489200; Lohr H, 2009, DEVELOPMENT, V136, P1007, DOI 10.1242/dev.033878; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; PETROV T, 1994, CELL TISSUE RES, V277, P289; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Rickmann M, 2007, NEUROSCIENCE, V146, P1220, DOI 10.1016/j.neuroscience.2007.02.061; Roussa E, 2008, STEM CELLS, V26, P1683, DOI 10.1634/stemcells.2007-0805; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Scicchitano MS, 2009, J HISTOCHEM CYTOCHEM, V57, P849, DOI 10.1369/jhc.2009.953497; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; TRULSON ME, 1987, BRAIN RES BULL, V18, P179, DOI 10.1016/0361-9230(87)90189-4; Xiao H, 1996, MECH DEVELOP, V58, P65, DOI 10.1016/S0925-4773(96)00559-X; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	44	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19239	10.1371/journal.pone.0019239	http://dx.doi.org/10.1371/journal.pone.0019239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541283	gold, Green Published, Green Submitted			2022-12-25	WOS:000290018400036
J	Kroeger, JH; Zerzour, R; Geitmann, A				Kroeger, Jens H.; Zerzour, Rabah; Geitmann, Anja			Regulator or Driving Force? The Role of Turgor Pressure in Oscillatory Plant Cell Growth	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; CYTOSOLIC-FREE CALCIUM; NICOTIANA-TABACUM; TIP GROWTH; WALL; MODEL; ROBUSTNESS; EXOCYTOSIS; PECTIN; ORIENTATION	Turgor generates the stress that leads to the expansion of plant cell walls during cellular growth. This has been formalized by the Lockhart equation, which can be derived from the physical laws of the deformation of viscoelastic materials. However, the experimental evidence for such a direct correlation between growth rate and turgor is inconclusive. This has led to challenges of the Lockhart model. We model the oscillatory growth of pollen tubes to investigate this relationship. We couple the Lockhart equation to the dynamical equations for the change in material properties. We find that the correct implementation of the Lockhart equation within a feedback loop leading to low amplitude oscillatory growth predicts that in this system changes in the global turgor do not influence the average growth rate in a linear manner, consistent with experimental observations. An analytic analysis of our model demonstrates in which regime the average growth rate becomes uncorrelated from the turgor pressure.	[Kroeger, Jens H.] McGill Univ, Dept Physiol, Ctr Nonlinear Dynam, Montreal, PQ, Canada; [Zerzour, Rabah; Geitmann, Anja] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada	McGill University; Universite de Montreal	Kroeger, JH (corresponding author), McGill Univ, Dept Physiol, Ctr Nonlinear Dynam, Montreal, PQ, Canada.	anja.geitmann@umontreal.ca	Geitmann, Anja/D-4696-2012	Geitmann, Anja/0000-0003-0390-0517	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research in the Geitmann lab is funded by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDRE J, 1991, BIOPHYS J, V60, P1326, DOI 10.1016/S0006-3495(91)82170-1; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Benkert R, 1997, PROTOPLASMA, V198, P1, DOI 10.1007/BF01282125; Blank PS, 2001, J GEN PHYSIOL, V118, P145, DOI 10.1085/jgp.118.2.145; Bolduc JF, 2006, BIOMECH MODEL MECHAN, V5, P227, DOI 10.1007/s10237-005-0010-1; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Boyer JS, 2009, FUNCT PLANT BIOL, V36, P383, DOI 10.1071/FP09048; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Campas O, 2009, CURR BIOL, V19, P2102, DOI 10.1016/j.cub.2009.10.075; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Dumais J, 2004, PLANT PHYSIOL, V136, P3266, DOI 10.1104/pp.104.043752; Dumais J, 2006, INT J DEV BIOL, V50, P209, DOI 10.1387/ijdb.052066jd; Dutta R, 2004, PLANT PHYSIOL, V135, P1398, DOI 10.1104/pp.104.041483; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Feijo JA, 1999, POLLEN TUBE OSCILLAT, P317, DOI [10.1007/978-3-642-59969-9_22, DOI 10.1007/978-3-642-59969-9_22]; Geitmann A, 2004, SEX PLANT REPROD, V17, P9, DOI 10.1007/s00497-004-0210-3; Geitmann A, 1996, BOT ACTA, V109, P102, DOI 10.1111/j.1438-8677.1996.tb00549.x; Geitmann A., 1999, FERTILIZATION HIGHER, P283; Geitmann A, 2006, PLANT CELL MONOGR, V3, P177, DOI 10.1007/7089_049; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; Kroeger JH, 2009, BIOPHYS J, V97, P1822, DOI 10.1016/j.bpj.2009.07.038; Landau L.D., 2000, FLUID MECH; Li YQ, 1996, PLANTA, V200, P41; Liu JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013157; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; MALHO R, 1994, PLANT J, V5, P331, DOI 10.1111/j.1365-313X.1994.00331.x; Malho R, 1996, PLANT CELL, V8, P1935, DOI 10.1105/tpc.8.11.1935; McKenna ST, 2009, PLANT CELL, V21, P3026, DOI 10.1105/tpc.109.069260; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Messerli MA, 1999, J CELL SCI, V112, P1497; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Messerli MA, 1998, PLANT J, V16, P87, DOI 10.1046/j.1365-313x.1998.00266.x; Messerli MA, 2003, PLANTA, V217, P147, DOI 10.1007/s00425-003-0972-0; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; MONEY NP, 1993, PLANTA, V190, P426; NEEDHAM D, 1989, BIOPHYS J, V55, P1001, DOI 10.1016/S0006-3495(89)82898-X; ORTEGA JKE, 1990, PHYSIOL PLANTARUM, V79, P116, DOI 10.1111/j.1399-3054.1990.tb05873.x; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Parre E, 2005, PLANT PHYSIOL, V137, P274, DOI 10.1104/pp.104.050773; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; PASSIOURA JB, 1992, AUST J PLANT PHYSIOL, V19, P565, DOI 10.1071/PP9920565; Proseus TE, 2005, ANN BOT-LONDON, V95, P967, DOI 10.1093/aob/mci113; Rinzel J, 1985, ORDINARY PARTIAL DIF, P304; Rojas E, 2008, TIP GROWTH POLLEN TU; Rounds CM, 2010, PLANT PHYSIOL, V152, P736, DOI 10.1104/pp.109.150896; Roy SJ, 1999, PLANT J, V19, P379, DOI 10.1046/j.1365-313X.1999.00515.x; Sastry S., 1999, NONLINEAR SYSTEMS AN; Ullah G, 2006, CELL CALCIUM, V39, P197, DOI 10.1016/j.ceca.2005.10.009; WAUGH RE, 1982, BIOPHYS J, V38, P19, DOI 10.1016/S0006-3495(82)84526-8; Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zonia L, 2006, CELL BIOCHEM BIOPHYS, V46, P209, DOI 10.1385/CBB:46:3:209; Zonia L, 2010, J EXP BOT, V61, P1939, DOI 10.1093/jxb/erq073; Zonia L, 2009, TRENDS PLANT SCI, V14, P318, DOI 10.1016/j.tplants.2009.03.008	59	95	99	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18549	10.1371/journal.pone.0018549	http://dx.doi.org/10.1371/journal.pone.0018549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541026	gold, Green Published, Green Submitted			2022-12-25	WOS:000290016800014
J	Engrav, LH; Tuggle, CK; Kerr, KF; Zhu, KQ; Numhom, S; Couture, OP; Beyer, RP; Hocking, AM; Carrougher, GJ; Ramos, MLC; Klein, MB; Gibran, NS				Engrav, Loren H.; Tuggle, Christopher K.; Kerr, Kathleen F.; Zhu, Kathy Q.; Numhom, Surawej; Couture, Oliver P.; Beyer, Richard P.; Hocking, Anne M.; Carrougher, Gretchen J.; Ramos, Maria Luiza C.; Klein, Matthew B.; Gibran, Nicole S.			Functional Genomics Unique to Week 20 Post Wounding in the Deep Cone/Fat Dome of the Duroc/Yorkshire Porcine Model of Fibroproliferative Scarring	PLOS ONE			English	Article							RED DUROC PIG; HUMAN HYPERTROPHIC SCAR; SET ENRICHMENT ANALYSIS; GROWTH-FACTOR; PROLIFERATIVE SCAR; EXPRESSION PATTERNS; HEALING PHENOTYPE; MAST-CELL; BURN SCAR; SKIN	Background: Hypertrophic scar was first described over 100 years ago; PubMed has more than 1,000 references on the topic. Nevertheless prevention and treatment remains poor, because 1) there has been no validated animal model; 2) human scar tissue, which is impossible to obtain in a controlled manner, has been the only source for study; 3) tissues typically have been homogenized, mixing cell populations; and 4) gene-by-gene studies are incomplete. Methodology/Principal Findings: We have assembled a system that overcomes these barriers and permits the study of genome-wide gene expression in microanatomical locations, in shallow and deep partial-thickness wounds, and pigmented and non-pigmented skin, using the Duroc( pigmented fibroproliferative)/Yorkshire( non-pigmented non-fibroproliferative) porcine model. We used this system to obtain the differential transcriptome at 1, 2, 3, 12 and 20 weeks post wounding. It is not clear when fibroproliferation begins, but it is fully developed in humans and the Duroc breed at 20 weeks. Therefore we obtained the derivative functional genomics unique to 20 weeks post wounding. We also obtained long-term, forty-six week follow-up with the model. Conclusions/Significance: 1) The scars are still thick at forty-six weeks post wounding further validating the model. 2) The differential transcriptome provides new insights into the fibroproliferative process as several genes thought fundamental to fibroproliferation are absent and others differentially expressed are newly implicated. 3) The findings in the derivative functional genomics support old concepts, which further validates the model, and suggests new avenues for reductionist exploration. In the future, these findings will be searched for directed networks likely involved in cutaneous fibroproliferation. These clues may lead to a better understanding of the systems biology of cutaneous fibroproliferation, and ultimately prevention and treatment of hypertrophic scarring.	[Engrav, Loren H.; Zhu, Kathy Q.; Numhom, Surawej; Hocking, Anne M.; Carrougher, Gretchen J.; Ramos, Maria Luiza C.; Klein, Matthew B.] Univ Washington, Dept Surg, Div Plast Surg, Seattle, WA 98195 USA; [Tuggle, Christopher K.; Couture, Oliver P.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Kerr, Kathleen F.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Numhom, Surawej] Mahidol Univ, Ramathibodi Hosp, Dept Surg, Bangkok 10700, Thailand; [Beyer, Richard P.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Ramos, Maria Luiza C.] Univ Fed Sao Paulo, Div Plast Surg, Dept Surg, Sao Paulo, Brazil	University of Washington; University of Washington Seattle; Iowa State University; University of Washington; University of Washington Seattle; Mahidol University; University of Washington; University of Washington Seattle; Universidade Federal de Sao Paulo (UNIFESP)	Engrav, LH (corresponding author), Univ Washington, Dept Surg, Div Plast Surg, Seattle, WA 98195 USA.	engrav@u.washington.edu	Kerr, Kathleen F./A-2893-2013	Kerr, Kathleen F./0000-0002-6438-9583; Hocking, Anne/0000-0003-2130-3732	The National Institute on Disability and Rehabilitation Research [H133G050022]; The National Institutes of Health [1R21GM074673, 5U54GM062119-09]; The Washington State Council of Fire Fighters Burn Foundation; The Northwest Burn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM074673, U54GM062119] Funding Source: NIH RePORTER	The National Institute on Disability and Rehabilitation Research; The National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Washington State Council of Fire Fighters Burn Foundation; The Northwest Burn Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	1) The National Institute on Disability and Rehabilitation Research, # H133G050022, http://www2.ed.gov/about/offices/list/osers/nidrr/index.html 2) The National Institutes of Health, # 1R21GM074673 and # 5U54GM062119-09, http://www.nih.gov/3) The Washington State Council of Fire Fighters Burn Foundation, and http://www.wscff.org/?zone=/unionactive/view_page.cfm&page = Burn20Foundation 4) The Northwest Burn Foundation. http://www.nwburn.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Aksoy HM, 2002, AESTHET PLAST SURG, V26, P388, DOI 10.1007/s00266-002-1121-z; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Bombaro KM, 2003, BURNS, V29, P299, DOI 10.1016/S0305-4179(03)00067-6; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Broerse JEW, 2010, BURNS, V36, P217, DOI 10.1016/j.burns.2009.04.004; Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x; Couture O, 2009, MAMM GENOME, V20, P768, DOI 10.1007/s00335-009-9234-1; Cui DP, 2006, PHYSIOL GENOMICS, V24, P276, DOI 10.1152/physiolgenomics.00109.2005; Cuttle L, 2006, BURNS, V32, P806, DOI 10.1016/j.burns.2006.02.023; Dabiri G, 2008, J INVEST DERMATOL, V128, P2518, DOI 10.1038/jid.2008.90; de Hemptinne I, 2008, WOUND REPAIR REGEN, V16, P132, DOI 10.1111/j.1524-475X.2007.00340.x; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gallant CL, 2004, WOUND REPAIR REGEN, V12, P305, DOI 10.1111/j.1067-1927.2004.012311.x; GALLANT CL, 2001, RED DUROC PIG MODEL; GALLANT CL, 2002, SKIN WOUND HEALING R; GALLANT CL, 2002, FULL PARTIAL THICKNE; Gallant-Behm CL, 2006, BURNS, V32, P180, DOI 10.1016/j.burns.2005.10.012; Gallant-Behm CL, 2006, WOUND REPAIR REGEN, V14, P46, DOI 10.1111/j.1524-475X.2005.00087.x; Gallant-Behm CL, 2008, WOUND REPAIR REGEN, V16, P226, DOI 10.1111/j.1524-475X.2008.00363.x; Gallant-Behm CL, 2007, J INVEST DERMATOL, V127, P233, DOI 10.1038/sj.jid.5700482; Gallant-Behm CL, 2005, J CUTAN MED SURG, V9, P165, DOI 10.1007/s10227-005-0105-4; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GENTLEMAN RC, 2009, BIOCONDUCTOR FAQ; Ha XQ, 2003, CHINESE MED J-PEKING, V116, P1029; Harunari N, 2006, BURNS, V32, P669, DOI 10.1016/j.burns.2006.03.015; JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413; King CL, 2005, J MOL DIAGN, V7, P57, DOI 10.1016/S1525-1578(10)60009-8; KISCHER CW, 1982, SCAN ELECTRON MICROS, P1699; KISCHER CW, 1972, TEX REP BIOL MED, V30, P327; KISCHER CW, 1989, ANAT REC, V225, P189; KISCHER CW, 1989, J TRAUMA, V29, P672, DOI 10.1097/00005373-198905000-00023; Ladak A, 2009, CLIN PLAST SURG, V36, P661, DOI 10.1016/j.cps.2009.05.014; Liang Z, 2004, BURNS, V30, P57, DOI 10.1016/j.burns.2003.09.004; MAK K, 2009, J DERMATOL SCI; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MAST BA, 1992, WOUND HEALING BIOCH; Matsumura H, 2001, WOUND REPAIR REGEN, V9, P269, DOI 10.1046/j.1524-475X.2001.00269.x; MATSUMURA H, 1998, CONES FAT DOMES HYPE, P47; MCDONALD WS, 1987, J TRAUMA, V27, P147, DOI 10.1097/00005373-198702000-00008; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Polo M, 1998, J SURG RES, V74, P187, DOI 10.1006/jsre.1997.5251; Polo M, 1999, ANN PLAS SURG, V43, P185; Reiken SR, 1997, LASER SURG MED, V21, P7, DOI 10.1002/(SICI)1096-9101(1997)21:1<7::AID-LSM2>3.0.CO;2-U; Robb E C, 1987, J Burn Care Rehabil, V8, P371, DOI 10.1097/00004630-198709000-00006; Robson MC, 2001, CURR PROB SURG, V38, P65; Ryge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003415; Santucci M, 2001, VIRCHOWS ARCH, V438, P457, DOI 10.1007/s004280000335; SHETLAR MR, 1991, CONNECT TISSUE RES, V26, P23, DOI 10.3109/03008209109152161; SHETLAR MR, 1985, P SOC EXP BIOL MED, V179, P549; SHOEMAKER JV, 2005, PRACTICAL TREATISE D; Silverstein P, 1976, ULTRASTRUCTURE COLLA, P213, DOI DOI 10.4103/09700358.101319; Silverstein P., 1972, ANN RES PROG REP US, V37, P1; SPURR ED, 1990, BURNS, V16, P179, DOI 10.1016/0305-4179(90)90034-T; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; TREDGET EE, 1994, ANN PLAS SURG, V33, P152; Wang X, 1999, J SURG RES, V87, P194, DOI 10.1006/jsre.1999.5757; WARREN JC, 1893, T AM S A, V11, P41; Wassermann RJ, 1998, J SURG RES, V75, P74, DOI 10.1006/jsre.1998.5267; Wolfort SF, 1996, J SURG RES, V62, P17, DOI 10.1006/jsre.1996.0166; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xie YF, 2007, J BURN CARE RES, V28, P500, DOI 10.1097/BCR.0B013E318053DAFE; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhu KQ, 2008, J BURN CARE RES, V29, P815, DOI 10.1097/BCR.0b013e3181848141; Zhu KQ, 2007, WOUND REPAIR REGEN, V15, pS32, DOI 10.1111/j.1524-475X.2007.00223.x; Zhu KQ, 2005, BURNS, V31, P5, DOI 10.1016/j.burns.2004.08.010; Zhu KQ, 2004, BURNS, V30, P518, DOI 10.1016/j.burns.2004.02.005; Zhu KQ, 2003, BURNS, V29, P649, DOI 10.1016/S0305-4179(03)00205-5; [No title captured]	78	20	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e19024	10.1371/journal.pone.0019024	http://dx.doi.org/10.1371/journal.pone.0019024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533106	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400051
J	Perfahl, H; Byrne, HM; Chen, TG; Estrella, V; Alarcon, T; Lapin, A; Gatenby, RA; Gillies, RJ; Lloyd, MC; Maini, PK; Reuss, M; Owen, MR				Perfahl, Holger; Byrne, Helen M.; Chen, Tingan; Estrella, Veronica; Alarcon, Tomas; Lapin, Alexei; Gatenby, Robert A.; Gillies, Robert J.; Lloyd, Mark C.; Maini, Philip K.; Reuss, Matthias; Owen, Markus R.			Multiscale Modelling of Vascular Tumour Growth in 3D: The Roles of Domain Size and Boundary Conditions	PLOS ONE			English	Article							INDUCED ANGIOGENESIS; NONLINEAR SIMULATION; NETWORKS; HYPOXIA; STRATEGIES	We investigate a three-dimensional multiscale model of vascular tumour growth, which couples blood flow, angiogenesis, vascular remodelling, nutrient/growth factor transport, movement of, and interactions between, normal and tumour cells, and nutrient-dependent cell cycle dynamics within each cell. In particular, we determine how the domain size, aspect ratio and initial vascular network influence the tumour's growth dynamics and its long-time composition. We establish whether it is possible to extrapolate simulation results obtained for small domains to larger ones, by constructing a large simulation domain from a number of identical subdomains, each subsystem initially comprising two parallel parent vessels, with associated cells and diffusible substances. We find that the subsystem is not representative of the full domain and conclude that, for this initial vessel geometry, interactions between adjacent subsystems contribute to the overall growth dynamics. We then show that extrapolation of results from a small subdomain to a larger domain can only be made if the subdomain is sufficiently large and is initialised with a sufficiently complex vascular network. Motivated by these results, we perform simulations to investigate the tumour's response to therapy and show that the probability of tumour elimination in a larger domain can be extrapolated from simulation results on a smaller domain. Finally, we demonstrate how our model may be combined with experimental data, to predict the spatio-temporal evolution of a vascular tumour.	[Perfahl, Holger; Lapin, Alexei; Reuss, Matthias] Univ Stuttgart, Ctr Syst Biol, Stuttgart, Germany; [Byrne, Helen M.; Owen, Markus R.] Univ Nottingham, Sch Math Sci, Ctr Math Med & Biol, Nottingham NG7 2RD, England; [Chen, Tingan; Estrella, Veronica; Gatenby, Robert A.; Gillies, Robert J.; Lloyd, Mark C.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Maini, Philip K.] Univ Oxford, Inst Math, Ctr Math Biol, Oxford OX1 3LB, England; [Alarcon, Tomas] Ctr Recerca Matemat, Barcelona, Spain; [Maini, Philip K.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Stuttgart; University of Nottingham; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Oxford; Centre de Recerca Matematica (CRM); University of Oxford	Perfahl, H (corresponding author), Univ Stuttgart, Ctr Syst Biol, Stuttgart, Germany.	holger@perfahl.org	Alarcon, Tomas/D-9083-2013; Alarcon, Tomas/AAW-2908-2021; Owen, Markus/F-3082-2011	Alarcon, Tomas/0000-0002-8566-3676; Alarcon, Tomas/0000-0002-8566-3676; Owen, Markus/0000-0002-3028-9138; Gillies, Robert/0000-0002-8888-7747; Byrne, Helen/0000-0003-1771-5910	Engineering and Physical Sciences Research Council [EP/D501083/1]; Marie Curie Network MMBNOTT [MEST-CT-2005-020723]; Royal Society; National Institutes of Health [1U54CA143970-01]; BMBF-Funding Initiative; Moffitt Cancer Center PS-OC NIH/National Cancer Institute [U54CA143970]; NATIONAL CANCER INSTITUTE [R01CA077575, U54CA143970] Funding Source: NIH RePORTER; EPSRC [EP/D501083/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie Network MMBNOTT; Royal Society(Royal Society of London); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF-Funding Initiative; Moffitt Cancer Center PS-OC NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MRO acknowledges the Engineering and Physical Sciences Research Council for financial support for the Interdisciplinary Angiogenesis Network (ANGIONET, EP/D501083/1, http://www.maths.nottingham.ac.uk/angionet/). HMB, MRO and HP acknowledge financial support by the Marie Curie Network MMBNOTT (Project No. MEST-CT-2005-020723). PKM was partially supported by a Royal Society Wolfson Research Merit Award. RAG and PKM acknowledge partial support from National Institutes of Health grant 1U54CA143970-01. HP, AL and MR thank the BMBF-Funding Initiative FORSYS Partner: "Predictive Cancer Therapy''. In vivo window chamber work was funded in part by Moffitt Cancer Center PS-OC NIH/National Cancer Institute U54CA143970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2005, MULTISCALE MODEL SIM, V3, P440, DOI 10.1137/040603760; Alarcon T, 2004, J THEOR BIOL, V229, P395, DOI 10.1016/j.jtbi.2004.04.016; Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; AlarcuEn T., 2006, COMPUT MATH METHOD M, V7, P85, DOI DOI 10.1080/10273660600968994; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Arakelyan L, 2005, EUR J CANCER, V41, P159, DOI 10.1016/j.ejca.2004.09.012; Arakelyan L., 2002, Angiogenesis, V5, P203, DOI 10.1023/A:1023841921971; Breward CJW, 2003, B MATH BIOL, V65, P609, DOI 10.1016/S0092-8240(03)00027-2; Clark ER, 1918, AM J ANAT, V23, P37, DOI 10.1002/aja.1000230103; Drasdo D, 2010, CELL MECH SINGLE SCA, P379; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Lee DS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058104; Lloyd BA, 2008, PHILOS T R SOC A, V366, P3301, DOI 10.1098/rsta.2008.0092; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Plank MJ, 2004, B MATH BIOL, V66, P1785, DOI 10.1016/j.bulm.2004.04.001; Pries AR, 2001, AM J PHYSIOL-HEART C, V281, pH1015, DOI 10.1152/ajpheart.2001.281.3.H1015; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; RISAU W, 1997, NATURE, V386, P871; Sachs L, 2006, ANGEW STAT; Schaller G, 2005, PHYS REV E, V71, P1; Secomb TW, 2000, MICROCIRCULATION, V7, P237, DOI 10.1038/sj.mn.7300114; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Stephanou A, 2005, MATH COMPUT MODEL, V41, P1137, DOI 10.1016/j.mcm.2005.05.008; TOZER GM, 2005, NATURE REV CANC, V5; Tracqui P, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/5/056701; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	32	119	120	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e14790	10.1371/journal.pone.0014790	http://dx.doi.org/10.1371/journal.pone.0014790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533234	Green Submitted, Green Published, gold			2022-12-25	WOS:000289458800002
J	Ghosh, S; Vassilev, AP; Zhang, JM; Zhao, YM; DePamphilis, ML				Ghosh, Soma; Vassilev, Alex P.; Zhang, Junmei; Zhao, Yingming; DePamphilis, Melvin L.			Assembly of the Human Origin Recognition Complex Occurs through Independent Nuclear Localization of Its Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; ORC6 PROTEIN; IN-VIVO; CELLS; BINDING; ARCHITECTURE; RECRUITMENT; CENTROSOME; INITIATION; SEQUENCE	Initiation of eukaryotic genome duplication begins when a six-subunit origin recognition complex (ORC) binds to DNA. However, the mechanism by which this occurs in vivo and the roles played by individual subunits appear to differ significantly among organisms. Previous studies identified a soluble human ORC(2-5) complex in the nucleus, an ORC(1-5) complex bound to chromatin, and an Orc6 protein that binds weakly, if at all, to other ORC subunits. Here we show that stable ORC(1-6) complexes also can be purified from human cell extracts and that Orc6 and Orc1 each contain a single nuclear localization signal that is essential for nuclear localization but not for ORC assembly. The Orc6 nuclear localization signal, which is essential for Orc6 function, is facilitated by phosphorylation at its cyclin-dependent kinase consensus site and by association with Kpna6/1, nuclear transport proteins that did not co-purify with other ORC subunits. These and other results support a model in which Orc6, Orc1, and ORC(2-5) are transported independently to the nucleus where they can either assemble into ORC(1-6) or function individually.	[Ghosh, Soma; Vassilev, Alex P.; DePamphilis, Melvin L.] NICHD, NIH, Bethesda, MD 20892 USA; [Zhang, Junmei] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago	DePamphilis, ML (corresponding author), NICHD, NIH, Bldg 6-3A-15,9000 Rockville Pike, Bethesda, MD 20892 USA.	depamphm@mail.nih.gov		Vassilev, Alex/0000-0002-5483-3791	National Institutes of Health (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000506] Funding Source: NIH RePORTER	National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health intramural research programs (NICHD).	Asano T, 2007, FEMS YEAST RES, V7, P1256, DOI 10.1111/j.1567-1364.2007.00299.x; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; Brand N, 2007, MOL GENET GENOMICS, V278, P623, DOI 10.1007/s00438-007-0278-1; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chesnokov I, 2001, P NATL ACAD SCI USA, V98, P11997, DOI 10.1073/pnas.211342798; Chesnokov IN, 2007, INT REV CYTOL, V256, P69, DOI 10.1016/S0074-7696(07)56003-1; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; CHOOK YM, 2010, BIOCHIM BIO IN PRESS; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; DePamphilis M. L., 2010, GENOME DUPLICATION C; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Dhar SK, 2001, J BIOL CHEM, V276, P29067, DOI 10.1074/jbc.M103078200; Diaz-Trivino S, 2005, NUCLEIC ACIDS RES, V33, P5404, DOI 10.1093/nar/gki854; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; ELION EA, 2007, CURR PROTOC PROTEIN, pCH19; Gillespie PJ, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-15; Giordano-Coltart J, 2005, P NATL ACAD SCI USA, V102, P69, DOI 10.1073/pnas.0408690102; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Huijbregts RPH, 2009, MOL BIOL CELL, V20, P270, DOI 10.1091/mbc.E08-07-0754; Kneissl M, 2003, J MOL BIOL, V327, P111, DOI 10.1016/S0022-2836(03)00079-2; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Lidonnici MR, 2004, J CELL SCI, V117, P5221, DOI 10.1242/jcs.01405; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Plant KE, 2006, PHARMACOGENET GENOM, V16, P647, DOI 10.1097/01.fpc.0000220570.82842.4d; Prasanth SG, 2002, SCIENCE, V297, P1026, DOI 10.1126/science.1072802; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Ranjan A, 2006, P NATL ACAD SCI USA, V103, P4864, DOI 10.1073/pnas.0510305103; Sasaki T, 2007, CURR OPIN CELL BIOL, V19, P337, DOI 10.1016/j.ceb.2007.04.007; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Siddiqui K, 2007, J BIOL CHEM, V282, P32370, DOI 10.1074/jbc.M705905200; Sivaprasad Umasundari, 2006, V47, P63; Stuermer A, 2007, EUR J CELL BIOL, V86, P37, DOI 10.1016/j.ejcb.2006.09.002; Takeda DY, 2005, GENE DEV, V19, P2827, DOI 10.1101/gad.1369805; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Vashee S, 2001, J BIOL CHEM, V276, P26666, DOI 10.1074/jbc.M102493200; Zhou G, 2005, PROTEOMICS, V5, P3814, DOI 10.1002/pmic.200401230	41	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23831	23841		10.1074/jbc.M110.215988	http://dx.doi.org/10.1074/jbc.M110.215988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21555516	Green Published, hybrid			2022-12-25	WOS:000292294900026
J	Brautigam, CA; Wynn, RM; Chuang, JL; Naik, MT; Young, BB; Huang, TH; Chuang, DT				Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Naik, Mandar T.; Young, Brittany B.; Huang, Tai-huang; Chuang, David T.			Structural and Thermodynamic Basis for Weak Interactions between Dihydrolipoamide Dehydrogenase and Subunit-binding Domain of the Branched-chain alpha-Ketoacid Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIENZYME COMPLEX; PROTEIN COMPLEX; HOT-SPOTS; ACID; COMPONENT; SEQUENCE; ENERGY	The purified mammalian branched-chain alpha-ketoacid dehydrogenase complex (BCKDC), which catalyzes the oxidative decarboxylation of branched-chain alpha-keto acids, is essentially devoid of the constituent dihydrolipoamide dehydrogenase component (E3). The absence of E3 is associated with the low affinity of the subunit-binding domain of human BCKDC (hSBDb) for hE3. In this work, sequence alignments of hSBDb with the E3-binding domain (E3BD) of the mammalian pyruvate dehydrogenase complex show that hSBDb has an arginine at position 118, where E3BD features an asparagine. Substitution of Arg-118 with an asparagine increases the binding affinity of the R118N hSBDb variant (designated hSBDb*) for hE3 by nearly 2 orders of magnitude. The enthalpy of the binding reaction changes from endothermic with the wild-type hSBDb to exothermic with the hSBDb* variant. This higher affinity interaction allowed the determination of the crystal structure of the hE3/hSBDb* complex to 2.4-angstrom resolution. The structure showed that the presence of Arg-118 poses a unique, possibly steric and/or electrostatic incompatibility that could impede E3 interactions with the wild-type hSBDb. Compared with the E3/E3BD structure, the hE3/hSBDb* structure has a smaller interfacial area. Solution NMR data corroborated the interactions of hE3 with Arg-118 and Asn-118 in wild-type hSBDb and mutant hSBDb*, respectively. The NMR results also showed that the interface between hSBDb and hE3 does not change significantly from hSBDb to hSBDb*. Taken together, our results represent a starting point for explaining the long standing enigma that the E2b core of the BCKDC binds E3 far more weakly relative to other alpha-ketoacid dehydrogenase complexes.	[Brautigam, Chad A.; Wynn, R. Max; Chuang, Jacinta L.; Young, Brittany B.; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Brautigam, Chad A.; Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Naik, Mandar T.; Huang, Tai-huang] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Huang, Tai-huang] Natl Taiwan Normal Univ, Dept Phys, Taipei 10677, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Academia Sinica - Taiwan; National Taiwan Normal University	Brautigam, CA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	chad.brautigam@utsouthwestern.edu; david.chuang@utsouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338; Naik, Mandar/0000-0002-7016-572X; Wynn, Richard/0000-0002-1879-2136	National Institutes of Health [DK26758, DK62306]; Welch Foundation [I-1286]; National Science Council, Taiwan [NSC98-2113-M-001-014]; National Health Research Institute, Taiwan [NHRI-EX99-9933B1]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Research Program for Genomic Medicine, the Republic of China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062306, R01DK026758, R01DK062306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Research Program for Genomic Medicine, the Republic of China(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK26758 and DK62306 (to D. T. C.), Grant I-1286 from the Welch Foundation (to D. T. C.), Grant NSC98-2113-M-001-014 from the National Science Council, Taiwan (to T. H. H.), and Grant NHRI-EX99-9933B1 from National Health Research Institute, Taiwan (to T.-h. H.).; The x-ray data are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the University of Chicago at Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. The NMR spectra were acquired at the High-field NMR Center Taiwan, which is supported by the National Research Program for Genomic Medicine, the Republic of China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Babady NE, 2007, P NATL ACAD SCI USA, V104, P6158, DOI 10.1073/pnas.0610618104; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; Chang CF, 2006, J BIOL CHEM, V281, P28345, DOI 10.1074/jbc.M605005200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuang DT, 2006, J NUTR, V136, p243S, DOI 10.1093/jn/136.1.243S; CHUANG DT, 1984, J BIOL CHEM, V259, P9277; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; DANNER DJ, 1988, METHOD ENZYMOL, V166, P298; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Goddard T. D., 2008, SPARKY 3; Harris RA, 1997, ADV ENZYME REGUL, V37, P271, DOI 10.1016/S0065-2571(96)00009-X; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Jung HI, 2002, PROTEIN SCI, V11, P1091, DOI 10.1110/ps.4970102; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Padrick SB, 2010, ANAL BIOCHEM, V407, P89, DOI 10.1016/j.ab.2010.07.017; PAXTON R, 1982, J BIOL CHEM, V257, P4433; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625	36	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23476	23488		10.1074/jbc.M110.202960	http://dx.doi.org/10.1074/jbc.M110.202960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543315	Green Published, hybrid			2022-12-25	WOS:000292025000078
J	Wu, CS; Agrawal, S; Vasanji, A; Drazba, J; Sarkaria, S; Xie, J; Welch, CM; Liu, ML; Anand-Apte, B; Horowitz, A				Wu, Chuanshen; Agrawal, Sudesh; Vasanji, Amit; Drazba, Judy; Sarkaria, Sandeep; Xie, Jing; Welch, Christopher M.; Liu, Miaoliang; Anand-Apte, Bela; Horowitz, Arie			Rab13-dependent Trafficking of RhoA Is Required for Directional Migration and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE EXCHANGE FACTOR; CELL-CELL JUNCTIONS; TIGHT JUNCTIONS; BRANCHING MORPHOGENESIS; ENDOCYTIC TRAFFICKING; GTPASE; PROTEIN; DOMAIN; JRAB/MICAL-L2; BINDING	Angiogenesis requires concomitant remodeling of cell junctions and migration, as exemplified by recent observations of extensive endothelial cell movement along growing blood vessels. We report that a protein complex that regulates cell junctions is required for VEGF-driven directional migration and for angiogenesis in vivo. The complex consists of RhoA and Syx, a RhoA guanine exchange factor cross-linked by the Crumbs polarity protein Mupp1 to angiomotin, a phosphatidylinositol-binding protein. The Syx-associated complex translocates to the leading edge of migrating cells by membrane trafficking that requires the tight junction recycling GTPase Rab13. In turn, Rab13 associates with Grb2, targeting Syx and RhoA to Tyr(1175)-phosphorylated VEGFR2 at the leading edge. Rab13 knockdown in zebrafish impeded sprouting of intersegmental vessels and diminished the directionality of their tip cells. These results indicate that endothelial cell mobility in sprouting vessels is facilitated by shuttling the same protein complex from disassembling junctions to the leading edges of cells.	[Vasanji, Amit] Cleveland Clin, Lerner Coll Med, Dept Biomed Engn, Cleveland, OH 44195 USA; [Xie, Jing; Anand-Apte, Bela] Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44195 USA; [Drazba, Judy] Cleveland Clin, Lerner Coll Med, Imaging Core Facil, Cleveland, OH 44195 USA; [Welch, Christopher M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Horowitz, Arie] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Liu, Miaoliang] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Wu, Chuanshen; Agrawal, Sudesh; Sarkaria, Sandeep; Horowitz, Arie] Cleveland Clin, Lerner Coll Med, Dept Mol Cardiol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; Dartmouth College; Case Western Reserve University; Cleveland Clinic Foundation	Horowitz, A (corresponding author), 9500 Euclid Ave, Cleveland, OH 44195 USA.	horowia@ccf.org	Horowitz, Arie/AAT-9482-2021; Horowitz, Arie/F-4628-2015	Horowitz, Arie/0000-0001-6239-1287	National Institutes of Health [F30-HL-094020, T32-GM-80079]; National Research Service Award [HL007914]; American Heart Association; NATIONAL EYE INSTITUTE [R01EY016490, R01EY020861] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL094020, T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Fellowships F30-HL-094020 and T32-GM-80079 (to C. M. W.).; Supported by National Research Service Award Training Grant HL007914.; Supported by an American Heart Association summer undergraduate research fellowship.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Cheshire AM, 2008, DEV DYNAM, V237, P2874, DOI 10.1002/dvdy.21709; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Estevez MA, 2008, J NEUROCHEM, V106, P1287, DOI 10.1111/j.1471-4159.2008.05472.x; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Janssens K, 2010, P NATL ACAD SCI USA, V107, P7323, DOI 10.1073/pnas.0915075107; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; Kawauchi T, 2010, NEURON, V67, P588, DOI 10.1016/j.neuron.2010.07.007; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Lee SS, 2000, J VIROL, V74, P9680, DOI 10.1128/JVI.74.20.9680-9693.2000; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; MANDERS EMM, 1992, J CELL SCI, V103, P857; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Thisse B., 2001, DIRECT DATA SUBMISSI; Ulrich F, 2009, TRAFFIC, V10, P811, DOI 10.1111/j.1600-0854.2009.00929.x; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Wells Claire M., 2004, V294, P31; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; ZAHRAOUI A, 1994, J CELL BIOL, V124, P101, DOI 10.1083/jcb.124.1.101; Zicha D, 1997, Methods Mol Biol, V75, P449	60	37	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23511	23520		10.1074/jbc.M111.245209	http://dx.doi.org/10.1074/jbc.M111.245209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543326	Green Published, hybrid			2022-12-25	WOS:000292025000081
J	Bao, YQ; Lu, ZG; Zhou, M; Li, HT; Wang, Y; Gao, MF; Wei, M; Jia, WP				Bao, Yuqian; Lu, Zhigang; Zhou, Mi; Li, Huating; Wang, Ye; Gao, Meifang; Wei, Meng; Jia, Weiping			Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with the Severity of Coronary Artery Disease in Chinese Women	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACTIVATED RECEPTOR-GAMMA; NATRIURETIC PEPTIDE; INSULIN-RESISTANCE; METABOLIC SYNDROME; LIPID-METABOLISM; AP2; OBESITY; CHOLESTEROL; ATHEROSCLEROSIS	Background: Adipocyte fatty acid-binding protein (A-FABP) has been described as a novel adipokine, playing an important role in the development of metabolic syndrome, type 2 diabetes and atherosclerosis. In this study, we investigated the relationship between serum levels of A-FABP and the presence and severity of coronary artery disease (CAD) in Chinese subjects. Methodology/Principal Findings: Circulating A-FABP level was determined by ELISA in 341 Chinese subjects (221 men, 120 women) who underwent coronary angiography. A-FABP levels in patients with CAD were significantly higher compared with non-CAD subjects (P = 0.029 in men; P = 0.031 in women). Serum A-FABP increased significantly in multi-vessel diseased patients than in non-CAD subjects (P = 0.011 in men, P = 0.004 in women), and showed an independent correlation with coronary atherosclerosis index (standardized beta = 0.173, P = 0.025). In multiple logistic regression analysis, serum A-FABP was an independent risk factor for CAD in women (OR = 5.637, 95% CI: 1.299-24.457, P = 0.021). In addition, amino terminal pro-brain natriuretic peptide (NT-proBNP) was demonstrated to be positively and independently correlated with A-FABP (standardized beta = 0.135, P = 0.027). Conclusions/Significance: Serum A-FABP is closely associated with the presence and severity of CAD in Chinese women.	[Bao, Yuqian; Zhou, Mi; Li, Huating; Wang, Ye; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Bao, Yuqian; Zhou, Mi; Li, Huating; Wang, Ye; Jia, Weiping] Shanghai Clin Ctr Diabet, Shanghai Key Lab Diabet Mellitus, Shanghai Diabet Inst, Shanghai, Peoples R China; [Lu, Zhigang; Gao, Meifang; Wei, Meng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Cardiol, Shanghai 200030, Peoples R China; [Zhou, Mi; Li, Huating; Wang, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Bao, YQ (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China.	mrweei@medmail.com.cn; wpjia@sjtu.edu	王, 强/F-4212-2011		Chinese National 973 Project [2007CB914702]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; Shanghai Municipality for Basic Research [08dj1400601]; National Key Technology R&D Program of China [2009BAI80B01]	Chinese National 973 Project(National Basic Research Program of China); Shanghai Key Laboratory of Diabetes Mellitus; Shanghai Municipality for Basic Research; National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was funded by Chinese National 973 Project (2007CB914702), Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200), Major Program of Shanghai Municipality for Basic Research (08dj1400601), and National Key Technology R&D Program of China (2009BAI80B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, pA60; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Goetze JP, 2004, CLIN CHEM, V50, P1503, DOI 10.1373/clinchem.2004.034272; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Jin J, 2010, CLIN CHIM ACTA, V411, P1761, DOI 10.1016/j.cca.2010.07.031; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; JUDKINS MP, 1968, RADIOL CLIN N AM, V6, P467; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2004, J NUTR, V134, p2464S, DOI 10.1093/jn/134.9.2464S; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyoshi T, 2010, ATHEROSCLEROSIS, V211, P164, DOI 10.1016/j.atherosclerosis.2010.01.032; Pasceri V, 2000, CIRCULATION, V102, P2165; Rhee EJ, 2009, EUR J ENDOCRINOL, V160, P165, DOI 10.1530/EJE-08-0665; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Sommer G, 2008, CLIN ENDOCRINOL, V69, P901, DOI 10.1111/j.1365-2265.2008.03277.x; Struthers AD, 2005, QJM-INT J MED, V98, P765, DOI 10.1093/qjmed/hci111; TATAMI R, 1981, CIRCULATION, V64, P1174, DOI 10.1161/01.CIR.64.6.1174; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274	36	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19115	10.1371/journal.pone.0019115	http://dx.doi.org/10.1371/journal.pone.0019115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552513	gold, Green Published, Green Submitted			2022-12-25	WOS:000290020700027
J	Walker, CG; Goff, L; Bluck, LJ; Griffin, BA; Jebb, SA; Lovegrove, JA; Sanders, TAB; Frost, GS				Walker, Celia G.; Goff, Louise; Bluck, Les J.; Griffin, Bruce A.; Jebb, Susan A.; Lovegrove, Julie A.; Sanders, Thomas A. B.; Frost, Gary S.		Risck Study Grp	Variation in the FFAR1 Gene Modifies BMI, Body Composition and Beta-Cell Function in Overweight Subjects: An Exploratory Analysis	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; FATTY-ACIDS; GLUCOSE-HOMEOSTASIS; GPR40; SCAN; LOCI; MICE	Background: FFAR1 receptor is a long chain fatty acid G-protein coupled receptor which is expressed widely, but found in high density in the pancreas and central nervous system. It has been suggested that FFAR1 may play a role in insulin sensitivity, lipotoxicity and is associated with type 2 diabetes. Here we investigate the effect of three common SNPs of FFAR1 (rs2301151; rs16970264; rs1573611) on pancreatic function, BMI, body composition and plasma lipids. Methodology/Principal Findings: For this enquiry we used the baseline RISCK data, which provides a cohort of overweight subjects at increased cardiometabolic risk with detailed phenotyping. The key findings were SNPs of the FFAR1 gene region were associated with differences in body composition and lipids, and the effects of the 3 SNPs combined were cumulative on BMI, body composition and total cholesterol. The effects on BMI and body fat were predominantly mediated by rs1573611 (1.06 kg/m(2) higher (P = 0.009) BMI and 1.53% higher (P = 0.002) body fat per C allele). Differences in plasma lipids were also associated with the BMI-increasing allele of rs2301151 including higher total cholesterol (0.2 mmol/L per G allele, P = 0.01) and with the variant A allele of rs16970264 associated with lower total (0.3 mmol/L, P = 0.02) and LDL (0.2 mmol/L, P < 0.05) cholesterol, but also with lower HDL-cholesterol (0.09 mmol/L, P < 0.05) although the difference was not apparent when controlling for multiple testing. There were no statistically significant effects of the three SNPs on insulin sensitivity or beta cell function. However accumulated risk allele showed a lower beta cell function on increasing plasma fatty acids with a carbon chain greater than six. Conclusions/Significance: Differences in body composition and lipids associated with common SNPs in the FFAR1 gene were apparently not mediated by changes in insulin sensitivity or beta-cell function.	[Walker, Celia G.; Bluck, Les J.; Jebb, Susan A.] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Goff, Louise; Frost, Gary S.] Univ London Imperial Coll Sci Technol & Med, Nutr & Dietet Res Grp, London, England; [Griffin, Bruce A.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Lovegrove, Julie A.] Univ Reading, Hugh Sinclair Unit Human Nutr, Reading, Berks, England; [Lovegrove, Julie A.] Univ Reading, ICMR, Reading, Berks, England; [Sanders, Thomas A. B.] Kings Coll London, Div Nutr Sci, London WC2R 2LS, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Imperial College London; University of Surrey; University of Reading; University of Reading; University of London; King's College London	Walker, CG (corresponding author), MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England.	g.frost@imperial.ac.uk		Goff, Louise/0000-0001-9633-8759; Jebb, Susan/0000-0001-9190-2920; Harman, Nicola/0000-0001-6958-6466; Sanders, Thomas/0000-0001-9529-095X; Rodriguez-Mateos, Ana/0000-0003-3242-402X	Food Standards Agency [NO2031]; Dairy Crest; Kerry Gold; Unilever; Medical Research Council [MC_UP_A090_1005, MC_U105960389] Funding Source: researchfish; MRC [MC_U105960389, MC_UP_A090_1005] Funding Source: UKRI	Food Standards Agency; Dairy Crest; Kerry Gold; Unilever(Unilever); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The RISCK dietary intervention trial was funded by the Food Standards Agency (http://www.food.gov.uk) project number NO2031. Genetic analyses were funded by the participating centres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors and their research groups have a number of links with the food industry. In a personal capacity GSF is a consultant to Coca-Cola, Premier Foods, and Unilever; and TABS has acted as a consultant to Seven Seas, is a member of the Scientific Advisory Committee for the Global Dairy Platform, the external scientific review committee of the Malaysian Palm Oil Board, and chairs Cadbury's Global Nutrition Advisory Panel. TABS, BAG, JAL, SAJ, and GSF have received ad hoc honoraria for lectures or writing articles. CGW reported no conflicts of interest. In a non-personal capacity, BAG was formerly a member of an expert group known as the Fat Panel, which was supported by Dairy Crest, Kerry Gold, and Unilever; SAJ is a member of Scientific Advisory Boards for Coca-Cola, Heinz, PepsiCo, Nestle and Kellogg's; SAJ and JAL sit on government advisory boards that also include food industry members. All research groups received products from a range of food companies gratis for research purposes, including Archer Daniel Mills, Croda, Matthews Foods, Nestle, PepsiCo, Jordan, GSK, and Unilever.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Jebb SA, 2010, AM J CLIN NUTR, V92, P748, DOI 10.3945/ajcn.2009.29096; Kalis M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001090; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Panhuysen CIM, 2003, DIABETOLOGIA, V46, P579, DOI 10.1007/s00125-003-1066-z; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Sawzdargo M, 1997, BIOCHEM BIOPH RES CO, V239, P543, DOI 10.1006/bbrc.1997.7513; van Tilburg JHO, 2003, J CLIN ENDOCR METAB, V88, P2223, DOI 10.1210/jc.2002-021252; Vettor R, 2008, J CLIN ENDOCR METAB, V93, P3541, DOI 10.1210/jc.2007-2680	15	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19146	10.1371/journal.pone.0019146	http://dx.doi.org/10.1371/journal.pone.0019146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552566	gold, Green Published			2022-12-25	WOS:000290020700033
J	Molina-Guijarro, JM; Macias, A; Garcia, C; Munoz, E; Garcia-Fernandez, LF; David, M; Nunez, L; Martinez-Leal, JF; Moneo, V; Cuevas, C; Lillo, MP; Jorge, CV; Valenzuela, C; Galmarini, CM				Molina-Guijarro, Jose M.; Macias, Alvaro; Garcia, Carolina; Munoz, Eva; Garcia-Fernandez, Luis F.; David, Miren; Nunez, Lucia; Martinez-Leal, Juan F.; Moneo, Victoria; Cuevas, Carmen; Pilar Lillo, M.; Villalobos Jorge, Carlos; Valenzuela, Carmen; Galmarini, Carlos M.			Irvalec Inserts into the Plasma Membrane Causing Rapid Loss of Integrity and Necrotic Cell Death in Tumor Cells	PLOS ONE			English	Article							KAHALALIDE-F; HKV1.5 CHANNELS; BLOCK; CANCER; PROLIFERATION; INHIBITION; PROTECTION; COMPOUND	Irvalec is a marine-derived antitumor agent currently undergoing phase II clinical trials. In vitro, Irvalec induces a rapid loss of membrane integrity in tumor cells, accompanied of a significant Ca(2+) influx, perturbations of membrane conductivity, severe swelling and the formation of giant membranous vesicles. All these effects are not observed in Irvalec-resistant cells, or are significantly delayed by pretreating the cells with Zn(2+). Using fluorescent derivatives of Irvalec it was demonstrated that the compound rapidly interacts with the plasma membrane of tumor cells promoting lipid bilayer restructuration. Also, FRET experiments demonstrated that Irvalec molecules localize in the cell membrane close enough to each other as to suggest that the compound could self-organize, forming supramolecular structures that likely trigger cell death by necrosis through the disruption of membrane integrity.	[Molina-Guijarro, Jose M.; Garcia-Fernandez, Luis F.; Martinez-Leal, Juan F.; Moneo, Victoria; Cuevas, Carmen; Galmarini, Carlos M.] PharmaMar SA, Dept Biol Celular, Madrid, Spain; [Macias, Alvaro; David, Miren; Valenzuela, Carmen] Inst Invest Biomed Alberto Sols CSIC UAM, Madrid, Spain; [Garcia, Carolina; Pilar Lillo, M.] Inst Quim Fis Rocasolano CSIC, Dept Biofis, Madrid, Spain; [Munoz, Eva; Nunez, Lucia; Villalobos Jorge, Carlos] Inst Biol & Genet Mol CSIC UVA, Valladolid, Spain	PharmaMar; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid	Molina-Guijarro, JM (corresponding author), PharmaMar SA, Dept Biol Celular, Madrid, Spain.	cgalmarini@pharmamar.com	Macias, Alvaro/N-7267-2015; molina-guijarro, jose manuel/B-1279-2018; Valenzuela, Carmen/L-3219-2015; nunez, lucia/AAG-8018-2019; Garcia, Carolina/E-9104-2015; Lillo, M. Pilar/O-2556-2013; Villalobos, Carlos/M-9839-2017; Leal, Juan F Martinez/N-6328-2013	Macias, Alvaro/0000-0002-9952-6947; molina-guijarro, jose manuel/0000-0003-4013-7792; Valenzuela, Carmen/0000-0003-3929-1960; Garcia, Carolina/0000-0001-5138-6191; Lillo, M. Pilar/0000-0001-8582-4591; Villalobos, Carlos/0000-0002-0429-3846; Leal, Juan F Martinez/0000-0002-7538-0875; Galmarini, Carlos Maria/0000-0001-5494-6617; Nunez, Lucia/0000-0002-9638-5747	Ministerio de Ciencia e Innovacion (MICINN), Spain [SAF2007-65868, SAF2010-14916, RECAVA FIS RD06/0014/0006, PIF200680F0023, S-BIO-0260/2006, CTQ 2009-12412]; RECAVA; JAE; PharmaMar S.A. JMMG	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RECAVA; JAE; PharmaMar S.A. JMMG	This work was supported by Ministerio de Ciencia e Innovacion (MICINN), Spain (SAF2007-65868, SAF2010-14916, Red Cooperativa de Enfermedades Cardiovasculares RECAVA FIS RD06/0014/0006 to CV, PIF200680F0023, S-BIO-0260/2006, CTQ 2009-12412 to MPL). MD and AM hold RECAVA contract and JAE-Predoc Grant, respectively. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the work of CV and CVJ was supported in part by a grant from PharmaMar S.A. JMMG, LFGF, JFML, VM, CC, and CMG are employees and shareholders of PharmaMar S. A. and played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the work of Carmen Valenzuela and Carlos Villalobos was supported in part by a grant from PharmaMar S.A.	Arias C, 2006, BBA-MOL CELL RES, V1763, P110, DOI 10.1016/j.bbamcr.2005.11.003; Arias C, 2003, CARDIOVASC RES, V57, P660, DOI 10.1016/S0008-6363(02)00726-5; Arias C, 2007, ANESTHESIOLOGY, V107, P641, DOI 10.1097/01.anes.0000282100.32923.5c; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Chadha VD, 2009, ONCOL RES, V18, P17, DOI 10.3727/096504009789745665; Coronado C, 2010, DRUG FUTURE, V35, P287, DOI 10.1358/dof.2010.035.04.1497635; Cruz LJ, 2009, MOL PHARMACEUT, V6, P813, DOI 10.1021/mp8001039; ENGLAND SK, 1995, J BIOL CHEM, V270, P28531, DOI 10.1074/jbc.270.48.28531; ENGLAND SK, 1995, P NATL ACAD SCI USA, V92, P6309, DOI 10.1073/pnas.92.14.6309; Franqueza L, 1997, CIRC RES, V81, P1053; GarciaRocha M, 1996, CANCER LETT, V99, P43, DOI 10.1016/0304-3835(95)04036-6; Gonzalez T, 2002, MOL PHARMACOL, V62, P1456, DOI 10.1124/mol.62.6.1456; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Herrero AB, 2008, CANCER RES, V68, P9779, DOI 10.1158/0008-5472.CAN-08-1981; Janmaat ML, 2005, MOL PHARMACOL, V68, P502, DOI 10.1124/mol.105.011361; Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063, DOI 10.1152/ajpcell.2000.278.6.C1063; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; NYHOLM PG, 1990, CHEM PHYS LIPIDS, V52, P1, DOI 10.1016/0009-3084(90)90002-9; PASTERNAK CA, 1987, BIOSCIENCE REP, V7, P81, DOI 10.1007/BF01121871; Provencio M, 2009, CLIN LUNG CANCER, V10, P295, DOI 10.3816/CLC.2009.n.041; Sewell JM, 2005, EUR J CANCER, V41, P1637, DOI 10.1016/j.ejca.2005.04.015; Suarez Y, 2003, MOL CANCER THER, V2, P863; Valenzuela C, 1996, CIRCULATION, V94, P562, DOI 10.1161/01.CIR.94.3.562; Valero RA, 2008, CELL CALCIUM, V44, P259, DOI 10.1016/j.ceca.2007.12.002; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179	26	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19042	10.1371/journal.pone.0019042	http://dx.doi.org/10.1371/journal.pone.0019042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556352	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400022
J	Dubois, E; Cordoba-Canero, D; Massot, S; Siaud, N; Gakiere, B; Domenichini, S; Guerard, F; Roldan-Arjona, T; Doutriaux, MP				Dubois, Emeline; Cordoba-Canero, Dolores; Massot, Sophie; Siaud, Nicolas; Gakiere, Bertrand; Domenichini, Severine; Guerard, Florence; Roldan-Arjona, Teresa; Doutriaux, Marie-Pascale			Homologous Recombination Is Stimulated by a Decrease in dUTPase in Arabidopsis	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DEOXYURIDINE TRIPHOSPHATASE; STRAND BREAKS; DNA; THALIANA; MUTANTS; URACIL; FRAGMENTATION	Deoxyuridine triphosphatase (dUTPase) enzyme is an essential enzyme that protects DNA against uracil incorporation. No organism can tolerate the absence of this activity. In this article, we show that dUTPase function is conserved between E. coli (Escherichia coli), yeast (Saccharomyces cerevisiae) and Arabidopsis (Arabidopsis thaliana) and that it is essential in Arabidopsis as in both micro-organisms. Using a RNA interference strategy, plant lines were generated with a diminished dUTPase activity as compared to the wild-type. These plants are sensitive to 5-fluoro-uracil. As an indication of DNA damage, inactivation of dUTPase results in the induction of AtRAD51 and AtPARP2, which are involved in DNA repair. Nevertheless, RNAi/DUT1 constructs are compatible with a rad51 mutation. Using a TUNEL assay, DNA damage was observed in the RNAi/DUT1 plants. Finally, plants carrying a homologous recombination (HR) exclusive substrate transformed with the RNAi/DUT1 construct exhibit a seven times increase in homologous recombination events. Increased HR was only detected in the plants that were the most sensitive to 5-fluoro-uracils, thus establishing a link between uracil incorporation in the genomic DNA and HR. Our results show for the first time that genetic instability provoked by the presence of uracils in the DNA is poorly tolerated and that this base misincorporation globally stimulates HR in plants.	[Dubois, Emeline; Massot, Sophie; Siaud, Nicolas; Gakiere, Bertrand; Domenichini, Severine; Doutriaux, Marie-Pascale] Univ Paris 11, CNRS, Inst Biol Plantes, UMR 8618, F-91405 Orsay, France; [Cordoba-Canero, Dolores; Roldan-Arjona, Teresa] Univ Cordoba, Dept Genet, Cordoba, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universidad de Cordoba	Dubois, E (corresponding author), CNRS, Ctr Genet Mol, Gif Sur Yvette, France.	Marie-Pascale.Doutriaux@u-psud.fr	Roldan-Arjona, Teresa/H-5976-2015; Cordoba Canero, Dolores/H-8450-2018	Roldan-Arjona, Teresa/0000-0003-2842-3956; Dubois, Emeline/0000-0002-2515-9128; Cordoba Canero, Dolores/0000-0002-9659-4928; DOMENICHINI, Severine/0000-0002-5997-2694; Gakiere, Bertrand/0000-0003-0285-5160	Ministerio de Educacion y Ciencia, Spain [BFU2007-60956/BMC]; Junta de Andalucia, Spain [P07-CVI-02770]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Junta de Andalucia, Spain(Junta de Andalucia)	ED was supported by an Ile de France grant for three years and then by an Association pour la Recherche sur le Cancer grant for nine months. An EMBO short term fellowship supported the ED collaboration with the Cordoba laboratory; this work was supported by the Ministerio de Educacion y Ciencia, Spain (grant number BFU2007-60956/BMC) and from the Junta de Andalucia, Spain (grant number P07-CVI-02770) grants to TRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESSMAN MJ, 1958, P NATL ACAD SCI USA, V44, P633, DOI 10.1073/pnas.44.7.633; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillo-Acosta VM, 2008, INT J BIOCHEM CELL B, V40, P2901, DOI 10.1016/j.biocel.2008.06.009; Cordoba-Canero D, 2010, J BIOL CHEM, V285, P7475, DOI 10.1074/jbc.M109.067173; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; DANENBERG PV, 1977, BIOCHIM BIOPHYS ACTA, V473, P73, DOI 10.1016/0304-419X(77)90001-4; Dengg M, 2006, EMBO REP, V7, P1046, DOI 10.1038/sj.embor.7400782; Deveaux Y, 2003, PLANT J, V36, P918, DOI 10.1046/j.1365-313X.2003.01922.x; Doucet-Chabeaud G, 2001, MOL GENET GENOMICS, V265, P954, DOI 10.1007/s004380100506; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; ELHAJJ HH, 1988, J BACTERIOL, V170, P1069, DOI 10.1128/jb.170.3.1069-1075.1988; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Friedberg E. C., 2006, DNA REPAIR MUTAGENES, P317; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; GREENBERG GR, 1962, P NATL ACAD SCI USA, V48, P247, DOI 10.1073/pnas.48.2.247; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; HOCHHAUSER SJ, 1978, J BACTERIOL, V134, P157, DOI 10.1128/JB.134.1.157-166.1978; KONRAD EB, 1975, P NATL ACAD SCI USA, V72, P2150, DOI 10.1073/pnas.72.6.2150; Kouzminova EA, 2006, J MOL BIOL, V355, P20, DOI 10.1016/j.jmb.2005.10.044; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Meng PH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007364; Molinier J, 2004, PLANT CELL, V16, P342, DOI 10.1105/tpc.019042; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Siaud N, 2004, EMBO J, V23, P1392, DOI 10.1038/sj.emboj.7600146; Siaud N, 2010, DNA REPAIR, V9, P567, DOI 10.1016/j.dnarep.2010.02.009	28	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18658	10.1371/journal.pone.0018658	http://dx.doi.org/10.1371/journal.pone.0018658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541310	Green Published, gold			2022-12-25	WOS:000290018400006
J	Richmond, GS; Khine, H; Zhou, TT; Ryan, DE; Brand, T; McBride, MT; Killeen, K				Richmond, Gregory S.; Khine, Htet; Zhou, Tina T.; Ryan, Daniel E.; Brand, Tony; McBride, Mary T.; Killeen, Kevin			MassCode Liquid Arrays as a Tool for Multiplexed High-Throughput Genetic Profiling	PLOS ONE			English	Article							MOLECULAR DETERMINATION; RESPIRATORY PATHOGENS; RHINOVIRUS GENOTYPE; SUSPENSION ARRAY; PCR; IDENTIFICATION; ASSAY; SYSTEM; PARTICLES; DNA	Multiplexed detection assays that analyze a modest number of nucleic acid targets over large sample sets are emerging as the preferred testing approach in such applications as routine pathogen typing, outbreak monitoring, and diagnostics. However, very few DNA testing platforms have proven to offer a solution for mid-plexed analysis that is high-throughput, sensitive, and with a low cost per test. In this work, an enhanced genotyping method based on MassCode technology was devised and integrated as part of a high-throughput mid-plexing analytical system that facilitates robust qualitative differential detection of DNA targets. Samples are first analyzed using MassCode PCR (MC-PCR) performed with an array of primer sets encoded with unique mass tags. Lambda exonuclease and an array of MassCode probes are then contacted with MC-PCR products for further interrogation and target sequences are specifically identified. Primer and probe hybridizations occur in homogeneous solution, a clear advantage over micro- or nanoparticle suspension arrays. The two cognate tags coupled to resultant MassCode hybrids are detected in an automated process using a benchtop single quadrupole mass spectrometer. The prospective value of using MassCode probe arrays for multiplexed bioanalysis was demonstrated after developing a 14plex proof of concept assay designed to subtype a select panel of Salmonella enterica serogroups and serovars. This MassCode system is very flexible and test panels can be customized to include more, less, or different markers.	[Richmond, Gregory S.; Khine, Htet; Zhou, Tina T.; Ryan, Daniel E.; Brand, Tony; McBride, Mary T.; Killeen, Kevin] Agilent Technol, Santa Clara, CA 95051 USA	Agilent Technologies	Richmond, GS (corresponding author), Agilent Technol, Santa Clara, CA 95051 USA.	gregory_richmond@agilent.com			Agilent Technologies	Agilent Technologies	This is a research and development project funded by Agilent Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhras MS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000223; Alon N, 2006, J COMPUT BIOL, V13, P1659, DOI 10.1089/cmb.2006.13.1659; Arrach N, 2008, J CLIN MICROBIOL, V46, P2581, DOI 10.1128/JCM.02147-07; Bahrdt C, 2010, ANAL BIOANAL CHEM, V396, P2103, DOI 10.1007/s00216-009-3380-x; BALADALLASAT JM, 2010, J CLIN VIROL; Birtwell S, 2009, INTEGR BIOL-UK, V1, P345, DOI 10.1039/b905502a; Blanchard AP, 1996, BIOSENS BIOELECTRON, V11, P687, DOI 10.1016/0956-5663(96)83302-1; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Cederquist KB, 2010, WIRES NANOMED NANOBI, V2, P578, DOI 10.1002/wnan.96; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Dunbar SA, 2003, J MICROBIOL METH, V53, P245, DOI 10.1016/S0167-7012(03)00028-9; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Fox A, 2006, J CLIN MICROBIOL, V44, P2677, DOI 10.1128/JCM.00971-06; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; HAN J, 2006, ADV TECHNIQUES DIAGN, V27, P472; Han J, 2006, J CLIN MICROBIOL, V44, P4157, DOI 10.1128/JCM.01762-06; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Hanley B, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-32; He B, 2006, LANGMUIR, V22, P8263, DOI 10.1021/la060187t; Herrera-Leon S, 2004, J CLIN MICROBIOL, V42, P2581, DOI 10.1128/JCM.42.6.2581-2586.2004; Hong Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-178; Jabado OJ, 2006, NUCLEIC ACIDS RES, V34, P6605, DOI 10.1093/nar/gkl966; Jennings TL, 2008, ANAL CHEM, V80, P2849, DOI 10.1021/ac7026035; Kim S, 2006, J CLIN MICROBIOL, V44, P3608, DOI 10.1128/JCM.00701-06; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Kokoris M, 2000, MOL DIAGN, V5, P329; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Leader BT, 2009, J CLIN MICROBIOL, V47, P1290, DOI 10.1128/JCM.02095-08; Lin X, 2007, CLIN CHEM, V53, P1372, DOI 10.1373/clinchem.2006.081810; MCKILLIP J, 2006, HDB FOOD SCI TECHNOL, V4, pCH187; Merante F, 2007, J CLIN VIROL, V40, pS31, DOI 10.1016/S1386-6532(07)70007-0; Mertes F, 2010, J MICROBIOL METH, V83, P217, DOI 10.1016/j.mimet.2010.09.005; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Perkins TT, 2003, SCIENCE, V301, P1914, DOI 10.1126/science.1088047; Pregibon DC, 2007, SCIENCE, V315, P1393, DOI 10.1126/science.1134929; Rachlin J, 2005, NUCLEIC ACIDS RES, V33, pW544, DOI 10.1093/nar/gki377; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; SANCHEZ S, 2006, METHODS FOODS CHAPTE, V4, P51; Scaria J, 2008, MOL CELL PROBE, V22, P238, DOI 10.1016/j.mcp.2008.04.002; Smith J, 2005, ANN NY ACAD SCI, V1050, P286, DOI 10.1196/annals.1313.030; TANKOUOSANDJONG AS, 2008, MICROBIAL BIOTECHNOL, V1, P10; Varley KE, 2008, GENOME RES, V18, P1844, DOI 10.1101/gr.078204.108; Wattiau P, 2008, J CLIN MICROBIOL, V46, P4037, DOI 10.1128/JCM.01405-08; Zhang WM, 2009, ANAL CHEM, V81, P2815, DOI 10.1021/ac802670q	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18967	10.1371/journal.pone.0018967	http://dx.doi.org/10.1371/journal.pone.0018967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544191	gold, Green Published, Green Submitted			2022-12-25	WOS:000290015800026
J	Radovanovic, I; Mullick, A; Gros, P				Radovanovic, Irena; Mullick, Alaka; Gros, Philippe			Genetic Control of Susceptibility to Infection with Candida albicans in Mice	PLOS ONE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; INBRED MOUSE STRAINS; INTERFERON-GAMMA; FUNGAL-INFECTIONS; IMMUNE-RESPONSES; TH17-ASSOCIATED CYTOKINES; SYSTEMIC CANDIDIASIS; TISSUE-DAMAGE; RESISTANCE; TRANSCRIPTION	Candida albicans is an opportunistic pathogen that causes acute disseminated infections in immunocompromised hosts, representing an important cause of morbidity and mortality in these patients. To study the genetic control of susceptibility to disseminated C. albicans in mice, we phenotyped a group of 23 phylogenetically distant inbred strains for susceptibility to infection as measured by extent of fungal replication in the kidney 48 hours following infection. Susceptibility was strongly associated with the loss-of-function mutant complement component 5 (C5/Hc) allele, which is known to be inherited by approximately 40% of inbred strains. Our survey identified 2 discordant strains, AKR/J (C5-deficient, resistant) and SM/J (C5-sufficient, susceptible), suggesting that additional genetic effects may control response to systemic candidiasis in these strains. Haplotype association mapping in the 23 strains using high density SNP maps revealed several putative loci regulating the extent of C. albicans replication, amongst which the most significant were C5 (P value = 2.43x10(-11)) and a novel effect on distal chromosome 11 (P value = 7.63x10(-9)). Compared to other C5-deficient strains, infected AKR/J strain displays a reduced fungal burden in the brain, heart and kidney, and increased survival, concomitant with uniquely high levels of serum IFN gamma. C5-independent genetic effects were further investigated by linkage analysis in an [A/JxAKR/J] F2 cross (n = 158) where the mutant Hc allele is fixed. These studies identified a chromosome 11 locus (Carg4, Candida albicans resistance gene 4; LOD = 4.59), and a chromosome 8 locus (Carg3; LOD = 3.95), both initially detected by haplotype association mapping. Alleles at both loci were inherited in a co-dominant manner. Our results verify the important effect of C5-deficiency in inbred mouse strains, and further identify two novel loci, Carg3 and Carg4, which regulate resistance to C. albicans infection in a C5-independent manner.	[Radovanovic, Irena; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Mullick, Alaka] Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	McGill University; National Research Council Canada	Radovanovic, I (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	philippe.gros@mcgill.ca		Radovanovic, Irena/0000-0002-3823-3729	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by a Team Grant in Fungal Pahtogenesis from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman RB, 1998, MICROB PATHOGENESIS, V25, P333, DOI 10.1006/mpat.1998.0240; Ashman RB, 1996, INFECT IMMUN, V64, P1866, DOI 10.1128/IAI.64.5.1866-1869.1996; Ashman RB, 1998, MICROB PATHOGENESIS, V25, P349, DOI 10.1006/mpat.1998.0248; Ashman RB, 2003, MICROB PATHOGENESIS, V34, P103, DOI 10.1016/S0882-4010(02)00211-5; Ashman RB, 1997, MICROB PATHOGENESIS, V22, P187, DOI 10.1006/mpat.1996.0102; ASHMAN RB, 1993, IMMUNOL CELL BIOL, V71, P221, DOI 10.1038/icb.1993.25; Ashman RB, 2008, FRONT BIOSCI-LANDMRK, V13, P3334; Balish E, 1998, J INFECT DIS, V178, P478, DOI 10.1086/515645; BANGE FC, 1994, J BIOL CHEM, V269, P1091; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BRUMMER E, 1994, CELL IMMUNOL, V157, P1, DOI 10.1006/cimm.1994.1200; BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; Cenci E, 1998, J IMMUNOL, V161, P3543; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; COHEN MS, 1981, AM J MED, V71, P59, DOI 10.1016/0002-9343(81)90259-X; DJEU JY, 1986, J IMMUNOL, V137, P2980; Duan BY, 2010, J IMMUNOL, V185, P335, DOI 10.4049/jimmunol.0903474; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Glocker EO, 2009, NEW ENGL J MED, V361, P1727, DOI 10.1056/NEJMoa0810719; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HECTOR RF, 1982, INFECT IMMUN, V38, P1020, DOI 10.1128/IAI.38.3.1020-1028.1982; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kirby A, 2010, GENETICS, V185, P1081, DOI 10.1534/genetics.110.115014; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kitsios GD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013782; KULLBERG BJ, 1993, J INFECT DIS, V168, P436, DOI 10.1093/infdis/168.2.436; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LANDER ES, 1989, GENETICS, V121, P185; Lanza F, 1998, J MOL MED-JMM, V76, P676, DOI 10.1007/s001090050267; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Manenti G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000331; MARODI L, 1993, J CLIN INVEST, V91, P2596, DOI 10.1172/JCI116498; Mathews Herbert L., 2002, P179; McClurg P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-61; Morgan Juliette, 2005, Curr Infect Dis Rep, V7, P429, DOI 10.1007/s11908-005-0044-7; Mullick A, 2004, INFECT IMMUN, V72, P5868, DOI 10.1128/IAI.72.10.5868-5876.2004; Mullick A, 2006, INFECT IMMUN, V74, P4439, DOI 10.1128/IAI.00159-06; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; RHODES JC, 1980, INFECT IMMUN, V29, P494; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; ROMANI L, 1994, J IMMUNOL, V152, P3514; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; SHEPHERD MG, 1985, ANNU REV MICROBIOL, V39, P579, DOI 10.1146/annurev.mi.39.100185.003051; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Su WL, 2010, MAMM GENOME, V21, P143, DOI 10.1007/s00335-010-9249-7; Tan J, 2008, J VIROL, V82, P4275, DOI 10.1128/JVI.02249-07; Tsoni SV, 2009, INFECT IMMUN, V77, P3679, DOI 10.1128/IAI.00233-09; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Tuite A, 2004, GENES IMMUN, V5, P576, DOI 10.1038/sj.gene.6364130; Vazquez-Torres A, 1999, INFECT IMMUN, V67, P670, DOI 10.1128/IAI.67.2.670-674.1999; Wang XY, 1996, BIOCHEM BIOPH RES CO, V229, P316, DOI 10.1006/bbrc.1996.1799; WATSON PA, 1994, J BIOL CHEM, V269, P28893; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; ZELLER R, 2001, FIXATION EMBEDDING S, pCH14; Zhang LQ, 2007, CELL SIGNAL, V19, P932, DOI 10.1016/j.cellsig.2006.11.002; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005	71	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18957	10.1371/journal.pone.0018957	http://dx.doi.org/10.1371/journal.pone.0018957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533108	Green Submitted, Green Published, gold			2022-12-25	WOS:000289719400039
J	Sklepkiewicz, P; Schermuly, RT; Tian, X; Ghofrani, HA; Weissmann, N; Sedding, D; Kashour, T; Seeger, W; Grimminger, F; Pullamsetti, SS				Sklepkiewicz, Piotr; Schermuly, Ralph Theo; Tian, Xia; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Sedding, Daniel; Kashour, Tarek; Seeger, Werner; Grimminger, Friedrich; Pullamsetti, Soni Savai			Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; BETA-CATENIN; WNT/BETA-CATENIN; UP-REGULATION; CYCLIN D1; INHIBITION; THERAPY; GROWTH; PATHWAYS; SURVIVAL	Rationale: Pulmonary arterial hypertension (PAH) is a rare progressive pulmonary vascular disorder associated with vascular remodeling and right heart failure. Vascular remodeling involves numerous signaling cascades governing pulmonary arterial smooth muscle cell (PASMC) proliferation, migration and differentiation. Glycogen synthase kinase 3beta (GSK3 beta) is a serine/threonine kinase and can act as a downstream regulatory switch for numerous signaling pathways. Hence, we hypothesized that GSK3 beta plays a crucial role in pulmonary vascular remodeling. Methods: All experiments were done with lung tissue or isolated PASMCs in a well-established monocrotaline (MCT)-induced PAH rat model. The mRNA expression of Wnt ligands (Wnt1, Wnt3a, Wnt5a), upstream Wnt signaling regulator genes (Frizzled Receptors 1, 2 and secreted Frizzled related protein sFRP-1) and canonical Wnt intracellular effectors (GSK3 beta, Axin1) were assessed by real-time polymerase chain reaction and protein levels of GSK3 beta, phospho-GSK3 beta (ser 9) by western blotting and localization by immunohistochemistry. The role of GSK3 beta in PASMCs proliferation was assessed by overexpression of wild-type GSK3 beta (WT) and constitutively active GSK3 beta S9A by [3H]-thymidine incorporation assay. Results: Increased levels of total and phosphorylated GSK3 beta (inhibitory phosphorylation) were observed in lungs and PASMCs isolated from MCT-induced PAH rats compared to controls. Further, stimulation of MCT-PASMCs with growth factors induced GSK3 beta inactivation. Most importantly, treatment with the PDGFR inhibitor, Imatinib, attenuated PDGF-BB and FCS induced GSK3 beta phosphorylation. Increased expression of GSK3 beta observed in lungs and PASMC isolated from MCT-induced PAH rats was confirmed to be clinically relevant as the same observation was identified in human iPAH lung explants. Overexpression of GSK3 beta significantly increased MCT-PASMCs proliferation by regulating ERK phosphorylation. Constitutive activation of GSK3 beta (GSK3 beta S9A, 9th serine replaced to alanine) inhibited MCT-PASMCs proliferation by decreasing ERK phosphorylation. Conclusion: This study supports a central role for GSK3 beta in vascular remodeling processes and suggests a novel therapeutic opportunity for the treatment of PAH.	[Sklepkiewicz, Piotr; Schermuly, Ralph Theo; Tian, Xia; Ghofrani, Hossein Ardeschir; Weissmann, Norbert; Seeger, Werner; Grimminger, Friedrich; Pullamsetti, Soni Savai] Univ Hosp, Med Clin 2 5, Giessen, Germany; [Schermuly, Ralph Theo; Seeger, Werner; Pullamsetti, Soni Savai] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Sedding, Daniel] Univ Hosp, Med Clin 1, Giessen, Germany; [Kashour, Tarek] King Fahad Med City, Riyadh, Saudi Arabia	Max Planck Society	Sklepkiewicz, P (corresponding author), Univ Hosp, Med Clin 2 5, Giessen, Germany.	soni.pullamsetti@mpi-bn.mpg.de	Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022	Ghofrani, Ardeschir/0000-0002-2029-4419; Pullamsetti, Soni Savai/0000-0003-0440-8831; Schermuly, Ralph/0000-0002-5167-6970; Weissmann, Norbert/0000-0003-2675-3871; Seeger, Werner/0000-0003-1946-0894	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 547, B11, C6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 547 "Kardiopulmonales Gefasssystem'', Projekt B11 and C6 (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Arciniegas E, 2007, AM J PHYSIOL-LUNG C, V293, pL1, DOI 10.1152/ajplung.00378.2006; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BENDEY JK, 2009, AM J PHYSIOL-LUNG C, V296, pL176; Bonnet S, 2009, CIRCULATION, V120, P1231, DOI 10.1161/CIRCULATIONAHA.109.848911; Chen XY, 2009, PHARMACOLOGY, V83, P67, DOI 10.1159/000178814; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; George SJ, 2006, ATHEROSCLEROSIS, V188, P1, DOI 10.1016/j.atherosclerosis.2005.12.017; GOODE N, 1992, J BIOL CHEM, V267, P16878; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Lai YJ, 2008, AM J RESP CRIT CARE, V178, P188, DOI 10.1164/rccm.200710-1519OC; Laumanns IP, 2009, AM J RESP CELL MOL, V40, P683, DOI 10.1165/rcmb.2008-0153OC; Li FH, 2009, PEDIATR CARDIOL, V30, P363, DOI 10.1007/s00246-008-9315-z; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Merklinger SL, 2005, CIRCULATION, V112, P423, DOI 10.1161/CIRCULATIONAHA.105.540542; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Park KW, 2003, ARTERIOSCL THROM VAS, V23, P1364, DOI 10.1161/01.ATV.0000081633.53390.B4; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Pullamsetti S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-128; Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Savai R, 2005, INT J ONCOL, V27, P393; Schermuly RT, 2007, CIRCULATION, V115, P2331, DOI 10.1161/CIRCULATIONAHA.106.676809; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shin HS, 2003, CIRC RES, V93, P302, DOI 10.1161/01.RES.0000086803.64109.9E; Tsakiridis T, 2001, BIOCHEM BIOPH RES CO, V288, P205, DOI 10.1006/bbrc.2001.5762; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Wedgwood S, 2007, PEDIATR RES, V61, P32, DOI 10.1203/01.pdr.0000250013.77008.28; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Zhang SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC613, DOI 10.1152/ajpcell.00421.2006	49	31	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18883	10.1371/journal.pone.0018883	http://dx.doi.org/10.1371/journal.pone.0018883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533110	Green Published, Green Submitted, gold			2022-12-25	WOS:000289620100027
J	Stein, DC; Miller, CJ; Bhoopalan, SV; Sommer, DD				Stein, Daniel C.; Miller, Clinton J.; Bhoopalan, Senthil V.; Sommer, Daniel D.			Sequence-Based Predictions of Lipooligosaccharide Diversity in the Neisseriaceae and Their Implication in Pathogenicity	PLOS ONE			English	Article							3-DEOXY-D-MANNO-OCTULOSONIC ACID TRANSFERASE; LIPOPOLYSACCHARIDE CORE OLIGOSACCHARIDES; ADHESION MOLECULE EXPRESSION; R-TYPE LIPOPOLYSACCHARIDES; STRUCTURAL HETEROGENEITY; PYOCIN RESISTANCE; KDO TRANSFERASE; GENETIC-LOCUS; GONORRHOEAE; MENINGITIDIS	Endotoxin [Lipopolysaccharide (LPS)/Lipooligosaccharide (LOS)] is an important virulence determinant in gram negative bacteria. While the genetic basis of endotoxin production and its role in disease in the pathogenic Neisseria has been extensively studied, little research has focused on the genetic basis of LOS biosynthesis in commensal Neisseria. We determined the genomic sequences of a variety of commensal Neisseria strains, and compared these sequences, along with other genomic sequences available from various sequencing centers from commensal and pathogenic strains, to identify genes involved in LOS biosynthesis. This allowed us to make structural predictions as to differences in LOS seen between commensal and pathogenic strains. We determined that all neisserial strains possess a conserved set of genes needed to make a common 3-Deoxy-D-manno-octulosonic acid -heptose core structure. However, significant genomic differences in glycosyl transferase genes support the published literature indicating compositional differences in the terminal oligosaccharides. This was most pronounced in commensal strains that were distally related to the gonococcus and meningococcus. These strains possessed a homolog of heptosyltransferase III, suggesting that they differ from the pathogenic strains by the presence a third heptose. Furthermore, most commensal strains possess homologs of genes needed to synthesize lipopolysaccharide (LPS). N. cinerea, a commensal species that is highly related to the gonococcus has lost the ability to make sialyltransferase. Overall genomic comparisons of various neisserial strains indicate that significant recombination/genetic acquisition/loss has occurred within the genus, and this muddles proper speciation.	[Stein, Daniel C.; Miller, Clinton J.; Bhoopalan, Senthil V.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Sommer, Daniel D.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Stein, DC (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dcstein@umd.edu	Bhoopalan, Senthil Velan/U-8477-2018	Bhoopalan, Senthil Velan/0000-0002-1402-6549; Stein, Daniel/0000-0003-3397-5720	National Institutes of Health [AI073667, LM006845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024452, R01AI073667] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from the National Institutes of Health to DCS, grant number AI073667 and DDS LM006845. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APICELLA MA, 1987, INFECT IMMUN, V55, P1755, DOI 10.1128/IAI.55.8.1755-1761.1987; Banerjee A, 1998, P NATL ACAD SCI USA, V95, P10872, DOI 10.1073/pnas.95.18.10872; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Brabetz W, 2000, J BIOL CHEM, V275, P34954, DOI 10.1074/jbc.M005204200; Buttcher V, 1999, BBA-PROTEIN STRUCT M, V1432, P406, DOI 10.1016/S0167-4838(99)00101-6; DANAHER RJ, 1995, J BACTERIOL, V177, P7275, DOI 10.1128/jb.177.24.7275-7279.1995; Delcher AL, 2003, CURRENT PROTOCOLS BI, DOI DOI 10.13.11-10.13.18; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dixon GLJ, 1999, INFECT IMMUN, V67, P5626, DOI 10.1128/IAI.67.11.5626-5633.1999; DRUMMOND AJ, 2009, GENEIOUS V4 7; Feil E, 1996, J MOL EVOL, V43, P631, DOI 10.1007/BF02202111; GAMIAN A, 1992, J BIOL CHEM, V267, P922; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; GIBSON BW, 1989, P NATL ACAD SCI USA, V86, P17, DOI 10.1073/pnas.86.1.17; Gilbert M, 1997, EUR J BIOCHEM, V249, P187, DOI 10.1111/j.1432-1033.1997.t01-1-00187.x; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; GOTSCHLICH EC, 1994, J EXP MED, V180, P2181, DOI 10.1084/jem.180.6.2181; JANTZEN E, 1976, ACTA PATH MICRO IM B, V84, P177; JENNINGS HJ, 1980, CAN J BIOCHEM CELL B, V58, P128, DOI 10.1139/o80-018; JOHN CM, 1991, J BIOL CHEM, V266, P19303; Kahler CM, 1996, J BACTERIOL, V178, P6677, DOI 10.1128/jb.178.23.6677-6684.1996; KERWOOD DE, 1992, BIOCHEMISTRY-US, V31, P12760, DOI 10.1021/bi00166a008; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; LAIRSON LL, 2004, J BIOL CHEM; Linz B, 2000, MOL MICROBIOL, V36, P1049, DOI 10.1046/j.1365-2958.2000.01932.x; LUCAS CE, 1995, MOL MICROBIOL, V16, P1001, DOI 10.1111/j.1365-2958.1995.tb02325.x; Maiden MCJ, 2008, CURR OPIN MICROBIOL, V11, P467, DOI 10.1016/j.mib.2008.09.002; MANDRELL RE, 1990, J EXP MED, V171, P1649, DOI 10.1084/jem.171.5.1649; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; MICHON F, 1990, J BIOL CHEM, V265, P7243; O'Connor ET, 2009, J BACTERIOL, V191, P3311, DOI 10.1128/JB.01433-08; O'Connor ET, 2006, J BACTERIOL, V188, P1039, DOI 10.1128/JB.188.3.1039-1048.2006; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; PETRICOIN EF, 1991, J BACTERIOL, V173, P7896, DOI 10.1128/jb.173.24.7896-7902.1991; PETRICOIN EF, 1989, INFECT IMMUN, V57, P2847, DOI 10.1128/IAI.57.9.2847-2852.1989; Piekarowicz A, 2002, J BACTERIOL, V184, P6410, DOI 10.1128/JB.184.23.6410-6416.2002; Plant L, 2006, INFECT IMMUN, V74, P1360, DOI 10.1128/IAI.74.2.1360-1367.2006; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SANDLIN R, 1991, FEMS MICROBIOL LETT, V90, P69, DOI 10.1016/0378-1097(91)90648-T; SANDLIN RC, 1994, J BACTERIOL, V176, P6869, DOI 10.1128/JB.176.22.6869-6876.1994; Smith H, 1995, MICROB PATHOGENESIS, V19, P365, DOI 10.1006/mpat.1995.0071; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Tong YH, 2002, GLYCOBIOLOGY, V12, P523, DOI 10.1093/glycob/cwf047; TSAI CM, 1987, INFECT IMMUN, V55, P1652, DOI 10.1128/IAI.55.7.1652-1656.1987; Tzeng YL, 2002, J BACTERIOL, V184, P2379, DOI 10.1128/JB.184.9.2379-2388.2002; van Passel MWJ, 2006, FEMS MICROBIOL LETT, V262, P77, DOI 10.1111/j.1574-6968.2006.00366.x; Wakarchuk W, 1996, J BIOL CHEM, V271, P19166, DOI 10.1074/jbc.271.32.19166; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Wang XY, 2010, OPT ENG, V49, DOI 10.1117/1.3281669; White KA, 1997, J BIOL CHEM, V272, P16555, DOI 10.1074/jbc.272.26.16555; YAMASAKI R, 1994, J BIOL CHEM, V269, P30345; YAMASAKI R, 1991, BIOCHEMISTRY-US, V30, P10566, DOI 10.1021/bi00107a028; Yamasaki R, 1999, J BIOL CHEM, V274, P36550, DOI 10.1074/jbc.274.51.36550; Zhang P, 2006, J LEUKOCYTE BIOL, V79, P731, DOI 10.1189/jlb.0405184; ZHOU DG, 1994, MOL MICROBIOL, V14, P609, DOI 10.1111/j.1365-2958.1994.tb01300.x; Zhu PX, 2002, MICROBIOL-SGM, V148, P1833, DOI 10.1099/00221287-148-6-1833; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	61	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18923	10.1371/journal.pone.0018923	http://dx.doi.org/10.1371/journal.pone.0018923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533118	Green Submitted, Green Published, gold			2022-12-25	WOS:000289620100029
J	Seredynski, AL; Ball, GF; Balthazart, J; Charlier, TD				Seredynski, Aurore L.; Ball, Gregory F.; Balthazart, Jacques; Charlier, Thierry D.			Specific Activation of Estrogen Receptor Alpha and Beta Enhances Male Sexual Behavior and Neuroplasticity in Male Japanese Quail	PLOS ONE			English	Article							MEDIAL PREOPTIC NUCLEUS; AROMATASE-IMMUNOREACTIVE CELLS; ER-BETA; MESSENGER-RNA; COTURNIX-JAPONICA; GENE DISRUPTION; RAT-BRAIN; VASOTOCINERGIC INNERVATION; CONSUMMATORY ASPECTS; INHIBITION BLOCKS	Two subtypes of estrogen receptors (ER), ER alpha and ER beta, have been identified in humans and numerous vertebrates, including the Japanese quail. We investigated in this species the specific role(s) of each receptor in the activation of male sexual behavior and the underlying estrogen-dependent neural plasticity. Castrated male Japanese quail received empty (CX) or testosterone-filled (T) implants or were daily injected with the ER general agonist diethylstilbestrol (DES), the ER alpha-specific agonist PPT, the ER beta-specific agonist DPN or the vehicle, propylene glycol. Three days after receiving the first treatment, subjects were alternatively tested for appetitive (rhythmic cloacal sphincter movements, RCSM) and consummatory aspects (copulatory behavior) of male sexual behavior. 24 hours after the last behavioral testing, brains were collected and analyzed for aromatase expression and vasotocinergic innervation in the medial preoptic nucleus. The expression of RCSM was activated by T and to a lesser extent by DES and PPT but not by the ER beta agonist DPN. In parallel, T fully restored the complete sequence of copulation, DES was partially active and the specific activation of ER alpha or ER beta only resulted in a very low frequency of mount attempts in few subjects. T increased the volume of the medial preoptic nucleus as measured by the dense cluster of aromatase-immunoreactive cells and the density of the vasotocinergic innervation within this nucleus. DES had only a weak action on vasotocinergic fibers and the two specific ER agonists did not affect these neural responses. Simultaneous activation of both receptors or treatments with higher doses may be required to fully activate sexual behavior and the associated neurochemical events.	[Seredynski, Aurore L.; Balthazart, Jacques; Charlier, Thierry D.] Univ Liege, Res Grp Behav Neuroendocrinol, GIGA Neurosci, Liege, Belgium; [Ball, Gregory F.] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA	University of Liege; Johns Hopkins University	Seredynski, AL (corresponding author), Univ Liege, Res Grp Behav Neuroendocrinol, GIGA Neurosci, Liege, Belgium.	tcharlier@ulg.ac.be	Charlier, Thierry/J-4668-2015	Ball, Gregory/0000-0002-4784-0520	NIMH [R01 MH50388]; Belgian FRFC [2.4537.9]; University of Liege; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050388] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Belgian FRFC(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant of the NIMH (R01 MH50388) to GFB and JB and by grants from the Belgian FRFC (Nbr. 2.4537.9), the University of Liege (Credits speciaux) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absil P, 2002, BRAIN BEHAV EVOLUT, V60, P13, DOI 10.1159/000064119; Absil P, 2002, J CHEM NEUROANAT, V24, P27, DOI 10.1016/S0891-0618(02)00017-0; Absil P, 2001, BRAIN RES REV, V37, P38, DOI 10.1016/S0165-0173(01)00122-9; ADKINS EK, 1980, PHYSIOL BEHAV, V24, P441, DOI 10.1016/0031-9384(80)90233-4; ADKINS EK, 1972, J COMP PHYSIOL PSYCH, V81, P27, DOI 10.1037/h0033315; ADKINS EK, 1978, J COMP PHYSIOL PSYCH, V92, P1169, DOI 10.1037/h0077523; ADKINS EK, 1976, HORM BEHAV, V7, P417, DOI 10.1016/0018-506X(76)90013-1; ALEXANDRE C, 1986, PHYSIOL BEHAV, V38, P581, DOI 10.1016/0031-9384(86)90429-4; Alves SE, 1998, P NATL ACAD SCI USA, V95, P3281, DOI 10.1073/pnas.95.6.3281; Aste N, 1998, J CHEM NEUROANAT, V14, P103, DOI 10.1016/S0891-0618(97)10023-0; AXELSON JF, 1990, J NEUROENDOCRINOL, V2, P209, DOI 10.1111/j.1365-2826.1990.tb00852.x; Ball GF, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P855; Ball GF, 2008, HORM BEHAV, V53, P307, DOI 10.1016/j.yhbeh.2007.09.023; BALTHAZART J, 1994, NEUROREPORT, V5, P1729, DOI 10.1097/00001756-199409080-00010; BALTHAZART J, 1990, HORM BEHAV, V24, P510, DOI 10.1016/0018-506X(90)90039-Z; Balthazart J, 1997, BEHAV NEUROSCI, V111, P381, DOI 10.1037/0735-7044.111.2.381; BALTHAZART J, 1990, PHYSIOL BEHAV, V47, P83, DOI 10.1016/0031-9384(90)90045-6; BALTHAZART J, 1983, GEN COMP ENDOCR, V51, P191, DOI 10.1016/0016-6480(83)90072-2; BALTHAZART J, 1985, PHYSIOL BEHAV, V35, P157, DOI 10.1016/0031-9384(85)90330-0; Balthazart J, 1996, J CHEM NEUROANAT, V11, P147, DOI 10.1016/0891-0618(96)00149-4; Balthazart J, 1998, J NEUROSCI, V18, P6512; BALTHAZART J, 1990, PHYSIOL BEHAV, V48, P599, DOI 10.1016/0031-9384(90)90198-D; BALTHAZART J, 1995, BEHAV NEUROSCI, V109, P485, DOI 10.1037/0735-7044.109.3.485; BALTHAZART J, 1989, BRAIN RES, V501, P205, DOI 10.1016/0006-8993(89)90638-0; Balthazart J, 1998, J NEUROBIOL, V35, P323; BALTHAZART J, 1991, J NEUROBIOL, V22, P143, DOI 10.1002/neu.480220205; BALTHAZART J, 1990, J COMP NEUROL, V301, P276, DOI 10.1002/cne.903010210; BALTHAZART J, 1997, PERSPECTIVES AVIAN E, P241; Balthazart J., 1998, ANN REV SEX RES, V9, P96; Balthazart J, 2007, FRONT NEUROENDOCRIN, V28, P161, DOI 10.1016/j.yfrne.2007.05.003; BEACH FA, 1956, NEBRASKA S MOTIVATIO, V4, P1; Bodo C, 2006, FRONT NEUROENDOCRIN, V27, P217, DOI 10.1016/j.yfrne.2006.02.004; Carere C, 2007, J COMP NEUROL, V500, P894, DOI 10.1002/cne.21210; Charlier TD, 2008, HORM BEHAV, V54, P488, DOI 10.1016/j.yhbeh.2008.03.001; Choleris E, 2004, J NEUROENDOCRINOL, V16, P383, DOI 10.1111/j.0953-8194.2004.01178.x; Choleris E, 2003, P NATL ACAD SCI USA, V100, P6192, DOI 10.1073/pnas.0631699100; CLIPPERTONALLEN AE, 2011, PSYCHONEURO IN PRESS, DOI DOI 10.1016/J.PSYNEUEN.2010.12.010; Cornil CA, 2004, PHYSIOL BEHAV, V83, P99, DOI 10.1016/j.physbeh.2004.07.011; DELVILLE Y, 1984, PHYSIOL BEHAV, V33, P817, DOI 10.1016/0031-9384(84)90053-2; Dominguez-Salazar E, 2004, HORM BEHAV, V46, P482, DOI 10.1016/j.yhbeh.2004.05.006; DOMJAN M, 1986, J COMP PSYCHOL, V100, P59, DOI 10.1037/0735-7036.100.1.59; DOMJAN M, 1987, BEHAV NEUROSCI, V101, P385, DOI 10.1037/0735-7044.101.3.385; FOIDART A, 1995, J CHEM NEUROANAT, V8, P267, DOI 10.1016/0891-0618(95)00054-B; Foidart A, 1999, J NEUROBIOL, V40, P327, DOI 10.1002/(SICI)1097-4695(19990905)40:3<327::AID-NEU5>3.0.CO;2-L; Grassi D, 2010, NEUROSCI LETT, V474, P135, DOI 10.1016/j.neulet.2010.03.022; GRAY DA, 1983, J COMP PHYSIOL, V151, P241, DOI 10.1007/BF00689924; Gustafsson JA, 1999, J ENDOCRINOL, V163, P379, DOI 10.1677/joe.0.1630379; Halldin K, 2006, J NEUROBIOL, V66, P148, DOI 10.1002/neu.20199; Hammond R, 2009, HORM BEHAV, V56, P309, DOI 10.1016/j.yhbeh.2009.06.008; HARADA N, 1993, BRAIN RES, V622, P243, DOI 10.1016/0006-8993(93)90825-8; Hrabovszky E, 1998, ENDOCRINOLOGY, V139, P2600, DOI 10.1210/en.139.5.2600; Hull EM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P5; HUTCHISON RE, 1978, HORM BEHAV, V11, P363, DOI 10.1016/0018-506X(78)90038-7; Jacome LF, 2010, NEUROBIOL LEARN MEM, V94, P488, DOI 10.1016/j.nlm.2010.08.016; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1997, FEBS LETT, V410, P87, DOI 10.1016/S0014-5793(97)00413-4; Kuiper GGJM, 1998, FRONT NEUROENDOCRIN, V19, P253, DOI 10.1006/frne.1998.0170; Laflamme N, 1998, J NEUROBIOL, V36, P357, DOI 10.1002/(SICI)1097-4695(19980905)36:3<357::AID-NEU5>3.0.CO;2-V; Lakaye B, 1998, NEUROREPORT, V9, P2743, DOI 10.1097/00001756-199808240-00011; Lund TD, 2005, ENDOCRINOLOGY, V146, P797, DOI 10.1210/en.2004-1158; Malamas MS, 2004, J MED CHEM, V47, P5021, DOI 10.1021/jm049719y; Manas ES, 2004, J AM CHEM SOC, V126, P15106, DOI 10.1021/ja047633o; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mattsson A, 2008, GEN COMP ENDOCR, V159, P150, DOI 10.1016/j.ygcen.2008.08.012; Mazzucco CA, 2008, BEHAV BRAIN RES, V191, P111, DOI 10.1016/j.bbr.2008.03.016; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Naftolin F, 1975, Adv Biosci, V15, P105; Neese SL, 2010, HORM BEHAV, V58, P878, DOI 10.1016/j.yhbeh.2010.08.017; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Nomura M, 2006, EUR J NEUROSCI, V23, P1860, DOI 10.1111/j.1460-9568.2006.04703.x; Nomura M, 2003, MOL BRAIN RES, V110, P7, DOI 10.1016/S0169-328X(02)00544-2; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5058, DOI 10.1210/en.139.12.5058; Panzica G, 1999, BRAIN RES, V850, P55, DOI 10.1016/S0006-8993(99)02098-3; Panzica GC, 1996, FRONT NEUROENDOCRIN, V17, P51, DOI 10.1006/frne.1996.0002; Panzica GC, 2001, BRAIN RES REV, V37, P178, DOI 10.1016/S0165-0173(01)00118-7; Panzica GC, 1998, J NEUROBIOL, V37, P684, DOI 10.1002/(SICI)1097-4695(199812)37:4<684::AID-NEU15>3.0.CO;2-U; Patisaul HB, 2003, J NEUROENDOCRINOL, V15, P787, DOI 10.1046/j.1365-2826.2003.01061.x; Pfaus JG, 1996, HORM BEHAV, V30, P187, DOI 10.1006/hbeh.1996.0024; Rhodes ME, 2006, NEUROBIOL LEARN MEM, V85, P183, DOI 10.1016/j.nlm.2005.10.003; Rissman EF, 2008, J NEUROENDOCRINOL, V20, P873, DOI 10.1111/j.1365-2826.2008.01738.x; Rissman EF, 1997, ENDOCRINOLOGY, V138, P507, DOI 10.1210/en.138.1.507; Rissman EF, 1999, BRAIN RES, V835, P80, DOI 10.1016/S0006-8993(99)01452-3; ROSELLI CE, 1991, NEUROENDOCRINOLOGY, V53, P79, DOI 10.1159/000125701; RYAN KJ, 1959, J BIOL CHEM, V234, P268; SACHS BD, 1967, SCIENCE, V157, P201, DOI 10.1126/science.157.3785.201; SCHUMACHER M, 1987, BRAIN RES, V422, P137, DOI 10.1016/0006-8993(87)90548-8; SCHUMACHER M, 1984, HORM BEHAV, V18, P298, DOI 10.1016/0018-506X(84)90018-7; SCHUMACHER M, 1983, PHYSIOL BEHAV, V30, P335, DOI 10.1016/0031-9384(83)90135-X; Scordalakes EM, 2002, REPRODUCTION, V124, P331, DOI 10.1530/rep.0.1240331; Seiwert CM, 1998, BRAIN BEHAV EVOLUT, V52, P61, DOI 10.1159/000006553; Shapiro RA, 2000, ENDOCRINOLOGY, V141, P4056, DOI 10.1210/en.141.11.4056; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Taziaux M, 2004, BEHAV PROCESS, V67, P461, DOI 10.1016/j.beproc.2004.07.007; Temple JL, 2003, HORM BEHAV, V44, P427, DOI 10.1016/j.yhbeh.2003.09.002; Tetel MJ, 2010, BBA-GEN SUBJECTS, V1800, P1084, DOI 10.1016/j.bbagen.2010.01.008; Thompson RR, 1998, BRAIN BEHAV EVOLUT, V51, P215; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; VIGLIETTIPANZICA C, 1994, BRAIN RES, V657, P171, DOI 10.1016/0006-8993(94)90965-2; Voigt C, 2009, J NEUROENDOCRINOL, V21, P1045, DOI 10.1111/j.1365-2826.2009.01929.x; Walf AA, 2005, NEUROPSYCHOPHARMACOL, V30, P1598, DOI 10.1038/sj.npp.1300713; WATSON JT, 1989, NEUROENDOCRINOLOGY, V49, P51, DOI 10.1159/000125091; Weiser MJ, 2008, BRAIN RES REV, V57, P309, DOI 10.1016/j.brainresrev.2007.05.013	106	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18627	10.1371/journal.pone.0018627	http://dx.doi.org/10.1371/journal.pone.0018627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533185	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600014
J	Reers, H; Jacot, A; Forstmeier, W				Reers, Hendrik; Jacot, Alain; Forstmeier, Wolfgang			Do Zebra Finch Parents Fail to Recognise Their Own Offspring?	PLOS ONE			English	Article							INDIVIDUAL RECOGNITION; BEGGING CALLS; MATE RECOGNITION; BIRDS; VOICE; COMMUNICATION; IDENTIFY; SONGBIRD; COLONY; CUES	Individual recognition systems require the sender to be individually distinctive and the receiver to be able to perceive differences between individuals and react accordingly. Many studies have demonstrated that acoustic signals of almost any species contain individualized information. However, fewer studies have tested experimentally if those signals are used for individual recognition by potential receivers. While laboratory studies using zebra finches have shown that fledglings recognize their parents by their "distance call'', mutual recognition using the same call type has not been demonstrated yet. In a laboratory study with zebra finches, we first quantified between-individual acoustic variation in distance calls of fledglings. In a second step, we tested recognition of fledgling calls by parents using playback experiments. With a discriminant function analysis, we show that individuals are highly distinctive and most measured parameters show very high potential to encode for individuality. The response pattern of zebra finch parents shows that they do react to calls of fledglings, however they do not distinguish between own and unfamiliar offspring, despite individual distinctiveness. This finding is interesting in light of the observation of a high percentage of misdirected feedings in our communal breeding aviaries. Our results demonstrate the importance of adopting a receiver's perspective and suggest that variation in fledgling contact calls might not be used in individual recognition of offspring.	[Reers, Hendrik; Jacot, Alain; Forstmeier, Wolfgang] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany; [Jacot, Alain] Swiss Ornithol Inst, Field Stn Valais, Salgesch, Switzerland; [Jacot, Alain] Univ Bern, IEE Conservat Biol, Bern, Switzerland	Max Planck Society; Swiss Ornithological Institute; University of Bern	Reers, H (corresponding author), Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Seewiesen, Germany.	hreers@gmail.com			DFG [FO 340/3-1]; Volkswagen Foundation [I/82-747]; Swiss National Science Foundation [PA00A - 111437]	DFG(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was partly funded by an Emmy-Noether Fellowship (DFG: FO 340/3-1 to WF), a research grant from the Volkswagen Foundation (I/82-747 to HR) and through a research grant from the Swiss National Science Foundation (PA00A - 111437 to AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; BARG JJ, 1994, AUK, V111, P459, DOI 10.2307/4088610; Bates D., 2009, IME4 LINEAR MIXED EF; BEECHER MD, 1986, EXP BIOL, V45, P179; BEECHER MD, 1988, BEHAV GENET, V18, P465, DOI 10.1007/BF01065515; Benedict L, 2007, CONDOR, V109, P79, DOI 10.1650/0010-5422(2007)109[79:ODWRCT]2.0.CO;2; Bonal R, 2009, IBIS, V151, P577, DOI 10.1111/j.1474-919X.2009.00926.x; Charrier I, 2001, ETHOLOGY, V107, P961, DOI 10.1046/j.1439-0310.2001.00748.x; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Draganoiu TI, 2006, ANIM BEHAV, V71, P1039, DOI 10.1016/j.anbehav.2005.06.022; Forstmeier W, 2009, EVOLUTION, V63, P2114, DOI 10.1111/j.1558-5646.2009.00688.x; Fox J, 2002, COX PROPORTIONAL HAZ; Gobes SMH, 2009, J COMP NEUROL, V516, P312, DOI 10.1002/cne.22113; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; HALPIN ZT, 1991, KIN RECOGNITION, P220; Jacot A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1515, DOI 10.1007/s00265-010-0965-5; Johnstone RA, 1997, P ROY SOC B-BIOL SCI, V264, P1547, DOI 10.1098/rspb.1997.0215; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; Knornschild M, 2008, ANIM BEHAV, V76, P1001, DOI 10.1016/j.anbehav.2008.05.018; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Ohms VR, 2010, P ROY SOC B-BIOL SCI, V277, P1003, DOI 10.1098/rspb.2009.1788; R Core Team, 2022, R LANG ENV STAT COMP; Reers Hendrik, 2011, BMC Ecology, V11, P3, DOI 10.1186/1472-6785-11-3; ROBISSON P, 1993, ETHOLOGY, V94, P279; Seddon N, 2010, P ROY SOC B-BIOL SCI, V277, P2475, DOI 10.1098/rspb.2010.0210; Sharp SP, 2005, BEHAVIOUR, V142, P1559, DOI 10.1163/156853905774831918; STEVENSON JG, 1970, NATURE, V226, P562, DOI 10.1038/226562a0; Tchernichovski O, 2004, SOUND ANAL PRO USER; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Zann RA., 1996, ZEBRA FINCH SYNTHESI; [No title captured]	37	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18466	10.1371/journal.pone.0018466	http://dx.doi.org/10.1371/journal.pone.0018466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533233	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800012
J	Xu, CF; Liu, J; Hsu, LC; Luo, YP; Xiang, R; Chuang, TH				Xu, Congfeng; Liu, Jin; Hsu, Li-Chung; Luo, Yunping; Xiang, Rong; Chuang, Tsung-Hsien			Functional interaction of heat shock protein 90 and Beclin 1 modulates Toll-like receptor-mediated autophagy	FASEB JOURNAL			English	Article						ubiquitination; pattern recognition receptor; innate immunity	PATTERN-RECOGNITION RECEPTORS; ENTERICA SEROVAR TYPHIMURIUM; HSP90 CHAPERONE MACHINERY; INNATE IMMUNE-RESPONSE; SIGNALING PATHWAYS; UBIQUITINATION; CELLS; DEGRADATION; MACROPHAGES; DISRUPTION	Autophagy is one of the downstream effector mechanisms for elimination of intracellular microbes following activation of the Toll-like receptors (TLRs). Although the detailed molecular mechanism for this cellular process is still unclear, Beclin 1, a key molecule for autophagy, has been suggested to play a role. Heat shock protein 90 (Hsp90) is a molecular chaperone that regulates the stability of signaling proteins. Herein, we show that Hsp90 forms a complex with Beclin 1 through an evolutionarily conserved domain to maintain the stability of Beclin 1. In monocytic cells, geldanamycin (GA), an Hsp90 inhibitor, effectively promoted proteasomal degradation of Beclin 1 in a concentration-dependent (EC50 100 nM) and time-dependent (t(50) 2 h) manner. In contrast, KNK437/Hsp inhibitor I had no effect. Hsp90 specifically interacted with Beclin 1 but not with other adapter proteins in the TLR signalsome. Treatment of cells with GA inhibited TLR3- and TLR4-mediated autophagy. In addition, S. typhimurium infection-induced autophagy was blocked by GA treatment. This further suggested a role of the Hsp90/Beclin 1 in controlling autophagy in response to microbial infections. Taken together, our data revealed that by maintaining the homeostasis of Beclin 1, Hsp90 plays a novel role in TLR-mediated autophagy.-Xu, C., Liu, J., Hsu, L. -C., Luo, Y., Xiang, R., Chuang, T. -H. Functional interaction of Hsp90 and Beclin 1 modulates Toll-like receptor-mediated autophagy. FASEB J. 25, 2700-2710 (2011). www.fasebj.org	[Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Miaoli County, Taiwan; [Xu, Congfeng; Liu, Jin; Chuang, Tsung-Hsien] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA USA; [Hsu, Li-Chung] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan; [Luo, Yunping] Peking Union Med Coll, Dept Immunol, Sch Basic Med, Beijing 100021, Peoples R China; [Xiang, Rong] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Xiang, Rong] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	National Health Research Institutes - Taiwan; Sanford Burnham Prebys Medical Discovery Institute; National Taiwan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Scripps Research Institute; Nankai University	Chuang, TH (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Miaoli County, Taiwan.	thchuang@nhri.org.tw	Xu, Congfeng/E-4806-2013; Chuang, Tsung-Hsien/F-9679-2010	Xu, Congfeng/0000-0002-8009-4865; Hsu, Li-Chung/0000-0001-7206-5231	National Science Council [NSC-98-2628-B-002-034-MY3]; National Natural Science Foundation of China [NSFC30671938, NSFC30830096, NBRP973-2007CB914804]; California Tobacco-Related Disease Research Program [16RT-0103]; U.S. National Institutes of Health [GM069652]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069652] Funding Source: NIH RePORTER	National Science Council(Ministry of Science and Technology, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); California Tobacco-Related Disease Research Program(University of California System); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Council grant NSC-98-2628-B-002-034-MY3 (L.C.H.), National Natural Science Foundation of China grants NSFC30671938 (Y.L.) and NSFC30830096, NBRP973-2007CB914804 (R.X.), California Tobacco-Related Disease Research Program grant 16RT-0103 (T.H.C.), and U.S. National Institutes of Health grant GM069652 (T.H.C.).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Birmingham CL, 2006, AUTOPHAGY, V2, P156, DOI 10.4161/auto.2825; Birmingham CL, 2009, METHOD ENZYMOL, V452, P325, DOI 10.1016/S0076-6879(08)03620-3; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chang ZY, 2009, SCI CHINA SER C, V52, P515, DOI 10.1007/s11427-009-0084-6; Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Fang SP, 2009, CELL IMMUNOL, V259, P49, DOI 10.1016/j.cellimm.2009.05.012; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hsu HY, 2007, MOL PHARMACOL, V71, P344, DOI 10.1124/mol.106.024240; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeong JH, 2008, J CELL BIOCHEM, V105, P585, DOI 10.1002/jcb.21859; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Lee J, 2009, BIOCHEM J, V421, P301, DOI 10.1042/BJ20090013; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shi LJ, 2009, MOL IMMUNOL, V46, P541, DOI 10.1016/j.molimm.2008.07.019; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Stravopodis DJ, 2007, CURR MED CHEM, V14, P3122, DOI 10.2174/092986707782793925; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Xu Y, 2008, AUTOPHAGY, V4, P110, DOI 10.4161/auto.5225; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853	56	69	69	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2700	2710		10.1096/fj.10-167676	http://dx.doi.org/10.1096/fj.10-167676			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21543763	Green Published			2022-12-25	WOS:000293337800019
J	Rabiet, MJ; Macari, L; Dahlgren, C; Boulay, F				Rabiet, Marie-Josephe; Macari, Laurence; Dahlgren, Claes; Boulay, Francois			N-Formyl Peptide Receptor 3 (FPR3) Departs from the Homologous FPR2/ALX Receptor with Regard to the Major Processes Governing Chemoattractant Receptor Regulation, Expression at the Cell Surface, and Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C5A ANAPHYLATOXIN RECEPTOR; BETA-ARRESTIN; DENDRITIC CELLS; BETA(2)-ADRENERGIC RECEPTOR; DIFFERENTIAL REGULATION; ACTIVATES NEUTROPHILS; ELICITED MACROPHAGES; CARBOXYL-TERMINUS; CLATHRIN ADAPTER; HL-60 CELLS	Among human N-formyl peptide chemoattractant receptors, FPR2/ALX and FPR3 share the highest degree of amino acid identity (83%), and trigger similar cell responses upon ligand binding. Although FPR2/ALX is a promiscuous receptor, FPR3 has only one specific high affinity ligand, F2L, and a more restricted tissue/cell distribution. In this study, we showed that FPR2/ALX behaved as the prototypical receptor FPR1. The agonist-dependent phosphorylation used a hierarchical mechanism with a prominent role of Ser(329), Thr(332), and Thr(335). Phosphorylation of FPR2/ALX was essential for its desensitization but the lack of phosphorylation did not result in enhanced or sustained responses. In contrast, resting FPR3 displayed a marked level of phosphorylation, which was only slightly increased upon agonist stimulation. Another noticeable difference between the two receptors was their subcellular distribution in unstimulated cells. Although FPR2/ALX was evenly distributed at the plasma membrane FPR3 was localized in small intracellular vesicles. By swapping domains between FPR2/ALX and FPR3, we uncovered the determinants involved in the basal phosphorylation of FPR3. Experiments aimed at monitoring receptor-bound antibody uptake showed that the intracellular distribution of FPR3 resulted from a constitutive internalization that was independent of C terminus phosphorylation. Unexpectedly, exchanging residues 1 to 53, which encompass the N-terminal extracellular region and the first transmembrane domain, between FPR2/ALX and FPR3 switched localization of the receptors from the plasma membrane to intracellular vesicles and vice versa. A clathrin-independent, possibly caveolae-dependent, mechanism was involved in FPR3 constitutive internalization. The peculiar behavior of FPR3 most probably serves distinct physiological functions that remain largely unknown.	[Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] INSERM, U1036, F-38054 Grenoble, France; [Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] CEA, DSV iRTSV, F-38054 Grenoble, France; [Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] CNRS, ERL 5261, F-38054 Grenoble, France; [Rabiet, Marie-Josephe; Macari, Laurence; Boulay, Francois] Univ Grenoble 1, F-38041 Grenoble, France; [Dahlgren, Claes] Univ Gothenburg, Dept Rheumatol & Inflammat Res, S-41346 Gothenburg, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Gothenburg	Boulay, F (corresponding author), CEA Grenoble, Lab Biol Canc & Infect, Inst Rech Technol & Sci Vivant, 17 Rue Martyrs, F-38054 Grenoble 9, France.	marie-josephe.rabiet@cea.fr						ALI H, 1993, J BIOL CHEM, V268, P24247; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Bennett TA, 2001, J BIOL CHEM, V276, P49195, DOI 10.1074/jbc.M106414200; Braun L, 2003, J BIOL CHEM, V278, P4277, DOI 10.1074/jbc.M210120200; Christophe T, 2001, J BIOL CHEM, V276, P21585, DOI 10.1074/jbc.M007769200; Christophe T, 2000, J BIOL CHEM, V275, P1656, DOI 10.1074/jbc.275.3.1656; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; Gilbert TL, 2001, BIOCHEMISTRY-US, V40, P3467, DOI 10.1021/bi001320y; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Graham GJ, 2006, TRENDS IMMUNOL, V27, P381, DOI 10.1016/j.it.2006.06.006; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Huet E, 2007, CELL SIGNAL, V19, P1939, DOI 10.1016/j.cellsig.2007.05.006; Key TA, 2001, J BIOL CHEM, V276, P49204, DOI 10.1074/jbc.M109475200; KISS AL, 1995, CELL BIOL INT, V19, P527, DOI 10.1006/cbir.1995.1097; Kiss AL, 1997, EUR J CELL BIOL, V73, P19; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Maestes DC, 1999, J BIOL CHEM, V274, P29791, DOI 10.1074/jbc.274.42.29791; McDonald PH, 2001, CELL SIGNAL, V13, P683, DOI 10.1016/S0898-6568(01)00203-0; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; Naik N, 1997, J CELL SCI, V110, P2381; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Potter RM, 2002, J BIOL CHEM, V277, P8970, DOI 10.1074/jbc.M111086200; Prossnitz ER, 1997, J BIOL CHEM, V272, P15213, DOI 10.1074/jbc.272.24.15213; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Tardif M, 1998, J IMMUNOL, V161, P6885; TARDIF M, 1993, J IMMUNOL, V150, P3534; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Xu ZQD, 2007, ACTA PHYSIOL, V190, P39, DOI 10.1111/j.1365-201X.2007.01695.x; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	46	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26718	26731		10.1074/jbc.M111.244590	http://dx.doi.org/10.1074/jbc.M111.244590			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21543323	Green Published, hybrid			2022-12-25	WOS:000293078200049
J	Mitra, N; Banda, K; Altheide, TK; Schaffer, L; Johnson-Pais, TL; Beuten, J; Leach, RJ; Angata, T; Varki, N; Varki, A				Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Schaffer, Lana; Johnson-Pais, Teresa L.; Beuten, Joke; Leach, Robin J.; Angata, Takashi; Varki, Nissi; Varki, Ajit			SIGLEC12, a Human-specific Segregating (Pseudo)gene, Encodes a Signaling Molecule Expressed in Prostate Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN EXPRESSION; ACUTE MYELOID-LEUKEMIA; NEGATIVE REGULATION; UP-REGULATION; GENE FUSIONS; CANCER; EVOLUTION; IDENTIFICATION; TRANSCRIPTION; MACROPHAGES	The primate SIGLEC12 gene encodes one of the CD33-related Siglec family of signaling molecules in immune cells. We had previously reported that this gene harbors a human-specific missense mutation of the codon for an Arg residue required for sialic acid recognition. Here we show that this R122C mutation of the Siglec-XII protein is fixed in the human population, i.e. it occurred prior to the origin of modern humans. Additional mutations have since completely inactivated the SIGLEC12 gene in some but not all humans. The most common inactivating mutation with a global allele frequency of 58% is a single nucleotide frame-shift that markedly shortens the open reading frame. Unlike other CD33-related Siglecs that are primarily found on immune cells, we found that Siglec-XII protein is expressed not only on some macrophages but also on various epithelial cell surfaces in humans and chimpanzees. We also found expression on certain human prostate epithelial carcinomas and carcinoma cell lines. This expression correlates with the presence of the nonframeshifted, intact SIGLEC12 allele. Although SIGLEC12 allele status did not predict prostate carcinoma incidence, restoration of expression in a prostate carcinoma cell line homozygous for the frameshift mutation induced altered regulation of several genes associated with carcinoma progression. These stably transfected Siglec-XII-expressing prostate cancer cells also showed enhanced growth in nude mice. Finally, monoclonal antibodies against the protein were internalized by Siglec-XII-expressing prostate carcinoma cells, allowing targeting of a toxin to such cells. Polymorphic expression of Siglec-XII in humans thus has implications for prostate cancer biology and therapeutics.	[Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Angata, Takashi; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Angata, Takashi; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Pathol, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Mitra, Nivedita; Banda, Kalyan; Altheide, Tasha K.; Angata, Takashi; Varki, Nissi; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Schaffer, Lana] Scripps Res Inst, La Jolla, CA 92037 USA; [Johnson-Pais, Teresa L.; Beuten, Joke; Leach, Robin J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; University of Texas System; University of Texas Health San Antonio	Varki, A (corresponding author), Univ Calif San Diego, Dept Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu		Mitra, Nivedita/0000-0003-3799-5681; Leach, Robin/0000-0002-3201-5579	National Institutes of Health [U01CA128442, R01CA38701]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [R01CA038701, U01CA128442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant U01CA128442 and R01CA38701 (to A. V.). This work was also supported by the G. Harold and Leila Y. Mathers Charitable Foundation.	Alphey MS, 2003, J BIOL CHEM, V278, P3372, DOI 10.1074/jbc.M210602200; Altheide TK, 2006, J BIOL CHEM, V281, P25689, DOI 10.1074/jbc.M604221200; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2002, J BIOL CHEM, V277, P24466, DOI 10.1074/jbc.M202833200; Angata T, 2001, J BIOL CHEM, V276, P40282, DOI 10.1074/jbc.M105926200; Angata T, 2004, P NATL ACAD SCI USA, V101, P13251, DOI 10.1073/pnas.0404833101; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Avril T, 2006, BIOCHEM SOC T, V34, P1024, DOI 10.1042/BST0341024; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Beuten J, 2010, CANCER EPIDEM BIOMAR, V19, P588, DOI 10.1158/1055-9965.EPI-09-0864; Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Cao H, 2008, EUR J IMMUNOL, V38, P2303, DOI 10.1002/eji.200738078; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Cao H, 2009, IMMUNOGENETICS, V61, P401, DOI 10.1007/s00251-009-0372-0; CARON PC, 1992, CANCER RES, V52, P6761; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Cheng L, 1996, AM J PATHOL, V148, P1375; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Consortium Y. C., 2002, GENOME RES, V12, P339, DOI DOI 10.1101/GR.217602; Cornish Ann L., 1998, Blood, V92, P2123; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; De Marzo AM, 1999, UROLOGY, V53, P707, DOI 10.1016/S0090-4295(98)00577-9; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kohls MD, 2000, BIOTECHNIQUES, V28, P162, DOI 10.2144/00281pf01; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Linden ECMBVD, 2007, GLYCOBIOLOGY, V17, P922, DOI 10.1093/glyco/cwm065; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; MCCLURE HM, 1973, AM J PHYS ANTHROPOL, V38, P425, DOI 10.1002/ajpa.1330380243; McMillan SJ, 2008, CARBOHYD RES, V343, P2050, DOI 10.1016/j.carres.2008.01.009; Miyake H, 2000, CANCER RES, V60, P3058; Nguyen DH, 2006, EXP HEMATOL, V34, P728, DOI 10.1016/j.exphem.2006.03.003; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Pratap J, 2011, BONE, V48, P30, DOI 10.1016/j.bone.2010.05.035; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Sarrats A, 2010, PROSTATE, V70, P1, DOI 10.1002/pros.21031; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schmitz M, 2007, INT J CANCER, V120, P1284, DOI 10.1002/ijc.22359; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; SEIBOLD HR, 1973, LAB ANIM SCI, V23, P533; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; UMBAS R, 1994, CANCER RES, V54, P3929; van der Velden VHJ, 2001, BLOOD, V97, P3197, DOI 10.1182/blood.V97.10.3197; Vanhara P, 2009, DIFFERENTIATION, V78, P213, DOI 10.1016/j.diff.2009.07.008; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A., 2009, ESSENTIALS GLYCOBIOL, P459; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Verhagen PCMS, 2006, J PATHOL, V208, P699, DOI 10.1002/path.1929; Vestergaard EM, 2010, INT J CANCER, V127, P1857, DOI 10.1002/ijc.25209; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011; Yngvadottir B, 2009, AM J HUM GENET, V84, P224, DOI 10.1016/j.ajhg.2009.01.008; Yu ZB, 2001, J BIOL CHEM, V276, P23816, DOI 10.1074/jbc.M102394200; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	62	38	38	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23003	23011		10.1074/jbc.M111.244152	http://dx.doi.org/10.1074/jbc.M111.244152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555517	Green Published, hybrid			2022-12-25	WOS:000292025000035
J	Myeku, N; Figueiredo-Pereira, ME				Myeku, Natura; Figueiredo-Pereira, Maria E.			Dynamics of the Degradation of Ubiquitinated Proteins by Proteasomes and Autophagy ASSOCIATION WITH SEQUESTOSOME 1/p62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; NEURODEGENERATIVE DISEASE; PROXIMITY LIGATION; SEQUESTOSOME 1/P62; PROSTAGLANDIN J2; BASAL AUTOPHAGY; CELL-DEATH; INHIBITION; ASSAYS; MICE	Proteotoxicity resulting from accumulation of damaged/unwanted proteins contributes prominently to cellular aging and neurodegeneration. Proteasomal removal of these proteins upon covalent polyubiquitination is highly regulated. Recent reports proposed a role for autophagy in clearance of diffuse ubiquitinated proteins delivered by p62/SQSTM1. Here, we compared the turnover dynamics of endogenous ubiquitinated proteins by proteasomes and autophagy by assessing the effect of their inhibitors. Autophagy inhibitors bafilomycin A1, ammonium chloride, and 3-methyladenine failed to increase ubiquitinated protein levels. The proteasome inhibitor epoxomicin raised ubiquitinated protein levels at least 3-fold higher than the lysosomotropic agent chloroquine. These trends were observed in SK-N-SH cells under serum or serum-free conditions and in WT or Atg5(-/-) mouse embryonic fibroblasts (MEFs). Notably, chloroquine considerably inhibited proteasomes in SK-N-SH cells and MEFs. In these cells, elevation of p62/SQSTM1 was greater upon proteasome inhibition than with all autophagy inhibitors tested and was reduced in Atg5(-/-) MEFs. With epoxomicin, soluble p62/SQSTM1 associated with proteasomes and p62/SQSTM1 aggregates contained inactive proteasomes, ubiquitinated proteins, and autophagosomes. Prolonged autophagy inhibition (96 h) failed to elevate ubiquitinated proteins in rat cortical neurons, although epoxomicin did. Moreover, prolonged autophagy inhibition in cortical neurons markedly increased p62/SQSTM1, supporting its degradation mainly by autophagy and not by proteasomes. In conclusion, we clearly demonstrate that pharmacologic or genetic inhibition of autophagy fails to elevate ubiquitinated proteins unless the proteasome is affected. We also provide strong evidence that p62/SQSTM1 associates with proteasomes and that autophagy degrades p62/SQSTM1. Overall, the function of p62/SQSTM1 in the proteasomal pathway and autophagy requires further elucidation.	[Myeku, Natura; Figueiredo-Pereira, Maria E.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA	City University of New York (CUNY) System; Hunter College (CUNY)	Figueiredo-Pereira, ME (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu			National Institutes of Health [NS41073]; NIA [AG028847]; NCRR/CTSC [UL-RR024996]; NIGMS/RCMI [RR03037]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR/CTSC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS41073 (SNRP) NINDS (to M. E. F.-P.), AG028847 from NIA (to M. E. F.-P.), UL-RR024996 from NCRR/CTSC (TL1 training award to N. M.), and RR03037 from NIGMS/RCMI (infrastructure to Hunter College, City University of New York).	Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; FREDRIKSSON S, 2009, NAT METHODS, V6, pR1; Gao ZH, 2010, AUTOPHAGY, V6, P126, DOI 10.4161/auto.6.1.10928; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2006, NATURE, V441, P819, DOI 10.1038/441819a; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Mayer RJ, 2003, DRUG NEWS PERSPECT, V16, P103, DOI 10.1358/dnp.2003.16.2.829327; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Ogburn KD, 2006, J BIOL CHEM, V281, P23274, DOI 10.1074/jbc.M600635200; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park I, 1995, P NATL ACAD SCI USA, V92, P12338, DOI 10.1073/pnas.92.26.12338; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Qiao LY, 2009, NEUROSCI LETT, V456, P15, DOI 10.1016/j.neulet.2009.03.085; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; SASAKI T, 1984, J BIOL CHEM, V259, P2489; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Shimizu S, 2010, AUTOPHAGY, V6, P290, DOI 10.4161/auto.6.2.11127; Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sprangers R, 2008, BIOCHEMISTRY-US, V47, P6727, DOI 10.1021/bi8005913; Stein RL, 1996, BIOCHEMISTRY-US, V35, P3899, DOI 10.1021/bi952262x; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Wang ZY, 2005, MOL CELL NEUROSCI, V29, P222, DOI 10.1016/j.mcn.2005.02.011; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	53	158	161	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22426	22440		10.1074/jbc.M110.149252	http://dx.doi.org/10.1074/jbc.M110.149252			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536669	Green Published, hybrid			2022-12-25	WOS:000291719900052
J	Wu, BX; Clarke, CJ; Matmati, N; Montefusco, D; Bartke, N; Hannun, YA				Wu, Bill X.; Clarke, Christopher J.; Matmati, Nabil; Montefusco, David; Bartke, Nana; Hannun, Yusuf A.			Identification of Novel Anionic Phospholipid Binding Domains in Neutral Sphingomyelinase 2 with Selective Binding Preference	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-C; PHOSPHATIDIC-ACID-BINDING; LUNG EPITHELIAL-CELLS; PLASMA-MEMBRANE; ACTIVATION; CERAMIDE; NSMASE2; METABOLISM; GROWTH	Sphingolipids such as ceramide are recognized as vital regulators of many biological processes. Neutral sphingomyelinase 2 (nSMase2) is one of the key enzymes regulating ceramide production. It was previously shown that the enzymatic activity of nSMase2 was dependent on anionic phospholipids (APLs). In this study, the structural requirements for APL-selective binding of nSMase2 were determined and characterized. Using lipid-protein overlay assays, nSMase2 interacted specifically and directly with several APLs, including phosphatidylserine and phosphatidic acid. Lipid-protein binding studies of deletion mutants identified two discrete APL binding domains in the N terminus of nSMase2. Further, mutagenesis experiments pinpointed the core sequences and major cationic amino acids in the domains that are necessary for the cooperative activation of nSMase2 by APLs. The first domain included the first amino-terminal hydrophobic segment and Arg-33, which were essential for nSMase2 to interact with APLs. The second binding domain was comprised of the second hydrophobic segment and Arg-92 and Arg-93. Moreover, mutation of one or both domains decreased APL binding and APL-dependent catalytic activity of nSMase2. Further, mutation of both domains in nSMase2 reduced its plasma membrane localization. Finally, these binding domains are also important for the capability of nSMase2 to rescue the defects of yeast lacking the nSMase homologue, ISC1. In conclusion, these data have identified the APL binding domains of nSMase2 for the first time. The analysis of interactions between nSMase2 and APLs will contribute to our understanding of signaling pathways mediated by sphingolipid metabolites.	[Wu, Bill X.; Clarke, Christopher J.; Matmati, Nabil; Montefusco, David; Bartke, Nana; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Bartke, Nana] Ctr Specialised Nutr, D-61381 Friedrichsdorf, Germany	Medical University of South Carolina	Hannun, YA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu			National Institutes of Health [GM 43825]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043825, R37GM043825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant GM 43825 (to Y. A. H.).	Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Cogolludo A, 2009, CARDIOVASC RES, V82, P296, DOI 10.1093/cvr/cvn349; Corbalan-Garcia S, 2003, BIOCHEMISTRY-US, V42, P11661, DOI 10.1021/bi034850d; Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hayashi Y, 1997, J BIOL CHEM, V272, P18082, DOI 10.1074/jbc.272.29.18082; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; NATARAJAN V, 1993, J BIOL CHEM, V268, P930; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Okamoto Y, 2002, J BIOL CHEM, V277, P46470, DOI 10.1074/jbc.M207779200; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Sethu S, 2008, J IMMUNOL, V180, P6027, DOI 10.4049/jimmunol.180.9.6027; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; Veldman RJ, 2001, BIOCHEM J, V355, P859, DOI 10.1042/bj3550859; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yabu T, 2009, J BIOL CHEM, V284, P20349, DOI 10.1074/jbc.M109.004580	53	22	26	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22362	22371		10.1074/jbc.M110.156471	http://dx.doi.org/10.1074/jbc.M110.156471			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21550973	hybrid, Green Published			2022-12-25	WOS:000291719900046
J	Causeret, F; Ensini, M; Teissier, A; Kessaris, N; Richardson, WD; de Couville, TL; Pierani, A				Causeret, Frederic; Ensini, Monica; Teissier, Anne; Kessaris, Nicoletta; Richardson, William D.; de Couville, Thibaut Lucas; Pierani, Alessandra			Dbx1-Expressing Cells Are Necessary for the Survival of the Mammalian Anterior Neural and Craniofacial Structures	PLOS ONE			English	Article							BRAIN-DEVELOPMENT; MOUSE EMBRYOS; SPINAL-CORD; CREST; FOREBRAIN; GENE; MORPHOGENESIS; EXPRESSION; MALFORMATION; RECOMBINASE	Development of the vertebrate forebrain and craniofacial structures are intimately linked processes, the coordinated growth of these tissues being required to ensure normal head formation. In this study, we identify five small subsets of progenitors expressing the transcription factor dbx1 in the cephalic region of developing mouse embryos at E8.5. Using genetic tracing we show that dbx1-expressing cells and their progeny have a modest contribution to the forebrain and face tissues. However, their genetic ablation triggers extensive and non cell-autonomous apoptosis as well as a decrease in proliferation in surrounding tissues, resulting in the progressive loss of most of the forebrain and frontonasal structures. Targeted ablation of the different subsets reveals that the very first dbx1-expressing progenitors are critically required for the survival of anterior neural tissues, the production and/or migration of cephalic neural crest cells and, ultimately, forebrain formation. In addition, we find that the other subsets, generated at slightly later stages, each play a specific function during head development and that their coordinated activity is required for accurate craniofacial morphogenesis. Our results demonstrate that dbx1-expressing cells have a unique function during head development, notably by controlling cell survival in a non cell-autonomous manner.	[Causeret, Frederic; Ensini, Monica; Teissier, Anne; de Couville, Thibaut Lucas; Pierani, Alessandra] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592, Paris, France; [Kessaris, Nicoletta; Richardson, William D.] UCL, Dept Cell & Dev Biol, London, England; [Kessaris, Nicoletta; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; University of London; University College London	Causeret, F (corresponding author), Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592, Paris, France.	pierani.alessandra@ijm.univ-paris-diderot.fr	Pierani, Alessandra/O-6136-2017; Causeret, Frédéric/C-3195-2017; Teissier, Anne/K-2075-2019; Kessaris, Nicoletta/AAD-6774-2019; Richardson FMedSci FRS, William D/C-1762-2008	Pierani, Alessandra/0000-0002-4872-4791; Causeret, Frédéric/0000-0002-0543-4938; Kessaris, Nicoletta/0000-0003-1191-6009; Richardson FMedSci FRS, William D/0000-0001-7261-2485; LUCAS de COUVILLE, Thibaut/0000-0003-2581-1750; Teissier, Anne/0000-0002-5172-9489	Junior/INSERM (Institut National de la Sante et de la Recherche Medicale); European Commission through STREP [005139]; French Ministry of Education; Association pour la Recherche sur le Cancer (ARC) [4940]; Agence Nationale de la Recherche [ANR-07-NEURO-046-01]; Fondation pour le Recherche Medicale [INE20060306503]; Ville de Paris [2006 ASES 102]; Medical Research Council [G0501173] Funding Source: researchfish; MRC [G0501173] Funding Source: UKRI	Junior/INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Commission through STREP(European CommissionEuropean Commission Joint Research Centre); French Ministry of Education; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour le Recherche Medicale(Fondation pour la Recherche Medicale); Ville de Paris; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	FC was supported by a Junior/INSERM (Institut National de la Sante et de la Recherche Medicale) contract. ME was supported by the European Commission through STREP contract number 005139 (INTERDEVO). AT was the recipient of fellowships from the French Ministry of Education. AP is a CNRS (Centre National de la Recherche Scientifique) Investigator. This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC) (grant # 4940), Agence Nationale de la Recherche (ANR-07-NEURO-046-01), Fondation pour le Recherche Medicale (INE20060306503), and Ville de Paris (2006 ASES 102) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Borello U, 2010, CURR OPIN GENET DEV, V20, P408, DOI 10.1016/j.gde.2010.05.003; Brault V, 2001, DEVELOPMENT, V128, P1253; Chai Y, 2000, DEVELOPMENT, V127, P1671; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Creuzet S, 2004, P NATL ACAD SCI USA, V101, P4843, DOI 10.1073/pnas.0400869101; Creuzet SE, 2006, P NATL ACAD SCI USA, V103, P14033, DOI 10.1073/pnas.0605899103; Creuzet SE, 2009, P NATL ACAD SCI USA, V106, P15774, DOI 10.1073/pnas.0906072106; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Etchevers HC, 1999, DEVELOPMENT, V126, P3533; FJOSE A, 1994, DEVELOPMENT, V120, P71; Griveau A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000440; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Houart C, 1998, NATURE, V391, P788, DOI 10.1038/35853; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; LU S, 1992, P NATL ACAD SCI USA, V89, P8053, DOI 10.1073/pnas.89.17.8053; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Schneider RA, 2001, DEVELOPMENT, V128, P2755; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Teissier A, 2010, J NEUROSCI, V30, P10563, DOI 10.1523/JNEUROSCI.0776-10.2010; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9	36	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19367	10.1371/journal.pone.0019367	http://dx.doi.org/10.1371/journal.pone.0019367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552538	Green Submitted, gold, Green Published			2022-12-25	WOS:000290020700052
J	Cosme, RC; Martinez, FP; Tang, QY				Cruz Cosme, Ruth; Puerta Martinez, Francisco; Tang, Qiyi			Functional Interaction of Nuclear Domain 10 and Its Components with Cytomegalovirus after Infections: Cross-Species Host Cells versus Native Cells	PLOS ONE			English	Article							DNA REPLICATION COMPARTMENTS; INTRINSIC IMMUNE DEFENSE; EARLY GENE-EXPRESSION; MURINE CYTOMEGALOVIRUS; PROMYELOCYTIC LEUKEMIA; MOUSE CYTOMEGALOVIRUS; SP100 PROTEINS; PP71 PROTEIN; PRODUCT PP71; PML	Species-specificity is one of the major characteristics of cytomegaloviruses (CMVs) and is the primary reason for the lack of a mouse model for the direct infection of human CMV (HCMV). It has been determined that CMV cross-species infections are blocked at the post-entry level by intrinsic cellular defense mechanisms, but few details are known. It is important to explore how CMVs interact with the subnuclear structure of the cross-species host cell. In our present study, we discovered that nuclear domain 10 (ND10) of human cells was not disrupted by murine CMV (MCMV) and that the ND10 of mouse cells was not disrupted by HCMV, although the ND10-disrupting protein, immediate-early protein 1 (IE1), also colocalized with ND10 in cross-species infections. In addition, we found that the UL131-repaired HCMV strain AD169 (vDW215-BADrUL131) can infect mouse cells to produce immediate-early (IE) and early (E) proteins but that neither DNA replication nor viral particles were detectable in mouse cells. Unrepaired AD169 can express IE1 only in mouse cells. In both HCMV-infected mouse cells and MCMV-infected human cells, the knocking-down of ND10 components (PML, Daxx, and SP100) resulted in significantly increased viral-protein production. Our observations provide evidence to support our hypothesis that ND10 and ND10 components might be important defensive factors against the CMV cross-species infection.	[Cruz Cosme, Ruth; Puerta Martinez, Francisco; Tang, Qiyi] Ponce Sch Med & Hlth Sci, AIDS Res Program, Dept Microbiol, Ponce, PR USA		Cosme, RC (corresponding author), Ponce Sch Med & Hlth Sci, AIDS Res Program, Dept Microbiol, Ponce, PR USA.	qtang@psm.edu			Research Center for Minority Institutes (RCMI) [2G12RR003050-24]; American Cancer Society [RSG-090289-01-MPC]; ACS-IRG [IRG-92-032-13, 60-14599-01-01-S6]; NIH/NCRR [U54RR022762]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022762, G12RR003050] Funding Source: NIH RePORTER	Research Center for Minority Institutes (RCMI); American Cancer Society(American Cancer Society); ACS-IRG(American Cancer Society); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a Pilot Grant from the Research Center for Minority Institutes (RCMI) program (2G12RR003050-24) (Q.T.), an American Cancer Society grant (RSG-090289-01-MPC) (Q.T), an ACS-IRG grant (IRG-92-032-13, subaward # 60-14599-01-01-S6) (Q.T.), and NIH/NCRR U54RR022762 (Q.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 1999, J VIROL, V73, P10458, DOI 10.1128/JVI.73.12.10458-10471.1999; Ahn JH, 1998, MOL CELL BIOL, V18, P4899, DOI 10.1128/MCB.18.8.4899; BRUGGEMAN CA, 1982, ARCH VIROL, V73, P231, DOI 10.1007/BF01318077; Cantrell SR, 2005, J VIROL, V79, P7792, DOI 10.1128/JVI.79.12.7792-7802.2005; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; Cheng B, 2009, J CLIN VIROL, V46, P244, DOI 10.1016/j.jcv.2009.07.025; EIZURU Y, 1984, J CLIN MICROBIOL, V20, P1012, DOI 10.1128/JCM.20.5.1012-1014.1984; Everett RD, 2006, CELL MICROBIOL, V8, P365, DOI 10.1111/j.1462-5822.2005.00677.x; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Gu HD, 2003, P NATL ACAD SCI USA, V100, P8963, DOI 10.1073/pnas.1533420100; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Hofmann H, 2002, J VIROL, V76, P5769, DOI 10.1128/JVI.76.11.5769-5783.2002; Ishov AM, 2002, J VIROL, V76, P7705, DOI 10.1128/JVI.76.15.7705-7712.2002; Ishov AM, 1997, J CELL BIOL, V138, P5, DOI 10.1083/jcb.138.1.5; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jiang MX, 2011, MBIO, V2, DOI 10.1128/mBio.00281-10; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; Kalejta RF, 2003, J VIROL, V77, P3451, DOI 10.1128/JVI.77.6.3451-3459.2003; LAFEMINA RL, 1988, J GEN VIROL, V69, P355, DOI 10.1099/0022-1317-69-2-355; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Louz D, 2005, J GENE MED, V7, P1263, DOI 10.1002/jgm.794; MacCormac LP, 1999, J MED VIROL, V57, P298, DOI 10.1002/(SICI)1096-9071(199903)57:3&lt;298::AID-JMV14&gt;3.0.CO;2-P; Martinez FP, 2010, J GEN VIROL, V91, P2664, DOI 10.1099/vir.0.022301-0; Maul GG, 2008, CURR TOP MICROBIOL, V325, P117; MISRA V, 1977, VIROLOGY, V83, P458, DOI 10.1016/0042-6822(77)90195-7; Mocarski ES, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P465; Negorev DG, 2009, J VIROL, V83, P5168, DOI 10.1128/JVI.02083-08; Preston CM, 2006, J GEN VIROL, V87, P1113, DOI 10.1099/vir.0.81566-0; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V221, P448, DOI 10.1006/excr.1995.1396; Revello MG, 2001, J GEN VIROL, V82, P1429, DOI 10.1099/0022-1317-82-6-1429; Roberts S, 2003, J VIROL, V77, P673, DOI 10.1128/JVI.77.1.673-684.2003; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Saffert RT, 2008, FUTURE VIROL, V3, P265, DOI 10.2217/17460794.3.3.265; Saffert RT, 2007, J VIROL, V81, P9109, DOI 10.1128/JVI.00827-07; Schumacher U, 2010, J VIROL, V84, P7994, DOI 10.1128/JVI.02624-09; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; SMITH CB, 1986, ARCH VIROL, V90, P313, DOI 10.1007/BF01317379; Tang QY, 2006, J VIROL, V80, P7510, DOI 10.1128/JVI.00684-06; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000; Tang QY, 2003, J VIROL, V77, P1357, DOI 10.1128/JVI.77.2.1357-1367.2003; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; WALKER D, 1987, ARCH VIROL, V92, P103, DOI 10.1007/BF01310066; WALKER DG, 1988, ARCH VIROL, V101, P143, DOI 10.1007/BF01310996; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Wang WJ, 2005, J VIROL, V79, P2115, DOI 10.1128/JVI.79.4.2115-2123.2005; WELLER TH, 1970, J INFECT DIS, V122, P532, DOI 10.1093/infdis/122.6.532; Woodhall DL, 2006, J BIOL CHEM, V281, P37652, DOI 10.1074/jbc.M604273200	51	11	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19187	10.1371/journal.pone.0019187	http://dx.doi.org/10.1371/journal.pone.0019187			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552525	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700035
J	Tanaka, H; Nogi, T; Yasui, N; Iwasaki, K; Takagi, J				Tanaka, Hiroki; Nogi, Terukazu; Yasui, Norihisa; Iwasaki, Kenji; Takagi, Junichi			Structural Basis for Variant-Specific Neuroligin-Binding by alpha-Neurexin	PLOS ONE			English	Article							LIGAND-BINDING; SECONDARY-STRUCTURE; CELL-ADHESION; PROTEIN; DOMAIN; BETA; COMPLEX; DIFFERENTIATION; GLYCOSYLATION; VALIDATION	Neurexins (Nrxs) are presynaptic membrane proteins with a single membrane-spanning domain that mediate asymmetric trans-synaptic cell adhesion by binding to their postsynaptic receptor neuroligins. alpha-Nrx has a large extracellular region comprised of multiple copies of laminin, neurexin, sex-hormone-binding globulin (LNS) domains and epidermal growth factor (EGF) modules, while that of beta-Nrx has but a single LNS domain. It has long been known that the larger alpha-Nrx and the shorter beta-Nrx show distinct binding behaviors toward different isoforms/variants of neuroligins, although the underlying mechanism has yet to be elucidated. Here, we describe the crystal structure of a fragment corresponding to the C-terminal one-third of the Nrx1 alpha ectodomain, consisting of LNS5-EGF3-LNS6. The 2.3 angstrom-resolution structure revealed the presence of a domain configuration that was rigidified by inter-domain contacts, as opposed to the more common flexible "beads-on-a-string" arrangement. Although the neuroligin-binding site on the LNS6 domain was completely exposed, the location of the alpha-Nrx specific LNS5-EGF3 segment proved incompatible with the loop segment inserted in the B+ neuroligin variant, which explains the variant-specific neuroligin recognition capability observed in alpha-Nrx. This, combined with a low-resolution molecular envelope obtained by a single particle reconstruction performed on negatively stained full-length Nrx1 alpha sample, allowed us to derive a structural model of the alpha-Nrx ectodomain. This model will help us understand not only how the large alpha-Nrx ectodomain is accommodated in the synaptic cleft, but also how the trans-synaptic adhesion mediated by alpha- and beta-Nrxs could differentially affect synaptic structure and function.	[Tanaka, Hiroki; Nogi, Terukazu; Yasui, Norihisa; Iwasaki, Kenji; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Osaka, Japan	Osaka University	Tanaka, H (corresponding author), Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Osaka, Japan.	takagi@protein.osaka-u.ac.jp	Yasui, Norihisa/V-8252-2019; Nogi, Terukazu/GPF-7203-2022	Yasui, Norihisa/0000-0001-7117-3070; Nogi, Terukazu/0000-0001-8663-3519	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT; Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), by the Grant-in-Aid for Scientific Research on Innovative Areas from MEXT, by the Protein 3000 Project grant from MEXT, by the Nanotechnology Network Project at the Research Center for Ultrahigh Voltage Electron Microscopy, Osaka University, and by the Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chen X, 2008, NAT STRUCT MOL BIOL, V15, P50, DOI 10.1038/nsmb1350; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; Geppert M, 1998, J BIOL CHEM, V273, P1705, DOI 10.1074/jbc.273.3.1705; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hata Y, 1996, J NEUROSCI, V16, P2488; Hoffman RC, 2004, BIOCHEMISTRY-US, V43, P1496, DOI 10.1021/bi035278t; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Koehnke J, 2010, NEURON, V67, P61, DOI 10.1016/j.neuron.2010.06.001; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sheckler LR, 2006, J BIOL CHEM, V281, P22896, DOI 10.1074/jbc.M603464200; Shen KC, 2008, STRUCTURE, V16, P422, DOI 10.1016/j.str.2008.01.005; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	51	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19411	10.1371/journal.pone.0019411	http://dx.doi.org/10.1371/journal.pone.0019411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552542	gold, Green Submitted, Green Published			2022-12-25	WOS:000290020700055
J	Deininger, KNW; Horikawa, A; Kitko, RD; Tatsumi, R; Rosner, JL; Wachi, M; Slonczewski, JL				Deininger, Kari N. W.; Horikawa, Akina; Kitko, Ryan D.; Tatsumi, Ryoko; Rosner, Judah L.; Wachi, Masaaki; Slonczewski, Joan L.			A Requirement of TolC and MDR Efflux Pumps for Acid Adaptation and GadAB Induction in Escherichia coli	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; OUTER-MEMBRANE; PH; BACTERIA; SYSTEM; EXPRESSION; REGULATOR; GENES; K-12; TYPHIMURIUM	Background: The TolC outer membrane channel is a key component of several multidrug resistance (MDR) efflux pumps driven by H+ transport in Escherichia coli. While tolC expression is under the regulation of the EvgA-Gad acid resistance regulon, the role of TolC in growth at low pH and extreme-acid survival is unknown. Methods and Principal Findings: TolC was required for extreme-acid survival (pH 2) of strain W3110 grown aerobically to stationary phase. A tolC deletion decreased extreme-acid survival (acid resistance) of aerated pH 7.0-grown cells by 10(5)-fold and of pH 5.5-grown cells by 10-fold. The requirement was specific for acid resistance since a tolC defect had no effect on aerobic survival in extreme base (pH 10). TolC was required for expression of glutamate decarboxylase (GadA, GadB), a key component of glutamate-dependent acid resistance (Gad). TolC was also required for maximal exponential growth of E. coli K-12 W3110, in LBK medium buffered at pH 4.5-6.0, but not at pH 6.5-8.5. The TolC growth requirement in moderate acid was independent of Gad. TolC-associated pump components EmrB and MdtB contributed to survival in extreme acid (pH 2), but were not required for growth at pH 5. A mutant lacking the known TolC-associated efflux pumps (acrB, acrD, emrB, emrY, macB, mdtC, mdtF, acrEF) showed no growth defect at acidic pH and a relatively small decrease in extreme-acid survival when pre-grown at pH 5.5. Conclusions: TolC and proton-driven MDR efflux pump components EmrB and MdtB contribute to E. coli survival in extreme acid and TolC is required for maximal growth rates below pH 6.5. The TolC enhancement of extreme-acid survival includes Gad induction, but TolC-dependent growth rates below pH 6.5 do not involve Gad. That MDR resistance can enhance growth and survival in acid is an important consideration for enteric organisms passing through the acidic stomach.	[Deininger, Kari N. W.; Kitko, Ryan D.; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Horikawa, Akina; Tatsumi, Ryoko; Wachi, Masaaki] Tokyo Inst Technol, Dept Bioengn, Yokohama, Kanagawa 227, Japan; [Rosner, Judah L.] NIDDK, NIH, Bethesda, MD USA	Kenyon College; Tokyo Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deininger, KNW (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu	Wachi, Masaaki/D-1220-2015	Wachi, Masaaki/0000-0002-3655-4035	National Science Foundation [MCB-1050080]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036003] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant MCB-1050080 to JLS from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono R, 1998, J BACTERIOL, V180, P938, DOI 10.1128/JB.180.4.938-944.1998; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Dhamdhere G, 2010, MOL MICROBIOL, V77, P743, DOI 10.1111/j.1365-2958.2010.07245.x; Eguchi Y, 2003, MICROBIOL-SGM, V149, P2819, DOI 10.1099/mic.0.26460-0; Ferhat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007732; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Kitko RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010078; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; LOMOVSKAYA O, 1995, J BACTERIOL, V177, P2328, DOI 10.1128/jb.177.9.2328-2334.1995; Martins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006656; Masuda N, 2003, MOL MICROBIOL, V48, P699, DOI 10.1046/j.1365-2958.2003.03477.x; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nishino K, 2005, J BACTERIOL, V187, P1763, DOI 10.1128/JB.187.5.1763-1772.2005; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2010, J ANTIMICROB CHEMOTH, V65, P1215, DOI 10.1093/jac/dkq079; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Raffa RG, 2002, MOL MICROBIOL, V45, P1599, DOI 10.1046/j.1365-2958.2002.03112.x; Reddy JD, 2007, MOL PLANT MICROBE IN, V20, P403, DOI 10.1094/MPMI-20-4-0403; Rice EW, 1993, APPL ENV MICROBIOL, V59; Rosner JL, 2009, J BACTERIOL, V191, P5283, DOI 10.1128/JB.00507-09; Sharff A, 2001, EUR J BIOCHEM, V268, P5011, DOI 10.1046/j.0014-2956.2001.02442.x; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Tatsumi R, 2008, J BACTERIOL, V190, P6228, DOI 10.1128/JB.00595-08; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wiriyathanawudhiwong N, 2009, APPL MICROBIOL BIOT, V81, P903, DOI 10.1007/s00253-008-1686-9; Yohannes E, 2004, J BACTERIOL, V186, P192, DOI 10.1128/JB.186.1.192-199.2004; Zhang A, 2008, MOL MICROBIOL, V69, P1450, DOI 10.1111/j.1365-2958.2008.06371.x	44	39	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18960	10.1371/journal.pone.0018960	http://dx.doi.org/10.1371/journal.pone.0018960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541325	Green Submitted, gold, Green Published			2022-12-25	WOS:000290018400019
J	Li, W; Yeo, LS; Vidal, C; McCorquodale, T; Herrmann, M; Fatkin, D; Duque, G				Li, Wei; Yeo, Li Sze; Vidal, Christopher; McCorquodale, Thomas; Herrmann, Markus; Fatkin, Diane; Duque, Gustavo			Decreased Bone Formation and Osteopenia in Lamin A/C-Deficient Mice	PLOS ONE			English	Article							A-TYPE LAMINS; OSTEOBLAST DIFFERENTIATION; SENILE OSTEOPOROSIS; NUCLEAR-ENVELOPE; STEM-CELLS; EXPRESSION; DEFECTS; MAINTENANCE; INHIBITION; MECHANISMS	Age-related bone loss is associated with changes in bone cellularity with characteristically low levels of osteoblastogenesis. The mechanisms that explain these changes remain unclear. Although recent in vitro evidence has suggested a new role for proteins of the nuclear envelope in osteoblastogenesis, the role of these proteins in bone cells differentiation and bone metabolism in vivo remains unknown. In this study, we used the lamin A/C null (Lmna(-/-)) mice to identify the role of lamin A/C in bone turnover and bone structure in vivo. At three weeks of age, histological and micro computed tomography measurements of femurs in Lmna(-/-) mice revealed a significant decrease in bone mass and microarchitecture in Lmna(-/-) mice as compared with their wild type littermates. Furthermore, quantification of cell numbers after normalization with bone surface revealed a significant reduction in osteoblast and osteocyte numbers in Lmna(-/-) mice compared with their WT littermates. In addition, Lmna(-/-) mice have significantly lower osteoclast number, which show aberrant changes in their shape and size. Finally, mechanistic analysis demonstrated that absence of lamin A/C is associated with increase expression of MAN-1 a protein of the nuclear envelope closely regulated by lamin A/C, which also colocalizes with Runx2 thus affecting its capacity as osteogenic transcription factor. In summary, these data clearly indicate that the presence of lamin A/C is necessary for normal bone turnover in vivo and that absence of lamin A/C induces low bone turnover osteopenia resembling the cellular changes of age-related bone loss.	[Li, Wei; Vidal, Christopher; McCorquodale, Thomas; Herrmann, Markus; Duque, Gustavo] Univ Sydney, Nepean Clin Sch, Ageing Bone Res Program, Penrith, NSW, Australia; [Yeo, Li Sze; Fatkin, Diane] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Fatkin, Diane] St Vincents Hosp, Dept Cardiol, Darlinghurst, NSW 2010, Australia; [Fatkin, Diane] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia	University of Sydney; Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney	Li, W (corresponding author), Univ Sydney, Nepean Clin Sch, Ageing Bone Res Program, Penrith, NSW, Australia.	gustavo.duque@sydney.edu.au	Duque, Gustavo/HDO-1243-2022; Duque, Gustavo/G-6656-2015; Duque, Gustavo/T-1538-2017	Duque, Gustavo/0000-0001-8126-0637; Duque, Gustavo/0000-0001-8126-0637; Duque, Gustavo/0000-0001-8126-0637	Australian National Health and Medical Research Council [632766, 213401, 354400, 404808]; Nepean Hospital Medical Research Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Nepean Hospital Medical Research Foundation	This work was supported by operating grants from the Australian National Health and Medical Research Council (Grant 632766 for GD and grants 213401, 354400, 404808 for DF), and the Nepean Hospital Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter R, 2009, J BONE MINER RES, V24, P283, DOI 10.1359/JBMR.081010; Bengtsson L, 2007, FEBS J, V274, P1374, DOI 10.1111/j.1742-4658.2007.05696.x; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brachner A, 2005, J CELL SCI, V118, P5797, DOI 10.1242/jcs.02701; Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Duque G, 2006, MECH AGEING DEV, V127, P378, DOI 10.1016/j.mad.2005.12.007; Duque G, 2011, BRIT J PHARMACOL, V162, P1109, DOI 10.1111/j.1476-5381.2010.01111.x; Duque G, 2008, J AM GERIATR SOC, V56, P935, DOI 10.1111/j.1532-5415.2008.01764.x; Duque G, 2009, STEM CELLS, V27, P550, DOI 10.1634/stemcells.2008-0886; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Guo DY, 2010, PROTEOMICS, V10, P3688, DOI 10.1002/pmic.201000306; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Kawaguchi H, 2000, CELL MOL LIFE SCI, V57, P731, DOI 10.1007/s000180050037; Kudlow BA, 2006, CURR BIOL, V16, pR652, DOI 10.1016/j.cub.2006.07.029; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pekovic V, 2008, J ANAT, V213, P5, DOI 10.1111/j.1469-7580.2008.00928.x; Pignolo RJ, 2008, AGING CELL, V7, P23, DOI 10.1111/j.1474-9726.2007.00350.x; Rauner M, 2009, J BONE MINER RES, V24, P78, DOI 10.1359/JBMR.080902; Rivas D, 2009, J GERONTOL A-BIOL, V64, P1015, DOI 10.1093/gerona/glp089; Rivas D, 2007, PPAR RES, V2007, DOI 10.1155/2007/81654; Rodrigues GHD, 2002, ANN GENET-PARIS, V45, P151, DOI 10.1016/S0003-3995(02)01119-X; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Ueda Y, 2007, STEM CELLS, V25, P1356, DOI 10.1634/stemcells.2006-0811; Uhlirova R, 2010, J CELL BIOCHEM, V109, P915, DOI 10.1002/jcb.22466; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	36	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19313	10.1371/journal.pone.0019313	http://dx.doi.org/10.1371/journal.pone.0019313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547077	Green Submitted, Green Published, gold			2022-12-25	WOS:000290016800041
J	Cao, SM; Liu, ZW; Jia, WH; Huang, QH; Liu, Q; Guo, X; Huang, TB; Ye, WM; Hong, MH				Cao, Su-Mei; Liu, Zhiwei; Jia, Wei-Hua; Huang, Qi-Hong; Liu, Qing; Guo, Xiang; Huang, Teng-Bo; Ye, Weimin; Hong, Ming-Huang			Fluctuations of Epstein-Barr Virus Serological Antibodies and Risk for Nasopharyngeal Carcinoma: A Prospective Screening Study with a 20-Year Follow-Up	PLOS ONE			English	Article							DEPENDENT ROC CURVES; PRESERVED FOODS; SERUM ANTIBODIES; IMMUNOGLOBULIN-A; GENE-EXPRESSION; EARLY ANTIGEN; SALTED FISH; MASS SURVEY; DIAGNOSIS; PATHOGENESIS	Background: The impact of variation of Epstein-Barr virus (EBV) antibody titers before the development of nasopharyngeal carcinoma (NPC) is still unclear. We analyzed the fluctuations of antibodies against EBV before histopathological diagnosis to assess the risk of NPC and aimed to provide a reliable basis for screening in high risk populations. Methods: This study was based on a population-based screening program in Sihui County in Guangdong Province of China. A total of 18,986 subjects were recruited in 1987 and 1992, respectively. Baseline and repeated serological tests were performed for IgA antibodies against EBV capsid antigen (VCA/IgA) and early antigen (EA/IgA). Follow-up until the end of 2007 was accomplished through linkage with population and health registers. Cox proportional hazards regression model was used to estimate the relative risk of NPC in association with EBV antibodies. Time-dependent receiver operating characteristic curve (ROC) analysis was used to further evaluate the predictive ability. Results: A total of 125 NPCs occurred during an average of 16.9 years of follow-up. Using baseline information alone or together with repeated measurements, serological levels of VCA/IgA and EA/IgA were significantly associated with increased risks for NPC, with a striking dose-response relationship and most prominent during the first 5 years of follow-up. Considering the fluctuant types of serological titers observed during the first three tests, relative risk was highest among participants with ascending titers of EBV VCA/IgA antibodies with an adjusted hazard ratio (HR) of 21.3 (95% confidence interval [CI] 7.1 to 64.1), and lowest for those with decreasing titers (HR = 1.5, 95% CI 0.2 to 11.4), during the first 5 years of follow-up. Time-dependent ROC analysis showed that VCA/IgA had better predictive performance for NPC incidence than EA/IgA. Conclusion: Our study documents that elevated EBV antibodies, particularly with ascending titers, are strongly associated with an increased risk for NPC.	[Cao, Su-Mei; Liu, Zhiwei; Liu, Qing; Huang, Teng-Bo; Hong, Ming-Huang] Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Epidemiol, Clin Trial Study Ctr,Canc Ctr, Guangzhou, Peoples R China; [Jia, Wei-Hua] Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Expt Res, Ctr Canc, Guangzhou, Peoples R China; [Huang, Qi-Hong] Sihui Canc Inst, Sihui, Peoples R China; [Guo, Xiang; Hong, Ming-Huang] Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Nasopharyngeal Carcinoma, Ctr Canc, Guangzhou, Peoples R China; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Karolinska Institutet	Cao, SM (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol So China, Dept Epidemiol, Clin Trial Study Ctr,Canc Ctr, Guangzhou, Peoples R China.	hongmh@sysucc.org.cn	Liu, Zhiwei/AAM-5300-2020	Liu, Zhiwei/0000-0002-0136-651X; ye, weimin/0000-0002-6859-4648	Seventh Chinese National Program for Science and Technology Development; Eighth Chinese National Program for Science and Technology Development; Ninth Chinese National Program for Science and Technology Development [969060103]; Tenth Chinese National Program for Science and Technology Development [2001BA703B07]; Eleventh National Science and Technology Support Program of China [2006BAI02A11]	Seventh Chinese National Program for Science and Technology Development; Eighth Chinese National Program for Science and Technology Development; Ninth Chinese National Program for Science and Technology Development; Tenth Chinese National Program for Science and Technology Development; Eleventh National Science and Technology Support Program of China	This study was supported by the Seventh (PI: Bao-Xiang Ou), Eighth (PI: Yin-Tang Wu), Ninth (969060103, PI: Teng-Bo Huang), Tenth (2001BA703B07, PI: Ming-Huang Hong) Chinese National Programs for Science and Technology Development and Eleventh (2006BAI02A11, PI: Ming-Huang Hong) National Science and Technology Support Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN X, 2011, CANCER; Ayadi W, 2009, J MED VIROL, V81, P1412, DOI 10.1002/jmv.21532; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chan KH, 2003, INT J CANCER, V105, P706, DOI 10.1002/ijc.11130; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Feng BJ, 2002, NAT GENET, V31, P395, DOI 10.1038/ng932; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HORIKAWA T, 2011, BR J CANC; Hsu WL, 2011, AM J EPIDEMIOL, V173, P292, DOI 10.1093/aje/kwq358; Hsu WL, 2009, CANCER EPIDEM BIOMAR, V18, P1218, DOI 10.1158/1055-9965.EPI-08-1175; Ji MF, 2007, BRIT J CANCER, V96, P623, DOI 10.1038/sj.bjc.6603609; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; KUNG CP, 2011, J VIROL; LANIER A, 1980, CANCER-AM CANCER SOC, V46, P2100, DOI 10.1002/1097-0142(19801101)46:9<2100::AID-CNCR2820460932>3.0.CO;2-G; LANIER AP, 1980, INT J CANCER, V26, P133, DOI 10.1002/ijc.2910260203; LANIER AP, 1981, INT J CANCER, V28, P301, DOI 10.1002/ijc.2910280308; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; Li X, 2009, CURR MOL MED, V9, P751, DOI 10.2174/156652409788970698; LIUT I, 1999, CRIT REV ONCOL HEMAT, V31, P55; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; LUNG ML, 1989, ONCOLOGY, V46, P310; Morris MA, 2009, FUTURE ONCOL, V5, P811, DOI [10.2217/fon.09.53, 10.2217/FON.09.53]; Murray PG, 1996, J PATHOL, V178, P44, DOI 10.1002/(SICI)1096-9896(199601)178:1<44::AID-PATH471>3.0.CO;2-0; Ng Mun-Hon, 2006, Ai Zheng, V25, P250; Niedobitek G, 1996, SEMIN CANCER BIOL, V7, P165, DOI 10.1006/scbi.1996.0023; NIEDOBITEK G, 1992, AM J PATHOL, V140, P879; Niedobitek G, 2000, J CLIN PATHOL-MOL PA, V53, P248, DOI 10.1136/mp.53.5.248; NIEDOBITEK G, 1991, J PATHOL, V165, P17, DOI 10.1002/path.1711650105; OLD LJ, 1966, P NATL ACAD SCI USA, V56, P1699, DOI 10.1073/pnas.56.6.1699; Paramita DK, 2007, J MED VIROL, V79, P1710, DOI 10.1002/jmv.20987; Paramita DK, 2011, J MED VIROL, V83, P665, DOI 10.1002/jmv.21960; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; Plaza G, 2002, ANN OTO RHINOL LARYN, V111, P210, DOI 10.1177/000348940211100304; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; RAABTRAUB N, 1987, INT J CANCER, V39, P25, DOI 10.1002/ijc.2910390106; Saika K, 2008, JPN J CLIN ONCOL, V38, P872, DOI 10.1093/jjco/hyn142; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; SIXBEY JW, 1992, SCIENCE, V255, P1578, DOI 10.1126/science.1312750; SUN Y, 1996, CLIN MED HLTH, P360; Tang JW, 2007, J CLIN VIROL, V40, P284, DOI 10.1016/j.jcv.2007.09.006; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; WOLF H, 1973, NATURE-NEW BIOL, V244, P245, DOI 10.1038/newbio244245a0; YE YZ, 1997, AI ZHENG, V16, P79; YI Z, 1980, INTERVIROLOGY, V13, P162, DOI 10.1159/000149121; YOU S, 2011, TUMOUR BIOL; YOUNG LS, 1988, J GEN VIROL, V69, P1051, DOI 10.1099/0022-1317-69-5-1051; Yu M C, 1987, IARC Sci Publ, P547; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; YU MC, 1988, CANCER RES, V48, P1954; YU MC, 1986, CANCER RES, V46, P956; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; ZENG Y, 1983, INTERVIROLOGY, V20, P190, DOI 10.1159/000149391; ZENG Y, 1986, AIDS RES HUM RETROV, V2, pS7; ZENG Y, 1982, INT J CANCER, V29, P139, DOI 10.1002/ijc.2910290204; ZHENG X, 1994, ACTA ONCOL, V33, P867; Zheng YY, 2006, BIOMETRICS, V62, P279, DOI 10.1111/j.1541-0420.2005.00441.x; ZONG YS, 1992, CANCER, V69, P3, DOI 10.1002/1097-0142(19920101)69:1&lt;3::AID-CNCR2820690104&gt;3.0.CO;2-7	62	101	108	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19100	10.1371/journal.pone.0019100	http://dx.doi.org/10.1371/journal.pone.0019100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544243	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800042
J	Rajapakse, AG; Yepuri, G; Carvas, JM; Stein, S; Matter, CM; Scerri, I; Ruffieux, J; Montani, JP; Ming, XF; Yang, ZH				Rajapakse, Angana G.; Yepuri, Gautham; Carvas, Joao M.; Stein, Sokrates; Matter, Christian M.; Scerri, Isabelle; Ruffieux, Jean; Montani, Jean-Pierre; Ming, Xiu-Fen; Yang, Zhihong			Hyperactive S6K1 Mediates Oxidative Stress and Endothelial Dysfunction in Aging: Inhibition by Resveratrol	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LIFE-SPAN; SIGNALING PATHWAY; RAT AORTA; TOR; KINASE; EXPRESSION; CELLS; MTOR; PREVENTS	Mammalian target of rapamycin (mTOR)/S6K1 signalling emerges as a critical regulator of aging. Yet, a role of mTOR/S6K1 in aging-associated vascular endothelial dysfunction remains unknown. In this study, we investigated the role of S6K1 in aging-associated endothelial dysfunction and effects of the polyphenol resveratrol on S6K1 in aging endothelial cells. We show here that senescent endothelial cells displayed higher S6K1 activity, increased superoxide production and decreased bioactive nitric oxide (NO) levels than young endothelial cells, which is contributed by eNOS uncoupling. Silencing S6K1 in senescent cells reduced superoxide generation and enhanced NO production. Conversely, over-expression of a constitutively active S6K1 mutant in young endothelial cells mimicked endothelial dysfunction of the senescent cells through eNOS uncoupling and induced premature cellular senescence. Like the mTOR/S6K1 inhibitor rapamycin, resveratrol inhibited S6K1 signalling, resulting in decreased superoxide generation and enhanced NO levels in the senescent cells. Consistent with the data from cultured cells, an enhanced S6K1 activity, increased superoxide generation, and decreased bioactive NO levels associated with eNOS uncoupling were also detected in aortas of old WKY rats (aged 20-24 months) as compared to the young animals (1-3 months). Treatment of aortas of old rats with resveratrol or rapamycin inhibited S6K1 activity, oxidative stress, and improved endothelial NO production. Our data demonstrate a causal role of the hyperactive S6K1 in eNOS uncoupling leading to endothelial dysfunction and vascular aging. Resveratrol improves endothelial function in aging, at least in part, through inhibition of S6K1. Targeting S6K1 may thus represent a novel therapeutic approach for aging-associated vascular disease.	[Rajapakse, Angana G.; Yepuri, Gautham; Carvas, Joao M.; Scerri, Isabelle; Ruffieux, Jean; Montani, Jean-Pierre; Ming, Xiu-Fen; Yang, Zhihong] Univ Fribourg, Dept Med, Div Physiol, CH-1700 Fribourg, Switzerland; [Stein, Sokrates; Matter, Christian M.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Stein, Sokrates; Matter, Christian M.] Univ Zurich Hosp, CH-8091 Zurich, Switzerland	University of Fribourg; University of Zurich; University of Zurich; University Zurich Hospital	Rajapakse, AG (corresponding author), Univ Fribourg, Dept Med, Div Physiol, CH-1700 Fribourg, Switzerland.	xiu-fen.ming@unifr.ch	Stein, Sokrates/D-4661-2009	Stein, Sokrates/0000-0001-6984-6934; Carvas, Joao/0000-0002-0929-2180; Yepuri, Gautham/0000-0002-6846-0295	Swiss National Science Foundation [310000-120435/1, 31-114094/1]; Swiss Heart Foundation; University Zurich, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; University Zurich, Switzerland	This study was supported by the Swiss National Science Foundation (310000-120435/1 to ZY and 31-114094/1 to CMM), the Swiss Heart Foundation to ZY and XFM, and the University Research Priority Program "Integrative Human Physiology'' at the University Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Demidenko ZN, 2009, CELL CYCLE, V8, P1901, DOI 10.4161/cc.8.12.8810; Desrois M, 2010, AM J PHYSIOL-HEART C, V299, pH1679, DOI 10.1152/ajpheart.00998.2009; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hink U, 2001, CIRC RES, V88, pE14; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jiang Hao, 2009, J Exp Ther Oncol, V8, P25; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kazuyama E, 2009, MOL CELL BIOCHEM, V332, P95, DOI 10.1007/s11010-009-0178-2; Labinskyy N, 2006, CURR MED CHEM, V13, P989, DOI 10.2174/092986706776360987; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Ming XF, 2010, FEBS LETT, V584, P135, DOI 10.1016/j.febslet.2009.11.030; Ming XF, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-12; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pierce GL, 2008, J PHYSIOL-LONDON, V586, P2673, DOI 10.1113/jphysiol.2008.154229; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rajapakse AG, 2009, AM J PHYSIOL-HEART C, V296, pH815, DOI 10.1152/ajpheart.00756.2008; Rice KM, 2005, MECH AGEING DEV, V126, P1213, DOI 10.1016/j.mad.2005.07.001; Rossi ML, 2005, EUR J HISTOCHEM, V49, P39; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Stockklauser-Farber K, 2000, BBA-MOL BASIS DIS, V1535, P10, DOI 10.1016/S0925-4439(00)00078-8; Tschudi MR, 1996, J CLIN INVEST, V98, P899, DOI 10.1172/JCI118872; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wilcox JN, 1997, ARTERIOSCL THROM VAS, V17, P2479, DOI 10.1161/01.ATV.17.11.2479; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	52	104	109	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19237	10.1371/journal.pone.0019237	http://dx.doi.org/10.1371/journal.pone.0019237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544240	Green Published, gold, Green Accepted			2022-12-25	WOS:000290015800054
J	Bezerra, PGM; Britto, MCA; Correia, JB; Duarte, MDMB; Fonceca, AM; Rose, K; Hopkins, MJ; Cuevas, LE; McNamara, PS				Bezerra, Patricia G. M.; Britto, Murilo C. A.; Correia, Jailson B.; Duarte, Maria do Carmo M. B.; Fonceca, Angela M.; Rose, Katie; Hopkins, Mark J.; Cuevas, Luis E.; McNamara, Paul S.			Viral and Atypical Bacterial Detection in Acute Respiratory Infection in Children Under Five Years	PLOS ONE			English	Article							REAL-TIME PCR; SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; TRACT DISEASE; HUMAN BOCAVIRUS; RISK-FACTORS; PATHOGENS; IDENTIFICATION; BRONCHIOLITIS; SURVEILLANCE	Background: Acute respiratory infection (ARI) is a leading cause of morbidity and mortality in children worldwide. This study aimed to determine the viral and atypical bacterial causes of different severities and clinical manifestations of ARI in preschool children from low-income families in North-East Brazil. Methods: Clinical/demographic data and nasopharyngeal aspirates (NPA) were prospectively collected from children,5 years presenting with ARI over one year to a paediatric A&E department. Disease severity was grouped according to presence of lower respiratory tract signs, need for hospital admission and need for oxygen. Clinical manifestation of ARI was based on discharge diagnosis from hospital with four conditions predominating: bronchiolitis, pneumonia, episodic viral wheeze/asthma and upper respiratory tract infection. Multiplex PCR was used to detect 17 common respiratory viral and atypical bacterial pathogens in NPA. Findings: 407 children with a median age of eight months were recruited. Pathogens were detected in 85. 5% samples with co-infection being particularly common (39. 5%). Respiratory Syncytial Virus (RSV; 37%), Adenoviruses (AdV; 25%), Rhinoviruses (hRV; 19%), Bocavirus (hBoV; 19%), human Meta-pneumovirus (hMPV; 10%) and Mycoplasma pneumoniae (Mpp; 10%) were most prevalent. Detection and co-infection rates were similar in all severities and clinical manifestations of ARI apart from RSV, which was associated with more severe disease and specifically more severe cases of bronchiolitis, and Mpp, which was associated with more severe cases of pneumonia. Mpp was detected in 17% of children admitted to hospital with pneumonia. Interpretation: This study underlines the importance of viral and atypical bacterial pathogens in ARI in pre-school children and highlights the complex epidemiology of these pathogens in this age group. Generally, viruses and atypical bacteria were detected in all severities and clinical manifestations of ARI but RSV and Mpp were associated with more severe cases of bronchiolitis and pneumonia respectively.	[Bezerra, Patricia G. M.; Britto, Murilo C. A.; Correia, Jailson B.; Duarte, Maria do Carmo M. B.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil; [Bezerra, Patricia G. M.; Britto, Murilo C. A.] Fac Pernambucana Saude, Recife, PE, Brazil; [Correia, Jailson B.] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil; [Fonceca, Angela M.; Rose, Katie; McNamara, Paul S.] Univ Liverpool, Dept Child Hlth, Inst Child Hlth, Alder Hey Childrens Hosp, Liverpool L69 3BX, Merseyside, England; [Hopkins, Mark J.] Royal Liverpool Univ Hosp, Liverpool Specialist Virol Ctr, Liverpool, Merseyside, England; [Cuevas, Luis E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade de Pernambuco (UPE); Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool	Bezerra, PGM (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.	mcnamp@liv.ac.uk	Britto, Murilo/AAQ-2951-2020; Correia, Jailson B./J-4331-2015; Cuevas, Luis E/I-3697-2015; Britto, Murilo/S-5543-2019	Cuevas, Luis E/0000-0002-6581-0587; Tripp, Ralph/0000-0002-2924-9956; de Barros Correia, Jailson/0000-0002-0927-2219; McNamara, Paul/0000-0002-7055-6034	Brazil's National Council for Scientific and Technological Development [479381/2006-2]; IMIP; Wellcome Trust	Brazil's National Council for Scientific and Technological Development; IMIP; Wellcome Trust(Wellcome TrustEuropean Commission)	Brazil's National Council for Scientific and Technological Development (Grant number 479381/2006-2) and IMIP's Fund for Teaching and Research supported this study. The Wellcome Trust also provided some funding for PMc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bharaj P, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-89; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; *COMM BTSSOC, 2002, THORAX S1, V57, P1; FOX JP, 1969, AM J EPIDEMIOL, V89, P25, DOI 10.1093/oxfordjournals.aje.a120913; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Gunson RN, 2005, J CLIN VIROL, V33, P341, DOI 10.1016/j.jcv.2004.11.025; Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2; Hopkins MJ, 2011, INFLUENZA OTHER RESP, V5, P110, DOI 10.1111/j.1750-2659.2010.00178.x; Kaplan NM, 2008, J MED VIROL, V80, P168, DOI 10.1002/jmv.21067; Manning A, 2006, J INFECT DIS, V194, P1283, DOI 10.1086/508219; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Peat J K, 2001, Paediatr Respir Rev, V2, P207, DOI 10.1053/prrv.2001.0142; Pyrc K, 2007, J VIROL, V81, P3051, DOI 10.1128/JVI.01466-06; Regamey N, 2008, PEDIATR INFECT DIS J, V27, P100, DOI 10.1097/INF.0b013e31815922c8; Russell KL, 2006, J INFECT DIS, V194, P877, DOI 10.1086/507426; Semple MG, 2007, J CLIN VIROL, V40, P241, DOI 10.1016/j.jcv.2007.08.019; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Sung RYT, 2009, J MED VIROL, V81, P153, DOI 10.1002/jmv.21364; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Weigl JAI, 2007, EUR J PEDIATR, V166, P957, DOI 10.1007/s00431-007-0496-x; WHO (World Health Organization), 1999, LEAD INF KILL	32	132	151	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18928	10.1371/journal.pone.0018928	http://dx.doi.org/10.1371/journal.pone.0018928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533115	Green Submitted, Green Published, gold			2022-12-25	WOS:000289620100031
J	Sunami, E; de Maat, M; Vu, A; Turner, RR; Hoon, DSB				Sunami, Eiji; de Maat, Michiel; Vu, Anna; Turner, Roderick R.; Hoon, Dave S. B.			LINE-1 Hypomethylation During Primary Colon Cancer Progression	PLOS ONE			English	Article							DNA HYPOMETHYLATION; MICROSATELLITE INSTABILITY; METHYLATION LEVEL; HYPERMETHYLATION; ELEMENTS; TISSUES; P16	Background: Methylation levels of genomic repeats such as long interspersed nucleotide elements (LINE-1) are representative of global methylation status and play an important role in maintenance of genomic stability. The objective of the study was to assess LINE-1 methylation status in colorectal cancer (CRC) in relation to adenomatous and malignant progression, tissue heterogeneity, and TNM-stage. Methodology/Principal Findings: DNA was collected by laser-capture microdissection (LCM) from normal, adenoma, and cancer tissue from 25 patients with TisN0M0 and from 92 primary CRC patients of various TNM-stages. The paraffin-embedded tissue sections were treated by in-situ DNA sodium bisulfite modification (SBM). LINE-1 hypomethylation index (LHI) was measured by absolute quantitative analysis of methylated alleles (AQAMA) realtime PCR; a greater index indicated enhanced hypomethylation. LHI in normal, cancer mesenchymal, adenoma, and CRC tissue was 0.38 (SD 0.07), 0.37 (SD 0.09), 0.49 (SD 0.10) and 0.53 (SD 0.08), respectively. LHI was significantly greater in adenoma tissue compared to its contiguous normal epithelium (P = 0.0003) and cancer mesenchymal tissue (P < 0.0001). LHI did not differ significantly between adenoma and early cancer tissue of Tis stage (P = 0.20). LHI elevated with higher T-stage (P < 0.04), was significantly greater in node-positive than node-negative CRC patients (P = 0.03), and was significantly greater in stage IV than all other disease stages (P < 0.05). Conclusion/Significance: By using in-situ SBM and LCM cell selection we demonstrated early onset of LINE-1 demethylation during adenomatous change of colorectal epithelial cells and demonstrated that LINE-1 demethylation progression is linear in relation to TNM-stage progression.	[Sunami, Eiji; de Maat, Michiel; Vu, Anna; Hoon, Dave S. B.] John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA; [Turner, Roderick R.] St Johns Hlth Ctr, Dept Surg Pathol, Santa Monica, CA USA	John Wayne Cancer Institute	Sunami, E (corresponding author), John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA USA.	hoon@jwci.org	Hoon, Dave SB/C-7146-2018	Hoon, Dave SB/0000-0003-1915-3683	Weil Family Foundation ( Los Angeles, CA); Leslie and Susan Gonda (Goldschmied) Foundation (Los Angeles, CA)	Weil Family Foundation ( Los Angeles, CA); Leslie and Susan Gonda (Goldschmied) Foundation (Los Angeles, CA)	The studies were supported by the Weil Family Foundation ( Los Angeles, CA) and the Leslie and Susan Gonda (Goldschmied) Foundation (Los Angeles, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Bariol C, 2003, AM J PATHOL, V162, P1361, DOI 10.1016/S0002-9440(10)63932-6; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; de Maat MFG, 2007, MOL CANCER RES, V5, P461, DOI 10.1158/1541-7786.MCR-06-0358; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Fend F, 2000, J CLIN PATHOL, V53, P666, DOI 10.1136/jcp.53.9.666; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Gu ZL, 2000, GENE, V259, P81, DOI 10.1016/S0378-1119(00)00434-0; Hernandez-Blazquez FJ, 2000, GUT, V47, P689, DOI 10.1136/gut.47.5.689; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; IBRAHIM AE, 2010, GUT; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kazazian HH, 2000, SCIENCE, V289, P1152, DOI 10.1126/science.289.5482.1152; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kwon HJ, 2010, VIRCHOWS ARCH, V457, P433, DOI 10.1007/s00428-010-0958-9; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Mesker WE, 2007, CELL ONCOL, V29, P387; Miyashiro I, 2001, CLIN CHEM, V47, P505; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Sunami E, 2008, ANN NY ACAD SCI, V1137, P171, DOI 10.1196/annals.1448.011; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Umetani N, 2005, BIOCHEM BIOPH RES CO, V329, P219, DOI 10.1016/j.bbrc.2005.01.088; Umetani N, 2006, MOL CANCER RES, V4, P303, DOI 10.1158/1541-7786.MCR-05-0199; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yang AS, 2006, CANCER RES, V66, P5495, DOI 10.1158/0008-5472.CAN-05-2385; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	34	118	124	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18884	10.1371/journal.pone.0018884	http://dx.doi.org/10.1371/journal.pone.0018884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533144	Green Published, Green Submitted, gold			2022-12-25	WOS:000289505600043
J	Templeton, SP; Buskirk, AD; Law, B; Green, BJ; Beezhold, DH				Templeton, Steven P.; Buskirk, Amanda D.; Law, Brandon; Green, Brett J.; Beezhold, Donald H.			Role of Germination in Murine Airway CD8(+) T-Cell Responses to Aspergillus Conidia	PLOS ONE			English	Article							FUMIGATUS; GENERATION; LUNG; MICE; HYPERREACTIVITY; EOSINOPHILS; VIRULENCE; EXPOSURE; REQUIRES; IMMUNITY	Pulmonary exposure to Aspergillus fumigatus has been associated with morbidity and mortality, particularly in immunocompromised individuals. A. fumigatus conidia produce beta-glucan, proteases, and other immunostimulatory factors upon germination. Murine models have shown that the ability of A. fumigatus to germinate at physiological temperature may be an important factor that facilitates invasive disease. We observed a significant increase in IFN-gamma-producing CD8(+) T cells in bronchoalveolar lavage fluid (BALF) of immunocompetent mice that repeatedly aspirated A. fumigatus conidia in contrast to mice challenged with A. versicolor, a species that is not typically associated with invasive, disseminated disease. Analysis of tissue sections indicated the presence of germinating spores in the lungs of mice challenged with A. fumigatus, but not A. versicolor. Airway IFN-gamma(+)CD8(+) T-cells were decreased and lung germination was eliminated in mice that aspirated A. fumigatus conidia that were formaldehyde-fixed or heat-inactivated. Furthermore, A. fumigatus particles exhibited greater persistence in the lungs of recipient mice when compared to non-viable A. fumigatus or A. versicolor, and this correlated with increased maintenance of airway memory-phenotype CD8(+) T cells. Therefore, murine airway CD8(+) T cell-responses to aspiration of Aspergillus conidia may be mediated in part by the ability of conidia to germinate in the host lung tissue. These results provide further evidence of induction of immune responses to fungi based on their ability to invade host tissue.	[Templeton, Steven P.; Buskirk, Amanda D.; Law, Brandon; Green, Brett J.; Beezhold, Donald H.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Buskirk, Amanda D.] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University	Templeton, SP (corresponding author), NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV 26505 USA.	STempleton@cdc.gov	Templeton, Steven/I-6635-2013	Templeton, Steven/0000-0003-3430-7011; Beezhold, Donald/0000-0001-5543-5747	National Institute of Occupational Safety and Health [Y1-ES-0001]	National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by an interagency agreement with the National Institute of Occupational Safety and Health (Y1-ES-0001). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Beck O, 2006, BLOOD, V107, P2562, DOI 10.1182/blood-2005-04-1660; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; Bhabhra R, 2004, INFECT IMMUN, V72, P4731, DOI 10.1128/IAI.72.8.4731-4740.2004; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Cenci E, 1998, J INFECT DIS, V178, P1750, DOI 10.1086/314493; Cenci E, 1999, J INFECT DIS, V180, P1957, DOI 10.1086/315142; Cenci E, 2000, J IMMUNOL, V165, P381, DOI 10.4049/jimmunol.165.1.381; Chaudhary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009036; CUSUMANO V, 1990, APPL ENVIRON MICROB, V56, P3482, DOI 10.1128/AEM.56.11.3482-3484.1990; Eduard W, 2009, CRIT REV TOXICOL, V39, P799, DOI 10.3109/10408440903307333; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Green BJ, 2003, J ALLERGY CLIN IMMUN, V111, P285, DOI 10.1067/mai.2003.57; Greenberger PA, 2004, ALLERGY ASTHMA PROC, V25, P219; Hebart H, 2002, BLOOD, V100, P4521, DOI 10.1182/blood-2002-01-0265; Hogaboam CM, 2000, AM J PATHOL, V156, P723, DOI 10.1016/S0002-9440(10)64775-X; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Kradin RL, 2008, ARCH PATHOL LAB MED, V132, P606, DOI 10.1043/1543-2165(2008)132[606:TPOPDD]2.0.CO;2; KURUP VP, 1992, J IMMUNOL, V148, P3783; Kurup VP, 1997, ALLERGY, V52, P1215, DOI 10.1111/j.1398-9995.1997.tb02526.x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lindell DM, 2005, J IMMUNOL, V174, P7920, DOI 10.4049/jimmunol.174.12.7920; Ma LL, 2002, J IMMUNOL, V169, P5787, DOI 10.4049/jimmunol.169.10.5787; Mehlhop PD, 1997, P NATL ACAD SCI USA, V94, P1344, DOI 10.1073/pnas.94.4.1344; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; MULLBACHER A, 1985, J GEN MICROBIOL, V131, P1251; Murdock BJ, 2011, INFECT IMMUN, V79, P125, DOI 10.1128/IAI.00508-10; Perruccio K, 2005, BLOOD, V106, P4397, DOI 10.1182/blood-2005-05-1775; Ramadan G, 2005, CLIN EXP IMMUNOL, V140, P81, DOI 10.1111/j.1365-2249.2005.02738.x; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Rivera A, 2005, INFECT IMMUN, V73, P7170, DOI 10.1128/IAI.73.11.7170-7179.2005; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Tao JM, 2006, J LEUKOCYTE BIOL, V80, P529, DOI 10.1189/jlb.0106026; Tomee JFC, 2000, CLIN EXP ALLERGY, V30, P476, DOI 10.1046/j.1365-2222.2000.00796.x; Woodland David L, 2005, Proc Am Thorac Soc, V2, P126; Zelante T, 2009, MED MYCOL, V47, pS162, DOI 10.1080/13693780802140766	41	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18777	10.1371/journal.pone.0018777	http://dx.doi.org/10.1371/journal.pone.0018777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533200	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800041
J	Zhou, Z; Yang, JL; Wang, LL; Zhang, HA; Gao, Y; Shi, XW; Wang, MQ; Kong, PF; Qiu, LM; Song, LS				Zhou, Zhi; Yang, Jialong; Wang, Lingling; Zhang, Huan; Gao, Yang; Shi, Xiaowei; Wang, Mengqiang; Kong, Pengfei; Qiu, Limei; Song, Linsheng			A Dopa Decarboxylase Modulating the Immune Response of Scallop Chlamys farreri	PLOS ONE			English	Article							AMINO-ACID DECARBOXYLASE; IMMUNOREGULATORY ROLE; INNATE IMMUNITY; HOST-DEFENSE; CATECHOLAMINES; MELANIZATION; STRESS; GENE; SYSTEM; SHRIMP	Background: Dopa decarboxylase (DDC) is a pyridoxal 5-phosphate (PLP)-dependent enzyme that catalyzes the decarboxylation of L-Dopa to dopamine, and involved in complex neuroendocrine-immune regulatory network. The function for DDC in the immunomodulation remains unclear in invertebrate. Methodology: The full-length cDNA encoding DDC (designated CfDDC) was cloned from mollusc scallop Chlamys farreri. It contained an open reading frame encoding a polypeptide of 560 amino acids. The CfDDC mRNA transcripts could be detected in all the tested tissues, including the immune tissues haemocytes and hepatopancreas. After scallops were treated with LPS stimulation, the mRNA expression level of CfDDC in haemocytes increased significantly (5.5-fold, P<0.05) at 3 h and reached the peak at 12 h (9.8-fold, P<0.05), and then recovered to the baseline level. The recombinant protein of CfDDC (rCfDDC) was expressed in Escherichia coli BL21 (DE3)-Transetta, and 1 mg rCfDDC could catalyze the production of 1.651 +/- 0.22 ng dopamine within 1 h in vitro. When the haemocytes were incubated with rCfDDC-coated agarose beads, the haemocyte encapsulation to the beads was increased significantly from 70% at 6 h to 93% at 24 h in vitro in comparison with that in the control (23% at 6 h to 25% at 24 h), and the increased haemocyte encapsulation was repressed by the addition of rCfDDC antibody (which is acquired via immunization 6-week old rats with rCfDDC). After the injection of DDC inhibitor methyldopa, the ROS level in haemocytes of scallops was decreased significantly to 0.41-fold (P<0.05) of blank group at 12 h and 0.47-fold (P<0.05) at 24 h, respectively. Conclusions: These results collectively suggested that CfDDC, as a homologue of DDC in scallop, modulated the immune responses such as haemocytes encapsulation as well as the ROS level through its catalytic activity, functioning as an indispensable immunomodulating enzyme in the neuroendocrine-immune regulatory network of mollusc.	[Zhou, Zhi; Yang, Jialong; Wang, Lingling; Zhang, Huan; Gao, Yang; Shi, Xiaowei; Wang, Mengqiang; Kong, Pengfei; Qiu, Limei; Song, Linsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhou, Zhi; Yang, Jialong; Gao, Yang; Shi, Xiaowei; Kong, Pengfei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, JL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn	Wang, Mengqiang/A-1215-2010; zhi, zhouzhi/J-8063-2013	Wang, Mengqiang/0000-0003-4702-3309; Kong, Pengfei/0000-0003-2944-5874	National Basic Research Program of China [2010CB126404]; NSFC [30925028, 30730070, 31072192]	National Basic Research Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (No. 2010CB126404), http://www.973.gov.cn/; and grants (No. 30925028, 30730070 to L.S., 31072192 to L.W.) from NSFC, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM WR, 1986, CLIN EXP PHARMACOL P, V13, P47, DOI 10.1111/j.1440-1681.1986.tb00314.x; Adamo SA, 2010, BRAIN BEHAV IMMUN, V24, P194, DOI 10.1016/j.bbi.2009.08.003; Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; BEIRAS R, 1995, MAR BIOL, V122, P597, DOI 10.1007/BF00350681; Bergmann M, 2002, WIEN KLIN WOCHENSCHR, V114, P752; Bertoldi M, 2005, FEBS LETT, V579, P5175, DOI 10.1016/j.febslet.2005.08.029; Bertoldi M, 2008, BIOCHEMISTRY-US, V47, P7187, DOI 10.1021/bi800478s; Bertoldi M, 2009, ARCH BIOCHEM BIOPHYS, V488, P130, DOI 10.1016/j.abb.2009.06.019; Besser MJ, 2005, J NEUROIMMUNOL, V169, P161, DOI 10.1016/j.jneuroim.2005.07.013; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Butts CL, 2008, CELL IMMUNOL, V252, P7, DOI 10.1016/j.cellimm.2007.09.009; Carroll MA, 2007, COMP BIOCHEM PHYS A, V148, P445, DOI 10.1016/j.cbpa.2007.06.003; Chang CC, 2007, AQUACULTURE, V270, P333, DOI 10.1016/j.aquaculture.2007.04.013; Chang CC, 2007, FISH SHELLFISH IMMUN, V23, P24, DOI 10.1016/j.fsi.2006.09.001; Chen MY, 2008, J EXP ZOOL PART A, V309A, P289, DOI 10.1002/jez.458; Cheng SF, 2006, J VIROL METHODS, V135, P173, DOI 10.1016/j.jviromet.2006.03.016; Chiu HT, 2006, AQUACULTURE, V251, P558, DOI 10.1016/j.aquaculture.2005.06.011; Costa MM, 2009, FISH SHELLFISH IMMUN, V26, P515, DOI 10.1016/j.fsi.2009.02.001; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; DRUMMOND AH, 1980, BRAIN RES, V184, P163, DOI 10.1016/0006-8993(80)90595-8; Ferdig MT, 2000, INSECT MOL BIOL, V9, P231, DOI 10.1046/j.1365-2583.2000.00187.x; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Flierl MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004414; FRAGOULIS EG, 1975, ARCH BIOCHEM BIOPHYS, V168, P15, DOI 10.1016/0003-9861(75)90223-4; Ghosh MC, 2003, INT IMMUNOPHARMACOL, V3, P1019, DOI 10.1016/S1567-5769(03)00100-0; GOSPE SM, 1983, LIFE SCI, V33, P1945, DOI 10.1016/0024-3205(83)90732-4; Han Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008826; Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143; Hooper C, 2007, FISH SHELLFISH IMMUN, V22, P363, DOI 10.1016/j.fsi.2006.06.009; Huang CY, 2005, INSECT MOL BIOL, V14, P237, DOI 10.1111/j.1365-2583.2004.00552.x; Jiang Jian-Lan, 2006, Shengli Xuebao, V58, P309; KHOTIMCHENKO YS, 1991, COMP BIOCHEM PHYS C, V100, P671, DOI 10.1016/0742-8413(91)90059-3; Kitahama K, 2009, J CHEM NEUROANAT, V38, P130, DOI 10.1016/j.jchemneu.2009.06.010; Kokkinou I, 2009, BLOOD CELL MOL DIS, V42, P92, DOI 10.1016/j.bcmd.2008.10.010; Kvetnansky R, 1995, ANN NY ACAD SCI, V771, P131, DOI 10.1111/j.1749-6632.1995.tb44676.x; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Li JT, 2005, FISH SHELLFISH IMMUN, V19, P269, DOI 10.1016/j.fsi.2005.01.003; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; Luna-Gonzalez A, 2003, FISH SHELLFISH IMMUN, V15, P275, DOI 10.1016/S1050-4648(02)00165-1; Malashkevich VN, 1999, ACTA CRYSTALLOGR D, V55, P568, DOI 10.1107/S0907444998006283; Noguchi H, 2003, INSECT BIOCHEM MOLEC, V33, P209, DOI 10.1016/S0965-1748(02)00192-3; PANI AK, 1995, CELL MOL NEUROBIOL, V15, P371, DOI 10.1007/BF02089947; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; Pavlova GA, 2001, J EXP BIOL, V204, P1625; RAHMAN MK, 1981, BIOCHEM PHARMACOL, V30, P645, DOI 10.1016/0006-2952(81)90139-8; RAHMAN MK, 1981, LIFE SCI, V28, P485, DOI 10.1016/0024-3205(81)90141-7; Sarkar C, 2010, BRAIN BEHAV IMMUN, V24, P525, DOI 10.1016/j.bbi.2009.10.015; Sideri M, 2008, IMMUNOLOGY, V123, P528, DOI 10.1111/j.1365-2567.2007.02722.x; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; Voronezhskaya EE, 2008, ZOOMORPHOLOGY, V127, P97, DOI 10.1007/s00435-007-0055-z; Wang LL, 2009, FISH SHELLFISH IMMUN, V26, P744, DOI 10.1016/j.fsi.2009.03.002; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Zhang H, 2010, FISH SHELLFISH IMMUN; ZHANG Y, 2010, AQUACULTURE RES; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zhou Z, 2011, FISH SHELLFISH IMMUN, V30, P154, DOI 10.1016/j.fsi.2010.09.020	59	20	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18596	10.1371/journal.pone.0018596	http://dx.doi.org/10.1371/journal.pone.0018596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533240	Green Submitted, Green Published, gold			2022-12-25	WOS:000289458800021
J	Stjepanovic, G; Kapp, K; Bange, G; Graf, C; Parlitz, R; Wild, K; Mayer, MP; Sinning, I				Stjepanovic, Goran; Kapp, Katja; Bange, Gert; Graf, Christian; Parlitz, Richard; Wild, Klemens; Mayer, Matthias P.; Sinning, Irmgard			Lipids Trigger a Conformational Switch That Regulates Signal Recognition Particle (SRP)-mediated Protein Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SRP; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; MEMBRANE-BINDING; INNER-MEMBRANE; BETA-SUBUNIT; RECEPTOR; DOMAIN; FTSY; PHOSPHATIDYLETHANOLAMINE	Co-translational protein targeting to the membrane is mediated by the signal recognition particle and its receptor (FtsY). Their homologous GTPase domains interact at the membrane and form a heterodimer in which both GTPases are activated. The prerequisite for protein targeting is the interaction of FtsY with phospholipids. However, the mechanism of FtsY regulation by phospholipids remained unclear. Here we show that the N terminus of FtsY (A domain) is natively unfolded in solution and define the complete membrane-targeting sequence. We show that the membrane-targeting sequence is highly dynamic in solution, independent of nucleotides and directly responds to the density of anionic phospholipids by a random coil-helix transition. This conformational switch is essential for tethering FtsY to membranes and activates the GTPase for its subsequent interaction with the signal recognition particle. Our results underline the dynamics of lipid-protein interactions and their importance in the regulation of protein targeting and translocation across biological membranes.	[Stjepanovic, Goran; Bange, Gert; Parlitz, Richard; Wild, Klemens; Sinning, Irmgard] Heidelberg Univ, Biochem Zentrum BZH, D-69120 Heidelberg, Germany; [Kapp, Katja; Graf, Christian; Mayer, Matthias P.] Heidelberg Univ, Zentrum Mol Biol ZMBH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Sinning, I (corresponding author), Heidelberg Univ, Biochem Zentrum BZH, INF 328, D-69120 Heidelberg, Germany.	irmi.sinning@bzh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013; Bange, Gert/AAB-3734-2021; Stjepanovic, Goran/A-7902-2010	Mayer, Matthias P./0000-0002-7859-3112; Stjepanovic, Goran/0000-0002-4841-9949; Bange, Gert/0000-0002-7826-0932	German-Israeli Foundation; Deutsche Forschungsgemeinschaft [GRK1188, SFB638]	German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German-Israeli Foundation and Deutsche Forschungsgemeinschaft Grants GRK1188 and SFB638.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Bibi E, 2011, BBA-BIOMEMBRANES, V1808, P841, DOI 10.1016/j.bbamem.2010.07.025; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engen JR, 2001, ANAL CHEM, V73, p256A, DOI 10.1021/ac012452f; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Erez E, 2010, J BIOL CHEM, V285, P40508, DOI 10.1074/jbc.M110.140921; Facey SJ, 2010, CELL MOL LIFE SCI, V67, P2343, DOI 10.1007/s00018-010-0303-0; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Herskovits AA, 2001, EMBO REP, V2, P1040, DOI 10.1093/embo-reports/kve226; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Millman JS, 2001, J BIOL CHEM, V276, P25982, DOI 10.1074/jbc.M011331200; Mircheva M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-76; Montoya G, 1997, PROTEINS, V28, P285, DOI 10.1002/(SICI)1097-0134(199706)28:2<285::AID-PROT15>3.0.CO;2-E; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; SAMUELSSON T, 1993, NUCLEIC ACIDS RES, V21, P847, DOI 10.1093/nar/21.4.847; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Szeto TH, 2003, J BIOL CHEM, V278, P40050, DOI 10.1074/jbc.M306876200; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; Vanounou S, 2003, MOL MICROBIOL, V49, P1067, DOI 10.1046/j.1365-2958.2003.03614.x; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Weiche B, 2008, J MOL BIOL, V377, P761, DOI 10.1016/j.jmb.2008.01.040; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853; WILSON C, 1988, J CELL BIOL, V107, P69, DOI 10.1083/jcb.107.1.69; YOUNG JC, 1995, J BIOL CHEM, V270, P15650, DOI 10.1074/jbc.270.26.15650; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; Zhang ZQ, 1996, BIOCHEMISTRY-US, V35, P779, DOI 10.1021/bi952227q	49	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23489	23497		10.1074/jbc.M110.212340	http://dx.doi.org/10.1074/jbc.M110.212340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543314	Green Published, hybrid			2022-12-25	WOS:000292025000079
J	Crossman, CA; Rohwer, VG; Martin, PR				Crossman, Carla A.; Rohwer, Vanya G.; Martin, Paul R.			Variation in the Structure of Bird Nests between Northern Manitoba and Southeastern Ontario	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; PREDATION; SIZE; EVOLUTION; BEHAVIOR; CONSERVATION; ADAPTATION; MORPHOLOGY; SURVIVAL; REVEALS	Traits that converge in appearance under similar environmental conditions among phylogenetically independent lineages are thought to represent adaptations to local environments. We tested for convergence in nest morphology and composition of birds breeding in two ecologically different locations in Canada: Churchill in northern Manitoba and Elgin in southeastern Ontario. We examined nests from four families of passerine birds (Turdidae: Turdus, Parulidae: Dendroica, Emberizidae: Passerculus and Fringillidae: Carduelis) where closely related populations or species breed in both locations. Nests of American Robins, Yellow Warblers, and Carduelis finches had heavier nest masses, and tended to have thicker nest-walls, in northern Manitoba compared with conspecifics or congenerics breeding in southeastern Ontario. Together, all species showed evidence for wider internal and external nest-cup diameters in northern Manitoba, while individual species showed varying patterns for internal nest-cup and external nest depths. American Robins, Yellow Warblers, and Carduelis finches in northern Manitoba achieved heavier nest masses in different ways. American Robins increased all materials in similar proportions, and Yellow Warblers and Common Redpolls used greater amounts of select materials. While changes in nest composition vary uniquely for each species, the pattern of larger nests in northern Manitoba compared to southeastern Ontario in three of our four phylogenetically-independent comparisons suggests that birds are adapting to similar selective pressures between locations.	[Crossman, Carla A.; Rohwer, Vanya G.; Martin, Paul R.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Martin, Paul R.] Yanayacu Biol Stn, Napo, Ecuador	Queens University - Canada; Yanayacu Biological Station	Crossman, CA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	crossman@zoology.ubc.ca			Churchill Northern Studies Centre; Advisory Research Committee; Queen's University; Natural Sciences and Engineering Council of Canada (NSERC); Baillie Family Endowment	Churchill Northern Studies Centre; Advisory Research Committee; Queen's University; Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Baillie Family Endowment	Funding was provided by a Churchill Northern Studies Centre Northern Research Fund award and grants to P. R. Martin from the Advisory Research Committee, Principal's Development Fund (Queen's University), the Natural Sciences and Engineering Council of Canada (NSERC), and by a Baillie Family Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Arnaiz-Villena A, 1998, CELL MOL LIFE SCI, V54, P1031, DOI 10.1007/s000180050230; BAIRD J, 1968, LIFE HIST N AM CAR 2, P678; Barbour, 1989, SNAKES E N AM; Briskie JV, 1995, J FIELD ORNITHOL, V66, P531; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Bryan SM, 1999, P ROY SOC B-BIOL SCI, V266, P157, DOI 10.1098/rspb.1999.0616; CALDER W A, 1973, Ecology (Washington D C), V54, P127, DOI 10.2307/1934381; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Collias N.E., 1984, NEST BUILDING BIRD B; COLLIAS NE, 1971, AUK, V88, P124, DOI 10.2307/4083967; Derryberry EP, 2009, AM NAT, V174, P24, DOI 10.1086/599298; Endler J.A., 1986, Monographs in Population Biology, pviii; Environment Canada, 2010, CAN CLIM NORM AV 197; FORSYTH A, 1985, MAMMALS CANADIAN WIL; Gamer M, 2010, IRR VARIOUS COEFFICI; Ghalambor CK, 2001, SCIENCE, V292, P494, DOI 10.1126/science.1059379; Godfrey WE, 1986, THE BIRDS OF CANADA; Grenier JL, 2005, EVOLUTION, V59, P1588; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; Hilton GM, 2004, AUK, V121, P777, DOI 10.1642/0004-8038(2004)121[0777:UANTTI]2.0.CO;2; HORVATH O, 1964, ECOLOGY, V45, P235, DOI 10.2307/1933836; JAMES FC, 1970, ECOLOGY, V51, P365, DOI 10.2307/1935374; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KERN MD, 1984, CONDOR, V86, P455, DOI 10.2307/1366826; KERN MD, 1984, CONDOR, V86, P443, DOI 10.2307/1366825; KERN MD, 1993, J FIELD ORNITHOL, V64, P367; KING JA, 1964, EVOLUTION, V18, P230, DOI 10.2307/2406395; Knox AG, 2000, BIRDS N AM, V543; Lowther PE, 1993, BIRDS N AM ONLINE; Lundy H., 1969, FERTILITY HATCHABILI, P143; LYNCH CB, 1980, GENETICS, V96, P757; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; McGraw K. J., 2009, BIRDS N AM ONLINE; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; MERINO S, 1995, OIKOS, V73, P95, DOI 10.2307/3545730; MOLLER AP, 1990, OIKOS, V57, P237, DOI 10.2307/3565945; MUUL I, 1974, J MAMMAL, V55, P840, DOI 10.2307/1379415; NIEMI GJ, 1985, ECOLOGY, V66, P1215, DOI 10.2307/1939175; NORMAN RF, 1975, AUK, V92, P610, DOI 10.2307/4084631; Palmgren M., 1939, Ornis Fennica Helsingfors, V16, P1; Perez JH, 2008, BIOL LETTERS, V4, P468, DOI 10.1098/rsbl.2008.0266; Reid JM, 2000, P ROY SOC B-BIOL SCI, V267, P37, DOI 10.1098/rspb.2000.0963; RICHNER H, 1993, J ANIM ECOL, V62, P703, DOI 10.2307/5390; Rohwer VG, 2010, CONDOR, V112, P596, DOI 10.1525/cond.2010.090229; Sallabanks R., 1999, BIRDS N AM ONLINE; SCHAEFER VH, 1976, CONDOR, V78, P443, DOI 10.2307/1367092; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Seddon N, 2005, EVOLUTION, V59, P200; SHUMP KA, 1978, AM MIDL NAT, V100, P103, DOI 10.2307/2424781; Spector D. A., 1999, BIRDS N AM ONLINE; *SPSS INC, 2008, SPSS STAT 17 0 0 WIN; SUAREZ F, 1993, BIOL CONSERV, V64, P77, DOI 10.1016/0006-3207(93)90385-E; WAGNER HELMUTH O., 1955, JOUR ORNITHOL, V96, P361, DOI 10.1007/BF01955682; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Weir R.D., 1989, BIRDS KINGSTON REGIO; West-Eberhard Mary Jane, 1992, P13; Wheelwright N. T., 2008, BIRDS N AM ONLINE; WHELAN CJ, 1994, AUK, V111, P945, DOI 10.2307/4088826; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Yanes M, 1996, CONSERV BIOL, V10, P881, DOI 10.1046/j.1523-1739.1996.10030881.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	64	67	69	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19086	10.1371/journal.pone.0019086	http://dx.doi.org/10.1371/journal.pone.0019086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552515	Green Submitted, Green Published, gold			2022-12-25	WOS:000290020700023
J	Duffy, DJ; Frank, U				Duffy, David J.; Frank, Uri			Modulation of COUP-TF Expression in a Cnidarian by Ectopic Wnt Signalling and Allorecognition	PLOS ONE			English	Article							STEM-CELLS; HYDRACTINIA-ECHINATA; NUCLEAR RECEPTORS; NEMATOCYST DISCHARGE; HYDROID HYDRACTINIA; WNT/BETA-CATENIN; GENE-EXPRESSION; NEURAL CREST; TRANSCRIPTION; DIFFERENTIATION	Background: COUP transcription factors are required for the regulation of gene expression underlying development, differentiation, and homeostasis. They have an evolutionarily conserved function, being a known marker for neurogenesis from cnidarians to vertebrates. A homologue of this gene was shown previously to be a neuronal and nematocyte differentiation marker in Hydra. However, COUP-TFs had not previously been studied in a colonial cnidarian. Methodology/Principal Findings: We cloned a COUP-TF homologue from the colonial marine cnidarian Hydractinia echinata. Expression of the gene was analysed during normal development, allorecognition events and ectopic Wnt activation, using in situ hybridisation and quantitative PCR. During normal Hydractinia development, the gene was first expressed in post-gastrula stages. It was undetectable in larvae, and its mRNA was present again in putative differentiating neurons and nematocytes in post-metamorphic stages. Global activation of canonical Wnt signalling in adult animals resulted in the upregulation of COUP-TF. We also monitored a strong COUP-TF upregulation in stolons undergoing allogeneic interactions. COUP-TF mRNA was most concentrated in the tissues that contacted allogeneic, non-self tissues, and decreased in a gradient away from the contact area. Interestingly, the gene was transiently upregulated during initial contact of self stolons, but dissipated rapidly following self recognition, while in non-self contacts high expression levels were maintained. Conclusions/Significance: We conclude that COUP-TF is likely involved in neuronal/nematocyte differentiation in a variety of contexts. This has now been shown to include allorecognition, where COUP-TF is thought to have been co-opted to mediate allorejection by recruiting stinging cells that are the effectors of cytotoxic rejection of allogeneic tissue. Our findings that Wnt activation upregulates COUP-TF expression suggests that Wnts' role in neuronal differentiation could be mediated through COUP-TF.	[Duffy, David J.] Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland; Natl Univ Ireland Galway, Martin Ryan Marine Sci Inst, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Duffy, DJ (corresponding author), Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland.	uri.frank@nuigalway.ie		Duffy, David/0000-0002-6075-8855; Frank, Uri/0000-0003-2094-6381	Science Foundation Ireland (SFI) [07/IN.1/B943]	Science Foundation Ireland (SFI)(Science Foundation Ireland)	Funding was provided by Science Foundation Ireland (SFI) grant no. 07/IN.1/B943 to UF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; Cadavid LF, 2004, GENETICS, V167, P357, DOI 10.1534/genetics.167.1.357; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; DAVID CN, 1974, J CELL SCI, V16, P359; DAVID CN, 1974, AM ZOOL, V14, P537; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Duffy DJ, 2010, DEVELOPMENT, V137, P3057, DOI 10.1242/dev.046631; Duffy DJ, 2011, COMMUNICATIVE INTEGR, V4, P1; Frank U, 2001, BIOESSAYS, V23, P963, DOI 10.1002/bies.1137; GAJEWSKI M, 1996, DEV GENES EVOL, V205, P232; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Gauchat D, 2004, DEV BIOL, V275, P104, DOI 10.1016/j.ydbio.2004.07.037; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Grasso LC, 2001, MOL PHYLOGENET EVOL, V21, P93, DOI 10.1006/mpev.2001.0994; Hauenschild VC, 1954, W ROUX ARCH ENTWICKL, V147, P1; Hauenschild VC, 1956, Z NATU FORSCH B; Hollande F, 2010, DRUG RESIST UPDATE, V13, P44, DOI 10.1016/j.drup.2009.01.002; HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; IVKER FB, 1972, BIOL BULL, V143, P162, DOI 10.2307/1540336; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; LANGE R, 1989, J EXP ZOOL, V249, P284, DOI 10.1002/jez.1402490307; Langlois MC, 2000, DEV GENES EVOL, V210, P471, DOI 10.1007/s004270000087; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LEITZ T, 1993, MAR BIOL, V115, P173, DOI 10.1007/BF00346332; Mali B, 2006, DEV COMP IMMUNOL, V30, P275, DOI 10.1016/j.dci.2005.04.004; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martinez-Morales PL, 2010, EMBO REP, V11, P466, DOI 10.1038/embor.2010.61; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Mokady O, 1996, GENETICS, V143, P823; Muller W, 2007, INT J DEV BIOL, V51, P211, DOI 10.1387/ijdb.062247wm; Muller W, 1964, DEV GENES EVOL, V155, P181; Muller WA, 2004, DEV BIOL, V275, P215, DOI 10.1016/j.ydbio.2004.08.006; Muller WA, 1973, PUB SETO MAR BIOL LA, V20, P194; Navab R, 2004, CANCER RES, V64, P5097, DOI 10.1158/0008-5472.CAN-03-1185; Navab R, 2002, AM J RESP CELL MOL, V27, P273, DOI 10.1165/rcmb.2002-0014OC; Nicotra ML, 2009, CURR BIOL, V19, P583, DOI 10.1016/j.cub.2009.02.040; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Plickert G, 2006, DEV BIOL, V298, P368, DOI 10.1016/j.ydbio.2006.06.043; Powell AE, 2007, GENETICS, V177, P2101, DOI 10.1534/genetics.107.075689; Reitzel AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-230; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shin SW, 2009, ONCOL REP, V21, P101, DOI 10.3892/or_00000195; Smirnov DA, 2001, VIROLOGY, V284, P13, DOI 10.1006/viro.2001.0913; Teo R, 2006, DEV BIOL, V289, P91, DOI 10.1016/j.ydbio.2005.10.009; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yoshinaga Y, 2010, CELL MOL NEUROBIOL, V30, P1049, DOI 10.1007/s10571-010-9536-6	54	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19443	10.1371/journal.pone.0019443	http://dx.doi.org/10.1371/journal.pone.0019443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552541	gold, Green Published, Green Submitted			2022-12-25	WOS:000290020700056
J	Rodriguez, NE; Dixit, UG; Allen, LAH; Wilson, ME				Rodriguez, Nilda E.; Dixit, Upasna Gaur; Allen, Lee-Ann H.; Wilson, Mary E.			Stage-Specific Pathways of Leishmania infantum chagasi Entry and Phagosome Maturation in Macrophages	PLOS ONE			English	Article							DONOVANI PROMASTIGOTES; HOST MACROPHAGES; MEMBRANE RAFTS; AMASTIGOTES; PHAGOCYTOSIS; LIPOPHOSPHOGLYCAN; SURFACE; AMAZONENSIS; BIOGENESIS; EXPRESSION	The life stages of Leishmania spp. include the infectious promastigote and the replicative intracellular amastigote. Each stage is phagocytosed by macrophages during the parasite life cycle. We previously showed that caveolae, a subset of cholesterol-rich membrane lipid rafts, facilitate uptake and intracellular survival of virulent promastigotes by macrophages, at least in part, by delaying parasitophorous vacuole (PV)-lysosome fusion. We hypothesized that amastigotes and promastigotes would differ in their route of macrophage entry and mechanism of PV maturation. Indeed, transient disruption of macrophage lipid rafts decreased the entry of promastigotes, but not amastigotes, into macrophages (P<0.001). Promastigote-containing PVs were positive for caveolin-1, and co-localized transiently with EEA-1 and Rab5 at 5 minutes. Amastigote-generated PVs lacked caveolin-1 but retained Rab5 and EEA-1 for at least 30 minutes or 2 hours, respectively. Coinciding with their conversion into amastigotes, the number of promastigote PVs positive for LAMP-1 increased from 20% at 1 hour, to 46% by 24 hours, (P<0.001, Chi square). In contrast, more than 80% of amastigote-initiated PVs were LAMP-1+ at both 1 and 24 hours. Furthermore, lipid raft disruption increased LAMP-1 recruitment to promastigote, but not to amastigote-containing compartments. Overall, our data showed that promastigotes enter macrophages through cholesterol-rich domains like caveolae to delay fusion with lysosomes. In contrast, amastigotes enter through a non-caveolae pathway, and their PVs rapidly fuse with late endosomes but prolong their association with early endosome markers. These results suggest a model in which promastigotes and amastigotes use different mechanisms to enter macrophages, modulate the kinetics of phagosome maturation, and facilitate their intracellular survival.	[Rodriguez, Nilda E.; Dixit, Upasna Gaur; Allen, Lee-Ann H.; Wilson, Mary E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Rodriguez, Nilda E.; Dixit, Upasna Gaur; Allen, Lee-Ann H.; Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Allen, Lee-Ann H.; Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa	Rodriguez, NE (corresponding author), Vet Affairs Med Ctr, Iowa City, IA 52242 USA.	nilda-rodriguez@uiowa.edu		Wilson, Mary/0000-0001-8680-7275; Allen, Lee-Ann/0000-0001-8929-6968; Rodriguez, Nilda/0000-0002-5755-3680	Department of Veterans Affairs [CDA-2]; NIH [AI045540, AI067874]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067874, R01AI045540] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Career Developmental Award (CDA-2) from the Department of Veterans Affairs (NER). Additional support was provided in part from a Department of Veterans' Affairs Gulf War grant (MEW) and Merit Review Grants (L-AHA) and (MEW) and NIH grants AI045540 and AI067874 (MEW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Basu MK, 2005, CRIT REV MICROBIOL, V31, P145, DOI 10.1080/10408410591005101; BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142; BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; Chang HK, 2007, INFECT IMMUN, V75, P1017, DOI 10.1128/IAI.00914-06; CHILDS GE, 1976, J PARASITOL, V62, P676, DOI 10.2307/3278936; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Clemens DL, 2000, INFECT IMMUN, V68, P2671, DOI 10.1128/IAI.68.5.2671-2684.2000; Coligan JKA, 1991, CURRENT PROTOCOLS IM; Courret N, 2002, J CELL SCI, V115, P2303; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Dermine JF, 2000, CELL MICROBIOL, V2, P115, DOI 10.1046/j.1462-5822.2000.00037.x; Desjardins M, 1998, RES IMMUNOL, V149, P689, DOI 10.1016/S0923-2494(99)80040-6; Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Duclos S, 2000, J CELL SCI, V113, P3531; GALVAOQUINTAO L, 1990, PARASITOLOGY, V101, P7, DOI 10.1017/S0031182000079683; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Gueirard P, 2008, CELL MICROBIOL, V10, P100, DOI 10.1111/j.1462-5822.2007.01018.x; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008; Ilgoutz SC, 2001, INT J PARASITOL, V31, P899, DOI 10.1016/S0020-7519(01)00197-7; Kane MM, 2000, CURR OPIN HEMATOL, V7, P26, DOI 10.1097/00062752-200001000-00006; Kenworthy A, 2002, TRENDS BIOCHEM SCI, V27, P435, DOI 10.1016/S0968-0004(02)02178-3; Kinchen JM, 2008, NAT REV MOL CELL BIO, V9, P781, DOI 10.1038/nrm2515; Lippuner C, 2009, FASEB J, V23, P483, DOI 10.1096/fj.08-108712; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Lodge R, 2006, EUR J IMMUNOL, V36, P2735, DOI 10.1002/eji.200636089; Lodge Robert, 2008, V47, P174; Love DC, 1998, EXP PARASITOL, V88, P161, DOI 10.1006/expr.1998.4232; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; McConville MJ, 2007, TRENDS PARASITOL, V23, P368, DOI 10.1016/j.pt.2007.06.009; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; Mollinedo F, 2010, J BIOL CHEM, V285, P34528, DOI 10.1074/jbc.M110.125302; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; PEARSON RD, 1983, J IMMUNOL, V131, P1994; Pham NK, 2005, INFECT IMMUN, V73, P8322, DOI 10.1128/IAI.73.12.8322-8333.2005; Riethmuller J, 2006, BBA-BIOMEMBRANES, V1758, P2139, DOI 10.1016/j.bbamem.2006.07.017; Rodman JS, 2000, J CELL SCI, V113, P183; Rodriguez NE, 2004, INFECT IMMUN, V72, P2111, DOI 10.1128/IAI.72.4.2111-2122.2004; Rodriguez NE, 2006, CELL MICROBIOL, V8, P1106, DOI 10.1111/j.1462-5822.2006.00695.x; RUSSELL DG, 1989, IMMUNOL TODAY, V10, P328, DOI 10.1016/0167-5699(89)90188-6; SACKS DL, 1995, J EXP MED, V181, P685, DOI 10.1084/jem.181.2.685; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344; WILSON ME, 1986, J IMMUNOL, V136, P4681; WOZENCRAFT AO, 1987, IMMUNOLOGY, V60, P559; WOZENCRAFT AO, 1986, J EXP MED, V164, P1332, DOI 10.1084/jem.164.4.1332; Yao CQ, 2008, EXP PARASITOL, V118, P129, DOI 10.1016/j.exppara.2007.06.012; ZARLEY JH, 1991, J CLIN INVEST, V88, P1511, DOI 10.1172/JCI115461	56	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19000	10.1371/journal.pone.0019000	http://dx.doi.org/10.1371/journal.pone.0019000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552562	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700012
J	Haslene-Hox, H; Oveland, E; Berg, KC; Kolmannskog, O; Woie, K; Salvesen, HB; Tenstad, O; Wiig, H				Haslene-Hox, Hanne; Oveland, Eystein; Berg, Kaja C.; Kolmannskog, Odd; Woie, Kathrine; Salvesen, Helga B.; Tenstad, Olav; Wiig, Helge			A New Method for Isolation of Interstitial Fluid from Human Solid Tumors Applied to Proteomic Analysis of Ovarian Carcinoma Tissue	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; BIOMARKER DISCOVERY; CANCER BIOMARKERS; MASS-SPECTROMETRY; ELECTROPHORESIS; MACROMOLECULES; IDENTIFICATION; MICRODIALYSIS; RESOURCE; SAMPLES	Major efforts have been invested in the identification of cancer biomarkers in plasma, but the extraordinary dynamic range in protein composition, and the dilution of disease specific proteins make discovery in plasma challenging. Focus is shifting towards using proximal fluids for biomarker discovery, but methods to verify the isolated sample's origin are missing. We therefore aimed to develop a technique to search for potential candidate proteins in the proximal proteome, i.e. in the tumor interstitial fluid, since the biomarkers are likely to be excreted or derive from the tumor microenvironment. Since tumor interstitial fluid is not readily accessible, we applied a centrifugation method developed in experimental animals and asked whether interstitial fluid from human tissue could be isolated, using ovarian carcinoma as a model. Exposure of extirpated tissue to 106 g enabled tumor fluid isolation. The fluid was verified as interstitial by an isolated fluid: plasma ratio not significantly different from 1.0 for both creatinine and Na+, two substances predominantly present in interstitial fluid. The isolated fluid had a colloid osmotic pressure 79% of that in plasma, suggesting that there was some sieving of proteins at the capillary wall. Using a proteomic approach we detected 769 proteins in the isolated interstitial fluid, sixfold higher than in patient plasma. We conclude that the isolated fluid represents undiluted interstitial fluid and thus a subproteome with high concentration of locally secreted proteins that may be detected in plasma for diagnostic, therapeutic and prognostic monitoring by targeted methods.	[Haslene-Hox, Hanne; Oveland, Eystein; Berg, Kaja C.; Kolmannskog, Odd; Tenstad, Olav; Wiig, Helge] Univ Bergen, Dept Biomed, Bergen, Norway; [Woie, Kathrine; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Salvesen, Helga B.] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Haslene-Hox, H (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	wiig@biomed.uib.no	Haslene-Hox, Hanne/AAD-1050-2020; salvesen, Helga B/C-1187-2017; Oveland, Eystein/X-6006-2019	salvesen, Helga B/0000-0002-4438-8831; Oveland, Eystein/0000-0003-2206-1480; Wiig, Helge/0000-0002-7740-8210; Haslene-Hox, Hanne/0000-0001-7298-7332	Research Council of Norway; Norwegian Cancer Association; Western Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); Norwegian Cancer Association; Western Norway Regional Health Authority	The authors gratefully acknowledge grants from The Research Council of Norway, The Norwegian Cancer Association and The Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; AMBROSE RT, 1983, CLIN CHEM, V29, P256; Amon LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011137; Ao XP, 2006, METHODS, V38, P331, DOI 10.1016/j.ymeth.2005.11.012; AUKLAND K, 1974, ACTA PHYSIOL SCAND, V90, P485, DOI 10.1111/j.1748-1716.1974.tb05611.x; Cadron I, 2009, GYNECOL ONCOL, V115, P497, DOI 10.1016/j.ygyno.2009.09.005; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Clement CC, 2010, TRENDS IMMUNOL; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Clough GF, 2005, AAPS J, V7, pE686, DOI 10.1208/aapsj070369; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Freitas I, 1997, ANTICANCER RES, V17, P165; Gast MCW, 2009, BREAST CANCER RES TR, V116, P17, DOI 10.1007/s10549-008-0263-3; GILANYI M, 1988, AM J PHYSIOL, V255, pF513, DOI 10.1152/ajprenal.1988.255.3.F513; Gortzak-Uzan L, 2008, J PROTEOME RES, V7, P339, DOI 10.1021/pr0703223; GULLINO PM, 1964, CANCER RES, V24, P780; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hofmann M, 2009, NEOPLASIA, V11, P812, DOI 10.1593/neo.09662; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kim JH, 2002, JAMA-J AM MED ASSOC, V287, P1671, DOI 10.1001/jama.287.13.1671; Kischel P, 2007, EXPERT REV PROTEOMIC, V4, P727, DOI 10.1586/14789450.4.6.727; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; NODDELAND H, 1982, SCAND J CLIN LAB INV, V42, P139; Paroni R, 2004, ELECTROPHORESIS, V25, P463, DOI 10.1002/elps.200305687; Pasco S, 2004, CRIT REV ONCOL HEMAT, V49, P221, DOI 10.1016/j.critrevonc.2003.09.006; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Simpson RJ, 2008, CURR OPIN CHEM BIOL, V12, P72, DOI 10.1016/j.cbpa.2008.02.010; Stone Matthew D, 2010, Clin Proteomics, V6, P75; Sun W, 2010, J PROTEOME RES, V9, P1020, DOI 10.1021/pr9009172; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wiig H, 2003, AM J PHYSIOL-HEART C, V284, pH416, DOI 10.1152/ajpheart.00327.2002; Wiig H, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-12; Williams TI, 2007, J PROTEOME RES, V6, P2936, DOI 10.1021/pr070041v; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xue H, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-52	40	65	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19217	10.1371/journal.pone.0019217	http://dx.doi.org/10.1371/journal.pone.0019217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541282	Green Published, gold, Green Submitted			2022-12-25	WOS:000290018400033
J	Idoate, F; Calbet, JAL; Izquierdo, M; Sanchis-Moysi, J				Idoate, Fernando; Calbet, Jose A. L.; Izquierdo, Mikel; Sanchis-Moysi, Joaquin			Soccer Attenuates the Asymmetry of Rectus Abdominis Muscle Observed in Non-Athletes	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; TRUNK MUSCLES; STRENGTH; MRI; WRESTLERS; ANATOMY; SIZE; MASS	Purpose: To determine the volume and degree of asymmetry of the rectus abdominis muscle (RA) in professional soccer players. Methods: The volume of the RA was determined using magnetic resonance imaging (MRI) in 15 professional male soccer players and 6 non-active male control subjects. Results: Soccer players had 26% greater RA volume than controls (P<0.05), due to hypertrophy of both the dominant (28% greater volume, P<0.05) and non-dominant (25% greater volume, P<0.01) sides, after adjusting for age, length of the RA muscle and body mass index (BMI) as covariates. Total volume of the dominant side was similar to the contralateral in soccer players (P = 0.42) and in controls (P = 0.75) (Dominant/non-dominant = 0.99, in both groups). Segmental analysis showed a progressive increase in the degree of side-to-side asymmetry from the first lumbar disc to the pubic symphysis in soccer players (r = 0.80, P<0.05) and in controls (r = 0.75, P<0.05). The slope of the relationship was lower in soccer players, although this trend was not statistically significant (P = 0.14). Conclusions: Professional soccer is associated with marked hypertrophy of the rectus abdominis muscle, which achieves a volume that is 26% greater than in non-active controls. Soccer induces the hypertrophy of the non-dominant side in proximal regions and the dominant side in regions closer to pubic symphysis, which attenuates the pattern of asymmetry of rectus abdominis observed in non-active population. It remains to be determined whether the hypertrophy of rectus abdominis in soccer players modifies the risk of injury.	[Idoate, Fernando] Clin San Miguel, Dept Radiol, Pamplona, Spain; [Calbet, Jose A. L.; Sanchis-Moysi, Joaquin] Univ Las Palmas Gran Canaria, Dept Phys Educ, Palmas De Gran Canaria, Spain; [Izquierdo, Mikel] Univ Publ Navarra, Dept Hlth Sci, Pamplona, Spain	Universidad de Las Palmas de Gran Canaria; Universidad Publica de Navarra	Idoate, F (corresponding author), Clin San Miguel, Dept Radiol, Pamplona, Spain.	jsanchis@def.ulpgc.es	SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Idoate Saralegui, Fernando/K-7485-2013; Calbet, Jose A L/H-6693-2015; Sanchis-Moysi, Joaquin/B-5561-2012; Izquierdo, Mikel/O-8049-2019; Izquierdo, Mikel/A-4894-2010	SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Idoate Saralegui, Fernando/0000-0001-5600-6055; Calbet, Jose A L/0000-0002-9215-6234; Izquierdo, Mikel/0000-0002-1506-4272; Marisol, Izquierdo/0000-0003-4297-210X; antunez, Ariel/0000-0002-2548-7885	Real Madrid - Universidad Europea de Madrid Research Chair [2009/04RM]	Real Madrid - Universidad Europea de Madrid Research Chair	This study was granted by Real Madrid - Universidad Europea de Madrid Research Chair (2009/04RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft LW, 2007, SEMIN MUSCULOSKEL R, V11, P16, DOI 10.1055/s-2007-984410; Behm DG, 2006, J STRENGTH COND RES, V20, P716; Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; Borghuis AJ, 2011, MED SCI SPORT EXER, V43, P108, DOI 10.1249/MSS.0b013e3181e93492; Charnock BL, 2009, SPORT BIOMECH, V8, P223, DOI 10.1080/14763140903229500; Cholewicki J, 2000, J BIOMECH, V33, P1377, DOI 10.1016/S0021-9290(00)00118-4; Cholewicki J, 2005, SPINE, V30, P2614, DOI 10.1097/01.brs.0000188273.27463.bc; Connell D, 2006, AM J ROENTGENOL, V187, P1457, DOI 10.2214/AJR.04.1929; Hides J, 2006, SPINE, V31, pE175, DOI 10.1097/01.brs.0000202740.86338.df; Hides J, 2010, BRIT J SPORT MED, V44, P563, DOI 10.1136/bjsm.2008.048751; Hides J, 2008, BRIT J SPORT MED, V42, P809, DOI 10.1136/bjsm.2007.044024; Hodges PW, 2005, J BIOMECH, V38, P1873, DOI 10.1016/j.jbiomech.2004.08.016; Iwai K, 2008, J STRENGTH COND RES, V22, P350, DOI 10.1519/JSC.0b013e3181635d25; Johnson Rob, 2006, Curr Sports Med Rep, V5, P99; KANEHISA H, 1994, EUR J APPL PHYSIOL, V68, P148, DOI 10.1007/BF00244028; Kibler W. B., 2002, PATHOPHYSIOLOGY TENN, P147; Kubo J, 2007, J STRENGTH COND RES, V21, P1251; Kubo T, INT J SPORTS MED; Kubo T, 2010, J STRENGTH COND RES, V24, P1472, DOI 10.1519/JSC.0b013e3181d32eb1; Lee RC, 2000, AM J CLIN NUTR, V72, P796, DOI 10.1093/ajcn/72.3.796; Masuda K, 2003, J SPORT SCI, V21, P851, DOI 10.1080/0264041031000102042; Matsuda S, 2008, J SPORT SCI, V26, P775, DOI 10.1080/02640410701824099; Norris C M, 1993, Br J Sports Med, V27, P19; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Raty HP, 1999, J SPINAL DISORD, V12, P266; Robertson BA, 2009, SPORTS MED, V39, P225, DOI 10.2165/00007256-200939030-00004; Sanchis-Moysi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015858; Stewart S, 2010, BRIT J SPORT MED, V44, P1173, DOI 10.1136/bjsm.2009.058909	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19022	10.1371/journal.pone.0019022	http://dx.doi.org/10.1371/journal.pone.0019022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541351	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800031
J	Rubin, CM; van der List, DA; Ballesteros, JM; Goloshchapov, AV; Chalupa, LM; Chapman, B				Rubin, Carol M.; van der List, Deborah A.; Ballesteros, Jose M.; Goloshchapov, Andrey V.; Chalupa, Leo M.; Chapman, Barbara			Mouse Mutants for the Nicotinic Acetylcholine Receptor beta 2 Subunit Display Changes in Cell Adhesion and Neurodegeneration Response Genes	PLOS ONE			English	Article							EYE-SPECIFIC SEGREGATION; LATERAL GENICULATE-NUCLEUS; CENTRAL-NERVOUS-SYSTEM; SPONTANEOUS RETINAL WAVES; MICE LACKING; E-CADHERIN; VISUAL-SYSTEM; SYNAPTIC-TRANSMISSION; CERULOPLASMIN GENE; DROSOPHILA-CRUMBS	Mice lacking expression of the beta 2 subunit of the neuronal nicotinic acetylcholine receptor (CHRNB2) display abnormal retinal waves and a dispersed projection of retinal ganglion cell (RGC) axons to their dorsal lateral geniculate nuclei (dLGNs). Transcriptomes of LGN tissue from two independently generated Chrnb2-/- mutants and from wildtype mice were obtained at postnatal day 4 (P4), during the normal period of segregation of eye-specific afferents to the LGN. Microarray analysis reveals reduced expression of genes located on the cell membrane or in extracellular space, and of genes active in cell adhesion and calcium signaling. In particular, mRNA for cadherin 1 (Cdh1), a known axon growth regulator, is reduced to nearly undetectable levels in the LGN of P4 mutant mice and Lypd2 mRNA is similarly suppressed. Similar analysis of retinal tissue shows increased expression of crumbs 1 (Crb1) and chemokine (C-C motif) ligand 21 (Ccl21) mRNAs in Chrnb2-/- mutant animals. Mutations in these genes are associated with retinal neuronal degeneration. The retinas of Chrnb2-/- mutants are normal in appearance, but the increased expression of these genes may also be involved in the abnormal projection patterns of RGC to the LGN. These data may provide the tools to distinguish the interplay between neural activity and molecular expression. Finally, comparison of the transcriptomes of the two different Chrnb2-/- mutant strains reveals the effects of genetic background upon gene expression.	[Rubin, Carol M.; van der List, Deborah A.; Ballesteros, Jose M.; Goloshchapov, Andrey V.; Chapman, Barbara] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Chalupa, Leo M.] George Washington Univ, Washington, DC USA; [Chapman, Barbara] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis; George Washington University; University of California System; University of California Davis	Rubin, CM (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	bxchapman@ucdavis.edu			Research to Prevent Blindness; National Institutes of Health [EY016182, EY003991]; NATIONAL EYE INSTITUTE [R01EY016182, R01EY003991, R01EY011369] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by grants from Research to Prevent Blindness and National Institutes of Health Grants EY016182 and EY003991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins MR, 2007, J COMP NEUROL, V501, P483, DOI 10.1002/cne.21270; Bansal A, 2000, J NEUROSCI, V20, P7672; Benson DL, 1998, J NEUROSCI, V18, P6892; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chawla S, 2002, EUR J PHARMACOL, V447, P131, DOI 10.1016/S0014-2999(02)01837-X; Chen L, 2004, EXP EYE RES, V79, P239, DOI 10.1016/j.exer.2004.05.002; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; den Hollander AI, 2002, MECH DEVELOP, V110, P203, DOI 10.1016/S0925-4773(01)00568-8; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Faulkner-Jones BE, 1999, EXP NEUROL, V156, P316, DOI 10.1006/exnr.1999.7026; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Huntley GW, 2002, NEUROSCIENTIST, V8, P221, DOI 10.1177/1073858402008003008; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Iwai L, 2009, NEUROSCIENCE, V159, P1326, DOI 10.1016/j.neuroscience.2009.02.010; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Kedmi M, 2007, PHYSIOL GENOMICS, V28, P213, DOI 10.1152/physiolgenomics.00155.2006; Klomp LWJ, 1996, HUM MOL GENET, V5, P1989, DOI 10.1093/hmg/5.12.1989; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Korostynski M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-146; Kury P, 2004, FASEB J, V18, P398, DOI 10.1096/fj.04-1777fje; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; MATTER JM, 1990, EMBO J, V9, P1021, DOI 10.1002/j.1460-2075.1990.tb08205.x; Mckay BE, 2007, BIOCHEM PHARMACOL, V74, P1120, DOI 10.1016/j.bcp.2007.07.001; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Oblander SA, 2007, MOL CELL NEUROSCI, V34, P481, DOI 10.1016/j.mcn.2006.12.002; OSAKI S, 1966, J BIOL CHEM, V241, P2746; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Rebsam A, 2009, J NEUROSCI, V29, P14855, DOI 10.1523/JNEUROSCI.3462-09.2009; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Ries A, 2007, J NEUROCHEM, V103, P1491, DOI 10.1111/j.1471-4159.2007.04858.x; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; Shah RD, 2008, J NEUROSCI, V28, P292, DOI 10.1523/JNEUROSCI.4276-07.2008; Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034; SHIMAMURA K, 1992, DEV BIOL, V152, P242, DOI 10.1016/0012-1606(92)90132-Z; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Stasi K, 2007, INVEST OPHTH VIS SCI, V48, P727, DOI 10.1167/iovs.06-0497; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Tribollet E, 2001, PHARMACOL BIOCHEM BE, V70, P457, DOI 10.1016/S0091-3057(01)00700-6; Valor LM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001303; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Xu W, 1999, J NEUROSCI, V19, P9298; Yamada S, 2007, ANNU REV BIOCHEM, V76, P267, DOI 10.1146/annurev.biochem.75.103004.142811; Zhang C, 2005, MOL VIS, V11, P887; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235	64	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18626	10.1371/journal.pone.0018626	http://dx.doi.org/10.1371/journal.pone.0018626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547082	Green Submitted, Green Published, gold			2022-12-25	WOS:000290016800017
J	Sagaram, US; Pandurangi, R; Kaur, J; Smith, TJ; Shah, DM				Sagaram, Uma Shankar; Pandurangi, Raghoottama; Kaur, Jagdeep; Smith, Thomas J.; Shah, Dilip M.			Structure-Activity Determinants in Antifungal Plant Defensins MsDef1 and MtDef4 with Different Modes of Action against Fusarium graminearum	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; AUTOMATED PROTEIN-STRUCTURE; PISUM-SATIVUM DEFENSIN-1; ANTIMICROBIAL PEPTIDES; I-TASSER; STRUCTURE PREDICTION; GROWTH-INHIBITION; FUNGAL GROWTH; COMPONENTS; HEXAPEPTIDE	Plant defensins are small cysteine-rich antimicrobial proteins. Their three-dimensional structures are similar in that they consist of an alpha-helix and three anti-parallel beta-strands stabilized by four disulfide bonds. Plant defensins MsDef1 and MtDef4 are potent inhibitors of the growth of several filamentous fungi including Fusarium graminearum. However, they differ markedly in their antifungal properties as well as modes of antifungal action. MsDef1 induces prolific hyperbranching of fungal hyphae, whereas MtDef4 does not. Both defensins contain a highly conserved gamma-core motif (GXCX(3-9)C), a hallmark signature present in the disulfide-stabilized antimicrobial peptides, composed of beta 2 and beta 3 strands and the interposed loop. The gamma-core motifs of these two defensins differ significantly in their primary amino acid sequences and in their net charge. In this study, we have found that the major determinants of the antifungal activity and morphogenicity of these defensins reside in their gamma-core motifs. The MsDef1-gamma 4 variant in which the gamma-core motif of MsDef1 was replaced by that of MtDef4 was almost as potent as MtDef4 and also failed to induce hyperbranching of fungal hyphae. Importantly, the gamma-core motif of MtDef4 alone was capable of inhibiting fungal growth, but that of MsDef1 was not. The analysis of synthetic gamma-core variants of MtDef4 indicated that the cationic and hydrophobic amino acids were important for antifungal activity. Both MsDef1 and MtDef4 induced plasma membrane permeabilization; however, kinetic studies revealed that MtDef4 was more efficient in permeabilizing fungal plasma membrane than MsDef1. Furthermore, the in vitro antifungal activity of MsDef1, MsDef1-gamma 4, MtDef4 and peptides derived from the gamma-core motif of each defensin was not solely dependent on their ability to permeabilize the fungal plasma membrane. The data reported here indicate that the gamma-core motif defines the unique antifungal properties of each defensin and may facilitate de novo design of more potent antifungal peptides.	[Sagaram, Uma Shankar; Pandurangi, Raghoottama; Kaur, Jagdeep; Smith, Thomas J.; Shah, Dilip M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Sagaram, US (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	dshah@danforthcenter.org	Shah, Dilip/M-2850-2013; Kaur, Jagdeep/C-4155-2015; Smith, Thomas J/K-9086-2013	Kaur, Jagdeep/0000-0002-3238-4825; Smith, Thomas J/0000-0003-3528-6793; SHAH, DILIP/0000-0001-9503-4729; Kaur, Jagdeep/0000-0002-2252-2489; Sagaram, Uma Shankar/0000-0003-4353-1090	NSF [MCB-0924124]; Direct For Biological Sciences [0924124] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research has been supported by the NSF grant MCB-0924124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Almeida MS, 2002, J MOL BIOL, V315, P749, DOI 10.1006/jmbi.2001.5252; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Bloch C, 1998, PROTEINS, V32, P334, DOI 10.1002/(SICI)1097-0134(19980815)32:3<334::AID-PROT9>3.0.CO;2-H; BROEKAERT WF, 1990, FEMS MICROBIOL LETT, V69, P55, DOI [10.1111/j.1574-6968.1990.tb04174.x, 10.1016/S0378-1097(98)00477-7]; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI [10.1104/pp.108.4.1353, 10.1016/j.chiabu.2021.105188]; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Carvalho AD, 2009, PEPTIDES, V30, P1007, DOI 10.1016/j.peptides.2009.01.018; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; DeSamblanx GW, 1997, J BIOL CHEM, V272, P1171, DOI 10.1074/jbc.272.2.1171; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; Fant F, 1999, PROTEINS, V37, P388, DOI 10.1002/(SICI)1097-0134(19991115)37:3<388::AID-PROT7>3.0.CO;2-F; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Jiang ZQ, 2008, CHEM BIOL DRUG DES, V72, P483, DOI 10.1111/j.1747-0285.2008.00728.x; Jiang ZQ, 2009, ADV EXP MED BIOL, V611, P561, DOI 10.1007/978-0-387-73657-0_246; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Lopez-Garcia B, 2003, INT J FOOD MICROBIOL, V89, P163, DOI 10.1016/S0168-1605(03)00118-1; Lopez-Garcia B, 2000, MOL PLANT MICROBE IN, V13, P837, DOI 10.1094/MPMI.2000.13.8.837; Marques L, 2009, J APPL MICROBIOL, V106, P1640, DOI 10.1111/j.1365-2672.2008.04131.x; Munoz A, 2006, ANTIMICROB AGENTS CH, V50, P3847, DOI 10.1128/AAC.00650-06; MURAD AM, 2007, PLANT J, V1, P39; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2007, CELL MICROBIOL, V9, P1491, DOI 10.1111/j.1462-5822.2006.00887.x; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schaaper WMM, 2001, J PEPT RES, V57, P409, DOI 10.1034/j.1399-3011.2001.00842.x; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; Tavares LS, 2008, PEPTIDES, V29, P1842, DOI 10.1016/j.peptides.2008.06.003; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Thevissen K, 1999, APPL ENVIRON MICROB, V65, P5451; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Thevissen K, 2005, CURR DRUG TARGETS, V6, P923, DOI 10.2174/138945005774912771; Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014; Thevissen K, 2007, DRUG DISCOV TODAY, V12, P966, DOI 10.1016/j.drudis.2007.07.016; Thomma Bart P. H. J., 2003, Current Drug Targets - Infectious Disorders, V3, P1, DOI 10.2174/1568005033342000; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; van der Weerden NL, 2010, J BIOL CHEM, V285, P37513, DOI 10.1074/jbc.M110.134882; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	48	112	125	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18550	10.1371/journal.pone.0018550	http://dx.doi.org/10.1371/journal.pone.0018550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533249	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800019
J	Scranton, RA; Fletcher, L; Sprague, S; Jimenez, DF; Digicaylioglu, M				Scranton, Robert A.; Fletcher, Lauren; Sprague, Shane; Jimenez, David F.; Digicaylioglu, Murat			The Rostral Migratory Stream Plays a Key Role in Intranasal Delivery of Drugs into the CNS	PLOS ONE			English	Article							GROWTH-FACTOR-I; ADULT MAMMALIAN BRAIN; OLFACTORY-BULB; SUBVENTRICULAR ZONE; NEURONAL MIGRATION; BLOOD-VESSELS; INSULIN; PROLIFERATION; MODEL; ERYTHROPOIETIN	Background: The blood brain barrier (BBB) is impermeable to most drugs, impeding the establishment of novel neuroprotective therapies and strategies for many neurological diseases. Intranasal administration offers an alternative path for efficient drug delivery into the CNS. So far, the anatomical structures discussed to be involved in the transport of intranasally administered drugs into the CNS include the trigeminal nerve, olfactory nerve and the rostral migratory stream (RMS), but the relative contributions are debated. Methods and Findings: In the present study we demonstrate that surgical transection, and the resulting structural disruption of the RMS, in mice effectively obstructs the uptake of intranasally administered radioligands into the CNS. Furthermore, using a fluorescent cell tracer, we demonstrate that intranasal administration in mice allows agents to be distributed throughout the entire brain, including olfactory bulb, hippocampus, cortex and cerebellum. Conclusions: This study provides evidence of the vital role the RMS has in the CNS delivery of intranasally administered agents. The identification of the RMS as the major access path for intranasally administered drugs into the CNS may contribute to the development of treatments that are tailored for efficient transport within this structure. Research into the RMS needs to continue to elucidate its limitations, capabilities, mechanisms of transport and potential hazards before we are able to advance this technique into human research.	[Scranton, Robert A.; Fletcher, Lauren; Sprague, Shane; Jimenez, David F.; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Scranton, RA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.	muratd@uthscsa.edu	Digicaylioglu, Murat H/D-3302-2009		UTHSCSA/Department of Neurosurgery; NIH-NCI [P30 CA54174]; NIH-NIA [P30 AG013319, P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013319, P01AG019316] Funding Source: NIH RePORTER	UTHSCSA/Department of Neurosurgery; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Images were generated in the Core Optical Imaging Facility, which is supported by UTHSCSA/Department of Neurosurgery, NIH-NCI P30 CA54174 (CTRC at UTHSCSA), NIH-NIA P30 AG013319 (Nathan Shock Center) and NIH-NIA P01AG19316. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala-Barraza SR, 2010, J DRUG TARGET, V18, P179, DOI 10.3109/10611860903318134; Alonso G, 1999, J COMP NEUROL, V405, P508, DOI 10.1002/(SICI)1096-9861(19990322)405:4<508::AID-CNE5>3.0.CO;2-5; ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Chazal G, 2000, J NEUROSCI, V20, P1446; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Danielyan L, 2011, REJUV RES, V14, P3, DOI 10.1089/rej.2010.1130; Danielyan L, 2010, REJUV RES, V13, P195, DOI 10.1089/rej.2009.0944; Danielyan L, 2009, EUR J CELL BIOL, V88, P315, DOI 10.1016/j.ejcb.2009.02.001; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Dhuria SV, 2009, J PHARM SCI; Digicaylioglu M, 2004, P NATL ACAD SCI USA, V101, P9855, DOI 10.1073/pnas.0403172101; Digicaylioglu M, 2010, EXPERT OPIN BIOL TH, V10, P937, DOI 10.1517/14712598.2010.481435; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Fehm HL, 2001, J CLIN ENDOCR METAB, V86, P1144, DOI 10.1210/jc.86.3.1144; FLETCHER L, 2009, J NEUROSURG; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; Guerra-Crespo M, 2010, J STROKE CEREBROVASC, V19, P3, DOI 10.1016/j.jstrokecerebrovasdis.2009.09.005; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Illum L, 2004, J PHARM PHARMACOL, V56, P3, DOI 10.1211/0022357022539; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; Johnson NJ, 2010, MOL PHARMACEUT, V7, P884, DOI 10.1021/mp100029t; Kaneko N, 2010, NEURON, V67, P213, DOI 10.1016/j.neuron.2010.06.018; Kang YJ, 2010, ANN NEUROL, V68, P342, DOI 10.1002/ana.22070; Lennington Jessica B, 2003, Reprod Biol Endocrinol, V1, P99, DOI 10.1186/1477-7827-1-99; Leonard B E, 1981, Int Rev Neurobiol, V22, P251; Lin SY, 2009, EXP NEUROL, V217, P361, DOI 10.1016/j.expneurol.2009.03.021; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Martinez JA, 2008, NEUROSCIENCE, V157, P908, DOI 10.1016/j.neuroscience.2008.08.073; Merlin MA, 2010, AM J EMERG MED, V28, P296, DOI 10.1016/j.ajem.2008.12.009; Moraes L, 2009, NEUROPATHOLOGY, V29, P140, DOI 10.1111/j.1440-1789.2008.00959.x; MUCKE L, 1991, NEW BIOL, V3, P465; Nie K, 2010, DEV NEUROSCI-BASEL, V32, P163, DOI 10.1159/000301135; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Prosser HM, 2007, EUR J NEUROSCI, V26, P3339, DOI 10.1111/j.1460-9568.2007.05958.x; Rajapaksa TE, 2010, J BIOL CHEM, V285, P23739, DOI 10.1074/jbc.M110.126359; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Reger MA, 2006, DRUGS TODAY, V42, P729, DOI 10.1358/dot.2006.42.11.1007675; SAKANE T, 1995, J PHARM PHARMACOL, V47, P379, DOI 10.1111/j.2042-7158.1995.tb05814.x; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Wu HB, 2008, EXPERT OPIN DRUG DEL, V5, P1159, DOI [10.1517/17425247.5.10.1159, 10.1517/17425247.5.10.1159 ]; Zueger A, 2005, NEUROSCI LETT, V374, P142, DOI 10.1016/j.neulet.2004.10.040	51	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18711	10.1371/journal.pone.0018711	http://dx.doi.org/10.1371/journal.pone.0018711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533252	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800033
J	Cotan, D; Cordero, MD; Garrido-Maraver, J; Oropesa-Avila, M; Rodriguez-Hernandez, A; Izquierdo, LG; De la Mata, M; De Miguel, M; Lorite, JB; Infante, ER; Jackson, S; Navas, P; Sanchez-Alcazar, JA				Cotan, David; Cordero, Mario D.; Garrido-Maraver, Juan; Oropesa-Avila, Manuel; Rodriguez-Hernandez, Angeles; Gomez Izquierdo, Lourdes; De la Mata, Mario; De Miguel, Manuel; Bautista Lorite, Juan; Rivas Infante, Eloy; Jackson, Sandra; Navas, Placido; Sanchez-Alcazar, Jose A.			Secondary coenzyme Q(10) deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts	FASEB JOURNAL			English	Article						autophagy; free radicals; mitochondrial diseases	STROKE-LIKE EPISODES; TRANSFER RNALEU(UUR) GENE; PERMEABILITY TRANSITION; LACTIC-ACIDOSIS; PROTEIN-SYNTHESIS; TRANSFER-RNA; CELL-DEATH; AUTOPHAGY; MUTATION; DNA	Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) is a mitochondrial disease most usually caused by point mutations in tRNA genes encoded by mtDNA. Here, we report on how this mutation affects mitochondrial function in primary fibroblast cultures established from 2 patients with MELAS who harbored the A3243G mutation. Both mitochondrial respiratory chain enzyme activities and coenzyme Q(10) (CoQ) levels were significantly decreased in MELAS fibroblasts. A similar decrease in mitochondrial membrane potential was found in intact MELAS fibroblasts. Mitochondrial dysfunction was associated with increased oxidative stress and the activation of mitochondrial permeability transition (MPT), which triggered the degradation of impaired mitochondria. Furthermore, we found defective autophagosome elimination in MELAS fibroblasts. Electron and fluorescence microscopy studies confirmed a massive degradation of mitochondria and accumulation of autophagosomes, suggesting mitophagy activation and deficient autophagic flux. Transmitochondrial cybrids harboring the A3243G mutation also showed CoQ deficiency and increased autophagy activity. All these abnormalities were partially restored by CoQ supplementation. Autophagy in MELAS fibroblasts was also abolished by treatment with antioxidants or cyclosporine, suggesting that both reactive oxygen species and MPT participate in this process. Furthermore, prevention of autophagy in MELAS fibroblasts resulted in apoptotic cell death, suggesting a protective role of autophagy in MELAS fibroblasts.-Cotan, D., Cordero, M. D., Garrido-Maraver, J., Oropesa-Avila, M., Rodriguez-Hernandez, A., Gomez Izquierdo, L., De la Mata, M., De Miguel, M., Bautista Lorite, J., Rivas Infante, E., Jackson, S., Navas, P., Sanchez-Alcazar, J. A. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J. 25, 2669-2687 (2011). www.fasebj.org	[Cotan, David; Cordero, Mario D.; Garrido-Maraver, Juan; Oropesa-Avila, Manuel; Rodriguez-Hernandez, Angeles; De la Mata, Mario; Navas, Placido; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, Consejo Super Invest Cient, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Cotan, David; Cordero, Mario D.; Garrido-Maraver, Juan; Oropesa-Avila, Manuel; Rodriguez-Hernandez, Angeles; De la Mata, Mario; Navas, Placido; Sanchez-Alcazar, Jose A.] Univ Pablo Olavide, Consejo Super Invest Cient, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Seville 41013, Spain; [Gomez Izquierdo, Lourdes] Hosp Virgen Rocio, Dept Anat Patol, Seville, Spain; [De Miguel, Manuel] Univ Seville, Fac Med, Dept Citol & Histol Normal & Patol, Seville, Spain; [Bautista Lorite, Juan] Hosp Sagrado Corazon, Seville, Spain; [Jackson, Sandra] Uniklinikum CG Carus, Dept Neurol, Dresden, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Universidad Pablo de Olavide; Virgen del Rocio University Hospital; University of Sevilla; Technische Universitat Dresden	Sanchez-Alcazar, JA (corresponding author), Univ Pablo Olavide, Consejo Super Invest Cient, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.	jasanalc@upo.es	De-Miguel, Manuel/B-3713-2017; NAVAS, PLACIDO/R-5943-2019; GARRIDO-MARAVER, JUAN/S-3846-2016; IBIS, TERAPIA CELULA/P-3297-2015; Sanchéz-Alcázar, José A. A/L-4925-2014; IBIS, NEUROCIENCIAS/C-2262-2016; Rodríguez-Hernández, Ángeles/K-9717-2015; DE LA MATA, MARIO DE-LA-MATA MARIODELAMATA/O-8844-2015; Cordero, Mario D./L-8006-2014; De la Mata, Mario/I-8800-2017; IBIS, ENF. RESPIRATO/P-3887-2015	De-Miguel, Manuel/0000-0002-6751-1695; NAVAS, PLACIDO/0000-0002-4115-7966; GARRIDO-MARAVER, JUAN/0000-0003-4534-4109; Sanchéz-Alcázar, José A. A/0000-0001-9705-1469; Rodríguez-Hernández, Ángeles/0000-0003-1846-0606; DE LA MATA, MARIO DE-LA-MATA MARIODELAMATA/0000-0003-1640-7887; Cordero, Mario D./0000-0003-0151-3644; De la Mata, Mario/0000-0003-1640-7887; Gomez-Izquierdo, Lourdes/0000-0001-5918-2134; Rivas Infante, Eloy/0000-0001-6014-8048	Ministerio de Sanidad, Spain [FIS PI080500, FIS EC08/00076]; Asociacion de Enfermos de Patologia Mitocondrial (AEPMI); Fundacion Espanola de Enfermedades Lisosomales (FEEL); Colegio Oficial de Farmaceuticos de Sevilla	Ministerio de Sanidad, Spain(Spanish Government); Asociacion de Enfermos de Patologia Mitocondrial (AEPMI); Fundacion Espanola de Enfermedades Lisosomales (FEEL); Colegio Oficial de Farmaceuticos de Sevilla	This work was supported by Ministerio de Sanidad, Spain, grants FIS PI080500 and FIS EC08/00076, and by Asociacion de Enfermos de Patologia Mitocondrial (AEPMI) and Fundacion Espanola de Enfermedades Lisosomales (FEEL). M. de la Mata is the recipient of a fellowship from Colegio Oficial de Farmaceuticos de Sevilla. This group was founded by the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII). The authors thank Pilar Jaraquemada, Loren Valbuena, Jose Maria Sanabria, Miguel Angel Martin, and Alberto Blazquez for their collaboration on the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Armstrong JS, 2003, J BIOL CHEM, V278, P49079, DOI 10.1074/jbc.M307841200; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; CHOMYN A, 1992, P NATL ACAD SCI USA, V89, P4221, DOI 10.1073/pnas.89.10.4221; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Cordero MD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2918; Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje; Davidson MM, 2009, MITOCHONDRION, V9, P463, DOI 10.1016/j.mito.2009.08.006; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x; Forte M, 2005, J BIOENERG BIOMEMBR, V37, P121, DOI 10.1007/s10863-005-6565-9; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Gu YP, 2004, FEBS LETT, V577, P357, DOI 10.1016/j.febslet.2004.10.040; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Molyneux Sarah L, 2008, Clin Biochem Rev, V29, P71; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; PLOMP PJAM, 1989, J BIOL CHEM, V264, P6699; Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092; Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113; Rodriguez-Hernandez A, 2009, AUTOPHAGY, V5, P19, DOI 10.4161/auto.5.1.7174; Rossmanith W, 2008, J MED GENET, V45, P117, DOI 10.1136/jmg.2007.052076; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sacconi S, 2010, NEUROMUSCULAR DISORD, V20, P44, DOI 10.1016/j.nmd.2009.10.014; Santos-Ocana C, 2002, J BIOL CHEM, V277, P10973, DOI 10.1074/jbc.M112222200; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; SCHELLENS JPM, 1991, HISTOCHEM J, V23, P460, DOI 10.1007/BF01041376; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; SCHON EA, 1992, BIOCHIM BIOPHYS ACTA, V1101, P206, DOI 10.1016/S0005-2728(05)80021-0; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011; Tafrechi RSJ, 2005, MUTAT RES-FUND MOL M, V578, P43, DOI 10.1016/j.mrfmmm.2005.02.002; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	51	106	108	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2669	2687		10.1096/fj.10-165340	http://dx.doi.org/10.1096/fj.10-165340			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21551238				2022-12-25	WOS:000293337800017
J	Ghosh, S; Paez-Cortez, JR; Boppidi, K; Vasconcelos, M; Roy, M; Cardoso, W; Ai, XB; Fine, A				Ghosh, Shamik; Paez-Cortez, Jesus R.; Boppidi, Karthik; Vasconcelos, Michelle; Roy, Monideepa; Cardoso, Wellington; Ai, Xingbin; Fine, Alan			Activation Dynamics and Signaling Properties of Notch3 Receptor in the Developing Pulmonary Artery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TUMOR-GROWTH; PATHWAY; LUNG; LOOP; HYPERTENSION; TRAFFICKING; EXPRESSION; APOPTOSIS; DELETION	Notch3 signaling is fundamental for arterial specification of systemic vascular smooth muscle cells (VSMCs). However, the developmental role and signaling properties of the Notch3 receptor in the mouse pulmonary artery remain unknown. Here, we demonstrate that Notch3 is expressed selectively in pulmonary artery VSMCs, is activated from late fetal to early postnatal life, and is required to maintain the morphological characteristics and smooth muscle gene expression profile of the pulmonary artery after birth. Using a conditional knock-out mouse model, we show that Notch3 receptor activation in VSMCs is Jagged1-dependent. In vitro VSMC lentivirus-mediated Jagged1 knockdown, confocal localization analysis, and co-culture experiments revealed that Notch3 activation is cell-autonomous and occurs through the physical engagement of Notch3 and VSMC-derived Jagged1 in the interior of the same cell. Although the current models of mammalian Notch signaling involve a two-cell system composed of a signal-receiving cell that expresses a Notch receptor on its surface and a neighboring signal-sending cell that provides membrane-bound activating ligand, our data suggest that pulmonary artery VSMC Notch3 activation is cell-autonomous. This unique mechanism of Notch activation may play an important role in the maturation of the pulmonary artery during the transition to air breathing.	[Ghosh, Shamik; Paez-Cortez, Jesus R.; Boppidi, Karthik; Vasconcelos, Michelle; Cardoso, Wellington; Ai, Xingbin; Fine, Alan] Boston Univ Sch Med, Ctr Pulm, Boston, MA 02118 USA; [Roy, Monideepa] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fine, A (corresponding author), Boston Univ Sch Med, Ctr Pulm, R-304,80 E Concord St, Boston, MA 02118 USA.	afine@bu.edu		Ai, Xingbin/0000-0002-2178-0080; Fine, Alan/0000-0001-9351-3048; Cardoso, Wellington/0000-0002-2550-3697	National Institutes of Health [HL-089795]; United States Army Medical Research Acquisition Activity; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research Acquisition Activity; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-089795. This work was also supported by a grant from the United States Army Medical Research Acquisition Activity.	Arboleda-Velasquez JF, 2005, HUM MOL GENET, V14, P1631, DOI 10.1093/hmg/ddi171; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellavia D, 2008, ONCOGENE, V27, P5092, DOI 10.1038/onc.2008.230; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; de Chantemele EJB, 2008, ARTERIOSCL THROM VAS, V28, P2216, DOI 10.1161/ATVBAHA.108.171751; deMello DE, 1997, AM J RESP CELL MOL, V16, P568, DOI 10.1165/ajrcmb.16.5.9160839; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Gao YS, 2010, PHYSIOL REV, V90, P1291, DOI 10.1152/physrev.00032.2009; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Murphy GJ, 2006, NAT MED, V12, P1093, DOI 10.1038/nm1376; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; White TA, 2010, AM J RESP CELL MOL, V43, P35, DOI 10.1165/rcmb.2009-0144OC; Wilkin M, 2008, DEV CELL, V15, P762, DOI 10.1016/j.devcel.2008.09.002; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; ZHU JH, 2010, AM J PHYSIOL-HEART C, V300, P1762	36	17	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22678	22687		10.1074/jbc.M111.241224	http://dx.doi.org/10.1074/jbc.M111.241224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536678	hybrid, Green Published			2022-12-25	WOS:000291719900074
J	Santhoshkumar, P; Raju, M; Sharma, KK				Santhoshkumar, Puttur; Raju, Murugesan; Sharma, K. Krishna			alpha A-Crystallin Peptide (SDRDKFVIFLDVKHF80)-S-66 Accumulating in Aging Lens Impairs the Function of alpha-Crystallin and Induces Lens Protein Aggregation	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DYNAMIC LIGHT-SCATTERING; CATARACTOUS HUMAN LENSES; AMYLOID FIBRIL FORMATION; B-CRYSTALLIN; MASS-SPECTROMETRY; CHAPERONE; IDENTIFICATION; FRAGMENTS; DISEASE	Background: The eye lens is composed of fiber cells that are filled with alpha-, beta-and gamma-crystallins. The primary function of crystallins is to maintain the clarity of the lens through ordered interactions as well as through the chaperone-like function of alpha-crystallin. With aging, the chaperone function of alpha-crystallin decreases, with the concomitant accumulation of water-insoluble, light-scattering oligomers and crystallin-derived peptides. The role of crystallin-derived peptides in age-related lens protein aggregation and insolubilization is not understood. Methodology/Principal Findings: We found that alpha A-crystallin-derived peptide, (SDRDKFVIFLDVKHF80)-S-66, which accumulates in the aging lens, can inhibit the chaperone activity of alpha-crystallin and cause aggregation and precipitation of lens crystallins. Age-related change in the concentration of alpha A-(66-80) peptide was estimated by mass spectrometry. The interaction of the peptide with native crystallin was studied by multi-angle light scattering and fluorescence methods. High molar ratios of peptide-to-crystallin were favourable for aggregation and precipitation. Time-lapse recordings showed that, in the presence of aA-(66-80) peptide, alpha-crystallin aggregates and functions as a nucleus for protein aggregation, attracting aggregation of additional alpha-, beta- and gamma-crystallins. Additionally, the alpha A-(66-80) peptide shares the principal properties of amyloid peptides, such as beta-sheet structure and fibril formation. Conclusions/Significance: These results suggest that crystallin-derived peptides such as alpha A-(66-80), generated in vivo, can induce age-related lens changes by disrupting the structure and organization of crystallins, leading to their insolubilization. The accumulation of such peptides in aging lenses may explain a novel mechanism for age-related crystallin aggregation and cataractogenesis.	[Santhoshkumar, Puttur; Raju, Murugesan; Sharma, K. Krishna] Univ Missouri, Sch Med, Dept Ophthalmol, Columbia, MO 65211 USA; [Sharma, K. Krishna] Univ Missouri, Dept Biochem, Sch Med, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Santhoshkumar, P (corresponding author), Univ Missouri, Sch Med, Dept Ophthalmol, Columbia, MO 65211 USA.	sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278	National Institutes of Health [EY11981, EY19878]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY019878, R01EY011981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by Grants EY11981 and EY19878 from National Institutes of Health grants and an unrestricted grant-in-aid from Research to Prevent Blindness to the Department of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Brun V, 2007, MOL CELL PROTEOMICS, V6, P2139, DOI 10.1074/mcp.M700163-MCP200; Datiles MB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1687, DOI 10.1001/archophthalmol.2008.507; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Fujii N, 2007, AMINO ACIDS, V32, P87, DOI 10.1007/s00726-006-0303-4; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Harrington V, 2007, MOL VIS, V13, P1680; Harrington V, 2004, MOL VIS, V10, P476; HORWITZ J, 1992, CURR EYE RES, V11, P817, DOI 10.3109/02713689209000754; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; JAFFE NS, 1991, TXB OPHTHALMOLOGY, V3; Konno T, 2001, BIOCHEMISTRY-US, V40, P2148, DOI 10.1021/bi002156h; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lanz TA, 2008, J NEUROSCI METH, V169, P16, DOI 10.1016/j.jneumeth.2007.11.009; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; MCFALLNGAI MJ, 1985, EXP EYE RES, V41, P745, DOI 10.1016/0014-4835(85)90183-6; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Murugesan R, 2008, MOL VIS, V14, P1835; Nakajima E, 2009, INVEST OPHTH VIS SCI, V50, P5828, DOI 10.1167/iovs.09-4015; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; PIRIE A, 1968, INVEST OPHTH VISUAL, V7, P634; Rao G, 2008, MOL VIS, V14, P666; ROY D, 1976, P NATL ACAD SCI USA, V73, P3484, DOI 10.1073/pnas.73.10.3484; Santhoshkumar P, 2004, MOL CELL BIOCHEM, V267, P147, DOI 10.1023/B:MCBI.0000049373.15558.b8; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Senthilkumar R, 2002, J BIOL CHEM, V277, P39136, DOI 10.1074/jbc.M204684200; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1996, CURR EYE RES, V15, P363, DOI 10.3109/02713689608995826; SHARMA KK, 1995, EXP EYE RES, V61, P413; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Simpanya MF, 2005, INVEST OPHTH VIS SCI, V46; Srivastava OP, 2004, J BIOL CHEM, V279, P10901, DOI 10.1074/jbc.M308884200; SRIVASTAVA OP, 1988, EXP EYE RES, V47, P525, DOI 10.1016/0014-4835(88)90092-9; Srivastava OP, 1996, CURR EYE RES, V15, P511, DOI 10.3109/02713689609000762; Su SP, 2010, EXP EYE RES, V91, P97, DOI 10.1016/j.exer.2010.04.010; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Udupa EGP, 2005, INVEST OPHTH VIS SCI, V46, P2514, DOI 10.1167/iovs.05-0031; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a	42	45	45	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19291	10.1371/journal.pone.0019291	http://dx.doi.org/10.1371/journal.pone.0019291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552534	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700047
J	Gao, GL; Zhang, SC; Wang, CF; Yang, X; Wang, YQ; Su, XJ; Du, JJ; Yang, CW				Gao, Guilan; Zhang, Shengchun; Wang, Chengfeng; Yang, Xiang; Wang, Yaqin; Su, Xiaojun; Du, Jinju; Yang, Chengwei			Arabidopsis CPR5 Independently Regulates Seed Germination and Postgermination Arrest of Development through LOX Pathway and ABA Signaling	PLOS ONE			English	Article							GUARD-CELL; SOYBEAN COTYLEDONS; DEFENSE RESPONSES; DROUGHT TOLERANCE; ACID; LIPOXYGENASE; GENE; PROTEIN; CATABOLISM; BIOSYNTHESIS	The phytohormone abscisic acid (ABA) and the lipoxygenases (LOXs) pathway play important roles in seed germination and seedling growth and development. Here, we reported on the functional characterization of Arabidopsis CPR5 in the ABA signaling and LOX pathways. The cpr5 mutant was hypersensitive to ABA in the seed germination, cotyledon greening and root growth, whereas transgenic plants overexpressing CPR5 were insensitive. Genetic analysis demonstrated that CPR5 gene may be located downstream of the ABI1 in the ABA signaling pathway. However, the cpr5 mutant showed an ABA independent drought-resistant phenotype. It was also found that the cpr5 mutant was hypersensitive to NDGA and NDGA treatment aggravated the ABA-induced delay in the seed germination and cotyledon greening. Taken together, these results suggest that the CPR5 plays a regulatory role in the regulation of seed germination and early seedling growth through ABA and LOX pathways independently.	[Gao, Guilan; Zhang, Shengchun; Wang, Chengfeng; Yang, Xiang; Wang, Yaqin; Du, Jinju; Yang, Chengwei] S China Normal Univ, Guangdong Key Lab Biotechnol Plant Dev, Coll Life Sci, Guangzhou, Peoples R China; [Su, Xiaojun] Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Peoples R China	South China Normal University; Hunan Agricultural University	Gao, GL (corresponding author), S China Normal Univ, Guangdong Key Lab Biotechnol Plant Dev, Coll Life Sci, Guangzhou, Peoples R China.	yangchw@scnu.edu.cn			National Science Foundation of China [30770201, 30871337]; Ministry of Agriculture [2009ZX08009-006B]; Program for New Century Excellent Talents in University [NCET-08-0644]; Guangdong Province Universities and Colleges Pearl River Scholar; Natural Science Foundation of Guangdong [82510631010000012]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Guangdong Province Universities and Colleges Pearl River Scholar; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This research was supported by the National Science Foundation of China (30770201,30871337), Ministry of Agriculture (National Key Program for Transgenic breeding 2009ZX08009-006B), the Program for New Century Excellent Talents in University (NCET-08-0644), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2010) and the Natural Science Foundation of Guangdong (82510631010000012). but these funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga S, 2005, J ETHNOPHARMACOL, V98, P231, DOI 10.1016/j.jep.2005.02.002; Assmann SM, 2003, TRENDS PLANT SCI, V8, P151, DOI 10.1016/S1360-1385(03)00052-9; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; BOKOCH GM, 1981, J BIOL CHEM, V256, P5317; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Bu QY, 2009, PLANT PHYSIOL, V150, P463, DOI 10.1104/pp.109.135269; Chen Y, 2006, PLANT PHYSIOL, V140, P302, DOI 10.1104/pp.105.069872; Chow B, 2004, J EXP BOT, V55, P247, DOI 10.1093/jxb/erh032; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CREELMAN RA, 1992, PLANT PHYSIOL, V99, P1258, DOI 10.1104/pp.99.3.1258; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Dekkers BJW, 2004, PLANTA, V218, P579, DOI 10.1007/s00425-003-1154-9; FARMER EE, 1994, PLANT MOL BIOL, V26, P1423, DOI 10.1007/BF00016483; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; FEUSSNER I, 1992, FEBS LETT, V298, P223, DOI 10.1016/0014-5793(92)80062-L; Feussner I, 2001, TRENDS PLANT SCI, V6, P268, DOI 10.1016/S1360-1385(01)01950-1; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Floriano-Sanchez E, 2006, FREE RADICAL RES, V40, P523, DOI 10.1080/10715760500419365; GIRAUDAT J, 1995, CURR OPIN CELL BIOL, V7, P232, DOI 10.1016/0955-0674(95)80033-6; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Holtman WL, 1997, EUR J BIOCHEM, V248, P452, DOI 10.1111/j.1432-1033.1997.00452.x; Ichida F, 1997, J Cardiol, V29, P217; Jing HC, 2008, PLANT SIGNAL BEHAV, V3, P562, DOI 10.4161/psb.3.8.5708; KATO T, 1992, PLANT PHYSIOL, V98, P324, DOI 10.1104/pp.98.1.324; Kirik V, 2001, CURR BIOL, V11, P1891, DOI 10.1016/S0960-9822(01)00590-5; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; MELAN MA, 1994, PLANT PHYSIOL, V105, P385, DOI 10.1104/pp.105.1.385; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; OHTA H, 1986, PLANT CELL PHYSIOL, V27, P911, DOI 10.1093/oxfordjournals.pcp.a077178; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; PARK TK, 1994, PLANT SCI, V96, P109, DOI 10.1016/0168-9452(94)90227-5; Porta H, 1999, PLANT CELL PHYSIOL, V40, P850, DOI 10.1093/oxfordjournals.pcp.a029614; Ramirez V, 2009, PLANT J, V58, P578, DOI 10.1111/j.1365-313X.2009.03804.x; Ren HB, 2007, J EXP BOT, V58, P211, DOI [10.1093/jxb/erl1117, 10.1093/jxb/erl117]; Ren HB, 2007, CHINESE SCI BULL, V52, P484, DOI 10.1007/s11434-007-0072-9; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Shang Y, 2010, PLANT CELL, V22, P1909, DOI 10.1105/tpc.110.073874; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Terp N, 2006, PHYTOCHEMISTRY, V67, P2030, DOI 10.1016/j.phytochem.2006.06.023; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; VANWAUWE J, 1983, PROSTAGLANDINS, V26, P725, DOI 10.1016/0090-6980(83)90057-6; VICK BA, 1976, PLANT PHYSIOL, V57, P780, DOI 10.1104/pp.57.5.780; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida S, 2002, PLANT J, V29, P427, DOI 10.1046/j.0960-7412.2001.01228.x; Zhu GH, 2009, PLANT CELL PHYSIOL, V50, P644, DOI 10.1093/pcp/pcp022; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	57	25	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19406	10.1371/journal.pone.0019406	http://dx.doi.org/10.1371/journal.pone.0019406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556325	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400057
J	Nowacek, DP; Friedlaender, AS; Halpin, PN; Hazen, EL; Johnston, DW; Read, AJ; Espinasse, B; Zhou, M; Zhu, YW				Nowacek, Douglas P.; Friedlaender, Ari S.; Halpin, Patrick N.; Hazen, Elliott L.; Johnston, David W.; Read, Andrew J.; Espinasse, Boris; Zhou, Meng; Zhu, Yiwu			Super-Aggregations of Krill and Humpback Whales in Wilhelmina Bay, Antarctic Peninsula	PLOS ONE			English	Article							EUPHAUSIA-SUPERBA; BEHAVIOR; BIOMASS	Ecological relationships of krill and whales have not been explored in the Western Antarctic Peninsula (WAP), and have only rarely been studied elsewhere in the Southern Ocean. In the austral autumn we observed an extremely high density (5.1 whales per km(2)) of humpback whales (Megaptera novaeangliae) feeding on a super-aggregation of Antarctic krill (Euphausia superba) in Wilhelmina Bay. The krill biomass was approximately 2 million tons, distributed over an area of 100 km(2) at densities of up to 2000 individuals m(-3); reports of such 'super-aggregations' of krill have been absent in the scientific literature for >20 years. Retentive circulation patterns in the Bay entrained phytoplankton and meso-zooplankton that were grazed by the krill. Tagged whales rested during daylight hours and fed intensively throughout the night as krill migrated toward the surface. We infer that the previously unstudied WAP embayments are important foraging areas for whales during autumn and, furthermore, that meso-scale variation in the distribution of whales and their prey are important features of this system. Recent decreases in the abundance of Antarctic krill around the WAP have been linked to reductions in sea ice, mediated by rapid climate change in this area. At the same time, baleen whale populations in the Southern Ocean, which feed primarily on krill, are recovering from past exploitation. Consideration of these features and the effects of climate change on krill dynamics are critical to managing both krill harvests and the recovery of baleen whales in the Southern Ocean.	[Nowacek, Douglas P.; Friedlaender, Ari S.; Halpin, Patrick N.; Hazen, Elliott L.; Johnston, David W.; Read, Andrew J.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Nowacek, Douglas P.; Friedlaender, Ari S.; Halpin, Patrick N.; Hazen, Elliott L.; Johnston, David W.; Read, Andrew J.] Duke Univ, Marine Lab, Pratt Sch Engn, Beaufort, NC 28516 USA; [Hazen, Elliott L.] Natl Ocean & Atmospher Adm NOAA, Pacific Fisheries Environm Lab, Pacific Grove, CA USA; [Hazen, Elliott L.] Univ Hawaii, JIMAR, Pacific Grove, CA USA; [Espinasse, Boris] Univ Mediterrane, CNRS, Ctr Oceanol Marseille, Lab Oceanog Phys & Biogeochim, Marseille, France; [Zhou, Meng; Zhu, Yiwu] Univ Massachusetts, Dept Environm Earth & Ocean Sci, Boston, MA 02125 USA	Duke University; Duke University; National Oceanic Atmospheric Admin (NOAA) - USA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Massachusetts System; University of Massachusetts Boston	Nowacek, DP (corresponding author), Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA.	dpn3@duke.edu	Hazen, Elliott/G-4149-2014; Espinasse, Boris/AAE-1435-2022; Johnston, David/AAJ-5013-2020; Espinasse, Boris/AFS-7849-2022; Read, Andrew/AAE-8386-2019	Hazen, Elliott/0000-0002-0412-7178; Espinasse, Boris/0000-0002-7490-5588; Johnston, David/0000-0003-2424-036X	National Science Foundation [ANT-07-39483, ANT-07-39566]	National Science Foundation(National Science Foundation (NSF))	This work was funded under a National Science Foundation Collaborative Research award, grant ANT-07-39483 to DPN and ANT-07-39566 to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barlow J, 2006, MAR MAMMAL SCI, V22, P446, DOI 10.1111/j.1748-7692.2006.00032.x; Brierley A.S., 1999, CCAMLR Science, V6, P47; Chu DZ, 1999, J ACOUST SOC AM, V106, P1732, DOI 10.1121/1.428036; Clapham PJ, 2001, REPORTS INT WHALING, V53, P1; Cox MJ, 2009, MAR ECOL PROG SER, V378, P199, DOI 10.3354/meps07795; FOOTE KG, 1990, J CONSEIL, V46, P284; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Friedlaender AS, DEEP SEA 2 IN PRESS; HAMNER WM, 1983, SCIENCE, V220, P433, DOI 10.1126/science.220.4595.433; Headley S, 2001, INT WHAL COMM SC 53; Hofmann EE, 2004, DEEP-SEA RES PT II, V51, P1921, DOI 10.1016/j.dsr2.2004.08.007; Jacquet J, 2010, NATURE, V467, P28, DOI 10.1038/467028a; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kasamatsu F, 2000, POLAR BIOL, V23, P466, DOI 10.1007/s003009900107; Lascara CM, 1999, DEEP-SEA RES PT I, V46, P951, DOI 10.1016/S0967-0637(98)00099-5; Lawson GL, 2008, DEEP-SEA RES PT II, V55, P432, DOI 10.1016/j.dsr2.2007.11.014; Lawson GL, 2004, DEEP-SEA RES PT II, V51, P2041, DOI 10.1016/j.dsr2.2004.07.022; Martin JE, 1997, ANTARCTIC J US 1997, V32, P117; Nicol S, 2000, DEEP-SEA RES PT II, V47, P2281, DOI 10.1016/S0967-0645(00)00026-6; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Quetin LB, 2003, MAR ECOL PROG SER, V259, P185, DOI 10.3354/meps259185; Reilly S, 2004, DEEP-SEA RES PT II, V51, P1397, DOI 10.1016/j/dsr2.2004.06.008; Santora JA, 2010, MAR ECOL PROG SER, V405, P255, DOI 10.3354/meps08513; Secchi Eduardo R., 2002, Memoirs of the Queensland Museum, V47, P571; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Takahashi A, 2003, MAR ECOL PROG SER, V250, P279, DOI 10.3354/meps250279; Tarling GA, 2009, DEEP-SEA RES PT I, V56, P1994, DOI 10.1016/j.dsr.2009.07.004; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Watkins JL, 2002, ICES J MAR SCI, V59, P1326, DOI 10.1006/jmsc.2002.1309; WIEBE PH, 1976, J MAR RES, V34, P313	36	104	110	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19173	10.1371/journal.pone.0019173	http://dx.doi.org/10.1371/journal.pone.0019173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556153	Green Published, gold			2022-12-25	WOS:000290019400036
J	Du, ZM; Hu, LF; Wang, HY; Yan, LX; Zeng, YX; Shao, JY; Ernberg, I				Du, Zi-Ming; Hu, Li-Fu; Wang, Hai-Yun; Yan, Li-Xu; Zeng, Yi-Xin; Shao, Jian-Yong; Ernberg, Ingemar			Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A	PLOS ONE			English	Article							B-CELL LYMPHOMAS; MICRORNA TARGET PREDICTIONS; BREAST-CANCER; GENE-EXPRESSION; STEM-CELLS; 2A LMP2A; PATHWAY; GROWTH; TRANSCRIPTION; SURVIVAL	The role of microRNA-155 (miR-155) has been associated with oncogenesis of several human tumors. However the expression pattern of miR-155 has not been investigated in nasopharyngeal carcinoma (NPC). The present study was to assess miR-155 expression pattern and its possible function in NPC, to identify its targets and evaluate their clinical applications in NPC. MiR-155 was found to be upregulated in two Epstein-Barr virus (EBV) negative NPC derived cell lines CNE1 and TW03, as well as in NPC clinical samples by quantitative Real-time PCR and in situ hybridization detection. EBV encoded LMP1 and LMP2A could further enhance the expression of miR-155 in NPC CNE1 and TW03 cells. JMJD1A and BACH1 were identified as putative targets of miR-155 in a bioinformatics screen. Overexpression of miR-155 downregulated a luciferase transcript fused to the 3'UTR of JMJD1A and BACH1. MiR-155 mimic could downregulate the expression of JMJD1A and BACH1, while miR-155 inhibitor could upregulate JMJD1A expression in NPC cell lines. Moreover, downregulation of JMJD1A was significantly correlated with N stage in TNM classification (p = 0.023), a lower five-year survival rate (p = 0.021), and a lower five-year disease-free survival rate (p = 0.049) of NPC patients. Taken together, upregulation of miR-155 in NPC is partly driven by LMP1 and LMP2A, and results in downregulation of JMJD1A, which is associated with N stage and poor prognosis of NPC patients. The potential of miR-155 and JMJD1A as therapeutic targets in NPC should be further investigated.	[Du, Zi-Ming; Wang, Hai-Yun; Yan, Li-Xu; Zeng, Yi-Xin; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Du, Zi-Ming; Wang, Hai-Yun; Yan, Li-Xu; Zeng, Yi-Xin; Shao, Jian-Yong] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Du, Zi-Ming; Hu, Li-Fu; Shao, Jian-Yong; Ernberg, Ingemar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Sun Yat Sen University; Sun Yat Sen University; Karolinska Institutet	Du, ZM (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	shaojy@sysucc.org.cn; ingemar.ernberg@ki.se		Yan, Li-Xu/0000-0002-5584-4265	Swedish International Development Cooperation Agency (SIDA); Swedish Cancer Society; Swedish Board for International co-operation; Maths O. Sundqvist family foundation; Chinese Scholarship Council; National High Technology Research and Development Program of China (863 Program) [20060102A4002]; Chinese State Key Basic Research Project [2010CB518708]	Swedish International Development Cooperation Agency (SIDA); Swedish Cancer Society(Swedish Cancer Society); Swedish Board for International co-operation; Maths O. Sundqvist family foundation; Chinese Scholarship Council(China Scholarship Council); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Chinese State Key Basic Research Project	This work was supported in part by a grant from Swedish International Development Cooperation Agency (SIDA), the Swedish Cancer Society, the Swedish Board for International co-operation and the Maths O. Sundqvist family foundation, and a grant from Chinese Scholarship Council, National High Technology Research and Development Program of China (863 Program) (No. 20060102A4002), and the Chinese State Key Basic Research Project (No. 2010CB518708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chen F, 2005, INT J CANCER, V113, P284, DOI 10.1002/ijc.20594; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; FAHRAEUS R, 1988, INT J CANCER, V42, P329, DOI 10.1002/ijc.2910420305; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Farias TP, 2003, ARCH OTOLARYNGOL, V129, P794, DOI 10.1001/archotol.129.7.794; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Guasparri L, 2008, BLOOD, V111, P3813, DOI 10.1182/blood-2007-03-080309; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Heussinger N, 2004, J PATHOL, V203, P696, DOI 10.1002/path.1569; HU LF, 1991, J GEN VIROL, V72, P2399, DOI 10.1099/0022-1317-72-10-2399; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kumar S., 1998, Indian Journal of Cancer, V35, P47; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Licitra L, 2003, CRIT REV ONCOL HEMAT, V45, P199, DOI 10.1016/S1040-8428(01)00210-4; LIN CT, 1993, LAB INVEST, V68, P716; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu F, 2008, J VIROL, V82, P10436, DOI 10.1128/JVI.00752-08; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; Mrazek J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm244; Nikiforova MN, 2008, J CLIN ENDOCR METAB, V93, P1600, DOI 10.1210/jc.2007-2696; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Ohira M, 1998, GENOMICS, V47, P300, DOI 10.1006/geno.1997.5080; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Pedersen IM, 2009, EMBO MOL MED, V1, P288, DOI 10.1002/emmm.200900028; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ryu JK, 2010, PANCREATOLOGY, V10, P66, DOI 10.1159/000231984; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Thompson RC, 2011, J BIOL CHEM, V286, P1675, DOI 10.1074/jbc.M110.177063; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Vargova K, 2011, BLOOD; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Wenger RH, 2000, J EXP BIOL, V203, P1253; Xu J, 1999, INT J CANCER, V84, P396, DOI 10.1002/(SICI)1097-0215(19990820)84:4&lt;396::AID-IJC11&gt;3.0.CO;2-#; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zhang XN, 2007, BIOCHEM BIOPH RES CO, V360, P263, DOI 10.1016/j.bbrc.2007.06.043	66	74	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19137	10.1371/journal.pone.0019137	http://dx.doi.org/10.1371/journal.pone.0019137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541331	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400026
J	Grinberg, YY; Milton, JG; Kraig, RP				Grinberg, Yelena Y.; Milton, John G.; Kraig, Richard P.			Spreading Depression Sends Microglia on Levy Flights	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; LONG-TERM POTENTIATION; GLIAL TNF-ALPHA; IN-VIVO; RECEPTOR TRAFFICKING; RESTING MICROGLIA; AMPA-RECEPTOR; CELL MOTILITY; RANDOM MOTION; SUPPRESSION	Spreading depression (SD) is thought to cause migraine aura, and perhaps migraine, and includes a transient loss of synaptic activity preceded and followed by increased neuronal excitability. Activated microglia influence neuronal activity and play an important role in homeostatic synaptic scaling via release of cytokines. Furthermore, enhanced neuronal function activates microglia to not only secrete cytokines but also to increase the motility of their branches, with somata remaining stationary. While SD also increases the release of cytokines from microglia, the effects on microglial movement from its synaptic activity fluctuations are unknown. Accordingly, we used time-lapse imaging of rat hippocampal slice cultures to probe for microglial movement associated with SD. We observed that in uninjured brain whole microglial cells moved. The movements were well described by the type of Levy flight known to be associated with an optimal search pattern. Hours after SD, when synaptic activity rose, microglial cell movement was significantly increased. To test how synaptic activity influenced microglial movement, we enhanced neuronal activity with chemical long-term potentiation or LPS and abolished it with TTX. We found that microglial movement was significantly decreased by enhanced neuronal activity and significantly increased by activity blockade. Finally, application of glutamate and ATP to mimic restoration of synaptic activity in the presence of TTX stopped microglial movement that was otherwise seen with TTX. Thus, synaptic activity retains microglial cells in place and an absence of synaptic activity sends them off to influence wider expanses of brain. Perhaps increased microglial movements after SD are a long-lasting, and thus maladaptive, response in which these cells increase neuronal activity via contact or paracrine signaling, which results in increased susceptibility of larger brain areas to SD. If true, then targeting mechanisms that retard activity-dependent microglial Levy flights may be a novel means to reduce susceptibility to migraine.	[Grinberg, Yelena Y.; Kraig, Richard P.] Univ Chicago, Med Ctr, Dept Neurol, Chicago, IL 60637 USA; [Grinberg, Yelena Y.; Kraig, Richard P.] Univ Chicago, Med Ctr, Comm Neurobiol, Chicago, IL 60637 USA; [Milton, John G.] Claremont Coll, Claremont, CA USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; Claremont Colleges; Claremont Graduate School	Grinberg, YY (corresponding author), Univ Chicago, Med Ctr, Dept Neurol, Chicago, IL 60637 USA.	rkraig@neurology.bsd.uchicago.edu	Milton, John G/H-7320-2012	Kraig, Richard/0000-0003-4584-1017	National Institutes of Neurological Disorders and Stroke [NS-19108]; National Institute of Child Health and Disease [PO1-HD09402]; Migraine Research Foundation; White Foundation; National Science Foundation [NSF-1028970]; National Institutes of General Medicine [5T32GM007839-31]; Pritzker Foundation; Division Of Behavioral and Cognitive Sci [1028970] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD009402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019108] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Migraine Research Foundation; White Foundation; National Science Foundation(National Science Foundation (NSF)); National Institutes of General Medicine; Pritzker Foundation; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Neurological Disorders and Stroke (NS-19108), the National Institute of Child Health and Disease (PO1-HD09402), the Migraine Research Foundation, and the White Foundation (RPK), National Science Foundation (NSF-1028970) (JGM), National Institutes of General Medicine (5T32GM007839-31) (YYG) and the Pritzker Foundation (YYG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Berg, 2018, RANDOM WALKS BIOL; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; BRAZIER MAB, 1963, P 1 C 1961 CORT EXC, pR18; Bures J., 1974, MECH APPL LEAOS SPRE; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Caggiano AO, 1996, J COMP NEUROL, V369, P93, DOI 10.1002/(SICI)1096-9861(19960520)369:1<93::AID-CNE7>3.0.CO;2-F; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; HANCOX NM, 1961, J BIOPHYS BIOCHEM CY, V11, P651, DOI 10.1083/jcb.11.3.651; Hulse RE, 2008, J NEUROSCI, V28, P12199, DOI 10.1523/JNEUROSCI.3856-08.2008; Hung J, 2010, BRAIN BEHAV IMMUN, V24, P31, DOI 10.1016/j.bbi.2009.06.150; Irwin DA, 1932, CAN MED ASSOC J, V27, P353; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kraig RP, 2010, DOSE-RESPONSE, V8, P389, DOI 10.2203/dose-response.09-056.Kraig; Kruger H, 1996, NEUROREPORT, V7, P2733; Kunkler PE, 2005, J NEUROSCI, V25, P3952, DOI 10.1523/JNEUROSCI.0491-05.2005; Kunkler PE, 2004, J CEREBR BLOOD F MET, V24, P829, DOI 10.1097/01.WCB.0000126566.34753.30; Kunkler PE, 1998, J NEUROSCI, V18, P3416; Kunkler PE, 1997, J CEREBR BLOOD F MET, V17, P26, DOI 10.1097/00004647-199701000-00005; Lauritzen M, 2005, HEADACHES, P269; Leonoudakis D, 2004, NEURON GLIA BIOL, V1, P263, DOI 10.1017/S1740925X05000608; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Lubashevsky I, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011110; MCGLADEMCCULLOH E, 1989, P NATL ACAD SCI USA, V86, P1093, DOI 10.1073/pnas.86.3.1093; Mitchell H.M., 2010, JOVE-J VIS EXP, DOI [10.3791/2192, DOI 10.3791/2192]; MITCHELL HM, 2011, J NEUROCHEM, DOI DOI 10.1111/J.1471-4159.2010.07103.X; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reynolds AM, 2010, PHYSICA A, V389, P273, DOI 10.1016/j.physa.2009.09.027; Reynolds AM, 2010, J R SOC INTERFACE, V7, P1753, DOI 10.1098/rsif.2010.0292; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Selmeczi D, 2008, EUR PHYS J-SPEC TOP, V157, P1, DOI 10.1140/epjst/e2008-00626-x; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Snedecor G.W., 1989, AMES IOWA STATE U PR; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Waldbaum S, 2009, EPILEPSIA, V50, P904, DOI 10.1111/j.1528-1167.2008.01939.x; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	50	50	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19294	10.1371/journal.pone.0019294	http://dx.doi.org/10.1371/journal.pone.0019294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541289	gold, Green Submitted, Green Published			2022-12-25	WOS:000290018400042
J	Yoshii, H; Kamiyama, H; Goto, K; Oishi, K; Katunuma, N; Tanaka, Y; Hayashi, H; Matsuyama, T; Sato, H; Yamamoto, N; Kubo, Y				Yoshii, Hiroaki; Kamiyama, Haruka; Goto, Kensuke; Oishi, Kazunori; Katunuma, Nobuhiko; Tanaka, Yuetsu; Hayashi, Hideki; Matsuyama, Toshifumi; Sato, Hironori; Yamamoto, Naoki; Kubo, Yoshinao			CD4-Independent Human Immunodeficiency Virus Infection Involves Participation of Endocytosis and Cathepsin B	PLOS ONE			English	Article							DEPENDENT FUSION; MEDIATED ENTRY; HIV-1; CELLS; PH; ACTIVATION; PROTEIN; CD8(+); INHIBITION; CORECEPTOR	During a comparison of the infectivity of mNDK, a CD4-independent human immunodeficiency virus type 1 (HIV-1) strain, to various cell lines, we found that HeLa cells were much less susceptible than 293T and TE671 cells. Hybridoma cells between HeLa and 293T cells were as susceptible as 293T cells, suggesting that cellular factors enhance the mNDK infection in 293T cells. By screening a cDNA expression library in HeLa cells, cystatin C was isolated as an enhancer of the mNDK infection. Because cathepsin B protease, a natural ligand of cystatin C, was upregulated in HeLa cells, we speculated that the high levels of cathepsin B activities were inhibitory to the CD4-independent infection and that cystatin C enhanced the infection by impairing the excessive cathepsin B activity. Consistent with this idea, pretreatment of HeLa cells with 125 mu M of CA-074Me, a cathepsin B inhibitor, resulted in an 8-fold enhancement of the mNDK infectivity. Because cathepsin B is activated by low pH in acidic endosomes, we further examined the potential roles of endosomes in the CD4-independent infection. Suppression of endosome acidification or endocytosis by inhibitors or by an Eps15 dominant negative mutant reduced the infectivity of mNDK in which CD4-dependent infections were not significantly impaired. Taken together, these results suggest that endocytosis, endosomal acidification, and cathepsin B activity are involved in the CD4-independent entry of HIV-1.	[Yoshii, Hiroaki; Kamiyama, Haruka; Sato, Hironori; Yamamoto, Naoki; Kubo, Yoshinao] Nagasaki Univ, Global Ctr Excellence GCOE, Inst Trop Med, Dept AIDS Res, Nagasaki 852, Japan; [Goto, Kensuke] Nagasaki Univ, Inst Trop Med, Dept Ecoepidemiol, Nagasaki 852, Japan; [Yoshii, Hiroaki; Oishi, Kazunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Prevent & Therapeut Res Infect Dis, Nagasaki 852, Japan; [Oishi, Kazunori] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Osaka, Japan; [Katunuma, Nobuhiko] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Grad Sch, Dept Immunol, Okinawa, Japan; [Tanaka, Yuetsu] Univ Ryukyus, Fac Med, Okinawa, Japan; [Hayashi, Hideki; Matsuyama, Toshifumi] Nagasaki Univ, Grad Sch Biomed Sci, Div Cytokine Signaling, Nagasaki 852, Japan; [Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Lab Viral Genom, Tokyo, Japan; [Yamamoto, Naoki] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Osaka University; Tokushima Bunri University; University of the Ryukyus; University of the Ryukyus; Nagasaki University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Yoshii, H (corresponding author), Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Lab Infect Dis,Dept Microbiol & Immunol, Aichi, Japan.	yoshinao@nagasaki-u.ac.jp	Hideki, Hayashi/AAW-9081-2021	Hayashi, Hideki/0000-0003-4585-6542	Nagasaki University; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22590416] Funding Source: KAKEN	Nagasaki University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by NEKKEN Research Grant of Nagasaki University, and by a grant-in-aid from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard RJO, 2004, J VIROL, V78, P10433, DOI 10.1128/JVI.78.19.10433-10441.2004; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bertrand P, 2008, J VIROL, V82, P2555, DOI 10.1128/JVI.01853-07; Brindley MA, 2008, J VIROL, V82, P1628, DOI 10.1128/JVI.01754-07; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chenine AL, 2002, VIROLOGY, V304, P403, DOI 10.1006/viro.2002.1689; CLAYTON LK, 1988, NATURE, V335, P363, DOI 10.1038/335363a0; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Dumonceaux J, 1998, J VIROL, V72, P512, DOI 10.1128/JVI.72.1.512-519.1998; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Edinger AL, 1999, J VIROL, V73, P4062, DOI 10.1128/JVI.73.5.4062-4073.1999; Espagne E, 2005, J VIROL, V79, P9765, DOI 10.1128/JVI.79.15.9765-9776.2005; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Greiner A, 2003, J LEUKOCYTE BIOL, V73, P235, DOI 10.1189/jlb.0802398; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Hoffman TL, 1999, P NATL ACAD SCI USA, V96, P6359, DOI 10.1073/pnas.96.11.6359; Iwakuma T, 1999, VIROLOGY, V261, P120, DOI 10.1006/viro.1999.9850; Jin S, 2005, J VIROL, V79, P14489, DOI 10.1128/JVI.79.23.14489-14497.2005; Kamiyama H, 2009, VIROLOGY, V386, P23, DOI 10.1016/j.virol.2008.12.033; Katunuma N, 2003, BIOL CHEM, V384, P883, DOI 10.1515/BC.2003.099; Kubo Y, 2008, VIROLOGY, V375, P130, DOI 10.1016/j.virol.2008.01.047; Kubo Y, 2007, J GEN VIROL, V88, P3139, DOI 10.1099/vir.0.83202-0; Kumar P, 2007, J VIROL, V81, P10506, DOI 10.1128/JVI.02853-06; Li JH, 2009, AM J PATHOL, V175, P1124, DOI 10.2353/ajpath.2009.090113; Li QD, 1997, IMMUNOPHARM IMMUNOT, V19, P215, DOI 10.3109/08923979709007660; Luciano-Montalvo C, 2008, PLACENTA, V29, P1016, DOI 10.1016/j.placenta.2008.09.005; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mori Y, 2007, J VIROL, V81, P8477, DOI 10.1128/JVI.00477-07; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Newlands GFJ, 2001, PARASITOLOGY, V122, P371, DOI 10.1017/S0031182001007302; Paraoan L, 2007, EXP EYE RES, V84, P1019, DOI 10.1016/j.exer.2006.01.024; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Picard-Maureau M, 2003, J VIROL, V77, P4722, DOI 10.1128/JVI.77.8.4722-4730.2003; Potempa S, 1997, J VIROL, V71, P4419, DOI 10.1128/JVI.71.6.4419-4424.1997; Puffer BA, 2002, J VIROL, V76, P2595, DOI 10.1128/JVI.76.6.2595-2605.2002; PURI A, 1988, J BIOL CHEM, V263, P4749; Reeves JD, 1997, J VIROL, V71, P1453, DOI 10.1128/JVI.71.2.1453-1465.1997; Saha K, 2001, NAT MED, V7, P65, DOI 10.1038/83365; Saha K, 2001, J ACQ IMMUN DEF SYND, V26, P199, DOI 10.1097/00126334-200103010-00001; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Shimizu N, 2000, J VIROL, V74, P619, DOI 10.1128/JVI.74.2.619-626.2000; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; SUBLER MA, 1994, J VIROL, V68, P103, DOI 10.1128/JVI.68.1.103-110.1994; Tanaka R, 2001, J VIROL, V75, P11534, DOI 10.1128/JVI.75.23.11534-11543.2001; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Vidricaire G, 2007, J MOL BIOL, V368, P1267, DOI 10.1016/j.jmb.2007.03.003; Xiao P, 2008, AIDS, V22, P1749, DOI 10.1097/QAD.0b013e328308937c; Yoshii H, 2009, VIROLOGY, V394, P227, DOI 10.1016/j.virol.2009.08.045; Zerhouni B, 2004, J VIROL, V78, P12288, DOI 10.1128/JVI.78.22.12288-12296.2004; Zerhouni B, 2004, J VIROL, V78, P1243, DOI 10.1128/JVI.78.3.1243-1255.2004	60	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19352	10.1371/journal.pone.0019352	http://dx.doi.org/10.1371/journal.pone.0019352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541353	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800043
J	Higley, MJ; Gittis, AH; Oldenburg, IA; Balthasar, N; Seal, RP; Edwards, RH; Lowell, BB; Kreitzer, AC; Sabatini, BL				Higley, Michael J.; Gittis, Aryn H.; Oldenburg, Ian A.; Balthasar, Nina; Seal, Rebecca P.; Edwards, Robert H.; Lowell, Bradford B.; Kreitzer, Anatol C.; Sabatini, Bernardo L.			Cholinergic Interneurons Mediate Fast VGluT3-Dependent Glutamatergic Transmission in the Striatum	PLOS ONE			English	Article							TONICALLY ACTIVE NEURONS; VESICULAR GLUTAMATE; DOPAMINE NEURONS; SEROTONINERGIC NEURONS; NUCLEUS-ACCUMBENS; RAT-BRAIN; ACETYLCHOLINE; TRANSPORTER-3; MODULATION; RECEPTORS	The neurotransmitter glutamate is released by excitatory projection neurons throughout the brain. However, non-glutamatergic cells, including cholinergic and monoaminergic neurons, express markers that suggest that they are also capable of vesicular glutamate release. Striatal cholinergic interneurons (CINs) express the Type-3 vesicular glutamate transporter (VGluT3), although whether they form functional glutamatergic synapses is unclear. To examine this possibility, we utilized mice expressing Cre-recombinase under control of the endogenous choline acetyltransferase locus and conditionally expressed light-activated Channelrhodopsin2 in CINs. Optical stimulation evoked action potentials in CINs and produced postsynaptic responses in medium spiny neurons that were blocked by glutamate receptor antagonists. CIN-mediated glutamatergic responses exhibited a large contribution of NMDA-type glutamate receptors, distinguishing them from corticostriatal inputs. CIN-mediated glutamatergic responses were insensitive to antagonists of acetylcholine receptors and were not seen in mice lacking VGluT3. Our results indicate that CINs are capable of mediating fast glutamatergic transmission, suggesting a new role for these cells in regulating striatal activity.	[Higley, Michael J.; Oldenburg, Ian A.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Balthasar, Nina; Lowell, Bradford B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med,Sch Med, Boston, MA 02215 USA; [Gittis, Aryn H.; Kreitzer, Anatol C.] Univ Calif San Francisco, Sch Med, Dept Physiol, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Gittis, Aryn H.; Kreitzer, Anatol C.] Univ Calif San Francisco, Sch Med, Dept Neurol, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes	Higley, MJ (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06520 USA.	bernardo_sabatini@hms.harvard.edu	Gittis, Aryn/I-6128-2016	Gittis, Aryn/0000-0002-3591-5775; Seal, Rebecca/0000-0003-4955-703X	Parkinson's Disease Foundation; NARSAD; HHMI; Keck Foundation; NIH [NS063663, NS046579, NS064984, MH50712, DA10154, DK075632, P30 DK046200, P30 DK057521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075632, P30DK057521, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050712, F32MH068085, F31MH093026, R37MH050712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS063663, R01NS064984, R01NS046579, R37NS046579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; NARSAD(NARSAD); HHMI(Howard Hughes Medical Institute); Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was funded by Parkinson's Disease Foundation, NARSAD, HHMI, Keck Foundation, and NIH (NS063663, NS046579, NS064984, MH50712,DA10154, DK075632, P30 DK046200 and P30 DK057521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella P, 2007, TRENDS NEUROSCI, V30, P299, DOI 10.1016/j.tins.2007.03.011; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Boulland JL, 2004, J COMP NEUROL, V480, P264, DOI 10.1002/cne.20354; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gras C, 2002, J NEUROSCI, V22, P5442; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Higley MJ, 2009, NAT NEUROSCI, V12, P1121, DOI 10.1038/nn.2368; IZZO PN, 1988, J COMP NEUROL, V269, P219, DOI 10.1002/cne.902690207; JOHNSON MD, 1994, NEURON, V12, P433, DOI 10.1016/0896-6273(94)90283-6; KANEKO T, 1990, BRAIN RES, V507, P151, DOI 10.1016/0006-8993(90)90535-J; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Manns ID, 2001, NEUROSCIENCE, V107, P249, DOI 10.1016/S0306-4522(01)00302-5; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; OTTERSEN OP, 1984, J COMP NEUROL, V229, P374, DOI 10.1002/cne.902290308; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Poulin AN, 2006, J COMP NEUROL, V498, P690, DOI 10.1002/cne.21081; ROSSI J, CELL METABO IN PRESS; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Stornetta RL, 2002, J COMP NEUROL, V444, P191, DOI 10.1002/cne.10141; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226	34	124	126	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19155	10.1371/journal.pone.0019155	http://dx.doi.org/10.1371/journal.pone.0019155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544206	Green Published, gold			2022-12-25	WOS:000290015800047
J	Waehre, A; Halvorsen, B; Yndestad, A; Husberg, C; Sjaastad, I; Nygard, S; Dahl, CP; Ahmed, MS; Finsen, AV; Reims, H; Louch, WE; Hilfiker-Kleiner, D; Vinge, LE; Roald, B; Attramadal, H; Lipp, M; Gullestad, L; Aukrust, P; Christensen, G				Waehre, Anne; Halvorsen, Bente; Yndestad, Arne; Husberg, Cathrine; Sjaastad, Ivar; Nygard, Stale; Dahl, Christen P.; Ahmed, M. Shakil; Finsen, Alexandra V.; Reims, Henrik; Louch, William E.; Hilfiker-Kleiner, Denise; Vinge, Leif E.; Roald, Borghild; Attramadal, Havard; Lipp, Martin; Gullestad, Lars; Aukrust, Pal; Christensen, Geir			Lack of Chemokine Signaling through CXCR5 Causes Increased Mortality, Ventricular Dilatation and Deranged Matrix during Cardiac Pressure Overload	PLOS ONE			English	Article							INDUCED MYOCARDIAL-INFARCTION; MESSENGER-RNA EXPRESSION; CONGESTIVE-HEART-FAILURE; PROTEIN-COUPLED RECEPTOR; SJOGRENS-SYNDROME; GERMINAL CENTER; EXTRACELLULAR-MATRIX; LYMPHOID FOLLICLES; GENE-EXPRESSION; TRANSGENIC MICE	Rationale: Inflammatory mechanisms have been suggested to play a role in the development of heart failure (HF), but a role for chemokines is largely unknown. Based on their role in inflammation and matrix remodeling in other tissues, we hypothesized that CXCL13 and CXCR5 could be involved in cardiac remodeling during HF. Objective: We sought to analyze the role of the chemokine CXCL13 and its receptor CXCR5 in cardiac pathophysiology leading to HF. Methods and Results: Mice harboring a systemic knockout of the CXCR5 (CXCR5(-/-)) displayed increased mortality during a follow-up of 80 days after aortic banding (AB). Following three weeks of AB, CXCR5(-/-) developed significant left ventricular (LV) dilatation compared to wild type (WT) mice. Microarray analysis revealed altered expression of several small leucine-rich proteoglycans (SLRPs) that bind to collagen and modulate fibril assembly. Protein levels of fibromodulin, decorin and lumican (all SLRPs) were significantly reduced in AB CXCR5(-/-) compared to AB WT mice. Electron microscopy revealed loosely packed extracellular matrix with individual collagen fibers and small networks of proteoglycans in AB CXCR5(-/-) mice. Addition of CXCL13 to cultured cardiac fibroblasts enhanced the expression of SLRPs. In patients with HF, we observed increased myocardial levels of CXCR5 and SLRPs, which was reversed following LV assist device treatment. Conclusions: Lack of CXCR5 leads to LV dilatation and increased mortality during pressure overload, possibly via lack of an increase in SLRPs. This study demonstrates a critical role of the chemokine CXCL13 and CXCR5 in survival and maintaining of cardiac structure upon pressure overload, by regulating proteoglycans essential for correct collagen assembly.	[Waehre, Anne; Husberg, Cathrine; Sjaastad, Ivar; Nygard, Stale; Louch, William E.; Christensen, Geir] Univ Oslo, Ulleval Hosp, Expt Med Res Inst, Oslo, Norway; [Halvorsen, Bente; Yndestad, Arne; Dahl, Christen P.; Finsen, Alexandra V.; Vinge, Leif E.; Gullestad, Lars; Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Ahmed, M. Shakil; Attramadal, Havard] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Surg Res, N-0027 Oslo, Norway; [Dahl, Christen P.; Finsen, Alexandra V.; Vinge, Leif E.; Gullestad, Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Sjaastad, Ivar] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway; [Reims, Henrik; Roald, Borghild] Univ Oslo, Ulleval Hosp, Dept Pathol, Oslo, Norway; [Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Lipp, Martin] Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, Berlin, Germany; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Waehre, Anne; Halvorsen, Bente; Yndestad, Arne; Sjaastad, Ivar; Ahmed, M. Shakil; Attramadal, Havard; Gullestad, Lars; Aukrust, Pal; Christensen, Geir] Univ Oslo, Fac Med, Oslo, Norway; [Waehre, Anne; Husberg, Cathrine; Sjaastad, Ivar; Nygard, Stale; Dahl, Christen P.; Ahmed, M. Shakil; Finsen, Alexandra V.; Louch, William E.; Vinge, Leif E.; Attramadal, Havard; Gullestad, Lars; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Nygard, Stale] Univ Oslo, Rikshosp, Oslo Univ Hosp, Bioinformat Core Facil,Inst Med Informat, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Waehre, A (corresponding author), Univ Oslo, Ulleval Hosp, Expt Med Res Inst, Oslo, Norway.	anne.waehre@medisin.uio.no	Nygård, Ståle/H-2148-2012; Nygård, Ståle/AGU-4330-2022	Reims, Henrik/0000-0002-2018-7787; Lipp, Martin/0000-0002-0087-2672; Attramadal, Havard/0000-0001-9506-0687; Nygard, Stale/0000-0002-5263-4748	Norwegian Research Council; Anders Jahre's Fund for the Promotion of Science; Joh. H. Andresen's Medical Fund	Norwegian Research Council(Research Council of NorwayEuropean Commission); Anders Jahre's Fund for the Promotion of Science; Joh. H. Andresen's Medical Fund	Funding: Norwegian Research Council, Anders Jahre's Fund for the Promotion of Science, Joh. H. Andresen's Medical Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amft N, 2001, ARTHRITIS RHEUM-US, V44, P2633, DOI 10.1002/1529-0131(200111)44:11<2633::AID-ART443>3.0.CO;2-9; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Aukrust P, 1999, AM J CARDIOL, V83, P376, DOI 10.1016/S0002-9149(98)00872-8; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Calvert JW, 2003, J APPL PHYSIOL, V95, P2072, DOI 10.1152/japplphysiol.00630.2003; Carlsen HS, 2002, GUT, V51, P364, DOI 10.1136/gut.51.3.364; Cyster JG, 2000, IMMUNOL REV, V176, P181; Dahl CP, 2009, CIRC-HEART FAIL, V2, P624, DOI 10.1161/CIRCHEARTFAILURE.108.821074; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; Damas JK, 2001, J AM COLL CARDIOL, V38, P187, DOI 10.1016/S0735-1097(01)01335-3; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dibbs Z, 1999, P ASSOC AM PHYSICIAN, V111, P423, DOI 10.1111/paa.1999.111.5.423; Ding B, 1999, CIRC RES, V84, P729, DOI 10.1161/01.RES.84.6.729; Djebbari A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-57; DOBNER T, 1992, EUR J IMMUNOL, V22, P2795, DOI 10.1002/eji.1830221107; Doi M, 2000, PATHOL RES PRACT, V196, P23, DOI 10.1016/S0344-0338(00)80018-7; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; FESTA ED, 2009, MULT SCLER; Finsen AV, 2005, J APPL PHYSIOL, V98, P680, DOI 10.1152/japplphysiol.00924.2004; Finsen AV, 2004, PHYSIOL GENOMICS, V16, P301, DOI 10.1152/physiolgenomics.00144.2002; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; FORSTER R, 1994, BLOOD, V84, P830; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Hocking AM, 1998, MATRIX BIOL, V17, P1; Hu CS, 2006, J IMMUNOL, V177, P6713, DOI 10.4049/jimmunol.177.10.6713; Hu CS, 2004, CELL MOL IMMUNOL, V1, P280; Husberg C, 2008, J MOL CELL CARDIOL, V45, P261, DOI 10.1016/j.yjmcc.2008.05.009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; LAURENT GJ, 1981, ANAL BIOCHEM, V113, P301, DOI 10.1016/0003-2697(81)90081-6; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Liu HJ, 1998, J CHROMATOGR A, V828, P383, DOI 10.1016/S0021-9673(98)00836-X; Mann D L, 2001, Heart Fail Rev, V6, P71, DOI 10.1023/A:1011449708842; Matsumori A, 2001, Heart Fail Rev, V6, P129; Meijer J, 2006, CANCER RES, V66, P9576, DOI 10.1158/0008-5472.CAN-06-1507; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1873; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Moser B, 2002, TRENDS IMMUNOL, V23, P250, DOI 10.1016/S1471-4906(02)02218-4; Muller G, 2003, IMMUNOL REV, V195, P117, DOI 10.1034/j.1600-065X.2003.00073.x; Muller G, 2001, BIOL CHEM, V382, P1387, DOI 10.1515/BC.2001.171; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Qiuping Zhang, 2005, Oncogene, V24, P573, DOI 10.1038/sj.onc.1208184; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; Schmutz C, 2005, ARTHRITIS RES THER, V7, pR217, DOI 10.1186/ar1475; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Singh S, 2009, INT J CANCER, V125, P2288, DOI 10.1002/ijc.24574; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TorreAmione G, 1996, CIRCULATION, V93, P704, DOI 10.1161/01.CIR.93.4.704; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyagi SC, 1998, J CELL BIOCHEM, V68, P403; Vinge LE, 2008, J BIOL CHEM, V283, P10601, DOI 10.1074/jbc.M708912200; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Woldbaek PR, 2005, AM J PHYSIOL-HEART C, V289, pH708, DOI 10.1152/ajpheart.01179.2004; Xanthou G, 2001, ARTHRITIS RHEUM-US, V44, P408; Yamamoto K, 1998, J MOL CELL CARDIOL, V30, P1749, DOI 10.1006/jmcc.1998.0737; Yamazaki T, 1998, CELL SIGNAL, V10, P693, DOI 10.1016/S0898-6568(98)00036-9	59	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18668	10.1371/journal.pone.0018668	http://dx.doi.org/10.1371/journal.pone.0018668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533157	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100011
J	Kim, SY; Ko, YJ; Jung, KW; Strain, A; Nielsen, K; Bahn, YS				Kim, Seo-Young; Ko, Young-Joon; Jung, Kwang-Woo; Strain, Anna; Nielsen, Kirsten; Bahn, Yong-Sun			Hrk1 Plays Both Hog1-Dependent and -Independent Roles in Controlling Stress Response and Antifungal Drug Resistance in Cryptococcus neoformans	PLOS ONE			English	Article							PROTEIN-KINASE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; MAP KINASE; SCHIZOSACCHAROMYCES-POMBE; ENVIRONMENTAL-STRESS; 2-COMPONENT SYSTEM; BUDDING YEAST; HOG PATHWAY	The HOG (High Osmolarity Glycerol response) pathway plays a central role in controlling stress response, ergosterol biosynthesis, virulence factor production, and differentiation of Cryptococcus neoformans, which causes fatal fungal meningoencephalitis. Recent transcriptome analysis of the HOG pathway discovered a Hog1-regulated gene (CNAG_00130.2), encoding a putative protein kinase orthologous to Rck1/2 in Saccharomyces cerevisiae and Srk1 in Schizosaccharomyces pombe. Its function is not known in C. neoformans. The present study functionally characterized the role of Hrk1 in C. neoformans. Northern blot analysis confirmed that HRK1 expression depends on the Hog1 MAPK. Similar to the hog1 Delta mutant, the hrk1 Delta mutant exhibited almost complete resistance to fludioxonil, which triggers glycerol biosynthesis via the HOG pathway. Supporting this, the hrk1 Delta mutant showed reduced intracellular glycerol accumulation and swollen cell morphology in response to fludioxonil, further suggesting that Hrk1 works downstream of the HOG pathway. However, Hrk1 also appeared to have Hog1-independent functions. Mutation of HRK1 not only further increased osmosensitivity of the hog1 Delta mutant, but also suppressed increased azole-resistance of the hog1 Delta mutant in an Erg11-independent manner. Furthermore, unlike the hog1 Delta mutant, Hrk1 was not involved in capsule biosynthesis. Hrk1 was slightly involved in melanin production but dispensable for virulence of C. neoformans. These findings suggest that Hrk1 plays both Hog1-dependent and -independent roles in stress and antifungal drug susceptibility and virulence factor production in C. neoformans. Particularly, the finding that inhibition of Hrk1 substantially increases azole drug susceptibility provides a novel strategy for combination antifungal therapy.	[Kim, Seo-Young; Ko, Young-Joon; Jung, Kwang-Woo; Bahn, Yong-Sun] Yonsei Univ, Ctr Fungal Pathogenesis, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea; [Strain, Anna; Nielsen, Kirsten] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA	Yonsei University; University of Minnesota System; University of Minnesota Twin Cities	Kim, SY (corresponding author), Yonsei Univ, Ctr Fungal Pathogenesis, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 120749, South Korea.	ysbhan@yonsei.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752; Nielsen, Kirsten/0000-0002-2318-168X	Korean government (MEST) [2010-0029117, 2008-0061963]; National Institute of Allergy and Infectious Diseases (National Institutes of Health) [AI070152]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080275, K22AI070152] Funding Source: NIH RePORTER	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); National Institute of Allergy and Infectious Diseases (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No 2010-0029117, No. 2008-0061963) (to YSB), and the National Institute of Allergy and Infectious Diseases (National Institutes of Health) K22 Grant AI070152 (to KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asp E, 2003, MOL GENET GENOMICS, V268, P585, DOI 10.1007/s00438-002-0786-y; Bahn YS, 2007, EUKARYOT CELL, V6, P2278, DOI 10.1128/EC.00349-07; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; DAHLKVIST A, 1994, GENE, V139, P27, DOI 10.1016/0378-1119(94)90519-3; DAHLKVIST A, 1995, MOL GEN GENET, V246, P316, DOI 10.1007/BF00288604; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Hicks JK, 2004, EUKARYOT CELL, V3, P14, DOI 10.1128/EC.3.1.14-26.2004; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Hughes AL, 2003, GENOME RES, V13, P794, DOI 10.1101/gr.714603; Jung KW, 2011, FUNGAL GENET BIOL, V48, P154, DOI 10.1016/j.fgb.2010.10.006; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; Lopez-Aviles S, 2008, MOL BIOL CELL, V19, P1670, DOI 10.1091/mbc.E07-07-0639; Maeng S, 2010, EUKARYOT CELL, V9, P360, DOI 10.1128/EC.00309-09; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Ramne A, 2000, MOL GEN GENET, V263, P253, DOI 10.1007/s004380051166; Sanchez-Piris M, 2002, J BIOL CHEM, V277, P17722, DOI 10.1074/jbc.M200104200; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Wemmie JA, 1997, J BIOL CHEM, V272, P7908, DOI 10.1074/jbc.272.12.7908	31	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18769	10.1371/journal.pone.0018769	http://dx.doi.org/10.1371/journal.pone.0018769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533251	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800039
J	Raposo, RAS; Thomas, B; Ridlova, G; James, W				Raposo, Rui Andre Saraiva; Thomas, Benjamin; Ridlova, Gabriela; James, William			Proteomic-Based Identification of CD4-Interacting Proteins in Human Primary Macrophages	PLOS ONE			English	Article							UBIQUITIN LIGASE ITCH; CD4 ENDOCYTOSIS; DOWN-REGULATION; MEMBRANE-PROTEINS; MASS-SPECTROMETRY; PLASMA-MEMBRANE; MULTIPROTEIN COMPLEXES; GEL-ELECTROPHORESIS; STATISTICAL-MODEL; RECEPTOR	Background: Human macrophages (M phi) express low levels of CD4 glycoprotein, which is constitutively recycled, and 40-50% of its localization is intracellular at steady-state. Although CD4-interacting proteins in lymphoid cells are well characterised, little is known about the CD4 protein interaction-network in human M phi, which notably lack LCK, a Src family protein tyrosine kinase believed to stabilise CD4 at the surface of T cells. As CD4 is the main cellular receptor used by HIV-1, knowledge of its molecular interactions is important for the understanding of viral infection strategies. Methodology/Principal Findings: We performed large-scale anti-CD4 immunoprecipitations in human primary M phi followed by high-resolution mass spectrometry analysis to elucidate the protein interaction-network involved in induced CD4 internalization and degradation. Proteomic analysis of CD4 co-immunoisolates in resting M phi showed CD4 association with a range of proteins found in the cellular cortex, membrane rafts and components of clathrin-adaptor proteins, whereas in induced internalization and degradation CD4 is associated with components of specific signal transduction, transport and the proteasome. Conclusions/Significance: This is the first time that the anti-CD4 co-immunoprecipitation sub-proteome has been analysed in human primary M phi. Our data have identified important M phi cell surface CD4-interacting proteins, as well as regulatory proteins involved in internalization and degradation. The data give valuable insights into the molecular pathways involved in the regulation of CD4 expression in M phi and provide candidates/targets for further biochemical studies.	[Thomas, Benjamin; Ridlova, Gabriela] Univ Oxford, Sir William Dunn Sch Pathol, Cent Prote Facil, Oxford OX1 3RE, England; [Raposo, Rui Andre Saraiva] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, P-4100 Oporto, Portugal	University of Oxford; Universidade do Porto	Raposo, RAS (corresponding author), Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA.	andre.saraivaraposo@path.ox.ac.uk	james, william/H-4289-2013	james, william/0000-0002-2506-1198; Raposo, R. Andre/0000-0001-5435-0290	Portuguese Foundation for Science and Technology [SFRH/BD/15903/2005]; Medical Research Council [G0401610] Funding Source: researchfish; MRC [G0401610] Funding Source: UKRI	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a PhD. grant from the Portuguese Foundation for Science and Technology to RASR (SFRH/BD/15903/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE P, 1995, CHEM PHYS LIPIDS, V77, P65, DOI 10.1016/0009-3084(95)02455-R; Bernhard OK, 2004, J AM SOC MASS SPECTR, V15, P558, DOI 10.1016/j.jasms.2003.12.006; Bernhard OK, 2004, BIOCHEMISTRY-US, V43, P256, DOI 10.1021/bi034847u; Bernhard OK, 2003, PROTEOMICS, V3, P139, DOI 10.1002/pmic.200390022; Bode G, 2008, J BIOL CHEM, V283, P31776, DOI 10.1074/jbc.M803908200; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carrascal M, 2002, PROTEOMICS, V2, P455, DOI 10.1002/1615-9861(200204)2:4<455::AID-PROT455>3.0.CO;2-E; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; COLLMAN R, 1990, J VIROL, V64, P4468, DOI 10.1128/JVI.64.9.4468-4476.1990; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Garofalo T, 1998, J BIOL CHEM, V273, P35153, DOI 10.1074/jbc.273.52.35153; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Grant SGN, 2001, TRENDS BIOTECHNOL, V19, pS49, DOI 10.1016/S0167-7799(01)01799-1; Graziani-Bowering GM, 2002, EXP CELL RES, V279, P141, DOI 10.1006/excr.2002.5581; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; HOXIE JA, 1988, J IMMUNOL, V140, P786; Husi H, 2001, J NEUROCHEM, V77, P281, DOI 10.1046/j.1471-4159.2001.t01-1-00248.x; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jin YJ, 2004, J IMMUNOL, V173, P5495, DOI 10.4049/jimmunol.173.9.5495; Jolly C, 2007, J VIROL, V81, P7873, DOI 10.1128/JVI.01845-06; Kaji K, 2001, J IMMUNOL, V166, P3256, DOI 10.4049/jimmunol.166.5.3256; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Karsten V, 1996, IMMUNOLOGY, V88, P55, DOI 10.1046/j.1365-2567.1996.d01-648.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Khati M, 2001, ARCH IMMUNOL THER EX, V49, P367; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krotov GI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1216, DOI 10.1134/S0006297907110077; Kurita-Taniguchi M, 2002, MOL IMMUNOL, V38, P689, DOI 10.1016/S0161-5890(01)00100-6; LAW SKA, 1987, EMBO J, V6, P915, DOI 10.1002/j.1460-2075.1987.tb04838.x; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Levesque K, 2003, J BIOL CHEM, V278, P28346, DOI 10.1074/jbc.M300327200; Lin Zhaosheng, 2003, J Biomol Tech, V14, P149; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lynch GW, 2006, IMMUNOL CELL BIOL, V84, P154, DOI 10.1111/j.1440-1711.2005.01403.x; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Patterson SD, 2003, NAT GENET, V33, P311, DOI 10.1038/ng1106; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; PELCHENMATTHEWS A, 1992, J CELL BIOL, V117, P279, DOI 10.1083/jcb.117.2.279; PELCHENMATTHEWS A, 1991, J EXP MED, V173, P575, DOI 10.1084/jem.173.3.575; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; PELCHENMATTHEWS A, 1995, J VIROL, V69, P8164, DOI 10.1128/JVI.69.12.8164-8168.1995; PETERSEN CM, 1992, EXP CELL RES, V201, P160, DOI 10.1016/0014-4827(92)90360-K; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Porcheray F, 2006, VIROLOGY, V349, P112, DOI 10.1016/j.virol.2006.02.031; Qi JC, 2006, BLOOD, V107, P135, DOI 10.1182/blood-2005-03-1312; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ranish JA, 2003, NAT GENET, V33, P349, DOI 10.1038/ng1101; Rappoport JZ, 2003, J BIOL CHEM, V278, P47357, DOI 10.1074/jbc.C300390200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; Schaefer MR, 2008, J IMMUNOL, V180, P7804, DOI 10.4049/jimmunol.180.12.7804; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tanaka M, 2003, VIROLOGY, V311, P316, DOI 10.1016/S0042-6822(03)00126-0; Thomas S, 2004, MOL IMMUNOL, V41, P399, DOI 10.1016/j.molimm.2004.03.022; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Walsh EP, 2002, BIOCHEMISTRY-US, V41, P2409, DOI 10.1021/bi015815e; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; ZollaPazner S, 1995, AIDS RES HUM RETROV, V11, P1449, DOI 10.1089/aid.1995.11.1449	84	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18690	10.1371/journal.pone.0018690	http://dx.doi.org/10.1371/journal.pone.0018690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533244	Green Published, gold			2022-12-25	WOS:000289458800028
J	Rajan, N; Elliott, R; Clewes, O; Mackay, A; Reis-Filho, JS; Burn, J; Langtry, J; Sieber-Blum, M; Lord, CJ; Ashworth, A				Rajan, N.; Elliott, R.; Clewes, O.; Mackay, A.; Reis-Filho, J. S.; Burn, J.; Langtry, J.; Sieber-Blum, M.; Lord, C. J.; Ashworth, A.			Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours	ONCOGENE			English	Article						cylindroma; tropomyosin receptor kinase; TRK; microarray; comparative genomic hybridization; CYLD	NF-KAPPA-B; BASAL-CELL CARCINOMAS; NERVE GROWTH-FACTOR; DEUBIQUITINATING ENZYME; NEUROTROPHIN RECEPTORS; DERMAL CYLINDROMA; BREAST CANCERS; EXPRESSION; GENE; MUTATIONS	Individuals with germline mutations in the tumour-suppressor gene CYLD are at high risk of developing disfiguring cutaneous appendageal tumours, the defining tumour being the highly organised cylindroma. Here, we analysed CYLD mutant tumour genomes by array comparative genomic hybridisation and gene expression microarray analysis. CYLD mutant tumours were characterised by an absence of copy-number aberrations apart from LOH chromosome 16q, the genomic location of the CYLD gene. Gene expression profiling of CYLD mutant tumours showed dysregulated tropomyosin kinase (TRK) signalling, with overexpression of TRKB and TRKC in tumours when compared with perilesional skin. Immunohistochemical analysis of a tumour microarray showed strong membranous TRKB and TRKC staining in cylindromas, as well as elevated levels of ERK phosphorylation and BCL2 expression. Membranous TRKC overexpression was also observed in 70% of sporadic BCCs. RNA interference-mediated silencing of TRKB and TRKC, as well as treatment with the small-molecule TRK inhibitor lestaurtinib, reduced colony formation and proliferation in 3D primary cell cultures established from CYLD mutant tumours. These results suggest that TRK inhibition could be used as a strategy to treat tumours with loss of functional CYLD. Oncogene (2011) 30, 4243-4260; doi: 10.1038/onc.2011.133; published online 9 May 2011	[Rajan, N.; Clewes, O.; Burn, J.; Sieber-Blum, M.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Elliott, R.; Mackay, A.; Reis-Filho, J. S.; Lord, C. J.; Ashworth, A.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Langtry, J.] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Newcastle University - UK	Rajan, N (corresponding author), Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	neil.rajan@ncl.ac.uk	Rajan, Neil/AAL-7702-2021; Lord, Christopher J/B-3295-2012; Lord, Christopher/AAX-7130-2021	Rajan, Neil/0000-0002-5850-5680; Lord, Christopher J/0000-0002-3226-0515; Burn, John/0000-0002-9823-2322	Newcastle Healthcare Charities Trust; North East Skin Research Fund; Breakthrough Breast Cancer; Cancer Research UK; Medical Research Council; MRC [G0701367] Funding Source: UKRI; Medical Research Council [G0701367] Funding Source: researchfish	Newcastle Healthcare Charities Trust; North East Skin Research Fund; Breakthrough Breast Cancer; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in part by grants from the Newcastle Healthcare Charities Trust, the North East Skin Research Fund, Breakthrough Breast Cancer, Cancer Research UK and the Medical Research Council. N Rajan is a MRC Clinical Training Fellow.	Adly MA, 2005, BRIT J DERMATOL, V153, P514, DOI 10.1111/j.1365-2133.2005.06763.x; Alvarez-Rodiguez R, 2007, J BIOL CHEM, V282, P37170, DOI 10.1074/jbc.M705414200; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Blasing H, 2005, ARCH DERMATOL RES, V296, P580, DOI 10.1007/s00403-005-0563-y; Bowen S, 2005, J INVEST DERMATOL, V124, P919, DOI 10.1111/j.0022-202X.2005.23688.x; BRUCKNERTUDERMAN L, 1991, J INVEST DERMATOL, V96, P729, DOI 10.1111/1523-1747.ep12470965; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; BUTTI MG, 1995, GENOMICS, V28, P15, DOI 10.1006/geno.1995.1100; Chen-Tsai CP, 2004, DERMATOL SURG, V30, P1009, DOI 10.1111/j.1524-4725.2004.30306.x; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Donovan J, 2009, DERMATOL SURG, V35, P1311, DOI 10.1111/j.1524-4725.2009.01236.x; Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85; Dutton R, 1999, CLIN EXP PHARMACOL P, V26, P746, DOI 10.1046/j.1440-1681.1999.03108.x; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2008, BIOCHEM BIOPH RES CO, V374, P33, DOI 10.1016/j.bbrc.2008.06.082; GERRETSEN AL, 1993, CANCER-AM CANCER SOC, V72, P1618, DOI 10.1002/1097-0142(19930901)72:5<1618::AID-CNCR2820720521>3.0.CO;2-5; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Hellerbrand C, 2007, CARCINOGENESIS, V28, P21, DOI 10.1093/carcin/bgl081; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; *ILL INC, 2009, BEADST GEN EXPR MOD; Jenner MW, 2007, BLOOD, V110, P3291, DOI 10.1182/blood-2007-02-075069; Jin W, 2007, CANCER RES, V67, P9869, DOI 10.1158/0008-5472.CAN-07-0436; Kavanagh DO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-1; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kikuno N, 2008, INT J CANCER, V123, P552, DOI 10.1002/ijc.23590; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kriegl L, 2009, BRIT J DERMATOL, V160, P1353, DOI 10.1111/j.1365-2133.2009.09144.x; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Marchio C, 2008, J PATHOL, V216, P399, DOI 10.1002/path.2423; Marshall JL, 2005, INVEST NEW DRUG, V23, P31, DOI 10.1023/B:DRUG.0000047103.64335.b0; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; MATSUMOTO K, 1995, CANCER RES, V55, P1798; Meybehm M, 1997, AM J DERMATOPATH, V19, P154, DOI 10.1097/00000372-199704000-00009; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oosterkamp HM, 2006, BRIT J DERMATOL, V155, P182, DOI 10.1111/j.1365-2133.2006.07224.x; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Rajan N, 2009, ARCH DERMATOL, V145, P1277, DOI 10.1001/archdermatol.2009.262; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Saggar S, 2008, J MED GENET, V45, P298, DOI 10.1136/jmg.2007.056127; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Saini HS, 2004, J NEUROCHEM, V89, P951, DOI 10.1111/j.1471-4159.2004.02365.x; Scala S, 1996, CANCER RES, V56, P3737; Shabbir M, 2010, EXPERT OPIN INV DRUG, V19, P427, DOI 10.1517/13543781003598862; Stegmeier F, 2007, P NATL ACAD SCI USA, V104, P8869, DOI 10.1073/pnas.0703268104; Stokes A, 2006, CELL SIGNAL, V18, P1584, DOI 10.1016/j.cellsig.2005.12.009; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Teh MT, 2005, CANCER RES, V65, P8597, DOI 10.1158/0008-5472.CAN-05-0842; TELLECHEA O, 1995, AM J DERMATOPATH, V17, P260, DOI 10.1097/00000372-199506000-00008; Thress K, 2009, MOL CANCER THER, V8, P1818, DOI 10.1158/1535-7163.MCT-09-0036; TIMPL R, 1984, CIBA F SYMP, V108, P25; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Trompouki E, 2009, NEOPLASIA, V11, P469, DOI 10.1593/neo.81424; Tunggal L, 2002, AM J PATHOL, V160, P459, DOI 10.1016/S0002-9440(10)64865-1; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Weeraratna AT, 2000, PROSTATE, V45, P140, DOI 10.1002/1097-0045(20001001)45:2<140::AID-PROS8>3.0.CO;2-#; WORKMAN C, 2002, GENOME BIOL, V0003; Wu CB, 2007, TRAFFIC, V8, P1503, DOI 10.1111/j.1600-0854.2007.00636.x; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	78	40	40	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	41					4243	4260		10.1038/onc.2011.133	http://dx.doi.org/10.1038/onc.2011.133			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HO	21552290	Green Accepted			2022-12-25	WOS:000296356300003
J	Urayama, A; Morales, R; Niehoff, ML; Banks, WA; Soto, C				Urayama, Akihiko; Morales, Rodrigo; Niehoff, Michael L.; Banks, William A.; Soto, Claudio			Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake	FASEB JOURNAL			English	Article						PrPSc; pharmacokinetics; blood-brain barrier	BLOOD-BRAIN-BARRIER; RECEPTOR-MEDIATED TRANSPORT; CYCLIC AMPLIFICATION; PRESYMPTOMATIC DETECTION; SCRAPIE INFECTIVITY; LYSOSOMAL-ENZYME; PROTEIN; NEUROINVASION; PERMEABILITY; REPLICATION	Prion diseases are infectious neurodegenerative disorders associated with the misfolded prion protein (PrPSc), which appears to be the sole component of the infectious agent (termed prion). To produce disease, prions have to be absorbed into the body and reach sufficient quantities in the brain. Very little is known about the biological mechanisms controlling the initial fate of prions. Here, we studied the systemic pharmacokinetics and biodistribution of PrPSc in vivo. After an intravenous injection of highly purified radiolabeled or native unlabeled PrPSc, the protein was eliminated rapidly from the serum (half-life of 3.24 h), mostly through tissue uptake. The quantity of intact PrPSc reaching the brain was similar to 0.2% of the injected dose per gram of brain tissue (ID/g). The highest levels were found in liver (similar to 20% ID/g), spleen (similar to 13% ID/g), and kidney (similar to 7.4% ID/g). Cell surface PrPC does not appear to play a role in PrPSc pharmacokinetics, since the infectious protein distributed similarly in wild-type and PrP-null mice. To measure tissue uptake kinetics and biodistribution accurately, vascular space in tissues was measured with radioactively labeled albumin coinjected with radioactively labeled PrPSc. Our results provide a fundamental pharmacokinetic characterization of PrPSc in vivo, which may be relevant to estimate tissue risks and mechanisms of prion neuroinvasion and to identify novel therapeutic strategies.-Urayama, A., Morales, R., Niehoff, M. L., Banks, W. A., Soto, C. Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake FASEB J. 25, 2792-2803 (2011). www.fasebj.org	[Urayama, Akihiko; Morales, Rodrigo; Soto, Claudio] Univ Texas Houston, Med Sch Houston, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA; [Niehoff, Michael L.] Vet Affairs Med Ctr St Louis, GRECC, St Louis, MO USA; [Niehoff, Michael L.] St Louis Univ, Sch Med, Dept Internal Med, Div Geriatr, St Louis, MO USA; [Banks, William A.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA USA; [Banks, William A.] Univ Washington, Sch Med, Dept Internal Med, Div Gerontol & Geriatr Med, Seattle, WA USA	University of Texas System; University of Texas Health Science Center Houston; Geriatric Research Education & Clinical Center; Saint Louis University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Urayama, A (corresponding author), Univ Texas Houston, Med Sch Houston, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, MSE R468,6431 Fannin St, Houston, TX 77030 USA.	akihiko.urayama@uth.tmc.edu; claudio.soto@uth.tmc.edu	Morales, Rodrigo/K-7173-2015; Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	U.S. National Institutes of Health [R01 NS050547, P01 AI77774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050547] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by U.S. National Institutes of Health grant R01 NS050547 (to W.A.B. and C.S.) and P01 AI77774 (to C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.U. designed the study, performed the bulk of the experiments, analyzed all data, wrote the manuscript, and managed the peer review process. R.M.L. helped on the characterization of iodinated PrP<SUP>Sc</SUP>. M.L.N. contributed to HPLC analysis. W.A.B. analyzed all data and critically reviewed the manuscript. C.S. developed the hypothesis, wrote the manuscript, and supervised the entire research project and the peer review process.	Aguzzi A, 2003, BRIT MED BULL, V66, P141, DOI 10.1093/bmb/66.1.141; Aguzzi A, 1997, LANCET, V349, P742, DOI 10.1016/S0140-6736(97)22011-8; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; ALLEN L, 1982, J CLIN PHARMACOL, V22, pS1; Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Baldauf E, 1997, J GEN VIROL, V78, P1187, DOI 10.1099/0022-1317-78-5-1187; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Banks WA, 2004, BIOCHEM BIOPH RES CO, V318, P125, DOI 10.1016/j.bbrc.2004.04.009; Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; Banks WA, 2001, PSYCHONEUROIMMUNOLOG, V2, P483; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; BOLTON DC, 1985, J VIROL, V53, P596, DOI 10.1128/JVI.53.2.596-606.1985; Bolton DC, 1998, J GEN VIROL, V79, P2557, DOI 10.1099/0022-1317-79-10-2557; Brandner S, 2000, EXP PHYSIOL, V85, P705, DOI 10.1111/j.1469-445X.2000.02091.x; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Brown P, 2005, VOX SANG, V89, P63, DOI 10.1111/j.1423-0410.2005.00683.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; DEDRICK RL, 1973, BIOCHEM PHARMACOL, V22, P2405, DOI 10.1016/0006-2952(73)90342-0; DIRINGER H, 1983, NATURE, V306, P476, DOI 10.1038/306476a0; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; GITLIN D, 1958, NATURE, V181, P1064, DOI 10.1038/1811064b0; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; Kruger D, 2009, VET RES, V40, DOI 10.1051/vetres:2008042; Luhr KM, 2002, J VIROL, V76, P12259, DOI 10.1128/JVI.76.23.12259-12264.2002; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; Poduslo JF, 1999, NEUROBIOL DIS, V6, P190, DOI 10.1006/nbdi.1999.0238; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Rodriguez EM, 2010, PEPTIDES, V31, P757, DOI 10.1016/j.peptides.2010.01.003; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scherbel C, 2006, VET RES, V37, P695, DOI 10.1051/vetres:2006024; SISO S, 2010, INTERDISCIP PERSPECT, P747; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Urayama A, 2004, P NATL ACAD SCI USA, V101, P12658, DOI 10.1073/pnas.0405042101; Urayama A, 2007, P NATL ACAD SCI USA, V104, P12873, DOI 10.1073/pnas.0705611104; ZLOKOVIC BV, 1993, BIOCHEM BIOPH RES CO, V197, P1034, DOI 10.1006/bbrc.1993.2582	51	13	13	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2792	2803		10.1096/fj.11-180729	http://dx.doi.org/10.1096/fj.11-180729			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21555356	Green Published			2022-12-25	WOS:000293337800027
J	Pavlyukov, MS; Antipova, NV; Balashova, MV; Vinogradova, TV; Kopantzev, EP; Shakhparonov, MI				Pavlyukov, Marat S.; Antipova, Nadezhda V.; Balashova, Maria V.; Vinogradova, Tatjana V.; Kopantzev, Evgenij P.; Shakhparonov, Mihail I.			Survivin Monomer Plays an Essential Role in Apoptosis Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; MICROTUBULE DYNAMICS; INHIBITS APOPTOSIS; MEDIATED APOPTOSIS; CRYSTAL-STRUCTURE; NUCLEAR EXPORT; CELL-CYCLE; CANCER; SMAC/DIABLO; ACTIVATION	Survivin was initially described as an inhibitor of apoptosis and attracted growing attention as one of the most tumor-specific genes in the human genome and a promising target for cancer therapy. Lately, it has been shown that survivin is a multifunctional protein that takes part in several crucial cell processes. At first, it was supposed that survivin functions only as a homodimer, but now data indicate that many processes require monomeric survivin. Moreover, recent studies reveal a special mechanism regulating the balance between monomeric and dimeric forms of the protein. In this paper we studied the mutant form of survivin that was unable to dimerize and investigated its role in apoptosis. We showed that survivin monomer interacts with Smac/DIABLO and X-linked inhibitor of apoptosis protein (XIAP) both in vitro and in vivo. Due to this feature, it protects cells from caspase-dependent apoptosis even more efficiently than the wild-type survivin. We also identified that mutant monomeric survivin prevents apoptosis-inducing factor release from the mitochondrial intermembrane space, protecting human fibrosarcoma HT1080 cells from caspase-independent apoptosis. On the other hand, our results indicate that only wild-type survivin, but not the monomer mutant form, enhances tubulin stability in cells. These findings suggest that survivin partly performs its functions as a monomer and partly as a dimer. The mechanism of dimer-monomer balance regulation may also work as a "switcher" between survivin functions and thereby explain remarkable functional diversities of this protein.	[Pavlyukov, Marat S.; Antipova, Nadezhda V.; Balashova, Maria V.; Vinogradova, Tatjana V.; Kopantzev, Evgenij P.; Shakhparonov, Mihail I.] Shemiakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Shakhparonov, MI (corresponding author), Ul Marshala Timoshenko 36, Moscow 121359, Russia.	shakhparonov.m@mail.ru	Pavlyukov, Marat S/ABB-6791-2021; Shakhparonov, Mikhail I/E-8377-2014; Pavlyukov, Marat S/E-7314-2014; Antipova, Nadine/E-7356-2014	Antipova, Nadine/0000-0002-5799-7767	presidium of Russian Academy of Science [2395.2008.4]; Department of Education and Science of Russian Federation [2007-02-2.2-05-01-006]; Russian Foundation for Basic Research [10-04-01206]; Fund for Assistance to Innovative Enterprises (FASIE)	presidium of Russian Academy of Science(Russian Academy of Sciences); Department of Education and Science of Russian Federation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Fund for Assistance to Innovative Enterprises (FASIE)	This work was supported by President Grant 2395.2008.4 for Scientific Schools, a grant from the Basic Research Program (Physico-Chemical Biology) of the presidium of Russian Academy of Science, Federal Program of the Department of Education and Science of Russian Federation Grant 2007-02-2.2-05-01-006, Russian Foundation for Basic Research (grant 10-04-01206), and by the Fund for Assistance to Innovative Enterprises (FASIE).	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Chan KS, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.34; Chantalat L, 2000, MOL CELL, V6, P183, DOI 10.1016/S1097-2765(00)00019-8; Chen JT, 2008, AM J RESP CELL MOL, V38, P559, DOI 10.1165/rcmb.2007-0001OC; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Engelsma D, 2007, TRAFFIC, V8, P1495, DOI 10.1111/j.1600-0854.2007.00629.x; Fortugno P, 2002, J CELL SCI, V115, P575; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Henkels KM, 1999, CANCER RES, V59, P3077; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; King MA, 2007, CYTOM PART A, V71A, P668, DOI 10.1002/cyto.a.20428; Lens SMA, 2003, CELL CYCLE, V2, P507, DOI 10.4161/cc.2.6.559; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liu T, 2004, ONCOGENE, V23, P39, DOI 10.1038/sj.onc.1206978; Liu T, 2006, J INVEST DERMATOL, V126, P2247, DOI 10.1038/sj.jid.5700381; McNeish IA, 2005, EXP CELL RES, V302, P69, DOI 10.1016/j.yexcr.2004.08.029; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Norberg E, 2010, EMBO J, V29, P3869, DOI 10.1038/emboj.2010.253; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pei YH, 2007, APOPTOSIS, V12, P1681, DOI 10.1007/s10495-007-0091-7; Rajalingam K, 2007, APOPTOSIS, V12, P1503, DOI 10.1007/s10495-007-0067-7; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Song ZY, 2004, MOL BIOL CELL, V15, P1287, DOI 10.1091/mbc.E03-07-0512; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wang HJ, 2010, J BIOL CHEM, V285, P36129, DOI 10.1074/jbc.M110.152777; Watanabe A, 2009, HUM REPROD, V24, P3172, DOI 10.1093/humrep/dep305; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; Wendt MD, 2007, BIOORG MED CHEM LETT, V17, P3122, DOI 10.1016/j.bmcl.2007.03.042; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223	42	61	69	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23296	23307		10.1074/jbc.M111.237586	http://dx.doi.org/10.1074/jbc.M111.237586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536684	Green Published, hybrid			2022-12-25	WOS:000292025000062
J	Liu, ZF; Bryant, DA				Liu, Zhenfeng; Bryant, Donald A.			Identification of a Gene Essential for the First Committed Step in the Biosynthesis of Bacteriochlorophyll c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROBIUM-TEPIDUM CHLOROSOMES; C-20 METHYLTRANSFERASE; REACTION CENTERS; CHLOROPHYLL; REDUCTASE; LIGHT; BCHU; INACTIVATION; AGGREGATION; BACTERIA	Bacteriochlorophylls (BChls) c, d, and e are the major chlorophylls in chlorosomes, which are the largest and one of the most efficient antennae produced by chlorophototrophic organisms. In the biosynthesis of these three BChls, a C-13(2)-methylcarboxyl group found in all other chlorophylls (Chls) must be removed. This reaction is postulated to be the first committed step in the synthesis of these BChls. Analyses of gene neighborhoods of (B)Chl biosynthesis genes and distribution patterns in organisms producing chlorosomes helped to identify a gene (bciC) that appeared to be a good candidate to produce the enzyme involved in this biochemical reaction. To confirm that this was the case, a deletion mutant of an open reading frame orthologous to bciC, CT1077, was constructed in Chlorobaculum tepidum, a genetically tractible green sulfur bacterium. The CT1077 deletion mutant was unable to synthesize BChl c but still synthesized BChl a and Chl a. The deletion mutant accumulated large amounts of various (bacterio)pheophorbides, all of which still had C-13(2)-methylcarboxyl groups. A C. tepidum strain in which CT1077 was replaced by an orthologous gene, Cabther_B0031 from "Candidatus Chloracidobacterium thermophilum" was constructed. Although the product of Cabther_B0031 was only 28% identical to the product of CT1077, this strain synthesized BChl c, BChl a, and Chl a in amounts similar to wild-type C. tepidum cells. To indicate their roles in the first committed step of BChl c, d, and e biosynthesis, open reading frames CT1077 and Cabther_B0031 have been redesignated bciC. The potential mechanism by which BciC removes the C-13(2)-methylcarboxyl moiety of chlorophyllide a is discussed.	[Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Althouse Lab 108, University Pk, PA 16802 USA.	dab14@psu.edu	Liu, Zhenfeng/B-8252-2015	Liu, Zhenfeng/0000-0001-5892-6429	United States Department of Energy [DE-FG02-94ER20137]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FG02-94ER20137 (to D. A. B.).	Airs RL, 2000, RAPID COMMUN MASS SP, V14, P125, DOI 10.1002/(SICI)1097-0231(20000215)14:3&lt;125::AID-RCM847&gt;3.0.CO;2-6; Beatty JT, 2005, P NATL ACAD SCI USA, V102, P9306, DOI 10.1073/pnas.0503674102; Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, V2, P399, DOI DOI 10.1007/0-306-47954-0; Bryant DA, 2002, BIOCHEMISTRY-US, V41, P14403, DOI 10.1021/bi026599s; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Chew AGM, 2004, PHOTOSYNTHESIS FUNDA, P875; Chew AGM, 2008, J BACTERIOL, V190, P747, DOI 10.1128/JB.01430-07; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Frigaard NU, 2002, J BACTERIOL, V184, P3368, DOI 10.1128/JB.184.12.3368-3376.2002; Frigaard NU, 2001, APPL ENVIRON MICROB, V67, P2538, DOI 10.1128/AEM.67.6.2538-2544.2001; Ganapathy S, 2009, P NATL ACAD SCI USA, V106, P8525, DOI 10.1073/pnas.0903534106; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; Harada J, 2005, FEBS LETT, V579, P1983, DOI 10.1016/j.febslet.2005.01.087; Harada J, 2008, PHOTOCH PHOTOBIO SCI, V7, P1179, DOI 10.1039/b802435a; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; KATZ JJ, 1975, PORPHYRINS METALLOPO, P399; KEELY BJ, 1990, ENERG FUEL, V4, P737, DOI 10.1021/ef00024a020; Kunieda M, 2004, PHOTOCHEM PHOTOBIOL, V79, P55, DOI 10.1111/j.1751-1097.2004.tb09857.x; Manske AK, 2005, APPL ENVIRON MICROB, V71, P8049, DOI 10.1128/AEM.71.12.8049-8060.2005; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Maresca JA, 2004, J BACTERIOL, V186, P2558, DOI 10.1128/JB.186.9.2558-2566.2004; Maresca JA, 2006, J BACTERIOL, V188, P6217, DOI 10.1128/JB.00766-06; MEYER M, 1995, PHOTOSYNTH RES, V44, P55, DOI 10.1007/BF00018296; Montano GA, 2003, BIOPHYS J, V85, P2560, DOI 10.1016/S0006-3495(03)74678-5; Oostergetel GT, 2007, FEBS LETT, V581, P5435, DOI 10.1016/j.febslet.2007.10.045; Pedersen MO, 2008, BIOCHEMISTRY-US, V47, P1435, DOI 10.1021/bi701616r; Sadekar S, 2006, MOL BIOL EVOL, V23, P2001, DOI 10.1093/molbev/msl079; Saga Y, 2004, J PHOTOCH PHOTOBIO B, V75, P89, DOI 10.1016/j.jphotobiol.2004.05.012; Scheer Hugo, 2006, V25, P1; SCHOCH S, 1981, Z NATURFORSCH C, V36, P827; Steensgaard DB, 2000, J PHYS CHEM B, V104, P10379, DOI 10.1021/jp0013356; Suzuki Y, 2006, PLANT PHYSIOL, V140, P716, DOI 10.1104/pp.105.071290; Suzuki Y, 2002, PHOTOSYNTH RES, V74, P225, DOI 10.1023/A:1020919929608; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Wada K, 2006, J MOL BIOL, V360, P839, DOI 10.1016/j.jmb.2006.05.057	40	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22393	22402		10.1074/jbc.M111.249433	http://dx.doi.org/10.1074/jbc.M111.249433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21550979	Green Published, hybrid			2022-12-25	WOS:000291719900049
J	Kobayashi, S; Tateno, M; Park, TW; Utsumi, K; Sohma, H; Ito, YM; Kokai, Y; Saito, T				Kobayashi, Seiju; Tateno, Masaru; Park, Tae Woo; Utsumi, Kumiko; Sohma, Hitoshi; Ito, Yoichi M.; Kokai, Yasuo; Saito, Toshikazu			Apolipoprotein E4 Frequencies in a Japanese Population with Alzheimer's Disease and Dementia with Lewy Bodies	PLOS ONE			English	Article							BRAIN PERFUSION SPECT; SCORE IMAGING-SYSTEM; E ALLELE EPSILON-4; BODY DISEASE; VASCULAR DEMENTIA; E GENOTYPE; E GENE; ONSET; DIAGNOSIS; AGE	Background: The apolipoprotein E (APOE) epsilon 4 allele has been reported to be a risk factor for Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Previous neuropathological studies have demonstrated similar frequencies of the APOE epsilon 4 allele in AD and DLB. However, the few ante-mortem studies on APOE allele frequencies in DLB have shown lower frequencies than post-mortem studies. One reason for this may be inaccuracy of diagnosis. We examined APOE genotypes in subjects with AD, DLB, and a control group using the latest diagnostic criteria and MRI, SPECT, and MIBG myocardial scintigraphy. Methods: The subjects of this study consisted of 145 patients with probable AD, 50 subjects with probable DLB, and a control group. AD subjects were divided into two groups based on age of onset: early onset AD (EOAD) and late onset AD (LOAD). All subjects had characteristic features on MRI, SPECT, and/or myocardial scintigraphy. Results: The rate of APOE4 carrier status was 18.3% and the frequency of the epsilon 4 allele was 9.7% in controls. The rate of APOE4 carrier status and the frequency of the epsilon 4 allele were 47% and 27% for LOAD, 50% and 31% for EOAD, and 42% and 31% for DLB, respectively. Conclusion: The APOE4 genotypes in this study are consistent with previous neuropathological studies suggesting accurate diagnosis of AD and DLB. APOE4 genotypes were similar in AD and DLB, giving further evidence that the epsilon 4 allele is a risk factor for both disorders.	[Kobayashi, Seiju; Tateno, Masaru; Park, Tae Woo; Saito, Toshikazu] Sapporo Med Univ, Dept Neuropsychiat, Sch Med, Sapporo, Hokkaido, Japan; [Utsumi, Kumiko] Sunagawa City Med Ctr, Dept Psychiat, Sunagawa, Japan; [Sohma, Hitoshi] Sapporo Med Univ, Dept Educ Dev, Ctr Med Educ, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Hokkaido Org Translat Res, Sapporo, Hokkaido, Japan; [Sohma, Hitoshi; Kokai, Yasuo] Sapporo Med Univ, Dept Biomed Engn, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Hokkaido University; Sapporo Medical University	Kobayashi, S (corresponding author), Sapporo Med Univ, Dept Neuropsychiat, Sch Med, Sapporo, Hokkaido, Japan.	seij@pastel.ocn.ne.jp	Ito, Yoichi/E-2042-2012	Ito, Yoichi M./0000-0001-5073-0827	Japan Society for the Promotion of Science (JSPS) [MT:22791134]; Ministry of Education, Sports, Science and Technology (MEXT); Grants-in-Aid for Scientific Research [22791134, 22791133] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in-Aid for Young Scientists (B)(MT:22791134) from the Japan Society for the Promotion of Science (JSPS) and Sapporo Biocluster "Bio-S", the Regional Innovation Cluster Program of the Ministry of Education, Sports, Science and Technology (MEXT). JSPS http://www.jsps.go.jp/english/. MEXT http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKATSUHIROYASU K, 2004, PSYCHOGERIATRICS, V4, P8; ARAI H, 1994, LANCET, V344, P1307, DOI 10.1016/S0140-6736(94)90799-4; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Garcia FC, 2008, NEUROLOGIA, V23, P152; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cummings JL, 2000, NEUROBIOL AGING, V21, P845, DOI 10.1016/S0197-4580(00)00183-4; DAI XY, 1994, NEUROSCI LETT, V175, P74, DOI 10.1016/0304-3940(94)91081-2; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Engelborghs S, 2003, J NEUROL NEUROSUR PS, V74, P1148, DOI 10.1136/jnnp.74.8.1148; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fujimori M, 1998, ALZ DIS ASSOC DIS, V12, P163, DOI 10.1097/00002093-199809000-00007; GALASKO D, 1994, NEUROLOGY, V44, P1950, DOI 10.1212/WNL.44.10.1950; HIXSON JE, 1990, J LIPID RES, V31, P545; Imamura T, 1998, NEUROPSYCHOLOGIA, V36, P945, DOI 10.1016/S0028-3932(98)00010-4; Ishii K, 1997, BRAIN RES, V748, P250, DOI 10.1016/S0006-8993(96)01363-7; JACOBS D, 1994, NEUROLOGY, V44, P1215, DOI 10.1212/WNL.44.7.1215; KAWAMATA J, 1994, J NEUROL NEUROSUR PS, V57, P1414, DOI 10.1136/jnnp.57.11.1414; Kawanishi C, 1996, J NEUROL SCI, V136, P140, DOI 10.1016/0022-510X(95)00312-P; Kobayashi S, 2008, J NEUROL SCI, V264, P27, DOI 10.1016/j.jns.2007.07.015; Kobayashi S, 2009, DEMENT GERIATR COGN, V28, P330, DOI 10.1159/000251935; Kobayashi S, 2009, PSYCHIAT RES-NEUROIM, V174, P76, DOI 10.1016/j.pscychresns.2009.02.006; KOSAKA K, 1990, J NEUROL, V237, P197, DOI 10.1007/BF00314594; Lane R, 2009, MOVEMENT DISORD, V24, P392, DOI 10.1002/mds.22357; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Matsuda Hiroshi, 2010, Brain and Nerve (Tokyo), V62, P743; Matsuda Hiroshi, 2007, Brain and Nerve (Tokyo), V59, P487; McKeith I, 1999, AUST NZ J PSYCHIAT, V33, P800, DOI 10.1046/j.1440-1614.1999.00650.x; MCKEITH I, 1992, BRIT MED J, V305, P673, DOI 10.1136/bmj.305.6855.673; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; OKUIZUMI K, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10b; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Singleton AB, 2002, DEMENT GERIATR COGN, V14, P167, DOI 10.1159/000066022; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Takeuchi Ryo, 2006, Radiat Med, V24, P538, DOI 10.1007/s11604-006-0054-x; Tateno M, 2008, DEMENT GERIATR COGN, V26, P453, DOI 10.1159/000165918; Tateno M, 2008, PROG NEURO-PSYCHOPH, V32, P1206, DOI 10.1016/j.pnpbp.2008.03.006; Tateno M, 2009, PSYCHIAT INVEST, V6, P233, DOI 10.4306/pi.2009.6.4.233; UEKI A, 1993, NEUROSCI LETT, V163, P166, DOI 10.1016/0304-3940(93)90373-S; Yamaguchi M, 2010, J NEUROSCI RES, V88, P2682, DOI 10.1002/jnr.22427; Yamanaka H, 1998, NEUROBIOL AGING, V19, pS43, DOI 10.1016/S0197-4580(98)00035-9	41	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18569	10.1371/journal.pone.0018569	http://dx.doi.org/10.1371/journal.pone.0018569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552550	gold, Green Published, Green Submitted			2022-12-25	WOS:000290020700001
J	Wang, XW; Zhong, PY; Luo, PP; Wang, KC				Wang, Xinwei; Zhong, Pinyu; Luo, Peter P.; Wang, Kevin C.			Antibody Engineering Using Phage Display with a Coiled-Coil Heterodimeric Fv Antibody Fragment	PLOS ONE			English	Article							SINGLE-CHAIN FV; FUNCTIONAL GABA(B) RECEPTOR; IN-VIVO; CRYSTAL-STRUCTURE; VARIABLE DOMAINS; FAB FRAGMENT; LIBRARIES; SELECTION; RESIDUES; AFFINITY	A Fab-like antibody binding unit, ccFv, in which a pair of heterodimeric coiled-coil domains was fused to V-H and V-L for Fv stabilization, was constructed for an anti-VEGF antibody. The anti-VEGF ccFv showed the same binding affinity as scFv but significantly improved stability and phage display level. Furthermore, phage display libraries in the ccFv format were constructed for humanization and affinity maturation of the anti-VEGF antibody. A panel of V-H frameworks and V-H-CDR3 variants, with a significant improvement in affinity and expressibility in both E. coli and yeast systems, was isolated from the ccFv phage libraries. These results demonstrate the potential application of the ccFv antibody format in antibody engineering.	[Wang, Xinwei; Zhong, Pinyu; Luo, Peter P.; Wang, Kevin C.] Merck & Co Inc, Merck Res Labs, Biol Discovery, Palo Alto, CA USA	Merck & Company	Wang, XW (corresponding author), MedImmune, Gaithersburg, MD USA.	kevin_wang@merck.com						Arndt KM, 1998, BIOCHEMISTRY-US, V37, P12918, DOI 10.1021/bi9810407; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Arndt KM, 2001, J MOL BIOL, V312, P221, DOI 10.1006/jmbi.2001.4915; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; de Haard HJW, 1998, PROTEIN ENG, V11, P1267, DOI 10.1093/protein/11.12.1267; Honegger A, 2009, PROTEIN ENG DES SEL, V22, P121, DOI 10.1093/protein/gzn077; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jung S, 2001, J MOL BIOL, V309, P701, DOI 10.1006/jmbi.2001.4665; Kammerer RA, 1999, BIOCHEMISTRY-US, V38, P13263, DOI 10.1021/bi991018t; Kim KJ, 1992, GROWTH FACTORS, V7, P53, DOI 10.3109/08977199209023937; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kipriyanov SM, 1997, PROTEIN ENG, V10, P445, DOI 10.1093/protein/10.4.445; Kontermann RE, 2010, CURR OPIN MOL THER, V12, P176; KORTT AA, 1994, EUR J BIOCHEM, V221, P151, DOI 10.1111/j.1432-1033.1994.tb18724.x; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LUO P, 2003, Patent No. 2003099999; Muller KM, 2000, METHOD ENZYMOL, V328, P261; Nelson AL, 2010, MABS-AUSTIN, V2, P77, DOI 10.4161/mabs.2.1.10786; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683, DOI 10.1038/10897; Presta LG, 1997, CANCER RES, V57, P4593; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; WANG C, 2003, Patent No. 6833441; WANG C, 2003, Patent No. 2003012069; Wang KC, 2010, J MOL BIOL, V395, P1088, DOI 10.1016/j.jmb.2009.11.068; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	29	5	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19023	10.1371/journal.pone.0019023	http://dx.doi.org/10.1371/journal.pone.0019023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552519	Green Submitted, Green Published, gold			2022-12-25	WOS:000290020700016
J	O'Reilly, AJ; Dacks, JB; Field, MC				O'Reilly, Amanda J.; Dacks, Joel B.; Field, Mark C.			Evolution of the Karyopherin-beta Family of Nucleocytoplasmic Transport Factors; Ancient Origins and Continued Specialization	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; MULTIPLE SEQUENCE ALIGNMENT; IMPORTIN-BETA; MOLECULAR ARCHITECTURE; TRICHOMONAS-VAGINALIS; TRANSCRIPTION FACTORS; BINDING PROTEIN; EXPORT PATHWAY; GAP PENALTIES; TRAFFICKING	Background: Macromolecular transport across the nuclear envelope (NE) is achieved through nuclear pore complexes (NPCs) and requires karyopherin-beta s (KAP-beta s), a family of soluble receptors, for recognition of embedded transport signals within cargo. We recently demonstrated, through proteomic analysis of trypanosomes, that NPC architecture is likely highly conserved across the Eukaryota, which in turn suggests conservation of the transport mechanisms. To determine if KAP-beta diversity was similarly established early in eukaryotic evolution or if it was subsequently layered onto a conserved NPC, we chose to identify KAP-beta sequences in a diverse range of eukaryotes and to investigate their evolutionary history. Results: Thirty six predicted proteomes were scanned for candidate KAP-beta family members. These resulting sequences were resolved into fifteen KAP-beta subfamilies which, due to broad supergroup representation, were most likely represented in the last eukaryotic common ancestor (LECA). Candidate members of each KAP-beta subfamily were found in all eukaryotic supergroups, except XPO6, which is absent from Archaeplastida. Phylogenetic reconstruction revealed the likely evolutionary relationships between these different subfamilies. Many species contain more than one representative of each KAP-beta subfamily; many duplications are apparently taxon-specific but others result from duplications occurring earlier in eukaryotic history. Conclusions: At least fifteen KAP-beta subfamilies were established early in eukaryote evolution and likely before the LECA. In addition we identified expansions at multiple stages within eukaryote evolution, including a multicellular plant-specific KAP-beta, together with frequent secondary losses. Taken with evidence for early establishment of NPC architecture, these data demonstrate that multiple pathways for nucleocytoplasmic transport were established prior to the radiation of modern eukaryotes but that selective pressure continues to sculpt the KAP-beta family.	[O'Reilly, Amanda J.; Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada	University of Cambridge; University of Alberta	O'Reilly, AJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mcf34@cam.ac.uk	Dacks, Joel/AAE-3308-2021; Field, Mark/AAD-6455-2021	Dacks, Joel/0000-0003-4520-5694; Field, Mark/0000-0002-4866-2885	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by the Wellcome Trust. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Calado A, 2002, EMBO J, V21, P6216, DOI 10.1093/emboj/cdf620; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Dacks JB, 2005, J EUKARYOT MICROBIOL, V52, p7S; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Field MC, 2007, ADV EXP MED BIOL, V607, P84; Field MC, 2009, CURR OPIN CELL BIOL, V21, P4, DOI 10.1016/j.ceb.2008.12.004; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frankel MB, 2009, DNA CELL BIOL, V28, P277, DOI 10.1089/dna.2009.0853; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Lal K, 2005, MOL BIOCHEM PARASIT, V143, P226, DOI 10.1016/j.molbiopara.2005.06.008; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mans BJ, 2004, CELL CYCLE, V3, P1612; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; Meier I, 2005, INT REV CYTOL, V244, P95, DOI 10.1016/S0074-7696(05)44003-6; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241; Nevin WD, 2009, PARASITOL INT, V58, P86, DOI 10.1016/j.parint.2008.12.002; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pemberton LF, 1997, J CELL BIOL, V139, P1645, DOI 10.1083/jcb.139.7.1645; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Ploski JE, 2004, MOL CELL BIOL, V24, P4824, DOI 10.1128/MCB.24.11.4824-4834.2004; Quan Y, 2008, MOL CELL PROTEOMICS, V7, P1254, DOI 10.1074/mcp.M700511-MCP200; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roger AJ, 2009, CURR BIOL, V19, pR165, DOI 10.1016/j.cub.2008.12.032; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Strom AC, 2001, GENOME BIOL, V2; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Sydorskyy Y, 2003, MOL CELL BIOL, V23, P2042, DOI 10.1128/MCB.23.6.2042-2054.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Titov AA, 1999, J CELL BIOL, V147, P235, DOI 10.1083/jcb.147.2.235; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; Wild T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000522; Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729; Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125	85	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19308	10.1371/journal.pone.0019308	http://dx.doi.org/10.1371/journal.pone.0019308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556326	gold, Green Submitted, Green Published			2022-12-25	WOS:000290019400049
J	Bjorge, JD; Pang, AS; Funnell, M; Chen, KY; Diaz, R; Magliocco, AM; Fujita, DJ				Bjorge, Jeffrey D.; Pang, Andy S.; Funnell, Melanie; Chen, Ke Yun; Diaz, Roman; Magliocco, Anthony M.; Fujita, Donald J.			Simultaneous siRNA Targeting of Src and Downstream Signaling Molecules Inhibit Tumor Formation and Metastasis of a Human Model Breast Cancer Cell Line	PLOS ONE			English	Article							PANCREATIC ADENOCARCINOMA CELLS; TYROSINE KINASE-ACTIVITY; C-SRC; RNA INTERFERENCE; PHOSPHATASE-ACTIVITY; MDA-MB-435 CELLS; GENE-EXPRESSION; MYC EXPRESSION; PROTECTS MICE; GROWTH-FACTOR	Background: Src and signaling molecules downstream of Src, including signal transducer and activator of transcription 3 (Stat3) and cMyc, have been implicated in the development, maintenance and/or progression of several types of human cancers, including breast cancer. Here we report the ability of siRNA-mediated Src knock-down alone, and simultaneous knock-down of Src and Stat3 and/or cMyc to inhibit the neoplastic phenotype of a highly metastatic human model breast cancer cell line, MDA-MB-435S, a widely used model for breast cancer research. Methodology/Results: Src and its downstream signaling partners were specifically targeted and knocked-down using siRNA. Changes in the growth properties of the cultured cancer cells/tumors were documented using assays that included anchorage-dependent and -independent (in soft agar) cell growth, apoptosis, and both primary and metastatic tumor growth in the mouse tumor model. siRNA-mediated Src knock-down alone, and simultaneous knock-down of Src and Stat3 and/or cMyc inhibited the neoplastic phenotype of a highly metastatic human model breast cancer cell line, MDA-MB-435S. This knock-down resulted in reduced growth in monolayer and soft agar cultures, and a reduced ability to form primary tumors in NOD/SCID mice. In addition, direct intra-tumoral injection of siRNAs targeting these signaling molecules resulted in a substantial inhibition of tumor metastases as well as of primary tumor growth. Simultaneous knock-down of Src and Stat3, and/or Myc exhibited the greatest effects resulting in substantial inhibition of primary tumor growth and metastasis. Conclusions/Significance: These findings demonstrate the effectiveness of simultaneous targeting of Src and the downstream signaling partners Stat3 and/or cMyc to inhibit the growth and oncogenic properties of a human cancer cell line. This knowledge may be very useful in the development of future therapeutic approaches involving targeting of specific genes products involved in tumor growth and metastasis.	[Bjorge, Jeffrey D.; Pang, Andy S.; Funnell, Melanie; Chen, Ke Yun; Fujita, Donald J.] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB, Canada; [Diaz, Roman; Magliocco, Anthony M.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Diaz, Roman; Magliocco, Anthony M.] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Bjorge, Jeffrey D.; Pang, Andy S.; Funnell, Melanie; Chen, Ke Yun; Fujita, Donald J.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Bjorge, JD (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	dfujita@ucalgary.ca			Alberta Cancer Board; Canadian Breast Cancer Foundation; Prairies Chapter; Canadian Breast Cancer Research Alliance/CIHR; U.S. Dept. of Defense [DAMD 17-02-1-0317]	Alberta Cancer Board; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Prairies Chapter; Canadian Breast Cancer Research Alliance/CIHR(Canadian Institutes of Health Research (CIHR)); U.S. Dept. of Defense(United States Department of Defense)	This work was supported by grants to D.J.F. from the Alberta Cancer Board, the Canadian Breast Cancer Foundation, Prairies Chapter, the Canadian Breast Cancer Research Alliance/CIHR, and the U.S. Dept. of Defense Breast Cancer Research Program (DAMD 17-02-1-0317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens N, 2005, INT J ONCOL, V26, P113; BARNEKOW A, 1987, CANCER RES, V47, P235; Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; BJORGE JD, 1987, J BIOL CHEM, V262, P6615; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chou Mary T-H, 2010, Genes Cancer, V1, P225; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; Dykxhoorn DM, 2006, ANNU REV BIOMED ENG, V8, P377, DOI 10.1146/annurev.bioeng.8.061505.095848; Egan C, 1999, ONCOGENE, V18, P1227, DOI 10.1038/sj.onc.1202233; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; HOLLESTELLE A, 2009, BREAST CANC RES TREA; Hollestelle A, 2009, CANCER RES, V69, P7893, DOI 10.1158/0008-5472.CAN-09-2396; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Ishizawar RC, 2004, J BIOL CHEM, V279, P23773, DOI 10.1074/jbc.M312368200; Jiang BH, 1997, CANCER RES, V57, P5328; Lebedeva S, 2001, HUM GENE THER, V12, P763, DOI 10.1089/104303401750148685; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Miyagishi M, 2003, ANTISENSE NUCLEIC A, V13, P1, DOI 10.1089/108729003764097296; Montel V, 2009, DIFFERENTIATION, V78, P283, DOI 10.1016/j.diff.2009.07.007; MONTESANO R, 1977, J NATL CANCER I, V59, P1651, DOI 10.1093/jnci/59.6.1651; Myoui A, 2003, CANCER RES, V63, P5028; Noritake H, 1999, CLIN EXP METASTAS, V17, P105, DOI 10.1023/A:1006596620406; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; ROSEN N, 1986, J BIOL CHEM, V261, P3754; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sakamoto M, 2001, JPN J CANCER RES, V92, P941, DOI 10.1111/j.1349-7006.2001.tb01184.x; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tofani S, 2002, IEEE T PLASMA SCI, V30, P1552, DOI 10.1109/TPS.2002.804209; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Trevino JG, 2005, CANCER RES, V65, P7214, DOI 10.1158/0008-5472.CAN-04-3858; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Wiener JR, 1999, CLIN CANCER RES, V5, P2164; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yano J, 2004, CLIN CANCER RES, V10, P7721, DOI 10.1158/1078-0432.CCR-04-1049; Zhang QB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009712; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	58	34	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19309	10.1371/journal.pone.0019309	http://dx.doi.org/10.1371/journal.pone.0019309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541295	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400047
J	Matson, EG; Gora, KG; Leadbetter, JR				Matson, Eric G.; Gora, Kasia G.; Leadbetter, Jared R.			Anaerobic Carbon Monoxide Dehydrogenase Diversity in the Homoacetogenic Hindgut Microbial Communities of Lower Termites and the Wood Roach	PLOS ONE			English	Article							H-2 PLUS CO2; CARBOXYDOTHERMUS-HYDROGENOFORMANS; RHODOSPIRILLUM-RUBRUM; CLOSTRIDIUM-THERMOACETICUM; TREPONEMA-PRIMITIA; ACETOGENIC BACTERIA; GUT BACTERIA; GENES; REDUCTASE; SYNTHASE	Anaerobic carbon monoxide dehydrogenase (CODH) is a key enzyme in the Wood-Ljungdahl (acetyl-CoA) pathway for acetogenesis performed by homoacetogenic bacteria. Acetate generated by gut bacteria via the acetyl-CoA pathway provides considerable nutrition to wood-feeding dictyopteran insects making CODH important to the obligate mutualism occurring between termites and their hindgut microbiota. To investigate CODH diversity in insect gut communities, we developed the first degenerate primers designed to amplify cooS genes, which encode the catalytic (beta) subunit of anaerobic CODH enzyme complexes. These primers target over 68 million combinations of potential forward and reverse cooS primer-binding sequences. We used the primers to identify cooS genes in bacterial isolates from the hindgut of a phylogenetically lower termite and to sample cooS diversity present in a variety of insect hindgut microbial communities including those of three phylogenetically-lower termites, Zootermopsis nevadensis, Reticulitermes hesperus, and Incisitermes minor, a wood-feeding cockroach, Cryptocercus punctulatus, and an omnivorous cockroach, Periplaneta americana. In total, we sequenced and analyzed 151 different cooS genes. These genes encode proteins that group within one of three highly divergent CODH phylogenetic clades. Each insect gut community contained CODH variants from all three of these clades. The patterns of CODH diversity in these communities likely reflect differences in enzyme or physiological function, and suggest that a diversity of microbial species participate in homoacetogenesis in these communities.	[Matson, Eric G.; Gora, Kasia G.; Leadbetter, Jared R.] CALTECH, Ronald & Maxine Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA	California Institute of Technology	Matson, EG (corresponding author), CALTECH, Ronald & Maxine Linde Ctr Global Environm Sci, Pasadena, CA 91125 USA.	ematson@caltech.edu		Leadbetter, Jared/0000-0002-7033-0844	Department of Energy [DE-FG02-07ER64484]; National Science Foundation [EF-0523267]	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the Department of Energy (DE-FG02-07ER64484) (www.energy.gov) and the National Science Foundation (EF-0523267) (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beaumont HJE, 2004, MOL MICROBIOL, V54, P148, DOI 10.1111/j.1365-2958.2004.04248.x; Beckwith TD, 1927, SCIENCE, V65, P165, DOI 10.1126/science.65.1676.165; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; BRAUMAN A, 1992, SCIENCE, V257, P1384, DOI 10.1126/science.257.5075.1384; BREZNAK JA, 1986, APPL ENVIRON MICROB, V52, P623, DOI 10.1128/AEM.52.4.623-630.1986; BREZNAK JA, 2002, PROKARYOTES EVOLVING; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Drake HL, 2008, ANN NY ACAD SCI, V1125, P100, DOI 10.1196/annals.1419.016; Drake HL, 2004, RES MICROBIOL, V155, P868, DOI 10.1016/j.resmic.2004.10.001; DRAKE HL, 1980, J BIOL CHEM, V255, P7174; Drake HL, 2002, ANTON LEEUW INT J G, V81, P203, DOI 10.1023/A:1020514617738; Drennan CL, 2004, J BIOL INORG CHEM, V9, P511, DOI 10.1007/s00775-004-0563-y; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Ebert A, 1997, APPL ENVIRON MICROB, V63, P4039, DOI 10.1128/AEM.63.10.4039-4046.1997; FERRY JG, 1995, ANNU REV MICROBIOL, V49, P305, DOI 10.1146/annurev.mi.49.100195.001513; Fujinaga K, 1999, MICROBIOL-SGM, V145, P3377, DOI 10.1099/00221287-145-12-3377; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; Gonzalez JM, 2000, FEMS MICROBIOL LETT, V191, P243, DOI 10.1111/j.1574-6968.2000.tb09346.x; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1307, DOI 10.1128/AEM.70.3.1307-1314.2004; Graber JR, 2004, APPL ENVIRON MICROB, V70, P1315, DOI 10.1128/AEM.70.3.1315-1320.2004; Heo J, 2002, J BACTERIOL, V184, P5894, DOI 10.1128/JB.184.21.5894-5897.2002; Heo J, 2002, J BIOL INORG CHEM, V7, P810, DOI 10.1007/s00775-002-0365-z; Huang SQ, 2000, APPL ENVIRON MICROB, V66, P1474, DOI 10.1128/AEM.66.4.1474-1478.2000; Hungate R. E., 1943, ANN ENT SOC AMERICA, V36, P730; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; KANE MD, 1991, APPL ENVIRON MICROB, V57, P2628, DOI 10.1128/AEM.57.9.2628-2634.1991; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; King GA, 2003, APPL ENVIRON MICROB, V69, P7257, DOI 10.1128/AEM.69.12.7257-7265.2003; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Lilburn TC, 2001, SCIENCE, V292, P2495, DOI 10.1126/science.1060281; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; Matson E, 2007, J VIS EXP; Matson EG, 2010, ENVIRON MICROBIOL, V12, P2245, DOI 10.1111/j.1462-2920.2010.02188.x; ODELSON DA, 1983, APPL ENVIRON MICROB, V45, P1602, DOI 10.1128/AEM.45.5.1602-1613.1983; Oelgeschlager E, 2008, ARCH MICROBIOL, V190, P257, DOI 10.1007/s00203-008-0382-6; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Paster BJ, 1996, APPL ENVIRON MICROB, V62, P347, DOI 10.1128/AEM.62.2.347-352.1996; Peres CM, 2006, J BACTERIOL, V188, P8662, DOI 10.1128/JB.01312-06; Pester M, 2007, ISME J, V1, P551, DOI 10.1038/ismej.2007.62; PEZACKA E, 1984, P NATL ACAD SCI-BIOL, V81, P6261, DOI 10.1073/pnas.81.20.6261; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Ragsdale SW, 2004, CRIT REV BIOCHEM MOL, V39, P165, DOI 10.1080/10409230490496577; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; Salmassi TM, 2003, MICROBIOL-SGM, V149, P2529, DOI 10.1099/mic.0.26351-0; Singer SW, 2006, BBA-BIOENERGETICS, V1757, P1582, DOI 10.1016/j.bbabio.2006.10.003; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Svetlitchnyi V, 2001, J BACTERIOL, V183, P5134, DOI 10.1128/JB.183.17.5134-5144.2001; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Yeoman KH, 2004, MICROBIOL-SGM, V150, P4065, DOI 10.1099/mic.0.27419-0; Zhang X, 2010, ENV MICROBIOL	59	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19316	10.1371/journal.pone.0019316	http://dx.doi.org/10.1371/journal.pone.0019316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541298	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000290018400051
J	Sato, Y; Aihara, K				Sato, Yoshiyuki; Aihara, Kazuyuki			A Bayesian Model of Sensory Adaptation	PLOS ONE			English	Article							SIMULTANEITY; PERCEPTION; MOTION; RECALIBRATION; CALIBRATION; INTEGRATION; ASYNCHRONY; EXPOSURE; STIMULI	Recent studies reported two opposite types of adaptation in temporal perception. Here, we propose a Bayesian model of sensory adaptation that exhibits both types of adaptation. We regard adaptation as the adaptive updating of estimations of time-evolving variables, which determine the mean value of the likelihood function and that of the prior distribution in a Bayesian model of temporal perception. On the basis of certain assumptions, we can analytically determine the mean behavior in our model and identify the parameters that determine the type of adaptation that actually occurs. The results of our model suggest that we can control the type of adaptation by controlling the statistical properties of the stimuli presented.	[Sato, Yoshiyuki] Univ Electrocommun, Grad Sch Informat Syst, Tokyo, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	University of Electro-Communications - Japan; University of Tokyo	Sato, Y (corresponding author), Univ Electrocommun, Grad Sch Informat Syst, Tokyo, Japan.	yoshi.sato@is.uec.ac.jp	Sato, Yoshiyuki/B-4163-2009	Sato, Yoshiyuki/0000-0002-8173-7666	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan [17022012]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research is partially supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)" and Grant-in-Aid for Scientific Research on Priority Areas-system study on higher-order brain functions-from the Ministry of Education, Culture, Sports, Science and Technology of Japan (17022012). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 1999, NAT NEUROSCI, V2, P1015, DOI 10.1038/14814; BENNETT RG, 1985, VISION RES, V25, P565, DOI 10.1016/0042-6989(85)90161-0; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Kording K, 2007, SCIENCE, V318, P606, DOI 10.1126/science.1142998; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Navarra J, 2007, NEUROSCI LETT, V413, P72, DOI 10.1016/j.neulet.2006.11.027; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Sato Y, 2009, ARTIF LIFE ROBOT, V14, P289, DOI 10.1007/s10015-009-0675-0; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Takahashi K, 2008, NEUROREPORT, V19, P319, DOI 10.1097/WNR.0b013e3282f4f039; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008	22	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19377	10.1371/journal.pone.0019377	http://dx.doi.org/10.1371/journal.pone.0019377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541346	gold, Green Published, Green Submitted			2022-12-25	WOS:000290016800044
J	Bandara, AB; Champion, AE; Wang, XS; Berg, G; Apicella, MA; McLendon, M; Azadi, P; Snyder, DS; Inzana, TJ				Bandara, Aloka B.; Champion, Anna E.; Wang, Xiaoshan; Berg, Gretchen; Apicella, Michael A.; McLendon, Molly; Azadi, Parastoo; Snyder, D. Scott; Inzana, Thomas J.			Isolation and Mutagenesis of a Capsule-Like Complex (CLC) from Francisella tularensis, and Contribution of the CLC to F. tularensis Virulence in Mice	PLOS ONE			English	Article							LIVE VACCINE STRAIN; LIPOPOLYSACCHARIDE O-ANTIGEN; GRAM-NEGATIVE BACTERIA; INFLUENZAE TYPE-B; PROTECTIVE IMMUNITY; SUBSPECIES TULARENSIS; ACTINOBACILLUS-PLEUROPNEUMONIAE; ENHANCED SENSITIVITY; BACILLUS-ANTHRACIS; AEROSOL CHALLENGE	Background: Francisella tularensis is a category-A select agent and is responsible for tularemia in humans and animals. The surface components of F. tularensis that contribute to virulence are not well characterized. An electron-dense capsule has been postulated to be present around F. tularensis based primarily on electron microscopy, but this specific antigen has not been isolated or characterized. Methods and Findings: A capsule-like complex (CLC) was effectively extracted from the cell surface of an F. tularensis live vaccine strain (LVS) lacking O-antigen with 0.5% phenol after 10 passages in defined medium broth and growth on defined medium agar for 5 days at 32 degrees C in 7% CO(2). The large molecular size CLC was extracted by enzyme digestion, ethanol precipitation, and ultracentrifugation, and consisted of glucose, galactose, mannose, and Proteinase K-resistant protein. Quantitative reverse transcriptase PCR showed that expression of genes in a putative polysaccharide locus in the LVS genome (FTL_1432 through FTL_1421) was upregulated when CLC expression was enhanced. Open reading frames FTL_1423 and FLT_1422, which have homology to genes encoding for glycosyl transferases, were deleted by allelic exchange, and the resulting mutant after passage in broth (LVS Delta 1423/1422_P10) lacked most or all of the CLC, as determined by electron microscopy, and CLC isolation and analysis. Complementation of LVS Delta 1423/1422 and subsequent passage in broth restored CLC expression. LVS Delta 1423/1422_P10 was attenuated in BALB/c mice inoculated intranasally (IN) and intraperitoneally with greater than 80 times and 270 times the LVS LD(50), respectively. Following immunization, mice challenged IN with over 700 times the LD(50) of LVS remained healthy and asymptomatic. Conclusions: Our results indicated that the CLC may be a glycoprotein, FTL_1422 and -FTL_1423 were involved in CLC biosynthesis, the CLC contributed to the virulence of F. tularensis LVS, and a CLC-deficient mutant of LVS can protect mice against challenge with the parent strain.	[Bandara, Aloka B.; Champion, Anna E.; Wang, Xiaoshan; Berg, Gretchen; Inzana, Thomas J.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Apicella, Michael A.; McLendon, Molly] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Azadi, Parastoo; Snyder, D. Scott] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Virginia Polytechnic Institute & State University; University of Iowa; University System of Georgia; University of Georgia	Bandara, AB (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA.	tinzana@vt.edu			National Institute of Allergy and Infectious Diseases/National Institutes of Health [U54-AI57168]; U.S. Army Medical Research and Material Command [DAMD17-03-1-0008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant U54-AI57168 from National Institute of Allergy and Infectious Diseases/National Institutes of Health to the mid-Atlantic Regional Center for Excellence (http://marce.vbi.vt.edu/), and by grant DAMD17-03-1-0008 from the U.S. Army Medical Research and Material Command (https://mrmc-www.army.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON P, 1976, INFECT IMMUN, V13, P581, DOI 10.1128/IAI.13.2.581-589.1976; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Balonova L, 2010, J PROTEOME RES, V9, P1995, DOI 10.1021/pr9011602; CHERWONOGRODZKY JW, 1994, VACCINE, V12, P773, DOI 10.1016/0264-410X(94)90284-4; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan J Wayne, 2004, Expert Rev Vaccines, V3, P307; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Cowley SC, 2003, J EXP MED, V198, P379, DOI 10.1084/jem.20030687; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DeShazer D, 2001, MICROB PATHOGENESIS, V30, P253, DOI 10.1006/mpat.2000.0430; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; Goldberg HA, 1997, ANAL BIOCHEM, V251, P227, DOI 10.1006/abio.1997.2252; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Green M, 2005, VACCINE, V23, P2680, DOI 10.1016/j.vaccine.2004.03.071; Hartley G, 2006, VACCINE, V24, P989, DOI 10.1016/j.vaccine.2005.08.075; HOOD AM, 1977, J HYG-CAMBRIDGE, V79, P47, DOI 10.1017/S0022172400052840; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Inzana TJ, 2004, J VET DIAGN INVEST, V16, P374, DOI 10.1177/104063870401600502; INZANA TJ, 1985, J INFECT DIS, V151, P869, DOI 10.1093/infdis/151.5.869; Jia QM, 2010, INFECT IMMUN, V78, P4341, DOI 10.1128/IAI.00192-10; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; McCoy G, 1912, J INFECT DIS, V10, P61, DOI 10.1093/infdis/10.1.61; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; MERKLE RK, 1994, METHOD ENZYMOL, V230, P1; Messner P, 2008, CARBOHYD RES, V343, P1934, DOI 10.1016/j.carres.2007.12.025; Michell SL, 2010, J MED MICROBIOL, V59, P1275, DOI 10.1099/jmm.0.018911-0; OTT LR, 1993, INTRO STAT ANAL, P260; Pavlov VM, 1996, FEMS IMMUNOL MED MIC, V13, P253, DOI 10.1111/j.1574-695X.1996.tb00247.x; Penn RL, 2005, MANDELL DOUGLAS BENN, Vsixth, P2674; Prior JL, 2003, J MED MICROBIOL, V52, P845, DOI 10.1099/jmm.0.05184-0; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Sambrook J., 2002, MOL CLONING LAB MANU; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; SJOSTEDT A, 2005, BERGEYS MANUAL SYSTE, P199; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sorokin VM, 1996, FEMS IMMUNOL MED MIC, V13, P249, DOI 10.1111/j.1574-695X.1996.tb00246.x; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Thomas RM, 2007, INFECT IMMUN, V75, P371, DOI 10.1128/IAI.01241-06; TIGERTT WD, 1962, BACTERIOL REV, V26, P354, DOI 10.1128/MMBR.26.3.354-373.1962; Ward CK, 1997, INFECT IMMUN, V65, P2491, DOI 10.1128/IAI.65.6.2491-2496.1997; WARD CK, 1994, J IMMUNOL, V153, P2110; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104	61	21	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19003	10.1371/journal.pone.0019003	http://dx.doi.org/10.1371/journal.pone.0019003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544194	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800030
J	Pele, J; Abdi, H; Moreau, M; Thybert, D; Chabbert, M				Pele, Julien; Abdi, Herve; Moreau, Matthieu; Thybert, David; Chabbert, Marie			Multidimensional Scaling Reveals the Main Evolutionary Pathways of Class A G-Protein-Coupled Receptors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MULTIVARIATE-ANALYSIS; ACTIVATION; SEQUENCE; SPACE; SUBSTITUTION; RHODOPSIN; RESIDUES; FAMILIES; DATABASE	Class A G-protein-coupled receptors (GPCRs) constitute the largest family of transmembrane receptors in the human genome. Understanding the mechanisms which drove the evolution of such a large family would help understand the specificity of each GPCR sub-family with applications to drug design. To gain evolutionary information on class A GPCRs, we explored their sequence space by metric multidimensional scaling analysis (MDS). Three-dimensional mapping of human sequences shows a non-uniform distribution of GPCRs, organized in clusters that lay along four privileged directions. To interpret these directions, we projected supplementary sequences from different species onto the human space used as a reference. With this technique, we can easily monitor the evolutionary drift of several GPCR sub-families from cnidarians to humans. Results support a model of radiative evolution of class A GPCRs from a central node formed by peptide receptors. The privileged directions obtained from the MDS analysis are interpretable in terms of three main evolutionary pathways related to specific sequence determinants. The first pathway was initiated by a deletion in transmembrane helix 2 (TM2) and led to three sub-families by divergent evolution. The second pathway corresponds to the differentiation of the amine receptors. The third pathway corresponds to parallel evolution of several sub-families in relation with a covarion process involving proline residues in TM2 and TM5. As exemplified with GPCRs, the MDS projection technique is an important tool to compare orthologous sequence sets and to help decipher the mutational events that drove the evolution of protein families.	[Pele, Julien; Moreau, Matthieu; Thybert, David; Chabbert, Marie] CNRS, UMR 6214, INSERM 771, Fac Med, Angers, France; [Abdi, Herve] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Texas System; University of Texas Dallas	Pele, J (corresponding author), CNRS, UMR 6214, INSERM 771, Fac Med, Angers, France.	marie.chabbert@univ-angers.fr	Abdi, Hervé/G-6620-2011; Chabbert, Marie/K-1245-2015	Thybert, David/0000-0001-7806-7318; Abdi, Herve/0000-0002-9522-1978	CNRS; INSERM; University of Angers; Conseil General de Maine-et-Loire	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Angers; Conseil General de Maine-et-Loire(Region Pays de la Loire)	This work was supported by institutional grants from CNRS, INSERM and University of Angers and by NEC Computers Services SARL (Angers, France) that kindly provided the server used for the computations. J. P. was supported by a fellowship from the Conseil General de Maine-et-Loire. M. M. was supported by a studentship from CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, P598, DOI DOI 10.4135/9781412952644; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Anctil M, 2007, GENE, V392, P14, DOI 10.1016/j.gene.2006.10.025; Blackshields G, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-21; CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; DELANO JW, PYMOL MOL GRAPHICS S; Deville J, 2009, J MOL EVOL, V68, P475, DOI 10.1007/s00239-009-9214-9; Domazet I, 2009, J BIOL CHEM, V284, P11922, DOI 10.1074/jbc.M808113200; Fitch W M, 1971, J Mol Evol, V1, P84, DOI 10.1007/BF01659396; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Gogos A, 2000, PROTEINS, V40, P98, DOI 10.1002/(SICI)1097-0134(20000701)40:1<98::AID-PROT110>3.0.CO;2-S; GOWER JC, 1968, BIOMETRIKA, V55, P582, DOI 10.2307/2334268; Greenacre M., 2007, CORRES ANAL PRACTICE; Grishin VN, 2002, BIOINFORMATICS, V18, P1523, DOI 10.1093/bioinformatics/18.11.1523; Haitina T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-24; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P15; Hou JT, 2005, P NATL ACAD SCI USA, V102, P3651, DOI 10.1073/pnas.0409772102; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu F, 2005, P NATL ACAD SCI USA, V102, P12332, DOI 10.1073/pnas.0505411102; Metpally RPR, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-41; Murtagh F., 2005, CORRES ANAL DATA COD; Nei M., 2005, EVOLUTIONARY DISTANC, P1; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SEALFON SC, 1995, J BIOL CHEM, V270, P16683, DOI 10.1074/jbc.270.28.16683; Shi WF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014454; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Studer RA, 2010, MOL BIOL EVOL, V27, P2618, DOI 10.1093/molbev/msq149; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Susko E, 2004, MOL BIOL EVOL, V21, P1629, DOI 10.1093/molbev/msh159; TAKANE Y, 2009, HDB QUANTITATIVE MET, P219; Togerson W.S., 1958, THEORY METHODS SCALI; Trosset MW, 2008, COMPUT STAT DATA AN, V52, P4635, DOI 10.1016/j.csda.2008.02.031; Tuffley C, 1998, MATH BIOSCI, V147, P63, DOI 10.1016/S0025-5564(97)00081-3; Tzeng J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-179; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wang HC, 2008, J MOL EVOL, V66, P50, DOI 10.1007/s00239-007-9062-4; WOOLLEY KJ, 1986, BIOCHEM BIOPH RES CO, V140, P808, DOI 10.1016/0006-291X(86)90705-9; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Ye K, 2006, PROTEINS, V63, P1018, DOI 10.1002/prot.20899; Yohannan S, 2004, J MOL BIOL, V341, P1, DOI 10.1016/j.jmb.2004.06.025; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101	60	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19094	10.1371/journal.pone.0019094	http://dx.doi.org/10.1371/journal.pone.0019094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544207	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800040
J	Zimmermann, E; Holst, C; Sorensen, TIA				Zimmermann, Esther; Holst, Claus; Sorensen, Thorkild I. A.			Morbidity, Including Fatal Morbidity, throughout Life in Men Entering Adult Life as Obese	PLOS ONE			English	Article							BODY-MASS INDEX; CAUSE-SPECIFIC MORTALITY; CORONARY-HEART-DISEASE; OVERWEIGHT YOUNG MEN; FOLLOW-UP; ADOLESCENCE; ASSOCIATION; COHORT; DEATH; AGE	Background: The association between obesity in adults and excess morbidity and mortality is well established, but the health impact throughout adult life of being obese in early adulthood needs elucidation. We investigated somatic morbidity, including fatal morbidity, throughout adulthood in men starting adult life as obese. Methods: Among 362,200 Danish young men, examined for military service between 1943 and 1977, all obese (defined as BMI >= 31.0 kg/m(2)), and, as controls, a random 1% sample of the others was identified. In the age range of 18-25 years, there were 1,862 obese, which encompass the men above the 99.5 percentile, and 3,476 controls. Information on morbidity was obtained via national registers. Cox regression models were used to estimate the relative morbidity assessed as first incidence of disease, occurrence of disease in the year preceding death and prevalent disease at time of death. Results: From age 18 through 80 years the obese had an increased risk of becoming diseased by or die from a broad range of diseases. Generally, the incidence of first event, occurrence in the year prior to death, and prevalence at time of death showed the same pattern. As an example, the relative hazard of type 2 diabetes was constant throughout life at 4.9 (95% confidence intervals [CI]: 4.1-5.9), 5.2 (95% CI: 3.6-7.5), and 6.8 (95% CI: 4.6-10.1), respectively. Conclusions: Our findings strongly support the continued need to avoid beginning adult life as obese, as obese young men experience an increased morbidity, including fatal morbidity, from many diseases throughout life.	[Zimmermann, Esther; Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Zimmermann, Esther] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Zimmermann, E (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	ez@ipm.regionh.dk	Sriwisit, Sukhumaphorn/G-1405-2011	Zimmermann, Esther/0000-0001-5854-0542	Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark; European Commission [LSHM-CT-2005-018734]; Danish Council for Strategic Research	Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The work was supported by grants from the Cluster for Endocrinology and Metabolism, University of Copenhagen, Denmark. This work is also part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP, http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme [Contract LSHM-CT-2005-018734], and part of the research activities in the Danish Obesity Research Centre (DanORC, http://www.danorc.dk/), which is supported by the Danish Council for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2000, WHO TECH REP SER, V894, pi; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; CHRISTENSEN U, 1981, HUM BIOL, V53, P403; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Falkstedt D, 2007, INT J OBESITY, V31, P777, DOI 10.1038/sj.ijo.0803480; HOFFMANS MDAF, 1989, J CLIN EPIDEMIOL, V42, P513, DOI 10.1016/0895-4356(89)90147-9; Juel K, 1999, DAN MED BULL, V46, P354; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Manson JE, 2007, J WOMENS HEALTH, V16, P168, DOI 10.1089/jwh.2006.0080; Neovius M, 2008, INT J OBESITY, V32, P1319, DOI 10.1038/ijo.2008.70; Neovius M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b496; Pedersen CB, 2006, DAN MED BULL, V53, P441; Petri C N, 1993, Qual Assur Health Care, V5, P315; SONNEHOLM S, 1977, J CHRON DIS, V30, P351, DOI 10.1016/0021-9681(77)90029-7; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; SORENSEN TIA, 1977, J CHRON DIS, V30, P359, DOI 10.1016/0021-9681(77)90030-3; WAALER HT, 1988, ACTA MED SCAND, V713, P17; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; ZIMMERMANN E, 2011, INT J OBESITY	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18546	10.1371/journal.pone.0018546	http://dx.doi.org/10.1371/journal.pone.0018546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21541254	gold, Green Published, Green Submitted			2022-12-25	WOS:000289719400011
J	Garonna, E; Botham, KM; Birdsey, GM; Randi, AM; Gonzalez-Perez, RR; Wheeler-Jones, CPD				Garonna, Elena; Botham, Kathleen M.; Birdsey, Graeme M.; Randi, Anna M.; Gonzalez-Perez, Ruben R.; Wheeler-Jones, Caroline P. D.			Vascular Endothelial Growth Factor Receptor-2 Couples Cyclo-Oxygenase-2 with Pro-Angiogenic Actions of Leptin on Human Endothelial Cells	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTORS; NITRIC-OXIDE SYNTHASE; P38 MAPK; IN-VIVO; VEGF; EXPRESSION; KINASE; CYCLOOXYGENASE-2; PROLIFERATION; TRANSACTIVATION	Background: The adipocyte-derived hormone leptin influences the behaviour of a wide range of cell types and is now recognised as a pro-angiogenic and pro-inflammatory factor. In the vasculature, these effects are mediated in part through its direct leptin receptor (ObRb)-driven actions on endothelial cells (ECs) but the mechanisms responsible for these activities have not been established. In this study we sought to more fully define the molecular links between inflammatory and angiogenic responses of leptin-stimulated human ECs. Methodology/Principal Findings: Immunoblotting studies showed that leptin increased cyclo-oxygenase-2 (COX-2) expression (but not COX-1) in cultured human umbilical vein ECs (HUVEC) through pathways that depend upon activation of both p38 mitogen-activated protein kinase (p38(MAPK)) and Akt, and stimulated rapid phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2) on Tyr(1175). Phosphorylation of VEGFR2, p38(MAPK) and Akt, and COX-2 induction in cells challenged with leptin were blocked by a specific leptin peptide receptor antagonist. Pharmacological inhibitors of COX-2, the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and p38(MAPK) abrogated leptin-induced EC proliferation (assessed by quantifying 5-bromo-2'-deoxyuridine incorporation, calcein fluorescence and propidium iodide staining), slowed the increased migration rate of leptin-stimulated cells (in vitro wound healing assay) and inhibited leptin-induced capillary-like tube formation by HUVEC on Matrigel. Inhibition of VEGFR2 tyrosine kinase activity reduced leptin-stimulated p38(MAPK) and Akt activation, COX-2 induction, and pro-angiogenic EC responses, and blockade of VEGFR2 or COX-2 activities abolished leptin-driven neo-angiogenesis in a chick chorioallantoic membrane vascularisation assay in vivo. Conclusions/Significance: We conclude that a functional endothelial p38(MAPK)/Akt/COX-2 signalling axis is required for leptin's pro-angiogenic actions and that this is regulated upstream by ObRb-dependent activation of VEGFR2. These studies identify a new function for VEGFR2 as a mediator of leptin-stimulated COX-2 expression and angiogenesis and have implications for understanding leptin's regulation of the vasculature in both non-obese and obese individuals.	[Garonna, Elena; Botham, Kathleen M.; Wheeler-Jones, Caroline P. D.] Univ London, Royal Vet Coll, Dept Basic Sci, London, England; [Birdsey, Graeme M.; Randi, Anna M.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Vasc Sci Sect, Natl Heart & Lung Inst, London, England; [Gonzalez-Perez, Ruben R.] Morehouse Sch Med, Atlanta, GA 30310 USA	University of London; University of London Royal Veterinary College; Imperial College London; Morehouse School of Medicine	Garonna, E (corresponding author), Univ London, Royal Vet Coll, Dept Basic Sci, London, England.	cwheeler@rvc.ac.uk		Botham, Kathleen/0000-0002-0221-979X; Birdsey, Graeme M./0000-0002-0981-8672	Biotechnology and Biological Sciences Research Council; British Heart Foundation [PG/02/002, PG/07/063/23289]; NIH/NCI [1SC1CA138658-03]; Georgia Cancer Coalition; British Heart Foundation [PG/09/096/28114] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [SC1CA138658] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition; British Heart Foundation(British Heart Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	EG was supported by a studentship from the Biotechnology and Biological Sciences Research Council (to CW-J); http://www.bbsrc.ac.uk/funding/funding-index.aspx. The work was funded principally by grants (to CW-J) from the British Heart Foundation (PG/02/002 and PG/07/063/23289); http://www.bhf.org.uk/research/research-grants.aspx. Synthesis of the leptin antagonist is supported by grants from NIH/NCI 1SC1CA138658-03; the Georgia Cancer Coalition Distinguished Cancer Scholar Award (to RG-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2008, ARTERIOSCL THROM VAS, V28, P2042, DOI 10.1161/ATVBAHA.108.175109; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Bocci G, 2004, EUR J PHARMACOL, V498, P9, DOI 10.1016/j.ejphar.2004.07.062; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Bouloumie A, 1999, FASEB J, V13, P1231, DOI 10.1096/fasebj.13.10.1231; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cirillo P, 2010, THROMB HAEMOSTASIS, V103, P1065, DOI 10.1160/TH09-06-0392; Clarkin CE, 2008, EXP CELL RES, V314, P3152, DOI 10.1016/j.yexcr.2008.07.027; Dashwood MR, 2011, INTERACT CARDIOV TH, V12, P170, DOI 10.1510/icvts.2010.247874; Eisenberg A, 2004, FEBS LETT, V565, P139, DOI 10.1016/j.febslet.2004.03.089; Elbatarny HS, 2005, AM J PHYSIOL-ENDOC M, V289, pE695, DOI 10.1152/ajpendo.00125.2005; Fischer C, 2006, Handb Exp Pharmacol, P157; Goetze S, 2002, HYPERTENSION, V40, P748, DOI 10.1161/01.HYP.0000035522.63647.D3; Gonzalez RR, 2003, ENDOCRINE, V21, P185, DOI 10.1385/ENDO:21:2:185; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Grethe S, 2006, BIOCHEM BIOPH RES CO, V347, P781, DOI 10.1016/j.bbrc.2006.06.159; Hamdulay SS, 2010, FREE RADICAL BIO MED, V48, P1013, DOI 10.1016/j.freeradbiomed.2010.01.017; Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807; Houliston RA, 2002, THROMB HAEMOSTASIS, V88, P321; Houliston RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1266, DOI 10.1152/ajpcell.2001.281.4.C1266; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Leahy KM, 2002, CANCER RES, V62, P625; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lewthwaite JC, 2006, J BIOL CHEM, V281, P11011, DOI 10.1074/jbc.M510680200; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Lorenzi O, 2008, J THROMB HAEMOST, V6, P1962, DOI 10.1111/j.1538-7836.2008.03138.x; Matsuda K, 2003, HYPERTENS RES, V26, P147, DOI 10.1291/hypres.26.147; Montecucco F, 2006, ANN NY ACAD SCI, V1069, P463, DOI 10.1196/annals.1351.045; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Ogunwobi O, 2006, ENDOCRINOLOGY, V147, P4505, DOI 10.1210/en.2006-0224; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Pula G, 2010, ARTERIOSCL THROM VAS, V30, P2631, DOI 10.1161/ATVBAHA.110.215855; Rajapurohitam V, 2003, CIRC RES, V93, P277, DOI 10.1161/01.RES.0000089255.37804.72; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Rodrigues S, 2003, FASEB J, V17, P7, DOI 10.1096/fj.02-0201com; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Smith CCT, 2006, BRIT J PHARMACOL, V149, P5, DOI 10.1038/sj.bjp.0706834; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Suganami E, 2004, DIABETES, V53, P2443, DOI 10.2337/diabetes.53.9.2443; Syeda F, 2006, J BIOL CHEM, V281, P11792, DOI 10.1074/jbc.M509292200; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Vecchione C, 2002, DIABETES, V51, P168, DOI 10.2337/diabetes.51.1.168; Wheeler-Jones CPD, 2008, PHARMACOL REP, V60, P109; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Zarkesh-Esfahani H, 2001, J IMMUNOL, V167, P4593, DOI 10.4049/jimmunol.167.8.4593; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df	48	76	80	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18823	10.1371/journal.pone.0018823	http://dx.doi.org/10.1371/journal.pone.0018823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533119	Green Published, Green Submitted, gold			2022-12-25	WOS:000289620100024
J	Guo, G; Huang, Y; Humphreys, P; Wang, XZ; Smith, A				Guo, Ge; Huang, Yue; Humphreys, Peter; Wang, Xiaozhong; Smith, Austin			A PiggyBac-Based Recessive Screening Method to Identify Pluripotency Regulators	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; SIGNALING PATHWAYS; ES CELLS; NANOG; TRANSCRIPTION; MAINTAINS; ENTRY; TCF3	Phenotype driven genetic screens allow unbiased exploration of the genome to discover new biological regulators. Bloom syndrome gene (Blm) deficient embryonic stem (ES) cells provide an opportunity for recessive screening due to frequent loss of heterozygosity. We describe a strategy for isolating regulators of mammalian pluripotency based on conversion to homozygosity of PiggyBac gene trap insertions combined with stringent selection for differentiation resistance. From a screen of 2000 mutants we obtained a disruptive integration in the Tcf3 gene. Homozygous Tcf3 mutants showed impaired differentiation and enhanced self-renewal. This phenotype was reverted in a dosage sensitive manner by excision of one or both copies of the gene trap. These results provide new evidence confirming that Tcf3 is a potent negative regulator of pluripotency and validate a forward screening methodology to identify modulators of pluripotent stem cell biology.	[Guo, Ge; Humphreys, Peter; Smith, Austin] Univ Cambridge, Dept Biochem, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QW, England; [Huang, Yue] Wellcome Trust Sanger Inst, Hinxton, S Cambs, England; [Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA	University of Cambridge; Wellcome Trust Sanger Institute; Northwestern University	Guo, G (corresponding author), Univ Cambridge, Dept Biochem, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QW, England.	Austin.Smith@cscr.cam.ac.uk		Smith, Austin/0000-0002-3029-4682; Huang, Yue/0000-0003-1800-1282	Biotechnology and Biological Sciences Research Council; European Commission; Medical Research Council; Wellcome Trust; Medical Research Council [G1100526, G0700665] Funding Source: researchfish; MRC [G0700665] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), European Commission Project EuroSyStem (www.eurosystemproject.eu/), the Medical Research Council (www.mrc.ac.uk), and the Wellcome Trust (www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 1997, GENE, V196, P187, DOI 10.1016/S0378-1119(97)00226-6; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Guo G, 2004, NATURE, V429, P891, DOI 10.1038/nature02653; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Rathjen J, 1999, J CELL SCI, V112, P601; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; TAM WL, 2008, STEM CELLS; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; WRAY J, 2011, NAT CELL BI IN PRESS; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646	34	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18189	10.1371/journal.pone.0018189	http://dx.doi.org/10.1371/journal.pone.0018189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533166	gold, Green Submitted, Green Published			2022-12-25	WOS:000289620100001
J	Wang, QZ; Zhang, TJ; Cui, J; Wang, XG; Zhou, H; Han, JG; Gislum, R				Wang, Quanzhen; Zhang, Tiejun; Cui, Jian; Wang, Xianguo; Zhou, He; Han, Jianguo; Gislum, Rene			Path and Ridge Regression Analysis of Seed Yield and Seed Yield Components of Russian Wildrye (Psathyrostachys juncea Nevski) under Field Conditions	PLOS ONE			English	Article							COEFFICIENT ANALYSIS; TRANSFORMATION; QUALITY	The correlations among seed yield components, and their direct and indirect effects on the seed yield (Z) of Russina wildrye (Psathyrostachys juncea Nevski) were investigated. The seed yield components: fertile tillers m(-2) (Y-1), spikelets per fertile tillers (Y-2), florets per spikelet(Y-3), seed numbers per spikelet (Y-4) and seed weight (Y-5) were counted and the Z were determined in field experiments from 2003 to 2006 via big sample size. Y-1 was the most important seed yield component describing the Z and Y-2 was the least. The total direct effects of the Y-1, Y-3 and Y-5 to the Z were positive while Y-4 and Y-2 were weakly negative. The total effects (directs plus indirects) of the components were positively contributed to the Z by path analyses. The seed yield components Y1, Y2, Y4 and Y5 were significantly (P<0.001) correlated with the Z for 4 years totally, while in the individual years, Y-2 were not significant correlated with Y-3, Y-4 and Y-5 by Peason correlation analyses in the five components in the plant seed production. Therefore, selection for high seed yield through direct selection for large Y-1, Y-2 and Y-3 would be effective for breeding programs in grasses. Furthermore, it is the most important that, via ridge regression, a steady algorithm model between Z and the five yield components was founded, which can be closely estimated the seed yield via the components.	[Wang, Quanzhen; Cui, Jian] NW A&F Univ, Dept Grassland Sci, Coll Sci & Technol, Yangling, Shaanxi Prov, Peoples R China; [Wang, Quanzhen; Wang, Xianguo; Zhou, He; Han, Jianguo] China Agr Univ, Inst Grassland Sci, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Zhang, Tiejun] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Gislum, Rene] Aarhus Univ, Dept Genet & Biotechnol, Fac Agr Sci, Slagelse, Denmark	Northwest A&F University - China; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Aarhus University	Wang, QZ (corresponding author), NW A&F Univ, Dept Grassland Sci, Coll Sci & Technol, Yangling, Shaanxi Prov, Peoples R China.	wangquanzhen191@163.com	Zhang, Tiejun/HDM-7091-2022	Gislum, Rene/0000-0002-1432-4781	National Basic Research and Development Programme (973 project) [2007CB106805]; 948 Research Project [202099]; Ministry of Agriculture of People's Republic of China	National Basic Research and Development Programme (973 project)(National Basic Research Program of China); 948 Research Project; Ministry of Agriculture of People's Republic of China	This work was funded by the National Basic Research and Development Programme (grant number 973 project, 2007CB106805; http://www.973.gov.cn/), 948 Research Project (grant number 202099), Ministry of Agriculture of People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; AMIRTHADEVARATH.A, 1983, AGR J, V70, P781; Asay K. H., 1991, Plant Breeding Abstracts, V61, P643; ASAY KH, 1992, HEREDITAS, V116, P167, DOI 10.1111/j.1601-5223.1992.tb00223.x; ASAY KH, 1995, WHEATGRASSES WILDRYE, P373; Atul-Nayyar, 2008, APPL SOIL ECOL, V40, P30, DOI 10.1016/j.apsoil.2008.03.004; BARRIOS C, 2010, SEED YIELD COMPONENT; Berdahl JD, 1997, J RANGE MANAGE, V50, P80, DOI 10.2307/4002709; BOELT B, 2010, SEED YIELD COMPONENT, P109; CANODE CL, 1980, GRASS SEED PRODUCTIO, P189; Chatterjee S, 1977, REGRESSION ANAL EXAM; COMEAU A, 1987, CAN J PLANT PATHOL, V9, P188, DOI 10.1080/07060668709501901; Das MK, 2009, EUPHYTICA, V167, P95, DOI 10.1007/s10681-008-9866-3; Deleuran L, 2009, ACTA AGR SCAND B-S P, V59, P57, DOI 10.1080/09064710701855221; DEWEY D R, 1984, P209; DEWEY DOUGLAS R., 1959, AGRON JOUR, V51, P515; El-Nakhlawy F. S., 2009, Electronic Journal of Environmental, Agricultural and Food Chemistry, V8, P287; Firincioglu HK, 2010, FIELD CROP RES, V116, P30, DOI 10.1016/j.fcr.2009.11.005; GAO S, 2005, STAT DECISION MAKING, V5, P142; Golparvar AR, 2009, RES CROP, V10, P147; GU A, 1994, GRASSLAND CHINA, V16, P12; HAMPTON JG, 1997, FORAGE SEED PRODUCTI; HAMPTON JG, 1998, COMPONENTS SEED YIEL, V1, P45; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; IBRAHIM S M, 1990, International Rice Research Newsletter, V15, P11; Jefferson P. G., 2007, Acta Agronomica Hungarica, V55, P49, DOI 10.1556/AAgr.55.2007.1.6; LAWLESS JF, 1976, COMMUN STAT A-THEOR, VA  5, P307, DOI 10.1080/03610927608827353; LIU Y, 2009, GENETIC DIVERSITY AN, V24, P107; Liu YongCai, 2009, Chinese Journal of Grassland, V31, P64; Lopes RR, 2009, REV BRAS ZOOTECN, V38, P1865, DOI 10.1590/S1516-35982009001000002; Ma ChunHui, 2004, Agricultural Sciences in China, V3, P553; MARQUARDT DW, 1975, AM STAT, V29, P3, DOI 10.2307/2683673; Meints PD, 2001, AGRON J, V93, P1276, DOI 10.2134/agronj2001.1276; MILLIGAN SB, 1990, CROP SCI, V30, P927, DOI 10.2135/cropsci1990.0011183X003000040034x; Mokhtassi Bidgoli A, 2006, EUPHYTICA, V148, P261, DOI 10.1007/s10681-005-9019-x; NEWELL GJ, 1981, J FOOD SCI, V46, P968, DOI 10.1111/j.1365-2621.1981.tb15400.x; Ofori I, 1996, EUPHYTICA, V91, P103, DOI 10.1007/BF00035280; Ozturk O, 2009, ASIAN J CHEM, V21, P1400; PEIYAN L, 1988, TORP AGR RES SER, V21, P230; Ram T, 1992, J ANDAMAN SCI ASS, V8, P26; Rashidi M., 2009, American-Eurasian Journal of Agricultural and Environmental Science, V5, P786; Samonte SOPB, 1998, CROP SCI, V38, P1130, DOI 10.2135/cropsci1998.0011183X003800050004x; SAS-Institute-Inc, 1988, SAS STAT US GUID; Sloane NJ., 1999, ORTHOGONAL ARRAYS TH, DOI [10.1007/978-1-4612-1478-6, DOI 10.1007/978-1-4612-1478-6]; Sodavadiya PR, 2009, LEGUME RES, V32, P203; SUN T, 2005, GRASSLAND CHINA, V27, P16; SUN T, 2004, EFFECTS FERTILIZER A; Sundaram T., 1994, Madras Agricultural Journal, V81, P28; Surek H., 1998, Oryza, V35, P15; Tamura K, 2009, J EXP BOT, V60, P893, DOI 10.1093/jxb/ern337; USDA, 2010, NAT RES CONS SERV CO; WANG B, 1990, GRASSLAND CHINA, V12, P17; Wang QuanZhen, 2001, Grassland of China, V23, P35; Wang QuanZhen, 2005, Acta Prataculturae Sinica, V14, P41; WANG QZ, 2004, J PLANT GENET RESOUR, V5, P324; WANG XR, 1996, MODERN FERTILIZER EX; Wang Yong, 2005, Grassland of China, V27, P66; Wang ZY, 2005, J PLANT PHYSIOL, V162, P103, DOI 10.1016/j.jplph.2004.07.009; Wang ZY, 2004, PLANT CELL REP, V22, P903, DOI 10.1007/s00299-004-0772-4; Yandell BS, 1997, PRACTICAL DATA ANAL; [No title captured]	61	12	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18245	10.1371/journal.pone.0018245	http://dx.doi.org/10.1371/journal.pone.0018245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533153	Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100002
J	Pennings, JLA; Rodenburg, W; Imholz, S; Koster, MPH; van Oostrom, CTM; Breit, TM; Schielen, PCJI; de Vries, A				Pennings, Jeroen L. A.; Rodenburg, Wendy; Imholz, Sandra; Koster, Maria P. H.; van Oostrom, Conny T. M.; Breit, Timo M.; Schielen, Peter C. J. I.; de Vries, Annemieke			Gene Expression Profiling in a Mouse Model Identifies Fetal Liver- and Placenta-Derived Potential Biomarkers for Down Syndrome Screening	PLOS ONE			English	Article							MATERNAL PLASMA; TS1CJE MOUSE; POSTNATAL-DEVELOPMENT; CRITICAL REGION; TRISOMY-21; SERUM; MICE; PHENOTYPES; HUMAN-CHROMOSOME-21; ABNORMALITIES	Background: As a first step to identify novel potential biomarkers for prenatal Down Syndrome screening, we analyzed gene expression in embryos of wild type mice and the Down Syndrome model Ts1Cje. Since current Down Syndrome screening markers are derived from placenta and fetal liver, these tissues were chosen as target. Methodology/Principal Findings: Placenta and fetal liver at 15.5 days gestation were analyzed by microarray profiling. We confirmed increased expression of genes located at the trisomic chromosomal region. Overall, between the two genotypes more differentially expressed genes were found in fetal liver than in placenta. Furthermore, the fetal liver data are in line with the hematological aberrations found in humans with Down Syndrome as well as Ts1Cje mice. Together, we found 25 targets that are predicted ( by Gene Ontology, UniProt, or the Human Plasma Proteome project) to be detectable in human serum. Conclusions/Significance: Fetal liver might harbor more promising targets for Down Syndrome screening studies. We expect these new targets will help focus further experimental studies on identifying and validating human maternal serum biomarkers for Down Syndrome screening.	[Pennings, Jeroen L. A.; Rodenburg, Wendy; Imholz, Sandra; van Oostrom, Conny T. M.; de Vries, Annemieke] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands; [Koster, Maria P. H.; Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening LIS, Bilthoven, Netherlands; [Breit, Timo M.] Univ Amsterdam UvA, MicroArray Dept MAD, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; University of Amsterdam	Pennings, JLA (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands.	Jeroen.Pennings@rivm.nl	Schielen, Peter/AAP-4539-2020	Pennings, Jeroen L.A./0000-0002-9188-6358				Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Baken Kirsten A, 2006, J Immunotoxicol, V3, P227, DOI 10.1080/15476910601023602; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carmichael CL, 2009, BLOOD, V113, P1929, DOI 10.1182/blood-2008-06-161422; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Cho CKJ, 2010, J PROTEOME RES, V9, P3574, DOI 10.1021/pr100088k; Chou CY, 2008, MAMM GENOME, V19, P398, DOI 10.1007/s00335-008-9121-1; Chung IH, 2005, J KOREAN MED SCI, V20, P82, DOI 10.3346/jkms.2005.20.1.82; Cuckle H, 2005, SEMIN PERINATOL, V29, P252, DOI 10.1053/j.semperi.2005.05.004; CUCKLE HS, 1987, BRIT J OBSTET GYNAEC, V94, P387, DOI 10.1111/j.1471-0528.1987.tb03115.x; Dauphinot L, 2005, HUM MOL GENET, V14, P373, DOI 10.1093/hmg/ddi033; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; Delabar JM, 2006, THESCIENTIFICWORLDJO, V6, P1945, DOI 10.1100/tsw.2006.322; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Gahtan E, 1998, EUR J NEUROSCI, V10, P538, DOI 10.1046/j.1460-9568.1998.00058.x; Gardiner K, 2006, AM J MED GENET C, V142C, P196, DOI 10.1002/ajmg.c.30098; GROPP A, 1975, CYTOGENET CELL GENET, V14, P42, DOI 10.1159/000130318; Gross SJ, 2002, AM J OBSTET GYNECOL, V187, P457, DOI 10.1067/mob.2002.123542; Hewitt CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011561; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kolialexi A, 2008, PRENATAL DIAG, V28, P691, DOI 10.1002/pd.2040; Kolla V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/952047; Koster MPH, 2009, PRENATAL DIAG, V29, P857, DOI 10.1002/pd.2294; Koster MPH, 2010, EXPERT REV MOL DIAGN, V10, P445, DOI 10.1586/ERM.10.32; Kudo LC, 2010, HUM MOL GENET, V19, P3233, DOI 10.1093/hmg/ddq232; Laffaire J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-138; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; Nagalla SR, 2007, J PROTEOME RES, V6, P1245, DOI 10.1021/pr060539h; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Olson LE, 2007, HUM MOL GENET, V16, P774, DOI 10.1093/hmg/ddm022; Oudejans CBM, 2003, CLIN CHEM, V49, P1445, DOI 10.1373/49.9.1445; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Patterson D, 2005, NAT REV GENET, V6, P137, DOI 10.1038/nrg1525; Pennings JLA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008010; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Potier MC, 2006, J NEUROCHEM, V97, P104, DOI 10.1111/j.1471-4159.2005.03624.x; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Rozovski U, 2007, HUM REPROD, V22, P2538, DOI 10.1093/humrep/dem214; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Schielen PCJI, 2006, PRENATAL DIAG, V26, P711, DOI 10.1002/pd.1486; Seregaza Z, 2006, BEHAV GENET, V36, P387, DOI 10.1007/s10519-006-9056-9; Shinohara T, 2001, HUM MOL GENET, V10, P1163, DOI 10.1093/hmg/10.11.1163; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsui DWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015069; Wald NJ, 1997, PRENATAL DIAG, V17, P821, DOI 10.1002/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.3.CO;2-X; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883; Wortelboer EJ, 2009, PRENATAL DIAG, V29, P588, DOI 10.1002/pd.2247; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	53	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18866	10.1371/journal.pone.0018866	http://dx.doi.org/10.1371/journal.pone.0018866			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533146	Green Submitted, gold, Green Published			2022-12-25	WOS:000289505600041
J	Sjodahl, G; Lauss, M; Gudjonsson, S; Liedberg, F; Hallden, C; Chebil, G; Mansson, W; Hoglund, M; Lindgren, D				Sjodahl, Gottfrid; Lauss, Martin; Gudjonsson, Sigurdur; Liedberg, Fredrik; Hallden, Christer; Chebil, Gunilla; Mansson, Wiking; Hoglund, Mattias; Lindgren, David			A Systematic Study of Gene Mutations in Urothelial Carcinoma; Inactivating Mutations in TSC2 and PIK3R1	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; BETA-CATENIN; SOMATIC MUTATIONS; MAMMALIAN TARGET; FGFR3 MUTATIONS; HA-RAS; BLADDER; RAPAMYCIN; PATHWAY; GROWTH	Background: Urothelial carcinoma (UC) is characterized by frequent gene mutations of which activating mutations in FGFR3 are the most frequent. Several downstream targets of FGFR3 are also mutated in UC, e.g., PIK3CA, AKT1, and RAS. Most mutation studies of UCs have been focused on single or a few genes at the time or been performed on small sample series. This has limited the possibility to investigate co-occurrence of mutations. Methodology/Principal Findings: We performed mutation analyses of 16 genes, FGFR3, PIK3CA, PIK3R1 PTEN, AKT1, KRAS, HRAS, NRAS, BRAF, ARAF, RAF1, TSC1, TSC2, APC, CTNNB1, and TP53, in 145 cases of UC. We show that FGFR3 and PIK3CA mutations are positively associated. In addition, we identified PIK3R1 as a target for mutations. We demonstrate a negative association at borderline significance between FGFR3 and RAS mutations, and show that these mutations are not strictly mutually exclusive. We show that mutations in BRAF, ARAF, RAF1 rarely occurs in UC. Our data emphasize the possible importance of APC signaling as 6% of the investigated tumors either showed inactivating APC or activating CTNNB1 mutations. TSC1, as well as TSC2, that constitute the mTOR regulatory tuberous sclerosis complex were found to be mutated at a combined frequency of 15%. Conclusions/Significance: Our data demonstrate a significant association between FGFR3 and PIK3CA mutations in UC. Moreover, the identification of mutations in PIK3R1 further emphasizes the importance of the PI3-kinase pathway in UC. The presence of TSC2 mutations, in addition to TSC1 mutations, underlines the involvement of mTOR signaling in UC.	[Sjodahl, Gottfrid; Lauss, Martin; Hoglund, Mattias; Lindgren, David] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Lund, Sweden; [Gudjonsson, Sigurdur; Liedberg, Fredrik; Mansson, Wiking] Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Liedberg, Fredrik] Vaxjo Cty Hosp, Urol Sect, Vaxjo, Sweden; [Lindgren, David] Lund Univ, Skane Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden; [Chebil, Gunilla] Helsingborg Hosp, Dept Pathol, Helsingborg, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Helsingborgs Hospital	Sjodahl, G (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci, Lund, Sweden.	mattias.hoglund@med.lu.se	Gudjonsson, S./K-6878-2015	Gudjonsson, S./0000-0002-5147-595X; Sjodahl, Gottfrid/0000-0002-7869-0473; Hoglund, Mattias/0000-0001-9283-4421	Swedish Cancer Society; Swedish Research Council; Gunnar, Arvid and Elisabeth Nilsson Cancer Foundation; Crafoord Foundation; Lund University; Swedish Society for Medical Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar, Arvid and Elisabeth Nilsson Cancer Foundation; Crafoord Foundation; Lund University; Swedish Society for Medical Research	This investigation was supported by The Swedish Cancer Society; The Swedish Research Council; The Gunnar, Arvid and Elisabeth Nilsson Cancer Foundation; The Crafoord Foundation; Lund University Research Funds; and the Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Askham JM, 2010, ONCOGENE, V29, P150, DOI 10.1038/onc.2009.315; Aveyard JS, 1999, BRIT J CANCER, V80, P904, DOI 10.1038/sj.bjc.6690439; Bakkar AA, 2003, CANCER RES, V63, P8108; Boulalas I, 2009, J UROLOGY, V181, P2312, DOI 10.1016/j.juro.2009.01.011; Boulalas I, 2009, INT J BIOL MARKER, V24, P17, DOI 10.1177/172460080902400103; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cairns P, 1998, ONCOGENE, V16, P3215, DOI 10.1038/sj.onc.1201855; Cattan N, 2000, ONCOL REP, V7, P497; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Garcia JA, 2008, MOL CANCER THER, V7, P1347, DOI 10.1158/1535-7163.MCT-07-2408; Gust KM, 2009, CANCER BIOL THER, V8, P2348, DOI 10.4161/cbt.8.24.10296; Hansel DE, 2010, AM J PATHOL, V176, P3062, DOI 10.2353/ajpath.2010.090872; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Hou GQ, 2010, CANCER LETT, V290, P248, DOI 10.1016/j.canlet.2009.09.015; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Kalinsky K, 2009, CLIN CANCER RES, V15, P5049, DOI 10.1158/1078-0432.CCR-09-0632; Kastritis E, 2009, INT J CANCER, V124, P103, DOI 10.1002/ijc.23917; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Lagarde A, 2010, J MED GENET, V47, P721, DOI 10.1136/jmg.2010.078964; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200; Olderoy G, 1998, ANTICANCER RES, V18, P2675; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Przybojewska B, 2000, CANCER GENET CYTOGEN, V121, P73, DOI 10.1016/S0165-4608(00)00223-5; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Rosner M, 2004, AMINO ACIDS, V27, P119, DOI 10.1007/s00726-004-0119-z; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Seager CM, 2009, CANCER PREV RES, V2, P1008, DOI 10.1158/1940-6207.CAPR-09-0169; Shiina H, 2002, J UROLOGY, V168, P2220, DOI 10.1016/S0022-5347(05)64359-5; Shiina H, 2001, CANCER RES, V61, P7101; Stoehr R, 2002, INT J ONCOL, V20, P905; Svirshchevskaya EV, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-176; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; van Rhijn BSW, 2004, CANCER RES, V64, P1911, DOI 10.1158/0008-5472.CAN-03-2421; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; Yu K, 2010, CANCER RES, V70, P621, DOI 10.1158/0008-5472.CAN-09-2340; Zhu XD, 2000, PATHOL INT, V50, P945, DOI 10.1046/j.1440-1827.2000.01139.x	47	80	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18583	10.1371/journal.pone.0018583	http://dx.doi.org/10.1371/journal.pone.0018583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533174	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600011
J	Driscoll, EE; Hoffman, JI; Green, LE; Medley, GF; Amos, W				Driscoll, Erin E.; Hoffman, Joseph I.; Green, Laura E.; Medley, Graham F.; Amos, William			A Preliminary Study of Genetic Factors That Influence Susceptibility to Bovine Tuberculosis in the British Cattle Herd	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX DISEASE GENES; MYCOBACTERIUM-BOVIS; WILD BOAR; POPULATION STRATIFICATION; GAMMA-INTERFERON; MARKERS; IDENTIFICATION; HUMANS; ALLELE	Associations between specific host genes and susceptibility to Mycobacterial infections such as tuberculosis have been reported in several species. Bovine tuberculosis (bTB) impacts greatly the UK cattle industry, yet genetic predispositions have yet to be identified. We therefore used a candidate gene approach to study 384 cattle of which 160 had reacted positively to an antigenic skin test ('reactors'). Our approach was unusual in that it used microsatellite markers, embraced high breed diversity and focused particularly on detecting genes showing heterozygote advantage, a mode of action often overlooked in SNP-based studies. A panel of neutral markers was used to control for population substructure and using a general linear model-based approach we were also able to control for age. We found that substructure was surprisingly weak and identified two genomic regions that were strongly associated with reactor status, identified by markers INRA111 and BMS2753. In general the strength of association detected tended to vary depending on whether age was included in the model. At INRA111 a single genotype appears strongly protective with an overall odds ratio of 2.2, the effect being consistent across nine diverse breeds. Our results suggest that breeding strategies could be devised that would appreciably increase genetic resistance of cattle to bTB (strictly, reduce the frequency of incidence of reactors) with implications for the current debate concerning badger-culling.	[Driscoll, Erin E.; Hoffman, Joseph I.; Amos, William] Univ Cambridge, Dept Zool, Cambridge, England; [Green, Laura E.; Medley, Graham F.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Cambridge; University of Warwick	Driscoll, EE (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	ed319@cam.ac.uk	Hoffman, Joseph i/K-7725-2012; Medley, Graham/B-7289-2008; Green, Laura/G-8345-2011	Hoffman, Joseph i/0000-0001-5895-8949; Medley, Graham/0000-0002-0030-7278; Green, Laura/0000-0003-2957-8773	slush fund	slush fund	This study was conducted as part of a self-financed PhD, with labwork supported by a "slush fund." Minor additional contributions came from Clare Hall College and DEFRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Allen AR, 2010, P ROY SOC B-BIOL SCI, V277, P2737, DOI 10.1098/rspb.2010.0830; AMOS W, 2010, P R SOC B IN PRESS; AMOS W, 2010, P R SOC B; Amos W, 2009, MOL ECOL RESOUR, V9, P1102, DOI 10.1111/j.1755-0998.2009.02560.x; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bellamy R, 1998, CURR OPIN IMMUNOL, V10, P483, DOI 10.1016/S0952-7915(98)80125-8; Bennett S, 2002, AM J EPIDEMIOL, V155, P1074, DOI 10.1093/aje/155.11.1074; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; Bourne J., 2007, BOVINE TB SCI EVIDEN; Buddle BM, 2005, VET IMMUNOL IMMUNOP, V108, P45, DOI 10.1016/j.vetimm.2005.08.002; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carrique-Mas JJ, 2008, PREV VET MED, V84, P85, DOI 10.1016/j.prevetmed.2007.11.001; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Estrada-Chavez C, 2001, INFECT IMMUN, V69, P7165, DOI 10.1128/IAI.69.11.7165-7168.2001; Fernando SL, 2006, IMMUNOL CELL BIOL, V84, P125, DOI 10.1111/j.1440-1711.2006.01420.x; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V129, P119, DOI 10.1016/j.vetimm.2008.12.012; Garnett BT, 2002, P ROY SOC B-BIOL SCI, V269, P1487, DOI 10.1098/rspb.2002.2072; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Li MH, 2010, ANIM GENET, V41, P150, DOI 10.1111/j.1365-2052.2009.01980.x; Lyons EJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-55; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Messaoudi I, 2002, SCIENCE, V298, P1797, DOI 10.1126/science.1076064; Novoa MA, 2010, J ANIM BREED GENET, V127, P161, DOI 10.1111/j.1439-0388.2009.00811.x; Ohashi J, 2001, J HUM GENET, V46, P478, DOI 10.1007/s100380170048; Ohashi J, 2001, ANN HUM GENET, V65, P197, DOI 10.1017/S000348000100851X; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2009, R FDN STAT COMP; RAMIREZVILLESCU.AM, 2009, VET MED, V92, P188; Schulman NF, 2004, J DAIRY SCI, V87, P443, DOI 10.3168/jds.S0022-0302(04)73183-5; Schulze TG, 2002, AM J MED GENET, V114, P1, DOI 10.1002/ajmg.10042; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Slate J, 2006, CURR BIOL, V16, pR790, DOI 10.1016/j.cub.2006.08.047; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Suekawa Y, 2010, MEAT SCI, V85, P285, DOI 10.1016/j.meatsci.2010.01.015; Waters WR, 2003, CLIN DIAGN LAB IMMUN, V10, P960, DOI 10.1128/CDLI.10.5.960-966.2003; Yoo YJ, 2010, GENET EPIDEMIOL, V34, P107, DOI 10.1002/gepi.20438; 2008, DEFRA EXPENDITURE RE	46	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18806	10.1371/journal.pone.0018806	http://dx.doi.org/10.1371/journal.pone.0018806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533277	Green Submitted, Green Published, gold			2022-12-25	WOS:000289404700036
J	Mavridou, DAI; Saridakis, E; Kritsiligkou, P; Goddard, AD; Stevens, JM; Ferguson, SJ; Redfield, C				Mavridou, Despoina A. I.; Saridakis, Emmanuel; Kritsiligkou, Paraskevi; Goddard, Alan D.; Stevens, Julie M.; Ferguson, Stuart J.; Redfield, Christina			Oxidation State-dependent Protein-Protein Interactions in Disulfide Cascades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C MATURATION; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BOND FORMATION; ACTIVE-SITE; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; DSBD; ISOMERASE	Bacterial growth and pathogenicity depend on the correct formation of disulfide bonds, a process controlled by the Dsb system in the periplasm of Gram-negative bacteria. Proteins with a thioredoxin fold play a central role in this process. A general feature of thiol-disulfide exchange reactions is the need to avoid a long lived product complex between protein partners. We use a multidisciplinary approach, involving NMR, x-ray crystallography, surface plasmon resonance, mutagenesis, and in vivo experiments, to investigate the interaction between the two soluble domains of the transmembrane reductant conductor DsbD. Our results show oxidation state-dependent affinities between these two domains. These observations have implications for the interactions of the ubiquitous thioredoxin-like proteins with their substrates, provide insight into the key role played by a unique redox partner with an immunoglobulin fold, and are of general importance for oxidative protein-folding pathways in all organisms.	[Mavridou, Despoina A. I.; Kritsiligkou, Paraskevi; Goddard, Alan D.; Stevens, Julie M.; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Saridakis, Emmanuel] Natl Ctr Sci Res Demokritos, Inst Phys Chem, GR-15310 Athens, Greece	University of Oxford; National Centre of Scientific Research "Demokritos"	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk	Kritsiligkou, Paraskevi/W-9399-2019; Goddard, Alan/E-9328-2013; Mavridou, Despoina/ABG-5940-2020	Kritsiligkou, Paraskevi/0000-0003-2452-141X; Mavridou, Despoina/0000-0002-7449-1151; Goddard, Alan/0000-0003-4950-7470; Redfield, Christina/0000-0001-7297-7708	Wellcome Trust [079440, 092532]; Value-in-People Award; Edward Penley Abraham Cephalosporin Fund; EMBL Hamburg [RII3-CT-2004-506008]; Biotechnology and Biological Sciences Research Council [BBE004865/1, BBD523019/1]	Wellcome Trust(Wellcome TrustEuropean Commission); Value-in-People Award; Edward Penley Abraham Cephalosporin Fund; EMBL Hamburg; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Wellcome Trust Grants 079440 and 092532 and a Value-in-People Award.; Supported by the Edward Penley Abraham Cephalosporin Fund.; Supported by EMBL Hamburg (Research Infrastructure Action under the "Structuring the European Research Area Programme" RII3-CT-2004-506008).; Supported by Biotechnology and Biological Sciences Research Council Grants BBE004865/1 and BBD523019/1.	Ausubel F. M., 1988, CURRENT PROTOCOLS MO; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; COLE JA, 1974, J GEN MICROBIOL, V85, P11, DOI 10.1099/00221287-85-1-11; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Goddard AD, 2010, J BIOL CHEM, V285, P22880, DOI 10.1074/jbc.M110.133421; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Gordon EHJ, 2003, J BIOL CHEM, V278, P11773, DOI 10.1074/jbc.M211886200; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Heras B, 2007, CURR OPIN STRUC BIOL, V17, P691, DOI 10.1016/j.sbi.2007.08.009; Heras B, 2010, J BIOL CHEM, V285, P18423, DOI 10.1074/jbc.M110.101360; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Mavridou DAI, 2009, J BIOL CHEM, V284, P3219, DOI 10.1074/jbc.M805963200; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Pan JL, 2008, J MOL BIOL, V377, P1433, DOI 10.1016/j.jmb.2008.01.058; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; POPE NR, 1982, J GEN MICROBIOL, V128, P219; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Quinternet M, 2008, BIOCHEMISTRY-US, V47, P8577, DOI 10.1021/bi800884w; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Rozhkova A, 2008, J MOL BIOL, V380, P783, DOI 10.1016/j.jmb.2008.05.050; Rozhkova A, 2007, J MOL BIOL, V367, P1162, DOI 10.1016/j.jmb.2006.12.033; Stevens JM, 2004, FEBS LETT, V576, P81, DOI 10.1016/j.febslet.2004.08.067; Stewart EJ, 1999, EMBO J, V18, P5963, DOI 10.1093/emboj/18.21.5963; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vlamis-Gardikas A, 2008, BBA-GEN SUBJECTS, V1780, P1170, DOI 10.1016/j.bbagen.2008.03.013	56	19	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24943	24956		10.1074/jbc.M111.236141	http://dx.doi.org/10.1074/jbc.M111.236141			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21543317	Green Published, hybrid			2022-12-25	WOS:000292547900043
J	Chang, N; Liang, T; Lin, XG; Kang, YH; Xie, HL; Feng, ZP; Gaisano, HY				Chang, Nathan; Liang, Tao; Lin, Xianguang; Kang, Youhou; Xie, Huanli; Feng, Zhong-Ping; Gaisano, Herbert Y.			Syntaxin-1A Interacts with Distinct Domains within Nucleotide-binding Folds of Sulfonylurea Receptor 1 to Inhibit beta-Cell ATP-sensitive Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; K+ CHANNELS; SUR1; COMPLEX; GLIBENCLAMIDE; PROTEINS; SUBUNIT; FUSION; MGADP	The ATP-sensitive potassium (K-ATP) channel regulates pancreatic beta-cell function by linking metabolic status to electrical activity. Syntaxin-1A (Syn-1A), a SNARE protein mediating exocytotic fusion, binds and inhibits the K-ATP channel via the nucleotide-binding folds (NBFs) of its sulfonylurea receptor-1 (SUR1) regulatory subunit. In this study, we elucidated the precise regions within the NBFs required for Syn-1A-mediated K-ATP inhibition, using in vitro binding assays, whole cell patch clamp and FRET assay. Specifically, NBF1 and NBF2 were each divided into three subregions, Walker A (W-A), signature sequence linker, and Walker B (W-B), to make GST fusion proteins. In vitro binding assays revealed that Syn-1A associates with W-A and W-B regions of both NBFs. Patch clamp recordings on INS-1 and primary rat beta-cells showed that Syn-1A-mediated channel inhibition was reversed by co-addition of NBF1-W-B (not NBF1-W-A), NBF2-W-A, and NBF2-W-B. The findings were corroborated by FRET studies showing that these truncates disrupted Syn-1A interactions with full-length SUR1. To further identify the binding sites, series single-site mutations were made in the Walker motifs of the NBFs. Only NBF1-W-A (K719M) or NBF2-W-A (K1385M) mutant no longer bound to Syn-1A; K1385M failed to disrupt Syn-1A-mediated inhibition of K-ATP channels. These data suggest that NBF1-W-A (Lys-719) and NBF2-W-A (Lys-1385) are critical for Syn-1A-K-ATP channel interaction. Taken together, Syn-1A intimately and functionally associates with the SUR1-NBF1/2 dimer via direct interactions with W-A motifs and sites adjacent to W-B motifs of NBF1 and NBF2 but transduces its inhibitory actions on K-ATP channel activity via some but not all of these NBF domains.	[Chang, Nathan; Liang, Tao; Lin, Xianguang; Kang, Youhou; Xie, Huanli; Feng, Zhong-Ping; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Hlth Network, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gaisano, HY (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes for Health Research [MOP 69083]; Heart and Stroke Foundation of Ontario [T-6064]; Heart and Stroke Foundation of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by Canadian Institutes for Health Research Grant MOP 69083 and Heart and Stroke Foundation of Ontario Grant T-6064 (to H. Y. G.).; Recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada.	Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashford M L, 1986, Adv Exp Med Biol, V211, P69; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Campbell JD, 2003, EMBO REP, V4, P1038, DOI 10.1038/sj.embor.7400003; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Cui NG, 2004, J BIOL CHEM, V279, P53259, DOI 10.1074/jbc.M410171200; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Kang YH, 2011, J BIOL CHEM, V286, P5876, DOI 10.1074/jbc.M109.089607; Lang Thorsten, 2008, V184, P107; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Matsuo M, 2005, J MOL CELL CARDIOL, V38, P907, DOI 10.1016/j.yjmcc.2004.11.021; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Michaelevski L, 2002, J BIOL CHEM, V277, P34909, DOI 10.1074/jbc.M203943200; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; NIKI I, 1990, BIOCHEM J, V268, P713, DOI 10.1042/bj2680713; Pasyk EA, 2004, J BIOL CHEM, V279, P4234, DOI 10.1074/jbc.M309667200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Uhde I, 1999, J BIOL CHEM, V274, P28079, DOI 10.1074/jbc.274.40.28079; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313	33	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23308	23318		10.1074/jbc.M111.217950	http://dx.doi.org/10.1074/jbc.M111.217950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540180	Green Published, hybrid			2022-12-25	WOS:000292025000063
J	Huang, W; Bansode, RR; Xie, Y; Rowland, L; Mehta, M; Davidson, NO; Mehta, KD				Huang, Wei; Bansode, Rishipal R.; Xie, Yan; Rowland, Leslie; Mehta, Madhu; Davidson, Nicholas O.; Mehta, Kamal D.			Disruption of the Murine Protein Kinase C beta Gene Promotes Gallstone Formation and Alters Biliary Lipid and Hepatic Cholesterol Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY RAT HEPATOCYTES; X RECEPTOR-ALPHA; 7-ALPHA-HYDROXYLASE GENE; BILE-ACIDS; DIETARY FATS; CELL DIFFERENTIATION; GALLBLADDER MOTILITY; INSULIN-RECEPTOR; WEIGHT-LOSS; PKC-BETA	The protein kinase C (PKC) family of Ca2+ and/or lipid-activated serine-threonine protein kinases is implicated in the pathogenesis of obesity and insulin resistance. We recently reported that protein kinase C beta(PKC beta), a calcium-, diacylglycerol-, and phospholipid-dependent kinase, is critical for maintaining whole body triglyceride homeostasis. We now report that PKC beta deficiency has profound effects on murine hepatic cholesterol metabolism, including hypersensitivity to diet-induced gallstone formation. The incidence of gallstones increased from 9% in control mice to 95% in PKC beta(-/-) mice. Gallstone formation in the mutant mice was accompanied by hyposecretion of bile acids with no alteration in fecal bile acid excretion, increased biliary cholesterol saturation and hydrophobicity indices, as well as hepatic p42/44(MAPK) activation, all of which enhance susceptibility to gallstone formation. Lithogenic diet-fed PKC beta(-/-) mice also displayed decreased expression of hepatic cholesterol-7 alpha-hydroxylase (CYP7A1) and sterol 12 alpha-hydroxylase (CYP8b1). Finally, feeding a modified lithogenic diet supplemented with milk fat, instead of cocoa butter, both increased the severity of and shortened the interval for gallstone formation in PKC beta(-/-) mice and was associated with dramatic increases in cholesterol saturation and hydrophobicity indices. Taken together, the findings reveal a hitherto unrecognized role of PKC beta in fine tuning diet-induced cholesterol and bile acid homeostasis, thus identifying PKC beta as a major physiological regulator of both triglyceride and cholesterol homeostasis.	[Huang, Wei; Bansode, Rishipal R.; Rowland, Leslie; Mehta, Kamal D.] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Mehta, Madhu] Ohio State Univ, Coll Med, Dept Med, Columbus, OH 43210 USA; [Xie, Yan; Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL)	Mehta, KD (corresponding author), Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Dept Mol & Cellular Biochem, 464 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	Mehta.80@osu.edu	Huang, Wei/E-3270-2011; Bansode, Rishipal/E-9293-2010	Bansode, Rishipal/0000-0001-7826-2711	National Institutes of Health [HL79091, DK56260, HL-38180, DK52574]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038180, R01HL038180, R01HL079091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, R01DK056260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL79091 (to K. D. M.) and DK56260, HL-38180, and DK52574 (to N. O. D.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Amigo L, 2000, GASTROENTEROLOGY, V118, P772, DOI 10.1016/S0016-5085(00)70147-8; Bansode RR, 2008, J BIOL CHEM, V283, P231, DOI 10.1074/jbc.M707268200; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Blanquart C, 2004, MOL ENDOCRINOL, V18, P1906, DOI 10.1210/me.2003-0327; Bouchard G, 2002, J LIPID RES, V43, P1105, DOI 10.1194/jlr.M200102-JLR200; BOUSCAREL B, 1995, AM J PHYSIOL-GASTR L, V268, pG300, DOI 10.1152/ajpgi.1995.268.2.G300; CAREY MC, 1978, J LIPID RES, V19, P945; Cheema SK, 1997, J LIPID RES, V38, P315; Couture P, 1999, J LIPID RES, V40, P1883; Crestani M, 1998, J LIPID RES, V39, P2192; Davis RA, 2002, J LIPID RES, V43, P533; Delvecchio CJ, 2008, J ENDOCRINOL, V197, P121, DOI 10.1677/JOE-07-0525; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P1619; DUAN RD, 1995, AM J PHYSIOL-GASTR L, V268, pG1060, DOI 10.1152/ajpgi.1995.268.6.G1060; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; EVERHART JE, 1993, ANN INTERN MED, V119, P1029, DOI 10.7326/0003-4819-119-10-199311150-00010; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gbaguidi GF, 2004, NUCLEIC ACIDS RES, V32, P1113, DOI 10.1093/nar/gkh260; Gineste R, 2008, MOL ENDOCRINOL, V22, P2433, DOI 10.1210/me.2008-0092; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Graewin SJ, 2004, J GASTROINTEST SURG, V8, P824, DOI 10.1016/j.gassur.2004.06.014; Graewin SJ, 2004, SURGERY, V136, P431, DOI 10.1016/j.surg.2004.05.020; Grundy SM, 2004, AM J CLIN NUTR, V80, P1; Gupta S, 2001, J BIOL CHEM, V276, P15816, DOI 10.1074/jbc.M010878200; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Hyogo H, 2003, J LIPID RES, V44, P1232, DOI 10.1194/jlr.M300029-JLR200; Hyogo H, 2002, J BIOL CHEM, V277, P34117, DOI 10.1074/jbc.M203912200; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Ishizuka T, 2004, ENDOCR RES, V30, P287, DOI 10.1081/ERC-120039580; Jiang ZY, 2004, WORLD J GASTROENTERO, V10, P1508; JONNALAGADDA SS, 1995, LIPIDS, V30, P415, DOI 10.1007/BF02536299; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kano M, 2002, J LAB CLIN MED, V139, P285, DOI 10.1067/mlc.2002.122863; Kuroki T, 2000, MUTAT RES-REV MUTAT, V462, P189, DOI 10.1016/S1383-5742(00)00036-3; Lammert F, 2001, GASTROENTEROLOGY, V120, P221, DOI 10.1053/gast.2001.20878; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li Y, 2005, LIPIDS, V40, P455, DOI 10.1007/s11745-005-1404-2; Lyons MA, 2005, MAMM GENOME, V16, P152, DOI 10.1007/s00335-004-2446-5; Lyons MA, 2006, GASTROENTEROLOGY, V131, P1943, DOI 10.1053/j.gastro.2006.10.024; Marrapodi M, 2000, J LIPID RES, V41, P514; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mendez-Sanchez N, 2003, FRONT BIOSCI-LANDMRK, V8, pE420, DOI 10.2741/1110; Mendez-Sanchez N, 2007, CLIN CHIM ACTA, V376, P1, DOI 10.1016/j.cca.2006.08.036; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Misciagna G, 1999, AM J CLIN NUTR, V69, P120; Miyake JH, 2002, ARTERIOSCL THROM VAS, V22, P121, DOI 10.1161/hq0102.102588; Miyasaka K, 2002, J GASTROENTEROL, V37, P102, DOI 10.1007/BF03326426; Mizuguchi K., 1997, NIPPON YAKURIGAKU ZA, V110, p50P; NISHINA PM, 1993, J LIPID RES, V34, P1413; NISHINA PM, 1990, J LIPID RES, V31, P859; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Ohshima A, 1996, LIPIDS, V31, P949, DOI 10.1007/BF02522688; Ortega RM, 1997, J AM COLL NUTR, V16, P88, DOI 10.1080/07315724.1997.10718655; Osterhoff MA, 2008, MOL GENET METAB, V93, P210, DOI 10.1016/j.ymgme.2007.09.004; Paigen B., 2002, GENETIC BASIS COMMON, P298; Pandak WM, 2001, GASTROENTEROLOGY, V120, P1801, DOI 10.1053/gast.2001.24833; Patel NA, 2004, MOL ENDOCRINOL, V18, P899, DOI 10.1210/me.2003-0391; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Rask-Madsen C, 2005, ARTERIOSCL THROM VAS, V25, P487, DOI 10.1161/01.ATV.0000155325.41507.e0; RINCHIK EM, 1992, MAMM GENOME, V3, pS104, DOI 10.1007/BF00648425; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Schafer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173; SHMUELI E, 1993, J INTERN MED, V234, P397, DOI 10.1111/j.1365-2796.1993.tb00761.x; Song KH, 2007, HEPATOLOGY, V46, P1993, DOI 10.1002/hep.21878; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; STRAVITZ RT, 1995, J LIPID RES, V36, P1359; Stravitz RT, 1996, AM J PHYSIOL-GASTR L, V271, pG293, DOI 10.1152/ajpgi.1996.271.2.G293; TANG EY, 1993, FEBS LETT, V326, P117, DOI 10.1016/0014-5793(93)81774-T; Tran KQ, 2003, J SURG RES, V113, P56, DOI 10.1016/S0022-4804(03)00157-4; TURLEY SD, 1978, J LIPID RES, V19, P924; Wang David Q-H, 2004, Curr Gastroenterol Rep, V6, P140, DOI 10.1007/s11894-004-0042-1; Wang DQH, 2009, J LIPID RES, V50, pS406, DOI 10.1194/jlr.R800075-JLR200; Wang SN, 2006, EUR J CLIN INVEST, V36, P176, DOI 10.1111/j.1365-2362.2006.01611.x; XIA P, 1994, DIABETES, V43, P1122, DOI 10.2337/diabetes.43.9.1122; Xie Y, 2009, J BIOL CHEM, V284, P16860, DOI 10.1074/jbc.M109.010173; Xie Y, 2009, J LIPID RES, V50, P977, DOI 10.1194/jlr.M800645-JLR200; Yamamoto T, 2010, J LIPID RES, V51, P1859, DOI 10.1194/jlr.M004234; Yan SF, 2006, J AM COLL CARDIOL, V48, pA47, DOI 10.1016/j.jacc.2006.05.063; YANG HY, 1992, DIGEST DIS SCI, V37, P912, DOI 10.1007/BF01300390; Zhu J, 2005, WORLD J GASTROENTERO, V11, P1685	86	12	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22795	22805		10.1074/jbc.M111.250282	http://dx.doi.org/10.1074/jbc.M111.250282			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550971	Green Published, hybrid			2022-12-25	WOS:000292025000014
J	Panter, G; Jerala, R				Panter, Gabriela; Jerala, Roman			The Ectodomain of the Toll-like Receptor 4 Prevents Constitutive Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; LPS BINDING-PROTEIN; LIPOPOLYSACCHARIDE LPS; NEUTROPHIL ELASTASE; SIGNAL-TRANSDUCTION; ADAPTIVE IMMUNITY; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; DENDRITIC CELLS; INNATE IMMUNITY	Toll-like receptor 4 (TLR4) is involved in activation of the innate immune response in a large number of different diseases. Despite numerous studies, the role of separate domains of TLR4 in the regulation of receptor activation is poorly understood. Replacement of the TLR4 ectodomain with LPS-binding proteins MD-2 or CD14 resulted in a robust ligand-independent constitutive activation comparable with the maximal stimulation of the receptor with LPS. The same effect was achieved by the replacement of the ectodomain with a monomeric fluorescent protein or a 24-kDa gyrase B fragment. This demonstrates an intrinsic dimerization propensity of the transmembrane and cytoplasmic domains of TLR4 and reveals a previously unknown function of the ectodomain in inhibiting spontaneous receptor dimerization. Constitutive activation was abolished by the replacement of the ectodomain by a bulkier protein ovalbumin. N-terminal deletion variants of TLR4 revealed that the smallest segment of the ectodomain that already prevents constitutive activity comprises only 90 residues (542 to 631) of the total 608 residues. We conclude that TLR4 represents a receptor with a low threshold of activation that can be rapidly activated by the release of inhibition exerted by its ectodomain. This is important for the sensitivity of TLR4 to activation by different agonists. The TLR4 ectodomain has multiple roles in enabling ligand regulated activation, providing proper localization while serving as an inhibitor to prevent spontaneous, ligand-independent dimerization.	[Panter, Gabriela; Jerala, Roman] Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Ljubljana 1000, Slovenia; [Panter, Gabriela; Jerala, Roman] Univ Ljubljana, Excellent NMR Future Innovat Sustainable Technol, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana; University of Ljubljana	Jerala, R (corresponding author), Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si			Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants from the Slovenian Research Agency.	Akashi-Takamura Sachiko, 2006, Journal of Infection and Chemotherapy, V12, P233, DOI 10.1007/s10156-006-0477-4; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Ashkar AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000233; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Brunn GJ, 2005, FASEB J, V19, P872, DOI 10.1096/fj.04-3211fje; Bulut Y, 2009, INFECT IMMUN, V77, P2683, DOI 10.1128/IAI.00248-09; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Farrar MA, 2000, METHOD ENZYMOL, V327, P421, DOI 10.1016/S0076-6879(00)27293-5; Fujimoto T, 2004, J BIOL CHEM, V279, P47431, DOI 10.1074/jbc.M408724200; Gay Nicholas J., 2008, V183, P181; GILBERT EJ, 1994, MOL MICROBIOL, V12, P365, DOI 10.1111/j.1365-2958.1994.tb01026.x; Gomi K, 2002, J IMMUNOL, V168, P2939, DOI 10.4049/jimmunol.168.6.2939; Hasan UA, 2004, BIOCHEM BIOPH RES CO, V321, P124, DOI 10.1016/j.bbrc.2004.06.134; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; HAZIOT A, 1988, J IMMUNOL, V141, P547; Hietaranta A, 2004, BIOCHEM BIOPH RES CO, V323, P192, DOI 10.1016/j.bbrc.2004.08.077; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawasaki K, 2003, J ENDOTOXIN RES, V9, P301, DOI 10.1179/096805103225002548; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Koskinen R, 1999, J IMMUNOL, V162, P4115; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lee HK, 2004, J BIOL CHEM, V279, P10564, DOI 10.1074/jbc.M311564200; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miguel RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000788; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Mossman KL, 2008, J IMMUNOL, V181, P6702, DOI 10.4049/jimmunol.181.10.6702; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Sasu S, 2001, CIRC RES, V89, P244, DOI 10.1161/hh1501.094184; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sepulveda FE, 2009, IMMUNITY, V31, P737, DOI 10.1016/j.immuni.2009.09.013; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Treeby M, 2009, BIOCHEM BIOPH RES CO, V381, P65, DOI 10.1016/j.bbrc.2009.02.017; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Veerman C, 2003, INT J BIOL MACROMOL, V33, P121, DOI 10.1016/S0141-8130(03)00076-X; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	67	37	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23334	23344		10.1074/jbc.M110.205419	http://dx.doi.org/10.1074/jbc.M110.205419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543336	Green Published, hybrid			2022-12-25	WOS:000292025000065
J	Susan-Resiga, D; Essalmani, R; Hamelin, J; Asselin, MC; Benjannet, S; Chamberland, A; Day, R; Szumska, D; Constam, D; Bhattacharya, S; Prat, A; Seidah, NG				Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Benjannet, Suzanne; Chamberland, Ann; Day, Robert; Szumska, Dorota; Constam, Daniel; Bhattacharya, Shoumo; Prat, Annik; Seidah, Nabil G.			Furin Is the Major Processing Enzyme of the Cardiac-specific Growth Factor Bone Morphogenetic Protein 10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE FURIN; CELL-SURFACE; IN-VITRO; PROTEOLYTIC ACTIVATION; PROHORMONE CONVERTASES; PRO-PROTEIN; INHIBITORS; EXPRESSION; IDENTIFICATION; PRECURSOR	Bone morphogenetic protein 10 (BMP10) is a member of the TGF-beta superfamily and plays a critical role in heart development. In the postnatal heart, BMP10 is restricted to the right atrium. The inactive pro-BMP10 (similar to 60 kDa) is processed into active BMP10 (similar to 14 kDa) by an unknown protease. Proteolytic cleavage occurs at the RIRR316 down arrow site (human), suggesting the involvement of proprotein convertase(s) (PCs). In vitro digestion of a 12-mer peptide encompassing the predicted cleavage site with furin, PACE4, PC5/6, and PC7, showed that furin cleaves the best, whereas PC7 is inactive on this peptide. Ex vivo studies in COS-1 cells, a cell line lacking PC5/6, revealed efficient processing of pro-BMP10 by endogenous PCs other than PC5/6. The lack of processing of overexpressed pro-BMP10 in the furin-and PACE4-deficient cell line, CHO-FD11, and in furin-deficient LoVo cells, was restored by stable (CHO-FD11/Fur cells) or transient (LoVo cells) expression of furin. Use of cell-permeable and cell surface inhibitors suggested that endogenous PCs process pro-BMP10 mostly intracellularly, but also at the cell surface. Ex vivo experiments in mouse primary hepatocytes (wild type, PC5/6 knock-out, and furin knock-out) corroborated the above findings that pro-BMP10 is a substrate for endogenous furin. Western blot analyses of heart right atria extracts from wild type and PACE4 knock-out adult mice showed no significant difference in the processing of pro-BMP10, implying no in vivo role of PACE4. Overall, our in vitro, ex vivo, and in vivo data suggest that furin is the major convertase responsible for the generation of BMP10.	[Susan-Resiga, Delia; Essalmani, Rachid; Hamelin, Josee; Asselin, Marie-Claude; Benjannet, Suzanne; Chamberland, Ann; Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Szumska, Dorota; Bhattacharya, Shoumo] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England; [Szumska, Dorota; Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Constam, Daniel] Swiss Inst Expt Canc Res, Sch Life Sci, Swiss Fed Inst Technol Lausanne, CH-1015 Lausanne, Switzerland	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Sherbrooke; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Seidah, NG (corresponding author), 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Prat, Annik/S-6757-2018; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Seidah, Nabil/I-3596-2013; Bhattacharya, Shoumo/F-4127-2010	Prat, Annik/0000-0002-8007-5277; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Seidah, Nabil/0000-0001-6503-9342; Bhattacharya, Shoumo/0000-0002-5571-0478; Szumska, Dorota/0000-0001-7764-9551; Constam, Daniel B./0000-0002-6256-3891	Canadian Institutes of Health Research [MOP-44363]; Strauss Foundation; Canada Chair [216684]; British Heart Foundation [CH/09/003]; Wellcome Trust [075491/Z/04];  [PG/08/045/25069]; British Heart Foundation [RG/10/17/28553, PG/07/045/22690] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); ; British Heart Foundation(British Heart Foundation)	This work was supported by Canadian Institutes of Health Research Grant MOP-44363, a Strauss Foundation grant, Canada Chair Grant 216684, British Heart Foundation Chair Award CH/09/003 (to S. Bhattacharya) and Project Grant Award PG/08/045/25069 (to S. B.), and Wellcome Trust Core Grant Award 075491/Z/04.	Bessa PC, 2009, PROTEIN EXPRES PURIF, V63, P89, DOI 10.1016/j.pep.2008.09.014; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Constam DB, 2000, DEVELOPMENT, V127, P245; Constam DB, 2000, GENE DEV, V14, P1146; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gordon VM, 1997, INFECT IMMUN, V65, P3370, DOI 10.1128/IAI.65.8.3370-3375.1997; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Lazure C, 1998, J BIOL CHEM, V273, P8572, DOI 10.1074/jbc.273.15.8572; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; PAQUET L, 1994, J BIOL CHEM, V269, P19279; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Roulet M, 2007, CELL TISSUE RES, V327, P323, DOI 10.1007/s00441-006-0294-1; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	46	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22785	22794		10.1074/jbc.M111.233577	http://dx.doi.org/10.1074/jbc.M111.233577			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550985	hybrid, Green Published			2022-12-25	WOS:000292025000013
J	Chiou, TT; Bonhomme, B; Jin, HB; Miralles, CP; Xiao, HY; Fu, ZY; Harvey, RJ; Harvey, K; Vicini, S; De Blas, AL				Chiou, Tzu-Ting; Bonhomme, Bevan; Jin, Hongbing; Miralles, Celia P.; Xiao, Haiyan; Fu, Zhanyan; Harvey, Robert J.; Harvey, Kirsten; Vicini, Stefano; De Blas, Angel L.			Differential Regulation of the Postsynaptic Clustering of gamma-Aminobutyric Acid Type A (GABA(A)) Receptors by Collybistin Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; INHIBITORY SYNAPSE FORMATION; GABAERGIC SYNAPSES; RAT-BRAIN; EXCHANGE FACTOR; IMMUNOCYTOCHEMICAL LOCALIZATION; NONSYNAPTIC LOCALIZATION; GLUTAMATERGIC SYNAPSES; MONOCLONAL-ANTIBODIES; GLYCINE RECEPTOR	Collybistin promotes submembrane clustering of gephyrin and is essential for the postsynaptic localization of gephyrin and gamma-aminobutyric acid type A (GABA(A)) receptors at GABAergic synapses in hippocampus and amygdala. Four collybistin isoforms are expressed in brain neurons; CB2 and CB3 differ in the C terminus and occur with and without the Src homology 3 (SH3) domain. We have found that in transfected hippocampal neurons, all collybistin isoforms (CB2(SH3+), CB2(SH3-), CB3(SH3+), and CB3(SH3-)) target to and concentrate at GABAergic postsynapses. Moreover, in non-transfected neurons, collybistin concentrates at GABAergic synapses. Hippocampal neurons co-transfected with CB2(SH3-) and gephyrin developed very large postsynaptic gephyrin and GABA(A) receptor clusters (superclusters). This effect was accompanied by a significant increase in the amplitude of miniature inhibitory postsynaptic currents. Co-transfection with CB2(SH3+) and gephyrin induced the formation of many (supernumerary) non-synaptic clusters. Transfection with gephyrin alone did not affect cluster number or size, but gephyrin potentiated the clustering effect of CB2(SH3-) or CB2(SH3+). Co-transfection with CB2(SH3-) or CB2(SH3+) and gephyrin did not affect the density of presynaptic GABAergic terminals contacting the transfected cells, indicating that collybistin is not synaptogenic. Nevertheless, the synaptic superclusters induced by CB2(SH3-) and gephyrin were accompanied by enlarged presynaptic GABAergic terminals. The enhanced clustering of gephyrin and GABA(A) receptors induced by collybistin isoforms was not accompanied by enhanced clustering of neuroligin 2. Moreover, during the development of GABAergic synapses, the clustering of gephyrin and GABA(A) receptors preceded the clustering of neuroligin 2. We propose a model in which the SH3- isoforms play a major role in the postsynaptic accumulation of GABA(A) receptors and in GABAergic synaptic strength.	[Chiou, Tzu-Ting; Bonhomme, Bevan; Jin, Hongbing; Miralles, Celia P.; Xiao, Haiyan; De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Fu, Zhanyan; Vicini, Stefano] Georgetown Univ Sch Med, Dept Physiol & Biophys, Washington, DC 20057 USA; [Harvey, Robert J.; Harvey, Kirsten] Univ London, Sch Pharm, Dept Pharmacol, London WC1N 1AX, England	University of Connecticut; Georgetown University; University of London; University College London; University of London School of Pharmacy	De Blas, AL (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	angel.deblas@uconn.edu	Harvey, Robert/D-3994-2016	Harvey, Robert/0000-0001-5956-6664; Vicini, Stefano/0000-0001-8671-5194	National Institutes of Health (NIH), NINDS [NS38752]; NIH, NIMH [MH085224]; Medical Research Council [G0501258]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038752] Funding Source: NIH RePORTER; Medical Research Council [G0800498] Funding Source: researchfish; MRC [G0501258, G0800498] Funding Source: UKRI	National Institutes of Health (NIH), NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NINDS, Grant NS38752 (to A. L. D.) and NIH, NIMH, Grant MH085224 (to Z. F.). This work was also supported by Medical Research Council Grant G0501258 (to K. H.).	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Chandra D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-30; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Christie SB, 2003, J COMP NEUROL, V456, P361, DOI 10.1002/cne.10535; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Christie SB, 2002, PROG BRAIN RES, V136, P157; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; DEBLAS AL, 1988, J NEUROSCI, V8, P602; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; EWERT M, 1992, BRAIN RES, V569, P57, DOI 10.1016/0006-8993(92)90368-J; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Goslin K., 1998, CULTURING NERVE CELL, P339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kalscheuer VM, 2009, HUM MUTAT, V30, P61, DOI 10.1002/humu.20814; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Li X, 2007, J NEUROCHEM, V102, P1329, DOI 10.1111/j.1471-4159.2007.04635.x; Li XJ, 2009, J BIOL CHEM, V284, P17253, DOI 10.1074/jbc.M109.008870; Li YF, 2010, J COMP NEUROL, V518, P3439, DOI 10.1002/cne.22390; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Miralles CP, 1999, J COMP NEUROL, V413, P535; MORENO JI, 1994, J COMP NEUROL, V350, P260, DOI 10.1002/cne.903500209; MURASE K, 1989, NEUROSCI LETT, V103, P56, DOI 10.1016/0304-3940(89)90485-0; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Patrizi A, 2008, P NATL ACAD SCI USA, V105, P13151, DOI 10.1073/pnas.0802390105; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Riquelme R, 2002, J NEUROSCI, V22, P10720; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Studler B, 2005, J COMP NEUROL, V484, P344, DOI 10.1002/cne.20472; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; VITORICA J, 1988, J NEUROSCI, V8, P615; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Yu W, 2008, J NEUROCHEM, V105, P2300, DOI 10.1111/j.1471-4159.2008.05311.x; Yu WD, 2008, J NEUROCHEM, V104, P830, DOI 10.1111/j.1471-4159.2007.05014.x; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	76	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22456	22468		10.1074/jbc.M111.236190	http://dx.doi.org/10.1074/jbc.M111.236190			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540179	hybrid, Green Published			2022-12-25	WOS:000291719900054
J	Li, X; Wen, WH; Liu, KD; Zhu, F; Malakhova, M; Peng, C; Li, TT; Kim, HG; Ma, WY; Cho, YY; Bode, AM; Dong, ZM; Dong, ZG				Li, Xiang; Wen, Weihong; Liu, Kangdong; Zhu, Feng; Malakhova, Margarita; Peng, Cong; Li, Tingting; Kim, Hong-Gyum; Ma, Weiya; Cho, Yong Yeon; Bode, Ann M.; Dong, Ziming; Dong, Zigang			Phosphorylation of Caspase-7 by p21-activated Protein Kinase (PAK) 2 Inhibits Chemotherapeutic Drug-induced Apoptosis of Breast Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-PAK; ESTROGEN-RECEPTOR; TAMOXIFEN RESISTANCE; ACTIVATION; DEATH; EXPRESSION; GROWTH; AUTOPHOSPHORYLATION; ONCOLOGY; CLEAVAGE	p21-activated kinase (PAK) 2, a member of the PAK family of serine/threonine protein kinases, plays an important role in physiological processes such as motility, survival, mitosis, and apoptosis. However, the role of PAK2 in resistance to chemotherapy is unclear. Here we report that PAK2 is highly expressed in human breast cancer cell lines and human breast invasive carcinoma tissue compared with a human non-tumorigenic mammary epithelial cell line and adjacent normal breast tissue, respectively. Interestingly, we found that PAK2 can bind with caspase-7 and phosphorylate caspase-7 at the Ser-30, Thr-173, and Ser-239 sites. Functionally, the phosphorylation of caspase-7 decreases its activity, thereby inhibiting cellular apoptosis. Our data indicate that highly expressed PAK2 mediates chemotherapeutic resistance in human breast invasive ductal carcinoma by negatively regulating caspase-7 activity.	[Li, Xiang; Liu, Kangdong; Dong, Ziming] Zhengzhou Univ, Physiol & Pathophysiol Basic Med Sch, Zhengzhou 450001, Henan, Peoples R China; [Li, Xiang; Wen, Weihong; Liu, Kangdong; Zhu, Feng; Malakhova, Margarita; Peng, Cong; Kim, Hong-Gyum; Ma, Weiya; Cho, Yong Yeon; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Li, Tingting] Luoyang Cent Hosp, Dept Radiotherapy, Luoyang 471009, Henan, Peoples R China	Zhengzhou University; University of Minnesota System; Zhengzhou University	Dong, ZM (corresponding author), Zhengzhou Univ, Physiol & Pathophysiol Basic Med Sch, Zhengzhou 450001, Henan, Peoples R China.	dongzm@zzu.edu.cn; zgdong@hi.umn.edu	ZHU, Feng/G-3567-2010; ZHU, Feng/C-1303-2010; Cho, Yong-Yeon/AAD-4263-2020; peng, cong/A-9454-2012; 温, 家琦/GYV-3177-2022	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA077646, CA120388, CAR37CA081064, ES016548]; Hormel Foundation; Minnesota Partnership for Biotechnology and Medical Genomics Grant [L9046001101]; NATIONAL CANCER INSTITUTE [R01CA120388, R37CA081064, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; Minnesota Partnership for Biotechnology and Medical Genomics Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA120388, CAR37CA081064, and ES016548. This work was also supported by The Hormel Foundation and Minnesota Partnership for Biotechnology and Medical Genomics Grant L9046001101.	Arpino G, 2004, CLIN CANCER RES, V10, P5670, DOI 10.1158/1078-0432.CCR-04-0110; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; Cillessen SAGM, 2007, CLIN CANCER RES, V13, P7012, DOI 10.1158/1078-0432.CCR-06-2891; Dowsett M, 2005, ENDOCR-RELAT CANCER, V12, pS113, DOI 10.1677/erc.1.01044; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; Gee JM, 2005, ENDOCR-RELAT CANCER, V12, pS99, DOI 10.1677/erc.1.01005; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Haagenson KK, 2010, CANCER METAST REV, V29, P143, DOI 10.1007/s10555-010-9208-5; Hajra KM, 2004, APOPTOSIS, V9, P691, DOI 10.1023/B:APPT.0000045786.98031.1d; Hara S, 2001, J UROLOGY, V166, P2491, DOI 10.1016/S0022-5347(05)65622-4; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Hsu YH, 2008, J BIOL CHEM, V283, P36397, DOI 10.1074/jbc.M805581200; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200; Jakobi R, 2000, EUR J BIOCHEM, V267, P4414, DOI 10.1046/j.1432-1327.2000.01488.x; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Kim PKM, 2001, DRUG RESIST UPDATE, V4, P293, DOI 10.1054/drup.2001.0223; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Kuribayashi K, 2006, CANCER BIOL THER, V5, P763, DOI 10.4161/cbt.5.7.3228; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Lamkanfi M, 2009, BLOOD, V113, P2742, DOI 10.1182/blood-2008-09-178038; Li TT, 2011, CARCINOGENESIS, V32, P659, DOI 10.1093/carcin/bgq271; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marlin JW, 2009, NEOPLASIA, V11, P286, DOI 10.1593/neo.81446; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Nheu T, 2004, CELL CYCLE, V3, P71; Puglisi F, 2006, EXPERT OPIN PHARMACO, V7, P2309, DOI 10.1517/14656566.7.16.2309; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Tuazon PT, 2002, FEBS LETT, V515, P84, DOI 10.1016/S0014-5793(02)02444-4; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Yang XH, 1998, J BIOL CHEM, V273, P34278, DOI 10.1074/jbc.273.51.34278; 2003, CENT EUR J PUBLIC HL, V11, P177	43	51	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22291	22299		10.1074/jbc.M111.236596	http://dx.doi.org/10.1074/jbc.M111.236596			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21555521	Green Published, hybrid			2022-12-25	WOS:000291719900037
J	Walzik, S; Schroeter, A; Benndorf, K; Zimmer, T				Walzik, Stefan; Schroeter, Annett; Benndorf, Klaus; Zimmer, Thomas			Alternative Splicing of the Cardiac Sodium Channel Creates Multiple Variants of Mutant T1620K Channels	PLOS ONE			English	Article							SICK SINUS SYNDROME; LONG-QT SYNDROME; BREAST-CANCER CELLS; BRUGADA-SYNDROME; NA+ CHANNEL; SCN5A MUTATION; CONDUCTION DISEASE; EXPRESSION; SUBUNIT; POLYMORPHISMS	Alternative splicing creates several Na(v)1.5 transcripts in the mammalian myocardium and in various other tissues including brain, dorsal root ganglia, breast cancer cells as well as neuronal stem cell lines. In total nine Na(v)1.5 splice variants have been discovered. Four of them, namely Na(v)1.5a, Na(v)1.5c, Na(v)1.5d, and Na(v)1.5e, generate functional channels in heterologous expression systems. The significance of alternatively spliced transcripts for cardiac excitation, in particular their role in SCN5A channelopathies, is less well understood. In the present study, we systematically investigated electrophysiological properties of mutant T1620K channels in the background of all known functional Na(v)1.5 splice variants in HEK293 cells. This mutation has been previously associated with two distinct cardiac excitation disorders: with long QT syndrome type 3 (LQT3) and isolated cardiac conduction disease (CCD). When investigating the effect of the T1620K mutation, we noticed similar channel defects in the background of hNa(v)1.5, hNa(v)1.5a, and hNa(v)1.5c. In contrast, the hNa(v)1.5d background produced differential effects: In the mutant channel, some gain-of-function features did not emerge, whereas loss-of-function became more pronounced. In case of hNa(v)1.5e, the neonatal variant of hNa(v)1.5, both the splice variant itself as well as the corresponding mutant channel showed electrophysiological properties that were distinct from the wild-type and mutant reference channels, hNa(v)1.5 and T1620K, respectively. In conclusion, our data show that alternative splicing is a mechanism capable of generating a variety of functionally distinct wild-type and mutant hNa(v)1.5 channels. Thus, the cellular splicing machinery is a potential player affecting genotype-phenotype correlations in SCN5A channelopathies.	[Walzik, Stefan; Schroeter, Annett; Benndorf, Klaus; Zimmer, Thomas] Univ Jena, Inst Physiol 2, Univ Hosp Jena, Jena, Germany	Friedrich Schiller University of Jena	Walzik, S (corresponding author), Univ Jena, Inst Physiol 2, Univ Hosp Jena, Jena, Germany.	thomas.zimmer@mti.uni-jena.de		Benndorf, Klaus/0000-0002-0707-4083	Friedrich Schiller University of Jena [923409]	Friedrich Schiller University of Jena	This work was supported by the Friedrich Schiller University of Jena (budget account no. 923409). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Benson DW, 2003, J CLIN INVEST, V112, P1019, DOI 10.1172/JCI200318062; Blechschmidt S, 2008, PROG BIOPHYS MOL BIO, V98, P309, DOI 10.1016/j.pbiomolbio.2009.01.009; Brackenbury WJ, 2007, BREAST CANCER RES TR, V101, P149, DOI 10.1007/s10549-006-9281-1; Camacho JA, 2006, J BIOL CHEM, V281, P9498, DOI 10.1074/jbc.M509716200; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chioni AM, 2005, J NEUROSCI METH, V147, P88, DOI 10.1016/j.jneumeth.2005.03.010; Chioni AM, 2009, INT J BIOCHEM CELL B, V41, P1216, DOI 10.1016/j.biocel.2008.11.001; Clancy CE, 2003, CIRCULATION, V107, P2233, DOI 10.1161/01.CIR.0000069273.51375.BD; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; GELLENS ME, 1992, P NATL ACAD SCI USA, V89, P554, DOI 10.1073/pnas.89.2.554; Grant AO, 2002, J CLIN INVEST, V110, P1201, DOI 10.1172/JCI200215570; Gui JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010985; Gui JH, 2010, J CARDIOVASC ELECTR, V21, P564, DOI 10.1111/j.1540-8167.2010.01762.x; Keller DI, 2005, CARDIOVASC RES, V67, P510, DOI 10.1016/j.cardiores.2005.03.024; Kranjcec D, 2007, PACE, V30, P1294, DOI 10.1111/j.1540-8159.2007.00857.x; Kyndt F, 2001, CIRCULATION, V104, P3081, DOI 10.1161/hc5001.100834; Laitinen-Forsblom PJ, 2006, J CARDIOVASC ELECTR, V17, P480, DOI 10.1111/j.1540-8167.2006.00411.x; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Onkal R, 2008, J CELL PHYSIOL, V216, P716, DOI 10.1002/jcp.21451; Ou SW, 2005, EUR J NEUROSCI, V22, P793, DOI 10.1111/j.1460-9568.2005.04280.x; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; Ruan YF, 2007, CIRCULATION, V116, P1137, DOI 10.1161/CIRCULATIONAHA.107.707877; Schroeter A, 2010, J MOL CELL CARDIOL, V49, P16, DOI 10.1016/j.yjmcc.2010.04.004; Shang LJL, 2005, J BIOL CHEM, V280, P933, DOI 10.1074/jbc.M409977200; Smits JPP, 2005, J MOL CELL CARDIOL, V38, P969, DOI 10.1016/j.yjmcc.2005.02.024; Surber R, 2008, CARDIOVASC RES, V77, P740, DOI 10.1093/cvr/cvm096; Tan BH, 2005, HEART RHYTHM, V2, P741, DOI 10.1016/j.hrthm.2005.04.021; Tateyama M, 2003, J BIOL CHEM, V278, P46718, DOI 10.1074/jbc.M308977200; Tateyama M, 2003, CIRCULATION, V107, P3216, DOI 10.1161/01.CIR.0000070936.65183.97; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; Wehrens XHT, 2000, CIRCULATION, V102, P584; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Zhang Y, 2008, ACTA PHYSIOL, V194, P311, DOI 10.1111/j.1748-1716.2008.01883.x; Zimmer T, 2002, J MEMBRANE BIOL, V186, P13, DOI 10.1007/s00232-001-0131-0; Zimmer T, 2002, AM J PHYSIOL-HEART C, V282, pH1007, DOI 10.1152/ajpheart.00644.2001; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19188	10.1371/journal.pone.0019188	http://dx.doi.org/10.1371/journal.pone.0019188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552533	gold, Green Published, Green Submitted			2022-12-25	WOS:000290020700036
J	Xu, F; Sridharan, B; Durmus, NG; Wang, SQ; Yavuz, AS; Gurkan, UA; Demirci, U				Xu, Feng; Sridharan, BanuPriya; Durmus, Naside Gozde; Wang, ShuQi; Yavuz, Ahmet Sinan; Gurkan, Umut Atakan; Demirci, Utkan			Living Bacterial Sacrificial Porogens to Engineer Decellularized Porous Scaffolds	PLOS ONE			English	Article							AGAROSE-GEL; TISSUE; HYDROGELS; CRYOGELS; MATRIX; TRANSPLANTATION; FABRICATION; DIFFUSION; TEMPLATE; POROSITY	Decellularization and cellularization of organs have emerged as disruptive methods in tissue engineering and regenerative medicine. Porous hydrogel scaffolds have widespread applications in tissue engineering, regenerative medicine and drug discovery as viable tissue mimics. However, the existing hydrogel fabrication techniques suffer from limited control over pore interconnectivity, density and size, which leads to inefficient nutrient and oxygen transport to cells embedded in the scaffolds. Here, we demonstrated an innovative approach to develop a new platform for tissue engineered constructs using live bacteria as sacrificial porogens. E. coli were patterned and cultured in an interconnected three-dimensional (3D) hydrogel network. The growing bacteria created interconnected micropores and microchannels. Then, the scafold was decellularized, and bacteria were eliminated from the scaffold through lysing and washing steps. This 3D porous network method combined with bioprinting has the potential to be broadly applicable and compatible with tissue specific applications allowing seeding of stem cells and other cell types.	[Xu, Feng; Sridharan, BanuPriya; Wang, ShuQi; Yavuz, Ahmet Sinan; Gurkan, Umut Atakan; Demirci, Utkan] Harvard Univ, Brigham & Womens Hosp, Demirci Bioacoust MEMS Med BAMM Lab, Dept Med,Ctr Biomed Engn,Med Sch, Boston, MA 02115 USA; [Durmus, Naside Gozde] Brown Univ, Div Biol & Med, Sch Engn, Providence, RI 02912 USA; [Demirci, Utkan] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Brown University; Harvard University	Xu, F (corresponding author), Harvard Univ, Brigham & Womens Hosp, Demirci Bioacoust MEMS Med BAMM Lab, Dept Med,Ctr Biomed Engn,Med Sch, Boston, MA 02115 USA.	udemirci@rics.bwh.harvard.edu	Gurkan, Umut A./Z-2496-2019; Xu, Feng/C-7430-2011; Xu, Feng/H-4468-2011; Wang, Shuqi/F-2861-2011	Gurkan, Umut A./0000-0002-0331-9960; Xu, Feng/0000-0003-4351-0222; Yavuz, Ahmet Sinan/0000-0003-4069-6105	Center for Integration of Medicine and Innovative Technology (CIMIT) [R21 (AI087107)]; Coulter Foundation; U.S. Army Medical Research and Materiel Command (USAMRMC); Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087107] Funding Source: NIH RePORTER	Center for Integration of Medicine and Innovative Technology (CIMIT); Coulter Foundation; U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by R21 (AI087107), the Center for Integration of Medicine and Innovative Technology (CIMIT) under U.S. Army Medical Research Acquisition Activity Cooperative Agreement, and the Coulter Foundation Early Career Award. Also, partially this research is made possible by a research grant that was awarded and administered by the U.S. Army Medical Research and Materiel Command (USAMRMC) and the Telemedicine and Advanced Technology Research Center (TATRC), at Fort Detrick, MD. No additional funding was received for this study. The funders had no role in study design, data collection an analysis, decision to publish, or preparation of the manuscript.	Bolgen N, 2007, J BIOMAT SCI-POLYM E, V18, P1165, DOI 10.1163/156856207781554064; BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208; Bren Linda, 2007, FDA Consum, V41, P20; Brezesinski T, 2010, NAT MATER, V9, P146, DOI [10.1038/NMAT2612, 10.1038/nmat2612]; Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033; Chiu YC, 2010, TISSUE ENG C; Dainiak MB, 2010, BIOMATERIALS, V31, P67, DOI 10.1016/j.biomaterials.2009.09.029; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275; Delaney JT, 2010, SOFT MATTER, V6, P866, DOI 10.1039/b922888h; Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j; Di Leonardo R, 2010, P NATL ACAD SCI USA, V107, P9541, DOI 10.1073/pnas.0910426107; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fatin-Rouge N, 2004, BIOPHYS J, V86, P2710, DOI 10.1016/S0006-3495(04)74325-8; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Hamasaki S, 2008, MAT SCI ENG C-BIO S, V28, P1250, DOI 10.1016/j.msec.2007.11.008; Haugh MG, 2009, TISSUE ENG C; Heo J, 2003, ANAL CHEM, V75, P22, DOI 10.1021/ac0259717; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT2608, 10.1038/nmat2608, 10.1038/NMAT260B]; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Kato N, 2004, COLLOID SURFACE B, V38, P191, DOI 10.1016/j.colsurfb.2004.01.018; Keskar V, 2009, TISSUE ENG PT A, V15, P1695, DOI 10.1089/ten.tea.2008.0238; Kim J, 2009, TISSUE ENG PART C-ME, V15, P583, DOI [10.1089/ten.tec.2008.0642, 10.1089/ten.TEC.2008.0642]; Kirsebom H, 2010, LANGMUIR, V26, P16129, DOI 10.1021/la102917c; Kumar A, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70202-9; Labille J, 2007, LANGMUIR, V23, P2083, DOI 10.1021/la0611155; Lee WK, 2003, J BIOMED MATER RES A, V67A, P1087, DOI 10.1002/jbm.a.10570; Lee W, 2010, P NATL ACAD SCI USA, V107, P20709, DOI 10.1073/pnas.1005211107; Levesque SG, 2005, BIOMATERIALS, V26, P7436, DOI 10.1016/j.biomaterials.2005.05.054; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020; Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]; Moon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017455; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Park JH, 2010, BIOTECHNOL BIOENG, V106, P138, DOI 10.1002/bit.22667; Park JH, 2010, BIOTECHNOL BIOENG; Plieva FM, 2005, SOFT MATTER, V1, P303, DOI 10.1039/b510010k; Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092; Rusk Nicole, 2010, Nat Methods, V7, P674; Salerno A, 2009, J MATER SCI-MATER M, V20, P2043, DOI 10.1007/s10856-009-3767-4; Samot J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017530; Shi QH, 2005, BIOTECHNOL BIOENG, V92, P643, DOI 10.1002/bit.20652; Song YS, 2010, P NATL ACAD SCI USA, V107, P4596, DOI 10.1073/pnas.0914059107; Song YS, 2009, ANAL BIOANAL CHEM, V395, P185, DOI 10.1007/s00216-009-2935-1; Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507; Thote AJ, 2005, DRUG DEV IND PHARM, V31, P43, DOI 10.1081/DDC-200043985; Tokuyama H, 2007, LANGMUIR, V23, P11246, DOI 10.1021/la701492u; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/NMAT2545, 10.1038/nmat2545]; Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024; WIDJOJOATMODJO MN, 1995, J CLIN MICROBIOL, V33, P2601, DOI 10.1128/JCM.33.10.2601-2606.1995; Xu F, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014105; Xu F, 2010, BIOFABRICATION, DOI [10.1088/1758-5082/1082/1081/014105, DOI 10.1088/1758-5082/1082/1081/014105]; Xu F, 2011, TISSUE ENG C; Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340; YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899; Yu GH, 2008, J BIOMAT SCI-POLYM E, V19, P87, DOI 10.1163/156856208783227703; Zhou JF, 2006, LANGMUIR, V22, P3332, DOI 10.1021/la052771s	65	22	23	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19344	10.1371/journal.pone.0019344	http://dx.doi.org/10.1371/journal.pone.0019344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552485	gold, Green Published			2022-12-25	WOS:000290020700050
J	Swedberg, JE; de Veer, SJ; Sit, KC; Reboul, CF; Buckle, AM; Harris, JM				Swedberg, Joakim E.; de Veer, Simon J.; Sit, Kei C.; Reboul, Cyril F.; Buckle, Ashley M.; Harris, Jonathan M.			Mastering the Canonical Loop of Serine Protease Inhibitors: Enhancing Potency by Optimising the Internal Hydrogen Bond Network	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROSTATE-SPECIFIC ANTIGEN; TRYPSIN-INHIBITOR; PROTEINASE-INHIBITOR; KALLIKREIN-4 HK4; CANCER-CELLS; SFTI-1; CHYMOTRYPSIN; FLEXIBILITY; MECHANISM	Background: Canonical serine protease inhibitors commonly bind to their targets through a rigid loop stabilised by an internal hydrogen bond network and disulfide bond(s). The smallest of these is sunflower trypsin inhibitor (SFTI-1), a potent and broad-range protease inhibitor. Recently, we re-engineered the contact beta-sheet of SFTI-1 to produce a selective inhibitor of kallikrein-related peptidase 4 (KLK4), a protease associated with prostate cancer progression. However, modifications in the binding loop to achieve specificity may compromise structural rigidity and prevent re-engineered inhibitors from reaching optimal binding affinity. Methodology/Principal Findings: In this study, the effect of amino acid substitutions on the internal hydrogen bonding network of SFTI were investigated using an in silico screen of inhibitor variants in complex with KLK4 or trypsin. Substitutions favouring internal hydrogen bond formation directly correlated with increased potency of inhibition in vitro. This produced a second generation inhibitor (SFTI-FCQR Asn(14)) which displayed both a 125-fold increased capacity to inhibit KLK4 (K-i = 0.0386 +/- 0.0060 nM) and enhanced selectivity over off-target serine proteases. Further, SFTI-FCQR Asn(14) was stable in cell culture and bioavailable in mice when administered by intraperitoneal perfusion. Conclusion/Significance: These findings highlight the importance of conserving structural rigidity of the binding loop in addition to optimising protease/inhibitor contacts when re-engineering canonical serine protease inhibitors.	[Swedberg, Joakim E.; de Veer, Simon J.; Sit, Kei C.; Harris, Jonathan M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Reboul, Cyril F.; Buckle, Ashley M.] Monash Univ, Sch Biomed Sci, Fac Med & Victorian Bioinformat Consortium, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Queensland University of Technology (QUT); Monash University	Swedberg, JE (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	j2.harris@qut.edu.au	swedberg, Joakim/K-1501-2014; de Veer, Simon/D-3915-2017; Buckle, Ashley/P-8366-2016	swedberg, Joakim/0000-0003-4243-8660; de Veer, Simon/0000-0002-7041-9937; Buckle, Ashley/0000-0003-2943-9044; Harris, Jonathan/0000-0003-4209-2380; Reboul, Cyril/0000-0002-6258-2697	National Health and Medical Research Council [497270]; Cancer Council Queensland [44323]; Prostate Cancer, Foundation of Australia [PR09]; Queensland Government, Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Prostate Cancer, Foundation of Australia; Queensland Government, Australia	Work in the corresponding author's laboratory is supported by the National Health and Medical Research Council (grant #497270), Cancer Council Queensland (Grant #44323) and the Prostate Cancer, Foundation of Australia (Grant #PR09). SJD receives funding from the Smart Futures Fund (Queensland Government, Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbenante G, 2000, LETT PEPT SCI, V7, P347, DOI 10.1023/A:1013016323676; Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; BAICI A, 1982, EUR J BIOCHEM, V129, P33, DOI 10.1111/j.1432-1033.1982.tb07017.x; Beaufort N, 2006, BIOL CHEM, V387, P217, DOI 10.1515/BC.2006.029; Costa JR, 2006, J PHYS CHEM B, V110, P18981, DOI 10.1021/jp0575299; Cozzini P, 2008, J MED CHEM, V51, P6237, DOI 10.1021/jm800562d; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; Descours A, 2002, CHEMBIOCHEM, V3, P318, DOI 10.1002/1439-7633(20020402)3:4<318::AID-CBIC318>3.0.CO;2-W; Diaz N, 2008, PROTEINS, V72, P50, DOI 10.1002/prot.21894; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haberkorn U, 2008, CURR MED CHEM, V15, P219, DOI 10.2174/092986708783497256; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; HEINZ DW, 1992, BIOCHEMISTRY-US, V31, P8755, DOI 10.1021/bi00152a011; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jain S, 2004, DRUG DELIV SYST SCI, V4, P3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kennedy AR, 1998, PHARMACOL THERAPEUT, V78, P167, DOI 10.1016/S0163-7258(98)00010-2; Korsinczky MLJ, 2001, J MOL BIOL, V311, P579, DOI 10.1006/jmbi.2001.4887; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Legowska A, 2009, BIOORGAN MED CHEM, V17, P3302, DOI 10.1016/j.bmc.2009.03.045; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Marx UC, 2003, J BIOL CHEM, V278, P21782, DOI 10.1074/jbc.M212996200; Matsumura M, 2005, PROSTATE, V62, P1, DOI 10.1002/pros.20101; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; Obiezu CV, 2006, BIOL CHEM, V387, P749, DOI 10.1515/BC.2006.094; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007730; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; SHAW GL, 1995, BIOCHEMISTRY-US, V34, P2225, DOI 10.1021/bi00007a017; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Swedberg JE, 2010, BIOL CHEM, V391, P357, DOI 10.1515/BC.2010.037; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Xi ZJ, 2004, CANCER RES, V64, P2365, DOI 10.1158/0008-5472.CAN-03-2025; Zakharova E, 2009, P NATL ACAD SCI USA, V106, P11034, DOI 10.1073/pnas.0902463106	49	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19302	10.1371/journal.pone.0019302	http://dx.doi.org/10.1371/journal.pone.0019302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556330	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400048
J	Huang, KHG; Goedhals, D; Carlson, JM; Brockman, MA; Mishra, S; Brumme, ZL; Hickling, S; Tang, CSW; Miura, T; Seebregts, C; Heckerman, D; Ndung'u, T; Walker, B; Klenerman, P; Steyn, D; Goulder, P; Phillips, R; van Vuuren, C; Frater, J				Huang, Kuan-Hsiang Gary; Goedhals, Dominique; Carlson, Jonathan M.; Brockman, Mark A.; Mishra, Swati; Brumme, Zabrina L.; Hickling, Stephen; Tang, Christopher S. W.; Miura, Toshiyuki; Seebregts, Chris; Heckerman, David; Ndung'u, Thumbi; Walker, Bruce; Klenerman, Paul; Steyn, Dewald; Goulder, Philip; Phillips, Rodney; van Vuuren, Cloete; Frater, John		Bloemfontein-Oxford Collaborative	Progression to AIDS in South Africa Is Associated with both Reverting and Compensatory Viral Mutations	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; IMMUNE ESCAPE; HIV-1 GAG; CLASS-I; RESISTANCE MUTATIONS; REPLICATION CAPACITY; LYMPHOCYTE RESPONSE; MAJOR DETERMINANTS; SET-POINT	We lack the understanding of why HIV-infected individuals in South Africa progress to AIDS. We hypothesised that in end-stage disease there is a shifting dynamic between T cell imposed immunity and viral immune escape, which, through both compensatory and reverting viral mutations, results in increased viral fitness, elevated plasma viral loads and disease progression. We explored how T cell responses, viral adaptation and viral fitness inter-relate in South African cohorts recruited from Bloemfontein, the Free State (n = 278) and Durban, KwaZulu-Natal (n = 775). Immune responses were measured by gamma-interferon ELISPOT assays. HLA-associated viral polymorphisms were determined using phylogenetically corrected techniques, and viral replication capacity (VRC) was measured by comparing the growth rate of gag-protease recombinant viruses against recombinant NL4-3 viruses. We report that in advanced disease (CD4 counts <100 cells/mu l), T cell responses narrow, with a relative decline in Gag-directed responses (p<0.0001). This is associated with preserved selection pressure at specific viral amino acids (e. g., the T242N polymorphism within the HLA-B*57/5801 restricted TW10 epitope), but with reversion at other sites (e.g., the T186S polymorphism within the HLA-B*8101 restricted TL9 epitope), most notably in Gag and suggestive of "immune relaxation''. The median VRC from patients with CD4 counts <100 cells/mu l was higher than from patients with CD4 counts >= 500 cells/mu l (91.15% versus 85.19%, p = 0.0004), potentially explaining the rise in viral load associated with disease progression. Mutations at HIV Gag T186S and T242N reduced VRC, however, in advanced disease only the T242N mutants demonstrated increasing VRC, and were associated with compensatory mutations (p = 0.013). These data provide novel insights into the mechanisms of HIV disease progression in South Africa. Restoration of fitness correlates with loss of viral control in late disease, with evidence for both preserved and relaxed selection pressure across the HIV genome. Interventions that maintain viral fitness costs could potentially slow progression.	[Huang, Kuan-Hsiang Gary; Mishra, Swati; Hickling, Stephen; Tang, Christopher S. W.; Klenerman, Paul; Phillips, Rodney; Frater, John] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Goedhals, Dominique; Steyn, Dewald; van Vuuren, Cloete] Univ Free State, Bloemfontein, South Africa; [Goedhals, Dominique] NHLS, Johannesburg, South Africa; [Carlson, Jonathan M.; Heckerman, David] Microsoft Res, ESci Grp, Los Angeles, CA USA; [Brockman, Mark A.; Brumme, Zabrina L.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Brockman, Mark A.; Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Brockman, Mark A.; Brumme, Zabrina L.; Miura, Toshiyuki] Harvard Univ, Ragon Inst, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Brockman, Mark A.; Brumme, Zabrina L.; Miura, Toshiyuki; Walker, Bruce] MIT, Boston, MA USA; [Miura, Toshiyuki] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Seebregts, Chris] MRC, Biomed Informat Res Div, Cape Town, South Africa; [Ndung'u, Thumbi; Walker, Bruce] Univ KwaZulu Natal, HIV Pathogenesis Programme, Doris Duke Med Res Inst, Durban, South Africa; [Walker, Bruce] Harvard Univ, Div AIDS, Boston, MA 02115 USA; [Goulder, Philip] Univ Oxford, Dept Paediat, Oxford, England; [Huang, Kuan-Hsiang Gary; Phillips, Rodney] James Martin 21st Century Sch, Oxford, England; [Klenerman, Paul; Phillips, Rodney; Frater, John] Oxford NIHR Biomed Res Ctr, Oxford, England	University of Oxford; University of the Free State; National Health Laboratory Service; Microsoft; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); University of Tokyo; University of Kwazulu Natal; Harvard University; University of Oxford; University of Oxford; University of Oxford	Huang, KHG (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	john.frater@ndm.ox.ac.uk	Seebregts, Christopher/AFL-9356-2022; Seebregts, Christopher/AAH-1421-2022; Brockman, Mark/D-1669-2016	Seebregts, Christopher/0000-0002-8212-9363; Seebregts, Christopher/0000-0002-8212-9363; Brockman, Mark/0000-0001-6432-1426; klenerman, paul/0000-0003-4307-9161; Brumme, Zabrina/0000-0002-8157-1037; Ndung'u, Thumbi/0000-0003-2962-3992; van Vuuren, Cloete/0000-0002-9095-0039; Frater, John/0000-0001-7163-7277; Mishra, Swati/0000-0002-6123-8712	James Martin 21st Century School; Medical Research Council; Wellcome Trust; NIHR Biomedical Research Centre; Canadian Institutes for Health Research (CIHR); International Development Research Centre (IDRC), Canada; Medical Research Council [G0800176, G108/626] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R01AI046995] Funding Source: NIH RePORTER; MRC [G108/626, G0800176] Funding Source: UKRI	James Martin 21st Century School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Development Research Centre (IDRC), Canada(CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	K-HGH is supported by the James Martin 21st Century School. JF is funded by the Medical Research Council. RP, PG and PK are supported by the Wellcome Trust. JF and PK are funded by NIHR Biomedical Research Centre Programme. ZLB is funded by the Canadian Institutes for Health Research (CIHR). The collection and analysis of 43 Free State sequences was funded by a grant from the ACACIA and Connectivity Africa programmes of the International Development Research Centre (IDRC), Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; BROCKMAN MA, 2010, J VIROL; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; BRUMME ZL, 2008, J VIROL; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Dinges WL, 2010, J VIROL, V84, P4461, DOI 10.1128/JVI.02438-09; Duda A, 2009, J VIROL, V83, P1228, DOI 10.1128/JVI.01545-08; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Gandhi RT, 2003, CLIN INFECT DIS, V37, P1693, DOI 10.1086/379773; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; HERBECK JT, J INFECT DIS, V201, P618; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; *SERV DOHAH, 2009, PAN ANT GUID AD AD G, P1; Shafer RW, 2008, ANTIVIR THER, V13, P59; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; WALKER S, 2009, DESIGN DART TRIAL KE; WRIGHT JK, 2010, J VIROL; Zhuang Y, 2008, CURR HIV RES, V6, P239, DOI 10.2174/157016208784324921	41	50	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19018	10.1371/journal.pone.0019018	http://dx.doi.org/10.1371/journal.pone.0019018			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544209	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800032
J	Tremblay, DC; Moseley, S; Chadwick, BP				Tremblay, Deanna C.; Moseley, Shawn; Chadwick, Brian P.			Variation in Array Size, Monomer Composition and Expression of the Macrosatellite DXZ4	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; INACTIVE X-CHROMOSOME; LYMPHOBLASTOID CELL-LINES; COPY NUMBER VARIATION; DNA REARRANGEMENTS; TANDEM REPEATS; GENE; METHYLATION; CHROMATIN; SEQUENCE	Macrosatellites are some of the most polymorphic regions of the human genome, yet many remain uncharacterized despite the association of some arrays with disease susceptibility. This study sought to explore the polymorphic nature of the X-linked macrosatellite DXZ4. Four aspects of DXZ4 were explored in detail, including tandem repeat copy number variation, array instability, monomer sequence polymorphism and array expression. DXZ4 arrays contained between 12 and 100 3.0 kb repeat units with an average array containing 57. Monomers were confirmed to be arranged in uninterrupted tandem arrays by restriction digest analysis and extended fiber FISH, and therefore DXZ4 encompasses 36-288 kb of Xq23. Transmission of DXZ4 through three generations in three families displayed a high degree of meiotic instability (8.3%), consistent with other macrosatellite arrays, further highlighting the unstable nature of these sequences in the human genome. Subcloning and sequencing of complete DXZ4 monomers identified numerous single nucleotide polymorphisms and alleles for the three microsatellite repeats located within each monomer. Pairwise comparisons of DXZ4 monomer sequences revealed that repeat units from an array are more similar to one another than those originating from different arrays. RNA fluorescence in situ hybridization revealed significant variation in DXZ4 expression both within and between cell lines. DXZ4 transcripts could be detected originiating from both the active and inactive X chromosome. Expression levels of DXZ4 varied significantly between males, but did not relate to the size of the array, nor did inheritance of the same array result in similar expression levels. Collectively, these studies provide considerable insight into the polymorphic nature of DXZ4, further highlighting the instability and variation potential of macrosatellites in the human genome.	[Tremblay, Deanna C.; Moseley, Shawn; Chadwick, Brian P.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tremblay, DC (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	chadwick@bio.fsu.edu		Moseley, Shawn/0000-0001-5255-8688; Chadwick, Brian/0000-0001-5272-8384	National Institutes of Health [GM073120]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (GM073120, B.P.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen R, 1998, HUM MOL GENET, V7, P2113, DOI 10.1093/hmg/7.13.2113; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bruce HA, 2009, PSYCHIAT GENET, V19, P64, DOI 10.1097/YPG.0b013e3283207ff6; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chadwick BP, 2008, GENOME RES, V18, P1259, DOI 10.1101/gr.075713.107; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Chen YT, 2006, GENE CHROMOSOME CANC, V45, P392, DOI 10.1002/gcc.20298; DEIDDA G, 1995, EUR J HUM GENET, V3, P155; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FLORIJN RJ, 1995, HUM MOL GENET, V4, P831, DOI 10.1093/hmg/4.5.831; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; Gjerstorff MF, 2008, TISSUE ANTIGENS, V71, P187, DOI 10.1111/j.1399-0039.2007.00997.x; Grafodatskaya D, 2010, GENOMICS, V95, P73, DOI 10.1016/j.ygeno.2009.12.001; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEMMERS RJ, 2010, SCIENCE; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Okada T, 2002, HUM GENET, V110, P302, DOI 10.1007/s00439-002-0698-2; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; Saferali A, 2010, EPIGENETICS-US, V5, P50, DOI 10.4161/epi.5.1.10436; Sambrook J., 2002, MOL CLONING LAB MANU; SNIDER L, 2009, HUM MOL GENET; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tremblay DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-632; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 1996, HUM MOL GENET, V5, P1567, DOI 10.1093/hmg/5.10.1567	37	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18969	10.1371/journal.pone.0018969	http://dx.doi.org/10.1371/journal.pone.0018969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544201	Green Submitted, Green Published, gold			2022-12-25	WOS:000290015800027
J	Chevalier, F; Herbiniere-Gaboreau, J; Bertaux, J; Raimond, M; Morel, F; Bouchon, D; Greve, P; Braquart-Varnier, C				Chevalier, Frederic; Herbiniere-Gaboreau, Juline; Bertaux, Joanne; Raimond, Maryline; Morel, Franck; Bouchon, Didier; Greve, Pierre; Braquart-Varnier, Christine			The Immune Cellular Effectors of Terrestrial Isopod Armadillidium vulgare: Meeting with Their Invaders, Wolbachia	PLOS ONE			English	Article							MACROBRACHIUM-ROSENBERGII; HORIZONTAL TRANSMISSION; ANTIMICROBIAL PEPTIDES; MONOCLONAL-ANTIBODIES; INNATE IMMUNITY; HEMOCYTES; INFECTION; CRUSTACEAN; HOST; ENDOSYMBIONTS	Background: Most of crustacean immune responses are well described for the aquatic forms whereas almost nothing is known for the isopods that evolved a terrestrial lifestyle. The latter are also infected at a high prevalence with Wolbachia, an endosymbiotic bacterium which affects the host immune system, possibly to improve its transmission. In contrast with insect models, the isopod Armadillidium vulgare is known to harbor Wolbachia inside the haemocytes. Methodology/Principal Findings: In A. vulgare we characterized three haemocyte types (TEM, flow cytometry): the hyaline and semi-granular haemocytes were phagocytes, while semi-granular and granular haemocytes performed encapsulation. They were produced in the haematopoietic organs, from central stem cells, maturing as they moved toward the edge (TEM). In infected individuals, live Wolbachia (FISH) colonized 38% of the haemocytes but with low, variable densities (6.45 +/- 0.46 Wolbachia on average). So far they were not found in hyaline haemocytes (TEM). The haematopoietic organs contained 7.6 +/- 0.7x10(3) Wolbachia, both in stem cells and differentiating cells (FISH). While infected and uninfected one-year-old individuals had the same haemocyte density, in infected animals the proportion of granular haemocytes in particular decreased by one third (flow cytometry, Pearson's test = 12 822.98, df=2, p < 0.001). Conclusions/Significance: The characteristics of the isopod immune system fell within the range of those known from aquatic crustaceans. The colonization of the haemocytes by Wolbachia seemed to stand from the haematopoietic organs, which may act as a reservoir to discharge Wolbachia in the haemolymph, a known route for horizontal transfer. Wolbachia infection did not affect the haemocyte density, but the quantity of granular haemocytes decreased by one third. This may account for the reduced prophenoloxidase activity observed previously in these animals.	[Chevalier, Frederic; Herbiniere-Gaboreau, Juline; Bertaux, Joanne; Raimond, Maryline; Bouchon, Didier; Greve, Pierre; Braquart-Varnier, Christine] Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France; [Morel, Franck] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, EA 4331, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Universite de Poitiers	Chevalier, F (corresponding author), Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France.	christine.braquart@univ-poitiers.fr	Braquart-Varnier, Christine/C-5217-2009; Morel, Franck/AAI-4274-2021; CHEVALIER, Frédéric D./E-6852-2010; Bouchon, Didier/B-2419-2012	Braquart-Varnier, Christine/0000-0001-6398-7832; Morel, Franck/0000-0003-3812-9304; CHEVALIER, Frédéric D./0000-0003-2611-8106; Bouchon, Didier/0000-0002-4938-408X	CNRS; University of Poitiers; Agence Nationale de la Recherche [ANR-06-BLAN-0316, ANR-09-JCJC-0109]; French Ministere de l'Education Nationale et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Poitiers; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministere de l'Education Nationale et de la Recherche	This research was funded by the CNRS, the University of Poitiers (Action Incitative: Diversite bacterienne et immunocompetence des hotes) and the Agence Nationale de la Recherche (EndoSymbArt ANR-06-BLAN-0316 - ADaWOL ANR-09-JCJC-0109). FC and JHG were supported by a fellowship from the French Ministere de l'Education Nationale et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bauchau A.G., 1981, INVERTEBRATE BLOOD C, P385; Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Bouchon D, 2008, INSECT SYMBIOSIS, P273; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Braquart-Varnier C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003286; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Broderick Nichole A., 2009, P13; Brownlie JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-68; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Christensen H, 1999, APPL ENVIRON MICROB, V65, P1753; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Cordaux R, 2001, J EVOLUTION BIOL, V14, P237, DOI 10.1046/j.1420-9101.2001.00279.x; COUTANT M, 1977, THESIS U POITIERS; Destoumieux D, 2000, J CELL SCI, V113, P461; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Felix C, 2008, RES MICROBIOL, V159, P481, DOI 10.1016/j.resmic.2008.05.007; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gargioni R, 1998, J MORPHOL, V236, P209, DOI 10.1002/(SICI)1097-4687(199806)236:3<209::AID-JMOR4>3.3.CO;2-G; Giulianini PG, 2007, MICRON, V38, P49, DOI 10.1016/j.micron.2006.03.019; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Goto S, 2006, APPL ENVIRON MICROB, V72, P4805, DOI 10.1128/AEM.00416-06; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Herbiniere J, 2005, DEV COMP IMMUNOL, V29, P489, DOI 10.1016/j.dci.2004.11.001; Herbiniere J, 2008, DEV COMP IMMUNOL, V32, P875, DOI 10.1016/j.dci.2008.01.007; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOSE JE, 1990, BIOL BULL, V178, P33, DOI 10.2307/1541535; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jaenicke E, 2009, DEV COMP IMMUNOL, V33, P1055, DOI 10.1016/j.dci.2009.05.005; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Kamoda S, 2000, J EXP BIOL, V203, P2503; Kang L, 2003, HEREDITY, V90, P71, DOI 10.1038/sj.hdy.6800180; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Matozzo V, 2010, FISH SHELLFISH IMMUN, V28, P534, DOI 10.1016/j.fsi.2009.12.003; Curley CM, 2007, ANN ENTOMOL SOC AM, V100, P345, DOI 10.1603/0013-8746(2007)100[345:EFFEOG]2.0.CO;2; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Rasband W, IMAGEJ; Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P6934, DOI 10.1128/AEM.01673-06; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; RODRIGUEZ J, 1995, J CELL SCI, V108, P1043; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Sicard M, 2010, NATURWISSENSCHAFTEN, V97, P819, DOI 10.1007/s00114-010-0699-2; Soderhall I, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P439; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Sung HH, 2002, J CRUSTACEAN BIOL, V22, P337, DOI 10.1651/0278-0372(2002)022[0337:UOMATC]2.0.CO;2; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Vazquez L, 1997, J MORPHOL, V234, P147, DOI 10.1002/(SICI)1097-4687(199711)234:2<147::AID-JMOR3>3.0.CO;2-9; Vazquez L, 2009, INNATE IMMUN-LONDON, V15, P179, DOI 10.1177/1753425909102876; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Zasloff M, 2002, LANCET, V360, P1116, DOI 10.1016/S0140-6736(02)11239-6	62	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18531	10.1371/journal.pone.0018531	http://dx.doi.org/10.1371/journal.pone.0018531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533137	Green Submitted, Green Published, gold			2022-12-25	WOS:000289719400010
J	Proia, DA; Foley, KP; Korbut, T; Sang, J; Smith, D; Bates, RC; Liu, YA; Rosenberg, AF; Zhou, D; Koya, K; Barsoum, J; Blackman, RK				Proia, David A.; Foley, Kevin P.; Korbut, Tim; Sang, Jim; Smith, Don; Bates, Richard C.; Liu, Yuan; Rosenberg, Alex F.; Zhou, Dan; Koya, Keizo; Barsoum, James; Blackman, Ronald K.			Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling	PLOS ONE			English	Article							TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; GROWTH-FACTOR; MYELOID DIFFERENTIATION; LUNG-CANCER; MUTATION; STATS; HEAT-SHOCK-PROTEIN-90; INTERLEUKIN-6	There is accumulating evidence that dysregulated JAK signaling occurs in a wide variety of cancer types. In particular, mutations in JAK2 can result in the constitutive activation of STAT transcription factors and lead to oncogenic growth. JAK kinases are established Hsp90 client proteins and here we show that the novel small molecule Hsp90 inhibitor ganetespib (formerly STA-9090) exhibits potent in vitro and in vivo activity in a range of solid and hematological tumor cells that are dependent on JAK2 activity for growth and survival. Of note, ganetespib treatment results in sustained depletion of JAK2, including the constitutively active JAK2(V617F) mutant, with subsequent loss of STAT activity and reduced STAT-target gene expression. In contrast, treatment with the pan-JAK inhibitor P6 results in only transient effects on these processes. Further differentiating these modes of intervention, RNA and protein expression studies show that ganetespib additionally modulates cell cycle regulatory proteins, while P6 does not. The concomitant impact of ganetespib on both cell growth and cell division signaling translates to potent antitumor efficacy in mouse models of xenografts and disseminated JAK/STAT-driven leukemia. Overall, our findings support Hsp90 inhibition as a novel therapeutic approach for combating diseases dependent on JAK/STAT signaling, with the multimodal action of ganetespib demonstrating advantages over JAK-specific inhibitors.	[Proia, David A.; Foley, Kevin P.; Korbut, Tim; Sang, Jim; Smith, Don; Bates, Richard C.; Liu, Yuan; Rosenberg, Alex F.; Zhou, Dan; Koya, Keizo; Barsoum, James; Blackman, Ronald K.] Synta Pharmaceut Corp, Lexington, MA USA		Proia, DA (corresponding author), Synta Pharmaceut Corp, Lexington, MA USA.	DProia@syntapharma.com	Foley, Kevin/ABC-1041-2020	Foley, Kevin/0000-0001-5148-7689				Al Shaer L, 2008, BRIT J HAEMATOL, V141, P483, DOI 10.1111/j.1365-2141.2008.07053.x; Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; BANSAL H, 2008, EXP HEMATOL, V36, P1266; Bareng J, 2007, LEUKEMIA LYMPHOMA, V48, P2189, DOI 10.1080/10428190701607576; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1159/000025316; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kerr IM, 2003, FEBS LETT, V546, P1, DOI 10.1016/S0014-5793(03)00411-3; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lee SO, 2003, CLIN CANCER RES, V9, P370; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li YY, 2009, DRUG RESIST UPDATE, V12, P17, DOI 10.1016/j.drup.2008.12.002; Lou W, 2000, PROSTATE, V42, P239, DOI 10.1002/(SICI)1097-0045(20000215)42:3<239::AID-PROS10>3.0.CO;2-G; MARUBAYASHI S, J CLIN INVEST, V120, P3578; Morgani KJ, 2008, ANNU REV MED, V59, P213, DOI 10.1146/annurev.med.59.061506.154159; Mukohara T, 2003, LUNG CANCER, V41, P123, DOI 10.1016/S0169-5002(03)00225-3; MULLALLY A, CANC CELL, V17, P584; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Niikura Y, 2006, ONCOGENE, V25, P4133, DOI 10.1038/sj.onc.1209461; Okamoto M, 1997, CANCER RES, V57, P141; Pardanani A., 2009, BLOOD, V114; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Peeters P, 1997, CANCER RES, V57, P564; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Reiter A, 2005, CANCER RES, V65, P2662, DOI 10.1158/0008-5472.CAN-04-4263; Sayyah J, 2009, CURR ONCOL REP, V11, P117, DOI 10.1007/s11912-009-0018-2; Schoof N, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-17; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Tefferi A, 2005, CELL CYCLE, V4, P1053; Verstovsek S., 2009, BLOOD, V114; Verstovsek Srdan, 2009, Hematology Am Soc Hematol Educ Program, P636, DOI 10.1182/asheducation-2009.1.636; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	49	59	66	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18552	10.1371/journal.pone.0018552	http://dx.doi.org/10.1371/journal.pone.0018552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533169	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600009
J	Kalogiannis, M; Hsu, E; Willie, JT; Chemelli, RM; Kisanuki, YY; Yanagisawa, M; Leonard, CS				Kalogiannis, Mike; Hsu, Emily; Willie, Jon T.; Chemelli, Richard M.; Kisanuki, Yaz Y.; Yanagisawa, Masashi; Leonard, Christopher S.			Cholinergic Modulation of Narcoleptic Attacks in Double Orexin Receptor Knockout Mice	PLOS ONE			English	Article							PONTINE RETICULAR-FORMATION; EYE-MOVEMENT SLEEP; REM-SLEEP; CANINE NARCOLEPSY; ACETYLCHOLINE TURNOVER; GABAERGIC NEURONS; RAT-BRAIN; CATAPLEXY; WAKEFULNESS; MECHANISMS	To investigate how cholinergic systems regulate aspects of the sleep disorder narcolepsy, we video-monitored mice lacking both orexin (hypocretin) receptors (double knockout; DKO mice) while pharmacologically altering cholinergic transmission. Spontaneous behavioral arrests in DKO mice were highly similar to those reported in orexin-deficient mice and were never observed in wild-type (WT) mice. A survival analysis revealed that arrest lifetimes were exponentially distributed indicating that random, Markovian processes determine arrest lifetime. Low doses (0.01, 0.03 mg/kg, IP), but not a high dose (0.08 mg/kg, IP) of the cholinesterase inhibitor physostigmine increased the number of arrests but did not alter arrest lifetimes. The muscarinic antagonist atropine (0.5 mg/kg, IP) decreased the number of arrests, also without altering arrest lifetimes. To determine if muscarinic transmission in pontine areas linked to REM sleep control also influences behavioral arrests, we microinjected neostigmine (50 nl, 62.5 mu M) or neostigmine + atropine (62.5 mM and 111 mM respectively) into the nucleus pontis oralis and caudalis. Neostigmine increased the number of arrests in DKO mice without altering arrest lifetimes but did not provoke arrests in WT mice. Co-injection of atropine abolished this effect. Collectively, our findings establish that behavioral arrests in DKO mice are similar to those in orexin deficient mice and that arrests have exponentially distributed lifetimes. We also show, for the first time in a rodent narcolepsy model, that cholinergic systems can regulate arrest dynamics. Since perturbations of muscarinic transmission altered arrest frequency but not lifetime, our findings suggest cholinergic systems influence arrest initiation without influencing circuits that determine arrest duration.	[Kalogiannis, Mike; Hsu, Emily; Leonard, Christopher S.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Willie, Jon T.] Washington Univ, Dept Neurosurg, St Louis, MO USA; [Chemelli, Richard M.; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Chemelli, Richard M.; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kisanuki, Yaz Y.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA	New York Medical College; Washington University (WUSTL); Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University	Kalogiannis, M (corresponding author), New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.	chris_leonard@nymc.edu	Kisanuki, Yasushi/E-3393-2011		National Institutes of Health (NIH) [NS27881, HL64150]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS027881, R01NS027881] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was supported by USPHS grants NS27881 and HL64150 from the National Institutes of Health (NIH) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH MS, 1993, PROG NEUROBIOL, V41, P533, DOI 10.1016/0301-0082(93)90042-Q; ALIMELKKILA T, 1993, ACTA ANAESTH SCAND, V37, P633, DOI 10.1111/j.1399-6576.1993.tb03780.x; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; BOURGIN P, 1995, NEUROREPORT, V6, P532, DOI 10.1097/00001756-199502000-00031; Brischoux F, 2008, J COMP NEUROL, V510, P607, DOI 10.1002/cne.21803; Brown RE, 2008, EUR J NEUROSCI, V27, P352, DOI 10.1111/j.1460-9568.2008.06024.x; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Coleman CG, 2004, NEUROSCIENCE, V126, P821, DOI 10.1016/j.neuroscience.2004.04.029; Datta S, 1997, J NEUROPHYSIOL, V77, P2975, DOI 10.1152/jn.1997.77.6.2975; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dong HX, 2005, PSYCHOPHARMACOLOGY, V181, P145, DOI 10.1007/s00213-005-2230-6; Espana RA, 2007, SLEEP, V30, P1417, DOI 10.1093/sleep/30.11.1417; Fenik VB, 2009, J SLEEP RES, V18, P99, DOI 10.1111/j.1365-2869.2008.00687.x; FRANKLIN KBJ, MOUSE BRAIN STEROTAX; Fujiki N, 2009, EXP NEUROL, V217, P46, DOI 10.1016/j.expneurol.2009.01.015; Fuller PM, 2007, J PHYSIOL-LONDON, V584, P735, DOI 10.1113/jphysiol.2007.140160; Gregory GG, 2002, J NEUROPHYSIOL, V88, P2589, DOI 10.1152/jn.00861.2001; GUILLEMINAULT C, 2002, PRINCIPLES PRACTICE, P676; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Kalogiannis M, 2010, EUR J NEUROSCI, V32, P130, DOI 10.1111/j.1460-9568.2010.07259.x; KARLEN B, 1979, N-S ARCH PHARMACOL, V308, P61, DOI 10.1007/BF00499720; Kilduff TS, 2000, TRENDS NEUROSCI, V23, P359, DOI 10.1016/S0166-2236(00)01594-0; KILDUFF TS, 1986, SLEEP, V9, P102, DOI 10.1093/sleep/9.1.102; Kisanuki Y, 2000, SLEEP, V23, pA91; Kisanuki YY, 2001, SLEEP, V24, pA22; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2006, J PHYSIOL-PARIS, V100, P271, DOI 10.1016/j.jphysparis.2007.05.006; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; NISHINO S, 1995, J NEUROSCI, V15, P4806; Nishino S, 2007, SLEEP MED, V8, P373, DOI 10.1016/j.sleep.2007.03.008; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; REID MS, 1994, NEUROSCIENCE, V59, P523, DOI 10.1016/0306-4522(94)90174-0; REID MS, 1994, NEUROSCIENCE, V59, P511, DOI 10.1016/0306-4522(94)90173-2; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; SCAMMELL T, 2009, SLEEP, V32, P1; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; TRABUCCHI M, 1975, J PHARMACOL EXP THER, V194, P57; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Willie JT, 2005, LESSONS SLEEPY MICE	50	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18697	10.1371/journal.pone.0018697	http://dx.doi.org/10.1371/journal.pone.0018697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533254	Green Published, gold, Green Submitted			2022-12-25	WOS:000289458800030
J	Norghauer, JM; Martin, AR; Mycroft, EE; James, A; Thomas, SC				Norghauer, Julian M.; Martin, Adam R.; Mycroft, Erin E.; James, Arlington; Thomas, Sean C.			Island Invasion by a Threatened Tree Species: Evidence for Natural Enemy Release of Mahogany (Swietenia macrophylla) on Dominica, Lesser Antilles	PLOS ONE			English	Article							BIG-LEAF MAHOGANY; EXOTIC PLANT INVASIONS; HYPSIPYLA-GRANDELLA; RAIN-FOREST; SHOOT-BORER; SEEDLING REGENERATION; TROPICAL FOREST; HERBIVORY; ALIEN; SUCCESS	Despite its appeal to explain plant invasions, the enemy release hypothesis (ERH) remains largely unexplored for tropical forest trees. Even scarcer are ERH studies conducted on the same host species at both the community and biogeographical scale, irrespective of the system or plant life form. In Cabrits National Park, Dominica, we observed patterns consistent with enemy release of two introduced, congeneric mahogany species, Swietenia macrophylla and S. mahagoni, planted almost 50 years ago. Swietenia populations at Cabrits have reproduced, with S. macrophylla juveniles established in and out of plantation areas at densities much higher than observed in its native range. Swietenia macrophylla juveniles also experienced significantly lower leaf-level herbivory (similar to 3.0%) than nine co-occurring species native to Dominica (8.4-21.8%), and far lower than conspecific herbivory observed in its native range (11%-43%, on average). These complimentary findings at multiple scales support ERH, and confirm that Swietenia has naturalized at Cabrits. However, Swietenia abundance was positively correlated with native plant diversity at the seedling stage, and only marginally negatively correlated with native plant abundance for stems >= 1-cm dbh. Taken together, these descriptive patterns point to relaxed enemy pressure from specialized enemies, specifically the defoliator Steniscadia poliophaea and the shoot-borer Hypsipyla grandella, as a leading explanation for the enhanced recruitment of Swietenia trees documented at Cabrits.	[Norghauer, Julian M.] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Martin, Adam R.; Mycroft, Erin E.; Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [James, Arlington] Forestry Wildlife & Pk Div, Roseau, Dominica	University of Bern; University of Toronto	Norghauer, JM (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	julian.norghauer@ips.unibe.ch	THOMAS, Sean C./B-6089-2008	THOMAS, Sean C./0000-0002-0686-2483; Norghauer, Julian/0000-0002-6484-6879; Martin, Adam Robert/0000-0002-7207-4004				Adams JM, 2009, BIOL INVASIONS, V11, P1005, DOI 10.1007/s10530-008-9312-4; Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Baret S, 2008, J TROP ECOL, V24, P337, DOI 10.1017/S0266467408004987; BROCKIE RE, 1988, BIOL CONSERV, V44, P9, DOI 10.1016/0006-3207(88)90003-1; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Dawson W, 2009, DIVERS DISTRIB, V15, P141, DOI 10.1111/j.1472-4642.2008.00527.x; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Dulloo ME, 2002, INT FOREST REV, V4, P277, DOI 10.1505/ifor.4.4.277.40525; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Edward E, 2009, BIOTROPICA, V41, P171, DOI 10.1111/j.1744-7429.2008.00474.x; Elton C., 1958; Fine PVA, 2002, J TROP ECOL, V18, P687, DOI [10.1017/S0266467402002456, 10.1017/S00266467402002456]; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Grogan J, 2006, BIOTROPICA, V38, P219, DOI 10.1111/j.1744-7429.2006.00121.x; Grogan J, 2005, FOREST ECOL MANAG, V204, P399, DOI 10.1016/j.foreco.2004.09.013; Grogan J, 2010, CONSERV LETT, V3, P12, DOI 10.1111/j.1755-263X.2009.00082.x; Gullison RE, 1996, BOT J LINN SOC, V122, P9; Harrison LC, 1935, ECON GEOGR, V11, P62, DOI 10.2307/140650; Haysom K.A., 2003, FBS3E FAO; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hodge WH, 1943, GEOGR REV, V33; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kometter RF, 2004, ECOL SOC, V9; KUEFFER C, 2004, FBS45E FAO; Lamb FB., 1966, MAHOGANY TROPICAL AM; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; LUGO AE, 1992, ECOL MONOGR, V62, P1, DOI 10.2307/2937169; Lugo AE, 2004, FRONT ECOL ENVIRON, V2, P265, DOI 10.2307/3868267; Makana JR, 2005, BIOTROPICA, V37, P227, DOI 10.1111/j.1744-7429.2005.00030.x; Malhotra Anita, 2007, APPLIED HERPETOLOGY, V4, P177, DOI 10.1163/157075407780681365; Martin PH, 2009, FRONT ECOL ENVIRON, V7, P142, DOI 10.1890/070096; Nair KSS, 2007, TROPICAL FOREST INSECT PESTS: ECOLOGY, IMPACT, AND MANAGEMENT, P1, DOI 10.1017/CBO9780511542695; NEWTON AC, 1993, FOREST ECOL MANAG, V57, P301, DOI 10.1016/0378-1127(93)90179-Q; NICOLSON DH, 1991, FLORA DOMINICA 2; Norghauer JM, 2008, J ECOL, V96, P103, DOI 10.1111/j.1365-2745.2007.01325.x; Norghauer JM, 2006, J TROP ECOL, V22, P451, DOI 10.1017/S0266467406003257; Norghauer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017488; Norghauer JM, 2010, OECOLOGIA, V162, P405, DOI 10.1007/s00442-009-1476-9; Perez-Salicrup DR, 2008, FOREST ECOL MANAG, V255, P324, DOI 10.1016/j.foreco.2007.09.054; Peters HA, 2001, BIOTROPICA, V33, P60, DOI 10.1111/j.1744-7429.2001.tb00157.x; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; REJMANEK M, 2002, ENV CONS, V29, P263; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Richardson DM, 1998, CONSERV BIOL, V12, P18, DOI 10.1046/j.1523-1739.1998.96392.x; Rose KE, 2005, ECOLOGY, V86, P453, DOI 10.1890/03-0697; Siemann E, 2003, ECOLOGY, V84, P1489, DOI 10.1890/0012-9658(2003)084[1489:HDRLAS]2.0.CO;2; Snook LK, 2005, FOREST ECOL MANAG, V206, P221, DOI 10.1016/j.foreco.2004.11.003; Sullivan JJ, 2003, OECOLOGIA, V136, P96, DOI 10.1007/s00442-003-1233-4; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Thomas SC, 1996, AM J BOT, V83, P556, DOI 10.2307/2445913; Thomas SC, 1996, OIKOS, V76, P145, DOI 10.2307/3545756; Thompson J, 2007, PLANT ECOL, V192, P289, DOI 10.1007/s11258-007-9318-5; VERISSIMO A, 1995, FOREST ECOL MANAG, V72, P39, DOI 10.1016/0378-1127(94)03432-V; Viisteensaari J, 2000, ENVIRON CONSERV, V27, P76, DOI 10.1017/S0376892900000096; Weber E., 2003, INVASIVE PLANT SPECI; White L., 2008, MAHOGANY; Whitmore T. C., 1991, Ecology of biological invasion in the tropics., P35; YAMAZAKI S, 1990, JARQ-JPN AGR RES Q, V24, P149; YAMAZAKI S, 1992, APPL ENTOMOL ZOOL, V27, P31, DOI 10.1303/aez.27.31; Zahibo N, 2007, ATMOS RES, V84, P13, DOI 10.1016/j.atmosres.2006.03.008	62	10	10	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18790	10.1371/journal.pone.0018790	http://dx.doi.org/10.1371/journal.pone.0018790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533206	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800043
J	Zhuang, LN; Hu, WX; Zhang, ML; Xin, SM; Jia, WP; Zhao, J; Pei, G				Zhuang, Le-nan; Hu, Wen-xiang; Zhang, Ming-liang; Xin, Shun-mei; Jia, Wei-ping; Zhao, Jian; Pei, Gang			beta-Arrestin-1 Protein Represses Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ENERGY-BALANCE; BETA-ARRESTIN; PPAR-GAMMA; RAT-BRAIN; FAT; ACTIVATION; PHOSPHORYLATION; CONTRIBUTES; SENSITIVITY	Diet-related obesity is a major metabolic disorder. Excessive fat mass is associated with type 2 diabetes, hepatic steatosis, and arteriosclerosis. Dysregulation of lipid metabolism and adipose tissue function contributes to diet-induced obesity. Here, we report that beta-arrestin-1 knock-out mice are susceptible to diet-induced obesity. Knock-out of the gene encoding beta-arrestin-1 caused increased fat mass accumulation and decreased whole-body insulin sensitivity in mice fed a high-fat diet. In beta-arrestin-1 knock-out mice, we observed disrupted food intake and energy expenditure and increased macrophage infiltration in white adipose tissue. At the molecular level, beta-arrestin-1 deficiency affected the expression of many lipid metabolic genes and inflammatory genes in adipose tissue. Consistently, transgenic overexpression of beta-arrestin-1 repressed diet-induced obesity and improved glucose tolerance and systemic insulin sensitivity. Thus, our findings reveal that beta-arrestin-1 plays a role in metabolism regulation.	[Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Zhuang, Le-nan; Hu, Wen-xiang] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Zhang, Ming-liang; Jia, Wei-ping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China; [Zhang, Ming-liang; Jia, Wei-ping] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	gpei@sibs.ac.cn	Hu, Wenxiang/W-3737-2017; Zhuang, Lenan/GZG-7254-2022; Zhao, Jian/E-2008-2019	Hu, Wenxiang/0000-0002-6754-5625; Zhao, Jian/0000-0002-8862-0591; Zhuang, Lenan/0000-0001-9561-8396	Ministry of Science and Technology [2007CB947100, 2009CB940903, 2011CB910202]; National Natural Science Foundation of China [30871285, 90713047]; Chinese Academy of Sciences [XDA01010302]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Sanofi-Aventis-Shanghai Institutes for Biological Sciences	This work was supported in part by Ministry of Science and Technology Grants 2007CB947100, 2009CB940903, and 2011CB910202; National Natural Science Foundation of China Grants 30871285 and 90713047; and Chinese Academy of Sciences Grant XDA01010302.; Supported by the Sanofi-Aventis-Shanghai Institutes for Biological Sciences Scholarship Program. To whom correspondence may be addressed. E-mail: jzhao@sibs.ac.cn.	Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bjorntorp P, 1997, LANCET, V350, P423, DOI 10.1016/S0140-6736(97)04503-0; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Diaz A, 2002, NEUROSCIENCE, V112, P345, DOI 10.1016/S0306-4522(02)00073-8; Fan XL, 2003, NEUROSCIENCE, V117, P383, DOI 10.1016/S0306-4522(02)00930-2; Haluzik MM, 2006, ENDOCRINOLOGY, V147, P4517, DOI 10.1210/en.2005-1624; HERBERG L, 1974, J LIPID RES, V15, P580; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luan B, 2005, EMBO J, V24, P4237, DOI 10.1038/sj.emboj.7600882; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pagliassotti MJ, 1997, ANN NY ACAD SCI, V827, P431, DOI 10.1111/j.1749-6632.1997.tb51853.x; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Shen HQ, 1999, METABOLISM, V48, P965, DOI 10.1016/S0026-0495(99)90191-9; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Usui I, 2004, MOL CELL BIOL, V24, P8929, DOI 10.1128/MCB.24.20.8929-8937.2004; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	31	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28396	28402		10.1074/jbc.M111.223206	http://dx.doi.org/10.1074/jbc.M111.223206			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21543334	hybrid, Green Published			2022-12-25	WOS:000293557800055
J	Rahmaniyan, M; Curley, RW; Obeid, LM; Hannun, YA; Kraveka, JM				Rahmaniyan, Mehrdad; Curley, Robert W.; Obeid, Lina M.; Hannun, Yusuf A.; Kraveka, Jacqueline M.			Identification of Dihydroceramide Desaturase as a Direct in Vitro Target for Fenretinide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLITE 4-OXO-FENRETINIDE; IRREVERSIBLE INHIBITION; ORAL FENRETINIDE; BREAST-CANCER; CELL-DEATH; CERAMIDE; SPHINGOLIPIDS; APOPTOSIS; CHEMOPREVENTION; BIOSYNTHESIS	The dihydroceramide desaturase (DES) enzyme is responsible for inserting the 4,5-trans-double bond to the sphingolipid backbone of dihydroceramide. We previously demonstrated that fenretinide (4-HPR) inhibited DES activity in SMS-KCNR neuroblastoma cells. In this study, we investigated whether 4-HPR acted directly on the enzyme in vitro. N-C8:0-D-erythro-dihydroceramide (C-8-dhCer) was used as a substrate to study the conversion of dihydroceramide into ceramide in vitro using rat liver microsomes, and the formation of tritiated water after the addition of the tritiated substrate was detected and used to measure DES activity. NADH served as a cofactor. The apparent K-m for C-8-dhCer and NADH were 1.92 +/- 0.36 mu M and 43.4 +/- 6.47 mu M, respectively; and the V-max was 3.16 +/- 0.24 and 4.11 +/- 0.18 nmol/min/g protein. Next, the effects of 4-HPR and its metabolites on DES activity were investigated. 4-HPR was found to inhibit DES in a dose-dependent manner. At 20 min, the inhibition was competitive; however, longer incubation times demonstrated the inhibition to be irreversible. Among the major metabolites of 4-HPR, 4-oxo-N-(4-hydroxyphenyl) retinamide (4-oxo-4-HPR) showed the highest inhibitory effect with substrate concentration of 0.5 mu M, with an IC50 of 1.68 mu M as compared with an IC50 of 2.32 mu M for 4-HPR. N-(4-Methoxyphenyl) retinamide (4-MPR) and 4-Oxo-N-(4-methoxyphenyl) retinamide (4-oxo-4-MPR) had minimal effects on DES activity. A known competitive inhibitor of DES, C-8-cyclopropenylceramide was used as a positive control. These studies define for the first time a direct in vitro target for 4-HPR and suggest that inhibitors of DES may be used as therapeutic interventions to regulate ceramide desaturation and consequent function.	[Rahmaniyan, Mehrdad; Kraveka, Jacqueline M.] Med Univ S Carolina, Dept Pediat, Div Hematol Oncol, Charleston, SC USA; [Curley, Robert W.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Obeid, Lina M.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; University System of Ohio; Ohio State University; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kraveka, JM (corresponding author), Med Univ S Carolina, Dept Pediat Hematol Oncol, 135 Rutledge Ave,MSC 558, Charleston, SC 29425 USA.	kravekjm@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health [K01-CA100767, P01-CA97132, R01-AG016583, R01-CA49837, C06-RR018823]; Office of Research and Development; Department of Veterans Affairs; Ralph H. Johnson VA Medical Center (Charleston, SC) from the National Center for Research Resources [P20-RR17677]; Rally Foundation for Childhood Cancer Research; Monica Kreber Golf Tournament; Chase After a Cure Foundation; Hyundai Hope on Wheels; NATIONAL CANCER INSTITUTE [K01CA100767, R01CA087584, R01CA049837, P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development; Department of Veterans Affairs(US Department of Veterans Affairs); Ralph H. Johnson VA Medical Center (Charleston, SC) from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rally Foundation for Childhood Cancer Research; Monica Kreber Golf Tournament; Chase After a Cure Foundation; Hyundai Hope on Wheels; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K01-CA100767 (to J. M. K.), P01-CA97132 (to Y. A. H. and L. M. O.), R01-AG016583 (to L. M. O.), R01-CA49837 (to R. W. C.), C06-RR018823 (Lipidomics Core), and by a MERIT award by the Office of Research and Development (to L. M. O.). This work was also supported by the Department of Veterans Affairs, Ralph H. Johnson VA Medical Center (Charleston, SC) by Grant P20-RR17677 from the National Center for Research Resources and by grants from the Rally Foundation for Childhood Cancer Research, the Monica Kreber Golf Tournament, the Chase After a Cure Foundation, and Hyundai Hope on Wheels (to J. M. K.).	BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bonanni B, 2007, EXPERT REV ANTICANC, V7, P423, DOI 10.1586/14737140.7.4.423; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; CHIESA F, 1993, J CELL BIOCHEM, P255; DiPietrantonio AM, 1998, INT J CANCER, V78, P53, DOI 10.1002/(SICI)1097-0215(19980925)78:1<53::AID-IJC10>3.0.CO;2-6; Formelli F, 2008, CANCER CHEMOTH PHARM, V62, P655, DOI 10.1007/s00280-007-0649-7; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Jiang Q, 2004, P NATL ACAD SCI USA, V101, P17825, DOI 10.1073/pnas.0408340102; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Marachelian A, 2009, J CLIN ONCOL, V27; Mershon SM, 2007, BIOORG MED CHEM LETT, V17, P836, DOI 10.1016/j.bmcl.2006.10.050; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mizutani Y, 2004, FEBS LETT, V563, P93, DOI 10.1016/S0014-5793(04)00274-1; Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Rege B, 2002, DRUG METAB DISPOS, V30, P1337, DOI 10.1124/dmd.30.12.1337; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Schulz A, 2006, J BIOL CHEM, V281, P2784, DOI 10.1074/jbc.M509483200; Schulze H, 2000, METHOD ENZYMOL, V311, P22; Separovic D, 2009, BRIT J CANCER, V100, P626, DOI 10.1038/sj.bjc.6604896; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; Stiban J, 2006, APOPTOSIS, V11, P773, DOI 10.1007/s10495-006-5882-8; Sukhodub Andrey L., 2005, Journal of Pharmacological and Toxicological Methods, V52, P330, DOI 10.1016/j.vascn.2005.04.016; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; TIPTON KF, 1983, BIOCHEM J, V209, P235, DOI 10.1042/bj2090235; Torrisi R, 2001, DRUGS, V61, P909, DOI 10.2165/00003495-200161070-00002; Triola G, 2004, MOL PHARMACOL, V66, P1671, DOI 10.1124/mol.104.003681; Triola G, 2003, J ORG CHEM, V68, P9924, DOI 10.1021/jo030141u; Triola G, 2001, ANGEW CHEM INT EDIT, V40, P1960, DOI 10.1002/1521-3773(20010518)40:10<1960::AID-ANIE1960>3.3.CO;2-M; Villablanca JG, 2006, J CLIN ONCOL, V24, P3423, DOI 10.1200/JCO.2005.03.9271; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Villani MG, 2004, CLIN CANCER RES, V10, P6265, DOI 10.1158/1078-0432.CCR-04-0655; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang HT, 2001, CANCER RES, V61, P5102; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	41	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24754	24764		10.1074/jbc.M111.250779	http://dx.doi.org/10.1074/jbc.M111.250779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21543327	hybrid, Green Published			2022-12-25	WOS:000292547900026
J	Warnatz, HJ; Schmidt, D; Manke, T; Piccini, I; Sultan, M; Borodina, T; Balzereit, D; Wruck, W; Soldatov, A; Vingron, M; Lehrach, H; Yaspo, ML				Warnatz, Hans-Joerg; Schmidt, Dominic; Manke, Thomas; Piccini, Ilaria; Sultan, Marc; Borodina, Tatiana; Balzereit, Daniela; Wruck, Wasco; Soldatov, Alexey; Vingron, Martin; Lehrach, Hans; Yaspo, Marie-Laure			The BTB and CNC Homology 1 (BACH1) Target Genes Are Involved in the Oxidative Stress Response and in Control of the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR VAULT PROTEIN; TRANSCRIPTION FACTOR BACH1; RNA-POLYMERASE-II; HEME OXYGENASE-1; BINDING-SITES; EXPRESSION; ASSOCIATION; PATHWAY; DOMAIN; CHIP	The regulation of gene expression in response to environmental signals and metabolic imbalances is a key step in maintaining cellular homeostasis. BTB and CNC homology 1 (BACH1) is a heme-binding transcription factor repressing the transcription from a subset of MAF recognition elements at low intracellular heme levels. Upon heme binding, BACH1 is released from the MAF recognition elements, resulting in increased expression of antioxidant response genes. To systematically address the gene regulatory networks involving BACH1, we combined chromatin immunoprecipitation sequencing analysis of BACH1 target genes in HEK 293 cells with knockdown of BACH1 using three independent types of small interfering RNAs followed by transcriptome profiling using microarrays. The 59 BACH1 target genes identified by chromatin immunoprecipitation sequencing were found highly enriched in genes showing expression changes after BACH1 knockdown, demonstrating the impact of BACH1 repression on transcription. In addition to known and new BACH1 targets involved in heme degradation (HMOX1, FTL, FTH1, ME1, and SLC48A1) and redox regulation (GCLC, GCLM, and SLC7A11), we also discovered BACH1 target genes affecting cell cycle and apoptosis pathways (ITPR2, CALM1, SQSTM1, TFE3, EWSR1, CDK6, BCL2L11, and MAFG) as well as subcellular transport processes (CLSTN1, PSAP, MAPT, and vault RNA). The newly identified impact of BACH1 on genes involved in neurodegenerative processes and proliferation provides an interesting basis for future dissection of BACH1-mediated gene repression in neurodegeneration and virus-induced cancerogenesis.	[Warnatz, Hans-Joerg; Schmidt, Dominic; Piccini, Ilaria; Sultan, Marc; Borodina, Tatiana; Balzereit, Daniela; Wruck, Wasco; Soldatov, Alexey; Lehrach, Hans; Yaspo, Marie-Laure] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Manke, Thomas; Vingron, Martin] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society	Yaspo, ML (corresponding author), Max Planck Inst Mol Genet, Dept Vertebrate Genom, Ihnestr 63-73, D-14195 Berlin, Germany.	yaspo@molgen.mpg.de	Manke, Thomas/L-9075-2019; Soldatov, Alexey/V-2383-2019	Borodina, Tatiana/0000-0002-6978-016X; Warnatz, Hans-Jorg/0000-0002-0327-9209; Manke, Thomas/0000-0003-3702-0868	Max Planck Society (Munich, Germany); European Commission [LSHG-CT-2006-037627]	Max Planck Society (Munich, Germany)(Max Planck Society); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Max Planck Society (Munich, Germany) and the European Commission under its Sixth Framework Programme Grant AnEUploidy LSHG-CT-2006-037627.	Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; BUSSOLATI O, 1992, J BIOL CHEM, V267, P8330; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Geetha T, 2002, FEBS LETT, V512, P19, DOI 10.1016/S0014-5793(02)02286-X; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; IGARASHI K, 1994, NATURE, V367, P568, DOI 10.1038/367568a0; Ito N, 2009, GENES CELLS, V14, P167, DOI 10.1111/j.1365-2443.2008.01259.x; Iwashita K, 2010, CANCER SCI, V101, P920, DOI [10.1111/j.1349-7006.2009.01481.x, 10.1111/j.1349-7006.2010.01481.x]; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Kremmidiotis G, 2001, GENOMICS, V76, P58, DOI 10.1006/geno.2001.6560; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Miyazaki T, 2010, CANCER SCI, V101, P1409, DOI 10.1111/j.1349-7006.2010.01550.x; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mueller C, 2010, J ALZHEIMERS DIS, V19, P1081, DOI 10.3233/JAD-2010-1303; Nijman SMB, 2006, J BIOL CHEM, V281, P21582, DOI 10.1074/jbc.M602312200; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Okada S, 2010, J BIOL CHEM, V285, P23581, DOI 10.1074/jbc.M109.068197; Paspalas CD, 2009, CEREB CORTEX, V19, P1666, DOI 10.1093/cercor/bhn203; Qin ZQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000742; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Reichard JF, 2008, J BIOL CHEM, V283, P22363, DOI 10.1074/jbc.M801784200; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Ryu SJ, 2009, EXPERT OPIN THER TAR, V13, P479, DOI [10.1517/14728220902832705 , 10.1517/14728220902832705]; Sanchez G, 2008, P NATL ACAD SCI USA, V105, P6004, DOI 10.1073/pnas.0710748105; Sanz N, 1997, BRIT J CANCER, V75, P487, DOI 10.1038/bjc.1997.85; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748; Singh VB, 2009, BIOCHEM BIOPH RES CO, V379, P710, DOI 10.1016/j.bbrc.2008.12.141; Slesina M, 2006, CELL TISSUE RES, V324, P403, DOI 10.1007/s00441-006-0158-8; Snider BJ, 2009, ARCH NEUROL-CHICAGO, V66, P638, DOI 10.1001/archneurol.2009.55; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Taylor J., 2007, CURR PROTOC BIOINFOR; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Warnatz HJ, 2010, NUCLEIC ACIDS RES, V38, P6112, DOI 10.1093/nar/gkq402; Weis N, 2009, MOL BIOL CELL, V20, P1280, DOI 10.1091/mbc.E08-10-1005; WU CL, 1995, MOL CELL BIOL, V15, P2536; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	74	113	118	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23521	23532		10.1074/jbc.M111.220178	http://dx.doi.org/10.1074/jbc.M111.220178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555518	hybrid, Green Published			2022-12-25	WOS:000292025000082
J	Gu, TL; Nardone, J; Wang, Y; Loriaux, M; Villen, J; Beausoleil, S; Tucker, M; Kornhauser, J; Ren, JM; MacNeill, J; Gygi, SP; Druker, BJ; Heinrich, MC; Rush, J; Polakiewicz, RD				Gu, Ting-lei; Nardone, Julie; Wang, Yi; Loriaux, Marc; Villen, Judit; Beausoleil, Sean; Tucker, Meghan; Kornhauser, Jon; Ren, Jianmin; MacNeill, Joan; Gygi, Steven P.; Druker, Brian J.; Heinrich, Michael C.; Rush, John; Polakiewicz, Roberto D.			Survey of Activated FLT3 Signaling in Leukemia	PLOS ONE			English	Article							INTERNAL TANDEM DUPLICATION; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR TYROSINE KINASE; B-CELL DEVELOPMENT; PHOSPHORYLATION; PROTEIN; ASSOCIATION; MUTATIONS; ROLES	Activating mutations of FMS-like tyrosine kinase-3 (FLT3) are found in approximately 30% of patients with acute myeloid leukemia (AML). FLT3 is therefore an attractive drug target. However, the molecular mechanisms by which FLT3 mutations lead to cell transformation in AML remain unclear. To develop a better understanding of FLT3 signaling as well as its downstream effectors, we performed detailed phosphoproteomic analysis of FLT3 signaling in human leukemia cells. We identified over 1000 tyrosine phosphorylation sites from about 750 proteins in both AML (wild type and mutant FLT3) and B cell acute lymphoblastic leukemia (normal and amplification of FLT3) cell lines. Furthermore, using stable isotope labeling by amino acids in cell culture (SILAC), we were able to quantified over 400 phosphorylation sites (pTyr, pSer, and pThr) that were responsive to FLT3 inhibition in FLT3 driven human leukemia cell lines. We also extended this phosphoproteomic analysis on bone marrow from primary AML patient samples, and identify over 200 tyrosine and 800 serine/threonine phosphorylation sites in vivo. This study showed that oncogenic FLT3 regulates proteins involving diverse cellular processes and affects multiple signaling pathways in human leukemia that we previously appreciated, such as Fc epsilon RI-mediated signaling, BCR, and CD40 signaling pathways. It provides a valuable resource for investigation of oncogenic FLT3 signaling in human leukemia.	[Gu, Ting-lei; Nardone, Julie; Wang, Yi; Beausoleil, Sean; Tucker, Meghan; Kornhauser, Jon; Ren, Jianmin; MacNeill, Joan; Rush, John; Polakiewicz, Roberto D.] Cell Signaling Technol Inc, Danvers, MA USA; [Loriaux, Marc] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Druker, Brian J.; Heinrich, Michael C.] Oregon Hlth & Sci Univ, Dept Hematol & Med Oncol, Portland, OR 97201 USA; [Druker, Brian J.] Howard Hughes Med Inst, Portland, OR USA; [Heinrich, Michael C.] Portland VA Med Ctr, Portland, OR USA	Oregon Health & Science University; Harvard University; Harvard Medical School; Oregon Health & Science University; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Gu, TL (corresponding author), Cell Signaling Technol Inc, Danvers, MA USA.	tgu@cellsignal.com; rpolakiewicz@cellsignal.com	Heinrich, Michael/AAC-6745-2019	Villen, Judit/0000-0002-1005-1739; Heinrich, Michael/0000-0003-3790-0478; Druker, Brian/0000-0001-8331-8206				Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brown P, 2005, BLOOD, V105, P812, DOI 10.1182/blood-2004-06-2498; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Del Nagro CJ, 2005, IMMUNOL RES, V31, P119, DOI 10.1385/IR:31:2:119; Demarchi F, 2003, J BIOL CHEM, V278, P39583, DOI 10.1074/jbc.M305676200; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Doepfner KT, 2007, CRIT REV ONCOL HEMAT, V63, P215, DOI 10.1016/j.critrevonc.2007.05.005; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; DOSIL M, 1993, MOL CELL BIOL, V13, P6572, DOI 10.1128/MCB.13.10.6572; Everley PA, 2006, J PROTEOME RES, V5, P1224, DOI 10.1021/pr0504891; FUJIMOTO K, 1995, GENE, V165, P183, DOI 10.1016/0378-1119(95)00507-3; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Goss VL, 2006, BLOOD; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hester KD, 2007, CELL CYCLE, V6, P1594, DOI 10.4161/cc.6.13.4336; Ibarrola N, 2003, ANAL CHEM, V75, P6043, DOI 10.1021/ac034931f; Ishiko J, 2005, ONCOGENE, V24, P8144, DOI 10.1038/sj.onc.1208957; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knapper S, 2006, BLOOD, V108, P3494, DOI 10.1182/blood-2006-04-015487; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Le Gallic L, 2004, MOL CELL BIOL, V24, P1206, DOI 10.1128/MCB.24.3.1206-1218.2004; Levis M, 2005, INT J HEMATOL, V82, P100, DOI 10.1532/IJH97.05079; Marchetto S, 1999, LEUKEMIA, V13, P1374, DOI 10.1038/sj.leu.2401527; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Moreno I, 2003, HAEMATOLOGICA, V88, P19; Naoe T, 2004, CELL MOL LIFE SCI, V61, P2932, DOI 10.1007/s00018-004-4274-x; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Orr SJ, J LEUKOC BIOL, V89, P11; Robinson LJ, 2005, EXP HEMATOL, V33, P469, DOI 10.1016/j.exphem.2005.01.004; Rocnik JL, 2006, BLOOD, V108, P1339, DOI 10.1182/blood-2005-11-011429; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Scheijen B, 2004, ONCOGENE, V23, P3338, DOI 10.1038/sj.onc.1207456; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Shih LY, 2002, BLOOD, V100, P2387, DOI 10.1182/blood-2002-01-0195; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang SL, 2000, BIOCHEM BIOPH RES CO, V277, P195, DOI 10.1006/bbrc.2000.3662; Zhang SL, 1999, BIOCHEM BIOPH RES CO, V254, P440, DOI 10.1006/bbrc.1998.9959; Zhang SL, 1999, J LEUKOCYTE BIOL, V65, P372, DOI 10.1002/jlb.65.3.372; Zhang Y., 2009, MOL CELL PROTEOMICS; Zhang YH, 2004, J BIOL CHEM, V279, P53116, DOI 10.1074/jbc.M405502200	56	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19169	10.1371/journal.pone.0019169	http://dx.doi.org/10.1371/journal.pone.0019169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552520	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700034
J	Luan, LJ; Ren, CR; Lau, BWM; Yang, J; Pickard, GE; So, KF; Pu, ML				Luan, Liju; Ren, Chaoran; Lau, Benson Wui-Man; Yang, Jian; Pickard, Gary E.; So, Kwok-Fai; Pu, Mingliang			Y-Like Retinal Ganglion Cells Innervate the Dorsal Raphe Nucleus in the Mongolian Gerbil (Meriones unguiculatus)	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; CENTRAL PROJECTIONS; DIURNAL-VARIATION; MIDBRAIN RAPHE; MELANOPSIN; MORPHOLOGY; SEROTONIN; PATHWAY; CATS; MICE	Background: The dorsal raphe nucleus (DRN) of the mesencephalon is a complex multi-functional and multi-transmitter nucleus involved in a wide range of behavioral and physiological processes. The DRN receives a direct input from the retina. However little is known regarding the type of retinal ganglion cell (RGC) that innervates the DRN. We examined morphological characteristics and physiological properties of these DRN projecting ganglion cells. Methodology/Principal Findings: The Mongolian gerbils are highly visual rodents with a diurnal/crepuscular activity rhythm. It has been widely used as experimental animals of various studies including seasonal affective disorders and depression. Young adult gerbils were used in the present study. DRN-projecting RGCs were identified following retrograde tracer injection into the DRN, characterized physiologically by extracellular recording and morphologically after intracellular filling. The result shows that DRN-projecting RGCs exhibit morphological characteristics typical of alpha RGCs and physiological response properties of Y-cells. Melanopsin was not detected in these RGCs and they show no evidence of intrinsic photosensitivity. Conclusions/Significance: These findings suggest that RGCs with alpha-like morphology and Y-like physiology appear to perform a non-imaging forming function and thus may participate in the modulation of DRN activity which includes regulation of sleep and mood.	[Luan, Liju; Ren, Chaoran; Pu, Mingliang] Peking Univ, Sch Basic Med Sci, Dept Anat, Beijing 100871, Peoples R China; [Luan, Liju; Ren, Chaoran; Pu, Mingliang] Peking Univ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Luan, Liju; Ren, Chaoran; Pu, Mingliang] Peking Univ, Key Lab Visual Impairment & Restore, Beijing 100871, Peoples R China; [Lau, Benson Wui-Man; Yang, Jian; So, Kwok-Fai] Univ Hong Kong, Dept Anat, LKS Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Pokfulam, Hong Kong, Peoples R China; [Lau, Benson Wui-Man; Yang, Jian; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Pickard, Gary E.] Univ Nebraska Lincoln, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [So, Kwok-Fai] Jinan Univ, Joint Lab Brain Funct & Hlth, Guangzhou, Guangdong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China	Peking University; Peking University; Peking University; University of Hong Kong; University of Hong Kong; University of Nebraska System; University of Nebraska Lincoln; Jinan University; University of Hong Kong	Luan, LJ (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Anat, Beijing 100871, Peoples R China.	hrmaskf@hkucc.hku.hk; mpu@hsc.pku.edu.cn	Ren, Chaoran/I-7904-2019	LAU, Wui Man/0000-0002-4552-2780; So, Kwok-Fai/0000-0003-4039-4246	National Science Foundation of China [30831160516]; Ministry of Science and Technology of China [2011CB510206, 2009CB320900]; National Institutes of Health, USA [R01 EY017809]; NSFC/RGC [N_HKU750/08]; Fundamental Research Funds for the Central Universities [21609101]; National Basic Research Program of China (973 Program) [2011CB707501]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Science Foundation of China grants (30831160516 to M. Pu); Ministry of Science and Technology of China grants (2011CB510206 & 2009CB320900 to M. Pu); National Institutes of Health, USA grant R01 EY017809 (G. E. Pickard); NSFC/RGC Joint Research Scheme under the contract N_HKU750/08 (K-F. So), the Fundamental Research Funds for the Central Universities (21609101, KF So); National Basic Research Program of China (973 Program) (2011CB707501, K-F. So). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; Arvanitogiannis A, 1999, NEUROSCI LETT, V261, P159, DOI 10.1016/S0304-3940(99)00021-X; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Birkett M, 2005, BRAIN RES, V1034, P180, DOI 10.1016/j.brainres.2004.11.053; BOYCOTT BB, 1974, J PHYSIOL-LONDON, V240, P397, DOI 10.1113/jphysiol.1974.sp010616; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; CLELAND BG, 1975, J PHYSIOL-LONDON, V248, P151, DOI 10.1113/jphysiol.1975.sp010967; Crook JD, 2008, J NEUROSCI, V28, P11277, DOI 10.1523/JNEUROSCI.2982-08.2008; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Filippov IV, 2004, NEUROSCI LETT, V363, P89, DOI 10.1016/j.neulet.2004.03.048; Fite KV, 1999, J COMP NEUROL, V414, P469, DOI 10.1002/(SICI)1096-9861(19991129)414:4<469::AID-CNE4>3.0.CO;2-P; Fite KV, 2003, BRAIN RES, V973, P146, DOI 10.1016/S0006-8993(03)02549-6; Fite KV, 2001, BRAIN RES, V895, P139, DOI 10.1016/S0006-8993(01)02061-3; FOOTE WE, 1978, BRAIN RES, V156, P135, DOI 10.1016/0006-8993(78)90089-6; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HEYM J, 1982, BRAIN RES, V232, P29, DOI 10.1016/0006-8993(82)90608-4; Janusonis S, 2001, J COMP NEUROL, V440, P31, DOI 10.1002/cne.1368; Kawano H, 1996, NEUROSCI LETT, V212, P143, DOI 10.1016/0304-3940(96)12795-6; KOONTZ MA, 1985, J COMP NEUROL, V236, P42, DOI 10.1002/cne.902360105; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; LEVENTHAL AG, 1985, J COMP NEUROL, V237, P216, DOI 10.1002/cne.902370206; Levick WR, 1996, PROG RETIN EYE RES, V15, P457, DOI 10.1016/1350-9462(96)00011-0; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Manookin MB, 2008, J NEUROSCI, V28, P4136, DOI 10.1523/JNEUROSCI.4274-07.2008; MARTIN CL, 1972, VET MED SM ANIM CLIN, V67, P885; MARTIN PR, 1986, EXP BRAIN RES, V62, P77; Morin LP, 2009, J BIOL RHYTHM, V24, P497, DOI 10.1177/0748730409349059; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Nan Y, 2010, INVEST OPHTH VIS SCI, V51, P1208, DOI 10.1167/iovs.09-4179; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; PEICHL L, 1981, PROC R SOC SER B-BIO, V212, P139, DOI 10.1098/rspb.1981.0030; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; PENN AA, 1994, J NEUROSCI, V14, P3805; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PU M, 1994, J NEUROSCI, V14, P4338; Pu ML, 2006, NEUROREPORT, V17, P1469, DOI 10.1097/01.wnr.0000234757.26610.e8; Pu ML, 1999, J COMP NEUROL, V414, P267; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; REESE BE, 1986, EXP BRAIN RES, V61, P375; Reuss S, 2000, BRAIN RES, V874, P66, DOI 10.1016/S0006-8993(00)02578-6; SAITO HA, 1983, J COMP NEUROL, V221, P279, DOI 10.1002/cne.902210304; Schiller PH, 2010, P NATL ACAD SCI USA, V107, P17087, DOI 10.1073/pnas.1011782107; SHEN H, 1994, BRAIN RES, V635, P159, DOI 10.1016/0006-8993(94)91435-4; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Van den Pol AN, 1998, AM J PHYSIOL-REG I, V275, pR654, DOI 10.1152/ajpregu.1998.275.2.R654; Vidal L, 2007, J NEUROSCI, V27, P3375, DOI 10.1523/JNEUROSCI.5496-06.2007; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WEHRHAHN C, 1992, J NEUROSCI, V12, P2247	55	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18938	10.1371/journal.pone.0018938	http://dx.doi.org/10.1371/journal.pone.0018938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552551	gold, Green Published			2022-12-25	WOS:000290020700008
J	Clay, Z; Zuberbuhler, K				Clay, Zanna; Zuberbuehler, Klaus			Bonobos Extract Meaning from Call Sequences	PLOS ONE			English	Article							FOOD-ASSOCIATED CALLS; WHITE-FACED CAPUCHINS; GOLDEN LION TAMARINS; COTTON-TOP TAMARINS; ALARM CALLS; PAN-PANISCUS; ELICITED VOCALIZATIONS; PLAYBACK EXPERIMENTS; CEBUS-CAPUCINUS; COMMUNICATION	Studies on language-trained bonobos have revealed their remarkable abilities in representational and communication tasks. Surprisingly, however, corresponding research into their natural communication has largely been neglected. We address this issue with a first playback study on the natural vocal behaviour of bonobos. Bonobos produce five acoustically distinct call types when finding food, which they regularly mix together into longer call sequences. We found that individual call types were relatively poor indicators of food quality, while context specificity was much greater at the call sequence level. We therefore investigated whether receivers could extract meaning about the quality of food encountered by the caller by integrating across different call sequences. We first trained four captive individuals to find two types of foods, kiwi (preferred) and apples (less preferred) at two different locations. We then conducted naturalistic playback experiments during which we broadcasted sequences of four calls, originally produced by a familiar individual responding to either kiwi or apples. All sequences contained the same number of calls but varied in the composition of call types. Following playbacks, we found that subjects devoted significantly more search effort to the field indicated by the call sequence. Rather than attending to individual calls, bonobos attended to the entire sequences to make inferences about the food encountered by a caller. These results provide the first empirical evidence that bonobos are able to extract information about external events by attending to vocal sequences of other individuals and highlight the importance of call combinations in their natural communication system.	[Clay, Zanna; Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Clay, Zanna] Twycross Zoo, Twycross, Atherstone, England	University of St Andrews	Clay, Z (corresponding author), Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland.	kz3@st-andrews.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X	Leverhulme Trust; Wissenschaftskolleg zu Berlin	Leverhulme Trust(Leverhulme Trust); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF))	This research was funded by a Leverhulme Trust Research Leadership Award and the Wissenschaftskolleg zu Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, NATURE, V441, P303, DOI 10.1038/441303a; BENZ JJ, 1993, ANIM BEHAV, V45, P443, DOI 10.1006/anbe.1993.1056; BENZ JJ, 1992, J COMP PSYCHOL, V106, P142, DOI 10.1037/0735-7036.106.2.142; Bermejo M, 1999, FOLIA PRIMATOL, V70, P328, DOI 10.1159/000021717; Boinski S, 1996, ETHOLOGY, V102, P826; CAINE NG, 1995, ANIM BEHAV, V50, P53, DOI 10.1006/anbe.1995.0220; Clarke E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000073; Clay Z, 2009, ANIM BEHAV, V77, P1387, DOI 10.1016/j.anbehav.2009.02.016; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; Di Bitetti MS, 2003, BEHAVIOUR, V140, P565, DOI 10.1163/156853903322149441; ELOWSON AM, 1991, ANIM BEHAV, V42, P931, DOI 10.1016/S0003-3472(05)80145-9; Evans CS, 1999, ANIM BEHAV, V58, P307, DOI 10.1006/anbe.1999.1143; Fichtel C, 2002, BEHAV ECOL SOCIOBIOL, V51, P262, DOI 10.1007/S00265-001-0436-0; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Genty E, 2010, ANIM COGN, V13, P287, DOI 10.1007/s10071-009-0266-4; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goodall J, 1963, FEEDING BEHAV WILD C, P39; Gros-Louis J, 2004, J COMP PSYCHOL, V118, P396, DOI 10.1037/0735-7036.118.4.396; Gros-Louis J, 2004, ANIM BEHAV, V67, P431, DOI 10.1016/j.anbehav.2003.04.009; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; Hollen LI, 2007, AM NAT, V169, P758, DOI 10.1086/516719; Kirchhof J, 2006, ETHOLOGY, V112, P346, DOI 10.1111/j.1439-0310.2006.01165.x; Kitzmann CD, 2009, ETHOLOGY, V115, P439, DOI 10.1111/j.1439-0310.2009.01622.x; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Owren M, 2010, BIOL PHIL, P1; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Roush RS, 2000, ETHOLOGY, V106, P673, DOI 10.1046/j.1439-0310.2000.00581.x; Savage-Rumbaugh S., 1994, KANZI APE BRINK HUMA; SAVAGERUMBAUGH ES, 1993, MONOGR SOC RES CHILD, V58, pR5; SAVAGERUMBAUGH S, 1986, J EXP PSYCHOL GEN, V115, P211, DOI 10.1037/0096-3445.115.3.211; SAVAGERUMBAUGH S, 1990, ADV INFANCY RES, V6, P221; Schel AM, 2009, J COMP PSYCHOL, V123, P136, DOI 10.1037/a0014280; Seyfarth RM, 2003, ANN NY ACAD SCI, V1000, P32, DOI 10.1196/annals.1280.004; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Slocombe KE, 2006, ANIM BEHAV, V72, P989, DOI 10.1016/j.anbehav.2006.01.030; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; SLOCOMBE KE, 2010, BEHAV ECOL IN PRESS; Stegmann UE, 2009, PHILOS SCI, V76, P864, DOI 10.1086/605820; VanKrunkelsven E, 1996, INT J PRIMATOL, V17, P207; Zuberbuhler K, 2003, ADV STUD BEHAV, V33, P265, DOI 10.1016/S0065-3454(03)33006-2; Zuberbuhler K, 1999, J COMP PSYCHOL, V113, P33, DOI 10.1037/0735-7036.113.1.33	47	69	71	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18786	10.1371/journal.pone.0018786	http://dx.doi.org/10.1371/journal.pone.0018786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756NO	21556149	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000290019400011
J	Croy, I; Springborn, M; Lotsch, J; Johnston, ANB; Hummel, T				Croy, Ilona; Springborn, Maria; Loetsch, Joern; Johnston, Amy N. B.; Hummel, Thomas			Agreeable Smellers and Sensitive Neurotics Correlations among Personality Traits and Sensory Thresholds	PLOS ONE			English	Article							5-FACTOR MODEL; ODOR DISCRIMINATION; PAIN; SEX; IDENTIFICATION; EXTROVERSION	Correlations between personality traits and a wide range of sensory thresholds were examined. Participants (N = 124) completed a personality inventory (NEO-FFI) and underwent assessment of olfactory, trigeminal, tactile and gustatory detection thresholds, as well as examination of trigeminal and tactile pain thresholds. Significantly enhanced odor sensitivity in socially agreeable people, significantly enhanced trigeminal sensitivity in neurotic subjects, and a tendency for enhanced pain tolerance in highly conscientious participants was revealed. It is postulated that varied sensory processing may influence an individual's perception of the environment; particularly their perception of socially relevant or potentially dangerous stimuli and thus, varied with personality.	[Croy, Ilona; Springborn, Maria; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Croy, Ilona] Univ Dresden, Sch Med, Dept Psychosomat Med, Dresden, Germany; [Loetsch, Joern] Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Zentrum Arzneimittelforsch Entwicklung & Sicherhe, Inst Clin Pharmacol, Frankfurt, Germany; [Johnston, Amy N. B.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia	Technische Universitat Dresden; Technische Universitat Dresden; Goethe University Frankfurt; Griffith University	Croy, I (corresponding author), Univ Dresden, Sch Med, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany.	ilona.croy@tu-dresden.de	Johnston, Amy N.B./B-2931-2010	Johnston, Amy N.B./0000-0002-9979-997X; Croy, Ilona/0000-0002-0361-5559; Lotsch, Jorn/0000-0002-5818-6958				AMMERMAN RT, 1986, CLIN PSYCHOL REV, V6, P67, DOI 10.1016/0272-7358(86)90019-X; Bennetto L, 2007, BIOL PSYCHIAT, V62, P1015, DOI 10.1016/j.biopsych.2007.04.019; Borkenau P., 2008, NEO FFI NEO FUNF FAK, V2.; Bortz J., 2006, FORSCHUNGSMETHODEN E, V4th Aufl, DOI [10.1007/978-3-540-33306-7, DOI 10.1007/978-3-540-33306-7]; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Cattell RB, 1943, J ABNORM SOC PSYCH, V38, P476, DOI 10.1037/h0054116; CORLIS R, 1967, NATURE, V216, P91, DOI 10.1038/216091a0; Costa P.T., 1992, NEO FFI PERSONALITY; Croy I, 2010, INT J PSYCHOPHYSIOL, V75, P326, DOI 10.1016/j.ijpsycho.2010.01.003; Croy I, 2009, CHEM SENSES, V34, P523, DOI 10.1093/chemse/bjp029; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Goldberg L.R., 1981, REV PERSONAL SOC PSY, V2, P141, DOI DOI 10.1037/0022-3514.59.6.1216; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; GOLDMAN D, 1983, J PERS SOC PSYCHOL, V45, P405, DOI 10.1037/0022-3514.45.2.405; Harrison D, 2010, ARCH DIS CHILD, V95, P406, DOI 10.1136/adc.2009.174227; Hollis J, 2007, OPHTHAL PHYSL OPT, V27, P603, DOI 10.1111/j.1475-1313.2007.00519.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2011, INT J PSYCHOPHYSIOLO, P21291919; Hummel Thomas, 2007, Clin Allergy Immunol, V19, P389; Jang KL, 2002, PERS INDIV DIFFER, V33, P83, DOI 10.1016/S0191-8869(01)00137-4; Karl A, 2006, BIOL PSYCHOL, V71, P123, DOI 10.1016/j.biopsycho.2005.03.004; Kobal G., 1996, Rhinology (Utrecht), V34, P222; KOELEGA HS, 1970, ACTA PSYCHOL, V34, P51, DOI 10.1016/0001-6918(70)90004-1; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; MCADAMS DP, 1992, J PERS, V60, P329, DOI 10.1111/j.1467-6494.1992.tb00976.x; McCrae RR, 2000, J PERS SOC PSYCHOL, V78, P173, DOI 10.1037/0022-3514.78.1.173; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MCCRAE RR, 1986, J PERS, V54, P430, DOI 10.1111/j.1467-6494.1986.tb00403.x; McCrae RR, 2003, PERSONALITY ADULTHOO, DOI DOI 10.4324/9780203428412; Mueller C, 2003, RHINOLOGY, V41, P2; Paine P, 2009, PAIN, V144, P236, DOI 10.1016/j.pain.2009.02.022; Pause BM, 1998, J RES PERS, V32, P510, DOI 10.1006/jrpe.1998.2228; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; SHIOMI K, 1978, PERCEPT MOTOR SKILL, V47, P1155, DOI 10.2466/pms.1978.47.3f.1155; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Villemure C, 2009, J NEUROSCI, V29, P705, DOI 10.1523/JNEUROSCI.3822-08.2009; Welge-Lussen A, 2009, B-ENT, P129; Zhou W, 2009, PSYCHOL SCI, V20, P1118, DOI 10.1111/j.1467-9280.2009.02413.x; Zverev Y, 2008, COLLEGIUM ANTROPOL, V32, P21	42	37	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18701	10.1371/journal.pone.0018701	http://dx.doi.org/10.1371/journal.pone.0018701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756NO	21556139	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400008
J	Taylor, CM; Fischer, K; Abubucker, S; Wang, ZY; Martin, J; Jiang, DJ; Magliano, M; Rosso, MN; Li, BW; Fischer, PU; Mitreva, M				Taylor, Christina M.; Fischer, Kerstin; Abubucker, Sahar; Wang, Zhengyuan; Martin, John; Jiang, Daojun; Magliano, Marc; Rosso, Marie-Noelle; Li, Ben-Wen; Fischer, Peter U.; Mitreva, Makedonka			Targeting Protein-Protein Interactions for Parasite Control	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; STRUCTURE PREDICTION; DRUG TARGETS; EXPRESSION; NEMATODES; NETWORK; DESIGN; UPDATE; IMPACT; PLANT	Finding new drug targets for pathogenic infections would be of great utility for humanity, as there is a large need to develop new drugs to fight infections due to the developing resistance and side effects of current treatments. Current drug targets for pathogen infections involve only a single protein. However, proteins rarely act in isolation, and the majority of biological processes occur via interactions with other proteins, so protein-protein interactions (PPIs) offer a realm of unexplored potential drug targets and are thought to be the next-generation of drug targets. Parasitic worms were chosen for this study because they have deleterious effects on human health, livestock, and plants, costing society billions of dollars annually and many sequenced genomes are available. In this study, we present a computational approach that utilizes whole genomes of 6 parasitic and 1 free-living worm species and 2 hosts. The species were placed in orthologous groups, then binned in species-specific ortholgous groups. Proteins that are essential and conserved among species that span a phyla are of greatest value, as they provide foundations for developing broad-control strategies. Two PPI databases were used to find PPIs within the species specific bins. PPIs with unique helminth proteins and helminth proteins with unique features relative to the host, such as indels, were prioritized as drug targets. The PPIs were scored based on RNAi phenotype and homology to the PDB (Protein DataBank). EST data for the various life stages, GO annotation, and druggability were also taken into consideration. Several PPIs emerged from this study as potential drug targets. A few interactions were supported by co-localization of expression in M. incognita (plant parasite) and B. malayi (H. sapiens parasite), which have extremely different modes of parasitism. As more genomes of pathogens are sequenced and PPI databases expanded, this methodology will become increasingly applicable.	[Taylor, Christina M.; Abubucker, Sahar; Wang, Zhengyuan; Martin, John; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA; [Fischer, Kerstin; Jiang, Daojun; Li, Ben-Wen; Fischer, Peter U.] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; [Magliano, Marc; Rosso, Marie-Noelle] UNSA, CNRS 6243, INRA 1301, Sophia Antipolis, France	Washington University (WUSTL); Washington University (WUSTL); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Taylor, CM (corresponding author), Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA.	mmitreva@watson.wustl.edu	Wang, Zhengyuan/GWV-6069-2022; wang, zhengyuan/HGA-0435-2022; Fischer, Peter/A-2746-2008	wang, zhengyuan/0000-0002-8447-9674; Fischer, Peter/0000-0003-4558-3417; Mitreva, Makedonka/0000-0001-9572-3436	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI081803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081803] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grant AI081803 to M. Mitreva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; [Anonymous], NUCL ACIDS RES; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; BARKER KR, 1994, J NEMATOL, V26, P127; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; Bourgeas R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009598; Brindley PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000538; Caffrey CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004413; Ceol A, 2009, NUCL ACIDS RES; Chan SK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-227; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Cherkasov A, 2005, PROTEINS, V58, P950, DOI 10.1002/prot.20391; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fatumo S, 2009, INFECT GENET EVOL, V9, P351, DOI 10.1016/j.meegid.2008.01.007; Fletcher S, 2006, J R SOC INTERFACE, V3, P215, DOI 10.1098/rsif.2006.0115; Fry DC, 2006, BIOPOLYMERS, V84, P535, DOI 10.1002/bip.20608; Fuentes G, 2009, CURR OPIN DRUG DISC, V12, P358; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hormozdiari F, 2009, J COMPUT BIOL, V16, P159, DOI 10.1089/cmb.2008.03TT; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jiang DJ, 2008, INT J PARASITOL, V38, P503, DOI 10.1016/j.ijpara.2007.09.010; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; McCarter JP, 2005, J NEMATOL, V37, P417; MCLEOD RS, 1995, INT J PARASITOL, V25, P1363, DOI 10.1016/0020-7519(95)00071-9; Mitreva M, 2007, VET PARASITOL, V148, P31, DOI 10.1016/j.vetpar.2007.05.008; Orti L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000418; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rosso MN, 1999, MOL PLANT MICROBE IN, V12, P585, DOI 10.1094/MPMI.1999.12.7.585; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott AL, 2009, PARASITOL INT, V58, P6, DOI 10.1016/j.parint.2008.09.003; Singh S, 2007, BIOINFORMATION, V2, P68, DOI 10.6026/97320630002068; Smith Katherine A., 2007, Invertebrate Neuroscience, V7, P227, DOI 10.1007/s10158-007-0058-y; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toomey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006195; van den Enden E, 2009, EXPERT OPIN PHARMACO, V10, P435, DOI [10.1517/14656560902722463, 10.1517/14656560902722463 ]; Wang ZY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-23; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Williamson Sally M., 2007, Invertebrate Neuroscience, V7, P219, DOI 10.1007/s10158-007-0056-0; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101	50	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18381	10.1371/journal.pone.0018381	http://dx.doi.org/10.1371/journal.pone.0018381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556146	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400005
J	Newington, JT; Pitts, A; Chien, A; Arseneault, R; Schubert, D; Cumming, RC				Newington, Jordan T.; Pitts, Andrea; Chien, Andrew; Arseneault, Robert; Schubert, David; Cumming, Robert C.			Amyloid Beta Resistance in Nerve Cell Lines Is Mediated by the Warburg Effect	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; HYPOXIA-INDUCIBLE FACTOR-1; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; LACTATE-DEHYDROGENASE; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; PROTEIN TOXICITY; IN-VIVO; CANCER-CELLS	Amyloid beta (Ab) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is closely associated with increased nerve cell death. However, many cells survive and it is important to understand the mechanisms involved in this survival response. Recent studies have shown that an anti-apoptotic mechanism in cancer cells is mediated by aerobic glycolysis, also known as the Warburg effect. One of the major regulators of aerobic glycolysis is pyruvate dehydrogenase kinase (PDK), an enzyme which represses mitochondrial respiration and forces the cell to rely heavily on glycolysis, even in the presence of oxygen. Recent neuroimaging studies have shown that the spatial distribution of aerobic glycolysis in the brains of AD patients strongly correlates with Ab deposition. Interestingly, clonal nerve cell lines selected for resistance to Ab exhibit increased glycolysis as a result of activation of the transcription factor hypoxia inducible factor 1. Here we show that Ab resistant nerve cell lines upregulate Warburg effect enzymes in a manner reminiscent of cancer cells. In particular, Ab resistant nerve cell lines showed elevated PDK1 expression in addition to an increase in lactate dehydrogenase A (LDHA) activity and lactate production when compared to control cells. In addition, mitochondrial derived reactive oxygen species (ROS) were markedly diminished in resistant but not sensitive cells. Chemically or genetically inhibiting LDHA or PDK1 re-sensitized resistant cells to Ab toxicity. These findings suggest that the Warburg effect may contribute to apoptotic-resistance mechanisms in the surviving neurons of the AD brain. Loss of the adaptive advantage afforded by aerobic glycolysis may exacerbate the pathophysiological processes associated with AD.	[Newington, Jordan T.; Pitts, Andrea; Chien, Andrew; Arseneault, Robert; Cumming, Robert C.] Univ Western Ontario, Dept Biol, London, ON, Canada; [Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA USA	Western University (University of Western Ontario); Salk Institute	Newington, JT (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	rcummin5@uwo.ca	Cumming, Robert/G-2185-2010		Natural Sciences and Engineering Research Council (NSERC) of Canada [355806-2008]; Alzheimer's Society of London; Middlesex	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alzheimer's Society of London; Middlesex	This work was funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada, Grant number 355806-2008. Salary support for JT Newington was provided by the Alzheimer's Society of London and Middlesex. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; BOYLE PJ, 1994, J CLIN INVEST, V93, P529, DOI 10.1172/JCI117003; Brooks WM, 2007, BRAIN RES, V1127, P127, DOI 10.1016/j.brainres.2006.09.106; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Cardoso SM, 2001, FASEB J, V15, P1439, DOI 10.1096/fj.00-0561fje; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; COOPER JA, 1984, J BIOL CHEM, V259, P7835; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; FRITZ PJ, 1965, SCIENCE, V150, P364, DOI 10.1126/science.150.3694.364; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; GOLDMAN RD, 1964, CANCER RES, V24, P389; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; LAMSTER IB, 1985, ARCH ORAL BIOL, V30, P235, DOI 10.1016/0003-9969(85)90039-1; Lawerenz J, 2010, J NEUROCHEM, V113, P502, DOI 10.1111/j.1471-4159.2010.06621.x; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; Sagara Y, 1996, J NEUROSCI, V16, P497; Schubert D, 2005, AGEING RES REV, V4, P240, DOI 10.1016/j.arr.2005.02.003; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; WARBURG O, 1956, SCIENCE, V124, P269; Yasykova MY, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1192; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	59	77	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19191	10.1371/journal.pone.0019191	http://dx.doi.org/10.1371/journal.pone.0019191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541279	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400030
J	Zhang, D; Terschak, JA; Harley, MA; Lin, JD; Hardege, JD				Zhang, Dong; Terschak, John A.; Harley, Maggy A.; Lin, Junda; Hardege, Joerg D.			Simultaneously Hermaphroditic Shrimp Use Lipophilic Cuticular Hydrocarbons as Contact Sex Pheromones	PLOS ONE			English	Article							MATE RECOGNITION; CHEMICAL COMMUNICATION; LYSMATA-WURDEMANNI; PALAEMONETES-PUGIO; IDENTIFICATION; SELECTION; UNIQUE; BEETLE; AGE	Successful mating is essentially a consequence of making the right choices at the correct time. Animals use specific strategies to gain information about a potential mate, which is then applied to decision-making processes. Amongst the many informative signals, odor cues such as sex pheromones play important ecological roles in coordinating mating behavior, enabling mate and kin recognition, qualifying mate choice, and preventing gene exchange among individuals from different populations and species. Despite overwhelming behavioral evidence, the chemical identity of most cues used in aquatic organisms remains unknown and their impact and omnipresence have not been fully recognized. In many crustaceans, including lobsters and shrimps, reproduction happens through a cascade of events ranging from initial attraction to formation of a mating pair eventually leading to mating. We examined the hypothesis that contact pheromones on the female body surface of the hermaphroditic shrimp Lysmata boggessi are of lipophilic nature, and resemble insect cuticular hydrocarbon contact cues. Via chemical analyses and behavioural assays, we show that newly molted euhermaphrodite-phase shrimp contain a bouquet of odor compounds. Of these, (Z)-9-octadecenamide is the key odor with hexadecanamide and methyl linoleate enhancing the bioactivity of the pheromone blend. Our results show that in aquatic systems lipophilic, cuticular hydrocarbon contact sex pheromones exist; this raises questions on how hydrocarbon contact signals evolved and how widespread these are in the marine environment.	[Zhang, Dong] China Acad Fisheries, E China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Terschak, John A.; Harley, Maggy A.; Hardege, Joerg D.] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Zhang, Dong; Lin, Junda] Florida Inst Technol, Vero Beach Marine Lab, Vero Beach, FL USA	Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; University of Hull; Florida Institute of Technology	Zhang, D (corresponding author), China Acad Fisheries, E China Sea Fisheries Res Inst, Shanghai, Peoples R China.	j.d.hardege@hull.ac.uk			National Science Foundation of China [3097044]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Science Foundation of China (Project No. 3097044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEYAWAKUMFI C, 1975, SCIENCE, V190, P1225, DOI 10.1126/science.1198111; ATEMA J, 1986, CAN J FISH AQUAT SCI, V43, P2283, DOI 10.1139/f86-279; Ayasse M, 2001, ANNU REV ENTOMOL, V46, P31, DOI 10.1146/annurev.ento.46.1.31; Baeza JA, 2006, EVOLUTION, V60, P1840; Bauer RT, 2000, J CRUSTACEAN BIOL, V20, P116, DOI 10.1163/1937240X-90000014; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bublitz R, 2008, BEHAVIOUR, V145, P1465, DOI 10.1163/156853908785765872; BURKENROAD MD, 1947, AM NAT, V81, P392, DOI 10.1086/281551; Caskey JL, 2005, J CRUSTACEAN BIOL, V25, P571, DOI 10.1651/C-2580.1; Caskey JL, 2009, INVERTEBR REPROD DEV, V53, P105, DOI 10.1080/07924259.2009.9652296; Caskey JL, 2009, INVERTEBR REPROD DEV, V53, P93, DOI 10.1080/07924259.2009.9652295; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; Dembitsky VM, 2000, PHYTOCHEMISTRY, V54, P965, DOI 10.1016/S0031-9422(00)00183-7; Dreanno C, 2007, J EXP MAR BIOL ECOL, V351, P276, DOI 10.1016/j.jembe.2007.07.003; Etges WJ, 2001, J CHEM ECOL, V27, P2125, DOI 10.1023/A:1012203222876; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Higgie M, 2000, SCIENCE, V290, P519, DOI 10.1126/science.290.5491.519; Howard RW, 2003, J CHEM ECOL, V29, P961, DOI 10.1023/A:1022992002239; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Kawasaki W, 1998, PHYTOCHEMISTRY, V47, P27, DOI 10.1016/S0031-9422(97)88555-X; Lacey ES, 2008, PHYSIOL ENTOMOL, V33, P209, DOI 10.1111/j.1365-3032.2008.00624.x; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Rundle HD, 2005, PLOS BIOL, V3, P1988, DOI 10.1371/journal.pbio.0030368; RYAN EP, 1966, SCIENCE, V151, P340, DOI 10.1126/science.151.3708.340; Schulz S, 1998, EUR J ORG CHEM, V1998, P13; Shine R, 2002, EVOLUTION, V56, P1655; SNELL TW, 1995, MAR BIOL, V123, P347, DOI 10.1007/BF00353626; SOKALL RR, 1995, BIOMETRY; Ting JH, 2000, MAR BIOL, V137, P31, DOI 10.1007/s002270000320; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; Yuan H, 2004, CAN J ZOOL, V82, P1596, DOI 10.1139/Z04-144; Zhang AJ, 2003, NATURWISSENSCHAFTEN, V90, P410, DOI 10.1007/s00114-003-0452-1; Zhang D, 2006, ANIM BEHAV, V71, P1191, DOI 10.1016/j.anbehav.2005.10.005; Zhang D, 2010, MAR BIOL, V157, P171, DOI 10.1007/s00227-009-1307-x; Zhang D, 2010, MAR BIOL, V157, P1, DOI 10.1007/s00227-009-1290-2; Zhang D, 2009, MAR BIOL RES, V5, P470, DOI 10.1080/17451000802626547; Zhao JY, 2004, Z NATURFORSCH C, V59, P153	39	21	21	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e17720	10.1371/journal.pone.0017720	http://dx.doi.org/10.1371/journal.pone.0017720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533136	gold, Green Published, Green Submitted			2022-12-25	WOS:000289719400002
J	Ding, F; Song, JH; Jung, JY; Lou, LD; Wang, M; Charles, L; Westover, A; Smith, PL; Pino, CJ; Buffington, DA; Humes, HD				Ding, Feng; Song, Joon Ho; Jung, Ju Young; Lou, Liandi; Wang, Min; Charles, Linda; Westover, Angela; Smith, Peter L.; Pino, Christopher J.; Buffington, Deborah A.; Humes, H. David			A Biomimetic Membrane Device That Modulates the Excessive Inflammatory Response to Sepsis	PLOS ONE			English	Article							REGIONAL CITRATE ANTICOAGULATION; NEUTROPHILS; INJURY; ENDOTHELIUM; MYELOPEROXIDASE; HEMODIALYSIS; DYSFUNCTION; FILGRASTIM; MORTALITY; INCREASE	Objective: Septic shock has a clinical mortality rate approaching fifty percent. The major clinical manifestations of sepsis are due to the dysregulation of the host's response to infection rather than the direct consequences of the invading pathogen. Central to this initial immunologic response is the activation of leukocytes and microvascular endothelium resulting in cardiovascular instability, lung injury and renal dysfunction. Due to the primary role of leukocyte activation in the sepsis syndrome, a synthetic biomimetic membrane, called a selective cytopheretic device (SCD), was developed to bind activated leukocytes. The incorporation of the SCD along an extracorporeal blood circuit coupled with regional anticoagulation with citrate to lower blood ionized calcium was devised to modulate leukocyte activation in sepsis. Design: Laboratory investigation. Setting: University of Michigan Medical School. Subjects: Pigs weighing 30-35 kg. Interventions: To assess the effect of the SCD in septic shock, pigs were administered 30x10(10) bacteria/kg body weight of Escherichia coli into the peritoneal cavity and within 1 hr were immediately placed in an extracorporeal circuit containing SCD. Measurements and Main Results: In this animal model, the SCD with citrate compared to control groups without the SCD or with heparin anticoagulation ameliorated the cardiovascular instability and lung sequestration of activated leukocytes, reduced renal dysfunction and improved survival time compared to various control groups. This effect was associated with minimal elevations of systemic circulating neutrophil activation. Conclusions: These preclinical studies along with two favorable exploratory clinical trials form the basis of an FDA-approved investigational device exemption for a pivotal multicenter, randomized control trial currently underway.	[Ding, Feng] Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China; [Song, Joon Ho] Inha Univ, Sch Med, Ctr Adv Med Educ Project BK21, Dept Internal Med, Inchon, South Korea; [Jung, Ju Young] Chungnam Natl Univ, Daejoen, South Korea; [Lou, Liandi; Wang, Min; Charles, Linda; Westover, Angela; Smith, Peter L.; Pino, Christopher J.; Buffington, Deborah A.; Humes, H. David] Innovat BioTherapies Inc, Ann Arbor, MI USA; [Humes, H. David] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Fudan University; Inha University; Chungnam National University; University of Michigan System; University of Michigan	Ding, F (corresponding author), Fudan Univ, Huashan Hosp, Div Nephrol, Shanghai 200433, Peoples R China.	dhumes@med.umich.edu		Buffington, Deborah/0000-0002-1541-2003; Humes, David/0000-0002-4309-1614; Westover, Angela/0000-0002-7556-9838; JUNG, JU YOUNG/0000-0002-6355-5738; Pino, Christopher/0000-0003-4063-9215	National Institutes of Health (NIH) [R43DK080529-01, 5 U42 RR006042-20]; DoD [W81XWH-05-2-0010]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [R44TR000630] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R43DK080529] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors appreciate grant support from National Institutes of Health (NIH) R43DK080529-01 (http://nih.gov/) and DoD W81XWH-05-2-0010 (http://www.defense.gov/). The authors acknowledge use of human tissues provided by the National Disease Research Interchange (NDRI), with support from NIH grant 5 U42 RR006042-20 (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Andonegui G, 2009, J CLIN INVEST, V119, P1921, DOI 10.1172/JCI36411; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baldus S, 2006, CIRCULATION, V113, P1871, DOI 10.1161/CIRCULATIONAHA.105.590083; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Boxer LA, 2003, PEDIATR REV, V24, P52, DOI 10.1542/pir.24-2-52; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005; DING F, 2010, ASAIO IN PRESS; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; FAN ST, 1993, J IMMUNOL, V150, P2972; Fietz S, 2008, RES VET SCI, V84, P347, DOI 10.1016/j.rvsc.2007.06.006; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hughes WT, 1997, CLIN INFECT DIS, V25, P551, DOI 10.1086/513764; Humes HD, 2010, BLOOD PURIFICAT, V29, P183, DOI 10.1159/000245645; Humes HD, 2003, CRIT CARE MED, V31, P2421, DOI 10.1097/01.CCM.0000089644.70597.C1; Kaneider NC, 2006, FEBS J, V273, P4416, DOI 10.1111/j.1742-4658.2006.05441.x; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; LOHR JW, 1989, AM J KIDNEY DIS, V13, P104, DOI 10.1016/S0272-6386(89)80126-X; Mandeville J T, 1996, Curr Opin Hematol, V3, P63; Marshall JC, 2005, CRIT CARE MED, V33, pS502, DOI 10.1097/01.CCM.0000186266.34541.5F; Navarini AA, 2009, P NATL ACAD SCI USA, V106, P7107, DOI 10.1073/pnas.0901162106; Nelson S, 1998, J INFECT DIS, V178, P1075, DOI 10.1086/515694; PINNICK RV, 1983, NEW ENGL J MED, V308, P258, DOI 10.1056/NEJM198302033080506; Root RK, 2003, CRIT CARE MED, V31, P367, DOI 10.1097/01.CCM.0000048629.32625.5D; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Sutton TA, 2003, AM J PHYSIOL-RENAL, V285, pF191, DOI 10.1152/ajprenal.00042.2003; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Tintinger G, 2005, CLIN EXP IMMUNOL, V141, P191, DOI 10.1111/j.1365-2249.2005.02800.x; Tobe SW, 2003, J CRIT CARE, V18, P121, DOI 10.1053/jcrc.2003.50006; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; WELBOURN CRB, 1992, BRIT J SURG, V79, P998, DOI 10.1002/bjs.1800791006; Wutzler S, 2009, J TRAUMA, V66, P1273, DOI 10.1097/TA.0b013e3181968054	36	30	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18584	10.1371/journal.pone.0018584	http://dx.doi.org/10.1371/journal.pone.0018584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533222	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600012
J	Yu, WQ; Robson, SC; Hill, WG				Yu, Weiqun; Robson, Simon C.; Hill, Warren G.			Expression and Distribution of Ectonucleotidases in Mouse Urinary Bladder	PLOS ONE			English	Article							GUINEA-PIG BLADDER; KIT-POSITIVE CELLS; INTERSTITIAL-CELLS; ATP RELEASE; RECEPTOR EXPRESSION; OUTLET OBSTRUCTION; UROTHELIAL CELLS; DETRUSOR OVERACTIVITY; P2X(3) RECEPTOR; SMOOTH-MUSCLE	Background: Normal urinary bladder function requires bidirectional molecular communication between urothelium, detrusor smooth muscle and sensory neurons and one of the key mediators involved in this intercellular signaling is ATP. Ectonucleotidases dephosphorylate nucleotides and thus regulate ligand exposure to P2X and P2Y purinergic receptors. Little is known about the role of these enzymes in mammalian bladder despite substantial literature linking bladder diseases to aberrant purinergic signaling. We therefore examined the expression and distribution of ectonucleotidases in the mouse bladder since mice offer the advantage of straightforward genetic modification for future studies. Principal Findings: RT-PCR demonstrated that eight members of the ectonucleoside triphosphate diphosphohydrolase (NTPD) family, as well as 5'-nucleotidase (NT5E) are expressed in mouse bladder. NTPD1, NTPD2, NTPD3, NTPD8 and NT5E all catalyze extracellular nucleotide dephosphorylation and in concert achieve stepwise conversion of extracellular ATP to adenosine. Immunofluorescent localization with confocal microscopy revealed NTPD1 in endothelium of blood vessels in the lamina propria and in detrusor smooth muscle cells, while NTPD2 was expressed in cells localized to a region of the lamina propria adjacent to detrusor and surrounding muscle bundles in the detrusor. NTPD3 was urothelial-specific, occurring on membranes of intermediate and basal epithelial cells but did not appear to be present in umbrella cells. Immunoblotting confirmed NTPD8 protein in bladder and immunofluorescence suggested a primary localization to the urothelium. NT5E was present exclusively in detrusor smooth muscle in a pattern complementary with that of NTPD1 suggesting a mechanism for providing adenosine to P1 receptors on the surface of myocytes. Conclusions: Ectonucleotidases exhibit highly cell-specific expression patterns in bladder and therefore likely act in a coordinated manner to regulate ligand availability to purinergic receptors. This is the first study to determine the expression and location of ectonucleotidases within the mammalian urinary bladder.	[Yu, Weiqun] Beth Israel Deaconess Med Ctr, Renal Res Div, Boston, MA 02215 USA; [Yu, Weiqun; Robson, Simon C.; Hill, Warren G.] Harvard Univ, Sch Med, Boston, MA USA; [Robson, Simon C.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Hill, Warren G.] Beth Israel Deaconess Med Ctr, Matrix Biol Div, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Yu, WQ (corresponding author), Beth Israel Deaconess Med Ctr, Renal Res Div, Boston, MA 02215 USA.	whill@bidmc.harvard.edu	Hill, Warren/AAM-1917-2020; Robson, Simon C./AAA-8537-2021	Hill, Warren/0000-0002-2772-7264; 	National Institutes of Health [DK083299, HL094400]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants DK083299 to WGH and HL094400 to SCR (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2007, KIDNEY INT, V72, P1057, DOI 10.1038/sj.ki.5002439; ARRIGHI S, 2010, VET MED INT; Birder LA, 2003, AM J PHYSIOL-RENAL, V285, pF423, DOI 10.1152/ajprenal.00056.2003; Brady CM, 2004, EUR UROL, V46, P247, DOI 10.1016/j.eururo.2003.12.017; BROWN C, 1979, BRIT J PHARMACOL, V65, P97, DOI 10.1111/j.1476-5381.1979.tb17337.x; Burnstock G, 1996, LANCET, V347, P1604, DOI 10.1016/S0140-6736(96)91082-X; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Canani LH, 2002, DIABETES, V51, P1188, DOI 10.2337/diabetes.51.4.1188; Chopra B, 2008, AM J PHYSIOL-RENAL, V294, pF821, DOI 10.1152/ajprenal.00321.2006; Chua WCN, 2007, EXP GERONTOL, V42, P686, DOI 10.1016/j.exger.2007.02.003; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Davidson RA, 2005, J UROLOGY, V173, P1385, DOI 10.1097/01.ju.0000146272.80848.37; Dranoff JA, 2002, HEPATOLOGY, V36, P1135, DOI 10.1053/jhep.2002.36823; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Gijsbers R, 2003, FEBS LETT, V538, P60, DOI 10.1016/S0014-5793(03)00133-9; Heppner TJ, 2009, J PHYSIOL-LONDON, V587, P5275, DOI 10.1113/jphysiol.2009.178806; Johnston L, 2010, J UROLOGY, V184, P370, DOI 10.1016/j.juro.2010.03.005; Kim JC, 2008, BJU INT, V101, P371, DOI 10.1111/j.1464-410X.2007.07251.x; King JA, 1997, GEN PHARMACOL, V29, P597, DOI 10.1016/S0306-3623(96)00573-3; Kumar V, 2004, J UROLOGY, V172, P744, DOI 10.1097/01.ju.0000131244.67160.f4ABSTRACT; KUMAR V, 2009, EUR UROL; Kumar V, 2010, EUR UROL, V57, P1087, DOI 10.1016/j.eururo.2009.11.042; Lagou M, 2006, BJU INT, V97, P1332, DOI 10.1111/j.1464-410X.2006.06203.x; Lee HY, 2000, J UROLOGY, V163, P2002, DOI 10.1016/S0022-5347(05)67618-5; Lewis SA, 2006, AM J PHYSIOL-RENAL, V291, pF332, DOI 10.1152/ajprenal.00340.2005; Liu F, 2009, INT J UROL, V16, P570, DOI 10.1111/j.1442-2042.2009.02307.x; McCloskey KD, 2009, BRIT J PHARMACOL, V156, P273, DOI 10.1111/j.1476-5381.2008.00006.x; McCloskey KD, 2002, J UROLOGY, V168, P832, DOI 10.1016/S0022-5347(05)64752-0; Metzger R, 2008, PEDIATR SURG INT, V24, P67, DOI 10.1007/s00383-007-2043-2; Moore KH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0002.2001; Munoz A, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-10; NICHOLLS J, 1992, BRIT J PHARMACOL, V105, P639, DOI 10.1111/j.1476-5381.1992.tb09032.x; O'Reilly BA, 2002, J UROLOGY, V167, P157, DOI 10.1016/S0022-5347(05)65403-1; O'Reilly BA, 2001, BJU INT, V87, P617, DOI 10.1046/j.1464-410x.2001.02179.x; Pezzone MA, 2003, AM J PHYSIOL-RENAL, V284, pF925, DOI 10.1152/ajprenal.00138.2002; Ray FR, 2003, CELL TISSUE RES, V314, P351, DOI 10.1007/s00441-003-0788-z; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sakagami H, 2005, J BIOL CHEM, V280, P23084, DOI 10.1074/jbc.M413438200; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Shafik A, 2004, UROLOGY, V64, P809, DOI 10.1016/j.urology.2004.05.031; Shirley DG, 2009, PURINERG SIGNAL, V5, P501, DOI 10.1007/s11302-009-9152-4; Smith CP, 2008, NEUROCHEM INT, V52, P1068, DOI 10.1016/j.neuint.2007.11.006; Smith CP, 2005, NEUROCHEM INT, V47, P291, DOI 10.1016/j.neuint.2005.04.021; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Stefan Cristiana, 2006, Purinergic Signal, V2, P361, DOI 10.1007/s11302-005-5303-4; STEHLE JH, 1992, MOL ENDOCRINOL, V6, P384, DOI 10.1210/me.6.3.384; Sun Y, 2006, AM J PHYSIOL-CELL PH, V290, pC27, DOI 10.1152/ajpcell.00552.2004; Sun Y, 2004, J UROLOGY, V171, P448, DOI 10.1097/01.ju.0000099660.46774.3c; Sun Y, 2002, BJU INT, V90, P381, DOI 10.1046/j.1464-410X.2002.02912.x; Tempest HV, 2004, BJU INT, V93, P1344, DOI 10.1111/j.1464-410X.2004.04858.x; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001; Vorhoff Thomas, 2005, Purinergic Signal, V1, P259, DOI 10.1007/s11302-005-6314-x; Wiseman OJ, 2003, BJU INT, V91, P89, DOI 10.1046/j.1464-410X.2003.03802.x; Yoshida M, 2004, UROLOGY, V63, P17, DOI 10.1016/j.urology.2003.11.003; Yu WQ, 2006, AM J PHYSIOL-CELL PH, V291, pC254, DOI 10.1152/ajpcell.00025.2006; Zhou HP, 2010, AM J PHYSIOL-RENAL, V299, pF387, DOI 10.1152/ajprenal.00185.2010	59	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18704	10.1371/journal.pone.0018704	http://dx.doi.org/10.1371/journal.pone.0018704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533188	Green Published, Green Submitted, gold			2022-12-25	WOS:000289505600023
J	Clepet, C				Clepet, Christian			RNA Captor: A Tool for RNA Characterization	PLOS ONE			English	Article							FULL-LENGTH CDNAS; MESSENGER-RNAS; CONSTRUCTION; LIGASE; DNA; BACTERIOPHAGE-T4; IDENTIFICATION; AMPLIFICATION; LIBRARIES; LIGATION	Background: In the genome era, characterizing the structure and the function of RNA molecules remains a major challenge. Alternative transcripts and non-protein-coding genes are poorly recognized by the current genome-annotation algorithms and efficient tools are needed to isolate the less-abundant or stable RNAs. Results: A universal RNA-tagging method using the T4 RNA ligase 2 and special adapters is reported. Based on this system, protocols for RACE PCR and full-length cDNA library construction have been developed. The RNA tagging conditions were thoroughly optimized and compared to previous methods by using a biochemical oligonucleotide tagging assay and RACE PCRs on a range of transcripts. In addition, two large-scale full-length cDNA inventories relying on this method are presented. Conclusion: The RNA Captor is a straightforward and accessible protocol. The sensitivity of this approach was shown to be higher compared to previous methods, and applicable on messenger RNAs, non-protein-coding RNAs, transcription-start sites and microRNA-directed cleavage sites of transcripts. This strategy could also be used to study other classes of RNA and in deep sequencing experiments.	INRA UMR1165 UEVE CNRS ERL 8196, URGV Plant Gen, Evry, France	INRAE	Clepet, C (corresponding author), INRA UMR1165 UEVE CNRS ERL 8196, URGV Plant Gen, Evry, France.	clepet@evry.inra.fr			UMR1165 INRA UEVE; CNRS [ERL8196]; International Grapevine Genome [ANR-05-GPLA-014]; International Cucurbit Genome Initiative	UMR1165 INRA UEVE; CNRS(Centre National de la Recherche Scientifique (CNRS)); International Grapevine Genome; International Cucurbit Genome Initiative	This work was supported by UMR1165 INRA UEVE, CNRS ERL8196, the International Grapevine Genome Project ANR-05-GPLA-014 and the International Cucurbit Genome Initiative. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bullard DR, 2006, BIOCHEM J, V398, P135, DOI 10.1042/BJ20060313; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2010, DNA RES, V17, P51, DOI 10.1093/dnares/dsq006; Clepet C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gng158; Djebali S, 2008, NAT METHODS, V5, P629, DOI 10.1038/nmeth.1216; EDERY I, 1995, MOL CELL BIOL, V15, P3363; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROMONTRACINE M, 1993, NUCLEIC ACIDS RES, V21, P1683, DOI 10.1093/nar/21.7.1683; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Ho CK, 2004, STRUCTURE, V12, P327, DOI 10.1016/j.str.2004.01.011; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; MARUYAMA K, 1994, GENE, V138, P171; Nandakumar J, 2004, J BIOL CHEM, V279, P31337, DOI 10.1074/jbc.M402394200; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Ohara Osamu, 2003, Methods Mol Biol, V221, P59; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PHEIFFER BH, 1983, NUCLEIC ACIDS RES, V11, P7853, DOI 10.1093/nar/11.22.7853; Samson F, 2002, NUCLEIC ACIDS RES, V30, P94, DOI 10.1093/nar/30.1.94; SEKINE S, 1993, NUCL ACIDS S SER, V29, P143; Suzuki Yutaka, 2003, Methods Mol Biol, V221, P73; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wang Z, 2009, METHODS, V48, P287, DOI 10.1016/j.ymeth.2009.02.021; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	26	8	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18445	10.1371/journal.pone.0018445	http://dx.doi.org/10.1371/journal.pone.0018445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533245	Green Published, gold, Green Submitted			2022-12-25	WOS:000289458800011
J	Delbosc, S; Alsac, JM; Journe, C; Louedec, L; Castier, Y; Bonnaure-Mallet, M; Ruimy, R; Rossignol, P; Bouchard, P; Michel, JB; Meilhac, O				Delbosc, Sandrine; Alsac, Jean-Marc; Journe, Clement; Louedec, Liliane; Castier, Yves; Bonnaure-Mallet, Martine; Ruimy, Raymond; Rossignol, Patrick; Bouchard, Philippe; Michel, Jean-Baptiste; Meilhac, Olivier			Porphyromonas gingivalis Participates in Pathogenesis of Human Abdominal Aortic Aneurysm by Neutrophil Activation. Proof of Concept in Rats	PLOS ONE			English	Article							STREPTOCOCCUS-PARASANGUIS ENDOCARDITIS; CARDIOVASCULAR-DISEASE; MURAL THROMBUS; CHLAMYDIA-PNEUMONIAE; EXTRACELLULAR TRAPS; DOXYCYCLINE; EVOLUTION; PROTEINS; FIMA; MATRIX-METALLOPROTEINASE-9	Background: Abdominal Aortic Aneurysms (AAAs) represent a particular form of atherothrombosis where neutrophil proteolytic activity plays a major role. We postulated that neutrophil recruitment and activation participating in AAA growth may originate in part from repeated episodes of periodontal bacteremia. Methods and Findings: Our results show that neutrophil activation in human AAA was associated with Neutrophil Extracellular Trap (NET) formation in the IntraLuminal Thrombus, leading to the release of cell-free DNA. Human AAA samples were shown to contain bacterial DNA with high frequency (11/16), and in particular that of Porphyromonas gingivalis (Pg), the most prevalent pathogen involved in chronic periodontitis, a common form of periodontal disease. Both DNA reflecting the presence of NETs and antibodies to Pg were found to be increased in plasma of patients with AAA. Using a rat model of AAA, we demonstrated that repeated injection of Pg fostered aneurysm development, associated with pathological characteristics similar to those observed in humans, such as the persistence of a neutrophil-rich luminal thrombus, not observed in saline-injected rats in which a healing process was observed. Conclusions: Thus, the control of periodontal disease may represent a therapeutic target to limit human AAA progression.	[Delbosc, Sandrine; Alsac, Jean-Marc; Journe, Clement; Louedec, Liliane; Michel, Jean-Baptiste; Meilhac, Olivier] INSERM, U698, Paris, France; [Delbosc, Sandrine; Journe, Clement; Louedec, Liliane; Bouchard, Philippe; Michel, Jean-Baptiste; Meilhac, Olivier] Univ Paris 07, Paris, France; [Castier, Yves] Hop Xavier Bichat Claude Bernard, APHP, Serv Chirurg Thorac & Vasc, Paris, France; [Alsac, Jean-Marc] Hop Europeen Georges Pompidou, APHP, Serv Chirurg Cardiovasc, Paris, France; [Bonnaure-Mallet, Martine] Univ Rennes 1, Univ Europeenne Bretagne, Equipe Microbiol, UPRES EA 1254, Rennes, France; [Ruimy, Raymond] Hop Xavier Bichat Claude Bernard, APHP, Serv Bacteriol & Virol, Paris, France; [Rossignol, Patrick] CHU Nancy, CIC, Vandoeuvre Les Nancy, France; [Rossignol, Patrick] CIC9501, Vandoeuvre Les Nancy, France; [Rossignol, Patrick] Univ Nancy, Fac Med, Vandoeuvre Les Nancy, France; [Rossignol, Patrick] INSERM, U961, Vandoeuvre Les Nancy, France; [Rossignol, Patrick] Hop Europeen Georges Pompidou, Serv Med Vasc & Hypertens, Paris, France; [Bouchard, Philippe] Hop Garanciere Rothschild, APHP, Serv Odontol, Dept Parodontol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Bretagne Occidentale; Universite de Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite	Delbosc, S (corresponding author), INSERM, U698, Paris, France.	olivier.meilhac@inserm.fr	Meilhac, Olivier/N-4385-2017; Ruimy, Raymond/P-6068-2016; Michel, Jean-Baptiste/AAH-9336-2020; DELBOSC, Sandrine/ABB-4618-2021	Journe, Clement/0000-0003-4467-435X; Bonnaure-Mallet, martine/0000-0001-5214-7803; Meilhac, Olivier/0000-0002-3740-7539; Delbosc, Sandrine/0000-0001-8076-6927; Bouchard, Philippe/0000-0003-2500-3219	European Community [HEALTH F2-2008-200647]; Fondation de la Recherche Medicale (FRM)	European Community(European Commission); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by European Community Fighting Aneurysmal Diseases (FAD) project (FP-7, HEALTH F2-2008-200647) and by the Fondation de la Recherche Medicale (FRM, DCV 2007, AAA diagnostics and therapeutics). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allaire E, 1996, TRANSPLANTATION, V62, P794, DOI 10.1097/00007890-199609270-00017; [Anonymous], 2015, NAT REV IMMUNOL, DOI [DOI 10.1902/jop.2009.097001, DOI 10.1038/nri3785]; AOYAMA N, 2010, J PERIODONTAL RES; Bamford CV, 2007, INFECT IMMUN, V75, P4364, DOI 10.1128/IAI.00258-07; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Blanchard JF, 2000, CLIN INFECT DIS, V30, P946, DOI 10.1086/313806; Bouchard P, 2010, EUR HEART J SUPPL, V12, pB13, DOI 10.1093/eurheartj/suq001; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BURNETTECURLEY D, 1995, INFECT IMMUN, V63, P4669, DOI 10.1128/IAI.63.12.4669-4674.1995; Colhoun HM, 2008, J PERIODONTAL RES, V43, P103, DOI 10.1111/j.1600-0765.2007.01001.x; DEJOUVENCEL T, ARTERIOSCLER THROMB, V30, P269; Dejouvencel T, 2010, ARTERIOSCL THROM VAS, V30, P269, DOI 10.1161/ATVBAHA.109.198309; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Falkensammer B, 2007, EUR J CLIN MICROBIOL, V26, P141, DOI 10.1007/s10096-006-0245-5; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Fontaine V, 2004, AM J PATHOL, V164, P2077, DOI 10.1016/S0002-9440(10)63766-2; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Gaetti-Jardim E, 2009, J MED MICROBIOL, V58, P1568, DOI 10.1099/jmm.0.013383-0; GOLUB LM, 1995, J CLIN PERIODONTOL, V22, P100; Grenier D, 2003, J PERIODONTOL, V74, P1316, DOI 10.1902/jop.2003.74.9.1316; Haffajee Anne D, 2003, Ann Periodontol, V8, P115, DOI 10.1902/annals.2003.8.1.115; Hannawa KK, 2005, CIRCULATION, V112, P241, DOI 10.1161/CIRCULATIONAHA.105.535625; Houard X, 2007, J PATHOL, V212, P20, DOI 10.1002/path.2148; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Houard X, 2009, CARDIOVASC RES, V82, P532, DOI 10.1093/cvr/cvp048; Imamura T, 2003, CURR PROTEIN PEPT SC, V4, P443, DOI 10.2174/1389203033487027; Imamura T, 2001, ANTIMICROB AGENTS CH, V45, P2871, DOI 10.1128/AAC.45.10.2871-2876.2001; Jimenez M, 2009, ANN NEUROL, V66, P505, DOI 10.1002/ana.21742; Perez-Chaparro PJ, 2009, BIOMEDICA, V29, P298; KAUFFMANN C, 2009, EUR J RADIOL; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kim HS, 2002, J IMMUNOL, V168, P2356, DOI 10.4049/jimmunol.168.5.2356; Kurihara N, 2004, EUR J VASC ENDOVASC, V28, P553, DOI 10.1016/j.ejvs.2004.08.010; Kurvers H, 2004, J AM COLL SURGEONS, V199, P709, DOI 10.1016/j.jamcollsurg.2004.07.031; Leclercq A, 2007, ATHEROSCLEROSIS, V191, P1, DOI 10.1016/j.atherosclerosis.2006.04.011; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; LIMET R, 1991, J VASC SURG, V14, P540, DOI 10.1016/0741-5214(91)90249-T; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P281, DOI 10.1053/ejvs.2000.1151; Lindholt JS, 1998, EUR J VASC ENDOVASC, V15, P161, DOI 10.1016/S1078-5884(98)80138-X; Ma AC, 2008, J THROMB HAEMOST, V6, P415, DOI 10.1111/j.1538-7836.2007.02865.x; Margraf S, 2008, SHOCK, V30, P352, DOI 10.1097/SHK.0b013e31816a6bb1; Martinez-Pinna R, 2010, ATHEROSCLEROSIS, V212, P333, DOI 10.1016/j.atherosclerosis.2010.05.031; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Meurman JH, 2004, CRIT REV ORAL BIOL M, V15, P403, DOI 10.1177/154411130401500606; Michel JB, 2001, ARTERIOSCL THROM VAS, V21, P1389; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; Mtairag EM, 2002, ARTERIOSCL THROM VAS, V22, P1824, DOI 10.1161/01.ATV.0000037102.31086.F4; Nakano K, 2009, ORAL MICROBIOL IMMUN, V24, P64, DOI 10.1111/j.1399-302X.2008.00479.x; NAKANO K, 2010, ORAL DIS; Nyberg A, 2008, EUR J VASC ENDOVASC, V36, P292, DOI 10.1016/j.ejvs.2008.04.017; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Parseghian MH, 2006, BIOCHEM CELL BIOL, V84, P589, DOI 10.1139/O06-082; Pathirana RD, 2006, MICROBIOL-SGM, V152, P2381, DOI 10.1099/mic.0.28787-0; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Sodeck G, 2004, EUR J VASC ENDOVASC, V28, P547, DOI 10.1016/j.ejvs.2004.07.019; Soolari A S, 1999, J Int Acad Periodontol, V1, P101; Touat Z, 2006, AM J PATHOL, V168, P1022, DOI 10.2353/ajpath.2006.050868; Viscount HB, 1997, INFECT IMMUN, V65, P994, DOI 10.1128/IAI.65.3.994-1002.1997; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005	63	105	109	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18679	10.1371/journal.pone.0018679	http://dx.doi.org/10.1371/journal.pone.0018679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533243	Green Submitted, gold, Green Published			2022-12-25	WOS:000289458800027
J	Dou, Z; von Schubert, C; Korner, R; Santamaria, A; Elowe, S; Nigg, EA				Dou, Zhen; von Schubert, Conrad; Koerner, Roman; Santamaria, Anna; Elowe, Sabine; Nigg, Erich A.			Quantitative Mass Spectrometry Analysis Reveals Similar Substrate Consensus Motif for Human Mps1 Kinase and Plk1	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; CENP-E; CHROMOSOMAL INSTABILITY; MITOTIC ARREST; PROTEIN-KINASE; PHOSPHORYLATION; ACTIVATION; LOCALIZATION; SPECIFICITY; EXPRESSION	Background: Members of the Mps1 kinase family play an essential and evolutionarily conserved role in the spindle assembly checkpoint (SAC), a surveillance mechanism that ensures accurate chromosome segregation during mitosis. Human Mps1 (hMps1) is highly phosphorylated during mitosis and many phosphorylation sites have been identified. However, the upstream kinases responsible for these phosphorylations are not presently known. Methodology/Principal Findings: Here, we identify 29 in vivo phosphorylation sites in hMps1. While in vivo analyses indicate that Aurora B and hMps1 activity are required for mitotic hyper-phosphorylation of hMps1, in vitro kinase assays show that Cdk1, MAPK, Plk1 and hMps1 itself can directly phosphorylate hMps1. Although Aurora B poorly phosphorylates hMps1 in vitro, it positively regulates the localization of Mps1 to kinetochores in vivo. Most importantly, quantitative mass spectrometry analysis demonstrates that at least 12 sites within hMps1 can be attributed to autophosphorylation. Remarkably, these hMps1 autophosphorylation sites closely resemble the consensus motif of Plk1, demonstrating that these two mitotic kinases share a similar substrate consensus. Conclusions/Significance: hMps1 kinase is regulated by Aurora B kinase and its autophosphorylation. Analysis on hMps1 autophosphorylation sites demonstrates that hMps1 has a substrate preference similar to Plk1 kinase.	[Dou, Zhen; Koerner, Roman; Santamaria, Anna; Elowe, Sabine; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; [von Schubert, Conrad; Santamaria, Anna; Nigg, Erich A.] Univ Basel, Biozentrum, Basel, Switzerland; [Dou, Zhen] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China	Max Planck Society; University of Basel; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dou, Z (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.	douzhen@ustc.edu.cn; erich.nigg@unibas.ch	DOU, ZHEN/N-2022-2013; Körner, Roman/G-8565-2011	Körner, Roman/0000-0001-9285-9290; nigg, erich/0000-0003-4835-5719; DOU, ZHEN/0000-0003-3303-9393	Max Planck Society; Chinese Academy of Sciences/Max Planck Society	Max Planck Society(Max Planck Society); Chinese Academy of Sciences/Max Planck Society(Max Planck SocietyChinese Academy of Sciences)	This work was supported by the Max Planck Society and Z.D. acknowledges support through a post-doctoral fellowship from the Chinese Academy of Sciences/Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; He XW, 1998, J CELL SCI, V111, P1635; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; HOGG D, 1994, ONCOGENE, V9, P89; Holinger EP, 2009, J BIOL CHEM, V284, P12949, DOI 10.1074/jbc.M900088200; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kemmler S, 2009, EMBO J, V28, P1099, DOI 10.1038/emboj.2009.62; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Sliedrecht T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010251; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zich J, 2010, TRENDS BIOCHEM SCI, V35, P18, DOI 10.1016/j.tibs.2009.09.002	58	61	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18793	10.1371/journal.pone.0018793	http://dx.doi.org/10.1371/journal.pone.0018793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533207	Green Published, gold, Green Submitted			2022-12-25	WOS:000289458800044
J	Lawlor, DA; Kim, L; Morris, R; Amuzu, A; Whincup, P; Ebrahim, S				Lawlor, Debbie A.; Kim, Lois; Morris, Richard; Amuzu, Antoinette; Whincup, Peter; Ebrahim, Shah			Survival with Treated and Well-Controlled Blood Pressure: Findings from a Prospective Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BRITISH WOMENS HEART; RISK-FACTORS; HEALTH; HYPERTENSION; QUALITY; BURDEN; STROKE; TRIALS; CARE	Aim: To compare survival and incident cardiovascular disease between normotensive, untreated hypertensive, treated and poorly-controlled hypertensive and treated and well-controlled hypertensive adults. Methods and Results: Data from the British Regional Heart Study (men) and British Women's Heart and Health Study (women) were used (N = 6476). Blood pressure and treatment were assessed at baseline (1998-2001) when participants were aged 60-79 years and participants were followed up for a median of 8 years. Date and cause of death were obtained from death certificates and non-fatal cardiovascular disease events were obtained from repeat detailed medical record reviews. Of the whole cohort 52% of women and 49% of men had untreated hypertension and a further 22% and 18%, respectively, had poorly treated hypertension. Just 3% of women and 4% of men had treated and well controlled hypertension and 23% and 29%, respectively, were normotensive. Compared to normotensive individuals, incident cardiovascular disease (fatal and non-fatal) was increased in those with poorly-controlled hypertension (Hazard Ratio (HR): 1.88; 95% CI: 1.53, 2.30), those with untreated hypertension (HR 1.46; 95% CI 1.22, 1.75) and those who were well-controlled hypertension (HR 1.38; 95% CI 0.94, 2.03). Adjustment for baseline differences in mean blood pressure between the groups resulted in attenuation of the increased risk in the poorly-controlled (1.52 (1.18, 1.97) and untreated groups (1.21 (0.97, 1.52), but did not change the association in the well-controlled group. All-cause mortality was also increased in all three hypertension groups but estimates were imprecise with wide confidence intervals. Conclusions: Half of women and men aged 60-79 in Britain had untreated hypertension and only a very small proportion of those with diagnosed and treated hypertension were well controlled. Those with hypertension, irrespective of whether this was treated and controlled or not, were at greater risk of future cardiovascular disease than those who are normotensive.	[Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Kim, Lois; Amuzu, Antoinette; Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Morris, Richard] UCL, Dept Primary Care & Populat Hlth, London, England; [Whincup, Peter] Univ London, Div Community Hlth Sci, London, England	University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London	Lawlor, DA (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk		Kim, Lois/0000-0002-4552-3820; Lawlor, Debbie A/0000-0002-6793-2262; Whincup, Peter/0000-0002-5589-4107; Morris, Richard/0000-0001-7240-4563	Department of Health (England); British Heart Foundation; UK Medical Research Council; University of Bristol; British Heart Foundation [RG/08/013/25942] Funding Source: researchfish; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	Department of Health (England); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Department of Health (England) Policy Research Programme and the British Heart Foundation provide core funding for both the British Women's Heart Study and the British Regional Heart Study. DAL works in a centre that is funded by the UK Medical Research Council and University of Bristol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are those of the authors and not necessarily any funding body.	ANDERSEN L, 1993, CLIN CHEM, V39, P578; Andersson OK, 1998, BMJ-BRIT MED J, V317, P167, DOI 10.1136/bmj.317.7152.167; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; General Register Office, 1966, CLASS OCC 1966; *JOINT FAM COMM, 2004, BRIT NAT FORM; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Patel R, 2006, J HUM HYPERTENS, V20, P733, DOI 10.1038/sj.jhh.1002064; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b; Turnbull F, 2003, LANCET, V362, P1527; Verdecchia P, 2005, HYPERTENSION, V46, P386, DOI 10.1161/01.HYP.0000174591.42889.a2; WARNICK GR, 1990, CLIN CHEM, V36, P15; Weinehall L, 2002, J HYPERTENS, V20, P2081, DOI 10.1097/00004872-200210000-00029; WHINCUP PH, 1992, J EPIDEMIOL COMMUN H, V46, P164, DOI 10.1136/jech.46.2.164	23	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e17792	10.1371/journal.pone.0017792	http://dx.doi.org/10.1371/journal.pone.0017792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533232	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000289458800006
J	Tricarico, E; Borrelli, L; Gherardi, F; Fiorito, G				Tricarico, Elena; Borrelli, Luciana; Gherardi, Francesca; Fiorito, Graziano			I Know My Neighbour: Individual Recognition in Octopus vulgaris	PLOS ONE			English	Article							WHITE-THROATED SPARROWS; RECEIVER PSYCHOLOGY; SOCIAL RECOGNITION; BEHAVIORAL-CHANGES; BODY PATTERNS; HERMIT-CRABS; DOMINANCE; MEMORY; CEPHALOPODS; EVOLUTION	Background: Little is known about individual recognition (IR) in octopuses, although they have been abundantly studied for their sophisticated behaviour and learning capacities. Indeed, the ability of octopuses to recognise conspecifics is suggested by a number of clues emerging from both laboratory studies (where they appear to form and maintain dominance hierarchies) and field observations (octopuses of neighbouring dens display little agonism between each other). To fill this gap in knowledge, we investigated the behaviour of 24 size-matched pairs of Octopus vulgaris in laboratory conditions. Methodology/Principal Findings: The experimental design was composed of 3 phases: Phase 1 (acclimatization): 12 "sigh-tallowed'' (and 12 "isolated'') pairs were maintained for 3 days in contiguous tanks separated by a transparent (and opaque) partition to allow (and block) the vision of the conspecific; Phase 2 (cohabitation): members of each pair (both sight-allowed and isolated) were transferred into an experimental tank and were allowed to interact for 15 min every day for 3 consecutive days; Phase 3 (test): each pair (both sight-allowed and isolated) was subject to a switch of an octopus to form pairs composed of either familiar ("sham switches'') or unfamiliar conspecifics ("real switches''). Longer latencies (i.e. the time elapsed from the first interaction) and fewer physical contacts in the familiar pairs as opposed to the unfamiliar pairs were used as proxies for recognition. Conclusions: Octopuses appear able to recognise conspecifics and to remember the individual previously met for at least one day. To the best of our knowledge, this is the first experimental study showing the occurrence of a form of IR in cephalopods. Future studies should clarify whether this is a "true'' IR.	[Tricarico, Elena; Gherardi, Francesca] Univ Florence, Dipartimento Biol Evoluzionist Leo Pardi, Florence, Italy; [Borrelli, Luciana] Telethon Inst Genet & Med, Naples, Italy; [Fiorito, Graziano] Staz Zool Anton Dohrn, Naples, Italy	University of Florence; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Stazione Zoologica Anton Dohrn di Napoli	Tricarico, E (corresponding author), Univ Florence, Dipartimento Biol Evoluzionist Leo Pardi, Florence, Italy.	elena.tricarico@unifi.it	Tricarico, Elena/ABC-9819-2021	Tricarico, Elena/0000-0002-7392-0794	Ministry of Education, University and Research (MIUR); Istituto Banco Napoli, Fondazione	Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Istituto Banco Napoli, Fondazione	The research was supported by Istituto Banco Napoli, Fondazione and in part financed by the Ministry of Education, University and Research (MIUR) under the project "PRIN 2008: Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Roland C., 2010, Ferrantia, V59, P8; Anderson RC, 2010, J APPL ANIM WELF SCI, V13, P261, DOI 10.1080/10888705.2010.483892; Aquiloni L, 2008, FRESHWATER BIOL, V53, P461, DOI 10.1111/j.1365-2427.2007.01911.x; Aquiloni L, 2010, ANIM BEHAV, V79, P265, DOI 10.1016/j.anbehav.2009.09.024; Aquiloni L, 2009, NATURWISSENSCHAFTEN, V96, P103, DOI 10.1007/s00114-008-0458-9; ARCHAWARANON M, 1991, BEHAVIOUR, V118, P42, DOI 10.1163/156853991X00193; Atema Jelle, 2007, P115; Barbato M, 2007, PATTERN RECOGN LETT, V28, P1854, DOI 10.1016/j.patrec.2006.12.023; BARNARD CJ, 1979, J THEOR BIOL, V81, P65, DOI 10.1016/0022-5193(79)90081-X; BARROWS EM, 1975, P NATL ACAD SCI USA, V72, P2824, DOI 10.1073/pnas.72.7.2824; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Boal JG, 2006, VIE MILIEU, V56, P69; Boal JG, 1997, BEHAVIOUR, V134, P975, DOI 10.1163/156853997X00340; Boal JG, 1998, J EXP MAR BIOL ECOL, V230, P183, DOI 10.1016/S0022-0981(98)00068-9; Boal JG, 1999, J EXP MAR BIOL ECOL, V235, P307, DOI 10.1016/S0022-0981(98)00187-7; Booksmythe I, 2010, ANIM BEHAV, V79, P419, DOI 10.1016/j.anbehav.2009.11.020; Borrelli L, 2007, THESIS OPEN U LONDON; Borrelli L., 2008, LEARNING MEMORY COMP, P605, DOI [10.1016/B978-012370509-9.00069-3, DOI 10.1016/B978-012370509-9.00069-3, 10.1016/b978-012370509-9.00069-3]; Borrelli L., 2006, CATALOGUE BODY PATTE; BOYLE PR, 1980, ANIM BEHAV, V28, P1123, DOI 10.1016/S0003-3472(80)80101-1; BOYLE PR, 1983, J EXP MAR BIOL ECOL, V69, P129, DOI 10.1016/0022-0981(83)90062-X; BROOKS RJ, 1975, CAN J ZOOL, V53, P879, DOI 10.1139/z75-101; CALDWELL RL, 1979, ANIM BEHAV, V27, P194, DOI 10.1016/0003-3472(79)90139-8; CHASE R, 1986, J COMP PHYSIOL A, V158, P375, DOI 10.1007/BF00603621; CIGLIANO JA, 1993, ANIM BEHAV, V46, P677, DOI 10.1006/anbe.1993.1244; D'Ettorre P, 2005, CURR BIOL, V15, P2170, DOI 10.1016/j.cub.2005.10.067; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; Edelman DB, 2009, TRENDS NEUROSCI, V32, P476, DOI 10.1016/j.tins.2009.05.008; Falls JB., 1982, ACOUSTIC COMMUNICATI, P237; Finn JK, 2009, CURR BIOL, V19, pR1069, DOI 10.1016/j.cub.2009.10.052; FIORITO G, 1990, MAR BEHAV PHYSIOL, V17, P129, DOI 10.1080/10236249009378762; FIORITO G, 1990, BEHAV NEURAL BIOL, V53, P217, DOI 10.1016/0163-1047(90)90441-8; FIORITO G, 1992, SCIENCE, V256, P545, DOI 10.1126/science.256.5056.545; Fisher J., 1954, P71; Gherardi F, 2005, ETHOLOGY, V111, P271, DOI 10.1111/j.1439-0310.2004.01060.x; Gherardi F, 2004, BEHAV ECOL SOCIOBIOL, V55, P524, DOI 10.1007/s00265-003-0734-9; Gherardi F, 2007, MAR FRESHW BEHAV PHY, V40, P201, DOI 10.1080/10236240701562297; Gherardi F, 2010, ANIM BEHAV, V80, P713, DOI 10.1016/j.anbehav.2010.07.008; Grimaldi AM, 2007, BRAIN RES, V1183, P66, DOI 10.1016/j.brainres.2007.09.032; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; HALPIN ZT, 1986, ADV STUD BEHAV, V16, P39, DOI 10.1016/S0065-3454(08)60187-4; Hanlon RT, 2009, PHILOS T R SOC B, V364, P429, DOI 10.1098/rstb.2008.0270; Hemsworth R, 2007, BIOL BULL-US, V213, P187, DOI 10.2307/25066634; Hochner B, 2008, CURR BIOL, V18, pR897, DOI 10.1016/j.cub.2008.07.057; Hochner B, 2006, BIOL BULL-US, V210, P308, DOI 10.2307/4134567; Huffard CL, 2007, J MOLLUS STUD, V73, P185, DOI 10.1093/mollus/eym015; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; KAYES R J, 1974, Marine Behaviour and Physiology, V2, P337; Kuba MJ, 2006, J COMP PSYCHOL, V120, P184, DOI 10.1037/0735-7036.120.3.184; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; MATHER JA, 1991, J COMP PHYSIOL A, V168, P491, DOI 10.1007/BF00199609; Mather JA, 1999, J COMP PSYCHOL, V113, P333, DOI 10.1037/0735-7036.113.3.333; MATHER JA, 1993, J COMP PSYCHOL, V107, P336, DOI 10.1037/0735-7036.107.3.336; MATHER JA, 1985, ANIM BEHAV, V33, P1138, DOI 10.1016/S0003-3472(85)80173-1; Mather JA, 2008, CONSCIOUS COGN, V17, P37, DOI 10.1016/j.concog.2006.11.006; Mcfarland D, 1981, OXFORD COMPANION ANI; Moriyama T, 1997, ETHOLOGY, V103, P499; PACKARD A, 1971, ANIM BEHAV, V19, P780, DOI 10.1016/S0003-3472(71)80181-1; PACKARD A, 1972, BIOL REV, V47, P241, DOI 10.1111/j.1469-185X.1972.tb00975.x; PACKARD A, 1988, CEPHALOPODS PRESENT, P89; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Rowe C, 1999, ANIM BEHAV, V57, P341, DOI 10.1006/anbe.1998.0974; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Scheffer SJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P17, DOI 10.1007/s002650050212; Sherman Paul W., 1997, P69; Shomrat T, 2008, CURR BIOL, V18, P337, DOI 10.1016/j.cub.2008.01.056; Steiger S, 2008, TRENDS ECOL EVOL, V23, P355, DOI 10.1016/j.tree.2008.01.014; Sumbre G, 2006, CURR BIOL, V16, P767, DOI 10.1016/j.cub.2006.02.069; Sumbre G, 2005, NATURE, V433, P595, DOI 10.1038/433595a; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; Tibbetts EA, 2008, TRENDS ECOL EVOL, V23, P356, DOI 10.1016/j.tree.2008.03.007; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; TOBACH ETHEL, 1965, VELIGER, V8, P16; Van der Velden J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001695; VANNINI M, 1981, MAR BEHAV PHYSIOL, V8, P13, DOI 10.1080/10236248109386999; Wells M.J., 1978, OCTOPUS PHYSL BEHAV, V1st; WELLS MJ, 1963, J EXP BIOL, V40, P187; Williamson R, 2004, NEUROSIGNALS, V13, P87, DOI 10.1159/000076160; Wilson E.O., 1975, P1; Wood JB, 2010, J EXP MAR BIOL ECOL, V388, P20, DOI 10.1016/j.jembe.2010.03.010; YOUNG JZ, 1991, BIOL BULL, V180, P200, DOI 10.2307/1542389; [No title captured]	85	42	42	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18710	10.1371/journal.pone.0018710	http://dx.doi.org/10.1371/journal.pone.0018710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533257	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800032
J	Wang, P; Hu, LL; Liu, GY; Jiang, N; Chen, XY; Xu, JY; Zheng, W; Li, L; Tan, M; Chen, ZG; Song, H; Cai, YD; Chou, KC				Wang, Ping; Hu, Lele; Liu, Guiyou; Jiang, Nan; Chen, Xiaoyun; Xu, Jianyong; Zheng, Wen; Li, Li; Tan, Ming; Chen, Zugen; Song, Hui; Cai, Yu-Dong; Chou, Kuo-Chen			Prediction of Antimicrobial Peptides Based on Sequence Alignment and Feature Selection Methods	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; SUBCELLULAR LOCATION PREDICTION; SECONDARY STRUCTURE-CONTENT; DISCRETE WAVELET TRANSFORM; COUPLED RECEPTOR CLASSES; SUPPORT VECTOR MACHINE; APPROXIMATE ENTROPY; APOPTOSIS PROTEINS; EVOLUTIONARY INFORMATION	Antimicrobial peptides (AMPs) represent a class of natural peptides that form a part of the innate immune system, and this kind of 'nature's antibiotics' is quite promising for solving the problem of increasing antibiotic resistance. In view of this, it is highly desired to develop an effective computational method for accurately predicting novel AMPs because it can provide us with more candidates and useful insights for drug design. In this study, a new method for predicting AMPs was implemented by integrating the sequence alignment method and the feature selection method. It was observed that, the overall jackknife success rate by the new predictor on a newly constructed benchmark dataset was over 80.23%, and the Mathews correlation coefficient is 0.73, indicating a good prediction. Moreover, it is indicated by an in-depth feature analysis that the results are quite consistent with the previously known knowledge that some amino acids are preferential in AMPs and that these amino acids do play an important role for the antimicrobial activity. For the convenience of most experimental scientists who want to use the prediction method without the interest to follow the mathematical details, a user-friendly web-server is provided at http://amp.biosino.org/.	[Wang, Ping; Liu, Guiyou; Jiang, Nan; Chen, Xiaoyun; Xu, Jianyong; Zheng, Wen; Li, Li; Tan, Ming; Chen, Zugen; Song, Hui] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Hu, Lele; Cai, Yu-Dong] Shanghai Univ, Coll Sci, Dept Chem, Shanghai, Peoples R China; [Chen, Zugen] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Cai, Yu-Dong; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Shanghai University; Shanghai University; University of California System; University of California Los Angeles	Wang, P (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China.	song_h@tib.cas.cn; cai_yud@yahoo.com.cn	JIANG, NAN/AHB-1945-2022; Chou, Kuo-Chen/A-8340-2009	cai, yudong/0000-0001-5664-7979; Tan, Ming/0000-0001-7547-4145; Liu, Guiyou/0000-0002-1126-2888	Tianjin Science and Technology Support Program [10ZCZDSY06400, 10ZCKFSY05500]; Chinese Academy of Sciences [KSCX2-YW-BR-3]; National Basic Research Program of China [2011CB510102, 2011CB510101]	Tianjin Science and Technology Support Program; Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This research was supported by grants from the Tianjin Science and Technology Support Program (10ZCZDSY06400, 10ZCKFSY05500), One Hundred Person Project of the Chinese Academy of Sciences (KSCX2-YW-BR-3), and the National Basic Research Program of China, 2011CB510102, 2011CB510101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, IEEE ACM T COMPUT BI, V8, P194, DOI 10.1109/TCBB.2009.69; Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Cai YD, 2006, J THEOR BIOL, V238, P395, DOI 10.1016/j.jtbi.2005.05.035; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, PROTEIN SCI, V13, P2857, DOI 10.1110/ps.04981104; Chou KC, 2004, BIOCHEM BIOPH RES CO, V320, P1236, DOI 10.1016/j.bbrc.2004.06.073; CHOU KC, 1982, P NATL ACAD SCI USA, V79, P7047, DOI 10.1073/pnas.79.22.7047; Chou KC, 1999, PROTEINS, V34, P137, DOI 10.1002/(SICI)1097-0134(19990101)34:1<137::AID-PROT11>3.3.CO;2-F; CHOU KC, 1995, FEBS LETT, V363, P127, DOI 10.1016/0014-5793(95)00245-5; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; CHOU KC, 2011, J THEORETICAL BIOL; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Dumontier M, 2005, J MOL BIOL, V350, P1061, DOI 10.1016/j.jmb.2005.05.037; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Fjell CD, 2007, BIOINFORMATICS, V23, P1148, DOI 10.1093/bioinformatics/btm068; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Garg Aarti, 2008, In Silico Biology, V8, P129; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; HADLEY EB, 2010, CURR TOP MED CHEM; Hammami R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-89; Hammami R, 2010, DRUG DISCOV TODAY, V15, P540, DOI 10.1016/j.drudis.2010.05.002; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hammami R, 2009, NUCLEIC ACIDS RES, V37, pD963, DOI 10.1093/nar/gkn655; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; Kamysz W, 2003, ACTA BIOCHIM POL, V50, P461; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Kohavi R., 1997, ARTIFICIAL INTELLIGE; Lata S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-263; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Lee S, 2006, PROTEINS, V62, P1107, DOI 10.1002/prot.20821; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li ZC, 2009, AMINO ACIDS, V37, P415, DOI 10.1007/s00726-008-0170-2; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Liu T, 2010, PROTEIN PEPTIDE LETT, V17, P1263, DOI 10.2174/092986610792231528; Manners JM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-225; McPhee JB, 2005, J PEPT SCI, V11, P677, DOI 10.1002/psc.704; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pestana-Calsa MC, 2010, CURR PROTEIN PEPT SC, V11, P199; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Sang Yongming, 2008, Animal Health Research Reviews, V9, P227, DOI 10.1017/S1466252308001497; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tamura T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-466; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Wang GS, 1996, BIOCHEMISTRY-US, V35, P10358, DOI 10.1021/bi960934t; Wang GS, 2002, FEBS LETT, V529, P157, DOI 10.1016/S0014-5793(02)03354-9; Wang YC, 2010, PROTEIN PEPTIDE LETT, V17, P1441, DOI 10.2174/0929866511009011441; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang SW, 2008, AMINO ACIDS, V35, P591, DOI 10.1007/s00726-008-0086-x; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zhang TL, 2008, J THEOR BIOL, V250, P186, DOI 10.1016/j.jtbi.2007.09.014; ZOU D, 2010, J COMPUT CHEM	88	149	152	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18476	10.1371/journal.pone.0018476	http://dx.doi.org/10.1371/journal.pone.0018476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533231	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800014
J	Leonard, BC; Chu, HT; Johns, JL; Gallo, RL; Moore, PF; Marks, SL; Bevins, CL				Leonard, Brian C.; Chu, Hiutung; Johns, Jennifer L.; Gallo, Richard L.; Moore, Peter F.; Marks, Stanley L.; Bevins, Charles L.			Expression and Activity of a Novel Cathelicidin from Domestic Cats	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; PROTEIN; GENE; LL-37; QUANTIFICATION; NEUTROPHILS; LEUKOCYTES; DEFENSINS; RECEPTOR; FAMILY	Cathelicidins are small cationic antimicrobial peptides found in many species including primates, mammals, marsupials, birds and even more primitive vertebrates, such as the hagfish. Some animals encode multiple cathelicidins in their genome, whereas others have only one. This report identifies and characterizes feline cathelicidin (feCath) as the sole cathelicidin in domestic cats (Felis catus). Expression of feCath is predominantly found in the bone marrow, with lower levels of expression in the gastrointestinal tract and skin. By immunocytochemistry, feCath localizes to the cytoplasm of neutrophils in feline peripheral blood. Structurally, the mature feCath sequence is most similar to a subgroup of cathelicidins that form linear alpha-helices. feCath possesses antimicrobial activity against E. coli D31, Salmonella enterica serovar Typhimurium (IR715), Listeria monocytogenes and Staphylococcus pseudintermedius (clinical isolate) similar to that of the human ortholog, LL-37. In contrast, feCath lacks the DNA binding activity seen with LL-37. Given its similarity in sequence, structure, tissue expression, and antimicrobial activity, the cathelicidin encoded by cats, feCath, belongs to the subgroup of linear cathelicidins found not only in humans, but also non-human primates, dogs, mice, and rats.	[Leonard, Brian C.; Chu, Hiutung; Bevins, Charles L.] UC Davis Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Johns, Jennifer L.; Moore, Peter F.] UC Davis Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA USA; [Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Gallo, Richard L.] VA San Diego Healthcare Syst, San Diego, CA USA; [Marks, Stanley L.] UC Davis Sch Vet Med, Dept Med & Epidemiol, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California Davis	Leonard, BC (corresponding author), UC Davis Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA.	clbevins@ucdavis.edu	Bevins, Charles L/P-4438-2015; Gallo, Richard L/A-8931-2009	Bevins, Charles L/0000-0003-2725-2622; Gallo, Richard L/0000-0002-1401-7861; Johns, Jennifer/0000-0003-4373-5982; Leonard, Brian/0000-0003-2080-8480; Chu, Hiutung/0000-0001-7489-0446	UC Davis School of Veterinary Medicine; Center for Companion Animal Health; NIH [AI050843, T32AI60555, T32RR021312]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR021312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R01AI050843, T32AI060555] Funding Source: NIH RePORTER	UC Davis School of Veterinary Medicine; Center for Companion Animal Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present study was supported in part by a grant from the UC Davis School of Veterinary Medicine, Center for Companion Animal Health (SLM, PFM) and NIH AI050843 (CLB). BCL received support from NIH T32AI60555 and T32RR021312, and the UC Davis School of Veterinary Medicine, Veterinary Scientist Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; AGERBERTH B, 1991, EUR J BIOCHEM, V202, P849, DOI 10.1111/j.1432-1033.1991.tb16442.x; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; COWLAND JB, 1995, FEBS LETT, V368, P173, DOI 10.1016/0014-5793(95)00634-L; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Huttner KM, 1998, GENE, V206, P85, DOI 10.1016/S0378-1119(97)00569-6; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; OOI CE, 1990, J BIOL CHEM, V265, P15956; ROMEO D, 1988, J BIOL CHEM, V263, P9573; Sang Y, 2007, DEV COMP IMMUNOL, V31, P1278, DOI 10.1016/j.dci.2007.03.007; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Scocchi M, 1999, FEBS LETT, V457, P459, DOI 10.1016/S0014-5793(99)01097-2; Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045; TOSSI A, 1997, ANTIMICROBIAL PEPTID; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; VERBANAC D, 1993, FEBS LETT, V317, P255, DOI 10.1016/0014-5793(93)81287-A; Wehkamp J, 2006, FEBS LETT, V580, P5344, DOI 10.1016/j.febslet.2006.08.083; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zaiou M, 2003, J INVEST DERMATOL, V120, P810, DOI 10.1046/j.1523-1747.2003.12132.x; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200	33	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18756	10.1371/journal.pone.0018756	http://dx.doi.org/10.1371/journal.pone.0018756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533281	Green Submitted, Green Published, gold			2022-12-25	WOS:000289404700031
J	Matsumoto, Y; Hayama, K; Sakakihara, S; Nishino, K; Noji, H; Iino, R; Yamaguchi, A				Matsumoto, Yoshimi; Hayama, Kohei; Sakakihara, Shouichi; Nishino, Kunihiko; Noji, Hiroyuki; Iino, Ryota; Yamaguchi, Akihito			Evaluation of Multidrug Efflux Pump Inhibitors by a New Method Using Microfluidic Channels	PLOS ONE			English	Article							RESISTANT PSEUDOMONAS-AERUGINOSA; BETA-GALACTOSIDASE ACTIVITY; NEGATIVE ENTERIC BACTERIA; ESCHERICHIA-COLI; OUTER-MEMBRANE; MEXAB-OPRM; AGENTS; PERMEABILITY; MECHANISMS; JAPAN	Fluorescein-di-beta-D-galactopyranoside (FDG), a fluorogenic compound, is hydrolyzed by beta-galactosidase in the cytoplasm of Escherichia coli to produce a fluorescent dye, fluorescein. We found that both FDG and fluorescein were substrates of efflux pumps, and have developed a new method to evaluate efflux-inhibitory activities in E. coli using FDG and a microfluidic channel device. We used E. coli MG1655 wild-type, Delta acrB (Delta B), DtolC (Delta C) and Delta acrB Delta tolC (Delta BC) harboring plasmids carrying the mexAB-oprM (pABM) or mexXY-oprM (pXYM) genes of Pseudomonas aeruginosa. Two inhibitors, MexB-specific pyridopyrimidine (D13-9001) and non-specific Phe-Arg-beta-naphthylamide (PAbN) were evaluated. The effects of inhibitors on pumps were observed using the microfluidic channel device under a fluorescence microscope. AcrAB-TolC and analogous pumps effectively prevented FDG influx in wild-type cells, resulting in no fluorescence. In contrast, Delta B or Delta C easily imported and hydrolyzed FDG to fluorescein, which was exported by residual pumps in Delta B. Consequently, fluorescent medium in Delta B and fluorescent cells of Delta C and Delta BC were observed in the microfluidic channels. D13-9001 substantially increased fluorescent cell number in Delta BC/pABM but not in Delta BC/pXYM. PA beta N increased medium fluorescence in all strains, especially in the pump deletion mutants, and caused fluorescein accumulation to disappear in Delta C. The checkerboard method revealed that D13-9001 acts synergistically with aztreonam, ciprofloxacin, and erythromycin only against the MexAB-OprM producer (Delta BC/pABM), and PA beta N acts synergistically, especially with erythromycin, in all strains including the pump deletion mutants. The results obtained from PA beta N were similar to the results from membrane permeabilizer, polymyxin B or polymyxin B nonapeptide by concentration. The new method clarified that D13-9001 specifically inhibited MexAB-OprM in contrast to PAbN, which appeared to be a substrate of the pumps and permeabilized the membranes in E. coli.	[Matsumoto, Yoshimi; Hayama, Kohei; Sakakihara, Shouichi; Nishino, Kunihiko; Noji, Hiroyuki; Iino, Ryota; Yamaguchi, Akihito] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Nishino, Kunihiko; Noji, Hiroyuki; Iino, Ryota] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan; [Noji, Hiroyuki; Iino, Ryota] Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo, Japan; [Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); University of Tokyo; Osaka University	Matsumoto, Y (corresponding author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	yoshimi@sanken.osaka-u.ac.jp; iino@sanken.osaka-u.ac.jp	Iino, Ryota/B-7746-2011	Iino, Ryota/0000-0003-0110-5704	National Institute of Biomedical Innovation [ID 07-03]; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Grant for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation (Project ID 07-03), by the CREST and PRESTO from Japan Science and Technology Agency, and by the Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elkins CA, 2007, ANTIMICROB AGENTS CH, V51, P923, DOI 10.1128/AAC.01048-06; Fieldler F, 1994, Eur J Biochem, V222, P75; Giske CG, 2008, MICROB DRUG RESIST, V14, P23, DOI 10.1089/mdr.2008.0778; HANCOCK REW, 1984, ANTIMICROB AGENTS CH, V26, P48, DOI 10.1128/AAC.26.1.48; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Kaatz GW, 2003, ANTIMICROB AGENTS CH, V47, P719, DOI 10.1128/AAC.47.2.719-726.2003; Kirikae T, 2008, J ANTIMICROB CHEMOTH, V61, P612, DOI 10.1093/jac/dkm537; Lenshof A, 2010, CHEM SOC REV, V39, P1203, DOI 10.1039/b915999c; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Lomovskaya O, 2001, ANTIMICROB AGENTS CH, V45, P105, DOI 10.1128/AAC.45.1.105-116.2001; Lundberg CV, 2010, J ANTIMICROB CHEMOTH, V65, P981, DOI 10.1093/jac/dkq072; Martins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006656; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P3322, DOI 10.1128/AAC.44.12.3322-3327.2000; Mesaros N, 2007, J ANTIMICROB CHEMOTH, V59, P378, DOI 10.1093/jac/dkl504; Mokhonov VV, 2004, BIOCHEM BIOPH RES CO, V322, P483, DOI 10.1016/j.bbrc.2004.07.140; Morita Y, 2001, J GEN APPL MICROBIOL, V47, P27, DOI 10.2323/jgam.47.27; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Nishino Kunihiko, 2008, Journal of Infection and Chemotherapy, V14, P23, DOI 10.1007/s10156-007-0575-y; RUSSOMARIE F, 1993, P NATL ACAD SCI USA, V90, P8194, DOI 10.1073/pnas.90.17.8194; Ryan BM, 2001, EXPERT OPIN INV DRUG, V10, P1409, DOI 10.1517/13543784.10.8.1409; Satoh Ritsuko, 2008, Journal of Infection and Chemotherapy, V14, P325, DOI 10.1007/s10156-008-0620-5; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Sekiguchi JI, 2005, ANTIMICROB AGENTS CH, V49, P3734, DOI 10.1128/AAC.49.9.3734-3742.2005; Sekiguchi Jun-ichiro, 2007, Journal of Infection and Chemotherapy, V13, P418, DOI 10.1007/s10156-007-0560-5; Sekiguchi JI, 2007, J CLIN MICROBIOL, V45, P979, DOI 10.1128/JCM.01772-06; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Tohidpour A, 2009, CURR MICROBIOL, V59, P352, DOI 10.1007/s00284-009-9444-5; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Vaara M, 1996, ANTIMICROB AGENTS CH, V40, P1801, DOI 10.1128/AAC.40.8.1801; VAARA M, 1983, ANTIMICROB AGENTS CH, V24, P114, DOI 10.1128/AAC.24.1.114; VAARA M, 1983, ANTIMICROB AGENTS CH, V24, P107, DOI 10.1128/AAC.24.1.107; Vaara M, 2010, ANTIMICROB AGENTS CH, V54, P3341, DOI 10.1128/AAC.01439-09; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Vidal-Aroca F, 2009, J MICROBIOL METH, V79, P232, DOI 10.1016/j.mimet.2009.09.021; VILJANEN P, 1984, ANTIMICROB AGENTS CH, V25, P701, DOI 10.1128/AAC.25.6.701; Viveiros M, 2008, INT J ANTIMICROB AG, V31, P458, DOI 10.1016/j.ijantimicag.2007.12.015; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yang NC, 2004, ANAL BIOCHEM, V325, P337, DOI 10.1016/j.ab.2003.11.012; Yoshida KI, 2007, BIOORGAN MED CHEM, V15, P7087, DOI 10.1016/j.bmc.2007.07.039	45	70	75	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18547	10.1371/journal.pone.0018547	http://dx.doi.org/10.1371/journal.pone.0018547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533264	Green Published, gold			2022-12-25	WOS:000289404700018
J	Dolan, KT; Duguid, EM; He, C				Dolan, Kyle T.; Duguid, Erica M.; He, Chuan			Crystal Structures of SlyA Protein, a Master Virulence Regulator of Salmonella, in Free and DNA-bound States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-SENSING MECHANISM; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; GLOBAL REGULATOR; TRANSCRIPTION; MARR; MEXR; IDENTIFICATION; TYPHIMURIUM; EXPRESSION	SlyA is a master virulence regulator that controls the transcription of numerous genes in Salmonella enterica. We present here crystal structures of SlyA by itself and bound to a high-affinity DNA operator sequence in the slyA gene. SlyA interacts with DNA through direct recognition of a guanine base by Arg-65, as well as interactions between conserved Arg-86 and the minor groove and a large network of non-base-specific contacts with the sugar phosphate backbone. Our structures, together with an unpublished structure of SlyA bound to the small molecule effector salicylate (Protein Data Bank code 3DEU), reveal that, unlike many other MarR family proteins, SlyA dissociates from DNA without large conformational changes when bound to this effector. We propose that SlyA and other MarR global regulators rely more on indirect readout of DNA sequence to exert control over many genes, in contrast to proteins (such as OhrR) that recognize a single operator.	[Dolan, Kyle T.; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Dolan, Kyle T.; Duguid, Erica M.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Dolan, Kyle T.; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St,GCIS 319B, Chicago, IL 60637 USA.	chuanhe@uchicago.edu		Duguid, Erica/0000-0003-4319-1030	National Institutes of Health [AI074658]; Predoctoral Training Program in Chemistry Biology [GM008720]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Predoctoral Training Program in Chemistry Biology; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI074658 and Predoctoral Training Program in Chemistry & Biology Grant GM008720 (to K. T. D.). This work was also supported by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (to C. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; Chen H, 2008, P NATL ACAD SCI USA, V105, P13586, DOI 10.1073/pnas.0803391105; Chen H, 2010, EMBO REP, V11, P685, DOI 10.1038/embor.2010.96; Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Haider F, 2009, INT MICROBIOL, V11, P245, DOI 10.2436/20.1501.01.68; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Newberry KJ, 2007, MOL CELL, V28, P652, DOI 10.1016/j.molcel.2007.09.016; Okada N, 2007, MICROBIOL-SGM, V153, P548, DOI 10.1099/mic.0.29259-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Poor CB, 2009, J BIOL CHEM, V284, P23517, DOI 10.1074/jbc.M109.015826; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Stoebel DM, 2008, MICROBIOL-SGM, V154, P2533, DOI 10.1099/mic.0.2008/020693-0; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wu RY, 2003, J BIOL CHEM, V278, P20240, DOI 10.1074/jbc.M300292200	31	64	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22178	22185		10.1074/jbc.M111.245258	http://dx.doi.org/10.1074/jbc.M111.245258			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21550983	Green Published, hybrid			2022-12-25	WOS:000291719900024
J	Shin, J; Chakraborty, G; Bharatham, N; Kang, CB; Tochio, N; Koshiba, S; Kigawa, T; Kim, W; Kim, KT; Yoon, HS				Shin, Joon; Chakraborty, Goutam; Bharatham, Nagakumar; Kang, CongBao; Tochio, Naoya; Koshiba, Seizo; Kigawa, Takanori; Kim, Wanil; Kim, Kyong-Tai; Yoon, Ho Sup			NMR Solution Structure of Human Vaccinia-related Kinase 1 (VRK1) Reveals the C-terminal Tail Essential for Its Structural Stability and Autocatalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; BIOLOGICAL MACROMOLECULES; BINDING-SITE; PHOSPHORYLATION; ACTIVATION; SYSTEM; BAF; CRYSTALLOGRAPHY; MECHANISM; CHROMATIN	Vaccinia-related kinase 1 (VRK1) is one of the mitotic kinases that play important roles in cell cycle, nuclear condensation, and transcription regulation. Kinase domain structures of two other VRK family members (VRK2 and VRK3) have been determined previously. However, the structure of VRK1, the most extensively studied and constitutively active VRK member, is yet to be characterized. Here, we present the nuclear magnetic resonance (NMR) solution structure of a catalytically active form of human VRK1 with its extended C-terminal tail (residues 1-361). The NMR structure of human VRK1 reveals that the C-terminal tail orients toward the catalytic site and forms a number of interactions that are critical for structural stability and catalysis. The role of this unique C-terminal tail was further investigated by deletion mutant studies where deletion of the terminal tail resulted in a dramatic reduction in the autocatalytic activity of VRK1. NMR titration studies carried out with ATP or an ATP analog confirm that ATP/ATP analogs interact with all of the crucial residues present in important motifs of the protein kinase such as the hinge region, catalytic loop, DYG motif, and thereby suggest that the catalytic domain of VRK1 is not atypical. In addition to the conventional interactions, some of the residues present on the extended C-terminal tail also interact with the ligands. These observations also substantiate the role of the extended C-terminal tail in the biological activity of VRK1.	[Shin, Joon; Chakraborty, Goutam; Bharatham, Nagakumar; Kang, CongBao; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tochio, Naoya; Koshiba, Seizo; Kigawa, Takanori] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Kim, Wanil; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; RIKEN; Pohang University of Science & Technology (POSTECH)	Yoon, HS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	hsyoon@ntu.edu.sg	Kigawa, Takanori/A-7679-2010; Tochio, Naoya/E-9495-2012; Yoon, Ho Sup/A-2193-2011; Kang, Congbao/AAP-7572-2020	Kigawa, Takanori/0000-0003-0146-9719; Yoon, Ho Sup/0000-0002-8243-3904; Kang, Congbao/0000-0002-9886-9374; KIM, KYONG-TAI/0000-0001-7292-2627	National Medical Research Council of Singapore [NMRC/1177/2008]; Core Research Program/Anti-aging and Well-being Research Center; Ministry of Education, Science, and Technology; National Research Foundation of Korea [20090063547, 20090081464]	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Core Research Program/Anti-aging and Well-being Research Center; Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported in part by National Medical Research Council of Singapore Grant NMRC/1177/2008; grants from the Core Research Program/Anti-aging and Well-being Research Center; the Brain Korea 21 program of the Ministry of Education, Science, and Technology; and National Research Foundation of Korea Grants 20090063547 and 20090081464 (the Original Technology Research Program for Brain Science).	Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; BOSSEMEYER D, 1995, FEBS LETT, V369, P57, DOI 10.1016/0014-5793(95)00580-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Goddard TD, 2007, SPARKY VERSION 3; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; Mueller GA, 2000, J MOL BIOL, V300, P197, DOI 10.1006/jmbi.2000.3842; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shchemelinin I, 2006, FOLIA BIOL-PRAGUE, V52, P81; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; TRAKTMAN P, 1989, J BIOL CHEM, V264, P21458; Trevino SR, 2007, J MOL BIOL, V366, P449, DOI 10.1016/j.jmb.2006.10.026; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012	40	32	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22131	22138		10.1074/jbc.M110.200162	http://dx.doi.org/10.1074/jbc.M110.200162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543316	hybrid, Green Published			2022-12-25	WOS:000291719900019
J	Wang, K; Li, WD; Zhang, CK; Wang, ZH; Glessner, JT; Grant, SFA; Zhao, HY; Hakonarson, H; Price, RA				Wang, Kai; Li, Wei-Dong; Zhang, Clarence K.; Wang, Zuoheng; Glessner, Joseph T.; Grant, Struan F. A.; Zhao, Hongyu; Hakonarson, Hakon; Price, R. Arlen			A Genome-Wide Association Study on Obesity and Obesity-Related Traits	PLOS ONE			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; EXTREME OBESITY; ADULT OBESITY; LOCI; RISK; VARIANTS; INDIVIDUALS; DEPENDENCE; GENE	Large-scale genome-wide association studies (GWAS) have identified many loci associated with body mass index (BMI), but few studies focused on obesity as a binary trait. Here we report the results of a GWAS and candidate SNP genotyping study of obesity, including extremely obese cases and never overweight controls as well as families segregating extreme obesity and thinness. We first performed a GWAS on 520 cases (BMI. 35 kg/m(2)) and 540 control subjects (BMI, 25 kg/m(2)), on measures of obesity and obesity-related traits. We subsequently followed up obesity-associated signals by genotyping the top similar to 500 SNPs from GWAS in the combined sample of cases, controls and family members totaling 2,256 individuals. For the binary trait of obesity, we found 16 genome-wide significant signals within the FTO gene (strongest signal at rs17817449, P = 2.5 x 10(-12)). We next examined obesity-related quantitative traits (such as total body weight, waist circumference and waist to hip ratio), and detected genome-wide significant signals between waist to hip ratio and NRXN3 (rs11624704, P = 2.67 x 10(-9)), previously associated with body weight and fat distribution. Our study demonstrated how a relatively small sample ascertained through extreme phenotypes can detect genuine associations in a GWAS.	[Wang, Kai; Glessner, Joseph T.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Wang, Kai] Univ So Calif, Dept Psychiat, Zilkha Neurogenet Inst, Los Angeles, CA USA; [Wang, Kai] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; [Li, Wei-Dong; Price, R. Arlen] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Zhang, Clarence K.] Yale Univ, Sch Med, WM Keck Lab, Div Biostat, New Haven, CT USA; [Wang, Zuoheng; Zhao, Hongyu] Yale Univ, Dept Biostat, New Haven, CT USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Southern California; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Yale University; Yale University; University of Pennsylvania	Wang, K (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	arlen@mail.med.upenn.edu		Glessner, Joseph/0000-0001-5131-2811; Li, Wei-Dong/0000-0003-0521-7412	NIH [R01DK44073, R01DK56210, R01DK076023]; American Heart Association [0630188N]; Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044073, R01DK056210, R01DK076023] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Children's Hospital of Philadelphia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants R01DK44073, R01DK56210, and R01DK076023 to R. A. P. and a Scientist Development Grant (0630188N) from the American Heart Association to W. D. L.. Genome-wide genotyping was funded in part by an Institutional Development Award to the Center for Applied Genomics (H. H.) from the Children's Hospital of Philadelphia. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Farooqi I Sadaf, 2006, Pediatr Endocrinol Rev, V3 Suppl 4, P528; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Malis C, 2005, OBES RES, V13, P2139, DOI 10.1038/oby.2005.265; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Novak G, 2009, WORLD J BIOL PSYCHIA, V10, P929, DOI 10.1080/15622970903079499; Price RA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-4; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2010, DIABETES, V59, P2690, DOI 10.2337/db10-0192; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	25	118	124	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18939	10.1371/journal.pone.0018939	http://dx.doi.org/10.1371/journal.pone.0018939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552555	Green Submitted, Green Published, gold			2022-12-25	WOS:000290020700009
J	Groemer, TW; Thiel, CS; Holt, M; Riedel, D; Hua, YF; Huve, J; Wilhelm, BG; Klingauf, J				Groemer, Teja W.; Thiel, Cora S.; Holt, Matthew; Riedel, Dietmar; Hua, Yunfeng; Hueve, Jana; Wilhelm, Benjamin G.; Klingauf, Juergen			Amyloid Precursor Protein Is Trafficked and Secreted via Synaptic Vesicles	PLOS ONE			English	Article							CLATHRIN-COATED VESICLES; ALZHEIMERS-DISEASE; APP TRAFFICKING; ENDOCYTOSIS; TRANSPORT; DISTINCT; ASSOCIATION; CLEAVAGE; NEURONS; IDENTIFICATION	A large body of evidence has implicated amyloid precursor protein (APP) and its proteolytic derivatives as key players in the physiological context of neuronal synaptogenesis and synapse maintenance, as well as in the pathology of Alzheimer's Disease (AD). Although APP processing and release are known to occur in response to neuronal stimulation, the exact mechanism by which APP reaches the neuronal surface is unclear. We now demonstrate that a small but relevant number of synaptic vesicles contain APP, which can be released during neuronal activity, and most likely represent the major exocytic pathway of APP. This novel finding leads us to propose a revised model of presynaptic APP trafficking that reconciles existing knowledge on APP with our present understanding of vesicular release and recycling.	[Groemer, Teja W.; Thiel, Cora S.; Hua, Yunfeng; Wilhelm, Benjamin G.; Klingauf, Juergen] Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany; [Hueve, Jana] Univ Munster, Inst Med Phys & Biophys, Fluorescence Microscopy Facil Munster, Munster, Germany; [Holt, Matthew] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Grp, D-37077 Gottingen, Germany; [Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany	Max Planck Society; University of Munster; Max Planck Society; Max Planck Society; University of Erlangen Nuremberg	Groemer, TW (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany.	mholt@gwdg.de; klingauf@uni-muenster.de		Groemer, Teja/0000-0003-3854-716X; Hua, Yunfeng/0000-0003-0072-7122; Holt, Matthew/0000-0002-8958-4027	Max Planck Society; European Science Foundation/Deutsche Forschungsgemeinschaft [CRP FP-020]; DFG [Kl 1334/1-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Science Foundation/Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)European Science Foundation (ESF)); DFG(German Research Foundation (DFG))	Financial support for this work was provided by the Max Planck Society, in addition to grants from the European Science Foundation/Deutsche Forschungsgemeinschaft (Euromembrane program, EuroSynapse CRP FP-020 to JK) and the DFG (Kl 1334/1-1 to CST and JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EJ, 2002, BIOTECHNIQUES, V33, P1152, DOI 10.2144/02335dd10; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Bethani I, 2007, EMBO J, V26, P3981, DOI 10.1038/sj.emboj.7601820; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Goldsbury C, 2006, TRAFFIC, V7, P873, DOI 10.1111/j.1600-0854.2006.00434.x; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Khvotchev M, 2004, J BIOL CHEM, V279, P47101, DOI 10.1074/jbc.M408474200; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; MANILOW R, 2008, SYNAPTIC PLASTICITY, P63; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Matteoli M, 2004, TRENDS CELL BIOL, V14, P133, DOI 10.1016/j.tcb.2004.01.007; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; O'Brien J, 2006, P NATL ACAD SCI USA, V103, P1575, DOI 10.1073/pnas.0507884103; QIZHI H, 2005, J MASS SPECTROM, V40, P430; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rebelo S, 2007, J MOL NEUROSCI, V32, P1, DOI 10.1007/s12031-007-0001-z; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Simons M, 1996, J NEUROSCI, V16, P899; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Sitzer DI, 2006, ACTA PSYCHIAT SCAND, V114, P75, DOI 10.1111/j.1600-0447.2006.00789.x; SUDHOF TC, 2004, J NEUROSCI, V28, P6627; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Takamori S, 2000, J NEUROSCI, V20, P4904; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; URLAUB H, 2008, PROTEOMICS NERVOUS S, P19; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739	61	72	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18754	10.1371/journal.pone.0018754	http://dx.doi.org/10.1371/journal.pone.0018754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556148	Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400010
J	Hall, MK; Cartwright, TA; Fleming, CM; Schwalbe, RA				Hall, M. K.; Cartwright, Tara A.; Fleming, Christa M.; Schwalbe, Ruth A.			Importance of Glycosylation on Function of a Potassium Channel in Neuroblastoma Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GATED K+ CHANNELS; UDP-N-ACETYLGLUCOSAMINE; MOLECULAR DIVERSITY; MAMMALIAN BRAIN; KV3 CHANNELS; RAT-BRAIN; EXPRESSION; TRAFFICKING; COMPLEX	The Kv3.1 glycoprotein, a voltage-gated potassium channel, is expressed throughout the central nervous system. The role of N-glycans attached to the Kv3.1 glycoprotein on conducting and non-conducting functions of the Kv3.1 channel are quite limiting. Glycosylated (wild type), partially glycosylated (N220Q and N229Q), and unglycosylated (N220Q/N229Q) Kv3.1 proteins were expressed and characterized in a cultured neuronal-derived cell model, B35 neuroblastoma cells. Western blots, whole cell current recordings, and wound healing assays were employed to provide evidence that the conducting and non-conducting properties of the Kv3.1 channel were modified by N-glycans of the Kv3.1 glycoprotein. Electrophoretic migration of the various Kv3.1 proteins treated with PNGase F and neuraminidase verified that the glycosylation sites were occupied and that the N-glycans could be sialylated, respectively. The unglycosylated channel favored a different whole cell current pattern than the glycoform. Further the outward ionic currents of the unglycosylated channel had slower activation and deactivation rates than those of the glycosylated Kv3.1 channel. These kinetic parameters of the partially glycosylated Kv3.1 channels were also slowed. B35 cells expressing glycosylated Kv3.1 protein migrated faster than those expressing partially glycosylated and much faster than those expressing the unglycosylated Kv3.1 protein. These results have demonstrated that N-glycans of the Kv3.1 glycoprotein enhance outward ionic current kinetics, and neuronal migration. It is speculated that physiological changes which lead to a reduction in N-glycan attachment to proteins will alter the functions of the Kv3.1 channel.	[Hall, M. K.; Cartwright, Tara A.; Fleming, Christa M.; Schwalbe, Ruth A.] E Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Hall, MK (corresponding author), E Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA.	schwalber@ecu.edu			East Carolina University	East Carolina University	This work was supported by East Carolina University Research Development Grant (to RAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks NL, 2006, FEBS J, V273, P3287, DOI 10.1111/j.1742-4658.2006.05339.x; Cartwright TA, 2007, BBA-GEN SUBJECTS, V1770, P666, DOI 10.1016/j.bbagen.2006.11.013; Cartwright TA, 2009, BIOSCIENCE REP, V29, P301, DOI 10.1042/BSR20080149; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; CRITZ SD, 1993, J NEUROCHEM, V60, P1175, DOI 10.1111/j.1471-4159.1993.tb03273.x; Freeze HH, 1999, BBA-MOL BASIS DIS, V1455, P167, DOI 10.1016/S0925-4439(99)00072-1; Gahmberg CG, 1996, TRENDS BIOCHEM SCI, V21, P308, DOI 10.1016/0968-0004(96)10034-7; GRISSMER S, 1992, J BIOL CHEM, V267, P20971; Hille B., 2001, IONIC CHANNELS EXCIT, P814; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; ITO Y, 1992, P ROY SOC B-BIOL SCI, V248, P95, DOI 10.1098/rspb.1992.0047; Johnson D, 2008, PFLUG ARCH EUR J PHY, V456, P393, DOI 10.1007/s00424-007-0378-0; Joho RH, 2009, CEREBELLUM, V8, P323, DOI 10.1007/s12311-009-0098-4; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; O'Grady SM, 2005, INT J BIOCHEM CELL B, V37, P1578, DOI 10.1016/j.biocel.2005.04.002; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; Ousingsawat J, 2007, CLIN CANCER RES, V13, P824, DOI 10.1158/1078-0432.CCR-06-1940; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; SAMBROOK J, 1992, MOL CLONING LAB MANU; Schachter H, 2002, BBA-GEN SUBJECTS, V1573, P292, DOI 10.1016/S0304-4165(02)00396-3; SCHWALBE RA, 1995, J BIOL CHEM, V270, P15336, DOI 10.1074/jbc.270.25.15336; Schwalbe RA, 2008, BIOCHEM CELL BIOL, V86, P21, DOI 10.1139/o07-152; Shi G, 1999, J MEMBRANE BIOL, V168, P265, DOI 10.1007/s002329900515; TAGLIALATELA M, 1991, MOL PHARMACOL, V40, P299; Thornhill WB, 1996, J BIOL CHEM, V271, P19093, DOI 10.1074/jbc.271.32.19093; Tiwari-Woodruff S, 2006, AM J PHYSIOL-CELL PH, V291, pC687, DOI 10.1152/ajpcell.00510.2005; Wang Y, 2002, BBA-GEN SUBJECTS, V1573, P301, DOI 10.1016/S0304-4165(02)00397-5; Watanabe I, 2004, J BIOL CHEM, V279, P8879, DOI 10.1074/jbc.M309802200; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Watanabe I, 2007, BRAIN RES, V1144, P1, DOI 10.1016/j.brainres.2007.01.092; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200	40	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19317	10.1371/journal.pone.0019317	http://dx.doi.org/10.1371/journal.pone.0019317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541302	Green Published, gold, Green Submitted			2022-12-25	WOS:000290018400052
J	Ohniwa, RL; Ushijima, Y; Saito, S; Morikawa, K				Ohniwa, Ryosuke L.; Ushijima, Yuri; Saito, Shinji; Morikawa, Kazuya			Proteomic Analyses of Nucleoid-Associated Proteins in Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, and Staphylococcus aureus	PLOS ONE			English	Article							HISTONE-LIKE PROTEIN; DNA-BINDING PROTEIN; H-NS PROTEIN; CYTOPLASMIC MEMBRANE; INITIATION PROTEIN; OXIDATIVE STRESS; GENE-EXPRESSION; OUTER-MEMBRANE; RIBOSOMAL-RNA; HOST FACTOR	Background: The bacterial nucleoid contains several hundred kinds of nucleoid-associated proteins (NAPs), which play critical roles in genome functions such as transcription and replication. Several NAPs, such as Hu and H-NS in Escherichia coli, have so far been identified. Methodology/Principal Findings: Log-and stationary-phase cells of E. coli, Pseudomonas aeruginosa, Bacillus subtilis, and Staphylococcus aureus were lysed in spermidine solutions. Nucleoids were collected by sucrose gradient centrifugation, and their protein constituents analyzed by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS). Over 200 proteins were identified in each species. Envelope and soluble protein fractions were also identified. By using these data sets, we obtained lists of contaminant-subtracted proteins enriched in the nucleoid fractions (csNAP lists). The lists do not cover all of the NAPs, but included Hu regardless of the growth phases and species. In addition, the csNAP lists of each species suggested that the bacterial nucleoid is equipped with the species-specific set of global regulators, oxidation-reduction enzymes, and fatty acid synthases. This implies bacteria individually developed nucleoid associated proteins toward obtaining similar characteristics. Conclusions/Significance: Ours is the first study to reveal hundreds of NAPs in the bacterial nucleoid, and the obtained data set enabled us to overview some important features of the nucleoid. Several implications obtained from the present proteomic study may make it a landmark for the future functional and evolutionary study of the bacterial nucleoid.	[Ohniwa, Ryosuke L.; Ushijima, Yuri; Saito, Shinji; Morikawa, Kazuya] Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan	University of Tsukuba	Ohniwa, RL (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 305, Japan.	ohniwa@md.tsukuba.ac.jp		Morikawa, Kazuya/0000-0002-1503-7151; Ushijima, Yuri/0000-0003-4169-315X	Ichiro Kanehara Foundation; Japan Society for the Promotion of Science; National Institute of Genetics, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Ichiro Kanehara Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Genetics, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant provided by The Ichiro Kanehara Foundation (to K. M), by a Grant-in-Aid for Young Scientists of the Japan Society for the Promotion of Science (to R.L.O), and by a Collaborative Research (B) grant from the National Institute of Genetics, Japan (to R.L.O). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Kunio Takeyasu for his valuable suggestions and for providing us with Hu antibody. The LC-MS/MS analyses were supported by the "Nanotechnology Network Project" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. In particular, Dr. Taro Takemura of the National Institute for Material Sciences kindly helped us with handling the LC-MS/MS devices. We also thank Dr. Flaminia for her helpful proof reading.	ALBERTS BM, 1968, COLD SPRING HARB SYM, V33, P289, DOI 10.1101/SQB.1968.033.01.033; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Balandina A, 2001, MOL MICROBIOL, V39, P1069, DOI 10.1046/j.1365-2958.2001.02305.x; Brescia CC, 2004, J MOL BIOL, V339, P505, DOI 10.1016/j.jmb.2004.03.067; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chodavarapu S, 2008, MOL MICROBIOL, V67, P1331, DOI 10.1111/j.1365-2958.2008.06127.x; Cunha S, 2001, BIOCHIMIE, V83, P149, DOI 10.1016/S0300-9084(01)01245-7; Daghfous D, 2006, CR BIOL, V329, P271, DOI 10.1016/j.crvi.2006.02.002; Dame RT, 2006, NATURE, V444, P387, DOI 10.1038/nature05283; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FILUTOWICZ M, 1992, J BACTERIOL, V174, P398, DOI 10.1128/jb.174.2.398-407.1992; FORSGREN A, 1966, J IMMUNOL, V97, P822; Fujimoto DF, 2009, MOL MICROBIOL, V74, P1445, DOI 10.1111/j.1365-2958.2009.06942.x; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; GUILLEN N, 1978, NUCLEIC ACIDS RES, V5, P475, DOI 10.1093/nar/5.2.475; Hanada M, 1996, FEBS LETT, V381, P25, DOI 10.1016/0014-5793(96)00066-X; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Horler RSP, 2009, BIOINFORMATICS, V25, P163, DOI 10.1093/bioinformatics/btn596; HWANG DS, 1992, J BIOL CHEM, V267, P23083; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Ishihama A, 2009, NUCLEOID OVERVIEW; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KANO Y, 1990, GENE, V89, P133, DOI 10.1016/0378-1119(90)90216-E; Karavolos MH, 2003, MICROBIOL-SGM, V149, P2749, DOI 10.1099/mic.0.26353-0; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; KORNBERG T, 1974, P NATL ACAD SCI USA, V71, P3189, DOI 10.1073/pnas.71.8.3189; Kruse T, 2006, GENE DEV, V20, P113, DOI 10.1101/gad.366606; Lai EM, 2004, MOL MICROBIOL, V52, P1029, DOI 10.1111/j.1365-2958.2004.04040.x; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lucchini S, 2009, MOL MICROBIOL; MATERMAN EC, 1978, J BACTERIOL, V133, P878, DOI 10.1128/JB.133.2.878-883.1978; Mayer O, 2002, BIOCHEM SOC T, V30, P1175, DOI 10.1042/bst0301175; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Murphy LD, 1997, J STRUCT BIOL, V119, P321, DOI 10.1006/jsbi.1997.3883; MURPHY LD, 1995, BIOPHYS CHEM, V57, P71, DOI 10.1016/0301-4622(95)00047-2; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nakamura M, 2009, PLANT CELL REP, V28, P313, DOI 10.1007/s00299-008-0635-5; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Oberto J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004367; Ohniwa RL, 2006, EMBO J, V25, P5591, DOI 10.1038/sj.emboj.7601414; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETTIJOH.DE, 1970, NATURE, V228, P235, DOI 10.1038/228235a0; PETTIJOHN DE, 1970, J MOL BIOL, V52, P281, DOI 10.1016/0022-2836(70)90031-8; Phadtare S, 2006, J BACTERIOL, V188, P2521, DOI 10.1128/JB.188.7.2521-2527.2006; Podkovyrov SM, 1996, NUCLEIC ACIDS RES, V24, P1747, DOI 10.1093/nar/24.9.1747; POLACZEK P, 1990, New Biologist, V2, P265; PORTALIER R, 1976, CELL, V8, P245, DOI 10.1016/0092-8674(76)90008-8; Ramsden JJ, 1998, PHYS REV E, V58, P7777, DOI 10.1103/PhysRevE.58.7777; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Sakata N, 2005, CURR MICROBIOL, V50, P47, DOI 10.1007/s00284-004-4381-9; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; SCHNAITM.CA, 1970, J BACTERIOL, V104, P890, DOI 10.1128/JB.104.2.890-901.1970; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; Sekine K, 2007, FEBS J, V274, P2054, DOI 10.1111/j.1742-4658.2007.05748.x; Soufo HJD, 2010, P NATL ACAD SCI USA, V107, P3163, DOI 10.1073/pnas.0911979107; STONINGT.OG, 1971, P NATL ACAD SCI USA, V68, P6, DOI 10.1073/pnas.68.1.6; Suzuki E, 1998, MOL MICROBIOL, V28, P95, DOI 10.1046/j.1365-2958.1998.00777.x; Swinger KK, 2003, EMBO J, V22, P3749, DOI 10.1093/emboj/cdg351; Takeyasu K, 2004, CYTOGENET GENOME RES, V107, P38, DOI 10.1159/000079570; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Teramoto J, 2010, NUCLEIC ACIDS RES, V38, P3605, DOI 10.1093/nar/gkq077; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; van den Ent F, 2010, EMBO J, V29, P1081, DOI 10.1038/emboj.2010.9; Vlamis-Gardikas A, 2008, BBA-GEN SUBJECTS, V1780, P1170, DOI 10.1016/j.bbagen.2008.03.013; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Weiner JH, 2008, BBA-BIOMEMBRANES, V1778, P1698, DOI 10.1016/j.bbamem.2007.07.020; Weinstein-Fischer D, 2000, MOL MICROBIOL, V35, P1413, DOI 10.1046/j.1365-2958.2000.01805.x; WOOLEY RE, 1975, J MED MICROBIOL, V8, P189, DOI 10.1099/00222615-8-1-189; Yamazaki T, 1999, BIOCHEM BIOPH RES CO, V258, P211, DOI 10.1006/bbrc.1999.0615; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; YUNG BYM, 1988, P NATL ACAD SCI USA, V85, P7202, DOI 10.1073/pnas.85.19.7202; Zimmerman SB, 2006, J STRUCT BIOL, V153, P160, DOI 10.1016/j.jsb.2005.10.011	91	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19172	10.1371/journal.pone.0019172	http://dx.doi.org/10.1371/journal.pone.0019172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541338	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400029
J	Willecke, F; Zeschky, K; Rodriguez, AO; Colberg, C; Auwarter, V; Kneisel, S; Hutter, M; Lozhkin, A; Hoppe, N; Wolf, D; von zur Muhlen, C; Moser, M; Hilgendorf, I; Bode, C; Zirlik, A				Willecke, Florian; Zeschky, Katharina; Rodriguez, Alexandra Ortiz; Colberg, Christian; Auwaerter, Volker; Kneisel, Stefan; Hutter, Melanie; Lozhkin, Andrey; Hoppe, Natalie; Wolf, Dennis; von zur Muehlen, Constantin; Moser, Martin; Hilgendorf, Ingo; Bode, Christoph; Zirlik, Andreas			Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice	PLOS ONE			English	Article							CB2 RECEPTOR; ENDOCANNABINOID SYSTEM; SELECTIVE LIGANDS; LEUKOCYTE SUBSETS; CD40 LIGAND; IN-VITRO; ATHEROSCLEROSIS; ACTIVATION; MIGRATION; IMMUNE	Background: Strong evidence supports a protective role of the cannabinoid receptor 2 (CB(2)) in inflammation and atherosclerosis. However, direct proof of its involvement in lesion formation is lacking. Therefore, the present study aimed to characterize the role of the CB(2) receptor in Murine atherogenesis. Methods and Findings: Low density lipoprotein receptor-deficient (LDLR(-/-)) mice subjected to intraperitoneal injections of the selective CB(2) receptor agonist JWH-133 or vehicle three times per week consumed high cholesterol diet (HCD) for 16 weeks. Surprisingly, intimal lesion size did not differ between both groups in sections of the aortic roots and arches, suggesting that CB(2) activation does not modulate atherogenesis in vivo. Plaque content of lipids, macrophages, smooth muscle cells, T cells, and collagen were also similar between both groups. Moreover, CB(2)(-/-)/LDLR(-/-) mice developed lesions of similar size containing more macrophages and lipids but similar amounts of smooth muscle cells and collagen fibers compared with CB(2)(+/+)/LDLR(-/-) controls. While JWH-133 treatment reduced intraperitoneal macrophage accumulation in thioglycollate-illicited peritonitis, neither genetic deficiency nor pharmacologic activation of the CB(2) receptor altered inflammatory cytokine expression in vivo or inflammatory cell adhesion in the flow chamber in vitro. Conclusion: Our study demonstrates that both activation and deletion of the CB(2) receptor do not relevantly modulate atherogenesis in mice. Our data do not challenge the multiple reports involving CB(2) in other inflammatory processes. However, in the context of atherosclerosis, CB(2) does not appear to be a suitable therapeutic target for reduction of the atherosclerotic plaque.	[Willecke, Florian; Zeschky, Katharina; Rodriguez, Alexandra Ortiz; Colberg, Christian; Lozhkin, Andrey; Hoppe, Natalie; Wolf, Dennis; von zur Muehlen, Constantin; Moser, Martin; Hilgendorf, Ingo; Bode, Christoph; Zirlik, Andreas] Univ Freiburg, Dept Cardiol, Freiburg, Germany; [Auwaerter, Volker; Kneisel, Stefan; Hutter, Melanie] Univ Med Ctr Freiburg, Inst Forens Med, Freiburg, Germany	University of Freiburg; University of Freiburg	Willecke, F (corresponding author), Univ Freiburg, Dept Cardiol, Freiburg, Germany.	andreas.zirlik@uniklinik-freiburg.de	Auwärter, Volker/D-1075-2012; Wolf, Dennis/G-8299-2012; Wolf, Dennis/S-9217-2018; Hilgendorf, Ingo/AFM-6379-2022; Zirlik, Andreas/A-6400-2011	Auwärter, Volker/0000-0002-1883-2804; Wolf, Dennis/0000-0003-1525-4348; Hilgendorf, Ingo/0000-0002-0024-1643; Zirlik, Andreas/0000-0001-6290-3297	Deutsche Forschungsgemeinschaft [DFG ZI 743/3-2]; University of Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Freiburg	The study was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG ZI 743/3-2) and internal grants of the University of Freiburg to Dr. Andreas Zirlik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavendiek U, 2005, ARTERIOSCL THROM VAS, V25, P1244, DOI 10.1161/01.ATV.0000161420.55482.ef; Braunersreuther V, 2006, CELL MOL LIFE SCI, V63, P2079, DOI 10.1007/s00018-006-6127-2; Defer N, 2009, FASEB J, V23, P2120, DOI 10.1096/fj.09-129478; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dol-Gleizes F, 2009, ARTERIOSCL THROM VAS, V29, P12, DOI 10.1161/ATVBAHA.108.168757; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Freeman-Anderson NE, 2008, J LIPID RES, V49, P2338, DOI 10.1194/jlr.M800105-JLR200; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Han KH, 2009, CARDIOVASC RES, V84, P378, DOI 10.1093/cvr/cvp240; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Huffman JW, 2000, CURR PHARM DESIGN, V6, P1323, DOI 10.2174/1381612003399347; Jonsson KO, 2006, LIFE SCI, V78, P598, DOI 10.1016/j.lfs.2005.05.059; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mach F, 2008, J NEUROENDOCRINOL, V20, P53, DOI 10.1111/j.1365-2826.2008.01685.x; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; Montecucco F, 2009, ATHEROSCLEROSIS, V205, P433, DOI 10.1016/j.atherosclerosis.2008.12.040; Montecucco F, 2009, J MOL CELL CARDIOL, V46, P612, DOI 10.1016/j.yjmcc.2008.12.014; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Netherland CD, 2010, ATHEROSCLEROSIS, V213, P102, DOI 10.1016/j.atherosclerosis.2010.07.060; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Patel HJ, 2003, BRIT J PHARMACOL, V140, P261, DOI 10.1038/sj.bjp.0705435; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Sacerdote P, 2000, J NEUROIMMUNOL, V109, P155, DOI 10.1016/S0165-5728(00)00307-6; Shimada K, 2009, CIRC J, V73, P994, DOI 10.1253/circj.CJ-09-0277; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Smith SR, 2001, EUR J PHARMACOL, V432, P107, DOI 10.1016/S0014-2999(01)01477-7; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Sugamura K, 2010, J ATHEROSCLER THROMB, V17, P141, DOI 10.5551/jat.2865; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; Xu HP, 2007, J LEUKOCYTE BIOL, V82, P532, DOI 10.1189/jlb.0307159; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d; Zhu LX, 2000, J IMMUNOL, V165, P373, DOI 10.4049/jimmunol.165.1.373; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	45	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19405	10.1371/journal.pone.0019405	http://dx.doi.org/10.1371/journal.pone.0019405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541300	gold, Green Published, Green Submitted			2022-12-25	WOS:000290018400056
J	Griffen, AL; Beall, CJ; Firestone, ND; Gross, EL; DiFranco, JM; Hardman, JH; Vriesendorp, B; Faust, RA; Janies, DA; Leys, EJ				Griffen, Ann L.; Beall, Clifford J.; Firestone, Noah D.; Gross, Erin L.; DiFranco, James M.; Hardman, Jori H.; Vriesendorp, Bastienne; Faust, Russell A.; Janies, Daniel A.; Leys, Eugene J.			CORE: A Phylogenetically-Curated 16S rDNA Database of the Core Oral Microbiome	PLOS ONE			English	Article							MOLECULAR ANALYSIS; SEQUENCES; IDENTIFICATION; POPULATIONS; DIVERSITY; PROGRAM; DISPLAY	Comparing bacterial 16S rDNA sequences to GenBank and other large public databases via BLAST often provides results of little use for identification and taxonomic assignment of the organisms of interest. The human microbiome, and in particular the oral microbiome, includes many taxa, and accurate identification of sequence data is essential for studies of these communities. For this purpose, a phylogenetically curated 16S rDNA database of the core oral microbiome, CORE, was developed. The goal was to include a comprehensive and minimally redundant representation of the bacteria that regularly reside in the human oral cavity with computationally robust classification at the level of species and genus. Clades of cultivated and uncultivated taxa were formed based on sequence analyses using multiple criteria, including maximum-likelihood-based topology and bootstrap support, genetic distance, and previous naming. A number of classification inconsistencies for previously named species, especially at the level of genus, were resolved. The performance of the CORE database for identifying clinical sequences was compared to that of three publicly available databases, GenBank nr/nt, RDP and HOMD, using a set of sequencing reads that had not been used in creation of the database. CORE offered improved performance compared to other public databases for identification of human oral bacterial 16S sequences by a number of criteria. In addition, the CORE database and phylogenetic tree provide a framework for measures of community divergence, and the focused size of the database offers advantages of efficiency for BLAST searching of large datasets. The CORE database is available as a searchable interface and for download at http://microbiome.osu.edu.	[Griffen, Ann L.; Gross, Erin L.; DiFranco, James M.] Ohio State Univ, Coll Dent, Div Pediat Dent, Columbus, OH 43210 USA; [Beall, Clifford J.; Firestone, Noah D.; Vriesendorp, Bastienne; Faust, Russell A.; Leys, Eugene J.] Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA; [Hardman, Jori H.; Janies, Daniel A.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Griffen, AL (corresponding author), Ohio State Univ, Coll Dent, Div Pediat Dent, Columbus, OH 43210 USA.	griffen.1@osu.edu	Griffen, Ann/AAC-5999-2019; Beall, Clifford/D-1035-2012	Beall, Clifford/0000-0002-2198-9124	NIDCR [R01DE016125, R01DE010467]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010467, R01DE016125] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR grants R01DE016125 and R01DE010467 (www.nidcr.nih.gov), and by an allocation of computing time from the Ohio Supercomputer Center (www.osc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARMOUGOM F, 2009, J COMPUT SCI SYST BI, V2, P69; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; de Lillo A, 2004, J CLIN MICROBIOL, V42, P5523, DOI 10.1128/JCM.42.12.5523-5527.2004; Dewhirst FE, 2010, J BACTERIOL; Dymock D, 1996, J CLIN MICROBIOL, V34, P537, DOI 10.1128/JCM.34.3.537-542.1996; HILLIS DM, 1993, SYST BIOL, P42; Hugenholtz P, 2003, INT J SYST EVOL MICR, V53, P289, DOI 10.1099/ijs.0.02441-0; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Maddison, 2019, MESQUITE MODULAR SYS; Munson MA, 2004, J CLIN MICROBIOL, V42, P3023, DOI 10.1128/JCM.42.7.3023-3029.2004; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	35	120	136	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19051	10.1371/journal.pone.0019051	http://dx.doi.org/10.1371/journal.pone.0019051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544197	Green Submitted, Green Published, gold			2022-12-25	WOS:000290015800036
J	Abdul-Rahman, MF; Qiu, AQ; Sim, K				Abdul-Rahman, Muhammad Farid; Qiu, Anqi; Sim, Kang			Regionally Specific White Matter Disruptions of Fornix and Cingulum in Schizophrenia	PLOS ONE			English	Article							EARLY-ONSET SCHIZOPHRENIA; HIGH GENETIC RISK; 1ST-EPISODE SCHIZOPHRENIA; DIFFUSION ANISOTROPY; CORTICAL THICKNESS; TENSOR; ANTERIOR; INTEGRITY; MRI; BRAIN	Limbic circuitry disruptions have been implicated in the psychopathology and cognitive deficits of schizophrenia, which may involve white matter disruptions of the major tracts of the limbic system, including the fornix and the cingulum. Our study aimed to investigate regionally specific abnormalities of the fornix and cingulum in schizophrenia using diffusion tensor imaging (DTI). We determined the fractional anisotropy (FA), radial diffusivity (RD), and axial diffusivity (AD) profiles along the fornix and cingulum tracts using a fibertracking technique and a brain mapping algorithm, the large deformation diffeomorphic metric mapping (LDDMM), in the DTI scans of 33 patients with schizophrenia and 31 age-, gender-, and handedness-matched healthy controls. We found that patients with schizophrenia showed reduction in FA and increase in RD in bilateral fornix, and increase in RD in left anterior cingulum when compared to healthy controls. In addition, tract-based analysis revealed specific loci of these white matter differences in schizophrenia, that is, FA reductions and AD and RD increases occur in the region of the left fornix further from the hippocampus, FA reductions and RD increases occur in the rostral portion of the left anterior cingulum, and RD and AD increases occur in the anterior segment of the left middle cingulum. In patients with schizophrenia, decreased FA in the specific loci of the left fornix and increased AD in the right cingulum adjoining the hippocampus correlated with greater severity of psychotic symptoms. These findings support precise disruptions of limbic-cortical integrity in schizophrenia and disruption of these structural networks may contribute towards the neural basis underlying the syndrome of schizophrenia and clinical symptomatology.	[Abdul-Rahman, Muhammad Farid; Qiu, Anqi] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Sim, Kang] Inst Mental Hlth, Res Dept, Singapore, Singapore; [Sim, Kang] Inst Mental Hlth, Dept Gen Psychiat, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Abdul-Rahman, MF (corresponding author), Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011	Qiu, Anqi/0000-0002-0215-6338; Sim, Kang/0000-0003-3209-9626	A*STAR [SERC 082-101-0025, SICS-09/1/1/001]; National Medical Research Council [NMRC/CG/NUHS/2010]; National University of Singapore [NUSYIA FY10 P07, MOE AcRF Tier 1]	A*STAR(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National University of Singapore(National University of Singapore)	The work reported here was supported by grants A*STAR SERC 082-101-0025, A*STAR SICS-09/1/1/001, a centre grant from the National Medical Research Council (NMRC/CG/NUHS/2010), the Young Investigator Award at National University of Singapore (NUSYIA FY10 P07), and National University of Singapore MOE AcRF Tier 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agartz I, 2001, NEUROREPORT, V12, P2251, DOI 10.1097/00001756-200107200-00041; Ardekani BA, 2003, NEUROREPORT, V14, P2025, DOI 10.1097/00001756-200311140-00004; Baiano M, 2007, SCHIZOPHR RES, V93, P1, DOI 10.1016/j.schres.2007.02.012; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bouras C, 2001, ACTA NEUROPATHOL, V102, P373; Brisch R, 2008, PSYCHIAT RES-NEUROIM, V164, P265, DOI 10.1016/j.pscychresns.2007.12.007; Buchsbaum MS, 1998, NEUROREPORT, V9, P425, DOI 10.1097/00001756-199802160-00013; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Chance SA, 1999, AM J PSYCHIAT, V156, P1720; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Davenport ND, 2010, PSYCHIAT RES-NEUROIM, V181, P193, DOI 10.1016/j.pscychresns.2009.10.012; Davies DC, 2001, NEUROSCI LETT, V301, P163, DOI 10.1016/S0304-3940(01)01637-8; FIRST MB, 1994, HOSP COMMUNITY PSYCH, V45, P18; First MB, 2002, STRUCTURED CLIN INTE; Fitzsimmons J, 2009, SCHIZOPHR RES, V107, P39, DOI 10.1016/j.schres.2008.10.022; Foong J, 2000, J NEUROL NEUROSUR PS, V68, P242, DOI 10.1136/jnnp.68.2.242; Fornito A, 2008, HUM BRAIN MAPP, V29, P478, DOI 10.1002/hbm.20412; Fujiwara H, 2007, SCHIZOPHR RES, V95, P215, DOI 10.1016/j.schres.2007.05.044; GAFFAN D, 1994, EXP BRAIN RES, V99, P423; Glaunes J, 2008, INT J COMPUT VISION, V80, P317, DOI 10.1007/s11263-008-0141-9; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Hao YH, 2009, SCHIZOPHR RES, V114, P128, DOI 10.1016/j.schres.2009.07.001; Hoptman MJ, 2008, SCHIZOPHR RES, V106, P115, DOI 10.1016/j.schres.2008.07.023; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kendi M, 2008, J AM ACAD CHILD PSY, V47, P826, DOI [10.1097/CHI.Ob013e318172ef36, 10.1097/CHI.0b013e318172ef36]; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kumar R, 2010, J NEUROSCI RES, V88, P2146, DOI 10.1002/jnr.22385; Kumra S, 2005, J AM ACAD CHILD PSY, V44, P934, DOI 10.1097/01.chi.0000170553.15798.94; Kuroki N, 2006, BIOL PSYCHIAT, V60, P22, DOI 10.1016/j.biopsych.2005.09.021; Lipska BK, 2004, J PSYCHIATR NEUROSCI, V29, P282; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Luck D, 2010, SCHIZOPHR RES, V119, P61, DOI 10.1016/j.schres.2010.03.027; Maniega SM, 2008, SCHIZOPHR RES, V106, P132, DOI 10.1016/j.schres.2008.09.016; Manoach DS, 2007, NEUROIMAGE, V37, P599, DOI 10.1016/j.neuroimage.2007.04.062; Minami T, 2003, NEUROPSYCHOBIOLOGY, V47, P141, DOI 10.1159/000070583; Mitelman SA, 2006, SCHIZOPHR RES, V87, P138, DOI 10.1016/j.schres.2006.06.016; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Narr KL, 2009, PSYCHIAT RES-NEUROIM, V171, P20, DOI 10.1016/j.pscychresns.2008.03.008; Nestor PG, 2007, SCHIZOPHR RES, V90, P308, DOI 10.1016/j.schres.2006.10.005; Peters BD, 2008, NEUROPSYCHOBIOLOGY, V58, P19, DOI 10.1159/000154476; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Qiu AQ, 2007, LECT NOTES COMPUT SC, V4791, P186; Qiu A, 2007, NEUROIMAGE, V37, P821, DOI 10.1016/j.neuroimage.2007.05.007; Qiu AQ, 2010, NEUROIMAGE, V52, P1181, DOI 10.1016/j.neuroimage.2010.05.046; Rosenberger G, 2008, SCHIZOPHR RES, V102, P181, DOI 10.1016/j.schres.2008.04.019; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; SEGAL D, 2010, NEUROIMAGE; Skelly LR, 2008, SCHIZOPHR RES, V98, P157, DOI 10.1016/j.schres.2007.10.009; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stark AK, 2004, AM J PSYCHIAT, V161, P882, DOI 10.1176/appi.ajp.161.5.882; Takei K, 2008, SCHIZOPHR RES, V103, P52, DOI 10.1016/j.schres.2008.03.008; Takei K, 2009, SCHIZOPHR RES, V114, P119, DOI 10.1016/j.schres.2009.05.012; Tang JS, 2010, BRAIN RES, V1343, P199, DOI 10.1016/j.brainres.2010.04.083; Tepest R, 2003, BIOL PSYCHIAT, V54, P1234, DOI 10.1016/S0006-3223(03)00702-9; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang F, 2004, AM J PSYCHIAT, V161, P573, DOI 10.1176/appi.ajp.161.3.573; Wang L, 2007, SCHIZOPHR RES, V93, P66, DOI 10.1016/j.schres.2007.02.021	61	69	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18652	10.1371/journal.pone.0018652	http://dx.doi.org/10.1371/journal.pone.0018652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533181	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600018
J	Asnani, MR; Fraser, RA; Reid, ME				Asnani, Monika R.; Fraser, Raphael A.; Reid, Marvin E.			Higher Rates of Hemolysis Are Not Associated with Albuminuria in Jamaicans with Sickle Cell Disease	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; PREVALENCE; ANEMIA; DEATH; GLOMERULOPATHY; ABNORMALITIES; HYPERTENSION; DYSFUNCTION; ADULTS	Albuminuria is a marker of glomerular damage in Sickle Cell Disease (SCD). In this study, we sought to determine the possible predictors of albuminuria in the two more prevalent genotypes of SCD among the Jamaica Sickle Cell Cohort Study participants. Methods: An age-matched cohort of 122 patients with HbSS or HbSC genotypes had measurements of their morning urine albumin concentration, blood pressure, body mass index, haematology and certain biochemistry parameters done. Associations of albuminuria with possible predictors including hematological parameters, reticulocyte counts, aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) levels were examined using multiple regression models. Results: A total of 122 participants were recruited (mean age 28.6 years +/- 2.5 years; 85 HbSS, 37 HbSC). 25.9% with HbSS and 10.8% with HbSC disease had microalbuminuria (urine albumin/creatinine ratio = 30-300 mg/g of creatinine) whereas 16.5% of HbSS and 2.7% of HbSC disease had macroalbuminuria (urine albumin/creatinine ratio. 300 mg/g of creatinine). Mean arterial pressure, hemoglobin levels, serum creatinine, reticulocyte counts and white blood cell counts were statistically significant predictors of albuminuria in HbSS, whereas white blood cell counts and serum creatinine predicted albuminuria in HbSC disease. Both markers of chronic hemolysis, i.e. AST and LDH levels, showed no associations with albuminuria in either genotype. Conclusions: Renal disease, as evidenced by excretion of increased amounts of albumin in urine due to a glomerulopathy, is a common end-organ complication in SCD. It is shown to be more severe in those with HbSS disease than in HbSC disease. Rising blood pressure, lower hemoglobin levels and higher white blood cell counts are hints to the clinician of impending renal disease, whereas higher rates of hemolysis do not appear to play a role in this complication of SCD.	[Asnani, Monika R.; Fraser, Raphael A.; Reid, Marvin E.] Univ W Indies, Sickle Cell Unit, Res Inst Trop Med, Kingston 7, Jamaica	University West Indies Mona Jamaica	Asnani, MR (corresponding author), Univ W Indies, Sickle Cell Unit, Res Inst Trop Med, Mona Campus, Kingston 7, Jamaica.	monika.parshadasnani@uwimona.edu.jm	Reid, Marvin/J-2884-2014	Reid, Marvin/0000-0003-4005-9384	Caribbean Health Research Council [5501-1606-16211]	Caribbean Health Research Council	This work was sponsored by a grant from the Caribbean Health Research Council (URL: http://www.chrc-caribbean.org/GrantProgram.php; grant number: 5501-1606-16211), which has provided the funds to meet the costs of data collection and analysis of blood and urine samples. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 1999, NEPHROL DIAL TRANSPL, V14, P304, DOI 10.1093/ndt/14.2.304; ALLON M, 1990, ARCH INTERN MED, V150, P501, DOI 10.1001/archinte.150.3.501; AOKI RY, 1995, AM J MED, V98, P432, DOI 10.1016/S0002-9343(99)80341-6; Asnani MR, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-40; Ataga KI, 2000, AM J HEMATOL, V63, P205, DOI 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.3.CO;2-#; Barton EN, 2004, W INDIAN MED J, V53, P81; Cumming V, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-46; FALK RJ, 1992, NEW ENGL J MED, V326, P910, DOI 10.1056/NEJM199204023261402; Foucan L, 1998, AM J MED, V104, P339, DOI 10.1016/S0002-9343(98)00056-4; Guasch A, 1996, KIDNEY INT, V49, P786, DOI 10.1038/ki.1996.109; Guasch A, 2006, J AM SOC NEPHROL, V17, P2228, DOI 10.1681/ASN.2002010084; Gurkan S, 2010, PEDIATR NEPHROL, V25, P2123, DOI 10.1007/s00467-010-1560-8; Hagar W, 2008, BRIT J HAEMATOL, V141, P346, DOI 10.1111/j.1365-2141.2008.07097.x; Haymann JP, 2010, CLIN J AM SOC NEPHRO, V5, P756, DOI 10.2215/CJN.08511109; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Maier-Redelsperger M, 2010, BLOOD CELL MOL DIS, V45, P289, DOI 10.1016/j.bcmd.2010.08.001; Okpala H, 2004, BLOOD REV, V18, P65, DOI 10.1016/S0268-960X(03)00037-7; Pegelow CH, 1997, AM J MED, V102, P171; POWARS DR, 1991, ANN INTERN MED, V115, P614, DOI 10.7326/0003-4819-115-8-614; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Saborio P, 1999, J AM SOC NEPHROL, V10, P187; Schmitt F, 1998, AM J KIDNEY DIS, V32, P208, DOI 10.1053/ajkd.1998.v32.pm9708603; Sesso R, 1998, BRAZ J MED BIOL RES, V31, P1257, DOI 10.1590/S0100-879X1998001000004; SKLAR AH, 1990, INT J ARTIF ORGANS, V13, P231, DOI 10.1177/039139889001300408; Taylor JG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002095; THOMAS AN, 1982, BRIT MED J, V285, P633, DOI 10.1136/bmj.285.6342.633; Thompson J, 2007, ARCH INTERN MED, V167, P701, DOI 10.1001/archinte.167.7.701; Wigfall DR, 2000, J PEDIATR-US, V136, P749, DOI 10.1016/S0022-3476(00)48828-1	28	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18863	10.1371/journal.pone.0018863	http://dx.doi.org/10.1371/journal.pone.0018863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533141	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600040
J	Chen, B; Hrycaj, S; Schinko, JB; Podlaha, O; Wimmer, EA; Popadic, A; Monteiro, A				Chen, Bin; Hrycaj, Steven; Schinko, Johannes B.; Podlaha, Ondrej; Wimmer, Ernst A.; Popadic, Aleksandar; Monteiro, Antonia			Pogostick: A New Versatile piggyBac Vector for Inducible Gene Over-Expression and Down-Regulation in Emerging Model Systems	PLOS ONE			English	Article							GERM-LINE TRANSFORMATION; DOUBLE-STRANDED-RNA; ECTOPIC EXPRESSION; DROSOPHILA; INTERFERENCE; TRANSPOSON; BEETLE; INFORMATION; DIPTERA	Background: Non-traditional model systems need new tools that will enable them to enter the field of functional genetics. These tools should enable the exploration of gene function, via knock-downs of endogenous genes, as well as over-expression and ectopic expression of transgenes. Methodology: We constructed a new vector called Pogostick that can be used to over-express or down-regulate genes in organisms amenable to germ line transformation by the piggyBac transposable element. Pogostick can be found at www.addgene.org, a non-profit plasmid repository. The vector currently uses the heat-shock promoter Hsp70 from Drosophila to drive transgene expression and, as such, will have immediate applicability to organisms that can correctly interpret this promotor sequence. We detail how to clone candidate genes into this vector and test its functionality in Drosophila by targeting a gene coding for the fluorescent protein DsRed. By cloning a single DsRed copy into the vector, and generating transgenic lines, we show that DsRed mRNA and protein levels are elevated following heat-shock. When cloning a second copy of DsRed in reverse orientation into a flanking site, and transforming flies constitutively expressing DsRed in the eyes, we show that endogenous mRNA and protein levels drop following heat-shock. We then test the over-expression vector, containing the complete cDNA of Ultrabithorax (Ubx) gene, in an emerging model system, Bicyclus anynana. We produce a transgenic line and show that levels of Ubx mRNA expression rise significantly following a heat-shock. Finally, we show how to obtain genomic sequence adjacent to the Pogostick insertion site and to estimate transgene copy number in genomes of transformed individuals. Significance: This new vector will allow emerging model systems to enter the field of functional genetics with few hurdles.	[Chen, Bin; Podlaha, Ondrej; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Chen, Bin] Chongqing Normal Univ, Inst Entomol & Mol Biol, Chongqing, Peoples R China; [Hrycaj, Steven; Popadic, Aleksandar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Schinko, Johannes B.; Wimmer, Ernst A.] Univ Gottingen, Dept Dev Biol, Gottingen, Germany	Yale University; Chongqing Normal University; Wayne State University; University of Gottingen	Chen, B (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	c_bin@hotmail.com; antonia.monteiro@yale.edu	Wilson, Matthew H/K-3193-2013; Wimmer, Ernst A./I-3333-2019; Monteiro, Antonia/J-6452-2013	Wimmer, Ernst A./0000-0002-2480-2804; Monteiro, Antonia/0000-0001-9696-459X	NSF [IBN-0316283, IOB-0653399]; National Natural Science Foundation of China [30870340]; Chongqing Municipal Education Commission [KJ100620]; European Community's Marie Curie Research Training Network ZOONET [MRTN-CT-2004-005624]; NIH [WSU09082]	NSF(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Municipal Education Commission; European Community's Marie Curie Research Training Network ZOONET; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NSF grants IBN-0316283 and IOB-0653399 to AM, and partially supported by the National Natural Science Foundation of China (Grant No. 30870340), and the Science and Technology Project of Chongqing Municipal Education Commission (No. KJ100620) to BC, the European Community's Marie Curie Research Training Network ZOONET under contract MRTN-CT-2004-005624 to EAW, and by NIH grant WSU09082 to AP and AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dai HJ, 2007, BIOMOL ENG, V24, P625, DOI 10.1016/j.bioeng.2007.10.004; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2002, INSECT BIOCHEM MOLEC, V32, P1211, DOI 10.1016/S0965-1748(02)00084-X; Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Johnson NA, 2005, GENE, V359, P26, DOI 10.1016/j.gene.2005.05.034; JORGENSEN R, 1990, TRENDS BIOTECHNOL, V8, P340, DOI 10.1016/0167-7799(90)90220-R; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; KAWCHUK LM, 1991, MOL PLANT MICROBE IN, V4, P247, DOI 10.1094/MPMI-4-247; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Kiran NS, 2006, J EXP BOT, V57, P985, DOI 10.1093/jxb/erj084; KLEBIG ML, 1995, P NATL ACAD SCI USA, V92, P4728, DOI 10.1073/pnas.92.11.4728; Kuwayama H, 2006, INSECT MOL BIOL, V15, P507, DOI 10.1111/j.1365-2583.2006.00665.x; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo NF, 2006, GENETICA, V128, P347, DOI 10.1007/s10709-006-7165-2; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Lu YY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp686; Mahfooz N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000866; Marcus JM, 2004, P ROY SOC B-BIOL SCI, V271, pS263, DOI 10.1098/rsbl.2004.0175; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Ramos DM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-55; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Sarkar A, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-27; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Schinko JB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-53; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; Shefi O, 2006, J NEUROSCI, V26, P6119, DOI 10.1523/JNEUROSCI.1237-06.2006; Shinmyo Y, 2004, DEV GROWTH DIFFER, V46, P343, DOI 10.1111/j.1440-169x.2004.00751.x; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Stein P, 2003, DEV BIOL, V256, P187, DOI 10.1016/S0012-1606(02)00122-7; Sumitani M, 2003, INSECT BIOCHEM MOLEC, V33, P449, DOI 10.1016/S0965-1748(03)00009-2; Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Zhao YG, 1999, INSECT MOL BIOL, V8, P31, DOI 10.1046/j.1365-2583.1999.810031.x	51	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18659	10.1371/journal.pone.0018659	http://dx.doi.org/10.1371/journal.pone.0018659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533190	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600019
J	Gouyer, V; Gottrand, F; Desseyn, JL				Gouyer, Valerie; Gottrand, Frederic; Desseyn, Jean-Luc			The Extraordinarily Complex but Highly Structured Organization of Intestinal Mucus-Gel Unveiled in Multicolor Images	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; MUCOUS LAYER; MUCIN; THICKNESS; COLON	The mucus that coats the gastrointestinal tract of all mammals is a dynamic and sticky gel layer and represents the first protective barrier between the host and the hostile environment. There is, however, a lack of detailed knowledge about the mucus gel organization because of the high water content and the complexity of MUC2, the main gel-forming molecule in the intestine. Histological staining and a multilabel immunofluorescence method were used to examine mucus blankets and Muc2 in mouse colon and ileum samples fixed in Carnoy's solution, unveiling an extraordinarily complex but highly structured mucus gel organization. The inner firmly adherent mucus blanket consists of alternating layers. The thicker outer loosely adherent mucus blanket in the colon is made of alternating laminated layers and loose curl-like structures. The layers consist of Muc2 molecules with different fucosylation states and glycoforms remain unmixed in the mucus. Importantly, distinct goblet cell subpopulations throughout the ileum along the crypt-to-villus axis with an alternation of goblet cells secreting fucosylated and non-fucosylated Muc2 are observed. A better understanding of the mucus structure should contribute to improve the efficiency of DNA and drug delivery and will allow for a better understanding and treatment of inflammatory and infectious intestinal diseases.	[Gouyer, Valerie; Gottrand, Frederic; Desseyn, Jean-Luc] Univ Lille Nord France, INSERM, U995, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Gouyer, V (corresponding author), Univ Lille Nord France, INSERM, U995, Lille, France.	jean-luc.desseyn@inserm.fr	gottrand, frederic F/G-7370-2015; Desseyn, Jean-Luc/M-5070-2018; Gouyer, Valérie/R-4984-2018	gottrand, frederic F/0000-0002-5290-0436; Desseyn, Jean-Luc/0000-0001-6876-8049; Gouyer, Valérie/0000-0002-4223-7060	Broad Foundation; l'ssociation Francois Aupetit	Broad Foundation; l'ssociation Francois Aupetit	This work was partly supported by the Broad Medical Research Program of The Broad Foundation (JLD; http://www.broadmedical.org/) and l'ssociation Francois Aupetit (JLD; http://www.afa.asso.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Gouyer V, 2010, HISTOCHEM CELL BIOL, V133, P517, DOI 10.1007/s00418-010-0688-8; Ho SB, 2004, DIGEST DIS SCI, V49, P1598, DOI 10.1023/B:DDAS.0000043371.12671.98; Hurd EA, 2005, GLYCOBIOLOGY, V15, P1002, DOI 10.1093/glycob/cwi089; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; MCMAHON RFT, 1994, HISTOCHEM J, V26, P504, DOI 10.1007/BF00157896; OLIVER MG, 1991, ANAT REC, V230, P513, DOI 10.1002/ar.1092300410; OTA H, 1992, HISTOCHEM J, V24, P86, DOI 10.1007/BF01082444; PODOLSKY DK, 1986, J CLIN INVEST, V77, P1263, DOI 10.1172/JCI112429; Strugala V, 2003, P NUTR SOC, V62, P237, DOI 10.1079/PNS2002205; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094	17	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18761	10.1371/journal.pone.0018761	http://dx.doi.org/10.1371/journal.pone.0018761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533274	Green Published, Green Submitted, gold			2022-12-25	WOS:000289404700032
J	Sestak, K; Conroy, L; Aye, PP; Mehra, S; Doxiadis, GG; Kaushal, D				Sestak, Karol; Conroy, Lauren; Aye, Pyone P.; Mehra, Smriti; Doxiadis, Gaby G.; Kaushal, Deepak			Improved Xenobiotic Metabolism and Reduced Susceptibility to Cancer in Gluten-Sensitive Macaques upon Introduction of a Gluten-Free Diet	PLOS ONE			English	Article							CELIAC-DISEASE; TISSUE TRANSGLUTAMINASE; RHESUS MACAQUES; SPRUE; NOMENCLATURE; ANTIBODIES; SPECTRUM; HUMANS	Background: A non-human primate (NHP) model of gluten sensitivity was employed to study the gene perturbations associated with dietary gluten changes in small intestinal tissues from gluten-sensitive rhesus macaques (Macacamulatta). Methodology: Stages of remission and relapse were accomplished in gluten-sensitive animals by administration of glutenfree (GFD) and gluten-containing (GD) diets, as described previously. Pin-head-sized biopsies, obtained non-invasively by pediatric endoscope from duodenum while on GFD or GD, were used for preparation of total RNA and gene profiling, using the commercialRhesus Macaque Microarray (Agilent Technologies), targetingexpression of over 20,000 genes. Principal Findings: When compared with normal healthy control, gluten-sensitive macaques showed differential gene expressions induced by GD. While observed gene perturbations were classified into one of 12 overlapping categories cancer, metabolism, digestive tract function, immune response, cell growth, signal transduction, autoimmunity, detoxification of xenobiotics, apoptosis, actin-collagen deposition, neuronal and unknown function - this study focused on cancer-related gene networks such as cytochrome P450 family (detoxification function) and actin-collagen-matrix metalloproteinases (MMP) genes. Conclusions/Significance: A loss of detoxification function paralleled with necessity to metabolize carcinogens was revealed in gluten sensitive animals while on GD. An increase in cancer-promoting factors and a simultaneous decrease in cancer-preventing factors associated with altered expression of actin-collagen-MMP gene network were noted. In addition, gluten-sensitive macaques showed reduced number of differentially expressed genes including the cancer-associated ones upon withdrawal of dietary gluten. Taken together, these findings indicate potentially expanded utility of gluten-sensitive rhesus macaques in cancer research.	[Sestak, Karol; Conroy, Lauren] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA 70433 USA; [Sestak, Karol; Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Aye, Pyone P.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Mehra, Smriti] Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, DNA Microarray & Express Core, Covington, LA USA; [Doxiadis, Gaby G.] Biomed Primate Res Ctr, Rijswijk, Netherlands	Tulane University; Tulane University; Tulane University; Tulane University	Sestak, K (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA 70433 USA.	ksestak@tulane.edu			National Institutes of Health [R01DK076653, 3R01DK076653]; TNPRC [RR000164]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TNPRC; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants R01DK076653 and 3R01DK076653 to KS and the base operating grant of the TNPRC RR000164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcia G, 2008, J AUTISM DEV DISORD, V38, P407, DOI 10.1007/s10803-007-0480-3; Bethune MT, 2009, CHEM BIOL, V16, P868, DOI 10.1016/j.chembiol.2009.07.009; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001614; Bethune MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001857; Bontrop RE, 2006, HUM IMMUNOL, V67, P388, DOI 10.1016/j.humimm.2006.03.007; Brandtzaeg P, 2006, IMMUNOL LETT, V105, P127, DOI 10.1016/j.imlet.2006.03.004; Cerqueira RM, 2010, EUR J GASTROEN HEPAT, V22, P868, DOI 10.1097/MEG.0b013e3283328341; Doxiadis GGM, 2007, P NATL ACAD SCI USA, V104, P8907, DOI 10.1073/pnas.0702964104; Doxiadis GGM, 2003, IMMUNOGENETICS, V55, P540, DOI 10.1007/s00251-003-0590-9; Doxiadis GGM, 2001, IMMUNOL REV, V183, P76, DOI 10.1034/j.1600-065x.2001.1830106.x; Ellis SA, 2006, IMMUNOGENETICS, V57, P953, DOI 10.1007/s00251-005-0071-4; FERRERI AJ, 2010, CRIT REV ON IN PRESS; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Jabri B, 2005, IMMUNOL REV, V206, P219, DOI 10.1111/j.0105-2896.2005.00294.x; Johnson TN, 2001, BRIT J CLIN PHARMACO, V51, P451, DOI 10.1046/j.1365-2125.2001.01370.x; Korponay-Szabo IR, 2000, J PEDIATR GASTR NUTR, V31, P520, DOI 10.1097/00005176-200011000-00013; Lang CC, 1996, CLIN PHARMACOL THER, V59, P41, DOI 10.1016/S0009-9236(96)90022-3; Lombardo Mauro, 2008, Cases J, V1, P159, DOI 10.1186/1757-1626-1-159; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Mazumdar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010228; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; MULDER CJJ, 1993, GUT, V34, P1740, DOI 10.1136/gut.34.12.1740; Myers TA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000659; Rubio-Tapia A, 2010, CURR OPIN GASTROEN, V26, P116, DOI 10.1097/MOG.0b013e3283365263; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Shamaly H, 2007, J PEDIATR GASTR NUTR, V44, P583, DOI 10.1097/MPG.0b013e3180320679; Simell S, 2010, DIABETES CARE, V33, P774, DOI 10.2337/dc09-1217; Sollid LM, 2006, NAT MED, V12, P611, DOI 10.1038/nm0606-611; Tjon JML, 2010, IMMUNOGENETICS, V62, P641, DOI 10.1007/s00251-010-0465-9	32	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18648	10.1371/journal.pone.0018648	http://dx.doi.org/10.1371/journal.pone.0018648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533263	gold, Green Published, Green Submitted			2022-12-25	WOS:000289404700025
J	Holleman, A; Chung, I; Olsen, RR; Kwak, B; Mizokami, A; Saijo, N; Parissenti, A; Duan, Z; Voest, EE; Zetter, BR				Holleman, A.; Chung, I.; Olsen, R. R.; Kwak, B.; Mizokami, A.; Saijo, N.; Parissenti, A.; Duan, Z.; Voest, E. E.; Zetter, B. R.			miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo	ONCOGENE			English	Article						paclitaxel resistance; miRNA-135a; APC; carcinoma	MICRORNA EXPRESSION PROFILES; BREAST-CANCER CELLS; ALKYLATING-AGENTS; DRUG-RESISTANCE; SENSITIVITY; PROSTATE; APC; MECHANISMS; PROTEIN; GENE	Cancer cell resistance to paclitaxel continues to be a major clinical problem. In this study, we utilized microRNA (miRNA) arrays to screen for differentially expressed miRNAs in paclitaxel-resistant cell lines established in vitro. We observed concordant upregulation of miR-135a in paclitaxel-resistant cell lines representing three human malignancies. Subsequently, the role of miRNA-135a was evaluated in an in vivo model of paclitaxel resistance. In this model, mice were inoculated subcutaneously with a non-small cell lung carcinoma cell line and treated with paclitaxel for a prolonged period. In paclitaxel-resistant cell lines, established either in vitro or in vivo, blockage of miR-135a sensitized resistant cell lines to paclitaxel-induced cell death. We further demonstrated a correlation between paclitaxel response and miR-135a expression in paclitaxel-resistant subclones that were established in vivo. The paclitaxel-resistant phenotype of these subclones was maintained upon retransplantation in new mice, as shown by decreased tumor response upon paclitaxel treatment compared with controls. Upregulation of miR-135a was associated with reduced expression of the adenomatous polyposis coli gene (APC). APC knockdown increased paclitaxel resistance in parental cell lines. Our results indicate that paclitaxel resistance is associated with upregulation of miR-135a, both in vitro and in vivo, and is in part determined by miR-135a-mediated downregulation of APC. Oncogene (2011) 30, 4386-4398; doi:10.1038/onc.2011.148; published online 9 May 2011	[Holleman, A.; Chung, I.; Olsen, R. R.; Kwak, B.; Zetter, B. R.] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA 02115 USA; [Holleman, A.] Meander Med Ctr, Dept Internal Med, Amersfoort, Netherlands; [Mizokami, A.] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Canc Therapy & Urol, Kanazawa, Ishikawa, Japan; [Saijo, N.] Natl Canc Ctr, Res Inst, Div Med Oncol, Tokyo 104, Japan; [Parissenti, A.] Hop Reg Sudbury Reg Hosp, Reg Canc Program, Sudbury, ON, Canada; [Duan, Z.] Massachusetts Gen Hosp, Sarcoma Biol Lab, Ctr Sarcoma & Connect Tissue Oncol, Boston, MA 02114 USA; [Voest, E. E.] Utrecht Med Ctr, Dept Med Oncol, Utrecht, Netherlands	Harvard University; Boston Children's Hospital; Harvard Medical School; Meander Medisch Centrum; Kanazawa University; National Cancer Center - Japan; Health Sciences North; Harvard University; Massachusetts General Hospital; Utrecht University; Utrecht University Medical Center	Zetter, BR (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, 300 Longwood Ave,Karp Bldg,Room 11-125, Boston, MA 02115 USA.	bruce.zetter@childrens.harvard.edu	Chung, Ivy/C-3804-2012	de Haar-Holleman, Amy/0000-0003-4929-2860	National Institutes of Health; Kendle; KWF Cancer Foundation; Stichting Fonds Catherine van Tussenbroek; US Department of Defense; NATIONAL CANCER INSTITUTE [R01CA037393, R37CA037393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kendle; KWF Cancer Foundation; Stichting Fonds Catherine van Tussenbroek; US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We sincerely thank Dr John Heymach of MD Anderson Cancer Institute, Houston, TX and Jeremy Force, Children's Hospital Boston, for kindly providing us with the A549TR cells. This work was supported in part by grant CA37393 from the National Institutes of Health (BRZ), Kendle (AH), KWF Cancer Foundation (AH), the Stichting Fonds Catherine van Tussenbroek (AH), and a US Department of Defense PCRP fellowship (IC).	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Chu Q, 2005, LUNG CANCER, V50, P355, DOI 10.1016/j.lungcan.2005.06.010; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dombernowsky P, 1996, SEMIN ONCOL, V23, P23; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fong GH, 2008, ANGIOGENESIS, V11, P121, DOI 10.1007/s10456-008-9107-3; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; GELFAND VI, 1991, ANNU REV CELL BIOL, V7, P93, DOI 10.1146/annurev.cb.07.110191.000521; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; GREENBERGER LM, 1988, P NATL ACAD SCI USA, V85, P3762, DOI 10.1073/pnas.85.11.3762; Haldar S, 1996, CANCER RES, V56, P1253; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HOFFMAN RM, 1991, CANCER CELL-MON REV, V3, P86; Huang GC, 2010, J CANCER RES CLIN, V136, P1201, DOI 10.1007/s00432-010-0770-6; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mackler NJ, 2005, NAT CLIN PRACT UROL, V2, P92, DOI 10.1038/ncpuro0099; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Oguri T, 2008, MOL CANCER THER, V7, P1150, DOI 10.1158/1535-7163.MCT-07-2088; Okugawa K, 2004, J CANCER RES CLIN, V130, P178, DOI 10.1007/s00432-003-0516-9; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Perkins C, 1998, CANCER RES, V58, P4561; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; STARLING JJ, 1990, CANCER RES, V50, P7634; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Takeda M, 2007, PROSTATE, V67, P955, DOI 10.1002/pros.20581; TEICHER BA, 1990, SCIENCE, V247, P1457, DOI 10.1126/science.2108497; Villeneuve DJ, 2006, BREAST CANCER RES TR, V96, P17, DOI 10.1007/s10549-005-9026-6; Wakelee H, 2005, EXPERT REV ANTICANC, V5, P13, DOI 10.1586/14737140.5.1.13; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zhang T, 2001, CANCER RES, V61, P8664; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	54	86	96	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2011	30	43					4386	4398		10.1038/onc.2011.148	http://dx.doi.org/10.1038/onc.2011.148			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HQ	21552288	Green Accepted			2022-12-25	WOS:000296356500002
J	Astle, MV; Ooms, LM; Cole, AR; Binge, LC; Dyson, JM; Layton, MJ; Petratos, S; Sutherland, C; Mitchell, CA				Astle, Megan V.; Ooms, Lisa M.; Cole, Adam R.; Binge, Lauren C.; Dyson, Jennifer M.; Layton, Meredith J.; Petratos, Steven; Sutherland, Calum; Mitchell, Christina A.			Identification of a Proline-rich Inositol Polyphosphate 5-Phosphatase (PIPP)center dot Collapsin Response Mediator Protein 2 (CRMP2) Complex That Regulates Neurite Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NEURONAL POLARITY; ALZHEIMERS-DISEASE; GSK-3 PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; MEMBRANE RUFFLES; AXON FORMATION; FEEDBACK LOOP; GROWTH CONES; RHO-KINASE	Neuron polarization is essential for the formation of one axon and multiple dendrites, establishing the neuronal circuitry. Phosphoinositide 3-kinase (PI3K) signaling promotes axon selection and elongation. Here we report in hippocampal neurons siRNA knockdown of the proline-rich inositol polyphosphate 5-phosphatase (PIPP), which degrades PI3K-generated PtdIns(3,4,5)P-3, results in multiple hyperelongated axons consistent with a polarization defect. We identify collapsin response mediator protein 2 (CRMP2), which regulates axon selection by promoting WAVE1 delivery via Kinesin-1 motors to the axon growth cone, as a PIPP-interacting protein by Y2H screening, direct binding studies, and coimmunoprecipitation of an endogenous PIPP, CRMP2, and Kinesin-1 complex from brain lysates. The C-terminal growth cone-targeting domain of PIPP facilitates its interaction with CRMP2. PIPP growth cone localization is CRMP2-dependent. PIPP knockdown in PC12 cells promotes neurite elongation, WAVE1 and Kinesin-1 growth cone localization, whereas knockdown of CRMP2 exhibits the opposite phenotype, with shorter neurites and decreased WAVE1/Kinesin-1 at the growth cone. In contrast, CRMP2 overexpression promotes neurite elongation, a phenotype rescued by full-length PIPP, or expression of the CRMP2-binding PIPP domain. Therefore this study identifies PIPP and CRMP2 exert opposing roles in promoting axon selection and neurite elongation and the complex between these proteins serves to regulate the localization of effectors that promote neurite extension.	[Astle, Megan V.; Ooms, Lisa M.; Binge, Lauren C.; Dyson, Jennifer M.; Layton, Meredith J.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Cole, Adam R.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Petratos, Steven] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia; [Petratos, Steven] RMIT Univ, Sch Med Sci, Bundoora, Vic 3083, Australia; [Sutherland, Calum] Univ Dundee, Ninewells Hosp, Biomed Res Inst, Dundee DD1 9SY, Scotland	Monash University; Garvan Institute of Medical Research; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); University of Dundee	Mitchell, CA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia.	christina.mitchell@monash.edu	Ooms, Lisa/AGZ-7420-2022	Sutherland, Calum/0000-0003-4398-7434; Ooms, Lisa Michelle/0000-0002-8918-9932; Mitchell, Christina A/0000-0001-9372-3192	National Health and Medical Research Council, Australia [436638]; Australian Research Council, Australia [DP110103655]; Alzheimers Research UK [ART-PG2005-1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [C18727] Funding Source: researchfish	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council, Australia(Australian Research Council); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Health and Medical Research Council, Australia, Grant 436638 and Australian Research Council, Australia, Grant DP110103655.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Arimura N, 2009, J NEUROCHEM, V111, P380, DOI 10.1111/j.1471-4159.2009.06317.x; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Astle MV, 2007, BIOCHEM SOC SYMP, V74, P161, DOI 10.1042/BSS2007c15; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; CLEVELAND DW, 1983, CELL, V34, P330, DOI 10.1016/0092-8674(83)90366-5; Cole AR, 2007, J NEUROCHEM, V103, P1132, DOI 10.1111/j.1471-4159.2007.04829.x; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GORDONWEEKS PR, 1991, BIOESSAYS, V13, P235, DOI 10.1002/bies.950130506; Goslin K., 1991, RAT HIPPOCAMPAL NEUR; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; He Y, 2002, J NEUROSCI, V22, P5982; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hensley K, 2010, J NEUROSCI, V30, P2979, DOI 10.1523/JNEUROSCI.5247-09.2010; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Liu HK, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-14; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mitsui N, 2002, EMBO J, V21, P3274, DOI 10.1093/emboj/cdf328; Mochizuki Y, 1999, J BIOL CHEM, V274, P36790, DOI 10.1074/jbc.274.51.36790; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Ooms LM, 2006, MOL BIOL CELL, V17, P607, DOI 10.1091/mbc.E05-05-0469; Pawlik M, 2007, BIOCHEM BIOPH RES CO, V355, P907, DOI 10.1016/j.bbrc.2007.02.047; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Rembutsu M, 2008, BIOCHEMISTRY-US, V47, P2153, DOI 10.1021/bi702030w; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Schwamborn JC, 2007, J BIOL CHEM, V282, P35259, DOI 10.1074/jbc.M703438200; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Soutar MPM, 2009, CURR ALZHEIMER RES, V6, P269, DOI 10.2174/156720509788486572; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Wang LH, 1996, J NEUROSCI, V16, P6197; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yoshida H, 1998, J BIOL CHEM, V273, P9761, DOI 10.1074/jbc.273.16.9761; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	61	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23407	23418		10.1074/jbc.M110.214247	http://dx.doi.org/10.1074/jbc.M110.214247			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550974	Green Published, hybrid			2022-12-25	WOS:000292025000072
J	Xiao, YP; Morice, AH; Compton, SJ; Sadofsky, L				Xiao, Yu Pei; Morice, Alyn H.; Compton, Steven J.; Sadofsky, Laura			N-Linked Glycosylation Regulates Human Proteinase-activated Receptor-1 Cell Surface Expression and Disarming via Neutrophil Proteinases and Thermolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET THROMBIN RECEPTOR; TETHERED LIGAND; CATHEPSIN-G; EPITHELIAL-CELLS; ENDOTHELIAL-CELLS; COUPLED RECEPTORS; PROTEASES; CLEAVAGE; TRYPTASE; DESENSITIZATION	Proteinase-activated receptor 1 (PAR(1)) induces activation of platelet and vascular cells after proteolytic cleavage of its extracellular N terminus by thrombin. In pathological situations, other proteinases may be generated in the circulation and might modify the responses of PAR(1) by cleaving extracellular domains. In this study, epitope-tagged wild-type human PAR(1) (hPAR(1)) and a panel of N-linked glycosylation-deficient mutant receptors were permanently expressed in epithelial cells (Kirsten murine sarcoma virus-transformed rat kidney cells and CHO cells). We have analyzed the role of N-linked glycosylation in regulating proteinase activation/disarming and cell global expression of hPAR(1). We reported for the first time that glycosylation in the N terminus of hPAR(1) downstream of the tethered ligand (especially Asn(75)) governs receptor disarming to trypsin, thermolysin, and the neutrophil proteinases elastase and proteinase 3 but not cathepsin G. In addition, hPAR1 is heavily N-linked glycosylated and sialylated in epithelial cell lines, and glycosylation occurs at all five consensus sites, namely, Asn(35), Asn(62), Asn(75), Asn(250), and Asn(259). Removing these N-linked glycosylation sequons affected hPAR(1) cell surface expression to varying degrees, and N-linked glycosylation at extracellular loop 2 (especially Asn(250)) of hPAR(1) is essential for optimal receptor cell surface expression and receptor stability.	[Xiao, Yu Pei; Morice, Alyn H.; Compton, Steven J.; Sadofsky, Laura] Univ Hull, Hull York Med Sch, Div Cardiovasc & Resp Studies, Kingston Upon Hull HU16 5JQ, E Yorkshire, England	University of Hull; University of York - UK	Sadofsky, L (corresponding author), Univ Hull, Hull York Med Sch, Div Cardiovasc & Resp Studies, Kingston Upon Hull HU16 5JQ, E Yorkshire, England.	L.R.Sadofsky@Hull.ac.uk	Sadofsky, Laura/AAK-2029-2020					BRASS LF, 1994, J BIOL CHEM, V269, P2943; BRASS LF, 1992, J BIOL CHEM, V267, P13795; Chen XL, 1996, BIOCHEM J, V314, P603, DOI 10.1042/bj3140603; Compton SJ, 2003, DRUG DEVELOP RES, V59, P350, DOI 10.1002/ddr.10303; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Hamilton JR, 1999, BRIT J PHARMACOL, V127, P617, DOI 10.1038/sj.bjp.0702583; Hansen KK, 2004, IMMUNOLOGY, V112, P183, DOI 10.1111/j.1365-2567.2004.01870.x; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Kuliopulos A, 1999, BIOCHEMISTRY-US, V38, P4572, DOI 10.1021/bi9824792; Loew D, 2000, BIOCHEMISTRY-US, V39, P10812, DOI 10.1021/bi0003341; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; MOLINO M, 1995, J BIOL CHEM, V270, P11168, DOI 10.1074/jbc.270.19.11168; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Nakayama T, 2003, BRIT J PHARMACOL, V138, P121, DOI 10.1038/sj.bjp.0705008; NORTON KJ, 1993, BLOOD, V82, P2125; OPDENAKKER G, 1993, FASEB J, V7, P1330, DOI 10.1096/fasebj.7.14.8224606; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; RAO NV, 1991, J BIOL CHEM, V266, P9540; Renesto P, 1997, BLOOD, V89, P1944, DOI 10.1182/blood.V89.6.1944; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Schechter NM, 1998, J CELL PHYSIOL, V176, P365, DOI 10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2; Shpacovitch V, 2007, TRENDS IMMUNOL, V28, P541, DOI 10.1016/j.it.2007.09.001; Sokolova E, 2007, PHARMACOL THERAPEUT, V115, P70, DOI 10.1016/j.pharmthera.2007.04.002; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; SUIDAN HS, 1994, P NATL ACAD SCI USA, V91, P8112, DOI 10.1073/pnas.91.17.8112; Suzuki T, 2005, AM J RESP CELL MOL, V33, P231, DOI 10.1165/rcmb.2005-0109OC; TORDAI A, 1995, BIOCHEM BIOPH RES CO, V206, P857, DOI 10.1006/bbrc.1995.1122; Ubl JJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1339, DOI 10.1152/ajplung.00392.2001; Ubl JJ, 2000, J PHYSIOL-LONDON, V525, P319, DOI 10.1111/j.1469-7793.2000.00319.x; Uehara A, 2002, J IMMUNOL, V169, P4594, DOI 10.4049/jimmunol.169.8.4594; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356	36	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22991	23002		10.1074/jbc.M110.204271	http://dx.doi.org/10.1074/jbc.M110.204271			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550978	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000292025000034
J	Cheng, SB; Quinn, JA; Graeber, CT; Filardo, EJ				Cheng, Shi-Bin; Quinn, Jeffrey A.; Graeber, Carl T.; Filardo, Edward J.			Down-modulation of the G-protein-coupled Estrogen Receptor, GPER, from the Cell Surface Occurs via a trans-Golgi-Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CONSTITUTIVE ENDOCYTOSIS; BREAST-CANCER; BETA-ARRESTIN; G-PROTEIN-COUPLED-RECEPTOR-30 GPR30; INDUCED INTERNALIZATION; ENDOPLASMIC-RETICULUM; CARBOXYL-TERMINUS; TRAFFICKING; CLATHRIN	GPER is a G(s)-coupled seven-transmembrane receptor that has been linked to specific estrogen binding and signaling activities that are manifested by plasma membrane-associated enzymes. However, in many cell types, GPER is predominately localized to the endoplasmic reticulum (ER), and only minor amounts of receptor are detectable at the cell surface, an observation that has caused controversy regarding its role as a plasma membrane estrogen receptor. Here, we show that GPER constitutively buds intracellularly into EEA-1+ endosomes from clathrin-coated pits. Nonvisual arrestins-2/-3 do not co-localize with GPER, and expression of arrestin-2 dominant-negative mutants lacking clathrin-or beta-adaptin interaction sites fails to block GPER internalization suggesting that arrestins are not involved in GPER endocytosis. Like beta 1AR, which recycles to the plasma membrane, GPER co-traffics with transferrin+, Rab11+ recycling endosomes. However, endocytosed GPER does not recycle to the cell surface, but instead returns to the trans-Golgi network (TGN) and does not re-enter the ER. GPER is ubiquitinated at the cell surface, exhibits a short half-life (t(1/2) < 1 h), and is protected from degradation by the proteasome inhibitor, MG132. Disruption of the TGN by brefeldin A induces the accumulation of endocytosed GPER in Rab11+ perinuclear endosomes and prevents GPER degradation. Our results provide an explanation as to why GPER is not readily detected on the cell surface in some cell types and further suggest that TGN serves as the checkpoint for degradation of endocytosed GPER.	[Filardo, Edward J.] Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, Providence, RI 02903 USA; Brown Univ, Providence, RI 02903 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Filardo, EJ (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, 593 Eddy St,Aldrich Bldg,Rm 708, Providence, RI 02903 USA.	edward_filardo@brown.edu		Filardo, Edward/0000-0002-3930-324X	National Institutes of Health [R01 CA119165-01A2]; NATIONAL CANCER INSTITUTE [R01CA119165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA119165-01A2 (to E. J. F.).	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; BENOVIC JL, 2000, REGULATION G PROTEIN, P4; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; CHENG SB, 2011, STEROIDS IN PRESS; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Cross BCS, 2009, J CELL SCI, V122, P1768, DOI 10.1242/jcs.046094; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2003, IDENTITIES OF MEMBRANE STEROID RECEPTORS -- AND OTHER PROTEINS MEDIATING NONGENOMIC STEROID ACTION, P139; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Forster R, 1998, J IMMUNOL, V160, P1522; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Hong YH, 2009, J NEUROCHEM, V111, P61, DOI 10.1111/j.1471-4159.2009.06289.x; Innamorati G, 1999, J RECEPT SIGNAL TR R, V19, P315, DOI 10.3109/10799899909036654; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Lamb ME, 2001, BIOCHEM J, V355, P741, DOI 10.1042/bj3550741; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Levin ER, 2009, ENDOCRINOLOGY, V150, P1563, DOI 10.1210/en.2008-1759; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Lok CN, 1998, BIOL SIGNAL RECEPT, V7, P157; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Quinn JA, 2009, MOL ENDOCRINOL, V23, P1052, DOI 10.1210/me.2008-0262; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Romisch K, 1999, J CELL SCI, V112, P4185; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Smith HO, 2009, GYNECOL ONCOL, V114, P465, DOI 10.1016/j.ygyno.2009.05.015; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Tarasova NI, 1997, J BIOL CHEM, V272, P14817, DOI 10.1074/jbc.272.23.14817; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Trischler M, 1999, J CELL SCI, V112, P4773; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Xu H, 2009, NEUROSCIENCE, V158, P1599, DOI 10.1016/j.neuroscience.2008.11.028; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015	64	85	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22441	22455		10.1074/jbc.M111.224071	http://dx.doi.org/10.1074/jbc.M111.224071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540189	hybrid, Green Published			2022-12-25	WOS:000291719900053
J	ZeRuth, GT; Yang, XP; Jetten, AM				ZeRuth, Gary T.; Yang, Xiao-Ping; Jetten, Anton M.			Modulation of the Transactivation Function and Stability of Kruppel-like Zinc Finger Protein Gli-similar 3 (Glis3) by Suppressor of Fused	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL DIABETES-MELLITUS; BETA-CELL FUNCTION; NEGATIVE REGULATOR; TRANSCRIPTION FACTOR; PRIMARY CILIA; SUFU; LOCI; ASSOCIATION; MUTATIONS; ROLES	Glis3 is a member of the Glis subfamily of Kruppel-like zinc finger transcription factors. Recently, Glis3 has been linked to both type I and type II diabetes and shown to positively regulate insulin gene expression. In this study, we have identified a region within the N terminus of Glis3 that shares high levels of homology with the Cubitus interruptus (Ci)/Gli family of proteins. We demonstrated that Glis3 interacts with Suppressor of Fused (SUFU), which involves a VYGHF motif located within this conserved region. We further showed that SUFU is able to inhibit the activation of the insulin promoter by Glis3 but not the activation by a Glis3 mutant deficient in its ability to bind SUFU, suggesting that the inhibitory effect is dependent on the interaction between the two proteins. Exogenous SUFU did not affect the nuclear localization of Glis3; however, Glis3 promoted the nuclear accumulation of SUFU. Additionally, we demonstrated that SUFU stabilizes Glis3 in part by antagonizing the Glis3 association with a Cullin 3-based E3 ubiquitin ligase that promotes the ubiquitination and degradation of Glis3. This is the first reported instance of Glis3 interacting with SUFU and suggests a novel role for SUFU in the modulation of Glis3 signaling. Given the critical role of Glis3 in pancreatic beta-cell generation and maintenance, the elevated Glis3 expression in several cancers, and the established role of SUFU as a tumor suppressor, these data provide further insight into Glis3 regulation and its function in development and disease.	[ZeRuth, Gary T.; Yang, Xiao-Ping; Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445	National Institutes of Health, NIEHS [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100485] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant Z01-ES-100485 from the Intramural Research Program of the NIEHS.	Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Beak JY, 2007, J BONE MINER RES, V22, P1234, DOI 10.1359/JBMR.070503; Boesgaard TW, 2010, DIABETOLOGIA, V53, P1647, DOI 10.1007/s00125-010-1753-5; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Claiborn KC, 2010, J CLIN INVEST, V120, P3713, DOI 10.1172/JCI40440; Croker JA, 2006, DEV BIOL, V291, P368, DOI 10.1016/j.ydbio.2005.12.020; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015542; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Keppler BR, 2011, BBA-GENE REGUL MECH, V1809, P109, DOI 10.1016/j.bbagrm.2010.08.005; Kim YS, 2008, MOL CELL BIOL, V28, P2358, DOI 10.1128/MCB.01722-07; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Leung A, 2009, ERNST SCHERING FOUND, V1, P75, DOI 10.1007/2789_2008_102; von Zangen IL, 2007, ACTA NEUROPATHOL, V113, P325, DOI 10.1007/s00401-006-0190-5; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; Nakanishi G, 2006, J INVEST DERMATOL, V126, P49, DOI 10.1038/sj.jid.5700018; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Stone DM, 1999, J CELL SCI, V112, P4437; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Vasanth S, 2011, J BIOL CHEM, V286, P4749, DOI 10.1074/jbc.M110.165951; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Yusenko MV, 2009, HISTOPATHOLOGY, V55, P687, DOI 10.1111/j.1365-2559.2009.03449.x; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106	50	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22077	22089		10.1074/jbc.M111.224964	http://dx.doi.org/10.1074/jbc.M111.224964			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543335	Green Published, hybrid			2022-12-25	WOS:000291719900014
J	Li, HZ; Wang, Q; Steyger, PS				Li, Hongzhe; Wang, Qi; Steyger, Peter S.			Acoustic Trauma Increases Cochlear and Hair Cell Uptake of Gentamicin	PLOS ONE			English	Article							FLUORESCENT GENTAMICIN; NOISE EXPOSURE; HEARING; SOUND; FREQUENCY; RESPONSES; BARRIER	Background: Exposure to intense sound or high doses of aminoglycoside antibiotics can increase hearing thresholds, induce cochlear dysfunction, disrupt hair cell morphology and promote hair cell death, leading to permanent hearing loss. When the two insults are combined, synergistic ototoxicity occurs, exacerbating cochlear vulnerability to sound exposure. The underlying mechanism of this synergism remains unknown. In this study, we tested the hypothesis that sound exposure enhances the intra-cochlear trafficking of aminoglycosides, such as gentamicin, leading to increased hair cell uptake of aminoglycosides and subsequent ototoxicity. Methods: Juvenile C57Bl/6 mice were exposed to moderate or intense sound levels, while fluorescently-conjugated or native gentamicin was administered concurrently or following sound exposure. Drug uptake was then examined in cochlear tissues by confocal microscopy. Results: Prolonged sound exposure that induced temporary threshold shifts increased gentamicin uptake by cochlear hair cells, and increased gentamicin permeation across the strial blood-labyrinth barrier. Enhanced intra-cochlear trafficking and hair cell uptake of gentamicin also occurred when prolonged sound, and subsequent aminoglycoside exposure were temporally separated, confirming previous observations. Acute, concurrent sound exposure did not increase cochlear uptake of aminoglycosides. Conclusions: Prolonged, moderate sound exposures enhanced intra-cochlear aminoglycoside trafficking into the stria vascularis and hair cells. Changes in strial and/or hair cell physiology and integrity due to acoustic overstimulation could increase hair cell uptake of gentamicin, and may represent one mechanism of synergistic ototoxicity.	[Li, Hongzhe; Wang, Qi; Steyger, Peter S.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University	Li, HZ (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	liho@ohsu.edu; steygerp@ohsu.edu	Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237	National Institutes of Health [DC04555, R03DC011622]; National Institute of Deafness and other Communication Disorders [DC05983 (P30)]; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R56DC004555, R03DC011622, R01DC004555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants DC04555 (PSS), R03DC011622 (HL) and DC05983 (P30) from the National Institute of Deafness and other Communication Disorders, and by the Deafness Research Foundation (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, EM WAR SURG; AXELSSON A, 1987, HEARING RES, V31, P183, DOI 10.1016/0378-5955(87)90125-0; BROWN JJ, 1978, ACTA OTO-LARYNGOL, V86, P394, DOI 10.3109/00016487809107518; CODY AR, 1987, J PHYSIOL-LONDON, V383, P551; COLLINS PWP, 1988, HEARING RES, V36, P249, DOI 10.1016/0378-5955(88)90066-4; Crabtree Thomas G, 2006, J Am Acad Orthop Surg, V14, pS75; Dai CF, 2006, HEARING RES, V213, P64, DOI 10.1016/j.heares.2005.11.011; Dai CF, 2008, HEARING RES, V235, P114, DOI 10.1016/j.heares.2007.10.010; DARROUZET J, 1963, Rev Bras Cir, V46, P120; Forge A, 2000, AUDIOL NEURO-OTOL, V5, P3, DOI 10.1159/000013861; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; GANNON RP, 1979, J LARYNGOL OTOL, V93, P341, DOI 10.1017/S0022215100087119; Gannon RP, 1969, EXCERPTA MED, V189, P98; Goff BJ, 2009, CARE COMBAT AMPUTEE, P191; Goldwyn BG, 1997, LARYNGOSCOPE, V107, P1112, DOI 10.1097/00005537-199708000-00019; HAYASHIDA T, 1989, ACTA OTO-LARYNGOL, V108, P404, DOI 10.3109/00016488909125546; Henderson Donald, 2008, V31, P195; HIEL H, 1993, AUDIOLOGY, V32, P78; Husbands JM, 1999, HEARING RES, V135, P135, DOI 10.1016/S0378-5955(99)00101-X; Karasawa T, 2008, J CELL SCI, V121, P2871, DOI 10.1242/jcs.023705; Koo JW, 2011, AUDIOL NEURO-OTOL, V16, P347, DOI 10.1159/000322851; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Li HZ, 2009, NOISE HEALTH, V11, P26, DOI 10.4103/1463-1741.45310; LIM DJ, 1986, AM J OTOLARYNG, V7, P73, DOI 10.1016/S0196-0709(86)80037-0; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Mitchell C, 1996, HEARING RES, V99, P38, DOI 10.1016/S0378-5955(96)00081-0; Mitkovic M, 2000, FACTA U MED BIOL, V7, P96; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Myrdal SE, 2005, HEARING RES, V204, P156, DOI 10.1016/j.heares.2005.02.002; NAKAI Y, 1988, ACTA OTO-LARYNGOL, P23; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; Ohlemiller KK, 2007, HEARING RES, V224, P34, DOI 10.1016/j.heares.2006.11.005; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Pillers DAM, 2005, VOLTA REV, V105, P205; QUIRK WS, 1992, HEARING RES, V63, P102, DOI 10.1016/0378-5955(92)90079-3; QUIRK WS, 1995, AM J OTOL, V16, P322; Rees KC, 2007, COMBINED EFFECT NOIS; Rybak Leonard P., 2008, V31, P219; Shi XR, 2002, HEARING RES, V172, P73, DOI 10.1016/S0378-5955(02)00513-0; Starnes BW, 2006, J TRAUMA, V60, P432, DOI 10.1097/01.ta.0000197628.55757.de; Suzuki M, 2002, HEARING RES, V164, P12, DOI 10.1016/S0378-5955(01)00397-5; THORNE PR, 1987, HEARING RES, V31, P229, DOI 10.1016/0378-5955(87)90192-4; Vernon J, 1978, OTOLARYNGOLOGY, V86, pORL; Wang Q, 2010, HEARING RES, V268, P250, DOI 10.1016/j.heares.2010.06.008; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4; YAMANE H, 1988, ACTA OTO-LARYNGOL, P28; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	47	30	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19130	10.1371/journal.pone.0019130	http://dx.doi.org/10.1371/journal.pone.0019130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552569	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700029
J	Jiang, Y; Kelly, R; Peters, A; Fulka, H; Dickinson, A; Mitchell, DA; St John, JC				Jiang, Yan; Kelly, Richard; Peters, Amy; Fulka, Helena; Dickinson, Adam; Mitchell, Daniel A.; St John, Justin C.			Interspecies Somatic Cell Nuclear Transfer Is Dependent on Compatible Mitochondrial DNA and Reprogramming Factors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; XENOMITOCHONDRIAL CYBRIDS; CLONED EMBRYOS; CUMULUS CELLS; SUS-SCROFA; OOCYTE; MTDNA; REPLICATION; TRANSMISSION; EXPRESSION	Interspecies somatic cell nuclear transfer (iSCNT) involves the transfer of a nucleus or cell from one species into the cytoplasm of an enucleated oocyte from another. Once activated, reconstructed oocytes can be cultured in vitro to blastocyst, the final stage of preimplantation development. However, they often arrest during the early stages of preimplantation development; fail to reprogramme the somatic nucleus; and eliminate the accompanying donor cell's mitochondrial DNA (mtDNA) in favour of the recipient oocyte's genetically more divergent population. This last point has consequences for the production of ATP by the electron transfer chain, which is encoded by nuclear and mtDNA. Using a murine-porcine interspecies model, we investigated the importance of nuclear-cytoplasmic compatibility on successful development. Initially, we transferred murine fetal fibroblasts into enucleated porcine oocytes, which resulted in extremely low blastocyst rates (0.48%); and failure to replicate nuclear DNA and express Oct-4, the key marker of reprogramming. Using allele specific-PCR, we detected peak levels of murine mtDNA at 0.14+/-0.055% of total mtDNA at the 2-cell embryo stage and then at ever-decreasing levels to the blastocyst stage (<0.001%). Furthermore, these embryos had an overall mtDNA profile similar to porcine embryos. We then depleted porcine oocytes of their mtDNA using 10 mu M 2',3'-dideoxycytidine and transferred murine somatic cells along with murine embryonic stem cell extract, which expressed key pluripotent genes associated with reprogramming and contained mitochondria, into these oocytes. Blastocyst rates increased significantly (3.38%) compared to embryos generated from non-supplemented oocytes (P < 0.01). They also had significantly more murine mtDNA at the 2-cell stage than the non-supplemented embryos, which was maintained throughout early preimplantation development. At later stages, these embryos possessed 49.99+/-2.97% murine mtDNA. They also exhibited an mtDNA profile similar to murine preimplantation embryos. Overall, these data demonstrate that the addition of species compatible mtDNA and reprogramming factors improves developmental outcomes for iSCNT embryos.	[Jiang, Yan; Kelly, Richard; Peters, Amy; Fulka, Helena; Dickinson, Adam; Mitchell, Daniel A.; St John, Justin C.] Warwick Med Sch, Clin Sci Res Inst, Mitochondrial & Reprod Genet Grp, Coventry, W Midlands, England; [Kelly, Richard; Dickinson, Adam; St John, Justin C.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic 3800, Australia; [Jiang, Yan; Peters, Amy; St John, Justin C.] Univ Birmingham, Sch Med, Mitochondrial & Reprod Genet Grp, Birmingham, W Midlands, England; [Fulka, Helena] Inst Anim Sci, Dept Reprod Biol, Prague, Czech Republic	University of Warwick; Monash University; University of Birmingham; Czech Research Institute of Animal Science	Jiang, Y (corresponding author), Warwick Med Sch, Clin Sci Res Inst, Mitochondrial & Reprod Genet Grp, Coventry, W Midlands, England.	Justin.StJohn@monash.edu	St. John, Justin C/A-2942-2010; Mitchell, Daniel A/A-6580-2009	Mitchell, Daniel A/0000-0003-0936-6212; St. John, Jus/0000-0002-3993-1449; Fulka, Helena/0000-0001-7414-5024	Medical Research Council, UK [G0600273]; MRC [G0600273] Funding Source: UKRI; Medical Research Council [G0600273] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council, UK (http://www.mrc.ac.uk), grant number: G0600273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Barrett SL, 2007, BIOL REPROD, V76, P949, DOI 10.1095/biolreprod.106.057141; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; Bowles EJ, 2008, STEM CELLS, V26, P775, DOI 10.1634/stemcells.2007-0747; Bowles EJ, 2007, GENETICS, V176, P1511, DOI 10.1534/genetics.106.070177; Bowles EJ, 2007, CURR TOP DEV BIOL, V77, P251, DOI 10.1016/S0070-2153(06)77010-7; Bruggerhoff K, 2002, BIOL REPROD, V66, P367, DOI 10.1095/biolreprod66.2.367; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Campbell KHS, 2003, REPRODUCTION, P477; Chaiyarit S, 2009, ANAL BIOCHEM, V394, P249, DOI 10.1016/j.ab.2009.07.026; Chang KH, 2003, FERTIL STERIL, V80, P1380, DOI 10.1016/j.fertnstert.2003.07.006; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; Do JT, 2002, BIOL REPROD, V67, P555, DOI 10.1095/biolreprod67.2.555; Dominko T, 1999, BIOL REPROD, V60, P1496, DOI 10.1095/biolreprod60.6.1496; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Heins N, 2004, STEM CELLS, V22, P367, DOI 10.1634/stemcells.22-3-367; Holden C, 2005, SCIENCE, V310, P1402, DOI 10.1126/science.310.5753.1402; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; JARRELL VL, 1991, BIOL REPROD, V44, P62, DOI 10.1095/biolreprod44.1.62; Jiang Y, 2004, ACTA BIOCH BIOPH SIN, V36, P371, DOI 10.1093/abbs/36.5.371; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Lloyd RE, 2006, GENETICS, V172, P2515, DOI 10.1534/genetics.105.055145; May-Panloup P, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-65; McConnell JML, 2004, REPROD BIOMED ONLINE, V9, P418, DOI 10.1016/S1472-6483(10)61277-1; McKenzie M, 2000, J BIOL CHEM, V275, P31514, DOI 10.1074/jbc.M004070200; McKenzie M, 2003, MOL BIOL EVOL, V20, P1117, DOI 10.1093/molbev/msg132; Meirelles FV, 2001, GENETICS, V158, P351; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; St John JC, 2005, MOL REPROD DEV, V72, P450, DOI 10.1002/mrd.20370; St John JC, 2004, REPRODUCTION, V127, P631, DOI 10.1530/rep.1.00138; St John J, 2007, NAT CELL BIOL, V9, P988, DOI 10.1038/ncb436; Steinborn R, 2002, GENETICS, V162, P823; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Takeda K, 2006, MOL REPROD DEV, V73, P306, DOI 10.1002/mrd.20403; Takeda K, 2005, BIOL REPROD, V72, P1397, DOI 10.1095/biolreprod.104.036129; Takeda K, 2003, MOL REPROD DEV, V64, P429, DOI 10.1002/mrd.10279; Tamassia M, 2004, BIOL REPROD, V71, P697, DOI 10.1095/biolreprod.103.026104; Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260; Ursing BM, 1998, J MOL EVOL, V47, P302, DOI 10.1007/PL00006388; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Walia H, 2009, CURR BIOL, V19, P1128, DOI 10.1016/j.cub.2009.05.068; Woods GL, 2003, SCIENCE, V301, P1063, DOI 10.1126/science.1086743; Yang CX, 2003, MOL REPROD DEV, V65, P396, DOI 10.1002/mrd.10320; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112	53	26	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e14805	10.1371/journal.pone.0014805	http://dx.doi.org/10.1371/journal.pone.0014805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556135	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400001
J	Silvertown, J; Cook, L; Cameron, R; Dodd, M; McConway, K; Worthington, J; Skelton, P; Anton, C; Bossdorf, O; Baur, B; Schilthuizen, M; Fontaine, B; Sattmann, H; Bertorelle, G; Correia, M; Oliveira, C; Pokryszko, B; Ozgo, M; Stalazas, A; Gill, E; Rammul, U; Solymos, P; Feher, Z; Juan, X				Silvertown, Jonathan; Cook, Laurence; Cameron, Robert; Dodd, Mike; McConway, Kevin; Worthington, Jenny; Skelton, Peter; Anton, Christian; Bossdorf, Oliver; Baur, Bruno; Schilthuizen, Menno; Fontaine, Benoit; Sattmann, Helmut; Bertorelle, Giorgio; Correia, Maria; Oliveira, Cristina; Pokryszko, Beata; Ozgo, Malgorzata; Stalazas, Arturs; Gill, Eoin; Rammul, Uellar; Solymos, Peter; Feher, Zoltan; Juan, Xavier			Citizen Science Reveals Unexpected Continental-Scale Evolutionary Change in a Model Organism	PLOS ONE			English	Article							SNAIL CEPAEA-NEMORALIS; CLIMATE-CHANGE IMPACTS; LAND-SNAIL; ARIANTA-ARBUSTORUM; SHELL POLYMORPHISM; SELECTION; POPULATIONS; ADAPTATION; AREA; VINDOBONENSIS	Organisms provide some of the most sensitive indicators of climate change and evolutionary responses are becoming apparent in species with short generation times. Large datasets on genetic polymorphism that can provide an historical benchmark against which to test for recent evolutionary responses are very rare, but an exception is found in the brown-lipped banded snail (Cepaea nemoralis). This species is sensitive to its thermal environment and exhibits several polymorphisms of shell colour and banding pattern affecting shell albedo in the majority of populations within its native range in Europe. We tested for evolutionary changes in shell albedo that might have been driven by the warming of the climate in Europe over the last half century by compiling an historical dataset for 6,515 native populations of C. nemoralis and comparing this with new data on nearly 3,000 populations. The new data were sampled mainly in 2009 through the Evolution MegaLab, a citizen science project that engaged thousands of volunteers in 15 countries throughout Europe in the biggest such exercise ever undertaken. A known geographic cline in the frequency of the colour phenotype with the highest albedo (yellow) was shown to have persisted and a difference in colour frequency between woodland and more open habitats was confirmed, but there was no general increase in the frequency of yellow shells. This may have been because snails adapted to a warming climate through behavioural thermoregulation. By contrast, we detected an unexpected decrease in the frequency of Unbanded shells and an increase in the Mid-banded morph. Neither of these evolutionary changes appears to be a direct response to climate change, indicating that the influence of other selective agents, possibly related to changing predation pressure and habitat change with effects on micro-climate.	[Silvertown, Jonathan; Dodd, Mike; Worthington, Jenny] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Cook, Laurence] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Cameron, Robert] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [McConway, Kevin] Open Univ, Dept Math & Stat, Milton Keynes MK7 6AA, Bucks, England; [Skelton, Peter] Open Univ, Dept Earth & Environm Sci, Milton Keynes MK7 6AA, Bucks, England; [Anton, Christian] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Bossdorf, Oliver] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Baur, Bruno] Univ Basel, Dept Environm Sci, Sect Conservat Biol, Basel, Switzerland; [Schilthuizen, Menno] Netherlands Ctr Biodivers Naturalis, Leiden, Netherlands; [Fontaine, Benoit] Museum Natl Hist Nat, Dept Ecol & Gest Biodivers, F-75231 Paris, France; [Sattmann, Helmut] Nat Hist Museum Vienna, Dept Invertebrate Zool, Vienna, Austria; [Bertorelle, Giorgio] Univ Ferrara, Dept Biol & Evolut, I-44100 Ferrara, Italy; [Correia, Maria; Oliveira, Cristina] Univ Porto, IBMC Inst Biol Mol & Celular, Ciencia Viva Natl Agcy Sci & Technol Culture, P-4100 Oporto, Portugal; [Pokryszko, Beata] Univ Wroclaw, Museum Nat Hist, PL-50138 Wroclaw, Poland; [Ozgo, Malgorzata] Pomeranian Univ, Inst Biol, Slupsk, Poland; [Stalazas, Arturs] Latvia State Inst Fruit Growing, Dobele, Latvia; [Gill, Eoin] Waterford Inst Technol, Waterford, Ireland; [Rammul, Uellar] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia; [Solymos, Peter] Univ Alberta, Alberta Biodivers Monitoring Inst, Dept Biol Sci, Edmonton, AB, Canada; [Feher, Zoltan] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary; [Juan, Xavier] INS St Quirze, Dept Sci, St Quirze Del Valles, Spain	Open University - UK; University of Manchester; University of Sheffield; Open University - UK; Open University - UK; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bern; University of Basel; Naturalis Biodiversity Center; Museum National d'Histoire Naturelle (MNHN); University of Ferrara; Universidade do Porto; University of Wroclaw; Pomeranian Medical University; Latvia State Institute of Fruit Growing; South East Technological University (SETU); Tallinn University of Technology; University of Alberta	Silvertown, J (corresponding author), Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England.	J.Silvertown@open.ac.uk	Bossdorf, Oliver/A-8328-2008; Stalažs, Arturs/AAH-1858-2021; McConway, Kevin/G-3729-2012; Schilthuizen, Menno/B-5156-2009; Bertorelle, Giorgio/AAE-9078-2022; Sólymos, Péter/B-2775-2008; Ożgo, Małgorzata/F-3150-2018; Oliveira, Cristina/B-6475-2015	Bossdorf, Oliver/0000-0001-7504-6511; Stalažs, Arturs/0000-0002-3971-6255; McConway, Kevin/0000-0002-0236-7231; Schilthuizen, Menno/0000-0001-6229-0347; Sólymos, Péter/0000-0001-7337-1740; Ożgo, Małgorzata/0000-0002-9999-8450; Bertorelle, Giorgio/0000-0002-2498-2702; Pokryszko, Beata/0000-0003-3631-3044; Oliveira, Cristina/0000-0002-0887-7961; Dodd, Michael/0000-0003-2741-7810	Royal Society; British Council; Open University in the UK; Volkswagen Foundation in Germany; BirdLife Switzerland; NCB Naturalis; NIBI; Prins Bernhard Cultuurfonds in The Netherlands; Environmental Investment Centre in Estonia; Museum National d'Histoire Naturelle in France; Museum of Natural History in Spain	Royal Society(Royal Society of London); British Council(The British Council in India); Open University in the UK; Volkswagen Foundation in Germany; BirdLife Switzerland; NCB Naturalis; NIBI; Prins Bernhard Cultuurfonds in The Netherlands; Environmental Investment Centre in Estonia; Museum National d'Histoire Naturelle in France; Museum of Natural History in Spain	This study was funded by the Royal Society, the British Council and the Open University in the UK and The Volkswagen Foundation in Germany, BirdLife Switzerland, NCB Naturalis, NIBI and The Prins Bernhard Cultuurfonds in The Netherlands, the Environmental Investment Centre in Estonia, the British Council and the Museum National d'Histoire Naturelle in France and The Museum of Natural History in Spain. The authors acknowledge support from the Italian Society for Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELREHIM AH, 1983, BIOL J LINN SOC, V20, P185, DOI 10.1111/j.1095-8312.1983.tb00362.x; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Bonebrake TC, 2010, P NATL ACAD SCI USA, V107, P12581, DOI 10.1073/pnas.0911841107; BURLA H, 1993, ECOGRAPHY, V16, P345, DOI 10.1111/j.1600-0587.1993.tb00223.x; CAIN AJ, 1954, GENETICS, V39, P89; CAIN AJ, 1968, PHILOS T R SOC B, V253, P447, DOI 10.1098/rstb.1968.0007; CAIN AJ, 1990, PROC R SOC SER B-BIO, V240, P231, DOI 10.1098/rspb.1990.0036; Cameron RAD, 2008, BIOL J LINN SOC, V95, P53, DOI 10.1111/j.1095-8312.2008.01042.x; Chang HW, 1991, J ZOOL, V225, P213; Cook LM, 2008, J MOLLUS STUD, V74, P239, DOI 10.1093/mollus/eyn011; COOK LM, 1986, BIOL J LINN SOC, V29, P101, DOI 10.1111/j.1095-8312.1986.tb01825.x; Davison A, 2000, P ROY SOC B-BIOL SCI, V267, P1399, DOI 10.1098/rspb.2000.1156; European_Environment_Agency, 2010, GLOB EUR TEMP CSI 01; Galeotti P, 2009, BIOL LETTERS, V5, P532, DOI 10.1098/rsbl.2009.0207; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Hastie TJ., 1990, GEN ADDITIVE MODELS; Haylock MR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010201; HAZEL WN, 1990, HEREDITY, V65, P449, DOI 10.1038/hdy.1990.116; HEATH DJ, 1975, OECOLOGIA, V19, P29, DOI 10.1007/BF00377587; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; JONES JS, 1977, ANNU REV ECOL SYST, V8, P109, DOI 10.1146/annurev.es.08.110177.000545; JONES JS, 1982, NATURE, V298, P749, DOI 10.1038/298749a0; JONES JS, 1974, HEREDITY, V32, P165, DOI 10.1038/hdy.1974.20; KAVALIERS M, 1992, J COMP PHYSIOL B, V162, P172, DOI 10.1007/BF00398344; Kohler HR, 2009, J EXP ZOOL PART B, V312B, P136, DOI 10.1002/jez.b.21253; LAMOTTE M, 1959, COLD SPRING HARB SYM, V24, P65, DOI 10.1101/SQB.1959.024.01.009; MURRAY J, 1978, MALACOLOGIA, V17, P317; MURRAY J. J., 1975, HDB GENETICS, V3, P3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phifer-Rixey M, 2008, J EVOLUTION BIOL, V21, P966, DOI 10.1111/j.1420-9101.2008.01549.x; Staikou AE, 1999, J MOLLUS STUD, V65, P171, DOI 10.1093/mollus/65.2.171; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Wood SN, WOOD SN GEN ADDITIVE; Worthington JP, EVOLUTION MEGA UNPUB	36	91	104	1	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18927	10.1371/journal.pone.0018927	http://dx.doi.org/10.1371/journal.pone.0018927			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556137	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000290019400019
J	Brett, SJ; Myles, P; Lim, WS; Enstone, JE; Bannister, B; Semple, MG; Read, RC; Taylor, BL; McMenamin, J; Nicholson, KG; Nguyen-Van-Tam, JS; Openshaw, PJM				Brett, Stephen J.; Myles, Puja; Lim, Wei Shen; Enstone, Joanne E.; Bannister, Barbara; Semple, Malcolm G.; Read, Robert C.; Taylor, Bruce L.; McMenamin, Jim; Nicholson, Karl G.; Nguyen-Van-Tam, Jonathan S.; Openshaw, Peter J. M.		Influenza Clinical Information	Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease	PLOS ONE			English	Article							GASTRIC-ACID SUPPRESSANTS; ACE-INHIBITORS; INFECTIONS; PNEUMONIA; THERAPY; SEPSIS; MORTALITY; DEATH; RISK	Background: Statins are drugs that are used to lower plasma cholesterol levels. Recently, contradictory claims have been made about possible additional effects of statins on progression of a variety of inflammatory disorders, including infections. We therefore examined the clinical course of patients admitted to hospital with 2009 pandemic influenza A(H1N1), who were or weren't taking statins at time of admission. Methods: A retrospective case-control study was performed using the United Kingdom Influenza Clinical Information Network (FLU-CIN) database, containing detailed information on 1,520 patients admitted to participating hospitals with confirmed 2009 pandemic influenza A(H1N1) infection between April 2009 and January 2010. We confined our analysis to those aged over 34 years. Univariate analysis was used to calculate unadjusted odds ratios (OR) and 95 percent confidence intervals (95% CI) for factors affecting progression to severe outcome (high dependency or intensive care unit level support) or death (cases); two multivariable logistic regression models were then established for age and sex, and for age, sex, obesity and "indication for statin" (e. g., heart disease or hypercholesterolaemia). Results: We found no statistically significant association between pre-admission statin use and severity of outcome after adjustment for age and sex [adjusted OR: 0.81 (95% CI: 0.46-1.38); n = 571]. After adjustment for age, sex, obesity and indication for statin, the association between pre-admission statin use and severe outcome was not statistically significant; point estimates are compatible with a small but clinically significant protective effect of statin use [adjusted OR: 0.72 (95% CI: 0.38-1.33)]. Conclusions: In this group of patients hospitalized with pandemic influenza, a significant beneficial effect of pre-admission statin use on the in-hospital course of illness was not identified. Although the database from which these observations are derived represents the largest available suitable UK hospital cohort, a larger study would be needed to confirm whether there is any benefit in this setting.	[Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Ctr Perioperat Med & Crit Care Res, London, England; [Myles, Puja; Enstone, Joanne E.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Lim, Wei Shen] Nottingham Univ Hosp NHS Trust, Dept Resp Med, Nottingham, England; [Bannister, Barbara] Dept Hlth, London SE1 6TE, England; [Semple, Malcolm G.] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Read, Robert C.] Univ Sheffield, Royal Hallamshire Hosp, Dept Infect & Immun, Sheffield S10 2JF, S Yorkshire, England; [Taylor, Bruce L.] Portsmouth Hosp NHS Trust, Dept Crit Care, Portsmouth, Hants, England; [McMenamin, Jim] NHS Natl Serv, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Nicholson, Karl G.] Univ Hosp Leicester NHS Trust, Infect Dis Unit, Leicester Royal Infirm, Leicester, Leics, England; [Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London, England	Imperial College London; University of Nottingham; Nottingham University Hospital NHS Trust; University of Liverpool; University of Sheffield; Portsmouth Hospitals NHS Trust; NHS National Services Scotland; University Hospitals of Leicester NHS Trust; University of Leicester; Imperial College London	Brett, SJ (corresponding author), Imperial Coll Healthcare NHS Trust, Ctr Perioperat Med & Crit Care Res, London, England.	stephen.brett@imperial.ac.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019; Semple, Malcolm Gracie/A-8790-2008; Openshaw, Peter/AAL-9442-2020	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Semple, Malcolm Gracie/0000-0001-9700-0418; Openshaw, Peter/0000-0002-7220-2555; Read, Robert/0000-0002-4297-6728; Myles, Puja/0000-0002-8976-890X	Department of Health in England; UK NIHR Biomedical Research Centre; Pfizer; Wyeth; MRC; NIHR; Novartis; MSD; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish	Department of Health in England; UK NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Pfizer(Pfizer); Wyeth(Wyeth); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Novartis(Novartis); MSD; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	The Department of Health in England was the main funder for the Influenza Clinical Information Network (FLU-CIN). Chairmanship of the FLU-CIN Strategy Group (which included all authors as members) was provided by the Department of Health, England. The FLU-CIN Strategy Group had final responsibility for the interpretation of findings and decision to submit for publication. SJB and PJMO wish to acknowledge the support of the UK NIHR Biomedical Research Centre scheme. For the study reported in this publication, the funders had no role in the design, the data analysis, the decision to publish or the preparation of the manuscript.; SJB has received consultancy fees from Pfizer. WSL has received an unrestricted educational grant from Wyeth (now Pfizer). KGN has received H5 avian influenza vaccines from Novartis and pH1N1 influenza vaccines from GlaxoSmithKline and Baxter to facilitate MRC and NIHR-funded trials. He has received consultancy fees from Novartis and MSD. RCR is Chief Investigator of a vaccine trial funded by Novartis. JSN-V-T was one of several collaborators who jointly received an unrestricted educational top-up grant for previous statin-related research from Pfizer (in 2005), he also received consultancy fees in 2008 (for work unrelated to statins) from Novartis. PJMO is a member of the European Scientific Working Group on Influenza (ESWI), which is funded by the pharmaceutical industry. This does not alter the authors' adherence to all the PLOS One policies on data sharing and materials.	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Almog Y, 2007, CRIT CARE MED, V35, P372, DOI 10.1097/01.CCM.0000253397.42079.D5; [Anonymous], 2009, WEELY EPIDEMIOL REC, V84, P305; Bewick T, 2011, THORAX, V66, P247, DOI 10.1136/thx.2010.151522; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dublin S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2137; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Fleming DM, 2010, EPIDEMIOL INFECT, V138, P1281, DOI 10.1017/S0950268810000105; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Janda S, 2010, J CRIT CARE, V25; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P269, DOI 10.1002/pds.1715; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Novack V, 2009, INTENS CARE MED, V35, P1255, DOI 10.1007/s00134-009-1429-0; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581	26	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18120	10.1371/journal.pone.0018120	http://dx.doi.org/10.1371/journal.pone.0018120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541017	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000290016800005
J	Hauser, S; Bickel, L; Weinspach, D; Gerg, M; Schafer, MK; Pfeifer, M; Hazin, J; Schelter, F; Weidle, UH; Ramser, J; Volkmann, J; Meindl, A; Schmitt, M; Schrotzlmair, F; Altevogt, P; Kruger, A				Hauser, Stephanie; Bickel, Laura; Weinspach, Dirk; Gerg, Michael; Schaefer, Michael K.; Pfeifer, Marco; Hazin, John; Schelter, Florian; Weidle, Ulrich H.; Ramser, Juliane; Volkmann, Juliane; Meindl, Alfons; Schmitt, Manfred; Schroetzlmair, Florian; Altevogt, Peter; Krueger, Achim			Full-Length L1CAM and Not Its Delta 2 Delta 27 Splice Variant Promotes Metastasis through Induction of Gelatinase Expression	PLOS ONE			English	Article							ADHESION MOLECULE L1; MATRIX METALLOPROTEINASE-2; TUMOR-GROWTH; THERAPEUTIC ANTIBODIES; OVARIAN CARCINOMAS; RETROVIRAL VECTORS; COLORECTAL-CANCER; GENE-EXPRESSION; IV COLLAGENASE; CELL-MIGRATION	Tumour-specific splicing is known to contribute to cancer progression. In the case of the L1 cell adhesion molecule (L1CAM), which is expressed in many human tumours and often linked to bad prognosis, alternative splicing results in a full-length form (FL-L1CAM) and a splice variant lacking exons 2 and 27 (SV-L1CAM). It has not been elucidated so far whether SV-L1CAM, classically considered as tumour-associated, or whether FL-L1CAM is the metastasis-promoting isoform. Here, we show that both variants were expressed in human ovarian carcinoma and that exposure of tumour cells to pro-metastatic factors led to an exclusive increase of FL-L1CAM expression. Selective overexpression of one isoform in different tumour cells revealed that only FL-L1CAM promoted experimental lung and/or liver metastasis in mice. In addition, metastasis formation upon upregulation of FL-L1CAM correlated with increased invasive potential and elevated Matrix metalloproteinase (MMP)-2 and -9 expression and activity in vitro as well as enhanced gelatinolytic activity in vivo. In conclusion, we identified FL-L1CAM as the metastasis-promoting isoform, thereby exemplifying that high expression of a so-called tumour-associated variant, here SV-L1CAM, is not per se equivalent to a decisive role of this isoform in tumour progression.	[Hauser, Stephanie; Bickel, Laura; Weinspach, Dirk; Gerg, Michael; Schelter, Florian; Schroetzlmair, Florian; Krueger, Achim] Tech Univ Munich, Klinikum Rechts Isar, Inst Expt Onkol & Therapieforsch, D-8000 Munich, Germany; [Schaefer, Michael K.] Univ Freiburg, Inst Anat & Zellbiol, Zentrum Neurowissensch, Freiburg, Germany; [Pfeifer, Marco; Hazin, John; Altevogt, Peter] Deutsch Krebsforschungszentrums, Abt Translat Immunol D015, Heidelberg, Germany; [Weidle, Ulrich H.] Roche Diagnost GmbH, Div Pharma, Penzberg, Germany; [Ramser, Juliane; Volkmann, Juliane; Meindl, Alfons; Schmitt, Manfred] Tech Univ Munich, Klinikum Rechts Isar, Frauenklin & Poliklin, D-8000 Munich, Germany	Technical University of Munich; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Roche Holding; Technical University of Munich	Hauser, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Expt Onkol & Therapieforsch, D-8000 Munich, Germany.	achim.krueger@lrz.tu-muenchen.de		Schafer, Michael K.E./0000-0001-6055-6244	Deutsche Forschungsgemeinschaft [KR2047/1-1]; European Framework Programme 7; Deutsche Krebshilfe [10-1307-3A1]; Mildred-Scheel-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Framework Programme 7; Deutsche Krebshilfe(Deutsche Krebshilfe); Mildred-Scheel-Stiftung(Deutsche Krebshilfe)	This work was supported by Deutsche Forschungsgemeinschaft (grant KR2047/1-1, URL: http://www.dfg.de/index.jsp) and European Framework Programme 7 (project HEALTH-2007-201279/Microenvimet, URL: http://www.microenvimet.eu) (both to Achim Kruger) as well as Deutsche Krebshilfe (grant 10-1307-3A1 und Schwerpunktprogramm "Invasion und Migration", URL: http://www.krebshilfe.de) and Mildred-Scheel-Stiftung (Schwerpunkt-programm "Analyse von L1 und ADAM10 im Ovarialkarzinom: neue Zielstrukturen fur die Therapie", URL: http://www.krebshilfe.de/dr-mildred-scheel-stiftung.html) (both to Peter Altevogt and Achim Kruger). Ulrich Weidle is employed by Roche Diagnostics and provided a plasmid construct with the splice variant and has intensively discussed the results with AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE T, 1994, CLIN EXP METASTAS, V12, P296, DOI 10.1007/BF01753836; Arlt M, 2002, CANCER RES, V62, P5543; Arlt MJE, 2006, CANCER RES, V66, P936, DOI 10.1158/0008-5472.CAN-05-1818; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Boo YJ, 2007, ANN SURG ONCOL, V14, P1703, DOI 10.1245/s10434-006-9281-8; BRATTAIN MG, 1981, CANCER RES, V41, P1751; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Coutelle O, 1998, GENE, V208, P7, DOI 10.1016/S0378-1119(97)00614-8; DAVIES B, 1993, CANCER RES, V53, P5365; De Angelis E, 2001, J BIOL CHEM, V276, P32738, DOI 10.1074/jbc.M105156200; Euer NI, 2005, ONCOL REP, V13, P375; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fogel M, 2003, LANCET, V362, P869, DOI 10.1016/S0140-6736(03)14342-5; Gast D, 2008, ONCOGENE, V27, P1281, DOI 10.1038/sj.onc.1210747; Gast D, 2005, INT J CANCER, V115, P658, DOI 10.1002/ijc.20869; Gast D, 2008, EXP CELL RES, V314, P2411, DOI 10.1016/j.yexcr.2008.04.004; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Gerg M, 2008, MOL CANCER RES, V6, P341, DOI 10.1158/1541-7786.MCR-07-2032; Ghigna C, 2008, CURR GENOMICS, V9, P556, DOI 10.2174/138920208786847971; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Gouveia RM, 2008, J BIOL CHEM, V283, P28038, DOI 10.1074/jbc.M804991200; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Huszar M, 2010, J PATHOL, V220, P551, DOI 10.1002/path.2673; Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.e03-05-0333; Itoh K, 2000, J NEUROSCI RES, V60, P579; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; JOUET M, 1995, MOL BRAIN RES, V30, P378, DOI 10.1016/0169-328X(95)00027-P; Kaifi JT, 2007, MODERN PATHOL, V20, P1183, DOI 10.1038/modpathol.3800955; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kopitz C, 2005, CANCER RES, V65, P8608, DOI 10.1158/0008-5472.CAN-05-1572; Kruger A, 2005, CANCER RES, V65, P3523, DOI 10.1158/0008-5472.CAN-04-3570; KRUGER A, 1994, INT J CANCER, V58, P275, DOI 10.1002/ijc.2910580222; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; MIURA M, 1992, J BIOL CHEM, V267, P10752; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Novak-Hofer I, 2008, CANCER LETT, V261, P193, DOI 10.1016/j.canlet.2007.11.012; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Raveh S, 2009, CANCER LETT, V282, P137, DOI 10.1016/j.canlet.2008.12.021; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Schroder C, 2009, ONCOL REP, V22, P1109, DOI 10.3892/or_00000543; Scotlandi K, 2007, ONCOGENE, V26, P6604, DOI 10.1038/sj.onc.1210481; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Siesser PF, 2009, CELL ADHES MIGR, V3, P275, DOI 10.4161/cam.3.3.8689; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Takeda Y, 1996, J NEUROCHEM, V66, P2338; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Togawa D, 1999, CANCER LETT, V146, P25, DOI 10.1016/S0304-3835(99)00214-1; Tyukhtenko S, 2008, BIOCHEMISTRY-US, V47, P4160, DOI 10.1021/bi702433q; Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045; Wolterink S, 2010, CANCER RES, V70, P2504, DOI 10.1158/0008-5472.CAN-09-3730; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564; Young TN, 1996, GYNECOL ONCOL, V62, P89, DOI 10.1006/gyno.1996.0195; Yu Q, 2000, GENE DEV, V14, P163; Zhang L, 2004, PROSTATE CANCER P D, V7, P327, DOI 10.1038/sj.pcan.4500750	73	14	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18989	10.1371/journal.pone.0018989	http://dx.doi.org/10.1371/journal.pone.0018989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541352	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800030
J	Dey, B; Jain, R; Khera, A; Gupta, UD; Katoch, VM; Ramanathan, VD; Tyagi, AK				Dey, Bappaditya; Jain, Ruchi; Khera, Aparna; Gupta, Umesh D.; Katoch, V. M.; Ramanathan, V. D.; Tyagi, Anil K.			Latency Antigen alpha-Crystallin Based Vaccination Imparts a Robust Protection against TB by Modulating the Dynamics of Pulmonary Cytokines	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; TNF-ALPHA; VACCINES; EXPRESSION; MEMORY; BCG; IMMUNOGENICITY; IMMUNOLOGY; INFECTION	Background: Efficient control of tuberculosis (TB) requires development of strategies that can enhance efficacy of the existing vaccine Mycobacterium bovis Bacille Calmette Guerin (BCG). To date only a few studies have explored the potential of latency-associated antigens to augment the immunogenicity of BCG. Methods/Principal Findings: We evaluated the protective efficacy of a heterologous prime boost approach based on recombinant BCG and DNA vaccines targeting alpha-crystallin, a prominent latency antigen. We show that "rBCG prime - DNA boost'' strategy (R/D) confers a markedly superior protection along with reduced pathology in comparison to BCG vaccination in guinea pigs (565 fold and 45 fold reduced CFU in lungs and spleen, respectively, in comparison to BCG vaccination). In addition, R/D regimen also confers enhanced protection in mice. Our results in guinea pig model show a distinct association of enhanced protection with an increased level of interleukin (IL) 12 and a simultaneous increase in immuno-regulatory cytokines such as transforming growth factor (TGF)beta and IL10 in lungs. The T cell effector functions, which could not be measured in guinea pigs due to technical limitations, were characterized in mice by multi-parameter flow cytometry. We show that R/D regimen elicits a heightened multi-functional CD4 Th1 cell response leading to enhanced protection. Conclusions/Significance: These results clearly indicate the superiority of alpha-crystallin based R/D regimen over BCG. Our observations from guinea pig studies indicate a crucial role of IL12, IL10 and TGF beta in vaccine-induced protection. Further, characterization of T cell responses in mice demonstrates that protection against TB is predictable by the frequency of CD4 T cells simultaneously producing interferon (IFN)gamma, tumor necrosis factor (TNF)alpha and IL2. We anticipate that this study will not only contribute toward the development of a superior alternative to BCG, but will also stimulate designing of TB vaccines based on latency antigens.	[Dey, Bappaditya; Jain, Ruchi; Khera, Aparna; Tyagi, Anil K.] Univ Delhi S Campus, Dept Biochem, New Delhi, India; [Gupta, Umesh D.; Katoch, V. M.] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India; [Ramanathan, V. D.] TB Res Ctr, Dept Clin Pathol, Madras, Tamil Nadu, India	University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Dey, B (corresponding author), Univ Delhi S Campus, Dept Biochem, New Delhi, India.	aniltyagi@south.du.ac.in	Dey, Bappaditya/H-1831-2018	Dey, Bappaditya/0000-0003-2728-4683	Department of Biotechnology, Ministry of Science and Technology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India. BD and RJ acknowledge Council of Scientific and Industrial Research, Government of India for a research fellowship (CSIR JRF/SRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Allen SS, 2003, INFECT IMMUN, V71, P4271, DOI 10.1128/IAI.71.8.4271-4277.2003; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dhar N, 2000, FEMS MICROBIOL LETT, V190, P309, DOI 10.1111/j.1574-6968.2000.tb09304.x; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; FLYNN JL, 1995, J IMMUNOL, V155, P2515; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Henao-Tamayo MI, 2010, CLIN VACCINE IMMUNOL, V17, P618, DOI 10.1128/CVI.00368-09; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Jain S, 1997, GENE, V190, P37, DOI 10.1016/S0378-1119(96)00746-9; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Keane MP, 2001, RESP RES, V3; Khera A, 2005, VACCINE, V23, P5655, DOI 10.1016/j.vaccine.2005.03.056; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Ly LH, 2007, CELL MICROBIOL, V9, P1127, DOI 10.1111/j.1462-5822.2006.00854.x; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; SMITH PGA, 1994, EPIDEMIOLOGY TUBERCU; Smith S, 2002, INFECT IMMUN, V70, P2082, DOI 10.1128/IAI.70.4.2082-2089.2002; Vekemans J, 2004, INFECT IMMUN, V72, P381, DOI 10.1128/IAI.72.1.381-388.2004; Wang LM, 2007, CHINESE MED J-PEKING, V120, P1220, DOI 10.1097/00029330-200707020-00003; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Yamada H, 2005, EXP ANIM TOKYO, V54, P163, DOI 10.1538/expanim.54.163; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996; Zakharova M, 2005, J IMMUNOL, V175, P5024, DOI 10.4049/jimmunol.175.8.5024; Zganiacz A, 2004, J CLIN INVEST, V113, P401, DOI 10.1172/JCI200418991	35	24	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18773	10.1371/journal.pone.0018773	http://dx.doi.org/10.1371/journal.pone.0018773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533158	Green Accepted, Green Submitted, gold, Green Published			2022-12-25	WOS:000289620100015
J	Evrard, B; Coudeyras, S; Dosgilbert, A; Charbonnel, N; Alame, J; Tridon, A; Forestier, C				Evrard, Bertrand; Coudeyras, Sophie; Dosgilbert, Annie; Charbonnel, Nicolas; Alame, Josette; Tridon, Arlette; Forestier, Christiane			Dose-Dependent Immunomodulation of Human Dendritic Cells by the Probiotic Lactobacillus rhamnosus Lcr35	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; REGULATORY T-CELLS; IN-VITRO; MATURATION; PREVENTION; COLONIZATION; METAANALYSIS; MODULATION; TOLERANCE; CYTOKINES	The response of the immune system to probiotics remains controversial. Some strains modulate the cytokine production of dendritic cells (DCs) in vitro and induce a regulatory response, while others induce conversely a pro-inflammatory response. These strain-dependent effects are thought to be linked to specific interactions between bacteria and pattern recognition receptors. We investigated the effects of a well characterized probiotic strain, Lactobacillus rhamnosus Lcr35, on human monocyte-derived immature DCs, using a wide range of bacterial concentrations (multiplicity of infection, MOI, from 0.01 to 100). DNA microarray and qRT-PCR analysis showed that the probiotic induced a large-scale change in gene expression (nearly 1,700 modulated genes, with 3-fold changes), but only with high doses (MOI, 100). The upregulated genes were mainly involved in immune response and identified a molecular signature of inflammation according to the model of Torri. Flow cytometry analysis also revealed a dose-dependent maturation of the DC membrane phenotype, until DCs reached a semi-mature state, with an upregulation of the membrane expression of CD86, CD83, HLA-DR and TLR4, associated with a down-regulation of DC-SIGN, MR and CD14. Measurement of the DC-secreted cytokines showed that Lcr35 induced a strong dose-dependent increase of the pro-Th1/Th17 cytokine levels (TNF alpha, IL-1 beta, IL-12p70, IL-12p40 and IL-23), but only a low increase in IL-10 concentration. The probiotic L. rhamnosus Lcr35 therefore induce a dose-dependent immunomodulation of human DCs leading, at high doses, to the semi-maturation of the cells and to a strong pro-inflammatory effect. These results contribute to a fuller understanding of the mechanism of action of this probiotic, and thus of its potential clinical indications in the treatment of either infectious or IgE-dependent allergic diseases.	[Evrard, Bertrand; Dosgilbert, Annie; Tridon, Arlette] CHU Clermont Ferrand, Immunol Lab, Clermont Ferrand, France; [Evrard, Bertrand; Alame, Josette; Tridon, Arlette] Univ Auvergne, Clermont Univ, Immunol Lab, UFR Med Pharm,EA4233, Clermont Ferrand, France; [Coudeyras, Sophie; Charbonnel, Nicolas; Forestier, Christiane] Univ Auvergne, Clermont Univ, Bacteriol Lab, UFR Pharm, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA)	Evrard, B (corresponding author), CHU Clermont Ferrand, Immunol Lab, Clermont Ferrand, France.	bevrard@chu-clermontferrand.fr	Evrard, Bertrand/D-7479-2019	Evrard, Bertrand/0000-0001-5839-0695				Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2009, EUR J IMMUNOL, V39, P637, DOI 10.1002/eji.200839050; Arques JL, 2009, GASTROENTEROLOGY, V137, P579, DOI 10.1053/j.gastro.2009.04.010; Baba N, 2008, J LEUKOCYTE BIOL, V84, P468, DOI 10.1189/jlb.0108017; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Camilleri M, 2008, J CLIN GASTROENTEROL, V42, pS123, DOI 10.1097/MCG.0b013e3181574393; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Cools N, 2007, J LEUKOCYTE BIOL, V82, P1365, DOI 10.1189/jlb.0307166; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Coudeyras S, 2008, APPL ENVIRON MICROB, V74, P2679, DOI 10.1128/AEM.02286-07; Coudeyras Sophie, 2008, Infect Dis Obstet Gynecol, V2008, P549640, DOI 10.1155/2008/549640; De Champs C, 2003, J CLIN MICROBIOL, V41, P1270, DOI 10.1128/JCM.41.3.1270-1273.2003; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Dogi CA, 2008, CYTOKINE, V41, P223, DOI 10.1016/j.cyto.2007.11.014; Drakes M, 2004, INFECT IMMUN, V72, P3299, DOI 10.1128/IAI.72.6.3299-3309.2004; Fang SB, 2009, J TROP PEDIATRICS, V55, P297, DOI 10.1093/tropej/fmp001; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hedin C, 2007, P NUTR SOC, V66, P307, DOI 10.1017/S0029665107005563; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Lammers KM, 2003, FEMS IMMUNOL MED MIC, V38, P165, DOI 10.1016/S0928-8244(03)00144-5; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Mazzoni A, 2004, J LEUKOCYTE BIOL, V75, P721, DOI 10.1189/jlb.1003482; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Niers LEM, 2007, CLIN EXP IMMUNOL, V149, P344, DOI 10.1111/j.1365-2249.2007.03421.x; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Ongol MP, 2008, BIOSCI BIOTECH BIOCH, V72, P2847, DOI 10.1271/bbb.80307; Pochard P, 2002, J ALLERGY CLIN IMMUN, V110, P617, DOI 10.1067/mai.2002.128528; Quah BJC, 2005, J CELL MOL MED, V9, P643, DOI 10.1111/j.1582-4934.2005.tb00494.x; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Sabatte J, 2007, CYTOKINE GROWTH F R, V18, P5, DOI 10.1016/j.cytogfr.2007.01.002; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Torri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009404; van Baarlen P, 2010, P NATL ACAD SCI US; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vidal M, 2010, J CLIN MICROBIOL, V48, P2595, DOI 10.1128/JCM.00473-10; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Yu J, 2010, ALLERGY ASTHMA IMMUN, V2, P199, DOI 10.4168/aair.2010.2.3.199; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	45	73	84	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18735	10.1371/journal.pone.0018735	http://dx.doi.org/10.1371/journal.pone.0018735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533162	Green Published, Green Submitted, gold			2022-12-25	WOS:000289620100014
J	Garcia-Torres, I; Cabrera, N; Torres-Larios, A; Rodriguez-Bolanos, M; Diaz-Mazariegos, S; Gomez-Puyou, A; Perez-Montfort, R				Garcia-Torres, Itzhel; Cabrera, Nallely; Torres-Larios, Alfredo; Rodriguez-Bolanos, Monica; Diaz-Mazariegos, Selma; Gomez-Puyou, Armando; Perez-Montfort, Ruy			Identification of Amino Acids that Account for Long-Range Interactions in Two Triosephosphate Isomerases from Pathogenic Trypanosomes	PLOS ONE			English	Article							SPECIES-SPECIFIC INHIBITION; INTERFACE; RESIDUES; CYSTEINE; BRUCEI; SUSCEPTIBILITY; PROTEINS; ENZYME; CRUZI	For a better comprehension of the structure-function relationship in proteins it is necessary to identify the amino acids that are relevant for measurable protein functions. Because of the numerous contacts that amino acids establish within proteins and the cooperative nature of their interactions, it is difficult to achieve this goal. Thus, the study of protein-ligand interactions is usually focused on local environmental structural differences. Here, using a pair of triosephosphate isomerase enzymes with extremely high homology from two different organisms, we demonstrate that the control of a seventy-fold difference in reactivity of the interface cysteine is located in several amino acids from two structurally unrelated regions that do not contact the cysteine sensitive to the sulfhydryl reagent methylmethane sulfonate, nor the residues in its immediate vicinity. The change in reactivity is due to an increase in the apparent pKa of the interface cysteine produced by the mutated residues. Our work, which involved grafting systematically portions of one protein into the other protein, revealed unsuspected and multisite long-range interactions that modulate the properties of the interface cysteines and has general implications for future studies on protein structure-function relationships.	[Garcia-Torres, Itzhel; Cabrera, Nallely; Torres-Larios, Alfredo; Rodriguez-Bolanos, Monica; Diaz-Mazariegos, Selma; Gomez-Puyou, Armando; Perez-Montfort, Ruy] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Garcia-Torres, I (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	ruy@ifc.unam.mx		Perez-Montfort, Ruy/0000-0003-0810-1159; Rodriguez Bolanos, Monica/0000-0002-9937-404X; Cabrera Gonzalez, Elizabeth Nallely/0000-0001-8766-6996; Torres-Larios, Alfredo/0000-0002-0702-350X; Garcia, Itzhel/0000-0002-3018-060X	Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [IN200507, IN202910]; Instituto de Ciencia y Tecnologia del Distrito Federal [304/2009, PIFUTP09-279]; Universidad Nacional Autonoma de Mexico; CONACyT [177322]	Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (IN200507 and IN202910) and by the Instituto de Ciencia y Tecnologia del Distrito Federal (304/2009 and PIFUTP09-279) to RPM and ATL, respectively, and also by the Universidad Nacional Autonoma de Mexico. IGT was the recipient of a fellowship from CONACyT (No. 177322). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x; Cabrera N, 2008, BIOCHEMISTRY-US, V47, P3499, DOI 10.1021/bi702439r; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Garza-Ramos G, 1998, EUR J BIOCHEM, V253, P684, DOI 10.1046/j.1432-1327.1998.2530684.x; GarzaRamos G, 1996, EUR J BIOCHEM, V241, P114, DOI 10.1111/j.1432-1033.1996.0114t.x; GomezPuyou A, 1995, CHEM BIOL, V2, P847, DOI 10.1016/1074-5521(95)90091-8; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; He Y, 2008, P NATL ACAD SCI USA, V105, P14412, DOI 10.1073/pnas.0805857105; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Law PY, 1999, BIOPOLYMERS, V51, P440, DOI 10.1002/(SICI)1097-0282(1999)51:6<440::AID-BIP6>3.0.CO;2-T; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; Maldonado E, 1997, PROTEIN PEPTIDE LETT, V4, P139; Maldonado E, 1998, J MOL BIOL, V283, P193, DOI 10.1006/jmbi.1998.2094; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OstoaSaloma P, 1997, EUR J BIOCHEM, V244, P700, DOI 10.1111/j.1432-1033.1997.00700.x; Perez-Montfort R, 1999, BIOCHEMISTRY-US, V38, P4114, DOI 10.1021/bi982425s; Perez-Montfort Ruy, 2002, Current Topics in Medicinal Chemistry, V2, P457, DOI 10.2174/1568026024607454; Reyes-Vivas H, 2002, PROTEINS, V48, P580, DOI 10.1002/prot.10179; Reyes-Vivas H, 2001, BIOCHEMISTRY-US, V40, P3134, DOI 10.1021/bi002619j; Sadelain M, 2009, CURR OPIN IMMUNOL, V21, P215, DOI 10.1016/j.coi.2009.02.009; Tellez-Valencia A, 2002, BIOCHEM BIOPH RES CO, V295, P958, DOI 10.1016/S0006-291X(02)00796-9; Yin DZ, 2004, MOL PHARMACOL, V65, P1323, DOI 10.1124/mol.65.6.1323; Yuan SM, 1998, PROTEINS, V30, P136, DOI 10.1002/(SICI)1097-0134(19980201)30:2<136::AID-PROT3>3.0.CO;2-L; Zomosa-Signoret V, 2003, BIOCHEMISTRY-US, V42, P3311, DOI 10.1021/bi0206560	28	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18791	10.1371/journal.pone.0018791	http://dx.doi.org/10.1371/journal.pone.0018791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533154	Green Submitted, gold, Green Published			2022-12-25	WOS:000289620100018
J	Le, TVL; Mironova, E; Garcin, D; Compans, RW				Le, Thuc-vy L.; Mironova, Elena; Garcin, Dominique; Compans, Richard W.			Induction of Influenza-Specific Mucosal Immunity by an Attenuated Recombinant Sendai Virus	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; LIPID RAFT MICRODOMAINS; RESPIRATORY-TRACT; A VIRUS; PARAINFLUENZA; HEMAGGLUTININ; VACCINE; TYPE-1; MICE; IGA	Background: Many pathogens initiate infection at the mucosal surfaces; therefore, induction of mucosal immune responses is a first level of defense against infection and is the most powerful means of protection. Although intramuscular injection is widely used for vaccination and is effective at inducing circulating antibodies, it is less effective at inducing mucosal antibodies. Methodology/Principal Findings: Here we report a novel recombinant, attenuated Sendai virus vector (GP42-H1) in which the hemagglutinin (HA) gene of influenza A virus was introduced into the Sendai virus genome as an additional gene. Infection of CV-1 cells by GP42-H1 resulted in cell surface expression of the HA protein. Intranasal immunization of mice with 1,000 plaque forming units (pfu) of GP42-H1 induced HA-specific IgG and IgA antibodies in the blood, brochoalveolar lavage fluid, fecal pellet extracts and saliva. The HA-specific antibody titer induced by GP42-H1 closely resembles the titer induced by sublethal infection by live influenza virus; however, in contrast to infection by influenza virus, immunization with GP42-H1 did not result in disease symptoms or the loss of body weight. In mice that were immunized with GP42-H1 and then challenged with 5LD(50) (1250 pfu) of influenza virus, no significant weight loss was observed and other visual signs of morbidity were not detected. Conclusions: These results demonstrate that the GP42-H1 Sendai virus recombinant is able to confer full protection from lethal infection by influenza virus, supporting the conclusion that it is a safe and effective mucosal vaccine vector.	[Le, Thuc-vy L.; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Le, Thuc-vy L.; Compans, Richard W.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Mironova, Elena; Garcin, Dominique] Univ Geneva, Sch Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland	Emory University; Emory University; University of Geneva	Le, TVL (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu	Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X	National Institute of Allergy and Infectious Diseases [AI064337, AI074579]; NIH [AI074492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579, T32AI074492] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants AI064337 and AI074579 from the National Institute of Allergy and Infectious Diseases. TVL was supported by NIH grant AI074492. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agungpriyono DR, 1999, J VET MED SCI, V61, P1299; Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; CHANOCK RM, 2001, FIELDS VIROLOGY, V1, P1341; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; CORNWELL HJC, 1976, VET REC, V98, P301, DOI 10.1136/vr.98.15.301; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; DiNapoli JM, 2007, J VIROL, V81, P11560, DOI 10.1128/JVI.00713-07; DiNapoli JM, 2007, P NATL ACAD SCI USA, V104, P9788, DOI 10.1073/pnas.0703584104; Ertl HCJ, 1996, J IMMUNOL, V156, P3579; Garcin D, 1998, VIROLOGY, V243, P340, DOI 10.1006/viro.1998.9063; Garcin D, 1995, EMBO J, V14, P6087, DOI 10.1002/j.1460-2075.1995.tb00299.x; GLEZEN WP, 1984, J INFECT DIS, V150, P851, DOI 10.1093/infdis/150.6.851; GORMAN WL, 1990, VIROLOGY, V175, P211, DOI 10.1016/0042-6822(90)90201-2; HENRICKSON KJ, 1991, J INFECT DIS, V164, P1128, DOI 10.1093/infdis/164.6.1128; HETHERINGTON SV, 1994, J INFECT DIS, V169, P248, DOI 10.1093/infdis/169.2.248; Hurwitz JL, 1997, VACCINE, V15, P533, DOI 10.1016/S0264-410X(97)00217-X; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Ito R, 2003, VACCINE, V21, P2362, DOI 10.1016/S0264-410X(03)00078-1; Jartti T, 2008, EUR RESPIR J, V32, P314, DOI 10.1183/09031936.00161907; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; KUROYA M., 1953, YOKOHAMA MED BULL, V4, P217; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; LYN D, 1991, J GEN VIROL, V72, P983, DOI 10.1099/0022-1317-72-4-983; Maeda Y, 2005, J VIROL, V79, P6674, DOI 10.1128/JVI.79.11.6674-6679.2005; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; MORGADO MG, 1989, EMBO J, V8, P3245, DOI 10.1002/j.1460-2075.1989.tb08484.x; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; ORTBALS DW, 1978, J CLIN MICROBIOL, V8, P431; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; ROTH MG, 1983, CELL, V33, P435, DOI 10.1016/0092-8674(83)90425-7; ROTH MG, 1979, P NATL ACAD SCI USA, V76, P6430, DOI 10.1073/pnas.76.12.6430; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; SANGSTER M, 1995, VIROLOGY, V212, P13, DOI 10.1006/viro.1995.1448; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Slobod KS, 2004, VACCINE, V22, P3182, DOI 10.1016/j.vaccine.2004.01.053; Steel J, 2008, VACCINE, V26, P522, DOI 10.1016/j.vaccine.2007.11.032; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Takimoto T, 2005, VIRAL IMMUNOL, V18, P255, DOI 10.1089/vim.2005.18.255; Takimoto T, 1998, J VIROL, V72, P9747, DOI 10.1128/JVI.72.12.9747-9754.1998; TAMURA S, 1990, VACCINE, V8, P479, DOI 10.1016/0264-410X(90)90250-P; Tompkins SM, 2007, VIROLOGY, V362, P139, DOI 10.1016/j.virol.2006.12.005; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; World Health Organization, 2002, WHO MAN AN INFL DIAG; Yonemitsu Y, 2000, NAT BIOTECHNOL, V18, P970, DOI 10.1038/79463; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000	48	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18780	10.1371/journal.pone.0018780	http://dx.doi.org/10.1371/journal.pone.0018780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533151	Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100016
J	Walker, KA; Sims-Lucas, S; Caruana, G; Cullen-McEwen, L; Li, JH; Sarraj, MA; Bertram, JF; Stenvers, KL				Walker, Kenneth A.; Sims-Lucas, Sunder; Caruana, Georgina; Cullen-McEwen, Luise; Li, Jinhua; Sarraj, Mai A.; Bertram, John F.; Stenvers, Kaye L.			Betaglycan Is Required for the Establishment of Nephron Endowment in the Mouse	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; METANEPHRIC KIDNEY DEVELOPMENT; URETERAL BUD OUTGROWTH; BRANCHING MORPHOGENESIS; TRANSFORMING GROWTH-FACTOR-BETA-1; TUMOR-SUPPRESSOR; EARLY ORGANOGENESIS; MAMMALIAN KIDNEY; III RECEPTOR; MUTANT MICE	Betaglycan is an accessory receptor for the transforming growth factor-beta (TGF beta) superfamily, many members of which play key roles in kidney development. The purpose of this study was to define the role of this co-receptor on fetal murine kidney development. Stereological examination of embryonic and adult betaglycan heterozygous kidneys revealed augmented nephron number relative to littermate controls. Fetal heterozygous kidneys exhibited accelerated ureteric branching, which correlated with augmented nephron development at embryonic day (e) 15.5. In contrast, betaglycan null kidneys exhibited renal hypoplasia from e13.5 and reduced nephron number at e15.5. Quantitative real-time PCR analysis of e11.5-e14.5 kidneys demonstrated that heterozygous kidneys exhibited a transient decrease in Bmp4 expression at e11.5 and a subsequent cascade of changes in the gene regulatory network that governs metanephric development, including significant increases in Pax2, Eya1, Gdnf, Ret, Wnt4, and Wt1 expression. Conversely, gene expression in null kidneys was normal until e13.5, when significant reductions were detected in the expression of Bmp4 as well as other key metanephric regulatory genes. Tgfb1 and Tgfb2 mRNA expression was down-regulated in both nulls and heterozygotes at e13.5 and e14.5. The opposing morphological and molecular phenotypes in betaglycan heterozygote and null mutants demonstrate that the levels of betaglycan must be tightly regulated for optimal kidney development.	[Walker, Kenneth A.; Sims-Lucas, Sunder; Caruana, Georgina; Cullen-McEwen, Luise; Li, Jinhua; Bertram, John F.; Stenvers, Kaye L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Walker, Kenneth A.; Sarraj, Mai A.; Stenvers, Kaye L.] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Sims-Lucas, Sunder] UPMC, Rangos Res Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Monash University; Prince Henry's Institute of Medical Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Walker, KA (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	Kenneth.Walker@princehenrys.org	Bertram, John F/I-2588-2014; Li, Jinhua/I-2741-2014	Bertram, John F/0000-0001-5863-6464; Li, Jinhua/0000-0003-4039-5759; Cullen-McEwen, Luise/0000-0003-2229-5762; Sims-Lucas, Sunder/0000-0003-1908-4809; Sarraj, Mai/0000-0001-9891-8159	National Health and Medical Research Council [338516]; National Heart Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation(National Heart Foundation of Australia)	Funding for this project came from a National Health and Medical Research Council Project grant #338516, 'Role of betaglycan in gonadal and adrenal tumourigenesis'. KAW was funded by a National Heart Foundation Postgraduate Biomedical Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram J F, 1992, Trends Cell Biol, V2, P177, DOI 10.1016/0962-8924(92)90038-O; Bertram JF, 1995, INT REV CYTOL, V161, P111; Bilandzic M, 2009, MOL ENDOCRINOL, V23, P539, DOI 10.1210/me.2008-0300; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Bush KT, 2004, DEV BIOL, V266, P285, DOI 10.1016/j.ydbio.2003.10.023; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Clarke JC, 2006, HUM MOL GENET, V15, P3420, DOI 10.1093/hmg/ddl418; Compton LA, 2007, CIRC RES, V101, P784, DOI 10.1161/CIRCRESAHA.107.152082; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; Cullen-McEwen LA, 2001, KIDNEY INT, V60, P31, DOI 10.1046/j.1523-1755.2001.00767.x; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Esparza-Lopez J, 2001, J BIOL CHEM, V276, P14588, DOI 10.1074/jbc.M008866200; Esquela AF, 2003, DEV BIOL, V257, P356, DOI 10.1016/S0012-1606(03)00100-3; HACKER A, 1995, DEVELOPMENT, V121, P1603; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Lewis KA, 2000, NATURE, V404, P411, DOI 10.1038/35006129; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Meyer TN, 2004, DEV BIOL, V275, P44, DOI 10.1016/j.ydbio.2004.07.022; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Oxburgh L, 2004, DEVELOPMENT, V131, P4593, DOI 10.1242/dev.01324; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Plisov SY, 2001, DEVELOPMENT, V128, P1045; Sakurai H, 1997, AM J PHYSIOL-RENAL, V272, pF139, DOI 10.1152/ajprenal.1997.272.1.F139; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sarraj MA, 2007, GROWTH FACTORS, V25, P334, DOI 10.1080/08977190701833619; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Sims-Lucas S, 2008, PEDIATR RES, V63, P607, DOI 10.1203/PDR.0b013e31816d9130; Sims-Lucas S, 2010, DIFFERENTIATION, V79, P272, DOI 10.1016/j.diff.2010.01.004; SIMSLUCAS S, 2007, INVESTIGATING ROLE T; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Stenvers KL, 2003, MOL CELL BIOL, V23, P4371, DOI 10.1128/MCB.23.12.4371-4385.2003; Tang BW, 1998, NAT MED, V4, P802, DOI 10.1038/nm0798-802; Tomoda T, 1996, DEV BIOL, V179, P79, DOI 10.1006/dbio.1996.0242; Valerius MT, 2008, GENE EXPR PATTERNS, V8, P297, DOI 10.1016/j.gep.2008.02.001; Walker KA, 2009, NEPHRON EXP NEPHROL, V111, pE42, DOI 10.1159/000191104; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; Winyard P, 2008, SEMIN FETAL NEONAT M, V13, P142, DOI 10.1016/j.siny.2007.10.009; Xu PX, 2003, DEVELOPMENT, V130, P3085, DOI 10.1242/dev.00536; Zhao JS, 1998, MECH DEVELOP, V75, P67, DOI 10.1016/S0925-4773(98)00083-5	51	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18723	10.1371/journal.pone.0018723	http://dx.doi.org/10.1371/journal.pone.0018723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533152	Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100012
J	Cao, J; Chen, QL; Zhang, HQ; Qi, PP; Liu, C; Yang, XF; Wang, NS; Qian, BH; Wang, JH; Jiang, SH; Yang, H; Sun, SH; Pan, W				Cao, Jie; Chen, Qiuli; Zhang, Huaqun; Qi, Peipei; Liu, Chao; Yang, Xufang; Wang, Niansong; Qian, Baohua; Wang, Jinhong; Jiang, Shaohua; Yang, Hua; Sun, Shuhan; Pan, Wei			Novel Evolved Immunoglobulin (Ig)-Binding Molecules Enhance the Detection of IgM against Hepatitis C Virus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; B-CELL ACTIVATION; ANTI-HCV; CLINICAL-COURSE; NON-A; 2ND-GENERATION; HEMODIALYSIS; ANTIBODIES; INFECTION; BINDING	Detection of specific antibodies against hepatitis C virus (HCV) is the most widely available test for viral diagnosis and monitoring of HCV infections. However, narrowing the serologic window of anti-HCV detection by enhancing anti-HCV IgM detection has remained to be a problem. Herein, we used LD5, a novel evolved immunoglobulin-binding molecule (NEIBM) with a high affinity for IgM, to develop a new anti-HCV enzyme-linked immunosorbent assay (ELISA) using horseradish peroxidase-labeled LD5 (HRP-LD5) as the conjugated enzyme complex. The HRP-LD5 assay showed detection efficacy that is comparable with two kinds of domestic diagnostic kits and the Abbott 3.0 kit when tested against the national reference panel. Moreover, the HRP-LD5 assay showed a higher detection rate (55.9%, 95% confidence intervals (95% CI, 0.489, 0.629) than that of a domestic diagnostic ELISA kit (Chang Zheng) (53.3%, 95% CI 0.463, 0.603) in 195 hemodialysis patient serum samples. Five serum samples that were positive using the HRP-LD5 assay and negative with the conventional anti-HCV diagnostic ELISA kits were all positive for HCV RNA, and 4 of them had detectable antibodies when tested with the established anti-HCV IgM assay. An IgM confirmation study revealed the IgM reaction nature of these five serum samples. These results demonstrate that HRP-LD5 improved anti-HCV detection by enhancing the detection of anti-HCV IgM, which may have potential value for the early diagnosis and screening of hepatitis C and other infectious diseases.	[Cao, Jie; Chen, Qiuli; Zhang, Huaqun; Qi, Peipei; Liu, Chao; Yang, Xufang; Wang, Jinhong; Jiang, Shaohua; Yang, Hua; Pan, Wei] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China; [Wang, Niansong] Fudan Univ, Zhongshan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Wang, Niansong] Shanghai Jiao Tong Univ, Dept Nephrol, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Qian, Baohua] Second Mil Med Univ, Changhai Hosp, Dept Blood Transfus, Shanghai, Peoples R China; [Jiang, Shaohua] Mil Gen Hosp Tibet PLA, Dept Cardiothorac Surg, Lasa, Peoples R China; [Yang, Hua] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai Key Lab TB, Shanghai 200092, Peoples R China; [Sun, Shuhan] Second Mil Med Univ, Dept Med Genet, Shanghai, Peoples R China	Naval Medical University; Fudan University; Shanghai Jiao Tong University; Naval Medical University; Tongji University; Naval Medical University	Cao, J (corresponding author), Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai, Peoples R China.	pwpanwei@yahoo.com.cn			National Natural Science Foundation of China (NSFC) [30872405, 30872246, 30972632, 30972799]; Shanghai Committee of Science and Technology [05dz19317]; National High Biotechnology Development Program of China [2006AA02A238]; Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases [2009ZX10004-105]; Chinese National Key Special Project for Major New Drug Discovery [2011ZX09506-001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National High Biotechnology Development Program of China(National High Technology Research and Development Program of China); Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases; Chinese National Key Special Project for Major New Drug Discovery	This study was funded by the National Natural Science Foundation of China (NSFC) [Grant numbers 30872405, 30872246, 30972632 and 30972799], Shanghai Committee of Science and Technology [05dz19317], National High Biotechnology Development Program of China [2006AA02A238], the Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases [2009ZX10004-105] and the Chinese National Key Special Project for Major New Drug Discovery [2011ZX09506-001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACH RD, 1991, NEW ENGL J MED, V325, P1325, DOI 10.1056/NEJM199111073251901; Abdel-Hamid M, 2002, J CLIN MICROBIOL, V40, P1656, DOI 10.1128/JCM.40.5.1656-1659.2002; AKBAR SMF, 1993, GASTROENTEROL JPN, V28, P71, DOI 10.1007/BF02989210; Al-Faleh F Z, 1995, Saudi J Kidney Dis Transpl, V6, P118; ALTER HJ, 1992, HEPATOLOGY, V15, P350, DOI 10.1002/hep.1840150228; [Anonymous], 1997, HEPATOLOGY, V26, pS2; BOERO R, 1995, RENAL FAILURE, V17, P565, DOI 10.3109/08860229509037621; Chevrier MC, 2004, HYBRIDOMA HYBRIDOM, V23, P362, DOI 10.1089/hyb.2004.23.362; FARCI P, 1991, NEW ENGL J MED, V325, P98, DOI 10.1056/NEJM199107113250205; GARSON JA, 1990, LANCET, V335, P1419, DOI 10.1016/0140-6736(90)91446-H; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Gretch DR, 1997, HEPATOLOGY, V26, pS43, DOI 10.1002/hep.510260708; HINO K, 1994, DIGEST DIS SCI, V39, P19, DOI 10.1007/BF02090055; HUANG CS, 1993, J CLIN MICROBIOL, V31, P1764, DOI 10.1128/JCM.31.7.1764-1769.1993; Jiang SHH, 2008, DNA CELL BIOL, V27, P423, DOI 10.1089/dna.2007.0708; KIKUCHI T, 1992, J GASTROEN HEPATOL, V7, P246, DOI 10.1111/j.1440-1746.1992.tb00972.x; KLEINMAN S, 1992, TRANSFUSION, V32, P805, DOI 10.1046/j.1537-2995.1992.32993110750.x; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Leon P, 1996, VOX SANG, V70, P213, DOI 10.1159/000462118; Liesenfeld O, 1997, J CLIN MICROBIOL, V35, P174, DOI 10.1128/JCM.35.1.174-178.1997; MURPHY RM, 1988, BIOPHYS J, V54, P45, DOI 10.1016/S0006-3495(88)82929-1; OKAMOTO H, 1990, JPN J EXP MED, V60, P215; PUOTI M, 1992, HEPATOLOGY, V16, P877, DOI 10.1002/hep.1840160404; Quinti I, 1995, J HEPATOL, V23, P640, DOI 10.1016/0168-8278(95)80028-X; QUIROGA JA, 1991, HEPATOLOGY, V14, P38, DOI 10.1002/hep.1840140107; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; RUDICH SM, 1985, J EXP MED, V162, P1236, DOI 10.1084/jem.162.4.1236; Souqiyyeh M Z, 1995, Saudi J Kidney Dis Transpl, V6, P167; VERHOFSTEDE C, 1989, J CLIN PATHOL, V42, P1285, DOI 10.1136/jcp.42.12.1285; Wang NS, 2000, WORLD J GASTROENTERO, V6, P888, DOI 10.3748/wjg.v6.i6.888; WANG NS, 1998, GUOWAI YIXUE LIUXING, V25, P115; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902; Yamaguchi N, 2000, CAN J GASTROENTEROL, V14, P593, DOI 10.1155/2000/248139; Yang H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-137; ZAAIJER HL, 1993, J MED VIROL, V40, P184, DOI 10.1002/jmv.1890400303	35	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18477	10.1371/journal.pone.0018477	http://dx.doi.org/10.1371/journal.pone.0018477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533225	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600006
J	Sim, BKL; Narum, DL; Chattopadhyay, R; Ahumada, A; Haynes, JD; Fuhrmann, SR; Wingard, JN; Liang, H; Moch, JK; Hoffman, SL				Sim, B. Kim Lee; Narum, David L.; Chattopadhyay, Rana; Ahumada, Adriana; Haynes, J. David; Fuhrmann, Steven R.; Wingard, Jennifer N.; Liang, Hong; Moch, J. Kathleen; Hoffman, Stephen L.			Delineation of Stage Specific Expression of Plasmodium falciparum EBA-175 by Biologically Functional Region II Monoclonal Antibodies	PLOS ONE			English	Article							ERYTHROCYTE BINDING ANTIGEN; MALARIA PARASITES; RECEPTOR-BINDING; INFECTED ERYTHROCYTES; MEROZOITE INVASION; PROTEINS; SURFACE; VACCINE; FAMILY; DOMAIN	Background: The malaria parasite Plasmodium falciparum EBA-175 binds its receptor sialic acids on glycophorin A when invading erythrocytes. The receptor-binding region (RII) contains two cysteine-rich domains with similar cysteine motifs (F1 and F2). Functional relationships between F1 and F2 domains and characterization of EBA-175 were studied using specific monoclonal antibodies (mAbs) against these domains. Methods and Findings: Five mAbs specific for F1 or F2 were generated. Three mAbs specific for F2 potently blocked binding of EBA-175 to erythrocytes, and merozoite invasion of erythrocytes (IC(50) 10 to 100 mu g/ml IgG in growth inhibition assays). A mAb specific for F1 blocked EBA-175 binding and merozoite invasion less effectively. The difference observed between the IC(50) of F1 and F2 mAbs was not due to differing association and disassociation rates as determined by surface plasmon resonance. Four of the mAbs recognized conformation-dependent epitopes within F1 or F2. Used in combination, F1 and F2 mAbs blocked the binding of native EBA-175 to erythrocytes and inhibited parasite invasion synergistically in vitro. MAb R217, the most potent, did not recognize sporozoites, 3-day hepatocyte stage parasites, nor rings, trophozoites, gametocytes, retorts, ookinetes, and oocysts but recognized 6-day hepatocyte stage parasites, and schizonts. Even though efficient at blocking binding to erythrocytes and inhibiting invasion into erythrocytes, MAb R217 did not inhibit sporozoite invasion and development in hepatocytes in vitro. Conclusions: The role of the F1 and F2 domains in erythrocyte invasion and binding was elucidated with mAbs. These mAbs interfere with native EBA-175 binding to erythrocyte in a synergistic fashion. The stage specific expression of EBA-175 showed that the primary focus of activity was the merozoite stage. A recombinant RII protein vaccine consisting of both F1 and F2 domains that could induce synergistic activity should be optimal for induction of antibody responses that interfere with merozoite invasion of erythrocytes.	[Sim, B. Kim Lee; Ahumada, Adriana; Hoffman, Stephen L.] Prot Potential LLC, Rockville, MD USA; [Narum, David L.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Chattopadhyay, Rana; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Haynes, J. David; Moch, J. Kathleen] US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Fuhrmann, Steven R.] Intercell USA, Gaithersburg, MD USA; [Wingard, Jennifer N.] Univ Virginia, Dept Mol Physiol & Biophys, Charlottesville, VA USA; [Liang, Hong] Infect Dis Res Inst, Seattle, WA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sanaria Inc.; University of Virginia	Sim, BKL (corresponding author), Prot Potential LLC, Rockville, MD USA.	ksim@protpot.com		Narum, David/0000-0003-3041-5402	Phase II National Institute of Allergy and Infectious Diseases (NIAID) Small Business Innovative Research [AI36758]; EntreMed Inc; Protein Potential; Sanaria Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI036758, R44AI036758] Funding Source: NIH RePORTER	Phase II National Institute of Allergy and Infectious Diseases (NIAID) Small Business Innovative Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EntreMed Inc; Protein Potential; Sanaria Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially funded by a Phase II National Institute of Allergy and Infectious Diseases (NIAID) Small Business Innovative Research Grant, AI36758 supplement awarded to BKLS. The authors BKLS, DLN, SRF, JNW and HL were employees of EntreMed Inc (funder). Currently BKLS, AA and SLH are employees of Protein Potential (funder) and the role they played on this manuscript was funded by Protein Potential. As the authors BKLS, DLN, SRF, JNW and HL were employees of EntreMed Inc. and BLKS, AA and SLH are employees of Protein Potential, the funders EntreMed and Protein Potential did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RC and SLH are also employees of Sanaria Inc. (funder) but their role on this manuscript was funded by Protein Potential. SRF is currently an employee of Intercell but only reviewed the manuscript at this time. Intercell provided no support for this project.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; ANDRYSIAK PM, 1986, AM J TROP MED HYG, V35, P251, DOI 10.4269/ajtmh.1986.35.251; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Charoenvit Y, 1997, INFECT IMMUN, V65, P3430, DOI 10.1128/IAI.65.8.3430-3437.1997; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; DEANS JA, 1978, PARASITOLOGY, V77, P333, DOI 10.1017/S0031182000050290; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Gruner AC, 2001, J INFECT DIS, V184, P892, DOI 10.1086/323394; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; Haynes J David, 2002, Methods Mol Med, V72, P535, DOI 10.1385/1-59259-271-6:535; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Jones TR, 2001, J INFECT DIS, V183, P303, DOI 10.1086/317933; Liang H, 2000, INFECT IMMUN, V68, P3564, DOI 10.1128/IAI.68.6.3564-3568.2000; Liang H, 1997, MOL BIOCHEM PARASIT, V84, P241, DOI 10.1016/S0166-6851(96)02791-0; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; MELLOUK S, 1990, B WORLD HEALTH ORGAN, V68, P52; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Narum DL, 2000, INFECT IMMUN, V68, P1964, DOI 10.1128/IAI.68.4.1964-1966.2000; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; ORLANDI PA, 1990, MOL BIOCHEM PARASIT, V40, P285, DOI 10.1016/0166-6851(90)90050-V; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; SIM BKL, 1992, MOL BIOCHEM PARASIT, V51, P157, DOI 10.1016/0166-6851(92)90211-2; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Sim BKL, 2001, MOL MED, V7, P247, DOI 10.1007/BF03401844; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Szunerits S, 2006, LANGMUIR, V22, P10716, DOI 10.1021/la060793o; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200; VERNES A, 1984, AM J TROP MED HYG, V33, P197, DOI 10.4269/ajtmh.1984.33.197	41	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18393	10.1371/journal.pone.0018393	http://dx.doi.org/10.1371/journal.pone.0018393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533224	Green Submitted, gold, Green Published			2022-12-25	WOS:000289505600004
J	Maurin, G; Fresquet, J; Granio, O; Wychowski, C; Cosset, FL; Lavillette, D				Maurin, Guillemette; Fresquet, Judith; Granio, Ophelia; Wychowski, Czeslaw; Cosset, Francois-Loic; Lavillette, Dimitri			Identification of Interactions in the E1E2 Heterodimer of Hepatitis C Virus Important for Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAINS; E2 GLYCOPROTEIN; NEUTRALIZING ANTIBODIES; HYPERVARIABLE REGION-1; ENVELOPE GLYCOPROTEINS; CHARGED RESIDUES; RECEPTOR; CD81; PSEUDOPARTICLES; LOCALIZATION	Several conserved domains critical for E1E2 assembly and hepatitis C virus entry have been identified in E1 and E2 envelope glycoproteins. However, the role of less conserved domains involved in cross-talk between either glycoprotein must be defined to fully understand how E1E2 undergoes conformational changes during cell entry. To characterize such domains and to identify their functional partners, we analyzed a set of intergenotypic E1E2 heterodimers derived from E1 and E2 of different genotypes. The infectivity of virions indicated that Con1 E1 did not form functional heterodimers when associated with E2 from H77. Biochemical analyses demonstrated that the reduced infectivity was not related to alteration of conformation and incorporation of Con1 E1/H77 E2 heterodimers but rather to cell entry defects. Thus, we generated chimeric E1E2 glycoproteins by exchanging different domains of each protein in order to restore functional heterodimers. We found that both the ectodomain and transmembrane domain of E1 influenced infectivity. Site-directed mutagenesis highlighted the role of amino acids 359, 373, and 375 in transmembrane domain in entry. In addition, we identified one domain involved in entry within the N-terminal part of E1, and we isolated a motif at position 219 that is critical for H77 function. Interestingly, using additional chimeric E1E2 complexes harboring substitutions in this motif, we found that the transmembrane domain of E1 acts as a partner of this motif. Therefore, we characterized domains of E1 and E2 that have co-evolved inside a given genotype to optimize their interactions and allow efficient entry.	[Maurin, Guillemette; Fresquet, Judith; Granio, Ophelia; Cosset, Francois-Loic; Lavillette, Dimitri] Univ Lyon 1, INSERM, IFR128, U758, F-69007 Lyon, France; [Maurin, Guillemette; Fresquet, Judith; Granio, Ophelia; Cosset, Francois-Loic; Lavillette, Dimitri] Ecole Normale Super Lyon, F-69007 Lyon, France; [Wychowski, Czeslaw] Univ Lille Nord France, Inst Pasteur Lille, INSERM, Ctr Infect & Immun Lille,CNRS,U1019,UMR8204, F-59021 Lille, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Cosset, FL (corresponding author), Ecole Normale Super Lyon, Unite Virol Humaine, INSERM, U758, 46 Allee Italie, F-69364 Lyon 07, France.	Flcosset@ens-lyon.fr; Dimitri.lavillette@ens-lyon.fr	Cosset, François-Loïc/M-5862-2019	Cosset, François-Loïc/0000-0001-8842-3726; Lavillette, Dimitri/0000-0002-4706-1519	Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales; FINOVI foundation; European Research Council [ERC-2008-AdG-233130-HEPCENT]	Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales(French National Research Agency (ANR)); FINOVI foundation; European Research Council(European Research Council (ERC)European Commission)	This work was supported by Agence Nationale pour la Recherche contre le SIDA et les Hepatites Virales, the FINOVI foundation, and by the European Research Council (ERC-2008-AdG-233130-HEPCENT).	Albecka A, 2011, J VIROL, V85, P1777, DOI 10.1128/JVI.02170-10; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003; BOWEN WD, 1992, J PHARMACOL EXP THER, V262, P32; Ciczora Y, 2005, J GEN VIROL, V86, P2793, DOI 10.1099/vir.0.81140-0; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cocquerel L, 2002, EMBO J, V21, P2893, DOI 10.1093/emboj/cdf295; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lamsoul I, 2005, MOL CELL BIOL, V25, P10391, DOI 10.1128/MCB.25.23.10391-10406.2005; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Leroux-Roels G, 2005, HUM VACCINES, V1, P61, DOI 10.4161/hv.1.2.1554; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LINDENBACH BD, 2007, FLAVIVIRIDAE VIRUSES, V1, P1001; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Mottola G, 2000, J BIOL CHEM, V275, P24070, DOI 10.1074/jbc.M910400199; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nevens F, 2003, HEPATOLOGY, V38, P1289, DOI 10.1053/jhep.2003.50474; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Patel AH, 2000, J GEN VIROL, V81, P2873, DOI 10.1099/0022-1317-81-12-2873; Patel J, 2001, VIROLOGY, V279, P58, DOI 10.1006/viro.2000.0693; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Rothwangl KB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-12; Russell RS, 2009, J VIRAL HEPATITIS, V16, P621, DOI 10.1111/j.1365-2893.2009.01111.x; Sandrin V, 2005, J GEN VIROL, V86, P3189, DOI 10.1099/vir.0.81428-0; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	52	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 8	2011	286	27					23865	23876		10.1074/jbc.M110.213942	http://dx.doi.org/10.1074/jbc.M110.213942			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	786HO	21555519	Green Published, hybrid			2022-12-25	WOS:000292294900029
J	Fukui, K; Wakamatsu, T; Agari, Y; Masui, R; Kuramitsu, S				Fukui, Kenji; Wakamatsu, Taisuke; Agari, Yoshihiro; Masui, Ryoji; Kuramitsu, Seiki			Inactivation of the DNA Repair Genes mutS, mutL or the Anti-Recombination Gene mutS2 Leads to Activation of Vitamin B-1 Biosynthesis Genes	PLOS ONE			English	Article							THERMUS-THERMOPHILUS HB8; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; MISMATCH REPAIR; OXIDATIVE STRESS; SUBSTRATE-SPECIFICITY; ENDONUCLEASE ACTIVITY; HELICOBACTER-PYLORI; EXCISION-REPAIR; IN-VITRO	Oxidative stress generates harmful reactive oxygen species (ROS) that attack biomolecules including DNA. In living cells, there are several mechanisms for detoxifying ROS and repairing oxidatively- damaged DNA. In this study, transcriptomic analyses clarified that disruption of DNA repair genes mutS and mutL, or the anti-recombination gene mutS2, in Thermus thermophilus HB8, induces the biosynthesis pathway for vitamin B-1, which can serve as an ROS scavenger. In addition, disruption of mutS, mutL, or mutS2 resulted in an increased rate of oxidative stress-induced mutagenesis. Coimmunoprecipitation and pull-down experiments revealed previously-unknown interactions of MutS2 with MutS and MutL, indicating that these proteins cooperatively participate in the repair of oxidatively damaged DNA. These results suggested that bacterial cells sense the accumulation of oxidative DNA damage or absence of DNA repair activity, and signal the information to the transcriptional regulation machinery for an ROS-detoxifying system.	[Fukui, Kenji; Agari, Yoshihiro; Masui, Ryoji; Kuramitsu, Seiki] RIKEN SPring 8 Ctr, Harima Inst, Kouto, Hyogo, Japan; [Wakamatsu, Taisuke; Agari, Yoshihiro; Kuramitsu, Seiki] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan	RIKEN; Osaka University; Osaka University	Fukui, K (corresponding author), RIKEN SPring 8 Ctr, Harima Inst, Kouto, Hyogo, Japan.	kuramitu@bio.sci.osaka-u.ac.jp	Wakamatsu, Taisuke/AAD-8007-2022	Fukui, Kenji/0000-0003-2463-7578	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20870042]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grants-in-Aid for Scientific Research (Grant 20870042 to K. F.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Agari Y, 2010, FEMS MICROBIOL LETT, V313, P127, DOI 10.1111/j.1574-6968.2010.02133.x; Agari Y, 2010, J MOL BIOL, V395, P270, DOI 10.1016/j.jmb.2009.10.057; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Arai T, 2002, CARCINOGENESIS, V23, P2005, DOI 10.1093/carcin/23.12.2005; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; BONNY C, 1991, BIOCHIM BIOPHYS ACTA, V1089, P213, DOI 10.1016/0167-4781(91)90010-J; Bulychev NV, 1996, BIOCHEMISTRY-US, V35, P13147, DOI 10.1021/bi960694h; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5398, DOI 10.1021/bi00391a027; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Fukui K, 2004, J BIOCHEM, V135, P375, DOI 10.1093/jb/mvh045; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Fukui K, 2008, J BIOL CHEM, V283, P33417, DOI 10.1074/jbc.M806755200; Gibson GE, 2007, ANTIOXID REDOX SIGN, V9, P1605, DOI 10.1089/ars.2007.1766; Harris RS, 1997, GENE DEV, V11, P2426, DOI 10.1101/gad.11.18.2426; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; JOVANOVIC SV, 1989, BIOCHIM BIOPHYS ACTA, V1008, P39, DOI 10.1016/0167-4781(89)90167-X; Jung IL, 2003, ENVIRON TOXICOL PHAR, V15, P19, DOI 10.1016/j.etap.2003.08.001; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kang J, 2005, J BACTERIOL, V187, P3528, DOI 10.1128/JB.187.10.3528-3537.2005; Kato R, 2001, J MOL BIOL, V309, P227, DOI 10.1006/jmbi.2001.4752; KOYAMA Y, 1986, J BACTERIOL, V166, P338, DOI 10.1128/jb.166.1.338-340.1986; Kung HC, 1997, J BIOL CHEM, V272, P9227; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LINDAHL T, 1990, MUTAT RES, V238, P305, DOI 10.1016/0165-1110(90)90022-4; Lukienko PI, 2000, B EXP BIOL MED+, V130, P874, DOI 10.1023/A:1015318413076; Luria SE, 1943, GENETICS, V28, P491; Macpherson P, 2005, NUCLEIC ACIDS RES, V33, P5094, DOI 10.1093/nar/gki813; Mauris J, 2010, J BIOL CHEM, V285, P11087, DOI 10.1074/jbc.M109.050955; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Mazurek A, 2002, J BIOL CHEM, V277, P8260, DOI 10.1074/jbc.M111269200; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Morita R, 2008, J BIOCHEM, V144, P267, DOI 10.1093/jb/mvn065; Okai Y, 2007, J CLIN BIOCHEM NUTR, V40, P42, DOI 10.3164/jcbn.40.42; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; PINARD R, 1993, FASEB J, V7, P173, DOI 10.1096/fasebj.7.1.7678560; Pinto AV, 2005, MOL CELL, V17, P113, DOI 10.1016/j.molcel.2004.11.035; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Rosenberg SM, 2003, SCIENCE, V300, P1382, DOI 10.1126/science.1085691; Sachadyn P, 2010, MUTAT RES-FUND MOL M, V694, P20, DOI 10.1016/j.mrfmmm.2010.08.009; Sakamoto K, 2008, GENE, V423, P153, DOI 10.1016/j.gene.2008.07.012; Salzano AM, 2008, METHOD ENZYMOL, V440, P3, DOI 10.1016/S0076-6879(07)00801-4; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Shimada A, 2010, NUCLEIC ACIDS RES, V38, P5692, DOI 10.1093/nar/gkq350; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Tian B, 2007, BBA-GEN SUBJECTS, V1770, P902, DOI 10.1016/j.bbagen.2007.01.016; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Vidales LE, 2009, J BACTERIOL, V191, P506, DOI 10.1128/JB.01210-08; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Wyrzykowski J, 2003, J BACTERIOL, V185, P1701, DOI 10.1128/JB.185.5.1701-1704.2003; Yamagata A, 2000, J BIOL CHEM, V275, P13235, DOI 10.1074/jbc.275.18.13235; Yoshida M, 1997, NUCLEIC ACIDS RES, V25, P1570, DOI 10.1093/nar/25.8.1570; Zhao JY, 2000, J BACTERIOL, V182, P5025, DOI 10.1128/JB.182.17.5025-5028.2000	72	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19053	10.1371/journal.pone.0019053	http://dx.doi.org/10.1371/journal.pone.0019053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552516	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700018
J	van Dijk, JH; Sutcliffe, CG; Munsanje, B; Sinywimaanzi, P; Hamangaba, F; Thuma, PE; Moss, WJ				van Dijk, Janneke H.; Sutcliffe, Catherine G.; Munsanje, Bornface; Sinywimaanzi, Pamela; Hamangaba, Francis; Thuma, Philip E.; Moss, William J.			HIV-Infected Children in Rural Zambia Achieve Good Immunologic and Virologic Outcomes Two Years after Initiating Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TREATMENT PROGRAM; ADHERENCE; FAILURE; PREDICTORS; CHALLENGES; EFAVIRENZ; COMMUNITY; TANZANIA; AFRICA	Background: Many HIV-infected children in sub-Saharan Africa reside in rural areas, yet most research on treatment outcomes has been conducted in urban centers. Rural clinics and residents may face unique barriers to care and treatment. Methods: A prospective cohort study of HIV-infected children was conducted between September 2007 and September 2010 at the rural HIV clinic in Macha, Zambia. HIV-infected children younger than 16 years of age at study enrollment who received antiretroviral therapy (ART) during the study were eligible. Treatment outcomes during the first two years of ART, including mortality, immunologic status, and virologic suppression, were assessed and risk factors for mortality and virologic suppression were evaluated. Results: A total of 69 children entered the study receiving ART and 198 initiated ART after study enrollment. The cumulative probabilities of death among children starting ART after study enrollment were 9.0% and 14.4% at 6 and 24 months after ART initiation. Younger age, higher viral load, lower CD4+ T-cell percentage and lower weight-for-age z-scores at ART initiation were associated with higher risk of mortality. The mean CD4(+) T-cell percentage increased from 16.3% at treatment initiation to 29.3% and 35.0% at 6 and 24 months. The proportion of children with undetectable viral load increased to 88.5% and 77.8% at 6 and 24 months. Children with longer travel times (>= 5 hours) and those taking nevirapine at ART initiation, as well as children who were non-adherent, were less likely to achieve virologic suppression after 6 months of ART. Conclusions: HIV-infected children receiving treatment in a rural clinic experienced sustained immunologic and virologic improvements. Children with longer travel times were less likely to achieve virologic suppression, supporting the need for decentralized models of ART delivery.	[van Dijk, Janneke H.; Munsanje, Bornface; Sinywimaanzi, Pamela; Hamangaba, Francis; Thuma, Philip E.] Macha Hosp, Macha Res Trust, Choma, Zambia; [Sutcliffe, Catherine G.; Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	van Dijk, JH (corresponding author), Macha Hosp, Macha Res Trust, Choma, Zambia.	wmoss@jhsph.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC) [U62/CCU322428]	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement U62/CCU322428 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Carlucci JG, 2008, JAIDS-J ACQ IMM DEF, V47, P615, DOI 10.1097/QAI.0b013e318165dc25; Central Statistical Office, 2002, DEM HLTH SURV ZAMB F; Ciaranello AL, 2009, CLIN INFECT DIS, V49, P1915, DOI 10.1086/648079; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Emmett SD, 2010, JAIDS-J ACQ IMM DEF, V54, P368, DOI 10.1097/QAI.0b013e3181cf4882; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Fredlund VG, 2007, J INFECT DIS, V196, pS469, DOI 10.1086/521115; Gusdal AK, 2009, AIDS CARE, V21, P1381, DOI 10.1080/09540120902883119; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kipp W, 2010, CURR HIV RES, V8, P179, DOI 10.2174/157016210790442722; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nyandiko WM, 2006, JAIDS-J ACQ IMM DEF, V43, P418, DOI 10.1097/01.qai.0000243122.52282.89; Ojikutu B, 2007, J INFECT DIS, V196, pS445, DOI 10.1086/521123; Posse M, 2009, AIDS PATIENT CARE ST, V23, P867, DOI 10.1089/apc.2009.0050; Puthanakit T, 2005, CLIN INFECT DIS, V41, P100, DOI 10.1086/430714; RONGKAVILIT C, 2007, J ADOLESC HLTH, V40; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Starr SE, 1999, NEW ENGL J MED, V341, P1874, DOI 10.1056/NEJM199912163412502; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Sutcliffe CG, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-54; *UNAIDS, 2008, 2008 REP GLOB AIDS E; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Wamalwa DC, 2007, JAIDS-J ACQ IMM DEF, V45, P311; WHO, 2001, IRON DEFICIENCY ANAE; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization (WHO), 2008, REP WHO TECHN REF GR	39	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19006	10.1371/journal.pone.0019006	http://dx.doi.org/10.1371/journal.pone.0019006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552521	Green Submitted, Green Published, gold			2022-12-25	WOS:000290020700013
J	Kang, JS; Lee, DW; Koh, YH; Lee, SH				Kang, Jae Soon; Lee, Dae-Weon; Koh, Young Ho; Lee, Si Hyeock			A Soluble Acetylcholinesterase Provides Chemical Defense against Xenobiotics in the Pinewood Nematode	PLOS ONE			English	Article							BUTYRYLCHOLINESTERASE GENETIC-VARIANTS; CAENORHABDITIS-ELEGANS; MOLECULAR-FORMS; BURSAPHELENCHUS-XYLOPHILUS; DEFICIENT MUTANTS; EXPRESSION; INHIBITION; PROTECTION; CHOLINESTERASES; TISSUE	The pinewood nematode genome encodes at least three distinct acetylcholinesterases (AChEs). To understand physiological roles of the three pinewood nematode AChEs (BxACE-1, BxACE-2, and BxACE-3), BxACE-3 in particular, their tissue distribution and inhibition profiles were investigated. Immunohistochemistry revealed that BxACE-1 and BxACE-2 were distributed in neuronal tissues. In contrast, BxACE-3 was detected from some specific tissues and extracted without the aid of detergent, suggesting its soluble nature unlike BxACE-1 and BxACE-2. When present together, BxAChE3 significantly reduced the inhibition of BxACE-1 and BxACE-2 by cholinesterase inhibitors. Knockdown of BxACE-3 by RNA interference significantly increased the toxicity of three nematicidal compounds, supporting the protective role of BxACE-3 against chemicals. In summary, BxACE-3 appears to have a non-neuronal function of chemical defense whereas both BxACE-1 and BxACE-2 have classical neuronal function of synaptic transmission.	[Kang, Jae Soon; Lee, Si Hyeock] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Lee, Dae-Weon; Koh, Young Ho] Hallym Univ, Ilsong Inst Life Sci, Anyang, South Korea; [Lee, Si Hyeock] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU); Hallym University; Seoul National University (SNU)	Kang, JS (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	shlee22@snu.ac.kr			Korea Forest Service [500-20060168]; Brain Korea 21 program	Korea Forest Service(Korea Forest Service); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Grant No. 500-20060168 from the Korea Forest Service (http://english.forest.go.kr). Jae Soon Kang was supported in part by the Brain Korea 21 program (http://bk.snu.ac.kr/_eng/engmain.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alles GA, 1940, J BIOL CHEM, V133, P375; ANGSTADT JD, 1989, J COMP NEUROL, V284, P374, DOI 10.1002/cne.902840305; AUGUSTINSSON KB, 1948, BIOL BULL, V95, P241; BALASUBRAMANIAN AS, 1993, FASEB J, V7, P1354, DOI 10.1096/fasebj.7.14.8224608; Bentley GN, 2005, MOL BIOCHEM PARASIT, V141, P119, DOI 10.1016/j.molbiopara.2005.01.019; Bery A, 2010, DEV GENES EVOL, V220, P61, DOI 10.1007/s00427-010-0328-2; Casida JE, 2004, CHEM RES TOXICOL, V17, P983, DOI 10.1021/tx0499259; CHANG S, 1991, MOL BIOCHEM PARASIT, V49, P205, DOI 10.1016/0166-6851(91)90064-D; CHANG S, 1992, J NEMATOL, V24, P148; Combes D, 2003, EUR J NEUROSCI, V18, P497, DOI 10.1046/j.1460-9568.2003.02749.x; Combes D, 2001, INT REV CYTOL, V209, P207; Combes D, 2000, J MOL BIOL, V300, P727, DOI 10.1006/jmbi.2000.3917; Culetto E, 1999, J MOL BIOL, V290, P951, DOI 10.1006/jmbi.1999.2937; CULOTTI JG, 1981, GENETICS, V97, P281; Denker E, 2008, CHEM-BIOL INTERACT, V175, P125, DOI 10.1016/j.cbi.2008.03.004; DUERR JS, 2006, COMMUNITY; Duysen EG, 2007, TOXICOLOGY, V233, P60, DOI 10.1016/j.tox.2006.11.069; JOHNSON CD, 1981, GENETICS, V97, P261; Kang JS, 2011, MOL BIOCHEM PARASIT, V175, P154, DOI 10.1016/j.molbiopara.2010.11.005; Kang JS, 2009, NEMATOLOGY, V11, P289, DOI 10.1163/156854109X429619; KOLSON DL, 1985, J NEUROGENET, V2, P93, DOI 10.3109/01677068509100145; KOLSON DL, 1985, J NEUROGENET, V2, P69, DOI 10.3109/01677068509100144; Kumar P, 2009, PHYTOTHER RES, V23, P172, DOI 10.1002/ptr.2578; LADU BN, 1991, CELL MOL NEUROBIOL, V11, P79, DOI 10.1007/BF00712801; LAYER PG, 1991, CELL MOL NEUROBIOL, V11, P7, DOI 10.1007/BF00712798; Lazari O, 2003, MOL BIOCHEM PARASIT, V132, P83, DOI 10.1016/j.molbiopara.2003.09.001; Lenz DE, 2005, CHEM-BIOL INTERACT, V157, P205, DOI 10.1016/j.cbi.2005.10.025; Lockridge O, 2000, NEUROTOXICOLOGY, V21, P113; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; MARTELLY I, 1988, BRAIN RES, V460, P205, DOI 10.1016/0006-8993(88)90365-4; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Miyazawa M, 1997, J AGR FOOD CHEM, V45, P677, DOI 10.1021/jf960398b; Miyazawa M, 2005, J AGR FOOD CHEM, V53, P1765, DOI 10.1021/jf040019b; Nickel M, 2010, INVERTEBR BIOL, V129, P1, DOI 10.1111/j.1744-7410.2010.00193.x; Perry NSL, 2000, J PHARM PHARMACOL, V52, P895, DOI 10.1211/0022357001774598; PEZZEMENTI L, 2010, CHEMICOBIOL IN PRESS; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Raveh L, 1997, TOXICOL APPL PHARM, V145, P43, DOI 10.1006/taap.1997.8160; Ryan TJ, 2009, NAT REV NEUROSCI, V10, P701, DOI 10.1038/nrn2717; Saxena A, 2006, J MOL NEUROSCI, V30, P145, DOI 10.1385/JMN:30:1:145; Takahashi T, 2010, FEBS LETT, V584, P511, DOI 10.1016/j.febslet.2009.11.081; Thullbery MD, 2005, J CELL BIOCHEM, V96, P599, DOI 10.1002/jcb.20530; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Wood WB, 1988, NEMATODE CAENORHABDI	46	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19063	10.1371/journal.pone.0019063	http://dx.doi.org/10.1371/journal.pone.0019063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556353	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400025
J	Chung, PC; Lin, WS; Scotting, PJ; Hsieh, FY; Wu, HL; Cheng, YC				Chung, Pei-Chen; Lin, Wen-Shiuan; Scotting, Paul J.; Hsieh, Fu-Yu; Wu, Hui-Lan; Cheng, Yi-Chuan			Zebrafish Her8a Is Activated by Su(H)-Dependent Notch Signaling and Is Essential for the Inhibition of Neurogenesis	PLOS ONE			English	Article							MIDBRAIN-HINDBRAIN BOUNDARY; GENE-EXPRESSION; ASTROCYTE DIFFERENTIATION; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; HES6; HAIRY/ENHANCER; DELTA; ACTS; TRANSPORTER	Understanding how diversity of neural cells is generated is one of the main tasks of developmental biology. The Hairy/E(spl) family members are potential targets of Notch signaling, which has been shown to be fundamental to neural cell maintenance, cell fate decisions, and compartment boundary formation. However, their response to Notch signaling and their roles in neurogenesis are still not fully understood. In the present study, we isolated a zebrafish homologue of hairy/E(spl), her8a, and showed this gene is specifically expressed in the developing nervous system. her8a is positively regulated by Su(H)-dependent Notch signaling as revealed by a Notch-defective mutant and injection of variants of the Notch intracellular regulator, Su(H). Morpholino knockdown of Her8a resulted in upregulation of proneural and post-mitotic neuronal markers, indicating that Her8a is essential for the inhibition of neurogenesis. In addition, markers for glial precursors and mature glial cells were down-regulated in Her8a morphants, suggesting Her8a is required for gliogenesis. The role of Her8a and its response to Notch signaling is thus similar to mammalian HES1, however this is the converse of what is seen for the more closely related mammalian family member, HES6. This study not only provides further understanding of how the fundamental signaling pathway, Notch signaling, and its downstream genes mediate neural development and differentiation, but also reveals evolutionary diversity in the role of H/E(spl) genes.	[Chung, Pei-Chen; Lin, Wen-Shiuan; Hsieh, Fu-Yu; Wu, Hui-Lan; Cheng, Yi-Chuan] Chang Gung Univ, Sch Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Scotting, Paul J.] Univ Nottingham, Queens Med Ctr, Childrens Brain Tumour Res Ctr, Ctr Genet & Genom, Nottingham NG7 2RD, England	Chang Gung University; University of Nottingham	Chung, PC (corresponding author), Chang Gung Univ, Sch Med, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	yccheng@mail.cgu.edu.tw			Chang Gung Memorial Hospital [CMRPD34019]; National Science Council of Taiwan, Republic of China [NSC96-2311-B-182-001]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital (CMRPD34019) and the National Science Council of Taiwan, Republic of China (NSC96-2311-B-182-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SK, 2000, DEVELOPMENT, V127, P2933; Bae YK, 2005, DEVELOPMENT, V132, P1375, DOI 10.1242/dev.01710; Belanger-Jasmin S, 2007, J NEUROCHEM, V103, P2022, DOI 10.1111/j.1471-4159.2007.04902.x; Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gajewski M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-21; Geling A, 2004, DEVELOPMENT, V131, P1993, DOI 10.1242/dev.01093; Hans S, 2004, DEVELOPMENT, V131, P2957, DOI 10.1242/dev.01167; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawamura A, 2005, GENE DEV, V19, P1156, DOI 10.1101/gad.1291205; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Latimer AJ, 2005, DEV DYNAM, V232, P1098, DOI 10.1002/dvdy.20264; Latimer AJ, 2002, DEVELOPMENT, V129, P2555; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Leve C, 2001, DEV GENES EVOL, V211, P493, DOI 10.1007/s00427-001-0181-4; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ninkovic J, 2005, DEVELOPMENT, V132, P75, DOI 10.1242/dev.01525; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; Pasini A, 2001, MECH DEVELOP, V100, P317, DOI 10.1016/S0925-4773(00)00538-4; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Sela-Donenfeld D, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-16; Shibata T, 1997, J NEUROSCI, V17, P9212; Shih YH, 2010, DEVELOPMENT, V137, P2671, DOI 10.1242/dev.054130; Sieger D, 2004, DEV GENES EVOL, V214, P393, DOI 10.1007/s00427-004-0427-z; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Takke C, 1999, DEVELOPMENT, V126, P3005; Takke C, 1999, DEVELOPMENT, V126, P1811; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Xu QL, 1995, DEVELOPMENT, V121, P4005; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	41	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19394	10.1371/journal.pone.0019394	http://dx.doi.org/10.1371/journal.pone.0019394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541299	gold, Green Published, Green Submitted			2022-12-25	WOS:000290018400055
J	Dai, Q; Motley, SS; Smith, JA; Concepcion, R; Barocas, D; Byerly, S; Fowke, JH				Dai, Qi; Motley, Saundra S.; Smith, Joseph A., Jr.; Concepcion, Raoul; Barocas, Daniel; Byerly, Susan; Fowke, Jay H.			Blood Magnesium, and the Interaction with Calcium, on the Risk of High-Grade Prostate Cancer	PLOS ONE			English	Article							DAIRY-PRODUCTS; VITAMIN-D; NATIONAL-HEALTH; SERUM-CALCIUM; UNITED-STATES; WOMEN; SUPPLEMENTATION; NUTRITION; MEN; METAANALYSIS	Background: Ionized calcium (Ca) and magnesium (Mg) compete as essential messengers to regulate cell proliferation and inflammation. We hypothesized that inadequate Mg levels, perhaps relative to Ca levels (e. g. a high Ca/Mg ratio) are associated with greater prostate cancer risk. Study Design: In this biomarker sub-study of the Nashville Men's Health Study (NMHS), we included 494 NMHS participants, consisting of 98 high-grade (Gleason >= 7) and 100 low-grade cancer cases, 133 prostate intraepithelial neoplasia (PIN) cases, and 163 controls without cancer or PIN at biopsy. Linear and logistic regression were used to determine associations between blood Ca, Mg, and the Ca/Mg ratio across controls and case groups while adjusting for potential confounding factors. Results: Serum Mg levels were significantly lower, while the Ca/Mg ratio was significantly higher, among high-grade cases vs. controls (p = 0.04, p = 0.01, respectively). Elevated Mg was significantly associated with a lower risk of high-grade prostate cancer (OR = 0.26 (0.09, 0.85)). An elevated Ca/Mg ratio was also associated with an increased risk of high-grade prostate cancer (OR = 2.81 (1.24, 6.36) adjusted for serum Ca and Mg). In contrast, blood Ca levels were not significantly associated with prostate cancer or PIN. Mg, Ca, or Ca/Mg levels were not associated with low-grade cancer, PIN, PSA levels, prostate volume, or BPH treatment. Conclusion: Low blood Mg levels and a high Ca/Mg ratio were significantly associated with high-grade prostate cancer. These findings suggest Mg affects prostate cancer risk perhaps through interacting with Ca.	[Dai, Qi; Motley, Saundra S.; Byerly, Susan; Fowke, Jay H.] Vanderbilt Univ, Med Ctr, Sch Med, Vanderbilt Epidemiol Ctr,Vanderbilt Ingram Canc C, Nashville, TN 37232 USA; [Smith, Joseph A., Jr.; Concepcion, Raoul; Barocas, Daniel] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Concepcion, Raoul] Urol Associates, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Dai, Q (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Vanderbilt Epidemiol Ctr,Vanderbilt Ingram Canc C, Nashville, TN 37232 USA.	qi.dai@vanderbilt.edu		Barocas, Daniel/0000-0002-7775-9205	National Cancer Institute [R01CA121060]; Vanderbilt; National Center for Research Resources, National Institutes of Health [1 UL1 RR024975]; National Center for Complementary and Alternative Medicine [R01 AT004660]; National Cancer Institute, National Institutes of Health, Department of Health and Human Services [R01 CA149633]; NATIONAL CANCER INSTITUTE [R01CA121060, R01CA149633] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004660] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by grant R01CA121060 from the National Cancer Institute and by Vanderbilt CTSA grant 1 UL1 RR024975 from the National Center for Research Resources, National Institutes of Health. Part of Dr. Dai's effort on this project was supported by grant R01 AT004660 from the National Center for Complementary and Alternative Medicine and grant R01 CA149633 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2007, CANCER EPIDEM BIOMAR, V16, P2623, DOI 10.1158/1055-9965.EPI-07-0601; Al-Delaimy WK, 2004, J AM COLL NUTR, V23, P63, DOI 10.1080/07315724.2004.10719344; Allen NE, 2008, BRIT J CANCER, V98, P1574, DOI 10.1038/sj.bjc.6604331; Baron JA, 2005, CANCER EPIDEM BIOMAR, V14, P586, DOI 10.1158/1055-9965.EPI-04-0319; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Bussiere FI, 2002, EUR J NUTR, V41, P197, DOI 10.1007/s00394-002-0376-0; Capiod T., 2007, V45, P405; Chan JM, 2001, AM J CLIN NUTR, V74, P549; COLDITZ GA, 1992, AM J CLIN NUTR, V55, P1018, DOI 10.1093/ajcn/55.5.1018; Dai Q, 2007, AM J CLIN NUTR, V86, P743, DOI 10.1093/ajcn/86.3.743; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Egan KM, 2008, CANCER CAUSE CONTROL, V19, P527, DOI 10.1007/s10552-008-9115-z; Ervin R Bethene, 2004, Adv Data, P1; Gao X, 2005, JNCI-J NATL CANCER I, V97, P1768, DOI 10.1093/jnci/dji402; Giovannucci E, 2006, CANCER EPIDEM BIOMAR, V15, P203, DOI 10.1158/1055-9965.EPI-05-0586; Halthur C, 2009, CANCER CAUSE CONTROL, V20, P1205, DOI 10.1007/s10552-009-9342-y; Hans CP, 2003, MAGNESIUM RES, V16, P13; HARDWICK LL, 1991, J NUTR, V121, P13, DOI 10.1093/jn/121.1.13; He K, 2006, CIRCULATION, V113, P1675, DOI 10.1161/CIRCULATIONAHA.105.588327; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kesse E, 2006, BRIT J NUTR, V95, P539, DOI 10.1079/BJN20051670; Larsson SC, 2005, JAMA-J AM MED ASSOC, V293, P86, DOI 10.1001/jama.293.1.86; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Mitrou PN, 2007, INT J CANCER, V120, P2466, DOI 10.1002/ijc.22553; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nasulewicz A, 2004, BBA-MOL BASIS DIS, V1739, P26, DOI 10.1016/j.bbadis.2004.08.003; PAOLISSO G, 1992, AM J CLIN NUTR, V55, P1161, DOI 10.1093/ajcn/55.6.1161; Rodriguez C, 2003, CANCER EPIDEM BIOMAR, V12, P597; Seelig M S, 1990, Magnes Res, V3, P197; Severi G, 2006, J NATL CANCER I, V98, P794, DOI 10.1093/jnci/djj215; SHIMIZU H, 1991, BRIT J CANCER, V63, P963, DOI 10.1038/bjc.1991.210; Skinner HG, 2008, CANCER EPIDEM BIOMAR, V17, P2302, DOI 10.1158/1055-9965.EPI-08-0365; Skinner HG, 2009, CANCER EPIDEM BIOMAR, V18, P575, DOI 10.1158/1055-9965.EPI-08-0915; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Tseng M, 2005, AM J CLIN NUTR, V81, P1147; Wolf FI, 2006, ARCH BIOCH BIOPHYS; Ziegler D, 2005, CURR MOL MED, V5, P309, DOI 10.2174/1566524053766095	40	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18237	10.1371/journal.pone.0018237	http://dx.doi.org/10.1371/journal.pone.0018237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541018	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800006
J	Malcom, JW				Malcom, Jacob W.			Smaller Gene Networks Permit Longer Persistence in Fast-Changing Environments	PLOS ONE			English	Article							POPULATION PERSISTENCE; RAPID EVOLUTION; EXTINCTION; EPISTASIS; ADAPTATION; SELECTION; DYNAMICS; ECOLOGY; PREY	The environments in which organisms live and reproduce are rarely static, and as the environment changes, populations must evolve so that phenotypes match the challenges presented. The quantitative traits that map to environmental variables are underlain by hundreds or thousands of interacting genes whose allele frequencies and epistatic relationships must change appropriately for adaptation to occur. Extending an earlier model in which individuals possess an ecologically-critical trait encoded by gene networks of 16 to 256 genes and random or scale-free topology, I test the hypothesis that smaller, scale-free networks permit longer persistence times in a constantly-changing environment. Genetic architecture interacting with the rate of environmental change accounts for 78% of the variance in trait heritability and 66% of the variance in population persistence times. When the rate of environmental change is high, the relationship between network size and heritability is apparent, with smaller and scale-free networks conferring a distinct advantage for persistence time. However, when the rate of environmental change is very slow, the relationship between network size and heritability disappears and populations persist the duration of the simulations, without regard to genetic architecture. These results provide a link between genes and population dynamics that may be tested as the -omics and bioinformatics fields mature, and as we are able to determine the genetic basis of ecologically-relevant quantitative traits.	Univ Texas Austin, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Malcom, JW (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	jmalcom@mail.utexas.edu	/AAD-1873-2020	/0000-0002-4904-8369	University of Texas at Austin	University of Texas at Austin	This work was supported in part by a start-up grant from the University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe D, 2009, AM NAT, V174, P255, DOI 10.1086/600085; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Antonovics J., 1976, Systematic Botany, V1, P233, DOI 10.2307/2418718; B³rger R., 2000, MATH THEORY SELECTIO; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Chase J.M., 2009, ECOLOGICAL NICHES LI; CHEVERUD JM, 1995, GENETICS, V139, P1455; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1958, GENETICAL THEORY NAT; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI [10.1111/j.1558-5646.1997.tb02384.x, 10.2307/2410956]; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lynch M, 2007, ORIGINS GENOME ARCHI; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malcom JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014645; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Neter J, 1985, APPL LINEAR REGRESSI; Patterson J. T., 1943, University of Texas Publications, Vno. 4313, P7; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Platts Adrian E., 2009, P227, DOI 10.1007/978-1-59745-440-7_13; PRICE T, 1991, EVOLUTION, V45, P853, DOI 10.1111/j.1558-5646.1991.tb04354.x; R Development Core Team, 2009, R FDN STAT COMP; Repsilber D, 2009, EURASIP J BIOINFO SY, V2009; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Willi Y, 2009, J EVOLUTION BIOL, V22, P124, DOI 10.1111/j.1420-9101.2008.01631.x; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	52	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e14747	10.1371/journal.pone.0014747	http://dx.doi.org/10.1371/journal.pone.0014747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541020	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800001
J	Wong, KY; So, CC; Loong, F; Chung, LP; Lam, WWL; Liang, R; Li, GKH; Jin, DY; Chim, CS				Wong, Kwan Yeung; So, Chi Chiu; Loong, Florence; Chung, Lap Ping; Lam, William Wai Lung; Liang, Raymond; Li, George Kam Hop; Jin, Dong-Yan; Chim, Chor Sang			Epigenetic Inactivation of the miR-124-1 in Haematological Malignancies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR GENE; MULTIPLE-MYELOMA; DNA METHYLATION; CELL LYMPHOMAS; HUMAN CANCER; HYPERMETHYLATION; PATHWAY; MICRORNAS; DYSREGULATION	miR-124-1 is a tumour suppressor microRNA (miR). Epigenetic deregulation of miRs is implicated in carcinogenesis. Promoter DNA methylation and histone modification of miR-124-1 was studied in 5 normal marrow controls, 4 lymphoma, 8 multiple myeloma (MM) cell lines, 230 diagnostic primary samples of acute myeloid leukaemia (AML), acute lymphoblastic leukaemia (ALL), chronic myeloid leukaemia (CML), chronic lymphocytic leukaemia (CLL), MM, and non-Hodgkin's lymphoma (NHL), and 53 MM samples at stable disease or relapse. Promoter of miR-124-1 was unmethylated in normal controls but homozygously methylated in 4 of 4 lymphoma and 4 of 8 myeloma cell lines. Treatment of 5-Aza-2'-deoxycytidine led to miR-124-1 demethylation and re-expression of mature miR-124, which also associated with emergence of euchromatic trimethyl H3K4 and consequent downregulation of CDK6 in myeloma cells harboring homozygous miR-124-1 methylation. In primary samples at diagnosis, miR-124-1 methylation was absent in CML but detected in 2% each of MM at diagnosis and relapse/progression, 5% ALL, 15% AML, 14% CLL and 58.1% of NHL (p<0.001). Amongst lymphoid malignancies, miR-124-1 was preferentially methylated in NHL than MM, CLL or ALL. In primary lymphoma samples, miR-124-1 was preferentially hypermethylated in B-or NK/T-cell lymphomas and associated with reduced miR-124 expression. In conclusion, miR-124-1 was hypermethylated in a tumour-specific manner, with a heterochromatic histone configuration. Hypomethylation led to partial restoration of euchromatic histone code and miR re-expression. Infrequent miR-124-1 methylation detected in diagnostic and relapse MM samples showed an unimportant role in MM pathogenesis, despite frequent methylation found in cell lines. Amongst haematological cancers, miR-124-1 was more frequently hypermethylated in NHL, and hence warrants further study.	[Wong, Kwan Yeung; Liang, Raymond; Chim, Chor Sang] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [So, Chi Chiu; Loong, Florence; Chung, Lap Ping] Univ Hong Kong, Dept Pathol, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Lam, William Wai Lung] Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Li, George Kam Hop] Univ Hong Kong, Dept Surg, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Jin, Dong-Yan] Univ Hong Kong, Dept Biochem, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Wong, KY (corresponding author), Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	jcschim@hkucc.hku.hk	Wong, Kwan Yeung/H-4649-2019; So, Jason/C-4398-2009	Wong, Kwan Yeung/0000-0002-5853-6022; Chim, CS/0000-0003-2427-915X	University of Hong Kong [200804159005, 200811159040]; Hong Kong Research Grants Council General Research Fund [763409M]	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council)	This work was supported by The University of Hong Kong Seed Funding Programme for Basic Research (Code: 200804159005 and 200811159040), and the Hong Kong Research Grants Council General Research Fund (Ref. 763409M) awarded to Dr C.S. Chim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Callet-Bauchu E, 2005, LEUKEMIA, V19, P1818, DOI 10.1038/sj.leu.2403909; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Chim CS, 2006, J HUM GENET, V51, P832, DOI 10.1007/s10038-006-0029-x; Chim CS, 2006, LEUKEMIA, V20, P1190, DOI 10.1038/sj.leu.2404205; Chim CS, 2008, CLIN LYMPHOMA MYELOM, V8, P331, DOI 10.3816/CLM.2008.n.048; Chim CS, 2007, J CLIN PATHOL, V60, P664, DOI 10.1136/jcp.2006.038331; Chim CS, 2007, J CLIN PATHOL, V60, P104, DOI 10.1136/jcp.2006.036715; Chim CS, 2002, HEMATOL ONCOL, V20, P167, DOI 10.1002/hon.694; Chim CS, 2005, LEUKEMIA, V19, P2352, DOI 10.1038/sj.leu.2403904; Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007; Chim CS, 2004, BLOOD, V103, P216, DOI 10.1182/blood-2003-05-1401; Chim CS, 2003, LEUKEMIA, V17, P2533, DOI 10.1038/sj.leu.2403133; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; FUJIWARA Y, 1995, ONCOGENE, V10, P891; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Kawamoto K, 2008, INT J CANCER, V123, P535, DOI 10.1002/ijc.23514; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lujambio A, 2008, PNAS; Lujambio A, 2007, CELL CYCLE, V6, P1455; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Martinez-Climent JA, 2001, BLOOD, V98, P3479, DOI 10.1182/blood.V98.12.3479; Seitz S, 1997, ONCOGENE, V14, P741, DOI 10.1038/sj.onc.1200881; Siu LLP, 2003, BRIT J HAEMATOL, V122, P70, DOI 10.1046/j.1365-2141.2003.04396.x; Swerdlow E., 2008, WHO CLASSIFICATION T; Van Hul W, 1998, GENOMICS, V47, P230, DOI 10.1006/geno.1997.5101; VANDENBERGHE H, 1988, BRIT J HAEMATOL, V68, P487, DOI 10.1111/j.1365-2141.1988.tb04242.x; Yuan BZ, 1998, CANCER RES, V58, P2196	36	100	110	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19027	10.1371/journal.pone.0019027	http://dx.doi.org/10.1371/journal.pone.0019027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544199	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800033
J	Bhaskar, A; Bala, J; Varshney, A; Yadava, P				Bhaskar, Ashima; Bala, Jyoti; Varshney, Akhil; Yadava, Pramod			Expression of Measles Virus Nucleoprotein Induces Apoptosis and Modulates Diverse Functional Proteins in Cultured Mammalian Cells	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CANCER-CELLS; BINDING; DEATH; GAPDH; PHOSPHOPROTEIN; TRANSLOCATION; TRANSLATION; ACTIVATION; PROHIBITIN	Background: Measles virus nucleoprotein (N) encapsidates the viral RNA, protects it from endonucleases and forms a virus specific template for transcription and replication. It is the most abundant protein during viral infection. Its C-terminal domain is intrinsically disordered imparting it the flexibility to interact with several cellular and viral partners. Principal Findings: In this study, we demonstrate that expression of N within mammalian cells resulted in morphological transitions, nuclear condensation, DNA fragmentation and activation of Caspase 3 eventuating into apoptosis. The rapid generation of intracellular reactive oxygen species (ROS) was involved in the mechanism of cell death. Addition of ascorbic acid (AA) or inhibitor of caspase-3 in the extracellular medium partially reversed N induced apoptosis. We also studied the protein profile of cells expressing N protein. MS analysis revealed the differential expression of 25 proteins out of which 11 proteins were up regulated while 14 show signs of down regulation upon N expression. 2DE results were validated by real time and semi quantitative RT-PCR analysis. Conclusion: These results show the pro-apoptotic effects of N indicating its possible development as an apoptogenic tool. Our 2DE results present prima facie evidence that the MV nucleoprotein interacts with or causes differential expression of a wide range of cellular factors. At this stage it is not clear as to what the adaptive response of the host cell is and what reflects a strategic modulation exerted by the virus.	[Bhaskar, Ashima; Bala, Jyoti; Varshney, Akhil; Yadava, Pramod] Jawaharlal Nehru Univ, Sch Life Sci, Appl Mol Biol Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bhaskar, A (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Appl Mol Biol Lab, New Delhi 110067, India.	pkyadava1953@gmail.com		BHASKAR, ASHIMA/0000-0002-7367-874X	JNU; UGC; DST, Government of India; CSIR	JNU; UGC(University Grants Commission, India); DST, Government of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants received from JNU, UGC and DST, Government of India. AB is the recipient of a Senior Research Fellowship of CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; EGELMAN EH, 1989, J VIROL, V63, P2233, DOI 10.1128/JVI.63.5.2233-2243.1989; FINCH JT, 1970, J GEN VIROL, V6, P141, DOI 10.1099/0022-1317-6-1-141; FOOKS AR, 1993, J GEN VIROL, V74, P1439, DOI 10.1099/0022-1317-74-7-1439; Griffin D., 2001, FIELDS VIROLOGY, P1401; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Karlin D, 2002, VIROLOGY, V302, P420, DOI 10.1006/viro.2002.1634; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KERR JFR, 1965, J PATHOL BACTERIOL, V90, P419, DOI 10.1002/path.1700900210; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Li AL, 2004, J BIOL CHEM, V279, P49251, DOI 10.1074/jbc.M407165200; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Muller N, 2006, TRAFFIC, V7, P849, DOI 10.1111/j.1600-0854.2006.00426.x; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Oh KS, 2005, J MICROBIOL, V43, P179; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Sato H, 2007, J VIROL, V81, P11569, DOI 10.1128/JVI.00570-07; Singh Narendra P., 1996, P3; SPEHNER D, 1991, J VIROL, V65, P6296, DOI 10.1128/JVI.65.11.6296-6300.1991; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang Z, 2004, CLIN CHEM, V50, P1939, DOI 10.1373/clinchem.2004.036871; WARNES A, 1995, GENE, V160, P173, DOI 10.1016/0378-1119(95)00227-W; WATANABE M, 1995, J VIROL, V69, P3206, DOI 10.1128/JVI.69.5.3206-3210.1995; Wickham TJ, 2000, GENE THER, V7, P110, DOI 10.1038/sj.gt.3301115; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	44	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18765	10.1371/journal.pone.0018765	http://dx.doi.org/10.1371/journal.pone.0018765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533140	Green Published, Green Submitted, gold			2022-12-25	WOS:000289505600030
J	Furuta, Y; Kawai, M; Uchiyama, I; Kobayashi, I				Furuta, Yoshikazu; Kawai, Mikihiko; Uchiyama, Ikuo; Kobayashi, Ichizo			Domain Movement within a Gene: A Novel Evolutionary Mechanism for Protein Diversification	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; HELICOBACTER-PYLORI; DNA RECOGNITION; STAPHYLOCOCCUS-AUREUS; GENOME REARRANGEMENTS; IC RESTRICTION; II RESTRICTION; DIVERSITY; RECOMBINATION; ENZYMES	A protein function is carried out by a specific domain localized at a specific position. In the present study, we report that, within a gene, a specific amino acid sequence can move between a certain position and another position. This was discovered when the sequences of restriction-modification systems within the bacterial species Helicobacter pylori were compared. In the specificity subunit of Type I restriction-modification systems, DNA sequence recognition is mediated by target recognition domain 1 (TRD1) and TRD2. To our surprise, several sequences are shared by TRD1 and TRD2 of genes (alleles) at the same locus (chromosomal location); these domains appear to have moved between the two positions. The gene/protein organization can be represented as x-(TRD1)-y-x-(TRD2)-y, where x and y represent repeat sequences. Movement probably occurs by recombination at these flanking DNA repeats. In accordance with this hypothesis, recombination at these repeats also appears to decrease two TRDs into one TRD or increase these two TRDs to three TRDs (TRD1-TRD2-TRD2) and to allow TRD movement between genes even at different loci. Similar movement of domains between TRD1 and TRD2 was observed for the specificity subunit of a Type IIG restriction enzyme. Similar movement of domain between TRD1 and TRD2 was observed for Type I restriction-modification enzyme specificity genes in two more eubacterial species, Streptococcus pyogenes and Mycoplasma agalactiae. Lateral domain movements within a protein, which we have designated DOMO (domain movement), represent novel routes for the diversification of proteins.	[Furuta, Yoshikazu; Kawai, Mikihiko; Kobayashi, Ichizo] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo, Japan; [Furuta, Yoshikazu; Kawai, Mikihiko; Kobayashi, Ichizo] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Kawai, Mikihiko; Uchiyama, Ikuo] Natl Inst Basic Biol, Lab Genome Informat, Okazaki, Japan; [Kobayashi, Ichizo] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Minato Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Tokyo	Furuta, Y (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo, Japan.	ikobaya@ims.u-tokyo.ac.jp	Furuta, Yoshikazu/AAB-2219-2020; Kawai, Mikihiko/AAA-4641-2020; Kobayashi, Ichizo/GVT-8377-2022	Furuta, Yoshikazu/0000-0003-4710-1389; Kawai, Mikihiko/0000-0001-7219-3823; Uchiyama, Ikuo/0000-0002-9197-5000; Kobayashi, Ichizo/0000-0002-3854-1879	MEXT; Urakami Foundation; Japan Society for the Promotion of Science [20310125]; Institute for Bioinformatics Research Development, Japan Science Technology Agency	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Urakami Foundation(Urakami Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute for Bioinformatics Research Development, Japan Science Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by grants from the global COE project of "Genome Information Big Bang" from MEXT, and from the Urakami Foundation and Grant-in-Aid for Scientific Research (20310125) from Japan Society for the Promotion of Science to IK and grants from the Institute for Bioinformatics Research Development, Japan Science Technology Agency to IU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADJIEVA A, 1993, NUCLEIC ACIDS RES, V21, P4435, DOI 10.1093/nar/21.19.4435; Andres S, 2010, HELICOBACTER, V15, P114, DOI 10.1111/j.1523-5378.2010.00745.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BRANDEN C, INTRO PROTEIN STRUCT; Dempsey RM, 2005, MICROBIOL-SGM, V151, P1301, DOI 10.1099/mic.0.27646-0; Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Fukuda E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r163; FULLERPACE FV, 1984, P NATL ACAD SCI-BIOL, V81, P6095, DOI 10.1073/pnas.81.19.6095; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; GANN AAF, 1987, MOL MICROBIOL, V1, P13, DOI 10.1111/j.1365-2958.1987.tb00521.x; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3; GRAUR D, FUNDAMENTALS MOL EVO; GUBLER M, 1992, EMBO J, V11, P233, DOI 10.1002/j.1460-2075.1992.tb05046.x; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; Handa N, 2001, MOL MICROBIOL, V40, P932, DOI 10.1046/j.1365-2958.2001.02436.x; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Ishikawa K, 2010, DNA RES, V17, P325, DOI 10.1093/dnares/dsq027; Ishikawa K, 2009, NUCLEIC ACIDS RES, V37, P3531, DOI 10.1093/nar/gkp214; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kita K, 2003, J BACTERIOL, V185, P2296, DOI 10.1128/JB.185.7.2296-2305.2003; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; Kong HM, 1998, J MOL BIOL, V279, P823, DOI 10.1006/jmbi.1998.1821; MEISTER J, 1993, EMBO J, V12, P4585, DOI 10.1002/j.1460-2075.1993.tb06147.x; Mochizuki A, 2006, GENETICS, V172, P1309, DOI 10.1534/genetics.105.042895; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Orlowski J, 2008, NUCLEIC ACIDS RES, V36, P3552, DOI 10.1093/nar/gkn175; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Pingoud A., 2004, RESTRICTION ENDONUCL; PRICE C, 1989, J MOL BIOL, V205, P115, DOI 10.1016/0022-2836(89)90369-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Rochepeau P, 1997, MOL GEN GENET, V256, P387, DOI 10.1007/s004380050582; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Sitaraman R, 2002, MOL MICROBIOL, V46, P1033, DOI 10.1046/j.1365-2958.2002.03206.x; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tsuru T, 2006, MOL BIOL EVOL, V23, P1269, DOI 10.1093/molbev/msk013; Uchiyama I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-472; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671	51	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18819	10.1371/journal.pone.0018819	http://dx.doi.org/10.1371/journal.pone.0018819			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533192	Green Submitted, gold, Green Published			2022-12-25	WOS:000289505600032
J	Park, C; Yan, W; Ward, SM; Hwang, SJ; Wu, QX; Hatton, WJ; Park, JK; Sanders, KM; Ro, S				Park, Chanjae; Yan, Wei; Ward, Sean M.; Hwang, Sung Jin; Wu, Qiuxia; Hatton, William J.; Park, Jong Kun; Sanders, Kenton M.; Ro, Seungil			MicroRNAs Dynamically Remodel Gastrointestinal Smooth Muscle Cells	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; INTERSTITIAL-CELLS; GENE-EXPRESSION; SMALL RNAS; DICER; MYOCARDIN; SRF; DIFFERENTIATION; PROLIFERATION; CONTRACTILE	Smooth muscle cells (SMCs) express a unique set of microRNAs (miRNAs) which regulate and maintain the differentiation state of SMCs. The goal of this study was to investigate the role of miRNAs during the development of gastrointestinal (GI) SMCs in a transgenic animal model. We generated SMC-specific Dicer null animals that express the reporter, green fluorescence protein, in a SMC-specific manner. SMC-specific knockout of Dicer prevented SMC miRNA biogenesis, causing dramatic changes in phenotype, function, and global gene expression in SMCs: the mutant mice developed severe dilation of the intestinal tract associated with the thinning and destruction of the smooth muscle (SM) layers; contractile motility in the mutant intestine was dramatically decreased; and SM contractile genes and transcriptional regulators were extensively down-regulated in the mutant SMCs. Profiling and bioinformatic analyses showed that SMC phenotype is regulated by a complex network of positive and negative feedback by SMC miRNAs, serum response factor (SRF), and other transcriptional factors. Taken together, our data suggest that SMC miRNAs are required for the development and survival of SMCs in the GI tract.	[Park, Chanjae; Yan, Wei; Ward, Sean M.; Hwang, Sung Jin; Wu, Qiuxia; Hatton, William J.; Sanders, Kenton M.; Ro, Seungil] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Park, Jong Kun] Wonkwang Univ, Div Biol Sci, Iksan, Chonbuk, South Korea	Nevada System of Higher Education (NSHE); University of Nevada Reno; Wonkwang University	Park, C (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA.	sro@medicine.nevada.edu	Yan, Wei/G-1618-2011; Yan, Wei/AAH-7943-2019	Ro, Seungil/0000-0003-0861-8334; Park, Jong Kun/0000-0003-3342-3088	National Institutes of Health [P20 RR018751]; NCRR [1 S10 RR16871]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048855, R01HD050281] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016871, P20RR018751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grant P20 RR018751 to K.M. Sanders. An equipment grant from the NCRR for a Zeiss LSM510 confocal microscope (1 S10 RR16871) was used for the morphological studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Angstenberger M, 2007, GASTROENTEROLOGY, V133, P1948, DOI 10.1053/j.gastro.2007.08.078; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Crosby ME, 2009, CURR PHARM DESIGN, V15, P3861, DOI 10.2174/138161209789649367; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Macdonald JA, 2008, NEUROGASTROENT MOTIL, V20, P737, DOI 10.1111/j.1365-2982.2008.01148.x; Majesky Mark W, 2003, Curr Atheroscler Rep, V5, P208, DOI 10.1007/s11883-003-0026-x; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Mericskay M, 2007, GASTROENTEROLOGY, V133, P1960, DOI 10.1053/j.gastro.2007.09.010; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Panganamamula Kashyap V, 2005, Curr Treat Options Gastroenterol, V8, P3, DOI 10.1007/s11938-005-0046-4; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; PARK C, 2011, GASTROENTER IN PRESS; Piotrowska AP, 2003, J PEDIATR SURG, V38, P749, DOI 10.1016/jpsu.2003.50159; Puri Prem, 2005, Semin Pediatr Surg, V14, P58, DOI 10.1053/j.sempedsurg.2004.10.026; Ro S, 2006, AM J PHYSIOL-GASTR L, V290, pG710, DOI 10.1152/ajpgi.00420.2005; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Ro S, 2010, GASTROENTEROLOGY, V138, P1068, DOI 10.1053/j.gastro.2009.11.007; Rolle U, 2002, PEDIATR SURG INT, V18, P2, DOI 10.1007/s003830200001; Rolle Udo, 2006, J Pediatr Urol, V2, P277, DOI 10.1016/j.jpurol.2006.01.017; Stenmark KR, 1998, CHEST, V114, p82S, DOI 10.1378/chest.114.1_Supplement.82S; Stevceva Liljana, 2001, BMC Clin Pathol, V1, P3, DOI 10.1186/1472-6890-1-3; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Szigeti R, 2010, PEDIATR DEVEL PATHOL, V13, P322, DOI 10.2350/09-07-0678-CR.1; Takwi A, 2009, CURR GENOMICS, V10, P194, DOI 10.2174/138920209788185270; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Vrees MD, 2002, ARCH SURG-CHICAGO, V137, P439, DOI 10.1001/archsurg.137.4.439; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Ward SM, 2000, J NEUROSCI, V20, P1393; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409	59	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18628	10.1371/journal.pone.0018628	http://dx.doi.org/10.1371/journal.pone.0018628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533178	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600015
J	Rudner, LA; Brown, KH; Dobrinski, KP; Bradley, DF; Garcia, MI; Smith, ACH; Downie, JM; Meeker, ND; Look, AT; Downing, JR; Gutierrez, A; Mullighan, CG; Schiffman, JD; Lee, C; Trede, NS; Frazer, JK				Rudner, L. A.; Brown, K. H.; Dobrinski, K. P.; Bradley, D. F.; Garcia, M. I.; Smith, A. C. H.; Downie, J. M.; Meeker, N. D.; Look, A. T.; Downing, J. R.; Gutierrez, A.; Mullighan, C. G.; Schiffman, J. D.; Lee, C.; Trede, N. S.; Frazer, J. K.			Shared acquired genomic changes in zebrafish and human T-ALL	ONCOGENE			English	Article						T-cell acute lymphoblastic leukemia (T-ALL); array comparative genome hybridization (aCGH); zebrafish; copy number aberration (CNA); leukemogenesis	ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSGENIC ZEBRAFISH; CELL TRANSPLANTATION; MODEL; ARRAY; HYBRIDIZATION; MUTATIONS; DELETION; MYC; SELECTION	T-cell acute lymphoblastic leukemia (T-ALL) is a challenging clinical entity with high rates of induction failure and relapse. To discover the genetic changes occurring in T-ALL, and those contributing to relapse, we studied zebrafish (Danio rerio) T-ALL samples using array comparative genomic hybridization (aCGH). We performed aCGH on 17 T-ALLs from four zebrafish T-ALL models, and evaluated similarities between fish and humans by comparing all D. rerio genes with copy number aberrations (CNAs) with a cohort of 75 published human T-ALLs analyzed by aCGH. Within all D. rerio CNAs, we identified 893 genes with human homologues and found significant overlap (67%) with the human CNA dataset. In addition, when we restricted our analysis to primary T-ALLs (14 zebrafish and 61 human samples), 10 genes were recurrently altered in 43 zebrafish cancers and >= 4 human cases, suggesting a conserved role for these loci in T-ALL transformation across species. We also conducted iterative allo-transplantation with three zebrafish malignancies. This technique selects for aggressive disease, resulting in shorter survival times in successive transplant rounds and modeling refractory and relapsed human T-ALL. Fifty-five percent of original CNAs were preserved after serial transplantation, demonstrating clonality between each primary and passaged leukemia. Cancers acquired an average of 34 new CNAs during passaging. Genes in these loci may underlie the enhanced malignant behavior of these neoplasias. We also compared genes from CNAs of passaged zebrafish malignancies with aCGH results from 50 human T-ALL patients who failed induction, relapsed or would eventually relapse. Again, many genes (88/164) were shared by both datasets. Further, nine recurrently altered genes in passaged D. rerio T-ALL were also found in multiple human T-ALL cases. These results suggest that zebrafish and human T-ALLs are similar at the genomic level, and are governed by factors that have persisted throughout evolution. Oncogene (2011) 30, 4289-4296; doi: 10.1038/onc.2011.138; published online 9 May 2011	[Schiffman, J. D.; Trede, N. S.; Frazer, J. K.] Univ Utah, Dept Pediat, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Brown, K. H.; Dobrinski, K. P.; Lee, C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Garcia, M. I.] Univ Texas Brownsville, Brownsville, TX 78520 USA; [Look, A. T.; Gutierrez, A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Look, A. T.; Gutierrez, A.] Childrens Hosp, Boston, MA 02115 USA; [Downing, J. R.; Mullighan, C. G.] St Jude Childrens Hosp, Memphis, TN 38105 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Rio Grande Valley; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; St Jude Children's Research Hospital	Frazer, JK (corresponding author), Univ Utah, Dept Pediat, Dept Oncol Sci, Huntsman Canc Inst, 2000 Circle Hope,HCI 4264, Salt Lake City, UT 84112 USA.	kimble.frazer@hsc.utah.edu	Downie, Jonathan/GPK-5981-2022; Mullighan, Charles/H-3253-2011; Downing, James R./N-8102-2018	Downie, Jonathan/0000-0002-5424-4401; Mullighan, Charles/0000-0002-1871-1850; Frazer, John Kimble/0000-0003-2936-2817; Brown, Kim/0000-0002-2358-8578; Gutierrez, Alejandro/0000-0002-0249-9007; Dobrinski, Kimberly/0000-0002-2626-1204	NIAID [R21-AI079784]; Huntsman Cancer Foundation; Eunice Kennedy Shriver NICHD [K08-HD053350]; CHRC at the University of Utah; PCMC Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD053350] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA042014, K08CA133103] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Huntsman Cancer Foundation; Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); CHRC at the University of Utah; PCMC Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Brett Milash for bioinformatics analyses, Ken Boucher for statistical expertise, and Bradley Demarest for assistance with figure preparation. NST was supported by NIAID award R21-AI079784 and the Huntsman Cancer Foundation. JKF was supported by Eunice Kennedy Shriver NICHD award K08-HD053350, the CHRC at the University of Utah, and the PCMC Foundation. Huntsman Cancer Institute core facilities supported by NCI P30-CA042014 also contributed to this work.	Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Frazer JK, 2009, LEUKEMIA, V23, P1825, DOI 10.1038/leu.2009.116; Freeman JL, 2009, GENE CHROMOSOME CANC, V48, P155, DOI 10.1002/gcc.20623; Gutierrez A, 2010, J CLIN ONCOL, V28, P3816, DOI 10.1200/JCO.2010.28.3390; Gutierrez A, 2010, BLOOD, V115, P2845, DOI 10.1182/blood-2009-07-234377; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Langenau DM, 2003, SCIENCE, V299, P887, DOI 10.1126/science.1080280; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Meeker ND, 2010, IMMUNOGENETICS, V62, P23, DOI 10.1007/s00251-009-0407-6; Mione MC, 2010, DIS MODEL MECH, V3, P517, DOI 10.1242/dmm.004747; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Panzer-Grumayer ER, 2005, CLIN CANCER RES, V11, P7720, DOI 10.1158/1078-0432.CCR-05-1239; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Peterson SM, 2009, ZEBRAFISH, V6, P355, DOI 10.1089/zeb.2009.0600; Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140; Remke M, 2009, BLOOD, V114, P1053, DOI 10.1182/blood-2008-10-186536; Ren MQ, 2009, BLOOD, V114, P1576, DOI 10.1182/blood-2009-03-212704; RUDNER LA, 2010, CURR TRENDS IMMUNOL, V10, P119; Sabaawy HE, 2006, P NATL ACAD SCI USA, V103, P15166, DOI 10.1073/pnas.0603349103; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Smith ACH, 2010, BLOOD, V115, P3296, DOI 10.1182/blood-2009-10-246488; Sulong S, 2009, BLOOD, V113, P100, DOI 10.1182/blood-2008-07-166801; Thomas R, 2007, J HERED, V98, P474, DOI 10.1093/jhered/esm053; Vago L, 2009, NEW ENGL J MED, V361, P478, DOI 10.1056/NEJMoa0811036; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	33	33	34	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT	2011	30	41					4289	4296		10.1038/onc.2011.138	http://dx.doi.org/10.1038/onc.2011.138			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	839HO	21552289	Green Accepted			2022-12-25	WOS:000296356300006
J	Lenasi, T; Peterlin, BM; Barboric, M				Lenasi, Tina; Peterlin, B. Matija; Barboric, Matjaz			Cap-binding Protein Complex Links Pre-mRNA Capping to Transcription Elongation and Alternative Splicing through Positive Transcription Elongation Factor b (P-TEFb)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II; FISSION YEAST; COUPLES TRANSCRIPTION; TERMINAL DOMAIN; KINASE; RECRUITMENT; GENES; TFIIH; PHOSPHORYLATION; MECHANISMS	Promoter-proximal pausing of RNAPII coincides with the formation of the cap structure at the 5' end of pre-mRNA, which is bound by the cap-binding protein complex (CBC). Although the positive transcription elongation factor b (P-TEFb) stimulates the release of RNAPII from pausing and promotes transcription elongation and alternative splicing by phosphorylating the RNAPII C-terminal domain at Ser2 (S2-P RNAPII), it is unknown whether CBC facilitates these events. In this study, we report that CBC interacts with P-TEFb and transcriptionally engaged RNAPII and is globally required for optimal levels of S2-P RNAPII. Quantitative nascent RNA immunoprecipitation and ChIP experiments reveal that depletion of CBC attenuates HIV-1 Tat transactivation and impedes transcription elongation of investigated CBC-dependent endogenous genes by decreasing the levels of P-TEFb and S2-P RNAPII, leading to accumulation of RNAPII in the body of these genes. Finally, CBC is essential for the promotion of alternative splicing through facilitating P-TEFb, S2-P RNAPII, and splicing factor 2/alternative splicing factor occupancy at a splicing minigene. These findings disclose a vital role of CBC in connecting pre-mRNA capping to transcription elongation and alternative splicing via P-TEFb.	[Lenasi, Tina; Barboric, Matjaz] Univ Helsinki, Res Programs Unit, FIN-00014 Helsinki, Finland; [Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Immunol, San Francisco, CA 94143 USA; [Peterlin, B. Matija] Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland	University of Helsinki; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Helsinki	Lenasi, T (corresponding author), Univ Helsinki, Biomedicum Helsinki 1, Haartmaninkatu 8,Rm B333b, FIN-00290 Helsinki, Finland.	tlenasi@yahoo.com	Barboric, Matjaz/C-9918-2009; Lenasi, Tina/A-5990-2010	Barboric, Matjaz/0000-0002-9715-2291; Lenasi, Tina/0000-0001-9091-3978	National Institutes of Health [AI058708, GM082250]; Academy of Finland [1127313, 137077, 140996]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P01AI058708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058708 and GM082250 (to B. M. P.). This work was also supported by Academy of Finland FiDiPro programme Grant 1127313 (to Kalle Saksela and B. M. P.) and Academy of Finland Grants 137077 and 140996 (to M. B.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Alexander RD, 2010, MOL CELL, V40, P582, DOI 10.1016/j.molcel.2010.11.005; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Colot HV, 1996, GENE DEV, V10, P1699, DOI 10.1101/gad.10.13.1699; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; Flaherty SM, 1997, P NATL ACAD SCI USA, V94, P11893, DOI 10.1073/pnas.94.22.11893; Fortes P, 1999, MOL CELL BIOL, V19, P6543; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Gornemann J., 2005, MOL CELL, V19, P53; Guiguen A, 2007, EMBO J, V26, P1552, DOI 10.1038/sj.emboj.7601627; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; Nechaev S., 2010, BIOCHIM BIOPHYS ACTA, V1809, P43; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Qiu HF, 2009, MOL CELL, V33, P752, DOI 10.1016/j.molcel.2009.02.018; Raczynska KD, 2010, NUCLEIC ACIDS RES, V38, P265, DOI 10.1093/nar/gkp869; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Shuman S, 2001, PROG NUCLEIC ACID RE, V66, P1; Viladevall L, 2009, MOL CELL, V33, P738, DOI 10.1016/j.molcel.2009.01.029; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008	42	53	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22758	22768		10.1074/jbc.M111.235077	http://dx.doi.org/10.1074/jbc.M111.235077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536667	Green Published, hybrid			2022-12-25	WOS:000292025000010
J	Triboulet, S; Arthur, M; Mainardi, JL; Veckerle, C; Dubee, V; NGuekam-Moumi, A; Gutmann, L; Rice, LB; Hugonnet, JE				Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Rice, Louis B.; Hugonnet, Jean-Emmanuel			Inactivation Kinetics of a New Target of beta-Lactam Antibiotics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; MYCOBACTERIUM-TUBERCULOSIS; ENTEROCOCCUS-FAECIUM; STREPTOCOCCUS-PNEUMONIAE; PEPTIDOGLYCAN BIOSYNTHESIS; RESISTANCE; TRANSPEPTIDASE; EXPRESSION; CLAVULANATE; INHIBITION	Peptidoglycan is predominantly cross-linked by serine DD-transpeptidases in most bacterial species. The enzymes are the essential targets of beta-lactam antibiotics. However, unrelated cysteine LD-transpeptidases have been recently recognized as a predominant mode of peptidoglycan cross-linking in Mycobacterium tuberculosis and as a bypass mechanism conferring resistance to all beta-lactams, except carbapenems such as imipenem, in Enterococcus faecium. Investigation of the mechanism of inhibition of this new beta-lactam target showed that acylation of the E. faecium enzyme (Ldt(fm)) by imipenem is irreversible. Using fluorescence kinetics, an original approach was developed to independently determine the catalytic constants for imipenem binding (k(1) = 0.061 mu M-1 min(-1)) and acylation (k(inact) = 4.5 min(-1)). The binding step was limiting at the minimal drug concentration required for bacterial growth inhibition. The Michaelis complex was committed to acylation because its dissociation was negligible. The emergence of imipenem resistance involved substitutions in Ldtfm that reduced the rate of formation of the non-covalent complex but only marginally affected the efficiency of the acylation step. The methods described in this study will facilitate development of new carbapenems active on extensively resistant M. tuberculosis.	[Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Hugonnet, Jean-Emmanuel] Univ Paris 06, Ctr Rech Cordeliers, Equipe 12, Lab Rech Mol Antibiot,UMRS 872, F-75006 Paris, France; [Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Hugonnet, Jean-Emmanuel] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Triboulet, Sebastien; Arthur, Michel; Mainardi, Jean-Luc; Veckerle, Carole; Dubee, Vincent; NGuekam-Moumi, Angele; Gutmann, Laurent; Hugonnet, Jean-Emmanuel] INSERM, U872, F-75006 Paris, France; [Mainardi, Jean-Luc; Gutmann, Laurent] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France; [Rice, Louis B.] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Hugonnet, JE (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, Equipe 12, Lab Rech Mol Antibiot,UMRS 872, 15 Rue Ecole Med, F-75006 Paris, France.	jean-emmanuel.hugonnet@crc.jussieu.fr	HUGONNET, Jean-Emmanuel/H-3581-2014; Dubée, Vincent/F-8768-2018; Triboulet, Sebastien/AAI-8676-2020; MAINARDI, Jean-Luc/E-2714-2014; HUGONNET, Jean-Emmanuel/ABC-7914-2021; Arthur, Michel/G-3680-2013	HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Dubée, Vincent/0000-0002-9982-4741; MAINARDI, Jean-Luc/0000-0002-4159-0129; HUGONNET, Jean-Emmanuel/0000-0003-4150-0944; Arthur, Michel/0000-0003-1007-636X	National Institutes of Health, NIAID [RO1 AI45626, AI046626]; Fondation pour la Recherche Medicale [DEQ200661107918]; FRM [FDT 20080914133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045626] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); FRM(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grants RO1 AI45626 and AI046626. This work was also supported by the Fondation pour la Recherche Medicale (Equipe FRM 2006; DEQ200661107918).; Recipient of FRM Fellowship FDT 20080914133. To whom correspondence should be addressed: Centre de Recherche des Cordeliers, UMRS-872-Equipe 12, 15 Rue de l'Ecole de Medecine, 75006 Paris. E-mail: jean-emmanuel.hugonnet@crc.jussieu.fr.	Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Chesnel L, 2005, ANTIMICROB AGENTS CH, V49, P2895, DOI 10.1128/AAC.49.7.2895-2902.2005; FRERE JM, 1975, EUR J BIOCHEM, V57, P343, DOI 10.1111/j.1432-1033.1975.tb02307.x; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; Mainardi JL, 2007, J BIOL CHEM, V282, P30414, DOI 10.1074/jbc.M704286200; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; Rice LB, 2004, ANTIMICROB AGENTS CH, V48, P3028, DOI 10.1128/AAC.48.8.3028-3032.2004; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sifaoui F, 2001, ANTIMICROB AGENTS CH, V45, P2594, DOI 10.1128/AAC.45.9.2594-2597.2001; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	17	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22777	22784		10.1074/jbc.M111.239988	http://dx.doi.org/10.1074/jbc.M111.239988			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543331	hybrid, Green Published			2022-12-25	WOS:000292025000012
J	Jin, Y; Wu, JP; Song, XX; Song, QH; Cully, BL; Messmer-Blust, A; Xu, M; Foo, SY; Rosenzweig, A; Li, J				Jin, Yi; Wu, Jiaping; Song, Xiaoxiao; Song, Qinhui; Cully, Brittany L.; Messmer-Blust, Angela; Xu, Ming; Foo, Shi-Yin; Rosenzweig, Anthony; Li, Jian			RTEF-1, an Upstream Gene of Hypoxia-inducible Factor-1 alpha, Accelerates Recovery from Ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; M-CAT ELEMENTS; FACTOR 1-ALPHA; ENDOTHELIAL-CELLS; TARGET GENES; KAPPA-B; TRANSCRIPTION; TEF-1; IDENTIFICATION; ANGIOGENESIS	The amount of available hypoxia-inducible factor (HIF)-1 alpha has been considered to be largely a consequence of post-translational modification by multiple ubiquitin-proteasome pathways. However, the role of transcriptional regulation of HIF-1 alpha is less certain, and the mechanisms of transcriptional regulation of HIF-1 alpha require further investigation. Here we report that related transcriptional enhancer factor-1 (RTEF-1), a member of the TEF transcriptional factor family, transcriptionally regulates the HIF-1 alpha gene under normoxic and hypoxic conditions. The expression of HIF-1 alpha mRNA was decreased in endothelial cells in which RTEF-1 was knocked down with siRNA. Sequential deletional analysis of the HIF-1 alpha promoter revealed that the MCAT-like element in the HIF-1 alpha promoter was essential for HIF-1 alpha transcription. Binding of RTEF-1 to the MCAT-like element was confirmed by ChIP. Treatment of endothelial cells with a HIF-1 inhibitor resulted in retardation of RTEF-1-induced proliferation and tube formation. Moreover, increased HIF-1 alpha expression was observed in transgenic mice expressing RTEF-1 under the VE-cadherin promoter (VE-Cad/RTEF-1). VE-Cad/RTEF-1 mice subjected to hindlimb ischemia demonstrated increased levels of HIF-1 alpha, accelerated recovery of blood flow, and increased capillary density compared with littermate controls. These results identify RTEF-1 as a regulator of HIF-1 alpha transcription, which results in up-regulation of HIF-1 alpha and acceleration of recovery from ischemia.	[Li, Jian] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, CardioVasc Inst,Ctr Life Sci, Boston, MA 02215 USA; [Jin, Yi; Li, Jian] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Peking University	Li, J (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, CardioVasc Inst,Ctr Life Sci, CLS 909,3 Blackfan Circle, Boston, MA 02215 USA.	jli@bidmc.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019	Messmer-Blust, Angela/0000-0001-9582-5301; Jin, Yi/0000-0001-9704-973X	National Institutes of Health [HLR01082837]; China Scholarship Council	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council)	This work was supported, in whole or in part, by National Institutes of Health Grant HLR01082837 (to J. L.). This work was also supported by the China Scholarship Council (to Y. J.).	Appukuttan B, 2007, INVEST OPHTH VIS SCI, V48, P3775, DOI 10.1167/iovs.06-1172; Azakie A, 1996, J BIOL CHEM, V271, P8260, DOI 10.1074/jbc.271.14.8260; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Chen HH, 2004, CIRCULATION, V110, P2980, DOI 10.1161/01.CIR.0000146902.84099.26; Couffinhal T, 1998, AM J PATHOL, V152, P1667; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Elson DA, 2000, CANCER RES, V60, P6189; FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234; Fukushima K, 2008, PLACENTA, V29, P324, DOI 10.1016/j.placenta.2008.01.006; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Larkin SB, 1996, MOL CELL BIOL, V16, P3742; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Richard DE, 2000, J BIOL CHEM, V275, P26765; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza Gregg L, 2006, Novartis Found Symp, V272, P2; Shie JL, 2004, J BIOL CHEM, V279, P25010, DOI 10.1074/jbc.M403103200; STEWART AFR, 1994, J BIOL CHEM, V269, P3147; Tritsaris K, 2007, P NATL ACAD SCI USA, V104, P15364, DOI 10.1073/pnas.0707302104; Ueyama T, 2000, J BIOL CHEM, V275, P17476, DOI 10.1074/jbc.M001970200; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085	26	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22699	22705		10.1074/jbc.M111.237024	http://dx.doi.org/10.1074/jbc.M111.237024			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540178	Green Published, hybrid			2022-12-25	WOS:000291719900076
J	Chourbaji, S; Hoyer, C; Richter, SH; Brandwein, C; Pfeiffer, N; Vogt, MA; Vollmayr, B; Gass, P				Chourbaji, Sabine; Hoyer, Carolin; Richter, S. Helene; Brandwein, Christiane; Pfeiffer, Natascha; Vogt, Miriam A.; Vollmayr, Barbara; Gass, Peter			Differences in Mouse Maternal Care Behavior - Is There a Genetic Impact of the Glucocorticoid Receptor?	PLOS ONE			English	Article							POSTPARTUM DEPRESSION; LIFE EVENTS; STRESS; MICE; ENVIRONMENT; MODEL; MOTHERS; ANXIETY; BRAIN; EXPRESSION	Depressive episodes are frequently preceded by stressful life events. Evidence from genetic association studies suggests a role for the glucocorticoid receptor (GR), an essential element in the regulation of stress responses, in the pathophysiology of the disorder. Since the stress response system is affected by pregnancy and postpartum-associated changes, it has also been implicated in the pathophysiology of postpartum depression. Using a 2x2 factorial design, we investigated whether a heterozygous deletion of GR would influence maternal care behavior in C57BL/6 and Balb/c mice, two inbred strains known to display qualitative differences in this behavior. Behavioral observation was carried out between postnatal days 1 and 7, followed by a pup retrieval test on postnatal days 7 or 8. While previously noted inter-strain differences were confirmed for different manifestations of caring behavior, self-maintenance and neglecting behaviors as well as the pup retrieval test, no strain-independent effect of the GR mutation was noted. However, an interaction between GR genotype and licking/grooming behavior was observed: it was down-regulated in heterozygous C57BL/6 mice to the level recorded for Balb/c mice. Home cage observation poses minimal disturbance of the dam and her litter as compared to more invasive assessments of dams' emotional behavior. This might be a reason for the absence of any overall effects of the GR mutation, particularly since GR heterozygous animals display a depressive-like phenotype under stressful conditions only. Still, the subtle effect we observed may point towards a role of GR in postpartum affective disorders.	[Chourbaji, Sabine; Hoyer, Carolin; Richter, S. Helene; Brandwein, Christiane; Pfeiffer, Natascha; Vogt, Miriam A.; Vollmayr, Barbara; Gass, Peter] Cent Inst Mental Hlth, D-6800 Mannheim, Germany	Central Institute of Mental Health	Chourbaji, S (corresponding author), Cent Inst Mental Hlth, D-6800 Mannheim, Germany.	carolin.hoyer@zi-mannheim.de		Vogt, Miriam Annika/0000-0002-3400-5067	Deutsche Forschungsgemeinschaft [SFB636/B3]; Bundesministerium fur Bildung und Forschung; BMBF (Bernstein Center for Computational Neuroscience Heidelberg-Mannheim) [C8]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); BMBF (Bernstein Center for Computational Neuroscience Heidelberg-Mannheim)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants to P.G. from the Deutsche Forschungsgemeinschaft (SFB636/B3) and from the Bundesministerium fur Bildung und Forschung (EU ERANET program, POSEIDON). B.V. and P.G. hold a common grant from the BMBF (Bernstein Center for Computational Neuroscience Heidelberg-Mannheim, C8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Arborelius L, 2007, NEUROSCIENCE, V145, P738, DOI 10.1016/j.neuroscience.2006.12.007; Arnett MG, 2010, MOL CELL ENDOCRINOL; BEUZEN A, 1995, PHYSIOL BEHAV, V58, P111, DOI 10.1016/0031-9384(95)00013-9; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Branchi I, 2009, NEUROSCI BIOBEHAV R, V33, P551, DOI 10.1016/j.neubiorev.2008.03.011; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Caldji C, 2004, NEUROPSYCHOPHARMACOL, V29, P1344, DOI 10.1038/sj.npp.1300436; Carola V, 2006, GENES BRAIN BEHAV, V5, P189, DOI 10.1111/j.1601-183X.2005.00152.x; Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013; Carola V, 2011, BEHAV BRAIN RES, V217, P188, DOI 10.1016/j.bbr.2010.10.020; Champagne F, 2001, Prog Brain Res, V133, P287; Champagne FA, 2007, PHYSIOL BEHAV, V91, P325, DOI 10.1016/j.physbeh.2007.03.014; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Choi H, 2010, PSYCHIAT CLIN NEUROS, V64, P120, DOI 10.1111/j.1440-1819.2010.02063.x; Chourbaji S, 2008, BRAIN RES REV, V57, P554, DOI 10.1016/j.brainresrev.2007.04.008; COHN JF, 1989, J AM ACAD CHILD PSY, V28, P242, DOI 10.1097/00004583-198903000-00016; Corwin EJ, 2008, J WOMENS HEALTH, V17, P1529, DOI 10.1089/jwh.2007.0725; Coutellier L, 2008, PHYSIOL BEHAV, V93, P395, DOI 10.1016/j.physbeh.2007.09.008; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Eklund MB, 2009, BEHAV BRAIN RES, V203, P69, DOI 10.1016/j.bbr.2009.04.017; Festing Michael F W, 2002, ILAR J, V43, P244; Francis DD, 1999, CURR OPIN NEUROBIOL, V9, P128, DOI 10.1016/S0959-4388(99)80016-6; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Galea LAN, 2001, BEHAV BRAIN RES, V122, P1, DOI 10.1016/S0166-4328(01)00170-X; Geller PA, 2004, CNS SPECTRUMS, V9, P188, DOI 10.1017/S1092852900008981; Hess CW, 2002, BEHAV GENET, V32, P259, DOI 10.1023/A:1019776729821; HOLM S, 1979, SCAND J STAT, V6, P65; Hoshino K, 2006, ENDOCRINOLOGY, V147, P1916, DOI 10.1210/en.2005-1343; Hunt J, 2002, P NATL ACAD SCI USA, V99, P6828, DOI 10.1073/pnas.092676199; Iwata E, 2007, PHYSIOL BEHAV, V91, P318, DOI 10.1016/j.physbeh.2007.03.013; Lesch KP, 2006, HANDB EXP PHARM, V175, P417; Lightman S L, 2001, Prog Brain Res, V133, P111; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mazure CM, 2000, AM J PSYCHIAT, V157, P896, DOI 10.1176/appi.ajp.157.6.896; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Reck C, 2004, PSYCHOPATHOLOGY, V37, P272, DOI 10.1159/000081983; Richter SH, 2009, NAT METHODS, V6, P257, DOI [10.1038/NMETH.1312, 10.1038/nmeth.1312]; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Smith JW, 2004, PSYCHONEUROENDOCRINO, V29, P227, DOI 10.1016/S0306-4530(03)00025-8; Sorenson DS, 2010, PERSPECT PSYCHIATR C, V46, P14, DOI 10.1111/j.1744-6163.2009.00234.x; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; van West D, 2006, NEUROPSYCHOPHARMACOL, V31, P620, DOI 10.1038/sj.npp.1300898; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Wurbel H, 2002, GENES BRAIN BEHAV, V1, P3, DOI 10.1046/j.1601-1848.2001.00006.x; Zaharia MD, 1996, PSYCHOPHARMACOLOGY, V128, P227, DOI 10.1007/s002130050130	52	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19218	10.1371/journal.pone.0019218	http://dx.doi.org/10.1371/journal.pone.0019218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552522	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700039
J	Clark, CE; Hasan, M; Bousso, P				Clark, Carolyn E.; Hasan, Milena; Bousso, Philippe			A Role for the Immediate Early Gene Product c-fos in Imprinting T Cells with Short-Term Memory for Signal Summation	PLOS ONE			English	Article							DENDRITIC CELLS; IN-VIVO; CUTTING EDGE; LYMPH-NODES; ACTIVATION; LYMPHOCYTES; RECEPTOR; KINASE; PHOSPHORYLATION; TRAFFICKING	T cells often make sequential contacts with multiple DCs in the lymph nodes and are likely to be equipped with mechanisms that allow them to sum up the successive signals received. We found that a period of stimulation as short as two hours could imprint on a T cell a "biochemical memory" of that activation signal that persisted for several hours. This was evidenced by more rapid induction of activation markers and earlier commitment to proliferation upon subsequent stimulation, even when that secondary stimulation occurred hours later. Upregulation of the immediate early gene product c-fos, a component of the AP-1 transcription factor, was maximal by 1-2 hours of stimulation, and protein levels remained elevated for several hours after stimulus withdrawal. Moreover, phosphorylated forms of c-fos that are stable and transcriptionally active persisted for a least a day. Upon brief antigenic stimulation in vivo, we also observed a rapid upregulation of c-fos that could be boosted by subsequent stimulation. Accumulation of phosphorylated c-fos may therefore serve as a biochemical fingerprint of previous suboptimal stimulation, leaving the T cell poised to rapidly resume its activation program upon its next encounter with an antigen-bearing DC.	[Clark, Carolyn E.; Bousso, Philippe] Inst Pasteur, Dynam Immune Responses Unit, Paris, France; [Clark, Carolyn E.; Bousso, Philippe] INSERM, U668, Paris, France; [Hasan, Milena] Inst Pasteur, Ctr Human Immunol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Clark, CE (corresponding author), Inst Pasteur, Dynam Immune Responses Unit, Paris, France.	philippe.bousso@pasteur.fr	Hasan, Milena/AAO-6610-2021; BOUSSO, Philippe/M-6547-2014	Hasan, Milena/0000-0002-0879-7099; BOUSSO, Philippe/0000-0002-6362-561X	Institut Pasteur; Inserm; Mairie de Paris; Marie-Curie Excellence Grant; Philippe Foundation	Institut Pasteur(European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Mairie de Paris(Region Ile-de-France); Marie-Curie Excellence Grant(European Commission); Philippe Foundation	This work was supported by the Institut Pasteur, Inserm, Mairie de Paris and a Marie-Curie Excellence Grant, in addition to a grant from the Philippe Foundation to CEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar GA, 2010, P NATL ACAD SCI US; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Celli S, 2007, IMMUNITY, V27, P625, DOI 10.1016/j.immuni.2007.08.018; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Cuddapah S, 2010, CURR OPIN IMMUNOL, V22, P341, DOI 10.1016/j.coi.2010.02.007; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Faroudi M, 2003, J IMMUNOL, V171, P1128, DOI 10.4049/jimmunol.171.3.1128; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Iezzi G, 2001, J EXP MED, V193, P987, DOI 10.1084/jem.193.8.987; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, J IMMUNOL, V148, P1240; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Locasale JW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000627; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MIETHKE T, 1993, J IMMUNOL, V151, P6777; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Munitic I, 2005, J IMMUNOL, V174, P4010, DOI 10.4049/jimmunol.174.7.4010; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; Schade AE, 2004, J IMMUNOL, V172, P5828, DOI 10.4049/jimmunol.172.10.5828; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421	27	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18916	10.1371/journal.pone.0018916	http://dx.doi.org/10.1371/journal.pone.0018916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552553	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700007
J	Liu, YC; Liu, YL; Su, JY; Liu, GY; Hung, HC				Liu, Yen-Chin; Liu, Yi-Liang; Su, Jia-Yang; Liu, Guang-Yaw; Hung, Hui-Chih			Critical Factors Governing the Difference in Antizyme-Binding Affinities between Human Ornithine Decarboxylase and Antizyme Inhibitor	PLOS ONE			English	Article							METHOTREXATE-INDUCED APOPTOSIS; ANALYTICAL ULTRACENTRIFUGATION; POLYAMINE METABOLISM; ANGSTROM RESOLUTION; HOMOLOGOUS PROTEIN; DEGRADATION; OVEREXPRESSION; GROWTH; ODC; FIBROBLASTS	Both ornithine decarboxylase (ODC) and its regulatory protein, antizyme inhibitor (AZI), can bind with antizyme (AZ), but the latter has a higher AZ-binding affinity. The results of this study clearly identify the critical amino acid residues governing the difference in AZ-binding affinities between human ODC and AZI. Inhibition experiments using a series of ODC mutants suggested that residues 125 and 140 may be the key residues responsible for the differential AZ-binding affinities. The ODC_N125K/M140K double mutant demonstrated a significant inhibition by AZ, and the IC50 value of this mutant was 0.08 mu M, three-fold smaller than that of ODC_WT. Furthermore, the activity of the AZ-inhibited ODC_N125K/M140K enzyme was hardly rescued by AZI. The dissociation constant (K-d) of the [ODC_N125K/M140K]-AZ heterodimer was approximately 0.02 mu M, which is smaller than that of WT_ODC by approximately 10-fold and is very close to the K-d value of AZI_WT, suggesting that ODC_N125K/M140K has an AZ-binding affinity higher than that of ODC_WT and similar to that of AZI. The efficiency of the AZI_K125N/K140M double mutant in the rescue of AZ-inhibited ODC enzyme activity was less than that of AZI_WT. The K-d value of [AZI_K125N/K140M]-AZ was 0.18 mu M, nine-fold larger than that of AZI_WT and close to the K-d value of ODC_WT, suggesting that AZI_K125N/K140M has an AZ-binding affinity lower than that of AZI_WT and similar to that of ODC. These data support the hypothesis that the differences in residues 125 and 140 in ODC and AZI are responsible for the differential AZ-binding affinities.	[Liu, Yen-Chin; Liu, Yi-Liang; Su, Jia-Yang; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yen-Chin; Liu, Yi-Liang; Su, Jia-Yang; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Gen & Bioinformat, Taichung 40227, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ & Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ & Hosp, Inst Immunol, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Liu, YC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Hung, Hui-Chih/L-8061-2019	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822; Su, Jia-Yang/0000-0002-2817-1659	National Science Council, Republic of China [NSC-99-2113-M-005-010, NSC-99-2314-B-040-002-MY3]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This work was supported by the National Science Council, Republic of China (NSC-99-2113-M-005-010 and NSC-99-2314-B-040-002-MY3), and in part by the Ministry of Education, Taiwan, Republic of China under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; Auvinen M, 1997, CANCER RES, V57, P3016; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Choi KS, 2005, BIOCHEM BIOPH RES CO, V328, P206, DOI 10.1016/j.bbrc.2004.11.172; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Coffino P, 1998, UBIQUITIN BIOL CELL, P411; Cohavi O, 2009, J MOL BIOL, V390, P503, DOI 10.1016/j.jmb.2009.05.029; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Deng AH, 2003, DIABETES, V52, P1235, DOI 10.2337/diabetes.52.5.1235; Furumitsu Y, 2000, J RHEUMATOL, V27, P1352; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; HAYASHI S, 1984, ADV ENZYME REGUL, V23, P311, DOI 10.1016/0065-2571(85)90054-8; Hsu PC, 2006, APOPTOSIS, V11, P389, DOI 10.1007/s10495-006-4002-0; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Liu GY, 2005, APOPTOSIS, V10, P569, DOI 10.1007/s10495-005-1891-2; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Morrison LD, 1998, J NEUROCHEM, V71, P288; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; OBrien TG, 1997, CANCER RES, V57, P2630; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Schluter KD, 2000, CARDIOVASC RES, V45, P410, DOI 10.1016/S0008-6363(99)00351-X; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Seiler N, 1998, INT J ONCOL, V13, P993; Smith MK, 1997, CANCER RES, V57, P2104; SOLANO F, 1985, FEBS LETT, V190, P324, DOI 10.1016/0014-5793(85)81311-9; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200	56	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19253	10.1371/journal.pone.0019253	http://dx.doi.org/10.1371/journal.pone.0019253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552531	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700045
J	Arzouan, Y; Solomon, S; Faust, M; Goldstein, A				Arzouan, Yossi; Solomon, Sorin; Faust, Miriam; Goldstein, Abraham			Big Words, Halved Brains and Small Worlds: Complex Brain Networks of Figurative Language Comprehension	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; RIGHT-HEMISPHERE; OSCILLATIONS; ORGANIZATION; PRECUNEUS; DYNAMICS; PATTERNS; ANATOMY	Language comprehension is a complex task that involves a wide network of brain regions. We used topological measures to qualify and quantify the functional connectivity of the networks used under various comprehension conditions. To that aim we developed a technique to represent functional networks based on EEG recordings, taking advantage of their excellent time resolution in order to capture the fast processes that occur during language comprehension. Networks were created by searching for a specific causal relation between areas, the negative feedback loop, which is ubiquitous in many systems. This method is a simple way to construct directed graphs using event-related activity, which can then be analyzed topologically. Brain activity was recorded while subjects read expressions of various types and indicated whether they found them meaningful. Slightly different functional networks were obtained for event-related activity evoked by each expression type. The differences reflect the special contribution of specific regions in each condition and the balance of hemispheric activity involved in comprehending different types of expressions and are consistent with the literature in the field. Our results indicate that representing event-related brain activity as a network using a simple temporal relation, such as the negative feedback loop, to indicate directional connectivity is a viable option for investigation which also derives new information about aspects not reflected in the classical methods for investigating brain activity.	[Arzouan, Yossi; Faust, Miriam; Goldstein, Abraham] Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel; [Arzouan, Yossi; Solomon, Sorin] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Faust, Miriam; Goldstein, Abraham] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel	Bar Ilan University; Hebrew University of Jerusalem; Bar Ilan University	Arzouan, Y (corresponding author), Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel.	goldsa@mail.biu.ac.il		Faust, Miriam/0000-0001-9012-9577; Goldstein, Abraham/0000-0002-9349-0621	Horowitz Foundation	Horowitz Foundation	YA was partially supported by the Horowitz Foundation (Complexity Science). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arzouan Y, 2007, BRAIN RES, V1160, P69, DOI 10.1016/j.brainres.2007.05.034; Arzouan Y, 2007, NEUROIMAGE, V36, P222, DOI 10.1016/j.neuroimage.2007.02.015; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chartrand G., 2005, GRAPHS DIGRAPHS; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; Harary F., 1969, GRAPH THEORY; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; Mashal N, 2005, NEUROPSYCHOLOGIA, V43, P2084, DOI 10.1016/j.neuropsychologia.2005.03.019; Muchnik L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016106; Pascual-Marqui R.D., 2002, JPN J CLIN NEUROPHYS, V30, P81; Pascual-Marqui RD., 1999, INT J BIOELECTROMAGN, V1, P1, DOI DOI 10.1186/1743-0003-5-25; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pigolotti S, 2007, P NATL ACAD SCI USA, V104, P6533, DOI 10.1073/pnas.0610759104; Ramachandran VS, 2004, BRIEF TOUR HUMAN CON; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Schmidt GL, 2009, BRAIN COGNITION, V71, P375, DOI 10.1016/j.bandc.2009.06.001; Snoussi El Houssine, 1998, Journal of Biological Systems, V6, P3, DOI 10.1142/S0218339098000042; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; St George M, 1999, BRAIN, V122, P1317, DOI 10.1093/brain/122.7.1317; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wasserman S., 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang XS, 2001, GEOPHYS RES LETT, V28, P2549, DOI 10.1029/2000GL011898; Zempleni MZ, 2007, NEUROIMAGE, V34, P1270, DOI 10.1016/j.neuroimage.2006.09.048	43	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19345	10.1371/journal.pone.0019345	http://dx.doi.org/10.1371/journal.pone.0019345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556324	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400051
J	Kampf-Lassin, A; Wei, J; Galang, J; Prendergast, BJ				Kampf-Lassin, August; Wei, Jenny; Galang, Jerome; Prendergast, Brian J.			Experience-Independent Development of the Hamster Circadian Visual System	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; SUPRACHIASMATIC NUCLEUS; RETINOHYPOTHALAMIC TRACT; MONOCULAR DEPRIVATION; POSTNATAL-DEVELOPMENT; ACTIVITY RHYTHMS; STRIATE CORTEX; GANGLION-CELLS; ENTRAINMENT; RAT	Experience-dependent functional plasticity is a hallmark of the primary visual system, but it is not known if analogous mechanisms govern development of the circadian visual system. Here we investigated molecular, anatomical, and behavioral consequences of complete monocular light deprivation during extended intervals of postnatal development in Syrian hamsters. Hamsters were raised in constant darkness and opaque contact lenses were applied shortly after eye opening and prior to the introduction of a light-dark cycle. In adulthood, previously-occluded eyes were challenged with visual stimuli. Whereas image-formation and motion-detection were markedly impaired by monocular occlusion, neither entrainment to a light-dark cycle, nor phase-resetting responses to shifts in the light-dark cycle were affected by prior monocular deprivation. Cholera toxin-b subunit fluorescent tract-tracing revealed that in monocularly-deprived hamsters the density of fibers projecting from the retina to the suprachiasmatic nucleus (SCN) was comparable regardless of whether such fibers originated from occluded or exposed eyes. In addition, long-term monocular deprivation did not attenuate light-induced c-Fos expression in the SCN. Thus, in contrast to the thalamocortical projections of the primary visual system, retinohypothalamic projections terminating in the SCN develop into normal adult patterns and mediate circadian responses to light largely independent of light experience during development. The data identify a categorical difference in the requirement for light input during postnatal development between circadian and non-circadian visual systems.	[Kampf-Lassin, August; Wei, Jenny; Galang, Jerome; Prendergast, Brian J.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Prendergast, Brian J.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kampf-Lassin, A (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	august@uchicago.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067406] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI067406] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANSTIS SM, 1967, SCIENCE, V155, P710, DOI 10.1126/science.155.3763.710; Aschoff, 1965, CIRCADIAN CLOCKS, P95; ASCHOFF J, 1954, Pflugers Arch Gesamte Physiol Menschen Tiere, V260, P170; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Canal-Corretger MM, 2001, CHRONOBIOL INT, V18, P683, DOI 10.1081/CBI-100106081; DAVIS FC, 1985, BIOL REPROD, V33, P353, DOI 10.1095/biolreprod33.2.353; DAVIS FC, 1988, AM J PHYSIOL, V255, pR439, DOI 10.1152/ajpregu.1988.255.3.R439; DAVIS FC, 1988, J COMP PHYSIOL A, V162, P601, DOI 10.1007/BF01342635; DEGUCHI T, 1975, P NATL ACAD SCI USA, V72, P2814, DOI 10.1073/pnas.72.7.2814; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Evans JA, 2009, CURR BIOL, V19, pR156, DOI 10.1016/j.cub.2009.01.023; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; FINLAY BL, 1980, J COMP PHYSIOL PSYCH, V94, P506, DOI 10.1037/h0077687; Gammie SC, 2001, BRAIN RES, V898, P232, DOI 10.1016/S0006-8993(01)02189-8; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HENDRICKSON AE, 1972, Z ZELLFORSCH MIK ANA, V135, P1, DOI 10.1007/BF00307084; Hooks BM, 2008, J NEUROSCI, V28, P4807, DOI 10.1523/JNEUROSCI.4667-07.2008; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Huberman AD, 2002, J NEUROSCI, V22, P9419; Isobe Y, 1997, BIOL RHYTHM RES, V28, P5, DOI 10.1076/brhm.28.3.5.5.13125; JOHNSON RF, 1988, BRAIN RES, V460, P297, DOI 10.1016/0006-8993(88)90374-5; JOHNSON RF, 1988, BRAIN RES, V462, P301, DOI 10.1016/0006-8993(88)90558-6; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Kriegsfeld Lance J., 2002, P33; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MOORE RY, 1972, J COMP NEUROL, V146, P1, DOI 10.1002/cne.901460102; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 2001, STEREOTAXIC ATLAS GO; MOWER GD, 1981, DEV BRAIN RES, V1, P418, DOI 10.1016/0165-3806(81)90079-1; Muscat L, 2005, J BIOL RHYTHM, V20, P513, DOI 10.1177/0748730405280458; Muscat L, 2003, J COMP NEUROL, V466, P513, DOI 10.1002/cne.10894; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Nelson DE, 1999, AM J PHYSIOL-REG I, V277, pR1351, DOI 10.1152/ajpregu.1999.277.5.R1351; OLSON CR, 1975, J NEUROPHYSIOL, V38, P26, DOI 10.1152/jn.1975.38.1.26; Park JH, 2005, J BIOL RHYTHM, V20, P49, DOI 10.1177/0748730404272967; Pickard G E, 1987, J Biol Rhythms, V2, P35, DOI 10.1177/074873048700200104; REPPERT SM, 1986, J NEUROSCI, V6, P2724; REPPERT SM, 1988, PSYCHONEUROENDOCRINO, V13, P63, DOI 10.1016/0306-4530(88)90007-8; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SPEH JC, 1993, DEV BRAIN RES, V76, P171, DOI 10.1016/0165-3806(93)90205-O; STEPHAN FK, 1978, BEHAV BIOL, V22, P77, DOI 10.1016/S0091-6773(78)92049-7; STEPHAN FK, 1972, PHYSIOL BEHAV, V8, P315, DOI 10.1016/0031-9384(72)90379-4; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; TAKAHASHI K, 1979, ENDOCRINOLOGY, V104, P954, DOI 10.1210/endo-104-4-954; VISWANATHAN N, 1994, J NEUROSCI, V14, P5393; VISWANATHAN N, 1985, NATURE, V317, P530, DOI 10.1038/317530a0; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; WINFIELD DA, 1976, NATURE, V263, P591, DOI 10.1038/263591a0	51	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e16048	10.1371/journal.pone.0016048	http://dx.doi.org/10.1371/journal.pone.0016048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556133	gold, Green Submitted, Green Published			2022-12-25	WOS:000290019400003
J	King, CC; Sastri, M; Chang, P; Pennypacker, J; Taylor, SS				King, Charles C.; Sastri, Mira; Chang, Philip; Pennypacker, Juniper; Taylor, Susan S.			The Rate of NF-kappa B Nuclear Translocation Is Regulated by PKA and A Kinase Interacting Protein 1	PLOS ONE			English	Article							CATALYTIC SUBUNIT; PHOSPHORYLATION SITES; GENE-EXPRESSION; TRANSCRIPTION; IMMUNE; ALPHA; P65; RESPONSES; CBP/P300; DYNAMICS	The mechanism of PKAc-dependent NF-kappa B activation and subsequent translocation into the nucleus is not well defined. Previously, we showed that A kinase interacting protein 1 (AKIP1) was important for binding and retaining PKAc in the nucleus. Since then, other groups have demonstrated that AKIP1 binds the p65 subunit of NF-kappa B and regulates its transcriptional activity through the phosphorylation at Ser 276 by PKAc. However, little is known about the formation and activation of the PKAc/AKIP1/p65 complex and the rate at which it enters the nucleus. Initially, we found that the AKIP1 isoform (AKIP 1A) simultaneously binds PKAc and p65 in resting and serum starved cells. Using peptide arrays, we refined the region of AKIP 1A binding on PKAc and mapped the non-overlapping regions on AKIP 1A where PKAc and p65 bind. A peptide to the amino-terminus of PKAc (CAT 1-29) was generated to specifically disrupt the interaction between AKIP 1A and PKAc to study nuclear import of the complex. The rate of p65 nuclear translocation was monitored in the presence or absence of overexpressed AKIP 1A and/or (CAT 1-29). Enhanced nuclear translocation of p65 was observed in the presence of overexpressed AKIP1 and/or CAT 1-29 in cells stimulated with TNF alpha, and this correlated with decreased phosphorylation of serine 276. To determine whether PKAc phosphorylation of p65 in the cytosol regulated nuclear translocation, serine 276 was mutated to alanine or aspartic acid. Accelerated nuclear accumulation of p65 was observed in the alanine mutant, while the aspartic acid mutation displayed slowed nuclear translocation kinetics. In addition, enhanced nuclear translocation of p65 was observed when PKAc was knocked-down by siRNA. Taken together, these results suggest that AKIP 1A acts to scaffold PKAc to NF-kappa B in the cytosol by protecting the phosphorylation site and thereby regulating the rate of nuclear translocation of p65.	[King, Charles C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Sastri, Mira; Pennypacker, Juniper; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Chang, Philip; Taylor, Susan S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	King, CC (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	staylor@ucsd.edu			NIH [DK54441]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Juvenile Diabetes Research Foundation (http://www.jdrf.org/) to CK, and NIH (http://www.nih.gov/) (DK54441) to SST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Banky P, 2000, J BIOL CHEM, V275, P35146, DOI 10.1074/jbc.M003961200; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Gangal M, 1999, P NATL ACAD SCI USA, V96, P12394, DOI 10.1073/pnas.96.22.12394; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; Gao N, J BIOL CHEM, V285, P28097; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; MA Y, 2002, J BIOL CHEM, V321, P703; Pepperkok R, 2000, J CELL BIOL, V148, P715, DOI 10.1083/jcb.148.4.715; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Xiao CC, 2005, ADV EXP MED BIOL, V560, P41; YONEMOTO W, 1993, J BIOL CHEM, V268, P18626; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	35	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18713	10.1371/journal.pone.0018713	http://dx.doi.org/10.1371/journal.pone.0018713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556136	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400009
J	Chen, Y; Dai, HZ; Chen, SD; Zhang, LY; Long, MY				Chen, Ying; Dai, Hongzheng; Chen, Sidi; Zhang, Luoying; Long, Manyuan			Highly Tissue Specific Expression of Sphinx Supports Its Male Courtship Related Role in Drosophila melanogaster	PLOS ONE			English	Article							ANTENNAL LOBE; BEHAVIOR; GENE; EVOLUTION; SYSTEM	Sphinx is a lineage-specific non-coding RNA gene involved in regulating courtship behavior in Drosophila melanogaster. The 59 flanking region of the gene is conserved across Drosophila species, with the proximal 300 bp being conserved out to D. virilis and a further 600 bp region being conserved amongst the melanogaster subgroup (D. melanogaster, D. simulans, D. sechellia, D. yakuba, and D. erecta). Using a green fluorescence protein transformation system, we demonstrated that a 253 bp region of the highly conserved segment was sufficient to drive sphinx expression in male accessory gland. GFP signals were also observed in brain, wing hairs and leg bristles. An additional similar to 800 bp upstream region was able to enhance expression specifically in proboscis, suggesting the existence of enhancer elements. Using anti-GFP staining, we identified putative sphinx expression signal in the brain antennal lobe and inner antennocerebral tract, suggesting that sphinx might be involved in olfactory neuron mediated regulation of male courtship behavior. Whole genome expression profiling of the sphinx knockout mutation identified significant up-regulated gene categories related to accessory gland protein function and odor perception, suggesting sphinx might be a negative regulator of its target genes.	[Chen, Ying; Dai, Hongzheng; Long, Manyuan] Univ Chicago, Comm Genet, Chicago, IL 60637 USA; [Chen, Sidi; Long, Manyuan] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Zhang, Luoying] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of Chicago; University of Chicago; Northwestern University	Chen, Y (corresponding author), Univ Chicago, Comm Genet, Chicago, IL 60637 USA.	mojiao@gmail.com; mlong@uchicago.edu	CHEN, SIDI/D-8284-2016	CHEN, SIDI/0000-0002-3819-5005	National Science Foundation [MCB0238168]; USA National Institutes of Health [R01GM065429-01A1, 1R01GM078070-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078070, R01GM065429] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER award (MCB0238168) and USA National Institutes of Health R01 grants (R01GM065429-01A1 and 1R01GM078070-01A1) to M. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein H, 2004, CURR OPIN NEUROBIOL, V14, P435, DOI 10.1016/j.conb.2004.07.008; BARTHMAIER P, 1995, DEV BIOL, V169, P770, DOI 10.1006/dbio.1995.1186; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dai HZ, 2008, P NATL ACAD SCI USA, V105, P7478, DOI 10.1073/pnas.0800693105; Drivenes O, 2000, BBA-GENE STRUCT EXPR, V1491, P240, DOI 10.1016/S0167-4781(00)00042-7; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KALB JM, 1993, P NATL ACAD SCI USA, V90, P8093, DOI 10.1073/pnas.90.17.8093; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Laissue PP, 1999, J COMP NEUROL, V405, P543; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Schuster EF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r125; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang W, 2002, P NATL ACAD SCI USA, V99, P4448, DOI 10.1073/pnas.072066399; Wang W, 2002, SCIENCE, V295, P134, DOI 10.1126/science.1064521	23	18	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18853	10.1371/journal.pone.0018853	http://dx.doi.org/10.1371/journal.pone.0018853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541324	Green Submitted, gold, Green Published			2022-12-25	WOS:000290018400013
J	Kersh, EN; Adams, DR; Youngpairoj, AS; Luo, W; Zheng, Q; Cong, ME; Aung, W; Mitchell, J; Otten, R; Hendry, RM; Heneine, W; McNicholl, J; Garcia-Lerma, JG				Kersh, Ellen N.; Adams, Debra R.; Youngpairoj, Ae S.; Luo, Wei; Zheng, Qi; Cong, Mian-er; Aung, Wutyi; Mitchell, James; Otten, Ron; Hendry, R. Michael; Heneine, Walid; McNicholl, Janet; Garcia-Lerma, J. Gerardo			T Cell Chemo-Vaccination Effects after Repeated Mucosal SHIV Exposures and Oral Pre-Exposure Prophylaxis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RHESUS MACAQUES; INFECTION; RESPONSES; TRANSMISSION; HIV; PREVENTION; PROTECTION; TENOFOVIR; MEMORY	Pre-exposure prophylaxis (PrEP) with anti-viral drugs is currently in clinical trials for the prevention of HIV infection. Induction of adaptive immune responses to virus exposures during anti-viral drug administration, i.e., a "chemo-vaccination'' effect, could contribute to PrEP efficacy. To study possible chemo-vaccination, we monitored humoral and cellular immune responses in nine rhesus macaques undergoing up to 14 weekly, low-dose SHIV(SF162P3) rectal exposures. Six macaques concurrently received PrEP with intermittent, oral Truvada; three were no-PrEP controls. PrEP protected 4 macaques from infection. Two of the four showed evidence of chemo-vaccination, because they developed anti-SHIV CD4(+) and CD8(+) T cells; SHIV-specific antibodies were not detected. Control macaques showed no anti-SHIV immune responses before infection. Chemo-vaccination-induced T cell responses were robust (up to 3,940 SFU/10(6) PBMCs), predominantly central memory cells, short-lived (<= 22 weeks), and appeared intermittently and with changing specificities. The two chemo-vaccinated macaques were virus-challenged again after 28 weeks of rest, after T cell responses had waned. One macaque was not protected from infection. The other macaque concurrently received additional PrEP. It remained uninfected and T cell responses were boosted during the additional virus exposures. In summary, we document and characterize PrEP-induced T cell chemo-vaccination. Although not protective after subsiding in one macaque, chemo-vaccination-induced T cells warrant more comprehensive analysis during peak responses for their ability to prevent or to control infections after additional exposures. Our findings highlight the importance of monitoring these responses in clinical PrEP trials and suggest that a combination of vaccines and PrEP potentially might enhance efficacy.	[Kersh, Ellen N.; Adams, Debra R.; Youngpairoj, Ae S.; Luo, Wei; Zheng, Qi; Cong, Mian-er; Aung, Wutyi; Mitchell, James; Otten, Ron; Hendry, R. Michael; Heneine, Walid; McNicholl, Janet; Garcia-Lerma, J. Gerardo] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, CDC, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Kersh, EN (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, CDC, Atlanta, GA 30333 USA.	egk6@cdc.gov			CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	CDC intramural funding enabled this work. The authors are employed by CDC and were responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahlers JD, 2010, BLOOD, V115, P1678, DOI 10.1182/blood-2009-06-227546; Buge SL, 2003, AIDS RES HUM RETROV, V19, P891, DOI 10.1089/088922203322493067; CONG ME, 2010, INT HIV HEP VIR DR S; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Garcia-Lerma JG, 2010, TRENDS PHARMACOL SCI, V31, P74, DOI 10.1016/j.tips.2009.10.009; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaul R, 2001, IMMUNOL LETT, V79, P3, DOI 10.1016/S0165-2478(01)00260-7; Kersh EN, 2008, AIDS RES HUM RETROV, V24, P543, DOI 10.1089/aid.2007.0222; Kersh EN, 2009, AIDS RES HUM RETROV, V25, P905, DOI 10.1089/aid.2008.0287; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Loffredo JT, 2009, J IMMUNOL, V182, P7763, DOI 10.4049/jimmunol.0900111; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Mueller SN, 2008, IMMUNOL REV, V224, P284, DOI 10.1111/j.1600-065X.2008.00657.x; Otten RA, 2005, J INFECT DIS, V191, P164, DOI 10.1086/426452; Pahar B, 2007, VIROLOGY, V363, P36, DOI 10.1016/j.virol.2007.01.010; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Promadej N, 2003, J INFECT DIS, V187, P1053, DOI 10.1086/368127; Promadej-Lanier N, 2008, VIROLOGY, V375, P492, DOI 10.1016/j.virol.2008.01.040; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Tasca S, 2007, VIROLOGY, V367, P196, DOI 10.1016/j.virol.2007.05.021; Van Rompay KKA, 1998, AIDS RES HUM RETROV, V14, P761, DOI 10.1089/aid.1998.14.761; Willberg CB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000185; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Willyard C, 2009, NAT MED, V15, P126, DOI 10.1038/nm0209-126	35	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19295	10.1371/journal.pone.0019295	http://dx.doi.org/10.1371/journal.pone.0019295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541293	gold, Green Published			2022-12-25	WOS:000290018400043
J	Krasnova, IN; Ladenheim, B; Hodges, AB; Volkow, ND; Cadet, JL				Krasnova, Irina N.; Ladenheim, Bruce; Hodges, Amber B.; Volkow, Nora D.; Cadet, Jean Lud			Chronic Methamphetamine Administration Causes Differential Regulation of Transcription Factors in the Rat Midbrain	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE; DOPAMINE TRANSPORTER; SUBSTANTIA-NIGRA; SONIC HEDGEHOG; INDUCED NEUROTOXICITY; NEUROCHEMICAL CONSEQUENCES; AMPHETAMINE NEUROTOXICITY; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; STRIATAL DOPAMINE	Methamphetamine (METH) is an addictive and neurotoxic psychostimulant widely abused in the USA and throughout the world. When administered in large doses, METH can cause depletion of striatal dopamine terminals, with preservation of midbrain dopaminergic neurons. Because alterations in the expression of transcription factors that regulate the development of dopaminergic neurons might be involved in protecting these neurons after toxic insults, we tested the possibility that their expression might be affected by toxic doses of METH in the adult brain. Male Sprague-Dawley rats pretreated with saline or increasing doses of METH were challenged with toxic doses of the drug and euthanized two weeks later. Animals that received toxic METH challenges showed decreases in dopamine levels and reductions in tyrosine hydroxylase protein concentration in the striatum. METH pretreatment protected against loss of striatal dopamine and tyrosine hydroxylase. In contrast, METH challenges caused decreases in dopamine transporters in both saline-and METH-pretreated animals. Interestingly, METH challenges elicited increases in dopamine transporter mRNA levels in the midbrain in the presence but not in the absence of METH pretreatment. Moreover, toxic METH doses caused decreases in the expression of the dopamine developmental factors, Shh, Lmx1b, and Nurr1, but not in the levels of Otx2 and Pitx3, in saline-pretreated rats. METH pretreatment followed by METH challenges also decreased Nurr1 but increased Otx2 and Pitx3 expression in the midbrain. These findings suggest that, in adult animals, toxic doses of METH can differentially influence the expression of transcription factors involved in the developmental regulation of dopamine neurons. The combined increases in Otx2 and Pitx3 expression after METH preconditioning might represent, in part, some of the mechanisms that served to protect against METH-induced striatal dopamine depletion observed after METH preconditioning.	[Krasnova, Irina N.; Ladenheim, Bruce; Hodges, Amber B.; Cadet, Jean Lud] NIDA, Mol Neuropsychiat Res Branch, DHHS, NIH,Intramural Res Program, Bethesda, MD 20892 USA; [Hodges, Amber B.] Morgan State Univ, Dept Psychol, Baltimore, MD 21239 USA; [Volkow, Nora D.] NIDA, NIH, US Dept Hlth & Human Serv DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Morgan State University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Krasnova, IN (corresponding author), NIDA, Mol Neuropsychiat Res Branch, DHHS, NIH,Intramural Res Program, Bethesda, MD 20892 USA.	jcadet@intra.nida.nih.gov			National Institute on Drug Abuse, NIH/DHHS; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000494, ZIADA000551, ZIADA000174, ZIADA000552] Funding Source: NIH RePORTER	National Institute on Drug Abuse, NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, NIH/DHHS. NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2007, DEV BIOL, V304, P447, DOI 10.1016/j.ydbio.2007.01.032; Adelbrecht C, 1996, MOL BRAIN RES, V43, P291, DOI 10.1016/S0169-328X(96)00214-8; Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Albertson TE, 1999, WESTERN J MED, V170, P214; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; BERGER K, 1991, BRAIN RES BULL, V26, P301, DOI 10.1016/0361-9230(91)90242-C; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Bowyer JF, 1998, J PHARMACOL EXP THER, V286, P1074; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cadet JL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-231; Cadet JL, 2009, NEUROTOX RES, V15, P252, DOI 10.1007/s12640-009-9026-0; Cadet J, 2009, MOL NEUROBIOL, V39, P50, DOI 10.1007/s12035-009-8051-6; CADET JL, 1992, BRAIN RES, V595, P316, DOI 10.1016/0006-8993(92)91066-N; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; Cazorla P, 2000, J NEUROCHEM, V74, P1829, DOI 10.1046/j.1471-4159.2000.0741829.x; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chen CK, 2003, PSYCHOL MED, V33, P1407, DOI 10.1017/S0033291703008353; Cho AK, 2002, J ADDICT DIS, V21, P21; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; Davidson C, 2005, NEUROCHEM INT, V46, P189, DOI 10.1016/j.neuint.2004.11.004; Friedman SD, 1998, PHARMACOL BIOCHEM BE, V61, P35, DOI 10.1016/S0091-3057(98)00066-5; Fumagalli F, 1998, J NEUROSCI, V18, P4861; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; Graham DL, 2008, J NEUROCHEM, V105, P1873, DOI 10.1111/j.1471-4159.2008.05269.x; Gramage E, 2010, NEUROSCIENCE, V170, P308, DOI 10.1016/j.neuroscience.2010.06.078; Guo C, 2008, J NEUROSCI, V28, P14097, DOI 10.1523/JNEUROSCI.3267-08.2008; Hammond R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007007; Hatzipetros T, 2007, J NEUROSCI, V27, P5895, DOI 10.1523/JNEUROSCI.5260-06.2007; Hornykiewicz O, 2008, NEURODEGENER DIS, V5, P114, DOI 10.1159/000113678; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; Hwang DY, 2003, MOL BRAIN RES, V114, P123, DOI 10.1016/S0169-328X(03)00162-1; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Johnson-Davis KL, 2004, J PHARMACOL EXP THER, V309, P578, DOI 10.1124/jpet.103.062695; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kita T, 2009, INT REV NEUROBIOL, V88, P43, DOI 10.1016/S0074-7742(09)88003-3; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; KRAMER JC, 1967, J AMER MED ASSOC, V201, P305, DOI 10.1001/jama.201.5.305; Krasnova IN, 2008, GENES BRAIN BEHAV, V7, P193, DOI 10.1111/j.1601-183X.2007.00338.x; Krasnova IN, 2005, FASEB J, V19, P851, DOI 10.1096/fj.04-2881fje; Krasnova IN, 2002, FASEB J, V16, P1379, DOI 10.1096/fj.01-0796com; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Krasnova IN, 2009, NEUROSCI RES, V65, P160, DOI 10.1016/j.neures.2009.06.007; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kuczenski R, 2007, EXP NEUROL, V207, P42, DOI 10.1016/j.expneurol.2007.05.023; Li QX, 2006, HISTOL HISTOPATHOL, V21, P533, DOI 10.14670/HH-21.533; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Neale A, 2009, INT J EAT DISORDER, V42, P188, DOI 10.1002/eat.20587; Omodei D, 2008, DEVELOPMENT, V135, P3459, DOI 10.1242/dev.027003; Prakash N, 2007, NEURODEGENER DIS, V4, P333, DOI 10.1159/000101891; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Roybon L, 2008, J NEUROSCI, V28, P3644, DOI 10.1523/JNEUROSCI.0311-08.2008; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; Segal DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1730, DOI 10.1038/sj.npp.1300247; Shepard JD, 2006, PSYCHOPHARMACOLOGY, V185, P505, DOI 10.1007/s00213-006-0316-4; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Thomas DM, 2008, J NEUROCHEM, V105, P605, DOI 10.1111/j.1471-4159.2007.05155.x; Thomas DM, 2005, J NEUROCHEM, V92, P790, DOI 10.1111/j.1471-4159.2004.02906.x; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Volkow ND, 2001, J NEUROSCI, V21, pU1; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; Webb KJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r81; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060; Yamauchi K, 2009, J NEUROSCI, V29, P4044, DOI 10.1523/JNEUROSCI.4794-08.2009; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	74	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19179	10.1371/journal.pone.0019179	http://dx.doi.org/10.1371/journal.pone.0019179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547080	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800035
J	Srinivasan, A; Uppuluri, P; Lopez-Ribot, J; Ramasubramanian, AK				Srinivasan, Anand; Uppuluri, Priya; Lopez-Ribot, Jose; Ramasubramanian, Anand K.			Development of a High-Throughput Candida albicans Biofilm Chip	PLOS ONE			English	Article							DRUG-RESISTANCE; FUNGAL BIOFILMS; UNITED-STATES; INFECTIONS; BACTERIAL; EPIDEMIOLOGY; CULTURE	We have developed a high-density microarray platform consisting of nano-biofilms of Candida albicans. A robotic microarrayer was used to print yeast cells of C. albicans encapsulated in a collagen matrix at a volume as low as 50 nL onto surface-modified microscope slides. Upon incubation, the cells grow into fully formed "nano-biofilms''. The morphological and architectural complexity of these biofilms were evaluated by scanning electron and confocal scanning laser microscopy. The extent of biofilm formation was determined using a microarray scanner from changes in fluorescence intensities due to FUN 1 metabolic processing. This staining technique was also adapted for antifungal susceptibility testing, which demonstrated that, similar to regular biofilms, cells within the on-chip biofilms displayed elevated levels of resistance against antifungal agents (fluconazole and amphotericin B). Thus, results from structural analyses and antifungal susceptibility testing indicated that despite miniaturization, these biofilms display the typical phenotypic properties associated with the biofilm mode of growth. In its final format, the C. albicans biofilm chip (CaBChip) is composed of 768 equivalent and spatially distinct nano-biofilms on a single slide; multiple chips can be printed and processed simultaneously. Compared to current methods for the formation of microbial biofilms, namely the 96-well microtiter plate model, this fungal biofilm chip has advantages in terms of miniaturization and automation, which combine to cut reagent use and analysis time, minimize labor intensive steps, and dramatically reduce assay costs. Such a chip should accelerate the antifungal drug discovery process by enabling rapid, convenient and inexpensive screening of hundreds-to-thousands of compounds simultaneously.	[Srinivasan, Anand; Ramasubramanian, Anand K.] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX 78249 USA; [Uppuluri, Priya; Lopez-Ribot, Jose] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Uppuluri, Priya; Lopez-Ribot, Jose; Ramasubramanian, Anand K.] Univ Texas San Antonio, Dept S Texas Ctr Emerging Infect Dis, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA)	Srinivasan, A (corresponding author), Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX 78249 USA.	jose.lopezribot@utsa.edu; anand.ramasubramanian@utsa.edu	Lopez-Ribot, Jose L/D-2048-2010	Lopez-Ribot, Jose/0000-0003-1992-3270	South Texas Technology Management [POCrr 2009.041]; National Center for Research Resources [UL 1RR025767]; National Institute of Dental & Craniofacial Research [5R21DE017294]; American Heart Association [10POST4280033]; Research Center for Minority Institutions (RCMI) Advance Imaging Center [5G12 RR01 3646-10]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767, G12RR013646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE017294] Funding Source: NIH RePORTER	South Texas Technology Management; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Heart Association(American Heart Association); Research Center for Minority Institutions (RCMI) Advance Imaging Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded in part by grants POCrr 2009.041 from the South Texas Technology Management (PoC SPARC Program), from the Institute for Integration of Medicine and Science through Award Number UL 1RR025767 from the National Center for Research Resources, and by grant numbered 5R21DE017294 from the National Institute of Dental & Craniofacial Research. Priya Uppuluri is supported by a postdoctoral fellowship, 10POST4280033, from the American Heart Association. We would like to thank the Research Center for Minority Institutions (RCMI) Advance Imaging Center, supported by Grant numbered 5G12 RR01 3646-10, for use of the confocal microscope. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institute of Dental & Craniofacial Research of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Crump JA, 2000, EUR J CLIN MICROBIOL, V19, P1, DOI 10.1007/s100960050001; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Fesenko DO, 2005, BIOSENS BIOELECTRON, V20, P1860, DOI 10.1016/j.bios.2004.06.005; Garnier G, 2000, LANGMUIR, V16, P3757, DOI 10.1021/la991440a; Gefen O, 2008, TRENDS BIOTECHNOL, V26, P345, DOI 10.1016/j.tibtech.2008.03.007; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hart T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007088; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; IVANOVA EP, 2002, P SOC PHOTO-OPT INS, P4937; Jabra-Rizk MA, 2004, EMERG INFECT DIS, V10, P14, DOI 10.3201/eid1001.030119; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105; Narayanaswamy R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r6; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nett JE, 2010, ANTIMICROB AGENTS CH, V54, P3505, DOI 10.1128/AAC.00227-10; Nett JE, 2010, J INFECT DIS, V202, P171, DOI 10.1086/651200; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Odabasi Z, 2007, ANTIMICROB AGENTS CH, V51, P4214, DOI 10.1128/AAC.01589-06; Perumal P, 2007, ANTIMICROB AGENTS CH, V51, P2454, DOI 10.1128/AAC.01237-06; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; Uppuluri P, 2009, FUTURE MICROBIOL, V4, P1235, DOI 10.2217/FMB.09.85; Viudes A, 2002, EUR J CLIN MICROBIOL, V21, P767, DOI 10.1007/s10096-002-0822-1; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	39	30	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19036	10.1371/journal.pone.0019036	http://dx.doi.org/10.1371/journal.pone.0019036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544190	gold, Green Published, Green Submitted			2022-12-25	WOS:000290015800034
J	Kuo, HC; Yang, KD; Juo, SHH; Liang, CD; Chen, WC; Wang, YS; Lee, CH; Hsi, E; Yu, HR; Woon, PY; Lin, IC; Huang, CF; Hwang, DY; Lee, CP; Lin, LY; Chang, WP; Chang, WC				Kuo, Ho-Chang; Yang, Kuender D.; Juo, Suh-Hang Hank; Liang, Chi-Di; Chen, Wei-Chiao; Wang, Yu-Shiuan; Lee, Chih-Hung; Hsi, Edward; Yu, Hong-Ren; Woon, Peng-Yeong; Lin, I-Chun; Huang, Chien-Fu; Hwang, Daw-Yang; Lee, Chiu-Ping; Lin, Li-Yan; Chang, Wei-Pin; Chang, Wei-Chiao			ITPKC Single Nucleotide Polymorphism Associated with the Kawasaki Disease in a Taiwanese Population	PLOS ONE			English	Article							IMMUNOGLOBULIN TREATMENT FAILURE; CORONARY-ARTERY LESIONS; SUSCEPTIBILITY	Kawasaki disease (KD) is characterized by systemic vasculitis with unknown etiology. Previous studies from Japan indicated that a gene polymorphism of ITPKC (rs28493229) is responsible for susceptibility to KD. We collected DNA samples from 1,531 Taiwanese subjects (341 KD patients and 1,190 controls) for genotyping ITPKC. In this study, no significant association was noted for the ITPKC polymorphism (rs28493229) between the controls and KD patients, although the CC genotype was overrepresented. We further combined our data with previously published case/control KD studies in the Taiwanese population and performed a meta-analysis. A significant association between rs28493229 and KD was found (Odds Ratio: 1.36, 95% Confidence Interval 1.12-1.66). Importantly, a significant association was obtained between rs28493229 and KD patients with aneurysm formation (P = 0.001, under the recessive model). Taken together, our results indicated that Callele of ITPKC SNP rs28493229 is associated with the susceptibility and aneurysm formation in KD patients in a Taiwanese population.	[Kuo, Ho-Chang; Yang, Kuender D.; Yu, Hong-Ren; Lee, Chiu-Ping; Lin, Li-Yan] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Pediat, Div Allergy Immunol & Rheumatol, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Yang, Kuender D.; Yu, Hong-Ren; Lee, Chiu-Ping; Lin, Li-Yan] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Clin Genom & Prote Core Lab, Kaohsiung, Taiwan; [Liang, Chi-Di; Lin, I-Chun; Huang, Chien-Fu] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Pediat, Div Cardiol, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Yang, Kuender D.; Yu, Hong-Ren] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank; Chen, Wei-Chiao; Wang, Yu-Shiuan; Chang, Wei-Chiao] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank; Chang, Wei-Chiao] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Hsi, Edward] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Woon, Peng-Yeong] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Hwang, Daw-Yang] Kaohsiung Med Univ Hosp, Dept Med, Div Nephrol, Kaohsiung, Taiwan; [Lee, Chih-Hung] Kaohsiung Med Univ, Grad Inst Med, Dept Dermatol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Kuo, HC (corresponding author), Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Pediat, Div Allergy Immunol & Rheumatol, Kaohsiung, Taiwan.	wpchang@mail.ypu.edu.tw; wcc@kmu.edu.tw	于, 鴻仁/AAW-6827-2021; Juo, Suh-Hang/C-9545-2009; Hsi, Edward/A-1356-2013; Lee, Chih-Hung/AAJ-5551-2020; Kuo, Ho-Chang/AAQ-6644-2020	于, 鴻仁/0000-0003-1242-8760; Hsi, Edward/0000-0002-8272-6707; Lee, Chih-Hung/0000-0001-9804-3874; Kuo, Ho-Chang/0000-0002-3295-2984; Chang, Wei-Chiao/0000-0002-8573-5924; Wang, Yu-Shiuan/0000-0001-7204-1256	excellence for cancer research center grant, Department of Health, Executive Yuan, Taiwan, ROC [DOH100-TD-C-111-002]; National Science Council, Taiwan, ROC [NSC 98-2320-B-037 -028 -MY2]; National Science Council of Taiwan [NSC 97-2314-B-182A-054-MY2]	excellence for cancer research center grant, Department of Health, Executive Yuan, Taiwan, ROC; National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by funding from excellence for cancer research center grant, Department of Health, Executive Yuan, Taiwan, ROC (NO.DOH100-TD-C-111-002) and a grant (NSC 98-2320-B-037 -028 -MY2) from the National Science Council, Taiwan, ROC to W.C. Chang. A grant (NSC 97-2314-B-182A-054-MY2) from the National Science Council of Taiwan to H.C. Kuo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Chi H, 2010, HUM MOL GENET, V19, P1147, DOI 10.1093/hmg/ddp586; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kuo HC, 2010, J CLIN IMMUNOL; Kuo HC, 2008, PEDIAT ALLERG IMM-UK, V19, P184, DOI 10.1111/j.1399-3038.2007.00657.x; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Kuo Ho-Chang, 2007, Journal of Microbiology Immunology and Infection, V40, P395; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; LIN MT, 2010, PEDIAT INFECT DIS J; Newburger JW, 2004, PEDIATRICS, V114, P1708, DOI 10.1542/peds.2004-2182; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2010, HUM MOL GENET, V19, P2898, DOI 10.1093/hmg/ddq176; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; SHIMIZU C, 2010, J HUM GENET; Shimizu C, 2011, CIRC-CARDIOVASC GENE, V4, P16, DOI 10.1161/CIRCGENETICS.110.940858; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa	23	66	71	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e17370	10.1371/journal.pone.0017370	http://dx.doi.org/10.1371/journal.pone.0017370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533171	gold, Green Submitted, Green Published			2022-12-25	WOS:000289505600001
J	David, MZ; Boyle-Vavra, S; Zychowski, DL; Daum, RS				David, Michael Z.; Boyle-Vavra, Susan; Zychowski, Diana L.; Daum, Robert S.			Methicillin-Susceptible Staphylococcus aureus as a Predominantly Healthcare-Associated Pathogen: A Possible Reversal of Roles?	PLOS ONE			English	Article							NATURAL-POPULATION; RISK-FACTORS; RESISTANT; INFECTIONS; CLONES; SKIN	Background: Methicillin-resistant Staphylococcus aureus (MRSA) strains have become common causes of skin and soft tissue infections (SSTI) among previously healthy people, a role of methicillin-susceptible (MSSA) isolates before the mid-1990s. We hypothesized that, as MRSA infections became more common among S. aureus infections in the community, perhaps MSSA infections had become more important as a cause of healthcare-associated infection. Methods: We compared patients, including children and adults, with MRSA and MSSA infections at the University of Chicago Medical Center (UCMC) from all clinical units from July 1, 2004-June 30, 2005; we also compared the genotypes of the MRSA and MSSA infecting bacterial strains. Results: Compared with MRSA patients, MSSA patients were more likely on bivariate analysis to have bacteremia, endocarditis, or sepsis (p = 0.03), to be an adult (p = 0.005), to be in the intensive care unit (21.9% vs. 15.6%) or another inpatient unit (45.6% vs. 40.7%) at the time of culture. MRSA (346/545) and MSSA (76/114) patients did not differ significantly in the proportion classified as HA-S. aureus by the CDC CA-MRSA definition (p = 0.5). The genetic backgrounds of MRSA and MSSA multilocus sequence type (ST) 1, ST5, ST8, ST30, and ST59 comprised in combination 94.5% of MRSA isolates and 50.9% of MSSA isolates. By logistic regression, being cared for in the Emergency Department (OR 4.6, CI 1.5-14.0, p = 0.008) was associated with MRSA infection. Conclusion: Patients with MSSA at UCMC have characteristics consistent with a health-care-associated infection more often than do patients with MRSA; a possible role reversal has occurred for MSSA and MRSA strains. Clinical MSSA and MRSA strains shared genotype backgrounds.	[David, Michael Z.; Boyle-Vavra, Susan; Zychowski, Diana L.; Daum, Robert S.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [David, Michael Z.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	David, MZ (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	mdavid@medicine.bsd.uchicago.edu	David, Michael Z./X-6737-2019	David, Michael Z./0000-0002-1926-7800; Zychowski, Diana/0000-0002-8553-0910	U.S. Centers for Disease Control [R01 C000373-01, R01 CCR523379-01]; Pfizer	U.S. Centers for Disease Control; Pfizer(Pfizer)	This work was supported by a grant from the U.S. Centers for Disease Control (R01 C000373-01 and R01 CCR523379-01). Support from Pfizer is also acknowledged (RSD). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; David MZ, 2008, J CLIN MICROBIOL, V46, P3222, DOI 10.1128/JCM.01423-08; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; Donker GA, 2009, CLIN MICROBIOL INFEC, V15, P137, DOI 10.1111/j.1469-0691.2008.02662.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Grundmann H, 2002, J CLIN MICROBIOL, V40, P4544, DOI 10.1128/JCM.40.12.4544-4546.2002; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lowy FD, 2007, J INFECT DIS, V196, P911, DOI 10.1086/520933; McCarthy NL, 2010, INFECT CONT HOSP EP, V31, P36, DOI 10.1086/649017; McCaskill ML, 2007, PEDIATR INFECT DIS J, V26, P1122, DOI 10.1097/INF.0b013e31814536e0; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Miller LG, 2007, CLIN INFECT DIS, V44, P471, DOI 10.1086/511033; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Mongkolrattanothai K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-112; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NCCLS, 2004, M100S14 NCCLS; Orscheln RC, 2009, CLIN INFECT DIS, V49, P536, DOI 10.1086/600881; Ruimy R, 2009, J BACTERIOL, V191, P5577, DOI 10.1128/JB.00493-09; Sattler CA, 2002, PEDIATR INFECT DIS J, V21, P910, DOI 10.1097/00006454-200210000-00005; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08	27	46	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18217	10.1371/journal.pone.0018217	http://dx.doi.org/10.1371/journal.pone.0018217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533238	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800008
J	Mohan, RR; Sinha, S; Tandon, A; Gupta, R; Tovey, JCK; Sharma, A				Mohan, Rajiv R.; Sinha, Sunilima; Tandon, Ashish; Gupta, Rangan; Tovey, Jonathan C. K.; Sharma, Ajay			Efficacious and Safe Tissue-Selective Controlled Gene Therapy Approaches for the Cornea	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; IN-VIVO; ADENOASSOCIATED VIRUSES; TRANSGENIC MICE; AAV VECTORS; DELIVERY; VITRO; HAZE; IDENTIFICATION; ANGIOGENESIS	Untargeted and uncontrolled gene delivery is a major cause of gene therapy failure. This study aimed to define efficient and safe tissue-selective targeted gene therapy approaches for delivering genes into keratocytes of the cornea in vivo using a normal or diseased rabbit model. New Zealand White rabbits, adeno-associated virus serotype 5 (AAV5), and a minimally invasive hair-dryer based vector-delivery technique were used. Fifty microliters of AAV5 titer (6.5 x 10(12) vg/ml) expressing green fluorescent protein gene (GFP) was topically applied onto normal or diseased (fibrotic or neovascularized) rabbit corneas for 2-minutes with a custom vector-delivery technique. Corneal fibrosis and neovascularization in rabbit eyes were induced with photorefractive keratectomy using excimer laser and VEGF (630 ng) using micropocket assay, respectively. Slit-lamp biomicroscopy and immunocytochemistry were used to confirm fibrosis and neovascularization in rabbit corneas. The levels, location and duration of delivered-GFP gene expression in the rabbit stroma were measured with immunocytochemistry and/or western blotting. Slot-blot measured delivered-GFP gene copy number. Confocal microscopy performed in whole-mounts of cornea and thick corneal sections determined geometric and spatial localization of delivered-GFP in three-dimensional arrangement. AAV5 toxicity and safety were evaluated with clinical eye exam, stereomicroscopy, slit-lamp biomicroscopy, and H&E staining. A single 2-minute AAV5 topical application via custom delivery-technique efficiently and selectively transduced keratocytes in the anterior stroma of normal and diseased rabbit corneas as evident from immunocytochemistry and confocal microscopy. Transgene expression was first detected at day 3, peaked at day 7, and was maintained up to 16 weeks (longest tested time point). Clinical and slit-lamp eye examination in live rabbits and H&E staining did not reveal any significant changes between AAV5-treated and untreated control corneas. These findings suggest that defined gene therapy approaches are safe for delivering genes into keratocytes in vivo and has potential for treating corneal disorders in human patients.	[Mohan, Rajiv R.; Sinha, Sunilima; Tandon, Ashish; Gupta, Rangan; Tovey, Jonathan C. K.; Sharma, Ajay] Harry S Truman Vet Mem Hosp, Columbia, MO 65201 USA; [Mohan, Rajiv R.; Sinha, Sunilima; Tandon, Ashish; Gupta, Rangan; Tovey, Jonathan C. K.; Sharma, Ajay] Univ Missouri, Sch Med, Mason Eye Inst, Columbia, MO USA; [Mohan, Rajiv R.] Univ Missouri, Coll Vet Med, Columbia, MO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Mohan, RR (corresponding author), Harry S Truman Vet Mem Hosp, Columbia, MO 65201 USA.	mohanr@health.missouri.edu			National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA [RO1EY17294, RO1EY17294S2]; Veteran Health Affairs, Washington, DC, USA [1I01BX000357-01]; Research to Prevent Blindness, New York, New York, USA; NATIONAL EYE INSTITUTE [R01EY017294] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000357] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veteran Health Affairs, Washington, DC, USA; Research to Prevent Blindness, New York, New York, USA(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by the RO1EY17294 (RRM) and RO1EY17294S2 (RRM) grants from the National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA, 1I01BX000357-01 (RRM) grant from the Veteran Health Affairs, Washington, DC, USA and an Unrestricted grant from the Research to Prevent Blindness, New York, New York, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Behrens A, 2002, ADV EXP MED BIOL, V506, P1315; Behrens A, 2002, INVEST OPHTH VIS SCI, V43, P968; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Borras T, 2001, J GENE MED, V3, P437, DOI 10.1002/jgm.210; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Carlson EC, 2004, INVEST OPHTH VIS SCI, V45, P2194, DOI 10.1167/iovs.03-1224; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Check E, 2002, NATURE, V420, P116, DOI 10.1038/420116a; Chen P, 2010, MOL VIS, V16, P310; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; Ghosh A, 2006, J GENE MED, V8, P298, DOI 10.1002/jgm.835; Gura T, 2001, SCIENCE, V291, P1692, DOI 10.1126/science.291.5509.1692; Herzog RW, 2010, DISCOV MED, V9, P105; Kays WT, 1997, P NATL ACAD SCI USA, V94, P13594, DOI 10.1073/pnas.94.25.13594; Klebe S, 2001, TRANSPLANTATION, V71, P1214, DOI 10.1097/00007890-200105150-00006; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Larkin DFP, 1996, TRANSPLANTATION, V61, P363, DOI 10.1097/00007890-199602150-00005; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Limberis MP, 2009, MOL THER, V17, P294, DOI 10.1038/mt.2008.261; Liu CY, 2000, GENE, V250, P85, DOI 10.1016/S0378-1119(00)00165-7; Liu J, 2008, MOL VIS, V14, P2087; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Mohan RR, 2010, MOL VIS, V16, P2494; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mohan RR, 2003, EXP EYE RES, V77, P395, DOI 10.1016/S0014-4835(03)00175-1; Mohan RR, 2003, EXP EYE RES, V76, P373, DOI 10.1016/S0014-4835(02)00275-0; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Oliveira HB, 2010, EUR J OPHTHALMOL, V20, P48, DOI 10.1177/112067211002000106; Saghizadeh M, 2010, INVEST OPHTH VIS SCI, V51, P1970, DOI 10.1167/iovs.09-4569; Seitz B, 1998, AM J OPHTHALMOL, V126, P630, DOI 10.1016/S0002-9394(98)00205-0; SHARMA A, 2010, ENCY EYE, P185; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Sharma A, 2010, MOL VIS, V16, P720; Sharma A, 2010, BRAIN RES BULL, V81, P273, DOI 10.1016/j.brainresbull.2009.07.005; Sharma A, 2009, INVEST OPHTH VIS SCI, V50, P2695, DOI 10.1167/iovs.08-2919; Surace EM, 2008, VISION RES, V48, P353, DOI 10.1016/j.visres.2007.07.027; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Williams KA, 2010, CLIN EXP OPHTHALMOL, V38, P93, DOI 10.1111/j.1442-9071.2009.02179.x; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	44	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18771	10.1371/journal.pone.0018771	http://dx.doi.org/10.1371/journal.pone.0018771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533273	Green Submitted, Green Published, gold			2022-12-25	WOS:000289404700033
J	Picazo-Juarez, G; Romero-Suarez, S; Nieto-Posadas, A; Llorente, I; Jara-Oseguera, A; Briggs, M; McIntosh, TJ; Simon, SA; Ladron-de-Guevara, E; Islas, LD; Rosenbaum, T				Picazo-Juarez, Giovanni; Romero-Suarez, Silvina; Nieto-Posadas, Andres; Llorente, Itzel; Jara-Oseguera, Andres; Briggs, Margaret; McIntosh, Thomas J.; Simon, Sidney A.; Ladron-de-Guevara, Ernesto; Islas, Leon D.; Rosenbaum, Tamara			Identification of a Binding Motif in the S5 Helix That Confers Cholesterol Sensitivity to the TRPV1 Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR; MEMBRANE DOMAINS; ACTIVATION; CAPSAICIN; PROTEIN; RAFT; HYPERCHOLESTEROLEMIA; MODULATION; ANANDAMIDE; EXPRESSION	The TRPV1 ion channel serves as an integrator of noxious stimuli with its activation linked to pain and neurogenic inflammation. Cholesterol, a major component of cell membranes, modifies the function of several types of ion channels. Here, using measurements of capsaicin-activated currents in excised patches from TRPV1-expressing HEK cells, we show that enrichment with cholesterol, but not its diastereoisomer epicholesterol, markedly decreased wild-type rat TRPV1 currents. Substitutions in the S5 helix, rTRPV1-R579D, and rTRPV1-F582Q, decreased this cholesterol response and rTRPV1-L585I was insensitive to cholesterol addition. Two human TRPV1 variants, with different amino acids at position 585, had different responses to cholesterol with hTRPV1-Ile(585) being insensitive to this molecule. However, hTRPV1-I585L was inhibited by cholesterol addition similar to rTRPV1 with the same S5 sequence. In the absence of capsaicin, cholesterol enrichment also inhibited TRPV1 currents induced by elevated temperature and voltage. These data suggest that there is a cholesterol-binding site in TRPV1 and that the functions of TRPV1 depend on the genetic variant and membrane cholesterol content.	[Picazo-Juarez, Giovanni; Romero-Suarez, Silvina; Nieto-Posadas, Andres; Llorente, Itzel; Rosenbaum, Tamara] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico; [Jara-Oseguera, Andres; Ladron-de-Guevara, Ernesto; Islas, Leon D.] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Mexico City 04510, DF, Mexico; [Briggs, Margaret; McIntosh, Thomas J.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Simon, Sidney A.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Duke University; Duke University	Rosenbaum, T (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Dept Neurodesarrollo & Fisiol, Mexico City 04510, DF, Mexico.	trosenba@ifc.unam.mx	Ladrón-de-Guevara, Ernesto/F-4304-2014; Islas, Leon D/AAW-9845-2020	Ladrón-de-Guevara, Ernesto/0000-0001-5122-1848; Islas, Leon D/0000-0002-7461-5214; Rosenbaum, Tamara/0000-0002-4791-3195; Nieto-Posadas, Andres/0000-0002-3339-8604; Jara Oseguera, Andres/0000-0001-5921-9320	National Institutes of Health [GM27278, DC-01065]; Direccion General de Asuntos del Personal Academico [PAPIIT IN204111-3]; Consejo Nacional de Ciencia y Tecnologia [129474, SNI 102152]; Fundacion Miguel Aleman; Instituto de Ciencia y Technologia del Distrito Federal [PIFUTP09-262];  [IN209209]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Asuntos del Personal Academico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman; Instituto de Ciencia y Technologia del Distrito Federal; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM27278 (to T. J. M.) and DC-01065 (to S. A. S.) and grants Direccion General de Asuntos del Personal Academico-PAPIIT IN204111-3, Consejo Nacional de Ciencia y Tecnologia 129474, and Consejo Nacional de Ciencia y Tecnologia-SNI 102152, and a grant from Fundacion Miguel Aleman (to T. R.), and IN209209 and Instituto de Ciencia y Technologia del Distrito Federal PIFUTP09-262 (to L. D. I.).	Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Cantero-Recasens G, 2010, J BIOL CHEM, V285, P27532, DOI 10.1074/jbc.C110.159491; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Christian AE, 1997, J LIPID RES, V38, P2264; Colquhoun D., 1995, FITTING STAT ANAL SI; Culshaw AJ, 2006, J MED CHEM, V49, P471, DOI 10.1021/jm051058x; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Genda S, 2002, J AM COLL CARDIOL, V40, P1339, DOI 10.1016/S0735-1097(02)02156-3; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Jara-Oseguera Andres, 2008, Curr Mol Pharmacol, V1, P255; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mathew V, 2001, ATHEROSCLEROSIS, V154, P329, DOI 10.1016/S0021-9150(00)00493-7; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Oddi S, 2011, J NEUROCHEM, V116, P858, DOI 10.1111/j.1471-4159.2010.07041.x; Oseguera AJ, 2007, BIOPHYS J, V92, P3901, DOI 10.1529/biophysj.106.102400; Pearce LV, 2004, ORG BIOMOL CHEM, V2, P2281, DOI 10.1039/b404506h; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Rosenbaum T, 2002, NEURON, V33, P703, DOI 10.1016/S0896-6273(02)00599-8; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Salton M R, 1968, J Gen Physiol, V52, P227, DOI 10.1085/jgp.52.1.227; Schumacher MA, 2010, FRONT BIOSCI-LANDMRK, V15, P872, DOI 10.2741/3651; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; SZALLASI A, 1989, NEUROSCIENCE, V30, P515, DOI 10.1016/0306-4522(89)90269-8; Szoke E, 2010, EUR J PHARMACOL, V628, P67, DOI 10.1016/j.ejphar.2009.11.052; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Tong JH, 2009, BIOPHYS J, V97, P2493, DOI 10.1016/j.bpj.2009.08.026; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Xu SH, 2008, ENDOCRINOLOGY, V149, P5540, DOI 10.1210/en.2008-0278; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Yogi A, 2009, AM J PHYSIOL-REG I, V296, pR201, DOI 10.1152/ajpregu.90602.2008	52	98	97	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2011	286	28					24966	24976		10.1074/jbc.M111.237537	http://dx.doi.org/10.1074/jbc.M111.237537			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	789WD	21555515	hybrid, Green Published			2022-12-25	WOS:000292547900045
J	Applebee, MK; Joyce, AR; Conrad, TM; Pettigrew, DW; Palsson, BO				Applebee, M. Kenyon; Joyce, Andrew R.; Conrad, Tom M.; Pettigrew, Donald W.; Palsson, Bernhard O.			Functional and Metabolic Effects of Adaptive Glycerol Kinase (GLPK) Mutants in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM EXPERIMENT; UTILIZATION IN-VIVO; PHOSPHOTRANSFERASE SYSTEM; ALLOSTERIC REGULATION; GENE-EXPRESSION; ORGANISMAL FITNESS; PROTEIN EVOLUTION; SALMONELLA-TYPHIMURIUM; SUBUNIT DISSOCIATION; MOLECULAR EVOLUTION	Herein we measure the effect of four adaptive non-synonymous mutations to the glycerol kinase (glpK) gene on catalytic function and regulation, to identify changes that correlate to increased fitness in glycerol media. The mutations significantly reduce affinity for the allosteric inhibitor fructose-1,6-bisphosphate (FBP) and formation of the tetramer, which are structurally related, in a manner that correlates inversely with imparted fitness during growth on glycerol, which strongly suggests that these enzymatic parameters drive growth improvement. Counterintuitively, the glpK mutations also increase glycerol-induced auto-catabolite repression that reduces glpK transcription in a manner that correlates to fitness. This suggests that increased specific GlpK activity is attenuated by negative feedback on glpK expression via catabolite repression, possibly to prevent methylglyoxal toxicity. We additionally report that glpK mutations were fixed in 47 of 50 independent glycerol-adapted lineages. By far the most frequently mutated locus (nucleotide 218) was mutated in 20 lineages, strongly suggesting this position has an elevated mutation rate. This study demonstrates that fitness correlations can be used to interrogate adaptive processes at the protein level and to identify the regulatory constraints underlying selection and improved growth.	[Applebee, M. Kenyon; Conrad, Tom M.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Pettigrew, Donald W.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station	Applebee, MK (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	mapplebe@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785	National Institutes of Health [R01-GM062791-06]; Texas Agrilife Research Project [TEX09208]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Agrilife Research Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part by National Institutes of Health Grant R01-GM062791-06 (to M. K. A., A. R. J., T. M. C., and B. O. P.) and Texas Agrilife Research Project TEX09208 (to D. W. P.).	Aponte RA, 2010, J MOL BIOL, V399, P154, DOI 10.1016/j.jmb.2010.03.060; Applebee MK, 2008, J BACTERIOL, V190, P5087, DOI 10.1128/JB.01976-07; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bokma E, 2006, FEBS LETT, V580, P5339, DOI 10.1016/j.febslet.2006.09.005; Booth I. R., 2005, MODULE 3 4 3 GLYCERO; Burkala E, 2007, MICROBIOL-SGM, V153, P2180, DOI 10.1099/mic.0.2007/005470-0; Bystrom CE, 1999, BIOCHEMISTRY-US, V38, P3508, DOI 10.1021/bi982460z; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Chagneau C, 2001, J BACTERIOL, V183, P5675, DOI 10.1128/JB.183.19.5675-5683.2001; Charusanti P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001186; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Conrad TM, 2010, P NATL ACAD SCI USA, V107, P20500, DOI 10.1073/pnas.0911253107; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Counago R, 2008, PROTEIN ENG DES SEL, V21, P19, DOI 10.1093/protein/gzm072; Counago R, 2006, MOL CELL, V22, P441, DOI 10.1016/j.molcel.2006.04.012; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717; Crozat E, 2010, MOL BIOL EVOL, V27, P2113, DOI 10.1093/molbev/msq099; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; DERIEL JK, 1978, BIOCHEMISTRY-US, V17, P5141, DOI 10.1021/bi00617a011; DERIEL JK, 1978, BIOCHEMISTRY-US, V17, P5134, DOI 10.1021/bi00617a010; Eppler T, 2002, J BACTERIOL, V184, P3044, DOI 10.1128/JB.184.11.3044-3052.2002; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; FREEDBERG WB, 1971, J BACTERIOL, V108, P137, DOI 10.1128/JB.108.1.137-144.1971; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; He XL, 2010, NAT GENET, V42, P272, DOI 10.1038/ng.524; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Holtman CK, 2001, J BACTERIOL, V183, P3336, DOI 10.1128/JB.183.11.3336-3344.2001; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751; Knight CG, 2006, NAT GENET, V38, P1015, DOI 10.1038/ng1867; KRYMKIEWICZ N, 1971, J BACTERIOL, V108, P1338, DOI 10.1128/JB.108.3.1338-1347.1971; LARSON TJ, 1987, J BIOL CHEM, V262, P15869; Le Gac M, 2010, MOL ECOL, V19, P2430, DOI 10.1111/j.1365-294X.2010.04664.x; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; LIU WZ, 1994, BIOCHEMISTRY-US, V33, P10120, DOI 10.1021/bi00199a040; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; MacLean RC, 2010, GENETICS, V186, P1345, DOI 10.1534/genetics.110.123083; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Miller SP, 2006, SCIENCE, V314, P458, DOI 10.1126/science.1133479; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; NOVOTNY MJ, 1985, J BACTERIOL, V162, P810, DOI 10.1128/JB.162.2.810-816.1985; Pettigrew DW, 2009, ARCH BIOCHEM BIOPHYS, V492, P29, DOI 10.1016/j.abb.2009.10.001; PETTIGREW DW, 1990, BIOCHEMISTRY-US, V29, P8620, DOI 10.1021/bi00489a018; Pettigrew DW, 1996, J BACTERIOL, V178, P2846, DOI 10.1128/jb.178.10.2846-2852.1996; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; POSTMA PW, 1984, J BACTERIOL, V158, P351, DOI 10.1128/JB.158.1.351-353.1984; Rohwer JM, 1998, MOL MICROBIOL, V29, P641, DOI 10.1046/j.1365-2958.1998.00963.x; Sota M, 2010, ISME J, V4, P1568, DOI 10.1038/ismej.2010.72; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WEISSENBORN DL, 1992, J BIOL CHEM, V267, P6122; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x; Wright BE, 2003, MOL MICROBIOL, V48, P429, DOI 10.1046/j.1365-2958.2003.t01-1-03436.x; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o; Yu P, 2003, BIOCHEMISTRY-US, V42, P4243, DOI 10.1021/bi027142l; Zhu MM, 2001, METAB ENG, V3, P218, DOI 10.1006/mben.2001.0186; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970; ZWAIG N, 1966, SCIENCE, V153, P755, DOI 10.1126/science.153.3737.755	73	46	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23150	23159		10.1074/jbc.M110.195305	http://dx.doi.org/10.1074/jbc.M110.195305			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550976	Green Published, hybrid			2022-12-25	WOS:000292025000049
J	Bhamidi, S; Scherman, MS; Jones, V; Crick, DC; Belisle, JT; Brennan, PJ; McNeil, MR				Bhamidi, Suresh; Scherman, Michael S.; Jones, Victoria; Crick, Dean C.; Belisle, John T.; Brennan, Patrick J.; McNeil, Michael R.			Detailed Structural and Quantitative Analysis Reveals the Spatial Organization of the Cell Walls of in Vivo Grown Mycobacterium leprae and in Vitro Grown Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; GRAM-NEGATIVE BACTERIA; MYCOLIC ACIDS; OUTER-MEMBRANE; LIPID-BILAYER; PEPTIDOGLYCAN; ARABINOGALACTAN; IDENTIFICATION; LOCATION; MODEL	The cell wall of mycobacteria consists of an outer membrane, analogous to that of Gram-negative bacteria, attached to the peptidoglycan (PG) via a connecting polysaccharide arabinogalactan (AG). Although the primary structure of these components is fairly well deciphered, issues such as the coverage of the PG layer by covalently attached mycolates in the outer membrane and the spatial details of the mycolic acid attachment to the arabinan have remained unknown. It is also not understood how these components work together to lead to the classical acid-fast staining of mycobacteria. Because the majority of Mycobacterium tuberculosis bacteria in established experimental animal infections are acid-fast negative, clearly cell wall changes are occurring. To address both the spatial properties of mycobacterial cell walls and to begin to study the differences between bacteria grown in animals and cultures, the cell walls of Mycobacterium leprae grown in armadillos was characterized and compared with that of M. tuberculosis grown in culture. Most fundamentally, it was determined that the cell wall of M. leprae contained significantly more mycolic acids attached to PG than that of in vitro grown M. tuberculosis (mycolate: PG ratios of 21: 10 versus 16: 10, respectively). In keeping with this difference, more arabinogalactan (AG) molecules, linking the mycolic acids to PG, were found. Differences in the structures of the AG were also found; the AG of M. leprae is smaller than that of M. tuberculosis, although the same basic structural motifs are retained.	[Bhamidi, Suresh; Scherman, Michael S.; Jones, Victoria; Crick, Dean C.; Belisle, John T.; Brennan, Patrick J.; McNeil, Michael R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	McNeil, MR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mmcneil@colostate.edu	Brennan, Patrick J/G-6896-2017; McNeil, Michael/G-3325-2019; Crick, Dean/H-8251-2017; Belisle, John T/B-8944-2017	Crick, Dean/0000-0001-9281-7058; Belisle, John T/0000-0002-2539-2798	National Institutes of Health, USPHS NIAID [AI-33706, AI049151, AI018357]; Bill and Melinda Gates Foundation [42775]; National Institutes of Health NIAID [AI 25469]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049151, R56AI049151, N01AI025469, R01AI018357, R01AI033706, R22AI018357, R37AI018357] Funding Source: NIH RePORTER	National Institutes of Health, USPHS NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-33706 (to M. R. M.), AI049151 (to D. C. C.), and AI018357 (to P. J. B.) from USPHS NIAID. This work was also supported by Grant 42775 from the Bill and Melinda Gates Foundation (to J. T. B. and D. C. C.).; We gratefully acknowledge Dr. John Spencer for providing the M. leprae cell wall core via National Institutes of Health NIAID Contract AI 25469 and Dr. Alan Schenkel for help with statistical analysis.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; AMARNACASCH C, 1970, B SOC CHIM BIOL, V52, P145; Bhamidi S, 2008, J BIOL CHEM, V283, P12992, DOI 10.1074/jbc.M800222200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; CRICK DC, 2004, TUBERCULOSIS, P115; CUMMINS CS, 1967, J GEN MICROBIOL, V49, P377, DOI 10.1099/00221287-49-3-377; CUNTO G, 1969, BIOCHIM BIOPHYS ACTA, V192, P358, DOI 10.1016/0304-4165(69)90378-X; DAFFE M, 1990, J BIOL CHEM, V265, P6734; DAVID HL, 1983, CURR MICROBIOL, V9, P269, DOI 10.1007/BF01567199; Dmitriev BA, 2003, J BACTERIOL, V185, P3458, DOI 10.1128/JB.185.11.3458-3468.2003; Dong X, 2006, APPL ENVIRON MICROB, V72, P2601, DOI 10.1128/AEM.72.4.2601-2605.2006; DRAPER P, 1987, J GEN MICROBIOL, V133, P1187; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HUNTER SW, 1990, J BIOL CHEM, V265, P14065; KUSAKA T, 1986, J GEN MICROBIOL, V132, P3403; Levy L, 1976, Lepr Rev, V47, P103; Mahapatra S, 2008, J BACTERIOL, V190, P655, DOI 10.1128/JB.00982-07; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; MINNIKIN DE, 1967, CHEM COMMUN, P916, DOI 10.1039/c19670000916; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P2013; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Sartain MJ, 2011, J LIPID RES, V52, P861, DOI 10.1194/jlr.M010363; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Shui GH, 2007, J LIPID RES, V48, P1976, DOI 10.1194/jlr.M700060-JLR200; SMITH DPE, 1987, P NATL ACAD SCI USA, V84, P969, DOI 10.1073/pnas.84.4.969; Song SH, 2009, J MICROBIOL METH, V77, P165, DOI 10.1016/j.mimet.2009.01.023; SWEET DP, 1975, CARBOHYD RES, V40, P217, DOI 10.1016/S0008-6215(00)82604-X; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Vijayaraghavan R, 2009, SCAND J LAB ANIM SCI, V36, P167; Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005; Villeneuve M, 2007, BBA-BIOMEMBRANES, V1768, P1717, DOI 10.1016/j.bbamem.2007.04.003; Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004; Watanabe M, 2002, MICROBIOL-SGM, V148, P1881, DOI 10.1099/00221287-148-6-1881; WIENTJES FB, 1991, J BACTERIOL, V173, P7684, DOI 10.1128/jb.173.23.7684-7691.1991; ZARITSKY A, 1979, FEBS LETT, V98, P29, DOI 10.1016/0014-5793(79)80144-1; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	39	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23168	23177		10.1074/jbc.M110.210534	http://dx.doi.org/10.1074/jbc.M110.210534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555513	Green Published, hybrid			2022-12-25	WOS:000292025000051
J	Liu, J; Yan, YL; Liu, LJ; Xie, ZJ; Malhotra, D; Joe, B; Shapiro, JI				Liu, Jiang; Yan, Yanling; Liu, Lijun; Xie, Zijian; Malhotra, Deepak; Joe, Bina; Shapiro, Joseph I.			Impairment of Na/K-ATPase Signaling in Renal Proximal Tubule Contributes to Dahl Salt-sensitive Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS CARDIOTONIC STEROIDS; SODIUM-PUMP; BLOOD-PRESSURE; OUABAIN; MARINOBUFAGENIN; RATS; EXCHANGER; LIGANDS; LLC-PK1; PROTEIN	We have observed that, in renal proximal tubular cells, cardiotonic steroids such as ouabain in vitro signal through Na/K-ATPase, which results in inhibition of transepithelial Na-22(+) transport by redistributing Na/K-ATPase and NHE3. In the present study, we investigate the role of Na/K-ATPase signaling in renal sodium excretion and blood pressure regulation in vivo. In Sprague-Dawley rats, high salt diet activated c-Src and induced redistribution of Na/K-ATPase and NHE3 in renal proximal tubules. In Dahl salt sensitive ( S) and resistant ( R) rats given high dietary salt, we found different effects on blood pressure but, more interestingly, different effects on renal salt handling. These differences could be explained by different signaling through the proximal tubular Na/K-ATPase. Specifically, in Dahl R rats, high salt diet significantly stimulated phosphorylation of c-Src and ERK1/2, reduced Na/K-ATPase activity and NHE3 activity, and caused redistribution of Na/K-ATPase and NHE3. In contrast, these adaptations were either much less effective or not seen in the Dahl S rats. We also studied the primary culture of renal proximal tubule isolated from Dahl S and R rats fed a low salt diet. In this system, ouabain induced Na/K-ATPase/c-Src signaling and redistribution of Na/K-ATPase and NHE3 in the Dahl R rats, but not in the Dahl S rats. Our data suggested that impairment of Na/K-ATPase signaling and consequent regulation of Na/K-ATPase and NHE3 in renal proximal tubule may contribute to salt-induced hypertension in the Dahl S rat.	[Liu, Jiang; Yan, Yanling; Xie, Zijian; Malhotra, Deepak; Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Med, Hlth Sci Campus,3000 Arlington Ave, Toledo, OH 43614 USA; [Liu, Lijun; Xie, Zijian; Joe, Bina; Shapiro, Joseph I.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Yan, Yanling] Yanshan Univ, Inst Biomed Engn, Qinhuangdao, Peoples R China	University System of Ohio; University of Toledo; University of Toledo Health Science Campus; University System of Ohio; University of Toledo; Yanshan University	Liu, J (corresponding author), Univ Toledo, Coll Med, Dept Med, Hlth Sci Campus,3000 Arlington Ave, Toledo, OH 43614 USA.	Jiang.Liu@utoledo.edu	Yan, Yanling/AAX-1691-2020; Yan, Yanling/AAE-8460-2021; Liu, Jiang/AAF-2742-2021	Yan, Yanling/0000-0001-6549-3393; 	National Institutes of Health [GM78565, HL36573, HL020176, HL076709]; American Heart Association Ohio Valley Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL020176, P01HL036573, R01HL076709, R01HL020176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Ohio Valley Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM78565 and HL36573 (to Z. X.) and HL020176 and HL076709 (to B. J.) from the National Institutes of Health and the American Heart Association Ohio Valley Affiliate (to J. L.).	Bacic D, 2003, KIDNEY INT, V64, P2133, DOI 10.1046/j.1523-1755.2003.00308.x; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bagrov AY, 2005, FRONT BIOSCI-LANDMRK, V10, P2250, DOI 10.2741/1694; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Blaustein MP, 2010, BBA-MOL BASIS DIS, V1802, P1219, DOI 10.1016/j.bbadis.2010.02.011; BLAUSTEIN MP, 1991, HYPERTENSION, V18, pS184; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; DAHL LK, 1974, CIRC RES, V34, P94, DOI 10.1161/01.RES.34.1.94; DAHL LK, 1962, NATURE, V194, P480, DOI 10.1038/194480b0; DAHL LK, 1969, CIRC RES, V24, pI21; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; Fedorova OV, 2006, HYPERTENSION, V48, P1160, DOI 10.1161/01.HYP.0000248129.20524.d0; Fedorova OV, 2010, BBA-MOL BASIS DIS, V1802, P1230, DOI 10.1016/j.bbadis.2010.03.011; Fedorova OV, 2005, J HYPERTENS, V23, P835, DOI 10.1097/01.hjh.0000163153.27954.33; Fedorova OV, 2002, CIRCULATION, V105, P1122, DOI 10.1161/hc0902.104710; Fedorova OV, 2000, CIRCULATION, V102, P3009; Jaitovich A, 2010, LIFE SCI, V86, P73, DOI 10.1016/j.lfs.2009.10.019; Kashkin VA, 2008, EUR NEUROPSYCHOPHARM, V18, P74, DOI 10.1016/j.euroneuro.2007.05.006; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Liu J, 2002, KIDNEY INT, V62, P2118, DOI 10.1046/j.1523-1755.2002.00672.x; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Mokry M, 2008, HYPERTENSION, V51, P922, DOI 10.1161/HYPERTENSIONAHA.107.108415; Nesher M, 2009, AM J PHYSIOL-HEART C, V297, pH2026, DOI 10.1152/ajpheart.00734.2009; Periyasamy SM, 2005, KIDNEY INT, V67, P1868, DOI 10.1111/j.1523-1755.2005.00285.x; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; RAPP JP, 1982, HYPERTENSION, V4, P753, DOI 10.1161/01.HYP.4.6.753; Ritz E, 2010, NEPHROLOGY, V15, P49, DOI 10.1111/j.1440-1797.2010.01311.x; ROMAN RJ, 1987, AM J PHYSIOL, V252, pR833, DOI 10.1152/ajpregu.1987.252.5.R833; Schoner W, 2008, NEPHROL DIAL TRANSPL, V23, P2723, DOI 10.1093/ndt/gfn325; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Yang LE, 2008, AM J PHYSIOL-RENAL, V295, pF1003, DOI 10.1152/ajprenal.90235.2008; YUAN C, 1993, J CARDIOVASC PHARM, V22, pS10, DOI 10.1097/00005344-199322002-00005; Zhang J, 2005, J PHYSIOL-LONDON, V569, P243, DOI 10.1113/jphysiol.2005.091801	36	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22806	22813		10.1074/jbc.M111.246249	http://dx.doi.org/10.1074/jbc.M111.246249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555512	Green Published, hybrid			2022-12-25	WOS:000292025000015
J	Pantazaka, E; Taylor, CW				Pantazaka, Evangelia; Taylor, Colin W.			Differential Distribution, Clustering, and Lateral Diffusion of Subtypes of the Inositol 1,4,5-Trisphosphate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; IP3 RECEPTORS; CA2+ WAVES; CHANNEL; TYPE-2; CALCIUM; PROTEIN; MOBILITY; LOCALIZATION; ACTIVATION	Regulation of inositol 1,4,5-trisphosphate (IP3) receptors (IP3R) by IP3 and Ca2+ allows them to initiate and regeneratively propagate intracellular Ca2+ signals. The distribution and mobility of IP3R determines the spatial organization of these Ca2+ signals. Until now, there has been no systematic comparison of the distribution and mobility of the three mammalian IP3R subtypes in a uniform background. We used confocal microscopy and fluorescence recovery after photobleaching to define these properties for each IP3R subtype expressed heterologously in COS-7 cells. IP(3)R1 and IP(3)R3 were uniformly distributed within the membranes of the endoplasmic reticulum (ER), but the distribution of IP(3)R2 was punctate. The mobile fractions (M-f = 84 +/- 2 and 80 +/- 2%) and diffusion coefficients (D = 0.018 +/- 0.001 and 0.016 +/- 0.002 mu m(2)/s) of IP(3)R1 and IP(3)R3 were similar. Other ER membrane proteins (ryanodine receptor type 1 and sarco/endoplasmic reticulum Ca2+-ATPase type 1) and a luminal protein (enhanced GFP with a KDEL retrieval sequence) had similar mobile fractions, suggesting that IP(3)R1 and IP(3)R3 move freely within an ER that is largely, although not entirely, continuous. IP(3)R2 was less mobile, but IP(3)R2 mobility differed between perinuclear (M-f = 47 +/- 4% and D = 0.004 +/- 0.001 mu m(2)/s) and near-plasma membrane (M-f = 64 +/- 6% and D = 0.013 +/- 0.004 mu m(2)/s) regions, whereas IP(3)R3 behaved similarly in both regions. We conclude that IP(3)R1 and IP(3)R3 diffuse freely within a largely continuous ER, but IP(3)R2 is more heterogeneously distributed and less mobile, and its mobility differs between regions of the cell.	[Pantazaka, Evangelia; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	; Taylor, Colin/G-2447-2010	PANTAZAKA, EVANGELIA/0000-0001-6737-8428; Taylor, Colin/0000-0001-7771-1044	Medical Research Council UK [G0700843]; Wellcome Trust [085295]; Medical Research Council [G0700843] Funding Source: researchfish; MRC [G0700843] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council UK Grant G0700843 and Wellcome Trust Grant 085295.	AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Berg H. C., 1983, RANDOM WALKS BIOL; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Betzenhauser MJ, 2009, J BIOL CHEM, V284, P25116, DOI 10.1074/jbc.M109.010132; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Bootman MD, 1996, CURR BIOL, V6, P855, DOI 10.1016/S0960-9822(02)00609-7; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; Chalmers M, 2006, BIOCHEM J, V394, P57, DOI 10.1042/BJ20051130; Cruttwell C, 2005, BIOL CELL, V97, P699, DOI 10.1042/BC20040503; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Ferreri-Jacobia M, 2005, J BIOL CHEM, V280, P3824, DOI 10.1074/jbc.M409462200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Fukatsu K, 2006, BIOCHEM BIOPH RES CO, V342, P573, DOI 10.1016/j.bbrc.2006.02.010; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Fukatsu K, 2010, J NEUROCHEM, V114, P1720, DOI 10.1111/j.1471-4159.2010.06885.x; Gibson CJ, 2008, CELL CALCIUM, V43, P228, DOI 10.1016/j.ceca.2007.05.008; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Joseph SK, 2000, J BIOL CHEM, V275, P16084, DOI 10.1074/jbc.M000506200; KWON G, 1994, CELL SIGNAL, V6, P663, DOI 10.1016/0898-6568(94)90049-3; Laflamme K, 2002, J CELL BIOCHEM, V85, P219, DOI 10.1002/jcb.10124; Mak DOD, 2000, J GEN PHYSIOL, V115, P241, DOI 10.1085/jgp.115.3.241; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Marchant J, 1999, EMBO J, V18, P5285, DOI 10.1093/emboj/18.19.5285; Marchant JS, 1997, CURR BIOL, V7, P510, DOI 10.1016/S0960-9822(06)00222-3; Meur G, 2007, J BIOL CHEM, V282, P23096, DOI 10.1074/jbc.M702457200; MIGNERY GA, 1990, J BIOL CHEM, V265, P12679; Newton T, 2003, BIOCHEM J, V371, P775, DOI 10.1042/BJ20021477; Pantazaka E, 2010, BIOCHEM J, V425, P61, DOI 10.1042/BJ20091051; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Rahman T, 2009, CHANNELS, V3, P226, DOI 10.4161/chan.3.4.9247; Ramos-Franco J, 2000, BIOPHYS J, V79, P1388, DOI 10.1016/S0006-3495(00)76391-0; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Sheppard CA, 1997, J NEUROCHEM, V68, P2317; Smith IF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000466; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Tateishi Y, 2005, J BIOL CHEM, V280, P6816, DOI 10.1074/jbc.M405469200; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Tovey SC, 2008, J CELL BIOL, V183, P297, DOI 10.1083/jcb.200803172; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465; Wiltgen SM, 2010, BIOPHYS J, V99, P437, DOI 10.1016/j.bpj.2010.04.037; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Wolfram F, 2010, BIOCHEM J, V428, P483, DOI 10.1042/BJ20100143	48	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23378	23387		10.1074/jbc.M111.236372	http://dx.doi.org/10.1074/jbc.M111.236372			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550988	hybrid, Green Published			2022-12-25	WOS:000292025000069
J	Swindall, AF; Bellis, SL				Swindall, Amanda F.; Bellis, Susan L.			Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; HUMAN COLORECTAL-CANCER; SIALYLTRANSFERASE ACTIVITY; SURFACE ANTIGEN; SUGAR CHAINS; N-GLYCANS; EXPRESSION; GLYCOSYLATION; CD95; RESISTANCE	The glycosyltransferase, ST6Gal-I, adds sialic acid in an alpha 2-6 linkage to the N-glycans of membrane and secreted glycoproteins. Up-regulation of ST6Gal-I occurs in many cancers, including colon carcinoma, and correlates with metastasis and poor prognosis. However, mechanisms by which ST6Gal-I facilitates tumor progression remain poorly understood due to limited knowledge of enzyme substrates. Herein we identify the death receptor, Fas (CD95), as an ST6Gal-I substrate, and show that alpha 2-6 sialylation of Fas confers protection against Fas-mediated apoptosis. Intriguingly, differences in ST6Gal-I activity do not affect the function of DR4 or DR5 death receptors upon treatment with TRAIL, implicating a selective effect of ST6Gal-I on the Fas receptor. Using ST6Gal-I knockdown and forced overexpression colon carcinoma cell models, we find that alpha 2-6 sialylation of Fas prevents apoptosis stimulated by FasL as well as the Fas-activating antibody, CH11, as evidenced by decreased activation of caspases 8 and 3. We also show that alpha 2-6 sialylation of Fas does not alter the binding of CH11, but rather inhibits the capacity of Fas to induce apoptosis by blocking the association of FADD with Fas cytoplasmic tails, an event that initiates death-inducing signaling complex formation. Furthermore, alpha 2-6 sialylation of Fas inhibits Fas internalization, which is required for apoptotic signaling. Although dysregulated Fas activity is a well known mechanism through which tumors evade apoptosis, the current study is the first to link Fas insensitivity to the actions of a specific sialyltransferase. This finding establishes a new paradigm by which death receptor function is impaired for the self-protection of tumors against apoptosis.	[Swindall, Amanda F.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), 1918 Univ Blvd,982A MCLM, Birmingham, AL 35294 USA.	bellis@uab.edu	Swindall, Amanda/F-3935-2012		NCI, NIH [R01 CA84248]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER	NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA84248 (to S. L. B.) from the NCI, NIH.; Supported by the Howard Hughes Med-into-Grad Ph.D. program, as well as a pre-doctoral fellowship from the American Heart Association.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Baldwin RL, 1999, GYNECOL ONCOL, V74, P265, DOI 10.1006/gyno.1999.5448; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; BRESALIER RS, 1990, CANCER RES, V50, P1299; Costa-Nogueira C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-431; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DALLOLIO F, 1989, INT J CANCER, V44, P434; DALLOLIO F, 1995, BIOCHEM BIOPH RES CO, V211, P554, DOI 10.1006/bbrc.1995.1849; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; GESSNER P, 1993, CANCER LETT, V75, P143, DOI 10.1016/0304-3835(93)90056-F; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HarduinLepers A, 1995, GLYCOBIOLOGY, V5, P741, DOI 10.1093/glycob/5.8.741; HARVEY BE, 1992, CANCER RES, V52, P1775; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; KANEKO Y, 1995, J HISTOCHEM CYTOCHEM, V43, P945, DOI 10.1177/43.9.7642967; Kaneko Y, 1996, ACTA NEUROPATHOL, V91, P284, DOI 10.1007/s004010050427; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Krzewinski-Recchi MA, 2003, EUR J BIOCHEM, V270, P950, DOI 10.1046/j.1432-1033.2003.03458.x; Landowski TH, 1997, BLOOD, V89, P1854, DOI 10.1182/blood.V89.6.1854; Lebel M, 1996, ONCOGENE, V12, P1127; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; LEMARER N, 1992, GLYCOBIOLOGY, V2, P49, DOI 10.1093/glycob/2.1.49; Li Y, 2007, INT J BIOCHEM CELL B, V39, P1625, DOI 10.1016/j.biocel.2007.04.002; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mahmood Z, 2010, EXP CELL RES, V316, P887, DOI 10.1016/j.yexcr.2009.12.011; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; MOLLER P, 1994, INT J CANCER, V57, P371, DOI 10.1002/ijc.2910570314; NATOLI G, 1995, ONCOGENE, V11, P1157; O'Connell J, 2000, ANN NY ACAD SCI, V910, P178; OEHM A, 1992, J BIOL CHEM, V267, P10709; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Petretti T, 1999, BBA-GEN SUBJECTS, V1428, P209, DOI 10.1016/S0304-4165(99)00080-X; Recchi MA, 1998, CANCER RES, V58, P4066; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Shirley S., 2010, CANC LETT IN PRESS; SKACEL PO, 1991, BLOOD, V78, P1452; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; VIERBUCHEN MJ, 1995, CANCER, V76, P727, DOI 10.1002/1097-0142(19950901)76:5<727::AID-CNCR2820760504>3.0.CO;2-R; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walker PR, 1997, J IMMUNOL, V158, P4521; Wang PH, 2003, GYNECOL ONCOL, V89, P395, DOI 10.1016/S0090-8258(03)00127-6; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	54	139	141	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22982	22990		10.1074/jbc.M110.211375	http://dx.doi.org/10.1074/jbc.M110.211375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550977	Green Published, hybrid			2022-12-25	WOS:000292025000033
J	Yamaguchi, S; Jha, A; Li, Q; Soyombo, AA; Dickinson, GD; Churamani, D; Brailoiu, E; Patel, S; Muallem, S				Yamaguchi, Soichiro; Jha, Archana; Li, Qin; Soyombo, Abigail A.; Dickinson, George D.; Churamani, Dev; Brailoiu, Eugen; Patel, Sandip; Muallem, Shmuel			Transient Receptor Potential Mucolipin 1 (TRPML1) and Two-pore Channels Are Functionally Independent Organellar Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; VARITINT-WADDLER PHENOTYPE; CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; MOBILIZES CALCIUM; ACIDIC ORGANELLES; PLASMA-MEMBRANE; RELEASE CHANNEL; CA2+ RELEASE; SEA-URCHIN	NAADP is a potent second messenger that mobilizes Ca2+ from acidic organelles such as endosomes and lysosomes. The molecular basis for Ca2+ release by NAADP, however, is uncertain. TRP mucolipins (TRPMLs) and two-pore channels (TPCs) are Ca2+-permeable ion channels present within the endolysosomal system. Both have been proposed as targets for NAADP. In the present study, we probed possible physical and functional association of these ion channels. Exogenously expressed TRPML1 showed near complete colocalization with TPC2 and partial colocalization with TPC1. TRPML3 overlap with TPC2 was more modest. TRPML1 and to some extent TRPML3 co-immuno-precipitated with TPC2 but less so with TPC1. Current recording, however, showed that TPC1 and TPC2 did not affect the activity of wild-type TRPML1 or constitutively active TRPML1(V432P). N-terminally truncated TPC2 (TPC2delN), which is targeted to the plasma membrane, also failed to affect TRPML1 and TRPML1(V432P) channel function or TRPML1(V432P)-mediated Ca2+ influx. Whereas overexpression of TPCs enhanced NAADP-mediated Ca2+ signals, overexpression of TRPML1 did not, and the dominant negative TRPML1(D471K) was without affect on endogenous NAADP-mediated Ca2+ signals. Furthermore, the single channel properties of NAADP-activated TPC2delN were not affected by TRPML1. Finally, NAADP-evoked Ca2+ oscillations in pancreatic acinar cells were identical in wild-type and TRPML1(-/-) cells. We conclude that although TRPML1 and TPCs are present in the same complex, they function as two independent organellar ion channels and that TPCs, not TRPMLs, are the targets for NAADP.	[Dickinson, George D.; Churamani, Dev; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Yamaguchi, Soichiro; Li, Qin; Soyombo, Abigail A.; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75235 USA; [Jha, Archana] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Brailoiu, Eugen] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA	University of London; University College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk; shmuel.muallem@nih.gov	jha, archana/AAQ-2120-2020; Yamaguchi, Soichiro/Q-8563-2019; Dickinson, George/H-6609-2016; Dickinson, George/D-1461-2009; Patel, Sandip/O-9591-2015	Dickinson, George/0000-0001-7711-0388; Dickinson, George/0000-0001-7711-0388; Soyombo, Abigail/0000-0003-0850-2593; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [DE12309, DK38938, HL90804]; NIDCR/DIR [ZIA DE000735-01]; Biotechnology and Biological Sciences Research Council [BB/G013721/1]; Uehara Memorial Foundation (Tokyo, Japan); BBSRC [BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR/DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Uehara Memorial Foundation (Tokyo, Japan)(Uehara Memorial Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DE12309 and DK38938 and the intramural NIDCR/DIR (Grant ZIA DE000735-01), National Institutes of Health (to S. M.) and HL90804 (to E. B.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BB/G013721/1 (to S. P.).; Supported by the Uehara Memorial Foundation (Tokyo, Japan).	Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Chandra M, 2011, GASTROENTEROLOGY, V140, P857, DOI 10.1053/j.gastro.2010.11.040; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dickinson GD, 2010, J BIOL CHEM, V285, P13321, DOI 10.1074/jbc.C110.112573; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kim HJ, 2010, J BIOL CHEM, V285, P16513, DOI 10.1074/jbc.M109.078204; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kim JY, 2006, J BIOL CHEM, V281, P32540, DOI 10.1074/jbc.M602496200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kiselyov K, 2010, CELL CALCIUM, V47, P103, DOI 10.1016/j.ceca.2009.12.007; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel SD, 2010, SURG LAPARO ENDO PER, V20, P20, DOI 10.1097/SLE.0b013e3181cd45f2; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Ruas M., 2010, CURR BIOL; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	50	64	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22934	22942		10.1074/jbc.M110.210930	http://dx.doi.org/10.1074/jbc.M110.210930			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540176	hybrid, Green Published			2022-12-25	WOS:000292025000028
J	Ding, PR; Tiwari, AK; Ohnuma, S; Lee, JWKK; An, X; Dai, CL; Lu, QS; Singh, S; Yang, DH; Talele, TT; Ambudkar, SV; Chen, ZS				Ding, Pei-Rong; Tiwari, Amit K.; Ohnuma, Shinobu; Lee, Jeferson W. K. K.; An, Xin; Dai, Chun-Ling; Lu, Qi-Si; Singh, Satyakam; Yang, Dong-Hua; Talele, Tanaji T.; Ambudkar, Suresh V.; Chen, Zhe-Sheng			The Phosphodiesterase-5 Inhibitor Vardenafil Is a Potent Inhibitor of ABCB1/P-Glycoprotein Transporter	PLOS ONE			English	Article							REVERSES MULTIDRUG-RESISTANCE; SUBFAMILY-B MEMBER-1; P-GLYCOPROTEIN; MOLECULAR-BASIS; CANCER; CHEMOTHERAPY; PHARMACOLOGY; MODULATION; SUBSTRATE; CELLS	One of the major causes of chemotherapy failure in cancer treatment is multidrug resistance (MDR) which is mediated by the ABCB1/P-glycoprotein. Previously, through the use of an extensive screening process, we found that vardenafil, a phosphodiesterase 5 (PDE-5) inhibitor significantly reverses MDR in ABCB1 overexpressing cancer cells, and its efficacy was greater than that of tadalafil, another PDE-5 inhibitor. The present study was designed to determine the reversal mechanisms of vardenafil and tadalafil on ABC transporters-mediated MDR. Vardenafil or tadalafil alone, at concentrations up to 20 mu M, had no significant toxic effects on any of the cell lines used in this study, regardless of their membrane transporter status. However, vardenafil when used in combination with anticancer substrates of ABCB1, significantly potentiated their cytotoxicity in ABCB1 overexpressing cells in a concentration-dependent manner, and this effect was greater than that of tadalafil. The sensitivity of the parenteral cell lines to cytotoxic anticancer drugs was not significantly altered by vardenafil. The differential effects of vardenafil and tadalafil appear to be specific for the ABCB1 transporter as both vardenafil and tadalafil had no significant effect on the reversal of drug resistance conferred by ABCC1 (MRP1) and ABCG2 (BCRP) transporters. Vardenafil significantly increased the intracellular accumulation of [H-3]-paclitaxel in the ABCB1 overexpressing KB-C2 cells. In addition, vardenafil significantly stimulated the ATPase activity of ABCB1 and inhibited the photolabeling of ABCB1 with [I-125]-IAAP. Furthermore, Western blot analysis indicated the incubation of cells with either vardenafil or tadalafil for 72 h did not alter ABCB1 protein expression. Overall, our results suggest that vardenafil reverses ABCB1-mediated MDR by directly blocking the drug efflux function of ABCB1.	[Ding, Pei-Rong; Tiwari, Amit K.; Lee, Jeferson W. K. K.; An, Xin; Dai, Chun-Ling; Lu, Qi-Si; Singh, Satyakam; Talele, Tanaji T.; Chen, Zhe-Sheng] St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Jamaica, NY 11439 USA; [Ding, Pei-Rong; An, Xin] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Ding, Pei-Rong] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China; [Ohnuma, Shinobu; Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [An, Xin] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Dong-Hua] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Saint John's University; Sun Yat Sen University; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sun Yat Sen University; Fox Chase Cancer Center	Ding, PR (corresponding author), St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Jamaica, NY 11439 USA.	Chenz@stjohns.edu	Tiwari, Amit/A-3667-2012; Ambudkar, Suresh V/L-1317-2016	Tiwari, Amit/0000-0002-7427-7155; Chen, Zhe-Sheng/0000-0002-8289-097X; Singh, Satyakam/0000-0001-9115-3296; Ohnuma, Shinobu/0000-0002-0205-8957; Tiwari, Amit/0000-0002-0275-0724	St. John's University [579-1110]; National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010030] Funding Source: NIH RePORTER	St. John's University; National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from St. John's University Seed Grant No. 579-1110, (Z.S.C.) and S.O. and S.V.A. were supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Aoki S, 2001, JPN J CANCER RES, V92, P886, DOI 10.1111/j.1349-7006.2001.tb01177.x; Black KL, 2008, BRAIN RES, V1230, P290, DOI 10.1016/j.brainres.2008.06.122; Corbin JD, 2003, J ANDROL, V24, pS38; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Ekins S, 2009, TRANSPORTERS DRUG CA; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hellstrom WJG, 2002, J ANDROL, V23, pS3; Hu JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010108; Jamroziak Krzysztof, 2004, Hematology, V9, P91, DOI 10.1080/10245330310001638974; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lage H, 2006, CURR DRUG TARGETS, V7, P813, DOI 10.2174/138945006777709566; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Maki N, 2003, J BIOL CHEM, V278, P18132, DOI 10.1074/jbc.M210413200; Modok S, 2006, CURR OPIN PHARMACOL, V6, P350, DOI 10.1016/j.coph.2006.01.009; Muller M, 2002, BIOCHEMISTRY-US, V41, P10123, DOI 10.1021/bi026075s; O'Connor R, 2007, ANTICANCER RES, V27, P1267; Ormrod D, 2002, DRUG AGING, V19, P217, DOI 10.2165/00002512-200219030-00005; Perez-Victoria JM, 2002, CURR DRUG TARGETS, V3, P311, DOI 10.2174/1389450023347588; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; Sarfati M, 2003, BLOOD, V101, P265, DOI 10.1182/blood-2002-01-0075; Sauna ZE, 2004, MOL PHARMACOL, V65, P675, DOI 10.1124/mol.65.3.675; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Shabbits J A, 2001, Expert Rev Anticancer Ther, V1, P585, DOI 10.1586/14737140.1.4.585; Shen T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007520; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Szabo G, 2009, EUR J CARDIO-THORAC, V36, P657, DOI 10.1016/j.ejcts.2009.03.065; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tan B, 2000, CURR OPIN ONCOL, V12, P450, DOI 10.1097/00001622-200009000-00011; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Zhu B, 2007, CURR TOP MED CHEM, V7, P437, DOI 10.2174/156802607779941198	41	61	66	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19329	10.1371/journal.pone.0019329	http://dx.doi.org/10.1371/journal.pone.0019329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552528	Green Submitted, gold, Green Published			2022-12-25	WOS:000290020700048
J	Goncalves, A; Zeller, R				Goncalves, Alexandre; Zeller, Rolf			Genetic Analysis Reveals an Unexpected Role of BMP7 in Initiation of Ureteric Bud Outgrowth in Mouse Embryos	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN HETERODIMERS; KIDNEY BRANCHING MORPHOGENESIS; MESODERM INDUCTION; METANEPHRIC KIDNEY; MAMMALIAN KIDNEY; SYSTEM; NEPHROGENESIS; ORGANOGENESIS; EXPRESSION; MESENCHYME	Background: Genetic analysis in the mouse revealed that GREMLIN1 (GREM1)-mediated antagonism of BMP4 is essential for ureteric epithelial branching as the disruption of ureteric bud outgrowth and renal agenesis in Grem1-deficient embryos is restored by additional inactivation of one Bmp4 allele. Another BMP ligand, BMP7, was shown to control the proliferative expansion of nephrogenic progenitors and its requirement for nephrogenesis can be genetically substituted by Bmp4. Therefore, we investigated whether BMP7 in turn also participates in inhibiting ureteric bud outgrowth during the initiation of metanephric kidney development. Methodology/Principal Findings: Genetic inactivation of one Bmp7 allele in Grem1-deficient mouse embryos does not alleviate the bilateral renal agenesis, while complete inactivation of Bmp7 restores ureteric bud outgrowth and branching. In mouse embryos lacking both Grem1 and Bmp7, GDNF/WNT11 feedback signaling and the expression of the Etv4 target gene, which regulates formation of the invading ureteric bud tip, are restored. In contrast to the restoration of ureteric bud outgrowth and branching, nephrogenesis remains aberrant as revealed by the premature loss of Six2 expressing nephrogenic progenitor cells. Therefore, very few nephrons develop in kidneys lacking both Grem1 and Bmp7 and the resulting dysplastic phenotype is indistinguishable from the one of Bmp7-deficient mouse embryos. Conclusions/Significance: Our study reveals an unexpected inhibitory role of BMP7 during the onset of ureteric bud outgrowth. As BMP4, BMP7 and GREM1 are expressed in distinct mesenchymal and epithelial domains, the localized antagonistic interactions of GREM1 with BMPs could restrict and guide ureteric bud outgrowth and branching. The robustness and likely significant redundancy of the underlying signaling system is evidenced by the fact that global reduction of Bmp4 or inactivation of Bmp7 are both able to restore ureteric bud outgrowth and epithelial branching in Grem1-deficient mouse embryos.	[Goncalves, Alexandre; Zeller, Rolf] Univ Basel, Fac Med, Dept Biomed, Basel, Switzerland	University of Basel; University of Geneva	Goncalves, A (corresponding author), Univ Basel, Fac Med, Dept Biomed, Basel, Switzerland.	rolf.zeller@unibas.ch	Zeller, Rolf/C-2610-2013	Zeller, Rolf/0000-0002-3186-7403	Swiss National Science Foundation [31003A-113866, 31003A-130803]; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/24301/2005]; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); University of Basel	This research was supported by the Swiss National Science Foundation (grant nos. 31003A-113866 and 31003A-130803), the Fundacao para a Ciencia e a Tecnologia (FCT; SFRH/BD/24301/2005 to AG), and the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755; Blank U, 2009, DEVELOPMENT, V136, P3557, DOI 10.1242/dev.036335; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1997, DEV DYNAM, V208, P349; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kulessa H, 2002, GENESIS, V32, P66, DOI 10.1002/gene.10032; Kuure S, 2010, DEVELOPMENT, V137, P1975, DOI 10.1242/dev.051656; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Oxburgh L, 2005, DEV BIOL, V286, P637, DOI 10.1016/j.ydbio.2005.08.024; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; Raatikainen-Ahokas A, 2000, DEV DYNAM, V217, P146, DOI 10.1002/(SICI)1097-0177(200002)217:2<146::AID-DVDY2>3.3.CO;2-9; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Shakya R, 2005, DEV BIOL, V283, P70, DOI 10.1016/j.ydbio.2005.04.008; SHI SR, 1993, J HISTOCHEM CYTOCHEM, V41, P1599, DOI 10.1177/41.11.7691930; SIMSLUCAS S, 2010, DEV DYN; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Zhang QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011709	34	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19370	10.1371/journal.pone.0019370	http://dx.doi.org/10.1371/journal.pone.0019370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552539	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700053
J	Meli, M; Gasset, M; Colombo, G				Meli, Massimiliano; Gasset, Maria; Colombo, Giorgio			Dynamic Diagnosis of Familial Prion Diseases Supports the beta 2-alpha 2 Loop as a Universal Interference Target	PLOS ONE			English	Article							SPONGIFORM ENCEPHALOPATHY; THERMODYNAMIC STABILITY; STRUCTURAL INSTABILITY; PROTEIN AGGREGATION; NMR STRUCTURES; BETA-SHEET; MUTATIONS; DOMAIN; CONVERSION; EPITOPE	Background: Mutations in the cellular prion protein associated to familial prion disorders severely increase the likelihood of its misfolding into pathogenic conformers. Despite their postulation as incompatible elements with the native fold, these mutations rarely modify the native state structure. However they variably have impact on the thermodynamic stability and metabolism of PrPC and on the properties of PrPSc aggregates. To investigate whether the pathogenic mutations affect the dynamic properties of the HuPrP(125-229) alpha-fold and find possible common patterns of effects that could help in prophylaxis we performed a dynamic diagnosis of ten point substitutions. Methodology/Principal Findings: Using all-atom molecular dynamics simulations and novel analytical tools we have explored the effect of D178N, V180I, T183A, T188K, E196K, F198S, E200K, R208H, V210I and E211Q mutations on the dynamics of HuPrP(125-228) alpha-fold. We have found that while preserving the native state, all mutations produce dynamic changes which perturb the coordination of the alpha 2-alpha 3 hairpin to the rest of the molecule and cause the reorganization of the patches for intermolecular recognition, as the disappearance of those for conversion inhibitors and the emergence of an interaction site at the beta 2-alpha 2 loop region. Conclusions/Significance: Our results suggest that pathogenic mutations share a common pattern of dynamical alterations that converge to the conversion of the beta 2-alpha 2 loop into an interacting region that can be used as target for interference treatments in genetic diseases.	[Meli, Massimiliano; Colombo, Giorgio] CNR, Dept Computat Biol, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy; [Gasset, Maria] CSIC, Inst Quim Fis Rocasolano, Dept Biol Phys Chem, Madrid, Spain	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Meli, M (corresponding author), CNR, Dept Computat Biol, Ist Chim Riconoscimento Mol, I-20133 Milan, Italy.	mgasset@iqfr.csic.es; g.colombo@icrm.cnr.it	Gasset, Maria/I-2050-2014; Gasset, Maria/K-4339-2012; Colombo, Giorgio/A-2730-2012; Meli, Massimiliano/AAY-8570-2020	Gasset, Maria/0000-0001-6436-4055; Gasset, Maria/0000-0001-6436-4055; Colombo, Giorgio/0000-0002-1318-668X; Meli, Massimiliano/0000-0003-3304-6104	MICINN [BFU2009-07971]; FundaciA3n Cien; Fondazione Cariplo; AIRC	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); FundaciA3n Cien; Fondazione Cariplo(Fondazione Cariplo); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported in parts by grants BFU2009-07971 from the MICINN (MG), FundaciA3n Cien (MG); Fondazione Cariplo (GC) and AIRC (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Brown DR, 2005, FOLIA NEUROPATHOL, V43, P229; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; Canello T, 2008, BIOCHEMISTRY-US, V47, P8866, DOI 10.1021/bi800801f; Canello T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000977; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Chen W, 2010, BIOCHEMISTRY-US, V49, P9874, DOI 10.1021/bi101449f; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Colacino S, 2006, PROTEINS, V62, P698, DOI 10.1002/prot.20804; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; Eghiaian F, 2004, P NATL ACAD SCI USA, V101, P10254, DOI 10.1073/pnas.0400014101; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Goldmann W, 2006, J GEN VIROL, V87, P3741, DOI 10.1099/vir.0.82083-0; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Hirschberger T, 2006, BIOPHYS J, V90, P3908, DOI 10.1529/biophysj.105.075341; Horiuchi M, 2001, J BIOL CHEM, V276, P15489, DOI 10.1074/jbc.M100288200; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lisa S, 2010, CELL MOL LIFE SCI, V67, P2825, DOI 10.1007/s00018-010-0363-1; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mishra RS, 2003, J ALZHEIMERS DIS, V5, P15, DOI 10.3233/JAD-2003-5103; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Piccardo P, 2001, AM J PATHOL, V158, P2201, DOI 10.1016/S0002-9440(10)64692-5; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rossetti G, 2010, PROTEINS, V78, P3270, DOI 10.1002/prot.22834; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scarabelli G, 2010, BIOPHYS J, V98, P1966, DOI 10.1016/j.bpj.2010.01.014; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Teng PK, 2009, PROTEIN ENG DES SEL, V22, P531, DOI 10.1093/protein/gzp037; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wolschner C, 2009, P NATL ACAD SCI USA, V106, P7756, DOI 10.1073/pnas.0902688106; Yamamoto N, 2009, J PHYS CHEM B, V113, P12853, DOI 10.1021/jp905572w; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	57	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19093	10.1371/journal.pone.0019093	http://dx.doi.org/10.1371/journal.pone.0019093			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552571	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700024
J	Anfora, G; Rigosi, E; Frasnelli, E; Ruga, V; Trona, F; Vallortigara, G				Anfora, Gianfranco; Rigosi, Elisa; Frasnelli, Elisa; Ruga, Vincenza; Trona, Federica; Vallortigara, Giorgio			Lateralization in the Invertebrate Brain: Left-Right Asymmetry of Olfaction in Bumble Bee, Bombus terrestris	PLOS ONE			English	Article							PROBOSCIS EXTENSION; APIS-MELLIFERA; BEHAVIOR; COMPETITION; HONEYBEES; EVOLUTION; ODORS	Brain and behavioural lateralization at the population level has been recently hypothesized to have evolved under social selective pressures as a strategy to optimize coordination among asymmetrical individuals. Evidence for this hypothesis have been collected in Hymenoptera: eusocial honey bees showed olfactory lateralization at the population level, whereas solitary mason bees only showed individual-level olfactory lateralization. Here we investigated lateralization of odour detection and learning in the bumble bee, Bombus terrestris L., an annual eusocial species of Hymenoptera. By training bumble bees on the proboscis extension reflex paradigm with only one antenna in use, we provided the very first evidence of asymmetrical performance favouring the right antenna in responding to learned odours in this species. Electroantennographic responses did not reveal significant antennal asymmetries in odour detection, whereas morphological counting of olfactory sensilla showed a predominance in the number of olfactory sensilla trichodea type A in the right antenna. The occurrence of a population level asymmetry in olfactory learning of bumble bee provides new information on the relationship between social behaviour and the evolution of population-level asymmetries in animals.	[Anfora, Gianfranco; Rigosi, Elisa; Trona, Federica] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy; [Rigosi, Elisa; Frasnelli, Elisa; Ruga, Vincenza; Vallortigara, Giorgio] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy	Fondazione Edmund Mach; University of Trento	Anfora, G (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.	gianfranco.anfora@iasma.it	Frasnelli, Elisa/M-2865-2017; Hernández, Juan/AAC-6250-2020; Frasnelli, Elisa/GZA-3976-2022	Frasnelli, Elisa/0000-0003-0493-0048; Rigosi, Elisa/0000-0002-2283-1257; ANFORA, Gianfranco/0000-0003-2545-1409	Provincia Autonoma di Trento; Fondazione Cassa di Risparmio di Trento e Rovereto	Provincia Autonoma di Trento(Autonomous Province of Trento); Fondazione Cassa di Risparmio di Trento e Rovereto(Fondazione Caritro)	This research was supported by the Provincia Autonoma di Trento (http://www.provincia.tn.it) and the Fondazione Cassa di Risparmio di Trento e Rovereto (http://www.fondazionecaritro.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades C, 2002, J INSECT BEHAV, V15, P563, DOI 10.1023/A:1016337418472; Agren L, 1996, APIDOLOGIE, V27, P433, DOI 10.1051/apido:19960601; Anfora G, 2010, BEHAV BRAIN RES, V206, P236, DOI 10.1016/j.bbr.2009.09.023; [Anonymous], 1974, SOCIAL BEHAV BEES; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bjostad L., 1998, METHODS CHEM ECOLOGY, V1, P339; Byrne RA, 2002, ANIM BEHAV, V64, P461, DOI 10.1006/anbe.2002.3089; Cooper R, 2011, J INSECT BEHAV, V24, P175, DOI 10.1007/s10905-010-9246-4; Davison A, 2009, BIOL LETTERS, V5, P20, DOI 10.1098/rsbl.2008.0528; Dornhaus A, 2003, J COMP PHYSIOL A, V189, P47, DOI 10.1007/s00359-002-0374-y; FONTA C, 1984, J CHEM ECOL, V10, P1157, DOI 10.1007/BF00988546; Frasnelli E, 2010, BEHAV BRAIN RES, V209, P221, DOI 10.1016/j.bbr.2010.01.046; Frasnelli E, 2010, BEHAV BRAIN RES, V209, P36, DOI 10.1016/j.bbr.2010.01.014; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; GOULSON D, 2003, BUMBLEBEES THEIR BEH; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Kells AR, 2001, J INSECT BEHAV, V14, P47, DOI 10.1023/A:1007897512570; Kight SL, 2008, BEHAV PROCESS, V79, P66, DOI 10.1016/j.beproc.2008.04.001; Laloi D, 1999, ENTOMOL EXP APPL, V90, P123, DOI 10.1023/A:1003598301272; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Molet M, 2009, NATURWISSENSCHAFTEN, V96, P213, DOI 10.1007/s00114-008-0465-x; Renner MA, 2008, INSECT SOC, V55, P417, DOI 10.1007/s00040-008-1021-6; Rogers LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002340; Rogers LJ., 2002, COMP VERTEBRATE LATE; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105	30	54	55	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18903	10.1371/journal.pone.0018903	http://dx.doi.org/10.1371/journal.pone.0018903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556150	Green Published, Green Accepted, gold			2022-12-25	WOS:000290019400017
J	Ray, S; Howells, C; Eaton, ED; Butler, CW; Shabala, L; Adlard, PA; West, AK; Bennett, WR; Guillemin, GJ; Chung, RS				Ray, Shannon; Howells, Claire; Eaton, Emma D.; Butler, Chris W.; Shabala, Lana; Adlard, Paul A.; West, Adrian K.; Bennett, William R.; Guillemin, Gilles J.; Chung, Roger S.			Tg2576 Cortical Neurons That Express Human Ab Are Susceptible to Extracellular A beta-Induced, K+ Efflux Dependent Neurodegeneration	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRANSGENIC MODEL; PRIMARY CULTURES; NA+/K+-ATPASE; VITAMIN-E; PEPTIDE; PROTEIN; BRAIN; IMPAIRMENT	Background: One of the key pathological features of AD is the formation of insoluble amyloid plaques. The major constituent of these extracellular plaques is the beta-amyloid peptide (A beta), although A beta is also found to accumulate intraneuronally in AD. Due to the slowly progressive nature of the disease, it is likely that neurons are exposed to sublethal concentrations of both intracellular and extracellular A beta for extended periods of time. Results: In this study, we report that daily exposure to a sublethal concentration of A beta(1-40) (1 mu M) for six days induces substantial apoptosis of cortical neurons cultured from Tg2576 mice (which express substantial but sublethal levels of intracellular A beta). Notably, untreated Tg2576 neurons of similar age did not display any signs of apoptosis, indicating that the level of intracellular A beta present in these neurons was not the cause of toxicity. Furthermore, wildtype neurons did not become apoptotic under the same chronic A beta(1-40) treatment. We found that this apoptosis was linked to Tg2576 neurons being unable to maintain K+ homeostasis following A beta treatment. Furthermore, blocking K+ efflux protected Tg2576 neurons from A beta-induced neurotoxicity. Interestingly, chronic exposure to 1 mu M A beta 1-40 caused the generation of axonal swellings in Tg2576 neurons that contained dense concentrations of hyperphosphorylated tau. These were not observed in wildtype neurons under the same treatment conditions. Conclusions: Our data suggest that when neurons are chronically exposed to sublethal levels of both intra-and extracellular A beta, this causes a K+-dependent neurodegeneration that has pathological characteristics similar to AD.	[Ray, Shannon; Howells, Claire; Eaton, Emma D.; Butler, Chris W.; Shabala, Lana; West, Adrian K.; Bennett, William R.; Chung, Roger S.] Univ Tasmania, NeuroRepair Grp, Menzies Res Inst, Hobart, Tas, Australia; [Adlard, Paul A.] Mental Hlth Res Inst, Synapt Neurobiol Lab, Melbourne, Vic, Australia; [Guillemin, Gilles J.] Univ New S Wales, Neuroinflammat Grp, Sydney, NSW, Australia	University of Tasmania; Menzies Institute for Medical Research; University of New South Wales Sydney	Ray, S (corresponding author), Univ Tasmania, NeuroRepair Grp, Menzies Res Inst, Hobart, Tas, Australia.	rschung@utas.edu.au	West, Adrian/AAR-8857-2021; Guillemin, Gilles J/C-3878-2015; Chung, Roger/ABF-8395-2020; Bennett, Bill/A-4039-2010	Guillemin, Gilles J/0000-0001-8105-4470; Chung, Roger/0000-0002-9286-947X; Shabala, Lana/0000-0002-5360-8496; Bennett, Bill/0000-0002-1559-3027	Australian Research Council (ARC) [DP0556630, DP0984673, LP0774820]; National Health and Medical Research Council [490025, 544913]; Jack & Ethel Goldin Foundation	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Jack & Ethel Goldin Foundation	This work was supported by research grants from the Australian Research Council (ARC, ID# DP0556630; DP0984673; LP0774820), National Health and Medical Research Council (ID# 490025, 544913) and Jack & Ethel Goldin Foundation. RSC holds an ARC Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boothby LA, 2005, ANN PHARMACOTHER, V39, P2073, DOI 10.1345/aph.1E495; Bores GM, 1998, BRAIN RES BULL, V46, P423, DOI 10.1016/S0361-9230(97)00382-1; Butterfield DA, 2002, NUTR NEUROSCI, V5, P229, DOI 10.1080/10284150290028954; Chung RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012030; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Dickey CA, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-7; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Esposito L, 2004, J NEUROCHEM, V91, P1260, DOI 10.1111/j.1471-4159.2004.02816.x; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Kerrigan TL, 2008, NEUROREPORT, V19, P839, DOI 10.1097/WNR.0b013e3282ff636b; KING AE, 2009, NEUROBIOL AGING; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Pereira C, 1999, NEUROBIOL DIS, V6, P209, DOI 10.1006/nbdi.1999.0241; Ramsden M, 2001, J NEUROCHEM, V79, P699, DOI 10.1046/j.1471-4159.2001.00618.x; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shabala L, 2006, FEMS MICROBIOL REV, V30, P472, DOI 10.1111/j.1574-6976.2006.00019.x; Shabala L, 2001, J MICROBIOL METH, V46, P119, DOI 10.1016/S0167-7012(01)00270-6; Shabala L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-30; Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yatin SM, 1999, NEUROBIOL AGING, V20, P325; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	32	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19026	10.1371/journal.pone.0019026	http://dx.doi.org/10.1371/journal.pone.0019026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556141	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400021
J	Gill, SR; McIntyre, LM; Nelson, CL; Remortel, B; Rude, T; Reller, LB; Fowler, VG				Gill, Steven R.; McIntyre, Lauren M.; Nelson, Charlotte L.; Remortel, Brian; Rude, Tom; Reller, L. Barth; Fowler, Vance G., Jr.			Potential Associations between Severity of Infection and the Presence of Virulence-Associated Genes in Clinical Strains of Staphylococcus aureus	PLOS ONE			English	Article							INCREASING FREQUENCY; ENDOCARDITIS; GENOME; BACTEREMIA; RESISTANCE; EVOLUTION; BIOFILM; HOST; SKIN	Background: The clinical spectrum of Staphylococcus aureus infection ranges from asymptomatic nasal carriage to osteomyelitis, infective endocarditis (IE) and death. In this study, we evaluate potential association between the presence of specific genes in a collection of prospectively characterized S. aureus clinical isolates and clinical outcome. Methodology/Principal Findings: Two hundred thirty-nine S. aureus isolates (121 methicillin-resistant S. aureus [MRSA] and 118 methicillin-susceptible S. aureus [MSSA]) were screened by array comparative genomic hybridization (aCGH) to identify genes implicated in complicated infections. After adjustment for multiple tests, 226 genes were significantly associated with severity of infection. Of these 226 genes, 185 were not in the SCCmec element. Within the 185 non-SCCmec genes, 171 were less common and 14 more common in the complicated infection group. Among the 41 genes in the SCCmec element, 37 were more common and 4 were less common in the complicated group. A total of 51 of the 2014 sequences evaluated, 14 non-SCCmec and 37 SCCmec, were identified as genes of interest. Conclusions/Significance: Of the 171 genes less common in complicated infections, 152 are of unknown function and may contribute to attenuation of virulence. The 14 non-SCCmec genes more common in complicated infections include bacteriophage-encoded genes such as regulatory factors and autolysins with potential roles in tissue adhesion or biofilm formation.	[Gill, Steven R.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA; [Gill, Steven R.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Gill, Steven R.] SUNY Buffalo, NYS Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA; [McIntyre, Lauren M.] Univ Florida, Gainesville, FL USA; [Nelson, Charlotte L.; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Remortel, Brian] J Craig Venter Inst, Rockville, MD USA; [Rude, Tom; Reller, L. Barth; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Reller, L. Barth] Duke Univ, Med Ctr, Clin Microbiol Lab, Durham, NC 27710 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of Florida; Duke University; J. Craig Venter Institute; Duke University; Duke University	Gill, SR (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14260 USA.	steven_gill@urmc.rochester.edu	Fowler, Vance/AAW-2017-2021; McIntyre, Lauren/J-8414-2012	McIntyre, Lauren/0000-0002-0077-3359	National Institutes of Health (NIH) [R01-AI059111, R01-AI068804]; Astellas; Cubist; Inhibitex; Merck; Theravance; Cerexa; Pfizer; Novartis; Advanced Liquid Logic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068804, R01AI059111] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astellas(Astellas Pharmaceuticals); Cubist; Inhibitex; Merck(Merck & Company); Theravance; Cerexa; Pfizer(Pfizer); Novartis(Novartis); Advanced Liquid Logic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from National Institutes of Health (NIH) (R01-AI059111 and R01-AI068804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Fowler has served as a consultant for Astellas, Cubist, Inhibitex, Merck, Johnson & Johnson, Shire, Leo Pharmaceuticals, NovaDigm, The Medicines Company, Baxter Pharmaceuticals & Biosynexus; has received grant or research support from Astellas, Cubist, Inhibitex, Merck, Theravance, Cerexa, Pfizer, Novartis, Advanced Liquid Logic and National Institute of Health; has received honoraria from Arpida, Astellas, Cubist, Inhibitex, Merck, Pfizer, Targanta, Theravance, Wyeth, Ortho-McNeil, Novartis & Vertex Pharmaceuticals; has served on an advisory committee for Cubist; is employed by Duke University; and has served as a speaker's bureau for Cubist.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Benjamin DK, 2004, SCAND J INFECT DIS, V36, P453, DOI 10.1080/00365540410020703; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Bhattacharya D, 2007, J CLIN MICROBIOL, V45, P1798, DOI 10.1128/JCM.01747-06; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Campbell SJ, 2008, J CLIN MICROBIOL, V46, P678, DOI 10.1128/JCM.01822-07; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Edgington E. S., 1995, RANDOMIZATION TESTS; FERNANDEZGUERRERO ML, 1995, CLIN INFECT DIS, V20, P16, DOI 10.1093/clinids/20.1.16; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Holden Matthew T. G., 2008, P1; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Ing M, 1997, STAPHYLOCOCCI HUMAN, P331; Jensen AG, 1997, J INFECTION, V34, P113, DOI 10.1016/S0163-4453(97)92395-1; Jensen AG, 1999, ARCH INTERN MED, V159, P1437, DOI 10.1001/archinte.159.13.1437; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Mathema Barun, 2008, V431, P285; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Resch A, 2005, FEMS MICROBIOL LETT, V252, P89, DOI 10.1016/j.femsle.2005.08.048; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rolain JM, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-1; SANABRIA TJ, 1990, ARCH INTERN MED, V150, P1305, DOI 10.1001/archinte.150.6.1305; Seo HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001047; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; van Belkum A, 2006, J CLIN MICROBIOL, V44, P1555, DOI 10.1128/JCM.44.4.1555-1557.2006; Verhoeven KJF, 2005, MOL BIOL EVOL, V22, P735, DOI 10.1093/molbev/msi058; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Wirtz C, 2009, MICROBIOL-SGM, V155, P3491, DOI 10.1099/mic.0.032466-0	39	34	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18673	10.1371/journal.pone.0018673	http://dx.doi.org/10.1371/journal.pone.0018673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541311	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400007
J	Joseph, B; Schwarz, RF; Linke, B; Blom, J; Becker, A; Claus, H; Goesmann, A; Frosch, M; Muller, T; Vogel, U; Schoen, C				Joseph, Biju; Schwarz, Roland F.; Linke, Burkhard; Blom, Jochen; Becker, Anke; Claus, Heike; Goesmann, Alexander; Frosch, Matthias; Mueller, Tobias; Vogel, Ulrich; Schoen, Christoph			Virulence Evolution of the Human Pathogen Neisseria meningitidis by Recombination in the Core and Accessory Genome	PLOS ONE			English	Article							STATISTICAL TEST; SEQUENCE; DISEASE; SEROGROUP; DNA; SELECTION; SECRETION; MUTATION; STRAINS; ISLANDS	Background: Neisseria meningitidis is a naturally transformable, facultative pathogen colonizing the human nasopharynx. Here, we analyze on a genome-wide level the impact of recombination on gene-complement diversity and virulence evolution in N. meningitidis. We combined comparative genome hybridization using microarrays (mCGH) and multilocus sequence typing (MLST) of 29 meningococcal isolates with computational comparison of a subset of seven meningococcal genome sequences. Principal Findings: We found that lateral gene transfer of minimal mobile elements as well as prophages are major forces shaping meningococcal population structure. Extensive gene content comparison revealed novel associations of virulence with genetic elements besides the recently discovered meningococcal disease associated (MDA) island. In particular, we identified an association of virulence with a recently described canonical genomic island termed IHT-E and a differential distribution of genes encoding RTX toxin-and two-partner secretion systems among hyperinvasive and non-hyperinvasive lineages. By computationally screening also the core genome for signs of recombination, we provided evidence that about 40% of the meningococcal core genes are affected by recombination primarily within metabolic genes as well as genes involved in DNA replication and repair. By comparison with the results of previous mCGH studies, our data indicated that genetic structuring as revealed by mCGH is stable over time and highly similar for isolates from different geographic origins. Conclusions: Recombination comprising lateral transfer of entire genes as well as homologous intragenic recombination has a profound impact on meningococcal population structure and genome composition. Our data support the hypothesis that meningococcal virulence is polygenic in nature and that differences in metabolism might contribute to virulence.	[Joseph, Biju; Claus, Heike; Frosch, Matthias; Vogel, Ulrich; Schoen, Christoph] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany; [Schwarz, Roland F.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge, England; [Linke, Burkhard; Blom, Jochen; Goesmann, Alexander] Univ Bielefeld, Ctr Biotechnol, Bielefeld, Germany; [Becker, Anke] Univ Freiburg, Fac Biol, Freiburg, Germany; [Claus, Heike; Frosch, Matthias; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Natl Reference Lab Meningococci NRZM, Wurzburg, Germany; [Mueller, Tobias] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany	University of Wurzburg; Cancer Research UK; CRUK Cambridge Institute; University of Bielefeld; University of Freiburg; University of Wurzburg; University of Wurzburg	Joseph, B (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany.	cschoen@hygiene.uni-wuerzburg.de	Schoen, Christoph U./G-9837-2013; Frosch, Matthias/H-2411-2013; Müller, Tobias/A-8952-2008	Schoen, Christoph U./0000-0003-2222-1085; Schwarz, Roland/0000-0001-9155-4268; Goesmann, Alexander/0000-0002-7086-2568; Becker, Anke/0000-0003-4561-9184	German Bundesministerium fur Bildung und Forschung (BMBF) [0313801A]	German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded by a grant from the German Bundesministerium fur Bildung und Forschung (BMBF) to MF and CS in the context of the PathoGenoMik and PathoGenoMik-Plus funding initiatives (grant 0313801A). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Bille E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003885; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CAUGANT DA, 2009, VACCINE S2, V27, pB64, DOI DOI 10.1016/j.vaccine.2009.04.061; Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Claus H, 2010, J CLIN MICROBIOL, V48, P3459, DOI 10.1128/JCM.00859-10; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Coppee JY, 2008, MICROBES INFECT, V10, P1067, DOI 10.1016/j.micinf.2008.07.003; CROWE BA, 1989, J INFECT DIS, V159, P686, DOI 10.1093/infdis/159.4.686; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Frosch M., 2006, HDB MENINGOCOCCAL DI, P145, DOI DOI 10.1002/3527608508.CH8; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505; Hartl D., 2007, PRINCIPLES POPULATIO; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Joseph B, 2010, J BACTERIOL, V192, P5363, DOI 10.1128/JB.00883-10; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Moxon ER, 2005, TRENDS MICROBIOL, V13, P563, DOI 10.1016/j.tim.2005.10.004; Novozhilov AS, 2005, MOL BIOL EVOL, V22, P1721, DOI 10.1093/molbev/msi167; Osicka R, 2001, INFECT IMMUN, V69, P5509; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Perrin A, 2002, INFECT IMMUN, V70, P7063, DOI 10.1128/IAI.70.12.7063-7072.2002; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2022, R LANG ENV STAT COMP; Roberts L, 2008, SCIENCE, V320, P1710, DOI 10.1126/science.320.5884.1710; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rusniok C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r110; Saunders NJ, 2002, MICROBIOL-SGM, V148, P3756, DOI 10.1099/00221287-148-12-3756; Schierup MH, 2010, BACTERIAL POPULATION, P3; Schmitt C, 2007, J BACTERIOL, V189, P7968, DOI 10.1128/JB.00851-07; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Schoen C, 2009, VACCINE, V27, pB103, DOI 10.1016/j.vaccine.2009.04.064; Schwarz R, 2010, J CLIN MICROBIOL, V48, P3105, DOI 10.1128/JCM.00233-10; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snyder LAS, 2007, MOL BIOL EVOL, V24, P2802, DOI 10.1093/molbev/msm215; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; Stabler RA, 2005, MICROBIOL-SGM, V151, P2907, DOI 10.1099/mic.0.28099-0; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAJIMA F, 1989, GENETICS, V123, P585; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Ulsen P, 2006, FEMS MICROBIOL REV, V30, P292, DOI 10.1111/j.1574-6976.2006.00013.x; van Ulsen P, 2008, INFECT IMMUN, V76, P4649, DOI 10.1128/IAI.00393-08; Vogel U, 2000, NEW ENGL J MED, V342, P219, DOI 10.1056/NEJM200001203420319; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; Vogel U, 2010, BACTERIAL POPULATION, P247; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wiuf C, 2001, MOL BIOL EVOL, V18, P1929, DOI 10.1093/oxfordjournals.molbev.a003733; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	84	53	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18441	10.1371/journal.pone.0018441	http://dx.doi.org/10.1371/journal.pone.0018441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541312	Green Published, Green Accepted, gold			2022-12-25	WOS:000290018400004
J	Prieto-Echague, V; Chan, PM; Craddock, BP; Manser, E; Miller, WT				Prieto-Echaguee, Victoria; Chan, Perry M.; Craddock, Barbara P.; Manser, Edward; Miller, W. Todd			PTB Domain-Directed Substrate Targeting in a Tyrosine Kinase from the Unicellular Choanoflagellate Monosiga brevicollis	PLOS ONE			English	Article							SRC FAMILY KINASES; SIGNALING PROPERTIES; EVOLUTION; PHOSPHORYLATION; RECOGNITION; SPECIFICITY; ACTIVATION; METAZOAN; ANIMALS; DIVERSE	Choanoflagellates are considered to be the closest living unicellular relatives of metazoans. The genome of the choanoflagellate Monosiga brevicollis contains a surprisingly high number and diversity of tyrosine kinases, tyrosine phosphatases, and phosphotyrosine-binding domains. Many of the tyrosine kinases possess combinations of domains that have not been observed in any multicellular organism. The role of these protein interaction domains in M. brevicollis kinase signaling is not clear. Here, we have carried out a biochemical characterization of Monosiga HMTK1, a protein containing a putative PTB domain linked to a tyrosine kinase catalytic domain. We cloned, expressed, and purified HMTK1, and we demonstrated that it possesses tyrosine kinase activity. We used immobilized peptide arrays to define a preferred ligand for the third PTB domain of HMTK1. Peptide sequences containing this ligand sequence are phosphorylated efficiently by recombinant HMTK1, suggesting that the PTB domain of HMTK1 has a role in substrate recognition analogous to the SH2 and SH3 domains of mammalian Src family kinases. We suggest that the substrate recruitment function of the noncatalytic domains of tyrosine kinases arose before their roles in autoinhibition.	[Prieto-Echaguee, Victoria; Craddock, Barbara P.; Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Sch Med, Stony Brook, NY 11794 USA; [Chan, Perry M.; Manser, Edward] Neurosci Res Partnership A Star, sGSK Grp, Singapore, Singapore	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Prieto-Echague, V (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Sch Med, Stony Brook, NY 11794 USA.	todd.miller@stonybrook.edu	Manser, Edward/ABD-2301-2020	Prieto-Echague, Victoria/0000-0001-9924-9591	National Institutes of Health [CA58530]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health grant CA58530 to W. T. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CASNELLIE JE, 1991, METHOD ENZYMOL, V200, P115; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Li WQ, 2008, J BIOL CHEM, V283, P15491, DOI 10.1074/jbc.M800002200; Li WQ, 2009, BIOCHEMISTRY-US, V48, P5180, DOI 10.1021/bi9000672; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Miller WT, 2003, ACCOUNTS CHEM RES, V36, P393, DOI 10.1021/ar020116v; Nars M, 2001, MOL BIOL EVOL, V18, P312, DOI 10.1093/oxfordjournals.molbev.a003807; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Pellicena P, 2002, FRONT BIOSCI-LANDMRK, V7, pD256, DOI 10.2741/pellicen; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Yadav SS, 2008, BIOCHEMISTRY-US, V47, P10871, DOI 10.1021/bi800930e; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Zhou Songyang, 1995, Nature (London), V373, P536	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19296	10.1371/journal.pone.0019296	http://dx.doi.org/10.1371/journal.pone.0019296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541291	gold, Green Published, Green Submitted			2022-12-25	WOS:000290018400044
J	Rainho, A; Palmeirim, JM				Rainho, Ana; Palmeirim, Jorge M.			The Importance of Distance to Resources in the Spatial Modelling of Bat Foraging Habitat	PLOS ONE			English	Article							HORSESHOE BAT; RHINOLOPHUS-MEHELYI; WATER AVAILABILITY; PLECOTUS-AURITUS; SELECTION; CHIROPTERA; LANDSCAPE; ECOLOGY; IMPACT; FLIGHT	Many bats are threatened by habitat loss, but opportunities to manage their habitats are now increasing. Success of management depends greatly on the capacity to determine where and how interventions should take place, so models predicting how animals use landscapes are important to plan them. Bats are quite distinctive in the way they use space for foraging because (i) most are colonial central-place foragers and (ii) exploit scattered and distant resources, although this increases flying costs. To evaluate how important distances to resources are in modelling foraging bat habitat suitability, we radio-tracked two cave-dwelling species of conservation concern (Rhinolophus mehelyi and Miniopterus schreibersii) in a Mediterranean landscape. Habitat and distance variables were evaluated using logistic regression modelling. Distance variables greatly increased the performance of models, and distance to roost and to drinking water could alone explain 86 and 73% of the use of space by M. schreibersii and R. mehelyi, respectively. Land-cover and soil productivity also provided a significant contribution to the final models. Habitat suitability maps generated by models with and without distance variables differed substantially, confirming the shortcomings of maps generated without distance variables. Indeed, areas shown as highly suitable in maps generated without distance variables proved poorly suitable when distance variables were also considered. We concluded that distances to resources are determinant in the way bats forage across the landscape, and that using distance variables substantially improves the accuracy of suitability maps generated with spatially explicit models. Consequently, modelling with these variables is important to guide habitat management in bats and similarly mobile animals, particularly if they are central-place foragers or depend on spatially scarce resources.	[Rainho, Ana; Palmeirim, Jorge M.] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal; [Rainho, Ana; Palmeirim, Jorge M.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Rainho, Ana] Inst Conservacao Nat & Biodiversidade, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Rainho, A (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal.	amrainho@fc.ul.pt	Rainho, Ana/K-5474-2014; Palmeirim, Jorge M/A-1323-2014	Rainho, Ana/0000-0001-8826-9458; Palmeirim, Jorge M/0000-0003-4734-8162	Fundacao para a Ciencia e Tecnologia [SFRH/BD/23800/2005]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Ana Rainho was supported by a PhD grant from Fundacao para a Ciencia e Tecnologia (SFRH/BD/23800/2005; http://alfa.fct.mctes.pt/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Arlettaz R, 2000, BIOL CONSERV, V93, P55, DOI 10.1016/S0006-3207(99)00112-3; Borralho R, 1998, IBIS, V140, P620, DOI 10.1111/j.1474-919X.1998.tb04707.x; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Bruun M, 2003, BIOL CONSERV, V114, P179, DOI 10.1016/S0006-3207(03)00021-1; Buchanan Bryant W., 2006, P192; Burke VJ, 2000, LANDSCAPE ECOL, V15, P1, DOI 10.1023/A:1008156303757; Constant P., 1957, Mammalia Paris, V21, P301; Daniel S, 2008, CAN J ZOOL, V86, P623, DOI 10.1139/Z08-041; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Dietz C, 2006, J MAMMAL, V87, P1241, DOI 10.1644/05-MAMM-A-299R2.1; Eastman J.R., 2003, IDRISI KILIMANJARO G; Franco AMA, 2004, BIOL CONSERV, V120, P63, DOI 10.1016/j.biocon.2004.01.026; Gaudioso Lacasa V, 2010, SMALL GAME WATER TRO; Gauthreaux Sidney A. Jr., 2006, P67; Greaves GJ, 2006, BIOL CONSERV, V132, P211, DOI 10.1016/j.biocon.2006.04.016; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; Holzkamper A, 2007, BIOL CONSERV, V136, P117, DOI 10.1016/j.biocon.2006.11.011; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hutson A. M., 2008, MINIOPTERUS SCHREIBE; Hutson AM, 2008, RHINOLOPHUS MEHELYI; IDRHa, 1999, CART CAP US SOL PORT; IGP, 2002, CART OC SOL COS 90; Jarvis A., 2008, HOLE FILLED SEAMLESS; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marques JT, 2004, ACTA CHIROPTEROL, V6, P99, DOI 10.3161/001.006.0108; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Milne DJ, 2006, BIOL CONSERV, V130, P370, DOI 10.1016/j.biocon.2005.12.031; Nemoz M, 2008, CONNAISSANCE CONSERV; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Olsson O, 2008, THEOR POPUL BIOL, V74, P22, DOI 10.1016/j.tpb.2008.04.005; Perry G, 2006, ECOLOGICAL CONSEQUEN, P164; Pocock MJO, 2008, J APPL ECOL, V45, P151, DOI 10.1111/j.1365-2664.2007.01361.x; Popa-Lisseanu AG, 2009, J ZOOL, V278, P126, DOI 10.1111/j.1469-7998.2009.00556.x; Rainho A, 2007, ACTA CHIROPTEROL, V9, P171, DOI 10.3161/1733-5329(2007)9[171:SFHOBI]2.0.CO;2; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; Russo D, 2005, J ZOOL, V266, P327, DOI 10.1017/S0952836905006990; Russo D, 2004, BIOL CONSERV, V117, P73, DOI 10.1016/S0006-3207(03)00266-0; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Salsamendi E, 2008, ACTA CHIROPTEROL, V10, P279, DOI 10.3161/150811008X414854; Santos CD, 2010, ACTA OECOL, V36, P166, DOI 10.1016/j.actao.2009.11.008; Sattler T, 2007, J APPL ECOL, V44, P1188, DOI 10.1111/j.1365-2664.2007.01328.x; Serra-Cobo J, 2000, ACTA THERIOL, V45, P347, DOI 10.4098/AT.arch.00-34; Speakman JR, 2003, BAT ECOLOGY, P430; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; SWIFT SM, 1983, J ZOOL, V200, P249, DOI 10.1111/j.1469-7998.1983.tb05787.x; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; USGS, 2004, EOS TERR ASTER IM; Webb PI, 1995, SYM ZOOL S, P203; WEBB PI, 1995, J ZOOL, V235, P269; White G.C., 1990, ANAL WILDLIFE RADIO; Wickramasinghe LP, 2003, J APPL ECOL, V40, P984, DOI 10.1111/j.1365-2664.2003.00856.x; Wilson KA, 2010, ECOL APPL, V20, P1721, DOI 10.1890/09-1051.1; Zarnetske PL, 2007, ECOL APPL, V17, P1714, DOI 10.1890/06-1312.1	67	93	94	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19227	10.1371/journal.pone.0019227	http://dx.doi.org/10.1371/journal.pone.0019227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547076	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800038
J	Vohradska, E; Vohradsky, J				Vohradska, Eliska; Vohradsky, Jiri			Virtual Mutagenesis of the Yeast Cyclins Genetic Network Reveals Complex Dynamics of Transcriptional Control Networks	PLOS ONE			English	Article							REGULATORY NETWORKS; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; BOOLEAN NETWORKS; MODEL; EXPRESSION; MULTISTATIONARITY; DIFFERENTIATION; IDENTIFICATION; CIRCUITS	Study of genetic networks has moved from qualitative description of interactions between regulators and regulated genes to the analysis of the interaction dynamics. This paper focuses on the analysis of dynamics of one particular network - the yeast cyclins network. Using a dedicated mathematical model of gene expression and a procedure for computation of the parameters of the model from experimental data, a complete numerical model of the dynamics of the cyclins genetic network was attained. The model allowed for performing virtual experiments on the network and observing their influence on the expression dynamics of the genes downstream in the regulatory cascade. Results show that when the network structure is more complicated, and the regulatory interactions are indirect, results of gene deletion are highly unpredictable. As a consequence of quantitative behavior of the genes and their connections within the network, causal relationship between a regulator and target gene may not be discovered by gene deletion. Without including the dynamics of the system into the network, its functional properties cannot be studied and interpreted correctly.	[Vohradska, Eliska; Vohradsky, Jiri] Inst Microbiol ASCR Vvi, Lab Bioinformat, Prague, Czech Republic; [Vohradska, Eliska] Fac Food & Biochem Technol, Inst Chem Technol, Prague, Czech Republic	Czech Academy of Sciences; University of Chemistry & Technology, Prague	Vohradska, E (corresponding author), Inst Microbiol ASCR Vvi, Lab Bioinformat, Prague, Czech Republic.	vohr@biomed.cas.cz			Czech Science Foundation [310/07/1009, P302/11/0229]; Institutional Research Concept [AV0Z50200510]	Czech Science Foundation(Grant Agency of the Czech Republic); Institutional Research Concept	Grants from the Czech Science Foundation, No. 310/07/1009, P302/11/0229 and Institutional Research Concept AV0Z50200510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2000, J COMPUT BIOL, V7, P331, DOI 10.1089/106652700750050817; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; BAHLER J, 2010, GENOME REGULATION FI; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barenco M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.84; Cuong CT, 2010, FASEB J, V24, P3468, DOI 10.1096/fj.10-160515; Davidich M, 2008, J THEOR BIOL, V255, P269, DOI 10.1016/j.jtbi.2008.07.020; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Honkela A, 2010, P NATL ACAD SCI USA, V107, P7793, DOI 10.1073/pnas.0914285107; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kim MS, 2010, BIOESSAYS, V32, P505, DOI 10.1002/bies.200900169; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; Matsuno H, 2000, Pac Symp Biocomput, P341; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Shmulevich I, 2009, METHOD ENZYMOL, V467, P335, DOI 10.1016/S0076-6879(09)67013-0; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Swain MT, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-459; SZALLASI Z, 1998, PAC S BIOCOMPUT, V16, P66; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Vandekerckhove J, 2006, GEN SIMULATED ANNEAL; Veitia RA, 2003, BIOL REV, V78, P149, DOI 10.1017/S1464793102006036; Vohradsky J, 2001, FASEB J, V15, P846, DOI 10.1096/fj.00-0361com; Vohradsky J, 2001, J BIOL CHEM, V276, P36168, DOI 10.1074/jbc.M104391200; Vu TT, 2007, NUCLEIC ACIDS RES, V35, P279, DOI 10.1093/nar/gkl1001; Vu TT, 2009, GENOMICS, V93, P426, DOI 10.1016/j.ygeno.2009.01.006; WUENSCHE A, 1993, GHOST MACHINE BASINS, P465	36	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18827	10.1371/journal.pone.0018827	http://dx.doi.org/10.1371/journal.pone.0018827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541341	gold, Green Published, Green Submitted			2022-12-25	WOS:000290016800020
J	Lauck, M; Hyeroba, D; Tumukunde, A; Weny, G; Lank, SM; Chapman, CA; O'Connor, DH; Friedrich, TC; Goldberg, TL				Lauck, Michael; Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Lank, Simon M.; Chapman, Colin A.; O'Connor, David H.; Friedrich, Thomas C.; Goldberg, Tony L.			Novel, Divergent Simian Hemorrhagic Fever Viruses in a Wild Ugandan Red Colobus Monkey Discovered Using Direct Pyrosequencing	PLOS ONE			English	Article							EQUINE ARTERITIS VIRUS; KIBALE NATIONAL-PARK; ALIGNMENT; SEQUENCE	Background: Simian hemorrhagic fever virus (SHFV) has caused lethal outbreaks of hemorrhagic disease in captive primates, but its distribution in wild primates has remained obscure. Here, we describe the discovery and genetic characterization by direct pyrosequencing of two novel, divergent SHFV variants co-infecting a single male red colobus monkey from Kibale National Park, Uganda. Methodology/Principal Findings: The viruses were detected directly from blood plasma using pyrosequencing, without prior virus isolation and with minimal PCR amplification. The two new SHFV variants, SHFV-krc1 and SHFV-krc2 are highly divergent from each other (51.9% nucleotide sequence identity) and from the SHFV type strain LVR 42-0/M6941 (52.0% and 51.8% nucleotide sequence identity, respectively) and demonstrate greater phylogenetic diversity within SHFV than has been documented within any other arterivirus. Both new variants nevertheless have the same 39 genomic architecture as the type strain, containing three open reading frames not present in the other arteriviruses. Conclusions/Significance: These results represent the first documentation of SHFV in a wild primate and confirm the unusual 39 genetic architecture of SHFV relative to the other arteriviruses. They also demonstrate a degree of evolutionary divergence within SHFV that is roughly equivalent to the degree of divergence between other arterivirus species. The presence of two such highly divergent SHFV variants co-infecting a single individual represents a degree of within-host viral diversity that exceeds what has previously been reported for any arterivirus. These results expand our knowledge of the natural history and diversity of the arteriviruses and underscore the importance of wild primates as reservoirs for novel pathogens.	[Lauck, Michael; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Hyeroba, David; Chapman, Colin A.] Jane Goodall Inst, Entebbe, Uganda; [Hyeroba, David; Tumukunde, Alex; Weny, Geoffrey; Goldberg, Tony L.] Makerere Univ, Biol Field Stn, Kibale EcoHlth Project, Kanyawara, Uganda; [Lank, Simon M.; O'Connor, David H.; Friedrich, Thomas C.; Goldberg, Tony L.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, Sch Environm, Montreal, PQ, Canada; [Chapman, Colin A.; Goldberg, Tony L.] Makerere Univ, Dept Biol, Kampala, Uganda; [Friedrich, Thomas C.; Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Makerere University; McGill University; McGill University; Makerere University; University of Wisconsin System; University of Wisconsin Madison	Lauck, M (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.	tgoldberg@vetmed.wisc.edu	Chapman, Colin/S-1911-2019	Chapman, Colin/0000-0002-8827-8140; Friedrich, Thomas/0000-0001-9831-6895; o'connor, david/0000-0003-2139-470X	University of Wisconsin School of Medicine and Public Health through Wisconsin Center for Infectious Disease (WisCID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098420] Funding Source: NIH RePORTER	University of Wisconsin School of Medicine and Public Health through Wisconsin Center for Infectious Disease (WisCID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the University of Wisconsin School of Medicine and Public Health from The Wisconsin Partnership Program through the Wisconsin Center for Infectious Disease (WisCID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CAVANAGH D, 1994, ARCH VIROL, V135, P227, DOI 10.1007/BF01309782; Chapman CA, 2005, INT J PRIMATOL, V26, P539, DOI 10.1007/s10764-005-4365-z; Chapman CA, 2000, BEHAV ECOL SOCIOBIOL, V47, P129, DOI 10.1007/s002650050003; DALGARD DW, 1992, LAB ANIM SCI, V42, P152; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Godeny EK, 1998, J VIROL, V72, P862, DOI 10.1128/JVI.72.1.862-867.1998; GODENY EK, 1993, VIROLOGY, V194, P585, DOI 10.1006/viro.1993.1298; Godeny EK, 2002, COMPARATIVE MED, V52, P229; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; GRAVELL M, 1986, P SOC EXP BIOL MED, V181, P112; Hanada K, 2005, MOL BIOL EVOL, V22, P1024, DOI 10.1093/molbev/msi089; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; LONDON WT, 1977, NATURE, V268, P344, DOI 10.1038/268344a0; Mittelholzer C, 2006, J VET MED B, V53, P55, DOI 10.1111/j.1439-0450.2006.00916.x; PALMER AE, 1968, AM J TROP MED HYG, V17, P404, DOI 10.4269/ajtmh.1968.17.404; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Snijder EJ, 1998, J GEN VIROL, V79, P961, DOI 10.1099/0022-1317-79-5-961; Stadejek T, 2006, ACTA VET HUNG, V54, P263, DOI 10.1556/AVet.54.2006.2.12; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; SWOFFORD DL, 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAURASO NM, 1968, AM J TROP MED HYG, V17, P422, DOI 10.4269/ajtmh.1968.17.422	27	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19056	10.1371/journal.pone.0019056	http://dx.doi.org/10.1371/journal.pone.0019056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544192	Green Published, gold			2022-12-25	WOS:000290015800038
J	Skuginna, V; Lech, M; Allam, R; Ryu, M; Clauss, S; Susanti, HE; Rommele, C; Garlanda, C; Mantovani, A; Anders, HJ				Skuginna, Veronika; Lech, Maciej; Allam, Ramanjaneyulu; Ryu, Mi; Clauss, Sebastian; Susanti, Heni Eka; Roemmele, Christoph; Garlanda, Cecilia; Mantovani, Alberto; Anders, Hans-Joachim			Toll-Like Receptor Signaling and SIGIRR in Renal Fibrosis upon Unilateral Ureteral Obstruction	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; KIDNEY INJURY; CELLS; TLR4; INFLAMMATION; MICE; NEPHROPATHY; RECOGNITION; TIR8/SIGIRR; FAILURE	Innate immune activation via IL-1R or Toll-like receptors (TLR) contibutes to acute kidney injury but its role in tissue remodeling during chronic kidney disease is unclear. SIGIRR is an inhibitor of TLR-induced cytokine and chemokine expression in intrarenal immune cells, therefore, we hypothesized that Sigirr-deficiency would aggravate postobstructive renal fibrosis. The expression of TLRs as well as endogenous TLR agonists increased within six days after UUO in obstructed compared to unobstructed kidneys while SIGIRR itself was downregulated by day 10. However, lack of SIGIRR did not affect the intrarenal mRNA expression of proinflammatory and profibrotic mediators as well as the numbers of intrarenal macrophages and T cells or morphometric markers of tubular atrophy and interstitial fibrosis. Because SIGIRR is known to block TLR/IL-1R signaling at the level of the intracellular adaptor molecule MyD88 UUO experiments were also performed in mice deficient for either MyD88, TLR2 or TLR9. After UUO there was no significant change of tubular interstitial damage and interstitial fibrosis in neither of these mice compared to wildtype counterparts. Additional in-vitro studies with CD90+ renal fibroblasts revealed that TLR agonists induce the expression of IL-6 and MCP-1/CCL2 but not of TGF-beta, collagen-1 alpha or smooth muscle actin. Together, postobstructive renal interstitial fibrosis and tubular atrophy develop independent of SIGIRR, TLR2, TLR9, and MyD88. These data argue against a significant role of these molecules in renal fibrosis.	[Skuginna, Veronika; Lech, Maciej; Allam, Ramanjaneyulu; Ryu, Mi; Clauss, Sebastian; Susanti, Heni Eka; Roemmele, Christoph; Anders, Hans-Joachim] Univ Munich, Med Poliklin, Dept Nephrol, D-8000 Munich, Germany; [Clauss, Sebastian] Univ Munich, Med Klin & Poliklin Grosshadern 1, Munich, Germany; [Garlanda, Cecilia; Mantovani, Alberto] Ist Clin Humanitas, Rozzano, Italy; [Garlanda, Cecilia; Mantovani, Alberto] Fdn Humanitas Ric, Rozzano, Italy	University of Munich; University of Munich; IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital	Skuginna, V (corresponding author), Univ Munich, Med Poliklin, Dept Nephrol, Pettenkoferstr 8A, D-8000 Munich, Germany.	hjanders@med.uni-muenchen.de	Garlanda, Cecilia/K-4601-2016; Clauss, Sebastian/HDL-7189-2022; Lech, Maciej/AAJ-7899-2021; Anders, Hans-Joachim/ABD-6247-2021; Allam, Ramanjaneyulu/N-4053-2016; Römmele, Christoph/GLN-4996-2022; Mantovani, Alberto/HCI-7449-2022	Garlanda, Cecilia/0000-0002-1510-7703; Clauss, Sebastian/0000-0002-5675-6128; Lech, Maciej/0000-0002-4293-2733; Allam, Ramanjaneyulu/0000-0002-2789-3596; Römmele, Christoph/0000-0002-8745-8510; Mantovani, Alberto/0000-0001-5578-236X; Anders, Hans-Joachim/0000-0003-2434-2956; Susanti, Eka/0000-0003-3713-3707	Deutsche Forschungsgemeinschaft [AN371/10-1, GRK1202]; Medical Faculty, University of Munich, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty, University of Munich, Germany	Grants from the Deutsche Forschungsgemeinschaft (AN371/10-1 and GRK1202) to ML and HJA. VS CR and RA were graduate fellows of the GRK 1202. SC was supported by the Molecular Medicine program of the Medical Faculty, University of Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2009, IMMUNOL REV, V227, P5, DOI 10.1111/j.1600-065X.2008.00739.x; Anders HJ, 2007, KIDNEY INT, V72, P1051, DOI 10.1038/sj.ki.5002436; Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Campbell MT, 2009, J SURG RES; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chowdhury P, 2010, NEPHRON EXP NEPHROL, V115, pE122, DOI 10.1159/000313493; Clayton A, 1997, J AM SOC NEPHROL, V8, pA2385; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0308680101; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; GONG J, 2009, J STRUCT BIOL; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Higgins DF, 2003, KIDNEY INT, V64, P2079, DOI 10.1046/j.1523-1755.2003.00306.x; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lech M, 2007, KIDNEY INT, V72, P182, DOI 10.1038/sj.ki.5002293; LECH M, 2009, J PATHOL; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lech M, 2009, J IMMUNOL, V183, P4109, DOI 10.4049/jimmunol.0900118; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lichtnekert J, 2009, AM J PHYSIOL-RENAL, V296, pF867, DOI 10.1152/ajprenal.90213.2008; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Ninichuk V, 2005, J AM SOC NEPHROL, V16, P977, DOI 10.1681/ASN.2004100871; Ninichuk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5163, DOI 10.2741/3072; Ninichuk V, 2007, AM J PATHOL, V170, P1267, DOI 10.2353/ajpath.2007.060937; Noris M, 2009, J IMMUNOL, V183, P4249, DOI 10.4049/jimmunol.0803549; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Patole PS, 2005, KIDNEY INT, V68, P2582, DOI 10.1111/j.1523-1755.2005.00729.x; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; RUSAI K, 2010, PEDIAT NEPHROL; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325; Wang SJ, 2010, DIS MODEL MECH, V3, P92, DOI 10.1242/dmm.003533; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	44	40	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19204	10.1371/journal.pone.0019204	http://dx.doi.org/10.1371/journal.pone.0019204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544241	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800052
J	Chambers, KF; Pearson, JF; Aziz, N; O'Toole, P; Garrod, D; Lang, SH				Chambers, Karen F.; Pearson, Joanna F.; Aziz, Naveed; O'Toole, Peter; Garrod, David; Lang, Shona H.			Stroma Regulates Increased Epithelial Lateral Cell Adhesion in 3D Culture: A Role for Actin/Cadherin Dynamics	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; HUMAN PROSTATE; ADHERENS JUNCTION; MORPHOGENESIS; EXPRESSION; MECHANISM; PATHWAYS; TISSUE; ACTIN	Background: Cell shape and tissue architecture are controlled by changes to junctional proteins and the cytoskeleton. How tissues control the dynamics of adhesion and cytoskeletal tension is unclear. We have studied epithelial tissue architecture using 3D culture models and found that adult primary prostate epithelial cells grow into hollow acinus-like spheroids. Importantly, when co-cultured with stroma the epithelia show increased lateral cell adhesions. To investigate this mechanism further we aimed to: identify a cell line model to allow repeatable and robust experiments; determine whether or not epithelial adhesion molecules were affected by stromal culture; and determine which stromal signalling molecules may influence cell adhesion in 3D epithelial cell cultures. Methodology/Principal Findings: The prostate cell line, BPH-1, showed increased lateral cell adhesion in response to stroma, when grown as 3D spheroids. Electron microscopy showed that 9.4% of lateral membranes were within 20 nm of each other and that this increased to 54% in the presence of stroma, after 7 days in culture. Stromal signalling did not influence E-cadherin or desmosome RNA or protein expression, but increased E-cadherin/actin co-localisation on the basolateral membranes, and decreased paracellular permeability. Microarray analysis identified several growth factors and pathways that were differentially expressed in stroma in response to 3D epithelial culture. The upregulated growth factors TGF beta 2, CXCL12 and FGF10 were selected for further analysis because of previous associations with morphology. Small molecule inhibition of TGF beta 2 signalling but not of CXCL12 and FGF10 signalling led to a decrease in actin and E-cadherin co-localisation and increased paracellular permeability. Conclusions/Significance: In 3D culture models, paracrine stromal signals increase epithelial cell adhesion via adhesion/cytoskeleton interactions and TGF beta 2-dependent mechanisms may play a key role. These findings indicate a role for stroma in maintaining adult epithelial tissue morphology and integrity.	[Chambers, Karen F.; Pearson, Joanna F.; Lang, Shona H.] Univ York, Dept Biol, YCR Canc Res Unit, York YO10 5DD, N Yorkshire, England; [Aziz, Naveed] Univ York, Dept Biol, Genom Lab, Technol Facil, York YO10 5DD, N Yorkshire, England; [O'Toole, Peter] Univ York, Dept Biol, Imaging & Cytometry Lab, Technol Facil, York YO10 5DD, N Yorkshire, England; [Garrod, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Garrod, David] King Saud Univ, Riyadh, Saudi Arabia	University of York - UK; University of York - UK; University of York - UK; University of Manchester; King Saud University	Chambers, KF (corresponding author), Univ York, Dept Biol, YCR Canc Res Unit, York YO10 5DD, N Yorkshire, England.	lang.short@talktalk.net	Lang, Shona Helen/M-8397-2019	Lang, Shona Helen/0000-0002-4883-8393; Garrod, David/0000-0003-0300-3947; O'Toole, Peter John/0000-0001-5295-2001; Chambers, Karen/0000-0002-6216-4794	Wellcome Trust [GR076612MA]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E021409/1]; BBSRC [BB/E021409/1] Funding Source: UKRI; MRC [G0700074] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021409/1] Funding Source: researchfish; Medical Research Council [G0700074] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust [GR076612MA] and Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E021409/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Berry PA, 2008, MOL CELL ENDOCRINOL, V288, P30, DOI 10.1016/j.mce.2008.02.024; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Blanchere M, 2001, PROSTATE, V46, P311, DOI 10.1002/1097-0045(20010301)46:4<311::AID-PROS1038>3.0.CO;2-2; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chambers KF, 2009, PROSTATE, V69, P1411, DOI 10.1002/pros.20986; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Cook BD, 2008, J CELL BIOCHEM, V105, P1367, DOI 10.1002/jcb.21935; Cowell HE, 1999, INT J CANCER, V80, P455; Danielpour D, 2005, EUR J CANCER, V41, P846, DOI 10.1016/j.ejca.2004.12.027; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Donjacour AA, 2003, DEV BIOL, V261, P39, DOI 10.1016/S0012-1606(03)00250-1; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Grammont M, 2007, J CELL BIOL, V177, P139, DOI 10.1083/jcb.200609079; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; HAYWARD SW, 1992, J CELL SCI, V102, P361; Howe KL, 2005, AM J PATHOL, V167, P1587, DOI 10.1016/S0002-9440(10)61243-6; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Komarova Y, 2008, DEV CELL, V15, P335, DOI 10.1016/j.devcel.2008.08.016; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Lang SH, 1999, CLIN EXP METASTAS, V17, P333; Lang SH, 2001, CELL GROWTH DIFFER, V12, P631; Lang SH, 1998, PROSTATE, V34, P203, DOI 10.1002/(SICI)1097-0045(19980215)34:3<203::AID-PROS8>3.0.CO;2-I; Lang SH, 2000, BRIT J CANCER, V82, P990, DOI 10.1054/bjoc.1999.1029; Lang SH, 2002, PROSTATE, V52, P253, DOI 10.1002/pros.10088; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Pearson JF, 2009, CELL DEATH DIFFER, V16, P475, DOI 10.1038/cdd.2008.181; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Prins GS, 2008, DIFFERENTIATION, V76, P641, DOI 10.1111/j.1432-0436.2008.00277.x; Sai X, 2008, CURR BIOL, V18, P976, DOI 10.1016/j.cub.2008.05.049; Schmelz M, 2005, EUR J CELL BIOL, V84, P341, DOI 10.1016/j.ejcb.2004.12.019; Scotton CJ, 2002, CANCER RES, V62, P5930; Shiou SR, 2007, CANCER RES, V67, P1571, DOI 10.1158/0008-5472.CAN-06-1680; Sugimura Y, 1996, INT J DEV BIOL, V40, P941; Swamydas M, 2010, IN VITRO CELL DEV-AN, V46, P673, DOI 10.1007/s11626-010-9323-1; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015	59	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18796	10.1371/journal.pone.0018796	http://dx.doi.org/10.1371/journal.pone.0018796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533155	gold, Green Published, Green Submitted			2022-12-25	WOS:000289620100019
J	Vasquez, SX; Gao, F; Su, F; Grijalva, V; Pope, J; Martin, B; Stinstra, J; Masner, M; Shah, N; Weinstein, DM; Farias-Eisner, R; Reddy, ST				Vasquez, Sergio X.; Gao, Feng; Su, Feng; Grijalva, Victor; Pope, John; Martin, Bill; Stinstra, Jeroen; Masner, Matthew; Shah, Neha; Weinstein, David M.; Farias-Eisner, Robin; Reddy, Srinivasa T.			Optimization of MicroCT Imaging and Blood Vessel Diameter Quantitation of Preclinical Specimen Vasculature with Radiopaque Polymer Injection Medium	PLOS ONE			English	Article								Vascular networks within a living organism are complex, multi-dimensional, and challenging to image capture. Radio-angiographic studies in live animals require a high level of infrastructure and technical investment in order to administer costly perfusion mediums whose signals metabolize and degrade relatively rapidly, diminishing within a few hours or days. Additionally, live animal specimens must not be subject to long duration scans, which can cause high levels of radiation exposure to the specimen, limiting the quality of images that can be captured. Lastly, despite technological advances in live-animal specimen imaging, it is quite difficult to minimize or prevent movement of a live animal, which can cause motion artifacts in the final data output. It is demonstrated here that through the use of postmortem perfusion protocols of radiopaque silicone polymer mediums and ex-vivo organ harvest, it is possible to acquire a high level of vascular signal in preclinical specimens through the use of micro-computed tomographic (microCT) imaging. Additionally, utilizing high-order rendering algorithms, it is possible to further derive vessel morphometrics for qualitative and quantitative analysis.	[Vasquez, Sergio X.; Martin, Bill; Stinstra, Jeroen; Masner, Matthew; Shah, Neha; Weinstein, David M.] Numira Biosci, Salt Lake City, UT 84108 USA; [Gao, Feng; Su, Feng; Farias-Eisner, Robin; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Grijalva, Victor; Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Pope, John] Integrated Syst Lab, Durham, NC USA; [Reddy, Srinivasa T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vasquez, SX (corresponding author), Numira Biosci, Salt Lake City, UT 84108 USA.	svasquez@numirabio.com			Women's Endowment; Roberta Deutsch Family Foundation; Joan English Fund for Women's Cancer Research; Ovarian Cancer Coalition; Helen Beller Foundation; USPHS [HL-082823]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082823] Funding Source: NIH RePORTER	Women's Endowment; Roberta Deutsch Family Foundation; Joan English Fund for Women's Cancer Research; Ovarian Cancer Coalition; Helen Beller Foundation; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funds from the Women's Endowment, Carl and Roberta Deutsch Family Foundation, the Joan English Fund for Women's Cancer Research, the Ovarian Cancer Coalition, the Helen Beller Foundation, and USPHS grant HL-082823 (STR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGER AC, 1966, ANN NY ACAD SCI, V139, P276, DOI 10.1111/j.1749-6632.1966.tb41202.x; Bui T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013082; Butcher JT, 2007, DEV DYNAM, V236, P802, DOI 10.1002/dvdy.20962; Ciszek B, 2007, J ANAT, V211, P53, DOI 10.1111/j.1469-7580.2007.00753.x; Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102; Hoff J, 2000, LAB ANIMAL, V29, P47; JIA Y, 2010, J NEUROSCI METHODS; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Liu P, 2010, J SYNCHROTRON RADIAT, V17, P517, DOI 10.1107/S0909049510018832; Malyar NM, 2004, AM J PHYSIOL-HEART C, V286, pH2386, DOI 10.1152/ajpheart.00682.2003; Moritz R, 2010, J COMPUT ASSIST TOMO, V34, P273, DOI 10.1097/RCT.0b013e3181bb0d32; Namati E, 2010, MED PHYS, V37, P4793, DOI 10.1118/1.3476454; RAGAN DK, 2010, NMR BIOMED; Rao B, 2010, OPT LETT, V35, P1521, DOI 10.1364/OL.35.001521; Savai R, 2009, NEOPLASIA, V11, P48, DOI 10.1593/neo.81036; Schambach SJ, 2010, METHODS, V50, P26, DOI 10.1016/j.ymeth.2009.09.003	16	44	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e19099	10.1371/journal.pone.0019099	http://dx.doi.org/10.1371/journal.pone.0019099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533123	Green Published, gold			2022-12-25	WOS:000289620100035
J	Yatsushiro, S; Akamine, R; Yamamura, S; Hino, M; Kajimoto, K; Abe, K; Abe, H; Kido, J; Tanaka, M; Shinohara, Y; Baba, Y; Ooie, T; Kataoka, M				Yatsushiro, Shouki; Akamine, Rie; Yamamura, Shohei; Hino, Mami; Kajimoto, Kazuaki; Abe, Kaori; Abe, Hiroko; Kido, Jun-ichi; Tanaka, Masato; Shinohara, Yasuo; Baba, Yoshinobu; Ooie, Toshihiko; Kataoka, Masatoshi			Quantitative Analysis of Serum Procollagen Type I C-Terminal Propeptide by Immunoassay on Microchip	PLOS ONE			English	Article							HUMAN PLASMA; MARKER; SYSTEM; BLOOD; INTEGRATION; SEPARATION; PROTEOME	Background: Sandwich enzyme-linked immunosorbent assay (ELISA) is one of the most frequently employed assays for clinical diagnosis, since this enables the investigator to identify specific protein biomarkers. However, the conventional assay using a 96-well microtitration plate is time-and sample-consuming, and therefore is not suitable for rapid diagnosis. To overcome these drawbacks, we performed a sandwich ELISA on a microchip. Methods and Findings: The microchip was made of cyclic olefin copolymer with straight microchannels that were 300 mu m wide and 100 mu m deep. For the construction of a sandwich ELISA for procollagen type I C-peptide (PICP), a biomarker for bone formation, we used a piezoelectric inkjet printing system for the deposition and fixation of the 1st anti-PICP antibody on the surface of the microchannel. After the infusion of the mixture of 2.0 mu l of peroxidase-labeled 2nd anti-PICP antibody and 0.4 mu l of sample to the microchannel and a 30-min incubation, the substrate for peroxidase was infused into the microchannel; and the luminescence intensity of each spot of 1st antibody was measured by CCD camera. A linear relationship was observed between PICP concentration and luminescence intensity over the range of 0 to 600 ng/ml (r(2) = 0.991), and the detection limit was 4.7 ng/ml. Blood PICP concentrations of 6 subjects estimated from microchip were compared with results obtained by the conventional method. Good correlation was observed between methods according to simple linear regression analysis (R-2 = 0.9914). The within-day and between-days reproducibilities were 3.2-7.4 and 4.4-6.8%, respectively. This assay reduced the time for the antigen-antibody reaction to 1/6, and the consumption of samples and reagents to 1/50 compared with the conventional method. Conclusion: This assay enabled us to determine serum PICP with accuracy, high sensitivity, time saving ability, and low consumption of sample and reagents, and thus will be applicable to clinic diagnosis.	[Yatsushiro, Shouki; Akamine, Rie; Yamamura, Shohei; Hino, Mami; Kajimoto, Kazuaki; Abe, Kaori; Abe, Hiroko; Tanaka, Masato; Baba, Yoshinobu; Ooie, Toshihiko; Kataoka, Masatoshi] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tokyo, Japan; [Kido, Jun-ichi] Univ Tokushima, Inst Hlth Biosci, Dept Periodontol & Endodontol Oral & Maxillofacia, Div Medicodent Dynam & Reconstruct, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 770, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Tokushima University; Tokushima University; Nagoya University	Yatsushiro, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tokyo, Japan.	m-kataoka@aist.go.jp	Ooie, Toshihiko/J-1498-2018; Tanaka, Masato/P-6700-2016; Kataoka, Masatoshi/M-6925-2018; YATSUSHIRO, shouki/M-8155-2018; Kajimoto, Kazuaki/L-6418-2018; Kajimoto, Kazuaki/A-3799-2012; Abe, Hiroko/L-2116-2018; yamamura, shohei/M-8071-2018	Ooie, Toshihiko/0000-0001-8725-0691; Tanaka, Masato/0000-0002-6164-7786; Kataoka, Masatoshi/0000-0001-9779-8319; YATSUSHIRO, shouki/0000-0002-6123-1561; Kajimoto, Kazuaki/0000-0002-1636-4154; Abe, Hiroko/0000-0003-1779-6212; yamamura, shohei/0000-0002-4971-4560				Abe K, 2008, ANAL CHEM, V80, P6928, DOI 10.1021/ac800604v; Allain LR, 2004, ANAL CHIM ACTA, V518, P77, DOI 10.1016/j.aca.2004.04.065; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Briggs C, 2008, BRIT J HAEMATOL, V142, P904, DOI 10.1111/j.1365-2141.2008.07274.x; Di Serio F, 2006, CLIN CHEM LAB MED, V44, P768, DOI 10.1515/CCLM.2006.125; Doraiswamy A, 2009, J BIOMED MATER RES B, V89B, P28, DOI 10.1002/jbm.b.31183; Hasenbank MS, 2008, ANAL CHIM ACTA, V611, P80, DOI 10.1016/j.aca.2008.01.048; Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284; KOHDA K, 1991, GUT, V32, P624, DOI 10.1136/gut.32.6.624; Maeda E, 2008, ELECTROPHORESIS, V29, P1902, DOI 10.1002/elps.200700688; Maeda E, 2007, ELECTROPHORESIS, V28, P2927, DOI 10.1002/elps.200600795; Merrin J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000663; Mohamadi MR, 2007, ANAL CHEM, V79, P3667, DOI 10.1021/ac0623890; Ohashi T, 2009, LAB CHIP, V9, P991, DOI 10.1039/b815475a; PARFITT AM, 1987, J BONE MINER RES, V2, P427; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; RISTELI J, 1991, CALCIFIED TISSUE INT, V49, pS24, DOI 10.1007/BF02555083; Sato K, 2004, LAB CHIP, V4, P570, DOI 10.1039/b411356j; Sato K, 2002, ELECTROPHORESIS, V23, P734, DOI 10.1002/1522-2683(200203)23:5<734::AID-ELPS734>3.0.CO;2-W; Sato K, 2001, ANAL CHEM, V73, P1213, DOI 10.1021/ac000991z; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; St-Louis P, 2000, CLIN BIOCHEM, V33, P427, DOI 10.1016/S0009-9120(00)00138-7; Stewart Thomas N., 2009, Biotechnology Journal, V4, P206, DOI 10.1002/biot.200800234; Tachi T, 2009, ANAL SCI, V25, P149, DOI 10.2116/analsci.25.149; Tachi T, 2009, LAB CHIP, V9, P966, DOI 10.1039/b813640h; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; Thadikkaran L, 2005, PROTEOMICS, V5, P3019, DOI 10.1002/pmic.200402053; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; von Lode P, 2005, CLIN BIOCHEM, V38, P591, DOI 10.1016/j.clinbiochem.2005.03.008; Wehmeier M, 2006, CLIN CHEM LAB MED, V44, P888, DOI 10.1515/CCLM.2006.141; Yasukawa T, 2007, BIOSENS BIOELECTRON, V22, P2730, DOI 10.1016/j.bios.2006.11.010	31	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18807	10.1371/journal.pone.0018807	http://dx.doi.org/10.1371/journal.pone.0018807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533125	Green Submitted, Green Published, gold			2022-12-25	WOS:000289458800047
J	Francisco, AB; Singh, R; Sha, HB; Yan, X; Qi, L; Lei, XG; Long, QM				Francisco, Adam B.; Singh, Rajni; Sha, Haibo; Yan, Xi; Qi, Ling; Lei, Xingen; Long, Qiaoming			Haploid Insufficiency of Suppressor Enhancer Lin12 1-like (SEL1L) Protein Predisposes Mice to High Fat Diet-induced Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BETA-CELL APOPTOSIS; QUALITY-CONTROL; INSULIN-RESISTANCE; DIABETES-MELLITUS; MOUSE MODEL; ER STRESS; TYPE-2; GENE; EXPRESSION	Increasing evidence suggests that endoplasmic reticulum (ER) stress plays an important role in the pathogenesis of type 2 diabetes mellitus. SEL1L is an ER membrane protein that is highly expressed in the pancreatic islet and acinar cells. We have recently reported that a deficiency of SEL1L causes systemic ER stress and leads to embryonic lethality in mice. Here we show that mice with one functional allele of Sel1l (Sel1l(+/-)) are more susceptible to high fat diet (HFD)-induced hyperglycemia. Sel1l(+/-) mice have a markedly reduced beta-cell mass as a result of decreased beta-cell proliferation. Consequently, Sel1l(+/-) mice are severely glucose-intolerant and exhibit significantly retarded glucose-stimulated insulin secretion. Pancreatic islets from Sel1l(+/-) mice stimulated with a high concentration of glucose in vitro express significantly higher levels of unfolded protein response genes than those from wild-type control mice. Furthermore, dominant-negative interference of SEL1L function in insulinoma cell lines severely impairs, whereas overexpression of SEL1L efficiently improves protein secretion. Taken together, our results indicate that haploid insufficiency of SEL1L predispose mice to high fat diet-induced hyperglycemia. Our findings highlight a critical and previously unknown function for SEL1L in regulating adult beta-cell function and growth.	[Francisco, Adam B.; Singh, Rajni; Sha, Haibo; Yan, Xi; Qi, Ling; Lei, Xingen; Long, Qiaoming] Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, Ithaca, NY 14850 USA	Cornell University	Long, QM (corresponding author), Cornell Univ, Dept Anim Sci, Coll Agr & Life Sci, 321 Morrison Hall, Ithaca, NY 14850 USA.	ql39@cornell.edu	Long, Qiaoming/L-5074-2017	Long, Qiaoming/0000-0001-8243-589X; Qi, Ling/0000-0001-8229-0184; Francisco, Adam B./0000-0001-8462-6569	College of Agriculture and Life Sciences; Vertebrate Functional Genomics Center, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER	College of Agriculture and Life Sciences; Vertebrate Functional Genomics Center, Cornell University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the College of Agriculture and Life Sciences and the Vertebrate Functional Genomics Center, Cornell University (to Q. L.).	Akiyama M, 2009, DIABETOLOGIA, V52, P653, DOI 10.1007/s00125-009-1270-6; Badr CE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000571; Biunno I, 1997, GENOMICS, V46, P284, DOI 10.1006/geno.1997.5018; Biunno I, 2006, J CELL PHYSIOL, V208, P23, DOI 10.1002/jcp.20574; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633; Cattaneo M, 2008, J CELL PHYSIOL, V215, P794, DOI 10.1002/jcp.21364; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Donoviel DB, 1998, MECH DEVELOP, V78, P203, DOI 10.1016/S0925-4773(98)00146-4; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2001, COLD SPRING HARB SYM, V66, P499, DOI 10.1101/sqb.2001.66.499; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Li SA, 2010, FEBS LETT, V584, P4121, DOI 10.1016/j.febslet.2010.08.042; Li SA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-19; Lipson KL, 2006, CURR MOL MED, V6, P71, DOI 10.2174/156652406775574613; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; ORCI L, 1986, J CELL BIOL, V103, P2273, DOI 10.1083/jcb.103.6.2273; Oresic K, 2009, BIOSCIENCE REP, V29, P173, DOI 10.1042/BSR20080143; Ortsater H, 2007, MOL CELL ENDOCRINOL, V277, P1, DOI 10.1016/j.mce.2007.06.006; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Rajan SS, 2007, INDIAN J MED RES, V125, P411; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P269, DOI 10.1080/10409230500315352; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002	54	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22275	22282		10.1074/jbc.M111.239418	http://dx.doi.org/10.1074/jbc.M111.239418			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536682	Green Published, hybrid			2022-12-25	WOS:000291719900035
J	Holbourn, KP; Malfois, M; Acharya, KR				Holbourn, Kenneth P.; Malfois, Marc; Acharya, K. Ravi			First Structural Glimpse of CCN3 and CCN5 Multifunctional Signaling Regulators Elucidated by Small Angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-GROWTH-FACTOR; VASCULAR ENDOTHELIAL-CELLS; IMMEDIATE-EARLY GENE; CRYSTAL-STRUCTURE; LAYERED FOLD; FAMILY; PROTEINS; NOV; EXPRESSION; DOMAINS	The CCN (cyr61, ctgf, nov) proteins (CCN1-6) are an important family of matricellular regulatory factors involved in internal and external cell signaling. They are central to essential biological processes such as adhesion, proliferation, angiogenesis, tumorigenesis, wound healing, and modulation of the extracellular matrix. They possess a highly conserved modular structure with four distinct modules that interact with a wide range of regulatory proteins and ligands. However, at the structural level, little is known although their biological function(s) seems to require cooperation between individual modules. Here we present for the first time structural determinants of two of the CCN family members, CCN3 and CCN5 (expressed in Escherichia coli), using small angle x-ray scattering. The results provide a description of the overall molecular shape and possible general three-dimensional modular arrangement for CCN proteins. These data unequivocally provide insight of the nature of CCN protein(s) in solution and thus important insight into their structure-function relationships.	[Holbourn, Kenneth P.; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Malfois, Marc] Diamond Light Source, Didcot OX11 0DE, Oxon, England	University of Bath; Diamond Light Source	Acharya, KR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	K.R.Acharya@bath.ac.uk	Malfois, Marc/L-2974-2014	Malfois, Marc/0000-0001-5231-1896; Acharya, K. Ravi/0000-0002-3009-4058	Royal Society; Cancer Research UK through a Biological Sciences Committee [C397/A12744]	Royal Society(Royal Society of London); Cancer Research UK through a Biological Sciences Committee	This work was supported by a Royal Society Industry Fellowship and Cancer Research UK through a Biological Sciences Committee project grant award (C397/A12744) (to K.R.A.).	Adams JC, 2000, DEV DYNAM, V218, P280; Altschuler EL, 1997, J PEPT RES, V50, P73; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Arai R, 2004, PROTEINS, V57, P829, DOI 10.1002/prot.20244; Ayer-Lelievre C., 2001, Molecular Pathology, V54, P105, DOI 10.1136/mp.54.2.105; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brigstock DR, 1997, J BIOL CHEM, V272, P20275, DOI 10.1074/jbc.272.32.20275; Brigstock DR, 2003, J CLIN PATHOL-MOL PA, V56, P127, DOI 10.1136/mp.56.2.127; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Davies SR, 2007, ANN SURG ONCOL, V14, P1909, DOI 10.1245/s10434-007-9376-x; De Winter P, 2008, GROWTH FACTORS, V26, P80, DOI 10.1080/08977190802025602; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOBSON CM, 1990, NATURE, V348, P198, DOI 10.1038/348198a0; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Gygi D, 2003, BIOCHEM BIOPH RES CO, V311, P685, DOI 10.1016/j.bbrc.2003.10.061; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Holbourn KP, 2011, BIOCHEM BIOPH RES CO, V407, P837, DOI 10.1016/j.bbrc.2011.03.122; Holbourn KP, 2009, J CELL COMMUN SIGNAL, V3, P25, DOI 10.1007/s12079-009-0048-4; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kubota S, 2006, BIOCHIMIE, V88, P1973, DOI 10.1016/j.biochi.2006.07.007; Kumar S, 1999, J BIOL CHEM, V274, P17123, DOI 10.1074/jbc.274.24.17123; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 1999, P NATL ACAD SCI USA, V96, P869, DOI 10.1073/pnas.96.3.869; Perbal B, 2001, B CANCER, V88, P645; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal B, 2006, ADV EXP MED BIOL, V587, P23; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Rudresh, 2002, PROTEIN ENG, V15, P627, DOI 10.1093/protein/15.8.627; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1991, J APPL CRYSTALLOGR, V24, P485, DOI 10.1107/S0021889891001280; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; Tong ZY, 2006, J ENDOCRINOL, V188, pR1, DOI 10.1677/joe.1.06719; Tossavainen H, 2006, PROTEIN SCI, V15, P1760, DOI 10.1110/ps.052068506; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zuo GW, 2010, HISTOL HISTOPATHOL, V25, P795, DOI 10.14670/HH-25.795	62	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22243	22249		10.1074/jbc.M111.225755	http://dx.doi.org/10.1074/jbc.M111.225755			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543320	hybrid, Green Published			2022-12-25	WOS:000291719900032
J	Braidy, N; Guillemin, GJ; Mansour, H; Chan-Ling, T; Poljak, A; Grant, R				Braidy, Nady; Guillemin, Gilles J.; Mansour, Hussein; Chan-Ling, Tailoi; Poljak, Anne; Grant, Ross			Age Related Changes in NAD plus Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							HISTONE H2AX PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASE; DNA-DAMAGE; CELL-DEATH; LIFE-SPAN; ACTIVATION; NICOTINAMIDE; FAMILY; PARP; INHIBITION	The cofactor nicotinamide adenine dinucleotide (NAD+) has emerged as a key regulator of metabolism, stress resistance and longevity. Apart from its role as an important redox carrier, NAD+ also serves as the sole substrate for NAD-dependent enzymes, including poly(ADP-ribose) polymerase (PARP), an important DNA nick sensor, and NAD-dependent histone deacetylases, Sirtuins which play an important role in a wide variety of processes, including senescence, apoptosis, differentiation, and aging. We examined the effect of aging on intracellular NAD+ metabolism in the whole heart, lung, liver and kidney of female wistar rats. Our results are the first to show a significant decline in intracellular NAD+ levels and NAD: NADH ratio in all organs by middle age (i.e. 12 months) compared to young (i.e. 3 month old) rats. These changes in [NAD(H)] occurred in parallel with an increase in lipid peroxidation and protein carbonyls (o- and m-tyrosine) formation and decline in total antioxidant capacity in these organs. An age dependent increase in DNA damage (phosphorylated H2AX) was also observed in these same organs. Decreased Sirt1 activity and increased acetylated p53 were observed in organ tissues in parallel with the drop in NAD+ and moderate over-expression of Sirt1 protein. Reduced mitochondrial activity of complex I-IV was also observed in aging animals, impacting both redox status and ATP production. The strong positive correlation observed between DNA damage associated NAD+ depletion and Sirt1 activity suggests that adequate NAD+ concentrations may be an important longevity assurance factor.	[Braidy, Nady; Guillemin, Gilles J.; Grant, Ross] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Fac Med, Sydney, NSW, Australia; [Guillemin, Gilles J.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Mansour, Hussein; Chan-Ling, Tailoi] Univ Sydney, Retinal & Dev Neurobiol Lab, Discipline Anat & Histol, Sch Med Sci, Sydney, NSW 2006, Australia; [Poljak, Anne] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Grant, Ross] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; Sydney Adventist Hospital	Braidy, N (corresponding author), Univ New S Wales, Dept Pharmacol, Sch Med Sci, Fac Med, Sydney, NSW, Australia.	r.grant@unsw.edu.au	Chan-Ling, Tailoi/X-2718-2019; Mansour, Hussein/S-2883-2019; Grant, Ross/H-1805-2015; Braidy, Nady/G-4928-2012; Chan-Ling, Tailoi/A-2177-2008; Guillemin, Gilles J/C-3878-2015	Mansour, Hussein/0000-0002-9559-3229; Chan-Ling, Tailoi/0000-0002-8225-3671; Guillemin, Gilles J/0000-0001-8105-4470; Poljak, Anne/0000-0001-9953-1984; Braidy, Nady/0000-0002-0497-5572	National Health and Medical Research Council of Australia; Rebecca Cooper Medical Research Foundation (Sydney, Australia); University of New South Wales; University of Sydney Medical Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Research Foundation (Sydney, Australia); University of New South Wales; University of Sydney Medical Foundation(University of Sydney)	This work was supported by grants to Professor Tailoi Chan-Ling from the National Health and Medical Research Council of Australia, and to Dr. Gilles J. Guillemin and Professor Tailoi Chan-Ling from the Rebecca Cooper Medical Research Foundation (Sydney, Australia). Nady Braidy is the recipient of an Australian Postgraduate Award at the University of New South Wales. Hussein Mansour is the recipient of a University of Sydney Medical Foundation/Bluesand Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Alvarez-Gonzalez R, FUNCTIONAL INTERACTI; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Behl C, 2002, BIOL CHEM, V383, P521, DOI 10.1515/BC.2002.053; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bradford MM, 1976, ANAL BIOCHEM, V53, P452, DOI DOI 10.1006/ABIO.1976; Braidy N, 2008, NEUROTOX RES, V13, P173, DOI 10.1007/BF03033501; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Burkle A, 2004, EXP GERONTOL, V39, P1599, DOI 10.1016/j.exger.2004.07.010; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; COLEMAN PD, 1989, NEUROBIOL AGING, V10, P115, DOI 10.1016/0197-4580(89)90019-5; COLLIER TJ, 1991, NEUROBIOL AGING, V12, P685, DOI 10.1016/0197-4580(91)90122-Z; Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Erdelyi K, 2005, CELL MOL LIFE SCI, V62, P751, DOI 10.1007/s00018-004-4506-0; Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763; Grant RS, 1998, J NEUROCHEM, V70, P1759; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang X, 2006, INT J ONCOL, V29, P495; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kiefmann R, 2004, INTENS CARE MED, V30, P1421, DOI 10.1007/s00134-004-2301-x; Kim MH, 2005, FASEB J, V19, pA1036; Koltai E, 2010, MECH AGEING DEV, V131, P21, DOI 10.1016/j.mad.2009.11.002; KUKIELKA E, 1989, ARCH BIOCHEM BIOPHYS, V275, P540, DOI 10.1016/0003-9861(89)90400-1; Lamming DW, 2004, MOL MICROBIOL, V53, P1003, DOI 10.1111/j.1365-2958.2004.04209.x; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Malanga M, 1998, J BIOL CHEM, V273, P11839, DOI 10.1074/jbc.273.19.11839; Marmorstein R, 2004, BIOCHEM SOC T, V32, P904, DOI 10.1042/BST0320904; Masoro EJ, 2004, MECH AGEING DEV, V125, P591, DOI 10.1016/j.mad.2004.08.011; Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0; Nakae D, 2000, LAB INVEST, V80, P249, DOI 10.1038/labinvest.3780028; Nestelbacher R, 2000, EXP GERONTOL, V35, P63, DOI 10.1016/S0531-5565(99)00087-X; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Poljak A, 2003, REDOX REP, V8, P371, DOI 10.1179/135100003225003401; Poljak A, 2000, REDOX REP, V5, P137, DOI 10.1179/135100000101535483; Putt KS, 2005, CHEMBIOCHEM, V6, P53, DOI 10.1002/cbic.200400330; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Radak Z, 2009, FREE RADICAL BIO MED, V46, P238, DOI 10.1016/j.freeradbiomed.2008.10.022; Radovits T, 2007, EXP GERONTOL, V42, P676, DOI 10.1016/j.exger.2007.01.013; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rebrin I, 2004, EXP GERONTOL, V39, P1513, DOI 10.1016/j.exger.2004.08.014; Rodriguez MI, 2008, EXP GERONTOL, V43, P749, DOI 10.1016/j.exger.2008.04.003; Roesner JP, 2006, INTENS CARE MED, V32, P1649, DOI 10.1007/s00134-006-0335-y; Sarkar D, 2006, CANC LETT, V236; Sauve AA, 2007, J PHARM EXP THER; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shevalye H, 2010, BBA-MOL BASIS DIS, V1802, P1020, DOI 10.1016/j.bbadis.2010.07.004; Sipos I, 2003, J NEUROCHEM, V84, P112, DOI 10.1046/j.1471-4159.2003.01513.x; Smith BC, 2006, STRUCTURE, V14, P1207, DOI 10.1016/j.str.2006.07.004; Smith JS, 2002, TRENDS CELL BIOL, V12, P404, DOI 10.1016/S0962-8924(02)02342-5; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Tanaka T, 2007, CYTOM PART A, V71A, P648, DOI 10.1002/cyto.a.20426; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Virag L, 1998, J IMMUNOL, V161, P3753; von Lukowicz T, 2008, CARDIOVASC RES, V78, P158, DOI 10.1093/cvr/cvm110; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	78	425	447	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19194	10.1371/journal.pone.0019194	http://dx.doi.org/10.1371/journal.pone.0019194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541336	Green Published, gold, Green Submitted			2022-12-25	WOS:000290018400031
J	Cheng, YW; Chou, KH; Fan, YT; Lin, CP				Cheng, Yawei; Chou, Kun-Hsien; Fan, Yang-Teng; Lin, Ching-Po			ANS: Aberrant Neurodevelopment of the Social Cognition Network in Adolescents with Autism Spectrum Disorders	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HIGH-FUNCTIONING AUTISM; MIRROR-NEURON SYSTEM; SEX-DIFFERENCES; HUMAN BRAIN; DEVELOPMENTAL DISORDERS; ORBITOFRONTAL CORTEX; MATTER VOLUME; GRAY-MATTER; HEAD GROWTH	Background: Autism spectrum disorders (ASD) are characterized by aberrant neurodevelopment. Although the ASD brain undergoes precocious growth followed by decelerated maturation during early postnatal period of childhood, the neuroimaging approach has not been empirically applied to investigate how the ASD brain develops during adolescence. Methodology/Principal Findings: We enrolled 25 male adolescents with high functioning ASD and 25 typically developing controls for voxel-based morphometric analysis of structural magnetic resonance image. Results indicate that there is an imbalance of regional gray matter volumes and concentrations along with no global brain enlargement in adolescents with high functioning ASD relative to controls. Notably, the right inferior parietal lobule, a role in social cognition, have a significant interaction of age by groups as indicated by absence of an age-related gain of regional gray matter volume and concentration for neurodevelopmental maturation during adolescence. Conclusions/Significance: The findings indicate the neural correlates of social cognition exhibits aberrant neurodevelopment during adolescence in ASD, which may cast some light on the brain growth dysregulation hypothesis. The period of abnormal brain growth during adolescence may be characteristic of ASD. Age effects must be taken into account while measures of structural neuroimaging have been clinically put forward as potential phenotypes for ASD.	[Cheng, Yawei; Chou, Kun-Hsien; Fan, Yang-Teng; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Cheng, Yawei] Natl Yang Ming Univ Hosp, Dept Phys Med & Rehabil, Yilan, Taiwan	National Yang Ming Chiao Tung University	Cheng, YW (corresponding author), Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan.	cplin@ym.edu.tw			National Science Council [NSC 99-2314-B-010-037-MY3, NSC 99-2517-S-004-001-MY3, NSC 99-2923-B-010-001-MY3]; National Yang-Ming University Hospital [RD2011-005]; Academia Sinica [AS-99-TP-AC1]; National Healthy Research Institute [NHRI-EX98-9813EC]; Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University Hospital; Academia Sinica(Academia Sinica - Taiwan); National Healthy Research Institute; Ministry of Education	The study was funded in part by National Science Council (NSC 99-2314-B-010-037-MY3; NSC 99-2517-S-004-001-MY3; NSC 99-2923-B-010-001-MY3), National Yang-Ming University Hospital (RD2011-005), Academia Sinica (AS-99-TP-AC1), National Healthy Research Institute (NHRI-EX98-9813EC) and a grant from the Ministry of Education (A grant from Ministry of Education, Aim for the Top University Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akshoomoff N, 2002, DEV PSYCHOPATHOL, V14, P613, DOI 10.1017/S0954579402003115; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ashburner J, 1997, NEUROIMAGE, V6, P209, DOI 10.1006/nimg.1997.0290; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bailey A, 1996, J CHILD PSYCHOL PSYC, V37, P89, DOI 10.1111/j.1469-7610.1996.tb01381.x; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Blumenthal JD, 2002, NEUROIMAGE, V16, P89, DOI 10.1006/nimg.2002.1076; Bonilha L, 2008, BRAIN DEV-JPN, V30, P396, DOI 10.1016/j.braindev.2007.11.006; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2010, NEUROIMAGE, V50, P873, DOI 10.1016/j.neuroimage.2010.01.011; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Dawson G, 2007, BIOL PSYCHIAT, V61, P458, DOI 10.1016/j.biopsych.2006.07.016; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dementieva YA, 2005, PEDIATR NEUROL, V32, P102, DOI 10.1016/j.pediatrneurol.2004.08.005; Frederikse ME, 1999, CEREB CORTEX, V9, P896, DOI 10.1093/cercor/9.8.896; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GirgiS RR, 2007, PROG NEURO-PSYCHOPH, V31, P41, DOI 10.1016/j.pnpbp.2006.06.007; Good CD, 2002, NEUROIMAGE, V17, P29, DOI 10.1006/nimg.2002.1202; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hardan AY, 2006, J CHILD NEUROL, V21, P866, DOI 10.1177/08830738060210100701; Hazlett HC, 2006, BIOL PSYCHIAT, V59, P1, DOI 10.1016/j.biopsych.2005.06.015; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Karmiloff-Smith A, 1998, TRENDS COGN SCI, V2, P389, DOI 10.1016/S1364-6613(98)01230-3; Ke XY, 2008, NEUROREPORT, V19, P921, DOI 10.1097/WNR.0b013e328300edf3; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lotspeich L, 2004, ARCH GEN PSYCHIAT, V61, P291, DOI 10.1001/archpsyc.61.3.291; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; McAlonan GM, 2008, J CHILD PSYCHOL PSYC, V49, P1287, DOI 10.1111/j.1469-7610.2008.01933.x; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Nordahl CW, 2007, J NEUROSCI, V27, P11725, DOI 10.1523/JNEUROSCI.0777-07.2007; Palmen SJMC, 2005, PSYCHOL MED, V35, P561, DOI 10.1017/S0033291704003496; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Peterson E, 2006, NEUROREPORT, V17, P1289, DOI 10.1097/01.wnr.0000233087.15710.87; Rojas DC, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-56; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Schumann CM, 2006, J NEUROSCI, V26, P7674, DOI 10.1523/JNEUROSCI.1285-06.2006; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Vogt BA, 2006, NEUROIMAGE, V29, P452, DOI 10.1016/j.neuroimage.2005.07.048; Wallace GL, 2010, BRAIN, V133, P3745, DOI 10.1093/brain/awq279; Wechsler D., 1991, WISC 3 WECHSLER INTE; World Health Organization, 2022, INT CLASS DIS, V11th; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	52	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18905	10.1371/journal.pone.0018905	http://dx.doi.org/10.1371/journal.pone.0018905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541322	Green Submitted, gold, Green Published			2022-12-25	WOS:000290018400017
J	Lee, ST; Wong, PF; Cheah, SC; Mustafa, MR				Lee, Sui-Ting; Wong, Pooi-Fong; Cheah, Shiau-Chuen; Mustafa, Mohd Rais			Alpha-Tomatine Induces Apoptosis and Inhibits Nuclear Factor-Kappa B Activation on Human Prostatic Adenocarcinoma PC-3 Cells	PLOS ONE			English	Article							CANCER CHEMOPREVENTION; DIETARY PHYTOCHEMICALS; ACTIN CYTOSKELETON; PATHWAYS; AGENTS; LIVER; GLYCOALKALOIDS; DEATH; PREVENTION; ALKALOIDS	Background: Alpha-tomatine (alpha-tomatine) is the major saponin in tomato (Lycopersicon esculentum). This study investigates the chemopreventive potential of alpha-tomatine on androgen-independent human prostatic adenocarcinoma PC-3 cells. Methodology/Principal Findings: Treatment of highly aggressive human prostate cancer PC-3 cells with alpha-tomatine resulted in a concentration-dependent inhibition of cell growth with a half-maximal efficient concentration (EC(50)) value of 1.67+/-0.3 mu M. It is also less cytotoxic to normal human liver WRL-68 cells and normal human prostate RWPE-1 cells. Assessment of real-time growth kinetics by cell impedance-based Real-Time Cell Analyzer (RTCA) showed that alpha-tomatine exhibited its cytotoxic effects against PC-3 cells as early as an hour after treatment. The inhibitory effect of alpha-tomatine on PC-3 cancer cell growth was mainly due to induction of apoptosis as evidenced by positive Annexin V staining and decreased in mitochondrial membrane potential but increased in nuclear condensation, polarization of F-actin, cell membrane permeability and cytochrome c expressions. Results also showed that alpha-tomatine induced activation of caspase-3, -8 and -9, suggesting that both intrinsic and extrinsic apoptosis pathways are involved. Furthermore, nuclear factor-kappa B (NF-kappa B) nuclear translocation was inhibited, which in turn resulted in significant decreased in NF-kappa B/p50 and NF-kappa B/p65 in the nuclear fraction of the treated cells compared to the control untreated cells. These results provide further insights into the molecular mechanism of the anti-proliferative actions of alpha-tomatine. Conclusion/Significance: alpha-tomatine induces apoptosis and inhibits NF-kappa B activation on prostate cancer cells. These results suggest that alpha-tomatine may be beneficial for protection against prostate cancer development and progression.	[Lee, Sui-Ting; Wong, Pooi-Fong; Cheah, Shiau-Chuen; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Lee, ST (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	rais@um.edu.my	Cheah, Shiau-Chuen/H-7564-2013; Mustafa, Mohamed R/B-1647-2009; WONG, POOI-FONG PF/B-5234-2010	Cheah, Shiau-Chuen/0000-0002-9247-7265; Mustafa, Mohamed R/0000-0002-7864-5189; WONG, POOI-FONG PF/0000-0002-6705-2521	University of Malaya [J-20005-73591]	University of Malaya(Universiti Malaya)	This study was funded by University of Malaya High Impact Factor Grant (J-20005-73591). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SB, 1997, BIOCHEM J, V323, P233, DOI 10.1042/bj3230233; Chassoux D, 1999, ANAL QUANT CYTOL, V21, P489; Chiu FL, 2008, FEBS LETT, V582, P2407, DOI 10.1016/j.febslet.2008.05.049; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Friedman M, 1996, J NUTR, V126, P989, DOI 10.1093/jn/126.4.989; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; Friedman M, 2007, MOL NUTR FOOD RES, V51, P1485, DOI 10.1002/mnfr.200700176; Friedman M, 2009, J AGR FOOD CHEM, V57, P5727, DOI 10.1021/jf900364j; Gourlay CW, 2005, FEMS YEAST RES, V5, P1193, DOI 10.1016/j.femsyr.2005.08.001; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Ito S, 2007, FEBS LETT, V581, P3217, DOI 10.1016/j.febslet.2007.06.010; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karunagaran D, 2005, CURR CANCER DRUG TAR, V5, P117, DOI 10.2174/1568009053202081; Khan N, 2008, BIOCHEM PHARMACOL, V76, P1333, DOI 10.1016/j.bcp.2008.07.015; Khan N, 2010, ENDOCR-RELAT CANCER, V17, pR39, DOI 10.1677/ERC-09-0262; Kruidering M, 1998, CELL DEATH DIFFER, V5, P601, DOI 10.1038/sj.cdd.4400392; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Martin KR, 2006, EXP BIOL MED, V231, P117; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Mishra Neerad C., 2005, Indian Journal of Experimental Biology, V43, P25; Morrow WJW, 2004, VACCINE, V22, P2380, DOI 10.1016/j.vaccine.2004.03.022; Neergheen VS, 2010, TOXICOLOGY, V278, P229, DOI 10.1016/j.tox.2009.10.010; Nobili S, 2009, PHARMACOL RES, V59, P365, DOI 10.1016/j.phrs.2009.01.017; Posey SC, 1999, J BIOL CHEM, V274, P4259, DOI 10.1074/jbc.274.7.4259; Ross Jeffrey S, 2003, Am J Clin Pathol, V120 Suppl, pS53; Roy AM, 2005, NEOPLASIA, V7, P24, DOI 10.1593/neo.04412; Russo GL, 2007, BIOCHEM PHARMACOL, V74, P533, DOI 10.1016/j.bcp.2007.02.014; Schneider P, 2000, Pharm Acta Helv, V74, P281, DOI 10.1016/S0031-6865(99)00038-2; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shih YW, 2009, FOOD CHEM TOXICOL, V47, P1985, DOI 10.1016/j.fct.2009.05.011; Simons V, 2006, ANTIMICROB AGENTS CH, V50, P2732, DOI 10.1128/AAC.00289-06; Stroh C, 1998, CELL DEATH DIFFER, V5, P997, DOI 10.1038/sj.cdd.4400451; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tan ML, 2009, PHARM RES-DORDR, V26, P1547, DOI 10.1007/s11095-009-9895-1; THORNE HV, 1985, ANTIVIR RES, V5, P335, DOI 10.1016/0166-3542(85)90003-8	44	55	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18915	10.1371/journal.pone.0018915	http://dx.doi.org/10.1371/journal.pone.0018915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541327	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000290018400018
J	Tanabe, K; Liu, Y; Hasan, SD; Martinez, SC; Cras-Meneur, C; Welling, CM; Bernal-Mizrachi, E; Tanizawa, Y; Rhodes, CJ; Zmuda, E; Hai, TW; Abumrad, NA; Permutt, MA				Tanabe, Katsuya; Liu, Yang; Hasan, Syed D.; Martinez, Sara C.; Cras-Meneur, Corentin; Welling, Cris M.; Bernal-Mizrachi, Ernesto; Tanizawa, Yukio; Rhodes, Christopher J.; Zmuda, Erik; Hai, Tsonwin; Abumrad, Nada A.; Permutt, M. Alan			Glucose and Fatty Acids Synergize to Promote B-Cell Apoptosis through Activation of Glycogen Synthase Kinase 3 beta Independent of JNK Activation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; TRANSCRIPTION FACTORS; BETA-CELLS; ER STRESS; ELEMENT; GLUCOLIPOTOXICITY; INHIBITION; PROTEINS; GENE	Background: The combination of elevated glucose and free-fatty acids (FFA), prevalent in diabetes, has been suggested to be a major contributor to pancreatic beta-cell death. This study examines the synergistic effects of glucose and FFA on beta-cell apoptosis and the molecular mechanisms involved. Mouse insulinoma cells and primary islets were treated with palmitate at increasing glucose and effects on apoptosis, endoplasmic reticulum (ER) stress and insulin receptor substrate (IRS) signaling were examined. Principal Findings: Increasing glucose (5-25 mM) with palmitate (400 mu M) had synergistic effects on apoptosis. Jun NH2-terminal kinase (JNK) activation peaked at the lowest glucose concentration, in contrast to a progressive reduction in IRS2 protein and impairment of insulin receptor substrate signaling. A synergistic effect was observed on activation of ER stress markers, along with recruitment of SREBP1 to the nucleus. These findings were confirmed in primary islets. The above effects associated with an increase in glycogen synthase kinase 3 beta (Gsk3 beta) activity and were reversed along with apoptosis by an adenovirus expressing a kinase dead Gsk3b beta. Conclusions/Significance: Glucose in the presence of FFA results in synergistic effects on ER stress, impaired insulin receptor substrate signaling and Gsk3 beta activation. The data support the importance of controlling both hyperglycemia and hyperlipidemia in the management of Type 2 diabetes, and identify pancreatic islet beta-cell Gsk3 beta as a potential therapeutic target.	[Tanabe, Katsuya; Liu, Yang; Hasan, Syed D.; Martinez, Sara C.; Cras-Meneur, Corentin; Welling, Cris M.; Bernal-Mizrachi, Ernesto; Permutt, M. Alan] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, Div Nutr Sci, St Louis, MO 63110 USA; [Tanizawa, Yukio] Yamaguchi Univ, Div Endocrinol Metab Hematol Sci & Therapeut, Dept Biosignal Anal, Grad Sch Med, Yamaguchi, Japan; [Rhodes, Christopher J.] Univ Chicago, Dept Med, Kovler Diabet Ctr, Chicago, IL 60637 USA; [Zmuda, Erik; Hai, Tsonwin] Ohio State Univ, Dept Mol & Cellular Biochem, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Washington University (WUSTL); Washington University (WUSTL); Yamaguchi University; University of Chicago; University System of Ohio; Ohio State University	Tanabe, K (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63130 USA.	apermutt@dom.wustl.edu	Cras-Meneur, Corentin/K-7728-2019; Hai, Tsonwin/E-3185-2011; Cras-Méneur, Corentin/A-2628-2008; Hai, Tsonwin/H-4480-2011	Cras-Meneur, Corentin/0000-0001-8921-8927; Hai, Tsonwin/0000-0003-4510-0315; Cras-Méneur, Corentin/0000-0001-8921-8927; Hai, Tsonwin/0000-0003-4510-0315	National Institutes of Health (NIH) [R37 DK16746, R01 DK33301, RO1 DK64938, P60 DK20579, P30DK056341]; Ministry of Education, Culture, Sports and Science [22590984]; Takeda Science Foundation; Banyu Life Science Foundation Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK016746, R01DK055267, R01DK033301, R01DK016746, R01DK064938, R01DK073716, P60DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Banyu Life Science Foundation Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R37 DK16746 to M. A. Permutt, R01 DK33301 to N.A. Abumrad, RO1 DK64938 to T. Hai, NIH P60 DK20579 to the Washington University DRTC, and NIH P30DK056341 to the Adipocyte Biology and Molecular Nutrition Core of the Nutrition Obesity Research Center. Katsuya Tanabe was granted from Grants-in-Aid for Scientific Research (22590984) from Ministry of Education, Culture, Sports and Science, a grant from Takeda Science Foundation and a grant from Banyu Life Science Foundation Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cnop M, 2008, BIOCHEM SOC T, V36, P348, DOI 10.1042/BST0360348; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Finlay D, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-15; Girish V, 2004, Indian J Cancer, V41, P47; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Ramalho RM, 2008, TRENDS MOL MED, V14, P54, DOI 10.1016/j.molmed.2007.12.001; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Unger R H, 2001, Journ Annu Diabetol Hotel Dieu, P129; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	43	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18146	10.1371/journal.pone.0018146	http://dx.doi.org/10.1371/journal.pone.0018146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541314	gold, Green Published			2022-12-25	WOS:000290018400003
J	Chaumeil, J; Waters, PD; Koina, E; Gilbert, C; Robinson, TJ; Graves, JAM				Chaumeil, Julie; Waters, Paul D.; Koina, Edda; Gilbert, Clement; Robinson, Terence J.; Graves, Jennifer A. Marshall			Evolution from XIST-Independent to XIST-Controlled X-Chromosome Inactivation: Epigenetic Modifications in Distantly Related Mammals	PLOS ONE			English	Article							HISTONE-H3 LYSINE-9 METHYLATION; EMBRYONIC STEM-CELLS; DOSAGE COMPENSATION; FACULTATIVE HETEROCHROMATIN; TRANSCRIPTIONAL ACTIVITY; MONOTREME MAMMALS; PLACENTAL MAMMALS; MOUSE; H3; GENE	X chromosome inactivation (XCI) is the transcriptional silencing of one X in female mammals, balancing expression of X genes between females (XX) and males (XY). In placental mammals non-coding XIST RNA triggers silencing of one X (Xi) and recruits a characteristic suite of epigenetic modifications, including the histone mark H3K27me3. In marsupials, where XIST is missing, H3K27me3 association seems to have different degrees of stability, depending on cell-types and species. However, the complete suite of histone marks associated with the Xi and their stability throughout cell cycle remain a mystery, as does the evolution of an ancient mammal XCI system. Our extensive immunofluorescence analysis (using antibodies against specific histone modifications) in nuclei of mammals distantly related to human and mouse, revealed a general absence from the mammalian Xi territory of transcription machinery and histone modifications associated with active chromatin. Specific repressive modifications associated with XCI in human and mouse were also observed in elephant (a distantly related placental mammal), as was accumulation of XIST RNA. However, in two marsupial species the Xi either lacked these modifications (H4K20me1), or they were restricted to specific windows of the cell cycle (H3K27me3, H3K9me2). Surprisingly, the marsupial Xi was stably enriched for modifications associated with constitutive heterochromatin in all eukaryotes (H4K20me3, H3K9me3). We propose that marsupial XCI is comparable to a system that evolved in the common therian (marsupial and placental) ancestor. Silent chromatin of the early inactive X was exapted from neighbouring constitutive heterochromatin and, in early placental evolution, was augmented by the rise of XIST and the stable recruitment of specific histone modifications now classically associated with XCI.	[Chaumeil, Julie; Waters, Paul D.; Koina, Edda; Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Comparat Genom Grp, Canberra, ACT, Australia; [Gilbert, Clement; Robinson, Terence J.] Univ Stellenbosch, Dept Zool, Evolutionary Genom Grp, Matieland, South Africa	Australian National University; Stellenbosch University	Chaumeil, J (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10012 USA.	julie.chaumeil@nyumc.org; paul.waters@anu.edu.au	Waters, Paul D/B-7871-2015; Gilbert, Clément/A-7538-2015; Robinson, Terence J./K-7342-2017	Waters, Paul D/0000-0002-4689-8747; Gilbert, Clément/0000-0002-2131-7467; Graves, Jennifer/0000-0001-6480-7856; CHAUMEIL, Julie/0000-0002-8976-2890; Robinson, Terence J./0000-0002-4298-4891	Association pour la Recherche sur le Cancer (France); Australian Research Council [DP0987091, DP1094868]; Research School of Biology, The Australian National University	Association pour la Recherche sur le Cancer (France)(Fondation ARC pour la Recherche sur le Cancer); Australian Research Council(Australian Research Council); Research School of Biology, The Australian National University(Australian National University)	JC was supported by the Association pour la Recherche sur le Cancer (France). PDW is supported by an Australian Research Fellowship (DP0987091) awarded by the Australian Research Council. The project was supported by institutional funding from the Research School of Biology, The Australian National University; and Australian Research Council discovery projects (DP0987091 and DP1094868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al Nadaf S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r122; Asher RJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-102; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Boggs BA, 1996, CHROMOSOMA, V105, P303, DOI 10.1007/BF02524648; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chadwick BP, 2003, HUM MOL GENET, V12, P2167, DOI 10.1093/hmg/ddg229; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; Chaumeil J, 2004, METHOD ENZYMOL, V376, P405; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Chureau C, 2002, GENOME RES, V12, P894, DOI 10.1101/gr.152902; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; COOPER DW, 1971, NATURE-NEW BIOL, V230, P155, DOI 10.1038/newbio230155a0; Coppola G, 2008, SEX DEV, V2, P12, DOI 10.1159/000117715; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Deakin JE, 2008, CHROMOSOME RES, V16, P1159, DOI 10.1007/s10577-008-1266-y; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; GRAVES JAM, 1967, EXP CELL RES, V46, P37; GRAVES JAM, 1986, SOMAT CELL MOLEC GEN, V12, P275, DOI 10.1007/BF01570786; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KASLOW DC, 1987, P NATL ACAD SCI USA, V84, P6210, DOI 10.1073/pnas.84.17.6210; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Koina E, 2009, CHROMOSOME RES, V17, P115, DOI 10.1007/s10577-009-9020-7; Loebel DAF, 1996, GENOME RES, V6, P114, DOI 10.1101/gr.6.2.114; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahadevaiah SK, 2009, CURR BIOL, V19, P1478, DOI 10.1016/j.cub.2009.07.041; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; PIPER AA, 1993, SOMAT CELL MOLEC GEN, V19, P141, DOI 10.1007/BF01233530; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rens W, 2010, P NATL ACAD SCI USA, V107, P17657, DOI 10.1073/pnas.0910322107; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Delgado CLR, 2009, CHROMOSOME RES, V17, P917, DOI 10.1007/s10577-009-9079-1; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Shevchenko AI, 2007, CHROMOSOME RES, V15, P127, DOI 10.1007/s10577-006-1115-9; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; VANDEBERG JL, 1987, ISOZYMES-CURR T BIOL, V15, P225; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Waters PD, 2007, CHROMOSOMA, V116, P511, DOI 10.1007/s00412-007-0116-6; Waters PD, 2004, CHROMOSOMA, V113, P137, DOI 10.1007/s00412-004-0301-9; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	61	53	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19040	10.1371/journal.pone.0019040	http://dx.doi.org/10.1371/journal.pone.0019040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541345	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800032
J	Moleirinho, A; Carneiro, J; Matthiesen, R; Silva, RM; Amorim, A; Azevedo, L				Moleirinho, Ana; Carneiro, Joao; Matthiesen, Rune; Silva, Raquel M.; Amorim, Antonio; Azevedo, Luisa			Gains, Losses and Changes of Function after Gene Duplication: Study of the Metallothionein Family	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GROWTH-INHIBITORY FACTOR; METAL-THIOLATE CLUSTERS; MAMMALIAN METALLOTHIONEIN; I GENE; EXPRESSION; BINDING; MUTATIONS; EVOLUTION; BRAIN	Metallothioneins (MT) are small proteins involved in heavy metal detoxification and protection against oxidative stress and cancer. The mammalian MT family originated through a series of duplication events which generated four major genes (MT1 to MT4). MT1 and MT2 encode for ubiquitous proteins, while MT3 and MT4 evolved to accomplish specific roles in brain and epithelium, respectively. Herein, phylogenetic, transcriptional and polymorphic analyses are carried out to expose gains, losses and diversification of functions that characterize the evolutionary history of the MT family. The phylogenetic analyses show that all four major genes originated through a single duplication event prior to the radiation of mammals. Further expansion of the MT1 gene has occurred in the primate lineage reaching in humans a total of 13 paralogs, five of which are pseudogenes. In humans, the reading frame of all five MT1 pseudogenes is reconstructed by sequence homology with a functional duplicate revealing that loss of invariant cysteines is the most frequent event accounting for pseudogeneisation. Expression analyses based on EST counts and RT-PCR experiments show that, as for MT1 and MT2, human MT3 is also ubiquitously expressed while MT4 transcripts are present in brain, testes, esophagus and mainly in thymus. Polymorphic variation reveals two deleterious mutations (Cys30Tyr and Arg31Trp) in MT4 with frequencies reaching about 30% in African and Asian populations suggesting the gene is inactive in some individuals and physiological compensation for its loss must arise from a functional equivalent. Altogether our findings provide novel data on the evolution and diversification of MT gene duplicates, a valuable resource for understanding the vast set of biological processes in which these proteins are involved.	[Moleirinho, Ana; Carneiro, Joao; Matthiesen, Rune; Silva, Raquel M.; Amorim, Antonio; Azevedo, Luisa] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Carneiro, Joao; Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Moleirinho, A (corresponding author), Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	lazevedo@ipatimup.pt	Azevedo, Luisa/J-4051-2013; Matthiesen, Rune/AAF-2167-2020; Carneiro, Joao/A-6289-2009; Moleirinho, Ana/I-5455-2013; Silva, Raquel M/B-8337-2008; Amorim, Antonio/A-7938-2008	Azevedo, Luisa/0000-0002-3157-7342; Matthiesen, Rune/0000-0002-6353-2616; Carneiro, Joao/0000-0002-5153-2395; Silva, Raquel M/0000-0001-5926-8042; Amorim, Antonio/0000-0002-7518-6247	Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-007167]; Fundacao para a Ciencia e a Tecnologia Ciencia; European Social Fund	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia Ciencia; European Social Fund(European Social Fund (ESF))	This work was supported by Fundacao para a Ciencia e a Tecnologia grant (FCOMP-01-0124-FEDER-007167). LA, RM, and RS are supported by Fundacao para a Ciencia e a Tecnologia Ciencia 2007 and by European Social Fund. Institute of Molecular Pathology and Immunology of the University of Porto is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by Fundacao para Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-266; BEACH LR, 1981, P NATL ACAD SCI-BIOL, V78, P2110, DOI 10.1073/pnas.78.4.2110; BOULANGER Y, 1983, P NATL ACAD SCI-BIOL, V80, P1501, DOI 10.1073/pnas.80.6.1501; BRAUN W, 1992, P NATL ACAD SCI USA, V89, P10124, DOI 10.1073/pnas.89.21.10124; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Cai B, 2006, J BIOL INORG CHEM, V11, P476, DOI 10.1007/s00775-006-0097-6; Cai B, 2005, PROTEIN J, V24, P327, DOI 10.1007/s10930-005-7588-0; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egli D, 2006, GENES CELLS, V11, P647, DOI 10.1111/j.1365-2443.2006.00971.x; Force A, 1999, GENETICS, V151, P1531; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAGER LJ, 1981, NATURE, V291, P340, DOI 10.1038/291340a0; Hahn Y, 2006, HUM GENET, V119, P169, DOI 10.1007/s00439-005-0125-6; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Haq F, 2003, MUTAT RES-FUND MOL M, V533, P211, DOI 10.1016/j.mrfmmm.2003.07.014; HOZUMI I, 1995, BRAIN RES, V688, P143, DOI 10.1016/0006-8993(95)00522-R; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Hughes AL, 2002, TRENDS GENET, V18, P433, DOI 10.1016/S0168-9525(02)02755-5; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; KARIN M, 1984, P NATL ACAD SCI-BIOL, V81, P5494, DOI 10.1073/pnas.81.17.5494; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Lahti DW, 2005, PROTEIN SCI, V14, P1151, DOI 10.1110/ps.041113005; Laukens D, 2009, CRIT REV EUKAR GENE, V19, P301, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.40; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Lynch M, 2007, ORIGINS GENOME ARCHI, P389; MARONI G, 1987, GENETICS, V117, P739; MASTERS BA, 1994, J NEUROSCI, V14, P5844; Meloni G, 2006, J BIOL CHEM, V281, P14588, DOI 10.1074/jbc.M601724200; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1987, GENETICS, V115, P207; OHTA T, 1990, THEOR POPUL BIOL, V37, P213, DOI 10.1016/0040-5809(90)90036-U; OTTO E, 1986, P NATL ACAD SCI USA, V83, P6025, DOI 10.1073/pnas.83.16.6025; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029; Rambaut A, TRACER V1 4; Duncan KER, 2006, EXP BIOL MED, V231, P1488, DOI 10.1177/153537020623100907; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Romero-Isart N, 2002, J BIOL CHEM, V277, P37023, DOI 10.1074/jbc.M205730200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHMIDT CJ, 1986, P NATL ACAD SCI USA, V83, P3346, DOI 10.1073/pnas.83.10.3346; Stennard, 1994, BIOCH BIOPHYS ACTA; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tio L, 2004, J BIOL CHEM, V279, P24403, DOI 10.1074/jbc.M401346200; Vasak M, 2000, CURR OPIN CHEM BIOL, V4, P177, DOI 10.1016/S1367-5931(00)00082-X; Villarreal L, 2006, FEBS J, V273, P523, DOI 10.1111/j.1742-4658.2005.05086.x; WAALKES MP, 1990, CHEM RES TOXICOL, V3, P281, DOI 10.1021/tx00016a001; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	59	52	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18487	10.1371/journal.pone.0018487	http://dx.doi.org/10.1371/journal.pone.0018487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541013	gold, Green Published, Green Submitted			2022-12-25	WOS:000290016800011
J	Sanbe, A; Marunouchi, T; Yamauchi, J; Tanonaka, K; Nishigori, H; Tanoue, A				Sanbe, Atsushi; Marunouchi, Tetsuro; Yamauchi, Junji; Tanonaka, Kouichi; Nishigori, Hideo; Tanoue, Akito			Cardioprotective Effect of Nicorandil, a Mitochondrial ATP-Sensitive Potassium Channel Opener, Prolongs Survival in HSPB5 R120G Transgenic Mice	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; CELL-DEATH; DESMIN; ISCHEMIA; CARDIOMYOPATHY; REPERFUSION; EXPRESSION; RELEASE; INJURY	Background: Transgenic (TG) mice with overexpression of an arg120gly (R120G) missense mutation in HSPB5 display desmin-related cardiomyopathy, which is characterized by formation of aggresomes. It is also known that progressive mitochondrial abnormalities and apoptotic cell death occur in the hearts of R120G TG mice. The role of mitochondrial dysfunction and apoptosis in disease progression, however, remains uncertain. Methods and Results: Mitochondrial abnormalities and apoptotic cell death induced by overexpression of HSPB5 R120G were analyzed in neonatal rat cardiomyocytes. Overexpression of mutant HSPB5 led to development of aggresomes with a concomitant reduction in cell viability in the myocytes. Overexpression of mutant HSPB5 induced a reduction in the cytochrome c level in the mitochondrial fraction and a corresponding increase in the cytoplasmic fraction in the myocytes. Down-regulation of BCL2 and up-regulation of BAX were detected in the myocytes expressing the mutant HSPB5. Concomitant with mitochondrial abnormality, the activation of caspase-3 and increased apoptotic cell death was observed. Cell viability was dose-dependently recovered in myocytes overexpressing HSPB5 R120G by treatment with nicorandil a mitochondrial ATP-sensitive potassium channel opener. Nicorandil treatment also inhibited the increase in BAX, the decrease in BCL2, activation of caspase-3 and apoptotic cell death by mutant HSPB5. To confirm the results of the in-vitro study, we analyzed the effect of nicorandil in HSPB5 R120G TG mice. Nicorandil treatment appeared to reduce mitochondrial impairment and apoptotic cell death and prolonged survival in HSPB5 R120G TG mice. Conclusions: Nicorandil may prolong survival in HSPB5 R120G TG mice by protecting against mitochondrial impairments.	[Sanbe, Atsushi; Nishigori, Hideo] Iwate Med Univ, Sch Pharm, Dept Pharmacotherapeut, Morioka, Iwate, Japan; [Sanbe, Atsushi; Yamauchi, Junji; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan; [Marunouchi, Tetsuro; Tanonaka, Kouichi] Tokyo Univ Pharm & Life Sci, Dept Pharmacol, Tokyo, Japan	Iwate Medical University; National Center for Child Health & Development - Japan; Tokyo University of Pharmacy & Life Sciences	Sanbe, A (corresponding author), Iwate Med Univ, Sch Pharm, Dept Pharmacotherapeut, Morioka, Iwate, Japan.	asanbe@iwate-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare; Japan Health Sciences Foundation; Chugai pharmaceutical Co. Ltd	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Chugai pharmaceutical Co. Ltd	This work was supported in part by research grants from the Scientific Fund of Ministry of Education, Culture, Sports, Science and Technology of Japan, Ministry of Health, Labour and Welfare, the Japan Health Sciences Foundation and Research grants from Chugai pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Ardehali H, 2005, CIRC RES, V97, P740, DOI 10.1161/01.RES.0000186277.12336.11; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Dargie HJ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.03.040; Das B, 2003, PHARMACOL RES, V47, P447, DOI 10.1016/S1043-6618(02)00335-3; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Hai S, 2005, TRANSPL P, V37, P428, DOI 10.1016/j.transproceed.2004.12.112; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kirshenbaum LA, 1997, CIRCULATION, V96, P1580, DOI 10.1161/01.CIR.96.5.1580; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Maloyan A, 2010, CIRC RES, V106, P1524, DOI 10.1161/CIRCRESAHA.109.212639; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nishikawa S, 2006, J MOL CELL CARDIOL, V40, P510, DOI 10.1016/j.yjmcc.2006.01.020; ROCKMAN HA, 1994, AM J PHYSIOL, V266, pH2468, DOI 10.1152/ajpheart.1994.266.6.H2468; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Sato T, 2000, J AM COLL CARDIOL, V35, P514, DOI 10.1016/S0735-1097(99)00552-5; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang LG, 2001, AM J PHYSIOL-HEART C, V280, pH2321, DOI 10.1152/ajpheart.2001.280.5.H2321; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Yamada M, J PHYSL, V588, P283	32	22	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18922	10.1371/journal.pone.0018922	http://dx.doi.org/10.1371/journal.pone.0018922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541347	gold, Green Published, Green Submitted			2022-12-25	WOS:000290016800027
J	Yanamandra, K; Gruden, MA; Casaite, V; Meskys, R; Forsgren, L; Morozova-Roche, LA				Yanamandra, Kiran; Gruden, Marina A.; Casaite, Vida; Meskys, Rolandas; Forsgren, Lars; Morozova-Roche, Ludmilla A.			alpha-Synuclein Reactive Antibodies as Diagnostic Biomarkers in Blood Sera of Parkinson's Disease Patients	PLOS ONE			English	Article							AMYLOID BETA-PEPTIDE; ALZHEIMERS-DISEASE; MOUSE MODEL; CEREBROSPINAL-FLUID; FIBRIL FORMATION; EQUINE LYSOZYME; OLIGOMERS; PROTEIN; TOXICITY; PLASMA	Background: Auto-antibodies with specificity to self-antigens have been implicated in a wide variety of neurological diseases, including Parkinson's (PD) and Alzheimer's diseases, being sensitive indicators of neurodegeneration and focus for disease prevention. Of particular interest are the studies focused on the auto-immune responses to amyloidogenic proteins associated with diseases and their applications in therapeutic treatments such as vaccination with amyloid antigens and antibodies in PD, Alzheimer's disease and potentially other neurodegeneration ailments. Methodology/Principal Findings: Generated auto-antibodies towards the major amyloidogenic protein involved in PD Lewy bodies - alpha-synuclein and its amyloid oligomers and fibrils were measured in the blood sera of early and late PD patients and controls by using ELISA, Western blot and Biacore surface plasmon resonance. We found significantly higher antibody levels towards monomeric alpha-synuclein in the blood sera of PD patients compared to controls, though the responses decreased with PD progression (P<0.0001). This indicates potential protective role of autoimmunity in maintaining the body homeostasis and clearing protein species whose disbalance may lead to amyloid assembly. There were no noticeable immune responses towards amyloid oligomers, but substantially increased levels of IgGs towards alpha-synuclein amyloid fibrils both in PD patients and controls, which subsided with the disease progression (P<0.0001). Pooled IgGs from PD patients and controls interacted also with the amyloid fibrils of A beta (1-40) and hen lysozyme, however the latter were recognized with lower affinity. This suggests that IgGs bind to the generic amyloid conformational epitope, displaying higher specificity towards human amyloid species associated with neurodegeneration. Conclusions/Significance: Our findings may suggest the protective role of autoimmunity in PD and therefore immune reactions towards PD major amyloid protein - alpha-synuclein can be of value in the development of treatment and diagnostic strategies, especially during the early disease stages.	[Yanamandra, Kiran; Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Gruden, Marina A.] PK Anokhin Inst Normal Physiol, Rams Moscow, Russia; [Casaite, Vida; Meskys, Rolandas] Vilnius Univ, Inst Biochem, Dept Mol Microbiol, Vilnius, Lithuania; [Casaite, Vida; Meskys, Rolandas] Vilnius Univ, Inst Biochem, Dept Biotechnol, Vilnius, Lithuania; [Forsgren, Lars] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden	Umea University; Russian Academy of Medical Sciences; Anokhin Institute of Normal Physiology; Vilnius University; Vilnius University; Umea University	Yanamandra, K (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	ludmilla.morozova-roche@medchem.umu.se	Morozova-Roche, Ludmilla/AAV-9983-2021; Yanamandra, Kiran/M-4037-2014; Morozova-Roche, Ludmilla A./AAU-9044-2021	Morozova-Roche, Ludmilla/0000-0001-5886-2023; Yanamandra, Kiran/0000-0002-4908-5848; Casaite, Vida/0000-0001-5334-1165				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; Gharibyan AL, 2007, J MOL BIOL, V365, P1337, DOI 10.1016/j.jmb.2006.10.101; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Grudena MA, 2004, DEMENT GERIATR COGN, V18, P165, DOI 10.1159/000079197; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hong DP, 2011, PROTEIN PEPTIDE LETT, V18, P230, DOI 10.2174/092986611794578332; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kuwahara T, 2008, HUM MOL GENET, V17, P2997, DOI 10.1093/hmg/ddn198; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Linder J, 2010, MOVEMENT DISORD, V25, P341, DOI 10.1002/mds.22987; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lundvig D, 2005, MOL BRAIN RES, V134, P3, DOI 10.1016/j.molbrainres.2004.09.001; Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200; Malisauskas M, 2003, J MOL BIOL, V330, P879, DOI 10.1016/S0022-2836(03)00551-5; Martin JB, 1999, NEW ENGL J MED, V340, P1970, DOI 10.1056/NEJM199906243402507; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Monsonego A, 2001, P NATL ACAD SCI USA, V98, P10273, DOI 10.1073/pnas.191118298; Morozova-Roche LA, 2000, J STRUCT BIOL, V130, P339, DOI 10.1006/jsbi.2000.4264; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; POLINSKY RJ, 1991, J NEUROL SCI, V106, P96, DOI 10.1016/0022-510X(91)90201-H; Ritter G, 2001, CANCER RES, V61, P6851; ROSS RA, 1985, CANCER RES, V45, P1628; Schapira AHV, 1999, BRIT MED J, V318, P311, DOI 10.1136/bmj.318.7179.311; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Sharma N, 2006, J MOL NEUROSCI, V28, P161, DOI 10.1385/JMN:28:2:161; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stolp HB, 2009, NEUROPATH APPL NEURO, V35, P132, DOI 10.1111/j.1365-2990.2008.01005.x; Thors L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012275; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Wilhelm KR, 2007, EUR J NEUROL, V14, P327, DOI 10.1111/j.1468-1331.2006.01667.x	64	121	131	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18513	10.1371/journal.pone.0018513	http://dx.doi.org/10.1371/journal.pone.0018513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541339	Green Published, gold			2022-12-25	WOS:000290016800013
J	Carter, KJ; Dunham, CM; Castro, F; Erickson, B				Carter, Kimbroe J.; Dunham, C. Michael; Castro, Frank; Erickson, Barbara			Comparative Analysis of Cervical Spine Management in a Subset of Severe Traumatic Brain Injury Cases Using Computer Simulation	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; RISK-FACTORS; BLUNT TRAUMA; IMMOBILIZATION; MORTALITY; STROKE; SAFE; COMA; MRI	Background: No randomized control trial to date has studied the use of cervical spine management strategies in cases of severe traumatic brain injury (TBI) at risk for cervical spine instability solely due to damaged ligaments. A computer algorithm is used to decide between four cervical spine management strategies. A model assumption is that the emergency room evaluation shows no spinal deficit and a computerized tomogram of the cervical spine excludes the possibility of fracture of cervical vertebrae. The study's goal is to determine cervical spine management strategies that maximize brain injury functional survival while minimizing quadriplegia. Methods/Findings: The severity of TBI is categorized as unstable, high risk and stable based on intracranial hypertension, hypoxemia, hypotension, early ventilator associated pneumonia, admission Glasgow Coma Scale (GCS) and age. Complications resulting from cervical spine management are simulated using three decision trees. Each case starts with an amount of primary and secondary brain injury and ends as a functional survivor, severely brain injured, quadriplegic or dead. Cervical spine instability is studied with one-way and two-way sensitivity analyses providing rankings of cervical spine management strategies for probabilities of management complications based on QALYs. Early collar removal received more QALYs than the alternative strategies in most arrangements of these comparisons. A limitation of the model is the absence of testing against an independent data set. Conclusions: When clinical logic and components of cervical spine management are systematically altered, changes that improve health outcomes are identified. In the absence of controlled clinical studies, the results of this comparative computer assessment show that early collar removal is preferred over a wide range of realistic inputs for this subset of traumatic brain injury. Future research is needed on identifying factors in projecting awakening from coma and the role of delirium in these cases.	[Carter, Kimbroe J.; Castro, Frank; Erickson, Barbara] St Elizabeth Hlth Ctr, Med Decis Making Soc Youngstown Ohio, Youngstown, OH USA; [Dunham, C. Michael] St Elizabeth Hlth Ctr, Trauma Crit Serv, Youngstown, OH USA; [Carter, Kimbroe J.] Northeastern Ohio Univ Coll Med & Pharm, Dept Pathol, Coll Med, Rootstown, OH USA; [Carter, Kimbroe J.] Northeastern Ohio Univ Coll Med & Pharm, Dept Pathol, Coll Pharm, Rootstown, OH USA	Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED)	Carter, KJ (corresponding author), St Elizabeth Hlth Ctr, Med Decis Making Soc Youngstown Ohio, Youngstown, OH USA.	mdmyo@msn.com		Dunham, C. Michael/0000-0002-7842-9750	St. Elizabeth Health Center Medical Research Committee, Youngstown, OH	St. Elizabeth Health Center Medical Research Committee, Youngstown, OH	A grant was awarded from St. Elizabeth Health Center Medical Research Committee, Youngstown, OH, for programming assistance and acquisition of computer resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; *CDC, 2010, WHAT IS TRAUM BRAIN; Chiu WC, 2001, J TRAUMA, V50, P457, DOI 10.1097/00005373-200103000-00009; Como JJ, 2009, J TRAUMA, V67, P651, DOI 10.1097/TA.0b013e3181ae583b; Day D, 2010, CRIT CARE NURSE, V30, P18, DOI 10.4037/ccn2010446; Demetriades D, 2000, J TRAUMA, V48, P724, DOI 10.1097/00005373-200004000-00022; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; DREIANGEL N, 2010, J TRAUMA IN PRESS; Dunham CM, 2008, CRIT CARE, V12, DOI 10.1186/cc6957; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Gentleman D, 1999, BRIT MED BULL, V55, P910, DOI 10.1258/0007142991902718; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; *J INS MED, 1999, J INSURANCE MED, V31, P104; Kerwin AJ, 2007, J TRAUMA, V63, P1308, DOI 10.1097/TA.0b013e31815b8361; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1764, DOI 10.1016/j.apmr.2004.06.062; McNett M, 2010, AM J CRIT CARE, V19, P250, DOI 10.4037/ajcc2009293; Muchow RD, 2008, J TRAUMA, V64, P179, DOI 10.1097/01.ta.0000238664.74117.ac; SACCO RL, 1990, ARCH NEUROL-CHICAGO, V47, P1181, DOI 10.1001/archneur.1990.00530110035013; Schwarzinger Michael, 2003, Popul Health Metr, V1, P9, DOI 10.1186/1478-7954-1-9; Shafer JS, 2009, WEST J EMERG MED, V10, P74; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Singer OC, 2004, NEUROLOGY, V62, P1848, DOI 10.1212/01.WNL.0000125320.53244.FA; SOULEN RL, 1994, CRIT CARE CLIN, V10, P401, DOI 10.1016/S0749-0704(18)30135-0; Stelfox HT, 2007, J TRAUMA, V63, P630, DOI 10.1097/TA.0b013e318076b537; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; van Middendorp JJ, 2009, J BONE JOINT SURG AM, V91A, P71, DOI 10.2106/JBJS.G.01347; ZASLER N, 2007, BRAIN INJURY MED PRI, P247	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19177	10.1371/journal.pone.0019177	http://dx.doi.org/10.1371/journal.pone.0019177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544239	Green Submitted, Green Published, gold			2022-12-25	WOS:000290015800049
J	Dehlink, E; Platzer, B; Baker, AH; LaRosa, J; Pardo, M; Dwyer, P; Yen, EH; Szepfalusi, Z; Nurko, S; Fiebiger, E				Dehlink, Eleonora; Platzer, Barbara; Baker, Alexandra H.; LaRosa, Jessica; Pardo, Michael; Dwyer, Peter; Yen, Elizabeth H.; Szepfalusi, Zsolt; Nurko, Samuel; Fiebiger, Edda			A Soluble Form of the High Affinity IgE Receptor, Fc-Epsilon-RI, Circulates in Human Serum	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BINDING FACTORS; ALLERGEN PRESENTATION; EXPRESSION; CD23; ASTHMA; ALPHA; CELLS; GALECTINS; COMPLEX	Soluble IgE receptors are potential in vivo modulators of IgE-mediated immune responses and are thus important for our basic understanding of allergic responses. We here characterize a novel soluble version of the IgE-binding alpha-chain of Fc-epsilon-RI (sFc epsilon RI), the high affinity receptor for IgE. sFc epsilon RI immunoprecipitates as a protein of similar to 40 kDa and contains an intact IgE-binding site. In human serum, sFc epsilon RI is found as a soluble free IgE receptor as well as a complex with IgE. Using a newly established ELISA, we show that serum sFc epsilon RI levels correlate with serum IgE in patients with elevated IgE. We also show that serum of individuals with normal IgE levels can be found to contain high levels of sFc epsilon RI. After IgE-antigen-mediated crosslinking of surface Fc epsilon RI, we detect sFc epsilon RI in the exosome-depleted, soluble fraction of cell culture supernatants. We further show that sFc epsilon RI can block binding of IgE to Fc epsilon RI expressed at the cell surface. In summary, we here describe the alpha-chain of Fc epsilon RI as a circulating soluble IgE receptor isoform in human serum.	[Dehlink, Eleonora; Platzer, Barbara; Baker, Alexandra H.; LaRosa, Jessica; Pardo, Michael; Dwyer, Peter; Yen, Elizabeth H.; Nurko, Samuel; Fiebiger, Edda] Harvard Univ, Sch Med, Dept Pediat, Div Gastroenterol & Nutr,Childrens Hosp Boston, Boston, MA 02115 USA; [Dehlink, Eleonora; Szepfalusi, Zsolt] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria	Harvard University; Boston Children's Hospital; Harvard Medical School; Medical University of Vienna	Dehlink, E (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Div Gastroenterol & Nutr,Childrens Hosp Boston, Boston, MA 02115 USA.	edda.fiebiger@childrens.harvard.edu	Baker, Alexandra/ABF-1321-2021	Szepfalusi, Zsolt/0000-0003-4852-3102; Nurko, Samuel/0000-0003-0936-4807; Yen, Elizabeth/0000-0002-7172-8723	Gerber Foundation; Thrasher Research Fund; National Institutes of Health (NIH) [R01AI075037, K24DK82792-1, DK081256]; Harvard Digestive Diseases Center (NIH) [DK34854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK081256, P30DK034854, R01DK084424, K24DK082792] Funding Source: NIH RePORTER	Gerber Foundation; Thrasher Research Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Gerber Foundation (to S.N. and E.F.) and the Thrasher Research Fund (to E.D.). Further support came from National Institutes of Health (NIH) grants R01AI075037 (to E.F.), K24DK82792-1 (to S.N.) and the Harvard Digestive Diseases Center (NIH Grant DK34854). B.P was supported by NIH grant DK081256. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; Bania J, 2003, P NATL ACAD SCI USA, V100, P6664, DOI 10.1073/pnas.1131604100; BONNEFOY JY, 1995, INT ARCH ALLERGY IMM, V107, P40, DOI 10.1159/000236924; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Campbell AM, 1998, AM J RESP CELL MOL, V19, P92, DOI 10.1165/ajrcmb.19.1.2648; Dehlink E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012204; Dehlink E, 2009, IMMUNOL ALLERGY CLIN, V29, P159, DOI 10.1016/j.iac.2008.09.004; DELESPESSE G, 1989, INT ARCH ALLER A IMM, V88, P18, DOI 10.1159/000234741; DELESPESSE G, 1989, IMMUNOL TODAY, V10, P159, DOI 10.1016/0167-5699(89)90173-4; Fiebiger E, 2005, J EXP MED, V201, P267, DOI 10.1084/jem.20041384; Firszt R, 2010, CURR OPIN PHARMACOL, V10, P266, DOI 10.1016/j.coph.2010.04.010; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; GRENIERBROSSETTE N, 1992, EUR J IMMUNOL, V22, P1573, DOI 10.1002/eji.1830220634; ISHIZAKA K, 1988, ANNU REV IMMUNOL, V6, P513; JUNG CM, 1995, J ALLERGY CLIN IMMUN, V95, P77, DOI 10.1016/S0091-6749(95)70155-9; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; LIANG Y, 2009, J IMMUNOL METHODS; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Liu FT, 2007, DRUG NEWS PERSPECT, V20, P455, DOI 10.1358/dnp.2007.20.7.1149628; MAURER D, 1995, J IMMUNOL, V154, P6285; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Meuleman N, 2008, LEUKEMIA, V22, P1882, DOI 10.1038/leu.2008.190; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Molimard M, 2010, RESP MED, V104, P1381, DOI 10.1016/j.rmed.2010.06.001; Platzer B, 2010, J BIOL CHEM, V285, P15314, DOI 10.1074/jbc.M110.104281; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; RA C, 1993, INT IMMUNOL, V5, P47, DOI 10.1093/intimm/5.1.47; REINISCH W, 1994, J CLIN ONCOL, V12, P2146, DOI 10.1200/JCO.1994.12.10.2146; RODRIGO GJ, 2010, CHEST 2011, V139, P28; SARFATI M, 1988, BLOOD, V71, P94; Seminario MC, 1999, J IMMUNOL, V162, P6893; Singleton TE, 2009, MOL IMMUNOL, V46, P2333, DOI 10.1016/j.molimm.2009.03.023; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Untersmayr E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009023; van der Boog PJM, 2002, J IMMUNOL, V168, P1252, DOI 10.4049/jimmunol.168.3.1252; Vangelista L, 1999, J CLIN INVEST, V103, P1571, DOI 10.1172/JCI6551; von Bubnoff D, 2003, CLIN EXP DERMATOL, V28, P184, DOI 10.1046/j.1365-2230.2003.01209.x; Wurzburg BA, 2002, MOL IMMUNOL, V38, P1063, DOI 10.1016/S0161-5890(02)00035-4	43	24	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19098	10.1371/journal.pone.0019098	http://dx.doi.org/10.1371/journal.pone.0019098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544204	Green Published, Green Submitted, gold			2022-12-25	WOS:000290015800041
J	Ren, BP; Li, DY; He, XM; Qiu, JH; Li, M				Ren, Baoping; Li, Dayong; He, Xinmin; Qiu, Junhua; Li, Ming			Female Resistance to Invading Males Increases Infanticide in Langurs	PLOS ONE			English	Article							MONKEY RHINOPITHECUS-ROXELLANA; INTERBIRTH INTERVAL; STRATEGIES; BEHAVIOR; BIETI	Background: Infanticide by adult male occurs in many mammalian species under natural conditions, and it is often assumed to be a goal-directed action and explained predominately by sexual selection. Motivation of this behavior in mammals is limitedly involved. Methodology and Principal Findings: We used long-term reproductive records and direct observation in captivity and in the field of two snub-nosed langur species on the basis of individual identification to investigate how infanticide happened and to be avoided in nonhuman primates. Our observations suggested that infanticide by invading males might be more accidental than goal-directed. The invading male seemed to monopolize all the females including lactating mothers during takeovers. Multiparous mothers who accepted the invading male shortly after takeovers avoided infanticide in most cases. Our results conjectured primiparous mothers would decrease infanticidal possibility if they sexually accepted the invading male during or immediately after takeovers. In the studied langur species, voluntary abortion or mating with the invading male was evidently adopted by females to limit or avoid infanticide by takeover males. Conclusions and Significance: The objective of the invading male was to monopolize all adult females after his takeover. It appeared that the mother's resistance to accepting the new male as a mating partner was the primary incentive for infanticide. Motivation analysis might be helpful to further understand why infanticide occurs in primate species.	[Ren, Baoping; Li, Dayong; Li, Ming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Li, Dayong] China W Normal Univ, Coll Life Sci, Nanchong, Sichuan, Peoples R China; [Qiu, Junhua] Baimaxueshan Natl Nat Reserve, Diqing Prefecture, Yunnan, Peoples R China; [He, Xinmin] Shanghai Wild Anim Pk, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; China West Normal University	Ren, BP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	lim@ioz.ac.cn	Ren, Baoping/HGE-5822-2022	Ren, Baoping/0000-0002-3574-0522	973 Program [2007CB411600]; Natural Science Foundation of China [30970442]; Project of Public Benefit [201104073]; TNC	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Public Benefit; TNC	This study was funded by 973 Program (2007CB411600), the project of Natural Science Foundation of China (No. 30970442), the Project of Public Benefit (No. 201104073), and TNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrell J, 1998, OIKOS, V83, P507, DOI 10.2307/3546678; Cui LW, 2006, AM J PRIMATOL, V68, P457, DOI 10.1002/ajp.20241; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; MOHNOT S M, 1971, Mammalia, V35, P175, DOI 10.1515/mamm.1971.35.2.175; Ren Bao-Ping, 2007, Acta Zoologica Sinica, V53, P755; Ren BP, 2003, INT J PRIMATOL, V24, P575; Struhsaker T.T., 1987, P83; van Schaik C.P., 2000, INFANTICIDE MALES IT; Xiang ZF, 2007, AM J PRIMATOL, V69, P249, DOI 10.1002/ajp.20333; Zhang P, 2008, AM J PRIMATOL, V70, P1013, DOI 10.1002/ajp.20591; Zhang SY, 1999, FOLIA PRIMATOL, V70, P274, DOI 10.1159/000021707; Zhao D, 2008, FOLIA PRIMATOL, V79, P93, DOI 10.1159/000109469	12	20	23	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18971	10.1371/journal.pone.0018971	http://dx.doi.org/10.1371/journal.pone.0018971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544198	gold, Green Submitted, Green Published			2022-12-25	WOS:000290015800028
J	Costa, V; Angelini, C; D'Apice, L; Mutarelli, M; Casamassimi, A; Sommese, L; Gallo, MA; Aprile, M; Esposito, R; Leone, L; Donizetti, A; Crispi, S; Rienzo, M; Sarubbi, B; Calabro, R; Picardi, M; Salvatore, P; Infante, T; De Berardinis, P; Napoli, C; Ciccodicola, A				Costa, Valerio; Angelini, Claudia; D'Apice, Luciana; Mutarelli, Margherita; Casamassimi, Amelia; Sommese, Linda; Gallo, Maria Assunta; Aprile, Marianna; Esposito, Roberta; Leone, Luigi; Donizetti, Aldo; Crispi, Stefania; Rienzo, Monica; Sarubbi, Berardo; Calabro, Raffaele; Picardi, Marco; Salvatore, Paola; Infante, Teresa; De Berardinis, Piergiuseppe; Napoli, Claudio; Ciccodicola, Alfredo			Massive-Scale RNA-Seq Analysis of Non Ribosomal Transcriptome in Human Trisomy 21	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; GENE-EXPRESSION PROFILE; DOWN-SYNDROME; SERIAL ANALYSIS; VASCULAR REPAIR; HUMAN GENOME; IDENTIFICATION; CHILDREN; DATABASE; REVEALS	Hybridization- and tag-based technologies have been successfully used in Down syndrome to identify genes involved in various aspects of the pathogenesis. However, these technologies suffer from several limits and drawbacks and, to date, information about rare, even though relevant, RNA species such as long and small non-coding RNAs, is completely missing. Indeed, none of published works has still described the whole transcriptional landscape of Down syndrome. Although the recent advances in high-throughput RNA sequencing have revealed the complexity of transcriptomes, most of them rely on polyA enrichment protocols, able to detect only a small fraction of total RNA content. On the opposite end, massive-scale RNA sequencing on rRNA-depleted samples allows the survey of the complete set of coding and non-coding RNA species, now emerging as novel contributors to pathogenic mechanisms. Hence, in this work we analysed for the first time the complete transcriptome of human trisomic endothelial progenitor cells to an unprecedented level of resolution and sensitivity by RNA-sequencing. Our analysis allowed us to detect differential expression of even low expressed genes crucial for the pathogenesis, to disclose novel regions of active transcription outside yet annotated loci, and to investigate a plethora of non-polyadenilated long as well as short non coding RNAs. Novel splice isoforms for a large subset of crucial genes, and novel extended untranslated regions for known genes-possibly novel miRNA targets or regulatory sites for gene transcription-were also identified in this study. Coupling the rRNA depletion of samples, followed by high-throughput RNA-sequencing, to the easy availability of these cells renders this approach very feasible for transcriptome studies, offering the possibility of investigating in-depth blood-related pathological features of Down syndrome, as well as other genetic disorders.	[Costa, Valerio; Aprile, Marianna; Esposito, Roberta; Leone, Luigi; Donizetti, Aldo; Crispi, Stefania; Ciccodicola, Alfredo] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Angelini, Claudia] CNR, Ist Applicaz Calcolo, I-80125 Naples, Italy; [D'Apice, Luciana; De Berardinis, Piergiuseppe] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Mutarelli, Margherita] TIGEM, Naples, Italy; [Casamassimi, Amelia; Rienzo, Monica; Napoli, Claudio] Univ Naples 2, Sch Med 1, Dept Gen Pathol, Naples, Italy; [Casamassimi, Amelia; Rienzo, Monica; Napoli, Claudio] Univ Naples 2, Excellence Res Ctr Cardiovasc Dis, Naples, Italy; [Sommese, Linda] Univ Naples 2, Sch Med 1, Dept Expt Med, Microbiol Sect, Naples, Italy; [Gallo, Maria Assunta] Ctr Diagnost San Ciro, Portici, Italy; [Sarubbi, Berardo; Calabro, Raffaele] Univ Naples 2, Dept Cardiol, Monaldi Hosp, Naples, Italy; [Picardi, Marco] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Salvatore, Paola] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol L Califano, Naples, Italy; [Salvatore, Paola] Ceinge Biotecnol Avanzate Scarl, Naples, Italy; [Infante, Teresa; Napoli, Claudio] IRCCS, Fdn SDN, Inst Diagnost & Nucl Dev, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate; IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN)	Costa, V (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy.	ciccodic@igb.cnr.it	Mutarelli, Margherita/K-1910-2019; De Berardinis, Piergiuseppe/AAX-1049-2020; Casamassimi, Amelia/AAD-2816-2020; Angelini, Claudia/J-4106-2012; Angelini, Claudia/AAL-2555-2020; De Berardinis, Piergiuseppe/HCI-0893-2022; Costa, Valerio/K-4505-2016; Infante, Teresa/K-8735-2016; Sarubbi, Berardo/AAL-1439-2021	De Berardinis, Piergiuseppe/0000-0001-6579-1729; Casamassimi, Amelia/0000-0002-6010-4261; Angelini, Claudia/0000-0001-8350-8464; Costa, Valerio/0000-0002-7294-6933; Infante, Teresa/0000-0002-1764-9610; Sarubbi, Berardo/0000-0001-9941-8500; DONIZETTI, Aldo/0000-0002-4344-0140; Napoli, Claudio/0000-0002-5455-555X; Rienzo, Monica/0000-0002-4496-4894; Mutarelli, Margherita/0000-0002-2168-5059; PICARDI, Marco/0000-0001-8508-2524; SALVATORE, Paola/0000-0002-7294-9253; Esposito, Roberta/0000-0001-6644-3195; Calabro, Raffaele/0000-0001-9546-8914; Ciccodicola, Alfredo/0000-0002-9924-1482; D'Apice, Luciana/0000-0002-6513-2237; Crispi, Stefania/0000-0002-7566-1554	COST Action from European Cooperation in the field of Scientific and Technical Research [BM1006]; Legge 5, Regione Campania; Progetto di Rilevante Interesse Nazionale Ministero Italiano Universita e Ricerca [Code0622153_002, Code2008T85HLH_002]; Regione Campania; Fondazione Telethon Funding Source: Custom	COST Action from European Cooperation in the field of Scientific and Technical Research; Legge 5, Regione Campania(Regione Campania); Progetto di Rilevante Interesse Nazionale Ministero Italiano Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Campania(Regione Campania); Fondazione Telethon(Fondazione Telethon)	This project was supported by COST Action BM1006: "Next Generation Sequencing Data Analysis Network" (NGS) from European Cooperation in the field of Scientific and Technical Research (C. Angelini and A. Ciccodicola); Legge 5, Regione Campania (A. Ciccodicola); Progetto di Rilevante Interesse Nazionale Ministero Italiano Universita e Ricerca 2006 and 2008 (Code0622153_002) "Meccanismi fisiopatologici di danno vascolare/trombotico ed angiogenesi" and (Code2008T85HLH_002) "Regolazione dell'espressione genica della via SIRT1/FoxO1- dipendente in cellule endoteliali progenitrici della nicchia vascolare" (C. Napoli); and Regione Campania 2008-2010 to the II University of Naples (C. Napoli). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildgaard L, 2006, ANN HEMATOL, V85, P275, DOI 10.1007/s00277-005-0045-5; ANDERS S, 2010, NATURE P; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Brochier C, 2008, PHYSIOL GENOMICS, V33, P170, DOI 10.1152/physiolgenomics.00125.2007; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Casamassimi A, 2007, J BIOCHEM, V141, P503, DOI 10.1093/jb/mvm060; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Cloonan N, 2009, BIOINFORMATICS, V25, P2615, DOI 10.1093/bioinformatics/btp459; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Costa V, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-40; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Diller GP, 2008, CIRCULATION, V117, P3020, DOI 10.1161/CIRCULATIONAHA.108.769646; DUKER AL, 2010, EUR J HUM GENET 0630; El-Meanawy MA, 2000, AM J PHYSIOL-RENAL, V279, pF383, DOI 10.1152/ajprenal.2000.279.2.F383; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; GREMMELS H, 2011, ANTIOXID REDOX 0214; Gruenblatt E, 2007, J ALZHEIMERS DIS, V12, P291; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harbers M, 2005, NAT METHODS, V2, P495, DOI 10.1038/NMETH768; Hashimoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004108; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Holmes DK, 2006, EXP HEMATOL, V34, P1611, DOI 10.1016/j.exphem.2006.10.013; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Jablonska B, 2006, CR BIOL, V329, P726, DOI 10.1016/j.crvi.2006.06.004; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001; Kuhn DE, 2008, BIOCHEM BIOPH RES CO, V370, P473, DOI 10.1016/j.bbrc.2008.03.120; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Langenberger D, 2010, BIOCOMPUT-PAC SYM, P80; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Lin AE, 2008, GENET MED, V10, P469, DOI [10.1097/GIM.0b013e3181772111, 10.1097GIM.0b013e3181772111]; Lindberg J, 2010, GENOMICS, V95, P1, DOI 10.1016/j.ygeno.2009.08.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malago W, 2005, CROAT MED J, V46, P647; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Napoli C, 2003, HEART, V89, P597, DOI 10.1136/heart.89.6.597; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; Napoli C, 2007, CURR PHARM DESIGN, V13, P3245, DOI 10.2174/138161207782341303; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Pauws E, 2000, J CLIN ENDOCR METAB, V85, P1923, DOI 10.1210/jc.85.5.1923; PONTING CP, 2010, HUM MOL GENET   0920; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; Salvatore P, 2008, P NATL ACAD SCI USA, V105, P9427, DOI 10.1073/pnas.0803602105; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Sommer CA, 2008, GENOME, V51, P19, DOI [10.1139/G07-100, 10.1139/g07-100]; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Taft RJ, 2010, NAT STRUCT MOL BIOL, V17, P1030, DOI 10.1038/nsmb.1841; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Takumi T, 2010, BRAIN DEV-JPN, V32, P753, DOI 10.1016/j.braindev.2010.05.001; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xu PT, 2007, MOL CELL NEUROSCI, V36, P313, DOI 10.1016/j.mcn.2007.06.009; Yamashita T, 2000, BIOCHEM BIOPH RES CO, V269, P110, DOI 10.1006/bbrc.2000.2272; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	79	49	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18493	10.1371/journal.pone.0018493	http://dx.doi.org/10.1371/journal.pone.0018493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533138	Green Submitted, gold, Green Published			2022-12-25	WOS:000289719400008
J	Liang, SL; He, LJ; Zhao, XD; Miao, Y; Gu, Y; Guo, CC; Xue, ZF; Dou, WJ; Hu, FR; Wu, KC; Nie, YZ; Fan, DM				Liang, Shuli; He, Lijie; Zhao, Xiaodi; Miao, Yu; Gu, Yong; Guo, Changcun; Xue, Zengfu; Dou, Weijia; Hu, Fengrong; Wu, Kaichun; Nie, Yongzhan; Fan, Daiming			MicroRNA Let-7f Inhibits Tumor Invasion and Metastasis by Targeting MYH9 in Human Gastric Cancer	PLOS ONE			English	Article							HEAVY-CHAIN PHOSPHORYLATION; BREAST-CANCER; MYOSIN-IIA; CELL-PROLIFERATION; EXPRESSION; GROWTH; PROFILES; SEQUENCE; DISEASE; BINDING	Background: MicroRNAs (miRNAs) are important regulators that play key roles in tumorigenesis and tumor progression. A previous report has shown that let-7 family members can act as tumor suppressors in many cancers. Through miRNA array, we found that let-7f was downregulated in the highly metastatic potential gastric cancer cell lines GC9811-P and SGC7901-M, when compared with their parental cell lines, GC9811 and SGC7901-NM; however, the mechanism was not clear. In this study, we investigate whether let-7f acts as a tumor suppressor to inhibit invasion and metastasis in gastric cancers. Methodology/Principal: Real-time PCR showed decreased levels of let-7f expression in metastatic gastric cancer tissues and cell lines that are potentially highly metastatic. Cell invasion and migration were significantly impaired in GC9811-P and SGC7901-M cell lines after transfection with let-7f-mimics. Nude mice with xenograft models of gastric cancer confirmed that let-7f could inhibit gastric cancer metastasis in vivo after transfection by the lentivirus pGCsil-GFP-let-7f. Luciferase reporter assays demonstrated that let-7f directly binds to the 3'UTR of MYH9, which codes for myosin IIA, and real-time PCR and Western blotting further indicated that let-7f downregulated the expression of myosin IIA at the mRNA and protein levels. Conclusions/Significance: Our study demonstrated that overexpression of let-7f in gastric cancer could inhibit invasion and migration of gastric cancer cells through directly targeting the tumor metastasis-associated gene MYH9. These data suggest that let-7f may be a novel therapeutic candidate for gastric cancer, given its ability to reduce cell invasion and metastasis.	[Liang, Shuli; He, Lijie; Zhao, Xiaodi; Miao, Yu; Gu, Yong; Guo, Changcun; Xue, Zengfu; Dou, Weijia; Hu, Fengrong; Wu, Kaichun; Nie, Yongzhan; Fan, Daiming] Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China; [Liang, Shuli; He, Lijie; Zhao, Xiaodi; Miao, Yu; Gu, Yong; Guo, Changcun; Xue, Zengfu; Dou, Weijia; Hu, Fengrong; Wu, Kaichun; Nie, Yongzhan; Fan, Daiming] Xijing Hosp Digest Dis, Inst Digest Dis, Xian, Peoples R China; [He, Lijie] Fourth Mil Med Univ, Dept Nephrol, Xijing Hosp, Xian 710032, Peoples R China; [Miao, Yu] Ningxia Med Univ, Dept Gastroenterol, Affiliated Hosp, Yinchuan, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Ningxia Medical University	Liang, SL (corresponding author), Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China.	nieyongzhan@gmail.com			National Natural Science Foundation of China [30801330, 30871143, 81030044]; National Basic Research Program of China [2010CB529300, 2010CB529306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (No. 30801330, No. 30871143, No. 81030044)) and the National Basic Research Program of China (No. 2010CB529300, No. 2010CB529306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Herszenyi L, 2010, EUR REV MED PHARMACO, V14, P249; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim EJ, 2003, J BIOL CHEM, V278, P30063, DOI 10.1074/jbc.M304909200; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Silva J, 2010, EUR RESP J; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Torrisani J, 2009, HUM GENE THER, V20, P831, DOI 10.1089/hum.2008.134; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634; White NM, 2010, BIOL CHEM, V391, P411, DOI 10.1515/BC.2010.041; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	49	153	170	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18409	10.1371/journal.pone.0018409	http://dx.doi.org/10.1371/journal.pone.0018409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533124	gold, Green Published, Green Submitted			2022-12-25	WOS:000289620100004
J	Pohle, G; Iken, K; Clarke, KR; Trott, T; Konar, B; Cruz-Motta, JJ; Wong, M; Benedetti-Cecchi, L; Mead, A; Miloslavich, P; Mieszkowska, N; Milne, R; Tamburello, L; Knowlton, A; Kimani, E; Shirayama, Y				Pohle, Gerhard; Iken, Katrin; Clarke, K. Robert; Trott, Thomas; Konar, Brenda; Jose Cruz-Motta, Juan; Wong, Melisa; Benedetti-Cecchi, Lisandro; Mead, Angela; Miloslavich, Patricia; Mieszkowska, Nova; Milne, Rebecca; Tamburello, Laura; Knowlton, Ann; Kimani, Edward; Shirayama, Yoshihisa			Aspects of Benthic Decapod Diversity and Distribution from Rocky Nearshore Habitat at Geographically Widely Dispersed Sites	PLOS ONE			English	Article							MARINE BIODIVERSITY; SPECIES-RICHNESS; PATTERNS; GRADIENTS	Relationships of diversity, distribution and abundance of benthic decapods in intertidal and shallow subtidal waters to 10 m depth are explored based on data obtained using a standardized protocol of globally-distributed samples. Results indicate that decapod species richness overall is low within the nearshore, typically ranging from one to six taxa per site (mean = 4.5). Regionally the Gulf of Alaska decapod crustacean community structure was distinguishable by depth, multivariate analysis indicating increasing change with depth, where assemblages of the high and mid tide, low tide and 1 m, and 5 and 10 m strata formed three distinct groups. Univariate analysis showed species richness increasing from the high intertidal zone to 1 m subtidally, with distinct depth preferences among the 23 species. A similar depth trend but with peak richness at 5 m was observed when all global data were combined. Analysis of latitudinal trends, confined by data limitations, was equivocal on a global scale. While significant latitudinal differences existed in community structure among ecoregions, a semi-linear trend in changing community structure from the Arctic to lower latitudes did not hold when including tropical results. Among boreal regions the Canadian Atlantic was relatively species poor compared to the Gulf of Alaska, whereas the Caribbean and Sea of Japan appeared to be species hot spots. While species poor, samples from the Canadian Atlantic were the most diverse at the higher infraordinal level. Linking 11 environmental variables available for all sites to the best fit family-based biotic pattern showed a significant relationship, with the single best explanatory variable being the level of organic pollution and the best combination overall being organic pollution and primary productivity. While data limitations restrict conclusions in a global context, results are seen as a first-cut contribution useful in generating discussion and more in-depth work in the still poorly understood field of biodiversity distribution.	[Pohle, Gerhard] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada; [Iken, Katrin; Konar, Brenda; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Clarke, K. Robert] Plymouth Marine Lab, Plymouth, Devon, England; [Trott, Thomas] Suffolk Univ, Dept Biol, Boston, MA 02114 USA; [Jose Cruz-Motta, Juan; Miloslavich, Patricia] Univ Simon Bolivar, Ctr Biodiversidad Marina, Dept Estudios Ambientales, Caracas, Venezuela; [Wong, Melisa] Bedford Inst Oceanog, Dartmouth, NS, Canada; [Benedetti-Cecchi, Lisandro; Tamburello, Laura] Univ Pisa, CoNISMa Natl Interuniv Consortium Marine Sci, Pisa, Italy; [Mead, Angela; Milne, Rebecca] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa; [Mieszkowska, Nova] Marine Biol Assoc UK, Plymouth, Devon, England; [Kimani, Edward] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Wakayama, Japan	University of Alaska System; University of Alaska Fairbanks; Plymouth Marine Laboratory; Suffolk University; Simon Bolivar University; Bedford Institute of Oceanography; University of Pisa; University of Cape Town; Marine Biological Association United Kingdom; Kyoto University	Pohle, G (corresponding author), Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada.	gpohle@huntsmanmarine.ca	Trott, Thomas J/N-4660-2018; Mieszkowska, Nova/U-8479-2019; Benedetti-Cecchi, Lisandro/J-8225-2019; Clarke, K Robert/A-5934-2012	Trott, Thomas J/0000-0002-1851-5243; Mieszkowska, Nova/0000-0002-9570-7759; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Cruz Motta, Juan Jose/0000-0001-6117-9014; Miloslavich, Patricia/0000-0001-5409-1401; TAMBURELLO, LAURA/0000-0003-1305-8802	Alfred P. Sloan Foundation; Alaska Sea Grant; South African Environmental Observation Network (SAEON); University of Pisa; Italian Ministry of Education and Research; History of Marine Populations (HMAP); Nippon Foundation; Coastal Biodiversity Lab (Cimar); West Indian Ocean Marine Science Association (WIOMSA); Fisheries and Oceans Canada (DFO); Suffolk University	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Alaska Sea Grant; South African Environmental Observation Network (SAEON)(National Research Foundation - South Africa); University of Pisa; Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); History of Marine Populations (HMAP); Nippon Foundation(Nippon Foundation); Coastal Biodiversity Lab (Cimar); West Indian Ocean Marine Science Association (WIOMSA); Fisheries and Oceans Canada (DFO); Suffolk University	Funding was provided by multiple sources, including the Alfred P. Sloan Foundation, the Exxon Valdez Oil Spill Gulf Ecosystem Monitoring Program, Alaska Sea Grant, the South African Environmental Observation Network (SAEON), the University of Pisa, the Italian Ministry of Education and Research, the History of Marine Populations (HMAP), the Nippon Foundation, the Marine Biodiversity and Ecosystem Functioning Program (MarBEF), the Coastal Biodiversity Lab (Cimar), the West Indian Ocean Marine Science Association (WIOMSA), Fisheries and Oceans Canada (DFO), Suffolk University, the History of the Near Shore (HNS) program, and the Gulf of Maine (GoMA) project. The sponsors had no role in the design or conduct of the study; data collection, analysis and interpretation; decision to publish, or preparation, review or approval of the manuscript.	Anderson MJ, 2008, PERMANOVA A PRIMER G; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benedetti-Cecchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012946; Boschi EE, 2000, J CRUSTACEAN BIOL, V20, P337, DOI 10.1163/1937240X-90000036; Bremner J, 2006, ECOL INDIC, V6, P609, DOI 10.1016/j.ecolind.2005.08.026; Bremner J, 2003, MAR ECOL PROG SER, V254, P11, DOI 10.3354/meps254011; BRIGGS JC, 1994, SYST BIOL, V43, P130, DOI 10.2307/2413586; Carlton JT, 1995, OCEANUS, V38, P6; CLARKE A, 1992, TRENDS ECOL EVOL, V7, P286, DOI 10.1016/0169-5347(92)90222-W; Clarke A, 1997, MARINE BIODIVERSITY-BOOK, P122, DOI 10.1017/CBO9780511752360.007; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Cullen V, 1995, OCEANUS, V38, P2; CULOTTA E, 1994, SCIENCE, V263, P918, DOI 10.1126/science.263.5149.918; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Gaston Kevin J., 1996, P202; Gaston KJ, 1996, PROG PHYS GEOG, V20, P466, DOI 10.1177/030913339602000406; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GRASSLE JF, 1991, BIOL INT SPECIAL ISS, V23, pR1; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Gray JS, 2001, POLAR BIOL, V24, P633, DOI 10.1007/s003000100244; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HINRICHSEN D, 1995, COASTS CRISIS; Iken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013845; Cruz-Motta JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014354; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Konar B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013195; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; LIDGARD S, 1990, PALEOBIOLOGY, V16, P304, DOI 10.1017/S0094837300010010; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; McClain CR, 2004, DEEP-SEA RES PT II, V51, P5, DOI 10.1016/j.dsr2.2003.11.001; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; *NAT RES COUNC, 1995, UND MAR BIOD RES AG, V7; Norse E.A., 1993, GLOBAL MARINE BIOL D; NORSE EA, 1995, B MAR SCI, V57, P10; NORSE EA, 2005, MARINE CONSERVATION, P105; Norse Elliott A., 2005, P1; Ormond RFG, 1996, J MAR BIOL ASSOC UK, V76, P151, DOI 10.1017/S0025315400029076; Pockley P, 2000, NATURE, V407, P932, DOI 10.1038/35039690; Raffaelli D, 2004, SCIENCE, V306, P1141, DOI 10.1126/science.1106365; RAY GC, 1991, BIOSCIENCE, V41, P453, DOI 10.2307/1311799; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; Rex MA, 2000, P NATL ACAD SCI USA, V97, P4082, DOI 10.1073/pnas.050589497; RIGBY PR, 2007, SAMPLING DIVERSITY C; Sherman K, 2007, NMFSNE208 NOAA US DE; Snelgrove PVR, 2010, DISCOVERIES CENSUS M, P286; STEVENSON JR, 1985, BIOL CRUSTACEA, V9, P3; Thorne-Miller B., 1991, LIVING OCEAN UNDERST; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	56	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18606	10.1371/journal.pone.0018606	http://dx.doi.org/10.1371/journal.pone.0018606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533220	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600013
J	Boch, S; Prati, D; Werth, S; Ruetschi, J; Fischer, M				Boch, Steffen; Prati, Daniel; Werth, Silke; Rueetschi, Joerg; Fischer, Markus			Lichen Endozoochory by Snails	PLOS ONE			English	Article							LOBARIA-PULMONARIA; SEED DISPERSAL; IDENTIFICATION	Endozoochory plays a prominent role for the dispersal of seed plants. However, for most other plant taxa it is not known whether this mode of dispersal occurs at all. Among those other taxa, lichens as symbiotic associations of algae and fungi are peculiar as their successful dispersal requires movement of propagules that leaves the symbiosis functional. However, the potential for endozoochorous dispersal of lichen fragments has been completely overlooked. We fed sterile thalli of two foliose lichen species (Lobaria pulmonaria and Physcia adscendens) differing in habitat and air-quality requirements to nine snail species common in temperate Europe. We demonstrated morphologically that L. pulmonaria regenerated from 29.0% of all 379 fecal pellets, whereas P. adscendens regenerated from 40.9% of all 433 fecal pellets, showing that lichen fragments survived gut passage of all snail species. Moreover, molecular analysis of regenerated lichens confirmed the species identity for a subset of samples. Regeneration rates were higher for the generalist lichen species P. adscendens than for the specialist lichen species L. pulmonaria. Furthermore, lichen regeneration rates varied among snail species with higher rates after gut passage of heavier snail species. We suggest that gastropods generally grazing on lichen communities are important, but so far completely overlooked, as vectors for lichen dispersal. This opens new ecological perspectives and questions the traditional view of an entirely antagonistic relationship between gastropods and lichens.	[Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Bot Garden, Inst Plant Sci, Bern, Switzerland; [Boch, Steffen; Prati, Daniel; Fischer, Markus] Univ Bern, Oeschger Ctr, Bern, Switzerland; [Werth, Silke] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland	University of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Boch, S (corresponding author), Univ Bern, Bot Garden, Inst Plant Sci, Bern, Switzerland.	steffen.boch@ips.unibe.ch	Werth, Silke/I-4757-2012; Boch, Steffen/L-5436-2016; Fischer, Markus/C-6411-2008; Werth, Silke/AAB-7138-2020	Werth, Silke/0000-0002-4981-7850; Fischer, Markus/0000-0002-5589-5900; 	DFG (German Research Foundation) [FI 1246/6-1]	DFG (German Research Foundation)(German Research Foundation (DFG))	The DFG (German Research Foundation; http://www.dfg.de/en/index.jsp) funded the study in the framework of the Biodiversity Exploratories SSP 1374 (FI 1246/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asplund J, 2008, OECOLOGIA, V155, P93, DOI 10.1007/s00442-007-0891-z; Asplund J, 2010, LICHENOLOGIST, V42, P113, DOI 10.1017/S0024282909990284; Asplund J, 2010, J ECOL, V98, P218, DOI 10.1111/j.1365-2745.2009.01584.x; Budel B, 2008, LICHEN BIOLOGY, 2ND EDITION, P40, DOI 10.1017/CBO9780511790478.005; Dal Grande F, 2010, CONSERV GENET, V11, P1147, DOI 10.1007/s10592-009-9904-2; Duthie C, 2006, SCIENCE, V311, P1575, DOI 10.1126/science.1123544; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Froberg L, 2001, LICHENOLOGIST, V33, P543, DOI 10.1006/lich.2001.0355; Fuentes M, 2000, TRENDS ECOL EVOL, V15, P487, DOI 10.1016/S0169-5347(00)02031-0; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gauslaa Y, 2008, PLANT BIOLOGY, V10, P711, DOI 10.1111/j.1438-8677.2008.00074.x; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; Lucking Robert, 2000, Ecotropica, V6, P23; Lutzoni F, 2009, CURR BIOL, V19, pR502, DOI 10.1016/j.cub.2009.04.034; Meier FA, 2002, BIOL J LINN SOC, V76, P259, DOI 10.1111/j.1095-8312.2002.tb02087.x; R Core Team, 2022, R LANG ENV STAT COMP; Rees W. J., 1965, Proceedings of the Malacological Society of London, V36, P269; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Seaward MRD, 2008, LICHEN BIOLOGY, 2ND EDITION, P274, DOI 10.1017/CBO9780511790478.015; Turke M, 2010, OECOLOGIA, V163, P681, DOI 10.1007/s00442-010-1612-6; Turner H., 1998, FAUNA HELVETICA, V2; Vatne S, 2010, LICHENOLOGIST, V42, P615, DOI 10.1017/S0024282910000356; Werth S, 2010, MOL ECOL RESOUR, V10, P401, DOI 10.1111/j.1755-0998.2009.02760.x; Werth S, 2008, AM J BOT, V95, P568, DOI 10.3732/ajb.2007024; Werth S, 2007, MOL ECOL, V16, P2807, DOI 10.1111/j.1365-294X.2007.03344.x; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; Werth S, 2010, LICHENOLOGIST, V43, P73, DOI 10.1017/S0024282910000563; White T., 1990, PCR PROTOCOLS GUIDE, P315; Widmer I, 2010, FUNGAL BIOL-UK, V114, P538, DOI 10.1016/j.funbio.2010.04.003	30	35	39	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18770	10.1371/journal.pone.0018770	http://dx.doi.org/10.1371/journal.pone.0018770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533256	Green Published, gold			2022-12-25	WOS:000289458800040
J	Marrelec, G; Fransson, P				Marrelec, Guillaume; Fransson, Peter			Assessing the Influence of Different ROI Selection Strategies on Functional Connectivity Analyses of fMRI Data Acquired During Steady-State Conditions	PLOS ONE			English	Article							PRINCIPAL-COMPONENT ANALYSIS; DEFAULT-MODE NETWORK; BOLD SIGNAL; HUMAN BRAIN; CINGULATE CORTEX; INTERACTIVITY; FLUCTUATIONS; ARCHITECTURE; INTEGRATION; REGIONS	In blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI), assessing functional connectivity between and within brain networks from datasets acquired during steady-state conditions has become increasingly common. However, in contrast to connectivity analyses based on task-evoked signal changes, selecting the optimal spatial location of the regions of interest (ROIs) whose timecourses will be extracted and used in subsequent analyses is not straightforward. Moreover, it is also unknown how different choices of the precise anatomical locations within given brain regions influence the estimates of functional connectivity under steady-state conditions. The objective of the present study was to assess the variability in estimates of functional connectivity induced by different anatomical choices of ROI locations for a given brain network. We here targeted the default mode network (DMN) sampled during both resting-state and a continuous verbal 2-back working memory task to compare four different methods to extract ROIs in terms of ROI features (spatial overlap, spatial functional heterogeneity), signal features (signal distribution, mean, variance, correlation) as well as strength of functional connectivity as a function of condition. We show that, while different ROI selection methods produced quantitatively different results, all tested ROI selection methods agreed on the final conclusion that functional connectivity within the DMN decreased during the continuous working memory task compared to rest.	[Marrelec, Guillaume] INSERM, U678, Paris, France; [Marrelec, Guillaume] Univ Paris 06, UMR S 678, Paris, France; [Marrelec, Guillaume] Univ Montreal, INSERM, LINeM, Montreal, PQ, Canada; [Fransson, Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal; Karolinska Institutet	Marrelec, G (corresponding author), INSERM, U678, Paris, France.	marrelec@imed.jussieu.fr	Fransson, Peter/M-5679-2014	Fransson, Peter/0000-0002-1305-9875	INSERM; Karolinska Institute Research Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Karolinska Institute Research Foundation(Karolinska Institutet)	G. M. was funded by the INSERM. P. F. was funded by a grant from the Karolinska Institute Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TW, 1962, ANN MATH STAT, V33, P1148, DOI 10.1214/aoms/1177704477; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Coynel D, 2010, NEUROIMAGE, V49, P759, DOI 10.1016/j.neuroimage.2009.08.048; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Della-Maggiore V, 2002, NEUROIMAGE, V17, P19, DOI 10.1006/nimg.2002.1113; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; FRONTIER S, 1976, J EXP MAR BIOL ECOL, V25, P67, DOI 10.1016/0022-0981(76)90076-9; Garner WR., 1962, UNCERTAINTY STRUCTUR; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; KIEFER J, 1959, ANN MATH STAT, V30, P420, DOI 10.1214/aoms/1177706261; KULLBACK S, 1968, INFORM THEORY STAT; LEHMANN EL, 1951, ANN MATH STAT, V22, P165, DOI 10.1214/aoms/1177729639; Lu YL, 2003, NEUROIMAGE, V20, P455, DOI 10.1016/S1053-8119(03)00352-5; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Marrelec G, 2005, IEEE IJCNN, P1528; Marrelec G, 2005, IEEE T SIGNAL PROCES, V53, P3503, DOI 10.1109/TSP.2005.853211; Marrelec G, 2009, HUM BRAIN MAPP, V30, P941, DOI 10.1002/hbm.20555; MARRELEC G, 2009, COMPUT INTEL NEUROSC; Marrelec G, 2008, MED IMAGE ANAL, V12, P484, DOI 10.1016/j.media.2008.02.002; Marrelec G, 2007, MAGN RESON IMAGING, V25, P1181, DOI 10.1016/j.mri.2007.02.012; Marrelec G, 2006, NEUROIMAGE, V32, P228, DOI 10.1016/j.neuroimage.2005.12.057; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; ROSENBLATT M, 1952, ANN MATH STAT, V23, P617, DOI 10.1214/aoms/1177729341; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; SALVADOR R, 2005, CEREB CORTEX, V34, P387; SAPORTA G, 1990, PROBABILITES ANAL DO; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sokal R. R., 2012, BIOMETRY; Strother SC, 2006, IEEE ENG MED BIOL, V25, P27, DOI 10.1109/MEMB.2006.1607667; Studeny M, 1998, NATO ADV SCI I D-BEH, V89, P261; STUDENY M, 1989, PROBL CONTROL INFORM, V18, P3; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanabe J, 2002, NEUROIMAGE, V15, P902, DOI 10.1006/nimg.2002.1053; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; WATANABE S, 1960, IBM J RES DEV, V4, P66, DOI 10.1147/rd.41.0066	56	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e14788	10.1371/journal.pone.0014788	http://dx.doi.org/10.1371/journal.pone.0014788			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533283	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800001
J	Alhouayek, M; Lambert, DM; Delzenne, NM; Cani, PD; Muccioli, GG				Alhouayek, Mireille; Lambert, Didier M.; Delzenne, Nathalie M.; Cani, Patrice D.; Muccioli, Giulio G.			Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation	FASEB JOURNAL			English	Article						monoacylglycerol lipase; fatty acid amide hydrolase; anandamide; endocannabinoid; lipopolysaccharide	CANNABINOID RECEPTOR 2; ACID AMIDE HYDROLASE; ULCERATIVE-COLITIS; BOWEL-DISEASE; MONOACYLGLYCEROL LIPASE; ENDOCANNABINOID SYSTEM; INTESTINAL PERMEABILITY; ANTAGONIST RIMONABANT; ALPHA PRODUCTION; GUT MICROBIOTA	Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions for which new therapeutic approaches are needed. Genetic and pharmacological data point to a protective role of CB1 and CB2 cannabinoid receptor activation in IBD experimental models. Therefore, increasing the endogenous levels of 2-arachidonoylglycerol, the main full agonist of these receptors, should have beneficial effects on colitis. 2-Arachidonoylglycerol levels were raised in the trinitrobenzene sulfonic acid (TNBS)-induced colitis mouse model by inhibiting monoacylglycerol lipase (MAGL), the primary enzyme responsible for hydrolysis of 2-arachidonoylglycerol, using the selective inhibitor JZL184. MAGL inhibition in diseased mice increased 2-arachidonoylglycerol levels, leading to a reduction of macroscopic and histological colon alterations, as well as of colonic expression of proinflammatory cytokines. The restored integrity of the intestinal barrier function after MAGL inhibition resulted in reduced endotoxemia as well as reduced peripheral and brain inflammation. Coadministration of either CB1 (SR141716A) or CB2 (AM630) selective antagonists with JZL184 completely abolished the protective effect of MAGL inhibition on TNBS-induced colon alterations, thus demonstrating the involvement of both cannabinoid receptors. In conclusion, increasing 2-arachidonoylglycerol levels resulted in a dramatic reduction of colitis and of the related systemic and central inflammation. This could offer a novel pharmacological approach for the treatment of IBD based on the new protective role of 2-arachidonoylglycerol described here.-Alhouayek, M., Lambert, D. M., Delzenne, N. M., Cani, P. D., Muccioli, G. G. Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. FASEB J. 25, 2711-2721 (2011). www.fasebj.org	[Alhouayek, Mireille; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, CHAM7230, B-1200 Brussels, Belgium; [Alhouayek, Mireille; Lambert, Didier M.] Catholic Univ Louvain, Med Chem Grp, CMFA7340, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Delzenne, Nathalie M.; Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, PMNT7369, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Muccioli, GG (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, CHAM7230, Av E Mounier 72, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	Alhouayek, Mireille/R-5058-2018; Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016	Alhouayek, Mireille/0000-0002-9193-0718; Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Muccioli, Giulio/0000-0002-1600-9259	Fonds Speciaux de Recherches (FSR; Universite Catholique de Louvain); Fonds National de la Recherche Scientifique, Belgium (FNRS) [FRFC 2.4555.08]	Fonds Speciaux de Recherches (FSR; Universite Catholique de Louvain); Fonds National de la Recherche Scientifique, Belgium (FNRS)(Fonds de la Recherche Scientifique - FNRS)	The authors thank Dr. Audrey Neyrinck, Owein Guillemot-Legris, and Damien Naslain for their skillful help. G.G.M. is the recipient of a subsidy from the Fonds Speciaux de Recherches (FSR; Universite Catholique de Louvain) and is also grateful to the Fonds National de la Recherche Scientifique, Belgium (FNRS; grant FRFC 2.4555.08). P.D.C. is a research associate with the Fonds de la Recherche Scientifique (FRS-FNRS).	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Ameho CK, 1997, GUT, V41, P487, DOI 10.1136/gut.41.4.487; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; Croci T, 2007, BRIT J PHARMACOL, V150, P559, DOI 10.1038/sj.bjp.0707138; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; D'Inca R, 1999, AM J GASTROENTEROL, V94, P2956, DOI 10.1111/j.1572-0241.1999.01444.x; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Duncan M, 2008, AM J PHYSIOL-GASTR L, V295, pG1255, DOI 10.1152/ajpgi.90500.2008; Engel MA, 2010, J PHYSIOL PHARMACOL, V61, P89; Engel MA, 2008, J PHYSIOL PHARMACOL, V59, P673; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Fiorino G, 2010, CURR DRUG TARGETS, V11, P249, DOI 10.2174/138945010790309975; Galvez J, 2000, BRIT J PHARMACOL, V130, P1949, DOI 10.1038/sj.bjp.0703505; GARDINER KR, 1995, GUT, V36, P897, DOI 10.1136/gut.36.6.897; Geng DC, 2010, J BIOMED MATER RES A, V95A, P321, DOI 10.1002/jbm.a.32836; Ghafouri N, 2004, BRIT J PHARMACOL, V143, P774, DOI 10.1038/sj.bjp.0705948; Ghosh N, 2010, INT REV IMMUNOL, V29, P4, DOI 10.3109/08830180903437212; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Melmed GY, 2010, NAT REV GASTRO HEPAT, V7, P110, DOI 10.1038/nrgastro.2009.218; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Rogler G, 2010, BEST PRACT RES CL GA, V24, P157, DOI 10.1016/j.bpg.2009.10.011; Schafer A, 2008, BRIT J PHARMACOL, V154, P1047, DOI 10.1038/bjp.2008.158; Shi DN, 2006, CELL RES, V16, P70, DOI 10.1038/sj.cr.7310009; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Storr M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009453; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Storr MA, 2009, INFLAMM BOWEL DIS, V15, P1678, DOI 10.1002/ibd.20960; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Suzuki K, 2007, PATHOL INT, V57, P413, DOI 10.1111/j.1440-1827.2007.02117.x; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Zhou F, 2010, J INT MED RES, V38, P2023, DOI 10.1177/147323001003800616	55	154	160	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2711	2721		10.1096/fj.10-176602	http://dx.doi.org/10.1096/fj.10-176602			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21551239				2022-12-25	WOS:000293337800020
J	Rauscher, AA; Simon, Z; Szollosi, GJ; Graf, L; Derenyi, I; Malnasi-Csizmadia, A				Rauscher, Anna A.; Simon, Zoltan; Szoellosi, Gergely J.; Graf, Laszlo; Derenyi, Imre; Malnasi-Csizmadia, Andras			Temperature dependence of internal friction in enzyme reactions	FASEB JOURNAL			English	Article						trypsin activation; rough energy landscape; Kramers' theory	SOLVENT VISCOSITY; ALPHA-CHYMOTRYPSIN; CONFORMATIONAL-CHANGES; CHEMICAL-REACTIONS; ENERGY LANDSCAPE; PROTEIN DYNAMICS; HUMAN TRYPSIN-4; LIGAND-BINDING; DIFFUSION; ACTIVATION	Our aim was to elucidate the physical background of internal friction of enzyme reactions by investigating the temperature dependence of internal viscosity. By rapid transient kinetic methods, we directly measured the rate constant of trypsin 4 activation, which is an interdomain conformational rearrangement, as a function of temperature and solvent viscosity. We found that the apparent internal viscosity shows an Arrhenius-like temperature dependence, which can be characterized by the activation energy of internal friction. Glycine and alanine mutations were introduced at a single position of the hinge of the interdomain region to evaluate how the flexibility of the hinge affects internal friction. We found that the apparent activation energies of the conformational change and the internal friction are interconvertible parameters depending on the protein flexibility. The more flexible a protein was, the greater proportion of the total activation energy of the reaction was observed as the apparent activation energy of internal friction. Based on the coupling of the internal and external movements of the protein during its conformational change, we constructed a model that quantitatively relates activation energy, internal friction, and protein flexibility.-Rauscher, A. A., Simon, Z., Szollosi, G. J., Graf, L., Derenyi, I., Malnasi-Csizmadia, A. Temperature dependence of internal friction in enzyme reactions. FASEB J. 25, 2804-2813 (2011). www.fasebj.org	[Rauscher, Anna A.; Simon, Zoltan; Graf, Laszlo; Malnasi-Csizmadia, Andras] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Szoellosi, Gergely J.; Derenyi, Imre] Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary; [Simon, Zoltan] Delta Informat Inc, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Malnasi-Csizmadia, A (corresponding author), Eotvos Lorand Univ, Dept Biochem, Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	malna@elte.hu	Szollosi, Gergely/AAG-5760-2019; Derenyi, Imre/G-8087-2011; Rauscher, Anna Á/I-3941-2017; Csizmadia, András Málnási/K-7632-2018	Szollosi, Gergely/0000-0002-8556-845X; Derenyi, Imre/0000-0003-1171-1214; Rauscher, Anna Á/0000-0002-4062-960X; Csizmadia, András Málnási/0000-0002-2430-8398	European Research Council; European Union; European Social Fund [TAMOP-4.2.1/B-09/1/KMR]; OTKA [K60665]	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); European Social Fund(European Social Fund (ESF)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The authors thank Vilmosne Enekes for the preparation of the enzyme constructs. This work was supported by European Research Council IDEAS 2007 (to A.M.-C.), the European Union and the European Social Fund (TAMOP-4.2.1/B-09/1/KMR; to A.M.-C., I.D., and L.G.), and the OTKA (K60665; to I.D.).	AGMON N, 1983, J CHEM PHYS, V78, P6947, DOI 10.1063/1.444643; ANSARI A, 1994, BIOCHEMISTRY-US, V33, P5128, DOI 10.1021/bi00183a017; ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001; Bobofchak KM, 2005, J BIOL CHEM, V280, P25644, DOI 10.1074/jbc.M503499200; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; FERSHT AR, 1974, BIOCHEMISTRY-US, V13, P1416, DOI 10.1021/bi00704a016; FESTA R, 1978, PHYSICA A, V90, P229, DOI 10.1016/0378-4371(78)90111-5; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gombos L, 2008, BIOCHEMISTRY-US, V47, P1675, DOI 10.1021/bi701454e; Hagen SJ, 2010, CURR PROTEIN PEPT SC, V11, P385; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; HEREMANS L, 1989, BIOCHIM BIOPHYS ACTA, V999, P192, DOI 10.1016/0167-4838(89)90217-3; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Neuweiler H, 2009, P NATL ACAD SCI USA, V106, P18569, DOI 10.1073/pnas.0910860106; Nevo R, 2005, EMBO REP, V6, P482, DOI 10.1038/sj.embor.7400403; Pabit SA, 2004, BIOCHEMISTRY-US, V43, P12532, DOI 10.1021/bi048822m; Plaxco KW, 1998, P NATL ACAD SCI USA, V95, P13591, DOI 10.1073/pnas.95.23.13591; Qiu LL, 2004, J AM CHEM SOC, V126, P3398, DOI 10.1021/ja049966r; Rampp M, 2000, CARBOHYD RES, V328, P561, DOI 10.1016/S0008-6215(00)00141-5; STOESZ JD, 1978, BIOCHEMISTRY-US, V17, P3693, DOI 10.1021/bi00611a003; Suda H, 2001, LANGMUIR, V17, P6045, DOI 10.1021/la0106384; Toth J, 2006, J BIOL CHEM, V281, P12596, DOI 10.1074/jbc.M512301200; Toth J, 2007, PROTEINS, V67, P1119, DOI 10.1002/prot.21398; Verheyden G, 2004, PROTEIN SCI, V13, P2533, DOI 10.1110/ps.04709604; Viswanath D. S., 2007, VISCOSITY LIQUIDS; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029; ZWANZIG R, 1992, J CHEM PHYS, V97, P3587, DOI 10.1063/1.462993	32	11	12	1	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2011	25	8					2804	2813		10.1096/fj.11-180794	http://dx.doi.org/10.1096/fj.11-180794			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21555355				2022-12-25	WOS:000293337800028
J	Leshchyns'ka, I; Tanaka, MM; Schachner, M; Sytnyk, V				Leshchyns'ka, Iryna; Tanaka, Mark M.; Schachner, Melitta; Sytnyk, Vladimir			Immobilized Pool of NCAM180 in the Postsynaptic Membrane Is Homeostatically Replenished by the Flux of NCAM180 from Extrasynaptic Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; LONG-TERM POTENTIATION; MEDIATED NEURITE OUTGROWTH; DENDRITIC SPINE STABILITY; NMDA RECEPTOR ACTIVATION; NULL MUTANT MICE; SYNAPTIC PLASTICITY; POLYSIALIC ACID; N-CAM; EXCITATORY SYNAPSE	Homeostatic mechanisms maintaining high levels of adhesion molecules in synapses over prolonged periods of time remain incompletely understood. We used fluorescence recovery after photobleaching experiments to analyze the steady state turnover of the immobile pool of green fluorescent protein-labeled NCAM180, the largest postsynaptically accumulating isoform of the neural cell adhesion molecule (NCAM). We show that there is a continuous flux of NCAM180 to the postsynaptic membrane from nonsynaptic regions of dendrites by diffusion. In the postsynaptic membrane, the newly delivered NCAM180 slowly intermixes with the immobilized pool of NCAM180. Preferential immobilization and accumulation of NCAM180 in the postsynaptic membrane is reduced after disruption of the association of NCAM180 with the spectrin cytoskeleton and in the absence of the homophilic interactions of NCAM180 in synapses. Our observations indicate that the homophilic interactions and binding to the cytoskeleton promote immobilization of NCAM180 and its accumulation in the postsynaptic membrane. Flux of NCAM180 from extrasynaptic regions and its slow intermixture with the immobile pool of NCAM180 in the postsynaptic membrane may be important for the continuous homeostatic replenishment of NCAM180 protein at synaptic contacts without compromising the long term synaptic contact stability.	[Leshchyns'ka, Iryna; Tanaka, Mark M.; Sytnyk, Vladimir] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Leshchyns'ka, Iryna; Schachner, Melitta; Sytnyk, Vladimir] Univ Krankenhaus Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of New South Wales Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sytnyk, V (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	v.sytnyk@unsw.edu.au	Sytnyk, Vladimir/A-3878-2010	Leshchyns'ka, Iryna/0000-0002-2025-5831; Sytnyk, Vladimir/0000-0003-1927-2199	Deutsche Forschungsgemeinschaft; National Health and Medical Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funds from the Deutsche Forschungsgemeinschaft (to M. S., I. L., and V. S.) and the National Health and Medical Research Council (to V. S.).	Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Andreyeva A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012018; Aonurm-Helm A, 2010, BRAIN RES, V1309, P1, DOI 10.1016/j.brainres.2009.11.003; Aonurm-Helm A, 2008, BRAIN RES, V1243, P104, DOI 10.1016/j.brainres.2008.08.091; Arai M, 2004, BIOL PSYCHIAT, V55, P804, DOI 10.1016/j.biopsych.2004.01.009; Atz ME, 2007, PSYCHIAT GENET, V17, P55, DOI 10.1097/YPG.0b013e328012d850; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; Conchonaud F, 2007, J BIOL CHEM, V282, P26266, DOI 10.1074/jbc.M608590200; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Fux CM, 2003, MOL CELL NEUROSCI, V24, P939, DOI 10.1016/j.mcn.2003.07.001; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Jacobson KA, 1997, BBA-BIOMEMBRANES, V1330, P138, DOI 10.1016/S0005-2736(97)00128-4; KEANE RW, 1988, J CELL BIOL, V106, P1307, DOI 10.1083/jcb.106.4.1307; Kielland A, 2009, NEURON, V62, P84, DOI 10.1016/j.neuron.2009.03.001; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KISS JZ, 1994, EMBO J, V13, P5284, DOI 10.1002/j.1460-2075.1994.tb06862.x; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Korshunova I, 2007, J NEUROCHEM, V100, P1599, DOI 10.1111/j.1471-4159.2006.04316.x; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Leshchyns'ka I, 2006, NEURON, V52, P1011, DOI 10.1016/j.neuron.2006.10.020; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Newpher TM, 2009, TRENDS CELL BIOL, V19, P218, DOI 10.1016/j.tcb.2009.02.004; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Park TU, 1997, BIOCHEM BIOPH RES CO, V234, P686, DOI 10.1006/bbrc.1997.6700; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Schapitz IU, 2010, J NEUROSCI, V30, P12733, DOI 10.1523/JNEUROSCI.0896-10.2010; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Simson R, 1998, BIOPHYS J, V74, P297, DOI 10.1016/S0006-3495(98)77787-2; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P902, DOI 10.1016/j.biopsych.2006.07.036; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; Thomas U, 2010, J NEUROGENET, V24, P109, DOI 10.3109/01677063.2010.493589; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Wu SH, 2009, DEV NEUROBIOL, V69, P547, DOI 10.1002/dneu.20723; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	62	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23397	23406		10.1074/jbc.M111.252098	http://dx.doi.org/10.1074/jbc.M111.252098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550975	hybrid, Green Published			2022-12-25	WOS:000292025000071
J	Patterson, KR; Remmers, C; Fu, YF; Brooker, S; Kanaan, NM; Vana, L; Ward, S; Reyes, JF; Philibert, K; Glucksman, MJ; Binder, LI				Patterson, Kristina R.; Remmers, Christine; Fu, Yifan; Brooker, Sarah; Kanaan, Nicholas M.; Vana, Laurel; Ward, Sarah; Reyes, Juan F.; Philibert, Keith; Glucksman, Marc J.; Binder, Lester I.			Characterization of Prefibrillar Tau Oligomers in Vitro and in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; TRANSGENIC MICE; MOUSE MODEL; A-BETA; CONFORMATIONAL-CHANGES; CASPASE CLEAVAGE; INDUCED DEFECTS; NEURONAL LOSS	Neurofibrillary tangles, composed of insoluble aggregates of the microtubule-associated protein Tau, are a pathological hallmark of Alzheimer disease (AD) and other tauopathies. However, recent evidence indicates that neuronal dysfunction precedes the formation of these insoluble fibrillar deposits, suggesting that earlier prefibrillar Tau aggregates may be neurotoxic. To determine the composition of these aggregates, we have employed a photochemical cross-linking technique to examine intermolecular interactions of full-length Tau in vitro. Using this method, we demonstrate that dimerization is an early event in the Tau aggregation process and that these dimers self-associate to form larger oligomeric aggregates. Moreover, using these stabilized Tau aggregates as immunogens, we generated a monoclonal antibody that selectively recognizes Tau dimers and higher order oligomeric aggregates but shows little reactivity to Tau filaments in vitro. Immunostaining indicates that these dimers/oligomers are markedly elevated in AD, appearing in early pathological inclusions such as neuropil threads and pre-tangle neurons as well as colocalizing with other early markers of Tau pathogenesis. Taken as a whole, the work presented herein demonstrates the existence of alternative Tau aggregates that precede formation of fibrillar Tau pathologies and raises the possibility that these hierarchical oligomeric forms of Tau may contribute to neurodegeneration.	[Patterson, Kristina R.; Remmers, Christine; Fu, Yifan; Brooker, Sarah; Vana, Laurel; Ward, Sarah; Reyes, Juan F.; Binder, Lester I.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Kanaan, Nicholas M.] Michigan State Univ, Div Translat Sci & Mol Med, Grand Rapids, MI 49503 USA; [Philibert, Keith; Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago Med Sch, Chicago, IL 60064 USA; [Philibert, Keith; Glucksman, Marc J.] Rosalind Franklin Univ Med & Sci, Midwest Proteome Ctr, Chicago Med Sch, Chicago, IL 60064 USA	Northwestern University; Feinberg School of Medicine; Michigan State University; Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	Patterson, KR (corresponding author), 300 E Super St,Tarry 8-754, Chicago, IL 60611 USA.	k-patterson@md.northwestern.edu	Brooker, Sarah/AAO-6122-2020; Kanaan, Nicholas M./J-3428-2016	Brooker, Sarah/0000-0002-5674-3124; Kanaan, Nicholas M./0000-0002-4362-2593	National Institutes of Health [T32 AF020506, AG09466]; National Center for Research Resources [S10 RR19325]; Health Resources and Services Administration [C76 HF03610-01-00]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG020506, P01AG009466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AF020506 (to K. R. P.), AG09466 (to L. I. B.), National Center for Research Resources S10 RR19325 (to M. J. G.), and Health Resources and Services Administration C76 HF03610-01-00 (to M. J. G.).	Abraha A, 2000, J CELL SCI, V113, P3737; Allen B, 2002, J NEUROSCI, V22, P9340; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Appelt DM, 1997, BRAIN RES, V745, P21, DOI 10.1016/S0006-8993(96)01121-3; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Balin BJ, 2000, METH MOLEC MED, V32, P395, DOI 10.1385/1-59259-195-7:395; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Berry RW, 2004, J NEUROCYTOL, V33, P287, DOI 10.1023/B:NEUR.0000044190.96426.b9; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CABRE F, 1989, J CHROMATOGR, V472, P347, DOI 10.1016/S0021-9673(00)94133-5; CARMEL G, 1994, J BIOL CHEM, V269, P7304; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; DUDEK SM, 1993, J NEUROCHEM, V61, P1159, DOI 10.1111/j.1471-4159.1993.tb03636.x; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P6136, DOI 10.1021/bi000201f; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P2252, DOI 10.1021/bi0272510; Garcia-Sierra F, 2003, J ALZHEIMERS DIS, V5, P65, DOI 10.3233/JAD-2003-5201; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; GUTTMANN RP, 1995, J NEUROCHEM, V64, P1209; Horowitz PM, 2006, BIOCHEMISTRY-US, V45, P12859, DOI 10.1021/bi061325g; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; Kanaan N. M., 2011, J NEUROSCI IN PRESS; Kanaan NM, 2007, J COMP NEUROL, V502, P683, DOI 10.1002/cne.21333; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu Q, 2005, FREE RADICAL BIO MED, V38, P746, DOI 10.1016/j.freeradbiomed.2004.11.005; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Luna-Munoz J, 2008, ACTA NEUROPATHOL, V116, P507, DOI 10.1007/s00401-008-0431-x; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Malaplate-Armand C, 2006, NEUROBIOL DIS, V23, P178, DOI 10.1016/j.nbd.2006.02.010; Mondragon-Rodriguez S, 2008, INT J EXP PATHOL, V89, P81, DOI 10.1111/j.1365-2613.2007.00568.x; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Novak M, 1989, Prog Clin Biol Res, V317, P755; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oosawa F., 1975, THERMODYNAMICS POLYM; Perez M, 1996, J NEUROCHEM, V67, P1183; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Poorkaj P, 2001, ARCH NEUROL-CHICAGO, V58, P383, DOI 10.1001/archneur.58.3.383; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Reyes JF, 2008, NEUROBIOL DIS, V31, P198, DOI 10.1016/j.nbd.2008.04.005; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sayre LM, 1997, J NEUROCHEM, V68, P2092; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Singer SM, 2002, NEUROCHEM INT, V40, P17, DOI 10.1016/S0197-0186(01)00061-4; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Tanemura K, 2001, NEUROBIOL DIS, V8, P1036, DOI 10.1006/nbdi.2001.0439; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382	86	230	240	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23063	23076		10.1074/jbc.M111.237974	http://dx.doi.org/10.1074/jbc.M111.237974			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550980	hybrid, Green Published			2022-12-25	WOS:000292025000041
J	Zhou, XX; Sun, X; Cooper, KL; Wang, F; Liu, KJ; Hudson, LG				Zhou, Xixi; Sun, Xi; Cooper, Karen L.; Wang, Feng; Liu, Ke Jian; Hudson, Laurie G.			Arsenite Interacts Selectively with Zinc Finger Proteins Containing C3H1 or C4 Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR; HUMAN KERATINOCYTES; SYNTHETIC PEPTIDES; MAMMALIAN-CELLS; PARP-1 ACTIVITY; DRINKING-WATER; BINDING; DAMAGE; POLY(ADP-RIBOSE); TOXICITY	Arsenic inhibits DNA repair and enhances the genotoxicity of DNA-damaging agents such as benzo[a] pyrene and ultraviolet radiation. Arsenic interaction with DNA repair proteins containing functional zinc finger motifs is one proposed mechanism to account for these observations. Here, we report that arsenite binds to both CCHC DNA-binding zinc fingers of the DNA repair protein PARP-1 (poly(ADP-ribose) polymerase-1). Furthermore, trivalent arsenite coordinated with all three cysteine residues as demonstrated by MS/MS. MALDI-TOF-MS analysis of peptides harboring site-directed substitutions of cysteine with histidine residues within the PARP-1 zinc finger revealed that arsenite bound to peptides containing three or four cysteine residues, but not to peptides with two cysteines, demonstrating arsenite binding selectivity. This finding was not unique to PARP-1; arsenite did not bind to a peptide representing the CCHH zinc finger of the DNA repair protein aprataxin, but did bind to an aprataxin peptide mutated to a CCHC zinc finger. To investigate the impact of arsenite on PARP-1 zinc finger function, we measured the zinc content and DNA-binding capacity of PARP-1 immunoprecipitated from arsenite-exposed cells. PARP-1 zinc content and DNA binding were decreased by 76 and 80%, respectively, compared with protein isolated from untreated cells. We observed comparable decreases in zinc content for XPA (xeroderma pigmentosum group A) protein (CCCC zinc finger), but not SP-1 (specificity protein-1) or aprataxin (CCHH zinc finger). These findings demonstrate that PARP-1 is a direct molecular target of arsenite and that arsenite interacts selectively with zinc finger motifs containing three or more cysteine residues.	[Zhou, Xixi; Sun, Xi; Cooper, Karen L.; Wang, Feng; Liu, Ke Jian; Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Liu, KJ (corresponding author), 1 Univ New Mexico, Coll Pharm, MSC09 5360, Albuquerque, NM 87131 USA.	kliu@salud.unm.edu; lhudson@salud.unm.edu	Zhou, Xixi/F-1760-2011; Zhou, Xixi/F-6474-2013	Zhou, Xixi/0000-0003-4202-8821; 	National Institutes of Health [R01 ES15826, R01 ES15826-03S1]; University of New Mexico Cancer Research and Treatment Center [NIH P30 CA118100]; University of New Mexico Proteomics/Mass Spectrometry Facility; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Cancer Research and Treatment Center; University of New Mexico Proteomics/Mass Spectrometry Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES15826 and R01 ES15826-03S1. This work was also supported by University of New Mexico Cancer Research and Treatment Center Grant NIH P30 CA118100 and the University of New Mexico Proteomics/Mass Spectrometry Facility.	Agency for Toxic Substances and Disease Registry U. S. Department of Health and Human Services. Syracuse Research Corporation, 2007, TOX PROF ARS; Aposhian HV, 2006, CHEM RES TOXICOL, V19, P1, DOI 10.1021/tx050106d; Asmuss M, 2000, CARCINOGENESIS, V21, P2097, DOI 10.1093/carcin/21.11.2097; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; Ding W, 2008, FREE RADICAL BIO MED, V45, P1065, DOI 10.1016/j.freeradbiomed.2008.06.022; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Germolec DR, 1998, AM J PATHOL, V153, P1775, DOI 10.1016/S0002-9440(10)65692-1; Hartwig A, 2003, TOXICOLOGY, V193, P161, DOI 10.1016/j.tox.2003.08.004; Hartwig A, 2003, INT J CANCER, V104, P1, DOI 10.1002/ijc.10911; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005; Hu Y, 1998, MUTAT RES-DNA REPAIR, V408, P203, DOI 10.1016/S0921-8777(98)00035-4; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; Kitchin KT, 2008, J INORG BIOCHEM, V102, P532, DOI 10.1016/j.jinorgbio.2007.10.021; Kitchin KT, 2006, J BIOCHEM MOL TOXIC, V20, P48, DOI 10.1002/jbt.20108; Kitchin KT, 2006, J BIOCHEM MOL TOXIC, V20, P35, DOI 10.1002/jbt.20112; Kitchin KT, 2005, TOXICOL APPL PHARM, V206, P66, DOI 10.1016/j.taap.2004.12.010; Kopera E, 2004, CHEM RES TOXICOL, V17, P1452, DOI 10.1021/tx049842s; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Lynn S, 1997, MUTAGENESIS, V12, P353, DOI 10.1093/mutage/12.5.353; Maier A, 2002, MUTAT RES-GEN TOX EN, V517, P101, DOI 10.1016/S1383-5718(02)00057-8; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Payne JC, 2003, BIOCHEMISTRY-US, V42, P14214, DOI 10.1021/bi035002l; Piatek K, 2008, CHEM RES TOXICOL, V21, P600, DOI 10.1021/tx7003135; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Qin XJ, 2008, CHEM RES TOXICOL, V21, P1806, DOI 10.1021/tx8001548; Rahman M, 2006, J EPIDEMIOL COMMUN H, V60, P242, DOI 10.1136/jech.2005.040212; Ramadan D, 2009, BIOCHEMISTRY-US, V48, P424, DOI 10.1021/bi801988x; Rossman TG, 2004, TOXICOL APPL PHARM, V198, P394, DOI 10.1016/j.taap.2003.10.016; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Schoen A, 2004, TOXICOL APPL PHARM, V198, P253, DOI 10.1016/j.taap.2003.10.011; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schuhmacher-Wolz U, 2009, CRIT REV TOXICOL, V39, P271, DOI 10.1080/10408440802291505; Schwerdtle T, 2003, DNA REPAIR, V2, P1449, DOI 10.1016/j.dnarep.2003.09.001; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; Snow Elizabeth T, 2005, Toxicol Appl Pharmacol, V207, P557, DOI 10.1016/j.taap.2005.01.048; Walter I, 2007, DNA REPAIR, V6, P61, DOI 10.1016/j.dnarep.2006.08.008; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; YAMAMOTO S, 1995, CANCER RES, V55, P1271; Yoshida T, 2004, TOXICOL APPL PHARM, V198, P243, DOI 10.1016/j.taap.2003.10.022; Yu HS, 2006, J BIOMED SCI, V13, P657, DOI 10.1007/s11373-006-9092-8	43	129	129	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22855	22863		10.1074/jbc.M111.232926	http://dx.doi.org/10.1074/jbc.M111.232926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550982	Green Published, hybrid			2022-12-25	WOS:000292025000020
J	Radulescu, AE; Mukherjee, S; Shields, D				Radulescu, Andreea E.; Mukherjee, Shaeri; Shields, Dennis			The Golgi Protein p115 Associates with gamma-Tubulin and Plays a Role in Golgi Structure and Mitosis Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-GOLGI; TETHERING PROTEIN; MEMBRANE-PROTEIN; CLEAVAGE FURROW; MATRIX PROTEIN; APPARATUS; GM130; CYTOKINESIS; DROSOPHILA; TRANSPORT	The Golgi apparatus is a network of polarized cisternae localized to the perinuclear region in mammalian cells. It undergoes extensive vesiculation at the onset of mitosis and its reassembly requires factors that are in part segregated via the mitotic spindle. Here we show that unlike typical Golgi markers, the Golgi-protein p115 partitioned with the spindle poles throughout mitosis. An armadillo-fold in its N terminus mediated a novel interaction between p115 and gamma-tubulin and functioned in its centrosomal targeting. Both the N- and C-terminal regions of p115 were required to maintain Golgi structure. Strikingly, p115 was essential for mitotic spindle function and the resolution of the cytokinetic bridge because its depletion resulted in spindle collapse, chromosome missegregation, and failed cytokinesis. We demonstrate that p115 plays a critical role in mitosis progression, implicating it as the only known golgin to regulate both mitosis and apoptosis.	[Radulescu, Andreea E.; Mukherjee, Shaeri; Shields, Dennis] Yeshiva Univ, Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Shields, Dennis] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Radulescu, AE (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	aradulescu@ucsd.edu; shaeri.mukherjee@yale.edu			National Institutes of Health [DK21860]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021860, R01DK021860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK21860 (to D. S.).	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; An Y, 2009, J MOL BIOL, V391, P26, DOI 10.1016/j.jmb.2009.04.062; Barr FA, 2005, J CELL BIOL, V168, P993, DOI 10.1083/jcb.200501088; Barr FA, 2004, J CELL BIOL, V164, P955, DOI 10.1083/jcb.200402011; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BARROSO M, 1995, P NATL ACAD SCI USA, V92, P527, DOI 10.1073/pnas.92.2.527; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Colanzi A, 2003, J CELL BIOL, V161, P27, DOI 10.1083/jcb.200208099; Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Goss JW, 2008, J CELL BIOL, V181, P1047, DOI 10.1083/jcb.200712137; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Kodani A, 2009, MOL BIOL CELL, V20, P1192, DOI 10.1091/mbc.E08-08-0834; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; Litvak V, 2002, MOL CELL BIOL, V22, P5064, DOI 10.1128/MCB.22.14.5064-5075.2002; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Mukherjee S, 2009, J BIOL CHEM, V284, P1709, DOI 10.1074/jbc.M807263200; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Puri S, 2004, J CELL SCI, V117, P451, DOI 10.1242/jcs.00863; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Radulescu AE, 2007, MOL BIOL CELL, V18, P94, DOI 10.1091/mbc.E06-06-0532; Rios RM, 2004, CELL, V118, P323; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Striegl H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004656; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830	55	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21915	21926		10.1074/jbc.M110.209460	http://dx.doi.org/10.1074/jbc.M110.209460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21536679	Green Published, hybrid			2022-12-25	WOS:000291464700086
J	Jirholt, J; Asling, B; Hammond, P; Davidson, G; Knutsson, M; Walentinsson, A; Jensen, JM; Lehmann, A; Agreus, L; Lagerstrom-Fermer, M				Jirholt, Johan; Asling, Bengt; Hammond, Paul; Davidson, Geoffrey; Knutsson, Mikael; Walentinsson, Anna; Jensen, Jorgen M.; Lehmann, Anders; Agreus, Lars; Lagerstrom-Fermer, Maria			4-Aminobutyrate Aminotransferase (ABAT): Genetic and Pharmacological Evidence for an Involvement in Gastro Esophageal Reflux Disease	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX; SPHINCTER RELAXATIONS; EROSIVE ESOPHAGITIS; LINKAGE ANALYSIS; RISK-FACTOR; POPULATION; SYMPTOMS; ACID; GERD; PREVALENCE	Gastro-esophageal reflux disease (GERD) is partly caused by genetic factors. The underlying susceptibility genes are currently unknown, with the exception of COL3A1. We used three independent GERD patient cohorts to identify GERD susceptibility genes. Thirty-six families, demonstrating dominant transmission of GERD were subjected to whole genome microsatellite genotyping and linkage analysis. Five linked regions were identified. Two families shared a linked region (LOD 3.9 and 2.0) on chromosome 16. We used two additional independent GERD patient cohorts, one consisting of 219 trios (affected child with parents) and the other an adult GERD case control cohort consisting of 256 cases and 485 controls, to validate individual genes in the linked region through association analysis. Sixty six single nucleotide polymorphism (SNP) markers distributed over the nine genes present in the linked region were genotyped in the independent GERD trio cohort. Transmission disequilibrium test analysis followed by multiple testing adjustments revealed a significant genetic association for one SNP located in an intron of the gene 4-aminobutyrate aminotransferase (ABAT) (P-adj = 0.027). This association did not replicate in the adult case-control cohort, possibly due to the differences in ethnicity between the cohorts. Finally, using the selective ABAT inhibitor vigabatrin (gamma-vinyl GABA) in a dog study, we were able to show a reduction of transient lower esophageal sphincter relaxations (TLESRs) by 57.3 +/- 11.4 % (p = 0.007) and the reflux events from 3.1 +/- 0.4 to 0.8 +/- 0.4 (p = 0.007). Our results demonstrate the direct involvement of ABAT in pathways affecting lower esophageal sphincter (LES) control and identifies ABAT as a genetic risk factor for GERD.	[Jirholt, Johan; Asling, Bengt; Knutsson, Mikael; Walentinsson, Anna; Jensen, Jorgen M.; Lehmann, Anders; Lagerstrom-Fermer, Maria] AstraZeneca R&D, Molndal, Sweden; [Hammond, Paul; Davidson, Geoffrey] Womens & Childrens Hosp, Gastroenterol Unit, Adelaide, SA, Australia; [Agreus, Lars] Karolinska Inst, Ctr Family & Community Med, Huddinge, Sweden	AstraZeneca; Womens & Childrens Hospital Australia; Karolinska Institutet	Jirholt, J (corresponding author), AstraZeneca R&D, Molndal, Sweden.	Bengt.Asling@astrazeneca.com			AstraZeneca RD; AstraZeneca R&D Molndal, Sweden; WHC, Adelaide, Australia; KI, Stockholm, Sweden; FIRSA (Friends of Infant Reflux Support Association) in South Australia	AstraZeneca RD(AstraZeneca); AstraZeneca R&D Molndal, Sweden(AstraZeneca); WHC, Adelaide, Australia; KI, Stockholm, Sweden; FIRSA (Friends of Infant Reflux Support Association) in South Australia	The study was funded by AstraZeneca R&D and the study design, generation of data, analysis of data, decision to publish as well as preparation of the manuscript was performed by the authors of which several are employed by AstraZeneca R&D, Sweden.; This study was funded and performed by AstraZeneca R&D Molndal, Sweden in collaboration with WHC, Adelaide, Australia and KI, Stockholm, Sweden. Several authors are currently employed at AstraZeneca R&D Molndal, Sweden. No other conflicts of interest exist.; We are grateful to all the GERD patients and their relatives for participating in this study. We thank FIRSA (Friends of Infant Reflux Support Association) in South Australia for their support. We also thank Lena Branden for expert help in running the dog experiments. We thank Christopher Lelliott for reading the manuscript and providing critical comments.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aro P, 2004, SCAND J GASTROENTERO, V39, P1280, DOI 10.1080/00365520410008141; Asling B, 2009, GUT, V58, P1063, DOI 10.1136/gut.2008.167353; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaumont H, 2008, BRIT J PHARMACOL, V153, P1195, DOI 10.1038/sj.bjp.0707681; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Cameron AJ, 2002, GASTROENTEROLOGY, V122, P55, DOI 10.1053/gast.2002.30301; Cantu P, 2003, ALIMENT PHARM THER, V18, P699, DOI 10.1046/j.1365-2036.2003.01740.x; Costa Aldo J. F., 2004, J. Pediatr. (Rio J.), V80, P291, DOI 10.1590/S0021-75572004000500008; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; DENT J, 1980, J CLIN INVEST, V65, P256, DOI 10.1172/JCI109667; DENT J, 1988, GUT, V29, P1020, DOI 10.1136/gut.29.8.1020; DODDS WJ, 1982, NEW ENGL J MED, V307, P1547, DOI 10.1056/NEJM198212163072503; El-Serag HB, 2004, AM J GASTROENTEROL, V99, P806, DOI 10.1111/j.1572-0241.2004.30098.x; Fass R, 2007, J CLIN GASTROENTEROL, V41, P131, DOI 10.1097/01.mcg.0000225631.07039.6d; Gilger MA, 2008, J PEDIATR GASTR NUTR, V47, P141, DOI 10.1097/MPG.0b013e31815eeabe; Gold BD, 2006, AM J GASTROENTEROL, V101, P641, DOI 10.1111/j.1572-0241.2006.00436.x; Holloway RH, 2000, BEST PRACT RES CL GA, V14, pVII; Hu FZ, 2000, JAMA-J AM MED ASSOC, V284, P325, DOI 10.1001/jama.284.3.325; JAEKEN J, 1984, NEUROPEDIATRICS, V15, P165, DOI 10.1055/s-2008-1052362; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; KLOPP CT, 1951, J THORAC SURG, V21, P490; KNUFF TE, 1984, DIGEST DIS SCI, V29, P194, DOI 10.1007/BF01296251; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEAPE LL, 1981, J PEDIATR SURG, V16, P379, DOI 10.1016/S0022-3468(81)80699-9; Lehmann A, 2008, EUR REV MED PHARMACO, V12, P103; Lehmann A, 1999, GASTROENTEROLOGY, V117, P1147, DOI 10.1016/S0016-5085(99)70400-2; Lehmann A, 2009, PHARMACOL THERAPEUT, V122, P239, DOI 10.1016/j.pharmthera.2009.02.008; Lembo A, 2007, ALIMENT PHARM THER, V25, P1343, DOI 10.1111/j.1365-2036.2007.03326.x; Martin AJ, 2002, PEDIATRICS, V109, P1061, DOI 10.1542/peds.109.6.1061; McMahon RL, 2002, SURG ENDOSC, V16, P67, DOI 10.1007/s004640080153; Medina-Kauwe LK, 1999, J INHERIT METAB DIS, V22, P414, DOI 10.1023/A:1005500122231; MITTAL RK, 1988, GASTROENTEROLOGY, V95, P593, DOI 10.1016/S0016-5085(88)80003-9; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; NYLANDER PO, 1991, HUM HERED, V41, P157, DOI 10.1159/000153995; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Orenstein SR, 2003, J PEDIATR GASTR NUTR, V37, pS29, DOI 10.1097/00005176-200311001-00007; PRICE C, 1999, PEOPLE PLACE, V7, P12; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Staunton E, 2000, AM J PHYSIOL-GASTR L, V279, pG157, DOI 10.1152/ajpgi.2000.279.1.G157; Tytgat G, 1990, ANN GASTROINTESTINAL, P15; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Vieira Mário C., 2004, J. Pediatr. (Rio J.), V80, P197, DOI 10.2223/1183; Waring JP, 2002, J PEDIATR GASTR NUTR, V35, P334, DOI 10.1097/00005176-200209000-00018; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Willich SN, 2006, ALIMENT PHARM THER, V23, P371, DOI 10.1111/j.1365-2036.2006.02763.x	55	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19095	10.1371/journal.pone.0019095	http://dx.doi.org/10.1371/journal.pone.0019095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552517	Green Submitted, Green Published, gold			2022-12-25	WOS:000290020700025
J	Kopena, R; Martin, J; Lopez, P; Herczeg, G				Kopena, Renata; Martin, Jose; Lopez, Pilar; Herczeg, Gabor			Vitamin E Supplementation Increases the Attractiveness of Males' Scent for Female European Green Lizards	PLOS ONE			English	Article							FEMORAL GLAND SECRETIONS; MATE CHOICE; CHEMICAL SIGNALS; SEXUAL SELECTION; QUALITY; PREFERENCES; SYMMETRY; HEALTH	Background: In spite that chemoreception is important in sexual selection for many animals, such as reptiles, the mechanisms that confer reliability to chemical signals are relatively unknown. European green lizards (Lacerta viridis) have substantial amounts of alpha-tocopherol (= vitamin E) in their femoral secretions. Because vitamin E is metabolically important and can only be attained from the diet, its secretion is assumed to be costly. However, its role in intraspecific communication is unknown. Methodology/Principal Findings: Here, we experimentally show that male European green lizards that received a dietary supplement of vitamin E increased proportions of vitamin E in their femoral secretions. Furthermore, our experiments revealed that females preferred to use areas scent marked by males with experimentally increased vitamin E levels in their secretions. Finally, female preferences were stronger when vitamin E differences between a pair of males' secretions were larger. Conclusions/Significance: Our results demonstrate that female green lizards are able to discriminate between males based on the vitamin E content of the males' femoral secretions. We suggest that the possible cost of allocating vitamin E to secretions, which might be dependent on male quality, may be a mechanism that confers reliability to scent marks of green lizards and allows their evolution as sexual signals.	[Kopena, Renata; Herczeg, Gabor] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary; [Kopena, Renata; Martin, Jose; Lopez, Pilar] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Herczeg, Gabor] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	Eotvos Lorand University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Helsinki	Kopena, R (corresponding author), Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary.	gabor.herczeg@helsinki.fi	Herczeg, Gábor/AAF-9978-2020; Kopena, Renata/AAG-4392-2020; Herczeg, Gabor/AAZ-1661-2021; Lopez, Pilar/K-6221-2014; Martin, Jose/B-1073-2014	Herczeg, Gabor/0000-0003-0441-342X; Lopez, Pilar/0000-0001-6577-1509; Martin, Jose/0000-0001-6648-3998; Kopena, Renata/0000-0001-7850-6472	Spanish Ministerio de Ciencia e Innovacion [MCI-CGL2008-02119/BOS]; Hungarian-Spanish Intergovernmental SandT Cooperation Programme [HH2006-0024]; Hungarian Scientific Research Fund [OTKA-F68403]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Hungarian-Spanish Intergovernmental SandT Cooperation Programme; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MCI-CGL2008-02119/BOS), the Hungarian-Spanish Intergovernmental SandT Cooperation Programme (HH2006-0024), and the Hungarian Scientific Research Fund (OTKA-F68403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO; ALBERTS AC, 1993, BRAIN BEHAV EVOLUT, V41, P255, DOI 10.1159/000113847; ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; Allen DG, 2004, HDB VET DRUGS; Andersson Malte, 1994; [Anonymous], 2014, PHEROMONES ANIMAL BE; Aragon P, 2001, J HERPETOL, V35, P346, DOI 10.2307/1566131; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bender DA, 2009, NUTRITIONAL BIOCH VI; Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Calsbeek R, 2002, P NATL ACAD SCI USA, V99, P14897, DOI 10.1073/pnas.242645199; Censky EJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P221, DOI 10.1007/s002650050336; Clark DC, 1997, BEHAV ECOL, V8, P46, DOI 10.1093/beheco/8.1.46; COOPER WE, 1984, J EXP ZOOL, V230, P199, DOI 10.1002/jez.1402300205; Cooper WE, 2002, J EXP ZOOL, V292, P523, DOI 10.1002/jez.10089; Fitze PS, 2005, EVOLUTION, V59, P2451, DOI 10.1554/05-208.1; Getty T, 1998, ANIM BEHAV, V56, P127, DOI 10.1006/anbe.1998.0744; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GUILFORD T, 1995, TRENDS ECOL EVOL, V10, P100, DOI 10.1016/S0169-5347(00)89001-1; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x; JOHNSTONE RA, 1995, J THEOR BIOL, V177, P87, DOI 10.1016/S0022-5193(05)80006-2; Johnstone RA, 1995, BIOL REV, V70, P1; Kopena R, 2009, Z NATURFORSCH C, V64, P434; LeBas NR, 2000, P ROY SOC LOND B BIO, V267, P45; Lopez P, 2005, BIOL LETT-UK, V1, P404, DOI 10.1098/rsbl.2005.0360; Lopez P, 2006, J CHEM ECOL, V32, P473, DOI 10.1007/s10886-005-9012-9; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V52, P342, DOI 10.1007/s00265-002-0514-y; Lopez P, 2006, Z NATURFORSCH C, V61, P763; Mader DR, 1996, REPTILE MED SURG; Mardones P, 2004, J NUTR BIOCHEM, V15, P252, DOI 10.1016/j.jnutbio.2004.02.006; Martin J, 2000, P ROY SOC B-BIOL SCI, V267, P1265, DOI 10.1098/rspb.2000.1137; Martin J, 2006, FUNCT ECOL, V20, P1087, DOI 10.1111/j.1365-2435.2006.01183.x; Martin J, 2008, BEHAV ECOL SOCIOBIOL, V62, P1927, DOI 10.1007/s00265-008-0624-2; Martin J, 2006, P ROY SOC B-BIOL SCI, V273, P2619, DOI 10.1098/rspb.2006.3619; Martin J, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 3: REPTILES, P141; Martin J, 2010, NATURWISSENSCHAFTEN, V97, P545, DOI 10.1007/s00114-010-0669-8; Martin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1743, DOI 10.1007/s00265-009-0794-6; Martinez A, 2008, J PHYS CHEM A, V112, P9037, DOI 10.1021/jp803218e; Mason R.T., 1992, P114; Mason RT, 2010, J COMP PHYSIOL A, V196, P729, DOI 10.1007/s00359-010-0551-3; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Olsson M., 1998, P503, DOI 10.1016/B978-012100543-6/50038-6; OLSSON M, 1995, BEHAV ECOL SOCIOBIOL, V36, P179, DOI 10.1007/BF00177794; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Proulx SR, 2002, P ROY SOC B-BIOL SCI, V269, P2291, DOI 10.1098/rspb.2002.2129; Proulx SR, 2001, P ROY SOC B-BIOL SCI, V268, P2307, DOI 10.1098/rspb.2001.1804; Rantala MJ, 2003, FUNCT ECOL, V17, P534, DOI 10.1046/j.1365-2435.2003.00764.x; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Weldon PJ, 2008, NAT PROD REP, V25, P738, DOI 10.1039/b509854h; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Winklhofer-Roob BM, 2003, MOL ASPECTS MED, V24, P391, DOI 10.1016/S0098-2997(03)00035-9; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	53	48	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19410	10.1371/journal.pone.0019410	http://dx.doi.org/10.1371/journal.pone.0019410			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552540	gold, Green Submitted, Green Published			2022-12-25	WOS:000290020700054
J	Hornak, M; Jeseta, M; Musilova, P; Pavlok, A; Kubelka, M; Motlik, J; Rubes, J; Anger, M				Hornak, Miroslav; Jeseta, Michal; Musilova, Petra; Pavlok, Antonin; Kubelka, Michal; Motlik, Jan; Rubes, Jiri; Anger, Martin			Frequency of Aneuploidy Related to Age in Porcine Oocytes	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; 1ST POLAR BODIES; CHROMOSOME-ABNORMALITIES; VITRO; PIG	It is generally accepted that mammalian oocytes are frequently suffering from chromosome segregation errors during meiosis I, which have severe consequences, including pregnancy loss, developmental disorders and mental retardation. In a search for physiologically more relevant model than rodent oocytes to study this phenomenon, we have employed comparative genomic hybridization (CGH), combined with whole genome amplification (WGA), to study the frequency of aneuploidy in porcine oocytes, including rare cells obtained from aged animals. Using this method, we were able to analyze segregation pattern of each individual chromosome during meiosis I. In contrast to the previous reports where conventional methods, such as chromosome spreads or FISH, were used to estimate frequency of aneuploidy, our results presented here show, that the frequency of this phenomenon was overestimated in porcine oocytes. Surprisingly, despite the results from human and mouse showing an increase in the frequency of aneuploidy with advanced maternal age, our results obtained by the most accurate method currently available for scoring the aneuploidy in oocytes indicated no increase in the frequency of aneuploidy even in oocytes from animals, whose age was close to the life expectancy of the breed.	[Hornak, Miroslav; Jeseta, Michal; Musilova, Petra; Rubes, Jiri; Anger, Martin] Vet Res Inst, CS-62132 Brno, Czech Republic; [Pavlok, Antonin; Kubelka, Michal; Motlik, Jan; Anger, Martin] Inst Anim Physiol & Genet, Libechov, Czech Republic	Czech Veterinary Research Institute; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences	Hornak, M (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	anger@iapg.cas.cz	Kubelka, Michal/G-7127-2014; Jeseta, Michal/A-3159-2013; Pavlok, Antonín/H-8398-2014; Anger, Martin/R-9917-2019; Motlik, Jan/G-7148-2014; Anger, Martin/A-3152-2015; Dalton-O'Reilly, Jessica/AAM-8569-2021; Musilova, Petra/B-7380-2011	Jeseta, Michal/0000-0003-1778-3454; Anger, Martin/0000-0003-0128-1054; Anger, Martin/0000-0003-0128-1054; 	Grant Agency of AS CR [IAA501620801]; Czech Science Foundation [523/09/0743]; EMBO [1817]; Marie Curie ERG [224931]; Purkyne Fellowship	Grant Agency of AS CR(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie ERG(European Commission); Purkyne Fellowship	This study was supported by Grant Agency of AS CR grant no. IAA501620801, Czech Science Foundation grant no. 523/09/0743, EMBO installation grant no. 1817, Marie Curie ERG no. 224931 and Purkyne Fellowship to M. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzacken B, 1998, J ASSIST REPROD GEN, V15, P105, DOI 10.1023/A:1023056502731; Duncan FE, 2009, BIOL REPROD, V81, P768, DOI 10.1095/biolreprod.109.077909; Fragouli E, 2009, REPROD BIOMED ONLINE, V19, P228, DOI 10.1016/S1472-6483(10)60078-8; Geraedts J, 2010, HUM REPROD, V25, P575, DOI 10.1093/humrep/dep446; Gutierrez-Mateo C, 2011, FERTIL STERIL, V95, P953, DOI 10.1016/j.fertnstert.2010.09.010; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hornak M, 2009, CYTOGENET GENOME RES, V126, P210, DOI 10.1159/000245922; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Hunt P, 2010, CURR BIOL, V20, pR699, DOI 10.1016/j.cub.2010.08.011; Keskintepe L, 2007, REPROD BIOMED ONLINE, V15, P303, DOI 10.1016/S1472-6483(10)60343-4; KOENIG JLF, 1993, BIOL REPROD, V49, P1158, DOI 10.1095/biolreprod49.6.1158; Kuliev A, 2005, CYTOGENET GENOME RES, V111, P193, DOI 10.1159/000086889; Lechniak D, 1998, CHROMOSOME RES, V6, P504, DOI 10.1023/A:1009264832003; Lechniak D, 2007, THERIOGENOLOGY, V68, P755, DOI 10.1016/j.theriogenology.2007.06.012; Nicodemo D, 2010, THERIOGENOLOGY, V73, P523, DOI 10.1016/j.theriogenology.2009.10.007; Pacchierotti F, 2007, ENVIRON RES, V104, P46, DOI 10.1016/j.envres.2006.12.001; Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048; Pellestor F, 2005, CYTOGENET GENOME RES, V111, P206, DOI 10.1159/000086891; PELLESTOR F, 1991, HUM REPROD, V6, P1252, DOI 10.1093/oxfordjournals.humrep.a137522; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Sosnowski J, 2003, THERIOGENOLOGY, V60, P571, DOI 10.1016/S0093-691X(03)00044-X; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Vozdova M, 2001, THERIOGENOLOGY, V56, P771, DOI 10.1016/S0093-691X(01)00606-9; Zuccotti M, 1998, MOL REPROD DEV, V50, P305, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;305::AID-MRD6&gt;3.0.CO;2-N	24	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18892	10.1371/journal.pone.0018892	http://dx.doi.org/10.1371/journal.pone.0018892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556143	gold, Green Published, Green Submitted			2022-12-25	WOS:000290019400013
J	Wirtz, S; Schuelke, M				Wirtz, Stefanie; Schuelke, Markus			Region-Specific Expression of Mitochondrial Complex I Genes during Murine Brain Development	PLOS ONE			English	Article							HIPPOCAMPAL CA1 AREA; POSTNATAL-DEVELOPMENT; CEREBELLAR CORTEX; HIGH-THROUGHPUT; NADH; RAT; NUCLEAR; DEFICIENCY; MATURATION; DISORDERS	Mutations in the nuclear encoded subunits of mitochondrial complex I (NADH: ubiquinone oxidoreductase) may cause circumscribed cerebral lesions ranging from degeneration of the striatal and brainstem gray matter (Leigh syndrome) to leukodystrophy. We hypothesized that such pattern of regional pathology might be due to local differences in the dependence on complex I function. Using in situ hybridization we investigated the relative expression of 33 nuclear encoded complex I subunits in different brain regions of the mouse at E11.5, E17.5, P1, P11, P28 and adult (12 weeks). With respect to timing and relative intensity of complex I gene expression we found a highly variant pattern in different regions during development. High average expression levels were detected in periods of intense neurogenesis. In cerebellar Purkinje and in hippocampal CA1/CA3 pyramidal neurons we found a second even higher peak during the period of synaptogenesis and maturation. The extraordinary dependence of these structures on complex I gene expression during synaptogenesis is in accord with our recent findings that gamma oscillations - known to be associated with higher cognitive functions of the mammalian brain - strongly depend on the complex I activity. However, with the exception of the mesencephalon, we detected only average complex I expression levels in the striatum and basal ganglia, which does not explain the exquisite vulnerability of these structures in mitochondrial disorders.	[Wirtz, Stefanie] Charite, NeuroCure Clin Res Ctr, Dept Neuropediat, D-13353 Berlin, Germany; Charite, NeuroCure Clin Res Ctr, Dept Dev Disorders Brain, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wirtz, S (corresponding author), Charite, NeuroCure Clin Res Ctr, Dept Neuropediat, D-13353 Berlin, Germany.	markus.schuelke@charite.de		Schuelke, Markus/0000-0003-2824-3891	Deutsche Forschungsgemeinschaft [SFB 665 TP A6, Exc 257]; German Ministry of Education and Research ( BMBF) [01GM0862]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research ( BMBF)(Federal Ministry of Education & Research (BMBF))	This research was supported by Deutsche Forschungsgemeinschaft via the SFB 665 TP A6 and Exc 257. M. S. is a member of the German network for mitochondrial disorders (mitoNET, 01GM0862), funded by the German Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403; ALTMAN J, 1972, J COMP NEUROL, V145, P399, DOI 10.1002/cne.901450402; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Ben-Shachar D, 2004, BIOCHEM PHARMACOL, V67, P1965, DOI 10.1016/j.bcp.2004.02.015; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Brenner-Lavie H, 2009, BIOCHEM PHARMACOL, V78, P85, DOI 10.1016/j.bcp.2009.03.024; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Cronan JE, 2005, FEBS LETT, V579, P4892, DOI 10.1016/j.febslet.2005.07.077; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Dietrich MO, 2008, J NEUROSCI, V28, P10766, DOI 10.1523/JNEUROSCI.2744-08.2008; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013; FRIEDRICH T, 1993, J BIOENERG BIOMEMBR, V25, P331, DOI 10.1007/BF00762458; GALANTE YM, 1979, ARCH BIOCHEM BIOPHYS, V192, P559, DOI 10.1016/0003-9861(79)90126-7; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Grigorieff N, 1999, CURR OPIN STRUC BIOL, V9, P476, DOI 10.1016/S0959-440X(99)80067-0; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; IZQUIERDO JM, 1990, J BIOL CHEM, V265, P9090; Kann O, 2011, BRAIN, V134, P345, DOI 10.1093/brain/awq333; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; KIM K, 1995, BIOCHEM J, V306, P353, DOI 10.1042/bj3060353; Kimura T, 2004, J HISTOCHEM CYTOCHEM, V52, P813, DOI 10.1369/jhc.4A6249.2004; LARSSON LI, 1994, HISTOCHEMISTRY, V101, P325, DOI 10.1007/BF00268993; Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624; LEIF H, 1993, BIOCHEM SOC T, V21, P998, DOI 10.1042/bst0210998; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lim CR, 2004, GENE, V333, P3, DOI 10.1016/j.gene.2004.02.026; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G; Minai L, 2008, MOL GENET METAB, V94, P120, DOI 10.1016/j.ymgme.2007.12.007; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; OHNISHI T, 1985, J BIOL CHEM, V260, P2782; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; POKORNY J, 1981, BRAIN RES BULL, V7, P121, DOI 10.1016/0361-9230(81)90076-9; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; SINGER TP, 1993, ADV NEUROL, V60, P300; Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Torraco A, 2009, BBA-MOL CELL RES, V1793, P171, DOI 10.1016/j.bbamcr.2008.06.003; Ugalde C, 2009, ADV EXP MED BIOL, V652, P85, DOI 10.1007/978-90-481-2813-6_7; van den Heuvel L, 2001, BIOESSAYS, V23, P518, DOI 10.1002/bies.1071; von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; Willems PHGM, 2009, INT J BIOCHEM CELL B, V41, P1773, DOI 10.1016/j.biocel.2009.01.012; Womack M, 2002, J NEUROSCI, V22, P10603; Zhao XY, 2001, J COMP NEUROL, V441, P187, DOI 10.1002/cne.1406	61	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18897	10.1371/journal.pone.0018897	http://dx.doi.org/10.1371/journal.pone.0018897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556144	Green Submitted, Green Published, gold			2022-12-25	WOS:000290019400016
J	Piscatelli, H; Kotkar, SA; McBee, ME; Muthupalani, S; Schauer, DB; Mandrell, RE; Leong, JM; Zhou, DG				Piscatelli, Heather; Kotkar, Shalaka A.; McBee, Megan E.; Muthupalani, Sureshkumar; Schauer, David B.; Mandrell, Robert E.; Leong, John M.; Zhou, Daoguo			The EHEC Type III Effector NleL Is an E3 Ubiquitin Ligase That Modulates Pedestal Formation	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CITROBACTER-RODENTIUM; SECRETION EFFECTORS; HOST-CELLS; TIR BINDS; PROTEIN; O157-H7; NCK; FAMILY	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 causes hemorrhagic colitis and may result in potentially fatal hemolytic uremia syndrome in humans. EHEC colonize the intestinal mucosa and promote the formation of actin-rich pedestals via translocated type III effectors. Two EHEC type III secreted effectors, Tir and EspFu/TccP, are key players for pedestal formation. We discovered that an EHEC effector protein called Non-LEE-encoded Ligase (NleL) is an E3 ubiquitin ligase. In vitro, we showed that the NleL C753 residue is critical for its E3 ligase activity. Functionally, we demonstrated that NleL E3 ubiquitin ligase activity is involved in modulating Tir-mediated pedestal formation. Surprisingly, EHEC mutant strain deficient in the E3 ligase activity induced more pedestals than the wild-type strain. The canonical EPEC strain E2348/69 normally lacks the nleL gene, and the ectopic expression of the wild-type EHEC nleL, but not the catalytically-deficient nleL(C753A) mutant, in this strain resulted in fewer actin-rich pedestals. Furthermore, we showed that the C. rodentium NleL homolog is a E3 ubiquitin ligase and is required for efficient infection of murine colonic epithelial cells in vivo. In summary, our study demonstrated that EHEC utilizes NleL E3 ubiquitin ligase activity to modulate Tir-mediated pedestal formation.	[Piscatelli, Heather; Kotkar, Shalaka A.; Zhou, Daoguo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [McBee, Megan E.; Muthupalani, Sureshkumar; Schauer, David B.] MIT, Dept Biol Engn & Comparat Med, Cambridge, MA 02139 USA; [Mandrell, Robert E.] ARS, USDA, Albany, CA USA; [Leong, John M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Massachusetts Institute of Technology (MIT); United States Department of Agriculture (USDA); University of Massachusetts System; University of Massachusetts Worcester	Piscatelli, H (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	zhoud@purdue.edu	Mandrell, Robert E/O-9814-2018; Muthupalani, Sureshkumar/C-7244-2015		National Institutes of Health (NIH) [AI078092, AI068655]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078092, K02AI068655] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research was supported by National Institutes of Health (NIH) grants AI078092 and AI068655 to D.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1999, MOL MICROBIOL, V33, P1162, DOI 10.1046/j.1365-2958.1999.01558.x; Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Abramovitch RB, 2006, P NATL ACAD SCI USA, V103, P2851, DOI 10.1073/pnas.0507892103; Allen-Vercoe E, 2006, INFECT IMMUN, V74, P6196, DOI 10.1128/IAI.00753-06; Arbeloa A, 2008, CELL MICROBIOL; Brumme S, 2007, VET MICROBIOL, V124, P274, DOI 10.1016/j.vetmic.2007.04.032; Campellone KG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000191; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Campellone KG, 2004, J CELL BIOL, V164, P407, DOI 10.1083/jcb.200306032; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Campellone KG, 2002, MOL MICROBIOL, V43, P1227, DOI 10.1046/j.1365-2958.2002.02817.x; CANTEY JR, 1991, INFECT IMMUN, V59, P3924, DOI 10.1128/IAI.59.11.3924-3929.1991; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Cody SH, 1999, ANN INTERN MED, V130, P202, DOI 10.7326/0003-4819-130-3-199902020-00005; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Deibel C, 1998, MOL MICROBIOL, V28, P463, DOI 10.1046/j.1365-2958.1998.00798.x; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Ebel F, 1998, MOL MICROBIOL, V30, P147, DOI 10.1046/j.1365-2958.1998.01046.x; Fischer JA, 2006, ANN REV CELL DEV BIO; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Garmendia J, 2004, CELL MICROBIOL, V6, P1167, DOI 10.1111/j.1462-5822.2004.00459.x; Goosney DL, 2000, ANNU REV CELL DEV BI, V16, P173, DOI 10.1146/annurev.cellbio.16.1.173; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Higashide W, 2006, J BACTERIOL, V188, P2411, DOI 10.1128/JB.188.7.2411-2420.2006; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; Matsuda N, 2001, J CELL SCI, V114, P1949; Mcbee ME, 2008, INFECT IMMUN, V76, P4851, DOI 10.1128/IAI.00745-08; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Simovitch M, 2010, CELL MICROBIOL, V12, P489, DOI 10.1111/j.1462-5822.2009.01410.x; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Vallance BA, 2002, INFECT IMMUN, V70, P6424, DOI 10.1128/IAI.70.11.6424-6435.2002; Warawa J, 2001, MOL MICROBIOL, V42, P1269, DOI 10.1046/j.1365-2958.2001.02693.x; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wu B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000960; Zhang Y, 2005, J BIOL CHEM, V280, P38682, DOI 10.1074/jbc.M506309200; Zhang Y, 2006, MOL MICROBIOL, V62, P786, DOI 10.1111/j.1365-2958.2006.05407.x; Zhu Y, 2008, NAT STRUCT MOL BIOL	65	35	37	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19331	10.1371/journal.pone.0019331	http://dx.doi.org/10.1371/journal.pone.0019331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541301	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400053
J	Verstraete, B; Van Elst, D; Steyn, H; Van Wyk, B; Lemaire, B; Smets, E; Dessein, S				Verstraete, Brecht; Van Elst, Daan; Steyn, Hester; Van Wyk, Braam; Lemaire, Benny; Smets, Erik; Dessein, Steven			Endophytic Bacteria in Toxic South African Plants: Identification, Phylogeny and Possible Involvement in Gousiekte	PLOS ONE			English	Article							SP-NOV; BURKHOLDERIA; CANDIDATUS; RUBIACEAE; ENDOSYMBIONTS; PSYCHOTRIA; SYMBIOSIS	Background: South African plant species of the genera Fadogia, Pavetta and Vangueria (all belonging to Rubiaceae) are known to cause gousiekte (literally 'quick disease'), a fatal cardiotoxicosis of ruminants characterised by acute heart failure four to eight weeks after ingestion. Noteworthy is that all these plants harbour endophytes in their leaves: nodulating bacteria in specialized nodules in Pavetta and non-nodulating bacteria in the intercellular spaces between mesophyll cells in Fadogia and Vangueria. Principal Findings: Isolation and analyses of these endophytes reveal the presence of Burkholderia bacteria in all the plant species implicated in gousiekte. Although the nodulating and non-nodulating bacteria belong to the same genus, they are phylogenetically not closely related and even fall in different bacterial clades. Pavetta harborii and Pavetta schumanniana have their own specific endophyte - Candidatus Burkholderia harborii and Candidatus Burkholderia schumanniana - while the non-nodulating bacteria found in the other gousiekte-inducing plants show high similarity to Burkholderia caledonica. In this group, the bacteria are host specific at population level. Investigation of gousiekte-inducing plants from other African countries resulted in the discovery of the same endophytes. Several other plants of the genera Afrocanthium, Canthium, Keetia, Psydrax, Pygmaeothamnus and Pyrostria were tested and were found to lack bacterial endophytes. Conclusions: The discovery and identification of Burkholderia bacteria in gousiekte-inducing plants open new perspectives and opportunities for research not only into the cause of this economically important disease, but also into the evolution and functional significance of bacterial endosymbiosis in Rubiaceae. Other South African Rubiaceae that grow in the same area as the gousiekte-inducing plants were found to lack bacterial endophytes which suggests a link between bacteria and gousiekte. The same bacteria are consistently found in gousiekte-inducing plants from different regions indicating that these plants will also be toxic to ruminants in other African countries.	[Verstraete, Brecht; Lemaire, Benny] Katholieke Univ Leuven, Lab Plant Systemat, Louvain, Belgium; [Van Elst, Daan] Univ Antwerp, Lab Plant Growth & Dev, B-2020 Antwerp, Belgium; [Steyn, Hester] S African Natl Biodivers Inst, Pretoria, South Africa; [Van Wyk, Braam] Univ Pretoria, HGWJ Schweickerdt Herbarium, ZA-0002 Pretoria, South Africa; [Smets, Erik] Leiden Univ, Netherlands Ctr Biodivers Nat, Leiden, Netherlands; [Dessein, Steven] Natl Bot Garden Belgium, Meise, Belgium	KU Leuven; University of Antwerp; South African National Biodiversity Institute; University of Pretoria; Leiden University; Leiden University - Excl LUMC; Naturalis Biodiversity Center	Verstraete, B (corresponding author), Katholieke Univ Leuven, Lab Plant Systemat, Louvain, Belgium.	brecht.verstraete@bio.kuleuven.be	Smets, Erik F/A-9875-2011; Dessein, Steven/I-9147-2014; Verstraete, Brecht/E-4141-2015; van Wyk, Abraham/A-2181-2008	Smets, Erik F/0000-0002-9416-983X; Dessein, Steven/0000-0002-3179-4005; Verstraete, Brecht/0000-0001-9332-7798; van Wyk, Abraham/0000-0002-0437-3272	Fund for Scientific Research, Flanders (FWO) [G.0343.09N, 1.1.722.10.N.00]; Katholieke Universiteit Leuven [OT/05/35]; King Leopold III Fund for Nature Exploration and Conservation; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [91158, 71488]	Fund for Scientific Research, Flanders (FWO)(FWO); Katholieke Universiteit Leuven(KU Leuven); King Leopold III Fund for Nature Exploration and Conservation; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was supported financially by the Fund for Scientific Research, Flanders (FWO, G.0343.09N), by the Katholieke Universiteit Leuven (OT/05/35) and by the King Leopold III Fund for Nature Exploration and Conservation. BV and BL hold a PhD research grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT, no. 91158 and no. 71488) and DVE holds a PhD research grant from the Fund for Scientific Research, Flanders (FWO, no. 1.1.722.10.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode ML, 2010, TETRAHEDRON, V66, P2026, DOI 10.1016/j.tet.2010.01.043; Botha CJ, 2008, J ETHNOPHARMACOL, V119, P549, DOI 10.1016/j.jep.2008.07.022; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; BURBAGE DA, 1982, PHYTOPATHOLOGY, V72, P706; Codd LE., 1961, J S AFR BIOL SOC, V2, P8; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Davis AP, 2009, ANN MO BOT GARD, V96, P68, DOI 10.3417/2006205; Drummond AJ, 2010, GENEIOUS V5 3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis CE, 2010, TOXICOL IN VITRO, V24, P1258, DOI 10.1016/j.tiv.2010.02.002; Ellis CE, 2010, TOXICON, V55, P1071, DOI 10.1016/j.toxicon.2009.12.006; Estrada-De los Santos P, 2001, APPL ENVIRON MICROB, V67, P2790, DOI 10.1128/AEM.67.6.2790-2798.2001; Kellerman T, 2005, PLANT POISONINGS MYC, V2nd; Lawrence JA, 2010, J S AFR VET ASSOC, V81, P170; Lemaire B, 2011, INT J SYST SCI, DOI ijs.0.028019-0; MILLER IM, 1990, ADV BOT RES, V17, P163, DOI 10.1016/S0065-2296(08)60134-2; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; Naude TW, 1996, J S AFR VET ASSOC, V67, P8; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prozesky L., 2008, THESIS U PRETORIA; RoBBRECHT E., 1988, OPERA BOT BELG, V1, P13, DOI DOI 10.2307/4110534; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Spilker T, 2009, J CLIN MICROBIOL, V47, P2607, DOI 10.1128/JCM.00770-09; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Swoffort DL, 2002, PAUP PHYLOGENETIC AN; Van Oevelen S, 2004, INT J SYST EVOL MICR, V54, P2237, DOI 10.1099/ijs.0.63188-0; Van Oevelen S, 2002, INT J SYST EVOL MICR, V52, P2023, DOI [10.1099/ijs.0.02103-0, 10.1099/00207713-52-6-2023]; Vandamme P, 2007, INT J SYST EVOL MICR, V57, P2228, DOI 10.1099/ijs.0.65142-0; VANWYK AE, 1990, S AFR J SCI, V86, P93; [No title captured]	36	22	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19265	10.1371/journal.pone.0019265	http://dx.doi.org/10.1371/journal.pone.0019265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541284	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400037
J	Zerebecki, RA; Sorte, CJB				Zerebecki, Robyn A.; Sorte, Cascade J. B.			Temperature Tolerance and Stress Proteins as Mechanisms of Invasive Species Success	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ASCIDIAN BOTRYLLUS-SCHLOSSERI; HSP70 GENE-EXPRESSION; RECENT CLIMATE-CHANGE; THERMAL TOLERANCE; EVOLUTIONARY; MYTILUS; CONSEQUENCES; ACCLIMATION; LATITUDE	Invasive species are predicted to be more successful than natives as temperatures increase with climate change. However, few studies have examined the physiological mechanisms that theoretically underlie this differential success. Because correlative evidence suggests that invasiveness is related to the width of a species' latitudinal range, it has been assumed but largely untested - that range width predicts breadth of habitat temperatures and physiological thermotolerances. In this study, we use empirical data from a marine community as a case study to address the hypotheses that (1) geographic temperature range attributes are related to temperature tolerance, leading to greater eurythermality in invasive species, and (2) stress protein expression is a subcellular mechanism that could contribute to differences in thermotolerance. We examined three native and six invasive species common in the subtidal epibenthic communities of California, USA. We assessed thermotolerance by exposing individuals to temperatures between 14 degrees C and 31 degrees C and determining the temperature lethal to 50% of individuals (LT(50)) after a 24 hour exposure. We found a strong positive relationship between the LT(50) and both maximum habitat temperatures and the breadth of temperatures experience across the species' ranges. In addition, of the species in our study, invasives tended to inhabit broader habitat temperature ranges and higher maximum temperatures. Stress protein expression may contribute to these differences: the more thermotolerant, invasive species Diplosoma listerianum expressed higher levels of a 70-kDa heat-shock protein than the less thermotolerant, native Distaplia occidentalis for which levels declined sharply above the LT(50). Our data highlight differences between native and invasive species with respect to organismal and cellular temperature tolerances. Future studies should address, across a broader phylogenetic and ecosystem scope, whether this physiological mechanism has facilitated the current success of invasive species and could lead to greater success of invasives than native species as global warming continues.	[Zerebecki, Robyn A.; Sorte, Cascade J. B.] Northeastern Univ, Ctr Marine Sci, Boston, MA 02115 USA; [Sorte, Cascade J. B.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA USA; [Sorte, Cascade J. B.] Univ Calif Davis, Dept Ecol & Evolut, Bodega Bay, CA USA	Northeastern University; University of California System; University of California Davis; University of California System; University of California Davis	Zerebecki, RA (corresponding author), Northeastern Univ, Ctr Marine Sci, Boston, MA 02115 USA.	cjsorte@ucdavis.edu			American Association of University Women; California Ocean Protection Council; National Science Foundation [OCE-0549944]; Three Seas Program	American Association of University Women; California Ocean Protection Council; National Science Foundation(National Science Foundation (NSF)); Three Seas Program	Funding was provided by an American Association of University Women (www.aauw.org) American Fellowship to C.J.B.S., a California Environmental Quality Initiative Fellowship to C.J.B.S. from the California Ocean Protection Council (www.opc.ca.gov), the National Science Foundation (OCE-0549944 to S. Williams and M. Bracken; www.nsf.gov), and the Three Seas Program (www.eastwest.neu.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Donald P., 2007, P949; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Boyd M. J., 1972, THESIS U CALIFORNIA; Braby C.E., 2004, THESIS STANFORD U CA; Braby CE, 2006, J EXP BIOL, V209, P2554, DOI 10.1242/jeb.02259; Byers JE, 2002, OIKOS, V97, P449, DOI 10.1034/j.1600-0706.2002.970316.x; *CAN DEP FISH OC, 2010, LIGHTH DAT; Carlton James T., 2000, P31; Carveth CJ, 2006, T AM FISH SOC, V135, P1433, DOI 10.1577/T05-025.1; Cohen AN, 2005, GUIDE EXOTIC SPECIES; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dijkstra JA, 2009, MAR ECOL PROG SER, V387, P71, DOI 10.3354/meps08117; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fields PA, 2006, J EXP BIOL, V209, P656, DOI 10.1242/jeb.02036; FORCELLA F, 1984, J AUST I AGR SCI, V50, P35; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; GROSBERG RK, 1988, EVOLUTION, V42, P900, DOI 10.1111/j.1558-5646.1988.tb02510.x; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Grosholz E, 2001, OECOLOGIA, V129, P58, DOI 10.1007/s004420100708; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris LG, 2007, SEASONAL APPEARANCE; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Henkel SK, 2009, MAR ECOL PROG SER, V386, P1, DOI 10.3354/meps08047; Henkel S, 2008, J APPL PHYCOL, V20, P915, DOI 10.1007/s10811-007-9275-3; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hofmann GE, 1996, MAR BIOL, V126, P65, DOI 10.1007/BF00571378; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Locarnini R. A., 2010, WORLD OCEAN ATLAS 20, V1; Locke Andrea, 2009, Aquatic Invasions, V4, P71, DOI 10.3391/ai.2009.4.1.7; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Morris R.H., 1980, INTERTIDAL INVERTEBR; *NOAA, 2010, NAT OC DAT CTR COAST; Olyarnik Suzanne V., 2009, V204, P215; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Rahel FJ, 2008, CONSERV BIOL, V22, P551, DOI 10.1111/j.1523-1739.2008.00953.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; REJMANEK M, 1995, PLANT INVASIONS, P3; RICHARDSON M, 2009, NEWSLETTER PADILLA B; Roberts DA, 1997, BIOL BULL, V192, P309, DOI 10.2307/1542724; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SANDERS BM, 1991, PHYSIOL ZOOL, V64, P1471, DOI 10.1086/physzool.64.6.30158225; *SMITHS TROP RES I, 2010, ENV SCI PROGR TAB IS; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero George N., 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-1; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sorte CJB, 2010, OIKOS, V119, P1909, DOI 10.1111/j.1600-0706.2010.18663.x; Sorte CJB, 2010, ECOLOGY, V91, P2198, DOI 10.1890/10-0238.1; Sorte CJB, 2005, MAR BIOL, V146, P985, DOI 10.1007/s00227-004-1508-2; Sorte CJB, 2004, MAR ECOL PROG SER, V274, P263, DOI 10.3354/meps274263; SORTE CJB, MAR ECOL PR IN PRESS; SORTE CJB, J EXP MAR B IN PRESS; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Tomanek L, 2008, PHYSIOL BIOCHEM ZOOL, V81, P709, DOI 10.1086/590163; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winne CT, 2005, COMP BIOCHEM PHYS A, V140, P141, DOI 10.1016/j.cbpb.2004.11.009; Yund PO, 2002, MAR BIOL, V141, P955, DOI 10.1007/s00227-002-0894-6	75	142	167	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e14806	10.1371/journal.pone.0014806	http://dx.doi.org/10.1371/journal.pone.0014806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541309	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400001
J	Motoyoshi, I				Motoyoshi, Isamu			Attentional Modulation of Temporal Contrast Sensitivity in Human Vision	PLOS ONE			English	Article							TRANSIENT SPATIAL ATTENTION; SERIAL VISUAL PRESENTATION; FEATURE-INTEGRATION; RESOLUTION; PERFORMANCE; COMPETITION; MECHANISMS; IMPROVES; OBJECTS; SEARCH	Recent psychophysical studies have shown that attention can alter contrast sensitivities for temporally broadband stimuli such as flashed gratings. The present study examined the effect of attention on the contrast sensitivity for temporally narrowband stimuli with various temporal frequencies. Observers were asked to detect a drifting grating of 0-40 Hz presented gradually in the peripheral visual field with or without a concurrent letter identification task in the fovea. We found that removal of attention by the concurrent task reduced the contrast sensitivity for gratings with low temporal frequencies much more profoundly than for gratings with high temporal frequencies and for flashed gratings. The analysis revealed that the temporal contrast sensitivity function had a more band-pass shape with poor attention. Additional experiments showed that this was also true when the target was presented in various levels of luminance noise. These results suggest that regardless of the presence of external noise, attention extensively modulates visual sensitivity for sustained retinal inputs.	Nippon Telegraph & Tel Corp, NTT Commun Sci Labs, Human & Informat Sci Lab, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Motoyoshi, I (corresponding author), Nippon Telegraph & Tel Corp, NTT Commun Sci Labs, Human & Informat Sci Lab, Atsugi, Kanagawa, Japan.	motoyosi@apollo3.brl.ntt.co.jp						Ariga A, 2008, PSYCHOL RES-PSYCH FO, V72, P192, DOI 10.1007/s00426-006-0100-4; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Breitmeyer B., 2006, VISUAL MASKING; Briand KA, 1998, J EXP PSYCHOL HUMAN, V24, P1243, DOI 10.1037/0096-1523.24.4.1243; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Carrasco M, 2006, PROG BRAIN RES, V154, P33; Dosher BA, 2000, VISION RES, V40, P1269, DOI 10.1016/S0042-6989(00)00019-5; Dosher BA, 2000, PSYCHOL SCI, V11, P139, DOI 10.1111/1467-9280.00229; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Herrmann K, 2010, NAT NEUROSCI, V13, P1554, DOI 10.1038/nn.2669; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lee DK, 1997, VISION RES, V37, P2409, DOI 10.1016/S0042-6989(97)00055-2; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Motoyoshi I, 2010, J VISION, V10, DOI 10.1167/10.9.6; Pestilli F, 2007, J VISION, V7, DOI 10.1167/7.7.9; Posner M.I, 1986, CHRONOMETRIC EXPLORA; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; ROBSON JG, 1966, J OPT SOC AM, V56, P1141, DOI 10.1364/JOSA.56.001141; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Thomas J.P., 1986, HDB PERCEPTION HUMAN, V1; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Yeshurun Y, 2004, VISION RES, V44, P1375, DOI 10.1016/j.visres.2003.12.016; Yeshurun Y, 2003, PSYCHOL SCI, V14, P225, DOI 10.1111/1467-9280.02436; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	40	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19303	10.1371/journal.pone.0019303	http://dx.doi.org/10.1371/journal.pone.0019303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756MU	21541355	Green Submitted, Green Published, gold			2022-12-25	WOS:000290016800040
J	Sun, LJ; Li, HM; Seufferheld, MJ; Walters, KR; Margam, VM; Jannasch, A; Diaz, N; Riley, CP; Sun, WL; Li, YF; Muir, WM; Xie, J; Wu, J; Zhang, F; Chen, JY; Barker, EL; Adamec, J; Pittendrigh, BR				Sun, Lijie; Li, Hong-Mei; Seufferheld, Manfredo J.; Walters, Kent R., Jr.; Margam, Venu M.; Jannasch, Amber; Diaz, Naomi; Riley, Catherine P.; Sun, Weilin; Li, Yueh-Feng; Muir, William M.; Xie, Jun; Wu, Jing; Zhang, Fan; Chen, Jake Y.; Barker, Eric L.; Adamec, Jiri; Pittendrigh, Barry R.			Systems-Scale Analysis Reveals Pathways Involved in Cellular Response to Methamphetamine	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; OXIDATIVE STRESS; GENE-EXPRESSION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CYTOSOLIC HEAT-SHOCK-PROTEIN-60; ALDEHYDE-DEHYDROGENASE; INDUCED NEUROTOXICITY; REACTIVE OXYGEN; PROTECTIVE ROLE; MESSENGER-RNA	Background: Methamphetamine (METH), an abused illicit drug, disrupts many cellular processes, including energy metabolism, spermatogenesis, and maintenance of oxidative status. However, many components of the molecular underpinnings of METH toxicity have yet to be established. Network analyses of integrated proteomic, transcriptomic and metabolomic data are particularly well suited for identifying cellular responses to toxins, such as METH, which might otherwise be obscured by the numerous and dynamic changes that are induced. Methodology/Results: We used network analyses of proteomic and transcriptomic data to evaluate pathways in Drosophila melanogaster that are affected by acute METH toxicity. METH exposure caused changes in the expression of genes involved with energy metabolism, suggesting a Warburg-like effect (aerobic glycolysis), which is normally associated with cancerous cells. Therefore, we tested the hypothesis that carbohydrate metabolism plays an important role in METH toxicity. In agreement with our hypothesis, we observed that increased dietary sugars partially alleviated the toxic effects of METH. Our systems analysis also showed that METH impacted genes and proteins known to be associated with muscular homeostasis/contraction, maintenance of oxidative status, oxidative phosphorylation, spermatogenesis, iron and calcium homeostasis. Our results also provide numerous candidate genes for the METH-induced dysfunction of spermatogenesis, which have not been previously characterized at the molecular level. Conclusion: Our results support our overall hypothesis that METH causes a toxic syndrome that is characterized by the altered carbohydrate metabolism, dysregulation of calcium and iron homeostasis, increased oxidative stress, and disruption of mitochondrial functions.	[Sun, Lijie; Li, Hong-Mei; Walters, Kent R., Jr.; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Sun, Lijie] J Craig Venter Inst, San Diego, CA USA; [Sun, Lijie; Margam, Venu M.; Li, Yueh-Feng] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Jannasch, Amber; Diaz, Naomi; Riley, Catherine P.] Purdue Univ, Bindley Biosci Ctr, Metabol Profiling Facil, W Lafayette, IN 47907 USA; [Li, Yueh-Feng] Chung Hwa Coll Med Technol, Tainan, Taiwan; [Muir, William M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Xie, Jun] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Wu, Jing] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Zhang, Fan; Chen, Jake Y.] Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA; [Adamec, Jiri] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA	University of Illinois System; University of Illinois Urbana-Champaign; J. Craig Venter Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Carnegie Mellon University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Nebraska System; University of Nebraska Lincoln	Sun, LJ (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL USA.	pittendr@illinois.edu	Li-Byarlay, Hongmei/AAQ-1341-2020; Margam, Venu M/E-5876-2010	Li-Byarlay, Hongmei/0000-0001-6579-5172; Chen, Jake/0000-0001-8829-7504; Margam, Venu/0000-0001-6510-4618	Department of Entomology at the University of Illinois; C.W. Kearns endowment fund; C.L. Metcalf endowment fund; W.P. Flint endowment fund	Department of Entomology at the University of Illinois; C.W. Kearns endowment fund; C.L. Metcalf endowment fund; W.P. Flint endowment fund	Support was provided to BRP from the Department of Entomology at the University of Illinois and from the C.W. Kearns, C.L. Metcalf and W.P. Flint endowment funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Alavi SH, 2008, SYST BIOL REPROD MEC, V54, P85, DOI 10.1080/19396360801952078; Albers DS, 1996, BRAIN RES, V718, P217, DOI 10.1016/0006-8993(96)00135-7; Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Asanuma M, 2002, NEUROSCI LETT, V325, P191, DOI 10.1016/S0304-3940(02)00291-4; Asanuma M, 2007, NEUROSCI LETT, V414, P263, DOI 10.1016/j.neulet.2006.12.036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashburner M., 1989, DROSOPHILA LAB HDB; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Brown JM, 2005, J NEUROCHEM, V95, P429, DOI 10.1111/j.1471-4159.2005.03379.x; Burrows KB, 2000, EUR J PHARMACOL, V398, P11, DOI 10.1016/S0014-2999(00)00264-8; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; CADET JL, 1994, J NEUROCHEM, V62, P380; Campbell AM, 2008, J BIOENERG BIOMEMBR, V40, P193, DOI 10.1007/s10863-008-9138-x; Chen JSK, 2002, BREAST CANCER RES TR, V71, P237, DOI 10.1023/A:1014461832403; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Chin MH, 2008, J PROTEOME RES, V7, P666, DOI 10.1021/pr070546l; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Downing KH, 1998, CURR OPIN STRUC BIOL, V8, P785, DOI 10.1016/S0959-440X(98)80099-7; Du ZX, 2007, ENDOCRINOLOGY, V148, P4352, DOI 10.1210/en.2006-1511; Ejeskar K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-161; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Gottlieb RA, 2003, ARCH BIOCHEM BIOPHYS, V420, P262, DOI 10.1016/j.abb.2003.07.004; Gupta S, 2002, CIRCULATION, V106, P2727, DOI 10.1161/01.CIR.0000038112.64503.6E; HASSETT CC, 1948, BIOL BULL, V95, P114, DOI 10.2307/1538158; Haughey HM, 1999, J NEUROCHEM, V72, P661, DOI 10.1046/j.1471-4159.1999.0720661.x; Herring NR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-49; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Hsu KW, 2008, MOL CELL BIOL, V28, P4829, DOI 10.1128/MCB.00175-08; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Hutchens JA, 1997, MOL BIOL CELL, V8, P481, DOI 10.1091/mbc.8.3.481; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; Ito Y, 1996, AM J PHYSIOL-HEART C, V270, pH81, DOI 10.1152/ajpheart.1996.270.1.H81; Jacobs H, 1998, MOL GEN GENET, V259, P383, DOI 10.1007/s004380050826; Jang M, 2009, MOL CELLS, V28, P559, DOI 10.1007/s10059-009-0151-7; Jayanthi S, 2002, MOL PHARMACOL, V61, P1124, DOI 10.1124/mol.61.5.1124; Jeng W, 2005, FREE RADICAL BIO MED, V39, P317, DOI 10.1016/j.freeradbiomed.2005.03.015; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim HJ, 2009, CELLS TISSUES ORGANS, V190, P1, DOI 10.1159/000153041; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; Liao WR, 2007, CARCINOGENESIS, V28, P1867, DOI 10.1093/carcin/bgm092; London ED, 2004, ARCH GEN PSYCHIAT, V61, P73, DOI 10.1001/archpsyc.61.1.73; LUDWIG MZ, 1991, BIOCHEM GENET, V29, P215, DOI 10.1007/BF00590103; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; MEHTA CR, 1984, BIOMETRICS, V40, P819, DOI 10.2307/2530927; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Oku K, 2005, J PHYS CHEM B, V109, P3032, DOI 10.1021/jp045906w; Parsch J, 2001, MOL BIOL EVOL, V18, P801, DOI 10.1093/oxfordjournals.molbev.a003862; Pavlik P, 2006, GENOMICS, V88, P347, DOI 10.1016/j.ygeno.2006.04.009; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; PONTIERI FE, 1990, PSYCHOPHARMACOLOGY, V102, P175, DOI 10.1007/BF02245919; Quinton MS, 2006, AAPS J, V8, pE337, DOI 10.1208/aapsj080238; Russell K, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-48; Ryu NK, 2007, J BIOCHEM MOL BIOL, V40, P475; SALIDO GM, 2009, OXIDATIVE STRESS INT; Salomon AR, 2000, P NATL ACAD SCI USA, V97, P14766, DOI 10.1073/pnas.97.26.14766; SARAH BB, 1999, J NEUROCHEM, V73, P1127; SCHIORRING E, 1981, PHARMACOL BIOCHEM BE, V14, P109, DOI 10.1016/S0091-3057(81)80018-4; Shaner John W, 2002, J Mich Dent Assoc, V84, P42; Shoshan-Barmatz V, 2008, J BIOENERG BIOMEMBR, V40, P183, DOI 10.1007/s10863-008-9147-9; Singh S, 2005, APOPTOSIS, V10, P1469, DOI 10.1007/s10495-005-1394-1; SMITH HJ, 1976, AM HEART J, V91, P792, DOI 10.1016/S0002-8703(76)80545-5; Specchia V, 2008, J BIOENERG BIOMEMBR, V40, P219, DOI 10.1007/s10863-008-9149-7; Stephans SE, 1998, J NEUROCHEM, V71, P613; STEPHEN RM, 1999, PROTEIN SCI, V8, P2444; STOCCHI V, 1994, ARCH BIOCHEM BIOPHYS, V311, P160, DOI 10.1006/abbi.1994.1221; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sucharov CC, 2003, J BIOL CHEM, V278, P31233, DOI 10.1074/jbc.M301917200; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Thomas DM, 2005, J PHARMACOL EXP THER, V313, P870, DOI 10.1124/jpet.104.080242; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Virmani A, 2002, ANN NY ACAD SCI, V965, P225; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015269; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Wilson KL, 2006, DEVELOPMENT, V133, P4871, DOI 10.1242/dev.02671; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; WOOD KA, 1995, J NEUROSCI, V15, P5851; Xiao YF, 1998, J PHYSIOL-LONDON, V508, P777, DOI 10.1111/j.1469-7793.1998.777bp.x; Xie T, 2002, J NEUROSCI, V22, P274, DOI 10.1523/JNEUROSCI.22-01-00274.2002; Yamamoto Y, 1999, J Obstet Gynaecol Res, V25, P353; Yu QL, 2003, LIFE SCI, V73, P129, DOI 10.1016/S0024-3205(03)00260-1; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhang XC, 2005, J APPL PHYSIOL, V99, P2246, DOI 10.1152/japplphysiol.00750.2005; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhu Bao-Li, 2007, Legal Medicine, V9, P115, DOI 10.1016/j.legalmed.2006.10.002	97	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18215	10.1371/journal.pone.0018215	http://dx.doi.org/10.1371/journal.pone.0018215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533132	Green Published, gold			2022-12-25	WOS:000289719400006
J	Linnman, C; Appel, L; Fredrikson, M; Gordh, T; Soderlund, A; Langstrom, B; Engler, H				Linnman, Clas; Appel, Lieuwe; Fredrikson, Mats; Gordh, Torsten; Soderlund, Anne; Langstroem, Bengt; Engler, Henry			Elevated [11C]D--Deprenyl Uptake in Chronic Whiplash Associated Disorder Suggests Persistent Musculoskeletal Inflammation	PLOS ONE			English	Article							NECK DISABILITY INDEX; BROWN ADIPOSE-TISSUE; D-DEPRENYL; RHEUMATOID-ARTHRITIS; CERVICAL-SPINE; ADULT HUMANS; BLOOD-FLOW; TASK-FORCE; RELIABILITY; (-)DEPRENYL	There are few diagnostic tools for chronic musculoskeletal pain as structural imaging methods seldom reveal pathological alterations. This is especially true for Whiplash Associated Disorder, for which physical signs of persistent injuries to the neck have yet to be established. Here, we sought to visualize inflammatory processes in the neck region by means Positron Emission Tomography using the tracer C-11 D-deprenyl, a potential marker for inflammation. Twenty-two patients with enduring pain after a rear impact car accident (Whiplash Associated Disorder grade II) and 14 healthy controls were investigated. Patients displayed significantly elevated tracer uptake in the neck, particularly in regions around the spineous process of the second cervical vertebra. This suggests that whiplash patients have signs of local persistent peripheral tissue inflammation, which may potentially serve as a diagnostic biomarker. The present investigation demonstrates that painful processes in the periphery can be objectively visualized and quantified with PET and that C-11 D-deprenyl is a promising tracer for these purposes.	[Linnman, Clas; Fredrikson, Mats] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Linnman, Clas] Harvard Univ, McLean Hosp, Sch Med, Boston, MA USA; [Appel, Lieuwe] PET Ctr Uppsala, Uppsala, Sweden; [Gordh, Torsten] Univ Uppsala Hosp, Dept Surg Sci, Div Anesthesiol & Intens Care Med, Lab Pain Res, Uppsala, Sweden; [Soderlund, Anne] Malardalen Univ, Sch Hlth Care & Social Welf, Dept Physiotherapy, Vasteras, Sweden; [Soderlund, Anne] Uppsala Univ, Dept Neurosci, Sect Physiotherapy, Uppsala, Sweden; [Langstroem, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden; [Langstroem, Bengt] Imperial Coll, Fac Med, Neuropsychopharmacol Sect, London, England; [Engler, Henry] Univ Republica, Ctr Nucl Res, Montevideo, Uruguay; [Engler, Henry] Univ Republica, Fac Med, Montevideo, Uruguay; [Engler, Henry] Uruguayan Ctr Mol Imaging, Montevideo, Uruguay; [Engler, Henry] Univ Uppsala Hosp, Dept Nucl Med, Uppsala, Sweden	Uppsala University; Harvard University; Harvard Medical School; McLean Hospital; Uppsala University; Uppsala University Hospital; Malardalen University; Uppsala University; Uppsala University; Imperial College London; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Uppsala University; Uppsala University Hospital	Linnman, C (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	linnman@nmr.mhg.harvard.edu	Engler, Henry/ABD-8950-2020	Engler, Henry/0000-0002-8966-3788; Linnman, Clas/0000-0001-8449-894X; Gordh, Torsten/0000-0003-1454-3148; Soderlund, Anne/0000-0002-4537-030X	Lansforsakringar Insurance Research Foundation; Swedish Research Council; Uppsala University; Uppsala Imanet AB	Lansforsakringar Insurance Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University; Uppsala Imanet AB	This work was supported by Lansforsakringar Insurance Research Foundation, the Swedish Research Council, The Uppsala University Amersham fund and Uppsala Imanet AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackelman BH, 2002, J REHABIL MED, V34, P284, DOI 10.1080/165019702760390383; Bannister G, 2009, J BONE JOINT SURG BR, V91B, P845, DOI 10.1302/0301-620X.91B7.22639; Bettinardi V, 2004, EUR J NUCL MED MOL I, V31, P867, DOI 10.1007/s00259-003-1444-2; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Danfors T, 1997, SCAND J RHEUMATOL, V26, P43, DOI 10.3109/03009749709065663; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; FINNEGAN KT, 1990, EUR J PHARMACOL, V184, P119, DOI 10.1016/0014-2999(90)90672-S; Fueger BJ, 2006, J NUCL MED, V47, P999; Jenei V, 2005, J NEURAL TRANSM, V112, P1433, DOI 10.1007/s00702-005-0295-3; Kaneta T, 2006, CLIN NUCL MED, V31, P209, DOI 10.1097/01.rlu.0000204124.79497.bb; KNOLL J, 1988, MECH AGEING DEV, V46, P237, DOI 10.1016/0047-6374(88)90128-5; LARSSON SE, 1994, PAIN, V57, P173, DOI 10.1016/0304-3959(94)90221-6; Linnman C, 2010, PAIN, V149, P64, DOI 10.1016/j.pain.2010.01.008; Linnman C, 2009, EUR J PAIN, V13, P65, DOI 10.1016/j.ejpain.2008.03.001; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; MACGREGOR RR, 1988, J LABELLED COMPD RAD, V25, P1, DOI 10.1002/jlcr.2580250102; MAGYAR K, 1967, ACTA PHYSIOL HUNG, V32, P377; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nordin M, 2008, SPINE, V33, pS101, DOI 10.1097/BRS.0b013e3181644ae8; Nygren A., 2000, NACKSKADOR EFTER BIL; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Simon L, 2005, LIFE SCI, V78, P225, DOI 10.1016/j.lfs.2005.04.078; Simon L, 2001, EUR J PHARMACOL, V430, P235, DOI 10.1016/S0014-2999(01)01375-9; Spielberger C.D., 1983, MANUAL STATE TRAIT A; SPITZER WO, 1995, SPINE, V20, pS1; Thie JA, 2004, J NUCL MED, V45, P1431; Thiffault C, 1997, MOL BRAIN RES, V49, P127, DOI 10.1016/S0169-328X(97)00135-6; Toussirot E, 2007, CURR MED CHEM, V14, P1095, DOI 10.2174/092986707780362826; UHLIG Y, 1995, J ORTHOP RES, V13, P240, DOI 10.1002/jor.1100130212; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409	30	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e19182	10.1371/journal.pone.0019182	http://dx.doi.org/10.1371/journal.pone.0019182			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21541010	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100055
J	Etter, PD; Preston, JL; Bassham, S; Cresko, WA; Johnson, EA				Etter, Paul D.; Preston, Jessica L.; Bassham, Susan; Cresko, William A.; Johnson, Eric A.			Local De Novo Assembly of RAD Paired-End Contigs Using Short Sequencing Reads	PLOS ONE			English	Article							PARALLEL; GENOME	Despite the power of massively parallel sequencing platforms, a drawback is the short length of the sequence reads produced. We demonstrate that short reads can be locally assembled into longer contigs using paired-end sequencing of restriction-site associated DNA (RAD-PE) fragments. We use this RAD-PE contig approach to identify single nucleotide polymorphisms (SNPs) and determine haplotype structure in threespine stickleback and to sequence E. coli and stickleback genomic DNA with overlapping contigs of several hundred nucleotides. We also demonstrate that adding a circularization step allows the local assembly of contigs up to 5 kilobases (kb) in length. The ease of assembly and accuracy of the individual contigs produced from each RAD site sequence suggests RAD-PE sequencing is a useful way to convert genome-wide short reads into individually-assembled sequences hundreds or thousands of nucleotides long.	[Etter, Paul D.; Preston, Jessica L.; Johnson, Eric A.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Bassham, Susan; Cresko, William A.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Etter, PD (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	eric-johnson@molbio.uoregon.edu	; Cresko, William/H-4010-2014	Preston, Jessica/0000-0002-9819-7352; Johnson, Eric/0000-0003-1037-4228; Cresko, William/0000-0002-3496-8074	National Human Genome Research Institute [R21HG003834]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG003834, R21HG006036] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The project described was supported by grant R21HG003834 from the National Human Genome Research Institute (E.A.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Hiatt JB, 2010, NAT METHODS, V7, P119, DOI [10.1038/NMETH.1416, 10.1038/nmeth.1416]; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Ng PC, 2010, METHODS MOL BIOL, V628, P215, DOI 10.1007/978-1-60327-367-1_12; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	13	157	160	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18561	10.1371/journal.pone.0018561	http://dx.doi.org/10.1371/journal.pone.0018561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21541009	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800020
J	Zhang, LH; Malik, S; Kelley, GG; Kapiloff, MS; Smrcka, AV				Zhang, Lianghui; Malik, Sundeep; Kelley, Grant G.; Kapiloff, Michael S.; Smrcka, Alan V.			Phospholipase C epsilon Scaffolds to Muscle-specific A Kinase Anchoring Protein (mAKAP beta) and Integrates Multiple Hypertrophic Stimuli in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-CELL HYPERTROPHY; RYANODINE RECEPTOR; SIGNALING COMPLEX; NUCLEAR-ENVELOPE; GAMMA-SUBUNITS; HEART-FAILURE; CA2+ RELEASE; RAS; ACTIVATION; INDUCTION	To define a role for phospholipase C epsilon (PLC epsilon) signaling in cardiac myocyte hypertrophic growth, PLC epsilon protein was depleted from neonatal rat ventricular myocytes (NRVMs) using siRNA. NRVMs with PLC epsilon depletion were stimulated with endothelin (ET-1), norepinephrine, insulin-like growth factor-1 (IGF-1), or isoproterenol and assessed for development of hypertrophy. PLC epsilon depletion dramatically reduced hypertrophic growth and gene expression induced by all agonists tested. PLC epsilon catalytic activity was required for hypertrophy development, yet PLC epsilon depletion did not reduce global agonist-stimulated inositol phosphate production, suggesting a requirement for localized PLC activity. PLC epsilon was found to be scaffolded to a muscle-specific A kinase anchoring protein (mAKAP beta) in heart and NRVMs, and mAKAP beta localizes to the nuclear envelope in NRVMs. PLC epsilon-mAKAP interaction domains were defined and overexpressed to disrupt endogenous mAKAP beta-PLC epsilon complexes in NRVMs, resulting in significantly reduced ET-1-dependent NRVM hypertrophy. We propose that PLC epsilon integrates multiple upstream signaling pathways to generate local signals at the nucleus that regulate hypertrophy.	[Zhang, Lianghui; Malik, Sundeep; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Aab Inst Cardiovasc Sci, Rochester, NY 14642 USA; [Kelley, Grant G.] St Josephs Hosp, Ctr Hlth, Dept Hosp Med, Syracuse, NY 13203 USA; [Kapiloff, Michael S.] Univ Miami, Dept Med, Interdisciplinary Stem Cell Inst, Miller Sch Med, Miami, FL 33101 USA; [Kapiloff, Michael S.] Univ Miami, Dept Pediat, Interdisciplinary Stem Cell Inst, Miller Sch Med, Miami, FL 33101 USA	University of Rochester; University of Rochester; University of Miami; University of Miami	Smrcka, AV (corresponding author), Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	Alan_Smrcka@urmc.rochester.edu		Kapiloff, Michael/0000-0002-7005-6953	National Institutes of Health [GM R01 053536, HL075398]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM R01 053536 (to A. V. S.) and HL075398 (to M. S. K.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Barki-Harrington L, 2004, CARDIOVASC RES, V63, P391, DOI 10.1016/j.cardiores.2004.03.011; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Duale H, 2005, EXP PHYSIOL, V90, P71, DOI 10.1113/expphysiol.2004.029173; Filtz TM, 2009, FASEB J, V23, P3564, DOI 10.1096/fj.09-133983; Foncea R, 1997, J BIOL CHEM, V272, P19115, DOI 10.1074/jbc.272.31.19115; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Kapiloff MS, 2001, J CELL SCI, V114, P3167; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Malik S, 2005, MOL PHARMACOL, V68, P129, DOI 10.1124/mol.104.010116; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Scott JD, 2010, CIRCULATION, V121, P1264, DOI 10.1161/CIRCULATIONAHA.109.896357; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026	41	73	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23012	23021		10.1074/jbc.M111.231993	http://dx.doi.org/10.1074/jbc.M111.231993			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21550986	hybrid, Green Published			2022-12-25	WOS:000292025000036
J	Gianulis, EC; Trudeau, MC				Gianulis, Elena C.; Trudeau, Matthew C.			Rescue of Aberrant Gating by a Genetically Encoded PAS (Per-Arnt-Sim) Domain in Several Long QT Syndrome Mutant Human Ether-a-go-go-related Gene Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFECTIVE PROTEIN TRAFFICKING; AMINO-TERMINAL DOMAIN; CARDIAC-ARRHYTHMIA; HERG; MUTATION; DEACTIVATION; MECHANISM; TEMPERATURE; EXPRESSION; FAMILY	Congenital long QT syndrome 2 (LQT2) is caused by loss-of-function mutations in the human ether-a-go-go-related gene (hERG) voltage-gated potassium (K+) channel. hERG channels have slow deactivation kinetics that are regulated by an N-terminal Per-Arnt-Sim (PAS) domain. Only a small percentage of hERG channels containing PAS domain LQT2 mutations (hERG PAS-LQT2) have been characterized in mammalian cells, so the functional effect of these mutations is unclear. We investigated 11 hERG PAS-LQT2 channels in HEK293 cells and report a diversity of functional defects. Most hERG PAS-LQT2 channels formed functional channels at the plasma membrane, as measured by whole cell patch clamp recordings and cell surface biotinylation. Mutations located on one face of the PAS domain (K28E, F29L, N33T, R56Q, and M124R) caused defective channel gating, including faster deactivation kinetics and less steady state inactivation. Conversely, the other mutations caused no measurable differences in channel gating (G53R, H70R, and A78P) or no measurable currents (Y43C, C66G, and L86R). We used a genetically encoded hERG PAS domain (NPAS) to examine whether channel dysfunction could be corrected. We found that NPAS fully restored wild-type-like deactivation kinetics and steady-state inactivation to the hERG PAS-LQT2 channels. Additionally, NPAS rescued aberrant currents in hERG R56Q channels during a dynamic ramp voltage clamp. Thus, our results reveal a putative "gating face" in the PAS domain where mutations within this region form functional channels with altered gating properties, and we show that NPAS is a general means for rescuing aberrant gating in hERG LQT2 mutant channels and may be a potential biological therapeutic.	[Gianulis, Elena C.] Univ Maryland, Sch Med, Program Mol Med, Baltimore, MD 21201 USA; [Gianulis, Elena C.; Trudeau, Matthew C.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Trudeau, MC (corresponding author), 660 W Redwood St,HH502, Baltimore, MD 21201 USA.	mtrudeau@som.umaryland.edu			National Institutes of Health [HL-083121, T32-GM 008181]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-083121 (to M. C. T.) and T32-GM 008181 (to E. C. G.) and a gift from the Helen Pumphrey Denit Trust.	Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Berecki G, 2005, BIOPHYS J, V88, P566, DOI 10.1529/biophysj.104.047290; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grilo LS, 2010, HEART RHYTHM, V7, P260, DOI 10.1016/j.hrthm.2009.09.026; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; MOSS AJ, 1991, CIRCULATION, V84, P1136, DOI 10.1161/01.CIR.84.3.1136; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Rossenbacker T, 2005, CIRCULATION, V111, P961, DOI 10.1161/01.CIR.0000156327.35255.D8; Roti ECR, 2002, J BIOL CHEM, V277, P47779, DOI 10.1074/jbc.M206638200; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Shushi L, 2005, ANN NONINVAS ELECTRO, V10, P334, DOI 10.1111/j.1542-474X.2005.00643.x; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	31	46	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22160	22169		10.1074/jbc.M110.205948	http://dx.doi.org/10.1074/jbc.M110.205948			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536673	Green Published, hybrid			2022-12-25	WOS:000291719900022
J	Zhang, QH; Wang, D; Singh, NK; Kundumani-Sridharan, V; Gadiparthi, L; Rao, CM; Rao, GN				Zhang, Qiuhua; Wang, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Gadiparthi, Laxmisilpa; Rao, Ch. Mohan; Rao, Gadiparthi N.			Activation of Cytosolic Phospholipase A(2) Downstream of the Src-Phospholipase D1 (PLD1)-Protein Kinase C gamma (PKC gamma) Signaling Axis Is Required for Hypoxia-induced Pathological Retinal Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACID-INDUCED ANGIOGENESIS; CELL-MIGRATION; VASCULAR-PERMEABILITY; INDUCED RETINOPATHY; TUMOR ANGIOGENESIS; VEGF EXPRESSION; TYROSINE KINASE; FATTY-ACIDS; NEOVASCULARIZATION	In view of understanding the mechanisms of retinal neovascularization, we had reported previously that vascular endothelial growth factor (VEGF)-induced pathological retinal angiogenesis requires the activation of Src-PLD1-PKC gamma signaling. In the present work, we have identified cytosolic phospholipase A(2) (cPLA(2)) as an effector molecule of Src-PLD1-PKC gamma signaling in the mediation of VEGF-induced pathological retinal angiogenesis based on the following observations. VEGF induced cPLA(2) phosphorylation in a time-dependent manner in human retinal microvascular endothelial cells (HRMVECs). VEGF also induced arachidonic acid (AA) release in a dose-, time-, and cPLA(2)-dependent manner. Depletion of cPLA(2) levels inhibited VEGF-induced HRMVEC DNA synthesis, migration, and tube formation. In addition, the exogenous addition of AA rescued VEGF-induced HRMVEC DNA synthesis, migration, and tube formation from inhibition by down-regulation of cPLA(2). Inhibition of Src, PLD1, or PKC gamma attenuated VEGF-induced cPLA(2) phosphorylation and AA release. Consistent with these findings, hypoxia induced cPLA(2) phosphorylation and activity in VEGF-Src-PLD1-PKC gamma-dependent manner in a mouse model of oxygen-induced retinopathy. In addition, siRNA-mediated down-regulation of cPLA(2) levels in the retina abrogated hypoxia-induced retinal endothelial cell proliferation and neovascularization. These observations suggest that cPLA(2)-dependent AA release is required for VEGF-induced Src-PLD1-PKC gamma-mediated pathological retinal angiogenesis.	[Zhang, Qiuhua; Wang, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Gadiparthi, Laxmisilpa; Rao, Gadiparthi N.] Univ Tennessee Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Rao, Ch. Mohan] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	University of Tennessee System; University of Tennessee Health Science Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Rao, GN (corresponding author), Univ Tennessee Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/I-4799-2016; zhang, qiuhua/C-4939-2013	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023	National Institutes of Health, NEI [EY014856]; NATIONAL EYE INSTITUTE [R01EY014856] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY014856 from NEI (to G. N. R.).	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; Barnett JM, 2010, INVEST OPHTH VIS SCI, V51, P1136, DOI 10.1167/iovs.09-3691; Cao RH, 2010, P NATL ACAD SCI USA, V107, P856, DOI 10.1073/pnas.0911661107; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; Herbert SP, 2006, J BIOL CHEM, V281, P35709, DOI 10.1074/jbc.M600699200; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kou RQ, 2005, BIOCHEMISTRY-US, V44, P15064, DOI 10.1021/bi0509898; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; Kubota Satoshi, 2007, Angiogenesis, V10, P1, DOI 10.1007/s10456-006-9058-5; Lehman N, 2006, BLOOD, V108, P3564, DOI 10.1182/blood-2006-02-005959; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Makanya AN, 2009, ANGIOGENESIS, V12, P113, DOI 10.1007/s10456-009-9129-5; Michaelis UR, 2008, INVEST OPHTH VIS SCI, V49, P1242, DOI 10.1167/iovs.07-1087; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Pechan P, 2009, GENE THER, V16, P10, DOI 10.1038/gt.2008.115; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Suram S, 2010, J BIOL CHEM, V285, P30676, DOI 10.1074/jbc.M110.143800; Szymczak M, 2008, BLOOD, V111, P3514, DOI 10.1182/blood-2007-08-109934; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wouters MM, 2009, J BIOL CHEM, V284, P21177, DOI 10.1074/jbc.M109.015859; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Zhang QH, 2010, BLOOD, V116, P1377, DOI 10.1182/blood-2010-02-271478; Zhao TQ, 2009, J LIPID RES, V50, P521, DOI 10.1194/jlr.M800388-JLR200	51	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22489	22498		10.1074/jbc.M110.217786	http://dx.doi.org/10.1074/jbc.M110.217786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536681	hybrid, Green Published			2022-12-25	WOS:000291719900057
J	Balabanov, S; Gontarewicz, A; Keller, G; Raddrizzani, L; Braig, M; Bosotti, R; Moll, J; Jost, E; Barett, C; Rohe, I; Bokemeyer, C; Holyoake, TL; Brummendorf, TH				Balabanov, Stefan; Gontarewicz, Artur; Keller, Gunhild; Raddrizzani, Laura; Braig, Melanie; Bosotti, Roberta; Moll, Juergen; Jost, Edgar; Barett, Christine; Rohe, Imke; Bokemeyer, Carsten; Holyoake, Tessa L.; Bruemmendorf, Tim H.			Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; STEM-CELLS; IMATINIB MESYLATE; AURORA KINASES; HEMATOPOIETIC PROGENITORS; CLINICAL RESISTANCE; CD34(+) CELLS; PRIMARY CML; THERAPY	The success of Imatinib (IM) therapy in chronic myeloid leukemia (CML) is compromised by the development of IM resistance and by a limited IM effect on hematopoietic stem cells. Danusertib (formerly PHA-739358) is a potent pan-aurora and ABL kinase inhibitor with activity against known BCR-ABL mutations, including T315I. Here, the individual contribution of both signaling pathways to the therapeutic effect of Danusertib as well as mechanisms underlying the development of resistance and, as a consequence, strategies to overcome resistance to Danusertib were investigated. Starting at low concentrations, a dose-dependent inhibition of BCR-ABL activity was observed, whereas inhibition of aurora kinase activity required higher concentrations, pointing to a therapeutic window between the two effects. Interestingly, the emergence of resistant clones during Danusertib exposure in vitro occurred considerably less frequently than with comparable concentrations of IM. In addition, Danusertib-resistant clones had no mutations in BCR-ABL or aurora kinase domains and remained IM-sensitive. Overexpression of Abcg2 efflux transporter was identified and functionally validated as the predominant mechanism of acquired Danusertib resistance in vitro. Finally, the combined treatment with IM and Danusertib significantly reduced the emergence of drug resistance in vitro, raising hope that this drug combination may also achieve more durable disease control in vivo.	[Balabanov, Stefan; Gontarewicz, Artur; Keller, Gunhild; Braig, Melanie; Barett, Christine; Rohe, Imke; Bokemeyer, Carsten; Bruemmendorf, Tim H.] Univ Klinikum Hamburg Eppendorf, UCCH, Sekt Pneumol, Klin Onkol Hamatol & Knochenmarktransplantat, Hamburg, Germany; [Raddrizzani, Laura; Bosotti, Roberta; Moll, Juergen] Nerviano, Nerviano Med Sci Oncol, Milan, Italy; [Jost, Edgar; Bruemmendorf, Tim H.] Rhein Westfal TH Aachen, Univ Klinikum Aachen, Klin Hamatol & Onkol, Med Klin 4, Aachen, Germany; [Holyoake, Tessa L.] Univ Glasgow, Sect Expt Haematol & Haemopoiet Stem Cells, Glasgow, Lanark, Scotland	University of Hamburg; University Medical Center Hamburg-Eppendorf; Nerviano Medical Sciences S.r.l; RWTH Aachen University; RWTH Aachen University Hospital; University of Glasgow	Balabanov, S (corresponding author), Univ Klinikum Hamburg Eppendorf, UCCH, Sekt Pneumol, Klin Onkol Hamatol & Knochenmarktransplantat, Hamburg, Germany.	tbruemmendorf@ukaachen.de	Balabanov, Stefan/E-9765-2014; holyoake, tessa/M-3668-2015	holyoake, tessa/0000-0002-0608-6066	European Leukemia Net (ELN); German Cancer Aid	European Leukemia Net (ELN); German Cancer Aid(Deutsche Krebshilfe)	The work was supported by Work Package 4 (chronic myeloid leukemia) of the European Leukemia Net (ELN). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Stefan Balabanov was supported by a fellowship of the German Cancer Aid.	Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Burger H, 2004, BLOOD, V104, P2940, DOI 10.1182/blood-2004-04-1398; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Gambacorti-Passerini C, 2000, JNCI-J NATL CANCER I, V92, P1641, DOI 10.1093/jnci/92.20.1641; Glauche I, 2007, BRIT J CANCER, V96, P677, DOI 10.1038/sj.bjc.6603603; Goldman J, 2005, CURR OPIN HEMATOL, V12, P33, DOI 10.1097/01.moh.0000148551.93303.9e; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gontarewicz A, 2010, RECENT RESULTS CANC, V184, P199, DOI 10.1007/978-3-642-01222-8_14; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; HD Jorge Cortes-Franco, 2009, BLOOD            NOV; Hiwase DK, 2010, LEUKEMIA, V24, P658, DOI 10.1038/leu.2009.242; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Jordanides NE, 2006, BLOOD, V108, P1370, DOI 10.1182/blood-2006-02-003145; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Jorgensen HG, 2002, BLOOD, V99, P713, DOI 10.1182/blood.V99.2.713; Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008; Keller G, RECENT RESULTS CANC, V184, P119; Konig H, 2008, BLOOD, V111, P2329, DOI 10.1182/blood-2007-05-092056; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Nicholson E, 2009, CLIN LYMPHOMA MYELOM, V9, pS376, DOI 10.3816/CLM.2009.s.037; Pellicano Francesca, 2007, Cancer Biomarkers, V3, P183; Puttini M, 2006, CANCER RES, V66, P11314, DOI 10.1158/0008-5472.CAN-06-1199; Ritchie E, 2006, CURR CANCER DRUG TAR, V6, P645, DOI 10.2174/156800906779010209; Roeder I, 2008, J MOL MED, V86, P17, DOI 10.1007/s00109-007-0241-y; Roy L, 2006, BLOOD, V108, P1478, DOI 10.1182/blood-2006-02-001495; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; von Bubnoff N, 2005, CELL CYCLE, V4, P400, DOI 10.4161/cc.4.3.1560; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wu ZIR, 2004, 1 J HOPK U DEP BIOST	42	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19164	10.1371/journal.pone.0019164	http://dx.doi.org/10.1371/journal.pone.0019164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541334	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000290018400028
J	Hsu, CY; Chan, YP				Hsu, Chin-Yuan; Chan, Yu-Pei			Identification and Localization of Proteins Associated with Biomineralization in the Iron Deposition Vesicles of Honeybees (Apis mellifera)	PLOS ONE			English	Article							SP STRAIN AMB-1; MAGNETOTACTIC BACTERIA; MAGNETOSOME MEMBRANE; PROTEOMIC ANALYSIS; MAGNETITE; FERRITIN; GRANULES; MODEL; MAGA	Honeybees (Apis mellifera) form superparamagnetic magnetite to act as a magnetoreceptor for magnetoreception. Biomineralization of superparamagnetic magnetite occurs in the iron deposition vesicles of trophocytes. Even though magnetite has been demonstrated, the mechanism of magnetite biomineralization is unknown. In this study, proteins in the iron granules and iron deposition vesicles of trophocytes were purified and identified by mass spectrometry. Antibodies against such proteins were produced. The major proteins include actin, myosin, ferritin 2, and ATP synthase. Immunolabeling and co-immunoprecipitation studies suggest that iron is stored in ferritin 2 for the purpose of forming 7.5-nm diameter iron particles and that actin-myosin-ferritin 2 may serve as a transporter system. This system, along with calcium and ATP, conveys the iron particles (ferritin) to the center of iron deposition vesicles for iron granules formation. These proteins and reactants are included in iron deposition vesicles during the formation of iron deposition vesicles from the fusion of smooth endoplasmic reticulum. A hypothetical model for magnetite biomineralization in iron deposition vesicles is proposed for honeybees.	[Hsu, Chin-Yuan] Chang Gung Univ, Dept Biomed Sci, Tao Yuan, Taiwan; [Hsu, Chin-Yuan; Chan, Yu-Pei] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University	Hsu, CY (corresponding author), Chang Gung Univ, Dept Biomed Sci, Tao Yuan, Taiwan.	hsu@mail.cgu.edu.tw			Chang Gung Memorial Hospital, Taiwan [CMRPD 180351]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by CMRPD 180351 grant from Chang Gung Memorial Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki A, 2008, J R SOC INTERFACE, V5, P977, DOI 10.1098/rsif.2008.0170; Diebel CE, 2000, NATURE, V406, P299, DOI 10.1038/35018561; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; FRANKEL RB, 1979, SCIENCE, V203, P1355, DOI 10.1126/science.203.4387.1355; FRANKEL RB, 1984, PHILOS T R SOC B, V304, P567, DOI 10.1098/rstb.1984.0047; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Herynek V, 2000, J BIOL INORG CHEM, V5, P51, DOI 10.1007/s007750050007; Hsu CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000395; Hsu CY, 2009, AGING CELL, V8, P726, DOI 10.1111/j.1474-9726.2009.00525.x; HSU CY, 1994, SCIENCE, V265, P95, DOI 10.1126/science.265.5168.95; Hsu CY, 2004, BIOL CELL, V96, P529, DOI 10.1016/j.biolcel.2004.05.001; HSU CY, 1993, J EXP BIOL, V180, P1; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Keim CN, 2002, MICRON, V33, P53, DOI 10.1016/S0968-4328(00)00071-8; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; MANN S, 1986, NATURE, V324, P565, DOI 10.1038/324565a0; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; NAKAMURA C, 1995, J BIOCHEM-TOKYO, V118, P23, DOI 10.1093/oxfordjournals.jbchem.a124884; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; Saunders M, 2009, J STRUCT BIOL, V167, P55, DOI 10.1016/j.jsb.2009.03.003; Suzuki T, 2007, FEBS LETT, V581, P3443, DOI 10.1016/j.febslet.2007.06.047; Tanaka M, 2006, PROTEOMICS, V6, P5234, DOI 10.1002/pmic.200500887; WALDO GS, 1993, BIOCHEMISTRY-US, V32, P13262, DOI 10.1021/bi00211a039; Weng LP, 2008, J PROTEOME RES, V7, P3765, DOI 10.1021/pr800042n; Wu CC, 2005, PROTEOMICS, V5, P3173, DOI 10.1002/pmic.200401133	28	24	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19088	10.1371/journal.pone.0019088	http://dx.doi.org/10.1371/journal.pone.0019088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541330	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400024
J	Nicolis, SC; Zabzina, N; Latty, T; Sumpter, DJT				Nicolis, Stamatios C.; Zabzina, Natalia; Latty, Tanya; Sumpter, David J. T.			Collective Irrationality and Positive Feedback	PLOS ONE			English	Article							CONTEXT-DEPENDENT PREFERENCES; DECISION-MAKING; AMEBOID ORGANISM; ROBUST BEAUTY; ANT COLONIES; FISH SHOALS; INFORMATION; CHOICE; MODEL; AGGREGATION	Recent experiments on ants and slime moulds have assessed the degree to which they make rational decisions when presented with a number of alternative food sources or shelter. Ants and slime moulds are just two examples of a wide range of species and biological processes that use positive feedback mechanisms to reach decisions. Here we use a generic, experimentally validated model of positive feedback between group members to show that the probability of taking the best of n options depends crucially on the strength of feedback. We show how the probability of choosing the best option can be maximized by applying an optimal feedback strength. Importantly, this optimal value depends on the number of options, so that when we change the number of options the preference of the group changes, producing apparent "irrationalities''. We thus reinterpret the idea that collectives show "rational" or "irrational" preferences as being a necessary consequence of the use of positive feedback. We argue that positive feedback is a heuristic which often produces fast and accurate group decision-making, but is always susceptible to apparent irrationality when studied under particular experimental conditions.	[Nicolis, Stamatios C.; Zabzina, Natalia; Sumpter, David J. T.] Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden; [Latty, Tanya] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Uppsala University; University of Sydney	Nicolis, SC (corresponding author), Uppsala Univ, Dept Math, S-75238 Uppsala, Sweden.	snicolis@math.uu.se		Nicolis, Stamatios C./0000-0002-7118-5298; Latty, Tanya/0000-0002-7469-8590	Human Frontier Science Program [RGP 51/2007]	Human Frontier Science Program(Human Frontier Science Program)	Human Frontier Science Program (RGP 51/2007) (http://www.hfsp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson M, 2003, P ROY SOC B-BIOL SCI, V270, P1271, DOI 10.1098/rspb.2003.2365; BECKERS R, 1992, J THEOR BIOL, V159, P397, DOI 10.1016/S0022-5193(05)80686-1; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; CONDORCET JAN, 1785, ESSAI APPL ANAL PRO; DAWES RM, 1979, AM PSYCHOL, V34, P571, DOI 10.1037/0003-066X.34.7.571; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Deneubourg JL, 2002, BIOL BULL-US, V202, P262, DOI 10.2307/1543477; Edwards SC, 2009, P ROY SOC B-BIOL SCI, V276, P3655, DOI 10.1098/rspb.2009.0981; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P416; GIGERENZER G, 2006, BOUNDED RATIONAL CON, P115; Ito K, 2010, NONLINEAR THEORY ITS, V1, P26; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Katsikopoulos KV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015505; Katsikopoulos KV, 2010, PSYCHOL REV, V117, P1259, DOI 10.1037/a0020418; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Latty T, 2011, P ROY SOC B-BIOL SCI, V278, P307, DOI 10.1098/rspb.2010.1045; Luce R.D, 1959, INDIVIDUAL CHOICE BE, P153; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nicolis SC, 2005, ANIM BEHAV, V69, P535, DOI 10.1016/j.anbehav.2004.06.007; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Pratt SC, 2005, ANIM BEHAV, V70, P1023, DOI 10.1016/j.anbehav.2005.01.022; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Sasaki T, 2011, BEHAV ECOL, V22, P276, DOI 10.1093/beheco/arq198; Shafir S, 2002, BEHAV ECOL SOCIOBIOL, V51, P180, DOI 10.1007/s00265-001-0420-8; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108	40	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18901	10.1371/journal.pone.0018901	http://dx.doi.org/10.1371/journal.pone.0018901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541321	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400016
J	Connolly, KL; Roberts, AL; Holder, RC; Reid, SD				Connolly, Kristie L.; Roberts, Amity L.; Holder, Robert C.; Reid, Sean D.			Dispersal of Group A Streptococcal Biofilms by the Cysteine Protease SpeB Leads to Increased Disease Severity in a Murine Model	PLOS ONE			English	Article							PYROGENIC EXOTOXIN-B; VIRULENCE FACTORS; MOLECULAR-BASIS; IN-VIVO; PYOGENES; SKIN; REGULATOR; IDENTIFICATION; INACTIVATION; PROTEINASE	Group A Streptococcus (GAS) is a Gram-positive human pathogen best known for causing pharyngeal and mild skin infections. However, in the 1980's there was an increase in severe GAS infections including cellulitis and deeper tissue infections like necrotizing fasciitis. Particularly striking about this elevation in the incidence of severe disease was that those most often affected were previously healthy individuals. Several groups have shown that changes in gene content or regulation, as with proteases, may contribute to severe disease; yet strains harboring these proteases continue to cause mild disease as well. We and others have shown that group A streptococci (MGAS5005) reside within biofilms both in vitro and in vivo. That is to say that the organism colonizes a host surface and forms a 3-dimensional community encased in a protective matrix of extracellular protein, DNA and polysaccharide(s). However, the mechanism of assembly or dispersal of these structures is unclear, as is the relationship of these structures to disease outcome. Recently we reported that allelic replacement of the streptococcal regulator srv resulted in constitutive production of the streptococcal cysteine protease SpeB. We further showed that the constitutive production of SpeB significantly decreased MGAS5005 Delta srv biofilm formation in vitro. Here we show that mice infected with MGAS5005 Delta srv had significantly larger lesion development than wild-type infected animals. Histopathology, Gram-staining and immunofluorescence link the increased lesion development with lack of disease containment, lack of biofilm formation, and readily detectable levels of SpeB in the tissue. Treatment of MGAS5005 Delta srv infected lesions with a chemical inhibitor of SpeB significantly reduced lesion formation and disease spread to wild-type levels. Furthermore, inactivation of speB in the MGAS5005 Delta srv background reduced lesion formation to wild-type levels. Taken together, these data suggest a mechanism by which GAS disease may transition from mild to severe through the Srv mediated dispersal of GAS biofilms.	[Connolly, Kristie L.; Roberts, Amity L.; Holder, Robert C.; Reid, Sean D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center	Connolly, KL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA.	sreid@wfubmc.edu		Connolly, Kristie/0000-0002-7516-4427	National Institutes of Health [R01AI063453]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Wake Forest Venture Funds and Public Health Service grant R01AI063453 from the National Institutes of Health to S. D. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, J DERMATOL SCI, V32, P193, DOI 10.1016/S0923-1811(03)00096-3; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Chaussee MS, 1997, INFECT IMMUN, V65, P1956, DOI 10.1128/IAI.65.5.1956-1959.1997; Chaussee MS, 1996, J INFECT DIS, V173, P901, DOI 10.1093/infdis/173.4.901; Chaussee MS, 2001, INFECT IMMUN, V69, P822, DOI 10.1128/IAI.69.2.822-831.2001; Chiang-Ni C, 2008, J FORMOS MED ASSOC, V107, P677, DOI 10.1016/S0929-6646(08)60112-6; Chiang-Ni C, 2006, MED MICROBIOL IMMUN, V195, P55, DOI 10.1007/s00430-005-0001-y; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Conley J, 2003, J CLIN MICROBIOL, V41, P4043, DOI 10.1128/JCM.41.9.4043-4048.2003; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 1999, VACCINE, V17, P193, DOI 10.1016/S0264-410X(98)00150-9; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; Doern CD, 2008, MICROBIOL-SGM, V154, P1998, DOI 10.1099/mic.0.2007/013466-0; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667; Gabillot-Carre M, 2007, CURR OPIN INFECT DIS, V20, P118, DOI 10.1097/QCO.0b013e32805dfb2d; Gilbert P, 1997, Adv Dent Res, V11, P160; Goldmann O, 2009, CELL MICROBIOL, V11, P138, DOI 10.1111/j.1462-5822.2008.01245.x; Govrin E, 1999, PROTEIN EXPRES PURIF, V15, P247, DOI 10.1006/prep.1999.1033; Heslop A, 2006, INT J PEDIATR OTORHI, V70, P1811, DOI 10.1016/j.ijporl.2006.06.009; Kagawa TF, 2005, MOL MICROBIOL, V57, P650, DOI 10.1111/j.1365-2958.2005.04708.x; Kansal RG, 2003, J INFECT DIS, V187, P398, DOI 10.1086/368022; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Loughman JA, 2006, J BACTERIOL, V188, P399, DOI 10.1128/JB.188.2.399-408.2006; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Lukomski S, 1999, INFECT IMMUN, V67, P1779; Luo F, 2008, MICROB PATHOGENESIS, V45, P217, DOI 10.1016/j.micpath.2008.05.009; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Martin Judith M, 2006, Semin Pediatr Infect Dis, V17, P140, DOI 10.1053/j.spid.2006.07.001; Matsumoto K, 1999, BIOPOLYMERS, V51, P99, DOI 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R; Mitrophanov AY, 2007, J THEOR BIOL, V246, P113, DOI 10.1016/j.jtbi.2006.11.009; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Nagamune Hideaki, 2005, Journal of Infection and Chemotherapy, V11, P1, DOI 10.1007/s10156-004-0354-y; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Nyberg P, 2004, MICROBIOL-SGM, V150, P1559, DOI 10.1099/mic.0.27076-0; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Reid SD, 2004, INFECT IMMUN, V72, P1799, DOI 10.1128/IAI.72.3.1799-1803.2004; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; Reid SD, 2006, FEMS IMMUNOL MED MIC, V48, P283, DOI 10.1111/j.1574-695X.2006.00150.x; Roberts AL, 2010, INFECT IMMUN; Roberts Amity L, 2010, BMC Res Notes, V3, P281, DOI 10.1186/1756-0500-3-281; Rogers RL, 2006, PRIMARY CARE, V33, P697, DOI 10.1016/j.pop.2006.06.005; Saouda M, 2001, J INFECT DIS, V184, P723, DOI 10.1086/323083; Segal N, 2005, CLIN INFECT DIS, V41, P35, DOI 10.1086/430605; Stahelin-Massik J, 2008, EUR J PEDIATR, V167, P541, DOI 10.1007/s00431-007-0549-1; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Tamura F, 2004, INFECT IMMUN, V72, P4836, DOI 10.1128/IAI.72.8.4836-4847.2004; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	71	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18984	10.1371/journal.pone.0018984	http://dx.doi.org/10.1371/journal.pone.0018984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21547075	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800029
J	Faver, JC; Benson, ML; He, X; Roberts, BP; Wang, B; Marshall, MS; Sherrill, CD; Merz, KM				Faver, John C.; Benson, Mark L.; He, Xiao; Roberts, Benjamin P.; Wang, Bing; Marshall, Michael S.; Sherrill, C. David; Merz, Kenneth M., Jr.			The Energy Computation Paradox and ab initio Protein Folding	PLOS ONE			English	Article							FORCE-FIELD; SEMIEMPIRICAL METHODS; MOLECULAR-DYNAMICS; CONFORMATIONS; PATHWAYS; SIMULATION; SET; OPTIMIZATION; PRINCIPLES; PARAMETERS	The routine prediction of three-dimensional protein structure from sequence remains a challenge in computational biochemistry. It has been intuited that calculated energies from physics-based scoring functions are able to distinguish native from nonnative folds based on previous performance with small proteins and that conformational sampling is the fundamental bottleneck to successful folding. We demonstrate that as protein size increases, errors in the computed energies become a significant problem. We show, by using error probability density functions, that physics-based scores contain significant systematic and random errors relative to accurate reference energies. These errors propagate throughout an entire protein and distort its energy landscape to such an extent that modern scoring functions should have little chance of success in finding the free energy minima of large proteins. Nonetheless, by understanding errors in physics-based score functions, they can be reduced in a post-hoc manner, improving accuracy in energy computation and fold discrimination.	[Faver, John C.; Benson, Mark L.; He, Xiao; Roberts, Benjamin P.; Wang, Bing; Merz, Kenneth M., Jr.] Univ Florida, Quantum Theory Project, Gainesville, FL 32611 USA; [Marshall, Michael S.; Sherrill, C. David] Georgia Inst Technol, Sch Chem & Biochem, Ctr Computat Mol Sci & Technol, Atlanta, GA 30332 USA; [Marshall, Michael S.; Sherrill, C. David] Georgia Inst Technol, Sch Computat Sci & Engn, Atlanta, GA 30332 USA	State University System of Florida; University of Florida; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Faver, JC (corresponding author), Univ Florida, Quantum Theory Project, Gainesville, FL 32611 USA.	merz@qtp.ufl.edu	Merz, Kenneth/A-2997-2019; He, Xiao/G-3114-2016	Merz, Kenneth/0000-0001-9139-5893; He, Xiao/0000-0002-4199-8175; Faver, John/0000-0002-0181-9283; Sherrill, David/0000-0002-5570-7666	National Institutes of Health [GM044974, GM066689]; National Science Foundation [CHE-1011360]; National Center for Computational Sciences at Oak Ridge National Laboratory [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM044974, R01GM044974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Computational Sciences at Oak Ridge National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financed by National Institutes of Health (http://nih.gov/) GM044974 and GM066689; National Science Foundation (http://www.nsf.gov/) CHE-1011360; and National Center for Computational Sciences at Oak Ridge National Laboratory (http://www.nccs.gov/) contract DE-AC05-00OR22725. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1961, J POLYM SCI, V49, P31, DOI 10.1002/pol.1961.1204915103; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; [Anonymous], 2010, MACR VERS 9 8; BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Baum B, 2010, J MOL BIOL, V397, P1042, DOI 10.1016/j.jmb.2010.02.007; Berka K, 2010, J CHEM THEORY COMPUT, V6, P2191, DOI 10.1021/ct100007y; BIXON M, 1967, TETRAHEDRON, V23, P769, DOI 10.1016/0040-4020(67)85023-3; Case D.A., 2022, AMBER 2020; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; DIXON SL, 1999, DIVCON99; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FAVER JC, 2010, J CHEM THEORY COMPUT; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Freddolino PL, 2009, BIOPHYS J, V96, P3772, DOI 10.1016/j.bpj.2009.02.033; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Ghosh K, 2007, J AM CHEM SOC, V129, P11920, DOI 10.1021/ja066785b; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Halkier A, 1998, CHEM PHYS LETT, V286, P243, DOI 10.1016/S0009-2614(98)00111-0; Helgaker T, 2008, MOL PHYS, V106, P2107, DOI 10.1080/00268970802258591; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; Kendall RA, 2000, COMPUT PHYS COMMUN, V128, P260, DOI 10.1016/S0010-4655(00)00065-5; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Korth M, 2010, J CHEM THEORY COMPUT, V6, P344, DOI 10.1021/ct900541n; Kryshtafovych A, 2009, PROTEINS, V77, P217, DOI 10.1002/prot.22562; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liwo A, 2005, P NATL ACAD SCI USA, V102, P2362, DOI 10.1073/pnas.0408885102; MARK AE, 1994, J MOL BIOL, V240, P167, DOI 10.1006/jmbi.1994.1430; Merz KM, 2010, J CHEM THEORY COMPUT, V6, P1769, DOI 10.1021/ct100102q; Molnar LF, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3173809; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Repasky MP, 2002, J COMPUT CHEM, V23, P1601, DOI 10.1002/jcc.10162; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Stewart J. J. P, 2008, MOPAC2009; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; TAYLOR JR, 1997, INTRO ERROR ANAL STU, pR17; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang B, 2010, J CHEM THEORY COMPUT, V6, P359, DOI 10.1021/ct900366m; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; WARSHEL A, 1970, J MOL SPECTROSC, V33, P84, DOI 10.1016/0022-2852(70)90054-8; Werner H.-J., 2009, MOLPRO; Zagrovic B, 2002, J MOL BIOL, V323, P927, DOI 10.1016/S0022-2836(02)00997-X; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	56	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18868	10.1371/journal.pone.0018868	http://dx.doi.org/10.1371/journal.pone.0018868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541343	gold, Green Submitted, Green Published			2022-12-25	WOS:000290016800022
J	Xie, RG; Zheng, DW; Xing, JL; Zhang, XJ; Song, Y; Xie, YB; Kuang, F; Dong, H; You, SW; Xu, H; Hu, SJ				Xie, Rou-Gang; Zheng, Da-Wei; Xing, Jun-Ling; Zhang, Xu-Jie; Song, Ying; Xie, Ya-Bin; Kuang, Fang; Dong, Hui; You, Si-Wei; Xu, Hui; Hu, San-Jue			Blockade of Persistent Sodium Currents Contributes to the Riluzole-Induced Inhibition of Spontaneous Activity and Oscillations in Injured DRG Neurons	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; MEMBRANE-POTENTIAL OSCILLATIONS; RAT HYPOGLOSSAL MOTONEURONS; SPIKE-FREQUENCY ADAPTATION; MESENCEPHALIC-V NEURONS; SPINAL NERVE INJURY; NEUROPATHIC PAIN; SUBTHRESHOLD OSCILLATIONS; CHRONIC COMPRESSION; TACTILE ALLODYNIA	In addition to a fast activating and immediately inactivating inward sodium current, many types of excitable cells possess a noninactivating or slowly inactivating component: the persistent sodium current (I-NaP). The I-NaP is found in normal primary sensory neurons where it is mediated by tetrodotoxin-sensitive sodium channels. The dorsal root ganglion (DRG) is the gateway for ectopic impulses that originate in pathological pain signals from the periphery. However, the role of I-NaP in DRG neurons remains unclear, particularly in neuropathic pain states. Using in vivo recordings from single medium-and large-diameter fibers isolated from the compressed DRG in Sprague-Dawley rats, we show that local application of riluzole, which blocks the I-NaP, also inhibits the spontaneous activity of A-type DRG neurons in a dose-dependent manner. Significantly, riluzole also abolished subthreshold membrane potential oscillations (SMPOs), although DRG neurons still responded to intracellular current injection with a single full-sized spike. In addition, the I-NaP was enhanced in medium-and large-sized neurons of the compressed DRG, while bath-applied riluzole significantly inhibited the I-NaP without affecting the transient sodium current (I-NaT). Taken together, these results demonstrate for the first time that the I-NaP blocker riluzole selectively inhibits I-NaP and thereby blocks SMPOs and the ectopic spontaneous activity of injured A-type DRG neurons. This suggests that the I-NaP of DRG neurons is a potential target for treating neuropathic pain at the peripheral level.	[Xie, Rou-Gang; Zheng, Da-Wei; Xing, Jun-Ling; Zhang, Xu-Jie; Song, Ying; Xie, Ya-Bin; Kuang, Fang; You, Si-Wei; Xu, Hui; Hu, San-Jue] Fourth Mil Med Univ, Inst Neurosci, Xi Jing Hosp, Xian 710032, Peoples R China; [Zhang, Xu-Jie] Fourth Mil Med Univ, Sch Stomatol, Xi Jing Hosp, Xian 710032, Peoples R China; [Dong, Hui] Fourth Mil Med Univ, Dept Anaesthiol, Xi Jing Hosp, Xian 710032, Peoples R China; [Song, Ying] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xuzhou Medical University	Xie, RG (corresponding author), Fourth Mil Med Univ, Inst Neurosci, Xi Jing Hosp, Xian 710032, Peoples R China.	xubz@fmmu.edu.cn; sjhu@fmmu.edu.cn		Xie, Rou-gang/0000-0001-7644-1492	National Natural Science Foundation of China [30870830, 30600581]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant NO. 30870830 and 30600581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2000, EUR J PHARMACOL, V403, P67, DOI 10.1016/S0014-2999(00)00502-1; Amir R, 1999, J NEUROSCI, V19, P8589; Baron Ralf, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79090-7_1; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Coderre TJ, 2007, J NEUROCHEM, V100, P1289, DOI 10.1111/j.1471-4159.2006.04304.x; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Cummins TR, 1998, J NEUROSCI, V18, P9607; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; Devor M, 2009, EXP BRAIN RES, V196, P115, DOI 10.1007/s00221-009-1724-6; Djouhri L, 2003, J PHYSIOL-LONDON, V546, P565, DOI 10.1113/jphysiol.2002.026559; Do MTH, 2003, NEURON, V39, P109, DOI 10.1016/S0896-6273(03)00360-X; Dong H, 2008, PHYSIOL RES, V57, P639, DOI 10.33549/physiolres.931164; Dong XW, 2008, PSYCHOPHARMACOLOGY, V195, P559, DOI 10.1007/s00213-007-0942-5; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Galer BS, 2000, NEUROLOGY, V55, P971, DOI 10.1212/WNL.55.7.971; Hammer NA, 1999, BRIT J ANAESTH, V82, P718, DOI 10.1093/bja/82.5.718; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1141, DOI 10.1152/jn.00335.2005; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Hu SJ, 1998, PAIN, V77, P15, DOI 10.1016/S0304-3959(98)00067-0; Hu SJ, 2000, NEUROSCIENCE, V101, P689, DOI 10.1016/S0306-4522(00)00414-0; Irifune M, 2007, ANESTH ANALG, V104, P1415, DOI 10.1213/01.ane.0000263267.04198.36; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Kononenko NI, 2004, J NEUROPHYSIOL, V91, P710, DOI 10.1152/jn.00770.2003; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; Lampert A, 2006, EXP BRAIN RES, V174, P660, DOI 10.1007/s00221-006-0511-x; Liu CN, 2000, J NEUROPHYSIOL, V84, P205, DOI 10.1152/jn.2000.84.1.205; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Miles GB, 2005, J PHYSIOL-LONDON, V566, P519, DOI 10.1113/jphysiol.2005.086033; Munro G, 2007, NEUROPHARMACOLOGY, V53, P609, DOI 10.1016/j.neuropharm.2007.07.002; Pieri M, 2009, EXP NEUROL, V215, P368, DOI 10.1016/j.expneurol.2008.11.002; Reboreda A, 2003, J PHYSIOL-LONDON, V551, P191, DOI 10.1113/jphysiol.2003.039917; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; SHEEN K, 1993, BRAIN RES, V610, P62, DOI 10.1016/0006-8993(93)91217-G; Song JH, 1997, J PHARMACOL EXP THER, V282, P707; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; Song XJ, 2006, J NEUROPHYSIOL, V95, P479, DOI 10.1152/jn.00503.2005; Stafstrom Carl E, 2007, Epilepsy Curr, V7, P15, DOI 10.1111/j.1535-7511.2007.00156.x; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Theiss RD, 2007, J PHYSIOL-LONDON, V580, P507, DOI 10.1113/jphysiol.2006.124123; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Vervaeke K, 2006, NEURON, V49, P257, DOI 10.1016/j.neuron.2005.12.022; Waxman SG, 2007, NAT NEUROSCI, V10, P405, DOI 10.1038/nn1857; Wokke J, 1996, LANCET, V348, P795, DOI 10.1016/S0140-6736(96)03181-9; Wu NP, 2005, J NEUROPHYSIOL, V93, P2710, DOI 10.1152/jn.00636.2004; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001; XIE YK, 1995, J NEUROPHYSIOL, V73, P1811, DOI 10.1152/jn.1995.73.5.1811; Xing JL, 2001, BRAIN RES, V901, P128, DOI 10.1016/S0006-8993(01)02329-0; Yang RH, 2009, PAIN, V143, P48, DOI 10.1016/j.pain.2009.01.020; Yue CY, 2005, J NEUROSCI, V25, P9704, DOI 10.1523/JNEUROSCI.1621-05.2005; Zeng JS, 2005, J NEUROPHYSIOL, V93, P1035, DOI 10.1152/jn.00831.2004	53	50	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18681	10.1371/journal.pone.0018681	http://dx.doi.org/10.1371/journal.pone.0018681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541342	gold, Green Published, Green Submitted			2022-12-25	WOS:000290016800018
J	He, F; Ren, J; Wang, W; Ma, J				He, Feng; Ren, Jie; Wang, Wei; Ma, Jun			A Multiscale Investigation of Bicoid-Dependent Transcriptional Events in Drosophila Embryos	PLOS ONE			English	Article							POSITIONAL INFORMATION; DOSAGE COMPENSATION; GENE-EXPRESSION; MORPHOGEN GRADIENT; PROTEIN; DETERMINES; ACTIVATION; HUNCHBACK; NOISE; ESTABLISHMENT	Background: Morphogen molecules form concentration gradients to provide spatial information to cells in a developing embryo. Precisely how cells decode such information to form patterns with sharp boundaries remains an open question. For example, it remains controversial whether the Drosophila morphogenetic protein Bicoid (Bcd) plays a transient or sustained role in activating its target genes to establish sharp expression boundaries during development. Methodology/Principal Findings: In this study, we describe a method to simultaneously detect Bcd and the nascent transcripts of its target genes in developing embryos. This method allows us to investigate the relationship between Bcd and the transcriptional status of individual copies of its target genes on distinct scales. We show that, on three scales analyzed concurrently-embryonic, nuclear and local, the actively-transcribing gene copies are associated with high Bcd concentrations. These results underscore the importance of Bcd as a sustained input for transcriptional decisions of individual copies of its target genes during development. We also show that the Bcd-dependent transcriptional decisions have a significantly higher noise than Bcd-dependent gene products, suggesting that, consistent with theoretical studies, time and/or space averaging reduces the noise of Bcd-activated transcriptional output. Finally, our analysis of an X-linked Bcd target gene reveals that Bcd-dependent transcription bursts at twice the frequency in males as in females, providing a mechanism for dosage compensation in early Drosophila embryos. Conclusion/Significance: Our study represents a first experimental uncovering of the actions of Bcd in controlling the actual transcriptional events while its positional information is decoded during development. It establishes a sustained role of Bcd in transcriptional decisions of individual copies of its target genes to generate sharp expression boundaries. It also provides an experimental evaluation of the effect of time and/or space averaging on Bcd-dependent transcriptional output, and establishes a dosage compensation mechanism in early Drosophila embryos.	[He, Feng; Ren, Jie; Wang, Wei; Ma, Jun] Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH 45229 USA; [Ma, Jun] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Ren, Jie] Peking Univ, Key Lab Cell Proliferat & Differentiat, Ctr Dev Biol & Genet, Coll Life Sci, Beijing 100871, Peoples R China	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Peking University	He, F (corresponding author), Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH 45229 USA.	jun.ma@cchmc.org	He, Feng/L-8343-2016; Ren, Jie/AAB-5475-2019; Ma, Jun/GLT-4809-2022	He, Feng/0000-0001-7114-8078; Ma, Jun/0000-0002-1609-3294	National Science Foundation [IOS-0843424]; National Institutes of Health [GM072812, GM78381]; AHA [10POST4170015]; China Scholarship Council [2008601047]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078381, R01GM072812] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation (IOS-0843424), National Institutes of Health (GM072812, GM78381), AHA (Postdoctoral Fellowship #10POST4170015), and China Scholarship Council (Exchange Student Fellowship #2008601047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Ashyraliyev M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000548; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Erdmann T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.258101; Franke A, 1996, DEVELOPMENT, V122, P2751; Gao Q, 1998, DEVELOPMENT, V125, P4185; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gilfillan GD, 2004, FEBS LETT, V567, P8, DOI 10.1016/j.febslet.2004.03.110; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hazelrigg T, 1998, DEV BIOL, V199, P245, DOI 10.1006/dbio.1998.8922; He F, 2008, DEV CELL, V15, P558, DOI 10.1016/j.devcel.2008.09.004; He F, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-80; He F, 2010, BIOPHYS J, V99, P697, DOI 10.1016/j.bpj.2010.04.073; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; JACKLE H, 1986, NATURE, V324, P668, DOI 10.1038/324668a0; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kerszberg M, 2007, CELL, V130, P205, DOI 10.1016/j.cell.2007.06.038; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Liu JB, 2011, NAT CELL BIOL, V13, P22, DOI 10.1038/ncb2141; Lohr U, 2009, P NATL ACAD SCI USA, V106, P21695, DOI 10.1073/pnas.0910225106; Lopes FJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000184; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lott SE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000590; Ma XG, 1996, DEVELOPMENT, V122, P1195; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Ochoa-Espinosa A, 2009, P NATL ACAD SCI USA, V106, P3823, DOI 10.1073/pnas.0807878105; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; Porcher A, 2010, DEVELOPMENT, V137, P2795, DOI 10.1242/dev.051300; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; RASTELLI L, 1995, MECH DEVELOP, V53, P223, DOI 10.1016/0925-4773(95)00438-7; Ronshaugen M, 2004, DEV CELL, V7, P925, DOI 10.1016/j.devcel.2004.11.001; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; To TL, 2010, SCIENCE, V327, P1142, DOI 10.1126/science.1178962; Tostevin F, 2007, PLOS COMPUT BIOL, V3, P763, DOI 10.1371/journal.pcbi.0030078; WARDICK O, 2009, COLD SPRING HARB PER, V1; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0; Wu YF, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-52; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337	55	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19122	10.1371/journal.pone.0019122	http://dx.doi.org/10.1371/journal.pone.0019122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544208	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800045
J	Cardy, AH; Sharp, L; Torrance, N; Hennekam, RC; Miedzybrodzka, Z				Cardy, Amanda H.; Sharp, Linda; Torrance, Nicola; Hennekam, Raoul C.; Miedzybrodzka, Zosia			Is There Evidence for Aetiologically Distinct Subgroups of Idiopathic Congenital Talipes Equinovarus? A Case-Only Study and Pedigree Analysis	PLOS ONE			English	Article							MATERNAL SMOKING; CLUB FOOT; EPIDEMIOLOGY; MALFORMATIONS; INHERITANCE; DEFORMITIES; ANOMALIES; GENETICS; RISK	Background: Idiopathic congenital talipes equinovarus (CTEV) is a common developmental foot disorder, the aetiology of which remains largely unknown. Some aspects of the epidemiology suggest the possibility of aetiologically distinct subgroups. Previous studies consider CTEV as a homogenous entity which may conceal risk factors in particular subgroups. We investigate evidence for aetiologically distinct subgroups of CTEV. Methods: Parents of 785 probands completed a postal questionnaire. Family pedigrees were compiled by telephone. Case-only analysis was used to investigate interactions between risk factors and sex of the proband, CTEV laterality and CTEV family history. Results: The male: female ratio was 2.3:1, 58% of probands were affected bilaterally and 11% had a first-second degree family history. There were modest interactions between family history and twin births (multivariate case - only odds ratio [ORca] = 3.87, 95%CI 1.19-12.62) and family history and maternal use of folic acid supplements in early pregnancy (ORca = 0.62, 95%CI 0.38-1.01); and between sex of the proband and maternal alcohol consumption during pregnancy (female, positive history and alcohol consumed: ORca = 0.33, 95%CI 0.12-0.89). Previous reports of an interaction between maternal smoking and family history were not confirmed. Relatives of female probands were affected more often than relatives of male probands. Conclusions: These results provide tentative evidence for aetiologically distinct CTEV subgroups. They support the 'Carter effect', suggesting CTEV develops though a multifactorial threshold model with females requiring a higher risk factor 'load', and suggest areas where future aetiological investigation might focus. Large multi-centre studies are needed to further advance understanding of this common condition.	[Cardy, Amanda H.; Torrance, Nicola; Miedzybrodzka, Zosia] Univ Aberdeen, Clubfoot Res Grp, Aberdeen, Scotland; [Sharp, Linda] Natl Canc Registry Ireland, Cork, Ireland; [Hennekam, Raoul C.] Univ Amsterdam, Dept Pediat, Amsterdam, Netherlands	University of Aberdeen; University of Amsterdam	Cardy, AH (corresponding author), Univ Aberdeen, Clubfoot Res Grp, Aberdeen, Scotland.	a.h.cardy@abdn.ac.uk		Torrance, Nicola/0000-0002-7856-7408	Sports Action Research for Kids (Sparks); Chief Scientist Office	Sports Action Research for Kids (Sparks); Chief Scientist Office	This work was supported by Sports Action Research for Kids (Sparks) and the Chief Scientist Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2001, AM J EPIDEMIOL, V154, P687, DOI 10.1093/aje/154.8.687; Alderman B W, 1991, Epidemiology, V2, P289, DOI 10.1097/00001648-199107000-00009; Barker S, 2003, J PEDIATR ORTHOPED, V23, P265, DOI 10.1097/00004694-200303000-00025; BELLYEI A, 1983, HUM HERED, V33, P58, DOI 10.1159/000153349; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Brent RL, 2005, BIRTH DEFECTS RES A, V73, P906, DOI 10.1002/bdra.20184; Byron-Scott R, 2005, PAEDIATR PERINAT EP, V19, P227, DOI 10.1111/j.1365-3016.2005.00647.x; CARDY AH, 1997, BMC MUSCULOSKEL DIS, V5, P62; Carey M, 2005, PAEDIATR PERINAT EP, V19, P238, DOI 10.1111/j.1365-3016.2005.00648.x; Carey M, 2003, PAEDIATR PERINAT EP, V17, P187, DOI 10.1046/j.1365-3016.2003.00477.x; CARTLIDGE I, 1984, J MED GENET, V21, P290, DOI 10.1136/jmg.21.4.290; Chapman C, 2000, J MED GENET, V37, P680, DOI 10.1136/jmg.37.9.680; Cornel M C, 1996, Int J Risk Saf Med, V8, P197, DOI 10.3233/JRS-1996-8302; CZEIZEL AE, 1995, CONTRACEPTION, V51, P19, DOI 10.1016/0010-7824(94)00008-K; DANIELSSON LG, 1992, ACTA ORTHOP SCAND, V63, P424, DOI 10.3109/17453679209154759; Duce S, 2010, J ANAT, V216, P108, DOI 10.1111/j.1469-7580.2009.01163.x; Engell V, 2006, J BONE JOINT SURG BR, V88B, P374, DOI 10.1302/0301-620X.88B3.16685; Honein MA, 2000, AM J EPIDEMIOL, V152, P658, DOI 10.1093/aje/152.7.658; KRICKER A, 1986, AM J OBSTET GYNECOL, V155, P1072, DOI 10.1016/0002-9378(86)90352-2; Kruse LM, 2008, J BONE JOINT SURG AM, V90A, P2688, DOI 10.2106/JBJS.G.01346; Lochmiller C, 1998, AM J MED GENET, V79, P90, DOI 10.1002/(SICI)1096-8628(19980901)79:2<90::AID-AJMG3>3.3.CO;2-M; MCDONALD AD, 1992, AM J PUBLIC HEALTH, V82, P91, DOI 10.2105/AJPH.82.1.91; Miedzybrodzka Z, 2003, J ANAT, V202, P37, DOI 10.1046/j.1469-7580.2003.00147.x; Moorthi RN, 2005, AM J MED GENET A, V132A, P376, DOI 10.1002/ajmg.a.30505; PALMER RM, 1974, ORTHOP CLIN N AM, V5, P99; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; PRYOR GA, 1991, J BONE JOINT SURG BR, V73, P632, DOI 10.1302/0301-620X.73B4.2071648; REBBECK TR, 1993, AM J HUM GENET, V53, P1051; Reefhuis J, 1998, AM J PUBLIC HEALTH, V88, P1554, DOI 10.2105/AJPH.88.10.1554; Sharp L, 2006, AM J EPIDEMIOL, V164, P852, DOI 10.1093/aje/kwj285; SHIONO PH, 1986, TERATOLOGY, V34, P65, DOI 10.1002/tera.1420340109; Skelly AC, 2002, TERATOLOGY, V66, P91, DOI 10.1002/tera.10071; Somppi E, 1984, Acta Orthop Scand Suppl, V209, P1; Ulrich M, 1999, EUR J OBSTET GYN R B, V87, P111, DOI 10.1016/S0301-2115(99)00085-8; Umbach DM, 1997, STAT MED, V16, P1731, DOI 10.1002/(SICI)1097-0258(19970815)16:15<1731::AID-SIM595>3.0.CO;2-S; Van den Eeden S K, 1990, Paediatr Perinat Epidemiol, V4, P147; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P464, DOI 10.1302/0301-620X.46B3.464; WYNNEDAVIES R, 1972, CLIN ORTHOP RELAT R, P9, DOI 10.1097/00003086-197205000-00003; 2007, NEUROSCI BIOBEHAV RE, V3	39	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e17895	10.1371/journal.pone.0017895	http://dx.doi.org/10.1371/journal.pone.0017895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21533128	Green Published, Green Submitted, gold			2022-12-25	WOS:000289719400003
J	Buckley, JG; Timmis, MA; Scally, AJ; Elliott, DB				Buckley, John G.; Timmis, Matthew A.; Scally, Andy J.; Elliott, David B.			When Is Visual Information Used to Control Locomotion When Descending a Kerb?	PLOS ONE			English	Article							ADAPTIVE LOCOMOTION; APPROACH PHASE; STEP DESCENT; OBSTACLE; VISION; FALLS; GAIT; MECHANICS; MOVEMENTS; FEEDBACK	Background: Descending kerbs during locomotion involves the regulation of appropriate foot placement before the kerb-edge and foot clearance over it. It also involves the modulation of gait output to ensure the body-mass is safely and smoothly lowered to the new level. Previous research has shown that vision is used in such adaptive gait tasks for feedforward planning, with vision from the lower visual field (lvf) used for online updating. The present study determined when lvf information is used to control/update locomotion when stepping from a kerb. Methodology/Principal Findings: 12 young adults stepped down a kerb during ongoing gait. Force sensitive resistors (attached to participants' feet) interfaced with an high-speed PDLC 'smart glass' sheet, allowed the lvf to be unpredictably occluded at either heel-contact of the penultimate or final step before the kerb-edge up to contact with the lower level. Analysis focussed on determining changes in foot placement distance before the kerb-edge, clearance over it, and in kinematic measures of the step down. Lvf occlusion from the instant of final step contact had no significant effect on any dependant variable (p>0.09). Occlusion of the lvf from the instant of penultimate step contact had a significant effect on foot clearance and on several kinematic measures, with findings consistent with participants becoming uncertain regarding relative horizontal location of the kerb-edge. Conclusion/Significance: These findings suggest concurrent feedback of the lower limb, kerb-edge, and/or floor area immediately in front/below the kerb is not used when stepping from a kerb during ongoing gait. Instead heel-clearance and pre-landing-kinematic parameters are determined/planned using lvf information acquired in the penultimate step during the approach to the kerb-edge, with information related to foot placement before the kerb-edge being the most salient.	[Buckley, John G.] Univ Bradford, Sch Engn Design & Technol, Bradford BD7 1DP, W Yorkshire, England; [Timmis, Matthew A.] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, Cambs, England; [Scally, Andy J.] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England; [Elliott, David B.] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; Anglia Ruskin University; University of Bradford; University of Bradford	Buckley, JG (corresponding author), Univ Bradford, Sch Engn Design & Technol, Bradford BD7 1DP, W Yorkshire, England.	j.buckley@bradford.ac.uk	Elliott, David/B-1806-2009	Elliott, David/0000-0001-9959-6841; Scally, Andy/0000-0002-6189-2247; Buckley, John/0000-0002-4085-4743	Health Foundation [3991/3322]; RCUK (Research Councils, UK)	Health Foundation; RCUK (Research Councils, UK)(UK Research & Innovation (UKRI))	Mat Timmis was supported by a studentship furnished from a grant from The Health Foundation (3991/3322, grant awarded to John Buckley). John Buckley is supported by an RCUK Academic Fellowship (Research Councils, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1986, SOCIAL FDN THOUGHT A; Buckley JG, 2005, GAIT POSTURE, V21, P65, DOI 10.1016/j.gaitpost.2003.12.001; Buckley JG, 2008, EXP BRAIN RES, V184, P223, DOI 10.1007/s00221-007-1096-8; Cowie D, 2008, EXP BRAIN RES, V186, P343, DOI 10.1007/s00221-008-1320-1; CRAIK RL, 1982, EXP BRAIN RES, V45, P399, DOI 10.1007/BF01208600; Elliott DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004577; Gallagher EM, 1997, CAN J PUBLIC HEALTH, V88, P129, DOI 10.1007/BF03403876; Graci V, 2010, OPTOMETRY VISION SCI, V87, P21, DOI 10.1097/OPX.0b013e3181c1d547; Hansen S, 2006, CAN J EXP PSYCHOL, V60, P200, DOI 10.1037/cjep2006019; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; JACK CIA, 1995, GERONTOLOGY, V41, P280; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 1998, ECOL PSYCHOL, V10, P287, DOI 10.1207/s15326969eco103&4_7; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; PATLA AE, 1993, GAIT POSTURE, V1, P45, DOI 10.1016/0966-6362(93)90042-Y; Patla AE, 2002, EXP BRAIN RES, V142, P551, DOI 10.1007/s00221-001-0948-x; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Rhea CK, 2007, NEUROSCI LETT, V418, P60, DOI 10.1016/j.neulet.2007.02.063; Rietdyk S, 2006, EXP BRAIN RES, V169, P272, DOI 10.1007/s00221-005-0345-y; Santello M, 1998, EXP PHYSIOL, V83, P857, DOI 10.1113/expphysiol.1998.sp004165; TIMMIS MA, 2010, VISUOMOTOR CONTROL S; Timmis MA, 2009, EXP BRAIN RES, V195, P219, DOI 10.1007/s00221-009-1773-x; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1207, DOI 10.1111/j.1532-5415.1995.tb07395.x; van Dieen JH, 2008, J BIOMECH, V41, P2417, DOI 10.1016/j.jbiomech.2008.05.022; ZELAZNIK HN, 1983, J MOTOR BEHAV, V15, P217	27	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e19079	10.1371/journal.pone.0019079	http://dx.doi.org/10.1371/journal.pone.0019079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	751LS	21533113	gold, Green Published, Green Submitted			2022-12-25	WOS:000289620100034
J	Li, SL; Symonds, ALJ; Zhu, B; Liu, MY; Raymond, MV; Miao, TZ; Wang, P				Li, Suling; Symonds, Alistair L. J.; Zhu, Bo; Liu, Mengya; Raymond, Meera V.; Miao, Tizong; Wang, Ping			Early Growth Response Gene-2 (Egr-2) Regulates the Development of B and T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; TRANSGENIC MICE; EXPRESSION; DIFFERENTIATION; PROLIFERATION; CD4(-)CD8(-); MATURATION; THYMOCYTES; INDUCTION; PROTEINS	Background: Understanding of how transcription factors are involved in lymphocyte development still remains a challenge. It has been shown that Egr-2 deficiency results in impaired NKT cell development and defective positive selection of T cells. Here we investigated the development of T, B and NKT cells in Egr-2 transgenic mice and the roles in the regulation of distinct stages of B and T cell development. Methods and Findings: The expression of Egr1, 2 and 3 were analysed at different stages of T and B cell development by RT-PCT and results showed that the expression was strictly regulated at different stages. Forced expression of Egr-2 in CD2(+) lymphocytes resulted in a severe reduction of CD4(+) CD8(+) (DP) cells in thymus and pro-B cells in bone marrow, which was associated with reduced expression of Notch1 in ISP thymocytes and Pax5 in pro-B cells, suggesting that retraction of Egr-2 at the ISP and pro-B cell stages is important for the activation of lineage differentiation programs. In contrast to reduction of DP and pro-B cells, Egr-2 enhanced the maturation of DP cells into single positive (SP) T and NKT cells in thymus, and immature B cells into mature B cells in bone marrow. Conclusions: Our results demonstrate that Egr-2 expressed in restricted stages of lymphocyte development plays a dynamic, but similar role for the development of T, NKT and B cells.	[Li, Suling; Liu, Mengya] Brunel Univ, Dept Biosci, London, England; [Symonds, Alistair L. J.; Zhu, Bo; Raymond, Meera V.; Miao, Tizong; Wang, Ping] Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London, England; [Zhu, Bo] Third Mil Med Univ, Xinqiao Hosp, Inst Canc, Chongqing, Peoples R China	Brunel University; University of London; Queen Mary University London; Army Medical University	Li, SL (corresponding author), Brunel Univ, Dept Biosci, London, England.	su-ling.li@brunel.ac.uk; p.wang@qmul.ac.uk		Symonds, Alistair/0000-0002-9461-0816	Arthritis Research UK; Versus Arthritis [18724] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	The study was supported by Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain G, 2001, NAT IMMUNOL, V2, P165, DOI 10.1038/84273; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Carleton M, 2002, J IMMUNOL, V168, P1649, DOI 10.4049/jimmunol.168.4.1649; Carter JH, 2007, J IMMUNOL, V178, P6796, DOI 10.4049/jimmunol.178.11.6796; David-Fung ES, 2006, IMMUNOL REV, V209, P212, DOI 10.1111/j.0105-2896.2006.00355.x; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Dinkel A, 1998, J EXP MED, V188, P2215, DOI 10.1084/jem.188.12.2215; Fiorini E, 2009, J IMMUNOL, V183, P7212, DOI 10.4049/jimmunol.0902432; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lawson VJ, 2010, EUR J IMMUNOL, V40, P232, DOI 10.1002/eji.200939567; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Miyazaki T, 1997, J EXP MED, V186, P877, DOI 10.1084/jem.186.6.877; Miyazaki T, 1998, J EXP MED, V188, P715, DOI 10.1084/jem.188.4.715; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Xi HK, 2006, IMMUNITY, V24, P813, DOI 10.1016/j.immuni.2006.03.023; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	25	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18498	10.1371/journal.pone.0018498	http://dx.doi.org/10.1371/journal.pone.0018498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533228	Green Published, gold			2022-12-25	WOS:000289505600007
J	Mateus, AM; Gorfinkiel, N; Schamberg, S; Arias, AM				Mateus, Ana Margarida; Gorfinkiel, Nicole; Schamberg, Sabine; Arias, Alfonso Martinez			Endocytic and Recycling Endosomes Modulate Cell Shape Changes and Tissue Behaviour during Morphogenesis in Drosophila	PLOS ONE			English	Article							RAC	During development tissue deformations are essential for the generation of organs and to provide the final form of an organism. These deformations rely on the coordination of individual cell behaviours which have their origin in the modulation of subcellular activities. Here we explore the role endocytosis and recycling on tissue deformations that occur during dorsal closure of the Drosophila embryo. During this process the AS contracts and the epidermis elongates in a coordinated fashion, leading to the closure of a discontinuity in the dorsal epidermis of the Drosophila embryo. We used dominant negative forms of Rab5 and Rab11 to monitor the impact on tissue morphogenesis of altering endocytosis and recycling at the level of single cells. We found different requirements for endocytosis (Rab5) and recycling (Rab11) in dorsal closure, furthermore we found that the two processes are differentially used in the two tissues. Endocytosis is required in the AS to remove membrane during apical constriction, but is not essential in the epidermis. Recycling is required in the AS at early stages and in the epidermis for cell elongation, suggesting a role in membrane addition during these processes. We propose that the modulation of the balance between endocytosis and recycling can regulate cellular morphology and tissue deformations during morphogenesis.	[Mateus, Ana Margarida; Gorfinkiel, Nicole; Schamberg, Sabine; Arias, Alfonso Martinez] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Mateus, Ana Margarida] Gulbenkian PhD Programme Biomed, Oeiras, Portugal	University of Cambridge	Mateus, AM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	amam3@cam.ac.uk; ama11@hermes.cam.ac.uk	Martinez Arias, Alfonso/F-1966-2010; Gorfinkiel, Nicole/F-4460-2010; Tsai, Yu-Chen/B-5852-2008	Gorfinkiel, Nicole/0000-0002-6847-6721; Fischer, Sabine C/0000-0001-7237-814X	Fundacao para a Ciencia e Tecnologia from Portugal; BBSRC; Wellcome Trust; EPSRC; BBSRC [BB/F012845/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012845/1] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia from Portugal(Portuguese Foundation for Science and Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Fundacao para a Ciencia e Tecnologia from Portugal (AMM), the BBSRC (AMA and NG), the Wellcome Trust (AMA) and the EPSRC (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Velasco C, 1999, MOL BIOL CELL, V10, P4419, DOI 10.1091/mbc.10.12.4419; ARIAS AM, 1993, DEV DROSOPHILA MELAN; Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Compagnon J, 2009, J CELL SCI, V122, P25, DOI 10.1242/jcs.033027; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Debreceni B, 2004, J BIOL CHEM, V279, P3777, DOI 10.1074/jbc.M308282200; Derrien V, 2002, J CELL SCI, V115, P2867; Dollar G, 2002, DEVELOPMENT, V129, P517; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; FERNANDEZ BG, 2007, MECH DEVELOP, P884; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; Frank LH, 1996, DEVELOPMENT, V122, P1343; Giansanti MG, 2007, MOL BIOL CELL, V18, P5034, DOI 10.1091/mbc.E07-05-0415; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Gorfinkiel N, 2009, DEVELOPMENT, V136, P1889, DOI 10.1242/dev.030866; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2009, CURR TOP DEV BIOL, V89, P55, DOI 10.1016/S0070-2153(09)89003-0; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; JACINTO A, 2003, MECH DEVELOP, P1337; Jankovics F, 2001, GENETICS, V158, P1177; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kumari S, 2010, CELL RES, V20, P256, DOI 10.1038/cr.2010.19; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103; Lee JY, 2010, CURR BIOL, V20, P253, DOI 10.1016/j.cub.2009.12.021; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Magie CR, 1999, DEVELOPMENT, V126, P5353; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; REED BH, 2004, CURR BIOL, P372; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; Sasikumar S, 2009, GENESIS, V47, P32, DOI 10.1002/dvg.20441; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Schober M, 2005, DEVELOPMENT, V132, P3493, DOI 10.1242/dev.01911; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Sugihara K, 2002, NAT CELL BIOL, V4, P73, DOI 10.1038/ncb720; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Wada A, 2007, DEV BIOL, V301, P340, DOI 10.1016/j.ydbio.2006.09.020; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	71	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18729	10.1371/journal.pone.0018729	http://dx.doi.org/10.1371/journal.pone.0018729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533196	Green Published, gold			2022-12-25	WOS:000289505600025
J	Pollpeter, D; Komuro, A; Barber, GN; Horvath, CM				Pollpeter, Darja; Komuro, Akihiko; Barber, Glen N.; Horvath, Curt M.			Impaired Cellular Responses to Cytosolic DNA or Infection with Listeria monocytogenes and Vaccinia Virus in the Absence of the Murine LGP2 Protein	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; RIG-I; ANTIVIRAL RESPONSES; HELICASE LGP2; DENDRITIC CELLS; DAI DLM-1/ZBP1; MICE LACKING; INTERFERON; RECEPTOR	Innate immune signaling is crucial for detection of and the initial response to microbial pathogens. Evidence is provided indicating that LGP2, a DEXH box domain protein related to the RNA recognition receptors RIG-I and MDA5, participates in the cellular response to cytosolic double-stranded DNA (dsDNA). Analysis of embryonic fibroblasts and macrophages from mice harboring targeted disruption in the LGP2 gene reveals that LGP2 can act as a positive regulator of type I IFN and antimicrobial gene expression in response to transfected dsDNA. Results indicate that infection of LGP2-deficient mice with an intracellular bacterial pathogen, Listeria monocytogenes, leads to reduced levels of type I IFN and IL12, and allows increased bacterial growth in infected animals, resulting in greater colonization of both spleen and liver. Responses to infection with vaccinia virus, a dsDNA virus, are also suppressed in cells lacking LGP2, reinforcing the ability of LGP2 to act as a positive regulator of antiviral signaling. In vitro mechanistic studies indicate that purified LGP2 protein does not bind DNA but instead mediates these responses indirectly. Data suggest that LGP2 may be acting downstream of the intracellular RNA polymerase III pathway to activate anti-microbial signaling. Together, these findings demonstrate a regulatory role for LGP2 in the response to cytosolic DNA, an intracellular bacterial pathogen, and a DNA virus, and provide a plausible mechanistic hypothesis as the basis for this activity.	[Pollpeter, Darja; Komuro, Akihiko; Horvath, Curt M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Barber, Glen N.] Univ Miami, Sch Med, Dept Med, Miami, FL USA; [Barber, Glen N.] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA	Northwestern University; University of Miami; University of Miami	Pollpeter, D (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	Horvath@northwestern.edu		Horvath, Curt/0000-0003-2449-225X	National Institutes of Health [AI077020, AI082984]; Northwestern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082984, R21AI077020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by National Institutes of Health grants AI077020 and AI082984 to CMH and the Northwestern University Presidential Fellowship to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Delaloye J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000480; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Portnoy DA, 2005, CURR OPIN IMMUNOL, V17, P25, DOI 10.1016/j.coi.2004.11.002; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Soulat D, 2006, FEBS LETT, V580, P2341, DOI 10.1016/j.febslet.2006.03.057; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; TRIPP CS, 1994, J IMMUNOL, V152, P1883; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	43	32	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18842	10.1371/journal.pone.0018842	http://dx.doi.org/10.1371/journal.pone.0018842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533147	gold, Green Published, Green Submitted			2022-12-25	WOS:000289505600036
J	Xu, LJ; Furlotte, N; Lin, YY; Heinrich, K; Berry, MW; George, EO; Homayouni, R				Xu, Lijing; Furlotte, Nicholas; Lin, Yunyue; Heinrich, Kevin; Berry, Michael W.; George, Ebenezer O.; Homayouni, Ramin			Functional Cohesion of Gene Sets Determined by Latent Semantic Indexing of PubMed Abstracts	PLOS ONE			English	Article							ENRICHMENT ANALYSIS; ONTOLOGY; DISCOVERY; TOOL; GRAPH	High-throughput genomic technologies enable researchers to identify genes that are co-regulated with respect to specific experimental conditions. Numerous statistical approaches have been developed to identify differentially expressed genes. Because each approach can produce distinct gene sets, it is difficult for biologists to determine which statistical approach yields biologically relevant gene sets and is appropriate for their study. To address this issue, we implemented Latent Semantic Indexing (LSI) to determine the functional coherence of gene sets. An LSI model was built using over 1 million Medline abstracts for over 20,000 mouse and human genes annotated in Entrez Gene. The gene-to-gene LSI-derived similarities were used to calculate a literature cohesion p-value (LPv) for a given gene set using a Fisher's exact test. We tested this method against genes in more than 6,000 functional pathways annotated in Gene Ontology (GO) and found that approximately 75% of gene sets in GO biological process category and 90% of the gene sets in GO molecular function and cellular component categories were functionally cohesive (LPv < 0.05). These results indicate that the LPv methodology is both robust and accurate. Application of this method to previously published microarray datasets demonstrated that LPv can be helpful in selecting the appropriate feature extraction methods. To enable real-time calculation of LPv for mouse or human gene sets, we developed a web tool called Gene-set Cohesion Analysis Tool (GCAT). GCAT can complement other gene set enrichment approaches by determining the overall functional cohesion of data sets, taking into account both explicit and implicit gene interactions reported in the biomedical literature.	[Xu, Lijing; Furlotte, Nicholas; George, Ebenezer O.; Homayouni, Ramin] Univ Memphis, Bioinformat Program, Memphis, TN 38152 USA; [Xu, Lijing; George, Ebenezer O.] Univ Memphis, Dept Math Sci, Memphis, TN 38152 USA; [Lin, Yunyue] Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA; [Heinrich, Kevin] Computable Genomix, Memphis, TN USA; [Berry, Michael W.] Univ Tennessee, Dept Elect & Comp Engn, Knoxville, TN 37996 USA; [Homayouni, Ramin] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA	University of Memphis; University of Memphis; University of Memphis; University of Tennessee System; University of Tennessee Knoxville; University of Memphis	Xu, LJ (corresponding author), Univ Memphis, Bioinformat Program, Memphis, TN 38152 USA.	rhomayon@memphis.edu	Homayouni, Ramin/U-2837-2019; Homayouni, Ramin/B-3547-2009	Homayouni, Ramin/0000-0003-0186-5076; Homayouni, Ramin/0000-0003-0186-5076; Berry, Michael/0000-0002-9191-9148	National Institutes of Health [HD52472]; Computable Genomix LLC; Assisi Foundation of Memphis; University of Memphis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Computable Genomix LLC; Assisi Foundation of Memphis; University of Memphis; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health award HD52472, Computable Genomix LLC (www.computablegenomix.com), The Assisi Foundation of Memphis, and The University of Memphis Bioinformatics Program. The funders had no role in study design or preparation of the manuscript. K. Heinrich from Computable Genomix LLC anticipated data analysis. He is one of the authors of this paper.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BERRY M, 1999, UNDERSTANDING SEARCH; Chagoyen M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-444; Chiaretti S, 2004, BLOOD, V103, P2771, DOI 10.1182/blood-2003-09-3243; Homayouni R, 2005, BIOINFORMATICS, V21, P104, DOI 10.1093/bioinformatics/bth464; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jelier R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-14; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Joslyn CA, 2004, BIOINFORMATICS, V20, P169, DOI 10.1093/bioinformatics/bth921; Kim TM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-453; Landauer TK, 2004, P NATL ACAD SCI USA, V101, P5214, DOI 10.1073/pnas.0400341101; Lee SG, 2004, BIOINFORMATICS, V20, P381, DOI 10.1093/bioinformatics/btg420; Manning C.D., 1999, FDN STAT NATURAL LAN; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Minguez P, 2009, NUCLEIC ACIDS RES, V37, pW109, DOI 10.1093/nar/gkp402; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Oron AP, 2008, BIOINFORMATICS, V24, P2586, DOI 10.1093/bioinformatics/btn465; Pan W, 2002, GENOME BIOL, V3; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Pepe MS, 2003, BIOMETRICS, V59, P133, DOI 10.1111/1541-0420.00016; Raychaudhuri S, 2003, BIOINFORMATICS, V19, P396, DOI 10.1093/bioinformatics/btg002; Raychaudhuri S, 2002, GENOME RES, V12, P1582, DOI 10.1101/gr.116402; Schuemie M, 2007, PROTEOMICS, V7, P921, DOI 10.1002/pmic.200600693; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Haagen HHHBM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007894; Wei L, 2008, J INTERF CYTOK RES, V28, P541, DOI 10.1089/jir.2007.0136; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Yona Golan, 2009, V541, P479, DOI 10.1007/978-1-59745-243-4_21; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; ZHENG B, 2007, AMIA ANN S P, V1174; Zheng B, 2007, GENOME BIOL, V8	34	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18851	10.1371/journal.pone.0018851	http://dx.doi.org/10.1371/journal.pone.0018851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533142	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600038
J	Feau, N; Decourcelle, T; Husson, C; Desprez-Loustau, ML; Dutech, C				Feau, Nicolas; Decourcelle, Thibaut; Husson, Claude; Desprez-Loustau, Marie-Laure; Dutech, Cyril			Finding Single Copy Genes Out of Sequenced Genomes for Multilocus Phylogenetics in Non-Model Fungi	PLOS ONE			English	Article							NUCLEAR INTRON SEQUENCES; BETA-TUBULIN GENE; MOLECULAR PHYLOGENY; POWDERY MILDEW; EVOLUTION; DNA; EXAMPLE; POLYMORPHISMS; POPULATION; ALGORITHM	Historically, fungal multigene phylogenies have been reconstructed based on a small number of commonly used genes. The availability of complete fungal genomes has given rise to a new wave of model organisms that provide large number of genes potentially useful for building robust gene genealogies. Unfortunately, cross-utilization of these resources to study phylogenetic relationships in the vast majority of non-model fungi (i.e. "orphan'' species) remains an unexamined question. To address this problem, we developed a method coupled with a program named "PHYLORPH'' (PHYLogenetic markers for ORPHans). The method screens fungal genomic databases (107 fungal genomes fully sequenced) for single copy genes that might be easily transferable and well suited for studies at low taxonomic levels (for example, in species complexes) in non-model fungal species. To maximize the chance to target genes with informative regions, PHYLORPH displays a graphical evaluation system based on the estimation of nucleotide divergence relative to substitution type. The usefulness of this approach was tested by developing markers in four non-model groups of fungal pathogens. For each pathogen considered, 7 to 40% of the 10-15 best candidate genes proposed by PHYLORPH yielded sequencing success. Levels of polymorphism of these genes were compared with those obtained for some genes traditionally used to build fungal phylogenies (e.g. nuclear rDNA, beta-tubulin, gamma-actin, Elongation factor EF-1 alpha). These genes were ranked among the best-performing ones and resolved accurately taxa relationships in each of the four non-model groups of fungi considered. We envision that PHYLORPH will constitute a useful tool for obtaining new and accurate phylogenetic markers to resolve relationships between closely related non-model fungal species.	[Feau, Nicolas; Decourcelle, Thibaut; Desprez-Loustau, Marie-Laure; Dutech, Cyril] INRA, BIOGEO, UMR1202, Cestas, France; [Husson, Claude] Nancy Univ, INRA, UMR1136, Interact Arbres Microorganismes IFR110, Champenoux, France	INRAE; INRAE; Universite de Lorraine	Feau, N (corresponding author), INRA, BIOGEO, UMR1202, Cestas, France.	nfeau@bordeaux.inra.fr	Husson, Claude/C-6113-2012	Husson, Claude/0000-0002-9148-9926	French National Agency; Institut National de la Recherche Agronomique; Conseil Regional d'Aquitaine [20030304002FA, 20040305003FA]; European Union [2003227]	French National Agency(French National Research Agency (ANR)); Institut National de la Recherche Agronomique; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Union(European Commission)	This research was supported by the French National Agency for Research project DRYADE project (Vulnerabilite, Milieux et Climat programme) and from the Institut National de la Recherche Agronomique [Projet innovant du departement EFPA 2010]. PCR products purifications and sequencing were performed at the genotyping and sequencing facility of Bordeaux (grants from the Conseil Regional d'Aquitaine n<SUP>o</SUP>20030304002FA and 20040305003FA and from the European Union FEDER n<SUP>o</SUP>2003227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2006, MOL ECOL NOTES, V6, P218, DOI 10.1111/j.1471-8286.2005.01198.x; Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ayliffe MA, 2001, MYCOL RES, V105, P818, DOI 10.1017/S0953756201004245; Begerow D, 2004, MYCOL RES, V108, P1257, DOI 10.1017/S0953756204001066; Bierne N, 2000, MOL ECOL, V9, P233, DOI 10.1046/j.1365-294x.2000.00842.x; Bridge PD, 2005, ADV BOT RES, V42, P33, DOI 10.1016/S0065-2296(05)42002-9; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; BRUNS TD, 1992, MOL BIOL EVOL, V9, P836; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; CAROLINA A, 2005, J MOL EVOL, V60, P726; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; CUOMO CA, 2010, FUNGAL GENOME INITIA, P833; DeBry RW, 2001, J MAMMAL, V82, P280, DOI 10.1644/1545-1542(2001)082<0280:NISFPO>2.0.CO;2; Desprez-Loustau ML, 2011, MYCOSCIENCE, V52, P165, DOI 10.1007/s10267-010-0100-5; DONALDSON GC, 1995, APPL ENVIRON MICROB, V61, P1331, DOI 10.1128/AEM.61.4.1331-1340.1995; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Einax E, 2003, ORG DIVERS EVOL, V3, P185, DOI 10.1078/1439-6092-00069; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Feau N, 2007, J MOL EVOL, V64, P489, DOI 10.1007/s00239-005-0309-7; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Gabaldon T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-235; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Garbelotto M, 2010, BIOL INVASIONS, V12, P943, DOI 10.1007/s10530-009-9514-4; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Husson C, 2011, EUR J PLANT PATHOL, V130, P311, DOI 10.1007/s10658-011-9755-9; Karlsson M, 2008, EVOL BIOINFORM, V4, P47; KIRK PM, 2001, DICT FUNGI; Kiss L, 1997, MYCOL RES, V101, P1073, DOI 10.1017/S0953756297003705; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; Kostka M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-341; Kretzer AM, 1999, MOL PHYLOGENET EVOL, V13, P483, DOI 10.1006/mpev.1999.0680; Kubisiak TL, 2007, MOL ECOL NOTES, V7, P428, DOI 10.1111/j.1471-8286.2006.01608.x; Kuramae EE, 2006, FEMS YEAST RES, V6, P1213, DOI 10.1111/j.1567-1364.2006.00119.x; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Landvik S, 2001, MYCOLOGIA, V93, P1151, DOI 10.2307/3761675; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lim S, 2004, FUNGAL GENET BIOL, V41, P1025, DOI 10.1016/j.fgb.2004.08.004; Lopez-Villavicencio M, 2010, FUNGAL GENET BIOL, V47, P693, DOI 10.1016/j.fgb.2010.05.002; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Marcet-Houben M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004357; Marthey S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-456; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; MOOERS AO, 2002, TRENDS ECOL EVOL, V15, P365; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Mougou A, 2008, FOREST PATHOL, V38, P275, DOI 10.1111/j.1439-0329.2008.00544.x; Murphy WJ, 2007, NAT PROTOC, V2, P3022, DOI 10.1038/nprot.2007.429; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Palumbi S, 1996, MOL SYSTEMATICS; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Podolak E, 2010, BIOTECHNIQUES, V48, P105, DOI 10.2144/000113371; Pringle A, 2009, MOL ECOL, V18, P817, DOI 10.1111/j.1365-294X.2008.04030.x; Prospero S, 2008, MOL ECOL, V17, P3366, DOI 10.1111/j.1365-294X.2007.03829.x; Queloz V, 2011, FOREST PATHOL, V41, P133, DOI 10.1111/j.1439-0329.2010.00645.x; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stajich JE, 2006, EUKARYOT CELL, V5, P789, DOI 10.1128/EC.5.5.789-793.2006; Tanabe Y, 2004, MOL PHYLOGENET EVOL, V30, P438, DOI 10.1016/S1055-7903(03)00185-4; Tanabe Y, 2002, MYCOL RES, V106, P1380, DOI 10.1017/S095375620200686X; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Tsui CKM, 2009, MOL ECOL RESOUR, V9, P1501, DOI 10.1111/j.1755-0998.2009.02717.x; Vialle A, 2009, MOL ECOL RESOUR, V9, P99, DOI 10.1111/j.1755-0998.2009.02637.x; Vijaykrishna D, 2006, FUNGAL DIVERS, V23, P351; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; Wenzel JW, 1999, CLADISTICS, V15, P51, DOI 10.1006/clad.1999.0084; Xhaard C, 2009, CONSERV GENET RESOUR, V1, P21, DOI 10.1007/s12686-009-9005-z; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; Zipfel RD, 2006, STUD MYCOL, P75, DOI 10.3114/sim.55.1.75; ZOLAN ME, 1986, MOL CELL BIOL, V6, P195, DOI 10.1128/MCB.6.1.195	84	42	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18803	10.1371/journal.pone.0018803	http://dx.doi.org/10.1371/journal.pone.0018803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533204	Green Submitted, Green Published, gold			2022-12-25	WOS:000289458800046
J	Gamble, KL; Motsinger-Reif, AA; Hida, A; Borsetti, HM; Servick, SV; Ciarleglio, CM; Robbins, S; Hicks, J; Carver, K; Hamilton, N; Wells, N; Summar, ML; McMahon, DG; Johnson, CH				Gamble, Karen L.; Motsinger-Reif, Alison A.; Hida, Akiko; Borsetti, Hugo M.; Servick, Stein V.; Ciarleglio, Christopher M.; Robbins, Sam; Hicks, Jennifer; Carver, Krista; Hamilton, Nalo; Wells, Nancy; Summar, Marshall L.; McMahon, Douglas G.; Johnson, Carl Hirschie			Shift Work in Nurses: Contribution of Phenotypes and Genotypes to Adaptation	PLOS ONE			English	Article							CIRCADIAN CLOCK GENES; SLEEP-PHASE SYNDROME; NIGHT SHIFTS; T3111C POLYMORPHISM; LENGTH POLYMORPHISM; METABOLIC SYNDROME; PER3 GENE; ASSOCIATION; MOOD; DISORDER	Background: Daily cycles of sleep/wake, hormones, and physiological processes are often misaligned with behavioral patterns during shift work, leading to an increased risk of developing cardiovascular/metabolic/gastrointestinal disorders, some types of cancer, and mental disorders including depression and anxiety. It is unclear how sleep timing, chronotype, and circadian clock gene variation contribute to adaptation to shift work. Methods: Newly defined sleep strategies, chronotype, and genotype for polymorphisms in circadian clock genes were assessed in 388 hospital day-and night-shift nurses. Results: Night-shift nurses who used sleep deprivation as a means to switch to and from diurnal sleep on work days (similar to 25%) were the most poorly adapted to their work schedule. Chronotype also influenced efficacy of adaptation. In addition, polymorphisms in CLOCK, NPAS2, PER2, and PER3 were significantly associated with outcomes such as alcohol/caffeine consumption and sleepiness, as well as sleep phase, inertia and duration in both single-and multi-locus models. Many of these results were specific to shift type suggesting an interaction between genotype and environment (in this case, shift work). Conclusions: Sleep strategy, chronotype, and genotype contribute to the adaptation of the circadian system to an environment that switches frequently and/or irregularly between different schedules of the light-dark cycle and social/workplace time. This study of shift work nurses illustrates how an environmental "stress'' to the temporal organization of physiology and metabolism can have behavioral and health-related consequences. Because nurses are a key component of health care, these findings could have important implications for health-care policy.	[Gamble, Karen L.; Hida, Akiko; Borsetti, Hugo M.; Servick, Stein V.; McMahon, Douglas G.; Johnson, Carl Hirschie] Vanderbilt Univ, Dept Biol Sci, Nashville, TN USA; [Motsinger-Reif, Alison A.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Ciarleglio, Christopher M.] Vanderbilt Univ, Grad Program Neurosci, Nashville, TN USA; [Robbins, Sam; Hicks, Jennifer; Carver, Krista; Hamilton, Nalo; Wells, Nancy] Vanderbilt Univ, Vanderbilt Sch Nursing, Nashville, TN USA; [Summar, Marshall L.; Johnson, Carl Hirschie] Childrens Natl Med Ctr, Washington, DC 20010 USA	Vanderbilt University; University of North Carolina; North Carolina State University; Vanderbilt University; Vanderbilt University; Children's National Health System	Gamble, KL (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	carl.h.johnson@vanderbilt.edu	Gamble, Karen/A-1753-2010; Johnson, Carl H/I-4655-2014; Ciarleglio, Christopher M/D-8463-2013; Motsinger-Reif, Alison/I-4167-2018	Ciarleglio, Christopher M/0000-0002-8490-8715; Motsinger-Reif, Alison/0000-0003-1346-2493; Gamble, Karen/0000-0003-3813-8577; Summar, Marshall/0000-0001-8920-0110	Vanderbilt University; National Center for Research Resources of the National Institutes of Health [M01 RR-00095]; Vanderbilt Joint Center for Nursing Research [U01 HL065962]; National Institute of Mental Health [R01 MH043836, R21 MH082258, P50 MH07080828, K99 GM086683]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL065962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043836, R21MH082258] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390335, 22791161] Funding Source: KAKEN	Vanderbilt University; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vanderbilt Joint Center for Nursing Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Discovery Grant from Vanderbilt University, a grant from the National Center for Research Resources of the National Institutes of Health to Vanderbilt's General Clinical Research Center (M01 RR-00095), the Vanderbilt Joint Center for Nursing Research, U01 HL065962 (to Dr. Dan Roden), and grants from the National Institute of Mental Health (R01 MH043836 and R21 MH082258 to CHJ, P50 MH07080828 to DGM, and K99 GM086683 to KLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEBRANDT KV, 2010, BIOL PSYCHIAT; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Ardekani Z Zamanian, 2008, Pak J Biol Sci, V11, P1605, DOI 10.3923/pjbs.2008.1605.1609; Artioli P, 2007, EUR NEUROPSYCHOPHARM, V17, P587, DOI 10.1016/j.euroneuro.2007.03.004; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Boivin DB, 2002, J BIOL RHYTHM, V17, P556, DOI 10.1177/0748730402238238; Boivin DB, 2007, SLEEP MED, V8, P578, DOI 10.1016/j.sleep.2007.03.015; Burch JB, 2009, OCCUP MED-OXFORD, V59, P159, DOI 10.1093/occmed/kqp015; Carpen JD, 2006, J HUM GENET, V51, P1122, DOI 10.1007/s10038-006-0060-y; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CASTANONCERVANT.O, 2010, J IMMUNOL; Chen JD, 2010, CHRONOBIOL INT, V27, P334, DOI 10.3109/07420520903502242; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; Crowley SJ, 2004, SLEEP, V27, P1077, DOI 10.1093/sleep/27.6.1077; Czeisler Charles A, 2009, Trans Am Clin Climatol Assoc, V120, P249; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; Groeger JA, 2008, SLEEP, V31, P1159; Hennig J, 1998, ERGONOMICS, V41, P610, DOI 10.1080/001401398186784; James FO, 2007, CHRONOBIOL INT, V24, P1009, DOI 10.1080/07420520701800736; Janssen D, 2004, REV SAUDE PUBL, V38, P11, DOI 10.1590/S0034-89102004000700003; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Laucht M, 2009, BIOL PSYCHIAT, V66, P102, DOI 10.1016/j.biopsych.2009.02.010; Lee C, 2006, CHRONOBIOL INT, V23, P859, DOI 10.1080/07420520600827160; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Lin YC, 2009, WORLD J GASTROENTERO, V15, P5654, DOI 10.3748/wjg.15.5654; Lipovcan K, 2004, REV SAUDE PUBL, V38, P3, DOI 10.1590/S0034-89102004000700002; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Lund J, 2001, J ENDOCRINOL, V171, P557, DOI 10.1677/joe.0.1710557; Marino JL, 2008, EPIDEMIOLOGY, V19, P477, DOI 10.1097/EDE.0b013e31816b7378; Mendlewicz J, 2009, CNS DRUGS, V23, P15, DOI 10.2165/11318630-000000000-00000; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Nataraj AJ, 1999, ELECTROPHORESIS, V20, P1177, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1177::AID-ELPS1177>3.0.CO;2-2; National Sleep Foundation, 2008, 2008 SLEEP AM POLL; Newey CA, 2004, J PROF NURS, V20, P187, DOI 10.1016/j.profnurs.2004.04.007; Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953; Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Pereira DS, 2005, SLEEP, V28, P29; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; ROGERS AE, 1993, NURS RES, V42, P368; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Serretti A, 2003, AM J MED GENET B, V121B, P35, DOI 10.1002/ajmg.b.20053; Smith L, 2005, IND HEALTH, V43, P151, DOI 10.2486/indhealth.43.151; Smith MR, 2009, J BIOL RHYTHM, V24, P161, DOI 10.1177/0748730409332068; Smith MR, 2008, SLEEP, V31, P1639, DOI 10.1093/sleep/31.12.1639; Suzuki K, 2005, J ADV NURS, V52, P445, DOI 10.1111/j.1365-2648.2005.03610.x; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takao T, 2007, EUR NEUROPSYCHOPHARM, V17, P273, DOI 10.1016/j.euroneuro.2006.09.002; TAYLOR E, 1997, INT J OCCUP ENV HEAL, V3, pS20; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Trinkoff AM, 2011, NURS RES, V60, P1, DOI 10.1097/NNR.0b013e3181fff15d; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Von Schantz M, 2008, J GENET, V87, P513, DOI 10.1007/s12041-008-0074-7; Weibel L, 1997, AM J PHYSIOL-REG I, V272, pR948, DOI 10.1152/ajpregu.1997.272.3.R948; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wulff K, 2009, CURR OPIN GENET DEV, V19, P237, DOI 10.1016/j.gde.2009.03.007; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193	74	122	125	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18395	10.1371/journal.pone.0018395	http://dx.doi.org/10.1371/journal.pone.0018395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	749IP	21533241	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800010
J	Lin, W; Cheng, XY; Xu, RM				Lin, Wen; Cheng, Xinyue; Xu, Rumei			Impact of Different Economic Factors on Biological Invasions on the Global Scale	PLOS ONE			English	Article							PLANT INVASIONS; BIOTIC RESISTANCE; ELEVATED CO2; BIODIVERSITY; INVASIBILITY; INVADERS; NITROGEN; SUCCESS	Social-economic factors are considered as the key to understand processes contributing to biological invasions. However, there has been few quantified, statistical evidence on the relationship between economic development and biological invasion on a worldwide scale. Herein, using principal factor analysis, we investigated the relationship between biological invasion and economic development together with biodiversity for 91 economies throughout the world. Our result indicates that the prevalence of invasive species in the economies can be well predicted by economic factors (R(2) = 0.733). The impact of economic factors on the occurrence of invasive species for low, lower-middle, upper-middle and high income economies are 0%, 34.3%, 46.3% and 80.8% respectively. Greenhouse gas emissions (CO(2), Nitrous oxide, Methane and Other greenhouse gases) and also biodiversity have positive relationships with the global occurrence of invasive species in the economies on the global scale. The major social-economic factors that are correlated to biological invasions are different for various economies, and therefore the strategies for biological invasion prevention and control should be different.	[Lin, Wen] Zhangzhou Entry Exit Inspect & Quarantine Bur, Zhangzhou, Fujian, Peoples R China; [Lin, Wen; Cheng, Xinyue; Xu, Rumei] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China	Beijing Normal University	Lin, W (corresponding author), Zhangzhou Entry Exit Inspect & Quarantine Bur, Zhangzhou, Fujian, Peoples R China.	xurumei@bnu.edu.cn						Byers JE, 2003, ECOLOGY, V84, P1428, DOI 10.1890/02-3131; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elton C. S., 1958, ECOLOGY INVASIONS AN; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hungate BA, 1996, ECOLOGY, V77, P2505, DOI 10.2307/2265749; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; MILCHUNAS DG, 1995, ECOL APPL, V5, P452, DOI 10.2307/1942035; Nagel JM, 2004, ECOLOGY, V85, P100, DOI 10.1890/02-3005; *NAT BUR STAT CHIN, 1996, CHIN NAT STAT YB; Nunez MA, 2010, BIOL INVASIONS, V12, P707, DOI 10.1007/s10530-009-9517-1; Perrings C, 2002, CONSERV ECOL, V6; Perry LG, 2010, OECOLOGIA, V163, P13, DOI 10.1007/s00442-010-1580-x; Pysek P, 2008, TRENDS ECOL EVOL, V23, P237, DOI 10.1016/j.tree.2008.02.002; Rao LE, 2010, OECOLOGIA, V162, P1035, DOI 10.1007/s00442-009-1516-5; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Song LY, 2010, BIOL INVASIONS, V12, P1221, DOI 10.1007/s10530-009-9541-1; Taylor BW, 2004, P NATL ACAD SCI USA, V101, P17725, DOI 10.1073/pnas.0405176101; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Weltzin JF, 2003, FRONT ECOL ENVIRON, V1, P146, DOI 10.1890/1540-9295(2003)001[0146:BIIAGW]2.0.CO;2; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williamson M., 1996, BIOL INVASIONS; Williamson M, 2006, BIOL INVASIONS, V8, P1561, DOI 10.1007/s10530-005-5849-7; World Bank, 2009, WORLD DEV IND 2009; Xu R., 2003, BIOL INVASION THEORY	32	9	13	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18797	10.1371/journal.pone.0018797	http://dx.doi.org/10.1371/journal.pone.0018797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533203	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800045
J	Wheeler, A; Anzures, G; Quinn, PC; Pascalis, O; Omrin, DS; Lee, K				Wheeler, Andrea; Anzures, Gizelle; Quinn, Paul C.; Pascalis, Olivier; Omrin, Danielle S.; Lee, Kang			Caucasian Infants Scan Own- and Other-Race Faces Differently	PLOS ONE			English	Article							NEOCLASSICAL FACIAL CANONS; RECOGNITION; MEMORY; CATEGORIZATION; INVERSION; CHINESE; GAZE	Young infants are known to prefer own-race faces to other race faces and recognize own-race faces better than other-race faces. However, it is entirely unclear as to whether infants also attend to different parts of own-and other-race faces differently, which may provide an important clue as to how and why the own-race face recognition advantage emerges so early. The present study used eye tracking methodology to investigate whether 6- to 10-month-old Caucasian infants (N = 37) have differential scanning patterns for dynamically displayed own-and other-race faces. We found that even though infants spent a similar amount of time looking at own-and other-race faces, with increased age, infants increasingly looked longer at the eyes of own-race faces and less at the mouths of own-race faces. These findings suggest experience-based tuning of the infant's face processing system to optimally process own-race faces that are different in physiognomy from other-race faces. In addition, the present results, taken together with recent own-and other-race eye tracking findings with infants and adults, provide strong support for an enculturation hypothesis that East Asians and Westerners may be socialized to scan faces differently due to each culture's conventions regarding mutual gaze during interpersonal communication.	[Wheeler, Andrea; Anzures, Gizelle; Omrin, Danielle S.; Lee, Kang] Univ Toronto, Dr Eric Jackman Inst Child Study, Toronto, ON, Canada; [Quinn, Paul C.] Univ Delaware, Dept Psychol, Newark, DE USA; [Pascalis, Olivier] Univ Pierre Mendes, Lab Psychol & NeuroCognit, Grenoble, France; [Lee, Kang] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Lee, Kang] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA	University of Toronto; University of Delaware; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of California System; University of California San Diego; University of California System; University of California San Diego	Wheeler, A (corresponding author), Univ Toronto, Dr Eric Jackman Inst Child Study, Toronto, ON, Canada.	kang.lee@utoronto.ca		Lauwereyns, Jan/0000-0003-0551-2550; pascalis, olivier/0000-0003-4609-3233	NSERC, National Institutes of Health (NIH) [R01HD046526]; NSERC, National Institutes of Health (NIH), NSFC [30528027, 31028010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER	NSERC, National Institutes of Health (NIH)(Natural Sciences and Engineering Research Council of Canada (NSERC)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC, National Institutes of Health (NIH), NSFC(Natural Sciences and Engineering Research Council of Canada (NSERC)National Natural Science Foundation of China (NSFC)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The present study was supported by a grant from NSERC, National Institutes of Health (NIH) (R01HD046526, NSFC (30528027 & 31028010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzures G, 2010, DEVELOPMENTAL SCI, V13, P553, DOI 10.1111/j.1467-7687.2009.00900.x; Bar-Haim Y, 2006, PSYCHOL SCI, V17, P159, DOI 10.1111/j.1467-9280.2006.01679.x; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Caldara R, 2006, PERCEPTION, V35, P659, DOI 10.1068/p5360; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; CHANCE JE, 1982, J PSYCHOL, V112, P29, DOI 10.1080/00223980.1982.9923531; Farkas LG, 2000, AESTHET PLAST SURG, V24, P179, DOI 10.1007/s002660010029; FEINMAN S, 1976, CHILD DEV, V47, P506, DOI 10.2307/1128809; Ferguson KT, 2009, INFANCY, V14, P263, DOI 10.1080/15250000902839369; Furl N, 2002, COGNITIVE SCI, V26, P797, DOI 10.1016/S0364-0213(02)00084-8; Ge LZ, 2009, PERCEPTION, V38, P1199, DOI 10.1068/p6136; Goodman GS, 2007, J EXP CHILD PSYCHOL, V98, P233, DOI 10.1016/j.jecp.2007.08.004; Hadjikhani N, 2008, BRAIN COGNITION, V68, P1, DOI 10.1016/j.bandc.2008.01.008; Hajnis Karle, 1994, P201; Hayden A, 2007, INFANCY, V12, P95, DOI 10.1111/j.1532-7078.2007.tb00235.x; Hayden A, 2009, PSYCHON B REV, V16, P270, DOI 10.3758/PBR.16.2.270; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; Kelly DJ, 2007, INFANCY, V11, P87, DOI 10.1207/s15327078in1101_4; Kelly DJ, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00006; Kelly DJ, 2009, J EXP CHILD PSYCHOL, V104, P105, DOI 10.1016/j.jecp.2009.01.006; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kinzler KD, 2009, SOC COGNITION, V27, P623, DOI 10.1521/soco.2009.27.4.623; Kisilevsky BS, 1998, DEV PSYCHOL, V34, P629, DOI 10.1037/0012-1649.34.4.629; Le TT, 2002, AESTHET PLAST SURG, V26, P64, DOI 10.1007/s00266-001-0033-7; LEE K, HDB FACE PE IN PRESS; Liu SY, 2011, J EXP CHILD PSYCHOL, V108, P180, DOI 10.1016/j.jecp.2010.06.008; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Muir D, 2003, INFANCY, V4, P483, DOI 10.1207/S15327078IN0404_03; Pezdek K, 2003, J APPL PSYCHOL, V88, P760, DOI 10.1037/0021-9010.88.4.760; Sangrigoli S, 2004, J CHILD PSYCHOL PSYC, V45, P1219, DOI 10.1111/j.1469-7610.2004.00319.x; Sangrigoli S, 2004, DEVELOPMENTAL SCI, V7, P74, DOI 10.1111/j.1467-7687.2004.00324.x; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; Shutts K, 2007, PSYCHOL SCI, V18, P763, DOI 10.1111/j.1467-9280.2007.01975.x; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Walker PM, 2006, APPL COGNITIVE PSYCH, V20, P461, DOI 10.1002/acp.1191	37	90	93	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18621	10.1371/journal.pone.0018621	http://dx.doi.org/10.1371/journal.pone.0018621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	749IP	21533235	Green Submitted, gold, Green Published			2022-12-25	WOS:000289458800022
J	Baumer, N; Tickenbrock, L; Tschanter, P; Lohmeyer, L; Diederichs, S; Baumer, S; Skryabin, BV; Zhang, F; Agrawal-Singh, S; Kohler, G; Berdel, WE; Serve, H; Koschmieder, S; Muller-Tidow, C				Baeumer, Nicole; Tickenbrock, Lara; Tschanter, Petra; Lohmeyer, Lisa; Diederichs, Sven; Baeumer, Sebastian; Skryabin, Boris V.; Zhang, Feng; Agrawal-Singh, Shuchi; Koehler, Gabriele; Berdel, Wolfgang E.; Serve, Hubert; Koschmieder, Steffen; Mueller-Tidow, Carsten			Inhibitor of Cyclin-dependent Kinase (CDK) Interacting with Cyclin A1 (INCA1) Regulates Proliferation and Is Repressed by Oncogenic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CELL-CYCLE; POTENTIAL MEDIATOR; TUMOR SUPPRESSION; A1-CDK2 COMPLEX; MICE; P27(KIP1); CANCER; FLT3; TUMORIGENESIS	The cell cycle is driven by the kinase activity of cyclin.cyclin-dependent kinase (CDK) complexes, which is negatively regulated by CDK inhibitor proteins. Recently, we identified INCA1 as an interaction partner and a substrate of cyclin A1 in complex with CDK2. On a functional level, we identified a novel cyclin-binding site in the INCA1 protein. INCA1 inhibited CDK2 activity and cell proliferation. The inhibitory effects depended on the cyclin-interacting domain. Mitogenic and oncogenic signals suppressed INCA1 expression, whereas it was induced by cell cycle arrest. We established a deletional mouse model that showed increased CDK2 activity in spleen with altered spleen architecture in Inca1(-/-) mice. Inca1(-/-) embryonic fibroblasts showed an increase in the fraction of S-phase cells. Furthermore, blasts from acute lymphoid leukemia and acute myeloid leukemia patients expressed significantly reduced INCA1 levels highlighting its relevance for growth control in vivo. Taken together, this study identifies a novel CDK inhibitor with reduced expression in acute myeloid and lymphoid leukemia. The molecular events that control the cell cycle occur in a sequential process to ensure a tight regulation, which is important for the survival of a cell and includes the detection and repair of genetic damage and the prevention of uncontrolled cell division.	[Baeumer, Nicole; Tickenbrock, Lara; Tschanter, Petra; Lohmeyer, Lisa; Diederichs, Sven; Baeumer, Sebastian; Zhang, Feng; Agrawal-Singh, Shuchi; Berdel, Wolfgang E.; Serve, Hubert; Koschmieder, Steffen; Mueller-Tidow, Carsten] Univ Munster, Dept Med, D-48129 Munster, Germany; [Baeumer, Nicole; Tschanter, Petra; Lohmeyer, Lisa; Skryabin, Boris V.; Serve, Hubert; Koschmieder, Steffen; Mueller-Tidow, Carsten] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48129 Munster, Germany; [Diederichs, Sven] Helmholtz Univ, Res Grp Mol RNA Biol & Canc, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Diederichs, Sven] Univ Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany; [Skryabin, Boris V.] Univ Munster, Inst Expt Pathol, D-48129 Munster, Germany; [Skryabin, Boris V.] Univ Munster, Ctr Mol Biol Inflammat ZMBE, D-48129 Munster, Germany; [Koehler, Gabriele] Univ Munster, Gerhard Domagk Inst Pathol, D-48129 Munster, Germany; [Serve, Hubert] Klinikum Johann Wolfgang Goethe Univ, Med Klin 2, D-60596 Frankfurt, Germany	University of Munster; University of Munster; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Munster; University of Munster; University of Munster; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Baumer, N (corresponding author), Univ Munster, Dept Med, Domagkstr 3, D-48129 Munster, Germany.	nbaeumer@uni-muenster.de; muellerc@uni-muenster.de	Baeumer, Sebastian/GYU-0544-2022; Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014; Skryabin, Boris/AAL-3100-2020; Diederichs, Sven/J-6237-2012	Müller-Tidow, Carsten/0000-0002-7166-5232; Skryabin, Boris/0000-0002-4392-185X; Koschmieder, Steffen/0000-0002-1011-8171; Diederichs, Sven/0000-0001-7901-4752; Serve, Hubert/0000-0001-8472-5516	Interdisciplinary Center for Clinical Research (IZKF) at University of Munster; Deutsche Forschungsgemeinschaft [Mu1328/6-1]	Interdisciplinary Center for Clinical Research (IZKF) at University of Munster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) at University of Munster and Deutsche Forschungsgemeinschaft Grants Mu1328/6-1.	Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Baumer N, 2002, DEVELOPMENT, V129, P4535; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Gao CY, 1997, BIOESSAYS, V19, P307, DOI 10.1002/bies.950190408; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Gladden AB, 2003, CANCER CELL, V4, P160, DOI 10.1016/S1535-6108(03)00217-4; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1993, CELL, V75, P805; HIRAI H, 1995, MOL CELL BIOL, V15, P2672; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mufti GJ, 1996, ATLAS MALIGNANT HAEM, P389; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Teller S, 2002, LEUKEMIA, V16, P1528, DOI 10.1038/sj.leu.2402630; Tickenbrock L, 2005, BLOOD, V105, P3699, DOI 10.1182/blood-2004-07-2924; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zindy F, 2003, CANCER RES, V63, P5420; Zindy F, 2000, MOL CELL BIOL, V20, P372, DOI 10.1128/MCB.20.1.372-378.2000	50	12	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28210	28222		10.1074/jbc.M110.203471	http://dx.doi.org/10.1074/jbc.M110.203471			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21540187	Green Published, hybrid			2022-12-25	WOS:000293557800039
J	Faralli, H; Martin, E; Core, N; Liu, QC; Filippi, P; Dilworth, FJ; Caubit, X; Fasano, L				Faralli, Herve; Martin, Elise; Core, Nathalie; Liu, Qi-Cai; Filippi, Pierre; Dilworth, F. Jeffrey; Caubit, Xavier; Fasano, Laurent			Teashirt-3, a Novel Regulator of Muscle Differentiation, Associates with BRG1-associated Factor 57 (BAF57) to Inhibit Myogenin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEXES; ADULT SKELETAL-MUSCLE; STEM-CELL FUNCTION; SATELLITE CELLS; SELF-RENEWAL; FUNCTIONAL-ANALYSIS; SWI/SNF COMPLEXES; SOMITIC ORIGIN; PROXIMAL LEG; MYOD	In adult muscles and under normal physiological conditions, satellite cells are found in a quiescent state but can be induced to enter the cell cycle by signals resulting from exercise, injury-induced muscle regeneration, or specific disease states. Once activated, satellite cells proliferate, self-renew, and differentiate to form myofibers. In the present study, we found that the zinc finger-containing factor Teashirt-3 (TSHZ3) was expressed in quiescent satellite cells of adult mouse skeletal muscles. We showed that following treatment with cardiotoxin TSHZ3 was strongly expressed in satellite cells of regenerating muscles. Moreover, immunohistochemical analysis indicated that TSHZ3 was expressed in both quiescent and activated satellite cells on intact myofibers in culture. TSHZ3 expression was maintained in myoblasts but disappeared with myotube formation. In C2C12 myoblasts, we showed that overexpression of Tshz3 impaired myogenic differentiation and promoted the down-regulation of myogenin (Myog) and up-regulation of paired-box factor 7 (Pax7). Moreover, knockdown experiments revealed a selective effect of Tshz3 on Myog regulation, and transcriptional reporter experiments indicated that TSHZ3 repressed Myog promoter. We identified the BRG1-associated factor 57 (BAF57), a subunit of the SWI/SNF complex, as a partner of TSHZ3. We showed that TSHZ3 cooperated with BAF57 to repress MYOD-dependent Myog expression. These results suggest a novel mechanism for transcriptional repression by TSHZ3 in which TSHZ3 and BAF57 cooperate to modulate MyoD activity on the Myog promoter to regulate skeletal muscle differentiation.	[Faralli, Herve; Martin, Elise; Core, Nathalie; Filippi, Pierre; Caubit, Xavier; Fasano, Laurent] Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR 6216, F-13288 Marseille 09, France; [Faralli, Herve; Liu, Qi-Cai; Dilworth, F. Jeffrey] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Ottawa; Ottawa Hospital Research Institute	Fasano, L (corresponding author), Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR 6216, Campus Luminy,Case 907, F-13288 Marseille 09, France.	laurent.fasano@univmed.fr	Fasano, Laurent/AFL-9580-2022; Fasano, Laurent/AAH-1688-2022	Fasano, Laurent/0000-0003-2307-8428; Fasano, Laurent/0000-0003-2307-8428; Dilworth, F. Jeffrey/0000-0002-6265-8102	Association Francaise contre les Myopathies (AFM) [12545, 13013]; Canadian Institutes of Health Research [MOP-93777]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Association Francaise contre les Myopathies (AFM) Grants 12545 and 13013 (to F. L.) and Canadian Institutes of Health Research Grant MOP-93777 (to F. J. D.).	Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Allen DL, 1996, J APPL PHYSIOL, V81, P145, DOI 10.1152/jappl.1996.81.1.145; Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7; Anderson JE, 1998, BIOCHEM CELL BIOL, V76, P13, DOI 10.1139/bcb-76-1-13; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Aziz A, 2009, DEV BIOL, V332, P116, DOI 10.1016/j.ydbio.2009.05.555; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bessa J, 2002, GENE DEV, V16, P2415, DOI 10.1101/gad.1009002; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Brown JK, 2004, J HISTOCHEM CYTOCHEM, V52, P1219, DOI 10.1369/jhc.3A6200.2004; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2000, MECH DEVELOP, V91, P445, DOI 10.1016/S0925-4773(99)00318-4; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Caubit X, 2010, J NEUROSCI, V30, P9465, DOI 10.1523/JNEUROSCI.1765-10.2010; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cooper RN, 1999, J CELL SCI, V112, P2895; Core N, 2007, DEV BIOL, V308, P407, DOI 10.1016/j.ydbio.2007.05.038; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Delfini MC, 2004, DEVELOPMENT, V131, P713, DOI 10.1242/dev.00967; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Erkner A, 1999, DEV BIOL, V215, P221, DOI 10.1006/dbio.1999.9452; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gallet A, 2000, DEVELOPMENT, V127, P5509; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hawke TJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1636, DOI 10.1152/ajpcell.00124.2007; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lu QL, 1998, J HISTOCHEM CYTOCHEM, V46, P977, DOI 10.1177/002215549804600813; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Onai T, 2007, EMBO J, V26, P2350, DOI 10.1038/sj.emboj.7601684; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 1999, GENE DEV, V13, P3171, DOI 10.1101/gad.13.24.3171; RODER L, 1992, DEVELOPMENT, V115, P1017; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Saller E, 2002, GENE DEV, V16, P1828, DOI 10.1101/gad.230002; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Soanes KH, 2001, MECH DEVELOP, V105, P145, DOI 10.1016/S0925-4773(01)00397-5; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Watanabe S, 2007, J CELL SCI, V120, P4178, DOI 10.1242/jcs.011668; Wu J, 2000, MECH DEVELOP, V94, P47, DOI 10.1016/S0925-4773(00)00311-7; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; YAMAGUCHI A, 1995, SEMIN CELL BIOL, V6, P165, DOI 10.1006/scel.1995.0023; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	82	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23498	23510		10.1074/jbc.M110.206003	http://dx.doi.org/10.1074/jbc.M110.206003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543328	hybrid, Green Published			2022-12-25	WOS:000292025000080
J	Borisova, SA; Christman, HD; Metcalf, MEM; Zulkepli, NA; Zhang, JK; van der Donk, WA; Metcalf, WW				Borisova, Svetlana A.; Christman, Harry D.; Metcalf, M. E. Mourey; Zulkepli, Nurul A.; Zhang, Jun Kai; van der Donk, Wilfred A.; Metcalf, William W.			Genetic and Biochemical Characterization of a Pathway for the Degradation of 2-Aminoethylphosphonate in Sinorhizobium meliloti 1021	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-FLUORESCENS 23F; BOND-CLEAVAGE ENZYME; ALDEHYDE DEHYDROGENASE; PHOSPHONOPYRUVATE HYDROLASE; SP PAL2; SUPERFAMILY; MUTAGENESIS; BACTERIA; SEQUENCE; BIODEGRADATION	A variety of microorganisms have the ability to use phosphonic acids as sole sources of phosphorus. Here, a novel pathway for degradation of 2-aminoethylphosphonate in the bacterium Sinorhizobium meliloti 1021 is proposed based on the analysis of the genome sequence. Gene deletion experiments confirmed the involvement of the locus containing phnW, phnA, and phnY genes in the conversion of 2-aminoethylphosphonate to inorganic phosphate. Biochemical studies of the recombinant PhnY and PhnA proteins verified their roles as phosphonoacetaldehyde dehydrogenase and phosphonoacetate hydrolase, respectively. This pathway is likely not limited to S. meliloti as suggested by the presence of homologous gene clusters in other bacterial genomes.	[Borisova, Svetlana A.; van der Donk, Wilfred A.; Metcalf, William W.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Christman, Harry D.; Metcalf, M. E. Mourey; Zhang, Jun Kai; Metcalf, William W.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Zulkepli, Nurul A.; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Borisova, Svetlana A.; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign	Metcalf, WW (corresponding author), B103 C&LSL,601 S Goodwin Ave, Urbana, IL 61801 USA.	metcalf@uiuc.edu	van der Donk, Wilfred/K-2961-2015	van der Donk, Wilfred/0000-0002-5467-7071	National Institutes of Health [GM P01 GM077596]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM077596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM P01 GM077596 from the National Institutes of Health and the Howard Hughes Medical Institute.	BALDOMA L, 1987, J BIOL CHEM, V262, P13991; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Borisova SA, 2010, CHEM BIOL, V17, P28, DOI 10.1016/j.chembiol.2009.11.017; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Capela D, 2001, P NATL ACAD SCI USA, V98, P9877, DOI 10.1073/pnas.161294398; Chen CCH, 2006, BIOCHEMISTRY-US, V45, P11491, DOI 10.1021/bi061208l; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698; FROST JW, 1987, J AM CHEM SOC, V109, P2166, DOI 10.1021/ja00241a039; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JIANG WH, 1995, J BACTERIOL, V177, P6411, DOI 10.1128/jb.177.22.6411-6421.1995; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; Kulakova AN, 2003, J BIOL CHEM, V278, P23426, DOI 10.1074/jbc.M301871200; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; LEE KS, 1992, J BACTERIOL, V174, P2501, DOI 10.1128/jb.174.8.2501-2510.1992; Marchal S, 1999, BIOCHEMISTRY-US, V38, P12950, DOI 10.1021/bi990453k; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; MCGRATH JW, 1995, EUR J BIOCHEM, V234, P225, DOI 10.1111/j.1432-1033.1995.225_c.x; MCMULLAN G, 1994, J BACTERIOL, V176, P320, DOI 10.1128/JB.176.2.320-324.1994; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Morais MC, 2004, J BIOL CHEM, V279, P9353, DOI 10.1074/jbc.M312345200; NAG DK, 1988, GENE, V64, P135, DOI 10.1016/0378-1119(88)90487-8; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Parker GF, 1999, J BACTERIOL, V181, P389, DOI 10.1128/JB.181.2.389-395.1999; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Quinn JP, 2007, ENVIRON MICROBIOL, V9, P2392, DOI 10.1111/j.1462-2920.2007.01397.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Ternan NG, 1998, SYST APPL MICROBIOL, V21, P346, DOI 10.1016/S0723-2020(98)80043-X; White AK, 2004, J BACTERIOL, V186, P4730, DOI 10.1128/JB.186.14.4730-4739.2004; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221	36	30	30	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22283	22290		10.1074/jbc.M111.237735	http://dx.doi.org/10.1074/jbc.M111.237735			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543322	Green Published, hybrid			2022-12-25	WOS:000291719900036
J	Matheoud, D; Baey, C; Vimeux, L; Tempez, A; Valente, M; Louche, P; Le Bon, A; Hosmalin, A; Feuillet, V				Matheoud, Diana; Baey, Camille; Vimeux, Lene; Tempez, Andy; Valente, Michael; Louche, Pauline; Le Bon, Agnes; Hosmalin, Anne; Feuillet, Vincent			Dendritic Cells Crosspresent Antigens from Live B16 Cells More Efficiently than from Apoptotic Cells and Protect from Melanoma in a Therapeutic Model	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; CROSS-PRESENTATION; TUMOR LYSATE; IN-VIVO; IMMUNE-RESPONSES; CANCER; VACCINATION; DEATH; IMMUNOTHERAPY; CD4(+)	Dendritic cells (DC) are able to elicit anti-tumoral CD8(+) T cell responses by cross-presenting exogenous antigens in association with major histocompatibility complex (MHC) class I molecules. Therefore they are crucial actors in cell-based cancer immunotherapy. Although apoptotic cells are usually considered to be the best source of antigens, live cells are also able to provide antigens for cross-presentation by DC. We have recently shown that prophylactic immunotherapy by DC after capture of antigens from live B16 melanoma cells induced strong CD8(+) T-cell responses and protection against a lethal tumor challenge in vivo in C57Bl/6 mice. Here, we showed that DC cross-presenting antigens from live B16 cells can also inhibit melanoma lung dissemination in a therapeutic protocol in mice. DC were first incubated with live tumor cells for antigen uptake and processing, then purified and irradiated for safety prior to injection. This treatment induced stronger tumor-specific CD8(+) T-cell responses than treatment by DC cross-presenting antigens from apoptotic cells. Apoptotic B16 cells induced more IL-10 secretion by DC than live B16 cells. They underwent strong native antigen degradation and led to the expression of fewer MHC class I/epitope complexes on the surface of DC than live cells. Therefore, the possibility to use live cells as sources of tumor antigens must be taken into account to improve the efficiency of cancer immunotherapy.	[Matheoud, Diana; Baey, Camille; Vimeux, Lene; Tempez, Andy; Valente, Michael; Louche, Pauline; Le Bon, Agnes; Hosmalin, Anne; Feuillet, Vincent] Inst Cochin, INSERM, U1016, Paris, France; [Matheoud, Diana; Baey, Camille; Vimeux, Lene; Tempez, Andy; Valente, Michael; Louche, Pauline; Le Bon, Agnes; Hosmalin, Anne; Feuillet, Vincent] CNRS, UMR8104, Paris, France; [Matheoud, Diana; Baey, Camille; Vimeux, Lene; Tempez, Andy; Valente, Michael; Louche, Pauline; Le Bon, Agnes; Hosmalin, Anne; Feuillet, Vincent] Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Matheoud, D (corresponding author), Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada.	anne.hosmalin@inserm.fr; vincent.feuillet@inserm.fr	Le Bon, Agnes/L-3237-2017; Hosmalin, Anne/AAF-8561-2019; Feuillet, Vincent/P-4988-2017	Le Bon, Agnes/0000-0003-4204-8136; Hosmalin, Anne/0000-0001-9021-3488; Feuillet, Vincent/0000-0003-1898-2527; valente, michael/0000-0002-0844-9799	Association de Recherche contre le Cancer (ARC), Ligue contre le Cancer; Agence Nationale de la Recherche contre le SIDA et les hepatites virales (ANRS); Region Ile de France; INSERM; Paris-Diderot University; CNRS	Association de Recherche contre le Cancer (ARC), Ligue contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche contre le SIDA et les hepatites virales (ANRS)(ANRS); Region Ile de France(Region Ile-de-France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris-Diderot University; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Association de Recherche contre le Cancer (ARC), Ligue contre le Cancer (studentship to C.B.), Agence Nationale de la Recherche contre le SIDA et les hepatites virales (ANRS; fellowship to D.M.), Region Ile de France (studentship to D.M.), INSERM (award to V.F.), Paris-Diderot University (studentship to M.V.), and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Berard F, 2000, J EXP MED, V192, P1535, DOI 10.1084/jem.192.11.1535; Bercovici N, 2008, J IMMUNOTHER, V31, P101, DOI 10.1097/CJI.0b013e318159f5ba; Blacher NE, 2005, PLOS BIOL, V3, P1070, DOI 10.1371/journal.pbio.0030185; Chang AE, 2002, CLIN CANCER RES, V8, P1021; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Gilboa E, 1998, CANCER IMMUNOL IMMUN, V46, P82, DOI 10.1007/s002620050465; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Jenne L, 2000, CANCER RES, V60, P4446; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Labarriere N, 2002, INT J CANCER, V101, P280, DOI 10.1002/ijc.10605; Lee WC, 2005, J IMMUNOTHER, V28, P496, DOI 10.1097/01.cji.0000171291.72039.e2; Lotze MT, 2006, GENE THER, V13, P191, DOI 10.1038/sj.gt.3302633; Maranon C, 2004, P NATL ACAD SCI USA, V101, P6092, DOI 10.1073/pnas.0304860101; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Paglia P, 1996, J EXP MED, V183, P317, DOI 10.1084/jem.183.1.317; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Pang BX, 2009, J IMMUNOL, V183, P1083, DOI 10.4049/jimmunol.0900861; Rawson PM, 2007, NAT MED, V13, P1431, DOI 10.1038/nm1679; Salcedo M, 2006, CANCER IMMUNOL IMMUN, V55, P819, DOI 10.1007/s00262-005-0078-6; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Uhl M, 2009, CELL DEATH DIFFER, V16, P991, DOI 10.1038/cdd.2009.8; Vulink A, 2008, ADV CANCER RES, V99, P363, DOI 10.1016/S0065-230X(07)99006-5; Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505; Zitvogel L, 1996, J EXP MED, V183, P87, DOI 10.1084/jem.183.1.87	39	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19104	10.1371/journal.pone.0019104	http://dx.doi.org/10.1371/journal.pone.0019104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552572	Green Published, gold, Green Submitted			2022-12-25	WOS:000290020700026
J	Robinson, N; Brackin, R; Vinall, K; Soper, F; Holst, J; Gamage, H; Paungfoo-Lonhienne, C; Rennenberg, H; Lakshmanan, P; Schmidt, S				Robinson, Nicole; Brackin, Richard; Vinall, Kerry; Soper, Fiona; Holst, Jirko; Gamage, Harshi; Paungfoo-Lonhienne, Chanyarat; Rennenberg, Heinz; Lakshmanan, Prakash; Schmidt, Susanne			Nitrate Paradigm Does Not Hold Up for Sugarcane	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; CROP PLANTS; SOIL; NITRIFICATION; N-15; FERTILIZER; RECOVERY; SYSTEMS; UREA	Modern agriculture is based on the notion that nitrate is the main source of nitrogen (N) for crops, but nitrate is also the most mobile form of N and easily lost from soil. Efficient acquisition of nitrate by crops is therefore a prerequisite for avoiding off-site N pollution. Sugarcane is considered the most suitable tropical crop for biofuel production, but surprisingly high N fertilizer applications in main producer countries raise doubt about the sustainability of production and are at odds with a carbon-based crop. Examining reasons for the inefficient use of N fertilizer, we hypothesized that sugarcane resembles other giant tropical grasses which inhibit the production of nitrate in soil and differ from related grain crops with a confirmed ability to use nitrate. The results of our study support the hypothesis that N-replete sugarcane and ancestral species in the Andropogoneae supertribe strongly prefer ammonium over nitrate. Sugarcane differs from grain crops, sorghum and maize, which acquired both N sources equally well, while giant grass, Erianthus, displayed an intermediate ability to use nitrate. We conclude that discrimination against nitrate and a low capacity to store nitrate in shoots prevents commercial sugarcane varieties from taking advantage of the high nitrate concentrations in fertilized soils in the first three months of the growing season, leaving nitrate vulnerable to loss. Our study addresses a major caveat of sugarcane production and affords a strong basis for improvement through breeding cultivars with enhanced capacity to use nitrate as well as through agronomic measures that reduce nitrification in	[Robinson, Nicole; Brackin, Richard; Vinall, Kerry; Soper, Fiona; Holst, Jirko; Gamage, Harshi; Paungfoo-Lonhienne, Chanyarat; Schmidt, Susanne] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Rennenberg, Heinz] Univ Freiburg, Inst Forest Bot & Tree Physiol, Freiburg, Germany; [Rennenberg, Heinz] King Saud Univ, Riyadh, Saudi Arabia; [Lakshmanan, Prakash] BSES Ltd, Indooroopilly, Qld, Australia	University of Queensland; University of Freiburg; King Saud University; BSES Limited	Robinson, N (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.	nicole.robinson@uq.edu.au	Paungfoo-Lonhienne, Chanyarat/A-5816-2011; Lakshmanan, Prakash/X-7789-2019; Lakshmanan, Prakash/A-8023-2013; Schmidt, Susanne/B-2780-2009; Rennenberg, Heinz/A-2083-2013; Brackin, Richard/D-8483-2013	Paungfoo-Lonhienne, Chanyarat/0000-0002-8361-2058; Schmidt, Susanne/0000-0001-8369-1238; Brackin, Richard/0000-0002-6899-5935; Rennenberg, Heinz/0000-0001-6224-2927; Soper, Fiona/0000-0002-9910-9377	CRC Sugar Industry Innovation through Biotechnology (CRCSIIB); Sugarcane Research and Development Cooperation [SRDC UQ043]; Alexander von Humboldt Society	CRC Sugar Industry Innovation through Biotechnology (CRCSIIB); Sugarcane Research and Development Cooperation; Alexander von Humboldt Society(Alexander von Humboldt Foundation)	This work was supported by CRC Sugar Industry Innovation through Biotechnology (CRCSIIB) and Sugarcane Research and Development Cooperation (SRDC UQ043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sabrina Latansio-Aidar, Jason Cleighton-Hills, Heather Vikstrom, Melissa Parish for assistance with field and glasshouse harvesting and Jessica Vogt for comments on the manuscript. Thanks to the Chapman family for access to their land and BSES for assistance. SS is grateful for a travel stipend from the Alexander von Humboldt Society to HR's laboratory at the University of Freiburg.	Allen DE, 2010, AGR ECOSYST ENVIRON, V136, P209, DOI 10.1016/j.agee.2009.11.002; Bell M. J., 2010, Proceedings of the 2010 Conference of the Australian Society of Sugar Cane Technologists held at Bundaberg, Queensland, Australia, 11-14 May 2010, P119; Biggs IM, 2002, PLANT SOIL, V238, P21, DOI 10.1023/A:1014280420779; Cardenas-Navarro R, 1999, J EXP BOT, V50, P613, DOI 10.1093/jexbot/50.334.613; CHAPMAN LS, 1994, AUST J AGR RES, V45, P1577, DOI 10.1071/AR9941577; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Glass ADM, 2003, CRIT REV PLANT SCI, V22, P453, DOI [10.1080/713989757, 10.1080/07352680390243512]; Hartemink AE, 2008, ADV AGRON, V99, P125, DOI 10.1016/S0065-2113(08)00403-3; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; Hoefsloot G, 2005, PLANT SOIL, V277, P85, DOI 10.1007/s11104-005-2581-0; Ishikawa S, 2009, SOIL SCI PLANT NUTR, V55, P485, DOI 10.1111/j.1747-0765.2009.00381.x; Franco HCJ, 2011, FIELD CROP RES, V121, P29, DOI 10.1016/j.fcr.2010.11.011; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kingston G., 2008, Proceedings of the 2008 Conference of the Australian Society of Sugar Cane Technologists held at Townsville, Queensland, Australia, 29 April - 2 May 2008, P202; Kronzucker HJ, 1997, NATURE, V385, P59, DOI 10.1038/385059a0; Lata JC, 1999, FUNCT ECOL, V13, P762, DOI 10.1046/j.1365-2435.1999.00380.x; Lui KH, 1999, PLANT CELL, V11, P865; Martinelli LA, 2008, ECOL APPL, V18, P885, DOI 10.1890/07-1813.1; Matsuoka S, 2009, IN VITRO CELL DEV-PL, V45, P372, DOI 10.1007/s11627-009-9220-z; Meier EA, 2006, AUST J SOIL RES, V44, P1, DOI 10.1071/SR05004; Meyer J. H., 2007, XXVI Congress, International Society of Sugar Cane Technologists, ICC, Durban, South Africa, 29 July - 2 August, 2007, P238; Miller AJ, 2008, ANN BOT-LONDON, V101, P485, DOI 10.1093/aob/mcm313; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Miller SA, 2010, ENVIRON SCI TECHNOL, V44, P3932, DOI 10.1021/es902405a; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Owen AG, 2001, SOIL BIOL BIOCHEM, V33, P651, DOI 10.1016/S0038-0717(00)00209-1; Rasiah V, 2003, AUST J SOIL RES, V41, P1145, DOI 10.1071/SR02076; Raven JA, 2005, ANN APPL BIOL, V146, P261, DOI 10.1111/j.1744-7348.2005.040138.x; Rossiter-Rachor NA, 2009, ECOL APPL, V19, P1546, DOI 10.1890/08-0265.1; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; STEWART GR, 1999, PHYSL PLANT ECOLOGY; Subbarao GV, 2007, PLANT SOIL, V290, P245, DOI 10.1007/s11104-006-9156-6; Subbarao GV, 2006, CRIT REV PLANT SCI, V25, P303, DOI 10.1080/07352680600794232; Thorburn PJ, 2005, FIELD CROP RES, V92, P337, DOI 10.1016/j.fcr.2005.01.016; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Urquiaga S, 1992, CONTRIBUTION NITROGE; Vallis I, 1996, AUST J AGR RES, V47, P355, DOI 10.1071/AR9960355; Wang W. J., 2008, Proceedings of the 2008 Conference of the Australian Society of Sugar Cane Technologists held at Townsville, Queensland, Australia, 29 April - 2 May 2008, P87; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2	42	104	113	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19045	10.1371/journal.pone.0019045	http://dx.doi.org/10.1371/journal.pone.0019045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552564	gold, Green Submitted, Green Published			2022-12-25	WOS:000290020700017
J	Goral, V; Jin, Y; Sun, HY; Ferrie, AM; Wu, Q; Fang, Y				Goral, Vasiliy; Jin, Yan; Sun, Haiyan; Ferrie, Ann M.; Wu, Qi; Fang, Ye			Agonist-Directed Desensitization of the beta(2)-Adrenergic Receptor	PLOS ONE			English	Article							DYNAMIC MASS REDISTRIBUTION; GUIDE GRATING BIOSENSOR; OPTICAL BIOSENSOR; ENDOTHELIAL-CELLS; SHEAR-STRESS; ACTIVATION; MECHANISMS; SELECTIVITY	The beta(2)-adrenergic receptor (beta(2)AR) agonists with reduced tachyphylaxis may offer new therapeutic agents with improved tolerance profile. However, receptor desensitization assays are often inferred at the single signaling molecule level, thus ligand-directed desensitization is poorly understood. Here we report a label-free biosensor whole cell assay with microfluidics to determine ligand-directed desensitization of the beta(2)AR. Together with mechanistic deconvolution using small molecule inhibitors, the receptor desensitization and resensitization patterns under the short-term agonist exposure manifested the long-acting agonism of salmeterol, and differentiated the mechanisms of agonist-directed desensitization between a full agonist epinephrine and a partial agonist pindolol. This study reveals the cellular mechanisms of agonist-selective beta(2)AR desensitization at the whole cell level.	[Goral, Vasiliy; Jin, Yan; Sun, Haiyan; Ferrie, Ann M.; Wu, Qi; Fang, Ye] Corning Inc, Biochem Technol, Div Sci & Technol, Corning, NY 14831 USA	Corning Inc; State University of New York (SUNY) System; SUNY Community College	Goral, V (corresponding author), Corning Inc, Biochem Technol, Div Sci & Technol, Corning, NY 14831 USA.	fangy2@corning.com	Wu, Qi/G-1573-2011	Fang, Ye/0000-0002-1322-7365	National Institutes of Health [5U54MH084691]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported in part by National Institutes of Health grant 5U54MH084691 (to YF). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio M, 2011, NEUROPHARMACOLOGY, V60, P45, DOI 10.1016/j.neuropharm.2010.08.006; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Charlton SJ, 2009, BRIT J PHARMACOL, V158, P165, DOI 10.1111/j.1476-5381.2009.00352.x; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Davis E, 2008, BRIT J PHARMACOL, V154, P584, DOI 10.1038/bjp.2008.164; DEEN WM, 1998, TOP CHEM ENGN NY, pR13; DELAVIERKLUTCHKO C, 1984, FEBS LETT, V169, P151, DOI 10.1016/0014-5793(84)80308-7; Duringer C, 2009, BRIT J PHARMACOL, V158, P169, DOI 10.1111/j.1476-5381.2009.00262.x; Fang Y, 2005, ANAL CHEM, V77, P5720, DOI 10.1021/ac050887n; Fang Y, 2005, FEBS LETT, V579, P6365, DOI 10.1016/j.febslet.2005.10.019; FANG Y, 2007, TRENDS SIGNAL TRANSD, P145; Fang Y, 2008, FEBS LETT, V582, P558, DOI 10.1016/j.febslet.2008.01.021; Fang Y, 2007, SENSORS-BASEL, V7, P2316, DOI 10.3390/s7102316; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.05.001; Fang Y, 2009, METHODS MOL BIOL, V552, P239, DOI 10.1007/978-1-60327-317-6_17; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrie AM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522894; Hahn C, 2009, CIRC RES, V104, P995, DOI 10.1161/CIRCRESAHA.108.186486; Hanania Nicola A., 2004, Current Drug Targets - Inflammation and Allergy, V3, P271, DOI 10.2174/1568010043343598; Jo H, 1997, J BIOL CHEM, V272, P1395, DOI 10.1074/jbc.272.2.1395; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; Jonas P, 2000, NEWS PHYSIOL SCI, V15, P83; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kenakin T, 2009, ACS CHEM BIOL, V4, P249, DOI 10.1021/cb800299s; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; McGraw Dennis W, 2005, Proc Am Thorac Soc, V2, P292, DOI 10.1513/pats.200504-027SR; Nelson HS, 2006, J ALLERGY CLIN IMMUN, V117, P3, DOI 10.1016/j.jaci.2005.10.013; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Sears Malcolm R., 2002, Journal of Allergy and Clinical Immunology, V110, pS322, DOI 10.1067/mai.2002.129966; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677	37	36	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19282	10.1371/journal.pone.0019282	http://dx.doi.org/10.1371/journal.pone.0019282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541288	gold, Green Submitted, Green Published			2022-12-25	WOS:000290018400040
J	Cammarato, A; Ahrens, CH; Alayari, NN; Qeli, E; Rucker, J; Reedy, MC; Zmasek, CM; Gucek, M; Cole, RN; Van Eyk, JE; Bodmer, R; O'Rourke, B; Bernstein, SI; Foster, DB				Cammarato, Anthony; Ahrens, Christian H.; Alayari, Nakissa N.; Qeli, Ermir; Rucker, Jasma; Reedy, Mary C.; Zmasek, Christian M.; Gucek, Marjan; Cole, Robert N.; Van Eyk, Jennifer E.; Bodmer, Rolf; O'Rourke, Brian; Bernstein, Sanford I.; Foster, D. Brian			A Mighty Small Heart: The Cardiac Proteome of Adult Drosophila melanogaster	PLOS ONE			English	Article							PEPTIDE IDENTIFICATIONS; MODEL; PROTEINS; CARDIOMYOPATHY; PREDICTION; DISCOVERY; DATABASE; MOUSE	Drosophila melanogaster is emerging as a powerful model system for the study of cardiac disease. Establishing peptide and protein maps of the Drosophila heart is central to implementation of protein network studies that will allow us to assess the hallmarks of Drosophila heart pathogenesis and gauge the degree of conservation with human disease mechanisms on a systems level. Using a gel-LC-MS/MS approach, we identified 1228 protein clusters from 145 dissected adult fly hearts. Contractile, cytostructural and mitochondrial proteins were most abundant consistent with electron micrographs of the Drosophila cardiac tube. Functional/Ontological enrichment analysis further showed that proteins involved in glycolysis, Ca2+-binding, redox, and G-protein signaling, among other processes, are also over-represented. Comparison with a mouse heart proteome revealed conservation at the level of molecular function, biological processes and cellular components. The subsisting peptidome encompassed 5169 distinct heart-associated peptides, of which 1293 (25%) had not been identified in a recent Drosophila peptide compendium. PeptideClassifier analysis was further used to map peptides to specific gene-models. 1872 peptides provide valuable information about protein isoform groups whereas a further 3112 uniquely identify specific protein isoforms and may be used as a heart-associated peptide resource for quantitative proteomic approaches based on multiple-reaction monitoring. In summary, identification of excitation-contraction protein landmarks, orthologues of proteins associated with cardiovascular defects, and conservation of protein ontologies, provides testimony to the heart-like character of the Drosophila cardiac tube and to the utility of proteomics as a complement to the power of genetics in this growing model of human heart disease.	[Cammarato, Anthony; Alayari, Nakissa N.; Bodmer, Rolf] NASCR Ctr, Sanford Burnham Med Res Inst, Dev & Aging Program, La Jolla, CA 92037 USA; [Cammarato, Anthony; Alayari, Nakissa N.; Bernstein, Sanford I.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Cammarato, Anthony; Alayari, Nakissa N.; Bernstein, Sanford I.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; [Ahrens, Christian H.; Qeli, Ermir] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Rucker, Jasma; O'Rourke, Brian; Foster, D. Brian] Johns Hopkins Univ, Sch Med, Div Cardiol, Inst Mol Cardiobiol, Baltimore, MD USA; [Reedy, Mary C.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC USA; [Zmasek, Christian M.] Sanford Burnham Med Res Inst, Bioinformat & Syst Biol Program, La Jolla, CA USA; [Van Eyk, Jennifer E.] Johns Hopkins Bayview Med Ctr, Div Cardiol, Dept Biol Chem, Baltimore, MD USA; [Van Eyk, Jennifer E.] Johns Hopkins Bayview Med Ctr, Div Cardiol, Dept Biomed Engn, Baltimore, MD USA	Sanford Burnham Prebys Medical Discovery Institute; California State University System; San Diego State University; California State University System; San Diego State University; University of Zurich; Johns Hopkins University; Duke University; Sanford Burnham Prebys Medical Discovery Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Cammarato, A (corresponding author), NASCR Ctr, Sanford Burnham Med Res Inst, Dev & Aging Program, La Jolla, CA 92037 USA.	dbrianfoster@jhmi.edu	Foster, D. Brian/S-9108-2019; Ahrens, Christian H./F-4656-2011; Foster, D. Brian/C-6350-2009	Foster, D. Brian/0000-0002-9290-9590; Ahrens, Christian H./0000-0002-8148-7257; Foster, D. Brian/0000-0002-9290-9590; Bernstein, Sanford/0000-0001-7094-5390; O'Rourke, Brian/0000-0002-5548-4853; Qeli, Ermir/0000-0002-0508-8043	AHA [10SDG4180089]; University of Zurich; National Institutes of Health (NIH) [R01-GM087218, R01-GM32443, R01 HL054732]; Ellison Medical Foundation; NHLBI Proteomics Initiative [N01-HV28180]; AHA Western States;  [P01 HL081427]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081427, ZICHL005903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087218, R01GM032443] Funding Source: NIH RePORTER	AHA(American Heart Association); University of Zurich; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NHLBI Proteomics Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA Western States; ; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AC was funded by an AHA Western States postdoctoral fellowship and by AHA 10SDG4180089. CHA and EQ are funded in part by the University of Zurich's Research Priority Project Functional Genomics/Systems Biology. CMZ by National Institutes of Health (NIH) R01-GM087218, SIB by NIH R01-GM32443, RB by NIH R01 HL054732 and by The Ellison Medical Foundation, JVE and RNC by the NHLBI Proteomics Initiative Contract N01-HV28180, BOR by P01 HL081427. DBF was supported by P01 HL081427 (to BOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 2010, NAT REV MOL CELL BIO, V11, P789, DOI 10.1038/nrm2973; Alayari NN, 2009, JOVE-J VIS EXP, pe1423, DOI DOI 10.3791/1423; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Arrell DK, 2010, CLIN PHARMACOL THER, V88, P120, DOI 10.1038/clpt.2010.91; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bousette N, 2009, J PROTEOME RES, V8, P1887, DOI 10.1021/pr800845a; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Buscemi N, 2005, AM J PHYSIOL-HEART C, V289, pH2325, DOI 10.1152/ajpheart.01041.2004; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; McCulloch AD, 2005, ANN NY ACAD SCI, V1047, P283, DOI 10.1196/annals.1341.025; Miller A, INTERNAL ANATOMY HIS; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Ocorr K, 2009, JOVE-J VIS EXP, pe1435; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Qeli E, 2010, NAT BIOTECHNOL, V28, P647, DOI 10.1038/nbt0710-647; Qian L, 2008, P NATL ACAD SCI USA, V105, P19833, DOI 10.1073/pnas.0808705105; RIZKI TM, 1978, DEV BIOL, V65, P476, DOI 10.1016/0012-1606(78)90042-8; Sanders WS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S23; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi R, 2007, J PROTEOME RES, V6, P2963, DOI 10.1021/pr0605668; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Tabb DL, 2006, NAT PROTOC, V1, P2213, DOI 10.1038/nprot.2006.330; Taghli-Lamallem O, 2008, DRUG DISCOV TODAY DI, V5, P125; Taghli-Lamallem O, 2008, AGING CELL, V7, P237, DOI 10.1111/j.1474-9726.2008.00367.x; Vogler Georg, 2009, J Vis Exp, DOI 10.3791/1425; Wasserthal LT, 2007, J EXP BIOL, V210, P3707, DOI 10.1242/jeb.007864; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Zeitouni B, 2007, PLOS GENET, V3, P1907, DOI 10.1371/journal.pgen.0030174; Zlatkovic-Lindor J, 2010, STEM CELLS, V28, P1355, DOI 10.1002/stem.465	43	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18497	10.1371/journal.pone.0018497	http://dx.doi.org/10.1371/journal.pone.0018497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541028	gold, Green Published, Green Submitted			2022-12-25	WOS:000290016800012
J	Jones, M; Ghoorah, A; Blaxter, M				Jones, Martin; Ghoorah, Anisah; Blaxter, Mark			jMOTU and Taxonerator: Turning DNA Barcode Sequences into Annotated Operational Taxonomic Units	PLOS ONE			English	Article							MICROBIAL DIVERSITY	Background: DNA barcoding and other DNA sequence-based techniques for investigating and estimating biodiversity require explicit methods for associating individual sequences with taxa, as it is at the taxon level that biodiversity is assessed. For many projects, the bioinformatic analyses required pose problems for laboratories whose prime expertise is not in bioinformatics. User-friendly tools are required for both clustering sequences into molecular operational taxonomic units (MOTU) and for associating these MOTU with known organismal taxonomies. Results: Here we present jMOTU, a Java program for the analysis of DNA barcode datasets that uses an explicit, determinate algorithm to define MOTU. We demonstrate its usefulness for both individual specimen-based Sanger sequencing surveys and bulk-environment metagenetic surveys using long-read next-generation sequencing data. jMOTU is driven through a graphical user interface, and can analyse tens of thousands of sequences in a short time on a desktop computer. A companion program, Taxonerator, that adds traditional taxonomic annotation to MOTU, is also presented. Clustering and taxonomic annotation data are stored in a relational database, and are thus amenable to subsequent data mining and web presentation. Conclusions: jMOTU efficiently and robustly identifies the molecular taxa present in survey datasets, and Taxonerator decorates the MOTU with putative identifications. jMOTU and Taxonerator are freely available from http://www.nematodes.org/.	[Jones, Martin; Ghoorah, Anisah; Blaxter, Mark] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Jones, M (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	mark.blaxter@ed.ac.uk	Blaxter, Mark L/B-4113-2010; Blaxter, Mark/O-2535-2019	Blaxter, Mark L/0000-0003-2861-949X; Ghoorah, Anisah/0000-0001-8273-6000	Leverhulme Trust [F/00158/BS]	Leverhulme Trust(Leverhulme Trust)	Martin Jones is funded by the Leverhulme Trust (F/00158/BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral Zettler Linda A., 2002, Nature (London), V417, P137, DOI 10.1038/417137a; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2004, P ROY SOC B-BIOL SCI, V271, pS189, DOI 10.1098/rsbl.2003.0130; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Hamp TJ, 2009, APPL ENVIRON MICROB, V75, P3263, DOI 10.1128/AEM.01931-08; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Machida RJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-438; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Species 2000, 2010, CAT LIF 2010 ANN CHE; Stockinger H, 2010, NEW PHYTOL; Stoeckle MY, 2008, SCI AM, V299, P82; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164	32	133	135	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e19259	10.1371/journal.pone.0019259	http://dx.doi.org/10.1371/journal.pone.0019259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541350	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800039
J	Lascorz, J; Chen, BW; Hemminki, K; Forsti, A				Lascorz, Jesus; Chen, Bowang; Hemminki, Kari; Forsti, Asta			Consensus Pathways Implicated in Prognosis of Colorectal Cancer Identified Through Systematic Enrichment Analysis of Gene Expression Profiling Studies	PLOS ONE			English	Article							II COLON-CANCER; LYMPH-NODE METASTASIS; THERAPEUTIC OPPORTUNITIES; NONNEOPLASTIC MUCOSA; PREDICTS RECURRENCE; LIVER METASTASIS; SIGNATURE; PROGRESSION; GENOME; METAANALYSIS	Background: A large number of gene expression profiling (GEP) studies on prognosis of colorectal cancer (CRC) has been performed, but no reliable gene signature for prediction of CRC prognosis has been found. Bioinformatic enrichment tools are a powerful approach to identify biological processes in high-throughput data analysis. Principal Findings: We have for the first time collected the results from the 23 so far published independent GEP studies on CRC prognosis. In these 23 studies, 1475 unique, mapped genes were identified, from which 124 (8.4%) were reported in at least two studies, with 54 of them showing consisting direction in expression change between the single studies. Using these data, we attempted to overcome the lack of reproducibility observed in the genes reported in individual GEP studies by carrying out a pathway-based enrichment analysis. We used up to ten tools for overrepresentation analysis of Gene Ontology (GO) categories or Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways in each of the three gene lists (1475, 124 and 54 genes). This strategy, based on testing multiple tools, allowed us to identify the oxidative phosphorylation chain and the extracellular matrix receptor interaction categories, as well as a general category related to cell proliferation and apoptosis, as the only significantly and consistently overrepresented pathways in the three gene lists, which were reported by several enrichment tools. Conclusions: Our pathway-based enrichment analysis of 23 independent gene expression profiling studies on prognosis of CRC identified significantly and consistently overrepresented prognostic categories for CRC. These overrepresented categories have been functionally clearly related with cancer progression, and deserve further investigation.	[Lascorz, Jesus; Chen, Bowang; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Hemminki, Kari; Forsti, Asta] Lund Univ, Ctr Primary Hlth Care Res, Clin Res Ctr, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University	Lascorz, J (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	j.lascorz@dkfz.de			German National Genome Research Network (NGFN-Plus) [01GS08181]; Deutsche Krebshilfe (German Cancer AID) [107318]; European Union (EU) [HEALTH-F4-2007-200767]	German National Genome Research Network (NGFN-Plus); Deutsche Krebshilfe (German Cancer AID)(Deutsche Krebshilfe); European Union (EU)(CGIAREuropean Commission)	This work was supported by the German National Genome Research Network (NGFN-Plus) (01GS08181), the Deutsche Krebshilfe (German Cancer AID) (107318), and the European Union (EU) (HEALTH-F4-2007-200767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Arango D, 2005, GASTROENTEROLOGY, V129, P874, DOI 10.1053/j.gastro.2005.06.066; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandres E, 2007, ONCOL REP, V17, P1089; Barrier A, 2007, ONCOGENE, V26, P2642, DOI 10.1038/sj.onc.1210060; Barrier A, 2005, DIS COLON RECTUM, V48, P2238, DOI 10.1007/s10350-005-0175-9; Barrier A, 2005, ONCOGENE, V24, P6155, DOI 10.1038/sj.onc.1208984; Barrier A, 2006, J CLIN ONCOL, V24, P4685, DOI 10.1200/JCO.2005.05.0229; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Cardoso J, 2007, BBA-REV CANCER, V1775, P103, DOI 10.1016/j.bbcan.2006.08.004; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Cavalieri D, 2007, ONCOL RES, V16, P535, DOI 10.3727/096504007783438376; Chan SK, 2008, CANCER EPIDEM BIOMAR, V17, P543, DOI 10.1158/1055-9965.EPI-07-2615; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Cuezva JM, 2007, J BIOENERG BIOMEMBR, V39, P259, DOI 10.1007/s10863-007-9087-9; D'Arrigo A, 2005, INT J CANCER, V115, P256, DOI 10.1002/ijc.20883; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Garman KS, 2008, P NATL ACAD SCI USA, V105, P19432, DOI 10.1073/pnas.0806674105; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ioannidis JPA, 2005, LANCET, V365, P454, DOI 10.1016/S0140-6736(05)17878-7; Jiang YQ, 2008, J MOL DIAGN, V10, P346, DOI 10.2353/jmoldx.2008.080011; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kleivi K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-2; Komuro K, 2005, J SURG RES, V124, P216, DOI 10.1016/j.jss.2004.10.009; Kwon HC, 2004, DIS COLON RECTUM, V47, P141, DOI 10.1007/s10350-003-0032-7; Liersch T, 2009, CANCER GENET CYTOGEN, V190, P57, DOI 10.1016/j.cancergencyto.2008.11.011; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Ristow M, 2006, CURR OPIN CLIN NUTR, V9, P339, DOI 10.1097/01.mco.0000232892.43921.98; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; WARBURG O, 1956, SCIENCE, V124, P269; Watanabe T, 2009, DIS COLON RECTUM, V52, P1941, DOI 10.1007/DCR.0b013e3181b53684; Watanabe T, 2009, CANCER, V115, P283, DOI 10.1002/cncr.24023; Yamasaki M, 2007, INT J ONCOL, V30, P129; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	51	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18867	10.1371/journal.pone.0018867	http://dx.doi.org/10.1371/journal.pone.0018867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541025	Green Submitted, Green Published, gold			2022-12-25	WOS:000290016800021
J	Wickramasinghe, S; Hua, S; Rincon, G; Islas-Trejo, A; German, JB; Lebrilla, CB; Medrano, JF				Wickramasinghe, Saumya; Hua, Serenus; Rincon, Gonzalo; Islas-Trejo, Alma; German, J. Bruce; Lebrilla, Carlito B.; Medrano, Juan F.			Transcriptome Profiling of Bovine Milk Oligosaccharide Metabolism Genes Using RNA-Sequencing	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SIALIC-ACID; EXPRESSION; LACTATION; IDENTIFICATION; CELLS	This study examines the genes coding for enzymes involved in bovine milk oligosaccharide metabolism by comparing the oligosaccharide profiles with the expressions of glycosylation-related genes. Fresh milk samples (n = 32) were collected from four Holstein and Jersey cows at days 1, 15, 90 and 250 of lactation and free milk oligosaccharide profiles were analyzed. RNA was extracted from milk somatic cells at days 15 and 250 of lactation (n = 12) and gene expression analysis was conducted by RNA-Sequencing. A list was created of 121 glycosylation-related genes involved in oligosaccharide metabolism pathways in bovine by analyzing the oligosaccharide profiles and performing an extensive literature search. No significant differences were observed in either oligosaccharide profiles or expressions of glycosylation-related genes between Holstein and Jersey cows. The highest concentrations of free oligosaccharides were observed in the colostrum samples and a sharp decrease was observed in the concentration of free oligosaccharides on day 15, followed by progressive decrease on days 90 and 250. Ninety-two glycosylation-related genes were expressed in milk somatic cells. Most of these genes exhibited higher expression in day 250 samples indicating increases in net glycosylation-related metabolism in spite of decreases in free milk oligosaccharides in late lactation milk. Even though fucosylated free oligosaccharides were not identified, gene expression indicated the likely presence of fucosylated oligosaccharides in bovine milk. Fucosidase genes were expressed in milk and a possible explanation for not detecting fucosylated free oligosaccharides is the degradation of large fucosylated free oligosaccharides by the fucosidases. Detailed characterization of enzymes encoded by the 92 glycosylation-related genes identified in this study will provide the basic knowledge for metabolic network analysis of oligosaccharides in mammalian milk. These candidate genes will guide the design of a targeted breeding strategy to optimize the content of beneficial oligosaccharides in bovine milk.	[Wickramasinghe, Saumya; Rincon, Gonzalo; Islas-Trejo, Alma; Medrano, Juan F.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Hua, Serenus; Lebrilla, Carlito B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Wickramasinghe, S (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	jfmedrano@ucdavis.edu	Lebrilla, Carlito Bangeles/ABE-6369-2020	Rincon, Gonzalo/0000-0002-6149-9103	Dairy Management Inc. [08 MEJ-01-NH]; California Dairy Research Foundation; Austin Eugene Lyons Graduate Fellowship	Dairy Management Inc.; California Dairy Research Foundation; Austin Eugene Lyons Graduate Fellowship	This work was supported by Dairy Management Inc. grant number 08 MEJ-01-NH and by the California Dairy Research Foundation. SW was supported by the Austin Eugene Lyons Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Barile D, 2010, J DAIRY SCI, V93, P3940, DOI 10.3168/jds.2010-3156; Bode L, 2004, J LEUKOCYTE BIOL, V76, P820, DOI 10.1189/jlb.0304198; Bode L, 2006, J NUTR, V136, P2127, DOI 10.1093/jn/136.8.2127; Boutinaud M, 2002, REPROD NUTR DEV, V42, P133, DOI 10.1051/rnd:2002013; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Casado B, 2009, J PROTEOMICS, V73, P196, DOI 10.1016/j.jprot.2009.09.018; Clark KJR, 2005, BIOTECHNOL BIOENG, V90, P568, DOI 10.1002/bit.20439; Cleary TG, 2004, ADV EXP MED BIOL, V554, P145; Engfer MB, 2000, AM J CLIN NUTR, V71, P1589; Finkelstein J, 2007, NATURE, V446, P999, DOI 10.1038/446999a; Finucane KA, 2008, FUNCT INTEGR GENOMIC, V8, P251, DOI 10.1007/s10142-008-0074-y; Garcia-Vallejo JJ, 2006, GENE EXPRESSION ANAL, P187; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gustafsson A, 2005, GLYCOCONJUGATE J, V22, P109, DOI 10.1007/s10719-005-0356-8; Hamosh M, 1998, BIOL NEONATE, V74, P163, DOI 10.1159/000014021; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Huizing M., 2005, DRUG DISCOV TODAY DI, V2, P519, DOI [10.1016/j.ddmec.2005.11.003, DOI 10.1016/J.DDMEC.2005.11.003]; Martin MJ, 2001, J DAIRY SCI, V84, P995, DOI 10.3168/jds.S0022-0302(01)74558-4; Martin SF, 2006, GLYCOCONJUGATE J, V23, P147, DOI 10.1007/s10719-006-7920-8; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; Morrone A, 2000, HUM MUTAT, V15, P354, DOI 10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.3.CO;2-C; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Niittymaki J, 2006, APMIS, V114, P539, DOI 10.1111/j.1600-0463.2006.apm_461.x; Pallesen LT, 2007, J DAIRY SCI, V90, P3143, DOI 10.3168/jds.2007-0082; Rudloff S, 2006, GLYCOBIOLOGY, V16, P477, DOI 10.1093/glycob/cwj092; Rueda R, 2007, BRIT J NUTR, V98, pS68, DOI 10.1017/S0007114507832946; SAITO T, 1987, CARBOHYD RES, V165, P43, DOI 10.1016/0008-6215(87)80076-9; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Suzuki A, 2006, P JPN ACAD B-PHYS, V82, P93, DOI 10.2183/pjab.82.93; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; Tao N, 2009, J DAIRY SCI, V92, P2991, DOI 10.3168/jds.2008-1642; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang B, 2003, EUR J CLIN NUTR, V57, P1351, DOI 10.1038/sj.ejcn.1601704; Wang B, 2007, AM J CLIN NUTR, V85, P561, DOI 10.1093/ajcn/85.2.561; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wiederschain GY, 2001, J NUTR BIOCHEM, V12, P559, DOI 10.1016/S0955-2863(01)00174-7; Wierinckx A, 1999, MOL BIOL EVOL, V16, P1535, DOI 10.1093/oxfordjournals.molbev.a026066; Wilson NL, 2008, J PROTEOME RES, V7, P3687, DOI 10.1021/pr700793k	42	58	60	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18895	10.1371/journal.pone.0018895	http://dx.doi.org/10.1371/journal.pone.0018895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541029	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800025
J	Su, L; Liao, QJ; Wu, Y; Chen, XL				Su, Ling; Liao, Qingjiao; Wu, Yang; Chen, Xulin			Kaposi's Sarcoma-Associated Herpesvirus-Encoded LANA Down-Regulates IL-22R1 Expression through a Cis-Acting Element within the Promoter Region	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENDOTHELIAL GROWTH-FACTOR; LYTIC CYCLE REPLICATION; NUCLEAR ANTIGEN; GENE-EXPRESSION; TERMINAL REPEAT; RECEPTOR COMPLEXES; RESPONSE ELEMENT; KINASE PATHWAYS; CUTTING EDGE	Kaposi's sarcoma-associated herpesvirus (KSHV) is considered to be a necessary, but not sufficient, causal agent of Kaposi's sarcoma (KS). All forms of KS are characterized by the proliferation of spindle-shaped cells, and most (>90%) spindle cells from KS lesions are latently infected with KSHV. During KSHV latency, only a few viral genes are expressed. Among those latent genes, the ORF 73 gene encodes the latency-associated nuclear antigen (LANA), which is critical for the establishment and maintenance of the latent KSHV infection. Much evidence suggests that many cytokines can increase the frequency and aggressiveness of KS. In this study, a microarray analysis of KS and normal tissues revealed that multiple cytokines and cytokine receptors are regulated by KSHV latent infection. Of special interest, IL-22R1 transcript level was found to be down-regulated in the KS tissue. To study the possible regulation of IL-22R1 by LANA, the IL-22R1 promoter was constructed and found to contain a LANA-binding site (LBS). LANA was demonstrated to down-regulate IL-22R1 expression via direct binding to the LBS located within the IL-22R1 promoter region. Furthermore, KSHV latently infected cells showed an impaired response to IL-22 stimulation. These results suggest that LANA can regulate host factor expression by directly binding to a cis-acting element within the factor's promoter to benefit latent viral infection and suppression of the antiviral immune response.	[Su, Ling; Liao, Qingjiao; Wu, Yang; Chen, Xulin] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Su, L (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan, Peoples R China.	chenxl@wh.iov.cn			National Natural Science Foundation of China [30870130]; Important National Science & Technology Specific Projects [2009ZX09301-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science & Technology Specific Projects	This work was jointly funded by the National Natural Science Foundation of China (grant 30870130) and the Important National Science & Technology Specific Projects (2009ZX09301-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2002, BLOOD, V99, P649, DOI 10.1182/blood.V99.2.649; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Cunningham CC, 2005, MOL THER, V11, P149, DOI 10.1016/j.ymthe.2004.09.019; Di Bartolo DL, 2008, BLOOD, V111, P4731, DOI 10.1182/blood-2007-09-110544; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Fujimuro M, 2003, J VIROL, V77, P8019, DOI 10.1128/JVI.77.14.8019-8030.2003; Galea P, 1998, J Hum Virol, V1, P273; Garber AC, 2002, J BIOL CHEM, V277, P27401, DOI 10.1074/jbc.M203489200; Garber AC, 2001, J VIROL, V75, P7882, DOI 10.1128/JVI.75.17.7882-7892.2001; Gasperini P, 2008, J LEUKOCYTE BIOL, V84, P994, DOI 10.1189/jlb.1107777; Groves AK, 2001, J VIROL, V75, P9446, DOI 10.1128/JVI.75.19.9446-9457.2001; Heuze-Vourc'h N, 2005, BIOCHEM BIOPH RES CO, V333, P470, DOI 10.1016/j.bbrc.2005.05.122; Hyun TS, 2001, J VIROL, V75, P8761, DOI 10.1128/JVI.75.18.8761-8771.2001; Inoue S, 2005, MOL THER, V12, P707, DOI 10.1016/j.ymthe.2005.05.015; Knight JS, 2001, J BIOL CHEM, V276, P22971, DOI 10.1074/jbc.M101890200; Kolomecki K, 2000, CYTOBIOS, V101, P55; Komatsu T, 2004, VIROLOGY, V319, P225, DOI 10.1016/j.virol.2003.11.002; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Krithivas A, 2000, J VIROL, V74, P9637, DOI 10.1128/JVI.74.20.9637-9645.2000; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lim C, 2000, J GEN VIROL, V81, P2645, DOI 10.1099/0022-1317-81-11-2645; Lu J, 2009, J VIROL, V83, P7129, DOI 10.1128/JVI.00397-09; Mattsson K, 2002, J GEN VIROL, V83, P179, DOI 10.1099/0022-1317-83-1-179; MCNUTT NS, 1983, AM J PATHOL, V111, P62; Monini P, 1999, BLOOD, V93, P4044; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; NAIR BC, 1992, SCIENCE, V255, P1430, DOI 10.1126/science.1542792; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Qin D, 2008, CELL MICROBIOL, V10, P713, DOI 10.1111/j.1462-5822.2007.01079.x; Ramesh R, 2003, CANCER RES, V63, P5105; Renne R, 2001, J VIROL, V75, P458, DOI 10.1128/JVI.75.1.458-468.2001; Roupelieva M, 2010, J GEN VIROL, V91, P1138, DOI 10.1099/vir.0.017715-0; Ruff KR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-35; Sakakibara S, 2004, J VIROL, V78, P7299, DOI 10.1128/JVI.78.14.7299-7310.2004; SAMANIEGO F, 1995, J IMMUNOL, V154, P3582; SAVAN R, 2005, BLOOD; SHIN S, 1995, J BACTERIOL, V177, P4696, DOI 10.1128/jb.177.16.4696-4702.1995; Verma SC, 2006, J VIROL, V80, P3445, DOI 10.1128/JVI.80.7.3445-3458.2006; Wang HM, 2004, J ADV MATER-COVINA, V36, P36; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002	50	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19106	10.1371/journal.pone.0019106	http://dx.doi.org/10.1371/journal.pone.0019106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544244	Green Submitted, gold, Green Published			2022-12-25	WOS:000290015800043
J	Bertini, I; Chevance, S; Del Conte, R; Lalli, D; Turano, P				Bertini, Ivano; Chevance, Soizic; Del Conte, Rebecca; Lalli, Daniela; Turano, Paola			The Anti-Apoptotic Bcl-x(L) Protein, a New Piece in the Puzzle of Cytochrome C Interactome	PLOS ONE			English	Article							BCL-X-L; ESCHERICHIA-COLI; PEPTIDE COMPLEX; CELL-SURVIVAL; BINDING; FAMILY; NMR; ACTIVATION; REGULATORS; CASPASE-9	A structural model of the adduct between human cytochrome c and the human anti-apoptotic protein Bcl-x(L), which defines the protein-protein interaction surface, was obtained from solution NMR chemical shift perturbation data. The atomic level information reveals key intermolecular contacts identifying new potentially druggable areas on cytochrome c and Bcl-x(L). Involvement of residues on cytochrome c other than those in its complexes with electron transfer partners is apparent. Key differences in the contact area also exist between the Bcl-x(L) adduct with the Bak peptide and that with cytochrome c. The present model provides insights to the mechanism by which cytochrome c translocated to cytosol can be intercepted, so that the apoptosome is not assembled.	[Bertini, Ivano; Chevance, Soizic; Del Conte, Rebecca; Lalli, Daniela; Turano, Paola] Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy; [Bertini, Ivano; Lalli, Daniela; Turano, Paola] Univ Florence, Dept Chem, Florence, Italy	University of Florence; University of Florence	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Florence, Italy.	bertini@cerm.unifi.it	chevance, soizic/AAC-4249-2019; Turano, Paola/F-9089-2011	Turano, Paola/0000-0002-7683-8614	European Community [LSHG-CT-2006-031220S]; Italian MIUR [RBRN07BMCT]; Progetto FIRB [RBNE03PX83]	European Community(European Commission); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Progetto FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	The research was funded thanks to the European Community-SPINE II-COMPLEXES Contract LSHG-CT-2006-031220S, the Italian MIUR contract FIRB PROTEOMICA - RBRN07BMCT and the financial support of Ente Cassa di Risparmio di Firenze. S. C. was the recipient of a fellowship provided by Progetto FIRB 2003 - RBNE03PX83. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; [Anonymous], [No title captured]; Banci L, 1999, J BIOL INORG CHEM, V4, P824, DOI 10.1007/s007750050356; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Bertini I, 2005, J BIOL INORG CHEM, V10, P613, DOI 10.1007/s00775-005-0011-7; Bertini I, 2011, METALLOMICS, V3, P354, DOI 10.1039/c0mt00108b; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Jeng WY, 2002, J BIOENERG BIOMEMBR, V34, P423, DOI 10.1023/A:1022561924392; KELLER R, 2002, NEW SOFTWARE ANAL PR; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Morison IM, 2008, NAT GENET, V40, P387, DOI 10.1038/ng.103; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Olteanu A, 2003, BIOCHEM BIOPH RES CO, V312, P733, DOI 10.1016/j.bbrc.2003.10.182; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Petros AM, 2005, J BIOMOL NMR, V32, P260, DOI 10.1007/s10858-005-7957-1; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SCOTT RA, 1996, CYTOCHROME C MULTIDI; Shao WP, 2003, BIOCHEMISTRY-US, V42, P14774, DOI 10.1021/bi030145t; Volkov AN, 2005, PROTEIN SCI, V14, P799, DOI 10.1110/ps.041150205; Wegerich F, 2009, ANAL CHEM, V81, P2976, DOI 10.1021/ac802571h; Yadaiah M, 2007, BBA-PROTEINS PROTEOM, V1774, P1370, DOI 10.1016/j.bbapap.2007.08.005; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Yuan SJ, 2011, STRUCTURE, V19, P128, DOI 10.1016/j.str.2010.10.009; Yuan SJ, 2010, STRUCTURE, V18, P571, DOI 10.1016/j.str.2010.04.001; [No title captured]	38	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18329	10.1371/journal.pone.0018329	http://dx.doi.org/10.1371/journal.pone.0018329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533126	gold, Green Published			2022-12-25	WOS:000289620100003
J	Henrich, N; Holmes, B				Henrich, Natalie; Holmes, Bev			What the Public Was Saying about the H1N1 Vaccine: Perceptions and Issues Discussed in On-Line Comments during the 2009 H1N1 Pandemic	PLOS ONE			English	Article							INFLUENZA VACCINATION; HEALTH; ACCEPTANCE; INTENTION; BEHAVIOR; RECEIVE; TRUST; MODEL	During the 2009 H1N1 pandemic, a vaccine was made available to all Canadians. Despite efforts to promote vaccination, the public's intent to vaccinate remained low. In order to better understand the public's resistance to getting vaccinated, this study addressed factors that influenced the public's decision making about uptake. To do this, we used a relatively novel source of qualitative data - comments posted on-line in response to news articles on a particular topic. This study analysed 1,796 comments posted in response to 12 articles dealing with H1N1 vaccine on websites of three major Canadian news sources. Articles were selected based on topic and number of comments. A second objective was to assess the extent to which on-line comments can be used as a reliable data source to capture public attitudes during a health crisis. The following seven themes were mentioned in at least 5% of the comments (% indicates the percentage of comments that included the theme): fear of H1N1 (18.8%); responsibility of media (17.8%); government competency (17.7%); government trustworthiness (10.7%); fear of H1N1 vaccine (8.1%); pharmaceutical companies (7.6%); and personal protective measures (5.8%). It is assumed that the more frequently a theme was mentioned, the more that theme influenced decision making about vaccination. These key themes for the public were often not aligned with the issues and information officials perceived, and conveyed, as relevant in the decision making process. The main themes from the comments were consistent with results from surveys and focus groups addressing similar issues, which suggest that on-line comments do provide a reliable source of qualitative data on attitudes and perceptions of issues that emerge in a health crisis. The insights derived from the comments can contribute to improved communication and policy decisions about vaccination in health crises that incorporate the public's views.	[Henrich, Natalie] Providence Hlth Care, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Henrich, Natalie; Holmes, Bev] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Holmes, Bev] Michael Smith Fdn Hlth Res, Vancouver, BC, Canada	University of British Columbia	Henrich, N (corresponding author), Providence Hlth Care, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.	nhenrich@cheos.ubc.ca			Genome British Columbia [B06-FLU]	Genome British Columbia	This work was funded by Genome British Columbia (www.genomebc.ca), grant number B06-FLU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Chan M., WORLD NOW START 2009; Chanley VA, 2000, PUBLIC OPIN QUART, V64, P239, DOI 10.1086/317987; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Editorial, 2009, NATURE, V461, P698; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Green LW, 2009, ANNU REV PUBL HEALTH, V30, P151, DOI 10.1146/annurev.publhealth.031308.100049; Gutteling J, 2006, PUBLIC UNDERST SCI, V15, P103, DOI 10.1177/0963662506057479; *INT WORLD STATS, 2010, INT US STAT; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; LUPTON D, 1992, AUST J PUBLIC HEALTH, V16, P145; MANOSEVITCH E, 2009, 10 INT S ON LIN J AU; Maurer J, 2010, PREV MED, V51, P185, DOI 10.1016/j.ypmed.2010.05.008; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011292; Oppewal H, 2003, INT J CONTEMP HOSP M, DOI DOI 10.1108/09596110310475694; Poland GA, 2010, VACCINE, V28, pD3, DOI 10.1016/j.vaccine.2010.08.024; Rhodes SD, 2003, J COMMUN HEALTH, V28, P347, DOI 10.1023/A:1025444629753; RITVO P, 2003, J IMMUNE BASED THER, V1; Rowe G, 2008, HEALTH RISK SOC, V10, P361, DOI 10.1080/13698570802166456; Sandelowski M, 2004, QUAL HEALTH RES, V14, P1366, DOI 10.1177/1049732304269672; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; SETBON M, 2010, EUR J PUBLIC HLTH; SHANAHAN MC, 2010, J SCI COMMUNICATION, V9, P1; Sinuff T, 2007, J CRIT CARE, V22, P104, DOI 10.1016/j.jcrc.2007.03.001; SOOYOUNG C, 2007, C PAPERS NATL COMMUN; SteelFisher GK, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1005102; Sypsa V, 2009, EUROSURVEILLANCE, V14, P2; Van D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-130; Wong LP, 2010, VACCINE, V28, P4499, DOI 10.1016/j.vaccine.2010.04.043; Wright N, 2006, PUBLIC UNDERST SCI, V15, P331, DOI 10.1177/0963662506063017; [No title captured]; [No title captured]; [No title captured]	34	72	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18479	10.1371/journal.pone.0018479	http://dx.doi.org/10.1371/journal.pone.0018479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	751LS	21533161	Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100005
J	Khoury, DS; Myerscough, MR; Barron, AB				Khoury, David S.; Myerscough, Mary R.; Barron, Andrew B.			A Quantitative Model of Honey Bee Colony Population Dynamics	PLOS ONE			English	Article							DIVISION-OF-LABOR; COLLAPSE DISORDER; BEHAVIORAL MATURATION; VARROA-DESTRUCTOR; LOSSES; BROOD; PESTICIDES; POLYETHISM; POLLEN	Since 2006 the rate of honey bee colony failure has increased significantly. As an aid to testing hypotheses for the causes of colony failure we have developed a compartment model of honey bee colony population dynamics to explore the impact of different death rates of forager bees on colony growth and development. The model predicts a critical threshold forager death rate beneath which colonies regulate a stable population size. If death rates are sustained higher than this threshold rapid population decline is predicted and colony failure is inevitable. The model also predicts that high forager death rates draw hive bees into the foraging population at much younger ages than normal, which acts to accelerate colony failure. The model suggests that colony failure can be understood in terms of observed principles of honey bee population dynamics, and provides a theoretical framework for experimental investigation of the problem.	[Khoury, David S.; Myerscough, Mary R.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Myerscough, Mary R.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia; [Barron, Andrew B.] Macquarie Univ, Dept Biol, Sydney, NSW 2109, Australia	University of Sydney; University of Sydney; Macquarie University	Khoury, DS (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia.	mary.myerscough@sydney.edu.au	Khoury, David/AAD-8772-2020	Khoury, David/0000-0002-2663-1551; Myerscough, Mary/0000-0002-4993-765X; Barron, Andrew/0000-0002-8135-6628	School of Mathematics and Statistics, The University of Sydney	School of Mathematics and Statistics, The University of Sydney(University of Sydney)	This work was supported by The School of Mathematics and Statistics, The University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 1956, ANN APPL BIOL, V44, P649, DOI 10.1111/j.1744-7348.1956.tb02164.x; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Chauzat MP, 2010, J APICULT RES, V49, P113, DOI 10.3896/IBRA.1.49.1.22; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cramp D, 2008, PRACTICAL MANUAL BEE; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; DEBNAM S, 2009, BEE CULTURE, V137, P34; DeGrandi-Hoffman G, 2004, INT J ACAROL, V30, P259, DOI 10.1080/01647950408684393; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Fahrbach SE, 1996, DEV NEUROSCI-BASEL, V18, P102, DOI 10.1159/000111474; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; MCLELLAN AR, 1978, J APPL ECOL, V15, P155, DOI 10.2307/2402927; Medrzycki P, 2010, J APICULT RES, V49, P52, DOI 10.3896/IBRA.1.49.1.07; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; OSKAY D, 2007, PLASTICITY FLIGHT MU; Pettis J, 2007, AM BEE J, V147, P595; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; ROBINSON GE, 1994, ANIM BEHAV, V48, P467, DOI 10.1006/anbe.1994.1260; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Rueppell O, 2009, EXP GERONTOL, V44, P447, DOI 10.1016/j.exger.2009.04.003; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Seeley T., 1995, WISDOM HIVE; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Visscher PK, 1997, INSECT SOC, V44, P1, DOI 10.1007/s000400050017; Watanabe ME, 2008, BIOSCIENCE, V58, P384, DOI 10.1641/B580503; Winston M.L., 1991, BIOL HONEY BEE; Woyciechowski M, 2009, INSECT SOC, V56, P193, DOI 10.1007/s00040-009-0012-6	40	168	168	7	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18491	10.1371/journal.pone.0018491	http://dx.doi.org/10.1371/journal.pone.0018491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533156	gold, Green Published, Green Submitted			2022-12-25	WOS:000289620100006
J	Thomas, JC; Figueira, M; Fennie, KP; Laufer, AS; Kong, Y; Pichichero, ME; Pelton, SI; Pettigrew, MM				Thomas, Jonathan C.; Figueira, Marisol; Fennie, Kristopher P.; Laufer, Alison S.; Kong, Yong; Pichichero, Michael E.; Pelton, Stephen I.; Pettigrew, Melinda M.			Streptococcus pneumoniae Clonal Complex 199: Genetic Diversity and Tissue-Specific Virulence	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; 7-VALENT CONJUGATE VACCINE; UNITED-STATES; SEROTYPE 19A; OTITIS-MEDIA; CHILDREN; STRAINS; PATHOGENESIS; EMERGENCE; CARRIAGE	Streptococcus pneumoniae is an important cause of otitis media and invasive disease. Since introduction of the heptavalent pneumococcal conjugate vaccine, there has been an increase in replacement disease due to serotype 19A clonal complex (CC) 199 isolates. The goals of this study were to 1) describe genetic diversity among nineteen CC199 isolates from carriage, middle ear, blood, and cerebrospinal fluid, 2) compare CC199 19A (n = 3) and 15B/C (n = 2) isolates in the chinchilla model for pneumococcal disease, and 3) identify accessory genes associated with tissue-specific disease among a larger collection of S. pneumoniae isolates. CC199 isolates were analyzed by comparative genome hybridization. One hundred and twenty-seven genes were variably present. The CC199 phylogeny split into two main clades, one comprised predominantly of carriage isolates and another of disease isolates. Ability to colonize and cause disease did not differ by serotype in the chinchilla model. However, isolates from the disease clade were associated with faster time to bacteremia compared to carriage clade isolates. One 19A isolate exhibited hypervirulence. Twelve tissue-specific genes/regions were identified by correspondence analysis. After screening a diverse collection of 326 isolates, spr0282 was associated with carriage. Four genes/regions, SP0163, SP0463, SPN05002 and RD8a were associated with middle ear isolates. SPN05002 also associated with blood and CSF, while RD8a associated with blood isolates. The hypervirulent isolate's genome was sequenced using the Solexa paired-end sequencing platform and compared to that of a reference serotype 19A isolate, revealing the presence of a novel 20 kb region with sequence similarity to bacteriophage genes. Genetic factors other than serotype may modulate virulence potential in CC199. These studies have implications for the long-term effectiveness of conjugate vaccines. Ideally, future vaccines would target common proteins to effectively reduce carriage and disease in the vaccinated population.	[Thomas, Jonathan C.; Laufer, Alison S.; Pettigrew, Melinda M.] Yale Univ, Sch Med, Div Epidemiol Microbial Dis, Yale Sch Publ Hlth, New Haven, CT 06520 USA; [Thomas, Jonathan C.] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Figueira, Marisol; Pelton, Stephen I.] Boston Univ, Sch Med & Publ Hlth, Boston Med Ctr, Boston, MA 02215 USA; [Fennie, Kristopher P.] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Kong, Yong] WM Keck Fdn Biotechnol Resource Lab, Dept Mol Biophys & Biochem, New Haven, CT USA; [Pichichero, Michael E.] Rochester Gen Hosp, Res Inst, Rochester, NY 14621 USA	Yale University; University of Mississippi; University of Mississippi Medical Center; Boston Medical Center; Boston University; Yale University; Rochester General Hospital	Thomas, JC (corresponding author), Yale Univ, Sch Med, Div Epidemiol Microbial Dis, Yale Sch Publ Hlth, New Haven, CT 06520 USA.	Melinda.Pettigrew@yale.edu	Kong, Yong/B-5105-2014; Pichichero, Michael E/AID-7886-2022	Kong, Yong/0000-0002-2881-5274; Thomas, Jonathan/0000-0002-1599-9123; Pelton, Stephen/0000-0003-4862-5344; Figueira, Marisol/0000-0003-4231-7500; Pettigrew, Melinda/0000-0001-8145-7536; Fennie, Kristopher/0000-0001-8038-7679	National Institute of Allergy and Infectious Diseases [R01 A1068043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068043] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (R01 A1068043) to MMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; FARRIS JS, 1977, SYST ZOOL, V26, P77, DOI 10.2307/2412867; Feil EJ, 2000, GENETICS, V154, P1439; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Gertz RE, 2003, J CLIN MICROBIOL, V41, P4194, DOI 10.1128/JCM.41.9.4194-4216.2003; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38; Greene CM, 2006, CLIN INFECT DIS, V43, P141, DOI 10.1086/505117; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Kim CC, 2002, GENOME BIOL, V3; Laufer AS, 2010, VACCINE, V28, P2450, DOI 10.1016/j.vaccine.2009.12.078; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Loeffler JM, 2006, INFECT IMMUN, V74, P4486, DOI 10.1128/IAI.00020-06; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; Mann B, 2006, INFECT IMMUN, V74, P821, DOI 10.1128/IAI.74.2.821-829.2006; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Moschioni M, 2010, CLIN MICROBIOL INFEC, V16, P1501, DOI [10.1111/j.1469-0691.2009.03105.x, 10.1111/j.1469-0691.2010.03105.x]; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Pettigrew MM, 2005, INFECT IMMUN, V73, P2805, DOI 10.1128/IAI.73.5.2805-2811.2005; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Rodgers GL, 2009, VACCINE, V27, P3802, DOI 10.1016/j.vaccine.2009.04.021; Romero P, 2009, J BACTERIOL, V191, P4854, DOI 10.1128/JB.01272-08; Romero P, 2009, APPL ENVIRON MICROB, V75, P1642, DOI 10.1128/AEM.02155-08; Sabharwal V, 2009, INFECT IMMUN, V77, P1121, DOI 10.1128/IAI.01148-08; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Sioson AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-215; van Gils EJM, 2010, JAMA-J AM MED ASSOC, V304, P1099, DOI 10.1001/jama.2010.1290; Xu QF, 2009, EMERG INFECT DIS, V15, P547, DOI 10.3201/eid1504.071704; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	54	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18649	10.1371/journal.pone.0018649	http://dx.doi.org/10.1371/journal.pone.0018649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533186	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600017
J	Hajibabaei, M; Shokralla, S; Zhou, X; Singer, GAC; Baird, DJ				Hajibabaei, Mehrdad; Shokralla, Shadi; Zhou, Xin; Singer, Gregory A. C.; Baird, Donald J.			Environmental Barcoding: A Next-Generation Sequencing Approach for Biomonitoring Applications Using River Benthos	PLOS ONE			English	Article							DNA; LIFE; AMPLIFICATION; TAXONOMY	Timely and accurate biodiversity analysis poses an ongoing challenge for the success of biomonitoring programs. Morphology-based identification of bioindicator taxa is time consuming, and rarely supports species-level resolution especially for immature life stages. Much work has been done in the past decade to develop alternative approaches for biodiversity analysis using DNA sequence-based approaches such as molecular phylogenetics and DNA barcoding. Ongoing assembly of DNA barcode reference libraries will provide the basis for a DNA-based identification system. The use of recently introduced next-generation sequencing (NGS) approaches in biodiversity science has the potential to further extend the application of DNA information for routine biomonitoring applications to an unprecedented scale. Here we demonstrate the feasibility of using 454 massively parallel pyrosequencing for species-level analysis of freshwater benthic macroinvertebrate taxa commonly used for biomonitoring. We designed our experiments in order to directly compare morphology-based, Sanger sequencing DNA barcoding, and next-generation environmental barcoding approaches. Our results show the ability of 454 pyrosequencing of mini-barcodes to accurately identify all species with more than 1% abundance in the pooled mixture. Although the approach failed to identify 6 rare species in the mixture, the presence of sequences from 9 species that were not represented by individuals in the mixture provides evidence that DNA based analysis may yet provide a valuable approach in finding rare species in bulk environmental samples. We further demonstrate the application of the environmental barcoding approach by comparing benthic macroinvertebrates from an urban region to those obtained from a conservation area. Although considerable effort will be required to robustly optimize NGS tools to identify species from bulk environmental samples, our results indicate the potential of an environmental barcoding approach for biomonitoring programs.	[Hajibabaei, Mehrdad; Shokralla, Shadi; Zhou, Xin; Singer, Gregory A. C.] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Baird, Donald J.] Univ New Brunswick, Dept Biol, Environm Canada, Canadian Rivers Inst, Fredericton, NB E3B 6E1, Canada	University of Guelph; Environment & Climate Change Canada; University of New Brunswick	Hajibabaei, M (corresponding author), Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	mhajibab@uoguelph.ca	Zhou, Xin/AAI-9326-2021; Zhou, Xin/D-4025-2009; Baird, Donald/A-5267-2009	Zhou, Xin/0000-0002-1407-7952; Zhou, Xin/0000-0002-1407-7952; 	Genome Canada through the Ontario Genomics Institute; Environment Canada	Genome Canada through the Ontario Genomics Institute(Genome Canada); Environment Canada(CGIAR)	This work was supported by funds from Genome Canada through the Ontario Genomics Institute and by Environment Canada through the CABIN, IPY and CESI programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chapman AD, 2009, NUMBERS LIVING SPECI; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; DeWaard Jeremy R., 2008, V410, P275; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hajibabaei M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S4; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Shokralla S, 2010, BIOTECHNIQUES, V48, P233, DOI 10.2144/000113362; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Singer GAC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S14; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; WILSON EO, 1985, SCIENCE, V230, P1227, DOI 10.1126/science.230.4731.1227	25	359	389	6	230	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e17497	10.1371/journal.pone.0017497	http://dx.doi.org/10.1371/journal.pone.0017497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533287	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000289458800003
J	Tsybovsky, Y; Krupenko, SA				Tsybovsky, Yaroslav; Krupenko, Sergey A.			Conserved Catalytic Residues of the ALDH1L1 Aldehyde Dehydrogenase Domain Control Binding and Discharging of the Coenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; CARBOXYL-TERMINAL DOMAIN; STREPTOCOCCUS-MUTANS; CRYSTAL-STRUCTURE; MECHANISTIC IMPLICATIONS; RETINAL SPECIFICITY; ANGSTROM RESOLUTION; ASIAN VARIANT; ACTIVE-SITE; ROLES	The C-terminal domain (C-t-FDH) of 10-formyltetrahydrofolate dehydrogenase (FDH, ALDH1L1) is an NADP(+)-dependent oxidoreductase and a structural and functional homolog of aldehyde dehydrogenases. Here we report the crystal structures of several C-t-FDH mutants in which two essential catalytic residues adjacent to the nicotinamide ring of bound NADP(+), Cys-707 and Glu-673, were replaced separately or simultaneously. The replacement of the glutamate with an alanine causes irreversible binding of the coenzyme without any noticeable conformational changes in the vicinity of the nicotinamide ring. Additional replacement of cysteine 707 with an alanine (E673A/C707A double mutant) did not affect this irreversible binding indicating that the lack of the glutamate is solely responsible for the enhanced interaction between the enzyme and the coenzyme. The substitution of the cysteine with an alanine did not affect binding of NADP(+) but resulted in the enzyme lacking the ability to differentiate between the oxidized and reduced coenzyme: unlike the wild-type C-t-FDH/NADPH complex, in the C707A mutant the position of NADPH is identical to the position of NADP(+) with the nicotinamide ring well ordered within the catalytic center. Thus, whereas the glutamate restricts the affinity for the coenzyme, the cysteine is the sensor of the coenzyme redox state. These conclusions were confirmed by coenzyme binding experiments. Our study further suggests that the binding of the coenzyme is additionally controlled by a long-range communication between the catalytic center and the coenzyme-binding domain and points toward an alpha-helix involved in the adenine moiety binding as a participant of this communication.	[Tsybovsky, Yaroslav; Krupenko, Sergey A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, SA (corresponding author), 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu			National Institutes of Health [DK54388]; Medical University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK54388 (to S. A. K.).; We thank Dr. Christopher Davies for helpful discussions. The x-ray crystallography facility used for this work is supported by the Medical University of South Carolina's Research Resource Facilities program. Data were also collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory.	Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARRES J, 1994, J BIOL CHEM, V269, P13854; FELDMAN RI, 1972, J BIOL CHEM, V247, P267; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Hammen PK, 2002, BIOCHEMISTRY-US, V41, P7156, DOI 10.1021/bi012197t; Hempel J., 2007, ENZYMOLOGY MOL BIOL, P9; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Johansson K, 1998, PROTEIN SCI, V7, P2106, DOI 10.1002/pro.5560071007; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krupenko SA, 1997, J BIOL CHEM, V272, P10266; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Mann CJ, 1999, PROTEIN SCI, V8, P1922, DOI 10.1110/ps.8.10.1922; Marchal S, 2001, CHEM-BIOL INTERACT, V130, P15, DOI 10.1016/S0009-2797(00)00218-0; Marchal S, 2000, BIOCHEMISTRY-US, V39, P3327, DOI 10.1021/bi9914208; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Moore SA, 1998, STRUCTURE, V6, P1541, DOI 10.1016/S0969-2126(98)00152-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Sheikh S, 1997, J BIOL CHEM, V272, P18817, DOI 10.1074/jbc.272.30.18817; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; TAKAHASHI K, 1980, ARCH BIOCHEM BIOPHYS, V205, P571, DOI 10.1016/0003-9861(80)90140-X; Talfournier F, 2009, CHEM-BIOL INTERACT, V178, P79, DOI 10.1016/j.cbi.2008.10.045; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Valenzuela-Soto EM, 2003, CHEM-BIOL INTERACT, V143, P139, DOI 10.1016/S0009-2797(02)00198-9; Wang MF, 2009, CHEM-BIOL INTERACT, V178, P36, DOI 10.1016/j.cbi.2008.10.002; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Wymore T, 2004, PROTEINS, V57, P758, DOI 10.1002/prot.20256; Wymore T, 2007, BIOCHEMISTRY-US, V46, P9495, DOI 10.1021/bi700555g; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245	44	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23357	23367		10.1074/jbc.M111.221069	http://dx.doi.org/10.1074/jbc.M111.221069			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21540484	hybrid, Green Published			2022-12-25	WOS:000292025000067
J	Taylor, M; Banerjee, T; Ray, S; Tatulian, SA; Teter, K				Taylor, Michael; Banerjee, Tuhina; Ray, Supriyo; Tatulian, Suren A.; Teter, Ken			Protein-disulfide Isomerase Displaces the Cholera Toxin A1 Subunit from the Holotoxin without Unfolding the A1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TRANSFORM INFRARED-SPECTROSCOPY; CHO-CELLS RESISTANT; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; THERMAL-STABILITY; FTIR SPECTROSCOPY; MAMMALIAN-CELLS; RICIN; CYTOSOL	Protein-disulfide isomerase (PDI) has been proposed to exhibit an "unfoldase" activity against the catalytic A1 subunit of cholera toxin (CT). Unfolding of the CTA1 subunit is thought to displace it from the CT holotoxin and to prepare it for translocation to the cytosol. To date, the unfoldase activity of PDI has not been demonstrated for any substrate other than CTA1. An alternative explanation for the putative unfoldase activity of PDI has been suggested by recent structural studies demonstrating that CTA1 will unfold spontaneously upon its separation from the holotoxin at physiological temperature. Thus, PDI may simply dislodge CTA1 from the CT holotoxin without unfolding the CTA1 subunit. To evaluate the role of PDI in CT disassembly and CTA1 unfolding, we utilized a real-time assay to monitor the PDI-mediated separation of CTA1 from the CT holotoxin and directly examined the impact of PDI binding on CTA1 structure by isotope-edited Fourier transform infrared spectroscopy. Our collective data demonstrate that PDI is required for disassembly of the CT holotoxin but does not unfold the CTA1 subunit, thus uncovering a new mechanism for CTA1 dissociation from its holotoxin.	[Ray, Supriyo; Tatulian, Suren A.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Taylor, Michael; Banerjee, Tuhina; Teter, Ken] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32826 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Teter, K (corresponding author), Biomol Res Annex, 12722 Res Pkwy, Orlando, FL 32826 USA.	kteter@mail.ucf.edu	Ray, Supriyo/L-1020-2019	Teter, Ken/0000-0003-4176-9361	National Institutes of Health [R01 AI073783]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI073783 (to K. T.).	Ampapathi RS, 2008, J MOL BIOL, V377, P748, DOI 10.1016/j.jmb.2007.12.075; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Banerjee T, 2010, BIOCHEMISTRY-US, V49, P8839, DOI 10.1021/bi101201c; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Day PJ, 2002, BIOCHEMISTRY-US, V41, P2836, DOI 10.1021/bi012012i; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; GOINS B, 1988, BIOCHEMISTRY-US, V27, P2046, DOI 10.1021/bi00406a035; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; HOLMES RK, 1983, INFECT IMMUN, V42, P914, DOI 10.1128/IAI.42.3.914-923.1983; Inaba K, 2010, EMBO J, V29, P3330, DOI 10.1038/emboj.2010.222; Kaiser E, 2009, CELL MICROBIOL, V11, P780, DOI 10.1111/j.1462-5822.2009.01291.x; LENCER WI, 1993, J CLIN INVEST, V92, P2941, DOI 10.1172/JCI116917; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Majoul I, 1997, FEBS LETT, V401, P104, DOI 10.1016/S0014-5793(96)01447-0; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Moore P, 2010, MOL BIOL CELL, V21, P1305, DOI 10.1091/mbc.E09-09-0826; MURAYAMA T, 1993, BIOCHEMISTRY-US, V32, P561, DOI 10.1021/bi00053a022; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Pande AH, 2006, BIOCHEMISTRY-US, V45, P13734, DOI 10.1021/bi061175+; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; SUREWICZ WK, 1990, BIOCHEMISTRY-US, V29, P8106, DOI 10.1021/bi00487a017; Tatulian SA, 2003, BIOCHEMISTRY-US, V42, P11898, DOI 10.1021/bi034235+; Tatulian SA, 1998, FEBS LETT, V423, P205, DOI 10.1016/S0014-5793(98)00091-X; Tatulian SA, 2010, SPECTROSC-INT J, V24, P37, DOI 10.1155/2010/634831; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teter K, 2006, INFECT IMMUN, V74, P2259, DOI 10.1128/IAI.74.4.2259-2267.2006; Teter K, 2004, INFECT IMMUN, V72, P6826, DOI 10.1128/IAI.72.12.6826-6835.2004; Teter K, 2003, TRAFFIC, V4, P232, DOI 10.1034/j.1600-0854.2003.00070.x; Teter K, 2002, INFECT IMMUN, V70, P6166, DOI 10.1128/IAI.70.11.6166-6171.2002; Teter K, 2002, INFECT IMMUN, V70, P6172, DOI 10.1128/IAI.70.11.6172-6179.2002; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wernick NLB, 2010, J BIOL CHEM, V285, P6145, DOI 10.1074/jbc.M109.062067; Worthington ZEV, 2007, INFECT IMMUN, V75, P2946, DOI 10.1128/IAI.02011-06; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	56	36	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22090	22100		10.1074/jbc.M111.237966	http://dx.doi.org/10.1074/jbc.M111.237966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21543321	hybrid, Green Published			2022-12-25	WOS:000291719900015
J	Sroubek, J; McDonald, TV				Sroubek, Jakub; McDonald, Thomas V.			Protein Kinase A Activity at the Endoplasmic Reticulum Surface Is Responsible for Augmentation of Human ether-a-go-go-related Gene Product (HERG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; CARDIAC SARCOPLASMIC-RETICULUM; CHRONIC HEART-FAILURE; POTASSIUM CHANNEL; CYCLIC-AMP; BETA(2)-ADRENERGIC RECEPTOR; ANCHORING PROTEINS; K+ CHANNEL; IN-VIVO; CAMP	Human ether-a-go-go-related gene product (HERG) is a cardiac potassium channel commonly implicated in the pathogenesis of the long QT syndrome, type 2 (LQT2). LQT2 mutations typically have incomplete penetrance and affect individuals at various stages of their lives; this may mirror variations in intracellular signaling and HERG regulation. Previous work showed that sustained protein kinase A (PKA) activity augments HERG protein abundance by a mechanism that includes enhanced protein translation. To investigate the subcellular site of this regulation, we generated site-specific probes to the cytoplasmic surface of the endoplasmic reticulum (ER), the presumed locale of channel synthesis. Real-time FRET-based indicators demonstrated both cAMP and PKA activity at the ER. A PKA inhibitor targeted to the ER surface (termed p4PKIg) completely abolished PKA-mediated augmentation of HERG in HEK293 cells as well as rat neonatal cardiomyocytes. Immunofluorescence colocalization, targeted FRET-based PKA biosensors, phosphospecific antibodies, and in vivo phosphorylation experiments confirmed that p4PKIg is preferentially active at the ER surface rather than the plasma membrane. Rerouting this inhibitor to the outer mitochondrial membrane diminishes its ability to block cAMP-dependent HERG induction. Our results support a model where PKA-dependent regulation of HERG synthesis occurs at the ER surface. Furthermore, reagents generated for this study provide novel experimental tools to probe compartmentalized cAMP/PKA signaling within cells.	[Sroubek, Jakub; McDonald, Thomas V.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [McDonald, Thomas V.] Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	McDonald, TV (corresponding author), 1300 Morris Pk Ave,F-G35, Bronx, NY 10461 USA.	tom.mcdonald@einstein.yu.edu			National Institutes of Health/NHLBI [HL077326]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health/NHLBI Grant HL077326 (to T. V. M.).	ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; AHN KS, 1993, J BIOL CHEM, V268, P18726; ALBERTS B, 2004, MOL BIOL CELL, P659; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Ananthanarayanan B, 2005, P NATL ACAD SCI USA, V102, P15081, DOI 10.1073/pnas.0502889102; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Bers DM, 2001, CIRC RES, V89, P373, DOI 10.1161/res.89.5.373; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Chen JA, 2010, MOL PHARMACOL, V78, P186, DOI 10.1124/mol.109.062216; Chen J, 2009, AM J PHYSIOL-HEART C, V296, pH1244, DOI 10.1152/ajpheart.01252.2008; Choe CU, 2006, HUM MOL GENET, V15, P2888, DOI 10.1093/hmg/ddl230; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Diviani D, 2008, CURR OPIN PHARMACOL, V8, P166, DOI 10.1016/j.coph.2007.11.001; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Eckardt L, 2000, J CARDIOVASC ELECTR, V11, P106, DOI 10.1111/j.1540-8167.2000.tb00746.x; Farkas AS, 2010, DRUGS, V70, P573, DOI 10.2165/11535230-000000000-00000; GLASS DB, 1989, J BIOL CHEM, V264, P8802; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Groppo R, 2009, CURR OPIN CELL BIOL, V21, P444, DOI 10.1016/j.ceb.2009.01.011; Heath BM, 2000, J PHYSIOL-LONDON, V522, P391, DOI 10.1111/j.1469-7793.2000.t01-2-00391.x; Hjalmarson A, 1999, LANCET, V353, P2001; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Hovland R, 1999, BIOCHEM J, V342, P369, DOI 10.1042/0264-6021:3420369; Huang LJS, 1999, J CELL BIOL, V145, P951, DOI 10.1083/jcb.145.5.951; Juhaszova M, 1997, ANN NY ACAD SCI, V834, P524, DOI 10.1111/j.1749-6632.1997.tb52310.x; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; Kagan A, 2002, EMBO J, V21, P1889, DOI 10.1093/emboj/21.8.1889; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; KIMURA Y, 1994, J MOL CELL CARDIOL, V26, P1145, DOI 10.1006/jmcc.1994.1133; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li Y, 2008, J MEMBRANE BIOL, V223, P107, DOI 10.1007/s00232-008-9118-4; Lissandron V, 2006, J MUSCLE RES CELL M, V27, P399, DOI 10.1007/s10974-006-9077-2; Ma YL, 2002, J BIOL CHEM, V277, P27328, DOI 10.1074/jbc.M201421200; Martin BR, 2007, CHEM BIOL, V14, P1031, DOI 10.1016/j.chembiol.2007.07.017; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Modell SM, 2006, GENET MED, V8, P143, DOI 10.1097/01.gim.0000204468.85308.86; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Rockman HA, 1996, J CLIN INVEST, V97, P1618, DOI 10.1172/JCI118587; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1991, CIRC RES, V68, P77, DOI 10.1161/01.RES.68.1.77; Satwani S, 2004, J CARDIOVASC PHARM T, V9, P243, DOI 10.1177/107424840400900404; SHAM JSK, 1995, P NATL ACAD SCI USA, V92, P121, DOI 10.1073/pnas.92.1.121; STEINBERG RA, 1980, P NATL ACAD SCI-BIOL, V77, P910, DOI 10.1073/pnas.77.2.910; Szczesna-Skorupa E, 1998, P NATL ACAD SCI USA, V95, P14793, DOI 10.1073/pnas.95.25.14793; SZCZESNASKORUPA E, 1995, J BIOL CHEM, V270, P24327, DOI 10.1074/jbc.270.41.24327; TADA M, 1975, J BIOL CHEM, V250, P2640; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vos MA, 1998, CIRCULATION, V98, P1125, DOI 10.1161/01.CIR.98.11.1125; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	62	15	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2011	286	24					21927	21936		10.1074/jbc.M110.201699	http://dx.doi.org/10.1074/jbc.M110.201699			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	775MX	21536683	hybrid, Green Published			2022-12-25	WOS:000291464700087
J	Hanlon, SE; Rizzo, JM; Tatomer, DC; Lieb, JD; Buck, MJ				Hanlon, Sean E.; Rizzo, Jason M.; Tatomer, Deirdre C.; Lieb, Jason D.; Buck, Michael J.			The Stress Response Factors Yap6, Cin5, Phd1, and Skn7 Direct Targeting of the Conserved Co-Repressor Tup1-Ssn6 in S-cerevisiae	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; GENE-EXPRESSION; GLUCOSE REPRESSION; PROTEIN-KINASE; MIG1 REPRESSOR; HYPOXIC GENES; GENOME-WIDE; YEAST; ALPHA-2; DNA	Maintaining the proper expression of the transcriptome during development or in response to a changing environment requires a delicate balance between transcriptional regulators with activating and repressing functions. The budding yeast transcriptional co-repressor Tup1-Ssn6 is a model for studying similar repressor complexes in multicellular eukaryotes. Tup1-Ssn6 does not bind DNA directly, but is directed to individual promoters by one or more DNA-binding proteins, referred to as Tup1 recruiters. This functional architecture allows the Tup1-Ssn6 to modulate the expression of genes required for the response to a variety of cellular stresses. To understand the targeting or the Tup1-Ssn6 complex, we determined the genomic distribution of Tup1 and Ssn6 by ChIP-chip. We found that most loci bound by Tup1-Ssn6 could not be explained by co-occupancy with a known recruiting cofactor and that deletion of individual known Tup1 recruiters did not significantly alter the Tup1 binding profile. These observations suggest that new Tup1 recruiting proteins remain to be discovered and that Tup1 recruitment typically depends on multiple recruiting cofactors. To identify new recruiting proteins, we computationally screened for factors with binding patterns similar to the observed Tup1-Ssn6 genomic distribution. Four top candidates, Cin5, Skn7, Phd1, and Yap6, all known to be associated with stress response gene regulation, were experimentally confirmed to physically interact with Tup1 and/or Ssn6. Incorporating these new recruitment cofactors with previously characterized cofactors now explains the majority of Tup1 targeting across the genome, and expands our understanding of the mechanism by which Tup1-Ssn6 is directed to its targets.	[Hanlon, Sean E.; Tatomer, Deirdre C.; Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27515 USA; [Hanlon, Sean E.; Tatomer, Deirdre C.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Rizzo, Jason M.; Buck, Michael J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Rizzo, Jason M.; Buck, Michael J.] SUNY Buffalo, Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hanlon, SE (corresponding author), Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27515 USA.	jlieb@bio.unc.edu; mjbuck@buffalo.edu		Hanlon, Sean/0000-0001-6899-6906	National Institutes of Health (NIH) [GM072518]; PhRMA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM072518 to J.D.L. and a PhRMA Pre-Doc Fellowship to J.M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALASUBRAMANIAN B, 1993, MOL CELL BIOL, V13, P6071, DOI 10.1128/MCB.13.10.6071; Boorsma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003112; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brombacher K, 2006, YEAST, V23, P741, DOI 10.1002/yea.1392; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Courey AJ, 2001, GENE DEV, V15, P2786; Crisp RJ, 2006, EMBO J, V25, P512, DOI 10.1038/sj.emboj.7600961; Davie JK, 2002, MOL CELL BIOL, V22, P693, DOI 10.1128/MCB.22.3.693-703.2002; Delling U, 1998, ANTIMICROB AGENTS CH, V42, P1034, DOI 10.1128/AAC.42.5.1034; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; DRANGINIS AM, 1990, NATURE, V347, P682, DOI 10.1038/347682a0; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Furuchi T, 2001, MOL PHARMACOL, V59, P470, DOI 10.1124/mol.59.3.470; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; Grbavec D, 1999, BIOCHEM J, V337, P13, DOI 10.1042/0264-6021:3370013; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; He XJ, 2005, MOL MICROBIOL, V58, P1454, DOI 10.1111/j.1365-2958.2005.04917.x; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Jimenez G, 2000, GENE DEV, V14, P224; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Klinkenberg LG, 2006, EUKARYOT CELL, V5, P1007, DOI 10.1128/EC.00045-06; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; Ness F, 2001, EUR J BIOCHEM, V268, P1585, DOI 10.1046/j.1432-1033.2001.02029.x; Nevitt T, 2004, YEAST, V21, P1365, DOI 10.1002/yea.1188; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; Papamichos-Chronakis M, 2002, MOL CELL, V9, P1297, DOI 10.1016/S1097-2765(02)00545-2; Park SH, 1999, MOL CELL BIOL, V19, P2044; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Regnacq M, 2001, MOL MICROBIOL, V40, P1085, DOI 10.1046/j.1365-2958.2001.02450.x; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Valentine SA, 1998, MOL CELL BIOL, V18, P6584, DOI 10.1128/MCB.18.11.6584; Xia ZX, 2008, J BIOL CHEM, V283, P28958, DOI 10.1074/jbc.M803980200; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200	57	55	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e19060	10.1371/journal.pone.0019060	http://dx.doi.org/10.1371/journal.pone.0019060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552514	gold, Green Published, Green Submitted			2022-12-25	WOS:000290020700020
J	Khatana, SAM; Kane, J; Taveira, TH; Bauer, MS; Wu, WC				Khatana, Sameed Ahmed M.; Kane, Joshua; Taveira, Tracey H.; Bauer, Mark S.; Wu, Wen-Chih			Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness	PLOS ONE			English	Article							CATIE SCHIZOPHRENIA TRIAL; ANTIPSYCHOTIC-DRUGS; CARDIOVASCULAR RISK; DISEASE RISK; LIFE-STYLE; HEALTH; BIPOLAR; GLUCOSE; OUTPATIENTS; DISORDERS	Background: Cardiovascular disease is the leading cause of mortality among patients with serious mental illness (SMI) and the prevalence of metabolic syndrome-a constellation of cardiovascular risk factors-is significantly higher in these patients than in the general population. Metabolic monitoring among patients using second generation antipsychotics (SGAs)-a risk factor for metabolic syndrome-has been shown to be inadequate despite the release of several guidelines. However, patients with SMI have several factors independent of medication use that predispose them to a higher prevalence of metabolic syndrome. Our study therefore examines monitoring and prevalence of metabolic syndrome in patients with SMI, including those not using SGAs. Methods and Findings: We retrospectively identified all patients treated at a Veterans Affairs Medical Center with diagnoses of schizophrenia, schizoaffective disorder or bipolar disorder during 2005-2006 and obtained demographic and clinical data. Incomplete monitoring of metabolic syndrome was defined as being unable to determine the status of at least one of the syndrome components. Of the 1,401 patients included (bipolar disorder: 822; schizophrenia: 222; and schizoaffective disorder: 357), 21.4% were incompletely monitored. Only 54.8% of patients who were not prescribed SGAs and did not have previous diagnoses of hypertension or hypercholesterolemia were monitored for all metabolic syndrome components compared to 92.4% of patients who had all three of these characteristics. Among patients monitored for metabolic syndrome completely, age-adjusted prevalence of the syndrome was 48.4%, with no significant difference between the three psychiatric groups. Conclusions: Only one half of patients with SMI not using SGAs or previously diagnosed with hypertension and hypercholesterolemia were completely monitored for metabolic syndrome components compared to greater than 90% of those with these characteristics. With the high prevalence of metabolic syndrome seen in this population, there appears to be a need to intensify efforts to reduce this monitoring gap.	[Khatana, Sameed Ahmed M.; Taveira, Tracey H.; Wu, Wen-Chih] Providence Vet Affairs Med Ctr, Res Enhancement Award Program, Providence, RI USA; [Khatana, Sameed Ahmed M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Kane, Joshua] Butler Hosp, Providence, RI 02906 USA; [Taveira, Tracey H.] Univ Rhode Isl, Coll Pharm, Kingston, RI 02881 USA; [Taveira, Tracey H.; Wu, Wen-Chih] Brown Univ, Dept Med, Providence Vet Affairs Med Ctr, Warren Alpert Med Sch, Providence, RI 02912 USA; [Bauer, Mark S.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Bauer, Mark S.] VA Boston Healthcare Syst, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Butler Hospital Rhode Island; University of Rhode Island; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Khatana, SAM (corresponding author), Providence Vet Affairs Med Ctr, Res Enhancement Award Program, Providence, RI USA.	skhatana@gmail.com	Khatana, Sameed/AAC-3151-2020	Khatana, Sameed Ahmed/0000-0002-1345-3004	VA Health Services Research & Development Grant [REA-08-263]	VA Health Services Research & Development Grant	The study was funded by VA Health Services Research & Development Grant # REA-08-263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR, pxii; Barnes TRE, 2007, SCHIZOPHRENIA BULL, V33, P1397, DOI 10.1093/schbul/sbm038; Barnett M, 2010, ANN CLIN PSYCHIATRY, V22, P9; Barrett E, 2004, OBES RES, V12, P362; Basu R, 2004, BIPOLAR DISORD, V6, P314, DOI 10.1111/j.1399-5618.2004.00126.x; Bobes J, 2010, SCHIZOPHR RES, V119, P101, DOI 10.1016/j.schres.2010.02.1030; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Cardenas J, 2008, J AFFECT DISORDERS, V106, P91, DOI 10.1016/j.jad.2007.05.030; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Cohn T, 2004, CAN J PSYCHIAT, V49, P753, DOI 10.1177/070674370404901106; Cohn TA, 2006, CAN J PSYCHIAT, V51, P492, DOI 10.1177/070674370605100804; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Correll Christoph U, 2010, Psychiatr Serv, V61, P892, DOI 10.1176/ps.2010.61.9.892; de Hert M, 2009, EUR PSYCHIAT, V24, pS1134, DOI [10.1016/S0924-9338(09)71367-7, DOI 10.1016/S0924-9338(09)71367-7]; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Garcia-Portilla MP, 2008, J AFFECT DISORDERS, V106, P197, DOI 10.1016/j.jad.2007.06.002; Goethe JW, 2007, J CLIN PSYCHIAT, V68, P22, DOI 10.4088/JCP.v68n0103; Hankin CS, 1999, AM J PSYCHIAT, V156, P1924; Haupt DW, 2009, AM J PSYCHIAT, V166, P345, DOI 10.1176/appi.ajp.2008.08030383; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Jennex A, 2008, CAN J PSYCHIAT, V53, P34, DOI 10.1177/070674370805300106; John AP, 2009, MED J AUSTRALIA, V190, P176, DOI 10.5694/j.1326-5377.2009.tb02342.x; JONES SH, 1995, BRIT J PSYCHIAT, V166, P654, DOI 10.1192/bjp.166.5.654; Kazis LE, 1999, AM J MED QUAL, V14, P28, DOI 10.1177/106286069901400105; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Keller PA, 2006, ARCH PHARM, V339, P346, DOI 10.1002/ardp.200600021; Kilbourne AM, 2007, J AFFECT DISORDERS, V102, P145, DOI 10.1016/j.jad.2007.01.006; Kilbourne AM, 2010, PSYCHIAT SERV, V61, P38, DOI 10.1176/appi.ps.61.1.38; Krein SL, 2000, MED CARE, V38, pS38; Levkovitz Y, 2007, MOL CELL NEUROSCI, V36, P305, DOI 10.1016/j.mcn.2007.05.009; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mackin P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-28; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P534, DOI 10.1192/bjp.183.6.534; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; Meyer Jonathan, 2006, J Psychiatr Pract, V12, P5, DOI 10.1097/00131746-200601000-00002; Morrato EH, 2008, J CLIN PSYCHIAT, V69, P316, DOI 10.4088/JCP.v69n0219; Morrato EH, 2010, ARCH GEN PSYCHIAT, V67, P17, DOI 10.1001/archgenpsychiatry.2009.179; Morrato EH, 2009, DIABETES CARE, V32, P1037, DOI 10.2337/dc08-1720; MUKHERJEE S, 1989, LANCET, V1, P495; Nasrallah HA, 2006, SCHIZOPHR RES, V86, P15, DOI 10.1016/j.schres.2006.06.026; Newcomer JW, 2007, AM J MANAG CARE, V13, pS170; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Rejas J, 2008, SCHIZOPHR RES, V99, P23, DOI 10.1016/j.schres.2007.10.015; Ryan MCM, 2003, AM J PSYCHIAT, V160, P284, DOI 10.1176/appi.ajp.160.2.284; Saari KM, 2005, J CLIN PSYCHIAT, V66, P559, DOI 10.4088/JCP.v66n0503; Shi LZ, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-80; Strassnig M, 2003, SCHIZOPHRENIA BULL, V29, P393, DOI 10.1093/oxfordjournals.schbul.a007013; Taylor D, 2004, BRIT J PSYCHIAT, V185, P152, DOI 10.1192/bjp.185.2.152; Thakore JH, 2002, INT J OBESITY, V26, P137, DOI 10.1038/sj.ijo.0801840; The Health Care System for Veterans, 2007, HLTH CARE SYSTEM VET; van Winkel R, 2008, BIPOLAR DISORD, V10, P342, DOI 10.1111/j.1399-5618.2007.00520.x; van Winkel R, 2010, SCHIZOPHR RES, V121, P193, DOI 10.1016/j.schres.2010.05.030; van Winkel R, 2010, INT CLIN PSYCHOPHARM, V25, P270, DOI 10.1097/YIC.0b013e32833bc60d; Vancampfort D, 2010, PSYCHIAT RES, V177, P271, DOI 10.1016/j.psychres.2010.03.011	57	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19298	10.1371/journal.pone.0019298	http://dx.doi.org/10.1371/journal.pone.0019298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	756NE	21541294	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000290018400045
J	Shirron, N; Yaron, S				Shirron, Natali; Yaron, Sima			Active Suppression of Early Immune Response in Tobacco by the Human Pathogen Salmonella Typhimurium	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157H7; SYRINGAE PV SYRINGAE; CELL-DEATH; HYPERSENSITIVE RESPONSE; ARABIDOPSIS-THALIANA; OXIDATIVE BURST; INNATE IMMUNITY; SALICYLIC-ACID; III EFFECTORS	The persistence of enteric pathogens on plants has been studied extensively, mainly due to the potential hazard of human pathogens such as Salmonella enterica being able to invade and survive in/on plants. Factors involved in the interactions between enteric bacteria and plants have been identified and consequently it was hypothesized that plants may be vectors or alternative hosts for enteric pathogens. To survive, endophytic bacteria have to escape the plant immune systems, which function at different levels through the plant-bacteria interactions. To understand how S. enterica survives endophyticaly we conducted a detailed analysis on its ability to elicit or evade the plant immune response. The models of this study were Nicotiana tabacum plants and cells suspension exposed to S. enterica serovar Typhimurium. The plant immune response was analyzed by looking at tissue damage and by testing oxidative burst and pH changes. It was found that S. Typhimurium did not promote disease symptoms in the contaminated plants. Live S. Typhimurium did not trigger the production of an oxidative burst and pH changes by the plant cells, while heat killed or chloramphenicol treated S. Typhimurium and purified LPS of Salmonella were significant elicitors, indicating that S. Typhimurium actively suppress the plant response. By looking at the plant response to mutants defective in virulence factors we showed that the suppression depends on secreted factors. Deletion of invA reduced the ability of S. Typhimurium to suppress oxidative burst and pH changes, indicating that a functional SPI1 TTSS is required for the suppression. This study demonstrates that plant colonization by S. Typhimurium is indeed an active process. S. Typhimurium utilizes adaptive strategies of altering innate plant perception systems to improve its fitness in the plant habitat. All together these results suggest a complex mechanism for perception of S. Typhimurium by plants.	[Shirron, Natali; Yaron, Sima] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Haifa, Israel	Technion Israel Institute of Technology	Shirron, N (corresponding author), Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Haifa, Israel.	simay@tx.technion.ac.il			Israeli Ministry of Agriculture; MINNA KROLL MEMORIAL	Israeli Ministry of Agriculture; MINNA KROLL MEMORIAL	This study was supported by a research grant of the Israeli Ministry of Agriculture, and by MINNA KROLL MEMORIAL research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.011802; Agostiano A, 2004, BIOELECTROCHEMISTRY, V63, P125, DOI 10.1016/j.bioelechem.2003.10.015; Allan AC, 2001, PLANT PHYSIOL, V126, P97, DOI 10.1104/pp.126.1.97; [Anonymous], 2008, MICROBIOLOGICAL HAZA; [Anonymous], 2008, ANN LISTING FOODBORN; [Anonymous], 2005, SALMONELLA OUTBREAKS; BAKER CJ, 1987, PHYTOPATHOLOGY, V77, P1268, DOI 10.1094/Phyto-77-1268; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Bernstein N, 2007, J FOOD PROTECT, V70, P1717, DOI 10.4315/0362-028X-70.7.1717; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Brandl MT, 2002, APPL ENVIRON MICROB, V68, P3614, DOI 10.1128/AEM.68.7.3614-3621.2002; Bruno VM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000538; Chaboute ME, 2002, J BIOL CHEM, V277, P17845, DOI 10.1074/jbc.M200959200; Charkowski AO, 2002, APPL ENVIRON MICROB, V68, P3114, DOI 10.1128/AEM.68.6.3114-3120.2002; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; David KM, 2001, PLANT PHYSIOL, V125, P1548, DOI 10.1104/pp.125.4.1548; de Pinto MC, 2002, PLANT PHYSIOL, V130, P698, DOI 10.1104/pp.005629; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Donne E, 2005, VET MICROBIOL, V107, P205, DOI 10.1016/j.vetmic.2005.01.027; Dorey S, 1999, PLANT PHYSIOL, V121, P163, DOI 10.1104/pp.121.1.163; ERCOLANI GL, 1976, APPL ENVIRON MICROB, V31, P847, DOI 10.1128/AEM.31.6.847-852.1976; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Franz E, 2008, J APPL MICROBIOL, V105, P1569, DOI 10.1111/j.1365-2672.2008.03915.x; GALAN JE, 1991, INFECT IMMUN, V59, P2901; GALAN JE, 1992, J BACTERIOL, V174, P4338; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gandhi M, 2001, J FOOD PROTECT, V64, P1891, DOI 10.4315/0362-028X-64.12.1891; Gerber Isak B, 2003, Methods Cell Sci, V25, P115; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; HUANG HC, 1988, J BACTERIOL, V170, P4748, DOI 10.1128/jb.170.10.4748-4756.1988; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Islam M, 2004, APPL ENVIRON MICROB, V70, P2497, DOI 10.1128/AEM.70.4.2497-2502.2004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KING EO, 1954, J LAB CLIN MED, V44, P301; Klerks MM, 2007, APPL ENVIRON MICROB, V73, P4905, DOI 10.1128/AEM.02522-06; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Krzymowska M, 2007, PLANT J, V50, P253, DOI 10.1111/j.1365-313X.2007.03046.x; Kutter S, 2006, FEMS MICROBIOL ECOL, V56, P262, DOI 10.1111/j.1574-6941.2005.00053.x; Kyle JL, 2010, APPL ENVIRON MICROB, V76, P1375, DOI 10.1128/AEM.02461-09; Lapidot A, 2006, INT J FOOD IN PRESS; Lapidot A, 2006, INT J FOOD MICROBIOL, V109, P229, DOI 10.1016/j.ijfoodmicro.2006.01.012; Lapidot A, 2009, J FOOD PROTECT, V72, P618, DOI 10.4315/0362-028X-72.3.618; Macvanin M, METHODS MOL BIOL, V642, P95; Mantena RKR, 2008, CELL MICROBIOL, V10, P1058, DOI 10.1111/j.1462-5822.2007.01105.x; Marenda M, 1998, MOL MICROBIOL, V27, P437, DOI 10.1046/j.1365-2958.1998.00692.x; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nagy G, 2004, INFECT IMMUN, V72, P4297, DOI 10.1128/IAI.72.7.4297-4301.2004; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Noel JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012406; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; SEQUEIRA L, 1985, J CELL SCI, P301, DOI 10.1242/jcs.1985.Supplement_2.16; Sigee DC, 1993, BACTERIAL PLANT PATH, P126; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Sukupolvi S, 1997, INFECT IMMUN, V65, P5320, DOI 10.1128/IAI.65.12.5320-5325.1997; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; THOMASHOW MF, 1987, J BACTERIOL, V169, P3209, DOI 10.1128/jb.169.7.3209-3216.1987; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; TSCHAPE H, 1995, EPIDEMIOL INFECT, V114, P441, DOI 10.1017/S0950268800052158; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhou JM, 2008, CURR OPIN MICROBIOL, V11, P179, DOI 10.1016/j.mib.2008.02.004	68	68	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e18855	10.1371/journal.pone.0018855	http://dx.doi.org/10.1371/journal.pone.0018855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541320	Green Submitted, Green Published, gold			2022-12-25	WOS:000290018400014
J	Siltanen, A; Kitabayashi, K; Lakkisto, P; Makela, J; Patila, T; Ono, M; Tikkanen, I; Sawa, Y; Kankuri, E; Harjula, A				Siltanen, Antti; Kitabayashi, Katsukiyo; Lakkisto, Paivi; Makela, Johanna; Patila, Tommi; Ono, Masamichi; Tikkanen, Ilkka; Sawa, Yoshiki; Kankuri, Esko; Harjula, Ari			hHGF Overexpression in Myoblast Sheets Enhances Their Angiogenic Potential in Rat Chronic Heart Failure	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; TRANSPLANTATION; EXPRESSION	After severe myocardial infarction (MI), heart failure results from ischemia, fibrosis, and remodeling. A promising therapy to enhance cardiac function and induce therapeutic angiogenesis via a paracrine mechanism in MI is myoblast sheet transplantation. We hypothesized that in a rat model of MI-induced chronic heart failure, this therapy could be further improved by overexpression of the antiapoptotic, antifibrotic, and proangiogenic hepatocyte growth factor (HGF) in the myoblast sheets. We studied the ability of wild type (L6-WT) and human HGF-expressing (L6-HGF) L6 myoblast sheet-derived paracrine factors to stimulate cardiomyocyte, endothelial cell, or smooth muscle cell migration in culture. Further, we studied the autocrine effect of hHGF-expression on myoblast gene expression profiles by use of microarray analysis. We induced MI in Wistar rats by left anterior descending coronary artery (LAD) ligation and allowed heart failure to develop for 4 weeks. Thereafter, we administered L6-WT (n = 15) or L6-HGF (n = 16) myoblast sheet therapy. Control rats (n = 13) underwent LAD ligation and rethoracotomy without therapy, and five rats underwent a sham operation in both surgeries. We evaluated cardiac function with echocardiography at 2 and 4 weeks after therapy, and analyzed cardiac angiogenesis and left ventricular architecture from histological sections at 4 weeks. Paracrine mediators from L6-HGF myoblast sheets effectively induced migration of cardiac endothelial and smooth muscle cells but not cardiomyocytes. Microarray data revealed that hHGF-expression modulated myoblast gene expression. In vivo, L6-HGF sheet therapy effectively stimulated angiogenesis in the infarcted and non-infarcted areas. Both L6-WT and L6-HGF therapies enhanced cardiac function and inhibited remodeling in a similar fashion. In conclusion, L6-HGF therapy effectively induced angiogenesis in the chronically failing heart. Cardiac function, however, was not further enhanced by hHGF expression.	[Siltanen, Antti; Kankuri, Esko] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Kitabayashi, Katsukiyo; Ono, Masamichi; Sawa, Yoshiki] Osaka Univ, Dept Cardiovasc Surg, Grad Sch Med, Osaka, Japan; [Lakkisto, Paivi; Makela, Johanna; Tikkanen, Ilkka] Minerva Fdn, Helsinki, Finland; [Lakkisto, Paivi] Univ Helsinki, Dept Clin Chem, Cent Hosp, SF-00100 Helsinki, Finland; [Patila, Tommi; Harjula, Ari] Univ Helsinki, Meilahti Hosp, Dept Cardiothorac Surg, Helsinki, Finland; [Tikkanen, Ilkka] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland	University of Helsinki; Osaka University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Siltanen, A (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	antti.siltanen@helsinki.fi		Kankuri, Esko/0000-0002-2193-8773; harjula, ari/0000-0001-6691-3636; Lakkisto, Paivi/0000-0001-9935-6573	Academy of Finland [120313]; Japanese Society for the Promotion of Science [120313]; Finnish Government EVO [TYH7201, TYH2009/301]; Japan Science and Technology Agency; Finnish Funding Agency for Technology and Innovation [40102/08]; Finnish Heart Association; Helsinki University Hospital [TYH2009206]; Finnish Foundation for Cardiovascular Research; Finska Lakaresallskapet	Academy of Finland(Academy of Finland); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Finnish Government EVO; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Heart Association; Helsinki University Hospital; Finnish Foundation for Cardiovascular Research; Finska Lakaresallskapet	This work was supported by Core-to-Core funding between the Academy of Finland (http://www.aka.fi) and the Japanese Society for the Promotion of Science (http://www.jsps.go.jp) [120313]; Finnish Government EVO grants (http://www.tem.fi) [TYH7201, TYH2009/301]; RAM collaboration between Japan Science and Technology Agency (http://www.jst.go.jp, YS) and the Finnish Funding Agency for Technology and Innovation (http://www.tekes.fi, EK) [40102/08]; Finnish Heart Association (http://www.sydanliitto.fi); Helsinki University Hospital Research Grants (http://www.hus.fi) [TYH2009206]; the Finnish Foundation for Cardiovascular Research (http://www.sydantutkimussaatio.fi) [2008, 2010]; and Finska Lakaresallskapet (http://www.fls.fi) [2010]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmet I, 2003, ANN THORAC SURG, V75, P1283, DOI 10.1016/S0003-4975(02)04677-5; Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104; Deten A, 2001, J MOL CELL CARDIOL, V33, P1191, DOI 10.1006/jmcc.2001.1383; Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074; Kitabayashi K, 2010, CELL TRANSPLANT, V19, P573, DOI 10.3727/096368909X486048; Krause K, 2010, CARDIOVASC THER, V28, pe101, DOI 10.1111/j.1755-5922.2010.00208.x; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Nakamura T, 2005, AM J PHYSIOL-HEART C, V288, pH2131, DOI 10.1152/ajpheart.01239.2003; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002; Siltanen A, 2010, TISSUE ENG A; Tambara K, 2005, CIRCULATION, V112, pI129, DOI 10.1161/CIRCULATIONAHA.104.526293; Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; Ueno S, 2001, J CARD FAIL, V7, P329, DOI 10.1054/jcaf.2001.27686; Wojakowski W, 2006, EUR HEART J, V27, P283, DOI 10.1093/eurheartj/ehi628; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100	22	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19161	10.1371/journal.pone.0019161	http://dx.doi.org/10.1371/journal.pone.0019161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541335	Green Published, Green Submitted, gold			2022-12-25	WOS:000290018400027
J	Rohloff, P; Miranda, K; Rodrigues, JCF; Fang, JM; Galizzi, M; Plattner, H; Hentschel, J; Moreno, SNJ				Rohloff, Peter; Miranda, Kildare; Rodrigues, Juliany C. F.; Fang, Jianmin; Galizzi, Melina; Plattner, Helmut; Hentschel, Joachim; Moreno, Silvia N. J.			Calcium Uptake and Proton Transport by Acidocalcisomes of Toxoplasma gondii	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; H+-PYROPHOSPHATASES; PUMPING PYROPHOSPHATASE; PLASMA-MEMBRANE; POLYPHOSPHATE; PARASITES; STORAGE; CRUZI; PLANT; LOCALIZATION	Acidocalcisomes are acidic calcium stores found in diverse organisms, being conserved from bacteria to humans. They possess an acidic matrix that contains several cations bound to phosphates, which are mainly present in the form of short and long polyphosphate chains. Their matrix is acidified through the action of proton pumps such as a vacuolar proton ATPase and a vacuolar proton pyrophosphatase. Calcium uptake occurs through a Ca(2+)/H(+) countertransporting ATPase located in the membrane of the organelle. Acidocalcisomes have been identified in a variety of microorganisms, including Apicomplexan parasites such as Plasmodium and Eimeria species, and in Toxoplasma gondii. We report the purification and characterization of an acidocalcisome fraction from T. gondii tachyzoites after subcellular fractionation and further discontinuous iodixanol gradient purification. Proton and calcium transport activities in the fraction were characterized by fluorescence microscopy and spectrophotometric methods using acridine orange and arsenazo III, respectively. This work will facilitate the understanding of the function of acidocalcisomes in Apicomplexan parasites, as we can now isolate highly purified fractions that could be used for proteomic analysis to find proteins that may clarify the biogenesis of these organelles.	[Rohloff, Peter; Miranda, Kildare; Rodrigues, Juliany C. F.; Fang, Jianmin; Galizzi, Melina; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Rohloff, Peter; Miranda, Kildare; Rodrigues, Juliany C. F.; Fang, Jianmin; Galizzi, Melina; Moreno, Silvia N. J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Miranda, Kildare; Rodrigues, Juliany C. F.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Plattner, Helmut; Hentschel, Joachim] Univ Konstanz, Fachbereich Biol, Constance, Germany	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Universidade Federal do Rio de Janeiro; University of Konstanz	Rohloff, P (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	smoreno@uga.edu	Rodrigues, Juliany Cola Fernandes/X-4977-2019; Rodrigues, Juliany Cola Fernandes/H-2836-2012; Rohloff, Peter/P-8722-2017	Rodrigues, Juliany Cola Fernandes/0000-0001-6807-8101; Rohloff, Peter/0000-0001-7274-8315	U.S. National Institutes of Health [AI-079625]; Ellison Medical Foundation; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa Jovens Pesquisadores CNPq-Brazil; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079625] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Jovens Pesquisadores CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. National Institutes of Health (http://www.nih.gov/) Grant AI-079625 to S. N. J. M. K. M. and J. C. F. R. were supported by a training grant from the Ellison Medical Foundation (http://www.ellisonfoundation.org/index.jsp) to the Center for Tropical and Emerging Global Diseases. K. M. was also supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, www.faperj.br/) and Programa Jovens Pesquisadores CNPq-Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAVIES JM, 1991, FEBS LETT, V278, P66, DOI 10.1016/0014-5793(91)80085-H; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; DOCAMPO R, 1995, BIOCHEM J, V310, P1005, DOI 10.1042/bj3101005; Drozdowicz YM, 2003, J BIOL CHEM, V278, P1075, DOI 10.1074/jbc.M209436200; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Ling Y, 2007, J BIOL CHEM, V282, P30804, DOI 10.1074/jbc.M703178200; Luo SH, 2005, MOL MICROBIOL, V55, P1034, DOI 10.1111/j.1365-2958.2004.04464.x; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Luo SH, 2001, EMBO J, V20, P55, DOI 10.1093/emboj/20.1.55; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; Metsis A, 1995, EXP PARASITOL, V81, P472, DOI 10.1006/expr.1995.1140; Miranda K, 2008, EXP PARASITOL, V118, P2, DOI 10.1016/j.exppara.2007.07.009; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; NORRBY R, 1968, J BACTERIOL, V96, P916, DOI 10.1128/JB.96.4.916-919.1968; PALMGREN MG, 1991, ANAL BIOCHEM, V192, P316, DOI 10.1016/0003-2697(91)90542-2; Rodrigues CO, 1999, MOL CELL BIOL, V19, P7712; Rodrigues CO, 2002, J BIOL CHEM, V277, P48650, DOI 10.1074/jbc.M208990200; Ruiz FA, 2001, J BIOL CHEM, V276, P46196, DOI 10.1074/jbc.M105268200; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; SCOTT DA, 1995, BIOCHEM J, V310, P789, DOI 10.1042/bj3100789; Scott DA, 2000, J BIOL CHEM, V275, P24215, DOI 10.1074/jbc.M002454200; Shaw MK, 1998, PARASITOLOGY, V117, P435, DOI 10.1017/S0031182098003278; Vercesi AE, 2000, FEBS LETT, V473, P203, DOI 10.1016/S0014-5793(00)01531-3; VERCESI AE, 1994, BIOCHEM J, V304, P227, DOI 10.1042/bj3040227; ZHEN RG, 1994, PLANT PHYSIOL, V104, P153, DOI 10.1104/pp.104.1.153	27	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18390	10.1371/journal.pone.0018390	http://dx.doi.org/10.1371/journal.pone.0018390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541023	Green Published, Green Submitted, gold			2022-12-25	WOS:000290016800007
J	Viola, AU; Tobaldini, E; Chellappa, SL; Casali, KR; Porta, A; Montano, N				Viola, Antoine U.; Tobaldini, Eleonora; Chellappa, Sarah L.; Casali, Karina Rabello; Porta, Alberto; Montano, Nicola			Short-Term Complexity of Cardiac Autonomic Control during Sleep: REM as a Potential Risk Factor for Cardiovascular System in Aging	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AGE-RELATED-CHANGES; POWER SPECTRUM ANALYSIS; PERIOD VARIABILITY; APPROXIMATE ENTROPY; INTERVAL DYNAMICS; TIME; FRACTALS; DISEASE	Introduction: Sleep is a complex phenomenon characterized by important modifications throughout life and by changes of autonomic cardiovascular control. Aging is associated with a reduction of the overall heart rate variability (HRV) and a decrease of complexity of autonomic cardiac regulation. The aim of our study was to evaluate the HRV complexity using two entropy-derived measures, Shannon Entropy (SE) and Corrected Conditional Entropy (CCE), during sleep in young and older subjects. Methods: A polysomnographic study was performed in 12 healthy young (21.1 +/- 0.8 years) and 12 healthy older subjects (64.9 +/- 1.9 years). After the sleep scoring, heart period time series were divided into wake (W), Stage 1-2 (S1-2), Stage 3-4 (S3-4) and REM. Two complexity indexes were assessed: SE(3) measuring the complexity of a distribution of 3-beat patterns (SE(3) is higher when all the patterns are identically distributed and it is lower when some patterns are more likely) and CCEmin measuring the minimum amount of information that cannot be derived from the knowledge of previous values. Results: Across the different sleep stages, young subjects had similar RR interval, total variance, SE(3) and CCEmin. In the older group, SE(3) and CCEmin were reduced during REM sleep compared to S1-2, S3-4 and W. Compared to young subjects, during W and sleep the older subjects showed a lower RR interval and reduced total variance as well as a significant reduction of SE(3) and CCEmin. This decrease of entropy measures was more evident during REM sleep. Conclusion: Our study indicates that aging is characterized by a reduction of entropy indices of cardiovascular variability during wake/sleep cycle, more evident during REM sleep. We conclude that during aging REM sleep is associated with a simplification of cardiac control mechanisms that could lead to an impaired ability of the cardiovascular system to react to cardiovascular adverse events.	[Viola, Antoine U.; Chellappa, Sarah L.] Univ Basel, Ctr Chronobiol, Basel, Switzerland; [Tobaldini, Eleonora; Montano, Nicola] Univ Milan, Dept Clin Sci, L Sacco Hosp, Milan, Italy; [Chellappa, Sarah L.] Minist Educ Brasil, CAPES Fdn, Brasilia, DF, Brazil; [Casali, Karina Rabello] Inst Cardiol Rio Grande Do Sul, Porto Alegre, RS, Brazil; [Porta, Alberto] Univ Milan, Dept Technol Hlth, Galeazzi Orthoped Inst, Milan, Italy	University of Basel; University of Milan; Luigi Sacco Hospital; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Universitaria de Cardiologia; IRCCS Istituto Ortopedico Galeazzi; University of Milan	Viola, AU (corresponding author), Univ Basel, Ctr Chronobiol, Basel, Switzerland.	nicola.montano@unimi.it	Casali, Karina R/I-7677-2012; viola, antoine U/C-5878-2008; Porta, Alberto/K-4390-2016; Tobaldini, Eleonora/K-8380-2016	Casali, Karina R/0000-0001-8281-0135; Porta, Alberto/0000-0002-6720-9824; Tobaldini, Eleonora/0000-0003-3627-8293; Chellappa, Sarah L./0000-0002-6190-464X; Montano, Nicola/0000-0001-9206-0075	PRIN [20072S2HT8_002 2007]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	The work was partially supported by PRIN Grant 20072S2HT8_002 2007 to N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; BERLAD I, 1993, J SLEEP RES, V2, P88, DOI 10.1111/j.1365-2869.1993.tb00067.x; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; Bonnet MH, 2009, SLEEP, V32, P441, DOI 10.1093/sleep/32.4.441; Brandenberger G, 2003, J SLEEP RES, V12, P173, DOI 10.1046/j.1365-2869.2003.00353.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Caples SM, 2007, SLEEP, V30, P291, DOI 10.1093/sleep/30.3.291; Claria F, 2008, PHYSIOL MEAS, V29, P401, DOI 10.1088/0967-3334/29/3/010; Crasset V, 2001, CIRCULATION, V103, P84; Fell J, 2000, BIOL CYBERN, V82, P485, DOI 10.1007/s004220050601; Goff EA, 2010, CLIN AUTON RES, V20, P175, DOI 10.1007/s10286-009-0027-0; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Huikuri HV, 2003, J ELECTROCARDIOL, V36, P95, DOI 10.1016/j.jelectrocard.2003.09.021; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Lavery CE, 1997, CIRCULATION, V96, P3321; Legramante JM, 2003, J HYPERTENS, V21, P1555, DOI 10.1097/00004872-200308000-00021; LIPSITZ LA, 1995, CHAOS, V5, P102, DOI 10.1063/1.166091; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Malliani A, 1998, CIRCULATION, V98, P2640; Malliani Alberto, 2002, Ital Heart J, V3, P439; Montano N, 2001, AUTON NEUROSCI-BASIC, V90, P29, DOI 10.1016/S1566-0702(01)00264-8; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Monti A, 2002, EUR J APPL PHYSIOL, V87, P174, DOI 10.1007/s00421-002-0597-1; Pikkujamsa SM, 1999, CIRCULATION, V100, P393, DOI 10.1161/01.CIR.100.4.393; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; Porta A, 2007, CHAOS, V17, DOI 10.1063/1.2404630; Porta A, 2004, COMPUT CARDIOL, V31, P645; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2007, IEEE T BIO-MED ENG, V54, P94, DOI 10.1109/TBME.2006.883789; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Trinder J, 2001, J SLEEP RES, V10, P253, DOI 10.1046/j.1365-2869.2001.00263.x; VANOLI E, 1995, CIRCULATION, V91, P1918, DOI 10.1161/01.CIR.91.7.1918; Vigo DE, 2010, AUTON NEUROSCI-BASIC, V154, P84, DOI 10.1016/j.autneu.2009.10.007; Vigo DE, 2005, AUTON NEUROSCI-BASIC, V123, P94, DOI 10.1016/j.autneu.2005.10.004; Virtanen I, 2007, AUTON NEUROSCI-BASIC, V134, P74, DOI 10.1016/j.autneu.2007.01.010; Voss A, 1996, CARDIOVASC RES, V31, P419; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323	42	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19002	10.1371/journal.pone.0019002	http://dx.doi.org/10.1371/journal.pone.0019002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544202	Green Submitted, gold, Green Published			2022-12-25	WOS:000290015800029
J	Sanz, A; Ungureanu, D; Pekkala, T; Ruijtenbeek, R; Touw, IP; Hilhorst, R; Silvennoinen, O				Sanz, Arturo; Ungureanu, Daniela; Pekkala, Tuija; Ruijtenbeek, Rob; Touw, Ivo P.; Hilhorst, Riet; Silvennoinen, Olli			Analysis of Jak2 Catalytic Function by Peptide Microarrays: The Role of the JH2 Domain and V617F Mutation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE JAK2; PSEUDOKINASE DOMAIN; POLYCYTHEMIA-VERA; PROTEIN-KINASES; MYELOPROLIFERATIVE DISORDERS; ERYTHROPOIETIN RECEPTOR; SURFACE EXPRESSION; JANUS KINASES; FERM DOMAIN	Janus kinase 2 (JAK2) initiates signaling from several cytokine receptors and is required for biological responses such as erythropoiesis. JAK2 activity is controlled by regulatory proteins such as Suppressor of Cytokine Signaling (SOCS) proteins and protein tyrosine phosphatases. JAK2 activity is also intrinsically controlled by regulatory domains, where the pseudokinase (JAK homology 2, JH2) domain has been shown to play an essential role. The physiological role of the JH2 domain in the regulation of JAK2 activity was highlighted by the discovery of the acquired missense point mutation V617F in myeloproliferative neoplasms (MPN). Hence, determining the precise role of this domain is critical for understanding disease pathogenesis and design of new treatment modalities. Here, we have evaluated the effect of inter-domain interactions in kinase activity and substrate specificity. By using for the first time purified recombinant JAK2 proteins and a novel peptide micro-array platform, we have determined initial phosphorylation rates and peptide substrate preference for the recombinant kinase domain (JH1) of JAK2, and two constructs comprising both the kinase and pseudokinase domains (JH1-JH2) of JAK2. The data demonstrate that (i) JH2 drastically decreases the activity of the JAK2 JH1 domain, (ii) JH2 increased the K-m for ATP (iii) JH2 modulates the peptide preference of JAK2 (iv) the V617F mutation partially releases this inhibitory mechanism but does not significantly affect substrate preference or K-m for ATP. These results provide the biochemical basis for understanding the interaction between the kinase and the pseudokinase domain of JAK2 and identify a novel regulatory role for the JAK2 pseudokinase domain. Additionally, this method can be used to identify new regulatory mechanisms for protein kinases that provide a better platform for designing specific strategies for therapeutic approaches.	[Sanz, Arturo; Touw, Ivo P.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Ungureanu, Daniela; Pekkala, Tuija; Silvennoinen, Olli] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Ruijtenbeek, Rob; Hilhorst, Riet] PamGene Int BV, Shertogenbosch, Netherlands; [Silvennoinen, Olli] Tampere Univ Hosp, Tampere, Finland	Erasmus University Rotterdam; Erasmus MC; Tampere University; PamGene International BV; Tampere University; Tampere University Hospital	Sanz, A (corresponding author), Erasmus MC, Dept Hematol, Rotterdam, Netherlands.	olli.silvennoinen@uta.fi		Hilhorst, Riet/0000-0002-8261-1299; Ungureanu, Daniela/0000-0002-9314-4972	EU Research Training Network ReceptEur; Medical Research Council of Academy of Finland; Sigrid Juselius Foundation; Tampere University Hospital; Finnish Cancer Foundation; Tampere Tuberculosis Foundation	EU Research Training Network ReceptEur; Medical Research Council of Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital; Finnish Cancer Foundation; Tampere Tuberculosis Foundation	This study was supported by EU Research Training Network ReceptEur, the Medical Research Council of Academy of Finland, the Sigrid Juselius Foundation, Competitive Research Funding of the Tampere University Hospital, the Finnish Cancer Foundation, and the Tampere Tuberculosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Copeland R. A., ENZYMES PRACTICAL IN; De Keersmaecker K, 2008, LEUKEMIA, V22, P2208, DOI 10.1038/leu.2008.242; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Haan C, 2010, J CELL MOL MED, V14, P504, DOI 10.1111/j.1582-4934.2010.01018.x; Hall T, 2010, PROTEIN EXPRES PURIF, V69, P54, DOI 10.1016/j.pep.2009.09.011; Hilhorst R, 2009, ANAL BIOCHEM, V387, P150, DOI 10.1016/j.ab.2009.01.022; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ishida-Takahashi R, 2006, MOL CELL BIOL, V26, P4063, DOI 10.1128/MCB.01589-05; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krupa A, 2004, J MOL BIOL, V339, P1025, DOI 10.1016/j.jmb.2004.04.043; Kundrapu K, 2008, CELL BIOCHEM BIOPHYS, V52, P103, DOI 10.1007/s12013-008-9025-4; Kurzer JH, 2004, MOL CELL BIOL, V24, P4557, DOI 10.1128/MCB.24.10.4557-4570.2004; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Lee TS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-58; Lee TS, 2009, CANCER-AM CANCER SOC, V115, P1692, DOI 10.1002/cncr.24183; Lemeer S, 2007, MOL CELL PROTEOMICS, V6, P2088, DOI 10.1074/mcp.M600482-MCP200; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; PETER VH, 2004, PROTEOMICS, V4, P1551; Poot AJ, 2009, CHEMBIOCHEM, V10, P2042, DOI 10.1002/cbic.200900199; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; SONGYANG Z, 1995, J BIOL CHEM, V270, P26029, DOI 10.1074/jbc.270.44.26029; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zaleskas VM, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000018; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhou SY, 1999, PROG BIOPHYS MOL BIO, V71, P359, DOI 10.1016/S0079-6107(98)00045-5	55	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18522	10.1371/journal.pone.0018522	http://dx.doi.org/10.1371/journal.pone.0018522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533163	Green Published, Green Submitted, gold			2022-12-25	WOS:000289620100008
J	Ao, A; Morrison, BJ; Wang, HM; Lopez, JA; Reynolds, BA; Lu, JR				Ao, Ada; Morrison, Brian J.; Wang, Heiman; Lopez, J. Alejandro; Reynolds, Brent A.; Lu, Jianrong			Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments	PLOS ONE			English	Article							IN-VITRO PROPAGATION; ENDOCRINE THERAPY; STEM-CELLS; EXPRESSION; PREVENTION; STABILITY; TAMOXIFEN; BINDING; ALPHA	Estrogen signaling plays a critical role in the pathogenesis of breast cancer. Because the majority of breast carcinomas express the estrogen receptor ER alpha, endocrine therapy that impedes estrogen-ER signaling reduces breast cancer mortality and has become a mainstay of breast cancer treatment. However, patients remain at continued risk of relapse for many years after endocrine treatment. It has been proposed that cancer recurrence may be attributed to cancer stem cells (CSCs)/tumor-initiating cells (TICs). Previous studies in breast cancer have shown that such cells can be enriched and propagated in vitro by culturing the cells in suspension as mammospheres/tumorspheres. Here we established tumorspheres from ER alpha-positive human breast cancer cell line MCF7 and investigated their response to antiestrogens Tamoxifen and Fulvestrant. The tumorsphere cells express lower levels of ERa and are more tumorigenic in xenograft assays than the parental cells. Both 4-hydroxytamoxifen (4-OHT) and Fulvestrant attenuate tumorsphere cell proliferation, but only 4-OHT at high concentrations interferes with sphere formation. However, treated tumorsphere cells retain the self-renewal capacity. Upon withdrawal of antiestrogens, the treated cells resume tumorsphere formation and their tumorigenic potential remains undamaged. Depletion of ER alpha shows that ER alpha is dispensable for tumorsphere formation and xenograft tumor growth in mice. Surprisingly, ER alpha-depleted tumorspheres display heightened sensitivity to 4-OHT and their sphere-forming capacity is diminished after the drug is removed. These results imply that 4-OHT may inhibit cellular targets besides ER alpha that are essential for tumorsphere growth, and provide a potential strategy to sensitize tumorspheres to endocrine treatment.	[Ao, Ada; Wang, Heiman; Lu, Jianrong] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Morrison, Brian J.; Lopez, J. Alejandro] Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Morrison, Brian J.; Lopez, J. Alejandro] Griffith Univ, Nathan, Qld 4111, Australia; [Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA	State University System of Florida; University of Florida; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Griffith University; State University System of Florida; University of Florida	Ao, A (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	ada.ao@vanderbilt.edu; jrlu@ufl.edu	Lopez, J. Alejandro/B-9290-2008; Lopez, J. Alejandro/P-4129-2019; Lu, Jianrong/F-5240-2013	Lopez, J. Alejandro/0000-0001-9370-1516; Lopez, J. Alejandro/0000-0001-9370-1516; Lu, Jianrong/0000-0002-4969-6040	NIH/NCI [R01CA137021]; Florida Bankhead-Coley Cancer Research Program [09BN-12-23092]; NATIONAL CANCER INSTITUTE [R01CA137021] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Bankhead-Coley Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was in part supported by NIH/NCI R01CA137021 and Florida Bankhead-Coley Cancer Research Program 09BN-12-23092 (to J.L.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson WF, 2002, BREAST CANCER RES TR, V76, P27, DOI 10.1023/A:1020299707510; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P181, DOI 10.2174/156802606776173483; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Cianfrocca M, 2008, CLIN BREAST CANCER, V8, P493, DOI 10.3816/CBC.2008.n.059; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Cleator SJ, 2009, CLIN BREAST CANCER, V9, pS6, DOI 10.3816/CBC.2009.s.001; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Johnston SJ, 2010, CURR MED CHEM, V17, P902, DOI 10.2174/092986710790820633; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lin NU, 2008, J CLIN ONCOL, V26, P1919, DOI 10.1200/JCO.2007.14.7744; MacCallum J, 2000, BRIT J CANCER, V82, P1629; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Sengupta S, 2008, ADV EXP MED BIOL, V630, P206; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200	35	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18810	10.1371/journal.pone.0018810	http://dx.doi.org/10.1371/journal.pone.0018810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533195	gold, Green Published			2022-12-25	WOS:000289505600031
J	Clotuche, G; Mailleux, AC; Fernandez, AA; Deneubourg, JL; Detrain, C; Hance, T				Clotuche, Gwendoline; Mailleux, Anne-Catherine; Fernandez, Aina Astudillo; Deneubourg, Jean-Louis; Detrain, Claire; Hance, Thierry			The Formation of Collective Silk Balls in the Spider Mite Tetranychus urticae Koch	PLOS ONE			English	Article							AERIAL-DISPERSAL BEHAVIOR; SPINNING BEHAVIOR; ACARI; PATTERNS; DECISION; COMMUNICATION; AGGREGATION; RESISTANCE; RESPONSES; ANTS	Tetranychus urticae is a phytophagous mite that forms colonies of several thousand individuals. These mites construct a common web to protect the colony. When plants become overcrowded and food resources become scarce, individuals gather at the plant apex to form a ball composed of mites and their silk threads. This ball is a structure facilitating group dispersal by wind or animal transport. Until now, no quantitative study had been done on this collective form of migration. This is the first attempt to understand the mechanisms that underlie the emergence and growth of the ball. We studied this collective behaviour under laboratory conditions on standardized infested plants. Our results show that the collective displacement and the formation of balls result from a recruitment process: by depositing silk threads on their way up to the plant apex, mites favour and amplify the recruitment toward the balls. A critical threshold ( quorum response) in the cumulative flow of mites must be reached to observe the emergence of a ball. At the beginning of the balls formation, mites form an aggregate. After 24 hours, the aggregated mites are trapped inside the silk balls by the complex network of silk threads and finally die, except for recently arrived individuals. The balls are mainly composed of immature stages. Our study reconstructs the key events that lead to the formation of silk balls. They suggest that the interplay between mites' density, plant morphology and plant density lead to different modes of dispersions ( individual or collective) and under what conditions populations might adopt a collective strategy rather than one that is individually oriented. Moreover, our results lead to discuss two aspects of the cooperation and altruism: the importance of Allee effects during colonization of new plants and the importance of the size of a founding group.	[Clotuche, Gwendoline; Mailleux, Anne-Catherine; Hance, Thierry] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium; [Fernandez, Aina Astudillo; Deneubourg, Jean-Louis; Detrain, Claire] Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium	Universite Catholique Louvain; Universite Libre de Bruxelles	Clotuche, G (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, B-1348 Louvain, Belgium.	Gwendoline.clotuche@uclouvain.be			Fonds pour la recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.) of Belgium; Fund for Fundamental and Collective Research (FRFC) [2.4622.06]	Fonds pour la recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.) of Belgium(Fonds de la Recherche Scientifique - FNRS); Fund for Fundamental and Collective Research (FRFC)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by Fonds pour la recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.) of Belgium and by the Fund for Fundamental and Collective Research (FRFC, convention 2.4622.06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W., 1938, SOCIAL LIFE ANIMALS; Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; Anderson JT, 2001, BEHAV ECOL, V12, P360, DOI 10.1093/beheco/12.3.360; [Anonymous], [No title captured]; Baker E.W., 1994, GUIDE SPIDER MITES T; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bergman CM, 2000, OECOLOGIA, V123, P364, DOI 10.1007/s004420051023; Bolland H.R., 1998, WORLD CATALOGUE SPID; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Bonte D, 2006, ANIM BEHAV, V72, P655, DOI 10.1016/j.anbehav.2005.11.026; BOYKIN LS, 1984, ENVIRON ENTOMOL, V13, P221, DOI 10.1093/ee/13.1.221; BRANDENBURG RL, 1982, ENTOMOL EXP APPL, V32, P269, DOI 10.1111/j.1570-7458.1982.tb03217.x; CAMAZINE S, 2001, SELF ORG BIOL SYSTEM, P538; Chapman CA, 2000, MOVE; Clark RJ, 1999, J INSECT BEHAV, V12, P753, DOI 10.1023/A:1020900925863; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; DEANGELIS JD, 1982, ENVIRON ENTOMOL, V11, P975, DOI 10.1093/ee/11.4.975; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Ebeling W., 1934, PANPACIFIC ENTOMOL, V10, P89; FITZGERALD TD, 1995, TENT CATERPILLARS; FLESCHNER CA, 1956, J ECON ENTOMOL, V49, P624, DOI 10.1093/jee/49.5.624; Glass EV, 1998, EXP APPL ACAROL, V22, P31, DOI 10.1023/A:1006081323887; Grasse PP., 1944, REV SCI, V82, P461; Hance T, 1999, ECOL MODEL, V114, P195, DOI 10.1016/S0304-3800(98)00148-3; Helle W, 1985, SPIDER MITES THEIR B, V1A, P405; HOELSCHER CE, 1967, ANN ENTOMOL SOC AM, V60, P673, DOI 10.1093/aesa/60.3.673; HUSSEY N. W., 1963, ENTOMOL EXP APPL, V6, P207, DOI 10.1007/BF00300527; Jeanson R, 2004, ANIM BEHAV, V67, P531, DOI 10.1016/j.anbehav.2003.06.013; Kennedy G.G., 1985, P233; Le Goff G, 2009, CR BIOL, V332, P927, DOI 10.1016/j.crvi.2009.06.002; LI JB, 1993, ENTOMOL EXP APPL, V68, P79, DOI 10.1007/BF02380584; Lioni A, 2004, NATURWISSENSCHAFTEN, V91, P237, DOI 10.1007/s00114-004-0519-7; Lioni A, 2001, J INSECT BEHAV, V14, P679, DOI 10.1023/A:1012283403138; MARGOLIES DC, 1987, ENVIRON ENTOMOL, V16, P928, DOI 10.1093/ee/16.4.928; MARGOLIES DC, 1988, ENTOMOL EXP APPL, V46, P233, DOI 10.1007/BF00364194; MILLER RW, 1985, J ECON ENTOMOL, V78, P1379, DOI 10.1093/jee/78.6.1379; Osakabe M, 2008, EXP APPL ACAROL, V44, P165, DOI 10.1007/s10493-008-9141-2; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Popov SY, 1996, ZOOL ZH, V75, P533; PRALAVORIO M, 1989, ENTOMOPHAGA, V34, P129, DOI 10.1007/BF02372596; Rahman K. A., 1940, INDIAN JOUR ENT, V2, P201; RANTA E, 1993, AM NAT, V142, P42, DOI 10.1086/285528; Ruf C, 2001, J INSECT BEHAV, V14, P231, DOI 10.1023/A:1007841828892; Saffre F, 1999, J INSECT BEHAV, V12, P277, DOI 10.1023/A:1020927102896; SAITO Y, 1979, JPN J APPL ENTOMOL Z, V23, P82, DOI 10.1303/jjaez.23.82; SAITO Y, 1977, JPN J APPL ENTOMOL Z, V21, P27, DOI 10.1303/jjaez.21.27; Saito Y, 2009, PLANT MITES SOCIALIT; Saito Yutaka, 1997, P443; SANCES FV, 1979, ENVIRON ENTOMOL, V8, P711, DOI 10.1093/ee/8.4.711; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Seeley T., 1995, WISDOM HIVE; Sempo G, 2009, ETHOLOGY, V115, P1150, DOI 10.1111/j.1439-0310.2009.01699.x; SIGAL MD, 1982, PHYSIOL ZOOL, V55, P355, DOI 10.1086/physzool.55.4.30155863; SMITLEY DR, 1985, ANN ENTOMOL SOC AM, V78, P609, DOI 10.1093/aesa/78.5.609; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; SUSKI Z. W., 1963, ADV ACAROLOGY, V1, P193; TOWNE W F, 1988, Journal of Insect Behavior, V1, P129, DOI 10.1007/BF01052234; Van Leeuwen T, 2008, P NATL ACAD SCI USA, V105, P5980, DOI 10.1073/pnas.0802224105; VANIMPE G, 1985, THESIS U CATHOLIQUE; Walter DE, 1999, MITES ECOLOGY EVOLUT; Weeks AR, 2000, J ECON ENTOMOL, V93, P1415, DOI 10.1603/0022-0493-93.5.1415; Wertheim B, 2005, OIKOS, V109, P117, DOI 10.1111/j.0030-1299.2005.13340.x; Yano S, 2008, ANN ENTOMOL SOC AM, V101, P247, DOI 10.1603/0013-8746(2008)101[247:CASBOT]2.0.CO;2; Yano S, 1998, EXP APPL ACAROL, V22, P595, DOI 10.1023/A:1006138527904; Yano S, 2004, EXP APPL ACAROL, V32, P243, DOI 10.1023/B:APPA.0000023241.73640.e4; YODER JA, 1992, ENTOMOL EXP APPL, V63, P203, DOI 10.1007/BF00343579; YODER JA, 1995, EXP APPL ACAROL, V19, P259, DOI 10.1007/BF00052618; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	79	48	49	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18854	10.1371/journal.pone.0018854	http://dx.doi.org/10.1371/journal.pone.0018854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533150	Green Submitted, gold, Green Published			2022-12-25	WOS:000289505600039
J	James, MM; Wang, L; Musoke, P; Donnell, D; Fogel, J; Towler, WI; Khaki, L; Nakabiito, C; Jackson, JB; Eshleman, SH				James, Maria M.; Wang, Lei; Musoke, Philippa; Donnell, Deborah; Fogel, Jessica; Towler, William I.; Khaki, Leila; Nakabiito, Clemensia; Jackson, J. Brooks; Eshleman, Susan H.			Association of HIV Diversity and Survival in HIV-Infected Ugandan Infants	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-DOSE NEVIRAPINE; FASTER DISEASE PROGRESSION; TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; VIRAL LOAD; SUBTYPE-A; VERTICAL TRANSMISSION; RANDOMIZED-TRIAL; IMMUNE-RESPONSE	Background: The level of viral diversity in an HIV-infected individual can change during the course of HIV infection, reflecting mutagenesis during viral replication and selection of viral variants by immune and other selective pressures. Differences in the level of viral diversity in HIV-infected infants may reflect differences in viral dynamics, immune responses, or other factors that may also influence HIV disease progression. We used a novel high resolution melting (HRM) assay to measure HIV diversity in Ugandan infants and examined the relationship between diversity and survival through 5 years of age. Methods: Plasma samples were obtained from 31 HIV-infected infants (HIVNET 012 trial). The HRM assay was used to measure diversity in two regions in the gag gene (Gag1 and Gag2) and one region in the pol gene (Pol). Results: HRM scores in all three regions increased with age from 6-8 weeks to 12-18 months (for Gag1: P = 0.005; for Gag2: P = 0.006; for Pol: P = 0.016). Higher HRM scores at 6-8 weeks of age (scores above the 75(th) percentile) were associated with an increased risk of death by 5 years of age (for Pol: P = 0.005; for Gag1/Gag2 (mean of two scores): P = 0.003; for Gag1/Gag2/Pol (mean of three scores): P = 0.002). We did not find an association between HRM scores and other clinical and laboratory variables. Conclusions: Genetic diversity in HIV gag and pol measured using the HRM assay was typically low near birth and increased over time. Higher HIV diversity in these regions at 6-8 weeks of age was associated with a significantly increased risk of death by 5 years of age.	[James, Maria M.; Fogel, Jessica; Towler, William I.; Khaki, Leila; Jackson, J. Brooks; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Wang, Lei; Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Musoke, Philippa; Nakabiito, Clemensia] Makerere Univ Johns Hopkins Univ Res Collaborat M, Baltimore, MD USA; [Musoke, Philippa; Nakabiito, Clemensia] Makerere Univ Johns Hopkins Univ Res Collaborat M, Kampala, Uganda; [Musoke, Philippa; Nakabiito, Clemensia] Makerere Univ, Sch Med, Kampala, Uganda	Johns Hopkins University; Fred Hutchinson Cancer Center; Johns Hopkins University; Makerere University; Makerere University	James, MM (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	seshlem@jhmi.edu		jackson, brooks/0000-0001-9458-135X; Donnell, Deborah/0000-0002-0587-7480	HIV Network for Prevention Trials (HIVNET); U.S. National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services (DHHS) [N01-AI035173]; Family Health International [N01-AI045200]; Fred Hutchinson Cancer Research Center [AI035173-417]; Johns Hopkins University; HIV Prevention Trials Network (HPTN); National Institutes of Child Health and Human Development (NICHD); National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, DHHS [U01-AI068613]; International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group, NIAID, NICHD, NIH [U01-AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613, U01AI068617, R01AI087139, N01AI045200, U01AI068632, N01AI035173] Funding Source: NIH RePORTER	HIV Network for Prevention Trials (HIVNET); U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services (DHHS); Family Health International; Fred Hutchinson Cancer Research Center; Johns Hopkins University(Johns Hopkins University); HIV Prevention Trials Network (HPTN); National Institutes of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute on Drug Abuse (NIDA)); International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group, NIAID, NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the HIV Network for Prevention Trials (HIVNET), sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), through contract N01-AI035173 with Family Health International, contract N01-AI045200 with Fred Hutchinson Cancer Research Center, and contract NOI-AI035173-417 with Johns Hopkins University; the HIV Prevention Trials Network (HPTN) sponsored by the NIAID, the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, DHHS (U01-AI068613); and the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Group, NIAID, NICHD, NIH (U01-AI068632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID US ANT AG PED H; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Baum Linda L, 2010, Curr HIV/AIDS Rep, V7, P11, DOI 10.1007/s11904-009-0036-6; BUSEYNE F, 1993, J IMMUNOL, V150, P3569; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Church JD, 2008, J INFECT DIS, V198, P1075, DOI 10.1086/591503; Delwart EL, 1997, J VIROL, V71, P7498, DOI 10.1128/JVI.71.10.7498-7508.1997; Eshleman SH, 2004, JAIDS-J ACQ IMM DEF, V35, P126, DOI 10.1097/00126334-200402010-00004; Frahm Nicole, 2007, Curr Infect Dis Rep, V9, P161, DOI 10.1007/s11908-007-0012-5; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Halapi E, 1997, AIDS, V11, P1709, DOI 10.1097/00002030-199714000-00007; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2010, CURR OPIN HIV AIDS, V5, P327, DOI 10.1097/COH.0b013e32833a0b9b; Keele BF, 2009, CURR OPIN HIV AIDS, V4, P352, DOI 10.1097/COH.0b013e32832d9fef; Leal E, 2007, INFECT GENET EVOL, V7, P694, DOI 10.1016/j.meegid.2007.07.008; Learn GH, 2002, J VIROL, V76, P11953, DOI 10.1128/JVI.76.23.11953-11959.2002; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu SY, 2008, ARCH VIROL, V153, P1233, DOI 10.1007/s00705-008-0107-9; Long EM, 2000, NAT MED, V6, P71; LUZURIAGA K, 1991, J PEDIATR-US, V119, P230, DOI 10.1016/S0022-3476(05)80732-2; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; Mullins JI, 2006, CURR TOP MICROBIOL, V299, P171; Musoke PM, 2009, JAIDS-J ACQ IMM DEF, V52, P560, DOI 10.1097/QAI.0b013e3181b93a5a; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Obimbo EM, 2009, JAIDS-J ACQ IMM DEF, V51, P209, DOI 10.1097/QAI.0b013e31819c16d8; Piantadosi A, 2009, AIDS, V23, P579, DOI 10.1097/QAD.0b013e328328f76e; Ross HA, 2002, J VIROL, V76, P11715, DOI 10.1128/JVI.76.22.11715-11720.2002; Sagar M, 2006, AIDS RES HUM RETROV, V22, P430, DOI 10.1089/aid.2006.22.430; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Shalekoff S, 2009, AIDS, V23, P789, DOI 10.1097/QAD.0b013e328329c784; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; STRUNNIKOVA N, 1995, J VIROL, V69, P7548, DOI 10.1128/JVI.69.12.7548-7558.1995; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Thobakgale CF, 2007, J VIROL, V81, P12775, DOI 10.1128/JVI.00624-07; TOWLER WI, 2010, 17 C RETR OPP INF SA; Towler WI, 2010, AIDS RES HUM RETROV, V26, P913, DOI 10.1089/aid.2009.0259; Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO, 2009, GUID HIV DIAGN MON A; WHO UNICEF, 2008, SCAL HIV REL PREV DI; Zhang H, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-73	51	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18642	10.1371/journal.pone.0018642	http://dx.doi.org/10.1371/journal.pone.0018642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533179	Green Submitted, Green Published, gold			2022-12-25	WOS:000289505600016
J	Rupp, B; Gunther, S; Makhmoor, T; Schlundt, A; Dickhaut, K; Gupta, S; Choudhary, I; Wiesmuller, KH; Jung, G; Freund, C; Falk, K; Rotzschke, O; Kuhne, R				Rupp, Bernd; Guenther, Sebastian; Makhmoor, Talat; Schlundt, Andreas; Dickhaut, Katharina; Gupta, Shashank; Choudhary, Iqbal; Wiesmueller, Karl-Heinz; Jung, Guenther; Freund, Christian; Falk, Kirsten; Roetzschke, Olaf; Kuehne, Ronald			Characterization of Structural Features Controlling the Receptiveness of Empty Class II MHC Molecules	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; INDUCED CONFORMATIONAL-CHANGE; MEDIATED PEPTIDE EXCHANGE; PROTEIN HLA-DR1; HYDROGEN-BOND; HLA-DM; CUTTING EDGE; IN-VITRO; BOUND PEPTIDE; BINDING	MHC class II molecules (MHC II) play a pivotal role in the cell-surface presentation of antigens for surveillance by T cells. Antigen loading takes place inside the cell in endosomal compartments and loss of the peptide ligand rapidly leads to the formation of a non-receptive state of the MHC molecule. Non-receptiveness hinders the efficient loading of new antigens onto the empty MHC II. However, the mechanisms driving the formation of the peptide inaccessible state are not well understood. Here, a combined approach of experimental site-directed mutagenesis and computational modeling is used to reveal structural features underlying "non-receptiveness.'' Molecular dynamics simulations of the human MHC II HLA-DR1 suggest a straightening of the alpha-helix of the beta 1 domain during the transition from the open to the non-receptive state. The movement is mostly confined to a hinge region conserved in all known MHC molecules. This shift causes a narrowing of the two helices flanking the binding site and results in a closure, which is further stabilized by the formation of a critical hydrogen bond between residues alpha Q9 and beta N82. Mutagenesis experiments confirmed that replacement of either one of the two residues by alanine renders the protein highly susceptible. Notably, loading enhancement was also observed when the mutated MHC II molecules were expressed on the surface of fibroblast cells. Altogether, structural features underlying the non-receptive state of empty HLA-DR1 identified by theoretical means and experiments revealed highly conserved residues critically involved in the receptiveness of MHC II. The atomic details of rearrangements of the peptide-binding groove upon peptide loss provide insight into structure and dynamics of empty MHC II molecules and may foster rational approaches to interfere with non-receptiveness. Manipulation of peptide loading efficiency for improved peptide vaccination strategies could be one of the applications profiting from the structural knowledge provided by this study.	[Rupp, Bernd; Guenther, Sebastian; Schlundt, Andreas; Freund, Christian; Kuehne, Ronald] Leibniz Inst Mol Pharmacol FMP, Berlin, Germany; [Guenther, Sebastian; Makhmoor, Talat; Dickhaut, Katharina; Gupta, Shashank; Falk, Kirsten; Roetzschke, Olaf] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Makhmoor, Talat; Choudhary, Iqbal] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Gupta, Shashank] Univ Copenhagen, Dept Dis Biol, Fac Life Sci, Copenhagen, Denmark; [Wiesmueller, Karl-Heinz; Jung, Guenther] Univ Tubingen, Tubingen, Germany; [Roetzschke, Olaf] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Karachi; University of Copenhagen; Eberhard Karls University of Tubingen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Rupp, B (corresponding author), Leibniz Inst Mol Pharmacol FMP, Berlin, Germany.	Olaf_Rotzschke@immunol.a-star.edu.sg; kuehne@fmp-berlin.de	Roetzschke, Olaf/GXH-0012-2022; Schlundt, Andreas/GXH-1521-2022; Guenther, Sebastian/GON-7207-2022; Schlundt, Andreas/D-2951-2017	Guenther, Sebastian/0000-0002-7329-6653; Schlundt, Andreas/0000-0003-2254-7560; Rupp, Bernd/0000-0001-9447-9638				Anderson MW, 2005, BIOCHEMISTRY-US, V44, P5617, DOI 10.1021/bi048675s; Buchli R, 2004, BIOCHEMISTRY-US, V43, P14852, DOI 10.1021/bi048580q; Carven GJ, 2005, BIOCHEMISTRY-US, V44, P13625, DOI 10.1021/bi050972p; Carven GJ, 2004, J BIOL CHEM, V279, P16561, DOI 10.1074/jbc.M314315200; Clement CC, 2011, TRENDS IMMUNOL, V32, P6, DOI 10.1016/j.it.2010.10.004; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferrante A, 2010, J IMMUNOL, V184, P1153, DOI 10.4049/jimmunol.0902878; Fourneau JM, 2004, J IMMUNOL METHODS, V285, P253, DOI 10.1016/j.jim.2003.11.011; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; GRIFFITH IJ, 1988, J EXP MED, V167, P541, DOI 10.1084/jem.167.2.541; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; Hopner S, 2006, J BIOL CHEM, V281, P38535, DOI 10.1074/jbc.M606437200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x; Lovitch SB, 2005, IMMUNOL REV, V207, P293, DOI 10.1111/j.0105-2896.2005.00298.x; McFarland BJ, 1999, J IMMUNOL, V163, P3567; McFarland BJ, 2005, J MOL BIOL, V350, P170, DOI 10.1016/j.jmb.2005.04.069; McFarland BJ, 2001, P NATL ACAD SCI USA, V98, P9231, DOI 10.1073/pnas.151131498; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Rotzschke O, 1997, P NATL ACAD SCI USA, V94, P14642, DOI 10.1073/pnas.94.26.14642; Saito K, 2004, MICROBIOL IMMUNOL, V48, P53, DOI 10.1111/j.1348-0421.2004.tb03487.x; Sant AJ, 1999, IMMUNOL REV, V172, P239, DOI 10.1111/j.1600-065X.1999.tb01369.x; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; Schlundt A, 2009, ANGEW CHEM INT EDIT, V48, P4142, DOI 10.1002/anie.200806149; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; Tan LJ, 1997, EUR J IMMUNOL, V27, P1479, DOI 10.1002/eji.1830270626; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wilson N, 2001, IMMUNITY, V14, P513, DOI 10.1016/S1074-7613(01)00140-6; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Zarutskie JA, 1999, BIOCHEMISTRY-US, V38, P5878, DOI 10.1021/bi983048m; Zavala-Ruiz Z, 2004, P NATL ACAD SCI USA, V101, P13279, DOI 10.1073/pnas.0403371101; Zhou ZM, 2009, J IMMUNOL, V183, P4187, DOI 10.4049/jimmunol.0901663	43	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18662	10.1371/journal.pone.0018662	http://dx.doi.org/10.1371/journal.pone.0018662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533180	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000289505600020
J	Velo-Anton, G; Becker, CG; Cordero-Rivera, A				Velo-Anton, Guillermo; Becker, Carlos G.; Cordero-Rivera, Adolfo			Turtle Carapace Anomalies: The Roles of Genetic Diversity and Environment	PLOS ONE			English	Article							FRESH-WATER TURTLE; CHELYDRA-SERPENTINA SERPENTINA; FLUCTUATING ASYMMETRY; EMYS-ORBICULARIS; DEVELOPMENTAL STABILITY; POPULATION-SIZE; GREAT-LAKES; BOTTLENECKED POPULATIONS; HATCHLING PHENOTYPE; HYDRIC CONDITIONS	Background: Phenotypic anomalies are common in wild populations and multiple genetic, biotic and abiotic factors might contribute to their formation. Turtles are excellent models for the study of developmental instability because anomalies are easily detected in the form of malformations, additions, or reductions in the number of scutes or scales. Methodology/Principal Findings: In this study, we integrated field observations, manipulative experiments, and climatic and genetic approaches to investigate the origin of carapace scute anomalies across Iberian populations of the European pond turtle, Emys orbicularis. The proportion of anomalous individuals varied from 3% to 69% in local populations, with increasing frequency of anomalies in northern regions. We found no significant effect of climatic and soil moisture, or climatic temperature on the occurrence of anomalies. However, lower genetic diversity and inbreeding were good predictors of the prevalence of scute anomalies among populations. Both decreasing genetic diversity and increasing proportion of anomalous individuals in northern parts of the Iberian distribution may be linked to recolonization events from the Southern Pleistocene refugium. Conclusions/Significance: Overall, our results suggest that developmental instability in turtle carapace formation might be caused, at least in part, by genetic factors, although the influence of environmental factors affecting the developmental stability of turtle carapace cannot be ruled out. Further studies of the effects of environmental factors, pollutants and heritability of anomalies would be useful to better understand the complex origin of anomalies in natural populations.	[Velo-Anton, Guillermo; Becker, Carlos G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Velo-Anton, Guillermo; Cordero-Rivera, Adolfo] Univ Vigo, EUE Forestal, Grp Ecoloxia Evolut & Conservac, Dept Ecoloxia & Bioloxia Anim, Pontevedra, Spain	Cornell University; Universidade de Vigo	Velo-Anton, G (corresponding author), Univ Porto, Inst Ciencias Agr Vairao, CIBIO Ctr Invest Biodiversidade & Recursos Genet, R Padre Armando Quintas, Vairao, Portugal.	gv47@cornell.edu	Cordero-Rivera, Adolfo/K-4182-2014; Becker, C. Guilherme/B-9887-2014; Antón, Guillermo Velo/I-7694-2013	Cordero-Rivera, Adolfo/0000-0002-5087-3550; Antón, Guillermo Velo/0000-0002-9483-5695	Galician Government (Conselleria de Innovacion, Industria e Comercio, Xunta de Galicia); Spanish Ministerio de Ciencia e Innovacion [2008-0890]; Xunta de Galicia [PGIDT01MAM37101PR, PGIDIT05RFO37101PR]; Catedra Filgueira Valverde-Universidade de Vigo	Galician Government (Conselleria de Innovacion, Industria e Comercio, Xunta de Galicia)(Xunta de Galicia); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Catedra Filgueira Valverde-Universidade de Vigo	GV-A was supported by a grant from Galician Government (Conselleria de Innovacion, Industria e Comercio, Xunta de Galicia) and a postdoctoral fellowship from the Spanish Ministerio de Ciencia e Innovacion (Ref: 2008-0890). Funding was provided by research grants from Xunta de Galicia (PGIDT01MAM37101PR, PGIDIT05RFO37101PR) and Catedra Filgueira Valverde-Universidade de Vigo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; AVISE JC, 1992, MOL BIOL EVOL, V9, P457; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bishop CA, 1998, ENVIRON POLLUT, V101, P143, DOI 10.1016/S0269-7491(98)00005-0; BISHOP CA, 1991, J TOXICOL ENV HEALTH, V33, P521, DOI 10.1080/15287399109531539; BISHOP CA, 1994, ARCH ENVIRON CON TOX, V27, P82, DOI 10.1007/BF00203891; Booth DT, 2002, J COMP PHYSIOL B, V172, P627, DOI 10.1007/s00360-002-0291-y; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cunningham J, 2002, CONSERV GENET, V3, P215, DOI 10.1023/A:1019909515202; Delmas V, 2008, PHYSIOL BIOCHEM ZOOL, V81, P345, DOI 10.1086/529459; Diaz-Paniagua C, 2003, AMPHIBIA-REPTILIA, V24, P429, DOI 10.1163/156853803322763891; DINERSTEIN E, 1990, CONSERV BIOL, V4, P417, DOI 10.1111/j.1523-1739.1990.tb00316.x; *ESRI, 2008, ARCV 9 3; Fernandez CA, 2004, BIOLOGIA, V59, P85; FOX W, 1948, COPEIA, P252; Fritz U, 2006, ZOOL SCR, V35, P97, DOI 10.1111/j.1463-6409.2005.00218.x; FRITZ U, 2001, HDB REPTILIEN AMPHIB, V3, P343; Fritz U, 2007, AMPHIBIA-REPTILIA, V28, P418, DOI 10.1163/156853807781374737; Frye F.L., 1991, BIOMEDICAL SURG ASPE; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gautschi B, 2002, CONSERV GENET, V3, P235, DOI 10.1023/A:1019924514465; GILBERTSON M, 1991, J TOXICOL ENV HEALTH, V33, P455, DOI 10.1080/15287399109531538; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hartl GB, 1995, PHILOS T R SOC B, V350, P313, DOI 10.1098/rstb.1995.0167; HARTL GB, 1994, BIODIVERS CONSERV, V3, P546, DOI 10.1007/BF00115160; Hauswaldt JS, 2005, MOL ECOL, V14, P723, DOI 10.1111/j.1365-294X.2005.02451.x; HEDRICK PW, 1986, EVOLUTION, V40, P856, DOI 10.1111/j.1558-5646.1986.tb00545.x; Herlands Rosalind, 2004, P13; Hewavisenthi S, 2001, COPEIA, P668, DOI 10.1643/0045-8511(2001)001[0668:IOIEOT]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Janzen FJ, 1995, FUNCT ECOL, V9, P913, DOI 10.2307/2389990; JUDGE D, 2001, THESIS U CANBERRA AU; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karvonen E, 2003, OIKOS, V100, P507, DOI 10.1034/j.1600-0706.2003.11851.x; Kazmaier Richard T., 2001, Transactions of the Kansas Academy of Science, V104, P178, DOI 10.1660/0022-8443(2001)104[0178:SAOOBT]2.0.CO;2; Keller C., 2002, ATLAS LIBRO ROJO ANF, P181; Keller C., 1997, THESIS U SEVILLA; Kennett R, 1998, CAN J ZOOL, V76, P1019, DOI 10.1139/cjz-76-6-1019; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Laikre L, 1999, ZOO BIOL, V18, P81, DOI 10.1002/(SICI)1098-2361(1999)18:2&lt;81::AID-ZOO1&gt;3.0.CO;2-2; LEARY RF, 1984, AM NAT, V124, P540, DOI 10.1086/284293; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; LYNN WG, 1950, COPEIA, P253, DOI 10.2307/1437903; MAC MJ, 1991, J TOXICOL ENV HEALTH, V33, P375, DOI 10.1080/15287399109531536; McDaniel TV, 2004, ARCH ENVIRON CON TOX, V47, P101, DOI 10.1007/s00244-004-3015-3; MCGEHEE MA, 1990, HERPETOLOGICA, V46, P251; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; Olsson M, 1996, J EVOLUTION BIOL, V9, P229, DOI 10.1046/j.1420-9101.1996.9020229.x; PACKARD GC, 1987, ECOLOGY, V68, P983, DOI 10.2307/1938369; PACKARD GC, 1988, BIOL REPTILIA, P524; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Raikkonen J, 2009, BIOL CONSERV, V142, P1025, DOI 10.1016/j.biocon.2009.01.014; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rivera AC, 2004, BIOLOGIA, V59, P161; RIVERA AC, 2008, REV ESP HERP, V22, P5; Salvador A., 2002, REPTILES ESPANOLES I; SCHWANER TD, 1990, COPEIA, P1168, DOI 10.2307/1446508; SEGURADO P, 2005, MANOURIA, V29, P19; Segurado P, 2007, ACTA OECOL, V32, P134, DOI 10.1016/j.actao.2007.03.015; Sokal, 2000, BIOMETRY PRINCIPLES; SOULE ME, 1979, EVOLUTION, V33, P396, DOI 10.1111/j.1558-5646.1979.tb04693.x; Swaddle, 1997, ASYMMETRY DEVELOPMEN; Tschirren B, 2010, MOL ECOL, V19, P624, DOI 10.1111/j.1365-294X.2009.04519.x; Tull JC, 2007, J WILDLIFE MANAGE, V71, P1944, DOI 10.2193/2006-397; Velo-Anton G, 2008, CONSERV GENET, V9, P1263, DOI 10.1007/s10592-007-9457-1; Velo-Anton G, 2007, AMPHIBIA-REPTILIA, V28, P475, DOI 10.1163/156853807782152589; White TA, 2008, J EVOLUTION BIOL, V21, P636, DOI 10.1111/j.1420-9101.2007.01481.x; Williams RN, 2008, BIOL LETTERS, V4, P549, DOI 10.1098/rsbl.2008.0233; Wright AN, 2002, J HERPETOL, V36, P129, DOI 10.2307/1565818; Zachos FE, 2007, HEREDITY, V98, P392, DOI 10.1038/sj.hdy.6800954; ZANGERL RAINER, 1957, FIELDIANA GEOL, V10, P341	78	47	53	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18714	10.1371/journal.pone.0018714	http://dx.doi.org/10.1371/journal.pone.0018714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533278	gold, Green Published, Green Submitted			2022-12-25	WOS:000289404700029
J	Than, TA; Lou, H; Ji, C; Win, S; Kaplowitz, N				Than, Tin Aung; Lou, Huan; Ji, Cheng; Win, Sanda; Kaplowitz, Neil			Role of cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 3 (CRTC3) in the Initiation of Mitochondrial Biogenesis and Stress Response in Liver Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LONG TERMINAL REPEAT; SKELETAL-MUSCLE; KEY REGULATOR; HEPG2 CELLS; PGC-1-ALPHA; ROTENONE; ACTIVATION; MECHANISMS; GLUCOSE	Peroxisome proliferator-activated receptor alpha, coactivator 1 alpha (PGC-1 alpha) is the master regulator of mitochondrial biogenesis. PGC-1 alpha expression is under the control of the transcription factor, cAMP-responsive element-binding protein (CREB). In searching for candidate transcription factors that mediate mitochondrial stress-initiated mitochondria-to-nucleus signaling in the regulation of mitochondrial biogenesis, we assessed the effect of silencing CREB-regulated transcription co-activators (CRTC). CRTC isoforms are co-activators of CREB-regulated transcription by a CREB phosphorylation-independent pathway. Using cultured HepG2 cells and primary mouse hepatocytes, we determined that mitochondrial stress imposed by the complex I inhibitor rotenone elicited mitochondrial biogenesis, which was dependent on an induction of PGC-1 alpha, which was inhibited by silencing PGC-1 alpha. PGC-1 alpha induction in response to rotenone was inhibited by silencing the expression of CRTC3, which blocked downstream mitochondria biogenesis. In contrast, silencing CRTC2 did not affect the induction of this pathway in response to rotenone. Thus, CRTC3 plays a selective role in mitochondrial biogenesis in response to rotenone.	Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, So Calif Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Kaplowitz, N (corresponding author), Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			National Institutes of Health [R21 AA017746, R01 DK067215, R01 AA014428]; National Institutes of Health Training [T32 AA07578]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215, P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014428, R21AA017746, R01AA018612, R01AA018846, T32AA007578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AA017746, R01 DK067215, and R01 AA014428 ( to N. K.) and National Institutes of Health Training Grant T32 AA07578.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Cederbaum A, 2009, EXPERT OPIN DRUG MET, V5, P1223, DOI 10.1517/17425250903143769; Chen S, 2008, FEBS LETT, V582, P603, DOI 10.1016/j.febslet.2008.01.028; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P1792, DOI 10.1016/j.biocel.2008.01.012; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Gill MB, 2009, J NEUROSCI RES, V87, P2047, DOI 10.1002/jnr.22019; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hishiki T, 2007, J BIOL CHEM, V282, P28335, DOI 10.1074/jbc.M702656200; Horibe T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000835; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; Ji C, 2008, J GASTROEN HEPATOL, V23, pS16, DOI 10.1111/j.1440-1746.2007.05276.x; Ji C, 2007, HEPATOLOGY, V46, P1586, DOI 10.1002/hep.21854; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kaplowitz N, 2006, J GASTROEN HEPATOL, V21, pS7, DOI 10.1111/j.1440-1746.2006.04581.x; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koga H, 2004, J BIOL CHEM, V279, P52978, DOI 10.1074/jbc.M409021200; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KUO SC, 1974, BIOCHEM BIOPH RES CO, V58, P287, DOI 10.1016/0006-291X(74)90925-5; Kyriakakis E, 2010, CELL SIGNAL, V22, P1308, DOI 10.1016/j.cellsig.2010.04.008; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Lund KC, 2007, ANTIMICROB AGENTS CH, V51, P2531, DOI 10.1128/AAC.00039-07; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Plock J, 2007, J HEPATOL, V47, P538, DOI 10.1016/j.jhep.2007.04.016; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SINGER TP, 1994, BBA-BIOENERGETICS, V1187, P198, DOI 10.1016/0005-2728(94)90110-4; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	55	49	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22047	22054		10.1074/jbc.M111.240481	http://dx.doi.org/10.1074/jbc.M111.240481			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21536665	Green Published, hybrid			2022-12-25	WOS:000291719900011
J	Aquino, RS; Grativol, C; Mourao, PAS				Aquino, Rafael S.; Grativol, Clicia; Mourao, Paulo A. S.			Rising from the Sea: Correlations between Sulfated Polysaccharides and Salinity in Plants	PLOS ONE			English	Article							ANTICOAGULANT ACTIVITY; GREEN-ALGA; SALT; TOLERANCE; STRESS	High salinity soils inhibit crop production worldwide and represent a serious agricultural problem. To meet our ever-increasing demand for food, it is essential to understand and engineer salt-resistant crops. In this study, we evaluated the occurrence and function of sulfated polysaccharides in plants. Although ubiquitously present in marine algae, the presence of sulfated polysaccharides among the species tested was restricted to halophytes, suggesting a possible correlation with salt stress or resistance. To test this hypothesis, sulfated polysaccharides from plants artificially and naturally exposed to different salinities were analyzed. Our results revealed that the sulfated polysaccharide concentration, as well as the degree to which these compounds were sulfated in halophytic species, were positively correlated with salinity. We found that sulfated polysaccharides produced by Ruppia maritima Loisel disappeared when the plant was cultivated in the absence of salt. However, subjecting the glycophyte Oryza sativa Linnaeus to salt stress did not induce the biosynthesis of sulfated polysaccharides but increased the concentration of the carboxylated polysaccharides; this finding suggests that negatively charged cell wall polysaccharides might play a role in coping with salt stress. These data suggest that the presence of sulfated polysaccharides in plants is an adaptation to high salt environments, which may have been conserved during plant evolution from marine green algae. Our results address a practical biological concept; additionally, we suggest future strategies that may be beneficial when engineering salt-resistant crops.	[Aquino, Rafael S.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Tecido Conjunt, Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Aquino, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Tecido Conjunt, Rio De Janeiro, Brazil.	rafael.aquino@childrens.harvard.edu	Mourao, Paulo/AAA-5386-2020	Grativol, Clicia/0000-0002-8873-701X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino RS, 2005, GLYCOBIOLOGY, V15, P11, DOI 10.1093/glycob/cwh138; Arad S, 2010, CURR OPIN BIOTECH, V21, P358, DOI 10.1016/j.copbio.2010.02.008; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Chevolot L, 1999, CARBOHYD RES, V319, P154, DOI 10.1016/S0008-6215(99)00127-5; DISCHE Z, 1947, J BIOL CHEM, V167, P189; Donnan FG, 1924, CHEM REV, V1, P73, DOI 10.1021/cr60001a003; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FAO, 2008, LAND PLANT NUTR MAN; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Gimmler H, 2000, J EXP BOT, V51, P1171, DOI 10.1093/jexbot/51.348.1171; Gould S. J., 1994, HENS TEETH HORSES TO; Hope AB, 1975, PHYSL GIANT ALGAL CE; KANTRUD HA, 1991, HABITAT WIGEONGRASS; KIRCHER HW, 1960, ANAL CHEM, V53, P1212; La Peyre MK, 2003, AQUAT BOT, V77, P235, DOI 10.1016/S0304-3770(03)00109-8; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Matsubara K, 2000, COMP BIOCHEM PHYS B, V125, P137, DOI 10.1016/S0305-0491(99)00161-3; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pereira MG, 2005, CARBOHYD RES, V340, P2015, DOI 10.1016/j.carres.2005.05.018; SAITO H, 1968, J BIOL CHEM, V243, P1536; UEHARA T, 1992, CARBOHYD RES, V235, P309, DOI 10.1016/0008-6215(92)80100-F; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Yamaguchi T, 2005, TRENDS PLANT SCI, V10, P615, DOI 10.1016/j.tplants.2005.10.002	26	88	91	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18862	10.1371/journal.pone.0018862	http://dx.doi.org/10.1371/journal.pone.0018862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552557	Green Submitted, Green Published, gold			2022-12-25	WOS:000290020700006
J	Jackson, GD				Jackson, George D.			The Development of the Pacific Ocean Shelf Tracking Project within the Decade Long Census of Marine Life	PLOS ONE			English	Editorial Material							MIGRATORY BEHAVIOR; SALMON; PHYSIOLOGY; TELEMETRY; SMOLTS; RIVER; SURVIVAL; POST		Weimar Coll, Dept Hlth Sci, Weimar, CA USA		Jackson, GD (corresponding author), Weimar Coll, Dept Hlth Sci, Weimar, CA USA.	gjackson@weimar.edu	Jackson, George D/AAI-7315-2021					Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Cooke SJ, 2008, FISHERIES, V33, P321, DOI 10.1577/1548-8446-33.7.321; Costa DP, 2010, P OCEANOBS, V9, P21; Dor R, 2010, P OC 09 SUST OC OBS, V1, P21; Greene CH, 2009, OCEANOGRAPHY, V22, P210, DOI 10.5670/oceanog.2009.21; Keefer ML, 2008, J FISH BIOL, V72, P27, DOI 10.1111/j.1095-8649.2007.01652.x; Lacroix GL, 1996, J FISH BIOL, V49, P1086; Lindley ST, 2008, T AM FISH SOC, V137, P182, DOI 10.1577/T07-055.1; McIntyre AD, 2010, LIFE WORLDS IN PRESS; Schaefer KM, 2007, MAR BIOL, V152, P503, DOI 10.1007/s00227-007-0689-x; Voegeli FA, 2001, ENVIRON BIOL FISH, V60, P267, DOI 10.1023/A:1007682304720; Voegeli FA, 1998, HYDROBIOLOGIA, V372, P35, DOI 10.1023/A:1017014903313; Welch DW, 2008, PLOS BIOL, V6, P2101, DOI 10.1371/journal.pbio.0060265; Welch DW, 2009, CAN J FISH AQUAT SCI, V66, P736, DOI 10.1139/F09-032; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Yarincik K, 2005, SCI MAR, V69, P201, DOI 10.3989/scimar.2005.69s1201	20	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2011	6	4							e18999	10.1371/journal.pone.0018999	http://dx.doi.org/10.1371/journal.pone.0018999			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NX	21552567	Green Published, Green Submitted, gold			2022-12-25	WOS:000290020700011
J	Babu, M; Aoki, H; Chowdhury, WQ; Gagarinova, A; Graham, C; Phanse, S; Laliberte, B; Sunba, N; Jessulat, M; Golshani, A; Emili, A; Greenblatt, JF; Ganoza, MC				Babu, Mohan; Aoki, Hiroyuki; Chowdhury, Wasimul Q.; Gagarinova, Alla; Graham, Chris; Phanse, Sadhna; Laliberte, Ben; Sunba, Noor; Jessulat, Matthew; Golshani, Ashkan; Emili, Andrew; Greenblatt, Jack F.; Ganoza, M. Clelia			Ribosome-Dependent ATPase Interacts with Conserved Membrane Protein in Escherichia coli to Modulate Protein Synthesis and Oxidative Phosphorylation	PLOS ONE			English	Article							ELONGATION-FACTOR G; CELL-DIVISION; UBIQUINONE OXIDOREDUCTASE; MESSENGER-RNA; BINDING-SITE; MIND PROTEIN; PROTON PUMP; COMPLEX-I; MECHANISM; TRANSLOCATION	Elongation factor RbbA is required for ATP-dependent deacyl-tRNA release presumably after each peptide bond formation; however, there is no information about the cellular role. Proteomic analysis in Escherichia coli revealed that RbbA reciprocally co-purified with a conserved inner membrane protein of unknown function, YhjD. Both proteins are also physically associated with the 30S ribosome and with members of the lipopolysaccharide transport machinery. Genome-wide genetic screens of rbbA and yhjD deletion mutants revealed aggravating genetic interactions with mutants deficient in the electron transport chain. Cells lacking both rbbA and yhjD exhibited reduced cell division, respiration and global protein synthesis as well as increased sensitivity to antibiotics targeting the ETC and the accuracy of protein synthesis. Our results suggest that RbbA appears to function together with YhjD as part of a regulatory network that impacts bacterial oxidative phosphorylation and translation efficiency.	[Babu, Mohan; Aoki, Hiroyuki; Chowdhury, Wasimul Q.; Gagarinova, Alla; Graham, Chris; Phanse, Sadhna; Emili, Andrew; Greenblatt, Jack F.; Ganoza, M. Clelia] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Gagarinova, Alla; Emili, Andrew; Greenblatt, Jack F.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Laliberte, Ben; Sunba, Noor; Jessulat, Matthew; Golshani, Ashkan] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Laliberte, Ben; Sunba, Noor; Jessulat, Matthew; Golshani, Ashkan] Carleton Univ, Ottawa Inst Syst Biol, Ottawa, ON K1S 5B6, Canada	University of Toronto; University of Toronto; Carleton University; Carleton University; University of Ottawa	Babu, M (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada.	m.ganoza@utoronto.ca	Mohan, Babu P./I-7362-2019	GANOZA MELGAREJO, MICHAEL RICHARD/0000-0003-0196-8104; Phanse, Sadhna/0000-0001-6306-0551	Canadian Institutes of Health Research (CIHR) [82852]; Natural Sciences and Engineering Council of Canada; Vanier Canada Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Canada Graduate Scholarship	This work was supported by a Canadian Institutes of Health Research (CIHR) grant (82852) to J.F.G. and A. E., as well as by the J.P. Bickell to M. C. G. and Natural Sciences and Engineering Council of Canada to A. G. (Ashkan Golshani, Ottawa) and M. C. G. AG (Alla Gagarinova, Toronto) is a recipient of Vanier Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Anokhina MM, 2004, NUCLEIC ACIDS RES, V32, P2594, DOI 10.1093/nar/gkh583; Asato Y, 2005, CURR ISSUES MOL BIOL, V7, P109; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu Mohan, 2009, Methods Mol Biol, V564, P373, DOI 10.1007/978-1-60761-157-8_22; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; COX GB, 1970, BIOCHEM J, V117, P551, DOI 10.1042/bj1170551; CROOKE E, 1992, J BIOL CHEM, V267, P16779; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Diaz-Mejia JJ, 2009, FEMS MICROBIOL REV, V33, P66, DOI 10.1111/j.1574-6976.2008.00141.x; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; FRIEDRICH T, 1994, EUR J BIOCHEM, V219, P691, DOI 10.1111/j.1432-1033.1994.tb19985.x; Ganoza MC, 2002, MICROBIOL MOL BIOL R, V66, P460, DOI 10.1128/MMBR.66.3.460-485.2002; GANOZA MC, 1995, J BIOL CHEM, V270, P26377, DOI 10.1074/jbc.270.44.26377; Ganoza MC, 2001, ANTIMICROB AGENTS CH, V45, P2813, DOI 10.1128/AAC.45.10.2813-2819.2001; Girgis HS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005629; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hirokawa G, 2008, NUCLEIC ACIDS RES, V36, P6676, DOI 10.1093/nar/gkn647; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Jaffe A, 1997, J BACTERIOL, V179, P3494, DOI 10.1128/jb.179.11.3494-3499.1997; Jewett MC, 2009, J BACTERIOL, V191, P1083, DOI 10.1128/JB.00852-08; Jiang M, 2007, J BACTERIOL, V189, P3434, DOI 10.1128/JB.00090-07; Johnson JE, 2002, J BACTERIOL, V184, P2951, DOI 10.1128/JB.184.11.2951-2962.2002; JONES NC, 1973, NATURE-NEW BIOL, V243, P100; Karcher A, 2008, J BIOL CHEM, V283, P7962, DOI 10.1074/jbc.M707347200; Kiel MC, 2001, EUR J BIOCHEM, V268, P278, DOI 10.1046/j.1432-1327.2001.01873.x; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KRULWICH TA, 1990, MICROBIOL REV, V54, P52, DOI 10.1128/MMBR.54.1.52-65.1990; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Marcussen M, 1996, CELL MOTIL CYTOSKEL, V35, P94, DOI 10.1002/(SICI)1097-0169(1996)35:2<94::AID-CM2>3.0.CO;2-I; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Muller M, 2001, PROG NUCLEIC ACID RE, V66, P107; Musser SM, 1998, J MOL EVOL, V46, P508, DOI 10.1007/PL00006332; Norris V, 2004, FEBS LETT, V561, P3, DOI 10.1016/S0014-5793(04)00135-8; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; RESNICK M, 1985, CURR MICROBIOL, V12, P183, DOI 10.1007/BF01573328; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Shoji S, 2009, ACS CHEM BIOL, V4, P93, DOI 10.1021/cb8002946; Southworth DR, 2002, J MOL BIOL, V324, P611, DOI 10.1016/S0022-2836(02)01196-8; Stolpe S, 2004, J BIOL CHEM, V279, P18377, DOI 10.1074/jbc.M311242200; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Thompson J, 2002, J MOL BIOL, V322, P273, DOI 10.1016/S0022-2836(02)00784-2; Thomsen ND, 2008, MOL MICROBIOL, V69, P1071, DOI 10.1111/j.1365-2958.2008.06364.x; Tran AX, 2008, J BIOL CHEM, V283, P20342, DOI 10.1074/jbc.M802503200; van Dalen A, 2000, EMBO REP, V1, P340, DOI 10.1093/embo-reports/kvd067; Xu J, 2006, NUCLEIC ACIDS RES, V34, P1158, DOI 10.1093/nar/gkj508; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	55	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18510	10.1371/journal.pone.0018510	http://dx.doi.org/10.1371/journal.pone.0018510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556145	Green Submitted, gold, Green Published			2022-12-25	WOS:000290019400006
J	Hill, PW; Quilliam, RS; DeLuca, TH; Farrar, J; Farrell, M; Roberts, P; Newsham, KK; Hopkins, DW; Bardgett, RD; Jones, DL				Hill, Paul W.; Quilliam, Richard S.; DeLuca, Thomas H.; Farrar, John; Farrell, Mark; Roberts, Paula; Newsham, Kevin K.; Hopkins, David W.; Bardgett, Richard D.; Jones, David L.			Acquisition and Assimilation of Nitrogen as Peptide-Bound and D-Enantiomers of Amino Acids by Wheat	PLOS ONE			English	Article							ALANYL-D-ALANINE; ORGANIC NITROGEN; SOIL; PLANTS; ARABIDOPSIS; GROWTH; MINERALIZATION; TRANSPORTERS	Nitrogen is a key regulator of primary productivity in many terrestrial ecosystems. Historically, only inorganic N (NH4+ and NO3-) and L-amino acids have been considered to be important to the N nutrition of terrestrial plants. However, amino acids are also present in soil as small peptides and in D-enantiomeric form. We compared the uptake and assimilation of N as free amino acid and short homopeptide in both L- and D-enantiomeric forms. Sterile roots of wheat (Triticum aestivum L.) plants were exposed to solutions containing either C-14-labelled L-alanine, D-alanine, L-trialanine or D-trialanine at a concentration likely to be found in soil solution (10 mu M). Over 5 h, plants took up L-alanine, D-alanine and L-trialanine at rates of 0.9+/-0.3, 0.3+/-0.06 and 0.3+/-0.04 mu mol g(-1) root DW h(-1), respectively. The rate of N uptake as L-trialanine was the same as that as L-alanine. Plants lost ca.60% of amino acid C taken up in respiration, regardless of the enantiomeric form, but more (ca.80%) of the L-trialanine C than amino acid C was respired. When supplied in solutions of mixed N form, N uptake as D-alanine was ca.5-fold faster than as NO3-, but slower than as L-alanine, L-trialanine and NH4+. Plants showed a limited capacity to take up D-trialanine (0.04+/-0.03 mmol g(-1) root DW h(-1)), but did not appear to be able to metabolise it. We conclude that wheat is able to utilise L-peptide and D-amino acid N at rates comparable to those of N forms of acknowledged importance, namely L-amino acids and inorganic N. This is true even when solutes are supplied at realistic soil concentrations and when other forms of N are available. We suggest that it may be necessary to reconsider which forms of soil N are important in the terrestrial N cycle.	[Hill, Paul W.; Quilliam, Richard S.; DeLuca, Thomas H.; Farrar, John; Farrell, Mark; Roberts, Paula; Jones, David L.] Bangor Univ, Environm Ctr Wales, Bangor, Gwynedd, Wales; [Farrell, Mark; Bardgett, Richard D.] Univ Lancaster, Soil & Ecosyst Ecol Lab, Lancaster Environm Ctr, Lancaster, England; [Farrell, Mark] Commonwealth Sci & Ind Res Org Land & Water, Glen Osmond, SA, Australia; [Newsham, Kevin K.] British Antarctic Survey, Nat Environm Res Council, Ecosyst Programme, Cambridge CB3 0ET, England; [Hopkins, David W.] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland; [Hopkins, David W.] Univ Stirling, Sch Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Hopkins, David W.] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland	Bangor University; Lancaster University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; James Hutton Institute; University of Stirling; Heriot Watt University	Hill, PW (corresponding author), Bangor Univ, Environm Ctr Wales, Bangor, Gwynedd, Wales.	p.w.hill@bangor.ac.uk	Roberts, Paula/B-4564-2011; Jones, Davey/AAD-6037-2020; DeLuca, Thomas/GYU-3468-2022; Quilliam, Richard S/E-6920-2011; jones, davey/AAN-5606-2020; DeLuca, Thomas Henry/B-4547-2012; Farrell, Mark/C-3676-2011; Hill, Paul W/C-2944-2013; Jones, Davey L/C-7411-2011	Roberts, Paula/0000-0003-3742-1856; Jones, Davey/0000-0002-1482-4209; Quilliam, Richard S/0000-0001-7020-4410; DeLuca, Thomas Henry/0000-0003-1561-9597; Farrell, Mark/0000-0003-4562-2738; Jones, Davey L/0000-0002-1482-4209; Hopkins, David/0000-0003-0953-8643	UK Natural Environment Research Council [AFI 8/08]; Natural Environment Research Council [bas0100025, ceh010010, NE/E017304/1] Funding Source: researchfish; NERC [NE/E017304/1, bas0100025] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by UK Natural Environment Research Council grant AFI 8/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelung W, 2006, GEODERMA, V130, P207, DOI 10.1016/j.geoderma.2005.01.017; Amelung W, 2003, J PLANT NUTR SOIL SC, V166, P677, DOI 10.1002/jpln.200321274; [Anonymous], NITROGEN AGR SOILS A; BOLLARD EG, 1966, PLANT SOIL, V25, P153, DOI 10.1007/BF01347815; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; Erikson O, 2005, PLANT MOL BIOL, V57, P425, DOI 10.1007/s11103-004-7902-9; Farrell M, 2011, SOIL BIOL BIOCHEM, V43, P835, DOI 10.1016/j.soilbio.2010.12.022; Forsum O, 2008, NEW PHYTOL, V179, P1058, DOI 10.1111/j.1469-8137.2008.02546.x; FRAHN JL, 1975, PHYTOCHEMISTRY, V14, P1464, DOI 10.1016/S0031-9422(00)98674-6; GIESLER R, 1993, SOIL SCI SOC AM J, V57, P1283, DOI 10.2136/sssaj1993.03615995005700050020x; Gordes D, 2011, AMINO ACIDS, V40, P553, DOI 10.1007/s00726-010-0674-4; Hill PW, 2008, SOIL BIOL BIOCHEM, V40, P616, DOI 10.1016/j.soilbio.2007.09.008; Hill PW, 2011, NAT CLIM CHANGE, V1, P50, DOI [10.1038/nclimate1060, 10.1038/NCLIMATE1060]; Jan MT, 2009, SOIL BIOL BIOCHEM, V41, P2272, DOI 10.1016/j.soilbio.2009.08.013; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Jones DL, 2002, SOIL BIOL BIOCHEM, V34, P1893, DOI 10.1016/S0038-0717(02)00203-1; JONES DL, 1994, PLANT SOIL, V163, P1; Knicker H, 2000, SOIL BIOL BIOCHEM, V32, P241, DOI 10.1016/S0038-0717(99)00154-6; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; MANABE H, 1981, SOIL SCI PLANT NUTR, V27, P383, DOI 10.1080/00380768.1981.10431293; MANABE H, 1985, AGR BIOL CHEM TOKYO, V49, P1203, DOI 10.1080/00021369.1985.10866877; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mulvaney RL, 1996, METHODS SOIL ANAL, V3, P1123; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; O'Dowd RW, 1997, SOIL BIOL BIOCHEM, V29, P1665, DOI 10.1016/S0038-0717(97)00080-1; Ono K, 2006, PHYTOCHEMISTRY, V67, P856, DOI 10.1016/j.phytochem.2006.02.017; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Paungfoo-Lonhienne C, 2009, J EXP BOT, V60, P2665, DOI 10.1093/jxb/erp111; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; STEINER HY, 1994, PLANT CELL, V6, P1289, DOI 10.1105/tpc.6.9.1289; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Waterworth WM, 2006, ANN BOT-LONDON, V98, P1, DOI 10.1093/aob/mcl099; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2	34	97	100	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2011	6	4							e19220	10.1371/journal.pone.0019220	http://dx.doi.org/10.1371/journal.pone.0019220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NE	21541281	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000290018400034
J	Hawthorn, L; Cowell, JK				Hawthorn, Lesleyann; Cowell, John K.			Analysis of Wilms Tumors Using SNP Mapping Array-Based Comparative Genomic Hybridization	PLOS ONE			English	Article							CHILDHOOD RENAL TUMORS; WT1 GENE; CHILDRENS-CANCER; POOR-PROGNOSIS; HETEROZYGOSITY; ABNORMALITIES; 16Q; MUTATION; CHROMOSOME-11; EVENTS	Wilms tumor (WT) has been a model to study kidney embryogenesis and tumorigenesis and, although associated with hereditary, cancer predisposition syndromes, the majority of tumors occur sporadically. To analyze genetic changes in WT we have defined copy number changes and loss of heterozygosity in 56 Wilms tumors using high resolution oligonucleotide arrays at a average resolution of similar to 12 Kb. Consistent deletions were seen on chromosomes 1p, 4q, 7p, 9q, 11p, 11q, 14q, 16q, and 21q. High frequency gains were seen for 1q and lower frequency gains were seen on 7q and chromosomes 8, 12 and 18. The high resolution provided by the SNP mapping arrays has defined minimal regions of deletion for many of these LOH events. Analysis of CNAs by tumor stage show relatively stable karyotypes in stage 1 tumors and more complex aCGH profiles in tumors from stages 3-5.	[Hawthorn, Lesleyann; Cowell, John K.] Med Coll Georgia, Sch Med, MCG Canc Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Hawthorn, L (corresponding author), Med Coll Georgia, Sch Med, MCG Canc Ctr, Augusta, GA 30912 USA.	lhawthorn@mcg.edu		Cowell, John/0000-0002-2079-5950; Hawthorn, Lesleyann/0000-0001-8179-0937	Medical College of Georgia	Medical College of Georgia	Funds were derived from the Medical College of Georgia start-up packages to the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, CNAT 4 0 COP NUMB LO; *AFF, APT COP PIP; Affymetrix, BRLMM IMPR GEN CALL; BAIRD PN, 1992, ONCOGENE, V7, P2141; BARDEESY N, 1994, NAT GENET, V7, P91, DOI 10.1038/ng0594-91; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; BECKWITH J B, 1969, Birth Defects Original Article Series, V5, P188; Bown N, 2002, MED PEDIATR ONCOL, V38, P11, DOI 10.1002/mpo.1258; Breslow NE, 1996, MED PEDIATR ONCOL, V27, P398; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COPPES MJ, 1989, J CLIN ONCOL, V7, P310, DOI 10.1200/JCO.1989.7.3.310; COWELL JK, 1991, ONCOGENE, V6, P595; Cowell JK, 2003, ADV CANCER RES, V90, P91, DOI 10.1016/S0065-230X(03)90003-0; Cowell JK, 2007, CURR MOL MED, V7, P103, DOI 10.2174/156652407779940387; Cowell JK, 2009, METHODS MOL BIOL, V556, P47, DOI 10.1007/978-1-60327-192-9_5; DENYS P, 1967, ARCH FR PEDIATR, V24, P729; DRASH A, 1970, J PEDIATR-US, V76, P585, DOI 10.1016/S0022-3476(70)80409-7; Gardina PJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-489; GESSLER M, 1994, HUM MUTAT, V3, P212, DOI 10.1002/humu.1380030307; Getman ME, 1998, CYTOGENET CELL GENET, V82, P284, DOI 10.1159/000015120; GRUNDY PE, 1994, CANCER RES, V54, P2331; Grundy PE, 2005, J CLIN ONCOL, V23, P7312, DOI 10.1200/JCO.2005.01.2799; GRUNDY RG, 1992, EUR J PEDIATR, V151, P895, DOI 10.1007/BF01954125; Grundy RG, 1998, BRIT J CANCER, V78, P1181, DOI 10.1038/bjc.1998.651; Grundy RG, 1998, ONCOGENE, V17, P395, DOI 10.1038/sj.onc.1201927; Grundy RG, 1998, INT J MOL MED, V1, P801; Hing S, 2001, AM J PATHOL, V158, P393, DOI 10.1016/S0002-9440(10)63982-X; KANEKO Y, 1991, CANCER RES, V51, P5937; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; Koesters R, 1999, CANCER RES, V59, P3880; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lo KC, 2008, GENE CHROMOSOME CANC, V47, P221, DOI 10.1002/gcc.20524; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MANNENS M, 1994, EUR J HUM GENET, V41, P1; MAW MA, 1992, CANCER RES, V52, P3094; McDonald JM, 1998, CANCER RES, V58, P1387; Messahel B, 2009, EUR J CANCER, V45, P819, DOI 10.1016/j.ejca.2009.01.005; NARAHARA K, 1984, HUM GENET, V66, P181, DOI 10.1007/BF00286597; Natrajan R, 2007, J PATHOL, V211, P52, DOI 10.1002/path.2087; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Rahman N, 1996, NAT GENET, V13, P461, DOI 10.1038/ng0896-461; RICCARDI VM, 1978, PEDIATRICS, V61, P604; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Ruteshouser EC, 2005, GENE CHROMOSOME CANC, V43, P172, DOI 10.1002/gcc.20169; Safford SD, 2003, ANN SURG ONCOL, V10, P136, DOI 10.1245/ASO.2003.03.038; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Shankar G, 2006, CANCER INFORM, V2, P36; SLATER RM, 1992, CANCER GENET CYTOGEN, V61, P111, DOI 10.1016/0165-4608(92)90071-F; SOLIS V, 1988, CANCER GENET CYTOGEN, V34, P223, DOI 10.1016/0165-4608(88)90264-6; Sossey-Alaoui K, 2003, GENE CHROMOSOME CANC, V36, P1, DOI 10.1002/gcc.10133; STILLER CA, 1990, BRIT J CANCER, V62, P1026, DOI 10.1038/bjc.1990.432; WADEY RB, 1990, ONCOGENE, V5, P901; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223; Williams RD, 2010, CLIN CANCER RES, V16, P2036, DOI 10.1158/1078-0432.CCR-09-2890; Wittmann S, 2007, GENE CHROMOSOME CANC, V46, P163, DOI 10.1002/gcc.20397; Yeh A, 2002, GENE CHROMOSOME CANC, V35, P156, DOI 10.1002/gcc.10110; Yuan E, 2005, MOL CANCER RES, V3, P493, DOI 10.1158/1541-7786.MCR-05-0082	60	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e18941	10.1371/journal.pone.0018941	http://dx.doi.org/10.1371/journal.pone.0018941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544195	Green Published, gold, Green Submitted			2022-12-25	WOS:000290015800024
J	Ng, TFF; Duffy, S; Polston, JE; Bixby, E; Vallad, GE; Breitbart, M				Ng, Terry Fei Fan; Duffy, Siobain; Polston, Jane E.; Bixby, Elise; Vallad, Gary E.; Breitbart, Mya			Exploring the Diversity of Plant DNA Viruses and Their Satellites Using Vector-Enabled Metagenomics on Whiteflies	PLOS ONE			English	Article							LEAF-CURL-VIRUS; MOTTLE-VIRUS; TOMATO; GEMINIVIRUS; IDENTIFICATION; BEGOMOVIRUSES; DISEASE; ASSOCIATION; GENERATION; RESISTANCE	Current knowledge of plant virus diversity is biased towards agents of visible and economically important diseases. Less is known about viruses that have not caused major diseases in crops, or viruses from native vegetation, which are a reservoir of biodiversity that can contribute to viral emergence. Discovery of these plant viruses is hindered by the traditional approach of sampling individual symptomatic plants. Since many damaging plant viruses are transmitted by insect vectors, we have developed "vector-enabled metagenomics'' (VEM) to investigate the diversity of plant viruses. VEM involves sampling of insect vectors (in this case, whiteflies) from plants, followed by purification of viral particles and metagenomic sequencing. The VEM approach exploits the natural ability of highly mobile adult whiteflies to integrate viruses from many plants over time and space, and leverages the capability of metagenomics for discovering novel viruses. This study utilized VEM to describe the DNA viral community from whiteflies (Bemisia tabaci) collected from two important agricultural regions in Florida, USA. VEM successfully characterized the active and abundant viruses that produce disease symptoms in crops, as well as the less abundant viruses infecting adjacent native vegetation. PCR assays designed from the metagenomic sequences enabled the complete sequencing of four novel begomovirus genome components, as well as the first discovery of plant virus satellites in North America. One of the novel begomoviruses was subsequently identified in symptomatic Chenopodium ambrosiodes from the same field site, validating VEM as an effective method for proactive monitoring of plant viruses without a priori knowledge of the pathogens. This study demonstrates the power of VEM for describing the circulating viral community in a given region, which will enhance our understanding of plant viral diversity, and facilitate emerging plant virus surveillance and management of viral diseases.	[Ng, Terry Fei Fan; Bixby, Elise; Breitbart, Mya] Univ S Florida, Coll Marine Sci, Tampa, FL 33620 USA; [Duffy, Siobain] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Polston, Jane E.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Vallad, Gary E.] Univ Florida, Gulf Coast Res & Educ Ctr, Gainesville, FL USA	State University System of Florida; University of South Florida; Rutgers State University New Brunswick; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ng, TFF (corresponding author), Univ S Florida, Coll Marine Sci, Tampa, FL 33620 USA.	mya@marine.usf.edu	Breitbart, Mya/B-1366-2009; Ng, Terry Fei Fan/H-5305-2019; Duffy, Siobain/A-9104-2009	Breitbart, Mya/0000-0003-3210-2899; Ng, Terry Fei Fan/0000-0002-4815-8697; Duffy, Siobain/0000-0003-0753-223X	USDA; National Science Foundation [DEB-1025915]; Elsie Knight Oceanographic Fellowship; New Jersey Agricultural Experiment Station; Rutgers School of Environmental and Biological Sciences; Direct For Biological Sciences [1026095] Funding Source: National Science Foundation	USDA(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Elsie Knight Oceanographic Fellowship; New Jersey Agricultural Experiment Station; Rutgers School of Environmental and Biological Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded through the USDA - Tropical-Subtropical Agriculture Research (T-STAR) program and the National Science Foundation Biodiversity Inventories program (DEB-1025915). TFFN was supported by the Elsie Knight Oceanographic Fellowship. SD was supported by funds from the New Jersey Agricultural Experiment Station and Rutgers School of Environmental and Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUZID AM, 1992, J GEN VIROL, V73, P3225, DOI 10.1099/0022-1317-73-12-3225; Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Akad F, 2008, PLANT DIS, V92, P648, DOI 10.1094/PDIS-92-4-0648C; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Brown JK, 2000, VIRUS RES, V71, P233, DOI 10.1016/S0168-1702(00)00221-5; Byrne DN, 1996, OECOLOGIA, V105, P320, DOI 10.1007/BF00328734; Byrne DN, 1999, AGR FOREST METEOROL, V97, P309, DOI 10.1016/S0168-1923(99)00074-X; Caciagli P, 1997, PHYTOPATHOLOGY, V87, P610, DOI 10.1094/PHYTO.1997.87.6.610; Castillo-Urquiza GP, 2008, ARCH VIROL, V153, P1985, DOI 10.1007/s00705-008-0172-0; Chen LF, 2010, PLANT DIS, V94, P99, DOI 10.1094/PDIS-94-1-0099; COHEN S, 1990, WHITEFLIES : THEIR BIONOMICS, PEST STATUS AND MANAGEMENT, P211; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dry IB, 1997, P NATL ACAD SCI USA, V94, P7088, DOI 10.1073/pnas.94.13.7088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hernandez-Zepeda C, 2007, VIRUS GENES, V35, P825, DOI 10.1007/s11262-007-0149-1; Idris AM, 2007, PLANT DIS, V91, P910, DOI 10.1094/PDIS-91-7-0910C; Idris AM, 2003, PHYTOPATHOLOGY, V93, P774, DOI 10.1094/PHYTO.2003.93.7.774; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; Jovel J, 2004, ARCH VIROL, V149, P829, DOI 10.1007/s00705-003-0235-1; Lapidot M, 1997, PLANT DIS, V81, P1425, DOI 10.1094/PDIS.1997.81.12.1425; Lapidot M, 2001, PHYTOPATHOLOGY, V91, P1209, DOI 10.1094/PHYTO.2001.91.12.1209; Legg JP, 2004, PLANT MOL BIOL, V56, P585, DOI 10.1007/s11103-004-1651-7; Li DM, 2007, J GEN VIROL, V88, P2073, DOI 10.1099/vir.0.82853-0; Lopez MM, 2003, INT MICROBIOL, V6, P233, DOI 10.1007/s10123-003-0143-y; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Mansoor S, 2003, TRENDS PLANT SCI, V8, P128, DOI 10.1016/S1360-1385(03)00007-4; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Mayer, 1995, BEMISIA 1995 TAXONOM, P93; MCGOVERN RJ, 1994, PLANT DIS, V78, P1102, DOI [10.1094/PD-78-1102, 10.1094/PD-78-0831B]; Muthukumar V, 2009, VIRUS RES, V141, P169, DOI 10.1016/j.virusres.2008.06.016; Nawaz-Ul-Rehman MS, 2009, FEBS LETT, V583, P1825, DOI 10.1016/j.febslet.2009.05.045; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Paprotka T, 2010, VIROLOGY, V404, P148, DOI 10.1016/j.virol.2010.05.003; POLSTON JE, 1990, PHYTOPATHOLOGY, V80, P850, DOI 10.1094/Phyto-80-850; Polston JE, 1999, PLANT DIS, V83, P984, DOI 10.1094/PDIS.1999.83.4.397A; Polston JE, 1997, PLANT DIS, V81, P1358, DOI 10.1094/PDIS.1997.81.12.1358; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ribeiro SG, 2007, PHYTOPATHOLOGY, V97, P702, DOI 10.1094/PHYTO-97-6-0702; ROJAS MR, 1993, PLANT DIS, V77, P340, DOI 10.1094/PD-77-0340; Romay G, 2010, ARCH VIROL, V155, P1843, DOI 10.1007/s00705-010-0760-7; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; Salati R, 2002, PHYTOPATHOLOGY, V92, P487, DOI 10.1094/PHYTO.2002.92.5.487; Saunders K, 2000, P NATL ACAD SCI USA, V97, P6890, DOI 10.1073/pnas.97.12.6890; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Symonds EM, 2009, APPL ENVIRON MICROB, V75, P1402, DOI 10.1128/AEM.01899-08; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wren JD, 2006, PLOS BIOL, V4, P314, DOI 10.1371/journal.pbio.0040080; Zhou XP, 1997, J GEN VIROL, V78, P2101, DOI 10.1099/0022-1317-78-8-2101; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	65	76	79	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2011	6	4							e19050	10.1371/journal.pone.0019050	http://dx.doi.org/10.1371/journal.pone.0019050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MO	21544196	Green Submitted, gold, Green Published			2022-12-25	WOS:000290015800035
J	Nielsen, JS; Larsen, MH; Lillebaek, EMS; Bergholz, TM; Christiansen, MHG; Boor, KJ; Wiedmann, M; Kallipolitis, BH				Nielsen, Jesper S.; Larsen, Marianne Halberg; Lillebaek, Eva Maria Sternkopf; Bergholz, Teresa M.; Christiansen, Mie H. G.; Boor, Kathryn J.; Wiedmann, Martin; Kallipolitis, Birgitte H.			A Small RNA Controls Expression of the Chitinase ChiA in Listeria monocytogenes	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; MESSENGER-RNA; BACILLUS-SUBTILIS; VIBRIO-CHOLERAE; GENE-EXPRESSION; REGULATORY RNA; NONCODING RNA; PROTEIN HFQ; VIRULENCE; PROMOTERS	In recent years, more than 60 small RNAs (sRNAs) have been identified in the gram-positive human pathogen Listeria monocytogenes, but their putative roles and mechanisms of action remain largely unknown. The sRNA LhrA was recently shown to be a post-transcriptional regulator of a single gene, lmo0850, which encodes a small protein of unknown function. LhrA controls the translation and degradation of the lmo0850 mRNA by an antisense mechanism, and it depends on the RNA chaperone Hfq for efficient binding to its target. In the present study, we sought to gain more insight into the functional role of LhrA in L. monocytogenes. To this end, we determined the effects of LhrA on global-wide gene expression. We observed that nearly 300 genes in L. monocytogenes are either positively or negatively affected by LhrA. Among these genes, we identified lmo0302 and chiA as direct targets of LhrA, thus establishing LhrA as a multiple target regulator. Lmo0302 encodes a hypothetical protein with no known function, whereas chiA encodes one of two chitinases present in L. monocytogenes. We show here that LhrA acts as a post-transcriptional regulator of lmo0302 and chiA by interfering with ribosome recruitment, and we provide evidence that both LhrA and Hfq act to down-regulate the expression of lmo0302 and chiA. Furthermore, in vitro binding experiments show that Hfq stimulates the base pairing of LhrA to chiA mRNA. Finally, we demonstrate that LhrA has a negative effect on the chitinolytic activity of L. monocytogenes. In marked contrast to this, we found that Hfq has a stimulating effect on the chitinolytic activity, suggesting that Hfq plays multiple roles in the complex regulatory pathways controlling the chitinases of L. monocytogenes.	[Nielsen, Jesper S.; Lillebaek, Eva Maria Sternkopf; Christiansen, Mie H. G.; Kallipolitis, Birgitte H.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Larsen, Marianne Halberg] Univ Copenhagen, Dept Vet Dis Biol, Fac Life Sci, Frederiksberg, Denmark; [Bergholz, Teresa M.; Boor, Kathryn J.; Wiedmann, Martin] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	University of Southern Denmark; University of Copenhagen; Cornell University	Nielsen, JS (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	bhk@bmb.sdu.dk	Wiedmann, Martin/A-9683-2008; Bergholz, Teresa M./A-2815-2010; Boor, Kathryn/B-3545-2009	Wiedmann, Martin/0000-0002-4168-5662; Bergholz, Teresa M./0000-0002-3976-5858; Boor, Kathryn/0000-0001-6810-3434; Kallipolitis, Birgitte H./0000-0003-1233-9776; Larsen, Marianne Halberg/0000-0001-6242-6937	Danish Agency for Science Technology and Innovation; National Institutes of Health-National Institute of Allergy and Infectious Diseases [R01 AI052151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052151] Funding Source: NIH RePORTER	Danish Agency for Science Technology and Innovation; National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the Danish Agency for Science Technology and Innovation (to BHK) and National Institutes of Health-National Institute of Allergy and Infectious Diseases R01 AI052151 (to KJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Bhowmick R, 2008, INFECT IMMUN, V76, P4968, DOI 10.1128/IAI.01615-07; Caramori T, 1998, MOL GEN GENET, V258, P385, DOI 10.1007/s004380050745; Chaturongakul S, 2011, APPL ENVIRON MICROB, V77, P187, DOI 10.1128/AEM.00952-10; Chaudhuri S, 2010, APPL ENVIRON MICROB, V76, P7302, DOI 10.1128/AEM.01338-10; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Frohlich KS, 2009, CURR OPIN MICROBIOL, V12, P674, DOI 10.1016/j.mib.2009.09.009; Gorke B, 2008, GENE DEV, V22, P2914, DOI 10.1101/gad.1717808; Gottesman S., 2010, COLD SPRING HARB PER, DOI [10.1101/cshperspect.a003798, DOI 10.1101/CSHPERSPECT.A003798]; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Larsen MH, 2010, APPL ENVIRON MICROB, V76, P6470, DOI 10.1128/AEM.00297-10; Larsen MH, 2006, MOL MICROBIOL, V61, P1622, DOI 10.1111/j.1365-2958.2006.05328.x; Larsen T, 2011, GLYCOBIOLOGY, V21, P426, DOI 10.1093/glycob/cwq174; Lease RA, 1998, P NATL ACAD SCI USA, V95, P12456, DOI 10.1073/pnas.95.21.12456; Leisner JJ, 2008, APPL ENVIRON MICROB, V74, P3823, DOI 10.1128/AEM.02701-07; Leisner JJ, 2009, J APPL MICROBIOL, V107, P2080, DOI 10.1111/j.1365-2672.2009.04420.x; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Milner MG, 2001, MICROBIOL-SGM, V147, P2689, DOI 10.1099/00221287-147-10-2689; Nielsen JS, 2008, J BACTERIOL, V190, P6264, DOI 10.1128/JB.00740-08; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Obana N, 2010, MOL MICROBIOL, V77, P1416, DOI 10.1111/j.1365-2958.2010.07258.x; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Ollinger J, 2009, INFECT IMMUN, V77, P2113, DOI 10.1128/IAI.01205-08; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Ramirez-Pena E, 2010, MOL MICROBIOL, V78, P1332, DOI 10.1111/j.1365-2958.2010.07427.x; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	49	54	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e19019	10.1371/journal.pone.0019019	http://dx.doi.org/10.1371/journal.pone.0019019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533114	Green Published, gold			2022-12-25	WOS:000289620100033
J	Sims, JD; McCready, J; Jay, DG				Sims, Jessica D.; McCready, Jessica; Jay, Daniel G.			Extracellular Heat Shock Protein (Hsp) 70 and Hsp90 alpha Assist in Matrix Metalloproteinase-2 Activation and Breast Cancer Cell Migration and Invasion	PLOS ONE			English	Article							MOLECULAR CHAPERONE; METASTASIS; MOTILITY; ATP; COLLAGENASE; INVOLVEMENT; EXPRESSION; COMPLEX; ASSAYS	Breast cancer is second only to lung cancer in cancer-related deaths in women, and the majority of these deaths are caused by metastases. Obtaining a better understanding of migration and invasion, two early steps in metastasis, is critical for the development of treatments that inhibit breast cancer metastasis. In a functional proteomic screen for proteins required for invasion, extracellular heat shock protein 90 alpha (Hsp90 alpha) was identified and shown to activate matrix metalloproteinase 2 (MMP-2). The mechanism of MMP-2 activation by Hsp90a is unknown. Intracellular Hsp90a commonly functions with a complex of co- chaperones, leading to our hypothesis that Hsp90a functions similarly outside of the cell. In this study, we show that a complex of co- chaperones outside of breast cancer cells assists Hsp90a mediated activation of MMP-2. We demonstrate that the co- chaperones Hsp70, Hop, Hsp40, and p23 are present outside of breast cancer cells and co-immunoprecipitate with Hsp90 alpha in vitro and in breast cancer conditioned media. These co- chaperones also increase the association of Hsp90 alpha and MMP-2 in vitro. This co-chaperone complex enhances Hsp90 alpha-mediated activation of MMP-2 in vitro, while inhibition of Hsp70 in conditioned media reduces this activation and decreases cancer cell migration and invasion. Together, these findings support a model in which MMP-2 activation by an extracellular co- chaperone complex mediated by Hsp90 alpha increases breast cancer cell migration and invasion. Our studies provide insight into a novel pathway for MMP-2 activation and suggest Hsp70 as an additional extracellular target for anti-metastatic drug development.	[Sims, Jessica D.; Jay, Daniel G.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Dept Cellular & Mol Physiol, Boston, MA 02111 USA; [McCready, Jessica] Tufts Univ, Sch Med, Dept Anat & Cellular Biol, Sackler Sch Biomed Sci, Boston, MA 02111 USA	Tufts University; Tufts University	Sims, JD (corresponding author), Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Dept Cellular & Mol Physiol, Boston, MA 02111 USA.	Daniel.jay@tufts.edu			National Cancer Institute [CA116642]; NATIONAL CANCER INSTITUTE [R01CA116642] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded entirely by a grant from the National Cancer Institute CA116642. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bartsch JE, 2003, J SURG RES, V110, P383, DOI 10.1016/S0022-4804(03)00007-6; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Brooks SA, 2010, ACTA HISTOCHEM, V112, P3, DOI 10.1016/j.acthis.2008.11.022; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Chen JH, 2008, TOXICOL SCI, V106, P364, DOI 10.1093/toxsci/kfn195; CHEN JS, 2010, J BIOL CHEM; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Chung SW, 2009, BIOCHEM BIOPH RES CO, V378, P444, DOI 10.1016/j.bbrc.2008.11.063; Deli T, 2008, PATHOL ONCOL RES, V14, P219, DOI 10.1007/s12253-008-9071-7; Ernst MF, 2007, BREAST, V16, P344, DOI 10.1016/j.breast.2007.01.001; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Haas TL, 2005, CAN J PHYSIOL PHARM, V83, P1, DOI 10.1139/Y04-120; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jezierska A, 2009, MED SCI MONITOR, V15, pRA32; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kanelakis KC, 2000, BIOCHEMISTRY-US, V39, P14314, DOI 10.1021/bi001671c; Kosano H, 1998, J BIOL CHEM, V273, P32973, DOI 10.1074/jbc.273.49.32973; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Loftus JP, 2006, VET IMMUNOL IMMUNOP, V113, P267, DOI 10.1016/j.vetimm.2006.05.010; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; McCready J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-294; Mickler M, 2009, NAT STRUCT MOL BIOL, V16, P281, DOI 10.1038/nsmb.1557; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Nagase H, 1997, BIOL CHEM, V378, P151; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Quesada AR, 1997, CLIN EXP METASTAS, V15, P26; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ratnikov BI, 2002, LAB INVEST, V82, P1583, DOI 10.1097/01.LAB.0000038555.67772.DB; RAY JM, 1995, EMBO J, V14, P908, DOI 10.1002/j.1460-2075.1995.tb07072.x; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; SONG X, 2010, BIOCH BIOPHYS RES CO; SONG X, 2010, J BIOL CHEM; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang AM, 2010, J BIOL CHEM, V285, P15714, DOI 10.1074/jbc.M109.098806; WojtowiczPraga SM, 1997, INVEST NEW DRUG, V15, P61, DOI 10.1023/A:1005722729132; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032	53	139	146	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18848	10.1371/journal.pone.0018848	http://dx.doi.org/10.1371/journal.pone.0018848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533148	Green Published, gold, Green Submitted			2022-12-25	WOS:000289505600037
J	Feng, WX; Mokrousov, I; Wang, BB; Nelson, H; Jiao, WW; Wang, J; Sun, L; Zhou, SR; Xiao, J; Gu, Y; Wu, XR; Ma, X; Shen, AD				Feng, Wei-Xing; Mokrousov, Igor; Wang, Bin-Bin; Nelson, Hugh; Jiao, Wei-Wei; Wang, Jing; Sun, Lin; Zhou, Si-Rui; Xiao, Jing; Gu, Yi; Wu, Xi-Rong; Ma, Xu; Shen, Adong			Tag SNP Polymorphism of CCL2 and Its Role in Clinical Tuberculosis in Han Chinese Pediatric Population	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CHEMOKINE RECEPTORS; CONFERS PROTECTION; GENE POLYMORPHISMS; NERVOUS-SYSTEM; SUSCEPTIBILITY; MENINGITIS; EXPRESSION; CHILDREN; PROTEIN	Background: Chemokine (C-C motif) ligand 2 CCL2/MCP-1 is among the key signaling molecules of innate immunity; in particular, it is involved in recruitment of mononuclear and other cells in response to infection, including tuberculosis (TB) and is essential for granuloma formation. Methodology/Principal Findings: We identified a tag SNP for the CCL2/MCP-1 gene (rs4586 C/T). In order to understand whether this SNP may serve to evaluate the contribution of the CCL2 gene to the expression of TB disease, we further analysed distribution of its alleles and genotypes in 301 TB cases versus 338 non-infected controls (all BCG vaccinated) representing a high-risk pediatric population of North China. In the male TB subgroup, the C allele was identified in a higher rate (P = 0.045), and, acting dominantly, was found to be a risk factor for clinical TB (P = 0.029). Homozygous TT genotype was significantly associated with lower CSF mononuclear leukocyte (ML) counts in patients with tuberculous meningitis (TBM) (P = 0.001). Conclusions/Significance: The present study found an association of the CCL2 tag SNP rs4586 C allele and pediatric TB disease in males, suggesting that gender may affect the susceptibility to TB even in children. The association of homozygous TT genotype with decreased CSF mononuclear leukocyte (ML) count not only suggests a clinical significance of this SNP, but indicates its potential to assist in the clinical assessment of suspected TBM, where delay is critical and diagnosis is difficult.	[Feng, Wei-Xing; Jiao, Wei-Wei; Sun, Lin; Xiao, Jing; Gu, Yi; Wu, Xi-Rong; Shen, Adong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Beijing, Peoples R China; [Wang, Bin-Bin; Wang, Jing; Zhou, Si-Rui; Ma, Xu] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Wang, Bin-Bin; Wang, Jing; Zhou, Si-Rui; Ma, Xu] Natl Res Inst Family Planning, Beijing, Peoples R China; [Mokrousov, Igor] St Petersburg Pasteur Inst, Mol Microbiol Lab, St Petersburg, Russia; [Nelson, Hugh] Int SOS Clin, Shenzhen, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China; Saint-Petersburg Pasteur Institute	Feng, WX (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Beijing, Peoples R China.	imokrousov@mail.ru; shenad16@hotmail.com	孙, 琳/HGE-6966-2022; Mokrousov, Igor/J-3640-2014; Mokrousov, Igor/Q-5941-2019	Mokrousov, Igor/0000-0001-5924-0576; Mokrousov, Igor/0000-0001-5924-0576	National Natural Science Foundation of China [30672258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was done in the Beijing Pediatric Research Institute, Beijing Children's Hospital affiliated to Capital Medical University, Beijing, China. It was partly supported by National Natural Science Foundation of China (grant No. 30672258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarasu K, 2009, INDIAN J MED RES, V130, P444; Alcais A, 2005, J EXP MED, V202, P1617, DOI 10.1084/jem.20052302; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Be NA, 2009, CURR MOL MED, V9, P94, DOI 10.2174/156652409787581655; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Buijtels PCAM, 2008, INT J TUBERC LUNG D, V12, P1485; Carlini DB, 2003, GENETICS, V163, P239; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; Cosar H, 2008, EUR J CLIN MICROBIOL, V27, P1165, DOI 10.1007/s10096-008-0573-8; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; FURUTANI Y, 1989, BIOCHEM BIOPH RES CO, V159, P249, DOI 10.1016/0006-291X(89)92430-3; GANACHARI M, PLOS ONE, V5, pE8881; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Hu YM, 2002, TXB PEDIAT, P970; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Jiang Z. F., 2006, PRACTICAL PEDIAT TUB; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Kim SH, 2010, CLIN INFECT DIS, V50, P1349, DOI 10.1086/652142; Leung KH, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-19; Lobato MN, 1998, PEDIATR INFECT DIS J, V17, P407, DOI 10.1097/00006454-199805000-00012; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Maher D., 1997, Treatment of tuberculosis: guidelines for national programmes. Second edition., P1; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; MEHRABIAN M, 1991, GENOMICS, V9, P200, DOI 10.1016/0888-7543(91)90239-B; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; MOLLER M, TUBERCULOSIS EDINB, V90, P71; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Onay H, 2010, SCAND J INFECT DIS, V42, P39, DOI 10.3109/00365540903253502; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Peiffer Daniel A., 2009, V529, P51, DOI 10.1007/978-1-59745-538-1_4; Penido C, 2003, J IMMUNOL, V171, P6788, DOI 10.4049/jimmunol.171.12.6788; Premack BA, 1996, NAT MED, V2, P1174, DOI 10.1038/nm1196-1174; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Rigouts L, 2009, EUR J PEDIATR, V168, P1285, DOI 10.1007/s00431-009-0988-y; Rock RB, 2005, J INFECT DIS, V192, P2054, DOI 10.1086/498165; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sambasivan V, 2010, DIS MARKERS, V28, P43, DOI [10.3233/DMA-2010-0682, 10.1155/2010/843729]; Schoeman J, 2002, DEV MED CHILD NEUROL, V44, P522, DOI 10.1017/S0012162201002493; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; van Rie A, 1999, ARCH DIS CHILD, V80, P433, DOI 10.1136/adc.80.5.433; Walls T, 2004, J INFECTION, V48, P13, DOI 10.1016/S0163-4453(03)00121-X; *WHO, 2009, GLOB TUB CONTR SHORT; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Xu Zhen-e, 2009, Zhonghua Er Ke Za Zhi, V47, P200; Xu ZL, 2007, EUR J HUM GENET, V15, P1063, DOI 10.1038/sj.ejhg.5201875; Yang Ben-fu, 2009, Zhonghua Jiehe He Huxi Zazhi, V32, P454, DOI 10.3760/cma.j.issn.1001-0939.2009.06.015; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	59	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14652	10.1371/journal.pone.0014652	http://dx.doi.org/10.1371/journal.pone.0014652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21556333	Green Published, gold, Green Submitted			2022-12-25	WOS:000287037000003
J	Gao, ZG; Zhang, J; Kheterpal, I; Kennedy, N; Davis, RJ; Ye, JP				Gao, Zhanguo; Zhang, Jin; Kheterpal, Indu; Kennedy, Norm; Davis, Roger J.; Ye, Jianping			Sirtuin 1 (SIRT1) Protein Degradation in Response to Persistent c-Jun N-terminal Kinase 1 (JNK1) Activation Contributes to Hepatic Steatosis in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; MULTIPLE SERINE KINASES; CALORIE RESTRICTION; GLUCOSE-HOMEOSTASIS; MAMMALIAN SIRTUIN-1; FATTY LIVER; RESISTANCE; PROMOTES; MICE; PHOSPHORYLATION	SIRT1 is involved in the pathogenesis of obesity, diabetes, and aging. However, it is not clear how SIRT1 activity is regulated by intracellular kinases in cells. In this study, we investigated SIRT1 phosphorylation and protein degradation in response to JNK1 activation in obese mice. Mouse SIRT1 is phosphorylated by JNK1 at Ser-46 (Ser-47 in human SIRT1), which is one of the four potential residues targeted by JNK1. The phosphorylation induces a brief activation of SIRT1 function and degradation of SIRT1 thereafter by the proteasome. Ubiquitination occurs in SIRT1 protein after the phosphorylation. Mutation of Ser-46 to alanine prevents the phosphorylation, ubiquitination, and degradation. In vivo, SIRT1 undergoes an extensive degradation in hepatocytes in obesity as a consequence of persistent activation of JNK1. The degradation leads to inhibition of SIRT1 function, which contributes to development of hepatic steatosis. The degradation disappears in obesity when JNK1 is inactivated in mice. JNK2 exhibits an opposite activity in the regulation of SIRT1 degradation. The JNK1-SIRT1 pathway provides a new molecular mechanism for the pathogenesis of hepatic steatosis in obesity.	[Gao, Zhanguo; Zhang, Jin; Kheterpal, Indu; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70808 USA; [Kennedy, Norm; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X; Davis, Roger/0000-0002-0130-1652	National Institutes of Health [DK068036, DK085495]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068036, R01DK068036, R01DK085495, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK068036 and DK085495 (to J. Y.).	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; Yang R, 2007, J BIOL CHEM, V282, P22765, DOI 10.1074/jbc.M700790200; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497	45	141	145	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 24	2011	286	25					22227	22234		10.1074/jbc.M111.228874	http://dx.doi.org/10.1074/jbc.M111.228874			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	778QP	21540183	hybrid, Green Published			2022-12-25	WOS:000291719900030
J	Ricker, LJAG; Kijlstra, A; Kessels, AGH; De Jager, W; Liem, ATA; Hendrikse, F; La Heij, EC				Ricker, Lukas J. A. G.; Kijlstra, Aize; Kessels, Alfons G. H.; De Jager, Wilco; Liem, Albert T. A.; Hendrikse, Fred; La Heij, Ellen C.			Interleukin and Growth Factor Levels in Subretinal Fluid in Rhegmatogenous Retinal Detachment: A Case-Control Study	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; PROLIFERATIVE VITREORETINOPATHY; VITREOUS-HUMOR; CLINICAL-TRIAL; DIABETIC-RETINOPATHY; MIGRATION; CYTOKINES; MEMBRANES; EYES; IL-8	Background: Rhegmatogenous retinal detachment (RRD) is a major cause of visual loss in developed countries. Proliferative vitreoretinopathy (PVR), an eye-sight threatening complication of RRD surgery, resembles a wound-healing process with inflammation, scar tissue formation, and membrane contraction. This study was performed to determine the possible involvement of a wide range of cytokines in the future development of PVR, and to identify predictors of PVR and visual outcome. Methodology: A multiplex immunoassay was used for the simultaneous detection of 29 different cytokines in subretinal fluid samples from patients with primary RRD. Of 306 samples that were collected and stored in our BioBank between 2001 and 2008, 21 samples from patients who developed postoperative PVR were compared with 54 age-, sex-, and storage-time-matched RRD control patients who had an uncomplicated postoperative course during the overall follow-up period. Findings: Levels of IL-1 alpha, IL-2, IL-3, IL-6, VEGF, and ICAM-1 were significantly higher (P<0.05) in patients who developed postoperative PVR after reattachment surgery than in patients with an uncomplicated postoperative course, whereas levels of IL-1 beta, IL-4, IL-5, IL-7, IL-9, IL-10, IL-11, IL-12p70, IL-13, IL-15, IL-17, IL-18, IL-21, IL-22, IL-23, IL-25, IL-33, TNF-alpha, IFN-gamma, IGF-1, bFGF, HGF, and NGF were not (P>0.05). Multivariate logistic regression analysis revealed that IL-3 (P = 0.001), IL-6 (P = 0.047), ICAM-1 (P = 0.010), and preoperative visual acuity (P = 0.026) were independent predictors of postoperative PVR. Linear regression analysis showed that ICAM-1 (P = 0.005) and preoperative logMAR visual acuity (P = 0.001) were predictive of final visual outcome after primary RRD repair. Conclusions/Significance: Our findings indicate that after RRD onset an exaggerated response of certain cytokines may predispose to PVR. Sampling at a time close to the onset of primary RRD may thus provide clues as to which biological events may initiate the development of PVR and, most importantly, may provide a means for therapeutic control.	[Ricker, Lukas J. A. G.; Kijlstra, Aize; Liem, Albert T. A.; Hendrikse, Fred; La Heij, Ellen C.] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands; [Ricker, Lukas J. A. G.] European Grad Sch Neurosci EURON, Maastricht, Netherlands; [Kessels, Alfons G. H.] Univ Hosp Maastricht, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands; [De Jager, Wilco] Univ Med Ctr Utrecht, Dept Pediat Immunol, Ctr Mol & Cellular Intervent CMCI, Utrecht, Netherlands; [La Heij, Ellen C.] Univ Med Ctr Utrecht, Dept Ophthalmol, Utrecht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Ricker, LJAG (corresponding author), Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands.	L.Ricker@NP.unimaas.nl		de Jager, Wilco/0000-0002-0014-0682	Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	This study was financially supported by the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (http://www.anvvb.nl/default2.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadieh H, 2008, OPHTHALMOLOGY, V115, P1938, DOI 10.1016/j.ophtha.2008.05.016; Bali E, 2010, GRAEF ARCH CLIN EXP, V248, P957, DOI 10.1007/s00417-010-1319-8; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; BAUDOUIN C, 1991, OPHTHALMOLOGICA, V203, P38, DOI 10.1159/000310223; Canataroglu H, 2005, OCUL IMMUNOL INFLAMM, V13, P375, DOI 10.1080/09273940490518900; CHARTERIS DG, 1993, OPHTHALMOLOGY, V100, P43; Chen YS, 1997, BRIT J OPHTHALMOL, V81, P919, DOI 10.1136/bjo.81.10.919; Chong DY, 2008, INVEST OPHTH VIS SCI, V49, P3193, DOI 10.1167/iovs.07-1641; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; DEVOS AF, 1992, CURR EYE RES, V11, P581, DOI 10.3109/02713689209001814; Dieudonne SC, 2004, INVEST OPHTH VIS SCI, V45, P4113, DOI 10.1167/iovs.04-0643; Dieudonne SC, 2007, OPHTHALMIC RES, V39, P148, DOI 10.1159/000103234; El-Ghrably IA, 2001, BRIT J OPHTHALMOL, V85, P461, DOI 10.1136/bjo.85.4.461; ELNER SG, 1992, LAB INVEST, V66, P200; Esser P, 1995, Ger J Ophthalmol, V4, P269; FERRICK MR, 1991, INVEST OPHTH VIS SCI, V32, P1534; FREDJREYGROBELLET D, 1991, OPHTHALMIC RES, V23, P154, DOI 10.1159/000267115; FRENDL G, 1990, J IMMUNOL, V144, P3392; GEBICKEHAERTER PJ, 1994, J NEUROIMMUNOL, V50, P203, DOI 10.1016/0165-5728(94)90047-7; GRANT MB, 1990, CURR EYE RES, V9, P323, DOI 10.3109/02713689008999620; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; Hollborn M, 2008, INVEST OPHTH VIS SCI, V49, P1262, DOI 10.1167/iovs.07-0879; Holtkamp GM, 1998, CLIN EXP IMMUNOL, V112, P34; Hosmer D., 1989, APPL LOGISTIC REGRES, P82; KAUFFMANN DJH, 1994, INVEST OPHTH VIS SCI, V35, P900; KIRCHHOF B, 1989, GRAEF ARCH CLIN EXP, V227, P60, DOI 10.1007/BF02169828; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kon CH, 1999, INVEST OPHTH VIS SCI, V40, P705; KUPPNER MC, 1995, IMMUNOLOGY, V84, P265; La Heij EC, 2002, AM J OPHTHALMOL, V134, P367, DOI 10.1016/S0002-9394(02)01536-2; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Limb GA, 1999, BRIT J OPHTHALMOL, V83, P953, DOI 10.1136/bjo.83.8.953; LIMB GA, 1993, GRAEF ARCH CLIN EXP, V231, P331, DOI 10.1007/BF00919029; LINDEMANN A, 1993, CANCER INVEST, V11, P609, DOI 10.3109/07357909309011680; MIETZ H, 1995, BRIT J OPHTHALMOL, V79, P874, DOI 10.1136/bjo.79.10.874; Mitamura Y, 2000, AM J OPHTHALMOL, V129, P678, DOI 10.1016/S0002-9394(00)00360-3; Nakazawa T, 2006, MOL VIS, V12, P867; Ogata N, 2002, AM J OPHTHALMOL, V133, P851, DOI 10.1016/S0002-9394(02)01406-X; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Rasier R, 2010, CURR EYE RES, V35, P505, DOI 10.3109/02713681003597248; Ricker LJAG, 2010, INVEST OPHTH VIS SCI, V51, P4143, DOI 10.1167/iovs.09-5057; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Spraul CW, 2004, OPHTHAL RES, V36, P166, DOI 10.1159/000077330; Su CY, 2000, J OCUL PHARMACOL TH, V16, P463, DOI 10.1089/jop.2000.16.463; Wickham L, 2007, OPHTHALMOLOGY, V114, P698, DOI 10.1016/j.ophtha.2006.08.042; Wiedemann P, 1998, AM J OPHTHALMOL, V126, P550, DOI 10.1016/S0002-9394(98)00115-9; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158	51	53	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e19141	10.1371/journal.pone.0019141	http://dx.doi.org/10.1371/journal.pone.0019141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556354	Green Published, gold, Green Submitted			2022-12-25	WOS:000290019400032
J	Cain, EL; Braun, SE; Beeser, A				Cain, Erica L.; Braun, Sterling E.; Beeser, Alexander			Characterization of a Human Cell Line Stably Over-Expressing the Candidate Oncogene, Dual Specificity Phosphatase 12	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; MET/HGF RECEPTOR; C-MET; PROTEIN; CANCER; GENE; MICE; YVH1; OVEREXPRESSION; IDENTIFICATION	Background: Analysis of chromosomal rearrangements within primary tumors has been influential in the identification of novel oncogenes. Identification of the "driver" gene(s) within cancer-derived amplicons is, however, hampered by the fact that most amplicons contain many gene products. Amplification of 1q21-1q23 is strongly associated with liposarcomas and microarray-based comparative genomic hybridization narrowed down the likely candidate oncogenes to two: the activating transcription factor 6 (atf6) and the dual specificity phosphatase 12 (dusp12). While atf6 is an established transcriptional regulator of the unfolded protein response, the potential role of dusp12 in cancer remains uncharacterized. Methodology/Principal Findings: To evaluate the oncogenic potential of dusp12, we established stable cell lines that ectopically over-express dusp12 in isolation and determined whether this cell line acquired properties frequently associated with transformed cells. Here, we demonstrate that cells over-expressing dusp12 display increased cell motility and resistance to apoptosis. Additionally, over-expression of dusp12 promoted increased expression of the c-met proto-oncogene and the collagen and laminin receptor intergrin alpha 1 (itga1) which is implicated in metastasis. Significance: Collectively, these results suggest that dusp12 is oncologically relevant and exposes a potential association between dusp12 and established oncogenes that could be therapeutically targeted.	[Cain, Erica L.; Braun, Sterling E.; Beeser, Alexander] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Cain, EL (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	albeeser@ksu.edu	Braun, Sterling/AAO-2622-2021; Braun, Sterling/AAN-8900-2021	Braun, Sterling/0000-0002-5684-3432; Cain, Erica/0000-0003-3690-8566	Sarcoma Foundation of America; Terry C. Johnson Center for Basic Cancer Research	Sarcoma Foundation of America; Terry C. Johnson Center for Basic Cancer Research	This work was supported by the Blade Cadkin Memorial award from the Sarcoma Foundation of America and from the Terry C. Johnson Center for Basic Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amstad PA, 1997, MOL CARCINOGEN, V20, P231, DOI 10.1002/(SICI)1098-2744(199710)20:2<231::AID-MC10>3.0.CO;2-B; Beeser AE, 2000, J BACTERIOL, V182, P3517, DOI 10.1128/JB.182.12.3517-3528.2000; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; DeoCampo ND, 2000, CARCINOGENESIS, V21, P1501, DOI 10.1093/carcin/21.8.1501; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fukuda T, 1998, PATHOL INT, V48, P757, DOI 10.1111/j.1440-1827.1998.tb03834.x; Grandori C, 2005, NAT CELL BIOL, V7, DOI 10.1038/ncb1257; Gratias S, 2005, INT J CANCER, V116, P555, DOI 10.1002/ijc.21051; GUAN K, 1992, P NATL ACAD SCI USA, V89, P12175, DOI 10.1073/pnas.89.24.12175; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; He Q, 2003, ONCOGENE, V22, P2674, DOI 10.1038/sj.onc.1206363; Hirai M, 1999, GENE CHROMOSOME CANC, V25, P261, DOI 10.1002/(SICI)1098-2264(199907)25:3<261::AID-GCC8>3.0.CO;2-#; Kemmler S, 2009, J CELL BIOL, V186, P863, DOI 10.1083/jcb.200904111; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Kresse SH, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-39; Kuhnen C, 1998, VIRCHOWS ARCH, V432, P337, DOI 10.1007/s004280050175; Lo KY, 2009, J CELL BIOL, V186, P849, DOI 10.1083/jcb.200904110; Lochter A, 1999, MOL BIOL CELL, V10, P271, DOI 10.1091/mbc.10.2.271; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Muda M, 1999, J BIOL CHEM, V274, P23991, DOI 10.1074/jbc.274.34.23991; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Pozzi M, 1998, J CELL BIOL, V142, P587; Pulido R, 2008, FEBS J, V275, P848, DOI 10.1111/j.1742-4658.2008.06250.x; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Schadendorf D, 1996, BRIT J CANCER, V74, P194, DOI 10.1038/bjc.1996.337; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Sharda PR, 2009, BIOCHEM J, V418, P391, DOI 10.1042/BJ20081484; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Tomida M, 2004, ONCOGENE, V23, P679, DOI 10.1038/sj.onc.1207190; Zhang YW, 2003, J CELL BIOCHEM, V88, P408, DOI 10.1002/jcb.10358	39	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2011	6	4							e18677	10.1371/journal.pone.0018677	http://dx.doi.org/10.1371/journal.pone.0018677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752UE	21556130	Green Published, gold, Green Submitted			2022-12-25	WOS:000289719400019
J	Rapali, P; Radnai, L; Suveges, D; Harmat, V; Tolgyesi, F; Wahlgren, WY; Katona, G; Nyitray, L; Pal, G				Rapali, Peter; Radnai, Laszlo; Sueveges, Daniel; Harmat, Veronika; Toelgyesi, Ferenc; Wahlgren, Weixiao Y.; Katona, Gergely; Nyitray, Laszlo; Pal, Gabor			Directed Evolution Reveals the Binding Motif Preference of the LC8/DYNLL Hub Protein and Predicts Large Numbers of Novel Binders in the Human Proteome	PLOS ONE			English	Article							DYNEIN LIGHT-CHAIN; MOLECULAR RECOGNITION FEATURES; SPLICED EXON-B; PHAGE-DISPLAY; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; COILED-COIL; MYOSIN-VA; FUNCTIONAL-ANALYSIS; LIGAND SPECIFICITY	LC8 dynein light chain (DYNLL) is a eukaryotic hub protein that is thought to function as a dimerization engine. Its interacting partners are involved in a wide range of cellular functions. In its dozens of hitherto identified binding partners DYNLL binds to a linear peptide segment. The known segments define a loosely characterized binding motif: [D/S](-4)K-3X-2[T/V/I](-1)Q(0)[T/V](1)[D/E](2). The motifs are localized in disordered segments of the DYNLL-binding proteins and are often flanked by coiled coil or other potential dimerization domains. Based on a directed evolution approach, here we provide the first quantitative characterization of the binding preference of the DYNLL binding site. We displayed on M13 phage a naive peptide library with seven fully randomized positions around a fixed, naturally conserved glutamine. The peptides were presented in a bivalent manner fused to a leucine zipper mimicking the natural dimer to dimer binding stoichiometry of DYNLL-partner complexes. The phage-selected consensus sequence V(-5)S(-4)R(-3)G(-2)T(-1)Q(0)T(1)E(2) resembles the natural one, but is extended by an additional N-terminal valine, which increases the affinity of the monomeric peptide twentyfold. Leu-zipper dimerization increases the affinity into the subnanomolar range. By comparing crystal structures of an SRGTQTE-DYNLL and a dimeric VSRGTQTE-DYNLL complex we find that the affinity enhancing valine is accommodated in a binding pocket on DYNLL. Based on the in vitro evolved sequence pattern we predict a large number of novel DYNLL binding partners in the human proteome. Among these EML3, a microtubule-binding protein involved in mitosis contains an exact match of the phage-evolved consensus and binds to DYNLL with nanomolar affinity. These results significantly widen the scope of the human interactome around DYNLL and will certainly shed more light on the biological functions and organizing role of DYNLL in the human and other eukaryotic interactomes.	[Rapali, Peter; Radnai, Laszlo; Sueveges, Daniel; Nyitray, Laszlo; Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Inst Chem, Budapest, Hungary; [Harmat, Veronika] Eotvos Lorand Univ, Hungarian Acad Sci, Prot Modeling Res Grp, Budapest, Hungary; [Toelgyesi, Ferenc] Semmelweis Univ, Inst Biophys & Radiat Biol, Budapest, Hungary; [Wahlgren, Weixiao Y.; Katona, Gergely] Univ Gothenburg, Dept Chem, Gothenburg, Sweden	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Semmelweis University; University of Gothenburg	Rapali, P (corresponding author), Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary.	nyitray@elte.hu; palgabor@elte.hu	Nyitray, László/AAE-5910-2020; Pal, Gabor/A-6244-2009; Harmat, Veronika/B-8033-2016; Katona, Gergely/B-3491-2008; Yuan Wahlgren, Weixiao/D-5589-2011	Nyitray, László/0000-0003-4717-5994; Pal, Gabor/0000-0001-7868-7971; Harmat, Veronika/0000-0002-1866-9904; Katona, Gergely/0000-0002-2031-8716; Radnai, Laszlo/0000-0001-6843-3740; Suveges, Daniel/0000-0003-4133-0447; Rapali, Peter/0000-0003-1422-6660	Hungarian Scientific Research Fund (OTKA) [NI49812, K81784, NK81950, K68408]; European Union; European Social Fund (TAMOP) [4.2.1./B-09/KMR-2010-0003]; Janos Bolyai Research Fellowship; Swedish Research Council [2008-4248, 2009-350]; Harald and Greta Jeanssons Foundation	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund (TAMOP)(European Social Fund (ESF)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences); Swedish Research Council(Swedish Research CouncilEuropean Commission); Harald and Greta Jeanssons Foundation	The work was supported by the Hungarian Scientific Research Fund (OTKA) NI49812; K81784; NK81950 (L.N.); and K68408 (G. P.) (www.otka.hu); as well as by the European Union and the European Social Fund (TAMOP) 4.2.1./B-09/KMR-2010-0003 (www.nfu.hu). G. P. is supported by the Janos Bolyai Research Fellowship (www.mta.hu). W.Y.W. and G. K. are supported by the Swedish Research Council (2008-4248, 2009-350) (www.vr.se) and the Harald and Greta Jeanssons Foundation (www.jeanssonsstiftelser.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Beekwilder J, 1999, GENE, V228, P23, DOI 10.1016/S0378-1119(99)00013-X; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Dente L, 1997, J MOL BIOL, V269, P694, DOI 10.1006/jmbi.1997.1073; Dick T, 1996, MOL CELL BIOL, V16, P1966; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; FUH G, 1990, J BIOL CHEM, V265, P3111; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Garcia-Mayoral MF, 2010, FEBS J, V277, P2340, DOI 10.1111/j.1742-4658.2010.07649.x; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; Herzig RP, 2000, J CELL SCI, V113, P4263; HODI Z, 2007, FEBS J S1, V274, P106; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kasanov J, 2001, CHEM BIOL, V8, P231, DOI 10.1016/S1074-5521(01)00005-9; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lajoix AD, 2004, MOL DIVERS, V8, P281, DOI 10.1023/B:MODI.0000036242.01129.27; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Lo KWH, 2007, J BIOL CHEM, V282, P36871, DOI 10.1074/jbc.M705991200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Lyon RP, 2003, BIOCHEMISTRY-US, V42, P10418, DOI 10.1021/bi0346188; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MIAGNM MW, 2000, ACTA CRYSTALLOGR, V57, P122; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Pal G, 2005, J MOL BIOL, V347, P489, DOI 10.1016/j.jmb.2005.01.040; Pal G, 2003, J MOL BIOL, V332, P195, DOI 10.1016/S0022-2836(03)00898-2; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; RADNAI L, 2010, J BIOL CHEM; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2000, J MOL BIOL, V296, P487, DOI 10.1006/jmbi.1999.3465; Sidhu SS, 2003, CHEMBIOCHEM, V4, P14, DOI 10.1002/cbic.200390008; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Szappanos B, 2010, FEBS LETT, V584, P1623, DOI 10.1016/j.febslet.2010.03.026; Szenthe B, 2007, J MOL BIOL, V370, P63, DOI 10.1016/j.jmb.2007.04.029; Tegha-Dunghu J, 2008, J CELL SCI, V121, P1718, DOI 10.1242/jcs.019174; Tochio H, 1998, NAT STRUCT BIOL, V5, P965, DOI 10.1038/2940; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200	84	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18818	10.1371/journal.pone.0018818	http://dx.doi.org/10.1371/journal.pone.0018818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533121	Green Published, gold, Green Submitted			2022-12-25	WOS:000289620100023
J	Sanders, LH; Devadoss, B; Raja, GV; O'Connor, J; Su, SC; Wozniak, DJ; Hassett, DJ; Berdis, AJ; Sutton, MD				Sanders, Laurie H.; Devadoss, Babho; Raja, Geraldine V.; O'Connor, Jaime; Su, Shengchang; Wozniak, Daniel J.; Hassett, Daniel J.; Berdis, Anthony J.; Sutton, Mark D.			Epistatic Roles for Pseudomonas aeruginosa MutS and DinB (DNA Pol IV) in Coping with Reactive Oxygen Species-Induced DNA Damage	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; MISMATCH REPAIR SYSTEM; POLYMERASE-KAPPA; Y-FAMILY; GENETIC ADAPTATION; BIOFILM INFECTIONS; HIGH-FREQUENCY; LESION-BYPASS; MUTAGENESIS; HYPERMUTATION	Pseudomonas aeruginosa is especially adept at colonizing the airways of individuals afflicted with the autosomal recessive disease cystic fibrosis (CF). CF patients suffer from chronic airway inflammation, which contributes to lung deterioration. Once established in the airways, P. aeruginosa continuously adapts to the changing environment, in part through acquisition of beneficial mutations via a process termed pathoadaptation. MutS and DinB are proposed to play opposing roles in P. aeruginosa pathoadaptation: MutS acts in replication-coupled mismatch repair, which acts to limit spontaneous mutations; in contrast, DinB (DNA polymerase IV) catalyzes error-prone bypass of DNA lesions, contributing to mutations. As part of an ongoing effort to understand mechanisms underlying P. aeruginosa pathoadaptation, we characterized hydrogen peroxide (H2O2)-induced phenotypes of isogenic P. aeruginosa strains bearing different combinations of mutS and dinB alleles. Our results demonstrate an unexpected epistatic relationship between mutS and dinB with respect to H2O2-induced cell killing involving error-prone repair and/or tolerance of oxidized DNA lesions. In striking contrast to these error-prone roles, both MutS and DinB played largely accurate roles in coping with DNA lesions induced by ultraviolet light, mitomycin C, or 4-nitroquinilone 1-oxide. Models discussing roles for MutS and DinB functionality in DNA damage-induced mutagenesis, particularly during CF airway colonization and subsequent P. aeruginosa pathoadaptation are discussed.	[Sanders, Laurie H.; Raja, Geraldine V.; O'Connor, Jaime; Sutton, Mark D.] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Sanders, Laurie H.; Sutton, Mark D.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Devadoss, Babho; Berdis, Anthony J.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Su, Shengchang; Hassett, Daniel J.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Wozniak, Daniel J.] Ohio State Univ, Dept Infect Dis & Microbiol, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Case Western Reserve University; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University	Sanders, LH (corresponding author), SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	mdsutton@buffalo.edu			Cystic Fibrosis Foundation [SUTTON07I0]; Public Health Service [RO1 GM066094, RO1 CA118408, RO1 GM069845, RO1 AI061396, RO1 HL58334]; NATIONAL CANCER INSTITUTE [R01CA118408] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069845, R56GM066094, R01GM066094] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Pilot and Feasibility grant SUTTON07I0 from the Cystic Fibrosis Foundation to MDS, as well as Public Health Service grants RO1 GM066094 to MDS, RO1 CA118408 to AJB, and RO1 GM069845 to DJH. DJW is supported by Public Health Service grants RO1 AI061396 and RO1 HL58334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai HB, 2007, J BACTERIOL, V189, P902, DOI 10.1128/JB.01513-06; Barone F, 2007, DNA REPAIR, V6, P355, DOI 10.1016/j.dnarep.2006.11.002; Bjedov I, 2007, GENETICS, V176, P1431, DOI 10.1534/genetics.107.072405; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Devadoss B, 2007, BIOCHEMISTRY-US, V46, P4486, DOI 10.1021/bi602438t; Dixon W. J., 1969, INTRO STAT ANAL; Fischhaber PL, 2002, J BIOL CHEM, V277, P37604, DOI 10.1074/jbc.M206027200; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Galan JC, 2007, FEMS MICROBIOL LETT, V275, P263, DOI 10.1111/j.1574-6968.2007.00902.x; Galhardo RS, 2005, NUCLEIC ACIDS RES, V33, P2603, DOI 10.1093/nar/gki551; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Haracska L, 2002, P NATL ACAD SCI USA, V99, P16000, DOI 10.1073/pnas.252524999; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hassett DJ, 2009, TRENDS MICROBIOL, V17, P130, DOI 10.1016/j.tim.2008.12.003; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Hogardt M, 2007, J INFECT DIS, V195, P70, DOI 10.1086/509821; Hori M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/807579; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jarosz DF, 2007, CELL CYCLE, V6, P817, DOI 10.4161/cc.6.7.4065; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JOHNSON WS, 1995, BIOORGAN MED CHEM, V3, P851, DOI 10.1016/0968-0896(95)00067-Q; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Koorits L, 2007, DNA REPAIR, V6, P863, DOI 10.1016/j.dnarep.2007.01.010; Kresse AU, 2003, MOL MICROBIOL, V47, P145, DOI 10.1046/j.1365-2958.2003.03261.x; Kumari A, 2008, J BIOL CHEM, V283, P27433, DOI 10.1074/jbc.M801237200; Ma S, 1998, J BACTERIOL, V180, P956, DOI 10.1128/JB.180.4.956-968.1998; Macia MD, 2005, ANTIMICROB AGENTS CH, V49, P3382, DOI 10.1128/AAC.49.8.3382-3386.2005; Macia MD, 2004, ANTIMICROB AGENTS CH, V48, P2665, DOI 10.1128/AAC.48.7.2665-2672.2004; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Mena A, 2007, J BACTERIOL, V189, P3665, DOI 10.1128/JB.00120-07; Miller JH, 1999, SHORT COURSE BACTERI; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; Morero NR, 2009, FEMS MICROBIOL LETT, V290, P217, DOI 10.1111/j.1574-6968.2008.01411.x; Moyano AJ, 2007, MOL MICROBIOL, V64, P547, DOI 10.1111/j.1365-2958.2007.05675.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Oliver A, 2004, ANTIMICROB AGENTS CH, V48, P4226, DOI 10.1128/AAC.48.11.4226-4233.2004; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Palma M, 2004, J BACTERIOL, V186, P248, DOI 10.1128/JB.186.1.248-252.2004; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; RUSH J, 1989, PREP BIOCHEM, V19, P329, DOI 10.1080/10826068908544921; Salunkhe P, 2005, J BACTERIOL, V187, P2565, DOI 10.1128/JB.187.8.2565-2572.2005; Sanders LH, 2006, J BACTERIOL, V188, P8573, DOI 10.1128/JB.01481-06; Sanders LH, 2009, FEMS MICROBIOL LETT, V294, P89, DOI 10.1111/j.1574-6968.2009.01550.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Wang G, 2005, MOL MICROBIOL, V58, P166, DOI 10.1111/j.1365-2958.2005.04833.x; Washington MT, 2002, P NATL ACAD SCI USA, V99, P1910, DOI 10.1073/pnas.032594399; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Yamada M, 2006, J BACTERIOL, V188, P4992, DOI 10.1128/JB.00281-06; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138	69	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18824	10.1371/journal.pone.0018824	http://dx.doi.org/10.1371/journal.pone.0018824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533111	Green Submitted, Green Published, gold			2022-12-25	WOS:000289620100025
J	Thuny, F; Habib, G; Le Dolley, Y; Canault, M; Casalta, JP; Verdier, M; Avierinos, JF; Raoult, D; Mege, JL; Morange, PE; Alessi, MC				Thuny, Franck; Habib, Gilbert; Le Dolley, Yvan; Canault, Matthias; Casalta, Jean-Paul; Verdier, Monique; Avierinos, Jean-Francois; Raoult, Didier; Mege, Jean-Louis; Morange, Pierre-Emmanuel; Alessi, Marie-Christine			Circulating Matrix Metalloproteinases in Infective Endocarditis: A Possible Marker of the Embolic Risk	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; ANTIMICROBIAL THERAPY; PROGNOSTIC VALUE; ECHOCARDIOGRAPHY; DISEASE; EVENTS; EXPRESSION; DIAGNOSIS; COMPLICATIONS; EMBOLIZATION	Background: Embolic events (EE) in infective endocarditis (IE) are caused by fragmentation of vegetations or valvular tissue. Vegetation length is considered to be the most potent predictor of EE, but does not take into account the degree of friability of the vegetation and of the surrounded infected tissue. Matrix metalloproteinases (MMPs) are enzymes involved in degradation of matrix extracellular components and play a role in the pathophysiology of IE. We aimed to determine whether, in addition to the vegetation size, circulating MMPs could provide accurate predictive value of embolism in IE. Methods: Among 145 patients referred for a native valve IE, we prospectively included 16 patients who experienced EE during antibiotic therapy (new-EE) and 30 patients without new-EE and treated without valvular surgery. A control group of 38 patients with a degenerative valvular heart disease was also included. In addition to clinical, microbiological and echocardiographic assessment, blood MMPs and their inhibitors were assayed in all patients at admission. Results: MMP-9 serum level was significantly higher in patients with new-EE compared to controls (median [interquartile range]; 250 ng/mL [175-455] vs. 111 ng/mL [70-144], respectively; p<0.0001) and patients with no new-EE ( 250 ng/mL [175-455] vs. 138 ng/mL [95-232]; p<0.01). A higher MMP-9 activity in patients who experienced new-EE was further confirmed by gelatin zymography analysis. Circulating MMP-9 remains a predictor of new-EE after adjustment for vegetation length and other potential confounders. This parameter provided incremental predictive value over vegetation measurements. Conclusions: MMP-9 serum level is associated with the risk of embolism during IE. This marker might help physicians in the management of the disease, but further propspective studies are need to confirm these preliminary results.	[Thuny, Franck; Habib, Gilbert; Le Dolley, Yvan; Avierinos, Jean-Francois] Univ Aix Marseille 2, Hop Timone, Assistance Publ Hop Marseille, Dept Cardiol, Marseille, France; [Thuny, Franck; Casalta, Jean-Paul; Raoult, Didier; Mege, Jean-Louis] Univ Aix Marseille 2, Unite Rech Malad Infect & Trop Emergentes, CNRS, Fac Med Marseille,UMR 6236, Marseille, France; [Canault, Matthias; Verdier, Monique; Morange, Pierre-Emmanuel; Alessi, Marie-Christine] Hop La Timone, Hematol Lab, Marseille, France; [Canault, Matthias; Verdier, Monique; Morange, Pierre-Emmanuel; Alessi, Marie-Christine] Univ Aix Marseille 2, INSERM, Fac Med Marseille, UMR 626, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Thuny, F (corresponding author), Univ Aix Marseille 2, Hop Timone, Assistance Publ Hop Marseille, Dept Cardiol, Marseille, France.	franck.thuny@gmail.com	ALESSI, Marie-christine/AAK-3582-2020; MEGE, JEAN-LOUIS/O-6063-2016; Canault, Matthias/H-5128-2013; Thuny, Franck/ABC-7157-2020; Morange, Pierre/T-9070-2019; RAOULT, Didier/A-8434-2008; Thuny, Franck/ABB-2408-2021; Thuny, Franck/GSD-2668-2022	ALESSI, Marie-christine/0000-0003-3927-5792; Canault, Matthias/0000-0002-7880-5250; Morange, Pierre/0000-0002-9065-722X; RAOULT, Didier/0000-0002-0633-5974; Thuny, Franck/0000-0002-8727-7154; Thuny, Franck/0000-0002-8727-7154; Avierinos, Jean Francois/0000-0002-3775-8371	Allocation de Recherche Clinique; Federation Francaise de Cardiologie	Allocation de Recherche Clinique; Federation Francaise de Cardiologie	The work was supported by the Allocation de Recherche Clinique 2007 (Assistance Publique-Hopitaux de Marseille) and The Federation Francaise de Cardiologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; BENOIT M, PLOS ONE, V5, pE8939; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Carrell TWG, 2002, CIRCULATION, V105, P477, DOI 10.1161/hc0402.102621; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Cooper HA, 2009, CIRCULATION, V120, P585, DOI 10.1161/CIRCULATIONAHA.108.834432; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; Di Salvo G, 2001, J AM COLL CARDIOL, V37, P1069, DOI 10.1016/S0735-1097(00)01206-7; Dickerman SA, 2007, AM HEART J, V154, P1086, DOI 10.1016/j.ahj.2007.07.023; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; HABIB G, 2009, EUR HEART J; Hetzer R, 2001, EUR HEART J, V22, P811, DOI 10.1053/euhj.2000.2520; Ileri M, 2003, AM J CARDIOL, V91, P689, DOI 10.1016/S0002-9149(02)03405-7; Korkmaz S, 2001, EUR HEART J, V22, P874, DOI 10.1053/euhj.2000.2401; Kupferwasser LI, 1999, J AM COLL CARDIOL, V33, P1365, DOI 10.1016/S0735-1097(99)00024-8; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Loftus IM, 2001, EUR J VASC ENDOVASC, V21, P17, DOI 10.1053/ejvs.2000.1278; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Orlandi A, 2005, AM J PATHOL, V166, P1619, DOI 10.1016/S0002-9440(10)62472-8; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911; Singer CF, 2002, BREAST CANCER RES TR, V72, P69, DOI 10.1023/A:1014918512569; Snygg-Martin U, 2008, CLIN INFECT DIS, V47, P23, DOI 10.1086/588663; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; THUNY F, 2007, EUR HEART J; Vilacosta I, 2002, J AM COLL CARDIOL, V39, P1489, DOI 10.1016/S0735-1097(02)01790-4; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Widmer Eleonora, 2006, Curr Infect Dis Rep, V8, P271, DOI 10.1007/s11908-006-0071-z; Yoshinaga M, 2008, AM J CARDIOL, V101, P114, DOI 10.1016/j.amjcard.2007.07.054	35	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18830	10.1371/journal.pone.0018830	http://dx.doi.org/10.1371/journal.pone.0018830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533198	Green Submitted, Green Published, gold			2022-12-25	WOS:000289505600033
J	Kiesecker, JM; Evans, JS; Fargione, J; Doherty, K; Foresman, KR; Kunz, TH; Naugle, D; Nibbelink, NP; Niemuth, ND				Kiesecker, Joseph M.; Evans, Jeffrey S.; Fargione, Joe; Doherty, Kevin; Foresman, Kerry R.; Kunz, Thomas H.; Naugle, Dave; Nibbelink, Nathan P.; Niemuth, Neal D.			Win-Win for Wind and Wildlife: A Vision to Facilitate Sustainable Development	PLOS ONE			English	Article							ENERGY FACILITIES; FATALITIES; BAT	Wind energy offers the potential to reduce carbon emissions while increasing energy independence and bolstering economic development. However, wind energy has a larger land footprint per Gigawatt (GW) than most other forms of energy production, making appropriate siting and mitigation particularly important. Species that require large unfragmented habitats and those known to avoid vertical structures are particularly at risk from wind development. Developing energy on disturbed lands rather than placing new developments within large and intact habitats would reduce cumulative impacts to wildlife. The U.S. Department of Energy estimates that it will take 241 GW of terrestrial based wind development on approximately 5 million hectares to reach 20% electricity production for the U.S. by 2030. We estimate there are similar to 7,700 GW of potential wind energy available across the U.S., with similar to 3,500 GW on disturbed lands. In addition, a disturbance-focused development strategy would avert the development of similar to 2.3 million hectares of undisturbed lands while generating the same amount of energy as development based solely on maximizing wind potential. Wind subsidies targeted at favoring low-impact developments and creating avoidance and mitigation requirements that raise the costs for projects impacting sensitive lands could improve public value for both wind energy and biodiversity conservation.	[Kiesecker, Joseph M.; Evans, Jeffrey S.] Nature Conservancy, Global Conservat Lands Program, Ft Collins, CO 80524 USA; [Fargione, Joe] Nature Conservancy, N Amer Conservat Reg, Minneapolis, MN USA; [Doherty, Kevin] Audubon Soc, Laramie, WY USA; [Foresman, Kerry R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA; [Naugle, Dave] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Nibbelink, Nathan P.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Niemuth, Neal D.] US Fish & Wildlife Serv, Bismarck, ND USA	Nature Conservancy; Nature Conservancy; University of Montana System; University of Montana; Boston University; University of Montana System; University of Montana; University System of Georgia; University of Georgia; United States Department of the Interior; US Fish & Wildlife Service	Kiesecker, JM (corresponding author), Nature Conservancy, Global Conservat Lands Program, Ft Collins, CO 80524 USA.	jkiesecker@TNC.ORG		Evans, Jeffrey/0000-0002-5533-7044	Robertson Foundation, U.S. Department of Energy; World Wildlife Fund	Robertson Foundation, U.S. Department of Energy(United States Department of Energy (DOE)); World Wildlife Fund	The work was supported by grants from the Robertson Foundation, U.S. Department of Energy and the World Wildlife Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakre D., 2009, WIND TURBINE LEASE C; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; *AWEA, 2010, MARK UPD REC 2009 LE; AWEA (American Wind Energy Association), 2009, WIND EN WILDL; Barclay RMR, 2007, CAN J ZOOL, V85, P381, DOI 10.1139/Z07-011; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Conservation Biology Institute, 2010, PROT AR DAT US VERS; Copeland HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007400; Department of Energy, 2008, 20 WIND EN 2030 INCR; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; FAPRI, 2010, US WORLD AGR OUTL; Fletcher RJ, 2011, FRONT ECOL ENVIRON, V9, P161, DOI 10.1890/090091; Forman R. T. T., 2003, ROAD ECOLOGY; HANNAH L, 2005, CLIMATE CHANGE BIODI, P329; Johnson CJ, 2005, WILDLIFE MONOGR, P1; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; LU X, 2009, PNAS; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; *NAT REN EN LAB, 2001, NRELCP50029164; *NAT RES COUNC COM, 2007, IMP WIND EN PROJ; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; R Development Core Team, 2009, R FDN STAT COMP; Rubbo MJ, 2005, CONSERV BIOL, V19, P504, DOI 10.1111/j.1523-1739.2005.000101.x; Stein B., 2000, PRECIOUS HERITAGE ST; Stephens SE, 2008, CONSERV BIOL, V22, P1320, DOI 10.1111/j.1523-1739.2008.01022.x; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; *US BUR CENS, 2009, TOP INT GEOGR ENC RE; *US GOV ACC OFF, 2005, GAO05906; *USFWS, 2002, MIGR BIRD MORT MAN H; Yang LM, 2003, CAN J REMOTE SENS, V29, P230, DOI 10.5589/m02-098	36	90	90	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e17566	10.1371/journal.pone.0017566	http://dx.doi.org/10.1371/journal.pone.0017566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533285	gold, Green Published, Green Submitted			2022-12-25	WOS:000289458800005
J	Hameed, S; Dhamgaye, S; Singh, A; Goswami, SK; Prasad, R				Hameed, Saif; Dhamgaye, Sanjiveeni; Singh, Ashutosh; Goswami, Shyamal K.; Prasad, Rajendra			Calcineurin Signaling and Membrane Lipid Homeostasis Regulates Iron Mediated MultiDrug Resistance Mechanisms in Candida albicans	PLOS ONE			English	Article							HEME-BINDING PROTEIN; DRUG SUSCEPTIBILITIES; YEAST; TRANSPORTER; STRESS; GENE; TARGET; IDENTIFICATION; ACQUISITION; INHIBITION	We previously demonstrated that iron deprivation enhances drug susceptibility of Candida albicans by increasing membrane fluidity which correlated with the lower expression of ERG11 transcript and ergosterol levels. The iron restriction dependent membrane perturbations led to an increase in passive diffusion and drug susceptibility. The mechanisms underlying iron homeostasis and multidrug resistance (MDR), however, are not yet resolved. To evaluate the potential mechanisms, we used whole genome transcriptome and electrospray ionization tandem mass spectrometry (ESI-MS/MS) based lipidome analyses of iron deprived Candida cells to examine the new cellular circuitry of the MDR of this pathogen. Our transcriptome data revealed a link between calcineurin signaling and iron homeostasis. Among the several categories of iron deprivation responsive genes, the down regulation of calcineurin signaling genes including HSP90, CMP1 and CRZ1 was noteworthy. Interestingly, iron deprived Candida cells as well as iron acquisition defective mutants phenocopied molecular chaperone HSP90 and calcineurin mutants and thus were sensitive to alkaline pH, salinity and membrane perturbations. In contrast, sensitivity to above stresses did not change in iron deprived DSY2146 strain with a hyperactive allele of calcineurin. Although, iron deprivation phenocopied compromised HSP90 and calcineurin, it was independent of protein kinase C signaling cascade. Notably, the phenotypes associated with iron deprivation in genetically impaired calcineurin and HSP90 could be reversed with iron supplementation. The observed down regulation of ergosterol (ERG1, ERG2, ERG11 and ERG25) and sphingolipid biosynthesis (AUR1 and SCS7) genes followed by lipidome analysis confirmed that iron deprivation not only disrupted ergosterol biosynthesis, but it also affected sphingolipid homeostasis in Candida cells. These lipid compositional changes suggested extensive remodeling of the membranes in iron deprived Candida cells. Taken together, our data provide the first novel insight into the intricate relationship between cellular iron, calcineurin signaling, membrane lipid homeostasis and drug susceptibility of Candida cells.	[Hameed, Saif; Dhamgaye, Sanjiveeni; Singh, Ashutosh; Goswami, Shyamal K.; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Hameed, S (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rp47@mail.jnu.ac.in	SINGH, ASHUTOSH/AAR-1283-2021	SINGH, ASHUTOSH/0000-0002-0995-6696	Department of Biotechnology [BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008]; Department of Science and Technology [SR/SO/BB-34/2008, DFG INT/DFG/P-05/2005]; Council of Scientific and Industrial Research, Government of India; National Science Foundation [EPS 0236913, MCB 0455318, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health [P20RR16475]; Johnson Cancer Center; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Cancer Center; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work presented in this paper has been supported in part by grants to R. P. from the Department of Biotechnology (BT/PR9100/Med/29/03/2007, BT/PR9563/BRB/10/567/2007, BT/PR11158/BRB/10/640/2008) and the Department of Science and Technology (SR/SO/BB-34/2008: DFG INT/DFG/P-05/2005). S. H. is thankful to the Council of Scientific and Industrial Research, Government of India, for awarding the Senior Research Fellowship. The lipid analysis described in this work was partly performed at the Kansas Lipidomics Research Center Analytical Laboratory, where equipment acquisition and method development were funded by the National Science Foundation (EPS 0236913, MCB 0455318, DBI 0521587), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institutes of Health (P20RR16475), Johnson Cancer Center and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeed PA, 2009, ANTIMICROB AGENTS CH, V53, P496, DOI 10.1128/AAC.00633-08; Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Banerjee D, 2008, EUKARYOT CELL, V7, P68, DOI 10.1128/EC.00256-07; Batova M, 2008, CURR GENET, V53, P313, DOI 10.1007/s00294-008-0187-9; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Blankenship JR, 2003, EUKARYOT CELL, V2, P422, DOI 10.1128/EC.2.3.422-430.2003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; Cerbon J, 2005, BIOCHEM J, V388, P169, DOI 10.1042/BJ20040475; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Dogra S, 1999, YEAST, V15, P111, DOI 10.1002/(SICI)1097-0061(19990130)15:2&lt;111::AID-YEA350&gt;3.0.CO;2-E; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; FONZI WA, 1993, GENETICS, V134, P717; Fratti RA, 1998, INFECT IMMUN, V66, P191, DOI 10.1128/IAI.66.1.191-196.1998; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Heymann P, 2002, INFECT IMMUN, V70, P5246, DOI 10.1128/IAI.70.9.5246-5255.2002; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Im YJ, 2003, FEMS MICROBIOL LETT, V223, P199, DOI 10.1016/S0378-1097(03)00375-6; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Onyewu Chiatogu, 2004, Infection and Immunity, V72, P7330, DOI 10.1128/IAI.72.12.7330-7333.2004; Pasrija R, 2007, EUKARYOT CELL, V6, P443, DOI 10.1128/EC.00315-06; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Prasad T, 2010, FEMS YEAST RES, V10, P587, DOI 10.1111/j.1567-1364.2010.00639.x; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Riggle PJ, 2006, EUKARYOT CELL, V5, P1957, DOI 10.1128/EC.00243-06; Ruprich-Robert G, 2008, EUKARYOT CELL, V7, P1071, DOI 10.1128/EC.00066-08; Russell NJ, 1995, INT J FOOD MICROBIOL, V28, P255, DOI 10.1016/0168-1605(95)00061-5; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Singh A, 2010, OMICS, V14, P665, DOI 10.1089/omi.2010.0041; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Sugimoto Yuichi, 2004, Current Drug Targets - Infectious Disorders, V4, P311, DOI 10.2174/1568005043340597; Weissman Z, 2002, MOL MICROBIOL, V44, P1551, DOI 10.1046/j.1365-2958.2002.02976.x; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	51	44	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18684	10.1371/journal.pone.0018684	http://dx.doi.org/10.1371/journal.pone.0018684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533276	gold, Green Published, Green Submitted			2022-12-25	WOS:000289404700027
J	Doyle, T; Chen, ZM; Muscoli, C; Obeid, LM; Salvemini, D				Doyle, Tim; Chen, Zhoumou; Muscoli, Carolina; Obeid, Lina M.; Salvemini, Daniela			Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-kappa B- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E-2 pathway	FASEB JOURNAL			English	Article						pain; sphingolipid; sphingosine-1-phosphate; COX inhibitor; NS-398	NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASES; PRIMARY SENSORY NEURONS; NERVE GROWTH-FACTOR; GENE-EXPRESSION; PROSTAGLANDIN SYNTHESIS; ENDOPLASMIC-RETICULUM; SIGNALING PATHWAYS; PHOSPHOLIPASE A(2); INFLAMMATORY PAIN	Inflammatory pain represents an important unmet clinical need with important socioeconomic implications. Ceramide, a potent proinflammatory sphingolipid, has been shown to elicit mechanical hyperalgesia, but the mechanisms remain largely unknown. We now demonstrate that, in addition to mechanical hyperalgesia, intraplantar injection of ceramide (10 mu g) led to the development of thermal hyperalgesia that was dependent on induction of the inducible cyclooxygenase (COX-2) and subsequent increase of prostaglandin E-2 (PGE(2)). The development of mechanical and thermal hyperalgesia and increased production of PGE(2) was blocked by NS-398 (15-150 ng), a selective COX-2 inhibitor. The importance of the COX-2 to PGE(2) pathway in ceramide signaling was underscored by the findings that intraplantar injection of a monoclonal PGE(2) antibody (4 mu g) blocked the development of hyperalgesia. Our results further revealed that COX-2 induction is regulated by NF-kappa B and p38 kinase activation, since intraplantar injection of SC-514 (0.1-1 mu g) or SB 203580 (1-10 mu g), well-characterized inhibitors of NF-kappa B and p38 kinase activation, respectively, blocked COX-2 induction and increased formation of PGE(2) and thermal hyperalgesia in a dose-dependent manner. Moreover, activation of NF-kappa B was dependent on upstream activation of p38 MAPK, since SB 203580 (10 mu g) blocked p65 phosphorylation, whereas p38 kinase phosphorylation was unaffected by NF-kappa B inhibition by SC-514 (1 mu g). Our findings not only provide mechanistic insight into the signaling pathways engaged by ceramide in the development of hyperalgesia, but also provide a potential pharmacological basis for developing inhibitors targeting the ceramide metabolic-to-COX-2 pathway as novel analgesics.-Doyle, T., Chen, Z., Muscoli, C., Obeid, L. M., Salvemini, D. Intraplantar-injected ceramide in rats induces hyperalgesia through an NF-kappa B- and p38 kinase-dependent cyclooxygenase 2/prostaglandin E-2 pathway. FASEB J. 25, 2782-2791 (2011). www.fasebj.org	[Doyle, Tim; Chen, Zhoumou; Muscoli, Carolina; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Muscoli, Carolina] Magna Graecia Univ Catanzaro, Fac Pharm, Catanzaro, Italy; [Muscoli, Carolina] Ist Ricovero & Cura Carattere Sci San Raffaele La, Rome, Italy; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Saint Louis University; Magna Graecia University of Catanzaro; Medical University of South Carolina	Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	salvemd@slu.edu	Muscoli, Carolina/G-2773-2011	Muscoli, Carolina/0000-0002-1047-4467; obeid, lina/0000-0002-0734-0847	U.S. National Institutes of Health (NIH) [R01 DA024074, R21 DA023056, RO1 GM062887]; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023056, R01DA024074] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Amanda Finley (Department of Pharmacological and Physiological Science, St. Louis University School of Medicine) for her help in performing p38 Western blot analysis. This study was supported by U.S. National Institutes of Health (NIH) grants R01 DA024074 and R21 DA023056 to D.S. and a U.S. Department of Veterans Affairs Merit Award and NIH grant RO1 GM062887 to L.O. The authors declare no conflicts of interest.	Ardail D, 2002, BBA-MOL CELL BIOL L, V1583, P305, DOI 10.1016/S1388-1981(02)00252-4; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Bryant L, 2009, NEUROSCI LETT, V463, P49, DOI 10.1016/j.neulet.2009.07.051; Camandola S, 2005, J BIOL CHEM, V280, P22287, DOI 10.1074/jbc.M410923200; CANDELA M, 1991, J EXP MED, V174, P1363, DOI 10.1084/jem.174.6.1363; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1261; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Cheng JK, 2008, NEUROCHEM RES, V33, P1970, DOI 10.1007/s11064-008-9711-z; Chi XX, 2010, J NEUROPHYSIOL, V104, P2741, DOI 10.1152/jn.00709.2010; Cohen S, 2010, CURR OPIN RHEUMATOL, V22, P330, DOI 10.1097/BOR.0b013e3283378e6f; COLLIER HOJ, 1972, NATURE-NEW BIOL, V236, P141, DOI 10.1038/newbio236141a0; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DAVIS KD, 1993, J NEUROPHYSIOL, V69, P1071, DOI 10.1152/jn.1993.69.4.1071; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; FERREIRA SH, 1978, PROSTAGLANDINS, V16, P31, DOI 10.1016/0090-6980(78)90199-5; FUTAKI N, 1993, GEN PHARMACOL, V24, P105, DOI 10.1016/0306-3623(93)90018-S; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Gutierrez G, 2007, ANTI-CANCER DRUG, V18, P149, DOI 10.1097/CAD.0b013e3280115111; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayakawa M, 1996, BIOCHEM BIOPH RES CO, V220, P681, DOI 10.1006/bbrc.1996.0464; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Huang CY, 2010, J CELL PHYSIOL, V224, P475, DOI 10.1002/jcp.22145; Huang H, 2006, CELL DEATH DIFFER, V13, P1879, DOI 10.1038/sj.cdd.4401882; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jarvis WD, 1997, MOL PHARMACOL, V52, P935, DOI 10.1124/mol.52.6.935; Joo JH, 2008, J BIOL CHEM, V283, P16391, DOI 10.1074/jbc.M800945200; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; KHASAR SG, 1995, NEUROSCIENCE, V67, P189, DOI 10.1016/0306-4522(94)00632-F; Kim HJ, 2006, TOXICOLOGY, V225, P36, DOI 10.1016/j.tox.2006.04.053; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Kitano M, 2006, ARTHRITIS RHEUM-US, V54, P742, DOI 10.1002/art.21668; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Li NX, 2000, METHOD ENZYMOL, V319, P273; LOZANO J, 1994, J BIOL CHEM, V269, P19200; MACHLEIDT T, 1994, J BIOL CHEM, V269, P13760; Majumdar S, 2002, J IMMUNOL, V168, P2644, DOI 10.4049/jimmunol.168.6.2644; MARTIN HA, 1987, NEUROSCIENCE, V22, P651, DOI 10.1016/0306-4522(87)90360-5; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MONCADA S, 1975, EUR J PHARMACOL, V31, P250, DOI 10.1016/0014-2999(75)90047-3; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; Ndengele MM, 2008, FASEB J, V22, P3154, DOI 10.1096/fj.08-108159; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Newton R, 2000, BIOCHEM BIOPH RES CO, V277, P675, DOI 10.1006/bbrc.2000.3722; Oliveira MS, 2008, EPILEPSY RES, V79, P14, DOI 10.1016/j.eplepsyres.2007.12.008; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137; RUEFF A, 1993, NEUROSCIENCE, V54, P527, DOI 10.1016/0306-4522(93)90272-H; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Sauane M, 2010, J CELL PHYSIOL, V222, P546, DOI 10.1002/jcp.21969; Schafers M, 2008, NEUROSCIENCE, V157, P414, DOI 10.1016/j.neuroscience.2008.08.067; Schafers M, 2003, J NEUROSCI, V23, P3028; SCHAIBLE HG, 1988, J PHYSIOL-LONDON, V403, P91, DOI 10.1113/jphysiol.1988.sp017240; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Subbaramaiah K, 1998, J BIOL CHEM, V273, P32943, DOI 10.1074/jbc.273.49.32943; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1990, NEUROSCIENCE, V38, P757, DOI 10.1016/0306-4522(90)90068-F; Tang N, 2009, J OROFAC PAIN, V23, P167; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Wang ZY, 2010, PAIN, V151, P194, DOI 10.1016/j.pain.2010.07.006; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Wilcox CM, 2006, CLIN GASTROENTEROL H, V4, P1082, DOI 10.1016/j.cgh.2006.04.010; WILLIAMS TJ, 1973, NATURE, V246, P215, DOI 10.1038/246215a0; WILLIS AL, 1973, PROSTAG OTH LIPID M, V3, P353, DOI 10.1016/0090-6980(73)90073-7; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2006, J NEUROPHYSIOL, V96, P1042, DOI 10.1152/jn.00120.2006; Zhang YH, 2004, NEUROSCI LETT, V366, P187, DOI 10.1016/j.neulet.2004.05.042; Zhang YH, 2002, J PHYSIOL-LONDON, V544, P385, DOI 10.1113/jphysiol.2002.024265	88	24	24	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2011	25	8					2782	2791		10.1096/fj.10-178095	http://dx.doi.org/10.1096/fj.10-178095			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	800CV	21551240	Green Published			2022-12-25	WOS:000293337800026
J	Kitamura, R; Fukatsu, R; Kakusho, N; Cho, YS; Taniyama, C; Yamazaki, S; Toh, G; Yanagi, K; Arai, N; Chang, HJ; Masai, H				Kitamura, Ryo; Fukatsu, Rino; Kakusho, Naoko; Cho, Yong-Soon; Taniyama, Chika; Yamazaki, Satoshi; Toh, Gaik-theng; Yanagi, Kazuo; Arai, Naoko; Chang, Ho-Jin; Masai, Hisao			Molecular Mechanism of Activation of Human Cdc7 Kinase BIPARTITE INTERACTION WITH Dbf4/ACTIVATOR OF S PHASE KINASE (ASK) ACTIVATION SUBUNIT STIMULATES ATP BINDING AND SUBSTRATE RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE CDC7; HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; DNA-REPLICATION; PROTEIN-KINASE; S-PHASE; CELL-CYCLE; HSK1 KINASE; REGULATORY SUBUNIT; MCM PROTEINS	Cdc7 is a serine/threonine kinase conserved from yeasts to human and is known to play a key role in the regulation of initiation at each replication origin. Its catalytic function is activated via association with the activation subunit Dbf4/activator of S phase kinase (ASK). It is known that two conserved motifs of Dbf4/ASK are involved in binding to Cdc7, and both are required for maximum activation of Cdc7 kinase. Cdc7 kinases possess unique kinase insert sequences (kinase insert I-III) that are inserted at defined locations among the conserved kinase domains. However, precise mechanisms of Cdc7 kinase activation are largely unknown. We have identified two segments on Cdc7, DAM-1 (Dbf4/ASK interacting motif-1; amino acids 448-457 near the N terminus of kinase insert III) and DAM-2 (C-terminal 10-amino acid segment), that interact with motif-M and motif-C of ASK, respectively, and are essential for kinase activation by ASK. The C-terminal 143-amino acid polypeptide (432-574) containing DAM-1 and DAM-2 can interact with Dbf4/ASK. Characterization of the purified ASK-free Cdc7 and Cdc7-ASK complex shows that ATP binding of the Cdc7 catalytic subunit requires Dbf4/ASK. However, the "minimum" Cdc7, lacking the entire kinase insert II and half of kinase insert III, binds to ATP and shows autophosphorylation activity in the absence of ASK. However, ASK is still required for phosphorylation of exogenous substrates by the minimum Cdc7. These results indicate bipartite interaction between Cdc7 and Dbf4/ASK subunits facilitates ATP binding and substrate recognition by the Cdc7 kinase.	[Kitamura, Ryo; Fukatsu, Rino; Kakusho, Naoko; Taniyama, Chika; Yamazaki, Satoshi; Toh, Gaik-theng; Yanagi, Kazuo; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan; [Cho, Yong-Soon; Chang, Ho-Jin] CrystalGenomics Inc, Seoul 138736, South Korea; [Taniyama, Chika; Arai, Naoko] SBI Biotech Co Ltd, Minato Ku, Tokyo 1080071, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [23657081] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for basic scientific research (A) and a grant-in-aid for scientific research on priority area "Chromosome Cycle" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Takeda Science Foundation, and by Astellas Foundation for Research on Metabolic Disorders (to H. M.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Coleman KG, 1997, J BIOL CHEM, V272, P18869, DOI 10.1074/jbc.272.30.18869; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fung AD, 2002, MOL CELL BIOL, V22, P4477, DOI 10.1128/MCB.22.13.4477-4490.2002; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jiang W, 1997, P NATL ACAD SCI USA, V94, P14320, DOI 10.1073/pnas.94.26.14320; Kim BJ, 2006, J BIOL CHEM, V281, P12041, DOI 10.1074/jbc.M512630200; Kim BJ, 2007, J BIOL CHEM, V282, P30029, DOI 10.1074/jbc.M703705200; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lei M, 2001, J CELL SCI, V114, P1447; MARCOTE MJ, 1993, MOL CELL BIOL, V13, P5122, DOI 10.1128/MCB.13.8.5122; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H., 1999, FRONT BIOSCI, V4, pD834; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Ogino K, 2006, P NATL ACAD SCI USA, V103, P8131, DOI 10.1073/pnas.0602498103; Ohtoshi A, 1997, MOL GEN GENET, V254, P562, DOI 10.1007/s004380050452; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sawa Masaaki, 2009, Drug Des Devel Ther, V2, P255; SCLAFANI RA, 1994, MOL MICROBIOL, V11, P805, DOI 10.1111/j.1365-2958.1994.tb00358.x; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Uno S., 2011, GENES CELLS IN PRESS; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Yamashita N, 2005, GENES CELLS, V10, P551, DOI 10.1111/j.1365-2443.2005.00857.x; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; You ZY, 1999, MOL CELL BIOL, V19, P8003; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	56	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23031	23043		10.1074/jbc.M111.243311	http://dx.doi.org/10.1074/jbc.M111.243311			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21536671	Green Published, hybrid			2022-12-25	WOS:000292025000038
J	Lopez-Santiago, LF; Brackenbury, WJ; Chen, CL; Isom, LL				Lopez-Santiago, Luis F.; Brackenbury, William J.; Chen, Chunling; Isom, Lori L.			Na+ Channel Scn1b Gene Regulates Dorsal Root Ganglion Nociceptor Excitability in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNEL; SENSORY NEURONS; BETA-SUBUNITS; FUNCTIONAL EXPRESSION; RAT; CURRENTS; NA(V)1.8; CELLS; PAIN; AUTOTOMY	Nociceptive dorsal root ganglion (DRG) neurons express tetrodotoxin-sensitive (TTX-S) and -resistant (TTX-R) Na+ current (I-Na) mediated by voltage-gated Na+ channels (VGSCs). In nociceptive DRG neurons, VGSC beta 2 subunits, encoded by Scn2b, selectively regulate TTX-S alpha subunit mRNA and protein expression, ultimately resulting in changes in pain sensitivity. We hypothesized that VGSCs in nociceptive DRG neurons may also be regulated by beta 1 subunits, encoded by Scn1b. Scn1b null mice are models of Dravet Syndrome, a severe pediatric encephalopathy. Many physiological effects of Scn1b deletion on CNS neurons have been described. In contrast, little is known about the role of Scn1b in peripheral neurons in vivo. Here we demonstrate that Scn1b null DRG neurons exhibit a depolarizing shift in the voltage dependence of TTX-S INa inactivation, reduced persistent TTX-RINa, a prolonged rate of recovery of TTX-RINa from inactivation, and reduced cell surface expression of Na(v)1.9 compared with their WT littermates. Investigation of action potential firing shows that Scn1b null DRG neurons are hyperexcitable compared with WT. Consistent with this, transient outward K+ current (I-to) is significantly reduced in null DRG neurons. We conclude that Scn1b regulates the electrical excitability of nociceptive DRG neurons in vivo by modulating both I-Na and I-K.	[Lopez-Santiago, Luis F.; Brackenbury, William J.; Chen, Chunling; Isom, Lori L.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Isom, LL (corresponding author), Univ Michigan, Dept Pharmacol, 1301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	lisom@umich.edu	Brackenbury, William/AAD-1759-2019; Brackenbury, William/D-8029-2014	Brackenbury, William/0000-0001-6882-3351; Brackenbury, William/0000-0001-6882-3351; Isom, Lori/0000-0002-9479-6729	National Institutes of Health [R01MH059980]; University of Michigan Gastrointestinal Peptide Research Center [2P30DK34933]; University of Michigan Center for Organogenesis; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059980] Funding Source: NIH RePORTER; Medical Research Council [G1000508] Funding Source: researchfish; MRC [G1000508] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Gastrointestinal Peptide Research Center(University of Michigan System); University of Michigan Center for Organogenesis(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01MH059980 (to L. L. I.) and 2P30DK34933 (from the University of Michigan Gastrointestinal Peptide Research Center to L. F. L.-S.). This work was also supported by a University of Michigan Center for Organogenesis Non-traditional Postdoctoral Fellowship (to W.J.B.).	Abdulla FA, 2002, J NEUROPHYSIOL, V88, P2518, DOI 10.1152/jn.00913.2001; Abdulla FA, 2001, J NEUROPHYSIOL, V85, P644, DOI 10.1152/jn.2001.85.2.644; Akopian A. N., 1999, NATURE, V402, P541; Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Blackburn-Munro G, 1999, NEUROSCIENCE, V90, P153, DOI 10.1016/S0306-4522(98)00415-1; Blair NT, 2002, J NEUROSCI, V22, P10277; Brackenbury WJ, 2008, EXPERT OPIN THER TAR, V12, P1191, DOI 10.1517/14728222.12.9.1191 ; Brackenbury WJ, 2006, J PHYSIOL-LONDON, V573, P343, DOI 10.1113/jphysiol.2006.106906; Brackenbury WJ, 2008, NEUROSCIENTIST, V14, P571, DOI 10.1177/1073858408320293; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Cummins TR, 1997, J NEUROSCI, V17, P3503; Dang K, 2004, AM J PHYSIOL-GASTR L, V286, pG573, DOI 10.1152/ajpgi.00258.2003; Decosterd I, 2002, PAIN, V96, P269, DOI 10.1016/S0304-3959(01)00456-0; Deschenes I, 2002, FEBS LETT, V528, P183, DOI 10.1016/S0014-5793(02)03296-9; Deschenes I, 2008, J MOL CELL CARDIOL, V45, P336, DOI 10.1016/j.yjmcc.2008.05.001; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Kazen-Gillespie KA, 2000, J BIOL CHEM, V275, P1079, DOI 10.1074/jbc.275.2.1079; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Priest BT, 2005, P NATL ACAD SCI USA, V102, P9382, DOI 10.1073/pnas.0501549102; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Safronov BV, 1996, J PHYSIOL-LONDON, V493, P393, DOI 10.1113/jphysiol.1996.sp021391; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Scheffer IE, 2007, BRAIN, V130, P100, DOI 10.1093/brain/awl272; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; Vijayaragavan K, 2004, BIOCHEM BIOPH RES CO, V319, P531, DOI 10.1016/j.bbrc.2004.05.026; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Xu GY, 2006, AM J PHYSIOL-GASTR L, V291, pG424, DOI 10.1152/ajpgi.00560.2005	36	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					22913	22923		10.1074/jbc.M111.242370	http://dx.doi.org/10.1074/jbc.M111.242370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21555511	hybrid, Green Published			2022-12-25	WOS:000292025000026
J	Pefani, DE; Dimaki, M; Spella, M; Karantzelis, N; Mitsiki, E; Kyrousi, C; Symeonidou, IE; Perrakis, A; Taraviras, S; Lygerou, Z				Pefani, Dafni-Eleutheria; Dimaki, Maria; Spella, Magda; Karantzelis, Nickolas; Mitsiki, Eirini; Kyrousi, Christina; Symeonidou, Ioanna-Eleni; Perrakis, Anastassis; Taraviras, Stavros; Lygerou, Zoi			Idas, a Novel Phylogenetically Conserved Geminin-related Protein, Binds to Geminin and Is Required for Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CEREBRAL-CORTEX; EMBRYONIC-DEVELOPMENT; G(2)/M CHECKPOINT; LICENSING FACTOR; CHROMOSOMAL DNA; RE-REPLICATION; NEURAL PLATE; CDT1; INHIBITION	Development and homeostasis of multicellular organisms relies on an intricate balance between cell proliferation and differentiation. Geminin regulates the cell cycle by directly binding and inhibiting the DNA replication licensing factor Cdt1. Geminin also interacts with transcriptional regulators of differentiation and chromatin remodelling factors, and its balanced interactions are implicated in proliferation-differentiation decisions during development. Here, we describe Idas (Idas being a cousin of the Gemini in Ancient Greek Mythology), a previously uncharacterised coiled-coil protein related to Geminin. We show that human Idas localizes to the nucleus, forms a complex with Geminin both in cells and in vitro through coiled-coil mediated interactions, and can change Geminin subcellular localization. Idas does not associate with Cdt1 and prevents Geminin from binding to Cdt1 in vitro. Idas depletion from cells affects cell cycle progression; cells accumulate in S phase and are unable to efficiently progress to mitosis. Idas protein levels decrease in anaphase, whereas its overexpression causes mitotic defects. During development, we show that Idas exhibits high level expression in the choroid plexus and the cortical hem of the mouse telencephalon. Our data highlight Idas as a novel Geminin binding partner, implicated in cell cycle progression, and a putative regulator of proliferation-differentiation decisions during development.	[Pefani, Dafni-Eleutheria; Dimaki, Maria; Symeonidou, Ioanna-Eleni; Lygerou, Zoi] Univ Patras, Sch Med, Biol Lab, Patras 26505, Greece; [Spella, Magda; Karantzelis, Nickolas; Kyrousi, Christina; Taraviras, Stavros] Univ Patras, Sch Med, Physiol Lab, Patras 26505, Greece; [Mitsiki, Eirini; Perrakis, Anastassis] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands	University of Patras; University of Patras; Netherlands Cancer Institute	Lygerou, Z (corresponding author), Univ Patras, Sch Med, Biol Lab, Patras 26505, Greece.	lygerou@med.upatras.gr	Perrakis, Anastassis/E-8704-2013; Taraviras, Stavros/AAJ-4690-2020	Perrakis, Anastassis/0000-0002-1151-6227; Taraviras, Stavros/0000-0002-7455-647X; Kyrousi, Christina/0000-0002-6234-8382; Karantzelis, Nikolaos/0000-0002-6582-6757	Association for International Cancer Research; European Grants; Erasmus and FEBS Summer Fellowships	Association for International Cancer Research; European Grants; Erasmus and FEBS Summer Fellowships	This work was supported by the Association for International Cancer Research, European Grants HYGEIA and 3D-Repertoire, and Erasmus and FEBS Summer Fellowships (to D. P. and N. K.).	Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Boos A, 2006, BIOL CELL, V98, P363, DOI 10.1042/BC20060007; Cara E, 2007, TRENDS CELL BIOL, V17, P580, DOI 10.1016/j.tcb.2007.09.008; Caro E, 2007, NATURE, V447, P213, DOI 10.1038/nature05763; De Marco V, 2009, P NATL ACAD SCI USA, V106, P19807, DOI 10.1073/pnas.0905281106; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gemund C, 2001, NUCLEIC ACIDS RES, V29, P1272, DOI 10.1093/nar/29.6.1272; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kroll KL, 2007, FRONT BIOSCI, V12, P1395, DOI 10.2741/2156; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lin JJ, 2007, J BIOL CHEM, V282, P30357, DOI 10.1074/jbc.M705178200; Luna-Vargas MPA, 2011, J STRUCT BIOL, V175, P113, DOI 10.1016/j.jsb.2011.03.017; Luo LF, 2004, CELL CYCLE, V3, P711; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lygerou Z, 2000, SCIENCE, V290, P2271; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Roukos V, 2007, J BIOL CHEM, V282, P9346, DOI 10.1074/jbc.M611643200; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Sugimoto N, 2008, MOL BIOL CELL, V19, P1007, DOI 10.1091/mbc.E07-09-0859; Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Thepaut M, 2004, J MOL BIOL, V342, P275, DOI 10.1016/j.jmb.2004.06.065; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Xouri G, 2004, EUR J BIOCHEM, V271, P3368, DOI 10.1111/j.1432-1033.2004.04271.x; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	52	36	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2011	286	26					23234	23246		10.1074/jbc.M110.207688	http://dx.doi.org/10.1074/jbc.M110.207688			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	782QP	21543332	Green Published, hybrid			2022-12-25	WOS:000292025000057
J	Chen, CM; Natale, DA; Finn, RD; Huang, HZ; Zhang, J; Wu, CH; Mazumder, R				Chen, Chuming; Natale, Darren A.; Finn, Robert D.; Huang, Hongzhan; Zhang, Jian; Wu, Cathy H.; Mazumder, Raja			Representative Proteomes: A Stable, Scalable and Unbiased Proteome Set for Sequence Analysis and Functional Annotation	PLOS ONE			English	Article							TAXONOMY	The accelerating growth in the number of protein sequences taxes both the computational and manual resources needed to analyze them. One approach to dealing with this problem is to minimize the number of proteins subjected to such analysis in a way that minimizes loss of information. To this end we have developed a set of Representative Proteomes (RPs), each selected from a Representative Proteome Group (RPG) containing similar proteomes calculated based on co-membership in UniRef50 clusters. A Representative Proteome is the proteome that can best represent all the proteomes in its group in terms of the majority of the sequence space and information. RPs at 75%, 55%, 35% and 15% co-membership threshold (CMT) are provided to allow users to decrease or increase the granularity of the sequence space based on their requirements. We find that a CMT of 55% (RP55) most closely follows standard taxonomic classifications. Further analysis of this set reveals that sequence space is reduced by more than 80% relative to UniProtKB, while retaining both sequence diversity (over 95% of InterPro domains) and annotation information (93% of experimentally characterized proteins). All sets can be browsed and are available for sequence similarity searches and download at http://www.proteininformationresource.org/rps, while the set of 637 RPs determined using a 55% CMT are also available for text searches. Potential applications include sequence similarity searches, protein classification and targeted protein annotation and characterization.	[Chen, Chuming; Huang, Hongzhan; Wu, Cathy H.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE 19716 USA; [Natale, Darren A.; Zhang, Jian; Wu, Cathy H.; Mazumder, Raja] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Finn, Robert D.] Howard Hughes Med Inst, Ashburn, VA USA	University of Delaware; Georgetown University; Howard Hughes Medical Institute	Chen, CM (corresponding author), Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE 19716 USA.	rm285@georgetown.edu	Chen, Chuming/A-7585-2009; Natale, Darren A/AAE-9303-2019; Crozier, Laura B./A-4821-2010	Chen, Chuming/0000-0002-7287-9013; Natale, Darren A/0000-0001-5809-9523; Wu, Cathy/0000-0001-6379-8601; Finn, Robert/0000-0001-8626-2148; Mazumder, Raja/0000-0001-8823-9945	Protein Information Resource (PIR); UNIDEL Foundation; National Institutes of Health [2U01HG02712-04]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG002712] Funding Source: NIH RePORTER	Protein Information Resource (PIR); UNIDEL Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The funding for the Open Access publication charges was provided by Protein Information Resource (PIR). The work conducted at the Delaware Center for Bioinformatics and Computational Biology and the PIR is partially funded by the UNIDEL Foundation grant (to CW). The underlying PIR bioinformatics infrastructure and UniRef database is partially supported by the National Institutes of Health grant 2U01HG02712-04 (to CHW). RF is supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Escobar-Paramo P, 2003, J MOL EVOL, V57, P140, DOI 10.1007/s00239-003-2460-3; Flicek P, 2011, NUCL ACIDS RES; Gabaldon T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-403; GO Consortium, 2009, PLOS COMPUT BIOL, V5; Huang HZ, 2007, FRONT BIOSCI-LANDMRK, V12, P5071, DOI 10.2741/2449; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Imhoff JF, 2003, INT J SYST EVOL MICR, V53, P941, DOI 10.1099/ijs.0.02403-0; Leinonen R, 2004, BIOINFORMATICS, V20, P3236, DOI 10.1093/bioinformatics/bth191; Mazumder R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-279; Nikolskayaw QN, 2006, EVOL BIOINFORM, V2, P197; Sammut SJ, 2008, BRIEF BIOINFORM, V9, P210, DOI 10.1093/bib/bbn010; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tindall BJ, 2005, INT J SYST EVOL MICR, V55, P521, DOI 10.1099/ijs.0.63580-0	15	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2011	6	4							e18910	10.1371/journal.pone.0018910	http://dx.doi.org/10.1371/journal.pone.0018910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756NO	21556138	gold, Green Submitted, Green Published			2022-12-25	WOS:000290019400018
J	Greenberg, E; Hershkovitz, L; Itzhaki, O; Hajdu, S; Nemlich, Y; Ortenberg, R; Gefen, N; Edry, L; Modai, S; Keisari, Y; Besser, MJ; Schachter, J; Shomron, N; Markel, G				Greenberg, Eyal; Hershkovitz, Liat; Itzhaki, Orit; Hajdu, Steven; Nemlich, Yael; Ortenberg, Rona; Gefen, Nir; Edry, Liat; Modai, Shira; Keisari, Yona; Besser, Michal J.; Schachter, Jacob; Shomron, Noam; Markel, Gal			Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs	PLOS ONE			English	Article							MALIGNANT-MELANOMA; VASCULOGENIC MIMICRY; UVEAL MELANOMA; C-MET; EXPRESSION; PROGRESSION; MIR-31; METASTASIS; MIRNA; PROLIFERATION	MicroRNAs (miRNAs) are small non-coding RNAs with regulatory roles, which are involved in a broad spectrum of physiological and pathological processes, including cancer. A common strategy for identification of miRNAs involved in cell transformation is to compare malignant cells to normal cells. Here we focus on identification of miRNAs that regulate the aggressive phenotype of melanoma cells. To avoid differences due to genetic background, a comparative high-throughput miRNA profiling was performed on two isogenic human melanoma cell lines that display major differences in their net proliferation, invasion and tube formation activities. This screening revealed two major cohorts of differentially expressed miRNAs. We speculated that miRNAs up-regulated in the more-aggressive cell line contribute oncogenic features, while the down-regulated miRNAs are tumor suppressive. This assumption was further tested experimentally on five candidate tumor suppressive miRNAs (miR-31, -34a, -184, -185 and -204) and on one candidate oncogenic miRNA (miR-17-5p), all of which have never been reported before in cutaneous melanoma. Remarkably, all candidate Suppressive-miRNAs inhibited net proliferation, invasion or tube formation, while miR-17-5p enhanced cell proliferation. miR-34a and miR-185 were further shown to inhibit the growth of melanoma xenografts when implanted in SCID-NOD mice. Finally, all six candidate miRNAs were detected in 15 different metastatic melanoma specimens, attesting for the physiological relevance of our findings. Collectively, these findings may prove instrumental for understanding mechanisms of disease and for development of novel therapeutic and staging technologies for melanoma.	[Greenberg, Eyal; Hershkovitz, Liat; Itzhaki, Orit; Hajdu, Steven; Nemlich, Yael; Ortenberg, Rona; Besser, Michal J.; Schachter, Jacob; Markel, Gal] Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel; [Greenberg, Eyal; Keisari, Yona; Markel, Gal] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Gefen, Nir] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Edry, Liat; Modai, Shira; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Markel, Gal] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Greenberg, E (corresponding author), Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel.	Markel@post.tau.ac.il			Recanati Foundation for Medical Research [6713]; Chief Scientist Office, Ministry of Health, Israel [3-4876]; Kurz-Lion Foundation; Tel-Aviv University, Faculty of Medicine, Schreiber Foundation; Wolfson Family Charitable Fund	Recanati Foundation for Medical Research; Chief Scientist Office, Ministry of Health, Israel; Kurz-Lion Foundation; Tel-Aviv University, Faculty of Medicine, Schreiber Foundation; Wolfson Family Charitable Fund	Gal Markel is supported by The Recanati Foundation for Medical Research (#6713). Noam Shomron is supported by Chief Scientist Office, Ministry of Health, Israel (#3-4876); The Kurz-Lion Foundation; The Tel-Aviv University, Faculty of Medicine, Schreiber Foundation; and The Wolfson Family Charitable Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arganda-Carreras I, 2010, MICROSC RES TECH; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YC, 2010, MOL THER, V18, P1650, DOI 10.1038/mt.2010.136; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Frenkel S, 2008, EYE, V22, P948, DOI 10.1038/sj.eye.6702783; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gloster HM, 1996, DERMATOL SURG, V22, P217, DOI 10.1111/j.1524-4725.1996.tb00312.x; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Ivanov SV, 2010, J BIOL CHEM, V285, P22807, DOI 10.1074/jbc.M110.100354; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li M, 2010, PATHOL ONCOL RES, V16, P259, DOI 10.1007/s12253-009-9220-7; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Melnikova VO, 2008, CANCER BIOL THER, V7, P997, DOI 10.4161/cbt.7.7.6535; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nachmani D, 2010, NAT IMMUNOL, V11, P806, DOI 10.1038/ni.1916; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; SUN B, 2006, VASCULOGENIC MIMICRY, P693; Takahashi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006677; Tap WD, 2010, NEOPLASIA, V12, P637, DOI 10.1593/neo.10414; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yan DS, 2009, INVEST OPHTH VIS SCI, V50, P1559, DOI 10.1167/iovs.08-2681	50	69	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18936	10.1371/journal.pone.0018936	http://dx.doi.org/10.1371/journal.pone.0018936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	21541354	Green Submitted, gold, Green Published			2022-12-25	WOS:000290016800028
J	Holtfreter, MC; Stachs, O; Reichard, M; Loebermann, M; Guthoff, RF; Reisinger, EC				Holtfreter, Martha Charlotte; Stachs, Oliver; Reichard, Maria; Loebermann, Micha; Guthoff, Rudolf Friedrich; Reisinger, Emil Christian			Confocal Laser Scanning Microscopy for Detection of Schistosoma mansoni Eggs in the Gut of Mice	PLOS ONE			English	Article							INFECTION; DIAGNOSIS; CHEMOTHERAPY; COMBINATION; SAMPLES; OOGRAM; PCR	Background: The gold standard for diagnosing Schistosoma mansoni infections is the detection of eggs from stool or biopsy specimens. The viability of collected eggs can be tested by the miracidium hatching procedure. Direct detection methods are often limited in patients with light or early infections, whereas serological tests and PCR methods fail to differentiate between an inactive and persistent infection and between schistosomal species. Recently, confocal laser scanning microscopy (CLSM) has been introduced as a diagnostic tool in several fields of medicine. In this study we evaluated CLSM for the detection of viable eggs of S. mansoni directly within the gut of infected mice. Methodology/Principal Findings: The confocal laser scanning microscope used in this study is based on the Heidelberg Retina Tomograph II scanning laser system in combination with the Rostock Cornea Module (image modality 1) or a rigid endoscope (image modality 2). Colon sections of five infected mice were examined with image modalities 1 and 2 for schistosomal eggs. Afterwards a biopsy specimen was taken from each colon section and examined by bright-field microscopy. Visualised eggs were counted and classified in terms of viability status. Conclusions/Significance: We were able to show that CLSM visualises eggs directly within the gut and permits discrimination of schistosomal species and determination of egg viability. Thus, CLSM may be a suitable non-invasive tool for the diagnosis of schistosomiasis in humans.	[Holtfreter, Martha Charlotte; Loebermann, Micha; Reisinger, Emil Christian] Univ Rostock, Dept Internal Med, Div Trop Med & Infect Dis, D-2500 Rostock, Germany; [Stachs, Oliver; Reichard, Maria; Guthoff, Rudolf Friedrich] Univ Rostock, Dept Ophthalmol, D-2500 Rostock, Germany	University of Rostock; University of Rostock	Holtfreter, MC (corresponding author), Univ Rostock, Dept Internal Med, Div Trop Med & Infect Dis, D-2500 Rostock, Germany.	emil.reisinger@uni-rostock.de	Loebermann, Micha/P-2592-2019	Loebermann, Micha/0000-0002-3453-8998	DFG [Transregio 37]	DFG(German Research Foundation (DFG))	The study was supported by the DFG (Transregio 37, Micro- and Nanosystems in Medicine - Reconstruction of Biological Functions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Oliveira LMA, 2010, DIAGN MICR INFEC DIS, V68, P416, DOI 10.1016/j.diagmicrobio.2010.07.016; CANCADO JR, 1965, B WORLD HEALTH ORGAN, V33, P557; CHEEVER AW, 1992, AM J TROP MED HYG, V46, P752, DOI 10.4269/ajtmh.1992.46.752; Dailey ME, 1995, HDB BIOL CONFOCAL MI, P381; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Farahati B, 2010, J ORAL PATHOL MED, V39, P318, DOI 10.1111/j.1600-0714.2009.00841.x; Gerger A, 2009, BRIT J DERMATOL, V160, P475, DOI 10.1111/j.1365-2133.2008.08995.x; GIBODA M, 1994, FOLIA PARASIT, V41, P55; Guthoff RF, 2009, CLIN EXP OPHTHALMOL, V37, P100, DOI 10.1111/j.1442-9071.2009.02016.x; Jurberg AD, 2009, DEV GENES EVOL, V219, P219, DOI 10.1007/s00427-009-0285-9; Mudawi HMY, 2006, NAT CLIN PRACT GASTR, V3, P700, DOI 10.1038/ncpgasthep0655; Nohr-Westphal C, 2009, UROLOGE, V48, P1025, DOI 10.1007/s00120-009-2078-1; PELLEGRINO J, 1963, J PARASITOL, V49, P365, DOI 10.2307/3275798; Sandoval N, 2006, PARASITOLOGY, V133, P581, DOI 10.1017/S0031182006000898; Sarvel AK, 2006, MEM I OSWALDO CRUZ, V101, P289, DOI 10.1590/S0074-02762006000900045; Stave J, 2002, OPHTHALMOLOGE, V99, P276, DOI 10.1007/s003470100535; Tarp B, 2000, TROP MED INT HEALTH, V5, P185, DOI 10.1046/j.1365-3156.2000.00539.x; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; van Gool T, 2002, J CLIN MICROBIOL, V40, P3432, DOI 10.1128/JCM.40.9.3432-3437.2002; Wichmann D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000422; Xu J, 2010, INT J PARASITOL, V40, P327, DOI 10.1016/j.ijpara.2009.08.010; Zhivov A, 2009, BRIT J OPHTHALMOL, V93, P667, DOI 10.1136/bjo.2008.137430	23	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18799	10.1371/journal.pone.0018799	http://dx.doi.org/10.1371/journal.pone.0018799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533168	Green Submitted, Green Published, gold			2022-12-25	WOS:000289620100020
J	Rogue, A; Lambert, C; Josse, R; Antherieu, S; Spire, C; Claude, N; Guillouzo, A				Rogue, Alexandra; Lambert, Carine; Josse, Rozenn; Antherieu, Sebastien; Spire, Catherine; Claude, Nancy; Guillouzo, Andre			Comparative Gene Expression Profiles Induced by PPAR gamma and PPAR alpha/gamma Agonists in Human Hepatocytes	PLOS ONE			English	Article							NUCLEAR RECEPTORS; CYTOCHROMES P450; CELL-LINE; HEPARG; ALPHA; TROGLITAZONE; LIVER; THIAZOLIDINEDIONE; MURAGLITAZAR; TESAGLITAZAR	Background: Several glitazones (PPAR gamma agonists) and glitazars (dual PPAR alpha/gamma agonists) have been developed to treat hyperglycemia and, simultaneously, hyperglycemia and dyslipidemia, respectively. However, most have caused idiosyncratic hepatic or extrahepatic toxicities through mechanisms that remain largely unknown. Since the liver plays a key role in lipid metabolism, we analyzed changes in gene expression profiles induced by these two types of PPAR agonists in human hepatocytes. Methodology/Principal Findings: Primary human hepatocytes and the well-differentiated human hepatoma HepaRG cells were exposed to different concentrations of two PPAR gamma (troglitazone and rosiglitazone) and two PPAR alpha/gamma (muraglitazar and tesaglitazar) agonists for 24 h and their transcriptomes were analyzed using human pangenomic Agilent microarrays. Principal Component Analysis, hierarchical clustering and Ingenuity Pathway Analysis (R) revealed large inter-individual variability in the response of the human hepatocyte populations to the different compounds. Many genes involved in lipid, carbohydrate, xenobiotic and cholesterol metabolism, as well as inflammation and immunity, were regulated by both PPAR gamma and PPAR alpha/gamma agonists in at least a number of human hepatocyte populations and/or HepaRG cells. Only a few genes were selectively deregulated by glitazars when compared to glitazones, indicating that PPAR alpha and PPAR alpha/gamma agonists share most of their target genes. Moreover, some target genes thought to be regulated only in mouse or to be expressed in Kupffer cells were also found to be responsive in human hepatocytes and HepaRG cells. Conclusions/Significance: This first comprehensive analysis of gene regulation by PPAR gamma and PPAR alpha/gamma agonists favor the conclusion that glitazones and glitazars share most of their target genes and induce large differential changes in gene profiles in human hepatocytes depending on hepatocyte donor, the compound class and/or individual compound, thereby supporting the occurrence of idiosyncratic toxicity in some patients.	[Rogue, Alexandra; Lambert, Carine; Josse, Rozenn; Antherieu, Sebastien; Guillouzo, Andre] Fac Sci Pharmaceut & Biol, INSERM, UMR U991, Rennes, France; [Rogue, Alexandra; Lambert, Carine; Josse, Rozenn; Antherieu, Sebastien; Guillouzo, Andre] Univ Rennes 1, Rennes, France; [Rogue, Alexandra; Spire, Catherine] Biol Servier, Gidy, France; [Claude, Nancy] Inst Rech Servier, Courbevoie, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Servier; Servier; Institut de Recherches Internationales Servier	Rogue, A (corresponding author), Fac Sci Pharmaceut & Biol, INSERM, UMR U991, Rennes, France.	catherine.spire@fr.netgrs.com; andre.guillouzo@univ-rennes1.fr	GUILLOUZO, Andre/Z-2373-2019; Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973	Biologie Servier (Gidy, France); European Economic Community [20222]; ARNT (French Ministry of Research); CIFRE	Biologie Servier (Gidy, France); European Economic Community; ARNT (French Ministry of Research)(Ministry of Research, France); CIFRE	The funders are Biologie Servier (Gidy, France), European Economic Community, contract Predict-IV, number 20222, and ARNT (French Ministry of Research), CIFRE contract. The funders had a role in study design but not in data collection and analysis, decision to publish, or preparation of the manuscript.	Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Anwer MS, 2004, HEPATOLOGY, V39, P581, DOI 10.1002/hep.20090; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; CAMPS L, 1991, J LIPID RES, V32, P1877; Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536; DeLuca JG, 2000, MOL PHARMACOL, V58, P470, DOI 10.1124/mol.58.3.470; Devasthale PV, 2005, J MED CHEM, V48, P2248, DOI 10.1021/jm0496436; Ericsson H, 2004, DRUG METAB DISPOS, V32, P923; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feinstein DL, 2005, BIOCHEM PHARMACOL, V70, P177, DOI 10.1016/j.bcp.2005.03.033; Fievet C, 2006, CURR OPIN PHARMACOL, V6, P606, DOI 10.1016/j.coph.2006.06.009; Funk C, 2001, TOXICOLOGY, V167, P83, DOI 10.1016/S0300-483X(01)00460-7; Gould Rothberg Bonnie E., 2001, Functional and Integrative Genomics, V1, P294, DOI 10.1007/s101420000022; Goyak KMO, 2008, TOXICOL APPL PHARM, V231, P216, DOI 10.1016/j.taap.2008.04.024; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; GUGUENGUILLOUZO C, 1982, CELL BIOL INT REP, V6, P625, DOI 10.1016/0309-1651(82)90187-4; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; Guo L, 2006, MOL DIVERS, V10, P349, DOI 10.1007/s11030-006-9038-0; Hellmold H, 2007, TOXICOL SCI, V98, P63, DOI 10.1093/toxsci/kfm094; Isley William L, 2003, Expert Opin Drug Saf, V2, P581, DOI 10.1517/14740338.2.6.581; Jennen DGJ, 2010, TOXICOL SCI, V115, P66, DOI 10.1093/toxsci/kfq026; Jigorel E, 2005, DRUG METAB DISPOS, V33, P1418, DOI 10.1124/dmd.105.004762; Josse R, 2008, DRUG METAB DISPOS, V36, P1111, DOI 10.1124/dmd.107.019901; Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P137, DOI 10.1124/dmd.107.017418; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Lambert CB, 2009, TOXICOL APPL PHARM, V234, P345, DOI 10.1016/j.taap.2008.11.008; Lauer B, 2009, CHEM-BIOL INTERACT, V179, P17, DOI 10.1016/j.cbi.2008.10.031; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Malik AH, 2000, DIGEST DIS SCI, V45, P210, DOI 10.1023/A:1005450519498; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Sahi J, 2000, XENOBIOTICA, V30, P273, DOI 10.1080/004982500237668; Scott MJ, 2010, J HEPATOL, V53, P693, DOI 10.1016/j.jhep.2010.04.026; Shishido S, 2003, HEPATOLOGY, V37, P136, DOI 10.1053/jhep.2003.50014; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Yamamoto Y, 2001, LIFE SCI, V70, P471, DOI 10.1016/S0024-3205(01)01432-1; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206	42	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2011	6	4							e18816	10.1371/journal.pone.0018816	http://dx.doi.org/10.1371/journal.pone.0018816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	751LS	21533120	Green Published, gold			2022-12-25	WOS:000289620100022
J	Li, W; Fan, QY; Ji, ZW; Qiu, XC; Li, Z				Li, Wei; Fan, Qingyu; Ji, Zhenwei; Qiu, Xiuchun; Li, Zhao			The Effects of Irreversible Electroporation (IRE) on Nerves	PLOS ONE			English	Article							ABLATION; REGENERATION; INJURY; REPAIR; CELLS; MODEL	Background: If a critical nerve is circumferentially involved with tumor, radical surgery intended to cure the cancer must sacrifice the nerve. Loss of critical nerves may lead to serious consequences. In spite of the impressive technical advancements in nerve reconstruction, complete recovery and normalization of nerve function is difficult to achieve. Though irreversible electroporation ( IRE) might be a promising choice to treat tumors near or involved critical nerve, the pathophysiology of the nerve after IRE treatment has not be clearly defined. Methods: We applied IRE directly to a rat sciatic nerve to study the long term effects of IRE on the nerve. A sequence of 10 square pulses of 3800 V/cm, each 100 mu s long was applied directly to rat sciatic nerves. In each animal of group I (IRE) the procedure was applied to produce a treated length of about 10 mm. In each animal of group II (Control) the electrodes were only applied directly on the sciatic nerve for the same time. Electrophysiological, histological, and functional studies were performed on immediately after and 3 days, 1 week, 3, 5, 7 and 10 weeks following surgery. Findings: Electrophysiological, histological, and functional results show the nerve treated with IRE can attain full recovery after 7 weeks. Conclusion: This finding is indicative of the preservation of nerve involving malignant tumors with respect to the application of IRE pulses to ablate tumors completely. In summary, IRE may be a promising treatment tool for any tumor involving nerves.	[Li, Wei; Fan, Qingyu; Ji, Zhenwei; Qiu, Xiuchun; Li, Zhao] Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Li, W (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Orthoped Oncol Inst Chinese PLA, Xian 710032, Shaanxi, Peoples R China.	leelieber@gmail.com		Li, Zhao/0000-0002-9276-9129				Abramov GS, 1996, BURNS, V22, P602, DOI 10.1016/S0305-4179(96)00055-1; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Ball C, 2010, ANESTH ANALG, V110, P1305, DOI 10.1213/ANE.0b013e3181d27b30; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Choi YS, 2010, TISSUE ENG PART C-ME, V16, P1245, DOI [10.1089/ten.tec.2009.0803, 10.1089/ten.TEC.2009.0803]; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Ferguson Peter C., 2009, V179, P243; Fernandes M, 2008, J NEUROSCI METH, V170, P16, DOI 10.1016/j.jneumeth.2007.12.009; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Fullarton AC, 2000, J HAND SURG-BRIT EUR, V25B, P52, DOI 10.1054/jhsb.1999.0337; George LT, 2003, J RECONSTR MICROSURG, V19, P41, DOI 10.1055/s-2003-37190; Goldberg SN, 2009, J VASC INTERV RADIOL, V20, pS377, DOI 10.1016/j.jvir.2009.04.011; Gordon T, 2009, INT REV NEUROBIOL, V87, P433, DOI 10.1016/S0074-7742(09)87024-4; Guo Y, 2010, CANCER RES, V70, P1555, DOI 10.1158/0008-5472.CAN-09-3067; HARE GMT, 1992, PLAST RECONSTR SURG, V89, P251, DOI 10.1097/00006534-199202000-00009; Hess JR, 2007, PLAST RECONSTR SURG, V119, P246, DOI 10.1097/01.prs.0000245341.71666.97; Lee EW, 2010, GUT LIVER, V4, pS99, DOI 10.5009/gnl.2010.4.S1.S99; Lee EW, 2010, RADIOLOGY, V255, P426, DOI 10.1148/radiol.10090337; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Maor E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004757; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Onik G, 2010, SER BIOMED ENG, P235, DOI 10.1007/978-3-642-05420-4_10; Pech M, 2011, CARDIOVASC INTER RAD, V34, P132, DOI 10.1007/s00270-010-9964-1; Rafiuddin M, 2003, BRAIN RES, V993, P208, DOI 10.1016/j.brainres.2003.08.057; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Shafiee H, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3143027; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; Tekle E, 2008, BIOCHEM BIOPH RES CO, V376, P256, DOI 10.1016/j.bbrc.2008.08.060; Terzis JK, 2008, FACIAL PLAST SURG, V24, P177, DOI 10.1055/s-2008-1075833; Thomson K, 2010, SER BIOMED ENG, P249, DOI 10.1007/978-3-642-05420-4_11; Tsuchihara T, 2008, J BONE JOINT SURG BR, V90B, P1097, DOI 10.1302/0301-620X.90B8.20428	32	32	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2011	6	4							e18831	10.1371/journal.pone.0018831	http://dx.doi.org/10.1371/journal.pone.0018831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749XQ	21533143	Green Published, Green Submitted, gold			2022-12-25	WOS:000289505600034
J	Cossu, D; Cocco, E; Paccagnini, D; Masala, S; Ahmed, N; Frau, J; Marrosu, MG; Sechi, LA				Cossu, Davide; Cocco, Eleonora; Paccagnini, Daniela; Masala, Speranza; Ahmed, Niyaz; Frau, Jessica; Marrosu, Maria Giovanna; Sechi, Leonardo A.			Association of Mycobacterium avium subsp paratuberculosis with Multiple Sclerosis in Sardinian Patients	PLOS ONE			English	Article							CROHNS-DISEASE; T-CELLS; PATHOGENESIS; ACTIVATION; INFECTION; NRAMP1	Mycobacterium avium subsp. paratuberculosis (MAP) infection is highly spread in the ruminant herds of Sardinia, in the Western Mediterranean. The objective of this study was to investigate prevalence of MAP infection in association with Multiple Sclerosis (MS) using clinical specimen from patients and controls. We analyzed samples for the presence of MAP specific DNA and to demonstrate humoral response to a MAP protein (MAP2694), a predicted homologue of the T-cell receptor gamma-chain/complement component 1 of the host. We found presence of MAP DNA in 42% of the MS patients and an extremely significant humoral immune response revealed by the MS patients against the MAP protein. In our opinion, this is the first report that significantly associates MAP infection with MS. Further studies will be required to confirm if MAP could be one of the triggers of MS, according to the molecular mimicry theory, in susceptible (and genetically at risk) individuals.	[Cossu, Davide; Paccagnini, Daniela; Masala, Speranza; Sechi, Leonardo A.] Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy; [Cocco, Eleonora; Frau, Jessica; Marrosu, Maria Giovanna] Univ Cagliari, Dipartimento Sci Cardiovasc & Neurol, Ctr Sclerosi Multipla, Cagliari, Italy; [Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Ahmed, Niyaz] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia	University of Sassari; University of Cagliari; University of Hyderabad; Universiti Malaya	Cossu, D (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sez Microbiol & Virol, I-07100 Sassari, Italy.	sechila@uniss.it	Cossu, Davide/AAD-7958-2019; Cocco, Eleonora/G-5064-2012; Cossu, Davide/C-4452-2013; Frau, Jessica/AAC-1622-2019; Sechi, Leonardo Antonio/Y-3109-2018; Ahmed, Niyaz/D-2589-2010	Cossu, Davide/0000-0002-0557-9467; Cocco, Eleonora/0000-0002-3878-8820; Ahmed, Niyaz/0000-0001-6425-7583; Masala, Speranza/0000-0003-4943-9164; sechi, leonardo antonio/0000-0003-0566-2049; Marrosu, Maria Giovanna/0000-0003-2334-2081	FISM - Fondazione Italiana Sclerosi Multipla [Cod. 2009/R/25]; Sardinian Region, L.R.	FISM - Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Sardinian Region, L.R.	We thank the FISM - Fondazione Italiana Sclerosi Multipla - Cod. 2009/R/25 and the Sardinian Region, L.R. 7, progetti di ricerca di base 2008, for partially supporting this research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell JM, 1999, IMMUNOL LETT, V65, P73, DOI 10.1016/S0165-2478(98)00127-8; Blink SE, 2009, CURR MOL MED, V9, P15, DOI 10.2174/156652409787314516; Brink BP, 2005, J NEUROPATH EXP NEUR, V64, P147, DOI 10.1093/jnen/64.2.147; Dai YD, 2009, DIABETES, V58, P156, DOI 10.2337/db07-1608; DISABATINO A, 2010, INFLAMM BOWEL D 0902; Gandhi R, 2010, J NEUROIMMUNOL, V221, P7, DOI 10.1016/j.jneuroim.2009.10.015; Gazouli M, 2008, CAN J NEUROL SCI, V35, P491, DOI 10.1017/S0317167100009173; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Kobayashi Y, 1997, J NEUROIMMUNOL, V73, P169, DOI 10.1016/S0165-5728(96)00187-7; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Oldstone MBA, 2005, CURR TOP MICROBIOL, V296, P1; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rosu V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004386; Sechi LA, 2005, J CLIN MICROBIOL, V43, P5275, DOI 10.1128/JCM.43.10.5275-5277.2005; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Sechi LA, 2008, CLIN INFECT DIS, V46, P148, DOI 10.1086/524084; Sechi LA, 2006, WORLD J GASTROENTERO, V12, P7161, DOI 10.3748/wjg.v12.i44.7161; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008	19	65	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18482	10.1371/journal.pone.0018482	http://dx.doi.org/10.1371/journal.pone.0018482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533236	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800015
J	Ho, YL; Lin, C; Lin, YH; Lo, MT				Ho, Yi-Lwun; Lin, Chen; Lin, Yen-Hung; Lo, Men-Tzung			The Prognostic Value of Non-Linear Analysis of Heart Rate Variability in Patients with Congestive Heart Failure-A Pilot Study of Multiscale Entropy	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; RANDOMIZED TRIAL; BETA-BLOCKADE; DYNAMICS; DYSFUNCTION; CARVEDILOL; MORTALITY; COMMUNITY; THERAPY; DEATH	Aims: The influences of nonstationarity and nonlinearity on heart rate time series can be mathematically qualified or quantified by multiscale entropy (MSE). The aim of this study is to investigate the prognostic value of parameters derived from MSE in the patients with systolic heart failure. Methods and Results: Patients with systolic heart failure were enrolled in this study. One month after clinical condition being stable, 24-hour Holter electrocardiogram was recording. MSE as well as other standard parameters of heart rate variability (HRV) and detrended fluctuation analysis (DFA) were assessed. A total of 40 heart failure patients with a mea age of 56+/-16 years were enrolled and followed-up for 684+/-441 days. There were 25 patients receiving beta-blockers treatment. During follow-up period, 6 patients died or received urgent heart transplantation. The short-term exponent of DFA and the slope of MSE between scale 1 to 5 were significantly different between patients with or without b-blockers (p = 0.014 and p = 0.028). Only the area under the MSE curve for scale 6 to 20 (Area(6-20)) showed the strongest predictive power between survival (n = 34) and mortality (n = 6) groups among all the parameters. The value of Area(6-20) <= 21.2 served as a significant predictor of mortality or heart transplant (p = 0.0014). Conclusion: The area under the MSE curve for scale 6 to 20 is not relevant to beta-blockers and could further warrant independent risk stratification for the prognosis of CHF patients.	[Ho, Yi-Lwun] Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei, Taiwan; [Ho, Yi-Lwun; Lin, Yen-Hung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Ho, Yi-Lwun; Lin, Yen-Hung] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Chungli 32054, Taiwan; [Lin, Chen; Lo, Men-Tzung] Natl Cent Univ, Res Ctr Adapt Data Anal, Tao Yuan, Taiwan; [Lin, Chen] Natl Cent Univ, Inst Syst Biol & Bioinformat, Tao Yuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Central University; National Central University; National Central University	Ho, YL (corresponding author), Natl Taiwan Univ Hosp, Grad Inst Clin Med, Taipei, Taiwan.	mzlo@ncu.edu.tw	huang, yuting/T-4341-2019; Lin, Yen-Hung/AAQ-1242-2020	Lin, Yen-Hung/0000-0001-8153-1441; Lin, Chen/0000-0001-6261-8509; HO, YI-LWUN/0000-0002-8936-9570	NSC (Taiwan, ROC) [99-2627-B-008-003]; CGH [CNJRF-99CGH-NCU-A3, VGHUST100-G1-4-3]; NCU [CNJRF-99CGH-NCU-A3, VGHUST100-G1-4-3]; NSC [NSC 99-2911-I-008100]	NSC (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); CGH; NCU; NSC(Ministry of Science and Technology, Taiwan)	M-T Lo was supported by NSC (Taiwan, ROC), Grant No 99-2627-B-008-003, joint foundation of CGH and NCU, Grant No CNJRF-99CGH-NCU-A3, VGHUST100-G1-4-3 and NSC support for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 99-2911-I-008100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchman TG, 2002, NATURE, V420, P246, DOI 10.1038/nature01260; Camm AJ, 1996, CIRCULATION, V93, P1043; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Costa M, 2006, 2006 COMPUTERS CARDI, P101; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Fauchier L, 1999, J AM COLL CARDIOL, V33, P1203, DOI 10.1016/S0735-1097(99)00021-2; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Ho KKL, 1997, CIRCULATION, V96, P842; Jagric T, 2007, TRANSL RES, V149, P145, DOI 10.1016/j.trsl.2006.09.004; Kantz H., 2004, NONLINEAR TIME SERIE; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; Lin LY, 2001, J CARDIOVASC ELECTR, V12, P26, DOI 10.1046/j.1540-8167.2001.00026.x; Lo MT, 2009, ADV DATA SCI ADAPT, V1, P461, DOI 10.1142/S1793536909000199; Lo MT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061924; Lombardi F, 2000, CIRCULATION, V101, P8, DOI 10.1161/01.CIR.101.1.8; Makikallio TH, 1999, AM J CARDIOL, V83, P836, DOI 10.1016/S0002-9149(98)01076-5; Mortara A, 2000, J AM COLL CARDIOL, V36, P1612, DOI 10.1016/S0735-1097(00)00900-1; Peng CK, 2009, ADV DATA SCI ADAPT, V1, P61, DOI 10.1142/S1793536909000035; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perc M, 2005, EUR J PHYS, V26, P757, DOI 10.1088/0143-0807/26/5/008; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Pikkujamsa SM, 1999, CIRCULATION, V100, P393, DOI 10.1161/01.CIR.100.4.393; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sanderson JE, 1999, CLIN SCI, V96, P137, DOI 10.1042/CS19980149; Sanderson JE, 1999, J AM COLL CARDIOL, V34, P1522, DOI 10.1016/S0735-1097(99)00367-8; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; van Jaarsveld CHM, 2006, EUR J HEART FAIL, V8, P23, DOI 10.1016/j.ejheart.2005.04.012; VANOLI E, 1995, CIRCULATION, V91, P1918, DOI 10.1161/01.CIR.91.7.1918; Wang TJ, 2003, CIRCULATION, V108, P977, DOI 10.1161/01.CIR.0000085166.44904.79; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Yuan HK, 2011, ACTA NEUROL SCAND, V123, P187, DOI 10.1111/j.1600-0404.2010.01384.x	35	80	84	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18699	10.1371/journal.pone.0018699	http://dx.doi.org/10.1371/journal.pone.0018699			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533258	Green Published, gold, Green Submitted			2022-12-25	WOS:000289458800031
J	Milani, P; Marilley, M; Sanchez-Sevilla, A; Imbert, J; Vaillant, C; Argoul, F; Egly, JM; Rocca-Serra, J; Arneodo, A				Milani, Pascale; Marilley, Monique; Sanchez-Sevilla, Albert; Imbert, Jean; Vaillant, Cedric; Argoul, Francoise; Egly, Jean-Marc; Rocca-Serra, Jose; Arneodo, Alain			Mechanics of the IL2RA Gene Activation Revealed by Modeling and Atomic Force Microscopy	PLOS ONE			English	Article							RNA-POLYMERASE-II; STRUCTURAL-PROPERTIES; TATA BOX; DNA; NUCLEOSOME; PROMOTER; BINDING; TRANSCRIPTION; YEAST; AFM	Transcription implies recruitment of RNA polymerase II and transcription factors (TFs) by DNA melting near transcription start site (TSS). Combining atomic force microscopy and computer modeling, we investigate the structural and dynamical properties of the IL2RA promoter and identify an intrinsically negative supercoil in the PRRII region (containing Elf-1 and HMGA1 binding sites), located upstream of a curved DNA region encompassing TSS. Conformational changes, evidenced by time-lapse studies, result in the progressive positioning of curvature apex towards the TSS, likely facilitating local DNA melting. In vitro assays confirm specific binding of the General Transcription Factors (GTFs) TBP and TFIIB over TATA-TSS position, where an inhibitory nucleosome prevented preinitiation complex (PIC) formation and uncontrolled DNA melting. These findings represent a substantial advance showing, first, that the structural properties of the IL2RA promoter are encoded in the DNA sequence and second, that during the initiation process DNA conformation is dynamic and not static.	[Milani, Pascale; Marilley, Monique; Sanchez-Sevilla, Albert; Rocca-Serra, Jose] Fac Med, RGFCP EA 3290, Marseille, France; [Milani, Pascale; Marilley, Monique; Vaillant, Cedric; Argoul, Francoise; Arneodo, Alain] Univ Lyon, Lyon, France; [Milani, Pascale; Marilley, Monique; Vaillant, Cedric; Argoul, Francoise; Arneodo, Alain] Ecole Normale Super Lyon, CNRS, Lab Joliot Curie, F-69364 Lyon, France; [Milani, Pascale; Marilley, Monique; Vaillant, Cedric; Argoul, Francoise; Arneodo, Alain] Ecole Normale Super Lyon, Phys Lab, CNRS, F-69364 Lyon, France; [Imbert, Jean] TAGC, INSERM, U928, Marseille, France; [Marilley, Monique; Imbert, Jean; Rocca-Serra, Jose] Univ Mediterranee, Marseille, France; [Egly, Jean-Marc] Univ Strasbourg, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Milani, P (corresponding author), Fac Med, RGFCP EA 3290, Marseille, France.	alain.arneodo@ens-lyon.fr	Argoul, Francoise/F-5944-2016; Imbert, Jean/AAG-1165-2020; Imbert, Jean/G-3248-2013; Arneodo, Alain/I-4412-2017	Argoul, Francoise/0000-0001-9157-3565; Imbert, Jean/0000-0002-0478-9593; Imbert, Jean/0000-0002-0478-9593; Arneodo, Alain/0000-0002-3690-2108	Conseil Regional PACA; Conseil General des Bouches du Rhone; Conseil Regional Rhone-Alpes; Agence Nationale de la Recherche [ANR-06-PCVI-0026]; "Collectivite Territoriale de Corse"	Conseil Regional PACA(Region Provence-Alpes-Cote d'Azur); Conseil General des Bouches du Rhone(Region Provence-Alpes-Cote d'Azur); Conseil Regional Rhone-Alpes(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche(French National Research Agency (ANR)); "Collectivite Territoriale de Corse"(Region Corse)	This work was supported by the Conseil Regional PACA, the Conseil General des Bouches du Rhone, the Conseil Regional Rhone-Alpes (Emergence 2005) and the Agence Nationale de la Recherche under project DNAnucl (ANR-06-PCVI-0026). P. Milani was supported by the "Collectivite Territoriale de Corse". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton MC, 1997, P NATL ACAD SCI USA, V94, P7257, DOI 10.1073/pnas.94.14.7257; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; Bussiek M, 2005, J MOL BIOL, V345, P695, DOI 10.1016/j.jmb.2004.11.016; Bussiek M, 2007, EUR BIOPHYS J BIOPHY, V37, P81, DOI 10.1007/s00249-007-0166-y; Chevereau G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.188103; Choi CH, 2004, NUCLEIC ACIDS RES, V32, P1584, DOI 10.1093/nar/gkh335; Cognet JAH, 1999, J MOL BIOL, V285, P997, DOI 10.1006/jmbi.1998.2322; Conaway RC, 1997, PROG NUCLEIC ACID RE, V56, P327, DOI 10.1016/S0079-6603(08)61009-0; CROTHERS DM, 1990, J BIOL CHEM, V265, P7093; Gabrielian Andrei E., 1999, In Silico Biology, V1, P183; Goodrich JA, 1996, CELL, V84, P825, DOI 10.1016/S0092-8674(00)81061-2; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; JOHN S, 1995, MOL CELL BIOL, V15, P1786; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Leblanc BP, 2000, P NATL ACAD SCI USA, V97, P10745, DOI 10.1073/pnas.200365097; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; Marilley M, 1996, NUCLEIC ACIDS RES, V24, P2204, DOI 10.1093/nar/24.12.2204; Marilley M, 2000, MOL GEN GENET, V263, P854, DOI 10.1007/s004380000253; Marilley M, 2007, NUCLEIC ACIDS RES, V35, P6832, DOI 10.1093/nar/gkm733; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Mielke SP, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2038767; Milani P, 2007, BIOCHIMIE, V89, P528, DOI 10.1016/j.biochi.2006.12.004; Milani P, 2009, P NATL ACAD SCI USA, V106, P22257, DOI 10.1073/pnas.0909511106; Montel F, 2009, BIOPHYS J, V97, P544, DOI 10.1016/j.bpj.2009.04.042; Moukhtar J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178101; Moukhtar J, 2010, J PHYS CHEM B, V114, P5125, DOI 10.1021/jp911031y; NISSEN MS, 1995, J BIOL CHEM, V270, P4355, DOI 10.1074/jbc.270.9.4355; Pastre D, 2003, BIOPHYS J, V85, P2507, DOI 10.1016/S0006-3495(03)74673-6; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Pisano S, 2006, BIOPHYS CHEM, V124, P81, DOI 10.1016/j.bpc.2006.05.012; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; RAMSTEIN J, 1988, P NATL ACAD SCI USA, V85, P7231, DOI 10.1073/pnas.85.19.7231; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Sanchez-Sevilla A, 2002, ULTRAMICROSCOPY, V92, P151, DOI 10.1016/S0304-3991(02)00128-6; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Santoni MJ, 1998, BBA-GENE STRUCT EXPR, V1399, P117, DOI 10.1016/S0167-4781(98)00093-1; Schatz T, 1997, J BIOMOL STRUCT DYN, V15, P265, DOI 10.1080/07391102.1997.10508191; Scipioni A, 2002, CHEM BIOL, V9, P1315, DOI 10.1016/S1074-5521(02)00282-X; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Sheridan SD, 1998, J BIOL CHEM, V273, P21298, DOI 10.1074/jbc.273.33.21298; Shlyakhtenko LS, 2009, BIOCHEMISTRY-US, V48, P7842, DOI 10.1021/bi900977t; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/0968-0004(96)10046-3; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Vaillant C, 2010, GENOME RES, V20, P59, DOI 10.1101/gr.096644.109; Yodh JG, 2002, BIOCHEMISTRY-US, V41, P3565, DOI 10.1021/bi011612e; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zlatanova J, 1998, BIOPHYS J, V74, P2554, DOI 10.1016/S0006-3495(98)77963-9; Zuccheri G, 2001, P NATL ACAD SCI USA, V98, P3074, DOI 10.1073/pnas.051631198	57	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2011	6	4							e18811	10.1371/journal.pone.0018811	http://dx.doi.org/10.1371/journal.pone.0018811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749IP	21533205	Green Published, Green Submitted, gold			2022-12-25	WOS:000289458800048
J	Jakob, L; Metzler, G; Chen, KM; Garbe, C				Jakob, Lena; Metzler, Gisela; Chen, Ko-Ming; Garbe, Claus			Non-AIDS Associated Kaposi's Sarcoma: Clinical Features and Treatment Outcome	PLOS ONE			English	Article							IMMUNOSUPPRESSIVE THERAPY; GUIDELINES; SIROLIMUS; IMIQUIMOD	Background: Kaposi's sarcoma (KS) in HIV negative patients is rare and has to be distinguished from AIDS associated KS. Two groups are at risk to develop non-AIDS related KS: elderly men mainly of Mediterranean origin and persons with iatrogenic immunosuppression. Patients and Methods: In order to define risk-groups and major clinical features we retrospectively evaluated clinical data of all patients with non-AIDS associated KS presenting to the Department of Dermatology, University Hospital Tuebingen between 1987 and 2009. Data were extracted from the tumor registry of the Comprehensive Cancer Center Tuebingen and from patient records. Results: 20 patients with non-AIDS KS have been identified. The average age at KS onset was 66.6 years; the male-to-female-ratio was 3:1. Most of the patients were immigrants from Mediterranean or Eastern European countries (60%). 15 cases of classic KS versus 5 cases of iatrogenic KS were observed. In 95% of the cases, KS was limited to the skin, without mucosal, lymph node or visceral manifestation. KS lesions were in all cases multiple and mostly bilateral, the most common localization was the skin of the lower extremities. Tumor control was achieved in nearly all cases by the use of local or systemic therapy. No patient died from KS. Conclusions: Unlike KS in AIDS patients, non-AIDS associated KS is a rather localized process which rarely involves lymph nodes or organs. It is mostly seen in elderly males from Mediterranean or Eastern European countries and in most cases responsive on local or systemic therapeutic strategies.	[Jakob, Lena; Metzler, Gisela; Chen, Ko-Ming; Garbe, Claus] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Jakob, L (corresponding author), Univ Tubingen, Dept Dermatol, Tubingen, Germany.	claus.garbe@med.uni-tuebingen.de	Garbe, Claus/ABH-2128-2021	Garbe, Claus/0000-0001-8530-780X				Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Brambilla L, 2008, BRIT J DERMATOL, V158, P1339, DOI 10.1111/j.1365-2133.2008.08517.x; Chang Y, 1996, INFECT AGENT DIS, V5, P215; Dal Maso L, 2005, BRIT J CANCER, V92, P188, DOI 10.1038/sj.bjc.6602265; Di Lorenzo G, 2008, J INVEST DERMATOL, V128, P1578, DOI 10.1038/sj.jid.5701215; Ensoli B, 2001, EUR J CANCER, V37, P1251, DOI 10.1016/S0959-8049(01)00121-6; *FDA, 1998, KS DRUG GOES FDA, V12, P7; GEDDES M, 1994, BRIT J CANCER, V69, P333, DOI 10.1038/bjc.1994.60; Goh SGN, 2008, HISTOPATHOLOGY, V52, P661, DOI 10.1111/j.1365-2559.2007.02924.x; GRULICH AE, 1992, BRIT J CANCER, V66, P1135, DOI 10.1038/bjc.1992.423; Hong Angela, 2002, Pathology and Oncology Research, V8, P31; HOSHAW RA, 1980, ARCH DERMATOL, V116, P1280, DOI 10.1001/archderm.116.11.1280; Iscovich J, 2000, CANCER-AM CANCER SOC, V88, P500, DOI 10.1002/(SICI)1097-0142(20000201)88:3<500::AID-CNCR3>3.3.CO;2-0; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; KLEPP O, 1978, CANCER, V42, P2626, DOI 10.1002/1097-0142(197812)42:6<2626::AID-CNCR2820420618>3.0.CO;2-7; MONTAGNINO G, 1994, AM J NEPHROL, V14, P121, DOI 10.1159/000168700; PENN I, 1979, TRANSPLANTATION, V27, P8, DOI 10.1097/00007890-197901000-00003; RONCHESE F, 1953, Postgrad Med, V14, P101; Royle JS, 2010, INT J CANC; Schartz NEC, 2008, J AM ACAD DERMATOL, V58, P585, DOI 10.1016/j.jaad.2007.11.005; Schwartz RA, 2008, J AM ACAD DERMATOL, V59, P179, DOI 10.1016/j.jaad.2008.05.001; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Szajerka T, 2007, AIDS REV, V9, P230; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Trakatelli M, 2010, INT J IMMUNOPATH PH, V23, P387, DOI 10.1177/039463201002300201; Vogt T, 2008, J DTSCH DERMATOL GES, V6, pS21	27	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18397	10.1371/journal.pone.0018397	http://dx.doi.org/10.1371/journal.pone.0018397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533260	Green Submitted, gold, Green Published			2022-12-25	WOS:000289404700011
J	Rozic, G; Lupowitz, Z; Piontkewitz, Y; Zisapel, N				Rozic, Gabriela; Lupowitz, Zipora; Piontkewitz, Yael; Zisapel, Nava			Dynamic Changes in Neurexins' Alternative Splicing: Role of Rho-Associated Protein Kinases and Relevance to Memory Formation	PLOS ONE			English	Article							EXCITATORY SYNAPSE FORMATION; CA2+-DEPENDENT EXOCYTOSIS; MENTAL-RETARDATION; ALPHA-NEUREXINS; WORKING-MEMORY; INHIBITOR; ROCK; NEUROLIGINS; ACTIVATION; MECHANISMS	The three neurexins genes (NRXN1/2/3) encode polymorphic synaptic membrane proteins that are involved in cognitive functioning. Neurexins' selectivity of function is presumably conferred through differential use of 2 promoters and 5 alternative splicing sites (SS#1/2/3/4/5). In day-old rat brain neurons grown in culture, activation (depolarization) induces reversible, calcium dependent, repression of NRXN2 alpha SS#3 insert. The effects of depolarization on NRXN1/2/3 alpha splicing and biochemical pathways mediating them were further studied in these neurons. NRXN1/2/3 alpha splicing in the course of memory formation in vivo was also explored, using fear conditioning paradigm in rats in which the animals were trained to associate an aversive stimulus (electrical shock) with a neutral context (a tone), resulting in the expression of fear responses to the neutral context. In the cultured neurons depolarization induced, beside NRXN2a SS#3, repression of SS#3 and SS#4 exons in NRXN3 alpha but not NRXN1 alpha. The repressions were mediated by the calcium/protein kinase C/Rho-associated protein kinase (ROCK) pathway. Fear conditioning induced significant and transient repressions of the NRXN1/2/3 alpha SS#4 exons in the rat hippocampus. ROCK inhibition prior to training attenuated the behavioral fear response, the NRXN1/2/3 alpha splicing repressions and subsequent recovery and the levels of excitatory (PSD95) and inhibitory (gephyrin) synaptic proteins in the hippocampus. No such effects were observed in the prefrontal cortex. Significant correlations existed between the fear response and hippocampal NRXN3 alpha and NRXN2 alpha SS#4 inserts as well as PSD95 protein levels. Hippocampal NRXN1 alpha SS#4 insert and gephyrin levels did not correlate with the behavioral response but were negatively correlated with each other. These results show for the first time dynamic, experience related changes in NRXN1/2/3 alpha alternative splicing in the rat brain and a role for ROCK in them. Specific neurexins' transcripts may be involved in synaptic remodeling occurring at an intermediate (hours) time scale in the course of memory formation.	[Rozic, Gabriela; Lupowitz, Zipora; Zisapel, Nava] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Piontkewitz, Yael] Tel Aviv Univ, Dept Psychol, Fac Social Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Rozic, G (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	navazis@post.tau.ac.il	Zisapel, Nava/GRO-1677-2022		AMN Foundation; Israel Ministry of Health Chief Scientist Office	AMN Foundation; Israel Ministry of Health Chief Scientist Office	This project was supported by research grants from the AMN Foundation and Israel Ministry of Health Chief Scientist Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI M, 1993, BIOCHEM PHARMACOL, V46, P1487, DOI 10.1016/0006-2952(93)90116-E; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chhatwal JP, 2005, J NEUROSCI, V25, P502, DOI 10.1523/JNEUROSCI.3301-04.2005; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dash PK, 2004, BIOCHEM BIOPH RES CO, V322, P893, DOI 10.1016/j.bbrc.2004.08.004; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Viti S, 2010, BEHAV BRAIN RES, V212, P78, DOI 10.1016/j.bbr.2010.03.049; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Garelick MG, 2005, P NATL ACAD SCI USA, V102, P9091, DOI 10.1073/pnas.0504017102; Huentelman MJ, 2009, BEHAV NEUROSCI, V123, P218, DOI 10.1037/a0014260; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Komuro R, 1996, GENES CELLS, V1, P943, DOI 10.1046/j.1365-2443.1996.760276.x; KUBISTA M, 2007, LAB J, V9, P33; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Lamprecht R, 2002, NEURON, V36, P727, DOI 10.1016/S0896-6273(02)01047-4; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Pilpel Y, 2004, EUR J NEUROSCI, V19, P3151, DOI 10.1111/j.0953-816X.2004.03380.x; Ramakers GJA, 2000, AM J MED GENET, V94, P367, DOI 10.1002/1096-8628(20001023)94:5<367::AID-AJMG4>3.0.CO;2-I; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Ressler KJ, 2002, J NEUROSCI, V22, P7892; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Saitoh A, 2006, PSYCHOPHARMACOLOGY, V188, P1, DOI 10.1007/s00213-006-0466-4; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Takuwa Y, 2002, J BIOCHEM, V131, P767, DOI 10.1093/oxfordjournals.jbchem.a003163; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Utsunomiya T, 2001, BRIT J PHARMACOL, V134, P1724, DOI 10.1038/sj.bjp.0704410; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Welling A, 2005, MOL PHARMACOL, V67, P541, DOI 10.1124/mol.104.006049; Xie JY, 2008, BBA-GENE REGUL MECH, V1779, P438, DOI 10.1016/j.bbagrm.2008.01.003; Yada T, 2005, J AM COLL CARDIOL, V45, P599, DOI 10.1016/j.jacc.2004.10.053; Yamaguchi Y, 2000, J NEUROCHEM, V75, P708, DOI 10.1046/j.1471-4159.2000.0750708.x; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	48	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18579	10.1371/journal.pone.0018579	http://dx.doi.org/10.1371/journal.pone.0018579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533271	Green Published, Green Submitted, gold			2022-12-25	WOS:000289404700021
J	Schnabel, K; Wu, CC; Kurth, T; Weidinger, G				Schnabel, Kristin; Wu, Chi-Chung; Kurth, Thomas; Weidinger, Gilbert			Regeneration of Cryoinjury Induced Necrotic Heart Lesions in Zebrafish Is Associated with Epicardial Activation and Cardiomyocyte Proliferation	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; MYOCARDIUM; INJURY; MODEL	In mammals, myocardial cell death due to infarction results in scar formation and little regenerative response. In contrast, zebrafish have a high capacity to regenerate the heart after surgical resection of myocardial tissue. However, whether zebrafish can also regenerate lesions caused by cell death has not been tested. Here, we present a simple method for induction of necrotic lesions in the adult zebrafish heart based on cryoinjury. Despite widespread tissue death and loss of cardiomyocytes caused by these lesions, zebrafish display a robust regenerative response, which results in substantial clearing of the necrotic tissue and little scar formation. The cellular mechanisms underlying regeneration appear to be similar to those activated in response to ventricular resection. In particular, the epicardium activates a developmental gene program, proliferates and covers the lesion. Concomitantly, mature uninjured cardiomyocytes become proliferative and invade the lesion. Our injury model will be a useful tool to study the molecular mechanisms of natural heart regeneration in response to necrotic cell death.	[Schnabel, Kristin] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; Tech Univ Dresden, Ctr Regenerat Therapies, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Schnabel, K (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	gilbert.weidinger@biotec.tu-dresden.de	Weidinger, Gilbert/A-8342-2010	Weidinger, Gilbert/0000-0003-3599-6760; Kurth, Thomas/0000-0001-5624-1717; Wu, Chi-Chung/0000-0003-3903-2512	Deutsche Forschungsgemeinschaft (DFG) [SFB655]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grant "Collaborative Research Center 655: Cells into tissues: stem cell and progenitor commitment and interactions during tissue formation", SFB655 to G.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2010, J SURG RES, V162, P239, DOI 10.1016/j.jss.2009.06.021; Bakkers J, 2009, DEV BIOL, V330, P213, DOI 10.1016/j.ydbio.2009.04.011; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Dhesi P, 2010, HEART FAIL REV, V15, P15, DOI 10.1007/s10741-009-9137-y; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kurth T, 2010, METHOD CELL BIOL, V96, P395, DOI 10.1016/S0091-679X(10)96017-2; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laube F, 2006, J CELL SCI, V119, P4719, DOI 10.1242/jcs.03252; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tanaka EM, 2003, CURR OPIN GENET DEV, V13, P497, DOI 10.1016/j.gde.2003.08.003; Thisse C, 2002, SCIENCE, V295, P457, DOI 10.1126/science.1063654; van Amerongen MJ, 2008, CARDIOVASC PATHOL, V17, P23, DOI 10.1016/j.carpath.2007.03.002; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; Wu MF, 2010, DEV CELL, V19, P114, DOI 10.1016/j.devcel.2010.06.011	28	178	182	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18503	10.1371/journal.pone.0018503	http://dx.doi.org/10.1371/journal.pone.0018503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533269	Green Published, gold			2022-12-25	WOS:000289404700016
J	Singhal, A; Aliouat, EM; Herve, M; Mathys, V; Kiass, M; Creusy, C; Delaire, B; Tsenova, L; Fleurisse, L; Bertout, J; Camacho, L; Foo, D; Tay, HC; Siew, JY; Boukhouchi, W; Romano, M; Mathema, B; Dartois, V; Kaplan, G; Bifani, P				Singhal, Amit; Aliouat, El Moukhtar; Herve, Maxime; Mathys, Vanessa; Kiass, Mehdi; Creusy, Colette; Delaire, Baptiste; Tsenova, Liana; Fleurisse, Laurence; Bertout, Julie; Camacho, Luis; Foo, Damian; Tay, Hui Chien; Siew, Jie Yee; Boukhouchi, Warda; Romano, Marta; Mathema, Barun; Dartois, Veronique; Kaplan, Gilla; Bifani, Pablo			Experimental Tuberculosis in the Wistar Rat: A Model for Protective Immunity and Control of Infection	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; DISCOVERY; VIRULENCE; BACILLI; MICE	Background: Despite the availability of many animal models for tuberculosis (TB) research, there still exists a need for better understanding of the quiescent stage of disease observed in many humans. Here, we explored the use of the Wistar rat model for the study of protective immunity and control of Mycobacterium tuberculosis (Mtb) infection. Methodology/Principal Findings: The kinetics of bacillary growth, evaluated by the colony stimulating assay (CFU) and the extent of lung pathology in Mtb infected Wistar rats were dependent on the virulence of the strains and the size of the infecting inoculums. Bacillary growth control was associated with induction of T helper type 1 (Th1) activation, the magnitude of which was also Mtb strain and dose dependent. Histopathology analysis of the infected lungs demonstrated the formation of well organized granulomas comprising epithelioid cells, multinucleated giant cells and foamy macrophages surrounded by large numbers of lymphocytes. The late stage subclinical form of disease was reactivated by immunosuppression leading to increased lung CFU. Conclusion: The Wistar rat is a valuable model for better understanding host-pathogen interactions that result in control of Mtb infection and potentially establishment of latent TB. These properties together with the ease of manipulation, relatively low cost and well established use of rats in toxicology and pharmacokinetic analyses make the rat a good animal model for TB drug discovery.	[Singhal, Amit; Herve, Maxime; Camacho, Luis; Foo, Damian; Tay, Hui Chien; Siew, Jie Yee; Dartois, Veronique; Bifani, Pablo] Novartis Inst Trop Dis, Singapore, Singapore; [Aliouat, El Moukhtar] Univ Lille Nord France, Fac Biol & Pharmaceut Sci, Dept Parasitol Mycol, Lille, France; [Aliouat, El Moukhtar] Univ Lille Nord France, CNRS, INSERM,Pasteur Inst Lille,U1019, Ctr Infect & Immun Lille,UMR 8204, Lille, France; [Mathys, Vanessa; Kiass, Mehdi; Boukhouchi, Warda; Romano, Marta] Sci Inst Publ Hlth, Brussels, Belgium; [Creusy, Colette; Delaire, Baptiste; Fleurisse, Laurence] Univ Catholique Lille, St Vincent Hosp, GHICL, Lille, France; [Tsenova, Liana; Mathema, Barun; Kaplan, Gilla] Univ Med & Dent New Jersey, TB Ctr, PHRI, Newark, NJ 07103 USA	Novartis; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite Catholique de Lille; Rutgers State University New Brunswick; Rutgers State University Medical Center	Singhal, A (corresponding author), Singapore Immunol Network SIgN, Singapore, Singapore.	pablo.bifani@novartis.com	Aliouat, El Moukhtar/D-2859-2018; ROMANO, Marta/ABD-9517-2021	Aliouat, El Moukhtar/0000-0003-2905-7126; ROMANO, Marta/0000-0001-8996-7899; Bifani, Pablo/0000-0001-9651-6439; Singhal, Amit/0000-0003-3913-8798; Mathema, Barun/0000-0003-2772-479X	Novartis Institute for Tropical Diseases, Singapore; Les Amis de l'Institut Pasteur, Brussels; Bill and Melinda Gates Foundation (BMGF) [42758]	Novartis Institute for Tropical Diseases, Singapore; Les Amis de l'Institut Pasteur, Brussels; Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	This work was initiated at the Pasteur Institute, Lille-France (EMA and PB) and continued at Pasteur-Brussels, Belgium (now Scientific Institute of Public Health) and the Novartis Institute for Tropical Diseases, Singapore. The work at Pasteur-Brussels was supported in part by Novartis Institute for Tropical Diseases, Singapore and Les Amis de l'Institut Pasteur, Brussels. The work has been supported primarily by the Bill and Melinda Gates Foundation (BMGF) Accelerator Grant (#42758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; DANNENBERG AM, 1994, TUBERCULOSIS PATHOGE, P135; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; DVORAK AM, 1983, J IMMUNOL, V131, P2965; Elwood RL, 2009, TUBERCULOSIS, V89, P183, DOI 10.1016/j.tube.2009.01.003; FLAX MH, 1962, J IMMUNOL, V89, P496; FLYNN JL, 2003, TUBERCULOSIS, P237; FLYNN JL, 2008, HDB TUBERCULOSIS IMM; Gloyne SR, 1923, J PATHOL BACTERIOL, V26, P224, DOI 10.1002/path.1700260213; GRAY DF, 1961, J HYG-CAMBRIDGE, V59, P471, DOI 10.1017/S0022172400039164; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jimenez E, 2002, ANTIMICROB AGENTS CH, V46, P2648, DOI 10.1128/AAC.46.8.2648-2650.2002; LEFFORD MJ, 1973, INFECT IMMUN, V8, P182, DOI 10.1128/IAI.8.2.182-189.1973; LIN PL, 2009, INFECT IMMUN; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; McMurray David N., 1994, P135; Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307; Migliori GB, 2008, CAN J INFECT DIS MED, V19, P169, DOI 10.1155/2008/857901; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Orme IM, 2001, INT J TUBERC LUNG D, V5, P589; ORNSTEIN GG, 1925, AM REV TUBERC, V12, P77; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rothel James S, 2005, Expert Rev Anti Infect Ther, V3, P981, DOI 10.1586/14787210.3.6.981; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Singhal A, 2010, COLOR ATLAS COMP PAT, P157; Sugawara I, 2006, CELL MICROBIOL, V8, P661, DOI 10.1111/j.1462-5822.2005.00658.x; Sugawara I, 2004, TOHOKU J EXP MED, V204, P135, DOI 10.1620/tjem.204.135; Sugawara I, 2004, INT J EXP PATHOL, V85, P125, DOI 10.1111/j.0959-9673.2004.00379.x; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; WESSELS C. C., 1941, American Review of Tuberculosis and Pulmonary Diseases, V43, P459; Young DL, 2009, EUR J IMMUNOL, V39, P2011, DOI 10.1002/eji.200939542; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	36	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2011	6	4							e18632	10.1371/journal.pone.0018632	http://dx.doi.org/10.1371/journal.pone.0018632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	748QE	21533270	gold, Green Published			2022-12-25	WOS:000289404700023
J	Burl, S; Adetifa, UJ; Cox, M; Touray, E; Whittle, H; McShane, H; Rowland-Jones, SL; Flanagan, KL				Burl, Sarah; Adetifa, Uche J.; Cox, Momodou; Touray, Ebrima; Whittle, Hilton; McShane, Helen; Rowland-Jones, Sarah L.; Flanagan, Katie L.			The Tuberculin Skin Test (TST) Is Affected by Recent BCG Vaccination but Not by Exposure to Non-Tuberculosis Mycobacteria (NTM) during Early Life	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; IMMUNE-RESPONSES; T-CELLS; REACTIVITY; HYPERSENSITIVITY; INTERLEUKIN-10; DEPRESSION; ANERGY	The tuberculin skin test (TST) is widely used in TB clinics to aid Mycobacterium tuberculosis (M.tb) diagnosis, but the definition and the significance of a positive test in very young children is still unclear. This study compared the TST in Gambian children at 41/2 months of age who either received BCG vaccination at birth (Group 1) or were BCG naive (Group 2) in order to examine the role of BCG vaccination and/or exposure to environmental mycobacteria in TST reactivity at this age. Nearly half of the BCG vaccinated children had a positive TST (>= 5 mm) whereas all the BCG naive children were non-reactive, confirming that recent BCG vaccination affects TST reactivity. The BCG naive children demonstrated in vitro PPD responses in peripheral blood in the absence of TST reactivity, supporting exposure to and priming by environmental mycobacterial antigens. Group 2 were then vaccinated at 41/2 months of age and a repeat TST was performed at 20-28 months of age. Positive reactivity (>= 5 mm) was evident in 11.1% and 12.5% infants from Group 1 and Group 2 respectively suggesting that the timing of BCG vaccination had little effect by this age. We further assessed for immune correlates in peripheral blood at 41/2 months of age. Mycobacterial specific IFN gamma responses were greater in TST responders than in non-responders, although the size of induration did not correlate with IFN gamma. However the IFN gamma: IL-10 ratio positively correlated with TST induration suggesting that the relationship between PPD induced IFN gamma and IL-10 in the peripheral blood may be important in controlling TST reactivity. Collectively these data provide further insights into how the TST is regulated in early life, and how a positive response might be interpreted.	[Burl, Sarah; Adetifa, Uche J.; Cox, Momodou; Touray, Ebrima; Whittle, Hilton; Flanagan, Katie L.] Med Res Council UK Gambia, Fajara, Gambia; [McShane, Helen] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England; [Rowland-Jones, Sarah L.] Univ Oxford, WIMM, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; Jenner Institute; University of Oxford	Burl, S (corresponding author), Med Res Council UK Gambia, Fajara, Gambia.	sburl0712@gmail.com		Levy, Ofer/0000-0002-5859-1945; Flanagan, Katie/0000-0002-1575-1953; McShane, Helen/0000-0002-2126-5142	Medical Research Council (MRC), The Gambia; MRC [MC_UP_A900_1115, MC_UP_A900_1122, MC_U190081990] Funding Source: UKRI; Medical Research Council [MC_U190081990, MC_U190085854] Funding Source: researchfish	Medical Research Council (MRC), The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Medical Research Council (MRC), The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODY JA, 1964, NEW ENGL J MED, V271, P1294, DOI 10.1056/NEJM196412172712505; BURL S, 2010, J IMMUNOLOG IN PRESS; Cavani A, 2003, J IMMUNOL, V171, P5760, DOI 10.4049/jimmunol.171.11.5760; Chan PC, 2008, INT J TUBERC LUNG D, V12, P1401; CORRAH PT, 1994, THESIS OPEN U FAJARA; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FINNEY O, 2009, THESIS U LONDON LOND; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; Ildirim I, 1995, PEDIATR INFECT DIS J, V14, P1060, DOI 10.1097/00006454-199512000-00006; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Martins MVBS, 2007, TUBERCULOSIS, V87, P202, DOI 10.1016/j.tube.2006.07.006; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; MENZIES R, 1992, AM REV RESPIR DIS, V145, P621, DOI 10.1164/ajrccm/145.3.621; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; MiretCuadras P, 1996, TUBERCLE LUNG DIS, V77, P52, DOI 10.1016/S0962-8479(96)90076-3; Mitchell AG, 1935, AM J DIS CHILD, V49, P695, DOI 10.1001/archpedi.1935.01970030141012; Nadler R, 2003, CLIN EXP IMMUNOL, V131, P206, DOI 10.1046/j.1365-2249.2003.02071.x; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Okan F, 2006, INT J TUBERC LUNG D, V10, P1337; Ota MOC, 2006, J TROP PEDIATRICS, V52, P136, DOI 10.1093/tropej/fmi087; PESANTI EL, 1994, AM J RESP CRIT CARE, V149, P1699, DOI 10.1164/ajrccm.149.6.7710481; RODYSILL KJ, 1989, J AM GERIATR SOC, V37, P435, DOI 10.1111/j.1532-5415.1989.tb02640.x; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; SEPULVEDA RL, 1994, TUBERCLE LUNG DIS, V75, P138, DOI 10.1016/0962-8479(94)90043-4; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Sigmundsdottir H, 2004, CLIN IMMUNOL, V111, P119, DOI 10.1016/j.clim.2004.01.003; STARR S, 1964, PEDIATRICS, V33, P769; STARR S, 1964, NEW ENGL J MED, V270, P386, DOI 10.1056/NEJM196402202700802; Sterne JAC, 1996, TUBERCLE LUNG DIS, V77, P117, DOI 10.1016/S0962-8479(96)90025-8; *UNICEF, 2005, GLANC GAMB STAT; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0	34	109	112	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12287	10.1371/journal.pone.0012287	http://dx.doi.org/10.1371/journal.pone.0012287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	21533209	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500019
J	Lin, HY; Kao, CH; Lin, KMC; Kaartinen, V; Yang, LT				Lin, Hsien-Yi; Kao, Cheng-Heng; Lin, Kurt Ming-Chao; Kaartinen, Vesa; Yang, Liang-Tung			Notch Signaling Regulates Late-Stage Epidermal Differentiation and Maintains Postnatal Hair Cycle Homeostasis	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; EPITHELIAL STEM-CELLS; RBP-J; MULTIPLE ROLES; FOLLICLE BULGE; MOUSE MODEL; O-FUCOSE; SKIN; EXPRESSION; ACTIVATION	Background: Notch signaling involves ligand-receptor interactions through direct cell-cell contact. Multiple Notch receptors and ligands are expressed in the epidermis and hair follicles during embryonic development and the adult stage. Although Notch signaling plays an important role in regulating differentiation of the epidermis and hair follicles, it remains unclear how Notch signaling participates in late-stage epidermal differentiation and postnatal hair cycle homeostasis. Methodology and Principal Findings: We applied Cre/loxP system to generate conditional gene targeted mice that allow inactivation of critical components of Notch signaling pathway in the skin. Rbpj, the core component of all four Notch receptors, and Pofut1, an essential factor for ligand-receptor interactions, were inactivated in hair follicle lineages and suprabasal layer of the epidermis using the Tgfb3-Cre mouse line. Rbpj conditional inactivation resulted in granular parakeratosis and reactive epidermal hyperplasia. Pofut1 conditional inactivation led to ultrastructural abnormalities in the granular layer and altered filaggrin processing in the epidermis, suggesting a perturbation of the granular layer differentiation. Disruption of Pofut1 in hair follicle lineages resulted in aberrant telogen morphology, a decrease of bulge stem cell markers, and a concomitant increase of K14-positive keratinocytes in the isthmus of mutant hair follicles. Pofut1-deficent hair follicles displayed a delay in anagen re-entry and dysregulation of proliferation and apoptosis during the hair cycle transition. Moreover, increased DNA double stand breaks were detected in Pofut1-deficent hair follicles, and real time PCR analyses on bulge keratinocytes isolated by FACS revealed an induction of DNA damage response and a paucity of DNA repair machinery in mutant bulge keratinocytes. Significance: our data reveal a role for Notch signaling in regulating late-stage epidermal differentiation. Notch signaling is required for postnatal hair cycle homeostasis by maintaining proper proliferation and differentiation of hair follicle stem cells.	[Lin, Hsien-Yi; Yang, Liang-Tung] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli Cty, Taiwan; [Kao, Cheng-Heng] Chang Gung Univ, Ctr Gen Educ, Tao Yuan, Taiwan; [Lin, Kurt Ming-Chao] Natl Hlth Res Inst, Div Med Engn, Miaoli Cty, Taiwan; [Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	National Health Research Institutes - Taiwan; Chang Gung University; National Health Research Institutes - Taiwan; University of Michigan System; University of Michigan	Lin, HY (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli Cty, Taiwan.	ltyang@nhri.org.tw	Kaartinen, Vesa/AAU-5396-2021; Yang, Liang-Tung/B-2661-2010; Lin, Kurt Ming-Chao/E-3975-2010	doddapaneni, harshavardhan/0000-0002-2433-633X; Kaartinen, Vesa/0000-0002-9432-510X; Lin, Kurt/0000-0003-1371-5569	CIRM [T2-00005]; NHRI [97A1-SCPP07-014, 98A1-CSPP13-014, 99A1-CSPP10-014]; NSC [97-2321-B-400-003-MY3]; NIH [DE013085]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013085] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); NHRI(National Health Research Institutes - Taiwan); NSC(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the CIRM (T2-00005), NHRI (97A1-SCPP07-014, 98A1-CSPP13-014, 99A1-CSPP10-014), NSC (97-2321-B-400-003-MY3), and NIH (DE013085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beres TM, 2006, MOL CELL BIOL, V26, P117, DOI 10.1128/MCB.26.1.117-130.2006; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Demehri S, 2009, DEVELOPMENT, V136, P891, DOI 10.1242/dev.030700; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guilmeau S, 2008, GASTROENTEROLOGY, V135, P849, DOI 10.1053/j.gastro.2008.05.050; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hewett DR, 2005, HUM MOL GENET, V14, P335, DOI 10.1093/hmg/ddi030; HOGAN B, 1994, MANIPULATING MOUSE E, pR17; HU B, GENES DEV, V24, P1519; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; KAO CH, 1995, ATHEROSCLEROSIS, V116, P27, DOI 10.1016/0021-9150(95)05519-3; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Nichols AM, 2004, GENESIS, V40, P40, DOI 10.1002/gene.20061; Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nowak Jonathan A., 2009, V482, P215, DOI 10.1007/978-1-59745-060-7_14; OKA C, 1995, DEVELOPMENT, V121, P3291; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Paulson QX, 2008, ONCOGENE, V27, P4954, DOI 10.1038/onc.2008.138; Paulson QX, 2006, CELL CYCLE, V5, P184, DOI 10.4161/cc.5.2.2307; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; SCHMID P, 1993, J PATHOL, V171, P191, DOI 10.1002/path.1711710307; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Turksen K, 2002, DEVELOPMENT, V129, P1775; Uyttendaele H, 2004, DIFFERENTIATION, V72, P396, DOI 10.1111/j.1432-0436.2004.07208006.x; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Weibel E. R., 1973, STEREOLOGICAL TECHNI; Yang LT, 2008, GENESIS, V46, P112, DOI 10.1002/dvg.20372; Zheng JL, 2000, DEVELOPMENT, V127, P4551	63	97	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2011	6	1							e15842	10.1371/journal.pone.0015842	http://dx.doi.org/10.1371/journal.pone.0015842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710NW	21552483	Green Submitted, gold, Green Published			2022-12-25	WOS:000286519500028
J	Wang, CQF; Cruz-Inigo, AE; Fuentes-Duculan, J; Moussai, D; Gulati, N; Sullivan-Whalen, M; Gilleaudeau, P; Cohen, JA; Krueger, JG				Wang, Claire Q. F.; Cruz-Inigo, Andres E.; Fuentes-Duculan, Judilyn; Moussai, Dariush; Gulati, Nicholas; Sullivan-Whalen, Mary; Gilleaudeau, Patricia; Cohen, Jules A.; Krueger, James G.			Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions	PLOS ONE			English	Article							REGULATORY T-CELLS; ATOPIC-DERMATITIS; AUTOIMMUNE-DISEASE; PSORIASIS; MELANOMA; HELPER; INFLAMMASOME; EXPRESSION; PATHWAYS; DISTINCT	Background: Vitiligo is a common skin disorder, characterized by progressive skin de-pigmentation due to the loss of cutaneous melanocytes. The exact cause of melanocyte loss remains unclear, but a large number of observations have pointed to the important role of cellular immunity in vitiligo pathogenesis. Methodology/Principal Findings: In this study, we characterized T cell and inflammation-related dermal dendritic cell (DC) subsets in pigmented non-lesional, leading edge and depigmented lesional vitiligo skin. By immunohistochemistry staining, we observed enhanced populations of CD11c+ myeloid dermal DCs and CD207+ Langerhans cells in leading edge vitiligo biopsies. DC-LAMP+ and CD1c+ sub-populations of dermal DCs expanded significantly in leading edge and lesional vitiligo skin. We also detected elevated tissue mRNA levels of IL-17A in leading edge skin biopsies of vitiligo patients, as well as IL-17A positive T cells by immunohistochemistry and immunofluorescence. Langerhans cells with activated inflammasomes were also noted in lesional vitiligo skin, along with increased IL-1 beta mRNA, which suggest the potential of Langerhans cells to drive Th17 activation in vitiligo. Conclusions/Significance: These studies provided direct tissue evidence that implicates active Th17 cells in vitiligo skin lesions. We characterized new cellular immune elements, in the active margins of vitiligo lesions (e. g. populations of epidermal and dermal dendritic cells subsets), which could potentially drive the inflammatory responses.	[Wang, Claire Q. F.; Fuentes-Duculan, Judilyn; Gulati, Nicholas; Sullivan-Whalen, Mary; Gilleaudeau, Patricia; Cohen, Jules A.; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Cruz-Inigo, Andres E.; Moussai, Dariush] Weill Cornell Med Coll, New York, NY USA	Rockefeller University; Cornell University	Wang, CQF (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	jgk@rockefeller.edu	Neyrolles, Olivier/AAG-3692-2019; Wang, Claire/K-8793-2012	Neyrolles, Olivier/0000-0003-0047-5885; wang, chuan/0000-0001-6104-6342	Clinical and Translational Science Award [UL1RR024143]; National Institutes of Health (NIH) [GM07739]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Clinical and Translational Science Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Milstein Medical Program provided the major support for this study. Research was also supported by a Clinical and Translational Science Award grant UL1RR024143. Nicholas Gulati was supported by National Institutes of Health (NIH) MSTP grant GM07739. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Basak PY, 2009, J AM ACAD DERMATOL, V60, P256, DOI 10.1016/j.jaad.2008.09.048; Becker JC, 1999, J INVEST DERMATOL, V113, P1033, DOI 10.1046/j.1523-1747.1999.00805.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Chamian F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-27; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fujita H, 2009, P NATL ACAD IN PRESS; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Guttman-Yassky E, 2007, J ALLERGY CLIN IMMUN, V119, P1210, DOI 10.1016/j.jaci.2007.03.006; Haider AS, 2008, J IMMUNOL, V180, P1913, DOI 10.4049/jimmunol.180.3.1913; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Jacobs JFM, 2009, CANCER IMMUNOL IMMUN, V58, P145, DOI 10.1007/s00262-008-0506-5; Jariwala SP, 2007, ARCH DERMATOL RES, V299, P359, DOI 10.1007/s00403-007-0775-4; Jarrett P, 1999, BRIT J DERMATOL, V141, P361; Jin Y, 2009, J INVEST DERMATOL; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Lambe T, 2006, J IMMUNOL, V177, P3055, DOI 10.4049/jimmunol.177.5.3055; Le Poole IC, 2004, J INVEST DERM SYMP P, V9, P68, DOI 10.1111/j.1087-0024.2004.00825.x; LePoole IC, 1996, AM J PATHOL, V148, P1219; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Mantovani S, 2003, J INVEST DERMATOL, V121, P308, DOI 10.1046/j.1523-1747.2003.12368.x; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Orosz Z, 1999, HISTOPATHOLOGY, V34, P517, DOI 10.1111/j.1365-2559.1999.00679.x; Oyarbide-Valencia K, 2006, AUTOIMMUN REV, V5, P486, DOI 10.1016/j.autrev.2006.03.012; Peck A, 2009, CLIN IMMUNOL, V132, P295, DOI 10.1016/j.clim.2009.03.522; Petrilli V, 2005, CURR BIOL, V15, pR581, DOI 10.1016/j.cub.2005.07.049; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Skurkovich B, 2006, E SCHERING RES FDN W, V56, P1; Steitz J, 2004, EUR J CELL BIOL, V83, P797, DOI 10.1078/0171-9335-00423; Steitz J, 2005, J INVEST DERMATOL, V124, P144, DOI 10.1111/j.0022-202X.2004.23538.x; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Sugita K, 2006, CLIN EXP DERMATOL, V31, P80, DOI 10.1111/j.1365-2230.2005.01987.x; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; van den Boorn JG, 2009, J INVEST DERMATOL; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Waterman EA, 2009, J INVEST DE IN PRESS; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yee C, 2000, J EXP MED, V192, P1637, DOI 10.1084/jem.192.11.1637; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2007, J CLIN INVEST, V117, P2517, DOI 10.1172/JCI32282; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194	57	237	267	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2011	6	4							e18907	10.1371/journal.pone.0018907	http://dx.doi.org/10.1371/journal.pone.0018907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756MU	22003408	Green Published, gold, Green Submitted			2022-12-25	WOS:000290016800026
J	Wang, C; Yang, SY; Sun, G; Tang, XY; Lu, SH; Neyrolles, O; Gao, Q				Wang, Chuan; Yang, Shunyao; Sun, Gang; Tang, Xuying; Lu, Shuihua; Neyrolles, Olivier; Gao, Qian			Comparative miRNA Expression Profiles in Individuals with Latent and Active Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MICRORNA EXPRESSION; GENE-EXPRESSION; ARCHITECTURE; REGULATORS; SIGNATURE; INFECTION; SYSTEM	The mechanism of latent tuberculosis (TB) infection remains elusive. Several host factors that are involved in this complex process were previously identified. Micro RNAs (miRNAs) are endogenous similar to 22 nt RNAs that play important regulatory roles in a wide range of biological processes. Several studies demonstrated the clinical usefulness of miRNAs as diagnostic or prognostic biomarkers in various malignancies and in a few nonmalignant diseases. To study the role of miRNAs in the transition from latent to active TB and to discover candidate biomarkers of this transition, we used human miRNA microarrays to probe the transcriptome of peripheral blood mononuclear cells (PBMCs) in patients with active TB, latent TB infection (LTBI), and healthy controls. Using the software package BRB Array Tools for data analyses, 17 miRNAs were differentially expressed between the three groups (P<0.01). Hierarchical clustering of the 17 miRNAs expression profiles showed that individuals with active TB clustered independently of individuals with LTBI or from healthy controls. Using the predicted target genes and previously published genome-wide transcriptional profiles, we constructed the regulatory networks of miRNAs that were differentially expressed between active TB and LTBI. The regulatory network revealed that several miRNAs, with previously established functions in hematopoietic cell differentiation and their target genes may be involved in the transition from latent to active TB. These results increase the understanding of the molecular basis of LTBI and confirm that some miRNAs may control gene expression of pathways that are important for the pathogenesis of this infectious disease.	[Wang, Chuan; Yang, Shunyao; Sun, Gang; Gao, Qian] Fudan Univ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Wang, Chuan; Yang, Shunyao; Sun, Gang; Gao, Qian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Tang, Xuying; Lu, Shuihua] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Resp Branch, Shanghai 200433, Peoples R China; [Neyrolles, Olivier] Univ Toulouse, Toulouse, France; [Neyrolles, Olivier] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France	Fudan University; Fudan University; Fudan University; Universite de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Wang, C (corresponding author), Fudan Univ, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	qgao99@yahoo.com	Neyrolles, Olivier/AAG-3692-2019; Wang, Claire/K-8793-2012	Neyrolles, Olivier/0000-0003-0047-5885; wang, chuan/0000-0001-6104-6342	Bill & Melinda Gates Foundation [ID: 52226]; Key Project of the Chinese National Program [2012ZX10003-004]; European Community [TB-VIR, 200973]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Key Project of the Chinese National Program; European Community(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Bill & Melinda Gates Foundation Grand Challenges Explorations, Phase I (ID: 52226), Key Project of the Chinese National Program (2012ZX10003-004) and European Community (FP7 project TB-VIR, 200973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SG, 2010, APOPTOSIS, V15, P541, DOI 10.1007/s10495-010-0456-1; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Joung JG, 2007, BIOINFORMATICS, V23, P1141, DOI 10.1093/bioinformatics/btm045; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; SELWYN PA, 1993, NEW ENGL J MED, V328, P671; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; World Health Organization, 2009, WHO REP 2009; Zhang JL, 2005, MICROBIOL IMMUNOL, V49, P845, DOI 10.1111/j.1348-0421.2005.tb03673.x; Zhao YD, 2008, CANCER INFORM, V6, P9	40	237	267	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e25832	10.1371/journal.pone.0025832	http://dx.doi.org/10.1371/journal.pone.0025832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22003408	gold, Green Published, Green Submitted			2022-12-25	WOS:000295970300029
